<SEC-DOCUMENT>0001628279-21-000163.txt : 20210422
<SEC-HEADER>0001628279-21-000163.hdr.sgml : 20210422
<ACCEPTANCE-DATETIME>20210312190839
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001628279-21-000163
CONFORMED SUBMISSION TYPE:	DRS
PUBLIC DOCUMENT COUNT:		42
FILED AS OF DATE:		20210315
<PUBLIC-REL-DATE>20210422
DATE AS OF CHANGE:		20210312

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MOLECULAR PARTNERS AG
		CENTRAL INDEX KEY:			0001745114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-04414
		FILM NUMBER:		21739319

	BUSINESS ADDRESS:	
		STREET 1:		WAGISTRASSE 14
		CITY:			Z?RICH-SCHLIEREN
		STATE:			V8
		ZIP:			8952
		BUSINESS PHONE:		41 44 755 77 00

	MAIL ADDRESS:	
		STREET 1:		WAGISTRASSE 14
		CITY:			Z?RICH-SCHLIEREN
		STATE:			V8
		ZIP:			8952
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iae433ad4a4734c849aad6029347be986_1"></div><div style="min-height:18pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As confidentially submitted to the U.S. Securities and Exchange Commission on March 12, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration No. 333- </font></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM F-1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SECURITIES ACT OF 1933</font></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">MOLECULAR PARTNERS AG</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter) </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Switzerland</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2836</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Not applicable</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction of<br>incorporation or organization)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Primary Standard Industrial<br>Classification Code Number)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer<br>Identification Number)</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Wagistrasse 14</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">8952 Z&#252;rich-Schlieren</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Switzerland</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Telephone&#58; +41 44 755 77 00</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices) </font></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Molecular Partners Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">245 Main Street</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cambridge, Massachusetts 02142</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(781) 420 2361</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, address, including zip code, and telephone number, including area code, of agent for service) </font></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Copies to&#58;&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Divakar Gupta<br>Ryan Sansom<br>Brandon Fenn<br>Cooley LLP<br>55 Hudson Yards<br>New York, New York 10001<br>Telephone&#58; (212) 479-6000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dieter Gericke<br>Lorenzo Togni<br>Homburger AG<br>Prime Tower<br>Hardstrasse 201<br>CH-8005 Zurich<br>Switzerland<br>Telephone&#58; +41 43 222 16 59</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deanna Kirkpatrick<br>Yasin Keshvargar<br>Davis Polk &#38; Wardwell LLP<br>450 Lexington Avenue<br>New York, NY 10017<br>(212) 450-4000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Thomas Reutter<br>Advestra AG<br>Uraniastrasse 9<br>CH-8001<br>Zurich, Switzerland<br>Telephone&#58; + 41 58 510 92 00</font></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approximate date of commencement of proposed sale to the public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; As soon as practicable after this Registration Statement becomes effective. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box. &#9744;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933. Emerging growth company </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CALCULATION OF REGISTRATION FEE</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.869%"><tr><td style="width:1.0%"></td><td style="width:20.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TITLE OF EACH CLASS OF<br>SECURITIES TO BE REGISTERED</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PROPOSED <br>MAXIMUM AGGREGATE<br>OFFERING PRICE(1)</font></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AMOUNT OF<br>REGISTRATION FEE(2)</font></td></tr><tr><td colspan="9" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common Shares, CHF 0.10 nominal value per share(3)</font></td><td colspan="3" style="border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</font></td><td colspan="3" style="border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">____________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes the aggregate offering price of additional common shares represented by American Depositary Shares, or ADSs, which the underwriters have the option to purchase to cover over-allotments, if any. See &#8220;Underwriting.&#8221;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, based on an estimate of the proposed maximum aggregate offering price.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;All common shares will be in the form of ADSs, with each ADS representing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares of the registrant.  ADSs issuable upon deposit of the common shares registered hereby have been registered pursuant to a separate registration statement on Form F-6.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.041%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_4"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#a6555f;font-family:'Helvetica Condensed',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The information contained in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.  </font></div><div style="margin-bottom:8pt"><font style="color:#a6555f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBJECT TO COMPLETION, DATED &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021.  </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRELIMINARY PROSPECTUS </font></div><div style="margin-bottom:8pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; American Depositary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Representing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Common Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-align:center"><img alt="image221.jpg" src="image221.jpg" style="height:70px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per American Depositary Share</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This is the initial public offering of our American Depositary Shares, or ADSs.  We are selling&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares in the form of ADSs in the United States. Each ADS represents the right to receive&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares and the ADSs may be evidenced by American Depositary Receipts, or ADRs. We intend to apply to list our ADSs on the Nasdaq Global Market, under the symbol &#8220;MOLN&#8221;. </font></div><div style="margin-bottom:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares are listed on the SIX Swiss Exchange Ltd, or the SIX Swiss Exchange, under the symbol &#8220;MOLN&#8221;. On &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, the last reported sale price of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares on the SIX Swiss Exchange was&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> share, equivalent to a price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per ADS, assuming an exchange rate of&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per U.S. dollar. </font></div><div style="margin-bottom:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The offering price per </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> share will be determined by reference to the prevailing market prices of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares on the SIX Swiss Exchange after taking into account market conditions and other factors, but will not be lower than a price that is &#160;&#160;&#160;&#160;% below the volume-weighted average price of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares on the SIX Swiss Exchange for the &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are an &#8220;emerging growth company&#8221; as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced public company reporting requirements. Investing in our ADSs involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 14 of this prospectus.  </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Neither the United States Securities and Exchange Commission nor any U.S. state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.848%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Per Common Share</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Per ADS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Offering price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;CHF</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Underwriting discounts and commissions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;CHF</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proceeds to us, before expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;CHF</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We refer you to &#8220;Underwriting&#8221; beginning on page 226 of this prospectus for additional information regarding underwriting compensation in the offering. </font></div><div style="margin-bottom:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have agreed to issue, at the option of the underwriters, within 30 days from the date of the underwriting agreement, up to an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; additional ADSs in the offering to be sold to the several underwriters at the applicable offering price. If the underwriters exercise this option in full, the total underwriting commissions payable by us will be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and the total proceeds to us, before expenses, will be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The underwriters expect to deliver the ADSs to purchasers in the offering on or about</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021 through the book-entry facilities of The Depository Trust Company, or DTC.  </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:33.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joint Book-Running Managers</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">J.P. Morgan</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">SVB Leerink</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Cowen</font></div></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prospectus dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021.  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prospectus Summary</a></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Special Note Regarding Forward-Looking Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">79</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Market, Industry and Other Data</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trademarks and Service Marks</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_28" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Proceeds</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_37" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Policy</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capitalization</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">87</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_46" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dilution</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_46" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selected Financial Data</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_52" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_52" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">92</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">106</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_82" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Management</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_82" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">160</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Executive Compensation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">167</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Related Party Transactions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">172</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_91" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Principal Shareholders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_91" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">174</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Description of Share Capital and Articles of Association</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">177</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_97" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations Affecting Shareholders of a Swiss Company</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_97" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">191</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_100" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Comparison of Shareholder Rights</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_100" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">193</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_103" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Description of American Depository Shares</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_103" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">206</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Shares and ADSs Eligible for Future Sale</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">216</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Material United States Federal Income Tax Considerations for U.S. Holders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">218</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Swiss Tax Implications for U.S. Holders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">223</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Underwriting</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">226</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">233</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Experts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">234</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_124" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enforcement of Civil Liabilities</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_124" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">235</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expenses Related to this Offering</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">237</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_130" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Where You Can Find More Information</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_130" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">238</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Index to Financial Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_133" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1</a></font></div></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are responsible for the information contained in this prospectus and in any free writing prospectus we prepare or authorize. We have not, and the underwriters have not, authorized anyone to provide you with different information, and we and the underwriters take no responsibility for any other information others may give you. We are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than its date.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For investors outside the United States&#58; neither we nor any of the underwriters have done anything that would permit the offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the ADSs and the distribution of this prospectus outside the United States.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our jurisdiction of incorporation is Switzerland and our registered office is in Schlieren, Canton of Zurich, Switzerland. A majority of our outstanding securities are owned by non-U.S. residents. Under the rules of the U.S. Securities and Exchange Commission, or the SEC, we are currently eligible for treatment as a foreign private issuer. As a foreign private issuer, we will not be required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. domestic issuers whose securities are registered under the Securities Exchange Act of 1934, as amended, referred to herein as the Exchange Act.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this prospectus, unless otherwise specified, all monetary amounts are in Swiss francs, all references to &#8220;CHF&#8221; and &#8220;Swiss francs&#8221; mean Swiss francs and all references to &#8220;U.S. dollars,&#8221; &#8220;$,&#8221; &#8220;US$&#8221; and &#8220;USD&#8221; mean United States dollars. Throughout this prospectus, references to ADSs mean ADSs or common shares represented by such ADSs, as the case may be.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">PROSPECTUS SUMMARY</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights information contained elsewhere in this prospectus. Because it is only a summary, it does not contain all of the information that you should consider before investing in our American Depositary Shares, or ADSs, and it is qualified in its entirety by, and should be read with, the more detailed information appearing elsewhere in this prospectus. You should read the entire prospectus and the registration statement of which this prospectus is a part carefully and in their entirety, including the information discussed under &#8220;Risk Factors,&#8221; &#8220;Business,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the related notes included elsewhere in this prospectus, before deciding to buy our ADSs. Unless the context requires otherwise, references in this prospectus to the &#8220;Company,&#8221; &#8220;Molecular Partners&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Molecular Partners AG and its wholly-owned subsidiary. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage biopharmaceutical company applying our pioneering DARPin&#174; product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology. Our DARPin platform, which is designed using ankyrin repeat proteins, allows us to build product candidates with multiple mechanisms of action to address complex biological problems, while potentially offering patients products with higher efficacy and fewer adverse events. We believe that DARPins represent a novel class of drugs with broad therapeutic applications that may overcome many of the limitations of conventional protein and antibody-based therapeutics. Our DARPin product candidates have been extensively tested in preclinical studies and clinical trials, including in approximately 2,000 patients in ophthalmology, infectious disease (SARS-CoV-2) and oncology, and have been observed to be highly active, present differentiated product profiles and be generally well-tolerated.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our DARPin Platform</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DARPin proteins are designed using natural repeat proteins, a class of binder proteins that are common in humans and most other species. Since our formation, we have gone on to develop and upgrade our DARPin libraries to include over a trillion DARPin modules, which we refer to as single-domain DARPins. Selected single-domain DARPins then serve as building blocks to create our multi-specific DARPin product candidates, which are able to engage multiple targets. Beyond the benefit of multi-specificity, DARPin constructs can be intelligently designed to be active only under certain conditions, including via slow activation mechanisms, or activation at site-specific tumor microenvironments.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting with a target patient or disease, we can rapidly generate thousands of different DARPin product candidates to interrogate a specific biological target, or targets, to address an underlying medical need. We are able to perform target-specific screenings not only with our single-domain DARPins, but also with numerous multi-specific DARPin candidates constructed from these single-domain DARPins, allowing us to screen for the ideal properties within potential multi-specific product candidates. As a result, we believe that we can combine multiple promising biological solutions in one product candidate, as in the case of MP0423, a product candidate from our infectious disease program that is designed to neutralize the spike protein of SARS-CoV-2 using up to three distinct mechanisms. Further, we believe our DARPin platform allows us to identify novel mechanisms of action, as in the case of AMG 506 (MP0310) and MP0317, the lead product candidates from our oncology program, which will only activate immune stimulating targets when clustered on fibroblast activation protein, or FAP, a tumor specific localizer.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a therapeutic class, DARPin proteins demonstrate advantageous development properties including stability, solubility and manufacturing yield-to-cost benefits. In our preclinical studies and clinical trials, we have observed that our DARPin product candidates perform as designed and are well tolerated. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our in-house DARPin programs are initially focused on infectious diseases, where we have seen positive progress on our first COVID-19 antiviral therapeutic product candidates in partnership with Novartis, and our oncology program, where we see great potential in the utility and flexibility of DARPin molecules to offer differentiated cancer treatments. Given the momentum of our COVID-19 antiviral therapeutic product candidates and the severity </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the ongoing COVID-19 pandemic, we are also expanding our research and development activities in our infectious disease program to tackle other current and future viral threats. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Pipeline</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key information about our partnered and proprietary product candidates and research&#58; </font></div><div style="text-align:center"><img alt="prospectusum1a1a.jpg" src="prospectusum1a1a.jpg" style="height:326px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our DARPin molecules have distinct features to elicit specific therapeutic actions for a particular target, each DARPin therapeutic modality can be utilized across multiple programs. We believe the key advantages of our DARPin platform include the&#58; (i) ability of our DARPin product candidates to target multiple escape pathways in parallel&#59; (ii) capacity to find and address new biology on known targets by using our DARPin approach&#59; (iii) flexible architecture of our DARPin product candidates enabling them to engage and locally activate immune cells&#59; (iv) ability of the pharmacokinetic profile for each of our DARPin product candidates to be tailored depending on the relevant therapeutic application targeted&#59; and (v) established and efficient process and ease of storage of our DARPin product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pipeline programs benefit from the learnings of earlier discoveries, such as the use of FAP as a localized activator for both AMG 506 (MP0310) and MP0317, escape prevention for our legacy product candidate MP0250, our new tetra-specific AML program, our COVID-19 therapeutic antiviral product candidates, and molecular handcuffing which is shared between our legacy product candidate MP0274 and our COVID-19 antiviral product </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">candidate MP0423. As we continue to unlock new therapeutic modalities, each insight from earlier discoveries will be leveraged and applied across new product candidates wherever appropriate. </font></div><div style="text-align:center"><img alt="prospectussum2a1a.jpg" src="prospectussum2a1a.jpg" style="height:260px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Once we develop a DARPin modality for one program, we can utilize it for some or all of the programs that follow. This figure depicts our various therapeutic modalities across our pipeline programs. Blue shading reflects the stage of development of each program.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Infectious Disease Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the emergence of the COVID-19 pandemic, starting in early 2020, it was apparent that all efforts must be made to explore how DARPins can assist in an emerging crisis. The straightforward development path of DARPin antiviral product candidates, enabled by their multi-specific binding mechanism of action, or MOA, allowed us to rapidly move from concept to clinic. To date we have developed two tri-specific COVID-19 antiviral therapeutic product candidates, MP0420, which we refer to as ensovibep, and MP0423. Both are designed to have strong binding and neutralizing potencies targeting multiple epitopes on the SARS-CoV-2 spike protein that are crucial for infection. The lead product candidate in our infectious disease program, ensovibep, in which we expect to commence a Phase 2&#47;3 clinical trial in           , with interim data expected in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and full data expected in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, has demonstrated a favorable tolerability profile in its Phase 1 trial of 16 healthy volunteers since commencement in 2020. Furthermore, we have partnered with Novartis to develop, manufacture and commercialize ensovibep and MP0423, which we believe will allow us to more rapidly develop this product candidate as a therapeutic for the treatment of COVID-19. Our clinical development strategy aims to achieve potential emergency use authorization in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differentiated multi-specific binding approach of product candidates in our infectious disease program offers potentially broader efficacy &#8211; across both therapeutic and prophylactic settings &#8211; and reduces the potential for the development of viral drug resistance. Preclinical potency data suggests that our COVID-19 antiviral therapeutic product candidates may be administrable as a subcutaneous injection, which could represent a significant advantage for ease of delivery.</font></div><div style="text-align:center"><img alt="prospectussum3a1a.jpg" src="prospectussum3a1a.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ensovibep is constructed from three RBD binding DARPin domains and two HSA binding half-life extension DARPin domains.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the potential of DARPins in treating SARS-CoV-2 through a viral neutralization mechanism, we have been exploring a number of potential infectious diseases which can be treated through multi-specific targeting. This evaluation includes additional work on pandemic threats, tropical diseases, and respiratory viruses such as Respiratory Syncytial Virus, or RSV.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Oncology Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing DARPin product candidates in our oncology program to treat diseases with high unmet medical need. To date, our oncology product development efforts have focused on known biological targets while the multi-specificity afforded by our DARPin technology has allowed us to unlock previously difficult-to-address tumor biology and expand the range of addressable tumor biology compared to current standard of care therapies. Our first product candidates were constructed to be activated only within a tumor or its supporting tissue, thereby avoiding systemic activation and minimizing adverse events. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing AMG 506 (MP0310), the lead product candidate in our oncology program and which is partnered with Amgen, as a tumor-localized, 4-1BB immune-cell activator for the potential treatment of FAP-positive cancers, which include multiple solid tumors To avoid potential toxicity concerns, and allow for potentially therapeutically meaningful activation of 4-1BB, we engineered AMG 506 (MP0310) to activate 4-1BB only when bound to FAP. FAP is found in the tumor stroma in high density, and its binding can create a local cluster effect. In our Phase 1 clinical trial, we observed that AMG 506 (MP0310) demonstrated the ability to generate localized immune cell activation with no systemic toxicity in interim data. The dose escalation stage of the Phase 1 clinical trial was initiated in late 2019 and we are currently conducting dosing regimen adaptations to identify the dosing regimen for sustained 4-1BB activation. We believe AMG 506 (MP0310) should be particularly relevant as a combination agent with potential combination studies in collaboration with Amgen currently expected to commence in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MP0317, the second product candidate in our oncology program, is designed to bind CD40 and FAP. CD40 is an immune agonist that has demonstrated the ability to exert anti-tumor activity, but its utility as a target has been somewhat limited in the clinic due to concerns regarding potential severe adverse events. We have designed MP0317 to increase localized activation of CD40 in the tumor microenvironment and as activation should only occur when both FAP and CD40 are simultaneously engaged, we believe MP0317 will trigger only tumor localized activity with minimal systemic side effects. We expect to enter the clinic with MP0317 in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our CD3 T-Cell Engager Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic evolution, we are focusing our efforts on creating DARPin product candidates that convey single-agent activity and do not require combination with additional compounds to show efficacy. Executing on this strategy over the last three years, we have developed CD3 T-cell engager, or TCE, therapeutic modalities that integrate the CD3-targeting approach to T-cell engagement into a multi-DARPin format that addresses the key challenges of CD3 targeting. We are initially focused on targeting AML and other liquid tumors, which we intend to present at the American Academy for Cancer Research, or AACR, annual meeting. </font></div><div style="text-align:center"><img alt="prospectussum4a1a.jpg" src="prospectussum4a1a.jpg" style="height:209px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We can control the activation of our multi-specific T cell to be restricted to a specific location and&#47;or activated slowly to avoid adverse events related to misdirected or overly strong activity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of tumor localization DARPin domains in addition to a CD3-binding DARPin domain has allowed the design of candidates with better tumor specificity, and consequently reduced &#8216;off-tumor&#8217; effects, potentially enabling the administration of higher dose levels and achieving better efficacy. In preclinical tests against AML cells, DARPin CD3&#47;TCE product candidates delivered highly potent and specific activity and the potential for a reduced systemic immune response.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to further expand the ability of our oncology program with DARPin product candidates that ensure CD3 is only targeted locally in the tumor microenvironment and is only activated slowly over time to further control the risk of side effects and provide sustained activity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Peptide-MHC DARPin Discovery Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to unlock and expand our therapeutic capabilities, pMHC-targeting DARPin molecules represent the next level of immune cell targeting DARPin product candidates. These highly differentiated and specialized therapeutic candidates are designed to engage specific pMHC complexes while avoiding off-target attacks on healthy tissue, potentially delivering greater efficacy with fewer side effects. pMHC DARPin molecules can identify a whole new array of targets that were previously hidden from external protein binders that are restricted to the extracellular environment. We believe the ability to target these intracellular proteins will allow us to pursue an entirely new set of potentially meaningful targets across the fields of oncology and infectious diseases. We have demonstrated proof-of-concept for the ability of DARPin therapeutics to effectively drug pMHC complexes. We are actively screening single-domain DARPin proteins for optimal binding to a range of pMHC complexes, which we expect to use to design DARPin product candidates with specific and potent diseased cell killing effects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Legacy Oncology Programs</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have previously developed two oncology product candidates demonstrating clinical proof-of-concept and validating the systemic administration of DARPin therapeutics in patients with both solid and hematologic malignancies.  MP0250 was designed to bind to and inhibit vascular endothelial growth factor, or VEGF, and hepatocyte growth factor, or HGF. MP0250 evidenced the ability to restore the efficacy of many standard of care cancer therapies, allowing patients who developed resistance to again respond to these therapies. The second legacy product candidate in our oncology program, MP0274, is a DARPin product candidate designed to bind to two different sites, or epitopes, on HER2, a receptor protein that promotes the growth of tumors. Through these legacy product candidates, we have demonstrated therapeutic benefit for patients in the clinic, shown that multi-specific DARPin therapies can be administered safely and with low immunogenicity, and validated the ability of our HSA-binding DARPin technologies to support long-lasting activity. While the activity and tolerability of these product candidates is encouraging, a strategic decision has been made to de-prioritize the product candidates in favor of investing in programs where a clear clinical differentiation could be made through the DARPin constructs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Ophthalmology Program and Collaborations with Allergan, an Abbvie Company </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most clinically advanced DARPin product candidate we have developed is abicipar, a VEGF inhibitor for the treatment of neovascular (wet) age-related macular degeneration, or nAMD, and diabetic macular edema, or DME. Abicipar, which we developed using our DARPin platform, has a longer duration of action and may enable less frequent injections into the eye than the current anti-VEGF treatments while providing equal or better improvements in vision. This program was exclusively licensed to Allergan, an Abbvie company, in 2011. Abicipar has completed two global Phase 3 clinical trials where it met its primary endpoints of non-inferiority to the market leading monthly treatment, Lucentis. Following submission of a Biologics Licensing Application, or BLA, to the U.S. Food and Drug Administration, or FDA, it was determined that the ocular inflammation profile see in the two Phase 2 clinical trials did not provide an adequate risk reward benefit as submitted, and additional work would be required to show the ocular inflammation profile of abicipar would be similar to those products already approved for the treatment of nAMD. Our partner, Abbvie, is currently evaluating potential next steps.  </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Team</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners is an international working environment comprised of 150+ individuals from numerous disciplines who contribute to our shared values of scientific excellence, respectful teamwork and personal aspiration. We foster true innovation and creative thinking to advance our therapeutic product candidates, and we continue to be inspired by the difference we can make for our patients. Our team members possess a curiosity and a passion to advance our shared goal of providing better treatment options for patients with serious diseases. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were founded in 2004 by the inventors of our DARPin platform. Our senior management, which includes two of our company&#8217;s co-founders, have significant prior experience in oncology, research, drug development and finance, and members of our team have served as senior executives at other well-established companies including Argenx, Bavarian Nordic, Celgene, Lonza, Roche and Takeda. Additionally, our board of directors includes current and former senior executives of Biogen, Millennium, Novartis AG, Roche, and Sanofi</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Strategy</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unlock and Expand Custom-Built Biology for Patients</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to leveraging our proprietary DARPin platform to unlock and expand the inherent advantages of DARPin molecules to potentially deliver innovative therapies to patients suffering from severe disease with significant unmet medical needs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key aspects of our strategy include the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Unlock novel biological solutions and expand therapeutic applications of clinically validated DARPin approaches. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the world leaders in DARPin engineering and research. With each technical breakthrough we achieve, we are able to apply key learnings across our portfolio, leveraging each insight to improve future programs.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Rapidly advance the clinical development of our COVID-19 antiviral therapeutic product candidates in our infectious disease program in collaboration with Novartis.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our clinical strategy aims to achieve potential emergency use authorization for ensovibep in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Given the positive preclinical data from our existing COVID-19 antiviral therapeutic product candidates and the clear fit between the DARPin therapeutic profile and compelling antiviral product profiles, we intend to pursue other high value antiviral indications with unmet global need. We expect to announce a new target indication in our infectious disease program in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Advance clinical development of AMG 506 (MP0310) and MP0317, the most advanced product candidates in our oncology program.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Utilizing our knowledge of DARPins, we have developed a method of locally clustering potent immunostimulatory molecules, which are designed to activate themselves only in the presence of specific conditions.  Our lead oncology product candidate, AMG 506 (MP0310), is being developed to locally activate immune cells in the tumor by binding to FAP on tumor stromal cells where it acts as a localizer, and co-stimulating T cells via 4-1BB, an immune modulator protein, for the treatment of FAP-positive cancers. We expect to commence a Phase 1 clinical trial for MP0317 (FAP x CD40) in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Expand the clinical applications of our newly unlocked next-generation CD3 capabilities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We plan to generate novel product candidates from our CD3 discovery programs, utilizing the concepts of multi-specific targeting, conditional activation, and slow activation, all of which we believe open an array of new opportunities for modulating the immune system to fight disease. We have developed methods of delivering highly specific CD3, multi-specific product candidates, starting with a tri-specific TCE for the treatment of AML. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Leverage our proprietary libraries to expand the applicability of DARPin therapeutics.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In pursuit of a sustainable and diversified portfolio, we plan to develop potentially innovative and transformational constructs directed against the most promising targets in our areas of focus. As part of this expansion, we have also developed methods of targeting pMHC complexes, which we believe provides us the capability to investigate a multitude of new targets that have previously been untargetable, both in infectious diseases and oncology.  </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Maintain a strategic approach to in-house versus partnered development. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To unlock and expand the full potential of our DARPin platform, we intend to independently develop and commercialize product candidates in our core focus areas, where we believe we have a clear clinical and regulatory approval pathway and the resources to commercialize successfully. To complement this approach, we also plan to collaborate with biopharmaceutical companies on product candidates that have promising utility in target areas or patient populations requiring greater global development capabilities or those outside of our strategic focus. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary Risk Factors </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investment in our ADSs involves a high degree of risk. Any of the factors set forth under &#8220;Risk Factors&#8221; may limit our ability to successfully execute our business strategy. You should carefully consider all of the information set forth in this prospectus and, in particular, should evaluate the specific factors set forth under &#8220;Risk Factors&#8221; in deciding whether to invest in our securities. Among these risks are the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are a clinical-stage biopharmaceutical company and have incurred significant losses since our inception. We expect to incur losses for the foreseeable future and may never achieve or maintain profitability.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future viability.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may need substantial additional funding in order to complete the development and commercialization of our product candidates. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate certain of our product development or research operations.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effects of health epidemics, including the ongoing COVID-19 coronavirus pandemic, in regions where we, or the third parties on which we rely, have business operations could adversely impact our business, including our preclinical studies and clinical trials, as well as the business or operations of third parties with whom we conduct business.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are heavily dependent on the success of our DARPin platform to identify and develop product candidates. If we or our collaborators are unable to successfully develop and commercialize product candidates based on our platform or experience significant delays in doing so, our business may be harmed. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">All of our product candidates are in preclinical or various stages of clinical development. Clinical drug development is a lengthy and expensive process with uncertain timelines and uncertain outcomes. If clinical trials of our product candidates, particularly ensovibep and MP0310 and product candidates that we have licensed to our partners, including abicipar, are prolonged or delayed, we or our collaborators may be unable to obtain required regulatory approvals, and therefore will be unable to commercialize our product candidates on a timely basis or at all, which will adversely affect our business.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Preclinical drug development is uncertain. Some or all of our preclinical programs may experience delays or may never advance to clinical trials, which would adversely affect our ability to obtain regulatory approvals or commercialize these product candidates on a timely basis or at all, which would have an adverse effect on our business.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Positive results from early preclinical studies of our product candidates are not necessarily predictive of the results of later preclinical studies and any future clinical trials of our product candidates. If we cannot replicate the positive results from our earlier preclinical studies of our product candidates in our later preclinical studies and future clinical trials, we may be unable to successfully develop, obtain regulatory or marketing approval for and commercialize our product candidates.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If any of our product candidates has negative side effects, public perception of our DARPin platform and commercial opportunities for all of our current and future product candidates could be adversely affected. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face significant competition for our drug discovery and development efforts, and if we do not compete effectively, our commercial opportunities will be reduced or eliminated.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our COVID-19 antiviral product candidates may face significant competition from vaccines and other treatments for COVID-19 that are in development.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our financial prospects are dependent upon the manufacture, development and marketing efforts of our licensees. Our licensees may act in their best interest rather than in our best interest, which could materially adversely affect our business, financial condition and results of operations.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on patents and other intellectual property rights to protect our product candidates and the DARPin technology, the prosecution, grant, enforcement, defense and maintenance of which may be challenging and costly. Failure to obtain, maintain, enforce or protect these rights adequately could harm our ability to compete and impair our business.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The base patents relating to the DARPin base technology we use to generate our DARPin product candidates, which we exclusively license from the University of Zurich, are expected to expire in September 2021, after which our competitors may be able to utilize the technology claimed in such patents, which may materially adversely affect our business and competitive position. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating, or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business. Intellectual property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities and negative outcomes could result in adverse effects on our business. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on our information technology systems, and any failure of these systems could harm our business. Security breaches, loss of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business, results of operations and financial condition.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Implications of Being an Emerging Growth Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We qualify as an &#8220;emerging growth company&#8221; as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As an emerging growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to present only two years of audited financial statements in addition to any required interim financial statements and correspondingly reduced disclosure in management&#8217;s discussion and analysis of financial condition and results of operations in the registration statement for the offering of which this prospectus forms a part&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exemption from the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent that we no longer qualify as a foreign private issuer, (1) reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and (2) exemptions from the requirements of holding a non-binding advisory vote on executive compensation, including golden parachute compensation. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may take advantage of these provisions for up to five years or such earlier time that we no longer qualify as an emerging growth company. We would cease to be an emerging growth company if we have more than $1.07 billion in total annual gross revenue, have more than $700 million in market value of our equity securities held by non-affiliates or issue more than $1.0 billion of non-convertible debt over a three-year period. We may choose to take advantage of some but not all of these available exemptions. For example, we have presented only two years of audited financial statements and only two years of related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations disclosure in this prospectus, and have taken advantage of the exemption from auditor attestation on the effectiveness of our internal control over financial reporting. To the extent that we take advantage of these exemptions, the information that we provide shareholders may be different than you might obtain from other public companies in which you hold equity interests. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. Since International Financial Reporting </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standards make no distinction between public and private companies for purposes of compliance with new or revised accounting standards, the requirements for our compliance as a private company and as a public company are the same.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Implications of Being a Foreign Private Issuer </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also considered a &#8220;foreign private issuer&#8221; under U.S. securities laws. In our capacity as a foreign private issuer, we are exempt from certain rules under the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act, that impose certain disclosure obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and &#8220;short-swing&#8221; profit recovery provisions of Section 16 of the Exchange Act and the rules under the Exchange Act with respect to their purchases and sales of our securities. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. In addition, we are not required to comply with Regulation FD, which restricts the selective disclosure of material information. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We will remain a foreign private issuer until such time that more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies&#58; (1) the majority of our executive officers or directors are U.S. citizens or residents&#59; (2) more than 50% of our assets are located in the United States&#59; or (3) our business is administered principally in the United States. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have taken advantage of certain reduced reporting and other requirements in this prospectus. Accordingly, the information contained herein may be different from the information you receive from other public companies in which you hold equity securities. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Corporate Information </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate name is Molecular Partners AG. We were incorporated as an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or AG, on November 22, 2004. Our principal executive offices are located at Wagistrasse 14, 8952 Schlieren, Switzerland. We are registered with the commercial register of the Canton of Zurich under number CHE-112.115.136. In November 2014, we completed the initial public offering of our common shares on the SIX Swiss Exchange. Our telephone number at our principal executive offices is +41 44 755 77 00. Our agent for service of process in the United States is Molecular Partners Inc. Our website address is www.molecularpartners.com. The reference to our website is an inactive textual reference only and information contained in, or that can be accessed through, our website or any other website cited in this registration statement is not part of this registration statement.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">THE OFFERING</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADSs offered by us</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADSs, representing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares</font></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares (including common shares underlying the ADSs) to be outstanding immediately after this offering</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option to purchase additional ADSs</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, we have granted the underwriters an option, exercisable within 30 days from the date of this prospectus, to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional ADSs representing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares to cover over-allotments</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADSs</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each ADS represents the right to receive&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares. You will have the rights of an ADS holder as provided in the deposit agreement among us, the depositary and all holders and beneficial owners of ADSs issued thereunder. To better understand the terms of the ADSs, you should carefully read the section in this prospectus entitled &#8220;Description of American Depositary Shares.&#8221; We also encourage you to read the deposit agreement, which is filed as an exhibit to the registration statement to which this prospectus forms a part.</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depositary</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank, N.A.</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of proceeds</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We estimate that we will receive net proceeds from the offering of approximately&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming an offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, after deducting estimated underwriting commissions and estimated offering expenses payable by us.&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents, to fund our planned Phase 1 clinical trial of MP0317, to advance the development of our infectious disease program, to advance our liquid tumor portfolio, to advance our platform and other potential product candidates and for working capital and other general corporate purposes.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See the section titled &#8220;Use of Proceeds&#8221; for a more complete description of the intended use of proceeds from this offering. </font></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend policy</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have never paid or declared dividends on our common shares, and we do not anticipate paying any cash dividends on our common shares in the foreseeable future. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See the section titled &#8220;Dividend Policy&#8221; for more information.</font></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk factors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See the section titled &#8220;Risk Factors&#8221; and other information included in this prospectus for a discussion of factors that you should consider carefully before deciding to invest in the ADSs.</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Listing</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We intend to apply to have the ADSs listed on the Nasdaq Global Market under the symbol &#8220;MOLN&#8221;</font></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.702%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss listing</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our common shares are listed on the SIX Swiss Exchange under the symbol &#8220;MOLN&#8221;</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common shares to be outstanding after this offering is based on a total of 29,146,992 common shares outstanding as of December 31, 2020 and excludes&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">382,059 common shares issuable upon the exercise of options at a weighted average price of CHF 6.42 ($7.26) per common share granted under our employee stock option plans but not exercised as of December 31, 2020&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">445,198 performance share units and 87,906 restricted share units granted or allocated under our employee stock option plans and long-term equity incentive plans but not vested as of December 31, 2020.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the information in this prospectus assumes&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no exercise by the underwriters of their option to purchase additional ADSs&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no exercise of outstanding options or vesting of performance share units or restricted share units subsequent to December 31, 2020.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SUMMARY FINANCIAL DATA</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following summary statement of comprehensive loss data for each of the years ended December 31, 2020 and 2019 and the summary statement of financial position data as of December 31, 2020 have been derived from our audited financial statements included elsewhere in this prospectus. Our audited financial statements have been prepared in accordance with International Financial Reporting Standards, or IFRS as issued by the International Accounting Standards Board, or IASB. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our historical results for any prior period do not necessarily indicate our results to be expected for any future period. The following summary financial data for the periods and as of the dates indicated are qualified by reference to and should be read in conjunction with our financial statements and related notes beginning on page F-1 of this prospectus, as well as the sections entitled &#8220;Selected Financial Data&#8221;, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Exchange Rate Information&#8221; included elsewhere in this prospectus. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We maintain our books and records in Swiss franc, and we prepare our financial statements in accordance with IFRS as issued by the IASB. We report our financial results in Swiss franc. For the convenience of the reader, we have translated Swiss franc amounts as of December 31, 2020 and for the year ended December 31, 2020 into U.S. dollars at the noon buying rate of the Federal Reserve Bank of New York on December 31, 2020, which was CHF 1.00 to $1.1311. These translations should not be considered representations that any such amounts have been, could have been or could be converted into U.S. dollars at that or any other exchange rate as of that or any other date.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Statement of Comprehensive Loss Data</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended<br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,569&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,075)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,426)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,498)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,595)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,545)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating result</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,326)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,973)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,660)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,816)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,447)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Result before income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,775)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,005)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,271)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net result, attributable to shareholders</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,764)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,992)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,288)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net result per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.84)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.69)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">See Note 21 to our consolidated financial statements appearing elsewhere in this prospectus for a description of the method used to compute basic and diluted net result per share.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Statement of Financial Position Data</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br>December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents plus short-term deposits</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,721</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,496</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,080&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,546</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,133</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,935&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,479</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,741</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,849&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,326)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,857)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,796)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative losses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,174)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220,761)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,870)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,220</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,277</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,139&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in the ADSs involves a high degree of risk. You should carefully consider the risks and uncertainties described below and the other information in this prospectus before making an investment decision. Our business, financial condition or results of operations could be adversely affected if any of these risks occurs, and as a result, the market price of the ADSs could decline and you could lose all or part of your investment. This prospectus also contains forward-looking statements that involve risks and uncertainties. See &#34;Special Note Regarding Forward-Looking Statements.&#34; Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Additional Capital </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a clinical-stage biopharmaceutical company with limited operating history. We have incurred significant losses since our inception, and we expect to incur losses for the foreseeable future and may never achieve or maintain profitability. We may need substantial additional funding in order to complete the development and commercialization of our product candidates. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate certain of our product development or research operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company with limited operating history. Since our inception, we have incurred significant operating losses, including total net losses of CHF 62.8 million and CHF 36.3 million for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, we had cumulative losses of CHF 195.2 million. Our losses resulted principally from costs incurred in research and development, preclinical testing, clinical development of our product candidates as well as costs incurred for research programs and from general and administrative costs associated with our operations. In the future, we intend to continue to conduct research and development, preclinical testing, clinical trials and regulatory compliance activities that, together with anticipated general and administrative expenses, will result in incurring further significant losses for the next several years. Our losses, among other things, will continue to cause our working capital and shareholders' equity to decrease. We anticipate that our expenses will increase substantially if and as we&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance clinical trials of ensovibep in SARS-CoV-2 positively diagnosed patients&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complete the Phase 1a clinical trial of MP0310 in fibroblast activation protein, or FAP, positive cancer patients&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to prepare for the Phase 1 clinical trial of MP0317, the second candidate in our oncology program&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand the clinical applications of our CD3 T cell engagement programs&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue the research and development of our other clinical- and preclinical-stage product candidates and discovery stage programs&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue the research and development of our other product candidates&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to enhance our DARPin technology and build on our proprietary product pipeline&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek regulatory approvals for any product candidates that successfully complete clinical trials&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish a sales, marketing and distribution infrastructure and scale-up manufacturing capabilities to commercialize any product candidates for which we may obtain regulatory approval&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain, maintain, expand, protect and enforce our intellectual property and other proprietary rights and obtain licenses to third-party intellectual property&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">add clinical, regulatory, scientific, operational, financial, legal, intellectual property, compliance and management information systems and personnel, including personnel to support our product development and potential future commercialization efforts&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">experience any delays or encounter any issues relating to any of the above, including failed studies, ambiguous trial results, safety issues, other regulatory challenges or third party supply or manufacturing issues. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2004, we have invested most of our resources in developing our product candidates, building our intellectual property portfolio, developing our supply chain, conducting business planning, raising capital and providing general and administrative support for these operations. We do not currently have any approved products and have never generated any revenue from product sales. To date, we have funded our operations through public and private placements of equity securities, upfront, milestone, option exercise, reservation fee, expense reimbursement, full time equivalent, or FTE, employees and sponsored research payments received from our collaborators, recharging of third party costs and interest income from the investment of our cash, cash equivalents and financial assets. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To become and remain profitable, we must succeed in developing and eventually commercializing products that generate significant revenue. This will require us to be successful in a range of challenging activities, including completing preclinical testing and clinical trials of our product candidates, discovering and developing additional product candidates, obtaining regulatory approval for any product candidates that successfully complete clinical trials, establishing manufacturing and marketing capabilities and ultimately selling any products for which we may obtain regulatory approval. We are only in the preliminary stages of most of these activities. We may never succeed in these activities and, even if we do, may never generate revenue that is significant enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with pharmaceutical and biological product development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve profitability. If we are required by the U.S. Food and Drug Administration, or FDA, the European Medicines Agency, or EMA, or other comparable foreign authorities to perform studies in addition to those we currently anticipate, or if there are any delays in completing our clinical trials or the development of any of our product candidates, our expenses could increase and revenue could be further delayed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we do generate product royalties or product sales, we may never achieve or sustain profitability on a quarterly or annual basis. Our failure to sustain profitability would depress the market price of the ADSs and could impair our ability to raise capital, expand our business, diversify our product offerings or continue our operations. A decline in the market price of the ADSs also could cause you to lose all or a part of your investment. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need substantial additional funding in order to complete the development and commercialization of our product candidates. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate certain of our product development or research operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have funded our operations through public and private placements of equity securities, upfront, milestone, option exercise, reservation fee, expense reimbursement, FTE and sponsored research payments received from our collaborators, recharging of third party costs and interest income from the investment of our cash, cash equivalents and financial assets. We expect to require additional funding in the future to sufficiently finance our operations and advance development of our product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our existing cash, cash equivalents and investments, together with anticipated net proceeds from this offering, will enable us to fund our operating expenses and capital expenditure requirements through at least&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we currently expect. Our future capital requirements for ensovibep, MP0310, MP0317 or our preclinical programs will depend on many factors, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the progress, timing and completion of preclinical testing and clinical trials for our current or any future product candidates&#59;  </font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of potential new product candidates we identify and decide to develop&#59;   </font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in growing our organization to the size needed to allow for the research, development and potential commercialization of our current or any future product candidates&#59;  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in filing patent applications, maintaining and enforcing patents or defending against infringement, misappropriation or other claims raised by third parties&#59;  </font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the maintenance of our existing license and collaboration agreements and the entry into new license and collaboration agreements&#59;  </font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and costs involved in obtaining regulatory approval for our product candidates and any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of our product candidates&#59;   </font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">selling and marketing activities undertaken in connection with the potential commercialization of our current or any future product candidates, if approved, and costs involved in the creation of an effective sales and marketing organization&#59; and   </font></div><div style="margin-bottom:8pt;padding-left:13.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amount of revenues, if any, we may derive either directly or in the form of royalty payments from future sales of our product candidates, if approved.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to raise additional funds will depend on financial, economic and market conditions and other factors, over which we may have no or limited control. Further, as a Swiss corporation, we have less flexibility to raise capital than U.S. companies, particularly in a quick and efficient manner. As a result, we may not be able to access the capital markets as frequently as comparable U.S. companies. See the Risk Factor entitled &#8220;Our status as a Swiss corporation means that our shareholders enjoy certain rights that may limit our flexibility to raise capital, issue dividends and otherwise manage ongoing capital needs&#8221; for additional information related to our ability to timely raise capital. If adequate funds are not available on commercially acceptable terms or at all when needed, we may be forced to delay, reduce or terminate the development or commercialization of all or part of our research programs or product candidates or we may be unable to take advantage of future business opportunities. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of health epidemics, including the ongoing COVID-19 coronavirus pandemic, in regions where we, or the third parties on which we rely, have business operations could adversely impact our business, including our preclinical studies and clinical trials, as well as the business or operations of third parties with whom we conduct business.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, a novel strain of coronavirus disease that causes COVID-19 was identified in Wuhan, China. The SARS-CoV-2 coronavirus has spread to a number of countries globally, and the disease outbreak was declared a pandemic by the World Health Organization in March 2020. More recently, other, potentially more infectious, variants of the SARS-CoV-2 coronavirus have been identified. The outbreak and government measures and regulations taken in response have also had a significant impact, both direct and indirect, on businesses and commerce, as worker shortages have occurred&#59; supply chains have been disrupted&#59; facilities and production have been suspended&#59; and demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services, such as travel, has fallen. In response to the spread of COVID-19, we requested most of our employees that are not required to work in the laboratory to work remotely. As the result of the pandemic, we may experience disruptions that could impact  our business, preclinical studies and clinical trials, including&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or difficulties in commencing enrollment of patients or healthy volunteers in our clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or difficulties in securing clinical trial site locations, and delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delay of submissions to, and approvals of, regulatory authorities&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials&#59;        </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures that are deemed non-essential, which may impact the integrity of subject data and clinical study endpoints&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption or delays in the operations of regulatory authorities, which may impact review and approval timelines, including delays in receiving approval from local regulatory authorities to initiate our planned clinical trials&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruptions in preclinical studies due to restricted or limited operations at our facilities&#59;             limitations on employee resources that would otherwise be focused on the conduct of our preclinical studies and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption or delays to our sourced discovery and clinical activities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, our Phase 1 trial of ensovibep, our lead COVID-19 antiviral product candidate, has been delayed due to an inability to dose healthy volunteers due to government restrictions in the UK, starting at the end of 2020, in response to the pandemic. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to rapidly evolve. The extent to which the outbreak ultimately impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing in Switzerland, the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in countries around the world to contain and treat the disease.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to holders of our common shares or purchasers of ADSs in this offering, restrict our operations or require us to relinquish rights to our technologies or product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our operations with our existing cash, cash equivalents and current financial assets, the net proceeds from this offering, revenue from our collaborations and interest income from the investment of our cash, cash equivalents and financial assets. In order to further advance development of our product candidates, discover additional product candidates and pursue our other business objectives, however, we will need to seek additional funds. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that future financing will be available in sufficient amounts or on commercially reasonable terms, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of holders of our common shares or the ADSs and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of the ADSs and our common shares to decline. The sale of additional equity or convertible securities would dilute all of our existing shareholders and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a holder of ADSs. The incurrence of indebtedness could result in increased fixed payment obligations and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborators or others at an earlier stage than otherwise would be desirable and we may be required to relinquish rights to some of our technologies or product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects. Further, any additional fundraising efforts may divert our management from its day-to-day activities, which may adversely affect our ability to develop and commercialize our product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any of our product candidates, or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to the Development and Clinical Testing of Our Product Candidates </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are heavily dependent on the success of our DARPin platform to identify and develop product candidates. If we or our collaborators are unable to successfully develop and commercialize product candidates based on our platforms or experience significant delays in doing so, our business may be harmed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are heavily dependent on the success our DARPin platform technology and the product candidates currently in our core programs. Our commercial prospects will be heavily dependent on product candidates identified and developed using our DARPin platform. To date, we have invested substantially all of our efforts and financial resources to identify, acquire intellectual property for, and develop our DARPin platform technology and our programs, including conducting preclinical studies and early-stage clinical trials, and providing general and administrative support for these operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be successful in our efforts to further develop our DARPin platform technology and current product candidates. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the FDA, EMA or comparable foreign regulatory authorities, and we may never receive such regulatory approval for any of our product candidates. Each of our product candidates will require significant additional clinical development, management of preclinical, clinical, and manufacturing activities, regulatory approval, adequate manufacturing supply, a commercial organization, and significant marketing efforts before we generate any revenue from product sales, if at all.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">All of our product candidates are in preclinical or various stages of clinical development. Clinical drug development is a lengthy and expensive process with uncertain timelines and uncertain outcomes. If clinical trials of our product candidates, particularly ensovibep and MP0310 and product candidates that we have licensed to our partners, including abicipar, are prolonged, delayed or not commercially viable, we or our collaborators may be unable to obtain required regulatory approvals, and therefore may be unable to commercialize our product candidates on a timely basis or at all, which will adversely affect our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain the requisite regulatory approvals to market and sell any of our product candidates, we or our collaborators for such candidates must demonstrate through extensive preclinical studies and clinical trials that our products are safe, pure and potent or effective in humans. Further, the process of obtaining regulatory approval is expensive, often takes many years following the commencement of clinical trials and can vary substantially based upon the type, complexity and novelty of the product candidates involved, as well as the target indications and patient population. Prior to obtaining approval to commercialize a product candidate in the United States or abroad, we or our potential future collaborators must demonstrate with substantial evidence from adequate and well-controlled clinical trials, and to the satisfaction of the FDA or comparable foreign regulatory authorities, that such product candidates are safe and effective for their intended uses. Additionally, clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process and our future clinical trial results may not be successful. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience delays in our ongoing clinical trials and we do not know whether planned clinical trials will begin on time, need to be redesigned, enroll patients on time or be completed on schedule, if at all. For example, our Phase 1 trial of ensovibep, our lead COVID-19 antiviral product candidate, has been delayed due to an inability to dose healthy volunteers due to government restrictions in the UK, starting at the end of 2020, in response to the pandemic. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials can be delayed, suspended, or terminated for a variety of reasons, including the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in or failure to obtain regulatory approval to commence a trial&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in or failure to reach agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in or failure to obtain institutional review board, or IRB, or ethics committee approval at each site&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in or failure to recruit suitable patients to participate in a trial&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to have patients complete a trial or return for post-treatment follow-up&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical sites deviating from trial protocol or dropping out of a trial&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adding new clinical trial sites&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing sufficient quantities of product candidate for use in clinical trials&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party actions claiming infringement by our product candidates in clinical trials and obtaining injunctions interfering with our progress&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety or tolerability concerns could cause us or our collaborators, as applicable, to suspend or terminate a trial if we or our collaborators find that the participants are being exposed to unacceptable health risks&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory requirements, policies and guidelines&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower than anticipated retention rates of patients and volunteers in clinical trials&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our third-party research contractors failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in establishing the appropriate dosage levels in clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the difficulty in certain countries in identifying the sub-populations that we are trying to treat in a particular trial, which may delay enrollment and reduce the power of a clinical trial to detect statistically significant results&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality or stability of the product candidate falling below acceptable standards&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the ongoing COVID-19 pandemic, which may slow potential enrollment, reduce the number of eligible patients for potential clinical trials, cause delays in clinical trials, or delays or difficulties in shipping and delivering in a timely manner supplies, samples or products required for our operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such trials are being conducted or ethics committees, by the Data Review Committee, or DRC, or Data Safety Monitoring Board, or DSMB, for such trial or by the EMA, the FDA or other regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the EMA, the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, including those relating to the class to which our product candidates belong, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.  For example, changes in local regulations as part of a response to the COVID-19 pandemic may require us to change the ways in which our clinical trials are conducted, which may result in unexpected costs, or cause us to discontinue the clinical trials altogether. If we experience delays in the completion of, or termination of, any clinical trial of our product candidates, the commercial prospects of our product candidates will be harmed. In addition, any delays in completing our clinical trials will increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. Significant clinical trial delays could also allow our competitors to bring products to market before we do or shorten any periods during which we have the exclusive right to commercialize our product candidates and impair our ability to commercialize our product candidates and may harm our business and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these occurrences may harm our business, financial condition and prospects significantly. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates or result in the development of our product candidates being stopped early. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials must be conducted in accordance with the FDA, the EMA and other applicable regulatory authorities' legal requirements and regulations, and are subject to oversight by these governmental agencies and IRBs at the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">medical institutions where the clinical trials are conducted or ethics committees. In addition, clinical trials must be conducted with supplies of our product candidates produced under current good manufacturing practices, or cGMP, requirements and other regulations. Furthermore, we rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials and while we have agreements governing their committed activities, we have limited influence over their actual performance. We depend on our collaborators and on medical institutions and CROs to conduct our clinical trials in compliance with Good Clinical Practice, or GCP, requirements. To the extent our collaborators or the CROs or investigators fail to enroll participants for our clinical trials, fail to conduct the study to GCP standards or are delayed for a significant time in the execution of trials, including achieving full enrollment, we may be affected by increased costs, program delays or both, which may harm our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, conducting clinical trials in multiple countries, such as the Phase 2&#47;3 global registration study for ensovibep, our lead COVID-19 antiviral product candidate, which we expect to commence in          , presents additional risks that may delay completion of our clinical trials. These risks include the failure of enrolled patients in foreign countries to adhere to clinical protocol as a result of differences in healthcare services or cultural customs, managing additional administrative burdens associated with adhering to good clinical practices, regulations and other foreign regulatory schemes, as well as political and economic risks relevant to such foreign countries.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, future clinical trials that could be conducted in countries outside Switzerland, the European Union and the United States may subject us to further delays and expenses as a result of increased shipment costs, additional regulatory requirements and the engagement of non-European Union and non-U.S. CROs, as well as expose us to risks associated with clinical investigators who are unknown to the FDA or the EMA, and different standards of diagnosis, screening and medical care. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in our efforts to use and expand our platform to build a pipeline of product candidates with commercial value.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A key element of our strategy is to use and expand our platform to build a pipeline of product candidates and progress these product candidates through clinical development.  So far none of the products candidates originating from our platform has received marketing approval from the FDA or other regulatory authorities. The scientific discoveries that form the basis for our efforts to discover and develop targeted oncology therapeutic candidates for cancer patients are relatively new. The scientific evidence to support the feasibility of developing product candidates based on these discoveries is both preliminary and limited. There can be no assurance that any development problems we may experience in the future related to our platform will not cause significant delays or unanticipated costs or that such development problems can be solved.  Even if we are successful in building our pipeline of product candidates, the potential product candidates that we identify may not be suitable for clinical development or generate acceptable clinical data, including as a result of being shown to have characteristics that indicate that they are unlikely to be products that will receive marketing approval from the FDA or other regulatory authorities or achieve market acceptance.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our COVID-19 antiviral product candidates may face significant competition from vaccines and other treatments for COVID-19 that are in development.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many biotechnology and pharmaceutical companies are developing treatments for COVID-19 or vaccines against severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, the virus that causes COVID-19, and any treatment we may develop could face significant competition.  Many of these companies, which include large pharmaceutical companies, have greater resources for development, manufacturing and established commercialization capabilities. These companies may develop treatments more rapidly or effectively than we do, may develop a treatment that becomes the standard of care, may develop a treatment at a lower cost, superior formulation or more convenient way of administration, or may be more successful at commercializing an approved treatment, all of which could adversely impact our business.  As a result, we or our partner Novartis may not be able to successfully commercialize our COVID-19 antiviral product candidates for the treatment of COVID-19, even if approved, or compete with other treatments or vaccines, which could adversely impact our business and operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preclinical drug development is uncertain. Some or all of our preclinical programs may experience delays or may never advance to clinical trials, which would adversely affect our ability to obtain regulatory approvals or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">commercialize these product candidates on a timely basis or at all, which would have an adverse effect on our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to obtain FDA or EMA approval to market a new pharmaceutical or biological product we must demonstrate proof of safety, purity and potency or efficacy in humans. To meet these requirements we will have to conduct adequate and well-controlled clinical trials. Before we can commence clinical trials for a product candidate, we must complete extensive preclinical testing and studies that support our planned Investigational New Drug application, or IND, in the United States, or a Clinical Trial Authorization Application, or CTA, in Europe. We cannot be certain of the timely completion or outcome of our preclinical testing and studies and cannot predict if the FDA or EMA will accept our proposed clinical programs or if the outcome of our preclinical testing and studies will ultimately support the further development of these product candidates. Thus, we cannot be sure that we will be able to submit INDs or CTAs for our preclinical programs on the timelines we expect, if at all, and we cannot be sure that submission of INDs or CTAs will result in the FDA or EMA allowing clinical trials to begin. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conducting preclinical testing is a lengthy, time-consuming and expensive process. The length of time may vary substantially according to the type, complexity, novelty and intended use of the product candidate, and often can be several years or more per product candidate. Delays associated with product candidates for which we are directly conducting preclinical testing and studies may cause us to incur additional operating expenses. We may encounter similar or different safety issues in this trial or our other clinical trials in the future. Moreover, we may continue to be affected by delays associated with the preclinical testing and studies of certain product candidates conducted by our potential partners over which we have no control. The commencement and rate of completion of preclinical studies and studies for a product candidate may be delayed by many factors, including, for example&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to generate sufficient preclinical or other in vivo or in vitro data to support the initiation of clinical studies&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in reaching a consensus with regulatory agencies on study design&#59; and   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or EMA not allowing us to rely on previous findings of safety and efficacy for other similar but approved products and published scientific literature.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, even if clinical trials do begin for our preclinical programs, our development efforts may not be successful, and clinical trials that we conduct or that third parties conduct on our behalf may not demonstrate sufficient safety, purity and potency or efficacy to obtain the requisite regulatory approvals for any of our product candidates or product candidates employing our technology. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Positive results from early preclinical studies of our product candidates are not necessarily predictive of the results of later preclinical studies and any future clinical trials of our product candidates. If we cannot replicate the positive results from our earlier preclinical studies of our product candidates in our later preclinical studies and future clinical trials, we may be unable to successfully develop, obtain regulatory or marketing approval for and commercialize our product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any positive results from our preclinical studies of our product candidates may not necessarily be predictive of the results from required later preclinical studies and clinical trials. Similarly, even if we are able to complete our planned preclinical studies or any future clinical trials of our product candidates according to our current development timeline, the positive results from such preclinical studies and clinical trials of our product candidates may not be replicated in subsequent preclinical studies or clinical trial results. For example, while we have observed promising biological activity in patient samples following administration of an initial dose in our ongoing MP0310 Phase I clinical trial, there can be no assurance that such biological activity will be similarly observed and maintained following administration of additional doses or any drop in biological activity could be overcome with additional development regarding more frequent dosing regimens, in each case with respect to our ongoing MP0310 Phase 1 trial or in future clinical trials with respect to our MP0310 program or in any of our other current or future product candidates, including MP0317, the second candidate in our oncology program. In addition, positive results in later stage clinical trials of one of our product candidates in an indication may not be predictive of the safety or efficacy of our other product candidates in other indications, even if they employ a similar mechanism of action. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive results in early-stage development and we cannot be certain that we will not face similar setbacks. For example, immuno-oncology therapeutics can result in the creation of anti-drug antibodies that can neutralize the effects of the product, or require that higher doses be used to obtain a therapeutic effect. Whether anti-drug antibodies will be created and how they react can often not be predicted from nonclinical or even clinical studies, and their detection or appearance can be delayed. These setbacks have been caused by, among other things, preclinical and other nonclinical findings made while clinical trials were underway, or safety or efficacy observations made in preclinical studies and clinical trials, including previously unreported adverse events. Moreover, preclinical, nonclinical and clinical data are often susceptible to varying interpretations and analyses and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials nonetheless failed to obtain FDA or EMA approval. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our product candidates utilize a novel mechanism of action which may result in greater research and development expenses, regulatory issues that could delay or prevent approval, or discovery of unknown or unanticipated adverse effects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our product candidates, such as AMG 506 (MP0310) and MP0317, the lead product candidates from our oncology program, utilize novel mechanisms of action which may result in greater research and development expenses, regulatory issues that could delay or prevent approval, or discovery of unknown or unanticipated adverse effects. Regulatory approval of novel product candidates such as ours can be more expensive, riskier and take longer than for other, more well-known or extensively studied pharmaceutical or biopharmaceutical product candidates due to our and regulatory agencies&#8217; lack of experience with them. The novelty of our mechanism of action may lengthen the regulatory review process, require us to conduct additional studies or clinical trials, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our product candidates or lead to significant post-approval limitations or restrictions. The novel mechanisms of action also means that fewer people are trained in or experienced with product candidates of such type, which may make it more difficult to find, hire and retain personnel for research, development and manufacturing positions. Any such events could adversely impact our business prospects, financial condition and results of operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to successfully validate, develop and obtain regulatory approval for companion diagnostics could harm our product development strategy.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As one of the key elements of our clinical development strategy, we seek to identify patient subsets within a disease category who may derive selective and meaningful benefit from the product candidates we are developing. In collaboration with partners, we may develop companion diagnostics to help us to more accurately identify patients within a particular subset, both during our clinical trials and in connection with the commercialization of our product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companion diagnostics are subject to regulation by the FDA and comparable foreign regulatory authorities as medical devices and require separate regulatory approval prior to commercialization. The FDA generally expects contemporaneous regulatory approvals of the companion diagnostic and the therapeutic product. We do not develop companion diagnostics internally and thus we are dependent on the sustained cooperation and effort of third-party collaborators in developing and obtaining regulatory approval for these companion diagnostics. We and our collaborators may encounter difficulties in developing and obtaining approval for the companion diagnostics, including issues relating to selectivity&#47;specificity, analytical validation, reproducibility or clinical validation. Any delay or failure by our collaborators to develop or obtain regulatory approval of the companion diagnostics could delay or prevent approval of our product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our collaborators may encounter production difficulties that could constrain the supply of the companion diagnostics, and both they and we may have difficulties gaining acceptance of the use of the companion diagnostics in the clinical community. If such companion diagnostics fail to gain market acceptance, it would have an adverse effect on our ability to derive revenues from sales of our products. In addition, the diagnostic company with whom we contract may decide to discontinue selling or manufacturing the companion diagnostic that we anticipate using in connection with development and commercialization of our product candidates or our relationship with such diagnostic company may otherwise terminate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to enter into arrangements with another diagnostic company to obtain supplies of an alternative diagnostic test for use in connection with the development and commercialization of our product candidates or do so on commercially reasonable terms, which could adversely affect and&#47;or delay the development or commercialization of our product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The results of preclinical studies and early-stage clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. Initial success in our ongoing clinical trials may not be indicative of results obtained when these trials are completed or in later stage trials. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. Furthermore, there can be no assurance that any of our clinical trials will ultimately be successful or support further clinical development of any of our product candidates. There is a high failure rate for drugs and biologics proceeding through clinical trials. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier studies, and any such setbacks in our clinical development could harm our business and operating results. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interim, topline and preliminary data from our clinical trials that we announce or publish may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may publish interim, topline or preliminary data from our clinical trials. Preliminary and interim data from our clinical trials may change as more patient data become available. Preliminary or interim data from our clinical trials are not necessarily predictive of final results. Preliminary and interim data are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues, more patient data become available and we issue our final clinical trial report. Interim, topline and preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, preliminary and interim data should be viewed with caution until the final data are available. Adverse changes in the final data compared to the interim data could significantly harm our business prospects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular preclinical study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is the material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular product, product candidate or our business. If the preliminary and interim data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because the number of patients in certain of our clinical trials is small, the results from such trials may be less reliable than results achieved in larger clinical trials. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A study design that is considered appropriate includes a sufficiently large sample size with appropriate statistical power to allow a meaningful interpretation of the results. The preliminary results of studies with smaller sample sizes can be disproportionately influenced by the impact the treatment had on a few individuals, which limits the ability to generalize the results across a broader community, thus making the study results less reliable than studies with a larger number of subjects. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidates may have serious adverse, undesirable or unacceptable side effects which may delay or prevent marketing approval. If side effects are identified during the development of our product candidates or following approval, if any, we may need to abandon our development of such product candidates, the commercial profile of any approved label may be limited, or we may be subject to other significant negative consequences following marketing approval, if any. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undesirable side effects that may be caused by our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA, the EMA or other comparable foreign authorities. While our preclinical and clinical studies for our product candidates to date have generally been well tolerated from a risk-benefit perspective, the results from ongoing and future trials may not support this conclusion. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of future clinical studies may show that our product candidates cause undesirable or unacceptable side effects or even death. In such an event, our trials could be suspended or terminated and the FDA, the EMA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our product candidates for any or all targeted indications. The drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our prospects significantly. Further, because all of our product candidates and preclinical programs are based on our DARPin technology, any adverse safety or efficacy findings related to any product candidate or preclinical program may adversely impact the viability of our other product candidates or preclinical programs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if any of our product candidates receives marketing approval and we or others later identify undesirable or unacceptable side effects caused by such products, a number of potentially significant negative consequences could result, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may withdraw approvals of such products and require us to take our approved product off the market&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require the addition of labeling statements, specific warnings, a contraindication or field alerts to physicians and pharmacies&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require a medication guide outlining the risks of such side effects for distribution to patients, or that we implement a risk evaluation and mitigation strategy, or REMS, plan to ensure that the benefits of the product outweigh its risks&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to change the way the product is administered, conduct additional clinical trials or change the labeling of the product&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of the product may decrease significantly&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to litigation or product liability claims&#59; and   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reputation may suffer.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could prevent us, our collaborators or our potential future partners from achieving or maintaining market acceptance of the affected product or could substantially increase commercialization costs and expenses, which in turn could delay or prevent us from generating significant revenue from the sale of our products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If any of our product candidates has negative side effects, public perception of our DARPin platform and commercial opportunities for all of our current and future product candidates could be adversely affected.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse side effects that may be caused by any of our product candidates could negatively impact the public perception of and commercial opportunities for all of our product candidates. The clinical and commercial success of our product candidates will depend in part on the absence of negative side effects caused by our product candidates. Even if an adverse side effect that results from one of our product candidates is unlikely to occur in our other product candidates, all of our product candidates could be adversely affected because the negative side effect may be perceived to be a likely side effect of all of our product candidates. In the clinical trials performed by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie for abicipar in wet AMD, for example, ocular inflammation has been reported as an undesirable side effect.  In June 2020, the FDA sent a CRL to AbbVie stating that ocular inflammation results in an unfavorable benefit-risk ratio in the treatment of nAMD. However unlikely it is that ocular inflammation will be a side effect of our other product candidates in indications outside of ophthalmology, the public may perceive our DARPin technology or our product candidates to pose a heightened risk of inflammation, thus negatively affecting the commercial opportunities of our current and future product candidates. Additionally, in our ongoing Phase 1 clinical trial of MP0310 in FAP positive cancer patients, we observed protocol defined infusion-related reactions, or IRRs, in 12 of 23 patients. These adverse events may negatively affect the perception of the DARPin technology platform, the commercial opportunity for our product candidates or cause us to suspend clinical trials. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face significant competition for our drug discovery and development efforts, and if we do not compete effectively, our commercial opportunities will be reduced or eliminated. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for pharmaceutical products is highly competitive. Our competitors include many established pharmaceutical companies, biotechnology companies, universities and other research or commercial institutions, many of which have substantially greater financial, research and development resources than us. Large pharmaceutical companies, in particular, have extensive experience in clinical testing, obtaining regulatory approvals, recruiting patients and manufacturing pharmaceutical products. Smaller and early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, the development of our products. The fields in which we operate are characterized by rapid technological change and innovation. There can be no assurance that our competitors are not currently developing, or will not in the future develop, technologies and products that are equally or more effective or are more economically attractive as any of our current or future technology or product. Competing products or technology platforms may gain faster or greater market acceptance than our products or technology platform and medical advances or rapid technological development by competitors may result in our product candidates or technology platforms becoming non-competitive or obsolete before we are able to recover our research and development and commercialization expenses. Additionally, certain of our product candidates may be administered in combination with approved pharmaceutical products. Our ability to develop and ultimately commercialize our product candidates used in combination with other therapies will depend on our ability to access these drugs on commercially reasonable terms for the clinical trials and their availability for use with the commercialized product, if approved. We cannot be certain that current or potential future commercial relationships will provide us with a sufficient supply of these drugs on commercially reasonable terms or at all. If we, our product candidates or our technology platforms do not compete effectively, it may have an adverse effect on our business and results of operation. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on enrollment of patients in our clinical trials for our product candidates. If we are unable to enroll patients in our clinical trials, our research and development efforts and business could be adversely affected. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifying and qualifying patients to participate in our clinical trials is critical to our success. Patient enrollment depends on many factors, including the size and nature of the patient population, eligibility criteria for the trial, the proximity of patients to clinical sites, the design of the clinical protocol, the availability of competing clinical trials, the availability of new drugs approved for the indication the clinical trial is investigating, and clinicians' and patients' perceptions as to the potential advantages of the drug being studied in relation to other available therapies. Since some of our product candidates could be focused on addressing sub-groups of cancer patients, there are limited patient pools from which to draw in order to complete our clinical trials in a timely and cost-effective manner. Furthermore, if the actual number of patients with these pathologies is smaller than we anticipate, we may encounter difficulties in enrolling patients in our clinical trials, thereby delaying or preventing development and approval of our drug candidates. Even once enrolled we may be unable to retain a sufficient number of patients to complete any of our trials.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our efforts to build relationships with patient communities may not succeed, which could result in delays in patient enrollment in our clinical trials. In addition, any negative results we may report in clinical trials of one of our product candidates may make it difficult or impossible to recruit and retain patients in other clinical trials </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of that same product candidate. Delays in the completion of any clinical trial of our product candidates will increase our costs, slow down our product candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, some of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. Changes in government regulations in response to the COVID-19 outbreak may require us to change the ways in which our clinical trials are conducted, which could result in delays. For example, our Phase 1 trial of ensovibep has been delayed due to an inability to dose healthy volunteers due to government restrictions in the UK, starting at the end of 2020, in response to the pandemic. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our ability to successfully initiate, enroll and complete clinical trials in foreign countries is subject to numerous risks unique to conducting business in foreign countries, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">different standards for the conduct of clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in identifying and partnering with qualified local consultants, physicians and partners&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential burden of complying with a variety of foreign laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology research and products.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become exposed to costly and damaging liability claims, either when testing our product candidates in the clinic or at the commercial stage, and our product liability insurance may not cover all damages from such claims. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of pharmaceutical products. Currently, we have no products that have been approved for commercial sale&#59; however, the current and future use of product candidates by us and our corporate collaborators in clinical trials, and the potential sale of any approved products in the future, may expose us to liability claims. These claims might be made by patients who use the product, healthcare providers, pharmaceutical companies, our corporate collaborators or others selling such products. Any claims against us, regardless of their merit, could be difficult and costly to defend and could adversely affect the market for our product candidates or any prospects for commercialization of our product candidates. Although the clinical trial process is designed to identify and assess potential side effects, it is always possible that a drug, even after regulatory approval, may exhibit unforeseen side effects. If any of our product candidates were to cause adverse side effects during clinical trials or after approval of the product candidate, we may be exposed to substantial liabilities. Physicians and patients may not comply with any warnings that identify known potential adverse effects and patients who should not use our product candidates. Regardless of the merits or eventual outcome, liability claims may result in&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for our products due to negative public perception and injury to our reputation&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of clinical trial participants or difficulties in recruiting new trial participants&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiation of investigations by regulators&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs to defend or settle the related litigation&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a diversion of management's time and our resources&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial monetary awards to trial participants or patients&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls, withdrawals or labeling, marketing or promotional restrictions&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of revenues from product sales&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to commercialize any of our product candidates, if approved.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain adequate clinical trial insurance for our product candidates, it is possible that our liabilities could exceed our insurance coverage. We intend to expand our insurance coverage to include the sale of commercial products if we obtain marketing approval for any of our product candidates. However, we may not be able to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maintain insurance coverage at a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful product liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired. Should any of the events described above occur, this could have an adverse effect on our business and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct clinical trials for our product candidates outside the United States, and the FDA and similar foreign regulatory authorities may not accept data from such trials. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also conduct clinical trials outside the United States, including in Europe and are likely to continue to do so in these or other foreign jurisdictions. The acceptance of trial data from clinical trials conducted outside the United States by the FDA may be subject to certain conditions. In cases where data from clinical trials conducted outside the United States are intended to serve as the sole basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i) the data are applicable to the United States population and United States medical practice&#59; (ii) the trials were performed by clinical investigators of recognized competence and (iii) the data may be considered valid without the need for an on-site inspection by the FDA or, if the FDA considers such an inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. Additionally, the FDA&#8217;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory bodies have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any similar foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any similar foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our product candidates not receiving approval or clearance for commercialization in the applicable jurisdiction.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory approval processes of the FDA, the EMA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The time required to obtain approval by the FDA, the EMA and comparable foreign authorities is unpredictable but typically takes many years, if obtained at all, following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions. We have not obtained regulatory approval for any product candidate or product candidates licensed to our partners and it is possible that none of such existing product candidates or any product candidates we may seek to develop in the future will ever obtain regulatory approval. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates could fail to receive regulatory approval for many reasons, including the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA, the EMA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials, including the size of our clinical trials or the doses tested&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to demonstrate to the satisfaction of the FDA, the EMA or comparable foreign regulatory authorities that a product candidate is safe, pure and potent or effective for its proposed indication&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of clinical trials may not meet the level of statistical significance required by the FDA, the EMA or comparable foreign regulatory authorities for approval&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to demonstrate that a product candidate's clinical and other benefits outweigh its safety risks&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA, the EMA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials or may require us to test additional dose regimens of our product candidates&#59;   </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a Biologics License Application, or BLA, to the FDA or other submission or to obtain regulatory approval in the United States, the European Union or elsewhere&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA, the EMA or comparable foreign regulatory authorities may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the approval policies or regulations of the FDA, the EMA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval to market any of our product candidates, which would significantly harm our business. The FDA, the EMA and other comparable foreign authorities have substantial discretion in the approval process, and determining when or whether regulatory approval will be obtained for any of our product candidates. Even if we believe the data collected from clinical trials of our product candidates are promising, such data may not be sufficient to support approval by the FDA, the EMA or any other regulatory authority. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may seek fast-track designation for some or all of our product candidates, but we may not receive such designation, and even if we do, it may not lead to a faster development or regulatory review or approval process, and will not increase the likelihood that such product candidates will receive marketing approval. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek fast-track designation and review for some or all of our product candidates. For example, our clinical development strategy for ensovibep, our lead COVID-19 antiviral therapeutic product candidate, aims to achieve potential emergency use authorization in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. If a drug is intended for the treatment of a serious or life-threatening condition or disease, and nonclinical or clinical data demonstrate the potential to address an unmet medical need, the product may qualify for FDA fast track designation, for which sponsors must apply. The FDA has broad discretion whether or not to grant this designation. Thus, even if we or our collaborators believe a particular product candidate is eligible for this designation, the FDA may decide not to grant it. Moreover, even if we do receive fast track designation, we or our collaborators may not experience a faster development process, review or approval compared to conventional FDA procedures. In addition, the FDA may withdraw fast track designation if it believes that the designation is no longer supported by data from the clinical development program.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if our product candidates obtain regulatory approval, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA, the EMA or a comparable foreign regulatory authority approves any of our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, recordkeeping, exporting and importing for the product will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMPs and GCPs for any clinical trials that we conduct post-approval, all of which may result in significant expense and limit our ability to commercialize such products. In addition, any regulatory approvals that we receive for our product candidates may also be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post marketing testing, including Phase 4 clinical trials, and surveillance to monitor the safety and efficacy of the product candidate. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of our product candidates, withdrawal of the product from the market or voluntary or mandatory product recalls&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on product distribution or use, or requirements to conduct post-marketing studies or clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, restitutions, disgorgement of profits or revenues, warning letters, untitled letters or holds on clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal by the FDA, the EMA or comparable foreign regulatory authorities to approve pending applications or supplements to approved applications filed by us or suspension or revocation of approvals&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure or detention, or refusal to permit the import or export of our product candidates&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenue and could require us to expend significant time and resources in response and could generate negative publicity. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if any of our product candidates is approved, our product labeling, advertising and promotion will be subject to regulatory requirements and continuing regulatory review. The FDA strictly regulates the promotional claims that may be made about drug products. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#8217;s approved labeling. If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label based on the physician&#8217;s independent medical judgement. If we are found to have promoted such off-label uses, we may become subject to significant liability. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant sanctions. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are classified as biologics in the United States and, therefore, can only be sold if we obtain a BLA from the FDA. The holder of a BLA is obligated to monitor and report adverse events and any failure of a product to meet the specifications in the BLA. The holder of a BLA must also submit new or supplemental applications and obtain FDA approval for certain changes to the approved product, product labeling or manufacturing process. Failure to comply with a BLA or any other ongoing regulatory obligation may result in suspension of approval to manufacture or distribute the relevant product, as well as fines or imprisonment for violations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we or one of our distributors, licensees or co-marketers are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. For example, the policies and executive actions of the Biden administration may impact our business and industry.  It is difficult to predict how these policies and executive actions will be implemented, and the extent to which they will impact the FDA&#8217;s ability to exercise its regulatory authority. If these policies or executive actions impose constraints on FDA&#8217;s ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due to our limited resources and access to capital, we must, and have in the past decided to, prioritize development of certain product candidates over other potential candidates. These decisions may prove to have been wrong and may adversely affect our revenues. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have limited resources and access to capital to fund our operations, we must decide which product candidates to pursue and the amount of resources to allocate to each. Our decisions concerning the allocation of research, collaboration, management and financial resources toward particular compounds, product candidates or therapeutic areas may not lead to the development of viable commercial products and may divert resources away from better opportunities. Similarly, our decisions to delay, terminate or collaborate with third parties in respect of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain product development programs may also prove not to be optimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the market potential of our product candidates or misread trends in the biopharmaceutical industry, in particular for our lead product candidates, our business, financial condition and results of operations could be adversely affected.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Commercialization of Our Product Candidates</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the European Union and other foreign jurisdictions, there have been a number of legislative and regulatory changes to the healthcare system that could affect our future results of operations. In particular, there have been and continue to be a number of initiatives at the United States federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the ACA, became law. The ACA is a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among the provisions of the ACA of importance to our potential product candidates are the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription drugs and biologic products, apportioned among these entities according to their market share in certain government healthcare programs, although this fee would not apply to sales of certain products approved exclusively for orphan indications&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to certain individuals with income at or below 133% of the federal poverty level, thereby potentially increasing a manufacturer's Medicaid rebate liability&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expansion of manufacturers' rebate liability under the Medicaid Drug Rebate Program by increasing the minimum rebate for both branded and generic drugs and revising the definition of &#34;average manufacturer price,&#34; or AMP, for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices and extending rebate liability to prescriptions for individuals enrolled in Medicare Advantage plans&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for products that are inhaled, infused, instilled, implanted or injected&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding the types of entities eligible for the 340B drug discount program&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing the Medicare Part D coverage gap discount program, which requires manufacturers to now provide 70%  point-of-sale-discount off the negotiated price of applicable products to eligible beneficiaries during their coverage gap period as a condition for the manufacturers' outpatient products to be covered under Medicare Part D&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a licensure framework for follow-on biologic products&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding for such research&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishment of the Center for Medicare and Medicaid Innovation within Centers for Medicare &#38; Medicaid, or CMS, to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription product spending.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been, executive, judicial and Congressional challenges to certain aspects of the ACA. While Congress has not passed comprehensive repeal legislation, several bills affecting the implementation of certain taxes under the ACA have been signed into law. The Tax Cuts and Jobs Act of 2017, or the Tax Act, includes a provision that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repealed, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate&#8221;. In addition, the 2020 federal spending package permanently eliminated, effective January 1, 2020, the ACA-mandated &#8220;Cadillac&#8221; tax on high-cost employer-sponsored health coverage and medical device tax and, effective January 1, 2021, also eliminated the health insurer tax. Further, the Bipartisan Budget Act of 2018, or the BBA, among other things, amended the ACA, effective January 1, 2019, to close the coverage gap in most Medicare drug plans, commonly referred to as the &#8220;donut hole&#8221;. On December 14, 2018, a Texas U.S. District Court Judge ruled that the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress as part of the Tax Act. Additionally, on December 18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court ruling that the individual mandate was unconstitutional and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. The U.S. Supreme Court is currently reviewing the case, although it is unknown when a decision will be made. Further, although the U.S. Supreme Court has not yet ruled on the constitutionality of the ACA, on January 28, 2021, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through May 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructs certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how the Supreme Court ruling, other such litigation, and the healthcare reform measures of the Biden administration will impact the ACA and our business.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted since the ACA was enacted.  For example, on August 2, 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by U.S. Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation's automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year. These reductions went into effect on April 1, 2013 and, due to subsequent legislative amendments to the statute, including the BBA, will remain in effect through 2030 with the exception of a temporary suspension from May 1, 2020 through March 31, 2021 unless additional U.S. Congressional action is taken. On January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently there has also been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for drugs. At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals, executive orders and policy initiatives. For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to prescription drug pricing that seek to implement several of the administration&#8217;s proposals. As a result, the FDA released a final rule on September 24, 2020, effective November 30, 2020, providing guidance for states to build and submit importation plans for drugs from Canada. Further, on November 20, 2020, the U.S. Department of Health &#38; Human Services, or HHS, finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Medicare Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January 1, 2022 to January 1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a new safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which have also been delayed pending review by the Biden administration until March 22, 2021. On November 20, 2020, CMS issued an interim final rule implementing the Trump administration&#8217;s Most Favored Nation executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries, effective </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2021. On December 28, 2020, the U.S. District Court in Northern California issued a nationwide preliminary injunction against implementation of the interim final rule. It is unclear whether the Biden administration will work to reverse these measures or pursue similar policy initiatives. At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions could harm our business, results of operations, financial condition and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce the ultimate demand for our products or put pressure on our product pricing, which could negatively affect our business, results of operations, financial condition and prospects. It is also possible that additional governmental action will be taken in response to the COVID-19 pandemic. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that additional U.S. federal healthcare reform measures will be adopted in the future, particularly in light of the new presidential administration, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, similar political, economic and regulatory developments may affect our ability to profitably commercialize our current or any future products. In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs. The delivery of healthcare in the European Union, including the establishment and operation of health services and the pricing and reimbursement of medicines, is almost exclusively a matter for national, rather than European Union, law and policy. National governments and health service providers have different priorities and approaches to the delivery of health care and the pricing and reimbursement of products in that context. In general, however, the healthcare budgetary constraints in most European Union member states have resulted in restrictions on the pricing and reimbursement of medicines by relevant health service providers. Coupled with ever-increasing European Union and national regulatory burdens on those wishing to develop and market products, this could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to commercialize any products for which we obtain marketing approval. In international markets, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific products and therapies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we or our collaborators are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we or our collaborators are not able to maintain regulatory compliance, our product candidates may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability, which would adversely affect our business.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to healthcare laws, regulation and enforcement. Our failure to comply with these laws could harm our results of operations and financial conditions.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not currently have any products on the market, our current and future operations may be directly, or indirectly through our relationships with healthcare providers, healthcare institutions, patients, customers and third-party payors, subject to various U.S. federal and state healthcare laws and regulations, including, without limitation, the U.S. federal Anti-Kickback Statute. Healthcare providers, physicians and others play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. These laws impact, among other things, our proposed sales, marketing and education programs and constrain our business and financial arrangements and relationships with third-party payors, healthcare professionals and healthcare institutions who participate in our clinical research programs, healthcare professionals and others who recommend, purchase, or provide our approved products, and other parties through which we market, sell and distribute our products for which we obtain marketing approval. In addition, we may be subject to patient data privacy and security regulation by both the U.S. federal government and the states in which we conduct our business. Finally, our current and future operations are subject to additional healthcare-related statutory and regulatory requirements and enforcement by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign regulatory authorities in jurisdictions in which we conduct our business. The laws that may affect our ability to operate include&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, individuals or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under U.S. federal and state healthcare programs such as Medicare and Medicaid&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. federal civil and criminal false claims and civil monetary penalties laws, including, without limitation, the civil False Claims Act (which can be enforced through &#34;qui tam,&#34; or whistleblower actions, by private citizens on behalf of the federal government), which prohibits, among other things, individuals or entities from knowingly presenting, or causing to be presented, to the U.S. federal government, claims for payment or approval that are false or fraudulent or for knowingly making a false statement to avoid, decrease or conceal an obligation to pay money to the U.S. federal government&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which prohibits, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and its implementing regulations, and as amended again by the Final HIPAA Omnibus Rule, published in January 2013, which imposes certain obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information without appropriate authorization by certain health plans, healthcare clearinghouses and healthcare providers, known as covered entities, as well as their business associates that perform certain services involving the use, disclosure or transmission of individually identifiable health information for or on behalf of a covered entity, and their covered subcontractors&#59;  </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. Federal Food, Drug, and Cosmetic Act, or FDCA, which prohibits, among other things, the adulteration or misbranding of drugs, biologics and medical devices&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. federal physician payment transparency legislation, commonly referred to as Physician Payments Sunshine Act, and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics and medical supplies that are reimbursable under Medicare, Medicaid, or the Children's Health Insurance Program to report annually to CMS information related to certain payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members, and, beginning in 2022, will require applicable manufacturers to report information regarding payments and other transfers of value provided in the previous year to physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, anesthesiologist assistants, and certified nurse midwives&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state laws and regulations, including&#58; state anti-kickback and false claims laws, which may apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers&#59; state laws that require pharmaceutical companies to comply with the pharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources&#59; and state laws and regulations that require drug manufacturers to file reports relating to pricing and marketing information, which requires tracking gifts and other remuneration and items of value provided to healthcare professionals and entities, state and local laws that require the registration of pharmaceutical sales representatives&#59; and state laws governing the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">European and other foreign law equivalents of each of the above laws, including reporting requirements detailing interactions with and payments to healthcare providers.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, reputational harm and the curtailment or restructuring of our operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk of us being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. For example, the definition of the &#8220;remuneration&#8221; under the U.S. federal Anti-Kickback Statute has been interpreted to include anything of value. Further, courts have found that if &#8220;one purpose&#8221; of remuneration is to induce referrals, the U.S. federal Anti-Kickback Statute is violated. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, recent healthcare reform legislation has strengthened federal and state healthcare fraud and abuse laws. For example, the ACA amends the intent requirement of the U.S. federal Anti-Kickback Statute and criminal healthcare fraud statutes to clarify that liability under these statutes does not require a person or entity to have actual knowledge of the statutes or a specific intent to violate them in order to have committed a violation. Moreover, the ACA provides that the government may assert that a claim that includes items or services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act. Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management's attention from the operation of our business. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The successful commercialization of our product candidates will depend in part on the extent to which governmental authorities and health insurers establish adequate reimbursement levels and pricing policies. Failure to obtain or maintain coverage and adequate reimbursement for our product candidates, if approved, could limit our ability to market those products and decrease our ability to generate revenue. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of coverage and adequate reimbursement by third-party payors, including governmental healthcare programs such as Medicare and Medicaid, private health insurers and managed care organizations, is essential for most patients to be able to afford products such as our product candidates, assuming approval. Our ability to achieve acceptable levels of coverage and reimbursement for products by third-party payors will have an effect on our ability to successfully commercialize, and attract additional collaboration partners to invest in the development of our product candidates. Assuming we obtain coverage for a given product by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. We cannot be sure that coverage and reimbursement in the United States, the European Union or elsewhere will be available for any product that we may develop, and any reimbursement that may become available may be decreased or eliminated in the future. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payors increasingly are challenging prices charged for pharmaceutical products and services, and many third-party payors may refuse to provide coverage and reimbursement for particular drugs when an equivalent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic drug or a less expensive therapy is available. It is possible that a third-party payor may consider our product candidate and other therapies as substitutable and only offer to reimburse patients for the less expensive product. Even if we show improved efficacy or improved convenience of administration with our product candidate, pricing of existing drugs may limit the amount we will be able to charge for our product candidate. Third-party payors may deny or revoke the reimbursement status of a given drug product or establish prices for new or existing marketed products at levels that are too low to enable us to realize an appropriate return on our investment in product development. If coverage and reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our product candidates, and may not be able to obtain a satisfactory financial return on products that we may develop. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty related to the third-party payor coverage and reimbursement of newly approved products. In the United States, third-party payors play an important role in determining the extent to which new drugs and biologics will be covered. The Medicare and Medicaid programs increasingly are used as models for how private payors and other governmental payors develop their coverage and reimbursement policies for drugs and biologics. Some third-party payors may require pre-approval of coverage for new or innovative devices or drug therapies before they will reimburse health care providers who use such therapies. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining reimbursement status is time-consuming and costly. No uniform policy for coverage and reimbursement for drug products exists among third-party payors in the United States. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Furthermore, rules and regulations regarding reimbursement change frequently, in some cases at short notice, and we believe that changes in these rules and regulations are likely. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics. Additionally, if any companion diagnostic provider is unable to obtain reimbursement or is inadequately reimbursed, that may limit the availability of such companion diagnostic, which would negatively impact prescriptions for our product candidates, if approved.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada and other countries has and will continue to put pressure on the pricing and usage of our product candidates. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. Other countries allow companies to fix their own prices for medical products, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenue and profits. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The delivery of healthcare in the European Union, including the establishment and operation of health services and the pricing and reimbursement of medicines, is almost exclusively a matter for national, rather than European Union, law and policy. National governments and health service providers have different priorities and approaches to the delivery of healthcare and the pricing and reimbursement of products in that context. In general, however, the healthcare budgetary constraints in most European Union member states have resulted in restrictions on the pricing and reimbursement of medicines by relevant health service providers. Coupled with ever-increasing European Union and national regulatory burdens on those wishing to develop and market products, this could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to commercialize any products for which we obtain marketing approval. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, increasing efforts by governmental and third-party payors in the European Union, the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. We expect to experience pricing pressures in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The future commercial success of our product candidates will depend on the degree of market acceptance of our potential products among physicians, patients, healthcare payors and the medical community.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are at varying stages of development and we may never have a product that is commercially successful. To date, we have no product authorized for marketing. Our lead product candidates are in the relatively early stages of clinical development. Our lead product candidates will require further clinical investigation, regulatory review, significant marketing efforts and substantial investment before they can provide us with any revenues. Furthermore, when available on the market, our products may not achieve an adequate level of acceptance by physicians, patients and the medical community, and we may not become profitable. If our products are not accepted, we may need to increase our efforts to educate the medical community and third-party payors on the benefits of our products, which may require significant resources and may never be successful. Market acceptance of our future products by physicians, patients and healthcare payors will depend on a number of factors, many of which are beyond our control, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the wording of the product label&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the standard of care for the targeted indications for any product candidate&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales, marketing and distribution support&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential product liability claims&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance by physicians, patients and healthcare payors of each product as safe and effective&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">relative convenience, ease of use, ease of administration and other perceived advantages over alternative products&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of coverage and adequate reimbursement from third-party payors and the willingness of patients to pay out-of-pocket in the absence of adequate reimbursement&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prevalence and severity of adverse events or publicity&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations, precautions or warnings listed in the summary of product characteristics, patient information leaflet, package labeling or instructions for use&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of treatment with our products in relation to alternative treatments&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which products are approved for inclusion and reimbursed on formularies of hospitals and managed care organizations&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether our products are designated in the label, under physician treatment guidelines or under reimbursement guidelines as a first-line, second-line, third-line or last-line therapy.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our product candidates fail to gain market acceptance, this will have a material adverse impact on our ability to generate revenues to provide a satisfactory, or any, return on our investments. Even if a potential product displays a favorable efficacy and safety profile in preclinical studies and clinical trials, market acceptance of the product will not be fully known until after it is launched. Furthermore, even if some products achieve market acceptance, the market may prove not to be large enough to allow us to generate significant revenues. In addition, upon exercise by Novartis of its option to in-license ensovibep and MP0423, we would be entitled to royalties on future commercial sales in certain territories but have agreed to forgo royalties in other territories, including lower income countries&#59; if our product candidates are commercialized more largely in territories for which we have agreed to forgo royalties, this could have a material adverse impact on our revenues and financial results. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have never commercialized a product candidate before and may lack the necessary expertise, personnel and resources to successfully commercialize our products on our own or together with suitable collaboration partners. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have a sales or marketing infrastructure and have no experience in the sale or marketing of pharmaceutical products. To achieve commercial success for any approved product, we must develop or acquire a sales and marketing organization, outsource these functions to third parties or enter into collaboration or license arrangements with third parties. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent possible, we may establish our own sales and marketing capabilities and promote our product candidates if and when regulatory approval has been obtained in the major European Union countries and the United States for certain of our product candidates. There are risks involved should we decide to establish our own sales and marketing capabilities or enter into arrangements with third parties to perform these services. Even if we establish sales and marketing capabilities, we may fail to launch or market our products effectively since we have no experience in the sales and marketing of pharmaceutical products. In addition, recruiting and training a sales force is expensive and time consuming and could delay any product launch. In the event that any such launch is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel. Factors that may inhibit our efforts to commercialize our products on our own include&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to recruit, train and retain adequate numbers of effective sales and marketing personnel&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of sales personnel to obtain access to or persuade adequate numbers of physicians to prescribe any future products&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unforeseen costs and expenses associated with creating an independent sales and marketing organization&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs of marketing and promotion above those anticipated by us.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we enter into arrangements with third parties to perform sales and marketing services, our product revenues or profitability could be lower than if we were to market and sell any products that we develop ourselves. Such collaborative arrangements may place the commercialization of our products outside of our control and would make us subject to a number of risks including that we may not be able to control the amount or timing of resources that our collaborative partner devotes to our products or that our collaborator's willingness or ability to complete its obligations, and our obligations under our arrangements, may be adversely affected by business combinations or significant changes in our collaborator's business strategy. In addition, we may not be successful in entering into arrangements with third parties to sell and market our products or may be unable to do so on terms that are favorable to us. Acceptable third parties may fail to devote the necessary resources and attention to sell and market our products effectively. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we may not be successful in commercializing our products, which in turn would have a material adverse effect on our business, prospects, financial condition and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidates for which we intend to seek approval as biologic products may face competition sooner than anticipated.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing the sponsor's own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potency of their product. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation and meaning are subject to uncertainty. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that any of our product candidates approved as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to U.S. Congressional action or otherwise, or that the FDA will not consider our product candidates to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve our projected development and commercialization goals in the timeframes we announce and expect, the commercialization of our product candidates or any future product candidates may be delayed, and our business will be harmed.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For planning purposes, we estimate the timing of achieving various scientific, clinical, regulatory, and other product development objectives. These milestones may include our expectations regarding the commencement or completion of scientific studies and clinical trials, regulatory submissions or commercialization objectives. From time to time, we may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing clinical trial, the initiation of clinical trials, receipt of regulatory approval, or the commercial launch of a product. The achievement of many of these milestones may be outside of our control. All of these milestones are based on a variety of assumptions, which may cause the timing of achieving the milestones to vary considerably from our estimates, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our available capital resources or capital constraints we experience&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of progress, costs, and results of our clinical trials and research and development activities, including the extent of scheduling conflicts with participating clinicians and collaborators&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify and enroll patients who meet clinical trial eligibility criteria&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our receipt of approvals by the FDA, EMA and comparable foreign regulatory authorities, and the timing thereof&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other actions, decisions, or rules issued by regulators&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to access sufficient, reliable, and affordable supplies of materials used in the manufacture of our product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture and supply clinical trial materials to our clinical sites on a timely basis&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efforts of our collaborators with respect to the commercialization of our approved products, if any&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the securing of, costs related to, and timing issues associated with, commercial product manufacturing, as well as sales and marketing activities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to achieve announced milestones in the timeframes we expect, the commercialization of our current or any future product candidates may be delayed, and our business, results of operations, financial condition, and prospects may be adversely affected.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nearly all aspects of our activities are subject to substantial regulation. No assurance can be given that any of our product candidates will fulfill regulatory compliance. Failure to comply with such regulations could result in delays, suspension, refusals and withdrawal of approvals, as well as fines. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The international biopharmaceutical and medical technology industry is highly regulated by the FDA, the EMA and other comparable foreign authorities and by other national or supra-national regulatory authorities that impose </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantial requirements covering nearly all aspects of our activities notably on research and development, manufacturing, preclinical tests, clinical trials, labeling, marketing, sales, storage, record keeping, promotion and pricing of our product candidates. Such regulation is further subject to regular review by the FDA, the EMA and other comparable foreign authorities which may result in changes in applicable regulation. If we do not comply with one or more of these requirements in a timely manner, or at all, our product development could experience significant delays as a result of the FDA, the EMA or other comparable regulatory authorities recommending non-approval or restrictions on approval of a product candidate, leading to an inability to successfully commercialize any of our product candidates, which would materially harm our business. Any failure of any of our product candidates in clinical studies or to receive regulatory approval could have a material adverse effect on our business, results of operations and financial condition. If any of our product candidates fails to obtain approval on the basis of any applicable condensed regulatory approval process, this will prevent such product candidate from obtaining approval in a shortened time frame, or at all, resulting in increased expenses which would materially harm our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with requirements laid down by local regulatory authorities is necessary in each country where we, or any of our partners or licensees, conduct said activities in whole or in part. Local regulatory authorities notably include the EMA and the FDA. In order to market our future products in regions such as the European Economic Area, United States of America, Asia Pacific and many other foreign jurisdictions, we must obtain separate regulatory approvals. The approval procedures vary among countries and can require additional clinical testing, and the time required to obtain approval may differ from that required to obtain for example FDA or EMA approval. Moreover, clinical studies conducted in one country may not be accepted by regulatory authorities in other countries. Approval by the FDA or EMA does not ensure approval by the comparable foreign authorities in other countries, and approval by one or more foreign regulatory authorities does not ensure approval by regulatory authorities in other foreign countries or by the FDA or EMA. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that our product candidates will fulfil the criteria required to obtain necessary regulatory approval to access the market. Also, at this time, we cannot guarantee or know the exact nature, precise timing and detailed costs of the efforts that will be necessary to complete the remainder of the development of our research programs and products candidates. Each of the FDA, the EMA and other comparable foreign authorities may impose its own requirements, may discontinue an approval or revoke a license, may refuse to grant approval, or may require additional data before granting approval, notwithstanding that approval may have been granted by the FDA, the EMA or one or more other comparable foreign authority. The FDA, the EMA or other comparable foreign authorities may also approve a product candidate for fewer or more limited indications or patient sub-segments than requested or may grant approval subject to the performance of  post-marketing studies. The EMA's, the FDA's or other regulatory authority's approval may be delayed, limited or denied for a number of reasons, most of which are beyond our control. Such reasons could include, among others, the production process or site not meeting the applicable requirements for the manufacture of regulated products, or the products not meeting applicable requirements for safety, purity or potency, or efficacy, during the clinical development stage or after marketing. No assurance can be given that clinical trials will be approved the FDA, the EMA or other comparable foreign authorities or that products will be approved for marketing by such regulatory authorities in any pre-determined indication or intended use. Any of the FDA, the EMA and other comparable foreign authorities may disagree with our interpretation of data submitted for their review. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our collaborative partners are, or may become subject to, numerous ongoing other regulatory obligations, such as data protection, environmental, health and safety laws and restrictions on the experimental use of animals. The costs of compliance with such applicable regulations, requirements or guidelines could be substantial, and failure to comply could result in sanctions, including fines, injunctions, civil penalties, denial of applications for marketing authorization of our products, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could significantly increase our or our collaborative partners' costs or delay the development and commercialization of our product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in funding for the FDA, the SEC, and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new or existing product candidates from being developed or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">commercialized in a timely manner, or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel, and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC, and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and&#47;or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times, and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC, and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, upon completion of this offering and in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our research and development activities could be affected or delayed as a result of possible restrictions on animal testing.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain laws and regulations require us to test our product candidates on animals before initiating clinical trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal testing activities by pressing for legislation and regulation in these areas and by disrupting these activities through protests and other means. To the extent the activities of these groups are successful, our research and development activities may be interrupted, delayed or become more expensive. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we are subject to environmental, health and safety laws and regulations, we may become exposed to liability and substantial expenses in connection with environmental compliance or remediation activities which may adversely affect our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations, including our research, development, testing and manufacturing activities, are subject to numerous environmental, health and safety laws and regulations. These laws and regulations govern, among other things, the controlled use, handling, release and disposal of and the maintenance of a registry for, hazardous materials and biological materials, such as chemical solvents, human cells, carcinogenic compounds, mutagenic compounds and compounds that have a toxic effect on reproduction, laboratory procedures and exposure to blood-borne pathogens. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our professional liability insurance and our accident insurance, which cover for costs and expenses we may incur due to environmental liability that may be asserted against us or due to injuries to our employees resulting from the use of hazardous materials, may not provide adequate coverage against potential liabilities. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with other companies engaged in activities similar to ours, we face a risk of environmental liability inherent in our current and historical activities, including liability relating to releases of or exposure to hazardous or biological materials. Environmental, health and safety laws and regulations are becoming more stringent. We may be required to incur substantial expenses in connection with future environmental compliance or remediation activities, in which case, our production and development efforts may be interrupted or delayed and our financial condition and results of operations may be adversely affected. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further with respect to the operations of our third-party contract manufacturers, it is possible that if they fail to operate in compliance with applicable environmental, health and safety laws and regulations or properly dispose of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">wastes associated with our product candidates or products, we could be held liable for any resulting damages, suffer reputational harm or experience a disruption in the manufacture and supply of our product candidates or products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in fraudulent conduct or other illegal activities. Misconduct by these parties could include intentional, reckless and negligent conduct or unauthorized activities that violate&#58; the regulations of the FDA, the EMA and other comparable foreign authorities, including those laws that require the reporting of true, complete and accurate information to such authorities&#59; manufacturing standards&#59; federal and state data privacy, security, fraud and abuse and other healthcare laws and regulations in the United States and abroad&#59; or laws that require the reporting of true, complete and accurate financial information and data. Specifically, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws could also involve the improper use or misrepresentation of information obtained in the course of clinical trials or creating fraudulent data in our preclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. Additionally, we are subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgements, possible exclusion from participation in Medicare, Medicaid and other U.S. federal healthcare programs, individual imprisonment, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, other sanctions, contractual damages, reputational harm, diminished profits and future earnings and curtailment of our operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our high dependency on public perception of our products may negatively influence the success of these products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our product candidates are approved for commercial sale, we will be highly dependent upon consumer perceptions of the safety and quality of our products. We could be adversely affected if we were subject to negative publicity or if any of our products or any similar products distributed by other companies prove to be, or are asserted to be, harmful to patients. Because of our dependence upon consumer perception, any adverse publicity associated with illness or other adverse effects resulting from patients' use or misuse of our products or any similar products distributed by other companies could have a material adverse impact on our business and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future adverse events in research into the oncology and virology fields that we focus our research efforts on, or the biopharmaceutical industry more generally, could also result in greater governmental regulation, stricter labeling requirements and potential regulatory delays in the testing or approvals of our products. Any increased scrutiny could delay or increase the costs of obtaining regulatory approval for our product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to successfully identify, develop and commercialize additional products or product candidates could impair our ability to grow. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although a substantial amount of our efforts will focus on the continued preclinical and clinical testing and potential approval of our product candidates in our current pipeline, a key element of our long-term growth strategy is to develop and market additional products and product candidates. Because we have limited managerial resources, research programs to identify product candidates will require substantial additional technical, financial and human resources, whether or not any product candidates are ultimately identified. The success of this strategy depends </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partly upon our ability to identify, select and develop promising product candidates and products. Our technology platforms may fail to discover and to generate additional product candidates that are suitable for further development. All product candidates are prone to risks of failure typical of pharmaceutical product development, including the possibility that a product candidate may not be suitable for clinical development as a result of its harmful side effects, limited efficacy or other characteristics that indicate that it is unlikely to be a product that will receive approval by the FDA, the EMA and other comparable foreign regulatory authorities and achieve market acceptance. If we do not successfully develop and commercialize product candidates based upon our DARPin technology approach, we may not be able to obtain product or collaboration revenues in future periods, which would adversely affect our business and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may expend our limited resources to pursue a particular DARPin product candidate or indication and fail to capitalize on DARPin product candidates or indications that may be more profitable or for which there is a greater likelihood of success. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have limited financial and managerial resources, we focus on research programs and DARPin product candidates for specific indications, mode of actions or targets. As a result, we may forego or delay pursuit of opportunities with other DARPin product candidates or other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and DARPin product candidates for specific indications may not yield any commercially viable products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not accurately evaluate the commercial potential or target market for a particular DARPin product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to retain sole development and commercialization rights. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service or supply failures, or other failures, business interruptions or other disasters affecting the manufacturing facilities of any party participating in the supply chain would adversely affect our ability to supply our products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are biologics and require processing steps that are more difficult than those required for most chemical pharmaceuticals. Accordingly, multiple steps are needed to control the manufacturing processes. Problems with these manufacturing processes, even minor deviations from the normal process or from the materials used in the manufacturing process, which may not be detectable by us in a timely manner, could lead to product defects or manufacturing failures, resulting in lot failures, product recalls, product liability claims and insufficient inventory. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, certain raw materials or other products necessary for the manufacture and formulation of our product candidates, some of which are difficult to source, are provided by single-source unaffiliated third-party suppliers. The COVID-19 pandemic has caused delays and difficulties in the timely shipping and delivery of supplies, samples and products required for our clinical trials. In addition, we rely on certain third parties to perform filling, finishing, distribution, laboratory testing and other services related to the manufacture of our product candidates, and to supply various raw materials and other products. We would be unable to obtain these raw materials, other products, or services for an indeterminate period of time if any of these third parties were to cease or interrupt production or otherwise fail to supply these materials, products, or services to us for any reason, including due to regulatory requirements or actions (including recalls), adverse financial developments at or affecting the supplier, failure by the supplier to comply with cGMPs, contamination, business interruptions, or labor shortages or disputes. In any such circumstances, we may not be able to engage a backup or alternative supplier or service provider in a timely manner or at all. This, in turn, could materially and adversely affect our ability to supply product candidates, which could materially and adversely affect our business and future prospects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may develop our DARPin platform and other current or future product candidates, in combination with other therapies, which exposes us to additional risks.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may develop our DARPin platform and other current or future product candidates in combination with one or more currently approved therapies. Even if any product candidates we develop were to receive marketing approval or be commercialized for use in combination with other existing therapies, we would continue to be subject to the risks that the FDA or comparable foreign regulatory authorities could revoke approval of the therapy used in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">combination with our DARPin platform or any other current or future product candidates or that safety, efficacy, manufacturing, or supply issues could arise with these existing therapies. This could result in our own product candidates being removed from the market or being less successful commercially.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also evaluate our DARPin platform or any other current or future product candidates in combination with one or more other therapies that have not yet been approved for marketing by the FDA or comparable foreign regulatory authorities. For example, we entered into a collaboration agreement with Amgen in December 2018 to evaluate AMG 506 (MP0310) in combination with Amgen&#96;s oncology pipeline products, including its investigational bispecific TCE, or BiTE&#174;, molecules. We will not be able to market and sell our DARPin product candidates or any product candidate we develop in combination with any such unapproved therapies that do not ultimately obtain marketing approval. These unapproved therapies may face the same risks described with respect to our product candidates, including the emergence of adverse events and delays in their clinical trials. If the FDA or comparable foreign regulatory authorities do not approve these other therapies or revoke their approval of, or if safety, efficacy, manufacturing, or supply issues arise with, the therapies we choose to evaluate in combination with our DARPin product candidates or any other product candidate we develop, we may be unable to obtain approval of or market our DARPin product candidates or any other product candidate we develop.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with data protection laws and regulations could lead to government enforcement actions (which could include civil or criminal penalties), private litigation, and&#47;or adverse publicity and could negatively affect our operating results and business.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection (i.e., laws and regulations that address privacy and data security) has become a significant issue in the United States, Europe and in many other countries and jurisdictions where we operate our business. We and any potential collaborators may be subject to U.S. federal, state, and foreign data protection laws, rules and regulations. In the United States, numerous federal and state laws, rules and regulations, including federal health information privacy laws, state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), that govern the collection, use, storage, retention, security, disclosure, and transfer of personal information, including health-related personal information, could apply to our operations or the operations of our collaborators. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and their respective implementing regulations. Depending on the facts and circumstances, we may be subject to civil, criminal, and administrative penalties if we knowingly obtain, use, or disclose individually identifiable health information in a manner that is not authorized or permitted by HIPAA.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several jurisdictions, including the United States, Switzerland, the EU, its member states, the United Kingdom, Japan, Australia, among others, have adopted legislation and regulations that govern, increase or change the requirements governing the collection, use, storage, retention, security, disclosure and transfer of the personal information of individuals in these jurisdictions. In the United States, the state of California enacted legislation, the California Consumer Privacy Act, or CCPA, effective January 1, 2020, which increases the requirements governing the collection, use, security, disclosure and transfer of the personal information of individuals in the state of California. Further, California voters recently passed the California Privacy Rights Act (CPRA), which will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January 1, 2023. These laws and regulations are complex and change frequently, at times due to changes in political climate, and existing laws and regulations are subject to different and conflicting interpretations, which adds to the complexity of processing personal data from these jurisdictions. These laws have the potential to increase costs of compliance, risks of noncompliance and penalties for noncompliance.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU&#8217;s General Data Protection Regulation, or GDPR, as well as EU member state implementing legislation, apply to the collection and processing of personal data, including health-related information, by companies located in the EU, and in certain circumstances, outside of the EU, and processing personal information of individuals located in the EU. EU member states are also able to legislate separately on health and genetic data, and we must </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comply with these local laws where we operate. Additionally, the United Kingdom implemented the Data Protection Act, effective May 2018 and statutorily amended in 2019, that contains provisions, including its own derogations, for how the GDPR is applied in the United Kingdom. These developments could increase the risk of non-compliance and the costs of providing our products and operating our business in a compliant manner. From the beginning of 2021 (when the transitional period following Brexit expired), companies have to continue to comply with the GDPR and also the Data Protection Act. The Swiss Federal Act on Data Protection, or DPA, also applies to the collection and processing of personal data, including health-related information, by companies located in Switzerland, or in certain circumstances, by companies located outside of Switzerland. The DPA has been revised and adopted by the Swiss Parliament, and the revised version and its revised ordinances are expected to enter into force in 2022. This revised law may result in an increase of costs of compliance, risks of noncompliance and penalties for noncompliance. Similarly, on June 5, 2020, Japan passed amendments to its Act on the Protection of Personal data, or APPI. The APPI broadly regulates the processing of personal data in a manner comparable to the GDPR, and violators of the APPI face substantial penalties.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These data privacy and security laws impose strict obligations related to the collection, use, storage, retention, security, disclosure, and transfer of personal data, including health-related information. This includes several requirements relating to (i) obtaining, in some situations, the consent of the individuals to whom the personal data relates, (ii) the information provided to the individuals about how their personal data is used, (iii) ensuring the security and confidentiality of the personal data, (iv) the obligation to notify regulatory authorities and affected individuals of personal data breaches, (v) extensive internal privacy governance obligations, and (vi) obligations to honor rights of individuals in relation to their personal data (for example, the right to access, correct and delete their personal data). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GDPR prohibits the transfer of personal data to countries outside of the EEA, such as the United States, which are not considered by the European Commission to provide an adequate level of data protection. The transfer of personal data to countries outside of the EEA must be subject to an approved compliance mechanism. Switzerland has adopted similar restrictions under the DPA. On July 16, 2020, the Court of Justice of the European Union issued a decision invalidating the EU-US Privacy Shield framework, which companies had generally relied upon for the transfer of data from the European Union (&#8220;EU&#8221;) to the United States, on the grounds that the EU-US Privacy Shield failed to offer adequate protections to EU personal data transferred to the United States. While the Court of Justice upheld the use of other data transfer mechanisms, such as the Standard Contractual Clauses, the decision has led to some uncertainty regarding the use of such mechanisms for data transfers to the United States, and the court made clear that reliance on Standard Contractual Clauses alone may not necessarily be sufficient in all circumstances. The use of Standard Contractual Clauses for the transfer of personal data specifically to the United States also remains under review by a number of European data protection supervisory authorities. For example, German and Irish supervisory authorities have indicated that the Standard Contractual Clauses alone provide inadequate protection for EU-US data transfers. Use of the data transfer mechanisms must now be assessed on a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals. The European Data Protection Board issued additional guidance regarding the Court of Justice&#8217;s decision on November 11, 2020, which imposes higher burdens on the use of data transfer mechanisms, such as the Standard Contractual Clauses, for cross-border data transfers. To comply with this guidance, we may need to implement additional safeguards to further enhance the security of personal data transferred out of the EEA, which could increase our compliance costs, expose us to further regulatory scrutiny and liability, and adversely affect our business. Further, the European Commission published new versions of the Standard Contractual Clauses for comment and is expected to finalize and implement the new Standard Contractual Clauses in early 2021. Any inability to transfer personal data to the United States from the EEA, Switzerland or the United Kingdom in compliance with the GDPR and European data protection laws may impede our ability to attract and retain customers and adversely affect our business and financial position. We may also be required to incur significant costs and increase our foreign data processing capabilities in an effort to comply with these requirements, and there is no assurance they will be successful.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential pecuniary fines for noncompliant companies may be up to the greater of &#8364;20 million or 4% of annual global revenue for GDPR breaches, and separately &#163;17.5 million or 4% of annual global revenue for United Kingdom law breaches. The GDPR and United Kingdom data protection law have increased our responsibility and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability in relation to personal data that we process, and we may be required to put in place additional potential mechanisms to ensure compliance with the EU, United Kingdom and Swiss data protection rules.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with U.S. and international data protection laws and regulations could require us to take on more onerous obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure to comply with these laws and regulations could result in government enforcement actions (which could include civil, criminal and administrative penalties), private litigation, and&#47;or adverse publicity and could negatively affect our operating results and business. Moreover, clinical trial subjects, employees and other individuals about whom we or our potential collaborators obtain personal information, as well as the providers who share this information with us, may limit our ability to collect, use and disclose the information. Claims that we have violated individuals&#8217; privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Dependence on Third Parties </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely, and expect to continue to rely, on third parties, including independent clinical investigators and CROs, to conduct our preclinical studies and clinical trials. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be harmed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied upon and plan to continue to rely upon third parties, including independent clinical investigators and third-party CROs mandated by us or by our partners, to conduct our preclinical studies and clinical trials and to monitor and manage data for our ongoing preclinical and clinical programs. We rely on these parties for execution of our preclinical studies and clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies and trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards, and our reliance on these third parties does not relieve us of our regulatory responsibilities. We and our third party contractors and CROs are required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA, the EMA and comparable foreign regulatory authorities for all of our products in clinical development. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If we, our investigators or any of our CROs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, the EMA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP regulations. In addition, our clinical trials must be conducted with product produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, these investigators and CROs are not our employees and we will not be able to control, other than by contract, the amount of resources, including time, which they devote to our product candidates and clinical trials. If independent investigators or CROs fail to devote sufficient resources to the development of our product candidates, or if their performance is substandard, it may delay or compromise the prospects for approval and commercialization of any product candidates that we develop. In addition, the use of third-party service providers requires us to disclose our proprietary information to these parties, which could increase the risk that this information will be misappropriated. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CROs have the right to terminate their agreements with us in the event of an uncured material breach. In addition, some of our CROs have an ability to terminate their respective agreements with us if it can be reasonably demonstrated that the safety of the subjects participating in our clinical trials warrants such termination, if we make a general assignment for the benefit of our creditors or if we are liquidated. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face the risk of potential infringement, unauthorized disclosure, misappropriation or other violation of our intellectual property by our third party contractors or CROs, which may reduce our trade secret protection and allow our potential competitors or other third parties to access and exploit our proprietary technology. Our third party contractors or CROs also may use our proprietary information and intellectual property in such a way as to invite </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">litigation or other intellectual property-related proceedings that could jeopardize or invalidate our proprietary information and intellectual property.  For more information regarding our intellectual property, see &#8220;Risk Factors&#8212;Risks Related to Intellectual Property&#8221;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a limited number of third-party service providers that specialize or have the expertise required to achieve our business objectives. If any of our relationships with these third-party CROs or clinical investigators terminate, we may not be able to enter into arrangements with alternative CROs or investigators or to do so on commercially reasonable terms. Switching or adding additional CROs (or investigators) involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. Though we carefully manage our relationships with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely and will continue to rely on collaborative partners regarding the development of our research programs and product candidates. If we are not able to maintain our current relationships or enter into new strategic relationships our business, financial condition, commercialization prospects and results of operations may be adversely affected. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and expect to continue to be, dependent on partnerships with partners relating to the development and commercialization of our existing and future research programs and product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have a collaborative research relationship with the pharmaceutical companies Novartis AG, or Novartis, Amgen Inc., or Amgen, and Allergan, an AbbVie, Inc. company, or AbbVie, for the development of product candidates resulting from such collaborations. We had, have and will continue to have discussions on potential partnering opportunities with various pharmaceutical companies. If we fail to enter into or maintain collaborations on reasonable terms or at all, our ability to develop our existing or future research programs and product candidates could be delayed, the commercial potential of our products could change and our costs of development and commercialization could increase. Furthermore, we may find that our programs require the use of intellectual property rights and other proprietary rights held by third parties, and the growth of our business may depend in part on our ability to acquire, in-license or use these intellectual property and other proprietary rights.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our dependence on collaborative partners subjects us to a number of risks, including, but not limited to, the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to control the amount and timing of resources that the collaboration partner devotes to our research programs and product candidates&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for collaboration agreements where we are solely or partially responsible for funding development expenses through a defined milestone event, the payments we receive from the collaboration partner may not be sufficient to cover the expenses we have or would need to incur in order to achieve that milestone event&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to relinquish significant rights, including intellectual property or other proprietary rights, marketing and distribution rights&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our anticipated payments under any partnership agreement (e.g., royalty payments for licensed products) may not materialize&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we rely on the information and data received from third parties regarding their research programs and product candidates and will not have control of the process conducted by the third party in gathering and composing such data and information. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if rights to develop and commercialize our product candidates subject to collaborations revert to us for any reason, we may not have sufficient financial resources to develop such product candidates, which may result in us failing to recognize any value from our investments in developing such product candidates&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaborative partner may decide not to pursue, or discontinue the collaborative development of, our product candidates&#59; for example, Novartis may decline to exercise its option to in-license ensovibep and MP0423, our COVID-19 antiviral product candidates&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaborative partner may develop a competing product either by itself or in collaboration with others, including one or more of our competitors&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our collaborative partners' willingness or ability to complete their obligations under our partnership arrangements may be adversely affected by business combinations or significant changes in a collaborative partner's business strategy&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience delays in, or increases in the costs of, the development of our research programs and product candidates due to the termination or expiration of collaborative research and development arrangements&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may have disagreements with collaborative partners, including disagreements over proprietary rights, contract interpretation or the preferred course of development, that might cause delays or termination of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborative partners may not properly maintain, enforce or defend our intellectual property rights or other proprietary information or may such use proprietary information in such a way as to invite litigation or other intellectual property-related proceedings that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation&#59; or  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborative partners may infringe, misappropriate or otherwise violate the intellectual property or other proprietary rights of third parties, which may expose us to litigation and potential liability, and collaborators may also allege that we are liable for potential infringement, misappropriation or other violations of third-party intellectual property or proprietary rights during the research and development work for the collaboration.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in seeking appropriate collaborative partners. Our ability to reach a definitive agreement for a partnership will depend, among other things, upon an assessment of the collaborator's resources and expertise, the terms and conditions of the proposed partnership and the proposed collaborator's evaluation of a number of factors. These factors may include the design or results of clinical trials, the likelihood of regulatory approval, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership regardless of the merits of the challenge and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a partnership could be more attractive than the one with us. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop product candidates or bring them to market and generate product revenue.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely completely on third parties to manufacture our preclinical and clinical drug supplies and we intend to rely on third parties to produce commercial supplies of any approved product candidate.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have the infrastructure or capability internally to manufacture our product candidates for use in the conduct of our clinical studies or for commercial supply, if our products are approved. Instead, we rely on, and expect to continue to rely on contract manufacturing organizations, or CMOs. We currently rely mainly on a few </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMOs for the manufacturing of our product candidate materials. Any replacement of our CMOs could require significant effort and expertise because there may be a limited number of qualified CMOs. Reliance on third-party providers may expose us to more risk than if we were to manufacture our product candidates ourselves. We are dependent on our CMOs for the production of our product candidates in accordance with relevant regulations (such as cGMP), which includes, among other things, quality control, quality assurance and the maintenance of records and documentation. Moreover, many of the third parties with whom we contract may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting product development activities that could harm our competitive position.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we were to experience an unexpected loss of supply of or if any supplier were unable to meet our demand for any of our product candidates, we could experience delays in our research or planned clinical studies or commercialization. We could be unable to find alternative suppliers of acceptable quality, in the appropriate volumes and at an acceptable cost. Moreover, our suppliers are subject to strict manufacturing requirements and rigorous testing requirements, which could limit or delay production. The long transition periods necessary to switch manufacturers and suppliers, if necessary, would significantly delay our clinical studies and the commercialization of our products, if approved, which would adversely affect our business and results of operation. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In complying with the manufacturing regulations of the FDA, the EMA and other comparable foreign authorities, we and our third-party suppliers must spend significant time, money and effort in the areas of design and development, testing, production, record-keeping and quality control to assure that the products meet applicable specifications and other regulatory requirements. The failure to comply with these requirements could result in an enforcement action against our CMOs and subsequently against us, including the seizure of products and shutting down of production. We and any of these third-party suppliers may also be subject to audits by the FDA, the EMA or other comparable foreign authorities. If any of our third-party suppliers fails to comply with cGMP or other applicable manufacturing regulations, our ability to develop and commercialize the products could suffer significant interruptions. We face risks inherent in relying on our CMOs, as any disruption, such as a fire, natural hazards or vandalism at any such CMO could significantly interrupt our manufacturing capability. Our CMOs currently do not have alternative production plans in place or disaster-recovery facilities available. In case of a disruption, we will have to establish alternative manufacturing sources. This would require substantial capital on our part, which we may not be able to obtain on commercially acceptable terms or at all. Additionally, we would likely experience months of manufacturing delays as the CMO builds or locates replacement facilities and seeks and obtains necessary regulatory approvals. If this occurs, we will be unable to satisfy manufacturing needs on a timely basis, if at all. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing of all of our product candidates requires using cells which are stored in a cell bank. We have one master cell bank for each product manufactured in accordance with cGMP. Working cell banks have not yet been manufactured. Half of each master cell bank is stored at a separate site so that in case of a catastrophic event at one site we believe sufficient vials of the master cell banks are left at the alternative storage site to continue manufacturing. We believe sufficient working cell banks could be produced from the vials of the master cell bank stored at a given site to assure product supply for the future. However, it is possible that we could lose multiple cell banks and have our manufacturing significantly impacted by the need to replace these cell banks, which could materially adversely affect our business, prospects, financial condition and results of operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not and will not have access to all information regarding the product candidates we license to our collaboration partners. Consequently, our ability to inform our shareholders about the status of such product candidates, and to make informed operational and investment decisions about the product candidates to which we have retained development and commercialization rights, may be limited.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not and will not have access to all information regarding the product candidates being developed and potentially commercialized by Novartis, Amgen or AbbVie, including potentially material information about clinical trial design and execution, safety reports from clinical trials, spontaneous safety reports if the product is later approved and marketed, regulatory affairs, process development, manufacturing, marketing and other areas known by Novartis, Amgen or AbbVie. In addition, we have confidentiality obligations under our agreement with Novartis, Amgen or AbbVie. Thus, our ability to keep our shareholders informed about the status of product candidates under our collaboration will be limited by the degree to which Novartis, Amgen or AbbVie keeps us informed and allows us to disclose such information to the public. If Novartis, Amgen or AbbVie fails to keep us informed about the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinical development and regulatory approval of our collaboration and product candidates licensed to it, we may make operational and investment decisions that we would not have made had we been fully informed, which may materially and adversely affect our business and operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial prospects are dependent upon the manufacture, development and marketing efforts of our licensees. Our licensees may act in their best interest rather than in our best interest, which could materially adversely affect our business, financial condition and results of operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our licensees to manufacture, fund and conduct the clinical development and commercialization of  product candidates, and our licensees have complete control over such activities. Our ability to generate revenue in the near term will depend primarily on the successful development, regulatory approval, marketing and commercialization of product candidates by our licensees. Such success is subject to significant uncertainty, and we have limited control over the manufacturing processes of such product candidates as well as the resources, time and effort that licensees may devote to such product candidates. Any of several events or factors could have a material adverse effect on our ability to generate revenue from our licensee&#8217;s potential commercialization of product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our licensees have the right to make decisions regarding the development and commercialization of product candidates under the collaborations without consulting us and may make decisions with which we do not agree. For example, in June 2020, AbbVie received a Complete Response Letter, or CRL, for the Biologics License Application, or BLA, of abicipar, and may decide to discontinue the development and commercialization of abicipar. Conflicts between our licensees and us may arise if there is a dispute about the progress of the clinical development of a product candidate, the achievement and payment of a milestone amount or the ownership of intellectual property developed during the course of our collaboration agreements. If any of our licenses terminate with our licensees, it may be necessary for us to assume responsibility at our own expense for the development of the applicable product candidates. In that event, we would likely be required to limit the size and scope of one or more of our programs or increase our expenditures and seek additional funding, which may not be available on acceptable terms or at all, which would materially adversely affect our business, financial condition and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on patents and other intellectual property rights to protect our product candidates and the DARPin technology, the prosecution, grant, enforcement, defense and maintenance of which may be challenging and costly. Failure to obtain, maintain, enforce or protect these rights adequately could harm our ability to compete and impair our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on obtaining and maintaining patents and other forms of intellectual property rights for our product candidates, methods used to manufacture those products and methods for treating patients using those products, or on licensing in such rights. Failure to obtain, maintain, enforce, protect or extend adequate patent and other intellectual property rights could adversely affect our ability to develop and market our products and product candidates or pursue collaborations with partners for our product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be certain that patents will be issued or granted with respect to applications that are currently pending, or that issued or granted patents will not later be found to be invalid or unenforceable. The patent position of biopharmaceutical companies is generally uncertain because it involves complex legal and factual considerations, and has been the subject of much litigation in recent years. The standards applied by the United States Patent and Trademark Office, or USPTO, the European Patent Office, or EPO, and other foreign patent offices in granting patents are not always identical or applied uniformly or predictably. For example, there is no uniform worldwide policy regarding patentable subject matter or the scope of claims allowable in biopharmaceutical patents. Consequently, patents may not issue from our pending patent applications or, if issued, patents may vary in scope depending on the jurisdiction. As such, we do not know the degree of future protection that we will have on our proprietary products and technology in the various jurisdictions. The scope of patent protection that the USPTO, the EPO and other foreign patent offices will grant with respect to the DARPin product candidates in our product pipeline is uncertain. It is possible that the USPTO, the EPO and other foreign patent offices will not allow broad claims that cover DARPin product candidates closely related to our product candidates or to the specific protein </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">building blocks. As a result, upon receipt of EMA or FDA approval, competitors may be free to market other products almost identical to ours, thereby decreasing our market share. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent prosecution process is expensive, time-consuming and complex, and we and our current or future licensors, licensees or collaboration partners may not be able to prepare, file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our licensors, licensees or collaboration partners will fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection for them. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&#8217;, licensees' or collaboration partners&#8217; patent rights are highly uncertain. Our and our licensors&#8217; pending and future patent applications may not result in patents being issued that protect our technology or products, in whole or in part, or that effectively prevent others from commercializing competitive technologies and products. Moreover, in some circumstances, we may not have the right to control the preparation, filing, prosecution and maintenance of the licensed patent applications or other intellectual property, or to maintain the patents, or may not have the first right to enforce the intellectual property. We may need to enter into new license or royalty agreements, covering technology that we license from or license to third parties or have developed in collaboration with our collaboration partners and are reliant on patent procurement activities of our licensors, licensees or collaboration partners. Therefore, we may not be able to adequately influence the patent prosecution or enforcement of these patents and patent applications, or prevent inadvertent lapses of coverage due to failure to pay maintenance fees and we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced and defended in a manner consistent with the best interests of our business and that does not compromise the patent rights. If our current or future licensors, licensees or collaboration partners fail to obtain, maintain, protect or enforce such patents and other intellectual property rights, such rights may be reduced or lost. If our licensors, licensees or collaboration partners are not fully cooperative or disagree with us as to the preparation, filing, prosecution, maintenance, defense or enforcement of any licensed patent rights, such patent rights could be compromised. The patent examination process may require us or our licensors, licensees or collaboration partners to narrow the scope of the claims of our or our licensors&#8217;, licensees&#8217; or collaboration partners&#8217; pending and future patent applications, which may limit the scope of patent protection that may be obtained. We cannot assure you that all of the potentially relevant prior art relating to our patents and patent applications has been found. If such prior art exists, it may invalidate patents in whole or in part or prevent patents from issuing from pending patent applications. Even if patents do successfully issue and even if such patents cover our product candidates, third parties may initiate an opposition, interference, re-examination, post-grant review, inter partes review, nullification, revocation, derivation, or other actions in court or before patent offices challenging the validity, enforceability or scope of such patents, which may result in the patent claims being narrowed, invalidated, or held unenforceable. Such proceedings have a higher impact in the biopharmaceutical industry than in other industries, given that biopharmaceutical products are often protected by only one or few patents. Our and our licensors&#8217;, licensees&#8217; or collaboration partners&#8217; patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications, and then only to the extent the issued claims cover the practiced technology. An adverse determination in any such proceeding could reduce the scope of, invalidate, or render unenforceable our patent rights, and allow third parties to commercialize our technology or products and compete directly with us, without payment to us. Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Even if our patent applications or those of our licensors, licensees or collaboration partners issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with any competitive advantage. Any patents may be challenged, narrowed, circumvented or invalidated by third parties. Consequently, we do not know whether any of our DARPin platform advances or product candidates will be protectable or remain protected by valid and enforceable patents. In addition, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our competitors or other third parties may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications are confidential for a period of time after filing, and some remain so until issued. Therefore, we cannot be certain that we or our licensors, licensees or collaborators were the first to make the inventions claimed in any patent application, or were the first to file any patent application related to a product candidate. Furthermore, as to the United States, if third parties have filed such patent applications on or before March 15, 2013, an interference proceeding can be initiated by such third parties to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. If third parties have filed such applications after March 15, 2013, a derivation proceeding can be initiated by such third parties to determine whether our invention was derived from theirs. Even where we have a valid and enforceable patent, we may not be able to exclude others from practicing our invention where the other party can show that they used the invention in commerce before our filing date, or if the other party is able to obtain a compulsory license. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such product candidates are commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours, including generic versions of such products. Moreover, it is possible that some future patents and patent applications owned or in-licensed by us may be co-owned with third parties, including our collaboration partners and other third parties with whom we conduct research and development. If we are unable to obtain an exclusive license to any such third party co-owners&#8217; interest in such patents or patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. In addition, we may need the cooperation of any such co-owners of our patents in order to enforce such patents against third parties, and such cooperation may not be provided to us.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, it is possible that some future patents and patent applications owned or in-licensed by us may be subject to a reservation of rights by one or more third parties. For example, this may happen if the research resulting in certain of our owned or in-licensed patent rights and technology was funded in part by the U.S. government. As a result, the government may have certain rights, or march-in rights, to such patent rights and technology. When new technologies are developed with government funding, the government generally obtains certain rights in any resulting patents, including a non-exclusive license authorizing the government to use the invention for noncommercial purposes. These rights may permit the government to disclose our confidential information to third parties and to exercise march-in rights to use or allow third parties to use our licensed technology. The government can exercise its march-in rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to U.S. industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may fail in enforcing our intellectual property rights and issued patents covering one or more of our product candidates or DARPin technology could be found invalid or unenforceable if challenged in court. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect our competitive position, we or our licensors or collaboration partners may from time to time need to resort to litigation in order to enforce or defend any patents or other intellectual property rights owned by or licensed to us, or to determine or challenge the scope or validity of patents or other intellectual property rights of third parties. Enforcement of intellectual property rights is difficult, unpredictable and expensive, and many of our or our licensors&#8217; or collaboration partners&#8217; adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we or our licensors or collaboration partners can. Accordingly, despite our or our licensors' or collaboration partners&#8217; efforts, we or our licensors or collaboration partners may not be able to prevent third parties from infringing upon, misappropriating or otherwise violating intellectual property rights we own or control, particularly in countries where the laws may not protect those rights as fully as in the European Union and the United States. We may fail in enforcing our rights, in which case our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competitors may be permitted to use our technology without being required to pay us any license fees. In addition, litigation involving our patents carries the risk that one or more of our patents will be held invalid (in whole or in part, on a claim-by-claim basis) or unenforceable. Such an adverse court ruling could allow third parties to commercialize our products or use our DARPin technology, and then compete directly with us, without payment to us. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or one of our licensors or collaboration partners were to initiate legal proceedings against a third party to enforce a patent covering one of our product candidates or our technology, including our DARPin technology, the defendant could counterclaim that our patent is invalid or unenforceable. In patent litigation in the United States and Europe, defendant counterclaims alleging invalidity or unenforceability are commonplace. Third parties could also raise challenges to the validity of patent claims before administrative bodies in the United States, Europe or other foreign jurisdictions, even outside the context of litigation. Such mechanisms include re-examination, post-grant review, inter partes review, interference proceedings, derivation proceedings and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). Such proceedings could result in the revocation of, cancellation of or amendment to our patent claims in such a way that they no longer cover our technology or DARPin platform, or any product candidates that we may develop. A claim for a validity challenge may be based on failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. A claim for unenforceability could involve an allegation that someone connected with prosecution of the patent withheld relevant information from or made a misleading statement to the USPTO, the EPO or other patent offices during prosecution. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity of our issued patents, for example, we cannot be certain that there is no invalidating prior art, of which we, our licensors or collaboration partners and the patent examiner were unaware during prosecution. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose part or all of the patent protection afforded by the affected patent. Such a loss of patent protection could have a material adverse impact on our business. Further, litigation could result in substantial costs and diversion of management resources, and reputational harm, regardless of the outcome, which could harm our business and financial results. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating, or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business. Intellectual property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities and negative outcomes could result in adverse effects on our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends, in part, on our ability to operate without infringing the patents and other proprietary intellectual property rights of third parties. This is generally referred to as having the &#8220;freedom to operate.&#8221; The biotechnology and pharmaceutical industries in which we plan to operate are subject to frequent and extensive litigation regarding patents and other intellectual property rights. In addition, companies producing therapeutics in the oncology and immuno-oncology fields have employed intellectual property litigation as a means to gain an advantage over their competitors. As a result, we may be required to defend against claims of intellectual property infringement, misappropriation or other violation that may be asserted by third parties against us and, if the outcome of any such litigation is adverse to us, it may affect our ability to compete effectively.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitive position may suffer if patents issued to third parties or other third-party intellectual property rights cover our products or elements thereof, our manufacture or uses relevant to our products or development plans, the targets of our product candidates, or other attributes of our product candidates or our technology. In such cases, we may not be in a position to develop or commercialize the applicable products or product candidates unless we successfully pursue litigation to nullify or invalidate the third-party intellectual property right concerned, or enter into a license agreement with the intellectual property right holder, which may not be available on commercially reasonable terms, or at all. In the event that a relevant patent has not expired at the time of approval of such product candidate and the patent owner were to bring an infringement action against us, we may have to argue that our product, its manufacture, importation or use does not infringe, misappropriate or otherwise violate a valid claim of the patent in question. Alternatively, if we were to challenge the validity of any issued U.S. patent in court, we would need to overcome a statutory presumption of validity that attaches to every U.S. patent. This means that in order to prevail, we would need to present clear and convincing evidence as to the invalidity of the patent's claims. There is no assurance that a court would find in our favor on questions of infringement or validity. In the event that a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patent is successfully asserted against us such that the patent is found to be valid and enforceable and infringed by our product, unless we obtain a license to such a patent, which may not be available on commercially reasonable terms or at all, we could be prevented from continuing to develop or commercialize our product. Similarly, the targets for certain of our product candidates have also been the subject of research by other companies, which have filed patent applications or own issued patents on aspects related to the targets or their uses. There can be no assurance that any such patents will not be asserted against us or that we will not need to seek licenses from such third parties. We may not be able to secure such licenses on acceptable terms, if at all, and any such litigation would be costly and time-consuming. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that we failed to identify relevant patents or applications. For example, certain U.S. applications filed after November 29, 2000 that will not be filed outside the United States may remain confidential until patents issue. In general, patent applications in the United States and elsewhere are published approximately 18 months after the earliest filing from which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Therefore, patent applications covering our products or platform technology could have been filed by others without our knowledge, in particular with respect to our COVID-19 antiviral product candidates. Furthermore, we operate in a highly competitive field, and given our limited resources, it is unreasonable to monitor all patent applications purporting to gain broad coverage in the areas in which we are active. Additionally, claims in pending patent applications which have been published can, subject to certain limitations, be later amended in a manner that could cover our platform technologies, our products or the use of our products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party intellectual property right holders, including our competitors, may actively bring infringement, misappropriation or other claims against us. We may not be able to successfully settle or otherwise resolve such claims. If we are unable to successfully settle future claims on terms acceptable to us, we may be required to engage in or continue costly, unpredictable and time-consuming litigation and may be prevented from or experience substantial delays in marketing our products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail in any such dispute, in addition to being forced to pay damages, we or our licensees may be temporarily or permanently prohibited from commercializing any of our product candidates that are held to be infringing, misappropriating or violating any third-party intellectual property rights. We might also be forced to redesign product candidates so that we no longer infringe, misappropriate or otherwise violate third-party intellectual property rights, which may result in significant cost or delay to us or be technically infeasible, or to seek a license to any such third-party intellectual property rights that we are found to infringe, misappropriate or otherwise violate, which license may not be available on commercially reasonable terms, or at all. Even if we or our licensors or collaboration partners obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us or our licensors or collaboration partners, and it could require us or our licensors or collaboration partners to make substantial royalty and other payments. In addition, we could be found liable for monetary damages, including treble damages and attorneys' fees, if we are found to have willfully infringed a patent. Any of these events, even if we were to ultimately prevail, could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our involvement in litigation, and in any interference, derivation, reexamination, inter partes review, post grant review, opposition or other post-grant proceedings or other intellectual property proceedings inside and outside of the European Union or the United States, even if resolved in our favor, may cause us to incur significant expenses, distract our technical and management personnel from their normal responsibilities and cause substantial delays in marketing our products. In addition, there could be public announcements of the results of hearings, motions, other interim proceedings or developments, or of final verdicts and if securities analysts or investors perceive these results to be negative, this could have a substantial adverse effect on the price of the ADSs. Such litigation or proceedings could substantially increase our operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have an adverse effect on our ability to compete in the marketplace. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if the breadth or strength of protection provided by our or our licensors&#8217; or collaboration partners&#8217; patents and patent applications is challenged or threatened, it could dissuade companies from collaborating with us </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to license, develop or commercialize current or future product candidates. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our rights to develop and commercialize our technology and product candidates are subject, in part, to the terms and conditions of licenses granted to us by others, and we may not be successful in obtaining or maintaining additional necessary rights related to our product candidates through acquisitions and in-licenses.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon licenses to certain patent rights and other intellectual property from third parties that are important or necessary to the development of our product candidates. For example, in November 2004 we entered into a license agreement with the University of Zurich under which we are granted rights to intellectual property that are necessary to the development and commercialization of our DARPin platform and are otherwise important to our business. We may also need to obtain additional licenses to advance the development and commercialization of any product candidates we may develop. Additionally, we have in the past collaborated and may in the future collaborate with U.S. and&#47;or European academic institutions to accelerate our preclinical research or development under written agreements with these institutions. In some instances, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration.  Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to other parties, potentially blocking our ability to pursue our applicable product candidate or program. Our current license and collaborations agreements also impose, and we expect that future agreements will likely impose various reporting, prosecution, diligence, fee payment, royalty and other obligations on us. If there is any conflict, dispute, disagreement or issue of non-performance between us and our licensing or collaboration partners regarding our rights or obligations under the agreements, including any such conflict, dispute or disagreement arising from our alleged failure to satisfy payment obligations under any such agreement, we may owe damages, the counterparty may have a right to terminate the affected agreement, and our and our licensees' ability to utilize the affected intellectual property in drug discovery and development efforts, and our ability to enter into collaboration or marketing agreements for an affected product candidate, may be adversely affected. Our business could also suffer if a licensor or collaborator fails to abide by the terms of the agreement, if any licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms or at all. Any of these events could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. For more information regarding our license and collaboration agreements, see &#8220;Business&#8212;License and Collaboration Agreements.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not have the right to control the preparation, filing, prosecution, maintenance, enforcement and defense of patents and patent applications covering the technology that we license from third parties. Therefore, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced and defended in a manner consistent with the best interests of our business. If our current or future licensors fail to prosecute, maintain, enforce and defend such patents, or lose rights to those patents or patent applications, the rights we have licensed may be reduced or eliminated, and our right to develop and commercialize any of our products that are subject of such licensed rights could be adversely affected.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current or future licensors may have relied on third party consultants or collaborators or on funds from third parties such that our licensors are not the sole and exclusive owners of the patents we in-licensed. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our programs may require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, in-license, maintain or use these proprietary rights. We may be unable to acquire or in-license, on reasonable terms or at all, any compositions, methods of use, processes, or other third-party intellectual property rights from third parties that we identify as necessary for our product candidates. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attractive. These established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment. If we are unable to successfully obtain a license to third-party intellectual property rights necessary for the development of a product candidate or program, we may have to abandon development of that product candidate or program and our business and financial condition could suffer. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If in the future we do undertake any acquisitions, the process of integrating an acquired business, technology, service, products or product candidates into our business may result in unforeseen operating difficulties and expenditures, including diversions of resources and management&#8217;s attention from our core business, or any acquired intellectual property may be subject to claims of invalidity or unenforceability or held to be invalid. In addition, we may fail to retain key executives and employees of the companies we acquire, which may reduce the value of the acquisition or give rise to additional integration costs. Future acquisitions could result in additional issuances of equity securities that would dilute the ownership of existing shareholders. Future acquisitions could also result in the incurrence of debt, actual or contingent liabilities or the amortization of expenses related to other intangible assets, any of which could adversely affect our operating results. In addition, we may fail to realize the anticipated benefits of any acquisition. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented, declared generic or determined to be infringing on other marks or names. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. If we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. If other entities use trademarks similar to ours in different jurisdictions, or have rights senior to ours, it could interfere with our use of our current trademarks throughout the world. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not obtain protection under the Hatch-Waxman Act Amendments and similar non-U.S. legislation for extending the term of patents covering each of our product candidates, our business may be materially harmed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents have a limited duration. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest effective U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates, their manufacture, or use are obtained, once the patent life has expired, we may be open to competition from competitive medications, including biosimilar medications or generic versions of such products. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours, at least not long enough to recoup the costs incurred in developing our products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending upon the timing, duration and conditions of FDA marketing approval of our product candidates, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Act and similar legislation in the European Union and several other relevant countries around the world. The Hatch-Waxman Act permits a patent term extension of up to five years for a patent covering an approved product as compensation for effective patent term lost during product development and the FDA regulatory review process. The patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent applicable to an approved drug may be extended, and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. However, we may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the length of the extension could be less than we request. If we are unable to obtain patent term extension or the term of any such extension is less than we request, the period during which we can enforce our patent rights for the applicable product will be shortened and our competitors may be able to enter the market with competing products sooner than we expect, and our business, financial condition, results of operations, and prospects could be materially harmed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The base patents relating to the DARPin base technology we use to generate our DARPin product candidates, which we exclusively license from the University of Zurich, are expected to expire in September 2021, after which our competitors may be able to utilize the technology claimed in such patents, which may materially adversely affect our business and competitive position.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold an exclusive license from the University of Zurich on patent applications and patents relating to the DARPin base technology that we use to generate our DARPin product candidates. The base patents under this license agreement will expire in September 2021, except that one U.S. patent under the license agreement will expire in 2023. After the patents expire or the potential termination of the license agreement, our competitors may be able to utilize the technology claimed in such patents to develop product candidates that compete with ours. In addition, we are exploring entering into a non-exclusive license with the University of Zurich for the remaining U.S. patent that will expire in 2023. If we do not enter into such non-exclusive license, a third party may obtain an exclusive license to the patent that will expire in 2023. Any of these events could harm our reputation as being the leader in the DARPin technology, and could have an adverse effect on our competitive position, business, financial conditions, results of operations and prospects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We enjoy only limited geographical protection with respect to certain patents and may face difficulties in certain jurisdictions, which may diminish the value of our intellectual property rights. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and the laws of foreign countries may not protect our rights to the same extent as the laws of the United States and the European Union. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States and the European Union, or from selling or importing products made using our inventions in and into all countries outside the United States and the European Union.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We often file our first patent application, or our priority filing, at the EPO or the USPTO. International applications under the Patent Cooperation Treaty, or PCT, are usually filed within twelve months after the priority filing. Based on the PCT filing, national and regional patent applications may be filed in additional jurisdictions where we believe our product candidates may be marketed. We have so far not filed for patent protection in all national and regional jurisdictions where such protection may be available. In addition, we may decide to abandon national and regional patent applications before grant. Finally, the grant proceeding of each national&#47;regional patent is an independent proceeding which may lead to situations in which applications might in some jurisdictions be refused by the relevant patent offices, while granted by others. It is also quite common that depending on the country, the scope of patent protection may vary for the same product candidate or technology.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may use our or our licensors&#8217; or collaboration partners&#8217; technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we and our licensors or collaboration partners have patent protection, but enforcement is not as strong as that in the United States and the European Union. These products may compete with our product candidates, and our and our licensors' or collaboration partners' patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some jurisdictions do not protect intellectual property rights to the same extent as the laws in the United States and the European Union, and companies have encountered significant difficulties in protecting and defending such rights in such jurisdictions. If we or our licensors encounter difficulties in protecting, or are otherwise precluded from effectively protecting, the intellectual property rights important for our business in such jurisdictions, the value of these rights may be diminished and we may face additional competition from others in those jurisdictions. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, some countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired and our business and results of operations may be adversely affected. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceedings to defend or enforce our and our licensors' or collaboration partners' patent rights in foreign jurisdictions could result in substantial costs and divert our and our licensors' or collaboration partners' efforts and attention from other aspects of our business, could put our and our licensors' or collaboration partners' patents at risk of being invalidated or interpreted narrowly, could put our and our licensors' or collaboration partners' patent applications at risk of not issuing and could provoke third parties to assert claims against us or our licensors or collaboration partners. We or our licensors or collaboration partners may not prevail in any lawsuits that we or our licensors or collaboration partners initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. If we or our licensors or collaborators encounter difficulties in protecting, or are otherwise precluded from effectively protecting, the intellectual property rights important for our business in such jurisdictions, the value of these rights may be diminished and we may face additional competition from others in those jurisdictions.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations under the agreements pursuant to which we license intellectual property rights from third parties, or otherwise experience disruptions to our business relationships with our licensors, we could lose the rights to intellectual property that are important to our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to agreements under which we are granted rights to intellectual property that are important to our business, including our license agreement with the University of Zurich, and we expect that we may need to enter into additional license agreements in the future. Under certain license agreements, we may not control the preparation, filing, prosecution or maintenance of the licensed intellectual property, or may not have the first right to enforce or defend the intellectual property. In those cases, we may not be able to adequately influence patent prosecution, enforcement or defense, or prevent inadvertent lapses of coverage due to failure to pay maintenance fees and we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced, and defended in a manner consistent with the best interests of our business and that does not compromise the patent rights. Existing license agreements impose, and we expect that future license agreements will impose, various development obligations as well as other obligations, such as payment of royalties. If we fail to comply with our obligations under these agreements, the licensor may have the right to terminate the license. The termination of any license agreements or failure to adequately protect such license agreements could prevent us from commercializing product candidates covered by the licensed intellectual property. For more information regarding our license and collaboration agreements, see &#8220;Business&#8212;License and Collaboration Agreements.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disputes may arise regarding intellectual property subject to a licensing agreement, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of rights granted under the license agreement and other interpretation-related issues&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which our technology and processes infringe, misappropriate or otherwise violate intellectual property of the licensor that is not subject to the licensing agreement&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sublicensing of patent and other rights under any current or future collaboration relationships&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our diligence obligations under the license agreement and what activities satisfy those diligence obligations&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our partners.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the agreements under which we currently license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that we may be unable to obtain any necessary additional licenses at a reasonable cost or on reasonable terms, if at all. In that event, we may be required to expend significant time and resources to redesign our technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected product candidates, which could harm our business, financial condition, results of operations, and prospects significantly. We cannot provide any assurances that third party patents do not exist which might be enforced against our current technology, including our DARPin product candidates, manufacturing methods or future methods or products resulting in either an injunction prohibiting our manufacture or sales, or, with respect to our sales, an obligation on our part to pay royalties or other forms of compensation to third parties, which could be significant.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights do not necessarily address all potential threats to our competitive advantage. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. For example&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may be able to make compounds that are similar or substantially equivalent to our product candidates but that are not covered by the claims of the patents that we own or have exclusively licensed.  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of third parties may have an adverse effect on our business.   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our current or future licensors or strategic partners might not have been the first to conceive or reduce to practice the inventions covered by the issued patent or pending patent application that we own or have licensed.   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our current or future licensors or strategic partners might not have been the first to file patent applications covering certain of our or their inventions.  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating our intellectual property rights&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it is possible that our current or future patent applications will not lead to issued patents.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issued patents that we own or license may not provide us with any competitive advantage, or may be held invalid or unenforceable, including as a result of legal challenges by our competitors.   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third parties performing manufacturing or testing for us using our products or technologies could use the intellectual property of third parties without obtaining a proper license, rendering us susceptible to claims of infringement, misappropriation or other violation of such third parties&#8217; intellectual property rights&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional technologies that are patentable&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others may have an adverse effect on our business&#59; in particular, our product candidates may in the future be tested for new indications, and if one proves to be effective against a specific new indication, we may be confronted with existing patents covering such indication.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations, and prospects.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in patent laws or patent jurisprudence could diminish the value of patents in general, thereby impairing our ability to protect our products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is heavily dependent on the extent of our intellectual property rights, particularly patents. Obtaining, defending and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity and is costly, time-consuming and inherently uncertain. Changes in either the patent laws or interpretation of the patent laws in the European Union, United States or other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. The Leahy-Smith America Invents Act, or the AIA, was enacted in the United States in September 2011, resulting in significant changes to the U.S. patent system. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, assuming that other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. As of March 16, 2013, under the AIA, the United States transitioned to a &#34;first-to-file&#34; system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. Therefore, a third party that files a patent application in the USPTO before us could therefore be awarded a patent covering an invention even if we had made the invention before it was made by the third party. This will require us to be cognizant of the time from invention to filing of a patent application, and circumstances could prevent or dissuade us from promptly filing patent applications on our inventions. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AIA also includes a number of significant changes that affect the way patent applications will be prosecuted and also may affect patent litigation. These include changes that limit where a patentee may file a patent infringement suit and that allow third party submissions of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO-administered post-grant proceedings, including post-grant review, inter partes review, and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in U.S. federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. The AIA and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, and other applicable bodies in the European Union and other foreign jurisdictions, the laws and regulations governing patents could change in unpredictable ways that could weaken our ability to obtain new patents or to defend and enforce our existing patents and patents that we might obtain in the future. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider proprietary trade secrets, confidential know-how and unpatented know-how to be important to our business and competitive position. We may rely on trade secrets or confidential know-how to protect our technology, especially where patent protection is believed to be of limited value. However, trade secrets and confidential know-how are difficult to protect. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect this type of information against disclosure or appropriation by competitors, our policy is to require our employees, consultants, contractors, CROs and advisors to enter into confidentiality agreements with us. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">secrets or proprietary technology and processes and, despite these efforts, any of these parties may unintentionally or willfully breach the agreements and disclose our confidential information to competitors, and such agreements may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Enforcing a claim that a third party illegally disclosed or misappropriated trade secrets or confidential know-how is expensive, time-consuming and unpredictable. In addition, the enforceability of confidentiality agreements and trade secrets may vary from jurisdiction to jurisdiction. Furthermore, if a third party lawfully obtained or independently developed any of our trade secrets, we would have no right to prevent such third party from using that technology or information to compete with us or from disclosing it to others, which could harm our competitive position. Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating our trade secrets. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to effectively maintain and protect trade secrets or confidential know-how could adversely affect our competitive position. Moreover, our competitors may independently develop substantially equivalent proprietary information and may even apply for patent protection in respect of the same. If successful in obtaining such patent protection, our competitors may be able to limit our use of our trade secrets or confidential know-how. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims by third parties asserting that we or our employees have infringed, misappropriated or otherwise violated their intellectual property, or claiming ownership of what we regard as our own intellectual property. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our consultants and employees, including our senior management, were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Some of these consultants and employees executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment. Although we try to ensure that our consultants and employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these consultants and employees have used or disclosed confidential information or intellectual property, including trade secrets or other proprietary information, of any such consultant's or employee's current or former employer, or have breached their non-competition agreement. Litigation may be necessary to defend against such claims. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we or our licensors may be subject to claims that former employees, consultants, collaborators or other third parties have an interest in our owned or in-licensed patents or other intellectual property as an inventor or co-inventor. While it is our policy to require our consultants and employees who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own. Our and their assignment agreements may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims they may bring against us, to determine the ownership of what we regard as our intellectual property.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel or sustain damages. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such a license may not be available on commercially reasonable terms or at all. Even if we successfully prosecute or defend against such claims, litigation could result in substantial costs and distract management. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance and annuity fees on any of our owned or licensed patents and patent applications are due to be paid to the USPTO, the EPO and other foreign patent agencies in several stages over the lifetime of the patents and patent applications. The USPTO, the EPO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we or our licensors or collaboration partners fail to maintain the patents and patent applications covering our product candidates, our competitors might be able to enter the market earlier with similar products or technology, which would have an adverse effect on our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Organization and Operations </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth and ability to compete depends on retaining our key personnel and recruiting additional qualified personnel. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends upon the continued contributions of our key management, scientific and technical personnel, many of whom have been instrumental for us and have substantial experience with our therapies and related technologies. These key management individuals include the members of our board of directors and executive management, including Dr. Patrick Amstutz, our Chief Executive Officer, Dr. Michael Tobias Stumpp, our Chief Operating Officer, Andreas Emmenegger, our Chief Financial Officer, and Dr. Nicolas Leupin, our Chief Medical Officer.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of key managers and senior scientists could delay our research and development activities. In addition, our ability to compete in the highly competitive biotechnology and pharmaceutical industries, and particularly, in the oncology and immuno-oncology fields, depends upon our ability to attract and retain highly qualified management, scientific and medical personnel. Many other biotechnology and pharmaceutical companies and academic institutions that we compete against for qualified personnel have greater financial and other resources, different risk profiles and a longer history in the industry than we do. Therefore, we might not be able to attract or retain these key persons on conditions that are economically acceptable. Furthermore, we will need to recruit new managers and qualified scientific personnel to develop our business if we expand into fields that will require additional skills. Additionally, there is a larger pool of qualified scientific and medical personnel in the United States than in Switzerland, and we may need to increase our presence in the United States in order to attract and retain the necessary human resources.  Our inability to attract and retain these key persons could prevent us from achieving our objectives and implementing our business strategy, which could have an adverse effect on our business and prospects.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to expand our development, regulatory and sales and marketing capabilities and, as a result, we may encounter difficulties in managing our growth, which could disrupt our operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to experience growth in the number of our employees and the scope of our operations, particularly in the areas of drug development, regulatory affairs, sales and marketing and support functions such as finance, human resources, legal, intellectual property, information technology and administration. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to integrate efficiently or achieve the expected benefits of any acquisitions of complementary businesses, product candidates or technologies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2004, we have grown organically without any acquisitions. Should we in the future contemplate to acquire any complementary business, product candidates or technologies, our ability to integrate and manage acquired businesses, product candidates or technologies effectively will depend upon a number of factors including the size of the acquired business, the complexity of any product candidate or technology and the resulting difficulty of integrating the acquired business's operations, if any. Our relationship with current employees or employees of any acquired business may become impaired. We may also be subject to unexpected claims and liabilities arising from such acquisitions. These claims and liabilities could be costly to defend, could be material to our financial position and might exceed either the limitations of any applicable indemnification provisions or the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial resources of the indemnifying parties. There can also be no assurance that we will be able to assess ongoing profitability and identify all actual or potential liabilities of a business, product candidate or technology prior to its acquisition. If we acquire businesses, product candidates or technologies that result in assuming unforeseen liabilities in respect of which it has not obtained contractual protections or for which protection is not available, this could materially adversely affect our business, prospects, financial condition and results of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our information technology systems, and any failure of these systems could harm our business. Security breaches, loss of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business, results of operations and financial condition.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect and maintain information in digital and other forms that is necessary to conduct our business, and we are increasingly dependent on information technology systems and infrastructure to operate our business. In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information. It is critical that we do so in a secure manner to maintain the privacy, security, confidentiality, availability and integrity of such confidential information. We have established physical, electronic and organizational security measures designed to safeguard and secure our systems to prevent a data compromise, and rely on commercially available systems, software, tools, and monitoring to provide security for our information technology systems and the processing, transmission and storage of digital information. We have also outsourced elements of our information technology infrastructure, and as a result a number of third-party vendors may have access to our confidential information. While we have taken steps to protect the security of the information that we handle, there can be no assurance that any security measures that we or our third-party vendors have implemented will be effective against current or future security threats. Our internal information technology systems and infrastructure, and those of our current and any future collaborators, contractors consultants, vendors, and other third parties on which we rely, are vulnerable to damage or unauthorized access or use resulting from computer viruses, malware, natural disasters, terrorism, war, telecommunication and electrical failures, cyber-attacks or cyber-intrusions over the Internet, denial or degradation of service attacks, ransomware, hacking, phishing and other social engineering attacks, attachments to emails, or intentional or accidental actions or omissions to act by persons inside our organization, or persons with access to systems inside our organization.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk of a security breach or disruption or data loss, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. In addition, the prevalent use of mobile devices that access confidential information increases the risk of lost or stolen devices, security incidents, and data security breaches, which could lead to the loss of confidential information or other intellectual property. As a result of the COVID-19 pandemic, we may face increased risks of a security breach or disruption due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. The costs to us to mitigate network security problems, bugs, viruses, worms, malicious software programs and security vulnerabilities could be significant, and while we have implemented security measures to protect our data security and information technology systems, our efforts to address these problems may not be successful, and these problems could result in unexpected interruptions, delays, cessation of service, negative publicity, and other harm to our business, our reputation and our competitive position. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our product development programs. For example, the loss of clinical trial data from completed or ongoing or planned clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Any security compromise affecting us, our partners or our industry, whether real or perceived, could harm our reputation, erode confidence in the effectiveness of our security measures, and lead to regulatory scrutiny. Moreover, if a computer security breach affects our systems or results in the unauthorized access to or unauthorized use, disclosure, release or other unauthorized processing of personal information, our reputation could be materially damaged. In addition, such a breach may require notification to governmental agencies, the media or individuals pursuant to various federal, state, and foreign privacy and security laws, if applicable, including HIPAA, as amended HITECH, and its implementing rules and regulations, as well as regulations promulgated by the Federal Trade Commission, state data breach notification laws, and the GDPR. We would also be exposed to a risk of loss, governmental investigations or enforcement, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">litigation and potential liability, any of which could materially adversely affect our business, results of operations and financial condition.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to economic, political, regulatory and other risks associated with international operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to risks associated with conducting business internationally. Accordingly, our future results could be harmed by a variety of factors, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic weakness, including inflation, increase of interest rates, or political instability in particular economies and markets&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing regulatory requirements for drug approvals&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing jurisdictions could present different issues for securing, maintaining or obtaining freedom to operate in such jurisdictions&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially reduced ability to obtain, maintain, protect and enforce intellectual property rights and other proprietary rights&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in compliance with different, complex and changing laws, regulations and court systems of multiple jurisdictions and compliance with a wide variety of foreign laws, treaties and regulations&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulations and customs, tariffs and trade barriers&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in currency exchange rates of the euro, U.S. dollar and Swiss franc and currency controls&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in a specific country's or region's political or economic environment&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade protection measures, import or export licensing requirements or other restrictive actions by governments&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing reimbursement regimes and price controls in certain international markets&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative consequences from changes in tax laws&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad, including, for example, the variable tax treatment in different jurisdictions of stock options granted under our employee stock plan&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">workforce uncertainty in countries where labor unrest is more common than in the United States&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation or administrative actions resulting from claims against us by current or former employees or consultants individually or as part of class actions, including claims of wrongful terminations, discrimination, misclassification or other violations of labor law or other alleged conduct&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation resulting from claims against us by third parties, including claims of breach of noncompete and confidentiality provisions of our employees' former employment agreements with such third parties&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties associated with staffing and managing international operations, including differing labor relations&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business interruptions resulting from cyber-attacks, geo-political actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods and fires.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange rate fluctuations or abandonment of the euro currency may materially affect our results of operations and financial condition. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the international scope of our operations, our assets, earnings and cash flows are influenced by movements in exchange rates of several currencies, particularly regarding U.S. dollars, euros, British pounds and Swiss francs. Our functional currency is the Swiss franc and the majority of our operating expenses are paid in Swiss francs, but we </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also may receive payments from our business partners, including Amgen and AbbVie, in U.S. dollars or euros and we regularly acquire services, consumables and materials in U.S. dollars and Swiss francs. Further, potential future revenue may be derived from abroad, particularly from the United States and the European Union. As a result, our business and share price may be affected by fluctuations in foreign exchange rates between the Swiss franc, the euro, the U.S. dollar and these other currencies, which may also have a significant impact on our reported results of operations and cash flows from period to period. Besides our natural hedging, currently, we do not have any exchange rate hedging arrangements in place. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the possible abandonment of the euro by one or more members of the European Union could materially affect our business in the future. Despite measures taken by the European Union to provide funding to certain European Union member states in financial difficulties and by a number of European countries to stabilize their economies and reduce their debt burdens, it is possible that the euro could be abandoned in the future as a currency by countries that have adopted its use. This could lead to the re-introduction of individual currencies in one or more European Union member states, or in more extreme circumstances, the abandonment of the euro or the dissolution of the European Union. The effects on our business of a potential dissolution of the European Union, the exit of one or more European Union member states from the European Union or the abandonment of the euro as a currency, are impossible to predict with certainty, and any such events could have a material adverse effect on our business, financial condition and results of operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent developments relating to the United Kingdom's referendum vote in favor of withdrawal from the European Union could adversely affect us. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom held a referendum on June 23, 2016, in which a majority voted for the United Kingdom's withdrawal from the European Union, or Brexit. As a result of this vote, the United Kingdom left the European Union on January 31, 2020, commonly referred to as Brexit. Pursuant to the formal withdrawal arrangements agreed between the United Kingdom and the European Union, the United Kingdom was subject to a transition period until December 31, 2020, or the Transition Period, during which European Union rules continued to apply. The Trade and Cooperation Agreement, or the Trade and Cooperation Agreement, which outlines the future trading relationship between the United Kingdom and the European Union was agreed in December 2020. The effects of Brexit have been and are expected to continue to be far-reaching. Brexit and the perceptions as to its impact may adversely affect business activity and economic conditions in Europe and globally and could continue to contribute to instability in global financial and foreign exchange markets. Since a significant proportion of the regulatory framework in the United Kingdom applicable to our business and our product candidates is derived from European Union directives and regulations, Brexit has had, and may continue to have, a material impact upon the regulatory regime with respect to the development, manufacture, importation, approval and commercialization of our product candidates in the United Kingdom. For example, Great Britain is no longer covered by the centralized procedures for obtaining European Union-wide marketing authorizations and a separate marketing authorization will be required to market our product candidates in Great Britain and the European Union, should any development or manufacturing of our product candidates take place in Great Britain. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is currently unclear whether the MHRA is sufficiently prepared to handle the increased volume of marketing authorization applications that it is likely to receive.  Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of Brexit or otherwise, could make it more difficult to commercialize, or prevent us from commercializing our product candidates in the European Union or in the United Kingdom and restrict our ability to generate revenue and achieve and sustain profitability. While the Trade and Cooperation Agreement provides for the tariff-free trade of medicinal products between the United Kingdom and the European Union, there may be additional non-tariff costs to such trade which did not exist prior to the end of the Transition Period.  Further, should the United Kingdom diverge from the European Union from a regulatory perspective in relation to medicinal products, tariffs could be put into place in the future.  We could therefore, both now and in the future, face significant additional expenses (when compared to the position prior to the end of the Transition Period) to operate our business, which could significantly and materially harm or delay our ability to generate revenues or achieve profitability of our business.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any further changes in international trade, tariff and import&#47;export regulations as a result of Brexit or otherwise may impose unexpected duty costs or other non-tariff barriers on us. These developments, or the perception that any of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">them could occur, may significantly reduce global trade and, in particular, trade between the impacted nations and the United Kingdom.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Brexit, other European countries may seek to conduct referenda with respect to their continuing membership in the European Union. Given these possibilities and others we may not anticipate, as well as the lack of comparable precedent, we cannot be certain of the full extent to which Brexit could adversely affect our business, results of operations and financial condition.   </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to unanticipated changes in tax laws and regulations, adjustments to our tax provisions, exposure to additional tax liabilities, or forfeiture of our tax assets.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of our provision for income taxes and other tax liabilities requires significant judgment, including the adoption of certain accounting policies and our determination of whether we will be able to obtain a future tax benefit from our deferred tax assets. We cannot guarantee that our interpretations will not be challenged by the relevant tax authorities, or that the relevant tax laws and regulations, or the interpretation thereof, including through tax rulings, by the relevant tax authorities, will not be subject to change. Any adverse outcome of such a challenge may lead to adjustments in the amounts recorded in our financial statements, and could have a material adverse effect on our operating results and financial condition. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws and regulations on tax levies and other charges or contributions in different countries, including transfer pricing and tax regulations applicable to the compensation of personnel and third parties. Transactions between current group companies, as well as additional companies that may form part of our group in the future, are subject to transfer pricing regulations, which may be subject to change or our existing transfer pricing system could be challenged by the relevant tax authority, and any such changes or challenges could adversely affect us. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate could be adversely affected by changes in tax laws, treaties and regulations, both internationally and domestically, or the interpretation thereof by the relevant tax authorities, including changes to the U.K. research and development tax credit regime or the &#34;patent box&#34; regime, possible changes to the corporate income tax base, changes to the additional deduction for expenditure on research and development personnel in Switzerland and other tax incentives . An increase in our effective tax rate could have an adverse effect on our business, financial position, results of operations and cash flows. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not be able to use, or changes in tax regulations may affect the use of, certain tax assets or credits that we have generated in prior years. For instance, as of December 31, 2020, we had substantial tax loss carry forwards. In general, some of these tax loss carry forwards may be forfeited in whole, or in part, as a result of various transactions, or their utilization may be restricted by statutory law in the relevant jurisdiction. Any corporate reorganization by us or any transaction relating to our shareholding structure may result in partial or complete forfeiture of tax loss carry forwards. If not used, tax loss carryforwards for Swiss corporate income tax purposes expire seven years after the tax year in which they were incurred. Due to our limited income, there is a high risk that our tax loss carryforwards will expire in part or in their entirety and therefore will not be able to be used to offset future taxable income for Swiss corporate income tax purposes. Furthermore, any tax loss carry forwards that we report on our Swiss tax returns are subject to review and confirmation by the competent Swiss tax authorities in their tax assessment of the tax year for which the tax loss carryforwards are used to offset taxable income. Consequently, we are exposed to the risk that the competent Swiss tax authorities may not accept the reported tax loss carryforwards in part or in their entirety.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our effective tax rate or tax liability may have an adverse effect on our results of operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate could increase due to several factors, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the relative amounts of income before taxes in the jurisdictions in which we operate that have differing statutory tax rates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws, tax treaties, and regulations or the interpretation of them&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to our assessment about our ability to realize any deferred tax assets that are based on estimates of our future results, the prudence and feasibility of possible tax planning strategies, and the economic and political environments in which we do business&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome of any current or future tax audits, examinations, or administrative appeals&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any limitations or adverse findings regarding our ability to do business in some jurisdictions.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these developments could adversely affect our business, results of operations and financial condition.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a result of changes in, or in the interpretation of, tax laws, treaties, rulings, regulations or agreements of Switzerland or any other country in which we currently operate or may in the future operate, the loss of a major tax dispute or a challenge to our operating structure, intercompany pricing policies or the taxable presence of our existing or any future subsidiaries in certain countries, or other factors, our effective income tax rates may increase in the future, which could adversely affect our net income and cash flows. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in multiple jurisdictions and our profits are taxed pursuant to the tax laws of these jurisdictions. The tax laws applicable to our business activities, however, are subject to changes in interpretation. Our tax position could be adversely impacted by changes in tax rates, tax laws, tax practice, tax treaties or tax regulations or changes in the interpretation thereof by the tax authorities in jurisdictions in which we currently do or may in the future elect to do business. Our effective income tax rate may be affected by changes in or interpretations of tax laws, treaties, rulings, regulations or agreements in any such jurisdiction, the resolution of issues arising from any future tax audits with various tax authorities, utilization of net operating loss and tax credit carryforwards, changes in geographical allocation of income and expense, and changes in management&#8217;s assessment of matters such as the realizability of deferred tax assets. In the past, we have experienced fluctuations in our effective income tax rate. Our actual tax rate may vary from our expectation and that variance may be material. Our effective income tax rate in a given fiscal year reflects a variety of factors that may not be present in the succeeding fiscal year or years. There is no assurance that our effective income tax rate will not change in future periods.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Swiss corporate tax law reform that took effect on January 1, 2020, all Swiss cantons, including the Canton of Zurich, have abolished previously existing cantonal tax privileges. Therefore, since January 1, 2020, we are subject to standard cantonal taxation. The standard effective corporate tax rate in Schlieren, Canton of Zurich, can change from time to time. The standard combined (federal, cantonal, municipal) effective corporate income tax rate, except for dividend income for which we could claim a participation exemption, for 2021 in Schlieren, Canton of Zurich, will be approximately 19.41%. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We urge our shareholders to consult with their legal and tax advisors with respect to the potential tax consequences of investing in or holding our ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to the Offering and the ADSs </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of the ADSs may be volatile and may fluctuate due to factors beyond our control. An active public trading market may not develop and&#47;or may not be sustained following this offering. And you may not be able to resell the ADSs at or above the public offering price. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, while our common shares have been traded on the SIX Swiss Exchange, there has been no public market on a U.S. national securities exchange for the ADSs or our common shares in the United States. If you purchase ADSs in this offering, you may not be able to resell those ADSs at or above the public offering price. The trading price of the common shares has fluctuated, and is likely to continue to fluctuate substantially. The trading price of those securities depends on a number of factors, including those described in this &#34;Risk Factors&#34; section, many of which are beyond our control and may not be related to our operating performance. In addition, although we anticipate our ADSs being approved for listing on the Nasdaq Global Market, an active trading market for our ADSs may never develop or be sustained following this offering. The offering price of our ADSs will be determined through negotiations between us and the underwriters. This offering price may not be indicative of the market price of our ADSs or common shares after this offering.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of the ADSs and our common shares may fluctuate significantly due to a variety of factors, many of which are beyond our control, including&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">positive or negative results of testing and clinical trials reported or conducted by us, strategic partners or competitors&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in entering into strategic relationships with respect to development or commercialization of our product candidates or entering into strategic relationships on terms that are not deemed to be favorable to us&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technological innovations or commercial product introductions by us or competitors&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government regulations&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments concerning proprietary rights, including patents and litigation matters&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public concern relating to the commercial value or safety of any of our product candidates&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financing or other corporate transactions&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">publication of research reports or comments by securities or industry analysts&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general market conditions in the pharmaceutical industry or in the economy as a whole&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of the COVID-19 pandemic on the economy or financial markets&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and volume fluctuations attributable to inconsistent trading volume levels of the ADSs and&#47;or common shares.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other market and industry factors may cause the market price and demand for the ADSs and common shares to fluctuate substantially, regardless of our actual operating performance, which may limit or prevent investors from readily selling their ADSs or common shares and may otherwise negatively affect the liquidity of the ADSs and common shares. In addition, the stock market in general, and biopharmaceutical companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur increased costs as a result of operating as a U.S.-listed public company, and our board of directors will be required to devote substantial time to new compliance initiatives and corporate governance practices. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company in the United States, and particularly after we no longer qualify as an emerging growth company, we will incur significant legal, accounting and other expenses that we did not incur as a public company listed only on the SIX Swiss Exchange. We are a corporation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), organized under the laws of Switzerland in accordance with articles 620 et seqq. CO  and subject to the listing rules and the applicable regulations for companies listed on the SIX Swiss Exchange, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Stock Market, or Nasdaq, and other applicable securities rules and regulations that impose various requirements on non-U.S. reporting public companies, including the establishment and maintenance of effective disclosure and financial controls and certain additional corporate governance practices. Our board of directors and other personnel will be required to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, we will be required to furnish a report on our internal control over financial reporting. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section 404 within the prescribed period, we are engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by Section 404. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain significant shareholders will continue to own a substantial number of our securities and as a result, may be able to exercise significant influence over the outcome of shareholder votes. These shareholders may have different interests from us or your interests. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a number of significant shareholders. For an overview of our current significant shareholders, please see &#34;Principal Shareholders.&#34; Following the completion of this offering, these significant shareholders and their affiliates, in the aggregate, will own approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % of our common shares (including common shares represented by the ADSs). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we are not aware that any of our existing shareholders have entered or will enter into a shareholders' agreement with respect to the exercise of their voting rights. Nevertheless, depending on the level of attendance at our general meetings of shareholders, or the General Meeting, these significant shareholders could have the ability to significantly influence the outcome of decisions taken at any such General Meeting. Any such voting by these shareholders may not be in accordance with our interests or those of our other shareholders. Among other consequences, this concentration of ownership may have the effect of delaying or preventing a change in control and might therefore negatively affect the market price of the ADSs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales, or the possibility of future sales, of a substantial number of our securities could adversely affect the price of the shares and dilute shareholders. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our existing shareholders sell, or indicate an intent to sell, substantial amounts of our securities in the public market, the trading price of the ADSs and our common shares could decline significantly and, in case of the ADSs, could decline below the public offering price in this offering. Upon completion of this offering, we will have &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; outstanding common shares outstanding (including common shares represented by the ADSs), approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of which are subject to a&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -day contractual lock-up. The representatives of the underwriters may permit us and the holders of the shares subject to lock-up agreements to sell shares or ADSs prior to the expiration of the lock-up agreements. See &#34;Underwriting.&#34; After the lock-up agreements pertaining to this offering expire, and based on the number of common shares (including common shares represented by ADSs) outstanding upon completion of this offering, these&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional common shares will be eligible for sale in the public market, all of which shares are held by directors and certain members of our executive management and will be subject to volume limitations under Rule 144 under the Securities Act of 1933, as amended, or the Securities Act, for sales in the United States. In addition, common shares subject to outstanding options under our equity incentive plans and the common shares reserved for future issuance under our equity incentive plan will become eligible for sale in the public market in the future, subject to certain legal and contractual limitations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to register all common shares that we may issue under our equity compensation plans. Once we register these common shares, they can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates and the lock-up agreements described in the &#34;Shares and ADSs Eligible for Future Sale&#34; section of this prospectus. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of our articles of association or Swiss corporate law might deter acquisition bids for us that might be considered favorable and prevent or frustrate any attempt to replace or remove the then board of directors. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions of our articles of association may make it more difficult for a third party to acquire control of us. For example, our board of directors is authorized to deny the preemptive rights of shareholders and allocate them to third parties as a defense of an actual, threatened or potential takeover bid, in relation to which our board of directors, upon consultation with an independent financial adviser retained by it, has not recommended to the shareholders acceptance on the basis that the board of directors has not found the takeover bid to be financially fair to the shareholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, several provisions of Swiss corporate law and certain other provisions of Swiss law, such as obligations to disclose significant shareholdings and merger control regulations, that apply to us may make an unsolicited tender offer, merger, change in management or other change in control of our company more difficult. These provisions could discourage potential takeover attempts that other shareholders may consider to be in their best interest and could adversely affect the market price of our securities. These provisions may also have the effect of depriving ADS holders of the opportunity to sell their ADSs at a premium. In addition, the board of directors of Swiss companies may in certain instances, and subject to prior authorization by the shareholders, deter or frustrate public takeover bids through dilutive issuances of equity securities (pursuant to the authorized capital) or through share buy-backs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If you purchase ADSs in this offering, you will suffer immediate dilution of your investment. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public offering price of the ADSs is substantially higher than the as adjusted net tangible book value per ADS. Therefore, if you purchase ADSs in this offering, you will pay a price per ADS that substantially exceeds our as adjusted net tangible book value per ADS after this offering. To the extent outstanding options are exercised, you will incur further dilution. Based on the assumed public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;  per ADS, you will experience immediate dilution of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  per ADS, representing the difference between our as adjusted net tangible book value per ADS after giving effect to this offering and the public offering price. See &#34;Dilution.&#34;   </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in the use of the net proceeds from this offering and may not use them effectively. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors will have broad discretion in the application of the net proceeds from this offering and could spend the proceeds in ways that do not improve our results of operations or enhance the value of the ADSs. The failure by our board of directors to apply these funds effectively could result in financial losses that could have a material adverse effect on our business, cause the price of the ADSs to decline and delay the development of our product candidates. Pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or that loses value. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluctuations in exchange rates may increase the risk of holding ADSs and common shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the international scope of our operations, our assets, earnings and cash flows are influenced by movements in exchange rates of several currencies, particularly the euro, U.S. dollar and Swiss franc. Our functional currency is the Swiss franc, and the majority of our operating expenses are paid in Swiss franc, but we also receive or may receive payments from business partners in U.S. dollars, and we regularly acquire services, consumables and materials in U.S. dollars and euros. Further, potential future revenue may be derived from abroad, particularly from the United States or the European Union. As a result, our business and the price of the ADSs and common shares may be affected by fluctuations in foreign exchange rates between the Swiss franc and these other currencies, which may also have a significant impact on our reported results of operations and cash flows from period to period. Besides natural hedging, currently, we do not have any exchange rate hedging arrangements in place. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, because our common shares currently trade on the SIX Swiss Exchange in Swiss francs, and the ADSs will trade on the Nasdaq Global Market in U.S. dollars, fluctuations in the exchange rate between the U.S. dollar and the Swiss franc may result in temporary differences between the value of the ADSs and the value of our common shares, which may result in heavy trading by investors seeking to exploit such differences. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will be traded on more than one market and this may result in price variations and adversely affect the liquidity and value of the ADSs&#59; in addition, investors may not be able to easily move common shares for trading between such markets. Furthermore, because of this dual listing, securities and stock exchange laws, regulations and rules will apply to us that may be irreconcilable or otherwise difficult to comply with contemporaneously. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares have traded on the SIX Swiss Exchange since 2014 and our ADSs will be traded on the Nasdaq Global Market. Trading in our ADSs or common shares on these markets takes place in different currencies (U.S. dollars on the Nasdaq Global Market and Swiss Francs on the SIX Swiss Exchange), and at different times (resulting from different time zones, different trading days and different public holidays in the United States and Switzerland). The trading prices of our common shares and our ADSs on these two markets may differ due to these and other factors. Any decrease in the price of our common shares on the SIX Swiss Exchange could cause a decrease in the trading price of our ADSs on the Nasdaq Global Market. Investors could seek to sell or buy our common shares to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">take advantage of any price differences between the markets through a practice referred to as arbitrage. Any arbitrage activity could create unexpected volatility in both our share prices on one exchange and the common shares available for trading on the other exchange. In addition, holders of ADSs cannot immediately surrender their ADSs and withdraw the underlying common shares for trading on the other market without effecting necessary procedures with the depositary. This could result in time delays and additional cost for holders of ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, our ADSs will be admitted to trading and listed on the Nasdaq Global Market, while our common shares will continue to be admitted to trading and listed on the SIX Swiss Exchange. Because different types of our equity securities will be admitted to trading and listed on two different stock exchanges in two different jurisdictions, two sets of securities laws and regulations and stock exchange rules will apply to us contemporaneously. It cannot be excluded that the laws, regulations and&#47;or rules of one jurisdiction or trading venue may require us to effect disclosures or filings or grant shareholders and&#47;or holders of our ADSs certain rights that would be unlawful under the laws, regulations and&#47;or rules of the respective other jurisdiction or trading venue. For this or other reasons, it may prove difficult or impossible for us to at all times comply with the laws, regulations and&#47;or rules of both jurisdictions and trading venues at the same time. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of ADSs are not treated as holders of our common shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By participating in this offering you will become a holder of ADSs with underlying common shares in a Swiss corporation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Holders of ADSs are not treated as holders of our common shares, unless they withdraw the common shares underlying their ADSs in accordance with the deposit agreement and applicable laws and regulations. The depositary is the holder of the common shares underlying the ADSs. Holders of ADSs therefore do not have any rights as holders of our common shares, other than the rights that they have pursuant to the deposit agreement. See &#34;Description of American Depositary Shares.&#34; </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of ADSs may be subject to limitations on the transfer of their ADSs and the withdrawal of the underlying common shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to time when it deems expedient in connection with the performance of its duties. The depositary may refuse to deliver, transfer or register transfers of ADSs generally when our books or the books of the depositary are closed, or at any time if we or the depositary think it is advisable to do so because of any requirement of law, government or governmental body, or under any provision of the deposit agreement, or for any other reason, subject to the right of ADS holders to cancel their ADSs and withdraw the underlying common shares. Temporary delays in the cancellation of your ADSs and withdrawal of the underlying common shares may arise because the depositary has closed its transfer books or we have closed our transfer books, the transfer of common shares is blocked to permit voting at a shareholders' meeting or we are paying a dividend on our common shares. In addition, ADS holders may not be able to cancel their ADSs and withdraw the underlying common shares when they owe money for fees, taxes and similar charges and when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of common shares or other deposited securities. See &#34;Description of American Depositary Shares&#8212;Withdrawal of Common Shares Upon Cancellation of ADSs.&#34; </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are entitled to amend the deposit agreement and to change the rights of ADS holders under the terms of such agreement, or to terminate the deposit agreement, without the prior consent of the ADS holders.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are entitled to amend the deposit agreement and to change the rights of the ADS holders under the terms of such agreement, without the prior consent of the ADS holders. We and the depositary may agree to amend the deposit agreement in any way we decide is necessary or advantageous to us or to the depositary. Amendments may reflect, among other things, operational changes in the ADS program, legal developments affecting ADSs or changes in the terms of our business relationship with the depositary. In the event that the terms of an amendment are materially disadvantageous to ADS holders, ADS holders will only receive 30 days&#8217; advance notice of the amendment, and no prior consent of the ADS holders is required under the deposit agreement. Furthermore, we may decide to direct the depositary to terminate the ADS facility at any time for any reason. For example, terminations may occur if we become the subject of a takeover or a going-private transaction. If the ADS facility will terminate, ADS holders will receive at least 30 days&#8217; prior notice, but no prior consent is required from them. Under the circumstances that we decide to make an amendment to the deposit agreement that is disadvantageous to ADS holders or terminate the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deposit agreement, the ADS holders may choose to sell their ADSs or surrender their ADSs and become direct holders of the underlying </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">common </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares, but will have no right to any compensation whatsoever.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deposit agreement governing the ADSs representing our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">common </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares provides that, to the fullest extent permitted by law, holders and beneficial owners of ADSs irrevocably waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to the ADSs or the deposit agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this jury trial waiver provision is not permitted by applicable law, an action could proceed under the terms of the deposit agreement with a jury trial. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by the United States Supreme Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of New York, which govern the deposit agreement, by a federal or state court in the City of New York, which has non-exclusive jurisdiction over matters arising under the deposit agreement. In determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider whether a party knowingly, intelligently and voluntarily waived the right to a jury trial. We believe that this is the case with respect to the deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before entering into the deposit agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you or any other holders or beneficial owners of ADSs bring a claim against us or the depositary in connection with matters arising under the deposit agreement or the ADSs, including claims under federal securities laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits against us and&#47;or the depositary. If a lawsuit is brought against us and&#47;or the depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature of the claims, the judge or justice hearing such claims, and the venue of the hearing.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No condition, stipulation or provision of the deposit agreement or ADSs serves as a waiver by any holder or beneficial owner of ADSs or by us or the depositary of compliance with any substantive provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, as the jury trial waiver relates to claims arising out of or relating to the ADSs or the deposit agreement, we believe that, as a matter of construction of the clause, the waiver would likely to continue to apply to ADS holders who withdraw the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">common </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares from the ADS facility with respect to claims arising before the cancellation of the ADSs and the withdrawal of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">common </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares, and the waiver would most likely not apply to ADS holders who subsequently withdraw the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">common </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares represented by ADSs from the ADS facility with respect to claims arising after the withdrawal. However, to our knowledge, there has been no case law on the applicability of the jury trial waiver to ADS holders who withdraw the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">common </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares represented by the ADSs from the ADS facility.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You will not have the same voting rights as the holders of our common shares and may not receive voting materials in time to be able to exercise your right to vote. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described in this prospectus and the deposit agreement, holders of the ADSs will not be able to exercise voting rights attaching to the common shares represented by the ADSs. Under the terms of the deposit agreement, holders of the ADSs may instruct the depositary to vote the common shares underlying their ADSs. Otherwise, holders of ADSs will not be able to exercise their right to vote unless they withdraw the common shares underlying their ADSs in accordance with the deposit agreement and applicable laws and regulations to vote them in person or by proxy in accordance with applicable Swiss laws and regulations and our articles of association. Even so, ADS holders may not know about a meeting far enough in advance to withdraw those common shares. If we ask for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instructions of holders of the ADSs, the depositary, upon timely notice from us, will notify ADS holders of the upcoming vote and arrange to deliver our voting materials to them. Upon our request, the depositary will mail to holders a shareholder meeting notice that contains, among other things, a statement as to the manner in which voting instructions may be given. We cannot guarantee that ADS holders will receive the voting materials in time to ensure that they can instruct the depositary to vote the common shares underlying their ADSs. A shareholder is only entitled to participate in, and vote at, the meeting of shareholders, provided that its shares are recorded in its name at midnight (Central European Time) at the end of the 28th day preceding the date of the meeting of shareholders. In addition, the depositary's liability to ADS holders for failing to execute voting instructions or for the manner of executing voting instructions is limited by the deposit agreement. As a result, holders of ADSs may not be able to exercise their right to give voting instructions or to vote in person or by proxy and they may not have any recourse against the depositary or us if their common shares are not voted as they have requested or if their shares cannot be voted. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our management may have the right to vote the shares underlying your ADSs</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the deposit agreement, if the depositary asks for your instructions how to vote the shares underlying your ADSs but does not receive those instructions by a specified date, the depositary may give a proxy to our management to vote those shares. This provision may tend to increase the power of our management as against shareholders and make it more difficult for ADS holders and our shareholders to exercise effective control over our board of directors and other matters submitted to a vote by shareholders.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A beneficial owner of our common shares that is not registered in our shareholders register may not be able to exercise certain rights attached to the common shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial rights attached to our common shares transfer to a holder of those shares upon purchasing such shares in a stock market transaction. Any voting rights or rights related to voting rights only transfer once the acquirer has been registered in the shareholders' register as shareholder of such common shares. A beneficial owner that is not directly registered in the shareholders' register can enjoy the financial rights, voting rights and rights related to voting rights only through the entity that acts as nominee or depositary for those common shares and is recorded in the shareholders' register as the shareholder of record of those shares. This is also the case if you hold ADSs. It is possible that a nominee or a depositary will be unwilling to exercise certain rights attached to the common shares, such as rights that require litigation. Therefore, failing to register in the shareholders' register may result in your inability to exercise certain rights as a shareholder. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay dividends in the foreseeable future. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not paid any dividends since our incorporation. Even if future operations lead to significant levels of distributable profits, we currently intend that any earnings will be reinvested in our business and that dividends will not be paid until we have an established revenue stream to support continuing dividends. In addition, payment of any future dividends to shareholders would be subject to shareholder approval at our General Meeting, upon proposal of the board of directors, which proposal would be subject to the approval of the majority of the non-executive directors after taking into account various factors including our business prospects, cash requirements, financial performance and new product development. In addition, certain limitations apply to the payment of future dividends pursuant to Swiss law and our articles of association. See &#34;Description of Share Capital and Articles of Association.&#34; For the taxation of future dividend payments, see &#34;Swiss Tax-Implications for U.S. Holders.&#34; In addition, payment of future cash dividends may be made only if our shareholders' equity exceeds the sum of our paid-in and called-up share capital plus the reserves required to be maintained by Swiss law or by our articles of association. Accordingly, investors cannot rely on cash dividend income from ADSs and any returns on an investment in the ADSs will likely depend entirely upon any future appreciation in the price of the ADSs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The registration of the authorized share capital increase in the commercial register may be blocked and the shareholders&#8217; resolutions regarding the creation of the underlying authorized share capital may be challenged.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This offering is based on, among other things, approval by the Company&#8217;s shareholders at the annual general meeting to be held on April&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021 of resolutions regarding the creation of authorized share capital necessary to source the common shares underlying the ADSs to be sold in this offering, and subject to, among other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">things, the execution by our board of directors of the share capital increase by which the common shares underlying the ADSs to be sold in this offering will be created, and the related filings that will need to be made prior to the completion of this offering. The issuance of new common shares will become effective upon registration in the commercial register. As with all share capital increases in Switzerland, the shareholders&#8217; resolutions regarding such share capital increase may be challenged in court within two months after such shareholders&#8217; meeting and&#47;or the registration of the capital increase in the commercial register may be blocked temporarily by a preliminary injunction or permanently by order of a competent court. Either action would prevent or delay the completion of this offering.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You may not receive distributions on our common shares represented by our ADS or any value for them if it is illegal or impractical to make them available to holders of ADSs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the depositary for our ADSs will agree to pay to you or distribute the cash dividends or other distributions it or the custodian receives on our common shares or other deposited securities after deducting its fees and expenses. You will receive these distributions in proportion to the number of our common shares your ADSs represent. However, in accordance with the limitations that we expect will be set forth in the deposit agreement, it may be unlawful or impractical to make a distribution available to holders of ADSs. We have no obligation to take any other action to permit the distribution of our ADSs, common shares, rights or anything else to holders of our ADSs. This means that you may not receive the distributions we make on our common shares or any value from them if it is unlawful or impracticable to make them available to you. These restrictions may have a material adverse effect on the value of your ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of our common shares outside Switzerland and ADS holders may not be able to exercise pre-emptive rights.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, shareholders may receive certain pre-emptive rights to subscribe on a pro rata basis for issuance of equity or other securities that are convertible into equity. Due to laws and regulations in their respective jurisdictions, however, non-Swiss shareholders may not be able to exercise such rights unless we take action to register or otherwise qualify the rights offering under the laws of that jurisdiction. There can be no assurance that we would take any such action and we reserve the right to determine whether we should take such action in any jurisdiction. If shareholders in such jurisdictions were unable to exercise their subscription rights, their ownership interest in the Company would be diluted. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADS holders have no pre-emptive rights to subscribe to newly issued shares unless we grant such rights to the foreign depositary. The right to exercise such pre-emptive rights is set out in the agreement between the ADS holder and the depositary.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a Swiss corporation. The rights of our shareholders may be different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a Swiss corporation. Our corporate affairs are governed by our articles of association and organizational rules and by the laws governing companies, including listed companies, incorporated in Switzerland. The rights of our shareholders and the responsibilities of members of our board of directors may be different from the rights and obligations of shareholders and directors of companies governed by the laws of U.S. jurisdictions. In the performance of its duties, our board of directors is required by Swiss law to consider the interests of our company, and may also have regard to the interests of our shareholders, our employees and other stakeholders, in all cases with due observation of the principles of reasonableness and fairness. It is possible that some of these parties will have interests that are different from, or in addition to, your interests as a holder of ADSs. Swiss corporate law limits the ability of our shareholders to challenge resolutions made or other actions taken by our board of directors in court. Our shareholders generally are not permitted to file a suit to reverse a decision or an action taken by our board of directors but are instead only permitted to seek damages for breaches of fiduciary duty. As a matter of Swiss law, shareholder claims against a member of our board of directors for breach of fiduciary duty would have to be brought to the competent courts in Schlieren, Canton of Zurich, Switzerland, or where the relevant member of our board of directors is domiciled. In addition, under Swiss law, any claims by our shareholders against us must be brought exclusively to the competent courts in Schlieren, Canton of Zurich, Switzerland. See &#8220;Description of Share Capital and Articles of Association&#8221; and &#8220;Comparison of Shareholder Rights.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, the Swiss Parliament approved legislation that will modernize certain aspects of Swiss corporate law. See &#34;Description of Share Capital and Articles of Association&#8212;Certain Important Provisions of our Articles of Association, Organizational Rules and Swiss Law.&#34; The new legislation, which will alter the rights of shareholders under Swiss law, is currently expected to come into force in 2023 or later. There can be no assurance that Swiss law will not once again change in the future, which could adversely affect the rights of our shareholders or holders of our ADSs. Furthermore, there can be no guarantee that Swiss law does or will protect our shareholders or the holders of our ADSs in a similar fashion as the laws of U.S. jurisdictions would, in particular as regards corporate law principles, if we were a U.S.-incorporated company.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our common shares are issued under the laws of Switzerland, which may not provide investors with the same protections provided by incorporation in Delaware.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized under the laws of Switzerland. A further summary of applicable Swiss law is contained in this prospectus. See &#34;Description of Share Capital and Articles of Association,&#34; &#34;Limitations Affecting Shareholders of a Swiss Company&#34; and &#34;Comparison of Shareholder Rights.&#34; There can be no assurance that Swiss law will not change in the future or that it will provide investors with the same protections afforded to investors of a Delaware corporation, which could adversely affect the rights of investors. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Claims of U.S. civil liabilities may not be enforceable against us. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated under the laws of Switzerland and our registered office and domicile is located in Schlieren, Switzerland. Substantially all of our assets are located outside the United States. A number of our directors and executive officers are not residents of the United States. As a result, it may not be possible for investors to effect service of process within the United States upon such persons or to enforce judgments obtained  against them or us in U.S. courts, including judgments predicated upon the civil liability provisions of the U.S. federal securities laws. We have been advised by our Swiss counsel that there is doubt as to the enforceability in Switzerland of original actions, or in actions for enforcement of judgments of U.S. courts, of civil liabilities to the extent solely predicated upon the federal and state securities laws of the United States. Original actions against persons in Switzerland based solely upon the U.S. federal or state securities laws are governed, among other things, by the principles set forth in the Swiss Federal Act on Private International Law.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States currently does not have a treaty with Switzerland providing for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. Consequently, a final judgment for payment given by a court in the United States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized or enforceable in Switzerland. In order to obtain a judgment which is enforceable in Switzerland, the party in whose favor a final and conclusive judgment of the U.S. court has been rendered will be required to file its claim with a court of competent jurisdiction in Switzerland. Such party may submit to the Swiss court the final judgment rendered by the U.S. court. If and to the extent that the Swiss court finds that the jurisdiction of the U.S. court has been based on grounds which are internationally acceptable and that proper legal procedures have been observed, the court of Switzerland will, in principle, give binding effect to the judgment of the U.S. court, unless such judgment contravenes principles of public policy of Switzerland. Also, mandatory provisions of Swiss law may be applicable regardless of any other law that would otherwise apply. Swiss courts may deny the recognition and enforcement of punitive damages or other awards. Moreover, a Swiss court may reduce the amount of damages granted by a U.S. court and recognize damages only to the extent that they are necessary to compensate actual losses or damages. Enforcement and recognition of judgments of U.S. courts in Switzerland are solely governed by the provisions of the Swiss Federal Private International Law Act. This statute provides in principle that a judgment rendered by a non-Swiss court may be enforced in Switzerland only if&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the non-Swiss court had jurisdiction pursuant to the Swiss Federal Act on Private International Law&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the judgment of such non-Swiss court has become final and non-appealable&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the judgment does not contravene Swiss public policy&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the court procedures and the service of documents leading to the judgment were in accordance with the due process of law&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no proceeding involving the same position and the same subject matter was first brought in Switzerland, or adjudicated in Switzerland, or was earlier adjudicated in a third state and this decision is recognizable in Switzerland.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the lack of a treaty as described above, U.S. investors may not be able to enforce against us or members of our board of directors or certain experts named herein who are residents of Switzerland or countries other than the United States any judgments obtained in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities laws. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our status as a Swiss corporation means that our shareholders enjoy certain rights that may limit our flexibility to raise capital, issue dividends and otherwise manage ongoing capital needs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss law reserves for approval by shareholders certain corporate actions over which a board of directors would have authority in some other jurisdictions. For example, the payment of dividends and cancellation of treasury shares must be approved by shareholders. Swiss law also requires that our shareholders themselves resolve to, or authorize our board of directors to, increase our share capital. While our shareholders may authorize share capital that can be issued by our board of directors without additional shareholder approval, Swiss law limits this authorization to 50% of the share capital registered in the commercial register  at the time of the authorization. The authorization, furthermore, has a limited duration of up to two years and must be renewed by the shareholders from time to time thereafter in order to be available for raising capital. Additionally, subject to specified exceptions, including exceptions explicitly described in our articles of association, Swiss law grants pre-emptive rights to existing shareholders to subscribe for new issuances of shares, which may be limited or withdrawn only under certain limited conditions. Swiss law also does not provide as much flexibility in the various rights and regulations that can attach to different categories of shares as do the laws of some other jurisdictions. These Swiss law requirements relating to our capital management may limit our flexibility, and situations may arise where greater flexibility would have provided benefits to our shareholders. See &#34;Description of Share Capital and Articles of Association,&#34; &#34;Limitations Affecting Shareholders of a Swiss Company&#34; and &#34;Comparison of Shareholder Rights under Swiss and Delaware Corporate Law.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a foreign private issuer and, as a result, we are not subject to U.S. proxy rules and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report under the Securities Exchange Act of 1934, as amended, or the Exchange Act, as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (i) the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act&#59; (ii) the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time&#59; and (iii) the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events. In addition, foreign private issuers are not required to file their annual report on Form 20-F until 120 days after the end of each fiscal year, while U.S. domestic issuers that are accelerated filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information. As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a foreign private issuer and as permitted by the listing requirements of Nasdaq, we rely on certain home country governance practices rather than the corporate governance requirements of Nasdaq. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a foreign private issuer. As a result, in accordance with Nasdaq Listing Rule 5615(a)(3), we comply with home country governance requirements and certain exemptions thereunder rather than complying with certain of the corporate governance requirements of Nasdaq.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss law does not require that a majority of our board of directors consist of independent directors. Our board of directors therefore may include fewer independent directors than would be required if we were subject to Nasdaq Listing Rule 5605(b)(1). In addition, we are not subject to Nasdaq Listing Rule 5605(b)(2), which requires that independent directors regularly have scheduled meetings at which only independent directors are present.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Swiss law also requires that we adopt a compensation committee, we follow home country requirements with respect to such committee. As a result, our practice varies from the requirements of Nasdaq Listing Rule 5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation committees. In addition, in accordance with Swiss law, we have opted not to implement a nominating committee. We have opted out of shareholder approval requirements for the issuance of securities in connection with certain events such as the acquisition of stock or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of us and certain private placements. To this extent, our practice varies from the independent director oversight of director nominations requirements of Nasdaq Listing Rule 5605(e).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, in accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. Our practice thus varies from the requirement of Nasdaq Listing Rule 5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock. To this extent, our practice varies from the requirements of Nasdaq Listing Rule 5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For an overview of our corporate governance principles, see &#8220;Description of Share Capital and Articles of Association&#8212;Certain Important Provisions of our Articles of Association, Organizational Rules and Swiss Law.&#8221; As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may lose our foreign private issuer status which would then require us to comply with the Exchange Act's domestic reporting regime and cause us to incur significant legal, accounting and other expenses. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a foreign private issuer, and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. We may no longer be a foreign private issuer as of June 30, 2022 (the end of our second fiscal quarter in the fiscal year after this offering), which would require us to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers as of January 1, 2022. In order to maintain our current status as a foreign private issuer, either (a) a majority of our common shares must be either directly or indirectly owned of record by non-residents of the United States or (b)(i) a majority of our executive officers or directors may not be U.S. citizens or residents, (ii) more than 50% of our assets cannot be located in the United States and (iii) our business must be administered principally outside the United States. If we lost foreign private issuer status, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We would be required to change our accounting from reporting under IFRS to reporting under U.S. generally accepted accounting principles. We would also be required to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time consuming and costly. We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would make it more difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult for us to attract and retain qualified members of our board of directors. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#34;emerging growth company,&#34; and we cannot be certain if the reduced reporting requirements applicable to &#34;emerging growth companies&#34; will make the ADSs less attractive to investors. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#34;emerging growth company,&#34; as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For as long as we continue to be an &#34;emerging growth company,&#34; we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not &#34;emerging growth companies,&#34; including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As an &#34;emerging growth company,&#34; we are required to report only two years of financial results and selected financial data compared to three and five years, respectively, for comparable data reported by other public companies. We may take advantage of these exemptions until we are no longer an &#34;emerging growth company.&#34; We could be an &#34;emerging growth company&#34; for up to the last day of the fiscal year ending after the fifth anniversary of our initial U.S. public offering, although circumstances could cause us to lose that status earlier, including if the aggregate market value of our common shares held by non-affiliates exceeds $700 million as of any June 30 (the end of our second fiscal quarter) before that time, in which case we would no longer be an &#34;emerging growth company&#34; as of the following December 31 (our fiscal year-end). We cannot predict if investors will find the ADSs less attractive because we may rely on these exemptions. If some investors find the ADSs less attractive as a result, there may be a less active trading market for the ADSs and the price of the ADSs may be more volatile. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of ADSs representing our shares or our shares.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inadequate internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of ADSs representing our shares or our shares.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management will be required to assess the effectiveness of our internal controls annually beginning with our second annual report to be filed with the SEC. However, for as long as we are an &#8220;emerging growth company&#8221; under the JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. An independent assessment of the effectiveness of our internal controls could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls could lead to financial statement restatements requiring us to incur the expense of remediation and could also result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts cease coverage of us, or publish inaccurate or unfavorable research about our business, the price of the ADSs and our trading volume could decline. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for the ADSs and our common shares will depend in part on the research and reports that securities or industry analysts publish about us or our business. If no or too few securities or industry analysts cover us, the trading price for the ADSs and our common shares would likely be negatively affected. If one or more of the analysts who cover us downgrade the ADSs or our common shares or publish inaccurate or unfavorable research about our business, the price of the ADSs and our common shares would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for the ADSs and our common shares could decrease, which might cause the price of the ADSs and our common shares and trading volume to decline. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be at risk of securities class action litigation.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because biotechnology and biopharmaceutical companies have experienced significant share price volatility in recent years. If we were to be sued, it could result in substantial costs and diversion of management's attention and resources, which could harm our business. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are or become classified as a passive foreign investment company, U.S. holders of ADSs may suffer adverse tax consequences as a result.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, for any taxable year, if at least 75% of our gross income is passive income, or at least 50% of the value of our assets is attributable to assets that produce passive income or are held for the production of passive income, including cash, we will be characterized as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes. For purposes of these tests, passive income includes dividends, interest, gains from commodities and securities transactions, the excess of gains over losses from the disposition of assets which produce passive income (including amounts derived by reason of the temporary investment of funds raised in offerings of our shares or ADSs) and rents and royalties other than rents and royalties which are received from unrelated parties in connection with the active conduct of a trade or business. If we are characterized as a PFIC, U.S. holders of our ADSs may suffer adverse tax consequences, including having gains realized on the sale of our ADSs treated as ordinary income rather than capital gain, the loss of the preferential rate applicable to dividends received on ADSs by individuals who are U.S. holders, and having interest charges apply to certain distributions by us and gains from the sales of our ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our status as a PFIC will depend on the nature and composition of our income and the nature, composition and value of our assets. Our status may also depend, in part, on how quickly we utilize the cash proceeds from this or any future offering of our common shares or ADSs in our business. Based upon the value of our assets and the nature and composition of our income and assets, we believe we may have been classified as a PFIC for the taxable year ended December 31, 2020, although no assurances can be made in this regard. We have not yet determined whether we were a PFIC for the taxable year ended December 31, 2020. In addition, we may be classified as a PFIC for the taxable year ended December 31, 2021. Because the determination of whether we are a PFIC for any taxable year is a factual determination made annually after the end of each taxable year, there can be no assurance that we will not be considered a PFIC in any taxable year. Accordingly, our U.S. counsel expresses no opinion with respect to our PFIC status for our taxable year ended December 31, 2020, and also expresses no opinion with regard to our expectations regarding our PFIC status in the future.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax consequences that would apply if we are classified as a PFIC would be different from those described above if a U.S. holder of ADSs were able to make a valid qualified electing fund, or QEF, election. At this time, we do not expect to provide U.S. holders of ADSs with the information necessary for a U.S. shareholder to make a QEF election. Accordingly, prospective investors should assume that a QEF election will not be available.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus, particularly the sections of this prospectus titled &#8220;Prospectus Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business,&#8221; contains forward-looking statements. All statements other than present and historical facts and conditions contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy, plans and our objectives for future operations, are forward-looking statements. Forward looking statements are based on our management's beliefs and assumptions and on information currently available to our management. When used in this prospectus, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;designed,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;objective,&#8221; &#8220;should,&#8221; or the negative of these and similar expressions identify forward-looking statements. Forward-looking statements include, but are not limited to, statements about&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, timing, progress and results of our clinical trials and preclinical studies, and our research and development programs&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to advance product candidates into, and successfully complete, clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of regulatory filings and the likelihood of favorable regulatory outcomes and approvals&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the regulatory treatment of our product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory developments in the European Union, United States and other countries&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commercialization of our product candidates, if approved&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing and reimbursement of our product candidates, if approved&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to contract on commercially reasonable terms with third-party suppliers and manufacturers&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model and strategy and the development of our product candidates and technology platforms&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of protection we are able to establish, obtain and maintain for intellectual property rights covering our product candidates and technology and our ability to protect and enforce such rights&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to operate our business without infringing on, misappropriating or otherwise violating the intellectual property rights of others&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of third parties with whom we contract to successfully conduct, supervise and monitor clinical trials for our product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimates of our expenses, future revenues, capital requirements and our needs for additional financing&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional funding for our operations&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential benefits of our strategic collaboration agreements and our ability to enter into future strategic arrangements&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain and establish collaborations or obtain additional funding&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate and degree of market acceptance of our product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19 on our business, operations and prospects and on our clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key scientific and management personnel&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and our industry, including competing therapies&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expected use of proceeds from the offering&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the future trading price of the ADSs and impact of securities analysts reports on these prices&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other risks and uncertainties, including those listed under the caption &#8220;Risk Factors.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should refer to the section of this prospectus titled &#8220;Risk Factors&#8221; for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. The Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act do not protect any forward-looking statements that we make in connection with this offering. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus is a part with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">MARKET, INDUSTRY AND OTHER DATA</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus contains estimates, projections and other information concerning our industry, our business and the markets for our product candidates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from our own internal estimates and research as well as from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources which we believe to be reliable. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, assumptions and estimates of our and our industry&#8217;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the section titled &#8220;Risk Factors.&#8221; These and other factors could cause our future performance to differ materially from our assumptions and estimates. See &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_28"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">TRADEMARKS AND SERVICE MARKS </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own trademark registrations for &#8220;Molecular Partners</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;DARPin</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Switzerland, the European Union, the United States and Japan. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other trade names, trademarks and service marks of other companies appearing in this prospectus are the property of their respective holders. Solely for convenience, the trademarks and trade names in this prospectus may be referred to without the&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or display other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that we will receive net proceeds from this offering of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming a public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per  American Depositary Shares, or ADS, based on the closing price of our common shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, and assuming no exercise of the underwriters&#8217; option to purchase additional ADSs. If the underwriters exercise in full their options to purchase additional ADSs, we estimate that we will receive net proceeds from this offering of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming a public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our common shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each&#160;$1.00 (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) increase (decrease) in the assumed offering price of&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share, based on the closing price of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, would increase or decrease our net proceeds from the offering by&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming the number of ADSs offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions. We may also increase or decrease the number of ADSs we are offering. An increase or decrease of 1,000,000 ADSs offered by us would increase or decrease the net proceeds to us from the sale of the ADSs we are offering by&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming that the assumed offering price remains the same and after deducting underwriting discounts and commissions. The actual net proceeds payable to us will adjust based on the actual number of ADSs offered by us, the actual offering price and other terms of the offering determined at pricing.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect to use the net proceeds from this offering, together with our existing cash and cash equivalents of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as follows&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million to fund our planned Phase 1 clinical trial for MP0317, the second product candidate in our oncology program&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million to advance the development of our infections disease program including our COVID-19 antiviral product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million to advance our liquid tumor portfolio initially with acute myeloid leukemia, or AML, and leveraging our CD3 platform to develop additional product candidates thereafter&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the remainder to fund the advancement of our platform and other potential product candidates, working capital and other general corporate purposes.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have no specific plans as to how the net proceeds from this offering will be allocated beyond the expected uses specified above and therefore management will retain discretion with respect to the use of the remainder of the net proceeds of this offering. We may also use a portion of the net proceeds to acquire, license or invest in complementary products, technologies or businesses&#59; however, we currently have no agreements, plans or commitments to complete any such transaction.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual expenditures and the extent of clinical development may vary significantly depending on numerous factors, including the progress of our development efforts, the status of and results from preclinical studies and any ongoing clinical trials or clinical trials that we may commence in the future, as well as any collaboration that we may enter into with third parties for our product candidates and any unforeseen cash needs. As a result, our future financing needs remain uncertain and our management will retain broad discretion over the allocation of the net proceeds from this offering. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of capital preservation investments, including term deposits, short-term, investment-grade, interest-bearing instruments and government securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">DIVIDEND POLICY </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any dividends on our common shares and we do not anticipate paying dividends on our equity securities in the foreseeable future. Instead, we intend to retain any earnings for use in the operation and expansion of our business, including for continued advancement of our proprietary DARPin product candidates, investment in research and development, building up our late-stage clinical development and, eventually, commercialization abilities. As a result, investors in our common shares or ADSs will benefit in the foreseeable future only if the common shares or ADSs appreciate in value.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for us to declare and pay dividends, the distribution must be approved by shareholders holding an absolute majority of the common shares represented at the general meeting of shareholders. Our board of directors may propose distributions in the form of a common dividend or in the form of a distribution of cash or property that is based upon a reduction of our share capital recorded in the commercial register.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common dividends may be paid only if we have sufficient distributable profits from previous years  (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gewinnvortrag</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or freely distributable reserves to allow the distribution of a dividend, in each case, as presented on our annual statutory standalone balance sheet prepared in accordance with Swiss company law after deduction of allocated statutory reserves and reserves required by our articles of association (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Statuten</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Our auditor must confirm that a proposal made by the board of directors to shareholders regarding the appropriation of our available earnings conforms to the requirements of the Swiss Code of Obligations of March 30, 1911, as amended, the CO, and our articles of association. In order for us to pay dividends to our shareholders out of reserves from capital contributions (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a shareholders&#8217; meeting must approve by the absolute majority of votes cast the reclassification of such reserves from capital contributions to freely distributable reserves (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frei verf&#252;gbare Reserven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (to the extent permissible by the CO). Furthermore, dividends can be paid out of reserves from capital reserves only if the same amount is paid out of the annual profit or ordinary reserves. Dividends and distributions against reserves from capital contributions are usually due and payable after the shareholders&#8217; resolution relating to the allocation of profit and distribution against reserves from capital contributions (if applicable) has been passed at the shareholders&#8217; meeting or at a later date as determined by the shareholders&#8217; dividend resolution. Under Swiss law, the statute of limitations with respect to dividend payments is five years. Dividends not collected within five years after their due date accrue to us and will be allocated to our general reserves. Dividends paid on common shares are subject to Swiss federal withholding tax, except if paid out of reserves from capital contributions. See &#8220;Swiss Tax Implications for U.S. Holders&#8212;Swiss Tax Considerations&#8212;Swiss Federal Withholding Tax&#8221; for a summary of certain Swiss tax consequences regarding dividends  and other distributions distributed to holders of our common shares. As of December 31, 2020, we had reserves from capital contributions in an aggregate  amount of CHF 275,557,000 of which CHF 127,557,000 were legal capital reserves and CHF 148,000,000 were free reserves.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A distribution of cash or property that is based on a reduction of our share capital requires a special audit report confirming that the claims of our creditors remain fully covered by our assets despite the reduction in the share capital recorded in the commercial register. Upon approval by the general meeting of the shareholders of the capital reduction, our board of directors must give public notice of the capital reduction in the Swiss Official Gazette of Commerce three times and notify our creditors that they may request, within two months of the third publication, satisfaction of or security for their claims. Distributions of cash or property that are based upon a capital reduction are not subject to Swiss federal withholding tax. See &#8220;Swiss Tax Implications for U.S. Holders&#8212;Swiss Tax Considerations&#8212;Swiss Federal Withholding Tax&#8221; for a summary of certain Swiss tax consequences regarding distributions paid on the common shares that are based upon a capital reduction. For a description of share capital reductions under the revised Swiss corporate law expected to enter into force in 2023, see &#34;Description of Share Capital and Articles of Association&#8212;Dividends and Other Distributions.&#34;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend distributions, if any in the future, will be declared and paid in Swiss francs and converted into U.S. dollars with respect to the ADSs, as provided in the deposit agreement. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors determines the date on which the dividend entitlement starts. Dividends are usually due and payable shortly after the shareholders have passed the resolution approving the payment, but shareholders may also resolve at the ordinary general meeting of shareholders to pay dividends in quarterly or other installments.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the taxation of dividends, see the section in this prospectus entitled &#8220;Swiss Tax Implications for U.S. Holders&#8212;Swiss Tax Considerations&#8212;Swiss Federal Withholding Tax.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_43"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">CAPITALIZATION</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our capitalization as of December 31, 2020&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on an actual basis&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">and on an as adjusted basis to reflect the issuance and sale of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ADSs in this offering at an assumed offering price of&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our common shares on the SIX Swiss Exchange on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capitalization following this offering will be adjusted based on the actual public offering price and other terms of this offering determined at pricing, including the amount by which actual offering expenses are higher or lower than estimated. The table should be read in conjunction with the information contained in &#8220;Use of Proceeds,&#8221; &#8220;Selected Financial Data&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; as well as our financial statements and the related notes included elsewhere in this prospectus. </font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Actual</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As adjusted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents and short-term time deposits</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,721&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital, 29,146,992 shares issued and outstanding, actual&#59;</font><font style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares issued and outstanding, as adjusted</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,479&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative losses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,174)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,220&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 50.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capitalization</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,220&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Each&#160;$1.00 (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) increase or decrease in the assumed offering price of&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our common shares on the SIX  Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, would increase or decrease each of as adjusted cash and cash equivalents and short-term time deposits, as adjusted total shareholders' equity and as adjusted total capitalization by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;), assuming that the number of ADSs, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting commissions and estimated offering expenses payable by us. Subject to applicable law, we may also increase or decrease the number of ADSs we are offering. Each increase or decrease of 1,000,000 ADSs offered by us, set forth on the cover page of this prospectus, would increase or decrease each of as adjusted total shareholders' equity and as adjusted total capitalization by approximately&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;), assuming that the assumed offering price remains the same, and after deducting underwriting commissions and estimated offering expenses payable by us. The as adjusted information discussed above is illustrative only and will change based on the actual offering price, the actual number of ADSs offered by us and other terms of the offering determined at pricing.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common shares to be outstanding after this offering is based on a total of 29,146,992 common shares outstanding as of December 31, 2020 and excludes&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">382,059 common shares issuable upon the exercise of options at a weighted average price of CHF 6.42 ($7.26) per common share granted under our employee stock option plans and long-term equity incentive plans but not exercised as of December 31, 2020&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">445,198 PSUs and 87,906 RSUs granted under our employee stock option plans and long-term equity incentive plans but not vested as of December 31, 2020.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_46"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">DILUTION </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you invest in our ADSs in this offering, your ownership interest will be diluted to the extent of the difference between the public offering price per ADS in this offering and the as adjusted net tangible book value per ADS after this offering. Our net tangible book value as of December 31, 2020 was CHF 106.9 million ($120.9 million), or CHF 3.67 ($4.15) per ADS. Net tangible book value per common share was determined by dividing our total assets less our intangible assets and our total liabilities by the number of common shares outstanding as of December 31, 2020, and excludes 382,059 common shares issuable upon the exercise of options at a weighted average price of CHF 6.42 ($7.26) per common share granted under our employee stock option plans and long-term equity incentive plans, but not exercised as of December 31, 2020, and 445,198 PSUs and 87,906 RSUs granted under our employee stock option plans and long-term equity incentive plans, but not vested as of December 31, 2020.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After giving effect to the receipt of the estimated net proceeds from our sale of ADSs in the offering, assuming a public offering price $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our common shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, and the application of the estimated net proceeds therefrom as described under &#8220;Use of Proceeds,&#8221; our as adjusted net tangible book value at December 31, 2020 would have been approximately CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;), or CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per common share. This represents an immediate increase in net tangible book value per ADS of CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) to existing shareholders and an immediate dilution in net tangible book value per ADS of CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) to you, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; %. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates this dilution on an ADS basis.  </font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed public offering price per ADS</font></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tangible book value per ADS as of December 31, 2020</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net tangible book value per ADS attributable to new investors</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As adjusted net tangible book value per ADS after this offering</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilution per ADS to new investors</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilution information discussed above is illustrative only and will change based on the actual offering price and other terms of the offering determined at pricing. Each&#160;$1.00 (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) increase or decrease in the assumed offering price of&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our common shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, would increase or decrease our as adjusted net tangible book value by approximately&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;), or approximately&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, and the dilution to new investors participating in the offering would be approximately&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, assuming that the number of ADSs offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting underwriting discounts and commissions. We may also increase or decrease the number of ADSs we are offering. An increase of 1,000,000 ADSs offered by us would increase the as adjusted net tangible book value by approximately CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;), or&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, and the dilution to new investors participating in the offering would be&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, assuming that the assumed offering price remains the same, and after deducting underwriting discounts and commissions. Similarly, a decrease of 1,000,000 ADSs offered by us would decrease the as adjusted net tangible book value by approximately&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;), or&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, and the dilution to new investors participating in the offering would be&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, assuming that the assumed offering price remains the same, and after deducting underwriting discounts and commissions. The as adjusted information discussed above is illustrative only and will be adjusted based on the actual offering price, the actual number of ADSs offered by us, and other terms of the offering determined at pricing.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the underwriters exercise their option to purchase additional ADSs in full, the as adjusted net tangible book value per share after the offering would be&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, the increase in the as adjusted net tangible book value to existing shareholders would be&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, and the dilution to new investors participating in the offering would be&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, consideration paid to us in cash for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares purchased from us by our existing shareholders and by new investors participating in this offering (including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares represented by ADSs), based on an assumed offering price of&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(CHF  &#160;&#160;&#160;&#160;)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per ADS, based on the closing price of our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares on the SIX Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, and before deducting underwriting discounts and commissions and estimated offering expenses payable by us&#58;</font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADSs purchased</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total consideration</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="6" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average price <br>per ADS</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing shareholders</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New investors</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each&#160;$1.00 (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) increase or decrease in the assumed offering price of&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) per ADS, based on the closing price of our common shares on the SIX  Swiss Exchange on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, would increase or decrease the total consideration paid by new investors participating in the offering by&#160;CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming that the number of ADSs offered by us, as set forth on the cover page of the prospectus, remains the same and before deducting underwriting discounts and commissions. We may also increase or decrease the number of ADSs we are offering. An increase or decrease in 1,000,000 ADSs offered by us would increase or decrease the total consideration paid by new investors participating in the offering by CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ($&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) million, assuming that the assumed offering price remains the same and before deducting underwriting discounts and commissions. The as adjusted information discussed above is illustrative only and will be adjusted based on the actual offering price, the actual number of ADSs offered by us and other terms of the offering determined at pricing.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if the underwriters exercise their option to purchase additional ADSs in full, the number of shares held by the existing shareholders after this offering would be reduced to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, or &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the total number of common shares (including common shares represented by ADSs) outstanding after this offering, and the number of shares held by new investors participating in this offering (including common shares represented by ADSs) would increase to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, or &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the total number of common shares outstanding after this offering (including common shares represented by ADSs).</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables and calculations above are based on the number of common shares that will be outstanding after this offering is based on 29,146,922 common shares outstanding as of December 31, 2020 and excludes&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">382,059 common shares issuable upon the exercise of options at a weighted average price of CHF 6.42 ($7.26) per common share granted under our employee stock option plans and long-term equity incentive plans but not exercised as of December 31, 2020&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">445,198 PSUs and 87,906 RSUs granted under our employee stock option plans and long-term equity incentive plans but not vested as of December 31, 2020.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_49"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SELECTED FINANCIAL DATA</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following selected statement of comprehensive loss data for the years ended December 31, 2020 and 2019 and the selected statement of financial position data as of December 31, 2020 and  2019 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our audited consolidated financial statements have been prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our historical results for any prior period do not necessarily indicate our results to be expected for any future period. The following selected financial data for the periods and as of the dates indicated are qualified by reference to and should be read in conjunction with our financial statements and related notes beginning on page F-1 of this prospectus, as well as the sections entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Exchange Rate Information&#8221; included elsewhere in this prospectus. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We maintain our books and records in Swiss franc, and we prepare our financial statements in accordance with IFRS as issued by the IASB. We report our financial results in Swiss franc. For the convenience of the reader, we have translated Swiss franc amounts as of and for the year ended December 31, 2020 into U.S. dollars at the noon buying rate of the Federal Reserve Bank of New York on December 31, 2020, which was CHF 1.00 to $1.1311. These translations should not be considered representations that any such amounts have been, could have been or could be converted into U.S. dollars at that or any other exchange rate as of that or any other date.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Statement of Comprehensive Loss Data</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended<br> December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,569&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,075)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,426)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,498)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,595)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,115)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,545)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating result</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,326)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,973)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,660)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,816)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,447)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Result before income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,775)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,005)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,271)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net result, attributable to shareholders</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,764)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,992)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,288)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net result per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.84)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.69)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">See Note 21 to our audited financial statements appearing elsewhere in this prospectus for a description of the method used to compute basic and diluted net result per share.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Statement of Financial Position Data</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:58.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents plus short-term time deposits</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,721</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,496</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,080&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,546</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,133</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,935&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,479</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,741</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,849&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,326)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,857)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,796)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative losses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,174)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220,761)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,870)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,220</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,277</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,139&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_52"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read together with the information in &#34;Selected Financial Data&#34; and our Annual Financial Statements, including the notes thereto. The following discussion is based on our financial information prepared in accordance with IFRS as issued by the IASB, which may differ in material respects from generally accepted accounting principles in other jurisdictions, including generally accepted accounting principles in the United States, or U.S. GAAP. The following discussion includes forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those described under &#34;Risk Factors&#34; and elsewhere in this prospectus.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For the convenience of the reader, we have translated some Swiss franc amounts as of and for the year ended December 31, 2020 into U.S. dollars at the noon buying rate of the Federal Reserve Bank of New York on December 31, 2020, which was CHF1.00 to $1.1311. These translations should not be considered representations that any such amounts have been, could have been or could be converted into U.S. dollars at that or any other exchange rate as of that or any other date.</font></div><div id="iae433ad4a4734c849aad6029347be986_55"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage biopharmaceutical company applying our pioneering DARPin product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology. Our DARPin platform, which is designed using ankyrin repeat proteins, allows us to build product candidates with multiple mechanisms of action to address complex biological problems, while potentially offering patients products with higher efficacy and fewer adverse events. We believe that DARPins represent a novel class of drugs with broad therapeutic applications that may overcome many of the limitations of conventional protein and antibody-based therapeutics. Our DARPin product candidates have been extensively tested in preclinical studies and clinical trials, including in approximately 2,000 patients in ophthalmology, infectious disease (SARS-CoV-2) and oncology, and have been observed to be highly active, present differentiated product profiles and be generally well-tolerated.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DARPin proteins are designed using natural repeat proteins, a class of binder proteins that are common in humans and most other species. Since our formation, we have gone on to develop and upgrade our DARPin libraries to include over a trillion DARPin modules, which we refer to as single-domain DARPins. Selected single-domain DARPins then serve as building blocks to create our multi-specific DARPin product candidates, which are able to engage multiple targets. Beyond the benefit of multi-specificity, DARPin constructs can be intelligently designed to be active only under certain conditions, including via slow activation mechanisms, or activation at site-specific tumor microenvironments.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting with a target patient or disease, we can rapidly generate thousands of different DARPin product candidates to interrogate a specific biological target, or targets, to address an underlying medical need. We are able to perform target-specific screenings not only with our single-domain DARPins, but also with numerous multi-specific DARPin candidates constructed from these single-domain DARPins, allowing us to screen for the ideal properties within potential multi-specific product candidates. As a result, we believe that we can combine multiple promising biological solutions in one product candidate, as in the case of MP0423, a product candidate from our infectious disease program that is designed to neutralize the spike protein of SARS-CoV-2 using up to three distinct mechanisms. Further, we believe our DARPin platform allows us to identify novel mechanisms of action, as in the case of AMG 506 (MP0310) and MP0317, the lead product candidates from our oncology program, which will only activate immune stimulating targets when clustered on fibroblast activation protein, or FAP, a tumor specific localizer.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a therapeutic class, DARPin proteins demonstrate advantageous development properties including stability, solubility and manufacturing yield-to-cost benefits. In our preclinical studies and clinical trials, we have observed that our DARPin product candidates perform as designed and are well tolerated. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our in-house DARPin programs are initially focused on infectious diseases, where we have seen positive progress on our first COVID-19 antiviral therapeutic product candidates, and our oncology program, where we see great potential in the utility and flexibility of DARPin molecules to offer differentiated cancer treatments. Given the momentum of our COVID-19 antiviral therapeutic product candidates and the severity of the ongoing COVID-19 pandemic, we are also expanding our research and development activities in our infectious disease program to tackle other current and future viral threats.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were co-founded by the inventors of our DARPin platform and our operations to date have focused upon organizing and staffing our company, business planning, raising capital, developing our DARPin platform and conducting research and preclinical studies and clinical trials. We do not have any products approved for sale. For the years ended December&#160;31, 2020 and 2019, we incurred net losses attributable to shareholders of CHF 62.8&#160;million and CHF 36.3&#160;million, respectively. As of December&#160;31, 2020, we had cumulative losses of CHF 195.2&#160;million. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur significant expenses and operating losses for the foreseeable future as we advance the clinical development of DARPin product candidates, and seek regulatory approval and pursue commercialization of DARPin products, if approved. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity and debt financings or other sources, including payments upon achievement of certain development, regulatory and sales milestone events and royalty payments under our existing partnership agreements, and future collaborations with other third parties. We cannot assure you that adequate additional financing will be available to us on acceptable terms, or at all. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2020, we have received a total of CHF 286.9 million in funding from our major partnership agreements. From inception through December 31, 2020, we have obtained a total of CHF 244.1 million in four equity financing rounds, net of cost of capital increases. Since November 2014, we have been listed on the SIX Swiss Exchange, or SIX, under the symbol &#8220;MOLN.&#8221; As of December 31, 2020, we had cash and cash equivalents plus short-term time deposits of CHF 173.7 million ($196.5 million).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recent Developments - COVID-19</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, a novel strain of coronavirus disease that causes COVID-19 was identified in Wuhan, China. The SARS-CoV-2 coronavirus has spread to a number of countries globally, and the disease outbreak was declared a pandemic by the World Health Organization in March 2020. In response, many countries around the world, including European countries and the United States, have imposed quarantines and restrictions on travel and mass gatherings to slow the spread of the virus, and have closed non-essential businesses. We have taken various mitigation measures in response to the pandemic, including requesting most of our employees that are not required to work in the laboratory to work remotely. To date, we have not experienced any material business disruption as a result of the COVID-19 pandemic.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty as to the duration and likely effects of this disease which may, among other things, materially impact our planned future clinical trials or ability to raise funding in the future. This pandemic or outbreak could result in difficulty securing clinical trial site locations, ability to enroll patients in future trials, CROs, and&#47;or trial monitors and other critical vendors and consultants supporting future trials. For example, our Phase 1 trial of ensovibep, our lead COVID-19 antiviral product candidate, has been delayed due to an inability to dose healthy volunteers due to government restrictions in the UK, starting at the end of 2020, in response to the pandemic. These situations, or others associated with COVID-19, could cause delays in our future clinical trial plans, delays in obtaining regulatory approval for potential products and could increase expected costs, all of which could have a material adverse effect on our business and financial condition. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 will impact our results and operations will depend on future developments that cannot be reliably predicted, including actions to contain or treat the disease and mitigate its impact on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">economies of the affected countries, among others. We will continue to monitor, assess and mitigate the COVID-19 pandemic and its potential impact on our business and operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensing and Collaboration Agreements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option and Equity Rights Agreement with Novartis</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we entered into an Option and Equity Rights agreement with Novartis, or the Novartis Agreement. Under the Novartis Agreement, we granted Novartis an option to exclusively license global rights of MP0420 and MP0423, our COVID-19 anti-viral DARPin product candidates. Under the terms of the Novartis Agreement, we received a non-refundable cash payment of CHF 20 million for development activities regarding technology transfer and manufacturing for the commercial supply of MP0420. As part of the transaction, Novartis also agreed to acquire CHF 40 million worth of our ordinary shares, at a price of CHF 23 per share. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Novartis Agreement, we will conduct Phase 1 clinical trials for MP0420. Additionally, if we and Novartis agree, we will perform all remaining preclinical work for MP0423 and conduct the MP0423 Phase 1 trial, and Novartis would pay us two milestone payments of CHF 2.5 million each in case of initiation and completion of such MP0423 Phase 1 trial. Novartis will conduct certain Phase 2&#47;3 clinical trials, with us as legal sponsor of the trials. We are responsible for supplying materials for clinical development of MP0420. We expect to commence a Phase 2&#47;3 clinical trial for MP0420 in        and MP0423 is currently being manufactured as we prepare for a Phase 1 clinical trial.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Novartis exercises its option, we would receive an upfront payment of CHF 150 million. In addition, Novartis would be obligated to pay us a 22% royalty on future commercial sales in certain agreed territories, as we have agreed to forgo royalties in lower-income countries. Upon exercise of such option, Novartis would be responsible for all further development and commercialization activities. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License and Collaboration Agreement with Amgen</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into a license and collaboration agreement with Amgen, or the Amgen Agreement, for the clinical development and commercialization of MP0310 &#47; AMG 506. Under the terms of the Amgen Agreement, we granted to Amgen an exclusive worldwide, royalty-bearing, sublicensable license under our patents and know-how to develop and commercialize MP0310 &#47; AMG 506. We retain the right to use our technology to perform our obligations under the Amgen Agreement and for all purposes not granted to Amgen, including certain rights to develop and commercialize our DARPin products in combination with MP0310 &#47; AMG 506. MP0310 &#47; AMG 506 is currently in Phase 1a clinical trials.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a non-refundable upfront payment of $50 million. In addition, we are eligible to receive up to $497 million in development, regulatory and commercial milestone payments. We are also entitled to receive tiered royalties based on commercial sales levels from low double digit up to the high teens percentages of net sales of licensed products for a specified period beginning with the first commercial sale of such a licensed product in a given country of sale and expiring no earlier than ten years after such sale. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abicipar Agreement with Allergan, an AbbVie Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2011, we entered into a license and collaboration agreement with Allergan, or the Allergan Agreement. Under the Allergan Agreement, we granted Allergan an exclusive, worldwide, royalty-bearing, sublicensable license under our patents and know-how relating to abicipar and other backup compounds to make, use, sell, offer for sale, and import products containing abicipar and its corresponding backups for ophthalmic indications. We retain the right to use our technology to perform our obligations under the license agreement, to conduct general research and discovery of DARPin compounds other than those licensed under the license agreement, and for all other uses not granted to Allergan. In addition, we granted Allergan a worldwide, perpetual, irrevocable, fully paid-up, royalty-free, exclusive, sublicensable license under certain joint inventions to make, use, sell, offer for sale and import certain compounds and products (other than DARPin compounds) outside of the field of ophthalmic diseases.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allergan is responsible, at its expense, for developing and commercializing abicipar, and must use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize abicipar in certain key countries, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including the United States, several major European markets and Japan. Allergan is also solely responsible for manufacture of abicipar, following a manufacturing technology transfer by us to Allergan.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allergan paid us an upfront license fee of $45 million in May 2011 and a regulatory milestone fee of $15 million upon the initiation of its Phase 3 clinical trials for nAMD in July 2015. We are also eligible to receive up to an additional $210 million upon the achievement of certain development and regulatory milestone events and $150 million upon the achievement of certain sales milestone events. In addition, we will receive a tiered royalty percentage ranging from the low to mid-teens on worldwide, aggregate annual net sales of abicipar for a specified period beginning with the first commercial sale of such a licensed product in a given country of sale and expiring no earlier than ten years after such sale.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, Allergan announced that the U.S. Food and Drug Administration issued a Complete Response Letter to the Biologics License Application for abicipar. AbbVie is to determine appropriate next steps with relevant regulatory agencies.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discovery Alliance Agreement with Allergan, an AbbVie Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2012, we entered into an exclusive discovery alliance agreement, or the Discovery Alliance Agreement, under we and Allergan agreed to collaborate to design and develop DARPin products against selected targets that are implicated in causing diseases of the eye. We and Allergan amended the Discovery Alliance Agreement in June 2013, September 2014, August 2016 and December 2017. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted Allergan three exclusive options to obtain an exclusive license under our patents and know-how to make, use, sell, offer for sale, and import products containing DARPin compounds directed against the applicable biological target for use with ophthalmological diseases. We also granted Allergan a non-exclusive license under our intellectual property as necessary for Allergan to conduct its activities under the Discovery Alliance Agreement during the research term in the field of ocular diseases. In February 2018, Allergan exercised its last of the three options. Upon execution of each option, Allergan is solely responsible for all downstream development, manufacturing, and commercialization activities, at its expense. Allergan must use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize licensed products.  We must use commercially reasonable efforts to perform our research activities under the Discovery Alliance Agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Discovery Alliance Agreement, we may not make, use, sell, offer for sale, import or otherwise develop, manufacture, commercialize or exploit certain DARPin compounds that bind to collaboration targets or their isoforms in the field of ocular diseases, or any DARPin compound that binds VEGF-A.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a one-time, non-refundable and non-creditable upfront payment of $40 million and a further $1.5 million upfront payment in connection with a 2014 amendment to the Discovery Alliance Agreement, and Allergan paid us an option exercise fee of $10 million upon its exercise of further options. In July 2015, Allergan made an accelerated payment of $30 million for the exercise of these options. We are eligible to receive additional success-based payments, including up to $960 million in development, regulatory and sales milestones. In addition, Allergan pays us tiered royalties ranging from the mid-single digits to the low-double digits on worldwide annual net sales of licensed products.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reservation Agreement with the Swiss Federal office of Public Health</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, we announced the reservation by the Swiss Federal Office of Public Health&#58; Bundesamt f&#252;r Gesundheit, or FOPH-BAG, of a defined number of initial doses of ensovibep, our lead COVID-19 antiviral therapeutic product candidate. The reservation agreement resulted in a current contract liability of CHF 7.0 million, as presented in the consolidated statement of financial position. The agreement consists of two reservation rights&#58; the first being FOPH-BAG's option to have priority access to the first 200,000 doses produced&#59; and the second being FOPH-BAG's option to obtain access to 5% of the additional planned total production, up to 3,000,000 doses, if such production is undertaken by us. Certain pricing provisions have been pre-negotiated, but remain subject to final therapeutic dose and while there is preferential pricing for the initial doses, which results in a performance obligation, the pricing for any further doses is expected to be at market prices. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the period ending December 31, 2020, we have met the contractually agreed milestone specified in the contract, meaning that the reservation fee received from the FOPH-BAG is no longer refundable. However, as the fee refers to a reservation right, it will only be recognized as revenue in case of successful development of a final drug and exercise or lapse of the related reservation right or, alternatively, in case the results from the research will not justify further development of the drug.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Royalties and License Fees</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreement with the University of Zurich</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold an exclusive. worldwide license from the University of Zurich on patent applications and patents relating to the DARPin base technology. The primary patents under this license agreement will expire in September 2021.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While such license agreement remains in effect, we are required to pay the University of Zurich flat royalties of a low single digit percentage on net sales of licensed products, which vary based on the field in which the licensed product is commercialized. In addition, we are obligated to pay the University of Zurich a percentage of license fee revenues it receives from sublicensing its rights to third parties in five tiers, ranging from the low single digits to the low teens, depending on the total amount of payments received for the particular sublicense granted. Finally, we are also obligated to pay the University of Zurich a percentage of the royalty payments it receives from sublicensees in three tiers based on their net sales of licensed products and the applicable field in which the licensed product is sold, ranging from the low single digits to the mid-teens.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Operations Overview</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, we have entered into partnerships pursuant to which we generally have been and will be entitled to upfront fees and milestone payments upon the achievement of pre-determined development, regulatory and sales events. Our revenue to date has primarily consisted of amounts received under our collaboration agreements, including upfront fees, option exercise fees, milestone payments and sponsored research payments. In addition, under the collaboration agreements, we will generally be entitled to royalty payments on the net sales of products ultimately developed and commercialized under our partnerships. For any of our proprietary product candidates that we have not yet licensed, we may decide to retain all or a portion of the commercialization rights. To date, we have not generated any revenue from commercial product sales.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue may vary substantially from quarter to quarter and year to year, depending on the structure and timing of milestone events, as well as the development and marketing strategies of commercialization partners from whom we will be entitled to receive royalty and other payments. We believe that period-to-period comparisons of our results of operations are therefore not meaningful and should not be relied on or to be indicative of our future performance. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist primarily of costs associated with research, preclinical studies and clinical testing, personnel-related costs and, to a lesser extent, royalty and license fees, facility expenses, professional fees for legal, tax, audit and strategic purposes, administrative expenses and depreciation of property, plant and equipment. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our operating expenses to increase substantially as compared to prior periods in connection with our ongoing activities, particularly as we continue the development of our proprietary product candidates, expand our proprietary product pipeline and invest in our DARPin platform. Our operating expenses may vary substantially from period to period mainly driven by the timing of enrollment of patients in clinical trials and other research and development activities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, upon the closing of this offering, we expect to incur additional costs associated with operating as a public company in the United States, hiring additional personnel and, potentially, expanding our facilities. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of compensation and other expenses related to&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development personnel&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Preclinical studies and clinical trials of our product candidates, including the costs of manufacturing the product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and services under our partnership agreements&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Attributable facility expenses, including depreciation and amortization of equipment and any intangible research and development assets. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2020, we cumulatively have spent a cash amount of approximately CHF 289 million on research and development activities which we classify as research and development expense for financial reporting purposes.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, we cannot reasonably estimate the nature, timing and estimated costs of the efforts that will be necessary to complete the development of, or the period, if any, in which material net cash inflows may commence from, any of our product candidates. This is due to numerous risks and uncertainties associated with developing product candidates, including the uncertainty of&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, rate of progress, results and cost of our clinical trials, preclinical studies and other related activities&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of manufacturing clinical supplies and establishing commercial supplies of our product candidates and any products that we may develop&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and characteristics of product candidates that we pursue&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost, timing, and outcomes of regulatory approvals&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing sales, marketing and distribution capabilities&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of any collaborative, licensing and other arrangements that we may establish, including any required milestone and royalty payments thereunder.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in the outcome of any of these variables with respect to the development of any of our current or future product candidates could mean a significant change in the costs and timing associated with the development of such product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, due to the inherently unpredictable nature of preclinical and clinical development and given the early stage of many of our programs and&#47;or product candidates, we generally do not track our internal research and development expenses on a program-by-program basis as they primarily relate to personnel, research and consumable costs, which are deployed across multiple projects under development. A portion of our research and development costs are external costs, which we do track on a program-by-program basis following the program's </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nomination to the development candidate stage. Included in table below are our external research and development expenses as well as external clinical and regulatory costs, presented by our most significant programs&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:49.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">External research and development expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP0250</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,024&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,641&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP0274</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP0310</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP0317</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,286&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,382&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP0420 &#47; MP0423</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,442&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,549&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,968&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,619&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,260</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,834</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,233</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charge all research and development expenses, including internal patent filing and patent maintenance costs, to research and development expenses when incurred, as the criteria for capitalization are currently not met.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative costs principally consist of salaries and related benefits, including share-based compensation, for personnel in our executive, finance and other administrative functions. Other general and administrative costs include facility-related costs and professional services fees for auditing, tax and general legal services, as well as expenses associated with the requirements of being a listed public company listed in Switzerland on the SIX. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial income and financial expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial income consists primarily of interest earned on our cash and cash equivalents and short-term time deposits as well as realized and unrealized gains of foreign exchange. The financial expenses are driven by realized and unrealized foreign exchange losses. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes and taxation</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating entities in two jurisdictions. In Switzerland, due to losses incurred to-date, we have not paid any income taxes since inception. For our U.S. based activities, we have paid the required tax amounts of both federal and state taxes, which are not material to our financial results.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are entitled under Swiss laws to carry forward any losses incurred for a period of seven years and can offset our losses carried forward against future taxes. As of December 31, 2020, in Switzerland, we had tax loss carry-forwards totaling CHF 157.9 million. No deferred tax assets have been recognized for these tax loss carry-forwards because it is not probable that such loss carry-forwards can be utilized in the foreseeable future. In addition, no deferred tax assets were recognized on other deductible temporary differences (e.g- pension liabilities) due to the significant tax losses carried forward.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_58"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Results of Operations</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our statements of income for the years ended December 31, 2020 and 2019 (in thousands CHF and thousands USD for reference only)&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:36.903%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.657%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2019</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Variance</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended <br>December 31, 2020</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from research and development collaborations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,039)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,569&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,344</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,383</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,039)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,569</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,075)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,498)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,577)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,426)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,595)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,545)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,115)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(67,670)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57,043)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,627)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(76,542)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating result</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58,326)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36,660)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21,666)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(65,973)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,232)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,816)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,606)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,447)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Result before income taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,775)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36,271)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26,504)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(71,005)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net result, attributable to shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,764)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36,288)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26,476)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70,992)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Operations for the Years Ended December 31, 2020 and 2019</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2020, we recognized total revenues of CHF 9.3 million, a decrease of 54% compared to the year ended December 31, 2019, in which we recognized total revenues of CHF 20.4 million. All revenue recognized in 2020 and 2019 was the result of our collaboration agreement with Amgen. We recognize revenue based on the ratio of the associated costs incurred to date and the total forecasted costs to satisfy the performance obligation. During the second half of 2020, we increased our estimate of the total future costs required to satisfy the performance obligation under the collaboration agreement. This increase resulted in a lower amount of revenue recognized for the twelve month period ended December 31, 2020, as compared to the comparable prior year period.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses in the year ended December 31, 2020 increased by CHF 10.6 million, or 19%, to CHF 67.7 million, compared to CHF 57.1 million in the year ended December 31, 2019. These costs included CHF 4.2 million in non-cash effective share-based compensation and pension costs as well as CHF 2.9 million in depreciation. The two major expense categories were personnel expenses of CHF 33.6 million, representing 50% of total operating expenses, and research materials and costs, totaling CHF 26.6 million, or 39% of total operating expenses. Personnel expenses for the year ended December 31, 2020 increased, in part, due to increases in our number of full-time employees as compared to the year ended December 31, 2019.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expenses in the year ended December 31, 2020 increased by CHF 12.6 million, or 29%, to CHF 56.1 million, compared to CHF&#160;43.5 million in the year ended December 31, 2019. This increase was mainly due to progress in our pipeline of product candidates, including our investment in our COVID-19 antiviral </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product candidates, and increased personnel costs, in part due to increases in our number of full-time employees as compared to the year ended December 31, 2019.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total selling, general and administrative expenses in the year ended December 31, 2020 decreased by CHF 2.0 million, or 15%, to CHF 11.6 million, compared to CHF 13.6 million in the year ended December 31, 2019. This decrease was, mainly due to lower professional fees.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial income &#47; financial expense</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2020, we recorded a net financial loss of CHF 4.4 million, compared to a net financial income of CHF 0.4 million in 2019. This loss is primarily attributable to foreign exchange losses of CHF 4.5 million on our cash and cash equivalents and short-term time deposits positions held in currencies other than the Swiss franc.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December 31, 2020 and 2019, we did not pay or accrue any income taxes in Switzerland. Molecular Partners Inc., our U.S. subsidiary, is subject to U.S. federal corporate income taxes and state income taxes for Massachusetts and California.</font></div><div id="iae433ad4a4734c849aad6029347be986_61"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2020, we have raised an aggregate of  CHF 244.1 million of net proceeds from the sale of our common shares and collected cash under our partnership agreements in an aggregate of CHF 286.9 million. Our primary uses of cash are to fund our ongoing research and development activities. We currently have no ongoing material financing commitments, such as lines of credit or guarantees.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, we had CHF 173.7 million and CHF 95.1 million, respectively, in cash and cash equivalents and short-term time deposits. We are investing our cash in risk-free money market instruments in line with our treasury guidelines to accommodate our financial needs over time. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the research and development of, continue or initiate clinical trials of, and seek marketing approval for, our product candidates. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to program sales, marketing, manufacturing and distribution to the extent that such sales, marketing and distribution are not the responsibility of current or future collaborators. Furthermore, following the completion of this offering, we expect to incur additional costs associated with operating as a public company in the United States. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs or future commercialization efforts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of our cash flows for the periods indicated&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:52.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.856%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br>December 31, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of<br>December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in USD thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,721&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,712&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,244&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,368&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173,721</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196,496</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95,080</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,983)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,783)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,189)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,746)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,597)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,836)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash from  &#47; (used in) financing activities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,202&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,043&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses on cash positions</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,464)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,049)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net increase (decrease) in cash and cash equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,614</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,246)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term time deposits at December 31, 2020 contain three positions in CHF with two major Swiss banks. The short-term time deposits at December 31, 2019 contain one position in USD with a major Swiss bank.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in operating activities</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, operating activities used CHF 29.0 million of cash, primarily as a result of the net loss attributable to shareholders of CHF 62.8 million partially offset by an increase in contract liability of CHF 17.6 million, and non-cash share based compensation costs of CHF 2.9 million.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, operating activities used CHF 1.2 million of cash, primarily as a result of the net loss attributable to shareholders of CHF 36.3 million but largely offset by an increase in trade and other receivables of CHF 49.6 million arising from the Amgen collaboration agreement and a reduction in contract liability of CHF 20.4 million related to that same agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in investing activities</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, we used net cash from investing activities of CHF 21.7 million, and in the year ended December, 31, 2019, we used CHF 19.8 million of cash in investing activities. In both years these amounts are related to net investments into short-term time deposits.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, a CHF 1.7 million outflow was recorded for capital expenditure in equipment and intangible assets and a CHF 0.6 million inflow was recorded from interest. During the year ended December 31, 2019,  a CHF 1.9 million outflow was recorded for capital expenditure in equipment and intangible assets and a CHF 1.4 million inflow was recorded from interest.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (used in) financing activities</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, net cash from financing activities was CHF 113.2 million, primarily related to the issuance of new shares that were issued following a financing round completed in July 2020 and as a result of the Option and Equity Rights agreement concluded with Novartis in October 2020.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, net cash used in financing activities was CHF 0.2 million, of which CHF 1.2 million related to the payment of the principal portion of our lease liabilities, offset by CHF 1.0 million received from the exercise of employee stock options.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding requirements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the net proceeds from this offering, together with our existing cash and cash equivalents and short-term time deposits, will be sufficient to fund our operating expenses and capital expenditure requirements for at least &#160;into &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. However, our present and future funding requirements may change and will depend on many factors, including, among other things&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timelines for preclinical and clinical development programs&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change in product development plans needed to address any set-backs in our research and development activities&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scope, prioritization and number of clinical trials and research and development  activities&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rate of progress and cost of the clinical trials, and other research and development activities&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terms and timing of any collaborative, licensing and other arrangements that may be established&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs and timing of preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the need or decision to acquire or license complementary compounds, technologies or complementary businesses or companies&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory approval, manufacturing or commercialization of our product candidates for which we receive marketing approval through partners&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs, timing and outcome of regulatory review of our product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs and timing of future commercialization activities, including drug manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive marketing approval&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory policies or laws that affect our operations&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competing medical treatment and market developments.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our operating expenses to increase over the next several years as we expand our research and development activities. In addition, we do not know whether any additional financings will be available at all or available on commercially acceptable terms when needed. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of any additional securities may include liquidation or other preferences that adversely affect your rights as a shareholder. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through additional collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</font></div><div id="iae433ad4a4734c849aad6029347be986_64"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Commitments</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and December 31, 2019, we did not have any capital commitments.</font></div><div id="iae433ad4a4734c849aad6029347be986_67"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defined under IFRS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_70"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our financial statements appearing at the end of this prospectus.</font></div><div id="iae433ad4a4734c849aad6029347be986_73"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate primarily in Switzerland, Europe and in the United States and are therefore exposed to market risk, which represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had cash and cash equivalents plus short-term time deposits of CHF 173.7 million ($196.5 million). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign exchange risk</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate primarily in Switzerland, Europe and in the United States and our functional currency is the Swiss franc, and as a result, we are exposed to (1) transactional foreign exchange risk when we enter into a transaction in a currency other than our functional currency and (2) translational foreign exchange risk when we translate our financial statements from USD into our functional currency. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to reduce our foreign exchange exposure, we may enter into currency contracts with selected high-quality financial institutions to hedge against foreign currency exchange rate risks. Our hedging policy is (1) to maximize natural hedging by matching expected future cash flows in the different currencies and (2) to consider hedging some of the remaining expected net currency exposure as the need arises. However, due to market volatilities and uncertainties in the cash flows, a 100% hedging of the currency exposure is impossible.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit risk</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum credit risk on financial instruments corresponds to the carrying amounts of our cash and cash equivalents and receivables. We have not entered into any guarantees or similar obligations that would increase the risk over and above the carrying amounts. As of December 31, 2020, substantially all of our cash and cash equivalents were held at major financial institutions located in Switzerland. We believe that these financial institutions are of high credit quality and continually monitor the credit worthiness of these financial institutions. We enter into partnerships with partners that have the appropriate credit history and a commitment to ethical business practices. Other receivables with credit risk mainly include interest receivables.</font></div><div id="iae433ad4a4734c849aad6029347be986_76"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Estimates and Judgments</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we have prepared in accordance with International Financial Reporting Standards, or IFRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our accounts are prepared on a going concern basis. The preparation of our financial statements in conformity with IFRS requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, contingent liabilities, income and expenses. These estimates take into consideration historical experience, developments in economic circumstances, known trends and current events, actions that we may undertake in the future and various other factors that we believe are reasonable under the circumstances. These estimates are subject to risks and uncertainties. Our actual results may deviate from these estimates. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are described in more detail in Note&#160;2 to our financial statements appearing elsewhere in this prospectus, we believe that the following accounting policy is the most critical to the judgments and estimates used in the preparation of our financial statements.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuation in revenues is common to biopharmaceutical companies focused on research and development as the revenues are often linked to up-front fees, reservation fees, milestones or license payments as well as income for delivery of drug substance, which occur sporadically. Depending on the complexity of the relevant agreements, judgment (for instance in regards to the performance obligations recognized using the cost based method, where </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue is recognized based on costs incurred in relation to our estimate of total estimated costs to complete satisfaction of the underlying performance obligations) is required to reflect the substance of the arrangement in the recognition of revenues. Under the cost-based method, our estimate of total costs to be incurred under certain agreements is for example, based on actual project-related contracts and history of similar contracts of other collaborations as well as industry experience. We are required to evaluate whether any changes in operational and&#47;or technical collaboration and project requirements could lead to a change in the timing and&#47;or amount of estimated project costs, and how such changes, if any, impact the recognition of revenue. Other revenue related judgments with regard to the determination of performance obligations under reservation agreements relate to assumptions on future production costs and market prices. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Implications of Being an Emerging Growth Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2012, the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, was enacted. Section 107 of the JOBS Act provides that an &#34;emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. Given that we currently report and expect to continue to report our financial results under IFRS as issued by the IASB, we will not be able to avail ourselves of this extended transition period and, as a result, we will adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required by the IASB.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as an emerging growth company, we may rely on other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, we are not required to, among other things, (1) provide an auditor's attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act and (2) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. These exemptions will apply for a period of five years following the completion of this offering or until we are no longer an &#34;emerging growth company.&#34; We would cease to be an emerging growth company if any of the following occurs&#58; 1) we have more than $1.07 billion in annual gross revenue, 2) we have more than $700 million in market value of our equity securities held by non-affiliates or 3) we issue more than $1.0 billion of non-convertible debt over a three-year period.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Implications of Being a Foreign Private Issuer</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the effectiveness of the registration statement of which this prospectus forms a part, we will report under the Exchange Act as a non-U.S. company with foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as we continue to qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we will not be required to file annual reports and financial statements with the SEC as promptly as U.S. domestic companies whose securities are registered under the Exchange Act, and are not required to comply with Regulation FD, which restricts the selective disclosure of material information. Both foreign private issuers and emerging growth companies are also exempt from certain more stringent executive compensation disclosure rules for U.S. public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Even if we no longer qualify as an emerging growth company, so long as we remain a foreign private issuer, we will continue to be exempt from such compensation disclosures.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_79"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">BUSINESS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage biopharmaceutical company applying our pioneering DARPin product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology. Our DARPin platform, which is designed using ankyrin repeat proteins, allows us to build product candidates with multiple mechanisms of action to address complex biological problems, while potentially offering patients products with higher efficacy and fewer adverse events. We believe that DARPins represent a novel class of drugs with broad therapeutic applications that may overcome many of the limitations of conventional protein and antibody-based therapeutics. Our DARPin product candidates have been extensively tested in preclinical studies and clinical trials, including in approximately 2,000 patients in ophthalmology, infectious disease (SARS-CoV-2) and oncology, and have been observed to be highly active, present differentiated product profiles and be generally well-tolerated.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were founded in 2004 by the inventors of our DARPin platform. Our senior management, which includes two of our company&#8217;s co-founders, have significant prior experience in oncology, research, drug development and finance, and members of our team have served as senior executives at other well-established companies including Argenx, Bavarian Nordic, Celgene, Lonza, Roche and Takeda. Additionally, our board of directors includes current and former senior executives of Biogen, Millennium, Novartis AG, Roche, and Sanofi.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our DARPin Platform</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DARPin proteins are designed using natural repeat proteins, a class of binder proteins that are common in humans and most other species. Since our formation, we have gone on to develop and upgrade our DARPin libraries to include over a trillion DARPin modules, which we refer to as single-domain DARPins, from which we can select specific DARPin proteins capable of binding to a target protein. Single-domain DARPins bind to a single target and serve as building blocks to create our multi-specific DARPin product candidates that can engage multiple targets. Beyond the benefit of multi-specificity, DARPin constructs can be intelligently designed to be active only under certain conditions, including via slow activation mechanisms, or activation at site-specific tumor microenvironments.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting with a target patient or disease, we can rapidly generate thousands of different DARPin product candidates to interrogate a specific biological target or targets to address an underlying medical need. We are able to perform target-specific screenings not only with our single-domain DARPins, but also with numerous multi-specific DARPin candidates constructed from these single-domain DARPins, allowing us to screen for the ideal properties within potential multi-specific product candidates. As a result, we believe that we can combine multiple promising biological solutions in one product candidate, as in the case of MP0423, a product candidate from our infectious disease program that is designed to neutralize the spike protein of SARS-CoV-2 using up to three distinct mechanisms. Further, we believe our DARPin platform allows us to identify novel mechanisms of action, as in the case of AMG 506 (MP0310) and MP0317, the lead product candidates from our oncology program, which will only activate immune stimulating targets when clustered on fibroblast activation protein, or FAP, a tumor specific localizer.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a therapeutic class, DARPin proteins demonstrate advantageous development properties including stability, solubility and manufacturing yield-to-cost benefits. In our preclinical studies and clinical trials, we have observed that our DARPin product candidates perform as designed and are well tolerated. As we have advanced our development programs, we have leveraged the insights from each product candidate to inform the development of the next product candidate, starting from a single-domain candidate (abicipar), and advancing to multi-specific candidates which are able to bind more than one target (MP0250 and the subsequently developed product candidates), bind a single target on more than one epitope (MP0274, and more recently MP0420 and MP0423), engage with the immune system (AMG 506 (MP0310) and MP0317, and our acute myeloid leukemia, or AML, program currently in development), and finally, bind a unique set of targets that other modalities cannot (our peptide-MHC, or pMHC, program).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our in-house DARPin programs are initially focused on infectious diseases, where we have seen positive progress on our first COVID-19 antiviral therapeutic product candidates in partnership with Novartis, and our oncology program, where we see great potential in the utility and flexibility of DARPin molecules to offer differentiated cancer treatments. Given the momentum of our COVID-19 antiviral therapeutic product candidates and the severity of the ongoing COVID-19 pandemic, we are also expanding our research and development activities in our infectious disease program to tackle other current and future viral threats. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accumulated preclinical and clinical experience developing and testing DARPin product candidates has allowed us to establish an intellectual property portfolio that, as of March 1, 2021, included over 150 granted and over 100 additional pending U.S. and foreign patent applications, across 25 patent families, covering both core and derivative aspects of our DARPin platform.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our DARPin platform was invented over twenty years ago by the co-founders of our company, then researchers from the University of Zurich. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Pipeline</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key information about our partnered and proprietary product candidates and research&#58; </font></div><div style="text-align:center"><img alt="businessfigure1a1a.jpg" src="businessfigure1a1a.jpg" style="height:326px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our DARPin molecules have distinct features to elicit specific therapeutic actions for a particular target, each DARPin therapeutic modality can be utilized across multiple programs. Our pipeline programs benefit from the learnings of earlier discoveries, such as the use of FAP as a localized activator for both AMG 506 (MP0310) and MP0317, escape prevention for our legacy product candidate MP0250, our new tetra-specific AML program, our COVID-19 therapeutic antiviral product candidates, and molecular handcuffing which is shared between our legacy product candidate MP0274 and our COVID-19 antiviral product candidate MP0423. As we continue to unlock new therapeutic modalities, each insight from earlier discoveries will be leveraged and applied across new product candidates wherever appropriate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure2a1a.jpg" src="businessfigure2a1a.jpg" style="height:261px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Once we develop a DARPin modality for one program, we can utilize it for some or all of the programs that follow. This figure depicts our various therapeutic modalities across our pipeline programs. Blue shading reflects the stage of development of each program.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Infectious Disease Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the emergence of the COVID-19 pandemic, starting in early 2020, it was apparent that all efforts must be made to explore how DARPins can assist in an emerging crisis. The straightforward development path of DARPin antiviral product candidates, enabled by their multi-specific binding mechanism of action, or MOA, allowed us to rapidly move from concept to clinic. To date we have developed two tri-specific COVID-19 antiviral therapeutic product candidates, MP0420, which we refer to as ensovibep, and MP0423. Both are designed to have strong binding and neutralizing potencies targeting multiple epitopes on the SARS-CoV-2 spike protein that are crucial for infection. The lead product candidate in our infectious disease program, ensovibep, for which we expect to commence a Phase 2&#47;3 clinical trial in     with interim data expected in       , and full data expected in      , has demonstrated a favorable tolerability profile in its Phase 1 trial of 16 healthy volunteers since commencement in 2020. Furthermore, we have partnered with Novartis to develop, manufacture and commercialize ensovibep and MP0423, which we believe will allow us to more rapidly develop this product candidate as a therapeutic for the treatment of COVID-19.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The product candidates in our infectious disease program offer a differentiated approach to treating COVID-19 through a single molecule that can engage multiple parts of the SARS-CoV-2 virus simultaneously to neutralize the virus through multiple mechanisms. This offers potentially broader efficacy &#8211; across both therapeutic and prophylactic settings &#8211; and reduces the potential for the development of viral drug resistance. Preclinical potency data suggests that our COVID-19 antiviral therapeutic product candidates may be administrable as a subcutaneous injection, which could represent a significant advantage for ease of delivery.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our COVID-19 antiviral therapeutic product candidates are also engineered with a half-life-enhancing DARPin domain that binds to human serum albumin, or HSA, to support long-lasting activity. HSA is found in elevated levels in the lung, which may provide a further benefit in a respiratory viral setting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensovibep was observed to be well tolerated in a Phase 1 clinical trial. Additional clinical work is ongoing in a Phase 2 clinical trial exploring the ability of ensovibep to halt the spread of the SARS-CoV-2 virus in infected patients, with data expected in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. A Phase 2&#47;3 global registrational study, named EMPATHY, is expected to commence in          , with interim data expected in &#160;&#160;&#160;&#160;&#160;&#160;&#160;, and full data expected in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Subject to the results of these trials and clinical need, our clinical development strategy aims to achieve potential emergency use authorization in  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure3a1a.jpg" src="businessfigure3a1a.jpg" style="height:101px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ensovibep is constructed from three RBD binding DARPin domains and two HSA binding half-life extension DARPin domains.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the potential of DARPins in treating SARS-CoV-2 through a viral neutralization mechanism, we have been exploring a number of potential infectious diseases which can be treated through multi-specific targeting. This evaluation includes additional work on pandemic threats, tropical diseases, and respiratory viruses such as Respiratory Syncytial Virus, or RSV.</font></div><div style="text-align:center"><img alt="businessfigure4a1a.jpg" src="businessfigure4a1a.jpg" style="height:241px;margin-bottom:5pt;vertical-align:text-bottom;width:602px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The DARPin platform has multiple advantages in creating novel antiviral candidate. Among these, DARPins have a mechanistic advantage of multi-specific, cooperative surface protein binding and inhibition of viral entry into human cells. We are exploring additional viral infectious diseases, including RSV, that can be targeted by our DARPins.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Oncology Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing DARPin product candidates in our oncology program to treat diseases with high unmet medical need. To date, our oncology product development efforts have focused on known biological targets while the multi-specificity afforded by our DARPin technology has allowed us to unlock previously difficult-to-address tumor biology and expand the range of addressable tumor biology compared to current standard of care therapies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have used our DARPin library to generate DARPin proteins directed against a broad range of oncology targets. From this library our DARPin technology allows us to construct DARPin product candidates that are only activated within a tumor or its supporting tissue, thereby avoiding systemic activation and minimizing adverse events. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing AMG 506 (MP0310), the lead product candidate in our oncology program and which is partnered with Amgen, as a tumor-localized, 4-1BB immune-cell activator for the potential treatment of FAP-positive cancers, which include multiple solid tumors. It is widely recognized that 4-1BB represents a promising anti-cancer target, but previous development attempts have resulted in minimal efficacy and&#47;or high levels of systemic toxicity. To avoid potential toxicity concerns, and allow for potentially therapeutically meaningful activation of 4-1BB, we engineered AMG 506 (MP0310) to activate 4-1BB only when bound to FAP. FAP is found in the tumor stroma in high density, and its binding can create a local cluster effect. In our Phase 1 clinical trial, we observed that AMG 506 (MP0310) demonstrated the ability to generate localized immune cell activation with no systemic toxicity in interim data. The dose escalation stage of the Phase 1 clinical trial was initiated in late 2019 to establish safety and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the tumor-restricted activation of immune-cells with initial results demonstrating proof of MOA after a single injection and a manageable adverse event profile consistent with MOA.  We are currently conducting dosing regimen adaptations to identify the dosing regimen for sustained 4-1BB activation. We believe AMG 506 (MP0310) should be particularly relevant as a combination agent with potential combination studies in collaboration with Amgen currently expected to commence in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MP0317, the second product candidate in our oncology program, is designed to bind CD40 and FAP. Similar to AMG 506 (MP0310), we believe that the FAP binding mechanism should allow MP0317 to activate immune cells specifically in the tumor and not in the rest of the body, potentially delivering greater efficacy with fewer side effects. CD40 is an immune agonist that has demonstrated the ability to exert anti-tumor activity, but its utility as a target has been somewhat limited in the clinic due to concerns regarding potential severe adverse events. We have designed MP0317 to increase localized activation of CD40 in the tumor microenvironment and as activation should only occur when both FAP and CD40 are simultaneously engaged, we believe MP0317 will trigger only tumor localized activity with minimal systemic side effects. We expect to enter the clinic with MP0317 in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Legacy Oncology Programs</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have previously developed two oncology product candidates demonstrating clinical proof-of-concept and validating the systemic administration of DARPin therapeutics in patients with both solid and hematologic malignancies.  MP0250, a legacy product candidate in our oncology program, was designed to bind to and inhibit vascular endothelial growth factor, or VEGF, and hepatocyte growth factor, or HGF. VEGF supports the growth of new blood vessels that are required to sustain tumor growth and HGF promotes tumor growth. We believe that by binding to and thereby inhibiting the VEGF and HGF pathways, MP0250 evidenced the ability to restore the efficacy of many standard of care cancer therapies, allowing patients who developed resistance to again respond to these therapies. The second legacy product candidate in our oncology program, MP0274, is a DARPin product candidate designed to bind to two different sites, or epitopes, on HER2, a receptor protein that promotes the growth of tumors. We believe that by binding to these two specific epitopes at the same time, MP0274 locked HER2 in an abnormal position thereby rendering it inactive, thereby inhibiting HER-mediated signaling and leading to apoptosis, or programmed cell death, in susceptible tumor cells that over express HER2. Through these legacy product candidates, we have demonstrated therapeutic benefit for patients in the clinic, shown that multi-specific DARPin therapies can be administered safely and with low immunogenicity, and validated the ability of our HSA-binding DARPin technologies to support long-lasting activity. While the activity and tolerability of these product candidates is encouraging, a strategic decision has been made to de-prioritize the product candidates in favor of investing in programs where a clear clinical differentiation could be made through DARPin constructs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our CD3 T-Cell Engager Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic evolution, we are focusing our efforts on creating DARPin product candidates that convey single-agent activity and do not require combination with additional compounds to show efficacy. Executing on this strategy over the last three years, we have developed CD3 T-cell engager, or TCE, therapeutic modalities, designed to activate relevant immune cells against specific cellular targets in a localized, specifically timed fashion. To date, many programs targeting CD3 have suffered from toxicity issues arising from CD3 activation outside the tumor and over-stimulation of the immune system. When dealing with complex, heterogeneous tumors, breakthrough efficacy has also been challenging to attain. In 2020, we made significant progress to integrate the CD3-targeting approach to T-cell engagement into a multi-DARPin format that addresses these key challenges. We are initially focused on targeting AML and other liquid tumors, which we intend to present at the American Academy for Cancer Research, or AACR, annual meeting.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure5a1a.jpg" src="businessfigure5a1a.jpg" style="height:208px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We can control the activation of our multi-specific T cell to be restricted to a specific location and&#47;or activated slowly to avoid adverse events related to misdirected or overly strong activity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of tumor localization DARPin domains in addition to a CD3-binding DARPin domain has allowed the design of candidates with better tumor specificity, and consequently reduced &#8216;off-tumor&#8217; effects, potentially enabling the administration of higher dose levels and achieving better efficacy. In preclinical tests against AML cells, DARPin CD3&#47;TCE product candidates delivered highly potent and specific activity and the potential for a reduced systemic immune response.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to further expand the ability of our oncology program with DARPin product candidates that ensure CD3 is only targeted locally in the tumor microenvironment and is only activated slowly over time to further control the risk of side effects and provide sustained activity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Peptide-MHC DARPin Discovery Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to unlock and expand our therapeutic capabilities, pMHC-targeting DARPin molecules represent the next level of immune cell targeting DARPin product candidates. These highly differentiated and specialized therapeutic candidates are designed to engage specific pMHC complexes while avoiding off-target attacks on healthy tissue, potentially delivering greater efficacy with fewer side effects. As pMHC complexes sample intracellular proteins and present them on the surface, specifically recognizing these complexes and binding to them allows pMHC DARPin molecules to identify a whole new array of targets that were previously hidden from external protein binders that are restricted to the extracellular environment. We believe the ability to target these intracellular proteins will allow us to pursue an entirely new set of potentially meaningful targets across the fields of oncology and infectious diseases. The small size and rigid binding surfaces of DARPins make them well suited for binding to pMHC targets that have been difficult to target using the large, flexible structures of antibodies. We have demonstrated proof-of-concept for the ability of DARPin therapeutics to effectively drug pMHC complexes. We are actively screening single-domain DARPin proteins for optimal binding to a range of pMHC complexes, which we expect to use to design DARPin product candidates with specific and potent diseased cell killing effects.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Ophthalmology Program and Collaborations with Allergan, an Abbvie Company </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most clinically advanced DARPin product candidate we have developed is abicipar, a VEGF inhibitor for the treatment of neovascular (wet) age-related macular degeneration, or nAMD, and diabetic macular edema, or DME. Abicipar, which we developed using our DARPin platform, has a longer duration of action and may enable less frequent injections into the eye than the current anti-VEGF treatments while providing equal or better improvements in vision. This program was exclusively licensed to Allergan, an Abbvie company, in 2011. Abicipar has completed two global Phase 3 clinical trials where it met its primary endpoints of non-inferiority to the market leading monthly treatment, Lucentis. Following submission of a Biologics Licensing Application, or BLA, to the U.S. Food and Drug Administration, or FDA, it was determined that the ocular inflammation profile see in the two Phase 2 clinical trials did not provide an adequate risk reward benefit as submitted, and additional work would be required to show the ocular inflammation profile of abicipar would be similar to those products already approved for the treatment of nAMD. Our partner, Abbvie, is currently evaluating potential next steps.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Team</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our name indicates, partnership and collaboration are at the core of our company, our research activities and our therapeutic designs. Molecular Partners is an international working environment comprised of 150+ individuals from numerous disciplines who contribute to our shared values of scientific excellence, respectful teamwork and personal aspiration. Whether it stems from our long-standing goal of improving the lives of patients with cancer, or to our more recent efforts to deploy our technology against COVID-19, we are a group dedicated to moving the needle of medicine. We foster true innovation and creative thinking to advance our therapeutic product candidates, and we continue to be inspired by the difference we can make for our patients. Our team members possess a curiosity and a passion to advance our shared goal of providing better treatment options for patients with serious diseases. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Strategy</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unlock and Expand Custom-Built Biology for Patients</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to leveraging our proprietary DARPin platform to unlock and expand the inherent advantages of DARPin molecules to potentially deliver innovative therapies to patients suffering from severe disease with significant unmet medical needs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key aspects of our strategy include the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unlock novel biological solutions and expand therapeutic applications of clinically validated DARPin approaches. We are the world leaders in DARPin engineering and research. With this expertise, we have developed a strategy of unlocking various technical hurdles which may limit other discovery platforms, and then expanding our clinical product candidates based upon each technological solution. Examples of this include the ability to locally activate highly potent, immunostimulatory molecules, potentially opening therapeutic windows which were previously unavailable to patients. With our COVID-19 antiviral therapeutic product candidates, our preclinical data demonstrate how a multi-specific molecule will allow for high viral neutralization, even when faced with multiple viral mutations. Our emerging CD3 discovery programs demonstrate the ability of our DARPin platform to carefully localize an antitumor response and prevent unwanted activation throughout the body, either through slow activation technologies or conditional activation technologies. With each technical breakthrough we achieve, we are able to apply key learnings across our portfolio, leveraging each insight to improve future programs.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rapidly advance the clinical development of our COVID-19 antiviral therapeutic product candidates in our infectious disease program in collaboration with Novartis. Our COVID-19 product candidates, ensovibep and MP0423, are two unique tri-specific DARPin product candidates which in preclinical studies have demonstrated the ability to inactivate the SARS-CoV-2 virus through binding to multiple target sites simultaneously.  We believe this result offers the potential to both treat and prevent COVID-19 and reduce the likelihood of the development of viral drug resistance, which can result from selection pressure on any single molecular target. A global Phase 2&#47;3 registrational clinical trial is expected to commence for our lead COVID-19 antiviral therapeutic product candidate, ensovibep, in          . Our clinical strategy aims to achieve potential emergency use authorization in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Given the positive preclinical data from our existing COVID-19 antiviral therapeutic product candidates and the clear fit between the DARPin therapeutic profile and compelling antiviral product profiles, we intend to pursue other high value antiviral indications with unmet global need. We expect to announce a new target indication in our infectious disease program in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Advance clinical development of AMG 506 (MP0310) and MP0317, the most advanced product candidates in our oncology program. Utilizing our knowledge of DARPins, we have developed a method of locally clustering potent immunostimulatory molecules, which are designed to activate themselves only in the presence of specific conditions.  Our lead oncology product candidate, AMG 506 (MP0310), is being developed to locally activate immune cells in the tumor by binding to FAP on tumor stromal cells where it acts as a localizer, and co-stimulating T cells via 4-1BB, an immune modulator protein, for the treatment of FAP-positive cancers. In a Phase 1 clinical trial, tumor biopsies from patients demonstrated that AMG 506 (MP0310) activated immune cells locally with minimal systemic side effects. Having unlocked this method of treatment, we are rapidly advancing our second lead oncology product candidate, MP0317, a tumor-localized immune-cell CD40 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activator that is also being developed for the potential treatment of FAP-positive cancers. We expect to commence a Phase 1 clinical trial for MP0317 in  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expand the clinical applications of our newly unlocked next-generation CD3 capabilities. We plan to generate novel product candidates from our CD3 discovery programs, utilizing the concepts of multi-specific targeting, conditional activation, and slow activation, all of which we believe open an array of new opportunities for modulating the immune system to fight disease. We have developed methods of delivering highly specific CD3, multi-specific product candidates, starting with a tri-specific TCE for the treatment of AML. Preclinical work shows that targeting three distinct tumor-associated antigens, or TAAs, against AML in combination with a CD3 DARPin results in a high anti-tumor response and offers the potential for an improved safety window, and limiting tumor escape. Beyond the multi-specific administration of our CD3 molecules, we have developed the capacity for both &#8216;slow activation&#8217; and &#8216;conditional activation&#8217; of T cells in the circulation, giving multiple levels of control over this key immuno-oncologic mechanism, which other T-cell activator approaches have struggled to leverage without accompanying systemic toxicity. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Leverage our proprietary libraries to expand the applicability of DARPin therapeutics. DARPin domains are designed to be added to new product candidates in a modular fashion to address novel disease biology. This process enables us to construct and screen multi-specific DARPins for new disease areas and to quickly identify and progress differentiated candidates for our infectious disease and oncology programs. For example, in our oncology program, we are exploring the use of FAP colocalization to selectively activate immune cells in tumors. In pursuit of a sustainable and diversified portfolio, we plan to develop potentially innovative and transformational constructs directed against the most promising targets in our areas of focus. As part of this expansion, we have also developed methods of targeting pMHC complexes, which we believe provides us the capability to investigate a multitude of new targets that have previously been untargetable, both in infectious diseases and oncology.  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maintain a strategic approach to in-house versus partnered development. To unlock and expand the full potential of our DARPin platform, we intend to independently develop and commercialize product candidates in our core focus areas, where we believe we have a clear clinical and regulatory approval pathway and the resources to commercialize successfully. To complement this approach, we also plan to collaborate with biopharmaceutical companies on product candidates that have promising utility in target areas or patient populations requiring greater global development capabilities or those outside of our strategic focus. This strategy has allowed us to pursue major therapeutic innovations for the DARPin platform, often in parallel, across our infectious disease, oncology and ophthalmology focus areas. To this end, we continue to support our partners across our portfolio as we pursue the advancement of AMG 506 (MP0310) in solid tumors in collaboration with Amgen, the rapid development and approval of our COVID-19 antiviral therapeutic product candidates with Novartis, and abicipar, which has seen success in two positive Phase 3 trials in nAMD, but which requires additional development by our partner Abbvie if it is to achieve regulatory approval. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our DARPin Platform</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our DARPin platform was invented over twenty years ago by the co-founders of our company, then researchers from the University of Zurich. DARPins were discovered as a result of our co-founders&#8217; quest to find a solution beyond antibodies. The ease of use and manufacturing of DARPins, along with the ability to design multi-specific molecules, made DARPin technology an ideal platform from which to pursue treatments beyond traditional protein therapeutics. The DARPin base technology we use in our DARPin platform to generate our DARPin product candidates is exclusively licensed to us by the University of Zurich.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leveraging our DARPin platform, we have designed DARPin product candidates with multiple MOAs that we believe have the potential to offer patients therapeutic options with higher efficacy and fewer adverse events as compared to standard-of-care therapies. Among these multiple MOAs, DARPin product candidates have been designed to block growth factors, localize activity, conditionally activate, neutralize viruses, adjust half-life as needed, and initiate cell death. These features, and others, are applied across our portfolio and utilized when required to elicit a specific therapeutic response. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We design our DARPin product candidates using natural ankyrin repeat proteins. Like monoclonal antibodies, or mAbs, ankyrin repeat proteins are a known class of natural binding protein, prevalent in humans and many other species, which display highly specific and strong target binding capacity. Ankyrin repeat proteins, through the ankyrin repeat fold, and mAbs, through the more geometrically complex immuno-globulin, or Ig, fold, have a framework and scaffold that preserves their structure and allows them to carry a variety of potential binding sites. The Ig fold in a mAb consists mainly of structures referred to as beta-sheets, and the ankyrin repeat fold in a single-domain DARPin consists primarily of alpha-helical structures. Since alpha-helical structures are less complex and are frequently easier to manipulate without loss of structure, produce and preserve compared to structures built with beta-sheet folds, we believe that our DARPin product candidates have significant potential advantages over current and future mAb treatments. The figure below highlights a few of the differences between mAbs and single-domain DARPins.</font></div><div style="text-align:center"><img alt="businessfigure6a1a.jpg" src="businessfigure6a1a.jpg" style="height:270px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In comparison to monoclonal antibodies, we believe the smaller size and simple architecture of DARPins make them ideally suited to perform multiple biological functions in a single molecule.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the architectural flexibility and novel geometry of single-domain DARPins will allow us to develop differentiated drugs with advantages over traditional mAb therapies and to explore therapeutic opportunities unavailable to most other platforms. We are able to generate different single-domain DARPins and linkers to create our DARPin product candidates, with multiple MOAs either directed at a single target, or several targets at once. For example, we have generated DARPins with six targets or MOAs in a single product candidate. The resulting molecular complex of this six factor DARPin is still approximately half the size of most single-target mAbs. The figure below illustrates the binding of mAbs and multi-DARPin product candidates to targets.</font></div><div style="text-align:center"><img alt="businessfigure7a1a.jpg" src="businessfigure7a1a.jpg" style="height:208px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DARPin product candidates can perform multiple biological functions at the same time. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our DARPin platform has the potential to yield novel product candidates with broad therapeutic application given their ability to overcome many of the limitations of conventional protein and mAb-based therapeutics.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Benefits and Advantages of our DARPin Platform over Traditional Approaches </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the effectiveness of our solution is driven by the architectural flexibility of our DARPin product candidates and the biophysical properties of single-domain DARPins, which allow us to select the optimal product candidates from among approximately 10,000 potential combinations simultaneously. </font></div><div style="text-align:center"><img alt="businessfigure8a1a.jpg" src="businessfigure8a1a.jpg" style="height:281px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We leverage the innate properties DARPins to create specific therapeutic outputs, based on a target patient.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the benefits of our DARPin platform include&#58;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ability of DARPin product candidates to target multiple escape pathways in parallel.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> When cancer cells or a virus are attacked by conventional therapies, they often develop resistance by loss of target, mutational escape or activating multiple escape pathways at once. To create effective products, we believe that we must understand the dynamics of these escape pathways and then target their key components in parallel. We believe our DARPin product candidates are ideally suited for this approach because of their ability to bind to multiple targets and inhibit multiple escape pathways at once. Our approach allows us to efficiently test product candidates to determine the affinity and target binding of our single-domain DARPin proteins in the relevant setting. The most effective combination of single-domain DARPin proteins is assembled into one DARPin product candidate for further product development. These DARPin product candidates can demonstrate cooperative binding, leading to high potency and preventing escape as demonstrated by our antiviral product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capacity to find and address new biology on known targets.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Using our DARPin approach, we are able to select single-domain DARPin proteins that bind to known targets in novel ways, thereby unlocking additional therapeutic solutions. For example, in our CD3 discovery programs, we &#8216;mask&#8217; a CD3 DARPin with another blocking DARPin utilizing a flexible linker to connect the two, which allows us to &#8216;unlock&#8217; the active therapeutic in a slow activation capacity and dampen potential cytokine release syndrome, or CRS, thereby limiting the adverse event profile. We can also achieve conditional activation where the molecule will activate only in the presence of a particular TAA. Our first nominated CD3 product candidate will utilize the power of multi-specific targeting to potentially enhance efficacy and minimize tumor resistance through simultaneously targeting three known hallmarks of AML, which, to our knowledge, have never been administered as one molecule until now. Previous preclinical studies have also demonstrated the capacity of single-domain DARPin proteins to bind to different epitopes on the same target. MP0274, for example, targets human epidermal growth factor 2, or HER2, on two distinct epitopes with two DARPin-proteins connected by a short linker locking HER2 in an abnormal position, forming a &#8216;molecular </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">handcuff&#8217; and thereby inducing cell death, or apoptosis. This approach is also used as one of the mechanisms of action for MP0423, which we believe can &#8216;handcuff&#8217; the spike protein of SAR-CoV-2 to prevent infection. We believe these results are not functionally feasible with conventional antibody approaches.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Flexible architecture to engage and locally activate immune cells</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Immuno-oncology relies on the activation of a patient&#8217;s immune response to fight tumors. In some cases, blocking negative checkpoint signals can produce a deep and durable effect in stopping the growth of, and regressing, tumors. We believe that our DARPin platform is well suited for the combined approaches of blocking negative checkpoint signals and engaging and activating immune cells. We have unlocked approaches that utilize single-domain DARPin proteins to direct tumor-localized activation of immune cells, resulting in the selective activation of immune system cells within a tumor, which may potentially avoid systemic adverse events. We have designed two of our DARPin product candidates, AMG 506 (MP0310) and MP0317, to cluster, thereby locally activating immune cells more effectively. AMG 506 (MP0310) is a tumor-restricted 4-1BB immune-cell activator for the potential treatment of FAP-positive cancers, and MP0317 activates CD40, also in an FAP-dependent manner. As these DARPin product candidates are directed to tumor supportive structures rather than tumor cells, we believe they will be less subject to the development of treatment resistance and will thereby retain activity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tailored pharmacokinetic profile.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are able to tailor the half-life of our DARPin product candidates in the body to match the relevant target disease biology ranging from hours to weeks. Depending on the relevant therapeutic application we are targeting, we have multiple approaches to choose from, each of which leads to a different pharmacokinetic profile for our DARPin product candidates. This allows us to equip each of our product candidates with the half-life that we believe is ideal for the specific therapeutic function.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Established and efficient process and ease of storage.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All or our DARPin product candidates are constructed to benefit from high-yield and low-cost microbial manufacturing. Unlike manufacturing using traditional mammalian cell lines, productions of DARPin molecules via microbial manufacturing allow for several key competitive advantages, including the ability to manufacture clinical batches every seven to ten days, versus a thirty-day mammalian campaign. This advantage is an imperative as we look to make our drugs available on a global scale. Additional benefits include high production yield of raw drug substance, 12-15g&#47;L for example, as well as high thermal stability, with certain programs demonstrating shelf stability at 4 degrees centigrade for several years. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Background of Our DARPin Platform&#58; A Source of Virtually Unlimited Binding Proteins</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fundamental building block for all of our DARPin product candidates is the single-domain DARPin protein. A single-domain DARPin protein consists of an engineered protein base structure, which we refer to as the scaffold. The DARPin scaffold is formed from consecutive copies of ankyrin repeat proteins, which are 33 amino acid long chains stacked together. The scaffold can be generated to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide a binding site to specifically recognize, or permit binding to, a desired target protein or other molecule, similar to how mAbs can be generated to recognize a single target antigen. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed and upgraded our DARPin libraries to include over 1 trillion single-domain DARPin proteins, each of which can potentially bind to a specific target structure. From this library we can screen and select within weeks single-domain DARPin proteins that are highly specific to and have high affinity with any given target structure. We use the selected single-domain DARPin proteins to build our DARPin product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Single-domain DARPin proteins are small, having a molecular weight of approximately 14&#8211;18 kilodaltons, or approximately the tenth of the size of a mAb. We believe this smaller size potentially enables increased tissue penetration and a higher potency at lower doses. The natural biophysical properties of single-domain DARPin proteins, including high affinity due to the rigidity of the scaffold and high solubility of the base structure, enable more distinct specificity for a particular target, or a specific site on a particular target, such as an epitope. These benefits have the potential to increase activity and efficacy of our product candidates on the target.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure9a1a.jpg" src="businessfigure9a1a.jpg" style="height:211px;margin-bottom:5pt;vertical-align:text-bottom;width:602px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our DARPin libraries allows us to identify single-domain DARPins with desired characteristics. We can then construct and screen numerous DARPin candidates to identify an optimal molecule.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">How We Use Single-Domain DARPin Proteins</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can select single-domain DARPin proteins to bind to a given target and form the basis of a product candidate, or we can genetically assemble single-domain DARPin proteins into DARPin product candidates using different linkers. This allows us to screen over 10,000 different DARPin product candidates for each target and select those with the optimal properties. We believe this process is more difficult with multi-specific mAbs or other complex proteins. Further, we can add additional elements either to increase the half-life of our product candidates to match the therapeutic need or to add functionality.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While antibodies generally have a long systemic half-life, most repeat proteins have a short half-life. The half-life of a single-domain DARPin protein is usually a few hours when injected into the blood stream. To increase the half-life of DARPin product candidates, we have created proprietary, patent-protected, specific single-domain DARPin proteins that bind to HSA. HSA is the most abundant protein in human blood and has a half-life of approximately three weeks. When administered intravenously, the HSA-DARPin protein binds to its target to extend its half-life to the same period as HSA. If this single-domain DARPin protein is used in a DARPin product candidate, the entire product candidate benefits from HSA's longer half-life. This approach allows us to tailor the half-life of our individual product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The image below depicts how we generate DARPin product candidates using our DARPin platform.</font></div><div style="text-align:center"><img alt="businessfigure10a1a.jpg" src="businessfigure10a1a.jpg" style="height:277px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">To best design molecules with a desired therapeutic effect, DARPins can be constructed in a multitude of conformations and combinations, including variable linkers, as well as the ability to attach DARPins to additional therapeutic modalities. E.g. cell therapies, antibodies, or other protein therapeutics. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Product Candidates and Research Program Pipeline</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key information about our proprietary and partnered product candidates and research&#58;</font></div><div style="text-align:center"><img alt="businessfigure11a1a.jpg" src="businessfigure11a1a.jpg" style="height:326px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. Our Infectious Disease Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020 we launched our first product candidate in our infectious disease program, which targets SARS-CoV-2, the causative agent of COVID-19. Our rapid candidate design and assessment process allowed us to quickly substantiate the potential of an antiviral DARPin approach and its differentiation compared to other therapeutic approaches. Based on the strong potential of DARPin therapeutics as antivirals, we have begun exploring other global viral threats with high unmet need as potential targets for new product candidates in our infectious disease program.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Product Candidates&#58; Ensovibep (MP0420) and MP0423</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ensovibep, a unique tri-specific DARPin product candidate that targets three different epitopes on the receptor-binding domain, or RBD, simultaneously.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">MP0423, a unique multi-mode tri-specific DARPin product candidate that targets three different parts of the coronavirus spike protein simultaneously, including the RBD.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Candidates display strong affinity to the spike protein and prevent infectivity in vitro and in vivo and remain active on known prevalent variants.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 1 clinical trial results demonstrate ensovibep to be well tolerated, with a favorable pharmacodynamic profile&#59; global registrational study expected to commence in                . </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2020, recognizing the global need for all scientific discovery to lend itself to solving the emerging SARS-Cov-2 pandemic, which would come to be known as COVID-19, we immediately began investigating what effect, if any, DARPins could produce as an antiviral therapy against SARS-Cov-2. In a matter of weeks, a rapid screening of thousands of our single-domain binders resulted in a reservoir of several hundred DARPins with high affinity to the SARS-CoV-2 spike protein. We then assembled several dozen intelligently designed DARPins, screened them again </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for spike-protein binding, and identified our two lead tri-specific COVID-19 antiviral therapeutic product candidates, ensovibep and MP0423. Concept to candidate identification took us less than eight weeks. Ensovibep was constructed from three distinct single-domain DARPins that target the RBD of the spike protein, whereas MP0423, which also takes advantage of strong RBD binding, includes two additional MOAs&#58; blocking protease cleavage and the formation of a &#8216;molecular handcuff&#8217; around the spike protein, preventing its ability to infect healthy cells.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These product candidates are engineered to target multiple epitopes on the SARS-CoV-2 spike protein that are crucial for infection. Our COVID-19 antiviral therapeutic product candidates are also built with two half-life enhancing DARPin domains that bind to HSA to support long-lasting activity. As HSA is found in elevated levels in the lung, its binding may provide a further benefit treating SARS-CoV-2 since it is a respiratory virus. In preclinical models, both of these product candidates have demonstrated strong binding and neutralizing potency.</font></div><div style="text-align:center"><img alt="businessfigure12a1a.jpg" src="businessfigure12a1a.jpg" style="height:340px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In vivo preclinical data demonstrating ability of ensovibep (MP420) to deliver high suppression of virus in the lung of animal models, providing essentially complete blocking of viral infectivity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are advancing the clinical development of ensovibep and MP0423 in collaboration with Novartis. Pursuant to the collaboration agreement, Novartis has the option to develop, manufacture and commercialize these product candidates. In addition to making an upfront payment and an equity investment totaling $60.0 million CHF, if Novartis exercises its option to invest in the clinical development and manufacturing of ensovibep we would potentially receive a near-term milestone to our company of $150.0 million CHF in the next 12 months. If Novartis chooses to commercialize ensovibep or MP0423, we would receive royalties of 22% on future commercial sales in certain agreed territories. We and Novartis have also agreed to forgo any profits in developing nations. We have also reached an agreement with the Swiss Government regarding rights to purchase up to 3.2 million doses of ensovibep if it is approved in Switzerland. In addition to our partnership with Novartis, we are collaborating with AGC Biologics and Baccinex to support development of their anti-COVID-19 programs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a Phase 1 clinical trial involving 16 volunteers, ensovibep was observed to be well tolerated within, and above, expected clinically relevant doses. In an ongoing Phase 2 clinical trial, we and Novartis are investigating the ability of ensovibep to inhibit viral transmission of SARS-CoV-2 in positively diagnosed patients. This ability has been demonstrated in preclinical experiments in animal models. This study seeks to enroll up to 30 symptomatic patients, positively diagnosed by PCR, who will be treated with ensovibep and monitored for viral replication. Data from this study is expected to be available in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. In addition, we expect that a global Phase 2&#47;3 registrational study, named EMPATHY, will commence in         , which will seek to enroll over 2,400 patients in the ambulatory setting, with the goal of demonstrating the ability of ensovibep to prevent disease worsening, hospitalizations, and death. This </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trial includes two phases, as illustrated in Figure 11 below, with interim data anticipated in the first 400-700 patients in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and full results available in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. In an effort to explore the potential benefit of ensovibep in additional settings, we have also aligned with the National Institute of Allergy and Infectious diseases, or NIAID, through an ongoing international master protocol&#47;platform study, ACTIV-3, which is a Phase 3 trial for COVID-19 positive patients in the hospitalized setting. This study will examine ensovibep plus a standardized treatment, remsividir, and will recruit 500 patients versus an additional arm of 500 patients treated with remdisivir plus standard-of-care as the control. The protocol includes an interim analysis for futility after the first 300 patients have been randomized and recruited.</font></div><div style="text-align:center"><img alt="businessfigure13b1a.jpg" src="businessfigure13b1a.jpg" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:654px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All dates are preliminary and subject to health authority input. As part of the global strategy to ensure the potential of ensovibep is realized, draft development plans include a clinical study for approval in the non-hospitalized setting, strategies for subcutaneous bridging, and upscaled manufacturing through our partner Novartis, allowing for sufficient global capacity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing of doses of MP0423 are also ongoing, and initial clinical trials are anticipated to commence in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the developed world is moving quickly toward vaccinating a large part of its population, we believe there is still a significant need for therapeutics such as our COVID-19 antiviral therapeutic product candidates, since there are both many parts of the world that have not been able to obtain vaccines due to lack of funding and&#47;or delivery issues and many people who cannot or will not get vaccinated. As our therapeutic product candidates are relatively inexpensive to produce and easy to deliver, we believe they can serve as a solution to specifically treat and stop the spread of the disease in under-vaccinated areas. Furthermore, even in areas where there are very high percentages of vaccinated population, there will continue to be a need for efficacious and easily administrated antiviral therapies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical potency data suggests that our DARPin product candidates may be administrable as a rapid infusion, or potentially as a subcutaneous injection, which would be a significant advantage for ease of delivery. Once an acceptable dose is identified from the ongoing Part A of the EMPATHY trial, clinical work can begin to optimize a subcutaneous dose formulation for ensovibep. We believe that the greatest potential for ensovibep will be its administration in the community care setting. While vaccines against SARS-CoV-2 continue to emerge, the need for an efficacious and easily administered antiviral will be key to the patients who still contract this virus. To that end, we believe a subcutaneous, potent antiviral will be a key component to the treatment paradigm.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Product Candidate Characteristics and Development Plan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ensovibep (MP420)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensovibep is a unique tri-specific DARPin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product candidate that has demonstrated cooperative target binding and sub-picomolar potency which is among the strongest virus inhibition reported to date. As shown in preclinical studies, ensovibep is a tri-specific DARPin product candidate that targets three different epitopes on the RBD simultaneously, but with different antigen-binding sequences, as shown in Figure 12 below, a concept we refer to as cooperative binding.  </font></div><div style="text-align:center"><img alt="businessfigure14a1a.jpg" src="businessfigure14a1a.jpg" style="height:101px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Full length design of ensovibep, a penta-DARPin including 3 RBD binding DARPins, as well as 2 HSA DARPins to extend half-life to approximately &#126;14 days.</font></div><div style="text-align:center"><img alt="businessfigure15a1a.jpg" src="businessfigure15a1a.jpg" style="height:331px;margin-bottom:5pt;vertical-align:text-bottom;width:528px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3D illustration of ensovibep showing its binding and neutralizing action at the &#8216;crown&#8217; of the SARS-CoV-2 spike protein, which the virus uses to infiltrate human cells.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preclinical models, we have demonstrated ensovibep&#8217;s ability to be a potent neutralizer of wild type, or WT, SARS-CoV-2. In addition, based on its multi-specific design and use of cooperative binding, ensovibep appears to remain highly potent against a number of emerging SARS-CoV-2 mutations, or variants, which have been initially identified in Brazil, South Africa, and the United Kingdom. These individual variants have been tested against ensovibep as well as MP0423. We intend to test new variants against our product candidates as they emerge as well. As demonstrated in Figure 14 below, while individual single-domain DARPin components can lose potency, the overall molecule will retain therapeutically relevant neutralization. We believe this is possible due to the cooperative binding of the molecule, where even if individual binders lose potency, the other binders should keep the molecule active and neutralizing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure16a1a.jpg" src="businessfigure16a1a.jpg" style="height:390px;margin-bottom:5pt;vertical-align:text-bottom;width:573px"></div><div style="margin-bottom:8pt;text-align:center"><img alt="image1.jpg" src="image1.jpg" style="height:110px;margin-bottom:5pt;vertical-align:text-bottom;width:473px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ensovibep was tested against multiple different mutated spike proteins to examine how the different mutations affect the binding of the full-length construct as well as each of single-domain RBD binders that constitute the candidate. One strain, F486V, is not naturally occurring and was constructed as a negative control. This variant would not be likely to infect healthy cells in humans due to its diminished binding capacities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Figure 14 shows, the full-length construct maintains binding to B.1.351 and B.1.1.7, the variants first observed in South Africa and the United Kingdom, respectively. Further, ensovibep also maintains binding when presented with multiple other reported mutations, not including the F486V negative control. Figure 14 also illustrates cooperative binding, demonstrating that some of the single-domain binders lose affinity to some of the mutants, but given the cooperative nature of the full-length construct, its binding strength remains largely the same. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we dosed the first cohort of healthy volunteers in a Phase 1, randomized, double-blind, placebo-controlled, first-in-human single ascending dose clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenously administered ensovibep in up to 16 healthy volunteers. The volunteers are divided into three dose cohorts, with each cohort stratified 3&#58;1 in favor of ensovibep. To date, interim results demonstrate that ensovibep is well tolerated. We expect to report data from this Phase 1 clinical trial in          . In an ongoing Phase 2 clinical trial, we and Novartis are investigating the ability of ensovibep to inhibit viral transmission of SARS-CoV-2 in positively diagnosed patients. This ability has been demonstrated in preclinical experiments in animal models. This study seeks to enroll up to 30 symptomatic patients, positively diagnosed by PCR, who will be treated with ensovibep and monitored for viral replication. Data from this study is expected to be available in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . Interim data from the EMPATHY global registrational study, which is expected to commence in             , is expected </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be reported in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Depending on the evolution of the global COVID-19 pandemic, we believe that ensovibep has the potential to be granted emergency use authorization from regulatory authorities in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MP0423</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MP0423 is a unique tri-specific DARPin product candidate that shows cooperative target binding and exhibits among the strongest virus inhibition potency reported by any clinical product candidate to date. MP0423 targets three different parts of the coronavirus spike protein simultaneously, including the RBD, as shown in Figure 15 below. By tackling multiple different viral spike domains in parallel, MP0423 is designed to provide additional protection against viral mutations that can reduce the binding ability of therapeutics to specific epitopes.</font></div><div style="text-align:center"><img alt="businessfigure17a1a.jpg" src="businessfigure17a1a.jpg" style="height:122px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Full length design of MP0423, a penta-DARPin including 3 distinct binding DARPins, including 1 RND binder, 2 additional binders on alternative binding sites, and 2 HSA DARPins to extend half-life approximately &#126;14 days.</font></div><div style="text-align:center"><img alt="businessfigure18a1a.jpg" src="businessfigure18a1a.jpg" style="height:392px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3D illustration of MP0423 showing its binding and neutralizing action through targeting multiple domains along the SARS-CoV-2 spike protein, which the virus uses to infiltrate human cells.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By binding to multiple epitopes on the spike protein, MP0423 can potentially neutralize SARS-CoV-2 through multiple MOAs. These MOAs include the ability to neutralize the virus at the RBD, blocking protease cleavage and the formation of a &#8216;molecular handcuff&#8217; around the spike protein, preventing its ability to infect healthy cells. This 3-in-1 mechanism was designed with the rationale that if the RBD were to mutate, and make other therapeutics less </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potent, MP0423 would still remain active against the virus.  MP0423 is currently being manufactured as we prepare for a Phase 1 clinical trial in MP0423 that is expected to commence in               .</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Infectious Disease Applications of our DARPin Platform </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the momentum of the COVID-19 product candidates in our infectious disease program, as well as the clear fit between the DARPin therapeutic profile and compelling antiviral product profiles, we intend to pursue other high value antiviral indications with unmet global need. Our rapid candidate design and assessment process has allowed us to quickly substantiate the potential of an antiviral DARPin approach and its differentiation against other therapeutic approaches. Based on the strong potential of DARPin therapeutics as antivirals, we have begun exploring other global viral threats with high unmet needs as potential targets for new product candidates. This evaluation includes additional work on pandemic threats, including potential pan-coronavirus treatments, tropical diseases, and respiratory viruses, such as RSV.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B. Our Oncology Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cancer Background and Treatment </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rapid development of immuno-oncology, or IO, therapies for multiple types of cancer has transformed the oncology treatment landscape and improved the long-term outlook for many cancer patients. Rather than targeting treatments directly at the tumor, IO therapies generally engage the immune system to promote its recognition and eradication of tumor cells. Key features of immune-mediated therapy include specificity, breadth of response, and memory. These features can contribute to complete tumor regressions, often providing more durable clinical outcomes and improved quality of life relative to other therapies. However, despite the early success observed with immune-method therapies, it has become clear that these immuno-oncology treatments can currently help only a minority of patients and are more effective in some tumor types than others. This limit arises from various factors, including differential target expression patterns by cancer cells, variable immune responses to the treatment, and cancer immune-escape via mutagenesis and proliferation of non-targeted cellular populations.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, through years of building our DARPin expertise, we have developed DARPin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product candidates that can unlock and expand IO capabilities through several mechanisms, which include targeting immuno-stimulatory proteins through multi-specific DARPin binders and also using delayed and&#47;or conditional activation of our immune engagers. These attributes allow us to optimize the potency, localization and&#47;or exposure of our product candidates and reduce the risk of off-target toxicity in order to improve their therapeutic index and overall profile.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Localized Immune Agonists&#58; AMG 506 (MP0310) and MP0317 Product Candidates</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A primary focus of our oncology program is product candidate development of localized immune agonists. We are currently developing&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AMG 506 (MP0310), in partnership with Amgen, which allows for tumor-restricted immune-cell 4-1BB activation for the potential treatment of FAP positive cancers&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">MP0317, which allows for tumor-restricted immune-cell CD40 activation for the treatment of FAP positive cancers.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development of our AMG 506 (MP0310) and MP0317 product candidates has leveraged the learnings from our two first generation product candidates in our oncology program, MP0250 and MP0274. Those candidates have demonstrated DARPin efficacy and tolerability in preclinical and clinical studies in patient populations who were resistant and &#47;or refractory to previous standard of care treatments. However, due to shifts in the market and the need for additional work and financial investment, we are now pursuing development of our first generation product candidates via partnerships and have paused our investments as single sponsors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AMG 506 (MP0310)&#58; DARPin Molecule Targeting 4-1BB x FAP</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potent costimulatory target 4-1BB on immune cells activated only in presence of FAP clustering on tumor-associated fibroblasts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Favorable tolerability profile demonstrated in ongoing Phase 1 clinical trial, with possible weekly dosing.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Engineered to offer a broader therapeutic index than other non-localized 4-1BB engagers.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Full data from ongoing Phase 1 clinical trial expected in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immunotherapies, such as checkpoint inhibitors, have produced unprecedented clinical outcomes in cancer. However, despite long term survival in some patients, the majority of patients still develop primary or secondary resistance to current immunotherapy approaches. Historically, development of 4-1BB monotherapies has been met with clinical hurdles, including systemic toxicities, and lack of tumor specificity. Aiming to address these limitations and expand the benefits of immunotherapies to more patients, we developed AMG 506 (MP0310). We expect that a 4-1BB activating DARPin can mitigate some key mechanisms of resistance to current treatments by recruiting and activating the immune system in a highly localized fashion in the tumor microenvironment via multi-specific binders that are designed to interact with immune targets only when they are in the tumor microenvironment. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4-1BB is a costimulatory receptor and member of the tumor necrosis factor, or TNF, superfamily that is expressed following activation of T cells and Natural Killer, or NK cells. Binding of 4-1BB by its natural ligand 4-1BBL, provided by antigen-presenting cells, or APCs, or by agonistic antibodies, has been reported to enhance proliferation, effector functions, memory formation and survival in CD8+ T cells both </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. 4-1BB is considered to be an attractive drug target as its upregulation in T cells is associated with an encounter with antigen in the tumor, which provides a costimulatory signal to the T cells. AMG 506 (MP0310) targets 4-1BB along with FAP. FAP is a membrane bound enzyme, highly expressed on the cell surface of activated but not quiescent fibroblasts. Expression in normal adult tissues is absent or low, but increases in remodeling processes such as wound healing, inflammation, or fibrosis when fibroblasts become activated. Importantly, FAP is highly expressed by cancer-associated fibroblasts, or CAFs, a major constituent of tumor stroma. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMG 506 (MP0310) is designed to activate itself only the local tumor microenvironment by binding to FAP on tumor stromal cells and to T cells via 4-1BB. We believe that this approach may be effective in re-opening the 4-1BB therapeutic window by excluding systemic 4-1BB effects.</font></div><div style="text-align:center"><img alt="businessfigure19a1a.jpg" src="businessfigure19a1a.jpg" style="height:126px;margin-bottom:5pt;vertical-align:text-bottom;width:623px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Full length design of AMG 506 (MP0310), a penta-DARPin molecule with 2 HSA DARPins, 2 4-1BB binders, and 1 FAP binder.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we presented preclinical data at the AACR annual meeting describing the pharmacokinetic and pharmacodynamic research used to establish the optimal dose range for the ongoing multiple ascending dose, Phase 1 clinical trial of this novel tumor-localized immune agonist. In the preclinical study, a translational pharmacokinetic-pharmacodynamic modeling approach to integrate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> data was demonstrated to support the estimation of a minimal anticipated biological effect level and the relevant dose range for first in human studies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary, non-adjudicated clinical data from the ongoing Phase 1 clinical trial were also presented in December 2020 at our R&#38;D day, which support our preclinical observations. True to its design, the FAP binding localization was shown to be effective&#59; AMG 506 (MP0310) colocalizes with the tumor as shown in Figure 18 below. At fairly low dose levels, AMG 506 (MP0310) begins to colocalize with FAP. This FAP binding is observed to be dose dependent, with a saturation of the tumor expressed FAP in high AMG 506 (MP0310) concentrations. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure20a1a.jpg" src="businessfigure20a1a.jpg" style="height:267px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 18. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AMG 506 (MP0310) is seen to colocalize, and saturate FAP in the tumor microenvironment of patients in a dose dependent manner.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By analyzing paired biopsies of some patients, significant tumor-localized increases in immune activation were seen across multiple immune cell types after a single injection, while systemic inflammatory markers were unchanged, and no AMG 506 (MP0310) activity was seen in peripheral tissues. As of November 30, 2020, the data cut-off date, AMG 506 (MP0310) was well tolerated with the protocol defined infusion-related reactions, or IRRs, observed in 12 of 23 patients. All of the IRRs were manageable and consistent with an immune-engaging drug. Notably, no other type of significant systemic toxicity was observed as of the data cut-off date. </font></div><div style="text-align:center"><img alt="businessfigure21a1a.jpg" src="businessfigure21a1a.jpg" style="height:282px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 19. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacodynamic activity of AMG 506 (MP0310) is shown to activate T cells and NK cells, while avoiding systemic activation. &#8593; T and NK population&#59; &#8593; IFN&#947; activation and cytotoxicity observed in cohort 3.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional dosing work is ongoing in the current Phase 1 clinical trial to identify the dosing regimen to obtain the durable activity after several injections of our tumor localized 4-1BB agonist. We expect to study weekly dosing of AMG 506 (MP0310), compared with three weekly dosing, and the potential to reduce the proportion of patients developing IRRs and extend the period of exposure of AMG 506 (MP0310) in the body. We are encouraged by repeated signals of drug localization and pathway activation in biopsies and anecdotal signs of clinical efficacy, which inform the study.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although a limited proportion of the patient population may benefit from this therapeutic candidate as a monotherapy, we designed AMG 506 (MP0310) expecting that the full therapeutic benefit for patients will be achieved by combining AMG 506 (MP0310) with a second oncology drug, and more specifically an additional therapeutic directing the activated T-cell to target tumor cells. Although 4-1BB activation can serve as a mechanism to attract immune cells to the tumor microenvironment, additional signals are likely required for full activation against specific tumors. The addition of a second immune-stimulating product should assist with activating and directing specific anti-cancer T cells to engage with their targets.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In other words, we believe that AMG 506 (MP0310) can create a localized immune response in the tumor microenvironment, and a second drug could specifically direct T cells to kill tumor cells. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have announced a strategic collaboration with Amgen, initiated in December 2018, to evaluate AMG 506 (MP0310) in combination with Amgen&#96;s oncology pipeline products, including its investigational bispecific TCE, or BiTE&#174;, molecules. Under the licensing agreement with Amgen, we retain certain rights to develop and commercialize our proprietary DARPin platform product candidates in combination with AMG 506 (MP0310). We believe our partnership with Amgen allows for a meaningful investigation of combination therapies, given Amgen&#8217;s expertise in the field of oncology. We expect that the ongoing Phase 1 clinical trial of AMG 506 (MP0310), should it demonstrate sustained activity of 4-1BB, will produce data in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to inform potential combination studies which would be conducted by Amgen assets. Pursuant to the collaboration, we received an upfront payment of $50.0 million and are eligible to receive up to $497.0 million in development, regulatory and commercial milestone payments and royalty payments from low double digit up to the high teens. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MP0317&#58; DARPin Molecule targeting FAP x CD40</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Designed to activate CD40 only in environments with high level of FAP expression, similar to AMG 506 (MP0310).</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Localized activation by FAP targeting underpins the therapeutic benefits while expanding the range of immune cell activation.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Designed to facilitate uses of other immune stimulating therapies. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">First in human Phase 1 clinical trial expected to commence in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tumor-localized immune agonist MP0317 is the second product candidate in our oncology program. MP0317 comprises a localizer to FAP and immune stimulator binding to CD40. FAP is found in the tumor stroma in high density and its binding is intended to create a cluster of CD40 on immune cells enabling immune activation. As depicted in Figure 20, MP0317 is designed to simultaneously engage FAP and CD40 to create tightly bound clusters around tumors, which are necessary to induce CD40-mediated local immune activation.</font></div><div style="text-align:center"><img alt="businessfigure22a1a.jpg" src="businessfigure22a1a.jpg" style="height:208px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 20. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MP0317 is seen to activate CD40 only when clustering with FAP, designed to prevent systemic activation. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CD40 plays a critical role in antigen presentation and the monocyte maturation process, and therefore, indirectly, T-cell activation. One of the main functions of CD40 signaling is to enhance antigen-presentation to T cells by activating dendritic cells, or DCs. CD40 engagement on the surface of DCs promotes cytokine and chemokine production, induces expression of costimulatory molecules, and facilitates the cross-presentation of antigens. This step increases the interaction of DCs with T cells by upregulating surface proteins such as CD54 and CD86, thereby activating the surface proteins. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agonist anti-CD40 antibody treatments have been associated with mild to moderate toxicity in the clinic, which we believe is related to on-target but off-tumor effects causing CRS and liver toxicity.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aiming to avoid CD40-related toxicity, we developed MP0317 to work as a locally activated CD40 engager, designed to only activate the immune system when both FAP and CD40 are simultaneously engaged. We expect this localizing mechanism to reduce the likelihood of extra-tumoral systemic side effects and allow an increase of the therapeutic index.</font></div><div style="text-align:center"><img alt="businessfigure23a1a.jpg" src="businessfigure23a1a.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 21. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Full length design of MP0317, a tetra-DARPin with 2 CD-40 DARPins, 1 FAP DARPin, and 1 HSA DARPin.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the AACR virtual annual meeting in June 2020, we presented preclinical data that supports the intended profile and CD40-mediated immune activation capabilities of MP0317. As depicted in Figure 22, MP0317 was found in human B cells, macrophages and DCs to activate the CD40 pathway solely in the presence of FAP-positive cells, confirming its strict dependence on FAP-mediated crosslinking.</font></div><div style="text-align:center"><img alt="businessfigure24a1a.jpg" src="businessfigure24a1a.jpg" style="height:315px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 22. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MP0317 demonstrates the ability to activate multiple immune cells, similar to a monoclonal CD40 antibody, while limiting activation when only in the presence of FAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, in a mouse model, a mouse-specific surrogate of MP0317 was found to substantially inhibit the progression of FAP-positive tumors without showing any of the toxicities seen with administration of a mouse CD40 antibody.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure25a1a.jpg" src="businessfigure25a1a.jpg" style="height:258px;margin-bottom:5pt;vertical-align:text-bottom;width:568px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 23. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In a colorectal cancer model, MP0317 is shown to activate in an FAP&#47;tumor specific manner, when compared with a monoclonal antibody targeting CD40 which demonstrates broad systemic activation of inflammatory markers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to present new data at the AACR virtual annual meeting in April 2021 to provide further supportive evidence of MP0317&#8217;s unique therapeutic potential in an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> model system. We expect that the results of our preclinical study will demonstrate an MP0317-dependent modulation of macrophage phenotypes and reveal a release of T cells from macrophage-mediated suppression. We also expect that the preclinical study will demonstrate FAP-dependent activation of CD40-expressing B-cell and myeloid cell populations in dissociated human tumors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate initiating a Phase 1 clinical trial for MP0317 in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. The clinical trial is expected to enroll patients with solid tumors which have per literature at least a moderate level of FAP expression. Leveraging our experience from the AMG 506 (MP0310) clinical trial into the clinical design of our MP0317 product candidate, we expect to achieve greater speed in treating patients at meaningful dose levels. In parallel and to complement the Phase 1 clinical trial of MP0317, we are planning to undertake the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A preclinical set of experiments to evaluate the relevance and optimal sequencing approach of combining MP0317 with radiation. Although high dose external beam radiotherapy, or XRT, is effective in releasing antigens, priming T cells, and mediating systemic immune mediated outcomes, it often leads to fibrosis and accumulation of CAFs at the primary site of irradiation. These CAFs express the FAP that we can use to our advantage for targeted drug delivery into the TME. Therefore, we hypothesize that combining the FAP-CD40 drug conjugate with XRT will yield high primary as well as secondary tumor control.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A clinical study combining MP0317 injected intratumorally with a PD1 inhibitor and a T-cell activating vaccine in neo-adjuvant melanoma. We expect studying neo-adjuvant pre-surgery melanoma will allow us to test an immune stimulating complex combining three drugs as well as provide robust collection of translational biomarkers documenting the modulation effect of MP0317 with other agents. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The translational component of the dose escalation study re-enforced by the two other preclinical and clinical modules will help inform the prioritization of the following dose expansions and efficacy combination studies once we have identified a biologically effective dose. We expect our future development plans to include&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Combining MP0317 with checkpoint inhibitors in FAP rich tumors that have high levels of infiltrated immune cells, or &#8216;hot&#8217; tumors, such as urothelial, non-small cell lung cancer, or NSCLC, and melanoma, and also in FAP rich tumors that have low levels of infiltrated immune cells, or &#8216;cold&#8217; tumors, such as pancreatic duct adenocarcinoma and sarcoma, with chemotherapies +&#47;- PD1 inhibitors.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A combination study with checkpoint inhibitors and radiation in NSCLC and&#47;or head and neck squamous cell carcinoma.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our CD3 &#47; TCE Program</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Novel CD3-binding T-cell engagement programs with a multitude of binding modules allowing optimized product efficacy and safety.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Designed to achieve single agent activity combined with a multi-specific cancer antigen targeting.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased specificity combined with target redundancy to treat more cancers and avoid healthy tissue.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prodrug capabilities which include attenuated and&#47;or localized activation of immune engagement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CD3 &#47; T-Cell Targeting DARPin molecules</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic evolution, we are focusing our efforts on creating DARPin product candidates that convey single-agent activity and do not explicitly require combination with additional compounds to show clinical efficacy. Executing on this strategy, we have developed a CD3 TCE therapeutic platform, designed to activate respective immune cells against specific cellular targets in a highly selective, localized and specifically timed fashion. We believe that our CD3-targeting approach to T-cell engagement has the potential to address the key challenges of currently existing CD3-targeting programs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Challenges of Existing TCE Approaches </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TCEs have been shown to be very potent anti-tumor drugs. The multiple efforts in developing bispecific T-cell redirecting molecules are fueled by the initial success of Blincyto, a CD19 directed TCE, that was approved in 2014 as the first TCE in cancer therapy, and is to date the only approved molecule of its kind.  Fast followers of this potent bispecific mainly involved T-cell redirecting molecules for hematological malignancies and recent data on CD20 directed TCEs has sparked new excitement in the field. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite these successes, the development of TCEs targeting tumor associated antigens is typically hampered by four major challenges summarized below.   </font></div><div style="text-align:center"><img alt="businessfigure26a1a.jpg" src="businessfigure26a1a.jpg" style="height:189px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 24&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Challenges of tumor antigen redirecting TCEs in the clinic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Efficacy can be compromised by the heterogeneity of the tumor with regards to target expression, target loss, mutation or downregulation.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Limited tissue penetration, the immunosuppressive microenvironment and the risk for T-cell exhaustion can further negatively affect the efficacy which may especially be true for solid tumor indications.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Due to the lack of truly tumor-specific targets, highly potent TCEs bear the risk of inducing on-target, but off-tumor toxicity by attacking normal healthy tissue, limiting the achievement of dose levels needed for optimal anti-tumor activity.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hyper-immune stimulation due to pan-T-cell activation may result in CRS, lymphocyte redistribution phenomenon, endothelial activation and neurological toxicity, all of which can further compromise optimal dosing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the suboptimal therapeutic window, many TCEs fail along the development process. Therefore, novel approaches with distinct features are needed to tackle those challenges and to control those highly potent molecules. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Beyond Bi-specifics&#58; Our Next Generation DARPin-based TCE Platform </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years we have made significant progress to integrate the CD3-targeting approach for T-cell engagement into a DARPin format that addresses these key challenges. To pursue T-cell activation, we have generated a toolbox of IND-ready CD3 DARPin product candidates to cover a broad CD3 affinity spectrum from very modest CD3 binding up to equivalent&#47;superior binding compared to existing high affinity benchmarks. The affinity range provides us with DARPin-based TCEs with different functional activities. This allows us to assemble multi-specific TCE DARPin drug candidates with CD3 engagement optimized for the targeted tumor antigen and MOA. Specifically, it enables the induction of an optimal T-cell response to efficiently attack tumor cells without over-simulation of the immune system that can result in toxicities or T-cell exhaustion. In combination with the unique format flexibility and modular design capabilities of DARPins, we believe the CD3 toolbox allows us to generate a superior suite of next generation TCE therapeutics.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Multi-targeting Strategy with Curative Intent for the Treatment of AML</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical need in AML remains high. Despite the achievement of remission for a majority of patients, up to 70% of adults and 30% of children will not survive beyond five years after initial clinical response due to relapsing disease. Further, the treatment of relapsed&#47;refractory AML, or r&#47;r AML, is therapeutically challenging due to high relapse rates with current standard-of-care treatments and the aggressive nature of the disease. Currently, a variety of highly potent mono-targeting TCE and CAR-T therapies have entered clinical development, but those therapies are often accompanied by dose limiting toxicities such as CRS and myelotoxicities, preventing dose escalation to induce robust anti-tumor efficacy. More selective therapies addressing the growing number of subclasses and rationally designed target combinations are needed to allow for extended dose escalation with a more acceptable safety profile and to achieve more durable responses.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In AML, leukemia stem cells, or LSCs, produce all the leukemic cells in the patient and therefore a lasting cure for this disease is dependent on eradication of these cells. However, LSCs are relatively resistant to standard therapies. For example, these cells are less sensitive to killing by daunorubicin and cytarabine, two commonly used chemotherapeutic agents. This is partially due to increased expression by LSCs of multidrug resistance genes, and also to their quiescent state, which reduces the effects of cytotoxic agents that target rapidly replicating cells. It is therefore essential to primarily target LSCs to achieve durable disease control.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some cancer antigens are also present on many healthy cells, but at a lower concentration, and as such it is difficult to select any single target to sufficiently differentiate between cancer cells and healthy tissue. To overcome this limitation and increase specificity, we leveraged our unique DARPin platform to generate a multi-specific TCE DARPin molecule, targeting different TAAs, with a fine-tuned and tailored affinity. To do so, we screened thousands of permutations of multi-specific DARPin molecules to optimize target combination, affinity and molecular architecture to ensure avidity driven, simultaneous binding to different TAAs in conjunction with our CD3-binding DARPin molecule. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In avidity driven selectivity, the presence of two or more binding targets on the cell, and the molecular interaction with these targets, increases the effective concentration of the binder and the resulting binding strength. This dependency of binding strength on the presence of more than one cancer antigen conveys a far superior selectivity to these multi-specific binders. This approach is a concept that is well known in the scientific community but has so far been limited by the availability of an optimal therapeutic platform to address the associated technical challenges. In order to find the right target combination, the optimal affinity to increase tumor specificity via avidity, as well as the best molecular architecture, we took advantage of our unique modular DARPin platform and screened hundreds of combinations of multi-specific DARPin molecules, binding simultaneously to three different TAAs. Furthermore, we combined our tri-specific binders with our CD3-binding TCE DARPin in one molecule. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:center"><img alt="businessfigure27a1a.jpg" src="businessfigure27a1a.jpg" style="height:246px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 25&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our dual-engaging tri-specific DARPin product candidates are designed to engage only cells that express two or three cancer antigens, while sparing healthy cells with one or fewer cancer antigens.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approach allowed the design of multi-specific TCEs which are simultaneously targeting CD33, CD123 and CD70, three well-known AML antigens that are co-expressed on approximately 50% of AML cells and of which at least two are expressed on approximately 70% of AML cells. To further optimize our molecules, we have devised a concentration dependent MOA utilizing moderate affinity binders rather than high affinity ones. When such a DARPin encounters a cell expressing only one antigen, there should only be transient interaction and the DARPin should quickly disengage the target with limited cytotoxic effect. However, when there are two or three targets, the mechanism of avidity driven selectivity activates, as illustrated in Figure 26 below. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preclinical tests against AML cells, we observed these new multi-specific DARPin CD3 TCE candidates to deliver highly potent and specific activity and the potential for a reduced effect on healthy normal cells. Adding to the increased selectivity, our candidates, which target three TAAs simultaneously, have the potential to counteract target escape mechanisms expected due to tumor heterogeneity. In addition, this mechanism is designed to capture a larger population of AML patients due to its ability to engage with any two of these targets simultaneously, while maintaining specificity. </font></div><div style="text-align:center"><img alt="businessfigure28a1a.jpg" src="businessfigure28a1a.jpg" style="height:269px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 26. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The concept of a multi-specific TCE DARPin with improved benefit&#47;risk in AML is demonstrated in this graphic illustrating a tri-specific TCE DARPin. The therapeutic window generated based on full potency on multi-target malignant AML cells (red) and minimal effect on healthy normal cells (green).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our multi-specific CD3-binding DARPin molecules targeting two or three different AML antigens with optimized affinity and geometry demonstrated substantial avidity gain and an increased selectivity window in preclinical studies. The avidity gain resulted in strongly enhanced in vitro potency as shown by activation of both CD8+ and CD4+ T cells and subsequent killing of AML tumor cells, with bioactivities in the range of established TCE benchmark formats such as BiTE and DART and compared to the reference constructs where TAA specific DARPins have been replaced by non-binding-DARPins, as shown in Figure 27. We generated selectivity data by comparing our multi-specific DARPin constructs on MOLM-13 AML cell lines where the respective TAAs have been knocked out individually or in combination, as shown in Figure 27. </font></div><div style="text-align:center"><img alt="businessfigure29a1a.jpg" src="businessfigure29a1a.jpg" style="height:266px;margin-bottom:5pt;vertical-align:text-bottom;width:611px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 27. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selectivity window gain shown on T-cell activation and killing using MOLM-13 cells.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tumor specificity, and resulting potential for a better safety profile, of our DARPin has been confirmed in an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> blood assay testing potential CRS liabilities. In this assay, our multi-specific DARPin induced profoundly less cytokine release as compared to benchmark molecules indicating an improved therapeutic window, as shown in Figure 28. </font></div><div style="text-align:center"><img alt="businessfigure30a1a.jpg" src="businessfigure30a1a.jpg" style="height:153px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Safety advantage of multi-targeting CD3 DARPin TCEs were compared to mono-targeting TCE benchmarks molecules using human ex vivo whole blood assays from healthy donors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following confirmation of additional preclinical safety and IND enabling work, we intend to initiate a Phase 1 clinical trial for CD3-AML in &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. We intend to study safety and dose levels, as well as ascertain any benefit seen in AML patients, likely in the relapsed&#47;refractory setting.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If preclinical studies are conclusive, we expect to run a classic 3x3 dose escalation trial in a Phase 1 in r&#47;r AML patients. We expect that second line patients will be unfit for aggressive treatment. The monotherapy will be escalated and run until a maximal tolerated dose, or MTD, is identified. Once a MTD is identified, if ever, we expect to propose an expansion on MTD and MTD-1. If early signals are confirmed with the expansion, if ever, we intend </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to commence a confirmatory Phase 2&#47;3 clinical trial. In addition to this primary indication, we anticipate exploring further indications also based on the MTD and MTD-1 approach.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conclusion, we have generated TCEs based on multi-specific DARPin constructs with high potency, selectivity and ultimately with the potential for an improved therapeutic window and the potential to address tumor heterogeneity and escape for the treatment of AML.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conditionally Activated TCEs </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the MOA involving a multi-specific targeting approach of a CD3 T-cell engaging DARPin, as illustrated with our AML program, we have identified two additional MOAs that we believe can conditionally activate CD3 TCEs. We believe these can further expand the applicability of DARPin CD3 TCEs for additional patients by using a platform for controlled activation of the CD3 effector function designed to further minimize the risk of side effects and provide sustained activity. We refer to these two programs as CD3 Slow Activation for temporal activation and CD3-Prodrug for spatial activation. CD3 Slow Activation is designed to optimize for slow activation over time in circulation to reduce the maximal active drug concentration at treatment start, increasing bioactivity over time and potentially avoiding hyper-immune stimulation. CD3-Prodrug is designed to optimize for a conditional activation locally in the TME for reduced on-target, off-tumor activity.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Slow activation</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first dose administration of TCEs carries a high risk for acute toxicities like endothelial activation, massive lymphocyte redistribution, neurological effects, and CRS. Mitigation strategies include pre-medication with immune-suppressive steroids, IL-6 receptor antagonists, step-dosing or continuous intravenous infusion. Despite the application of these mitigation strategies, severe side effects which may lead to death in the extreme case are still observed in clinical trials with TCE therapies.</font></div><div style="text-align:center"><img alt="businessfigure31a1a.jpg" src="businessfigure31a1a.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:313px"><img alt="businessfigure32a1a.jpg" src="businessfigure32a1a.jpg" style="height:125px;margin-bottom:5pt;vertical-align:text-bottom;width:257px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our designed DARPin blocker domain can mask the CD3 engager domain and inhibit it. Due to a slow dissociation rate of the blocker, the candidate becomes active slowly over time, avoiding a peak of over activity seen in other TCEs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our solution to this toxicity limitation of TCEs is analogous to the combination of continuous intravenous infusion and step dosing. By forming a non-covalent, inactive complex of TCE and a blocker molecule to its CD3-binding moiety, we can ensure a slow, continuous activation of the TCE over time, while the short-lived blocker molecule is eliminated quickly.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our preclinical study, we demonstrated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cell-based assays that a panel of blockers was able to inhibit the activation of a DARPin based TCE at low picomolar, or pM, concentrations and that the activation-rate of the TCE is determined solely by the off-rate of the super-high affinity blocker molecule. In our </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> preclinical study in a human whole-blood test system using an active, non-blocked versus a transiently blocked TCE we demonstrated that cytokine release can be prevented by our slow activation concept. Finally, we were able to show a reduction in cytokine release in a set of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> preclinical studies in PBMC-humanized NOG mice engrafted with tumor cells by administering a transiently blocked TCE to mice with established tumors (&#62; 200 mm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). At the same time, the transiently blocked TCE led to comparable tumor growth inhibition as the non-blocked TCE.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, the slow activation concept for DARPin based TCEs resulted in reduced acute toxicity in the form of reduced cytokine release, while showing equivalent efficacy. Notably, this approach may hold promise beyond </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TCEs and could be applied to any drug where acute side effects could be overcome by a slower onset of the therapeutic effect. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Spatial activation &#8211; CD3 Prodrug</font></div><div style="text-align:center"><img alt="businessfigure33a1a.jpg" src="businessfigure33a1a.jpg" style="height:265px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Concept of conditionally activated DARPin CD3 prodrug.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to overcome toxicity-related challenges seen with previous approaches, we have developed a proof-of-concept anti-CD3 Prodrug DARPin, CD3-PDD, consisting of an EGFR-binder and a CD3-binder, linked via a protease-cleavable linker to a CD3-binder masking DARPin, which we refer to as a blocker. This &#945;-EGFR x &#945;-CD3 x blocker is unable to bind and recruit T-cells in its non-cleaved state, but is designed to become activated in the tumor microenvironment upon linker cleavage by tumor-associated proteases. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T-cell activation and tumor cell killing assays, we have shown that this design allowed a large masking window, or the difference in EC50 between the masked and the unmasked TCE, for active TCE as compared to non-cleavable CD3-PDD. Cleavable CD3-PDD was found to become partially activated in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assays by secreted proteases and therefore showed an EC50 value in-between the active TCE and the non-cleavable CD3-PDD, as shown in Figure 31.</font></div><div style="text-align:center"><img alt="businessfigure34a1a.jpg" src="businessfigure34a1a.jpg" style="height:210px;margin-bottom:5pt;vertical-align:text-bottom;width:603px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 31&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> T-cell activation and tumor cell killing for active TCE, cleavable CD3-PDD, pre-cleaved CD3-PDD and non-cleavable CD3-PDD, tested with HCT 116 tumor cells and effector pan T-cells. Non-cleavable CD3-PDD showed neither T-cell activation nor tumor cell killing, whereas active TCE and pre-cleaved CD3-PDD exhibited potency in the single digit pM range.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Next, we performed an in vivo proof-of-principle study in a human colon carcinoma xenograft model, HCT 116, using immunodeficient mice humanized with hematopoietic stem cells, CD34+, and optimized for the presence of human myeloid cells. The mouse cross-reactivity of the EGFR-binder allowed us to assess both anti-tumor efficacy and define a therapeutic window in this model. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cleavable CD3-PDD demonstrated robust anti-tumor activity, similar to the one observed with active TCE. Most importantly, while the active TCE elicited strong toxicity, leading to loss of animals and requiring us to stop treatment, we were able to dose the cleavable CD3-PDD without significant safety concerns. </font></div><div style="text-align:center"><img alt="businessfigure35a1a.jpg" src="businessfigure35a1a.jpg" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Figure 32&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On the left, results from our spatially activated DARPin TCE demonstrate that the cleavable DARPin is as active against the tumor as the unmasked control. The non-cleavable protein had a lesser effect over the tumor size. However, when we observe how each DARPin effected the test animal health, we can see that the unmasked control affected the animals&#8217; health detrimentally, while the masked constructs had minimal effect, if any.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the conditionally activated CD3-PDD shows similar efficacy but none of the toxicity of the active TCE, we believe that our approach holds great promise for the development of future CD3-PDDs as therapeutics, enabling utilization of less tumor-specific targets for highly potent TCEs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that ongoing preclinical work will continue to validate potential solid tumor targets which might benefit from conditional activation via protease cleavage. Tumor targets like EGFR, or other similar targets, may prove to be of interest.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C. Our Peptide MHC Program</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">High specificity binders against extremely hard to drug targets, leveraging unique geometric properties and high throughput screening capabilities.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provide the ability to drug intra-cellular targets, which include up to 95% of cancer antigens.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ease of development - generated quickly and reliably with capability for half-life extension, easy to manufacture.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential for a multi-specific pMHC DARPin to cover more peptides of the same antigen or peptides from more than one antigen.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While potent T-cell activating or redirecting modalities have shown significant promise against a range of cancers in recent years, the number of suitable tumor-specific targets is often limited due to their reliance on targeting transmembrane proteins that are highly expressed on tumors but with minimal expression on non-target tissue. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contrast, almost all intracellular proteins are processed and presented as peptides on the cell surface by major histocompatibility complexes, or MHC class I molecules, known as human leukocyte antigens, or HLA, in humans. It is thought that up to 95% tumor specific antigens are intracellular, with very few extracellular, so unlocking the ability to target these provides a significant gain in the breadth of potential tumor specific targets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development of biologics, including soluble TCRs and TCR-like antibodies, or cell therapeutics which target pMHC complexes have so far been hindered by low target abundance, weak affinity, cross-reactivity to similar pMHC complexes, or complexity in manufacture and administration. DARPin-based therapeutics offer the potential to overcome these limitations through their excellent biophysical properties and advantageous structural characteristics allowing them to bind pMHC complexes with both high selectivity and high affinity. Moreover, such DARPins can be manufactured and administered with comparative ease in contrast to adoptive cell therapies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to present preclinical data at the AACR meeting in April 2021 showing the development and characterization of bispecific DARPin TCE proteins (pMHC x CD3 DARPin) binding with high specificity to a peptide derived from the cancer testis antigen NY-ESO-1 (SLLMWITQC), presented in the context of the MHC HLA-A. These data illustrate the successful selection of DARPin binders against pMHC complexes from our extensive library of over a trillion DARPin variants, which were then formatted into bispecific TCEs with an additional CD3-binding DARPin domain to enable potent re-direction and activation of T cells. This MOA also allows highly sensitive analysis of pMHC specificity and potential cross-reactivity. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using a number of cellular assays, we confirmed that the selected DARPin proteins displayed a high specificity for the selected complex. Architectural fine tuning and sequence engineering allowed us to further increase the potency of the selected candidates without compromising the specificity. The potential of these engineered molecules for tumor elimination was illustrated through potent DARPin mediated T-cell activation towards tumor cell lines expressing the peptide-HLA-A2 antigen, and in contrast, lack of activation towards comparable tumor cell lines that do not present the NY-ESO-1 peptide. Furthermore, HLA-A2+&#47;SLL+ cells but not HLA-A2+&#47;SLL- cells were effectively killed in the presence of these specific DARPin TCEs in a concentration dependent manner, illustrating the potential for elimination of target positive tumor cells in a dose-controlled fashion. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current bi-specific TCR molecules in clinical trials face the challenge of short serum half-lives and rapid elimination. To address this, we have established a platform to provide good systemic exposure for our pMHC x CD3 DARPins without compromising potency and specificity, making the DARPin technology platform highly instrumental for the development of a new class of anti-cancer therapeutics.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, we believe that DARPin proteins represent a valuable alternative to specifically target pMHC complexes expressed in a broad range of cancers and&#47;or virology indications. Moreover, thanks to the modular nature of DARPin proteins, this platform may be utilized to target at-risk tissues in auto-immune diseases by utilizing immune-suppressive effector functions in place of CD3 engagement. The outstanding biophysical properties, capacity for multi-specific formatting and level of specificity exhibited by pMHC-specific DARPin proteins prompts investigations on their broader application for alternative treatment modalities (drug conjugates, radio therapy, CAR-T-cells) and pMHC-specific diagnostics. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the technological capability to target these complexes may enable DARPins to offer therapeutic benefits for a number of diseases, our current strategic approach is to co-develop these therapeutics with third-party collaborators who have a strong working knowledge of which targets may prove to offer the most benefit for patients.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D. Our Legacy Oncology Product Candidates</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have observed each of our legacy product candidates in our oncology program, MP0250 and MP0274, to be well tolerated and exhibit promising levels of biological activity. Our experience in developing our legacy product candidates provided key learnings that we leverage as we progress the development of our other product candidates. While the activity and tolerability of these programs are encouraging, a strategic decision was made to invest in programs where a clear clinical differentiation could be made through the DARPin constructs. The competitive landscape for these programs, coupled with the need to be used in combination with other therapies, make these compounds attractive investments for potential partnerships. It is our intent to explore additional clinical development for MP0250 and MP0274 through clinical collaborations and partnerships, but we believe that further solo investment in these assets is unlikely.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MP0250</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our first oncology DARPin product candidate was MP0250, a proprietary multi-DARPin product candidate consisting of four DARPin domains. One targets VEGF, the activating ligand of the VEGF receptor, one targets </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hepatocyte growth factor, or HGF, the activating ligand of the c-MET receptor, and two target HSA. The VEGF and HGF targeting single-domain DARPin proteins are designed to effectively bind to and thereby neutralize VEGF and HGF, while HSA binding increases MP0250&#8217;s half-life to extend treatment activity and may increase tissue penetration. We have conducted two Phase 2 clinical trials of MP0250, one in multiple myeloma patients and one in EGFR-mutated NSCLC patients, both in combination with standard-of-care treatments. MP0250 was administered to a total of 86 patients. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our clinical development of MP0250 established the ability of our DARPin product candidates to bind to more than one target, which we believe is a key element of preventing tumor escape and is a foundational attribute of many of our other product candidates. In addition, our learnings from including HSA binding in MP0250 to extend treatment activity have proven vital for our other product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MP0274</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our second DARPin product candidate in oncology was MP0274, a proprietary DARPin product candidate designed to bind to two epitopes on HER2. MP0274 is designed to inhibit HER2 activation and any subsequent activation of HER2 in conjunction with the HER 1 and HER3 receptor proteins that promote the growth of cancer cells. MP0274 was administered to a total of 22 patients.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the early evidence of biological activity, we incorporated the learnings from the DARPin&#8217;s ability to bind a single target on more than one epitope validated by MP0274 in developing our MP0420 and MP0423 product candidates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E. Our Ophthalmology Program</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abicipar is a DARPin therapeutic candidate designed to inhibit VEGF, which we have licensed to Allergan, an Abbvie company. It is at the registrational stage as an investigational candidate for the treatment of nAMD. Abicipar is also an investigational candidate for diabetic macular edema, or DME. Abicipar is designed to remain in the eye longer than current treatments and consequently offers the potential for less frequent dosing. In June 2020, AbbVie received a Complete Response Letter, or CRL, for the BLA of abicipar. The agency&#8217;s notice indicated that the rate of intraocular inflammation observed following administration of abicipar pegol results in an unfavorable benefit-risk ratio in the treatment of nAMD. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie has withdrawn its filings for abicipar with both the European Medicines Agency and the Japanese Regulatory Agency and is committed to working with these agencies to determine appropriate next steps and requirements for potential resubmissions for abicipar. There is substantial need for better treatment options for nAMD and we remain confident in the totality of data supporting abicipar&#8217;s clinical profile for this indication. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a first-generation single domain DARPin, abicipar delivered on its promise of a powerful anti-VEGF mechanism and long half-life and is foundational in our understanding of leveraging our DARPin platform in our other product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Intellectual Property</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our ability to obtain, maintain, enforce and defend patents and other intellectual property and proprietary protection for our product candidates and technology</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to preserve the confidentiality of our trade secrets,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to operate without infringing, misappropriating or otherwise violating  patents and other proprietary rights of others, and to prevent others from infringing, misappropriating or otherwise violating our patent and other proprietary rights. We seek to protect our proprietary position by, among other methods, filing patent applications covering our proprietary technology, improvements thereof, product candidates, and other inventions  in Europe, the United States and other relevant jurisdictions that are important to the development of our business. To protect </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection, we rely on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trade secrets, know-how, confidential information and continuing technological innovation. We also rely on in-licensing opportunities to develop and maintain our proprietary position. We may further rely on statutory market exclusivity and patent term extensions that may be available for our product candidates once they achieve regulatory approval.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain three categories of patent protection for, respectively, our DARPin technology platform, key single-binding domain DARPin proteins binding to specific targets and our DARPin product candidates. The first category of protection covers our DARPin technology platform and relies on both in-licensed and Molecular Partners-owned issued patents and pending patent applications&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The DARPin base technology we use in our DARPin platform to generate our DARPin product candidates is exclusively licensed to us by the University of Zurich. See &#8220;Business&#8212;License and Collaboration Agreements&#8212;License Agreement with the University of Zurich&#8221; for information on the terms of this in-license. The patent family covering this technology is based on the international patent application WO 2002&#47;020565 and relates to the processes we use to generate our DARPin libraries, the DARPin libraries themselves and the DARPin binding proteins we select from our libraries. As of March 12, 2021, we have exclusively licensed four issued U.S. patents and 11 issued foreign patents in this family. The issued patents are expected to expire in 2021, with the exception of one U.S. patent that received patent term adjustment and is expected to expire in 2023. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We also own a patent family, based on international patent application WO 2012&#47;069655, relating to DARPin binding proteins comprising certain improved N-terminal capping modules. As of March 12, 2021, we own three issued U.S. patents, eight issued foreign patents and three pending foreign patent applications in this family. Any issued patents in this family are expected to expire in 2031. The disclosed improvement of the DARPin platform is included in our DARPin product candidates MP0250, MP0274,  MP0310, MP0317, MP0420 (ensovibep) and MP0423. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other patent applications falling in this category have been filed and are pending, but have not been published yet.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A second category of protection covers our key single-binding domain DARPin proteins binding to specific targets. These single domain DARPin binding proteins can be used in multiple DARPin product candidates. Our patent applications and corresponding patents directed to key single domain DARPin binding proteins currently include&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2010&#47;060748, relating to single domain DARPin binding proteins with specificity for vascular endothelial growth factor A, or VEGF-A. As of March 12, 2021, we owned one issued U.S. patent, twenty-nine issued foreign patents and four pending foreign patent applications in this family. Any issued patents in this family are expected to expire in 2029, with the exception of one U.S. patent that received patent term adjustment and is expected to expire in 2031. VEGF-specific DARPin binding proteins are used in our DARPin product candidates abicipar and MP0250 .</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A family of patent applications based on international patent application WO 2014&#47;191574, relating to single domain DARPin binding proteins with specificity for hepatocyte growth factor, or HGF. As of March 12, 2021, we own one pending U.S. patent application and two pending foreign patent applications in this family. If granted, patents in this patent family are expected to expire in 2034. A  HGF-specific DARPin binding protein is used in our DARPin product candidate MP0250.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2012&#47;069654, relating to single domain DARPin binding proteins with specificity for human serum albumin, or HSA. As of March 12, 2021, we own two issued U.S. patents, eight issued foreign patents and eight pending foreign patent applications in this family. Any issued patents in this family are expected to expire in 2031. HSA-specific DARPin binding proteins are used in our DARPin product candidates MP0250, MP0274,  MP0310 MP0317, MP0420 (ensovibep) and MP0423.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A family of patent applications based on international patent application WO 2014&#47;083208, relating to DARPin product candidates comprising two different DARPin binding proteins that bind to specific, but distinct, sites on HER2. As of March 12, 2021, we own one issued U.S. patent, six issued foreign patents and six pending foreign patent applications in this family. If granted, patents in this patent family are expected to expire in 2033. Such a DARPin molecule comprising two different HER2-specific DARPin binding proteins is used in our product candidate MP0274.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2020&#47;245173, relating to single domain DARPin binding proteins with specificity for fibroblast activation protein, or FAP. As of March 12, 2021, we own a pending PCT international patent application, which has not reached the national phase yet, in this family. Any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued patents in this family are expected to expire in 2040. FAP-specific DARPin binding proteins are used in our DARPin product candidates MP0310 and MP0317.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2020&#47;245175, relating to single domain DARPin binding proteins with specificity for 4-1BB. As of March 12, 2021, we own a pending PCT international patent application, which has not reached the national phase yet, in this family. Any issued patents in this family are expected to expire in 2040. 4-1BB-specific DARPin binding proteins are used in our DARPin product candidate MP0310.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2020&#47;245171, relating to improved single domain DARPin binding proteins with specificity for HSA. As of March 12, 2021, we own a pending PCT international patent application, which has not reached the national phase yet, in this family. Any issued patents in this family are expected to expire in 2040. Disclosed HSA-specific DARPin binding proteins are used in our DARPin product candidates MP0310 and MP0317.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other patent applications falling in this category have been filed and are pending, but have not been published yet.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A third category of protection covers the composition of matter of certain of our DARPin product candidates  (e.g., the specific combination and structure of DARPin binding proteins and additional elements that constitute the DARPin product candidate) as well as other product-specific inventions (e.g. formulation, manufacturing process or dosing schedule). Our patent applications and corresponding patents directed to our DARPin product candidates currently include&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2011&#47;135067, relating to abicipar. As of March 12, 2021, we own four issued U.S. patents, one pending U.S. patent application, sixty-five issued foreign patents and four pending foreign patent applications in this family. Any issued patents in this family are expected to expire in 2031, not considering any patent term extensions that may be available in various jurisdictions if abicipar obtains regulatory approval there.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2016&#47;156596, relating to MP0250. As of March 12, 2021, we own two issued U.S. patent, one pending U.S. patent application, six issued foreign patents and twenty pending foreign patent applications in this family. Any patent that has been or may be granted in this patent family is expected to expire in 2036, not considering any patent term extensions that may be available in various jurisdictions if MP0250 obtains regulatory approval there.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family of patent applications based on international patent application WO 2018&#47;054971, relating to MP0274. As of March 12, 2021, we own one issued U.S. patent, one pending U.S. patent application, two issued foreign patents and twenty-one pending foreign patent applications in this family. Any patents that may be granted in this patent family are expected to expire in 2037, not considering any patent term extensions that may be available in various jurisdictions if MP0274 obtains regulatory approval there.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A patent family based on international patent application WO 2020&#47;245746, relating to MP0310. As of March 7, 2021, we own one pending U.S. patent application, four pending foreign patent applications and one pending PCT international patent application in this family. Any patents that may be granted in this patent family are expected to expire in 2040, not considering any patent term extensions that may be available in various jurisdictions if MP0310 obtains regulatory approval there.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other patent applications falling in this category have been filed and are pending, but have not been published yet, including patent applications relating to abicipar, MP0317, ensovibep and MP0423. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual protection afforded by a patent may vary on a product-by-product basis and from country to country and can depend upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of an individual patent depends upon the legal term for patents in the countries in which they are granted. In most jurisdictions, including the United States and countries that are members of the European Patent Convention, the patent term is generally 20 years from the earliest effective filing date of a non-provisional patent application in the applicable country.  In the United States, a patent&#8217;s term may, in certain cases, be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in granting a patent, or may be shortened if a patent is terminally disclaimed over a co-owned patent or patent application having an earlier expiration date or over a non-commonly owned patent or patent application having an earlier expiration date that was filed as a result of activities undertaken within the scope of a joint research agreement. In addition, patent term provisions are available in the United States, the member states of the European Union and certain other jurisdictions to extend the term of a patent that covers an approved drug to recapture a portion of the term effectively lost as a result of the regulatory review period. However, in the United States, the restoration period cannot be longer than five years, the total patent term including the restoration period must not exceed 14 years following U.S. Food and Drug Administration, or FDA, approval, only one patent applicable to each regulatory review period may be extended and only those claims covering the approved drug, method for using it or a method of manufacturing it may be extended. In the future, if and when our product candidates, including abicipar, MP0250, MP0274, MP0310, MP0317, ensovibep and MP0423 receive approval by the FDA, EMA or any other relevant jurisdiction&#8217;s regulatory authorities, we expect, where possible, to apply for patent term extensions on issued patents covering those products, depending upon the length of the clinical trials for each product candidate and other factors. The expiration dates referred to above are without regard to potential patent term extensions that may be available to us and without regard to potential patent term adjustments or terminal disclaimers that may become applicable.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding our efforts, we cannot be sure that patents will be granted with respect to any patent applications we have licensed or filed or may license or file in the future, and we cannot be sure that any patents we have licensed, or that have been granted to us or any patents that may be licensed or granted to us in the future will not be challenged, invalidated, rendered unenforceable or circumvented or that such patents will be commercially useful in protecting our technologies or product candidates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may rely, in some circumstances, on trade secrets and </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">know-how</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to protect our technology. However, trade secrets and </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">know-how</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> can be difficult to protect. We seek to protect our proprietary technology and processes, in part, through confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and commercial partners. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical security of our premises and physical and electronic security of our information technology systems.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own registrations for the trademarks &#8220;Molecular Partners&#8221; and &#8220;DARPin&#8221; in Switzerland, the European Union, the United States and Japan. Further, we intend to build up a trademark portfolio for the names of our technologies and product candidates as potential commercialization approaches.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding the risks related to our intellectual property, please see &#8220;Risk Factors&#8212;Risks Related to Intellectual Property.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">License and Collaboration Agreements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Option and Equity Rights Agreement with Novartis</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we entered into an Option and Equity Rights agreement with Novartis, or the Novartis Agreement. Under the Novartis Agreement, we granted Novartis an option to exclusively license global rights of ensovibep and MP0423, our COVID-19 antiviral DARPin product candidates. Under the terms of the Novartis Agreement, we received a non-refundable cash payment of CHF 20 million for development activities regarding technology transfer and manufacturing for the commercial supply of ensovibep. As part of the transaction, Novartis also agreed to acquire CHF 40 million worth of our common shares, at a price of CHF 23 per share. As a result, Novartis holds approximately 6% of our outstanding shares as of December 31, 2020. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Novartis Agreement, we will conduct Phase 1 clinical trials for ensovibep. Additionally, if we and Novartis agree, we will perform all remaining preclinical work for MP0423 and conduct the MP0423 Phase 1 trial, and Novartis would pay us two milestone payments of CHF 2.5 million each in case of initiation and completion of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such MP0423 Phase 1 trial. Novartis will conduct certain Phase 2&#47;3 clinical trials, with us as legal sponsor of the trials. We are responsible for supplying materials for our clinical development of ensovibep. We expect to commence a Phase 2&#47;3 clinical trial for ensovibep in        and MP0423 is currently being manufactured as we prepare for a Phase 1 clinical trial.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Novartis exercises its option, we would grant Novartis a sublicensable worlwide license to research, develop, manufacture, commercialize and otherwise exploit ensovibep and MP0423 and products comprising those compounds in all indications on (i) an exclusive royalty-bearing basis under our patents having claims solely and specifically covering ensovibep and MP0423 and their use, composition, formulation, preparation or manufacture and related know-how and (ii) a non-exclusive basis under our other patent rights and other intellectual property rights that are necessary or reasonably useful to research, develop, manufacture, prepare, use or commercialize ensovibep and MP0423.  If Novartis exercises its option, we would receive an upfront payment of CHF 150 million. In addition, Novartis would be obligated to pay us a 22% royalty on future commercial sales in certain agreed territories, as we have agreed to forgo royalties in lower-income countries. Upon exercise of such option, Novartis would be responsible for all further development and commercialization activities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Novartis Agreement will expire nine months after the effective date, although Novartis may unilaterally extend the term for an additional six months upon prior written notice. If Novartis exercises its option, the Novartis Agreement will continue in effect until execution of the definitive license agreements. Novartis may terminate the Novartis Agreement at any time upon (i) a specified period of prior written notice in the event of our change of control, or (ii) immediately in the event any clinical trial is terminated or otherwise stopped. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">License and Collaboration Agreement with Amgen</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we entered into a License and Collaboration Agreement with Amgen, or the Amgen Agreement, for the clinical development and commercialization of MP0310 &#47; AMG 506. Under the terms of the Amgen Agreement, we granted to Amgen an exclusive worldwide, royalty-bearing, sublicensable license under our patents and know-how to develop and commercialize MP0310 &#47; AMG 506. We retain the right to use our technology to perform our obligations under the Amgen Agreement and for all purposes not granted to Amgen, including certain rights to develop and commercialize our  DARPin products in combination with MP0310 &#47; AMG 506. MP0310 &#47; AMG 506 is currently in Phase 1a clinical trials.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amgen Agreement, we and Amgen will jointly evaluate MP0310 &#47; AMG 506 in combination with Amgen&#8217;s oncology pipeline products, including its investigational BiTE molecules. In accordance with a mutually agreed development plan, we will conduct the Phase 1a clinical trials and Amgen will be responsible for all subsequent development of MP0310 &#47; AMG 506 after completion of the Phase 1a clinical trials. We and Amgen have established a joint steering committee to oversee the research, information sharing, and potential amendments of the research plan. Each party is responsible for development costs incurred by it until the beginning of Phase 2 clinical trial, after which point the parties will each contribute a fixed percentage of the development costs on the first three indications. Amgen is required to use commercially reasonable efforts to develop MP0310 &#47; AMG 506 in combination with at least one of Amgen&#8217;s oncology pipeline products in certain major markets.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Amgen Agreement, we cannot directly or through a third party develop, manufacture or commercialize any product that binds to or targets the same target as the licensed bispecific TCE, subject to certain exceptions and limitations for third party acquiror products. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a non-refundable upfront payment of $50 million. In addition, we are eligible to receive up to $497 million in development, regulatory and commercial milestone payments. We are also entitled to receive tiered royalties based on commercial sales levels from low double digit up to the high teens percentages of net sales of licensed products for a specified period beginning with the first commercial sale of such a licensed product in a given country of sale and expiring no earlier than ten years after such sale. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amgen Agreement expires on a country-by-country basis upon the expiration of Amgen&#8217;s payment obligations in such country. Amgen may terminate the Amgen Agreement in its entirety for convenience following a certain notice period. Either party may terminate the Amgen Agreement upon an uncured material breach of the agreement or insolvency of the other party following a certain notice period. Following any termination, we have certain rights </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to receive a license to certain intellectual property generated by Amgen under the Amgen Agreement for purposes of continued development and commercialization of MP0310 &#47; AMG 506.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Abicipar Agreement with Allergan, an AbbVie Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2011, we entered into a license and collaboration agreement with Allergan, or the Allergan Agreement. Under the Allergan Agreement, we granted Allergan an exclusive, worldwide, royalty-bearing, sublicensable license under our patents and know-how relating to abicipar and other backup compounds to make, use, sell, offer for sale, and import products containing abicipar and its corresponding backups for ophthalmic indications. We retain the right to use our technology to perform our obligations under the license agreement, to conduct general research and discovery of DARPin compounds other than those licensed under the license agreement, and for all other uses not granted to Allergan.In addition, we granted Allergan a worldwide, perpetual, irrevocable, fully paid-up, royalty-free, exclusive, sublicensable license under certain joint inventions to make, use, sell, offer for sale and import certain compounds and products (other than DARPin compounds) outside of the field of ophthalmic diseases.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allergan is responsible, at its expense, for developing and commercializing abicipar, and must use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize abicipar in certain key countries, including the United States, several major European markets and Japan. Allergan is also solely responsible for manufacture of abicipar, following a manufacturing technology transfer by us to Allergan.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Allergan Agreement, we are prohibited from developing and commercializing any abicipar in any indication, as well certain DARPin compounds that inhibit vascular endothelial growth factor A receptors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allergan paid us an upfront license fee of $45 million in May 2011 and a regulatory milestone fee of $15 million upon the initiation of its Phase 3 clinical trials for nAMD in July 2015. We are also eligible to receive up to an additional $210 million upon the achievement of certain development and regulatory milestone events and $150 million upon the achievement of certain sales milestone events. In addition, we will receive a tiered royalty percentage ranging from the low to mid-teens on worldwide, aggregate annual net sales of abicipar for a specified period beginning with the first commercial sale of such a licensed product in a given country of sale and expiring no earlier than ten years after such sale.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Allergan Agreement remains in effect on a product-by-product and country-by-country basis until the latest of (i) the expiration of the last-to-expire patent licensed in such country that would be infringed, absent a license, by the sale of such licensed product at the time of sale under the agreement, (ii) the expiration of regulatory exclusivity in such country, and (iii) the tenth anniversary of the first commercial sale of such licensed product in such country. Allergan may terminate the Allergan Agreement in its entirety for convenience following a certain notice period. We may terminate immediately the Allergan Agreement immediately upon written notice to Allergan if Allergan challenges the validity, enforceability or scope of any of the patents we license to Allergan under the agreement. Either party may terminate the agreement upon the other party&#8217;s uncured material breach of the agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, Allergan announced that the U.S. Food and Drug Administration issued a Complete Response Letter to the Biologics License Application for abicipar. AbbVie is to determine appropriate next steps with relevant regulatory agencies.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Discovery Alliance Agreement with Allergan, an AbbVie Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2012, we strategically expanded our existing relationship with Allergan by entering into an exclusive discovery alliance agreement, or the Discovery Alliance Agreement, under we and Allergan agreed to collaborate to design and develop DARPin products against selected targets that are implicated in causing diseases of the eye. We and Allergan amended the Discovery Alliance Agreement in June 2013, September 2014, August 2016 and December 2017. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted Allergan three exclusive options to obtain an exclusive license under our patents and know-how to make, use, sell, offer for sale, and import products containing DARPin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compounds directed against the applicable biological target for use with ophthalmological diseases. We also granted Allergan a non-exclusive license under our intellectual property as necessary for Allergan to conduct its activities under the Discovery Alliance Agreement during the research term in the field of ocular diseases. In February 2018, Allergan exercised its last of the three </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options. Upon execution of each option, Allergan is solely responsible for all downstream development, manufacturing, and commercialization activities, at its expense. Allergan must use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize licensed products. We must use commercially reasonable efforts to perform our research activities under the Discovery Alliance Agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Discovery Alliance Agreement, we may not make, use, sell, offer for sale, import or otherwise develop, manufacture,  commercialize or exploit certain DARPin compounds that bind to collaboration targets or their isoforms in the field of ocular diseases, or any DARPin compound that binds VEGF-A. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a one-time, non-refundable and non-creditable upfront payment of $40 million and a further $1.5 million upfront payment in connection with a 2014 amendment to the Discovery Alliance Agreement, and Allergan paid us an option exercise fee of $10 million upon its exercise of further options. In July 2015, Allergan made an accelerated payment of $30 million for the exercise of these options. We are eligible to receive additional success-based payments, including up to $960 million in development, regulatory and sales milestones. In addition, Allergan pays us tiered royalties ranging from the mid-single digits to the low-double digits on worldwide annual net sales of licensed products.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Discovery Alliance Agreement remains in effect on a product-by-product and country-by-country basis until the latest of (i) the expiration of the last-to-expire patent licensed in such country that would be infringed, absent a license, by the sale of such licensed product at the time of sale under the agreement, (ii) the expiration of regulatory exclusivity in such country and (iii) the tenth anniversary of the first commercial sale of such licensed product in such country. We may terminate immediately upon written notice to Allergan if Allergan challenges the validity, enforceability or scope of any of the patents we license to Allergan anywhere in the world.  Either party may terminate the agreement upon the other party&#8217;s uncured material breach of the agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">License Agreement with the University of Zurich</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold an exclusive, worldwide license from the University of Zurich on patent applications and patents relating to the DARPin base technology. The primary patents under this license agreement will expire in September 2021.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While such license agreement remains in effect, we are required to pay the University of Zurich flat royalties of a low single digit percentage on net sales of licensed products, which vary based on the field in which the licensed product is commercialized. In addition, we are obligated to pay the University of Zurich a percentage of license fee revenues it receives from sublicensing its rights to third parties in five tiers, ranging from the low single digits to the low teens, depending on the total amount of payments received for the particular sublicense granted. Finally, we are also obligated to pay the University of Zurich a percentage of the royalty payments it receives from sublicensees in three tiers based on their net sales of licensed products and the applicable field in which the licensed product is sold, ranging from the low single digits to the mid-teens. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Government Regulation and Product Approval</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a biopharmaceutical company that operates in the United States, we are subject to extensive regulation. Government authorities in the United States (at the federal, state and local level) and in other countries extensively regulate, among other things, the research, development, testing, manufacturing, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of biopharmaceutical products such as those we are developing. Our product candidates must be approved by the FDA before they may be legally marketed in the United States and by the appropriate foreign regulatory agency before they may be legally marketed in foreign countries. Generally, our activities in other countries will be subject to regulation that is similar in nature and scope as that imposed in the United States, although there can be important differences. Additionally, some significant aspects of regulation in Europe are addressed in a centralized way, but country-specific regulation remains essential in many respects. The process for obtaining regulatory marketing approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Product Development Process</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the FDA regulates pharmaceutical and biological products under the Federal Food, Drug and Cosmetic Act, or the FDCA, the Public Health Service Act, or the PHSA, and their implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to administrative or judicial sanctions. FDA sanctions could include, among other actions, refusal to approve pending applications, withdrawal of an approval, a clinical hold, warning letters, product recalls or withdrawals from the market, product seizures, total or partial suspension of production or distribution injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us. The process required by the FDA before a biological product may be marketed in the United States generally involves the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of nonclinical laboratory tests and animal studies according to good laboratory practices, or GLPs, and applicable requirements for the humane use of laboratory animals or other applicable regulations&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an IND, which must become effective before human clinical trials may begin&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval by an independent Institutional Review Board, or IRB, or ethics committee at each clinical site before the trial is commenced&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials according to the FDA&#8217;s regulations commonly referred to as good clinical practices, or GCPs, and any additional requirements for the protection of human research patients and their health information, to establish the safety and efficacy of the proposed biological product for its intended use&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of a Biologics Licensing Application, or BLA, for marketing approval that includes substantial evidence of safety, purity, and potency from results of nonclinical testing and clinical trials&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of an FDA Advisory Committee review, if applicable&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of an FDA inspection of the manufacturing facility or facilities where the biological product is produced to assess compliance with cGMP, to assure that the facilities, methods and controls are adequate to preserve the biological product&#8217;s identity, strength, quality and purity&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential FDA audit of the nonclinical study and clinical trial sites that generated the data in support of the BLA&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA review and approval or licensure of the BLA.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before testing any biological product candidate, including our product candidates, in humans, the product candidate enters the preclinical testing stage. Preclinical tests, also referred to as nonclinical studies, include laboratory evaluations of product chemistry, toxicity and formulation, as well as animal studies to assess the potential safety and activity of the product candidate. The conduct of the preclinical tests must comply with federal regulations and requirements including GLPs. The clinical trial sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and a proposed clinical protocol, to the FDA as part of the IND. Some preclinical testing may continue even after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions regarding the proposed clinical trials and places the trial on a clinical hold within that 30-day time period. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. The FDA may also impose clinical holds on a biological product candidate at any time before or during clinical trials due to safety concerns or non-compliance. If the FDA imposes a clinical hold, trials may not recommence without FDA authorization and then only under terms authorized by the FDA. Accordingly, we cannot be sure that submission of an IND will result in the FDA allowing clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate such trials.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials involve the administration of the biological product candidate to patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#8217;s control. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria, and the parameters to be used to monitor subject safety, including stopping rules that assure a clinical trial will be stopped if certain adverse events should occur. Each protocol and any amendments to the protocol must be submitted to the FDA as part of the IND. Clinical trials must be conducted and monitored in accordance with the FDA&#8217;s regulations comprising the GCP requirements, including the requirement that all research patients provide informed consent. Further, each clinical trial must be reviewed and approved by an independent IRB at or servicing each institution at which the clinical trial will be conducted. An IRB is charged with protecting the welfare and rights of trial participants and considers such items as whether the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the form and content of the informed consent that must be signed by each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing clinical studies and clinical study results to public registries.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human clinical trials are typically conducted in three sequential phases that may overlap or be combined&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The biological product is initially introduced into healthy human subjects and tested for safety. In the case of some products for severe or life-threatening diseases, especially when the product may be too inherently toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The biological product is evaluated in a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance, optimal dosage and dosing schedule.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Clinical trials are undertaken to further evaluate dosage, clinical efficacy, potency, and safety in an expanded patient population at geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk to benefit ratio of the product and provide an adequate basis for product labeling.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-approval clinical trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These clinical trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication, particularly for long-term safety follow-up. During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data, and clinical trial investigators. Annual progress reports detailing the results of the clinical trials must be submitted to the FDA. Written IND safety reports must be promptly submitted to the FDA and the investigators for serious and unexpected adverse events, any findings from other studies, tests in laboratory animals or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> testing that suggest a significant risk for human patients, or any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. Phase 1, Phase 2 and Phase 3 clinical trials may not be completed successfully within any specified period, if at all. The FDA or the sponsor or its data safety monitoring board may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research patients are being exposed to an unacceptable health risk, including risks inferred from other unrelated immunotherapy trials. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements or if the biological product has been associated with unexpected serious harm to patients.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with clinical trials, companies usually complete additional studies and must also develop additional information about the physical characteristics of the biological product as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. To help reduce the risk of the introduction of adventitious agents with use of biological products, the PHSA emphasizes the importance of manufacturing control for products whose attributes cannot be precisely defined. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, the sponsor must develop methods for testing the identity, strength, quality, potency and purity of the final biological product. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the biological product candidate does not undergo unacceptable deterioration over its shelf life.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Review and Approval Processes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the completion of clinical trials of a biological product, FDA approval of a BLA must be obtained before commercial marketing of the biological product. The BLA submission must include results of product development, laboratory and animal studies, human trials, information on the manufacture and composition of the product, proposed labeling and other relevant information. The testing and approval processes require substantial time and effort and there can be no assurance that the FDA will accept the BLA for filing and, even if filed, that any approval will be granted on a timely basis, if at all.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Prescription Drug User Fee Act, or PDUFA, as amended, each BLA must be accompanied by a significant user fee. The FDA adjusts the PDUFA user fees on an annual basis. PDUFA also imposes an annual program fee for biological products. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on BLAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within 60 days following submission of the application, the FDA reviews a BLA submitted to determine if it is substantially complete before the agency accepts it for filing. The FDA may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the BLA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the BLA. The FDA reviews the BLA to determine, among other things, whether the proposed product is safe, potent, and&#47;or effective for its intended use, and has an acceptable purity profile, and whether the product is being manufactured in accordance with cGMP to assure and preserve the product&#8217;s identity, safety, strength, quality, potency and purity. The FDA may refer applications for novel biological products or biological products that present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. During the biological product approval process, the FDA also will determine whether a Risk Evaluation and Mitigation Strategy, or REMS, is necessary to assure the safe use of the biological product. A REMS is a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. If the FDA concludes a REMS is needed, the sponsor of the BLA must submit a proposed REMS. The FDA will not approve a BLA without a REMS, if required.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving a BLA, the FDA will inspect the facilities at which the product is manufactured. The FDA will not approve the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure that the clinical trials were conducted in compliance with IND trial requirements and GCP requirements. To assure cGMP and GCP compliance, an applicant must incur significant expenditure of time, money and effort in the areas of training, record keeping, production, and quality control.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the submission of relevant data and information, the FDA may ultimately decide that the BLA does not satisfy its regulatory criteria for approval and deny approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data. If the agency decides not to approve the BLA in its present form, the FDA will issue a complete response letter that describes all of the specific deficiencies in the BLA identified by the FDA. The deficiencies identified may be minor, for example, requiring labeling changes, or major, for example, requiring additional clinical trials. Additionally, the complete response letter may include recommended actions that the applicant might take to place the application in a condition for approval. If a complete response letter is issued, the applicant may either resubmit the BLA, addressing all of the deficiencies identified in the letter, or withdraw the application.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a product receives regulatory approval, the approval may be limited to specific diseases and dosages or the indications for use may otherwise be limited, which could restrict the commercial value of the product. Further, the FDA may require that certain contraindications, warnings or precautions be included in the product labeling. The FDA may impose restrictions and conditions on product distribution, prescribing, or dispensing in the form of a risk management plan, or otherwise limit the scope of any approval. In addition, the FDA may require post marketing clinical trials, sometimes referred to as Phase 4 clinical trials, designed to further assess a biological product&#8217;s safety and effectiveness, and testing and surveillance programs to monitor the safety of approved products that have been commercialized.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Pediatric Research Equity Act, or PREA, a BLA or supplement to a BLA must contain data to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of data or full or partial waivers. Unless otherwise required by regulation, PREA does not apply to any product for an indication for which orphan designation has been granted. However, if only one indication for a product has orphan designation, a pediatric assessment may still be required for any applications to market that same product for the non-orphan indication or indications.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Approval Requirements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any products for which we receive FDA approvals are subject to continuing regulation by the FDA, including, among other things, record-keeping requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy information, product sampling and distribution requirements, and complying with FDA promotion and advertising requirements, which include, among others, standards for direct-to-consumer advertising, restrictions on promoting products for uses or in patient populations that are not described in the product&#8217;s approved uses (known as &#8220;off-label use&#8221;), limitations on industry-sponsored scientific and educational activities, and requirements for promotional activities involving the internet. Although a physician may prescribe a legally available product for an off-label use, if the physician deems such product to be appropriate in his&#47;her professional medical judgment, a manufacturer may not market or promote off-label uses.Violations, including actual or alleged promotion of products for unapproved or off-label uses, are subject to enforcement letters, inquiries and investigations, and civil and criminal sanctions by the FDA or comparable foreign bodies. Any actual or alleged failure to comply with labeling and promotion requirements may result in fines, warning letters, mandates to corrective information to healthcare practitioners, injunctions, or civil or criminal penalties.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, quality control and manufacturing procedures must continue to conform to applicable manufacturing requirements after approval to ensure the long-term stability of the product. cGMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. In addition, changes to the manufacturing process are strictly regulated, and depending on the significance of the change, may require prior FDA approval before being implemented. Other types of changes to the approved product, such as adding new indications and claims, are also subject to further FDA review and approval. Discovery of problems with a product after approval may result in restrictions on a product, manufacturer, or holder of an approved BLA, including, among other things, recall or withdrawal of the product from the market. Other potential consequences include, among other things&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, warning letters, untitled letters, or clinical holds&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of product approvals&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse publicity, FDA mandated corrective advertising or communications with doctors&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure or detention, or refusal to permit the import or export of products&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also may require post-marketing testing, known as Phase 4 testing, and surveillance to monitor the effects of an approved product. Newly discovered or developed safety or effectiveness data may require changes to a product&#8217;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Marketing Exclusivity</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biologics Price Competition and Innovation Act, or BPCIA, amended the PHSA to authorize the FDA to approve similar versions of innovative biologics, commonly known as biosimilars. A competitor seeking approval of a biosimilar must file an application to establish its molecule as highly similar to an approved innovator biologic, among other requirements. The BPCIA, however, bars the FDA from approving biosimilar applications referencing that biologic for 12 years after an innovator biological product receives initial marketing approval. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product. Pediatric exclusivity is another type of regulatory market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric trial in accordance with an FDA-issued &#8220;Written Request&#8221; for such a trial.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Healthcare Laws</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A biopharmaceutical company&#8217;s operations may be directly, or indirectly through relationships with healthcare providers, healthcare institutions, patients, customers and third-party payors, subject to various federal and state healthcare laws and regulations. These laws impact, among other things, sales, marketing and education programs and may constrain business and financial arrangements and relationships with third-party payors, healthcare professionals and healthcare institutions who participate in a biopharmaceutical company&#8217;s clinical research programs, healthcare professionals and others who recommend, purchase, or provide a biopharmaceutical company&#8217;s approved drug products, and other parties through which it markets, sells and distributes its approved drug products. In addition, a biopharmaceutical company may be subject to patient data privacy and security regulation by both the federal government and the states in which it conducts its business. The laws that may affect a biopharmaceutical company&#8217;s ability to operate include&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, individuals or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under federal and state healthcare programs such as Medicare and Medicaid&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims laws, including, without limitation, the civil False Claims Act (which can be enforced through &#34;qui tam,&#34; or whistleblower actions, by private citizens on behalf of the federal government), and the federal civil monetary penalties law, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false or fraudulent or for knowingly making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which prohibits, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and its implementing regulations, and as amended again by the Final HIPAA Omnibus Rule, published in January 2013, which imposes certain obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information without appropriate authorization on certain health plans, healthcare clearinghouses and healthcare providers, known as covered entities, as well as their business associates that perform certain services involving the use, disclosure or transmission of individually identifiable health information for or on behalf of a covered entity, and their covered subcontractors&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Federal Food, Drug, and Cosmetic Act which prohibits, among other things, the adulteration or misbranding of drugs, biologics and medical devices&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician payment transparency legislation commonly referred to as the Physician Payments Sunshine Act, and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics and medical supplies (with certain exceptions) that are reimbursable under Medicare, Medicaid, or the Children's Health Insurance Program to report annually to the Centers for Medicare &#38; Medicaid, or CMS, information related to certain payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members, and, beginning in 2022, will require applicable manufacturers to report information regarding payments and other transfers of value provided in the previous year to physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, anesthesiologist assistants, and certified nurse midwives&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state laws and regulations, including&#58; state anti-kickback and false claims laws, which may apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers&#59; state laws that require pharmaceutical companies to comply with the pharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources&#59; state laws and regulations that require drug manufacturers to file reports relating to pricing and marketing information, which requires tracking gifts and other remuneration and items of value provided to healthcare professionals and entities&#59; state and local laws that require the registration of pharmaceutical sales representatives&#59; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that governmental authorities will conclude that a biopharmaceutical company&#8217;s business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If a biopharmaceutical company&#8217;s operations are found to be in violation of any of these laws or any other governmental regulations that may apply to it, it may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, reputational harm and the curtailment or restructuring of operations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk of being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. For example, the definition of &#34;remuneration&#34; under the federal Anti-Kickback Statute has been interpreted to include anything of value. Further, courts have found that if &#34;one purpose&#34; of remuneration is to induce referrals, the federal Anti-Kickback Statute is violated. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, recent healthcare reform legislation has strengthened federal and state healthcare fraud and abuse laws. For example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation Act of 2010, or collectively the ACA, amends the intent requirement of the federal Anti-Kickback Statute and criminal healthcare fraud statutes to clarify that liability under these statutes does not require a person or entity to have actual knowledge of the statutes or a specific intent to violate them in order to have committed a violation. Moreover, the ACA provides that the government may assert that a claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act. Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available, it is possible that some of a biopharmaceutical company&#8217;s business activities could be subject to challenge under one or more of such laws. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Healthcare Reform</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, there have been a number of legislative and regulatory changes at the federal and state levels which seek to reduce healthcare costs and improve the quality of healthcare. For example, in March 2010, the ACA became law. The ACA is a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among the provisions of the ACA of importance to biopharmaceutical companies are the following&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic products, apportioned among these entities according to their market share in certain government healthcare programs, although this fee would not apply to sales of certain products approved exclusively for orphan indications&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to certain individuals with income at or below 133% of the federal poverty level, thereby potentially increasing a manufacturer's Medicaid rebate liability&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expansion of manufacturers' rebate liability under the Medicaid Drug Rebate Program by increasing the minimum rebate for both branded and generic drugs and revising the definition of &#34;average manufacturer price,&#34; or AMP, for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices and extending rebate liability to prescriptions for individuals enrolled in Medicare Advantage plans&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for products that are inhaled, infused, instilled, implanted or injected&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding the types of entities eligible for the 340B drug discount program&#59;   </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing the Medicare Part D coverage gap discount program, which requires manufacturers to now provide a 70% point-of-sale-discount off the negotiated price of applicable products to eligible beneficiaries during their coverage gap period as a condition for the manufacturers' outpatient products to be covered under Medicare Part D&#59;  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a licensure framework for follow-on biologic products&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding for such research&#59; and  </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishment of the Center for Medicare and Medicaid Innovation within CMS, to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription product spending.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been executive, judicial and Congressional challenges to certain aspects of the ACA. While Congress has not passed comprehensive repeal legislation, several bills affecting the implementation of certain taxes under the ACA have been signed into law. The Tax Cuts and Jobs Act of 2017, or the Tax Act,  included a provision, which repealed, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the &#8220;individual mandate&#8221;. In addition, the 2020 federal spending package permanently eliminated, effective January 1, 2020, the ACA-mandated &#8220;Cadillac&#8221; tax on high-cost employer-sponsored health coverage and medical device tax and, effective January 1, 2021, also eliminated the health insurer tax. Further, the Bipartisan Budget Act of 2018, or the BBA, among other things, amended the ACA, effective January 1, 2019, to close the coverage gap in most Medicare drug plans, commonly referred to as the &#8220;donut hole&#8221;. On December 14, 2018, a Texas U.S. District Court Judge ruled that the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress as part of the Tax Act. Additionally, on December 18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court ruling that the individual mandate was unconstitutional and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. The U.S. Supreme Court is currently reviewing the case, although it is unknown when a decision will be made. Further, although the U.S. Supreme Court has not yet ruled on the constitutionality of the ACA, on January 28, 2021, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through May 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructs certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how the Supreme Court ruling, other such litigation, and the healthcare reform measures of the Biden administration will impact the ACA. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. For example, on August 2, 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation's automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year. These reductions went into effect on April 1, 2013 and, due to subsequent legislative amendments to the statute, including the BBA, will remain in effect through 2030 with the exception of a temporary suspension from May 1, 2020 through March 31, 2021 unless additional Congressional action is taken. On January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there has also been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Specifically, there have been several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for drugs. At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals, executive orders and policy initiatives. For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to prescription drug pricing that seek to implement several of the administration&#8217;s proposals. As a result, the FDA released a final rule on September 24, 2020, effective November 30, 2020, providing guidance for states to build and submit importation plans for drugs from Canada. Further, on November 20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Medicare Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January 1, 2022 to January 1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a new safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which have also been delayed pending review by the Biden administration until March 22, 2021. On November 20, 2020, CMS issued an interim final rule implementing the Trump administration&#8217;s Most Favored Nation executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries, effective January 1, 2021. On December 28, 2020, the U.S. District Court in Northern California issued a nationwide preliminary injunction against implementation of the interim final rule. It is unclear whether the Biden administration will work to reverse these measures or pursue similar policy initiatives. At </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. It is also possible that additional governmental action will be taken in response to the COVID-19 pandemic.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Trials in the European Union</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials of medicinal products in the European Union must be conducted in accordance with European Union and national regulations and the international council for harmonization, or ICH, guidelines on GCP.  Additional GCP guidelines from the EC, focusing in particular on traceability, apply to clinical trials of advanced therapy medicinal products.  The sponsor must take out a clinical trial insurance policy, and in most European Union countries, the sponsor is liable to provide &#8220;no fault&#8221; compensation to any study subject injured in the clinical trial.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to commencing a clinical trial, the sponsor must obtain a clinical trial authorization from the competent authority, and a positive opinion from an independent ethics committee.  The application for a clinical trial authorization must include, among other things, a copy of the trial protocol and an investigational medicinal product dossier containing information about the manufacture and quality of the medicinal product under investigation.  Currently, clinical trial authorization applications must be submitted to the competent authority in each European Union Member State in which the trial will be conducted.  Under the new Regulation on Clinical Trials, which is expected to take effect in 2021, there will be a centralized application procedure where one national authority takes the lead in reviewing the application and the other national authorities have only a limited involvement.  Any substantial changes to the trial protocol or other information submitted with the clinical trial applications must be notified to or approved by the relevant competent authorities and ethics committees. The requirements and process governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. In all cases, the clinical trials are conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. Medicines used in clinical trials must be manufactured in accordance with cGMP.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the development of a medicinal product</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the EMA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and national medicines regulators within the European Union provide the opportunity for dialogue and guidance on the development program.  At the EMA level, this is usually done in the form of scientific advice, which is given by the Scientific Advice Working Party of the Committee for Medicinal Products for Human Use.  A fee is incurred with each scientific advice procedure.  Advice from the EMA is typically provided based on questions concerning, for example, quality (chemistry, manufacturing and controls testing), nonclinical testing and clinical studies, and pharmacovigilance plans and risk-management programs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Authorizations in the European Union</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to market a new medicinal product in the European Union, a company must submit a marketing authorization application, or MAA, to either the EMA using the centralized procedure, or competent authorities in European Union Member States using the other procedures </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(decentralized procedure, national procedure, or mutual recognition procedure). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A marketing authorization, or MA may only be granted to an applicant established in the European Union, or Norway, Iceland, and Liechtenstein, who are members of the European Economic Area, or European Economic Area.  Medicinal products can only be commercialized after obtaining an MA pursuant to one of the three processes outlined below&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Centralized MA, which is issued by the European Commission through the Centralized Procedure, based on the scientific opinion of the Committee for Medicinal Products for Human Use of the EMA, and which is valid throughout the entire territory of the European Union&#47;European Economic Area.  The Centralized Procedure is mandatory for certain types of products, such as (i) biotechnology medicinal products such as genetic engineering, (ii) orphan medicinal products, (iii) medicinal products containing a new active substance indicated for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune and viral diseases and (iv) advanced-therapy medicines, such as gene therapy, somatic cell therapy or tissue-engineered medicines.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Centralized Procedure is optional for products containing a new active substance not yet authorized in the European Union&#47;European Economic Area, or for products that constitute a significant therapeutic, scientific or technical innovation or which are in the interest of public health in the European Union.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decentralized Procedure MAs are available for products not falling within the mandatory scope of the Centralized Procedure.  An identical dossier is submitted to the competent authorities of each of the Member States in which the MA is sought, one of which is selected by the applicant as the Reference Member State, or RMS, to lead the evaluation of the regulatory submission.  The competent authority of the RMS prepares a draft assessment report, a draft summary of the product characteristics, or SmPC, and a draft of the labeling and package leaflet as distilled from the preliminary evaluation, which are sent to the other Member States (referred to as the Concerned Member States) for their approval.  If the Concerned Member States raise no objections, based on a potential serious risk to public health, to the assessment, SmPC, labeling, or packaging proposed by the RMS, the RMS records the agreement, closes the procedure and informs the applicant accordingly.  Each Member State concerned by the procedure is required to adopt a national decision to grant a national MA in conformity with the approved assessment report, SmPC and the labeling and package leaflet as approved.  Where a product has already been authorized for marketing in a Member State of the European Economic Area, the granted national MA can be used for mutual recognition in other Member States through the Mutual Recognition Procedure, or MRP, resulting in progressive national approval of the product in the European Union&#47;European Economic Area. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">National MAs, which are issued by a single competent authority of the Member States of the European Economic Area and only covers their respective territory, are also available for products not falling within the mandatory scope of the Centralized Procedure.  Once a product has been authorized for marketing in a Member State of the European Economic Area through the National Procedure, this National MA can also be recognized in other Member States through the Mutual Recognition Procedure. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the procedures described above, before granting the MA, the EMA or the competent authority(ies) of the Member State(s) of the European Economic Area prepare an assessment of the risk-benefit balance of the product against the scientific criteria concerning its quality, safety and efficacy. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Exclusivity in the European Union</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Regulation (EC) No 726&#47;2004&#47;EC and Directive 2001&#47;83&#47;EC (each as amended), the European Union has adopted a harmonized approach to data and market protection or exclusivity (known as the 8 + 2 + 1 formula).  The data exclusivity period begins to run on the date when the first MA is granted in the European Union.  It confers on the MA holder of the reference medicinal product eight years of data exclusivity and ten years of market exclusivity.  A reference medicinal product is defined to mean a medicinal product authorized based on a full dossier consisting of pharmaceutical and preclinical testing results and clinical trial data, such as a medicinal product containing a new active substance.  The ten-year market protection can be extended cumulatively to a maximum period of eleven years if during the first eight years of those ten years of protection period, the MA holder obtains an authorization for one or more new therapeutic indications that are deemed to bring a significant clinical benefit compared to existing therapies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exclusivity period means that an applicant for a generic medicinal product is not permitted to rely on preclinical pharmacological, toxicological, and clinical data contained in the file of the reference medicinal product of the originator until the first eight years of data exclusivity have expired.  Thereafter, a generic product application may be submitted and generic companies may rely on the preclinical and clinical data relating to the reference medicinal product to support approval of the generic product.  However, a generic product cannot market until ten years have elapsed from the initial authorization of the reference medicinal product or eleven years if the protection period is extended, based on the formula of 8+2+1.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, where an application is made for a new indication for a well-established substance, a non-cumulative period of one year of data exclusivity may be granted, provided that significant preclinical or clinical studies were carried out in relation to the new indication.  Finally, where a change of classification of a medicinal product has been authorized on the basis of significant preclinical tests or clinical trials, the competent authority shall not refer to the results of those tests or trials when examining an application by another applicant for or holder </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of marketing authorization for a change of classification of the same substance for one year after the initial change was authorized.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 8 + 2 + 1 exclusivity scheme applies to products that have been authorized in the European Union by the European Commission through the Centralized Procedure or the competent authorities of the Member States of the European Economic Area nationally, including through the Decentralized and Mutual Recognition procedures. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a medicinal product which has received orphan designation under Regulation 141&#47;2000, it will, benefit from a period of ten years of orphan market exclusivity which essentially constitutes a period of market monopoly.  During this period of orphan market exclusivity, no European Union regulatory authority is permitted to accept or approve an application for marketing authorization for a similar medicinal product or an extension application for the same therapeutic indication.  This period can be extended cumulatively to a total of twelve years if the marketing authorization holder or applicant complies with the requirements for an agreed pediatric investigation plan pursuant to Regulation 1901&#47;2006.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post Authorization Obligations in the European Union</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holder of a Centralized MA or National MA is subject to various obligations under the applicable European Union laws, such as pharmacovigilance obligations, requiring it to, among other things, report and maintain detailed records of adverse reactions, and to submit periodic safety update reports, or PSURs, to the competent authorities.  All new marketing authorization applications must include a risk management plan, or RMP, describing the risk management system that the company will put in place and documenting measures to prevent or minimize the risks associated with the product.  The regulatory authorities may also impose specific obligations as a condition of the marketing authorization.  Such risk-minimization measures or post-authorization obligations may include additional safety monitoring, more frequent submission of PSURs, or the conduct of additional clinical trials or post-authorization safety studies.  RMPs and PSURs are routinely available to third parties requesting access, subject to limited redactions. All advertising and promotional activities for the product must be consistent with the approved summary of product characteristics, and therefore all off-label promotion is prohibited.  Direct-to-consumer advertising of prescription medicines is also prohibited in the European Union.  The holder must also ensure that the manufacturing and batch release of its product is in compliance with the applicable requirements.  The MA holder is further obligated to ensure that the advertising and promotion of its products complies with applicable European Union laws and industry code of practice as implemented in the domestic laws of the Member States of the European Union&#47;European Economic Area.  The advertising and promotional rules are enforced nationally by the European Union&#47;European Economic Area Member States.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Development in the European Union</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, companies developing a new medicinal product must agree to a Pediatric Investigation Plan, or PIP, with the EMA and must conduct pediatric clinical trials in accordance with that PIP, unless a deferral or waiver applies, (e.g., because the relevant disease or condition occurs only in adults). The marketing authorization application for the product must include the results of pediatric clinical trials conducted in accordance with the PIP, unless a waiver applies, or a deferral has been granted, in which case the pediatric clinical trials must be completed at a later date. Products that are granted a marketing authorization on the basis of the pediatric clinical trials conducted in accordance with the PIP are eligible for a six month extension of the protection under a supplementary protection certificate (if any is in effect at the time of approval) or, in the case of orphan medicinal products, a two year extension of the orphan market exclusivity. This pediatric reward is subject to specific conditions and is not automatically available when data in compliance with the PIP are developed and submitted.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pricing and Reimbursement in the European Union </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governments influence the price of medicinal products in the European Union through their pricing and reimbursement rules and control of national healthcare systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a particular product candidate to currently available therapies. Other European Union Member States allow companies to fix their own </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prices for medicines, but monitor and control company profits. The downward pressure on healthcare costs in general, particularly prescription medicines, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brexit and the Regulatory Framework in the United Kingdom </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2016, the electorate in the United Kingdom voted in favor of Brexit and the United Kingdom officially withdrew from the European Union on January 31, 2020. Pursuant to the formal withdrawal arrangements agreed between the United Kingdom and the European Union, the United Kingdom was subject to a transition period until December 31, 2020, during which European Union rules continued to apply. A trade and cooperation agreement, or the Trade and Cooperation Agreement, which outlines the future trading relationship between the United Kingdom and the European Union was agreed in December 2020.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Great Britain is no longer covered by the European Union&#8217;s procedures for the grant of marketing authorizations (Northern Ireland is covered by the centralized authorization procedure and can be covered under the decentralized or mutual recognition procedures). A separate marketing authorization will be required to market drugs in Great Britain.  For two years from 1 January 2021, the Medicines and Healthcare products Regulatory Agency, or MHRA, may adopt decisions taken by the European Commission on the approval of new marketing authorizations through the centralized procedure, and the MHRA will have regard to marketing authorizations approved in a country in the European Economic Area (although in both cases a marketing authorization will only be granted if any Great Britain-specific requirements are met). Various national procedures are now available to place a drug on the market in the United Kingdom, Great Britain, or Northern Ireland, with the main national procedure having a maximum timeframe of 150 days (excluding time taken to provide any further information or data required).  The data exclusivity periods in the United Kingdom are currently in line with those in the European Union, but the Trade and Cooperation Agreement provides that the periods for both data and market exclusivity are to be determined by domestic law, and so there could be divergence in the future. It is currently unclear whether the MHRA in the United Kingdom is sufficiently prepared to handle the increased volume of marketing authorization applications that it is likely to receive. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan designation in Great Britain following Brexit is essentially identical to the position in the European Union, but is based on the prevalence of the condition in Great Britain.  It is therefore possible that conditions that are currently designated as orphan conditions in Great Britain will no longer be and that conditions that are not currently designated as orphan conditions in the European Union will be designated as such in Great Britain. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Union&#8217;s regulatory environment for clinical trials is being harmonized as part of the Clinical Trial Regulations, which are due to enter into full effect at the end of 2021, but it is currently unclear as to what extent the United Kingdom will seek to align its regulations with the European Union.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Coverage and Reimbursement</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of coverage and adequate reimbursement by third-party payors, including governmental healthcare programs such as Medicare and Medicaid, private health insurers and managed care organizations, is essential for most patients to be able to afford drug products. Achieving acceptable levels of coverage and reimbursement for drug products by third-party payors affects a biopharmaceutical company&#8217;s ability to successfully commercialize, and attract collaboration partners to invest in, the development its drug products. Even if coverage is obtained from a third-party payor for a given drug product, the resulting reimbursement rates may not be adequate or may require co-payments that patients find unacceptably high. There is no guarantee that coverage and reimbursement will be provided for a given drug product, and any reimbursement that may become available can be decreased or eliminated in the future. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payors are increasingly challenging prices charged for drug products and services, and many third-party payors may refuse to provide coverage and reimbursement for particular drug products when an equivalent generic drug product or a less expensive therapy is available. It is possible that a third-party payor may consider a drug product and other therapies as substitutable and only offer to reimburse patients for the less expensive drug product or therapy. Even if a drug product shows improved efficacy or improved convenience of administration, pricing of existing drug products may limit the amount that can be charged for a new drug product. Third-party payors may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deny or revoke the reimbursement status of a given drug product or establish prices for new or existing marketed drug products at levels that are too low to enable a biopharmaceutical company to realize an appropriate return on its investment in drug product development. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty related to third-party payor coverage and reimbursement of newly approved drug products. In the United States, third-party payors play an important role in determining the extent to which new drugs products will be covered. The Medicare and Medicaid programs increasingly are used as models for how private payors and other governmental payors develop their coverage and reimbursement policies for drug products. Some third-party payors may require pre-approval of coverage for new or innovative devices or drug products before they will reimburse health care providers who use such therapies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining reimbursement status is time-consuming and costly. No uniform policy for coverage and reimbursement for drug products exists among third-party payors in the United States. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that requires the provision of scientific and clinical support for the use of a drug product to each payor separately. Furthermore, rules and regulations regarding reimbursement change frequently and, in some cases, upon short notice. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics. Additionally, if any companion diagnostic provider is unable to obtain reimbursement or is inadequately reimbursed, that may limit the availability of such companion diagnostic, which would negatively impact prescriptions for our product candidates, if approved.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations. Increasing emphasis on cost-containment initiatives in Europe, Canada and other countries puts pressure on the pricing and usage of drug products. In many countries, the prices of drug products are subject to varying price control mechanisms as part of national health systems. Other countries allow companies to fix their own prices for drug products, but monitor and control company profits. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The delivery of healthcare in the European Union, including the establishment and operation of health services and the pricing and reimbursement of drug products, is almost exclusively a matter for national, rather than European Union, law and policy. National governments and health service providers have different priorities and approaches to the delivery of healthcare and the pricing and reimbursement of drug products in that context. In general, however, the healthcare budgetary constraints in most European Union member states have resulted in restrictions on the pricing and reimbursement of drug products by relevant health service providers. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasing efforts by governmental and third-party payors in the European Union, the United States and abroad to cap or reduce healthcare costs can cause such organizations to limit coverage and reimbursement for drug products. Additionally, a trend toward managed healthcare, and the influence of health maintenance organizations, have increased pricing pressure on the sale of drug products. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Competition</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete in a highly innovative industry characterized by a rapidly growing understanding of disease biology, evolving technologies and strong intellectual property barriers to entry. While we believe that our DARPin platform and product candidates, strategic collaborations and scientific expertise may provide us with competitive advantages, our business may be impacted competitively from many different sources. We compete with a wide range of pharmaceutical companies, biotechnology companies, academic institutions and other research organizations for novel therapeutic antibody targets, new technologies for optimizing antibodies, talent, financial resources, intellectual property rights and collaboration opportunities. Many of our competitors and potential competitors have substantially greater scientific, research and product development capabilities, and greater financial, manufacturing, marketing and sales and human resources than we do. In addition, there is intense competition for establishing clinical trial sites and recruiting and registering patients for clinical trials. Many specialized biotechnology </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies have formed collaborations with large, established companies to support the research, development and commercialization of products that may be competitive with ours. Accordingly, our competitors may be more successful than we may be in developing, commercializing and achieving widespread market acceptance. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regarding ensovibep and MP0423, our COVID-19 antiviral product candidates, there are a number of preventative vaccines in development for COVID-19, with three receiving an Emergency Use Authorization to date. However, as, in our view, vaccine coverage and efficacy will be less than 100%, we believe there will remain a need for therapeutic intervention for COVID-19 patients. There are hundreds of clinical trials examining various methods of treating COVID-19. To date, only a small number of these trials have resulted in data positive enough for regulators to approve therapeutics on either an emergency use or permanent basis. Therapeutics receiving Emergency Use Authorization for the treatment of COVID-19 patients include co-administration of casirivimab and imdevimab from Regeneron Pharmaceuticals, Inc., baricitinib (in combination with remdesivir), and bamlanivimab from Eli Lilly, and remdesivir from Gilead Sciences, Inc.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the oncology space is intense, with several common methods of treatment for patients with cancer,  including surgery, radiation and drug therapy, and approved drugs that are well established therapies widely accepted by physicians, patients and third party payers. In addition, companies focused on immunotherapies, such as checkpoint inhibitors, seek to differentiate their immuno-oncology products either by identifying novel immune checkpoint targets or by combining established immune checkpoint inhibitors. If approved, either of MP0310 or MP0317 would compete with agents that are currently in development including monoclonal antibodies, or mAbs, and other small molecule approaches. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We face competition from segments of the pharmaceutical, biotechnology and other related markets with respect to our CD3 and peptide-MHC, or pMHC, programs. Any  product candidates that we successfully develop and commercialize from these platforms may compete with existing products and new products that may become available in the future. There is intense competition in the field  from multiple different treatment modalities and new approaches are continually emerging from different competitors, including Adaptimmune Therapeutics plc, TCR&#178; Therapeutics, Immatics N.V., Immunocore Holdings plc and Harpoon Therapeutics Inc. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the ophthalmology space is intense, with currently approved anti-vascular endothelial growth factors, or VEGFs, such as Lucentis, Beovu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Eylea, as well as Avastin, which is widely prescribed off-label, are well established therapies and are widely accepted by physicians, patients and third-party payers as the standard of care for the treatment of nAMD. There are several other companies with marketed products or products in development for the treatment of nAMD, including Novartis, Roche, Bayer, Kodiak Sciences, REGENXBIO and Adverum Biotechnologies.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved for the treatment of nAMD, abicipar is expected to compete with both approved anti-VEGF monotherapies, anti-platelet-derived growth factor, or PDGF therapies that are currently in development for combination therapy and multispecific drugs targeting both VEGF and PDGF. In addition, we may face competition from a number of product candidates currently in development.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved for treatment of DME, abicipar is expected to compete with currently approved therapies including steroids, laser therapy and anti-VEGF agents. Anti-VEGF drugs currently approved for DME include Lucentis, Eylea, Macugen,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as well as Avastin, which is used off-label. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial opportunity could be reduced or eliminated if our competitors&#8217; products prove to be safer and more tolerable, more effective, more convenient to dose, less expensive, faster to approve, or more effectively marketed and reimbursed than any of our product candidates that may gain regulatory approval. In addition, the level of generic competition and the availability of reimbursement from government and other third-party payors will impact the commercial viability of our programs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Manufacturing</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently own or operate manufacturing facilities for the production of clinical or commercial quantities of our DARPin product candidates. We utilize third-party contract manufacturers for the manufacture of drug substances and products for human use. Since we rely on third-party contract manufacturers to produce our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proprietary product candidates, we have recruited personnel with experience to manage the third-party contract manufacturers that will produce our proprietary product candidates in clinical or commercial quantities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We design and develop the manufacturing process for the mono-DARPin proteins and multi-DARPin product candidates that are included in our DARPin product candidates, whether or not they are partnered. For purposes of our and our partner&#8217;s DARPin preclinical studies, we supply high quality gram scale DARPin material that we produce in our own facilities. We currently operate both a five- and ten-liter fermenter, which provides us with sufficient capacity to produce the quantities needed for DARPin preclinical studies. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employees</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had 145 full-time equivalent employees. None of our employees are represented by collective bargaining agreements. We believe that we maintain good relations with our employees. At each date shown, we had the following number of full time employees, broken out by department. The very large majority of our employees are based in Zurich, Switzerland. Two of our employees are based in Boston, Massachusetts.</font></div><div style="margin-bottom:2pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full-time equivalent employees</font></div></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Function</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Properties </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease our principal executive office and laboratory space, animal facility and other facilities, consisting of an aggregate of 3,200 square meters, in Zurich-Schlieren, Switzerland. The leases for our principal executive office and laboratory space expire on December 31, 2026. We also have an office in Massachusetts for our U.S. subsidiary, Molecular Partners Inc. We believe our current facilities are sufficient to meet our short-term needs. If we need to add new facilities or expand existing facilities as we add employees, we believe that suitable additional space will be available to accommodate any such expansion of our operations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, results of operations, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_82"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">MANAGEMENT</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Executive Officers and Directors </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our executive officers, also referred to as members of the Management Board, and directors as of December 31, 2020. Unless otherwise stated, the business address for our directors and executive officers is c&#47;o Molecular Partners AG, Wagistrasse 14,8952 Schlieren, Switzerland. &#160;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.374%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Age</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Position</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Executive Officers</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Tobias Stumpp</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andreas Emmenegger</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Nicolas Leupin</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Medical Officer</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Non-Employee Directors</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Burns</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Gwendolyn Anne Fyfe</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven H. Holtzman</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandip Kapadia </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Vito Palombella</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Vasconcelles </font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Officers </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Patrick Amstutz, Ph.D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., one of our founders, has served as our Chief Executive Officer since November 2016, as an executive director since 2017 and as a member of the Company&#8217;s management team since its inception in 2004. Previously, he served as our Chief Operating Officer from 2014 to 2016 and as our Chief Business Officer from 2006 to 2014. Since 2017, Dr. Amstutz has served as Vice-President of the Board of the Swiss Biotech Association. Dr. Amstutz holds a Master of Science from the ETH Zurich and a Ph.D. in molecular biology from the University of Zurich. Our board of directors believes that Dr. Amstutz's leadership of our company since its inception as well as his scientific background provide him with the qualifications and skills to serve as a director.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Michael Tobias Stumpp, Ph.D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., one of our founders, has served as our Chief Operating Officer since June 2018. Previously, he served as our Chief Scientific Officer from 2007 to June 2018. Prior to joining our company, Dr. Stumpp studied at Imperial College London from 1995 to 1996, studied at Swiss Federal Institute of Technology from 1993 to 1997, and studied at Tokyo Institute of Technology from 1997 to 1999. Dr. Stumpp received his Ph.D. in 2004 from the University of Zurich. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Andreas Emmenegger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer and Co-Entrepreneur since February 2007. Prior to joining Molecular Partners, he was the Chief Financial Officer of Glycart Biotechnology AG where he had a leading role in the CHF 235 million trade sale to F. Hoffmann-La Roche AG in 2005. Mr. Emmenegger was Head of Strategic Alliance Finance (Genentech) for Roche Headquarters, Basel, Switzerland. He has more than 20 years of experience as a chief financial officer of several public and private multinational companies, 15 years of which have been in the biotechnology industry. He led our SIX Swiss Exchange initial public offering in 2014. In addition, Mr. Emmenegger has more than 10 years of international industry experience in banking, capital markets, mergers and acquisitions and human resources. Since 2016, he has been a member of the board of directors of the Luzerner Kantonalbank, Switzerland, a publicly listed bank. Mr. Emmenegger holds a degree in finance, economics and business administration as well as an Executive MBA degree from IESE Business School, Barcelona.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Nicolas Leupin, M.D., MBA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our Chief Medical Officer since September 2019 Nicolas is a medical oncologist with a proven track record in drug development, most recently as Chief Medical Officer of argenx from 2016 to 2019, a clinical-stage biotechnology company developing antibody-based therapies for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment of severe autoimmune diseases and cancer. In that role he led the company&#8217;s global clinical strategy and execution, successfully supporting the company&#8217;s transformation into a late-stage clinical company, and was responsible for translating preclinical hypotheses into innovative proof-of concept clinical trials. Prior to argenx, Nicolas held roles of increasing responsibility at Celgene, where he supported the clinical development of several drug candidates in lymphoma and multiple myeloma, resulting in regulatory filings in Europe and the United States.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Directors </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">William M. Burns </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as Chairman of our board of directors since April 2018 and a director since October 2017. Mr. Burns has served in numerous executive positions at Roche Pharmaceuticals, including as Chief Executive Officer from January 2004 to December 2009, Head of the Pharmaceuticals Division from 2001 to 2004, Head of Europe and International Business from 1998 to 2001, and Global Head of Strategic Marketing and Business from 1991 to 1998. Mr. Burns has served as Non-Executive Vice Chairman of Mesoblast Limited since September 2016 and as Chairman of Vestergaard Frandsen S.A. since 2017. He served as an Independent Non-Executive Director of Shire plc from March 2010 to April 2016, when he became its Senior Independent Non-Executive Director until he retired from the board in April 2018. He serves as a member of the Novo Holdings Advisory Group. Mr. Burns is also a Governor&#47;Trustee of two charities&#58; the Wellcome Trust and the Institute of Cancer Research, both in the UK. Mr. Burns also serves as a member of the Scientific Advisory Board of the University of Cologne&#47;Bonn Center for Integrated Oncology. Mr. Burns holds a Bachelor of Arts in Business Economics from the University of Strathclyde. Our board of directors believes that Mr. Burns' experience with the healthcare and pharmaceutical industries and his broad management experience provide him with the qualifications and skills to serve as a director.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Gwendolyn Anne Fyfe </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as a director since May 2017. She has more than 20 years of drug development experience in oncology. She held various positions at Genentech from 1997-2009, including Vice President, Oncology Development, playing an important role in the development of Genentech's approved oncology agents. In recent years, she has consulted for venture capital firms and for a variety of biotechnology companies. A recognized expert in the broader oncology community, Dr. Fyfe has been an invited member of Institute of Medicine panels, National Cancer Institute working groups and grant committees, and oversight committees of the American Society of Clinical Oncology (ASCO). She performed residency training in pediatrics at the University of California, San Francisco and postdoctoral fellowship training in immunology at Washington University Medical School in St. Louis. Dr. Fyfe holds bachelor and medical degrees from the Washington University Medical School in St. Louis and is a board Certified Pediatric Oncologist. Our board of directors believes that Dr. Fyfe's over 20 years of experience in oncology, as well as her medical and scientific background, provide her with the qualifications and skills to serve as a director.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Steven H. Holtzman</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director since May 2014. He is the chair of the boards of directors of Qihan Biotech and Camp4 Biotherapeutics, and a founder and member of the board of directors of Shoreline Bio, all private biotechnology companies. Since January 2020, he has served as a strategic advisor to Decibel Therapeutics, a private biotechnology company, where he served as the company&#8217;s first president and chief executive officer and a member of the board of directors from 2016 to 2020. Prior to joining Decibel, he served as Executive Vice President, Corporate Development of Biogen Idec with responsibility for Business Development and Mergers and Acquisitions, and Program Leadership and Management from January 2011 to March 2016. From July 2001 to January 2011, he served as the founder, Chief Executive Officer and Chairman of Infinity Pharmaceuticals, a cancer drug discovery and development company.  He is a  trustee of The Berklee College of Music and a senior fellow at the Belfer Center for Science and International Affairs at the Harvard Kennedy School. Mr. Holtzman received a BA in Philosophy from Michigan State University in 1976 and a B.Phil. in Philosophy from Oxford University in 1979, which he attended as a Rhodes Scholar. Our board of directors believes that Mr. Holtzman's experience in the biotechnology industry and his broad management experience provide him with the qualifications and skills to serve as a director.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sandip Kapadia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director since April 2020. Mr. Kapadia currently serves as chief financial officer and treasurer of Intercept Pharmaceuticals. Mr. Kapadia has over 20 years of experience in building and leading finance and administration teams at life sciences companies both in Europe and in the United States. Prior to joining Intercept in 2016, Mr. Kapadia held numerous finance leadership positions over 19 years at Novartis and Novartis </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affiliates in the United States, Switzerland, the Netherlands, and the United Kingdom, including Chief Financial Officer of North America at Novartis&#8217;s generic division, Sandoz. Mr. Kapadia is currently a director of Passage Bio since January 2020 and Vectiv Bio Holding AG since December 2020, and previously of Therachon AG. Mr. Kapadia earned his bachelor&#8217;s degree in business administration and accounting from Montclair State University, an MBA from Rutgers Graduate School of Management, and is a certified public accountant. Our board of directors believes that Mr. Kapadia&#8217;s over 20 years of experience in the life science industry and his broad finance and management experience provide him with the qualifications and skills to serve as a director.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Vito J. Palombella, Ph.D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as a director since April 2020. Currently, Dr. Palombella is the chief scientific officer of Surface Oncology, where he has led the company&#8217;s drug discovery and translational research efforts since 2016. Dr. Palombella has over 25 years of scientific leadership and experience advancing first-in-class therapeutic programs, as well as a successful track record of building drug discovery and development organizations. Prior to joining Surface Oncology, Dr. Palombella was executive vice president and chief scientific officer from 2010 to 2016, and vice president, biology&#47;research, from 2004 to 2010, at Infinity Pharmaceuticals, Inc., where he was responsible for drug discovery and preclinical development. Prior to that, he was director of molecular biology and protein chemistry at Syntonix Pharmaceuticals, senior director of cell and molecular biology at Millennium Pharmaceuticals. Dr. Palombella earned his bachelor&#8217;s degree in microbiology from Rutgers University and a master&#8217;s degree and doctorate degree in viral oncology and immunology from the New York University Medical Center and completed his post-doctoral training at Harvard University. Our board of directors believes that Dr. Palombella&#8217;s over 25 years of scientific leadership and experience, as well as his medical and scientific background, provide him with the qualifications and skills to serve as a director.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Michael Vasconcelles, M.D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director since April 2020. He is currently the chief medical officer of Flatiron Health, Inc., where he has expertise in strategic planning, thought leadership, and clinical research methods. Prior to joining Flatiron Health in 2019, Dr. Vasconcelles served as Chief Medical Officer at Unum Therapeutics Inc. from 2015 to 2019. Prior to Unum, he spent several years at Takeda&#47;Millennium where he was accountable for the research and development strategy and execution of the oncology portfolio, from discovery through product licensure and post-approval. Dr. Vasconcelles joined the faculty of the Harvard Medical School in 1996 and is currently a clinical instructor in medicine at Harvard Medical School and a practicing oncologist and associate physician at the Dana-Farber Cancer Institute and Brigham &#38; Women&#8217;s Hospitals in Boston. Dr. Vasconcelles is a member of numerous professional societies, including the American Society of Clinical Oncology and the American Society of Hematology. His board commitments have included the Personalized Medicine Coalition and the eastern New England board of the American Cancer Society. Dr. Vasconcelles completed his postgraduate training in internal medicine at the Beth Israel Hospital and in hematology-oncology at the Brigham and Women&#8217;s Hospital and received his B.A. and M.D. from Northwestern University. Our board of directors believes that Dr. Vasconcelles&#8217; extensive experience in the life sciences industry and clinical development programs, as well as his medical and scientific background, provide him with the qualifications and skills to serve as a director. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Family Relationships</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of our executive officers or directors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Composition of our Board of Directors </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have &#160;&#160;&#160;&#160;&#160;&#160;&#160; directors, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of whom are citizens or residents of the United States. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our articles of association provide that our board of directors shall consist of a minimum of three members and maximum of eleven members. All directors (including the chairperson of the board of directors) are appointed to and removed from the board of directors exclusively by shareholders&#8217; resolution for a maximum term of office of one year, extending until completion of the next annual shareholders' meeting. Directors may be re-elected at any time. In the event the office of the chairperson is vacant, the board of directors shall appoint a new chairperson from its members for the remaining term of office. The board of directors may elect a vice-chairperson from its members each year immediately following the annual shareholders' meeting for a term ending at the closing of the following annual shareholders' meeting. The board of directors shall further appoint the secretary, who need not be a member of the board of directors. The secretary shall be entitled to participate in the deliberations and discussions of the board of directors, but shall not vote, unless he or she is a member of the board of directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the names of our directors, the year of their initial appointment as directors and the expiration dates of their current term&#58;</font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Position</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year of Initial Appointment</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Term Expiration Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Burns</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer, Director and Co-Founder</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Gwendolyn Anne Fyfe</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven H. Holtzman</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandip Kapadia </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Vito Palombella</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Vasconcelles</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</font></td></tr></table></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">At the end of the general meeting of shareholders during the year in which their term office expires, in each case as indicated.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Director Independence </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a foreign private issuer, under the listing requirements and rules of Nasdaq, we are not required to have independent directors on our board of directors, except to the extent that our audit committee is required to consist of independent directors, subject to certain phase-in schedules. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nevertheless, our board of directors has undertaken a review of the independence of the directors and considered whether any director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. Based upon information requested from, and provided by, each director concerning such director&#8217;s background, employment and affiliations, including family relationships, our board of directors determined that&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;are &#8220;independent directors&#8221; as defined under applicable Nasdaq rules and the independence requirements contemplated by Rule 10A-3 under the Securities Exchange Act of 1933, as amended, or the Exchange Act. In making these determinations, our board of directors considered the current and prior relationships that each non-employee director has with us and all other facts and circumstances that our board of directors deemed relevant in determining the director&#8217;s independence, including the number of common shares beneficially owned by the director and his or her affiliated entities (if any). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Role of the Board in Risk Oversight </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is primarily responsible for the oversight of our risk management activities and has delegated to the audit and finance committee the responsibility to assist our board of directors in this task. The audit and finance committee also monitors the issues relating to the preparation and supervision of accounting and financial information. The audit and finance committee, among other things, monitors the effectiveness of the internal control and risk management systems as well as, where applicable, of internal audit, with regard to the procedures relating to the preparation and processing of accounting and financial information, without undermining the independence of the board of directors. While our board of directors oversees our risk management, our management is responsible for day-to-day risk management processes. Our board of directors expects our management to consider risk and risk management in each business decision, to proactively develop and monitor risk management strategies and processes for day-to-day activities and to effectively implement risk management strategies adopted by the board of directors. We believe this division of responsibilities is the most effective approach for addressing the risks we face. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Corporate Governance Practices </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act of 2002, as well as related rules subsequently implemented by the SEC, requires foreign private issuers, including our company, to comply with various corporate governance practices. In addition, Nasdaq rules provide that foreign private issuers may follow home country practice in lieu of the Nasdaq corporate governance standards, subject to certain exceptions and except to the extent that such exemptions would be contrary to U.S. federal securities laws. However, if the laws of a foreign private issuer&#8217;s home country require that any such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">matter be approved by the board of directors or the shareholders, the audit committee&#8217;s responsibilities or powers with respect to such matter may instead be advisory. Under Swiss law, the audit committee may only have an advisory role and appointment of our statutory auditors, in particular, must be decided by the shareholders at our annual meeting.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we are a foreign private issuer, our members of our board of directors, executive board members and senior management are not subject to short-swing profit and insider trading reporting obligations under Section 16 of the Exchange Act. They will, however, be subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board Committees </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the Swiss ordinance against excessive compensation in listed stock corporations, known as the &#8220;Say on Pay&#8221; rule, which requires companies listed on the SIX Swiss Exchange to establish a compensation committee. Our board of directors has established an audit and finance committee, a nomination and compensation committee and a science committee, which operate pursuant to our articles of association, the charter of the audit and finance committee, the charter of the nomination and compensation committee and the charter of the research and development committee. The composition and functioning of all of our committees will comply with all applicable requirements of Swiss law, the Exchange Act, the Nasdaq Global Market and SEC rules and regulations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit and Finance Committee </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit and finance committee assists our board of directors in its oversight of our corporate accounting and financial reporting by making an independent assessment of the quality of the external auditors, our financial statements and our internal controls. Sandip Kapadia, William M. Burns and Steven Holtzman currently serve on our audit and finance committee. Mr. Kapadia is chairperson of our audit and finance committee. Our board of directors has determined that&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is independent within the meaning of the applicable listing rules and the independence requirements contemplated by Rule 10A-3 under the Exchange Act. Our board of directors has further determined that&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is an &#8220;audit committee financial expert&#8221; as defined by SEC rules and regulations and that each of the members of the audit committee qualifies as financially sophisticated under the applicable exchange listing rules. We intend to comply with the applicable independence requirements with respect to our audit committee within the applicable time frame under the applicable transition rules of the SEC. We are required to have one audit committee member who meets the independence requirements for the first 90 days following the closing of the offering. By the end of the first year following the closing of the offering, a majority of our audit committee members must meet the independence requirements. The principal duties and responsibilities of our audit committee include (1) analyzing economic and financial information and (2) ensuring the accuracy and honesty of our company&#8217;s financial statements, as well as the quality of the information provided. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has specifically assigned the following duties to the audit and finance committee&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessing the quality and effectiveness of the external audit&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessing the quality of the internal control system, including risk management and the efficiency and state of compliance and monitoring with applicable norms within the Company&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing the stand-alone Swiss statutory and consolidated financial statements as well as all reporting prepared by the external auditor&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deciding whether the year-end stand-alone Swiss statutory and consolidated financial statements be recommended to the board of directors for presentation to the general shareholders&#8217; meeting&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessing the performance and the fees charged by the external auditors and ascertain their independence&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing the scope of the prospective external audit, the estimated fees thereof and any other matters pertaining to such audit&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">taking notice of all comments from the external auditors on accounting procedures and systems of control&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing with the external auditors and&#47;or the CFO&#47;CEO any questions, comments or suggestions they may have regarding the internal control, risk management, accounting practices and procedures of the Company and its subsidiaries&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discussing with the management any legal matters that may have a material impact on the Company's financial statements and any material reports or inquiries from regulatory or governmental agencies which could materially impact the Company's contingent liabilities and risks&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supporting the board of directors with regard to the financial planning as well as the principles of accounting and financial control&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating management&#8217;s principles and proposals for, and formulate recommendations to the board of directors in regards to financial planning (capital structure, management of resources, inter-company financing), dividend policy and capital market relations&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing proposed concepts of financial objectives such as costs of capital, enhancement of shareholders&#8217; value, Company and divisional objectives, project objectives (capital expenditures and M&#38;A)&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing finance policy and operations in treasury, controlling, insurance, taxes and investment and acquisitions. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nomination and Compensation Committee</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nomination and compensation committee assists our board of directors in establishing and reviewing the compensation strategy and guidelines as well as in preparing the compensation plans and proposals to the general meeting of shareholders regarding the compensation of the board of directors and executive officers. William M. Burns, Steven H. Holtzman and Dr. Michael Vasconcelles currently serve on the nomination and compensation committee. Mr. Burns is the chairperson of our nomination and compensation committee. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We are subject to the Swiss ordinance against excessive compensation in listed stock corporations, known as the &#8220;Say on Pay&#8221; rule. As a result of the Say on Pay rule, the members of the nomination and compensation committee must be elected by our shareholders and the aggregate compensation of our board of directors and executive officers must also be approved by our shareholders.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal duties and responsibilities of our nomination and compensation committee include&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations regarding the compensation strategy and guidelines of the Company&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations regarding the compensation of the members of the board of directors and the executive management&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations regarding compensation plans (cash and&#47;or equity-based plans), and where appropriate or required, make recommendations to adopt, amend and terminate such plans&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">administering the compensation plans&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations regarding any employment agreements (including any benefits) for members of the executive management&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations regarding the proposals of the board of directors for the aggregate amount of the compensation of the board of directors and of the executive management to be submitted to the annual general shareholders' meeting for approval&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ensuring that any reporting obligation with respect to compensation matters, specifically any necessary disclosures in the annual report and&#47;or compensation report, are met&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing considerations relating to the composition of the board of directors, including the size and the criteria for membership on the board of directors&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating candidates to the board of directors and making recommendations to the board of directors in this respect&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating candidates to the Management Board and making recommendations to the board of directors in this respect.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Committee</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The research and development committee (i) provides strategic advice and brings recommendations to the Management Board and the board of directors regarding current and planned research and development programs, (ii) provides strategic advice to the board of directors regarding emerging science and technology issues and trends, and (iii) conducts a review of the effectiveness and competitiveness of our research and development function.  Dr. Michael Vasconcelles,  Dr. Gwen Fyfe and Dr. Vito Palombella currently serve on the research and development committee. Dr. Vasconcelles is the chairperson of the research and development committee.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Code of Conduct</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct which is applicable to all of our employees, executive officers and directors. The Code of Conduct is available on our website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.molecularpartners.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The audit and finance committee of our board of directors is responsible for overseeing the Code of Conduct and is required to approve any waivers of the Code of Conduct for employees, executive officers and directors. We expect that any amendments to the Code of Conduct will be disclosed on our website.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_85"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Compensation of Directors and Executive Officers </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate compensation paid by us to our executive officers and directors, including share-based compensation, for the year ended December 31, 2020, was CHF 4,311,000.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director Compensation </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by the &#34;Say on Pay&#34; rules, our articles of association set out the principles for the elements of the compensation of the members of our board of directors. The compensation of the members of our board of directors may consist of fixed and variable compensation. The total compensation takes into account the position and level of responsibility of the respective member of the board of directors, including board and committee chairmanship and membership and a travel fee. Members of our board of directors are paid for their service over one year starting with their election at the ordinary shareholders&#8217; meeting and ending with the subsequent ordinary shareholders&#8217; meeting. Our shareholders at the 2020 annual general meeting held on April 29, 2020 set the maximum aggregate amount of compensation for  the board of directors for their term of office until the 2021 general meeting at CHF 953,700. Our shareholders at the 2021 annual general meeting, which we expect to hold on April      , 2021, will set the maximum aggregate amount of compensation for the board of directors for their term of office until the 2022 general meeting. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, the compensation of the members of our board of directors consisted of fixed compensation only. Compensation of the members of our board of directors for the year ended December 31, 2020 consisted of a fixed cash fee and restricted share units, or RSUs. The following table sets out information regarding the compensation earned by our directors for service on our board of directors during the year ended December 31, 2020. Dr. Amstutz, our Chief Executive Officer and a member of our board of directors, does not receive any additional compensation for his service as a director. </font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:57.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fees Earned</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Burns</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. G&#246;ran Ando</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven H. Holtzman</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. William A. Lee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Petri Vainio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Gwendolyn Anne Fyfe</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandip Kapadia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vito J. Palombella</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Vasconcelles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">The total compensation awarded to the members of the board of directors shown in this table does not include the payments of approximately CHF 7,000 we made in 2020 to cover the mandatory employer social security contribution on the base fees. In addition, upon vesting of the RSUs 2020 in 2023, we will be obliged to make employer contributions to social security pursuant to applicable mandatory law. As an estimate based on currently applicable contribution rates, the employer contributions on the RSUs 2020 expected to vest in 2023 will amount to approximately CHF 9,000.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Dr. G&#246;ran Ando did not stand for re-election at the 2020 annual general meeting held on April 29, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Dr. William A. Lee did not stand for re-election at the 2020 annual general meeting held on April 29, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Dr. Petri Vainio did not stand for re-election at the 2020 annual general meeting held on April 29, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Dr. Gwendolyn Anne Fyfe will not stand for re-election at the 2021 annual general meeting to be held on April     , 2021.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Sandip Kapadia was elected as new member of the board of directors at the 2020 annual general meeting held on April 29, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Vito J. Palombella was elected as new member of the board of directors at the 2020 annual general meeting held on April 29, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Michael Vasconcelles was elected as new member of the board of directors at the 2020 annual general meeting held on April 29, 2020.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">For our Chief Executive Officer&#8217;s compensation other than in connection with his service on our board of directors, please refer to &#8220;&#8212;Senior Executive Compensation.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, all members of our board of directors were non-executives, except for Dr. Amstutz. None of the members of our board of directors has any significant business connections with the Company or was a member of the Management Board of the Company, except for Dr. Amstutz, who has been a member of the Management Board since the Company's inception in 2004.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described in the section of this prospectus entitled &#8220;Related Party Transactions&#8212;Agreements with Our Directors and Executive Officers&#8221;, there are no arrangements or understandings between us and any of our directors providing for benefits upon termination of their service as our directors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation of the Management Board, also referred to herein as our executive officers, may consist of fixed and variable compensation. Fixed compensation comprises the base salary and the corresponding pension contributions. Variable compensation comprises  short-term and long-term variable compensation elements&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the short-term variable compensation, paid as a cash bonus, is determined exclusively by the achievement of pre-defined annual corporate goals&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the long-term variable compensation, granted as Performance Share Units, or PSUs, is determined based on (i) the achievement of annual corporate goals, (ii) the achievement of long-term value-driving milestones outside of such corporate goals and (iii) the development of the share price of the Company.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets out information regarding compensation earned by the Management Board during the year ended December 31, 2020. </font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and principal position</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Equity <br>Incentive Plan <br>Compensation </font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Other <br>Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer, Director and Co-Founder</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Management </font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Represents amounts earned in 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Represents pension contributions.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">All other compensation awarded to the members of the Management Board shown in this table does not include the payments of CHF 101,000 we made in 2020 to cover the mandatory employer social security contribution on the base salary and on the bonus. In addition, upon vesting of the PSUs 2020 in 2023, we will be obliged to make employer contributions to social security pursuant to applicable mandatory law. As an estimate based on currently applicable contribution rates, the employer contributions on the PSUs 2020 expected to vest in 2023 will amount to approximately CHF 67,000 (assuming 100% target achievement and full vesting of the PSUs).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation Arrangements </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our employment arrangements with our executive officers, see the section of this prospectus entitled &#8220;Related Party Transactions&#8212;Agreements with Our Directors and Executive Officers&#8212;Employment Arrangements.&#8221; Except for the arrangements described in the section of this prospectus entitled &#8220;Related Party Transactions&#8212;Agreements with Our Directors and Executive Officers&#8212;Employment Arrangements,&#8221; there are no arrangements or understanding between us and any of our other executive officers providing for benefits upon termination of their employment, other than as required by applicable law.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Liability and Indemnification Matters</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss corporate law, an indemnification of a director or member of the executive management in relation to potential personal liability is not effective to the extent the director or member of the executive management intentionally or negligently violated his or her corporate duties towards the company (certain views advocate that at least a grossly negligent violation is required to exclude the indemnification). Most violations of corporate law are regarded as violations of duties towards the company rather than towards the shareholders. In addition, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indemnification of controlling persons is not permitted under Swiss corporate law, including shareholders of the company.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nevertheless, the articles of association of a Swiss corporation may set forth that the company shall indemnify and hold harmless to the extent permitted by the law, the directors and executive managers out of assets of the company against threatened, pending or completed actions. However, our articles of association do not provide for such an indemnification provision. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the same limitations, articles of association of a Swiss corporation may also provide that the directors shall be entitled to the reimbursement of all expenses incurred in the interests of the corporation. Our articles of association contain such a provision.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a corporation may enter into and pay for directors' and officers' liability insurance which typically covers negligent acts as well.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to extend liability insurance for our directors and officers, including insurance coverage for liability under the Securities Act. We believe that this insurance is necessary to attract qualified directors and executive officers.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Equity Incentives </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our ability to grant incentive awards is a valuable and necessary compensation tool that allows us to attract and retain the best available personnel for positions of substantial responsibility, provides additional incentives to directors, executive officers, and  employees and promotes the success of our business. Historically, we have granted several different equity incentive instruments to our directors, employees and other service providers, including&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricted Share Units, or RSUs, granted to our directors&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Performance Share Units, or PSUs, granted to our executive officers and employees&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">share options granted to employees, directors and selected advisors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our articles of association authorize the board of directors to issue one or more participations plans and&#47;or policies. An amendment or renewal of the relevant provision in our articles of association must be approved by an absolute majority of the votes represented at the general meeting of shareholders. Once our board of directors' authority is approved by our shareholders, the maximum aggregate amounts of the variable compensation elements actually granted to the directors and executive officers must be approved by an absolute majority of the votes represented at the general meeting of shareholders and shall continue for the duration of the current financial year. Compensation may be paid out prior to approval by the general meeting of shareholders subject to subsequent approval. If the general meeting of shareholders does not approve a proposal of the board of directors, the board of directors must newly determine the maximum aggregate amount or maximum partial amounts taking into account all relevant factors and submit such amounts for approval to the same general meeting of shareholders, to an extraordinary general meeting of shareholders or to the next ordinary general meeting of shareholders.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Options </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our initial public offering on SIX Swiss Exchange on November 5, 2014, which we refer to as our Swiss IPO, our board of directors established three share option plans&#58; (i) the Employee Share Option Plan 2007, or ESOP 2007, (ii) the Employee Share Option Plan 2009, or ESOP 2009, and (iii) the Employee Share Option Plan 2014, or ESOP 2014, with similar features as the ESOP 2009, but no longer providing for accelerated vesting of options in the event of our Swiss IPO. Each option entitles its holder to purchase one of our shares at the pre-defined exercise price. The number of options granted to each participant was determined by the board of directors based on a participant&#8217;s position and level of responsibility. As a rule, the options vested quarterly over a four year period. At the end of the option term, the unexercised options expire without value. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, no options were outstanding under the ESOP 2007, and an aggregate of 382,059 options were outstanding under the ESOP 2009 and ESOP 2014, together. As of December 31, 2020, all of the outstanding options were fully vested.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our Swiss IPO, no further grants were made under any of the ESOP 2007, ESOP 2009 or ESOP 2014, and we do not intend to make any further grants under any of these plans in the future. For additional information, see Note 18 to our financial statements as of and for the year ended December 31, 2020 included elsewhere in this prospectus.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Share Units (RSUs)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the LTI Plans, described in &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Incentive Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, members of our board of directors are eligible to be granted RSUs. RSUs are contingent rights to receive a certain number of our shares at the end of a three-year blocking period. RSUs vest over a one-year period from their date of grant, following the lapse of which they are no longer subject to forfeiture if a member of our board resigns. The number of shares to be received is not variable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the number of shares does not depend on the achievement of certain pre-defined performance metrics. In certain circumstances, including a change of control, a full or partial early vesting of the RSUs may occur.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 87,906 RSUs were outstanding.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share Units (PSUs)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the LTI Plans, described in &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Incentive Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, executive officers and certain other employees are eligible to be granted PSUs. PSUs are contingent rights to receive a variable number of our shares either in aggregate at the end of a three-year cliff-vesting period or in annual installments over a three-year vesting period. The number of PSUs granted to a plan participant is calculated by dividing the CHF amount approved for the respective individual by the fair value of each PSU at the grant date based on the average share price in the two months preceding the grant date. While the PSUs are designed to allow the beneficiaries to participate in the long-term share price development, the number of shares to be earned in relation to a PSU  depends on (i) the achievement of annual corporate goals for the respective year, (ii) the achievement of long-term value-driving milestones outside of such corporate goals during such year and (iii) the development of the share price of the Company. In accordance with these parameters, the number of shares to be issued based on the PSUs can be between zero and 120% of the number of PSUs granted. Even after the determination of goal achievement, participants may lose their entitlements in full or in part depending on certain conditions relating to their employment. In certain circumstances, including a change of control, a full or partial accelerated vesting of the PSUs may occur.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 445,198 PSUs were outstanding.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Incentive Plans</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term incentive plans established in March of 2015, March of 2016, March of 2017, March of 2018, March of 2019, March of  2020 and March of 2021, respectively, which we collectively refer to as the LTI Plans, are rolled out annually.  This allows our board of directors to review and adjust the terms and targets of the LTI Plans on an annual basis. Employees generally receive the grants on April 1 of each calendar year. With respect to members of the Management Board, the annual grants are usually made on April 1 subject to approval of the ordinary shareholders&#8217; meeting at which the necessary amounts for variable compensation are approved by the shareholders. With respect to members of our board of directors, the annual grants are made following the ordinary shareholders&#8217; meeting, at which the necessary amounts for variable compensation are approved by the shareholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Ownership  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the number of common shares, options, RSUs and PSUs held by the individual members of the board of directors and the Management Board as of December 31, 2020&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:49.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Burns</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,186</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Gwendolyn Anne Fyfe</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,944</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven H. Holtzman</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,944</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandip Kapadia</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,781</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vito J. Palombella</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,781</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Vasconcelles</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,781</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701,023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,080</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,325</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Tobias Stumpp</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760,437</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,070</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,787</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andreas Emmenegger</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,878</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,070</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,787</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Nicolas Leupin</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,389</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_88"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">RELATED PARTY TRANSACTIONS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2018, we have engaged in the following transactions with our directors, executive officers and holders of more than 3% of our outstanding voting securities and their affiliates, which we refer to as our related parties. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Agreements with Our Directors and Executive Officers </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment Arrangements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into customary employment agreements with all of our executive officers. These agreements provide for a base salary and annual incentive bonus opportunity, as well as participation in our equity incentive plans. These agreements generally require advance notice of termination of six months.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Agreements </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to enter into indemnification agreements with each of our directors and executive officers. See the section of this prospectus entitled &#8220;Executive Compensation&#8212;Limitation on Liability and Indemnification Matters.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Agreements with Shareholders</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we entered into the Novartis Agreement. See &#8220;Business&#8212;License and Collaboration Agreements&#34; for information regarding the Novartis Agreement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Related Party Transactions Policy</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related party transaction policies are generally not required by statutory Swiss law. However, our articles of association provide for the following rules in connection with transactions with members of the board of directors and the executive management&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may enter into mandate or other agreements with the members of our board of directors regarding their compensation as directors for a fixed term or for an indefinite term. The duration and termination are subject to term of office and the law. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may enter into employment agreements with the members of the executive management for a fixed term or for an indefinite term. The duration of fixed term agreements may not exceed one year. A renewal of a fixed term agreement is permissible. Agreements for an indefinite term may have a termination notice period of a maximum of one year. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may enter into non-competition agreements with members of the executive management for the period after the termination of the employment agreement. The duration of any such non-competition undertaking by a member of the executive management shall not exceed two years, and the consideration paid for a non-competition undertaking shall not exceed the sum of the total annual compensation of the respective member of the executive management last paid.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loans to members of the board of directors and the executive management may be granted, provided they are at standard market rates and the aggregate amount of the loan extended to the member of the board of directors or executive management does not exceed 200% of the total annual compensation of the respective member of the executive management last paid or payable for the first time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subject to the approval by the meeting of shareholders, we may grant to members of our board of directors or the executive management post-retirement benefits beyond the occupational benefit scheme, if such post-retirement benefits do not exceed 100% of the total annual compensation of the respective member last paid. In case of capital settlements, the value is determined by recognized actuarial methods.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_91"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">PRINCIPAL SHAREHOLDERS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table and accompanying footnotes set forth, as of December 31, 2020, information regarding beneficial ownership of our common shares by&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person, or group of affiliated persons, known by us to beneficially own more than 3% of our common shares&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our executive officers&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our directors&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our executive officers and directors as a group.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting power or investment power with respect to that security, including common shares that vest within 60 days of December 31, 2020 and options and warrants that are currently exercisable or exercisable within 60 days of December 31, 2020. Shares issuable under PSUs or RSUs that vest within 60 days of December 31, 2020 and shares subject to options currently exercisable or exercisable within 60 days of December 31, 2020 are deemed to be outstanding for computing the percentage ownership of the person holding these free shares, options and the percentage ownership of any group of which the holder is a member, but are not deemed outstanding for computing the percentage of any other person.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as indicated by the footnotes below, we believe, based on the information furnished or otherwise known to us, that the persons named in the table below have sole voting and investment power with respect to all shares shown that they beneficially own, subject to community property laws where applicable. The information does not necessarily indicate beneficial ownership for any other purpose, including for purposes of Sections 13(d) and 13(g) of the Securities Act or applicable Swiss law.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our calculation of the percentage of beneficial ownership prior to the offering is based on 29,146,992 of our common shares outstanding as of December 31, 2020. We have based our calculation of the percentage of beneficial ownership of our common shares outstanding immediately after the closing of the offering of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ADSs, assuming no exercise of the underwriters&#8217; option to purchase additional ADSs in the offering.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise indicated in the following table, addresses of the directors, executive officers and named beneficial owners are in care of Molecular Partners AG, Wagistrasse 14, 8952 Schlieren, Switzerland.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:53.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Beneficially Owned Prior to Offering</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Beneficially Owned After Offering</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Beneficial Owner</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Principal Shareholders</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark N. Lampert</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)(3)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.49 %</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hansjoerg Wyss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(4)(5)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,041,347&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suvretta Capital Management, LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(6)(7)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis AG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(8)(9)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739,130&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.97&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federated Hermes, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(10)(11)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675,900&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Essex Woodlands Health Ventures VIII, LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(12)(13)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620,247&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UBS Fund Management (Switzerland) AG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(14)(15)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074,122&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.69&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Directors and Executive Officers</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Tobias Stumpp</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(17)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796,507&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.73 %</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andreas Emmenegger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(18)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,948&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.95 %</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Nicolas Leupin</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Burns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(19)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;0.01 %</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Gwendolyn Anne Fyfe</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(20)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;0.01 %</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven H. Holtzman</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(21)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,027&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09 %</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandip Kapadia</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Vito Palombella</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Vasconcelles</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All current directors and executive officers as a group (10 individuals)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(22)</font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872,900&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Number of voting rights carried by shares as reported by our shareholders in notifications filed with SIX Swiss Exchange, in each case dated as specified in the applicable following footnotes.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Pursuant to notification filed with SIX Swiss Exchange on November 5, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Mark N. Lampert is the beneficial owner&#59; each of Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P. and MSI BVF SPV, LLC are direct&#47;indirect shareholders.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Pursuant to notification filed with SIX Swiss Exchange on April 11, 2017.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Hansjoerg Wyss is the beneficial owner&#59; Hansjorg Wyss Revocable Trust dated December 16, 1994 is the direct&#47;indirect shareholder.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Pursuant to notification filed with SIX Swiss Exchange on July 15, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Suvretta Capital Management, LLC is the licensee&#59; each of Suvretta Master Fund, Ltd., Averill Master Fund, Ltd., Vitruvius US Equity and Suvretta Long Master Fund, Ltd. are collective investors.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Pursuant to notification filed with SIX Swiss Exchange on October 30, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Novartis AG is the beneficial owner&#59; Novartis Pharma AG is the direct&#47;indirect shareholder.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Pursuant to notification filed with SIX Swiss Exchange on July 21, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Federated Hermes, Inc. is the licensee&#59; Federated Hermes Kaufmann Fund is the collective investor.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Pursuant to notification filed with SIX Swiss Exchange on November 4, 2017.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Essex Woodlands Health Ventures VIII, LLC is the beneficial owner&#59; each of Essex Woodlands Health Ventures VIII, LP, Essex Woodlands Health Ventures Fund VIII-A, LP and Essex Woodlands Health Ventures Fund VIII-B, LP are direct&#47;indirect shareholders.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Pursuant to notification filed with SIX Swiss Exchange on June 4, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">UBS Fund Management (Switzerland) AG is the licensee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 701,023 common shares and 70,080 common shares issuable upon exercise of options that are exercisable within 60 days of December 31, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 760,437 common shares and 36,070 common shares issuable upon exercise of options that are exercisable within 60 days of December 31, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 241,878 common shares and 36,070 common shares issuable upon exercise of options that are exercisable within 60 days of December 31, 2020.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 1,315 common shares.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 2,144 common shares.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 6,027 common shares and 20,000 common shares issuable upon exercise of options that are exercisable within 60 days of December 31, 2020.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:5.52pt">Consists of 1,710,680 common shares and 162,200 common shares issuable upon exercise of options that are exercisable within 60 days of December 31, 2020.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_94"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description of our share capital summarizes certain provisions of our articles of association as they will be in effect upon the completion of this offering. The following summary does not purport to be complete. For a more complete discussion, please refer to our articles of association, a copy of which has been filed as an exhibit to the registration statement of which this prospectus forms a part. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a Swiss stock corporation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) organized under the laws of Switzerland. We were incorporated on November 22, 2004. Our principal executive offices are located at Wagistrasse 14, 8952 Schlieren, Switzerland. We are registered with the commercial register of the Canton of Zurich under number CHE-112.115.136. Our corporate name is Molecular Partners AG.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, our issued share capital was CHF 2,914,699.20, consisting of 29,146,992 common shares with a nominal value of CHF 0.10 each. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All shares rank </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with each other and no preferred shares exist.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, to the best of our knowledge, approximately 10,818,504, or 37.1%, of our issued common shares as recorded in the commercial register of the Canton of Zurich were held of record by residents of the United States.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of this offering, based on the number of common shares issued as of December 31, 2021 as set out above, our issued share capital as will be recorded in the commercial register of the Canton of Zurich is expected to be&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the underwriters do not (neither fully nor partially) exercise their option to purchase additional ADSs in the offering, CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, consisting of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares with a nominal value of CHF 0.10 each&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the underwriters exercise their option to purchase additional ADSs in the offering in full, CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, consisting of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares with a nominal value of CHF 0.10 each.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">History of Changes to the Number of our Issued Shares Recorded in Commercial Register</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From January 1, 2018 through March 1, 2021, the number of our issued common shares as recorded in the commercial register of the Canton of Zurich underwent the following changes&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">2018</font></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on January 1, 2018.........................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20,724,345</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reflecting in commercial register on January 22, 2018 of prior issuance of new shares with a nominal value of CHF 0.10 each issued (but not reflected) in the one-year period ended December 31, 2017 out of conditional share capital...................................</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">319,717</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on December 31, 2018..................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21,044,062</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">2019</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on January 1, 2019.........................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21,044,062</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reflecting in commercial register on January 22, 2019 of prior issuance of new shares with a nominal value of CHF 0.10 each issued (but not reflected) in the one-year period ended December 31, 2018 out of conditional share capital...................................</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">184,531</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on December 31, 2019..................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21,228,593</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">2020</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on January 1, 2020.........................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21,228,593</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reflecting in commercial register on January 20, 2020 of prior issuance of new shares with a nominal value of CHF 0.10 each issued (but not reflected) in the one-year period ended December 31, 2019 out of conditional share capital...................................</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">372,599</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issuance in an accelerated bookbuilding transaction of new shares with a nominal value of CHF 0.10 each on July 8, 2020 out of authorized share capital immediately reflected in the commercial register on July 8, 2020.........................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,528,089</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issuance of new shares with a nominal value of CHF 0.10 each to Novartis Pharma AG on October 28, 2020 out of conditional share capital, immediately reflected in commercial register on October 28, 2020.......................................................</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,739,130</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on December 31, 2020..................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28,868,411</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">2021 (through  March 1 , 2021)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued shares recorded on January 1, 2021.........................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28,868,411</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reflecting in commercial register on January 20, 2021 of prior issuance of new shares with a nominal value of CHF 0.10 each issued (but not reflected) in the one-year period ended December 31, 2020 out of conditional share capital...................................</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">278,581</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">History of Securities Issuances</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From January 1, 2018 through March 1, 2021, the events set out above and further described below have changed our issued share capital and, in parallel, the number of our issued common shares, in each case as recorded in the commercial register of the Canton of Zurich.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of January 1, 2018, our issued share capital as recorded in the commercial register of the Canton of Zurich was CHF 2,072,434.50, consisting of 20,724,345  common shares with a nominal value of CHF 0.10 each. </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 22, 2018, our share capital was increased by CHF 31,971.70  through the issuance of 319,717  new shares with a nominal value of CHF 0.10 each. These shares had been issued out of conditional share capital (but were not recorded in the commercial register until January 22, 2018) in the one-year period ended December 31, 2017, based on the resolution of the general meeting of shareholders held on October 6, 2014 regarding a conditional capital increase of up to CHF 400,000 through the issuance of up to 4,000,000 registered shares with a nominal value of CHF 0.10 to be fully paid in each. Our articles of incorporation were amended accordingly to reflect the new share capital.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 22, 2019, our share capital was increased by CHF 18,453.10 through the issuance of 184,531 new shares with a nominal value of CHF 0.10 each. These shares had been issued out of conditional share capital (but were not recorded in the commercial register until January 22, 2019) in the one-year period ended December 31, 2018 based on the resolution of the general meeting of shareholders held on October 6, 2014 regarding a conditional capital increase of up to CHF 400,000 through the issuance of up to 4,000,000 registered shares with a nominal value of CHF 0.10 (to be fully paid in) each. Our articles of incorporation were amended accordingly to reflect the new share capital.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 20, 2020, our share capital was increased by CHF 37,259.90 through the issuance of 372,599 new shares with a nominal value of CHF 0.10 each. These shares had been issued out of conditional share capital (but were not recorded in the commercial register until January 20, 2020) in the one-year period ended December 31, 2019, based on the resolution of the general meeting of shareholders held on October 6, 2014 regarding a conditional capital increase of up to CHF 400,000 through the issuance of up to 4,000,000 registered shares with a nominal value of CHF 0.10 (to be fully paid in) each. Our articles of incorporation were amended accordingly to reflect the new share capital.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 8, 2020, our share capital was increased by CHF 552,808.90 through the issuance of 5,528,089 new shares with a nominal value of CHF 0.10 each. These shares were issued out of authorized share capital based on the resolution of the general meeting of shareholders held on April 29, 2020 regarding an authorized share capital increase of up to CHF 565,986 through the issuance of up to 5,659,860 registered shares with a nominal value of CHF 0.10 (to be fully paid in) each on or before April 29, 2022. The new shares were placed with institutional investors in an accelerated bookbuilding transaction, under withdrawal of statutory pre-emptive rights of existing shareholders. Our articles of incorporation were amended accordingly to reflect the new share capital.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 28, 2020, our share capital was increased by CHF 173,913.00 through the issuance of 1,739,130 new shares with a nominal value of CHF 0.10 each. These shares were issued out of conditional share capital based on the resolution of the general meeting of shareholders held on October 6, 2014 regarding a conditional capital increase of up to CHF 400,000 through the issuance of up to 4,000,000 registered shares with a nominal value of CHF 0.10 (to be fully paid in) each. The new shares were issued to Novartis Pharma AG in connection with an option and equity rights agreement providing for a collaboration to develop, manufacture and commercialize certain product candidates and&#47;or therapies. Our articles of incorporation were amended accordingly to reflect the new share capital.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 20, 2021, our share capital was increased by CHF 27,858.10 through the issuance of 278,581 new shares with a nominal value of CHF 0.10 each. These shares had been issued out of conditional share capital (but were not recorded in the commercial register until January 20, 2021) in the one-year period ended December 31, 2020, based on the resolution of the general meeting of shareholders held on October 6, 2014 regarding a conditional capital increase of up to CHF 400,000 through the issuance of up to 4,000,000 registered shares with a nominal value of CHF 0.10 (to be fully paid in) each. Our articles of incorporation were amended accordingly to reflect the new share capital.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Important Provisions of our Articles of Association, Organizational Rules and Swiss Law </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of certain important provisions of our articles of association, organizational rules and certain related provisions of Swiss law. Please note that this is only a summary and as such is not, is not  intended to be and does not purport to be exhaustive. For a more complete discussion, please refer to our articles of association, organizational rules and Swiss law.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, the Swiss Parliament approved legislation that will modernize certain aspects of Swiss corporate law. Most relevantly, the legislative reform addresses, among other topics, (i) the modernization and increased flexibility for a stock corporation&#8217;s capital base, (ii) corporate governance and executive compensation matters, (iii) the strengthening of shareholder rights and the protection of minorities, (iv) financial distress&#47;restructuring measures and (v) certain socio-political topics (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, gender representation and disclosure requirements for companies active in the raw materials sector). Other than with respect to the new rules on gender representation and disclosure </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements for companies active in the raw materials sector, which, subject to transitional periods, entered into force on January 1, 2021, the effective date of the new legislation has not yet been announced&#59; it is not expected to come into force before 2022 (with certain transitional periods as provided for therein). In light of these reforms, certain sub-sections discussed in more detail below will be subject to the changes and modifications pursuant to this new legislation.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary Capital Increase, Authorized and Conditional Share Capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, we may increase our share capital (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktienkapital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with a resolution of the general meeting of shareholders (ordinary capital increase) that must be carried out by the board of directors within three months in order to become effective. In case of a subscription and increase against contributions in cash, a resolution passed by an absolute majority of the votes represented at the general meeting of shareholders is required. In the case of a subscription and increase against contributions in kind or to fund acquisitions in kind, when shareholders' statutory pre-emptive rights are withdrawn or where transformation of reserves into share capital is involved, a resolution passed by two-thirds of the votes represented at a general meeting of shareholders and the absolute majority of the nominal value of the shares represented is required. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, under the Swiss Code of Obligations, or the CO, our shareholders, by a resolution passed by two-thirds of the votes represented at a general meeting of shareholders and the absolute majority of the nominal amount of the shares represented, may empower the board of directors to issue shares of a specific aggregate nominal amount up to a maximum of 50% of the existing issued share capital in the form of&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conditional capital </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(bedingtes Kapital)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the purpose of issuing shares in connection with, among other things, (i) options and conversion rights granted in connection with warrants and convertible bonds of the Company or one of our subsidiaries or (ii) grants of rights to employees, members of the board of directors or consultants or subsidiaries to subscribe for new shares (conversion or option rights)&#59; and&#47;or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorized capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (genehmigtes Kapital)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be utilized by the board of directors within a period determined by the shareholders but not exceeding two years from the date of the shareholder approval. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-emptive Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the CO, shareholders have pre-emptive rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bezugsrechte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) to subscribe for newly issued shares. With respect to conditional capital in connection with the issuance of conversion rights, convertible bonds or similar debt instruments, shareholders have advance subscription rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vorwegzeichnungsrechte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) for the subscription of these instruments. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A resolution passed at a general meeting of shareholders by two-thirds of the votes represented and the absolute majority of the nominal value of the shares represented may authorize the board of directors to withdraw or limit pre-emptive  rights and&#47;or advance subscription rights in certain circumstances. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If pre-emptive rights are granted, but not exercised, the board of directors may allocate the pre-emptive rights as it elects. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our authorized share capital, the board of directors is authorized by our articles of association to withdraw or limit the pre-emptive rights of shareholders, and to allocate them to certain shareholders and third parties if the shares are to be used&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for the acquisition of companies, part of companies or participations, for the acquisition of products, intellectual property or licenses or for investment projects or for the financing or refinancing of such transactions through a placement of shares&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for the purpose of broadening the shareholder constituency or in connection with a listing of shares on domestic or foreign stock exchanges&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the issue price of the new shares is determined by reference to the market price&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for purposes of granting an over-allotment option (greenshoe) of up to 20% of the total number of shares in a placement or sale of shares to the respective initial purchaser or underwriters&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of the share capital registered in the commercial register without having submitted to the other shareholders a takeover offer recommended by the board of directors&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for the defense of an actual, threatened or potential takeover bid, in relation to which the board of directors, upon consultation with an independent financial advisor retained by it, has not recommended to the shareholders acceptance on the basis that the board of directors has not found the takeover bid to be financially fair to the shareholders. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors may permit pre-emptive rights that have been granted but not exercised to expire or it may place these rights respectively the shares as to which pre-emptive rights have been granted but not exercised, at market conditions or use them for other purposes in the interest of the Company. Any shares for which the granted preferential subscription rights have not been exercised will be at the disposal of the board of directors, who may sell them at market conditions or use them for other purposes in the interest of the Company. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Authorized Share Capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our articles of association, our board of directors is authorized to increase the share capital at any time on or before April 21, 2023, by a maximum aggregate amount of CHF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; through the issuance of not more than &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares, which would have to be fully paid-in, with a nominal value of CHF 0.10 each.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases in partial amounts are permitted. The board of directors has the power to determine the type of contributions, the issue price and the date on which the dividend entitlement starts. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors is also authorized to withdraw or limit pre-emptive rights as described above. This authorization is exclusively linked to the particular available authorized share capital set out in the respective article. If the period to increase the share capital lapses without having been used by the board of directors, the authorization to withdraw or to limit the pre-emptive rights lapses simultaneously with such capital. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares to be sold in this offering will be issued out of our authorized share capital. Accordingly upon the consummation of this offering, our authorized but unissued share capital will decrease by the amount of CHF &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (or by a larger amount to the extent that any over-allotment shares will be issued).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Conditional Share Capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share capital may be increased by a (following the transactions set out in &#34;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">History of Securities Issuances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;, residual) maximum aggregate amount of CHF 176,067.70 through the issuance of not more than 1,760,677 common shares, which would need to be fully paid-in, with a nominal value of CHF 0.10 each, through the direct or indirect issuance of shares, options or pre-emptive rights thereof granted to employees and members of our board of directors as well as to members of any advisory boards. Shares, options or pre-emptive rights thereof shall be issued in accordance with one or more participation plans and&#47;or policies to be issued by our board of directors and in accordance with our articles of association.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our share capital may be increased by a (following the transactions set out in &#34;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">History of Securities Issuances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;, residual) maximum aggregate amount of CHF 226,087 through the issuance of up to 2,260,870 fully paid up shares with a nominal value of CHF 0.10 each through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights for the subscription of shares granted to shareholders or third parties alone or in connection with bonds, notes, options, warrants or other securities or contractual obligations by us or any of our group companies.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-emptive rights and advance subscription rights of our shareholders are excluded in connection with the issuance of any shares, options or pre-emptive rights under our conditional share capital.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertificated Securities</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shares are uncertificated securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wertrechte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, within the meaning of article 973c of the CO) and, when administered by a custodian (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verwahrungsstelle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, within the meaning of the Federal Act on Intermediated Securities, or FISA), and credited to one or more securities deposit account (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effektenkonto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) qualify as intermediated securities </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bucheffekten</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, within the meaning of the FISA). In accordance with article 973c of the CO, we maintain a non-public register of uncertificated securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wertrechtebuch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We may at any time without the approval of our shareholders and at our cost convert shares issued as uncertificated securities into another form (including global certificates) or convert shares issued in one form into another form. Following the entry in the share register, a shareholder may at any time request from us a written confirmation in respect of the shares held by such shareholder. Shareholders are not entitled, however, to request the printing and delivery of certificates or the conversion of the shares in one form into another form. We may print and deliver certificates for shares at any time.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Exercisable for Common Shares </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentives </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section of this prospectus entitled &#8220;Executive Compensation&#8212;Equity Incentives&#8221; for a description of securities granted by our board of directors to our directors, executive officers, employees and other service providers. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General Meeting of Shareholders</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The general meeting of shareholders is our supreme corporate body. Under Swiss law, ordinary and extraordinary general meetings of shareholders may be held. Under Swiss law, an ordinary general meeting of shareholders must be held annually within six months after the end of a corporation&#8217;s financial year. In our case, this means on or before June&#160;30 of any calendar year.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following powers are vested exclusively in the general meeting of shareholders&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adoption and amendment of our articles of association&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">election of the members of the board of directors, the chairperson of the board of directors, the members of the compensation committee, the independent voting rights representative and the auditors&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval of the annual management report and the consolidated financial statements and approval of the annual financial statements and decision on the allocation of profits shown on the balance sheet, in particular with regard to dividends&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval of the compensation of the board of directors and of the executive management pursuant to article 28 of our articles of association&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">granting discharge to the members of the board of directors and the persons entrusted with the executive management&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dissolving the Company with or without liquidation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">passing of resolutions as to all matters reserved by law or under our articles of association to the authority of the general meeting of shareholders.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An extraordinary general meeting of shareholders may be called by a resolution of the board of directors or, under certain circumstances, by our auditor, liquidator or the representatives of bondholders, if any. In addition, the board of directors is required to convene an extraordinary general meeting of shareholders if shareholders representing at least 10% of the share capital request such general meeting of shareholders in writing. Such request must set forth the items to be discussed and the proposals to be acted upon. The board of directors must convene an extraordinary general meeting of shareholders and propose financial restructuring measures if, based on our stand-alone annual statutory balance sheet, half of our share capital and reserves are not covered by our assets.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting and Quorum Requirements</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholder resolutions and elections (including elections of members of the board of directors) require the affirmative vote of the absolute majority of the votes represented at the general meeting of shareholders, unless otherwise stipulated by law or our articles of association.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss corporate law and our articles of association, a resolution of the general meeting of the shareholders passed by two-thirds of the votes represented at the meeting, and the absolute majority of the nominal value of the shares represented is required for&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amendment or modification of the purpose of the company&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the creation of shares with privileged voting rights&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the restriction on the transferability of shares and the cancellation of such restriction&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an authorized or conditional increase of the share capital&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of the share capital through the conversion of capital surplus, through contribution in kind or for purposes of an acquisition of assets, or the granting of special privileges&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the limitation or withdrawal of pre-emptive rights&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the relocation of the registered office of the company&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dissolution of the company.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a rule, the same voting requirements apply to resolutions regarding transactions among corporations based on Switzerland&#8217;s Federal Act on Mergers, Demergers, Transformations and the Transfer of Assets of 2003, as amended, or the Swiss Merger Act (including a merger, demerger or conversion of a corporation). See &#8220;&#8212;Compulsory Acquisitions&#59; Appraisal Rights.&#8221;</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Swiss law and generally accepted business practices, our articles of association do not provide for quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice varies from the requirement of Nasdaq Listing Rule 5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting shares.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General meetings of shareholders must be convened by the board of directors at least twenty days before the date of the meeting. The general meeting of shareholders is convened by way of a notice appearing in our official publication medium, currently the Swiss Official Gazette of Commerce. Registered shareholders may also be informed by mail. The notice of a general meeting of shareholders must state the items on the agenda, the proposals to be acted upon and, in case of elections, the names of the nominated candidates. Except in the limited circumstances listed below, a resolution may not be passed at a general meeting without proper notice. This limitation does not apply to proposals to convene an extraordinary general meeting of shareholders or to initiate a special investigation. No previous notification is required for proposals concerning items included in the agenda or for debates that do not result in a vote.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The owners or representatives of all of our shares may, if no objection is raised, hold a general meeting of shareholders without complying with the formal requirements for convening general meetings of shareholders (a universal meeting). This universal meeting of shareholders may discuss and pass binding resolutions on all matters within the purview of the ordinary general meeting of shareholders, provided that the owners or representatives of all the shares are present at the meeting.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agenda Requests</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Swiss law, one or more shareholders whose combined shareholdings represent the lower of (1) one tenth of the share capital or (2) an aggregate nominal value of at least CHF 1,000,000, may request that an item be included on the agenda for a general meeting of shareholders. To be timely, the shareholder&#8217;s request must be received by us at least 45 calendar days in advance of the meeting.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business report, the compensation report and the auditor&#8217;s report must be made available for inspection by the shareholders at our registered office no later than 20 days prior to the ordinary general meeting. Shareholders of record must be notified of this in writing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Proposals</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss statutory law, at any general meeting of shareholders any shareholder may put proposals to the meeting if the proposal is part of an agenda item. In addition, even if the proposal is not part of any agenda item, any shareholder may propose to the meeting to convene an extraordinary general meeting of shareholders or to have a specific matter investigated by means of a special audit where this is necessary for the proper exercise of shareholders&#8217; rights.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our shares entitles a holder to one vote. The shares are not divisible. The right to vote and the other rights of share ownership may only be exercised by shareholders (including any nominees) or usufructuaries who are entered in our share register at cut-off date determined by the board of directors. Those entitled to vote in the general meeting of shareholders may be represented by the independent proxy holder (annually elected by the general meeting of shareholders), another registered shareholder or third person with written authorization to act as proxy or the shareholder&#8217;s legal representative.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends and Other Distributions</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors may propose to shareholders that a dividend or other distribution be paid but cannot itself authorize the distribution. Under our articles of association, dividend payments require a resolution passed by an absolute majority of the votes represented at a general meeting of shareholders. In addition, our auditors must confirm that the dividend proposal of our board of directors conforms to Swiss statutory law and our articles of association.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, we may pay dividends only if we have sufficient distributable profits brought forward from the previous business years, or if we have distributable reserves, each as evidenced by our audited stand-alone statutory balance sheet prepared pursuant to Swiss law, and after allocations to reserves required by Swiss law and the articles of association have been deducted. We may not be permitted to pay interim dividends out of profit of the current business year.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributable reserves are booked either as &#8220;retained earnings&#8221; or as reserves from capital contributions. Under the CO, if our general reserves amount to less than 20% of our share capital recorded in the commercial register (i.e., 20% of the aggregate nominal value of our issued capital), then at least 5% of our annual profit must be retained as general reserves. In addition, if our general reserves amount to less than 50% of our share capital, 10% of the amounts distributed beyond payment of a dividend of 5% must be retained as general reserves. The CO permits us to accrue additional general reserves. Further, a purchase of our own shares (whether by us or a subsidiary) reduces the distributable reserves in an amount corresponding to the purchase price of such own shares. Finally, the CO under certain circumstances requires the creation of revaluation reserves which are not distributable.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributions out of issued share capital (i.e. the aggregate nominal value of our issued shares) are not allowed and may be made only by way of a share capital reduction. Such a capital reduction requires a resolution passed by an absolute majority of the votes represented at a general meeting of shareholders. The resolution of the shareholders must be recorded in a public deed and a special audit report must confirm that claims of our creditors remain fully covered despite the reduction in the share capital recorded in the commercial register. Upon approval by the general meeting of shareholders of the capital reduction, the board of directors must give public notice of the capital reduction resolution in the Swiss Official Gazette of Commerce three times and notify creditors that they may request, within two months of the third publication, satisfaction of or security for their claims. The reduction of the share capital may be implemented only after expiration of this time limit. Pursuant to the revised CO, the board of directors must give public notice of the capital reduction in the Swiss Official Gazette of Commerce (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Schweizerisches Handelsamtsblatt</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) only once (instead of three times) and notify the Company's creditors that they may request, within thirty days of the publication (instead of two months of the third publication as under the current law), satisfaction of, or security for, their claims. The revised CO is expected to enter into force in 2023.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inspection of Books and Records</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the CO, a shareholder has a right to inspect our share register with respect to his, her or its own shares and otherwise to the extent necessary to exercise his, her or its shareholder rights. No other person has a right to inspect our share register. Our books and correspondence may be inspected with the express authorization of the general meeting of shareholders or by resolution of the board of directors and subject to the safeguarding of our business secrets. See &#8220;Comparison of Shareholder Rights&#8212;Inspection of Books and Records.&#8221;</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Investigation</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the shareholders&#8217; inspection rights as outlined above prove to be insufficient in the judgment of the shareholder, any shareholder may propose to the general meeting of shareholders that specific facts be examined by a special examiner in a special investigation. If the general meeting of shareholders approves the proposal, we or any shareholder may, within 30 calendar days after the general meeting of shareholders, request a court sitting at our registered office (currently in Schlieren, Switzerland) to appoint a special examiner. If the general meeting of shareholders rejects the request, one or more shareholders representing at least 10% of the share capital or holders of shares in an aggregate nominal value of at least CHF 2,000,000 may request that the court appoint a special examiner. The court will issue such an order if the petitioners can demonstrate that the board of directors, any member of the board of directors or our executive management infringed the law or our articles of association and thereby caused damages to us or the shareholders. The costs of the investigation would generally be allocated to us and only in exceptional cases to the petitioners.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shareholders&#8217; Rights to Bring Actions for the Benefit of the Company</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the CO, an individual shareholder may bring an action, in its own name and for the benefit of the Company, against the Company&#8217;s directors, officers or liquidators for the recovery of any losses we have suffered as a result of the intentional or negligent breach by such directors, officers or liquidators of their duties.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Compulsory Acquisitions&#59; Appraisal Rights</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business combinations and other transactions that are governed by the Swiss Merger Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, mergers, demergers, conversion of a corporation and certain asset transfers)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are binding on all shareholders. A statutory merger or demerger requires approval of two-thirds of the votes represented at a general meeting of shareholders and the absolute majority of the nominal value of the shares represented at such meeting.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a transaction under the Swiss Merger Act receives all of the necessary consents, all shareholders are compelled to participate in such transaction.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss corporations may be acquired by an acquirer through the direct acquisition of shares. The Swiss Merger Act provides for the possibility of a so-called &#8220;cash-out&#8221; or &#8220;squeeze-out&#8221; merger if 90% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the shareholders of the transferring company who are entitled to vote give their consent</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In these limited circumstances, minority shareholders of the corporation being acquired may be compensated in a form other than through shares of the acquiring corporation (for instance, through cash or securities of a parent corporation of the acquiring corporation or of another corporation).</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For business combinations effected in the form of a statutory merger or demerger and subject to Swiss law, the Swiss Merger Act provides that if equity rights have not been adequately preserved or compensation payments in the transaction are not adequate, a shareholder may request the competent court to determine </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an adequate amount of compensation. Shareholders who consider their equity rights not to have been adequately preserved or the compensation received or to be received to be inadequate are entitled to exercise appraisal rights in accordance with the Swiss Merger Act by filing a suit against the surviving corporation with the competent Swiss civil court at the registered office of the surviving corporation or of the transferring corporation. The suit must be filed within two months after the merger or demerger resolution has been published in the Swiss Official Gazette of Commerce. If such a suit is filed, the court must assess whether the equity rights have been adequately preserved or the compensation paid or to be paid to the shareholders is adequate compensation and, should the court consider it to be inadequate, determine any additional adequate compensation. A decision issued by a competent court in this respect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">can be acted upon by any person who has the same legal status as the claimant. The filing of an appraisal suit will not prevent completion of the merger or demerger. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under Swiss law, the sale of all or substantially all of our assets may be construed as a&#160;de facto&#160;dissolution of the Company, and consequently require the approval of two-thirds of the votes represented at a general meeting of shareholders and the absolute majority of the nominal value of the shares represented at such meeting. Whether a shareholder resolution is required depends on the particular transaction, and the following circumstances are generally deemed relevant in this respect&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a core part of the company&#8217;s business is sold without which it is economically impracticable or unreasonable to continue to operate the remaining business&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the company&#8217;s assets, after the divestment, are not invested in accordance with the company&#8217;s  business purpose set forth in its articles of association&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the proceeds of the divestment are not earmarked for reinvestment in accordance with the company&#8217;s business purpose but, instead, are intended for distribution to the company&#8217;s shareholders or for financial investments unrelated to the company&#8217;s business.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board of Directors</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Number of Directors&#59; Election</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our articles of association provide that our board of directors shall consist of a minimum of three members and a maximum of 11 members.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of our board of directors and the chairperson are elected annually by the general meeting of shareholders for a term of office until  completion of the next annual general meeting of shareholders and are eligible for re-election. Each member of our board of directors must be elected individually.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Powers</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors has the following non-delegable and inalienable powers and duties&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ultimate direction of the business of the company and the issuance of the necessary instructions&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the determination of the organization of the company&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the administration of accounting, financial control and financial planning&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the appointment and removal of the persons entrusted with executive management and their representation of the company&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ultimate supervision of the persons entrusted with management of the company, specifically in view of their compliance with the law, these articles of association, the regulations and directives&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the preparation of the business report, the compensation report and the general meetings of shareholders as well as the implementation of the resolutions adopted by the general meetings of shareholders&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the adoption of resolutions regarding the subsequent payment of capital with respect to non-fully paid up shares and the amendments to the articles of association related thereto&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the adoption of resolutions concerning an increase of the share capital to the extent that such power is vested in the board of directors (article 651 paragraph 4 CO) and of resolutions concerning the confirmation of capital increases and corresponding amendments to the Articles of Incorporation, as well as the preparation of the required report on the capital increase&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the non-delegable and inalienable duties and powers of the board of directors pursuant to the Merger Act&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the notification of the court if liabilities exceed assets&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other matter reserved to the board of directors by the law or the articles of association.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors may, while retaining such non-delegable and inalienable powers and duties, delegate some of its powers, in particular direct management, to a single or to several of its members, managing directors, committees or to third parties who need be neither members of the board of directors nor shareholders. Pursuant to Swiss law, details of the delegation must be set in the organizational rules issued by the board of directors. The organizational rules may also contain other procedural rules such as quorum requirements.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification of Executive Management and Directors</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under general principles of Swiss employment law, an employer may be required to indemnify an employee against losses and expenses incurred by such employee in the proper execution of his or her duties under the employment agreement with the employer. See the section of this prospectus entitled &#8220;Comparison of Shareholder Rights&#8212;Indemnification of Directors and Executive Management and Limitation of Liability.&#8221;</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to enter into indemnification agreements with each of the members of our board of directors and executive management. See the section of this prospectus entitled &#8220;Related Party Transactions&#8212;Indemnification Agreements.&#8221;</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conflict of Interest, Management Transactions</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss law does not have a specific provision regarding conflicts of interest. However, the CO contains a provision that requires our directors and executive management to safeguard the company&#8217;s interests and imposes a duty of loyalty and duty of care on our directors and executive management. This rule is generally understood to disqualify directors and executive management from participation in decisions that directly affect them. Our directors and executive officers are personally liable to us for breach of these provisions. In addition, Swiss law contains provisions under which directors and all persons engaged in the company&#8217;s management are liable to the company, each shareholder and the company&#8217;s creditors for damages caused by an intentional or negligent violation of their duties. Furthermore, Swiss law contains a provision under which payments made to any of the company&#8217;s shareholders or directors or any person associated with any such shareholder or director, other than payments made at arm&#8217;s length, must be repaid to the company if such shareholder, director or associated person acted in bad faith.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Code of Conduct and organizational rules also cover a broad range of matters, including the handling of conflicts of interest.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Principles of the Compensation of the Board of Directors and the Executive Management</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Swiss law, our shareholders must annually approve the compensation of the board of directors and the persons whom the board of directors has, fully or partially, entrusted with our management, which we refer to as our &#8220;executive management&#8221;. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors is responsible for the annual preparation of a written compensation report in accordance with Swiss Law and the Ordinance against Excessive Compensation in Stock Exchange Listed Companies, or the Ordinance.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our statutory auditor conducts an audit of the compensation report as required by articles 14-16 of the Ordinance in accordance with Swiss law and Swiss auditing standards. The compensation report must disclose all compensation, loans and other forms of indebtedness granted by us, directly or indirectly, to current or former members of the board of directors and executive management to the extent related to their former role or not on customary market terms.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosure concerning compensation, loans and other forms of indebtedness must include&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the aggregate amount for the board of directors as well as the particular amount for each member of the board of directors, specifying the name and function of each respective person&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the aggregate amount for the executive management as well as the particular amount for the member of the executive management with the highest compensation, specifying the name and function of such member.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">187</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain forms of compensation are prohibited for members of our board of directors and executive management, such as&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">severance payments provided for either contractually or in the articles of association (compensation due during the notice period before termination of a contractual relationship does not qualify as severance payment)&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance compensation&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incentive fees for the acquisition or transfer of corporations or parts thereof by us or by companies being, directly or indirectly, controlled by the us&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loans, other forms of indebtedness, pension benefits not based on occupational pension schemes and performance-based compensation not provided for in the articles of association&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">equity securities and conversion and option rights awards not provided for in the articles of association.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation to members of the board of directors and executive management for activities in entities that are, directly or indirectly, controlled by us is prohibited if the compensation (1) would have been prohibited if it was paid directly by us, (2) is not provided for in our articles of association and (3) has not been approved by the general meeting of shareholders.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders annually vote on the proposals of the board of directors with respect to&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the maximum aggregate amount of compensation of the board of directors until the next annual general meeting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the maximum aggregate amount of compensation of the executive management for the following financial year.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors may submit for approval at the general meeting of shareholders deviating or additional proposals relating to the same or different periods.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the general meeting of shareholders does not approve a compensation proposal made by the board of directors, the board of directors must convene an extraordinary general meeting and submit a new compensation proposal to such meeting.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to fixed compensation, members of the executive management and, under certain circumstances, the board of directors may be paid variable compensation, depending on the achievement of certain performance criteria or for retention purposes.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance criteria may include corporate targets and targets in relation to the market, other companies or comparable benchmarks and individual targets, taking into account the position and level of responsibility of the recipient of the variable compensation. The board of directors or, where delegated to it, the compensation committee shall determine the relative weight of the performance criteria and the respective target values.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation may be paid or granted in the form of cash, shares, financial instruments, or in the form of other types of benefits. The board of directors or, where delegated to it, the compensation committee shall determine grant, vesting, exercise and forfeiture conditions.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Borrowing Powers</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither Swiss law nor our articles of association restrict in any way our power to borrow and raise funds. The decision to borrow funds is made by or under the direction of our board of directors, and no approval by the shareholders is required in relation to any such borrowing.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchases of Shares and Purchases of Own Shares</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CO limits our right to purchase and hold our own shares. We and our subsidiaries may purchase shares only if and to the extent that (1) we have freely distributable reserves in the amount of the purchase price&#59; and (2) the aggregate nominal value of all shares held by us does not exceed 10% of our share capital. Pursuant to Swiss law, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where shares are acquired in connection with a transfer restriction set out in the articles of association, the foregoing upper limit is 20%. We currently do not have any transfer restriction in our articles of association. If we own shares that exceed the threshold of 10% of our share capital, the excess must be sold or cancelled by means of a capital reduction within two years.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares held by us or our subsidiaries are not entitled to vote at the general meeting of shareholders but are entitled to the economic benefits applicable to the shares generally, including dividends and pre-emptive rights in the case of share capital increases.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, selective share repurchases are only permitted under certain circumstances. Within these limitations, as is customary for Swiss corporations, we may purchase and sell our own shares from time to time in order to meet our obligations under our equity plans, to meet imbalances of supply and demand, to provide liquidity and to even out variances in the market price of shares.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notification and Disclosure of Substantial Share Interests</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosure obligations generally applicable to shareholders of Swiss corporations under the Federal Act on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading of 2015, or the Financial Market Infrastructure Act, are applicable to us. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Financial Market Infrastructure Act, persons who directly, indirectly or in concert with other parties acquire or dispose of common shares or are granted the power to exercise voting rights attached to common shares at their own discretion, or delegated voting rights, or acquire or dispose of purchase or sale rights relating to common shares, and thereby reach, exceed or fall below a threshold of 3, 5, 10, 15, 20, 25, 33 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8260;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 50 or 66 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8260;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percent of our voting rights (whether exercisable or not) must report such acquisition or disposal to us and the SIX Swiss Exchange in writing within four trading days. Within two trading days of the receipt of such notification, we must publish such information through SIX Swiss Exchange's electronic reporting and publishing platform. For purposes of calculating whether a threshold has been reached or crossed, shares, delegated voting rights and acquisition rights or obligations, or Acquisition Positions, on the one hand and sale rights or obligations, or Disposal Positions, on the other hand may not be netted. Rather the Acquisition Positions and the Disposal Positions need to be accounted for separately and may each trigger disclosure obligations if the respective positions reach one of the thresholds. In addition, actual share ownership and delegated voting rights must be reported separately from other Purchase Positions if they reach one of the thresholds.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to article 663c of the CO, Swiss corporations whose shares are listed on a stock exchange must disclose their significant shareholders and their shareholdings in the notes to their balance sheet, where this information is known or ought to be known. Significant shareholders are defined as shareholders and groups of shareholders acting in concert who hold more than 5% of all voting rights.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Mandatory Bid Rules</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the applicable provisions of the Financial Market Infrastructure Act, any person that acquires shares of a listed Swiss company, whether directly or indirectly or acting in concert with third parties, which shares, when taken together with any other shares of such company held by such person, exceed the threshold of 33 1&#47;3% of the voting rights (whether exercisable or not) of such company, must make a takeover bid to acquire all the other listed shares of such company. A company&#8217;s articles of association may either eliminate this provision of the Financial Market Infrastructure Act or may raise the relevant threshold to 49%, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">opting-out</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">opting-up,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively. Our articles of association do not contain any opting-out or opting-up provision. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A waiver of the mandatory rules may be granted by the Swiss Takeover Board or FINMA under certain circumstances. If no waiver is granted, the mandatory takeover bid must be made pursuant to the procedural rules set forth in the Financial Market Infrastructure Act and the implementing ordinances thereunder. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no obligation to make a takeover bid under the Financial Market Infrastructure Act if the voting rights in question are acquired as a result of a gift, succession or partition of an estate, a transfer based upon matrimonial property law or execution proceedings.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation of Liability and Indemnification </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent and Registrar </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of this offering, the transfer agent and registrar for the ADSs will be Citibank, N.A. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to list the ADSs on the Nasdaq Global Market under the symbol &#8220;MOLN.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_97"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">LIMITATIONS AFFECTING SHAREHOLDERS OF A SWISS COMPANY</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer of Shares and Transfer Restrictions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">So long as shares are intermediated securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bucheffekten</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the meaning of the Swiss Federal Act on Intermediated Securities, or FISA) based on uncertificated securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wertrechte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) entered into the main register of a custodian and credited to one or more securities deposit account (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effektenkonto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), (i) any transfer of shares is effected by a corresponding entry in the securities deposit account of a bank or a depository institution, (ii) no shares can be transferred by way of assignment, and (iii) a security interest in any shares cannot be granted by way of assignment. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its share register through areg.ch ag, an external service provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and enters the full name, address and nationality (in the case of legal entities, the company name and registered office) of the shareholders (including nominees) and usufructuaries therein. A person entered into the share register must notify the share registrar of any change in address. Until such notification occurs, all written communication from the Company to persons entered in the share register is deemed to have been validly made if sent to the relevant address recorded in the share register. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person who acquires shares may submit an application to the Company requesting it to enter such person into the share register as a shareholder with voting rights, provided such person expressly declares to the Company that it has acquired and holds such shares in its own name and for its own account. Any such person that does not expressly state in his or her application to the Company that the relevant shares were acquired for his or her own account (any such person, a nominee) may be entered in the share register as a shareholder with voting rights for the relevant shares, provided that nominee has entered into an agreement with the Company regarding its position and is subject to a recognized banking or finance supervision. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors may, after having heard the concerned shareholder of record or nominee, cancel entries in the share register that were based on inaccurate or misleading information, or if such information becomes inaccurate or misleading, with retroactive effect to the date of the entry. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any acquirer of shares who is not registered in the share register as a shareholder with voting rights may not vote at or participate in any general meetings of shareholders of the Company, but will still be entitled to dividends and other rights with financial value with respect to such shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ownership of ADSs or Shares by Non-Swiss Residents </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the limitations on voting rights described above applicable to shareholders generally and the sanctions referred to below, there is no limitation under Swiss law or our articles of association on the right of non-Swiss residents or nationals to own ADSs or common shares or to exercise voting rights attached to the common shares underlying the ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Foreign Investment and Exchange Control Regulations in Switzerland</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than in connection with government sanctions imposed on certain persons from, in or related to the Republic of Iraq, Iran, Central African Republic, Yemen, Lebanon, Libya, Sudan, the Republic of South Sudan, the Republic of Mali, Burundi, the Democratic Republic of Congo, Myanmar (Burma), Somalia, Syria, Guinea, Guinea-Bissau, Zimbabwe, Belarus, the Democratic People's Republic of Korea (North Korea), Venezuela, Nicaragua, persons and organizations with a connection to Osama bin Laden, the &#34;Al-Qaeda&#34; group or the Taliban and certain persons in connection with the assassination of Rafik Hariri as well as measures to prevent the circumvention of international sanctions in connection with the situation in Ukraine, there are currently no governmental laws, decrees or regulations in Switzerland that restrict the export or import of capital, including, but not limited to, Swiss foreign exchange controls on the payment of dividends, interest or liquidation proceeds, if any, to non-resident holders of shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pre-emptive Rights and Advance Subscription Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Swiss law, any share issue, whether for cash or non-cash consideration, is subject to the prior approval of the shareholders at a general meeting of shareholders. Shareholders have certain pre-emptive rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Bezugsrechte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) to subscribe for new issues of shares and advance subscription rights (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Vorwegzeichnungsrechte</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) to subscribe convertible or warrant-bearing bonds or other financial market instruments in proportion to the nominal amount of shares held. A resolution adopted at a general meeting of shareholders by a majority of at least two-thirds of the votes and the absolute majority of the nominal share capital each as represented at such a meeting, may limit or withdraw pre-emptive rights or advance subscription rights in certain circumstances. Under our articles of association, the board of directors is authorized to limit or withdraw pre-emptive rights and advance subscription rights based on the authorized share capital and the conditional share capital. See &#8220;Description of Share Capital and Articles of Association&#8212;Certain Important Provisions of our Articles of Association, Organizational Rules and Swiss Law&#8212;Our Authorized Share Capital&#8221; and &#8220;Description of Share Capital and Articles of Association&#8212;Certain Important Provisions of our Articles of Association, Organizational Regulations and Swiss Law&#8212;Our Conditional Share Capital.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">192</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_100"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">COMPARISON OF SHAREHOLDER RIGHTS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a corporation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), organized under the laws of Switzerland in accordance with articles 620 et seqq. CO. The laws applicable to a Swiss </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> differ from laws applicable to U.S. corporations and their shareholders. The following discussion summarizes material differences between the rights of holders of our common shares and the rights of holders of the common shares of a typical corporation incorporated under the laws of the state of Delaware, which result from differences in governing documents and the laws of Switzerland and Delaware. For a more complete discussion, please refer to the Delaware General Corporation Law, or the DGCL, Swiss law, and our governing corporate statutes. </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Switzerland</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Delaware</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Directors</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Swiss law, the board of directors must consist of at least one member, unless the articles of association set out a specific number of directors. Our articles of association provide that our board of directors shall consist of a minimum of three members and a maximum of eleven members.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the bylaws, unless the certificate of incorporation fixes the number of directors, in which case a change in the number of directors shall be made only by amendment of the certificate of incorporation.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director Qualifications</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any natural person can be elected as a member of the board of directors even without being a shareholder of the corporation. As a minimum standard a director has to be in the position to fulfill his or her fiduciary duties, the duty of care and the duty of loyalty. It lies within the competence of the board of directors to determine a set of qualifications when proposing potential candidates to the general meeting of shareholders for election, or the articles of association may set out guidelines. While our articles of association generally do not set out such guidelines, our organizational regulations and committee charters stipulate certain requirements as to independence and, with respect to the audit and finance committee, financial literacy.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Further, the corporation must be able to be represented by one person who is resident in Switzerland with sole signature authority or two persons who are resident in Switzerland with joint signature authority by two. This person or these persons may be either a member of the board of directors or an executive officer. They must have access to the share register and the register of beneficial owners notified to the company.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, a corporation may prescribe qualifications for directors under its certificate of incorporation or bylaws.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard of Conduct for Directors</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A director of a Swiss corporation has a fiduciary duty to the corporation only. This duty has two components&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the duty of care&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the duty of loyalty.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The duty of care requires that a director acts in good faith, with the care that an ordinary prudent director would exercise under similar circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The duty of loyalty requires that a director acts in a manner he or she reasonably believes to be in the best interest of the corporation. He or she must not use his or her corporate position for personal gain or advantage. This duty prohibits in principle self-dealing by a director and mandates that the best interest of the corporation take precedence over a director&#8217;s interest.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors must afford the shareholders equal treatment in equal circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The burden of proof for a violation of these duties is with the corporation or with the shareholder (or creditor) bringing a suit against the director.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Swiss Federal Supreme Court established the doctrine to restrict its review of a business decision if the decision has been taken upon proper preparation, on an informed basis and without conflicts of interest.</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The DGCL does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary duties of directors is generally determined by the courts of the State of Delaware. In general, directors have a duty to act without self-interest, on a well-informed basis and in a manner they reasonably believe to be in the best interest of the stockholders.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification of Directors and Executive Committee and Limitation of Liability</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Swiss law, a corporation cannot limit the personal liability of a director or another person entrusted with its management. However, the general meeting of shareholders may grant discharge to the directors and the persons entrusted with its management from liability arising from actions taken during the past financial year. Such discharge is effective only, however, for disclosed facts and only against the corporation and those shareholders who approved the discharge or who have since acquired shares in full knowledge of the discharge.<br><br>Under Swiss law, subject to certain limitations, a corporation may indemnify and hold harmless directors and other persons entrusted with its management out of the assets of the corporation from and against actions, costs, charges, losses, damages and expenses which they or any of them may incur or sustain by or by reason of any act done, concurred in or omitted, in connection with the execution of their statutory duties, provided that such indemnity (if any) shall not extend to any matter in which any of said persons is found to have committed an intentional or grossly negligent breach of his or her duties.<br><br>Subject to the limitations described above, the articles of association of a Swiss corporation may therefore provide that the corporation shall indemnify and hold harmless to the extent permitted by law the directors and members of the executive committee out of assets of the corporation against threatened, pending or completed actions. Within the same limitations, articles of association of a Swiss corporation may also provide that the directors shall be entitled to the reimbursement of all expenses incurred in the interests of the corporation. Our articles of association contain such a provision.<br><br>Further, a corporation may enter into and pay for directors&#8217; and officers&#8217; liability insurance which may cover negligent acts as well.<br></font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, a corporation&#8217;s certificate of incorporation may include a provision eliminating or limiting the personal liability of a director to the corporation or its shareholders for monetary damages arising from a breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director for&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any breach of the director&#8217;s duty of loyalty to the corporation or its shareholders&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">intentional or negligent payment of unlawful dividends or unlawful share purchases or redemptions&#59; or</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any transaction from which the director derives an improper personal benefit.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Delaware corporation may indemnify any person who was or is a party or is threatened to be made a party to any proceeding, other than an action by or on behalf of the corporation, because the person is or was a director or officer, against liability incurred in connection with the proceeding if the director or officer acted in good faith and in a manner reasonably believed to be in, or not opposed to, the best interests of the corporation&#59; and the director or officer, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless ordered by a court, any foregoing indemnification is subject to a determination that the director or officer has met the applicable standard of conduct&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by a majority vote of the directors who are not parties to the proceeding, even though less than a quorum&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by a committee of directors designated by a majority vote of the eligible directors, even though less than a quorum&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by independent legal counsel in a written opinion if there are no eligible directors, or if the eligible directors so direct&#59; or</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">by the shareholders.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Moreover, a Delaware corporation may not indemnify a director or officer in connection with any proceeding in which the director or officer has been adjudged to be liable to the corporation unless and only to the extent that the court determines that, despite the adjudication of liability but in view of all the circumstances of the case, the director or officer is fairly and reasonably entitled to indemnity for those expenses which the court deems proper.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual Vote on Board Renewal</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The general meeting of shareholders elects annually and individually the members of the board of directors, the chairperson of the board of directors and the members of the compensation committee for a term of office until completion of the next annual general meeting of shareholders. Re-election is possible.</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One-year terms are mandatory under Swiss law for listed companies. Classified boards are therefore not permitted.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cumulative voting is not permitted under Swiss law. Our directors, the chairperson of the board of directors and the members of the compensation committee are elected by the affirmative vote of the absolute majority of the votes represented at the general meeting of shareholders.</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless directors are elected by written consent in lieu of an annual meeting, directors are elected in an annual meeting of shareholders on a date and at a time designated by or in the manner provided in the bylaws. Re-election is possible.</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Classified boards are permitted.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation provides for it.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Removal of Directors</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The general meeting of shareholders may remove, with or without cause, any director at any time with a resolution passed by an absolute majority of the votes represented at a general meeting of shareholders where a proposal for such removal was properly set on the agenda. The articles of association may require the approval by a qualified majority of the shares represented at a meeting for the removal of a director.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the DGCL, directors may be removed from office, with or without cause, by a majority stockholder vote, though in the case of a corporation whose board is classified, unless otherwise provided in the certificate of incorporation, stockholders may effect such removal only for cause.</font></div></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vacancies on the Board of Directors</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to fill a vacancy on the board of directors, a new member of the board of directors must be elected by a general meeting of shareholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event the office of the chairperson of the board of directors is vacant, the board of directors shall appoint a new chairperson from among its members for the remaining term of office. If there are vacancies on the compensation committee, the board of directors may appoint substitute members from among its members for the remaining term of office. The articles of association may set forth other rules to fill vacancies on the compensation committee. Our articles of association do not stipulate such other rules.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the DGCL, unless otherwise provided in the certificate of incorporation or bylaws, a vacancy or a newly created directorship may be filled by a majority of the directors then in office, although less than a quorum, or by the sole remaining director. Any newly elected director usually holds office for the remainder of the full term expiring at the annual meeting of shareholders at which the term of the class of directors to which the newly elected director has been elected expires.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">196</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual General Meeting or Special Meetings</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The annual general meeting of shareholders must take place annually within six months after the close of the financial year. Amongst other competences, the general meeting of shareholders individually elects the members of the board of directors, the chairperson of the board of directors and the members of the compensation committee. The notice of convening the meeting must include the place and date of the general meeting, the agenda items, the proposals by the board of directors and shareholders (if any), and necessary directions and instructions by the board of the directors.<br><br>Extraordinary general meetings of shareholders shall be called as often as necessary by the board of directors or, if necessary, by the statutory auditors as well as in all other cases required by law. Unless the articles of association provide for a lower threshold, one or more shareholders representing at least 10% of the share capital may request in writing that the board of directors call an extraordinary general meeting of shareholders. The request must contain an agenda and the suggested proposals.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be provided by the certificate of incorporation or by the bylaws, or by the board of directors if neither the certificate of incorporation or bylaws so provide.<br><br>Under the DGCL, unless directors are elected by written consent in lieu of an annual meeting as permitted by the DGCL, the annual meeting of stockholders shall be held for the election of directors on a date and at a time as designated by or in the manner provided in the bylaws.<br><br>Under the DGCL, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate of incorporation or by the bylaws.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Proposals</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At any general meeting of shareholders any shareholder may put proposals to the meeting if the proposal is part of an agenda item. Generally, no resolution may be passed on proposals relating to agenda items that were not duly notified. Unless the articles of association provide for a lower threshold or for additional shareholders&#8217; rights (which is not the case under our articles of association)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">one or several shareholders representing 10% of the share capital may ask in writing that a general meeting of shareholders be called for specific agenda items and specific proposals&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">one or several shareholders representing 10% of the share capital or CHF 1 million of nominal share capital, whichever is lower, may ask in writing that an agenda item including a specific proposal be put on the agenda for a scheduled general meeting of shareholders, provided such request is made with appropriate notice. Our articles of association provide that such request must be made at least 45 calendar days prior to a general meeting of shareholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, any shareholder is entitled, at a general meeting of shareholders and without advance notice, to (i) request information from the board of directors on the affairs of the company (note, however, that the right to obtain such information is limited), (ii) request information from the statutory auditors on the methods and results of their audit, (iii) propose that an extraordinary general meeting of shareholders be called or (iv) propose that a special investigation be carried out.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DGCL, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate of incorporation or by the bylaws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A stockholder of a Delaware corporation has the right to put any proposal before the annual meeting of stockholders, provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but stockholders may be precluded from calling special meetings.</font></div></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice of General Meetings</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Swiss law and our articles of association, notice of the general meeting of shareholders has to be given at least 20 calendar days before the date for which the meeting is scheduled in the form prescribed by the articles of association. The agenda must specify the place, date, hour, agenda items, and the proposals of the board of directors and the shareholders who have requested that a general meeting be called or an item be placed on the agenda (if any).</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Delaware law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders must be given to each stockholder entitled to vote at the meeting not less than 10 nor more than 60 days before the date of the meeting and shall specify the place, date, hour and purpose or purposes of the meeting.</font></div></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proxy</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Swiss law requires that the independent proxy may be present at a general meeting of shareholders. Registered shareholders may give proxy and voting instructions to the independent proxy in writing or electronically. Pursuant to our articles of association, registered shareholders may also give proxy to a representative of their choice.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, each shareholder entitled to vote at a meeting of shareholders or to express consent or dissent to corporate action in writing without a meeting may authorize another person or persons to act for such shareholders by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Action by Written Consent</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders of a Swiss corporation may only exercise their voting rights in a general meeting of shareholders and may not act by written consents.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shareholders of record may, however, vote at the general meeting of shareholders through proxy and related instructions (&#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Proxy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;).</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL a corporation&#8217;s certificate of incorporation (1) may permit shareholders to act by written consent if such action is signed by all shareholders, (2) may permit shareholders to act by written consent signed by shareholders having the minimum number of votes that would be necessary to take such action at a meeting or (3) may prohibit actions by written consent. Unless otherwise provided in the certificate of incorporation, any action that is required by the DGCL to be, or that can be, taken at an annual or special meeting of the shareholders may be taken without a meeting, without prior notice and without a vote, if written consent to the action is signed by the holders of outstanding shares having not less than the minimum number of votes necessary to authorize or take the action at a meeting at which all shares entitled to vote thereon were present and voted.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-emptive Rights</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Swiss corporate law, shareholders have pre-emptive rights to subscribe for newly issued shares and advance subscription rights to subscribe for warrants, convertible bonds or similar debt&#47;finance instruments with option or conversion rights. Under certain circumstances, shareholders may limit or withdraw, or authorize the board of directors to limit or withdraw, pre-emptive rights or advance subscription rights. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">However, the shareholders&#8217; pre-emptive rights or advance subscription rights can only be limited or withdrawn for valid reasons. Preventing a particular shareholder to exercise influence over the company is generally believed not to be a valid reason to limit or withdraw shareholders&#8217; pre-emptive rights.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, no shareholder shall have any pre-emptive right to subscribe to an additional issue of shares or to any security convertible into such shares unless, and except to the extent that, such right is expressly granted to such shareholder in the corporation&#8217;s certificate of incorporation.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">198</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sources of Dividends</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend payments are subject to the approval of the general meeting of shareholders. The board of directors may propose to shareholders that a dividend be paid but cannot itself authorize the distribution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Payments out of share capital of a Swiss corporation (in other words, the aggregate nominal value of the corporation&#8217;s registered share capital) in the form of dividends are not allowed&#59; however, payments out of share capital may be made by way of a capital reduction. Dividends may be paid only from the profits brought forward from the previous financial years or if the corporation has distributable reserves, each as will be presented on the corporation&#8217;s audited stand-alone statutory balance sheet. The dividend may be determined only after the allocations to reserves required by Swiss law or the articles of association have been deducted and the corporation&#8217;s statutory auditors have confirmed that the dividend proposal complies with Swiss law and the corporation&#8217;s articles of association. </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, subject to any restrictions contained in the certificate of incorporation, the directors of a corporation may declare and pay dividends upon the shares of its capital stock either (1) out of its surplus or (2) if there is no surplus, out of its net profits for the fiscal year in which the dividend is declared and&#47;or the preceding fiscal year, except when the capital of the corporation is diminished by depreciation in the value of its property, or by losses, or otherwise, to an amount less than the aggregate amount of capital represented by the issued and outstanding shares of all classes having a preference on the distribution of assets. &#8220;Surplus&#8221; is defined in the DGCL as the excess of the net assets of the corporation over capital, as such capital may be adjusted by the board of directors.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Repurchase of Shares</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Swiss corporation (or its subsidiaries) may repurchase its own shares under the following conditions&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">it can only repurchase its own shares out of freely disposable equity capital in the required amount&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the combined value of all such shares cannot exceed 10% of the share capital. Where shares are acquired in connection with a transfer restriction set out in the articles of association, the foregoing upper limit is 20%&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the voting rights on the corporation&#8217;s own shares are suspended&#59; and</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amount of the purchase price for the shares repurchased is presented on its stand-alone statutory balance sheet as a negative item in its equity.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, a corporation may generally purchase or redeem shares of its stock&#59; provided, however, that no corporation shall purchase or redeem its own shares of capital stock if the capital of the corporation is impaired or such redemption or repurchase would impair the capital of the corporation, except that a corporation may purchase or redeem out of capital any of its own shares which are entitled upon any distribution of its assets to a preference over another class or series of its shares, or, if no shares entitled to such a preference are outstanding, any of its own shares, if such shares will be retired upon their acquisition and the capital of the corporation reduced in accordance with the DGCL.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Voting Rights and Transfer Restrictions</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each common share carries one vote at any general meeting of shareholders. A shareholder must be registered in the corporation&#8217;s share register as a shareholder with voting rights in order to exercise his, her or its voting rights.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The articles of association may restrict the registration of a shareholder in the corporation&#8217;s share register in order to ensure that no person or entity is registered as a shareholder with voting rights for more than a certain percentage, and that no person or entity directly or indirectly, formally, constructively or beneficially owns, or otherwise controls or directs voting rights (whether exercisable or not) with respect to a certain percentage of the share capital registered in the Commercial Register. Furthermore, a corporation may under certain circumstances refuse to enter an acquirer of shares in the share register as a shareholder with voting rights if such acquirer fails to declare to the corporation that the relevant shares were acquired for his, her or its own account. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Limitations Affecting Shareholders of a Swiss Company&#8212;Transfer of Shares and Transfer Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the articles of association may provide that no shareholder may exercise, directly or indirectly, voting rights with respect to own or represented shares in excess of a certain percentage of the share capital registered in the Commercial Register.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The articles of association of a Swiss corporation may, subject to certain limitations, provide for shares with preferred voting rights. Our current articles of association do not contain such a provision.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, unless otherwise provided in the certificate of incorporation, each shareholder is entitled to one vote for each share of capital stock held by such shareholder.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Vote on Certain Transactions</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, with certain exceptions, a merger or a demerger of the corporation pursuant to the Swiss Merger Act or a sale of all or substantially all of the assets of a corporation must be approved by two-thirds of the votes represented at the respective general meeting of shareholders as well as the absolute majority of the nominal value of shares represented at such meeting. The articles of association may increase the voting threshold (which is not the case under our articles of association). Swiss law also requires that if the merger agreement provides only for a compensation payment, at least 90% of all members in the transferring legal entity who are entitled to vote shall approve the merger agreement. However, there has been some uncertainty and dispute as to whether the 90% approval requirement relates to the total number of votes represented by all shares of the target company outstanding, or the total number of shareholders of the target company entitled to vote.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Swiss law also provides that a parent corporation, by resolution of its board of directors, may merge with any subsidiary of which it owns at least 90% of the shares without a shareholder vote by shareholders of such subsidiary if the shareholders of the subsidiary are offered the payment of the fair value in cash as an alternative to shares of the parent.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, certain fundamental changes such as amendments to the certificate of incorporation, a merger, consolidation, sale, lease, exchange or other disposition of all or substantially all of the property of a corporation not in the usual and regular course of the corporation&#8217;s business, or a dissolution of the corporation, are generally required to be approved by the holders of a majority of the outstanding shares entitled to vote on the matter, unless the certificate of incorporation requires a higher percentage.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">However, under the DGCL, mergers in which less than 20% of a corporation&#8217;s shares outstanding immediately prior to the effective date of the merger is issued generally do not require shareholder approval. In addition, mergers in which one corporation owns 90% or more of each class of shares of a second corporation may be completed without the vote of the second corporation&#8217;s board of directors or shareholders. In certain situations, the approval of a business combination may require approval by a certain number of the holders of a class or series of shares. In addition, Section 251(h) of the DGCL provides that shareholders of a constituent corporation need not vote to approve a merger if&#58; (i) the merger agreement permits or requires the merger to be effected under Section 251(h) and provides that the merger shall be effected as soon as practicable following the tender offer or exchange offer, (ii) a corporation consummates a tender or exchange offer for any and all of the outstanding shares of such constituent corporation that would otherwise be entitled to vote to approve the merger, (iii) following the consummation of the offer, the stock accepted for purchase or exchanges plus the stock owned by the consummating corporation equals at least the percentage of stock that would be required to adopt the agreement of merger under the DGCL, (iv) the corporation consummating the offer merges with or into such constituent corporation , and (v) each outstanding share of each class or series of stock of the constituent corporation that was the subject of and not irrevocably accepted for purchase or exchange in the offer is to be converted in the merger into, or the right to receive, the same consideration to be paid for the shares of such class or series of stock of the constituent corporation irrevocably purchased or exchanged in such offer.</font></div></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Vote on Board and Management Compensation</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Compensation Ordinance, the aggregate amount of compensation for the members of the board of directors and the executive committee must be approved by the general meeting of shareholders.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, the board of directors has the authority to fix the compensation of directors, unless otherwise restricted by the certificate of incorporation or bylaws.</font></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dissenters&#8217; Appraisal Rights</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For business combinations effected in the form of a statutory merger or demerger, the Swiss Merger Act provides that if the equity rights have not been adequately preserved or compensation payments in the transaction are not adequate, a shareholder may request the competent court to determine an adequate amount of compensation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shareholders who consider their equity rights not to have been adequately preserved or the compensation received to be inadequate are entitled to exercise appraisal rights in accordance with the Swiss Merger Act by filing a suit against the surviving corporation with the competent Swiss civil court at the registered office of the surviving corporation or of the transferring corporation. The suit must be filed within two months after the merger or demerger resolution has been published in the Swiss Official Gazette of Commerce. If such a suit is filed, the court must assess whether the equity rights have been adequately preserved or the compensation paid or to be paid to the shareholders of the transferring corporation is adequate and, should the court consider it to be inadequate, determine any additional adequate compensation. A decision issued by a competent court in this respect can be acted upon by any person who has the same legal status as the claimant. The filing of an appraisal suit will not prevent completion of the merger or demerger.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, any shareholder of a corporation who holds share of stock on the date of making a demand for appraisal of such shareholder&#8217;s shares under the DGCL, who continuously holds such shares through the effective date of a merger or consolidation, who has neither voted in favor of the merger or consolidation nor consented thereto shall be entitled to an appraisal by the Delaware Court of Chancery of the fair value of the shareholder&#8217;s shares of stock&#59; provided, however, that no appraisal rights are available for shares of any class or series that is listed on a national securities exchange or held of record by more than 2,000 shareholders, unless the agreement of merger or consolidation requires the holders to accept for their shares anything other than&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">shares of stock of the surviving corporation&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">shares of stock of another corporation that are either listed on a national securities exchange or held of record by more than 2,000 shareholders&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">cash in lieu of fractional shares of the stock described in the two preceding bullet points&#59; or</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#160;any combination of the above.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, appraisal rights shall be available for the shares of any class or series of stock of a constituent corporation if the holders of such corporation are required by the agreement of merger or consolidation to accept for such stock anything but&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">shares of stock of the surviving corporation or depository receipts in respect thereof&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">shares of stock of another corporation, or depository receipts in respect thereof, that are either listed on a national securities exchange or held of record by more than 2,000 shareholders&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">cash in lieu of fractional shares or fractional depository receipts described in the two preceding bullet points&#59; or</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any combination of the above.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, appraisal rights are not available to holders of shares of the surviving corporation in specified mergers that do not require the vote of the shareholders of the surviving corporation.</font></div></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">202</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Lawsuits</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, an individual shareholder may bring an action in the shareholder&#8217;s own name, for the benefit of the corporation, against the corporation&#8217;s directors, officers or liquidators to recover any damages the corporation has incurred as a result of an intentional or negligent breach of duties by such directors, officers or liquidators. Class actions and derivative actions as such are not available under Swiss law. Nevertheless, certain actions may, to a limited extent, have a similar effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Swiss law, the winning party is generally entitled to recover or partially recover attorney's fees incurred in connection with such action, provided, however, that the court has discretion to permit the shareholder whose claim has been dismissed to recover attorney's fees incurred to the extent he or she acted in good faith.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, a shareholder may initiate a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must state that the plaintiff was a shareholder at the time of the transaction of which the plaintiff complains or that the plaintiff&#8217;s shares thereafter devolved on the plaintiff by operation of law&#59; provided, however, that under Delaware case law, the plaintiff generally must be a shareholder not only at the time of the transaction which is the subject of the suit, but through the duration of the derivative suit. Delaware law also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff, unless such demand would be futile. An individual also may commence a class action suit on behalf of himself or herself and other similarly situated shareholders where the requirements for maintaining a class action have been met.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amendment of Governing Documents</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The articles of association of a Swiss corporation may generally be amended by the general meeting of shareholders with a resolution passed by an absolute majority of the votes represented at such meeting, unless otherwise provided in the articles of association or required by law. There are a number of resolutions, such as an amendment of the stated purpose of the corporation and the introduction of authorized and conditional capital, that pursuant to Swiss law require the approval by two-thirds of the votes and an absolute majority of the nominal value of the shares represented at the general meeting of shareholders. The articles of association may increase the voting thresholds.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subject to certain requirements, shareholders may submit a proposal to be voted on at a general meeting of shareholders to amend the articles of association</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, a corporation may amend its certificate of incorporation if&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">its board of directors has adopted a resolution setting forth the amendment proposed and declaring its advisability&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">if a majority of the outstanding stock entitled to vote on the amendment, and a majority of the outstanding stock of each class entitled to vote on the amendment as a class, has been voted in favor of the amendment.</font></div><div style="margin-bottom:1pt;padding-left:11.25pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the DGCL, the shareholders entitled to vote have the power to adopt, amend or repeal bylaws. A corporation may also confer, in its certificate of incorporation, such power upon the directors. The fact that such power has been so conferred upon the directors shall not divest the shareholders of the power nor limit their power to adopt, amend or repeal bylaws.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Creation and Issuance of New Shares</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The creation of new shares requires a resolution of the general meeting of shareholders. An authorized or conditional capital increase requires at least two-thirds of the votes represented at the general meeting of shareholders and an absolute majority of the nominal value of shares represented at such meeting. The board of directors may issue shares out of the authorized share capital, once created by shareholders&#8217; resolution, subject to the limitations set forth in the authorization, within a period of no longer than two years. Shares out of the conditional capital are created and issued through the exercise of options or of conversion rights related to debt&#47;finance instruments issued by the board of directors or such rights issued to employees.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All creation of shares require the board of directors to adopt a resolution or resolutions, pursuant to authority expressly vested in the board of directors by the provisions of the company&#8217;s certificate of incorporation.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">203</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inspection of Books and Records</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, a shareholder may request to inspect a corporation&#8217;s minutes of general meetings of shareholders. A corporation&#8217;s annual report, compensation report and the auditors&#8217; reports must be made available for inspection by shareholders at the corporation&#8217;s registered office at least 20 calendar days prior to each annual general meeting of shareholders. Shareholders registered in the share register of a corporation must be notified of the availability of these documents in writing. Any shareholder may request a copy of these reports in advance of, or after, the relevant annual general meeting of shareholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, a shareholder of record is further entitled to inspect the corporation&#8217;s share register with regard to his, her or its own shares and otherwise to the extent necessary to exercise his, her or its shareholder rights. No other person has a right to inspect the share register.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The books and correspondence of a corporation may be inspected by a shareholder with the express authorization of the general meeting of shareholders, or by resolution of the board of directors, subject to the safeguarding of a corporation&#8217;s business secrets. At a general meeting of shareholders, any shareholder may request information from the board of directors concerning the corporation&#8217;s affairs. Shareholders may also ask the corporation&#8217;s statutory auditors questions regarding their audit of the corporation. The board of directors and the statutory auditors must answer shareholders&#8217; questions to the extent necessary for the exercise of shareholders&#8217; rights and subject to prevailing business secrets or other material interests of the corporation.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Stockholders of a Delaware corporation, upon written demand under oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose, and to obtain copies of list(s) of stockholders and other books and records of the corporation and its subsidiaries, if any, to the extent the books and records of such subsidiaries are available to the corporation.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Lawsuits</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, an individual shareholder may bring an action in the shareholder&#8217;s own name, for the benefit of the corporation, against the corporation&#8217;s directors, officers or liquidators to recover any damages the corporation has incurred as a result of an intentional or negligent breach of duties by such directors, officers or liquidators. Class actions and derivative actions as such are not available under Swiss law. Nevertheless, certain actions may, to a limited extent, have a similar effect.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Swiss law, the winning party is generally entitled to recover a limited amount of attorneys&#8217; fees incurred in connection with such action. The court has discretion to permit the shareholder who lost the lawsuit to recover attorneys&#8217; fees incurred to the extent that he, she or it acted in good faith.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the DGCL, a stockholder may initiate a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must state that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiff&#8217;s shares thereafter devolved on the plaintiff by operation of law&#59; provided, however, that under Delaware case law, the plaintiff generally must be a stockholder not only at the time of the transaction which is the subject of the suit, but through the duration of the derivative suit. Delaware law also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff, unless such demand would be futile. An individual also may commence a class action suit on behalf of himself or herself and other similarly situated stockholders where the requirements for maintaining a class action have been met.</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dissolution&#59; Winding-up</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, a corporation may be dissolved at any time by way of liquidation, based on a shareholders&#8217; resolution. Such resolution requires the approval by two-thirds of the votes represented as well as the absolute majority of the nominal value of the shares represented at the general meeting of shareholders passing a resolution on such dissolution and winding up. The articles of association may increase the voting thresholds required for such a resolution (which is not the case under our articles of association).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dissolution by law or court order is possible if, for example, a corporation becomes bankrupt.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Swiss law, any surplus arising out of a liquidation (after the settlement of all claims of all creditors) is distributed to shareholders in proportion to the paid up nominal value of shares held. The articles of association may provide for another distribution (which is not the case under our articles of association).</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless the board of directors of a Delaware corporation approves the proposal to dissolve, dissolution must be approved by shareholders holding 100.0% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_103"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">American Depositary Shares </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Citibank, N.A., or Citibank, has agreed to act as the depositary for the American Depositary Shares. Citibank&#8217;s depositary offices are located at 388 Greenwich Street, New York, New York 10013. American Depositary Shares are frequently referred to as ADSs and represent ownership interests in securities that are on deposit with the depositary. ADSs may be represented by certificates that are commonly known as American Depositary Receipts or ADRs. The depositary typically appoints a custodian to safekeep the securities on deposit. In this case, the custodian is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, located at &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have appointed Citibank as depositary pursuant to a deposit agreement. A copy of the deposit agreement is filed as an exhibit to the registration statement of which this prospectus forms a part. You may obtain a copy of the deposit agreement from the SEC&#8217;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549 and from the SEC&#8217;s website (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Please refer to Registration Number 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;when retrieving such copy.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are providing you with a summary description of the material terms of the ADSs and of your material rights as an owner of ADSs. Please remember that summaries by their nature lack the precision of the information summarized and that the rights and obligations of an owner of ADSs will be determined by reference to the terms of the deposit agreement and not by this summary. We urge you to review the deposit agreement in its entirety. The portions of this summary description that are italicized describe matters that may be relevant to the ownership of ADSs but that may not be contained in the deposit agreement. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each ADS represents the right to receive and to exercise the beneficial ownership interests in&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares that is on deposit with the depositary and&#47;or the custodian. An ADS also represents the right to receive, and to exercise the beneficial interests in, any other property received by the depositary or the custodian on behalf of the owner of the ADS but that has not been distributed to the owners of ADSs because of legal restrictions or practical considerations. We and the depositary may agree to change the ADS-to-common share ratio by amending the deposit agreement. This amendment may give rise to, or change, the depositary fees payable by ADS owners. The custodian, the depositary and their respective nominees will hold all deposited property for the benefit of the holders and beneficial owners of ADSs. The deposited property does not constitute the proprietary assets of the depositary, the custodian or their nominees. Beneficial ownership in the deposited property will under the terms of the deposit agreement be vested in the beneficial owners of the ADSs. The depositary, the custodian and their respective nominees will be the record holders of the deposited property represented by the ADSs for the benefit of the holders and beneficial owners of the corresponding ADSs. A beneficial owner of ADSs may or may not be the holder of ADSs.  Beneficial owners of ADSs will be able to receive, and to exercise beneficial ownership interests in, the deposited property only through the registered holders of the ADSs, by the registered holders of the ADSs (on behalf of the applicable ADS owners) only through the depositary, and by the depositary (on behalf of the owners of the corresponding ADSs) directly, or indirectly through the custodian or their respective nominees, in each case upon the terms of the deposit agreement. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you become an owner of ADSs, you will become a party to the deposit agreement and therefore will be bound to its terms and to the terms of any ADR that represents your ADSs. The deposit agreement and the ADR specify our rights and obligations as well as your rights and obligations as owner of ADSs and those of the depositary. As an ADS holder you appoint the depositary to act on your behalf in certain circumstances. The deposit agreement and the ADRs are governed by New York law. However, as an ADS holder, you will not be treated as one of our shareholders and you will not have shareholder rights. Swiss law, which may be different from the laws in the United States, governs shareholder rights and our obligations to the holders of common shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, applicable laws and regulations may require you to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. You are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary, the custodian, us nor any of their or our respective agents or affiliates shall be required to take any actions whatsoever on your behalf to satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations. For the requirement to disclose major shareholdings with SIX Swiss Exchange see &#34;--Notification and Disclosure of Substantial Share Interests.&#34;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manner in which you own the ADSs (e.g., in a brokerage account vs. as registered holder, or as holder of certificated vs. uncertificated ADSs) may affect your rights and obligations under the deposit agreement, and the manner in which, and extent to which, the depositary bank&#8217;s services are made available to you.  As an owner of ADSs, we will not treat you as one of our shareholders and you will not have direct shareholder rights. The depositary will hold on your behalf the shareholder rights attached to the common shares underlying your ADSs. As an owner of ADSs you will be able to exercise the shareholders rights for the common shares represented by your ADSs through the depositary only to the extent contemplated in the deposit agreement. To exercise any shareholder rights not contemplated in the deposit agreement you will, as an ADS owner, need to arrange for the cancellation of your ADSs and become a direct shareholder. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an owner of ADSs, you may hold your ADSs either by means of an ADR registered in your name, through a brokerage or safekeeping account, or through an account established by the depositary in your name reflecting the registration of uncertificated ADSs directly on the books of the depositary, commonly referred to as the direct registration system, or DRS. The direct registration system reflects the uncertificated (book-entry) registration of ownership of ADSs by the depositary. Under the direct registration system, ownership of ADSs is evidenced by periodic statements issued by the depositary to the holders of the ADSs. The direct registration system includes automated transfers between the depositary and The Depository Trust Company, or DTC, the central book-entry clearing and settlement system for equity securities in the United States. If you decide to hold your ADSs through your brokerage or safekeeping account, you must rely on the procedures of your broker or bank to assert your rights as ADS owner. Banks and brokers typically hold securities such as the ADSs through clearing and settlement systems such as DTC. The procedures of such clearing and settlement systems may limit your ability to exercise your rights as an owner of ADSs. Please consult with your broker or bank if you have any questions concerning these limitations and procedures. All ADSs held through DTC will be registered in the name of a nominee of DTC. This summary description assumes you have opted to own the ADSs directly by means of an ADS registered in your name and, as such, we will refer to you as the &#8220;holder.&#8221; When we refer to &#8220;you,&#8221; we assume the reader owns ADSs and will own ADSs at the relevant time. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration of the common shares in the name of the depositary or the custodian shall, to the maximum extent permitted by applicable law, vest in the depositary or the custodian the record ownership in the applicable common shares, with the beneficial ownership rights and interests in such common shares being at all times vested with the beneficial owners of the ADSs representing the common shares.  The depositary or the custodian shall at all times be entitled to exercise the beneficial ownership rights in all deposited property, in each case only on behalf of the holders and beneficial owners of the ADSs representing the deposited property. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends and Distributions </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a holder of ADSs, you generally have the right to receive the distributions we make on the securities deposited with the custodian. Your receipt of these distributions may be limited, however, by practical considerations and legal limitations. Holders of ADSs will receive such distributions under the terms of the deposit agreement in proportion to the number of ADSs held as of a specified record date, after deduction the applicable fees, taxes and expenses. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions of Cash </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we make a cash distribution for the securities on deposit with the custodian, we will deposit the funds with the custodian. Upon receipt of confirmation of the deposit of the requisite funds, the depositary will arrange for the funds received in a currency other than U.S. dollars to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders, subject to Swiss laws and regulations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are transferable to the United States. The depositary will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the custodian in respect of securities on deposit. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of cash will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. The depositary will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable holders and beneficial owners of ADSs until the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distribution can be effected or the funds that the depositary holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions of Shares </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we make a free distribution of common shares for the securities on deposit with the custodian, we will deposit the applicable number of common shares with the custodian. Upon receipt of confirmation of such deposit, the depositary will either distribute to holders new ADSs representing the common shares deposited or modify the ADS-to- common share ratio, in which case each ADS you hold will represent rights and interests in the additional common shares so deposited. Only whole new ADSs will be distributed. Fractional entitlements will be sold and the proceeds of such sale will be distributed as in the case of a cash distribution. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of new ADSs or the modification of the ADS-to- common share ratio upon a distribution of common shares will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes or governmental charges, the depositary may sell all or a portion of the new common shares so distributed. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No such distribution of new ADSs will be made if it would violate a law (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the U.S. securities laws) or if it is not operationally practicable. If the depositary does not distribute new ADSs as described above, it may sell the common shares received upon the terms described in the deposit agreement and will distribute the proceeds of the sale as in the case of a distribution of cash. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributions of Rights </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we intend to distribute rights to subscribe for additional common shares, we will give prior notice to the depositary and we will assist the depositary in determining whether it is lawful and reasonably practicable to distribute rights to subscribe for additional ADSs to holders. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will establish procedures to distribute rights to subscribe for additional ADSs to holders and to enable such holders to exercise such rights if it is lawful and reasonably practicable to make the rights available to holders of ADSs, and if we provide all of the documentation contemplated in the deposit agreement (such as opinions to address the lawfulness of the transaction). You may have to pay fees, expenses, taxes and other governmental charges to subscribe for the new ADSs upon the exercise of your rights. The depositary is not obligated to establish procedures to facilitate the distribution and exercise by holders of rights to subscribe for new common shares other than in the form of ADSs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> distribute the rights to you if&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we do not timely request that the rights be distributed to you or we request that the rights not be distributed to you&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to deliver satisfactory documents to the depositary&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it is not reasonably practicable to distribute the rights.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will sell the rights that are not exercised or not distributed if such sale is lawful and reasonably practicable. The proceeds of such sale will be distributed to holders as in the case of a cash distribution. If the depositary is unable to sell the rights, it will allow the rights to lapse. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Elective Distributions </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we intend to distribute a dividend payable at the election of shareholders either in cash or in additional shares, we will give prior notice thereof to the depositary and will indicate whether we wish the elective distribution to be made available to you. In such case, we will assist the depositary in determining whether such distribution is lawful and reasonably practicable. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will make the election available to you only if it is reasonably practicable and if we have provided all of the documentation contemplated in the deposit agreement. In such case, the depositary will establish procedures to enable you to elect to receive either cash or additional ADSs, in each case as described in the deposit agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">208</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the election is not made available to you, you will receive either cash or additional ADSs, depending on what a shareholder in Switzerland would receive upon failing to make an election, as more fully described in the deposit agreement. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Distributions </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we intend to distribute property other than cash, common shares or rights to subscribe for additional common shares, we will notify the depositary in advance and will indicate whether we wish such distribution to be made to you. If so, we will assist the depositary in determining whether such distribution to holders is lawful and reasonably practicable. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is reasonably practicable to distribute such property to you and if we provide to the depositary all of the documentation contemplated in the deposit agreement, the depositary will distribute the property to the holders in a manner it deems practicable. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution will be made net of fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes and governmental charges, the depositary may sell all or a portion of the property received. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> distribute the property to you and will sell the property if&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we do not request that the property be distributed to you or if we ask that the property not be distributed to you&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we do not deliver satisfactory documents to the depositary&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the depositary determines that all or a portion of the distribution to you is not reasonably practicable.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proceeds of such a sale will be distributed to holders as in the case of a cash distribution. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we decide to redeem any of the securities on deposit with the custodian, we will notify the depositary in advance. If it is practicable and if we provide all of the documentation contemplated in the deposit agreement, the depositary will provide notice of the redemption to the holders. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The custodian will be instructed to surrender the shares being redeemed against payment of the applicable redemption price. The depositary will convert the redemption funds received in a currency other than U.S. dollars into U.S. dollars upon the terms of the deposit agreement and will establish procedures to enable holders to receive the net proceeds from the redemption upon surrender of their ADSs to the depositary. You may have to pay fees, expenses, taxes and other governmental charges upon the redemption of your ADSs. If less than all ADSs are being redeemed, the ADSs to be retired will be selected by lot or on a pro rata basis, as the depositary may determine. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Changes Affecting Common Shares </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common shares held on deposit for your ADSs may change from time to time. For example, there may be a change in nominal or par value, a split-up, cancellation, consolidation or reclassification of such common shares or a recapitalization, reorganization, merger, consolidation or sale of assets. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any such change were to occur, your ADSs would, to the extent permitted by law and the deposit agreement, represent the right to receive the property received or exchanged in respect of the common shares held on deposit. The depositary may in such circumstances deliver new ADSs to you, amend the deposit agreement, the ADRs and the applicable Registration Statement(s) on Form F-6, call for the exchange of your existing ADSs for new ADSs and take any other actions that are appropriate to reflect as to the ADSs the change affecting the Shares. If the depositary may not lawfully distribute such property to you, the depositary may sell such property and distribute the net proceeds to you as in the case of a cash distribution. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">209</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance of ADSs upon Deposit of Common Shares </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, the common shares being offered pursuant to this prospectus will be deposited by us with the custodian. Upon receipt of confirmation of such deposit, the depositary will issue ADSs to the underwriters named in this prospectus. Upon receipt of confirmation of such deposit, the depositary will issue ADSs to the underwriters named in this prospectus. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing of this offer, the depositary may create ADSs on your behalf if you or your broker deposit common shares with the custodian. The depositary will deliver these ADSs to the person you indicate only after you pay any applicable issuance fees and any charges and taxes payable for the transfer of the common shares to the custodian. Your ability to deposit common shares and receive ADSs may be limited by U.S. and Swiss legal considerations applicable at the time of deposit. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of ADSs may be delayed until the depositary or the custodian receives confirmation that all required approvals have been given and that the common shares have been duly transferred to the custodian. The depositary will only issue ADSs in whole numbers. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When you make a deposit of common shares, you will be responsible for transferring good and valid title to the depositary. As such, you will be deemed to represent and warrant that&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The common shares are duly authorized, validly issued, fully paid, non-assessable and legally obtained.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">All pre-emptive (and similar) rights, if any, with respect to such common shares have been validly waived or exercised.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">You are duly authorized to deposit the common shares.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The common shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage or adverse claim, and are not, and the ADSs issuable upon such deposit will not be, &#8220;restricted securities&#8221; (as defined in the deposit agreement).</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The common shares presented for deposit have not been stripped of any rights or entitlements.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the representations or warranties are incorrect in any way, we and the depositary may, at your cost and expense, take any and all actions necessary to correct the consequences of the misrepresentations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer, Combination and Split Up of ADRs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an ADR holder, you will be entitled to transfer, combine or split up your ADRs and the ADSs evidenced thereby. For transfers of ADRs, you will have to surrender the ADRs to be transferred to the depositary and also must&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ensure that the surrendered ADR is properly endorsed or otherwise in proper form for transfer&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide such proof of identity and genuineness of signatures as the depositary deems appropriate&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide any transfer stamps required by the State of New York or the United States&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay all applicable fees, charges, expenses, taxes and other government charges payable by ADR holders pursuant to the terms of the deposit agreement, upon the transfer of ADRs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To have your ADRs either combined or split up, you must surrender the ADRs in question to the depositary with your request to have them combined or split up, and you must pay all applicable fees, charges and expenses payable by ADR holders, pursuant to the terms of the deposit agreement, upon a combination or split up of ADRs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may restrict transfers of ADSs where such transfer may result in the total number of shares represented by the ADSs owned by a single holder or beneficial owner to exceed limits imposed by applicable law or the Articles. We may instruct the depositary to take actions with respect to the ownership interests of any holder or beneficial owner in excess of such limits including the imposing of restrictions on transfers of ADSs, the removal or limitation of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting rights, or mandatory sale or disposition of ADSs held by such holder of beneficial owner in excess of such limitations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Withdrawal of Common Shares Upon Cancellation of ADSs </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a holder, you will be entitled to present your ADSs to the depositary for cancellation and then receive the corresponding number of underlying common shares at the custodian&#8217;s offices. Your ability to withdraw the common shares held in respect of the ADSs may be limited by U.S. and Swiss legal considerations applicable at the time of withdrawal. In order to withdraw the common shares represented by your ADSs, you will be required to pay to the depositary the fees for cancellation of ADSs and any charges and taxes payable upon the transfer of the common shares being withdrawn. You assume the risk for delivery of all funds and securities upon withdrawal. Once canceled, the ADSs will not have any rights under the deposit agreement. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you hold ADSs registered in your name, the depositary may ask you to provide proof of identity and genuineness of any signature and such other documents as the depositary may deem appropriate before it will cancel your ADSs. The withdrawal of the common shares represented by your ADSs may be delayed until the depositary receives satisfactory evidence of compliance with all applicable laws and regulations. Please keep in mind that the depositary will only accept ADSs for cancellation that represent a whole number of securities on deposit. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will have the right to withdraw the securities represented by your ADSs at any time except for&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">temporary delays that may arise because (i)&#160;the transfer books for the ADSs or common shares are closed, or (ii)&#160;common shares are immobilized on account of a shareholders&#8217; meeting or a payment of dividends&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obligations to pay fees, taxes and similar charges&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions imposed because of laws or regulations applicable to ADSs or the withdrawal of securities on deposit.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deposit agreement may not be modified to impair your right to withdraw the securities represented by your ADSs except to comply with mandatory provisions of law. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Voting Rights </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a holder, you generally have the right under the deposit agreement to instruct the depositary to exercise the voting rights for the common shares represented by your ADSs. The voting rights of holders of common shares are described in the sections of this prospectus titled &#8220;Description of Share Capital and Articles of Association&#8221; and &#8220;Limitations Affecting Shareholders of a Swiss Company.&#8221; </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our request, the depositary will distribute to you any notice of general meetings of shareholders or other solicitations of consents received from us and arrange to deliver our voting materials to you. Those materials will describe the matters to be voted on and explain how to instruct the depositary to exercise the voting rights of the securities represented by ADSs. For instructions to be valid, they must reach the depositary by a date set by the depositary.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will try, as far as practical, and subject to the laws of Switzerland and to the Articles, to vote or have its agents vote the common shares as instructed by ADS holders. If we requested the depositary to act at least 30 days prior to the meeting date and the depositary does not receive voting instructions by the specified date, it will not vote common shares represented by your ADSs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary (in person or by proxy) will only vote or attempt to vote as you instruct. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the ability of the depositary to carry out voting instructions may be limited by practical and legal limitations and the terms of the securities on deposit. We cannot assure you that you will receive voting materials in time to enable you to return voting instructions to the depositary in a timely manner. Shares for which no voting instructions have been received will not be voted (unless otherwise contemplated in the deposit agreement). In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions, provided that any such failure is in good faith. This means that you may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not be able to exercise your right to vote and there may be nothing you can do if your common shares are not voted ad you requested. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited shares, if we request the depositary to act, we will give the depositary notice of any such meeting and details concerning the matters to be voted upon no later than 20 days in advance of the meeting, which is in line with Swiss law and the provision in our articles of association. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fees and Charges </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an ADS holder, you will be required to pay the following service fees to the depositary under the terms of the deposit agreement&#58; </font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Service</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fees</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Issuance of ADSs (e.g., an issuance of ADS upon a deposit of common shares, upon a change in the ADS(s)-to- common share(s) ratio, or for any other reason), excluding ADS issuances as a result of distributions of common shares)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS issued</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited property, upon a change in the ADS(s)-to- common share(s) ratio, or for any other reason)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS canceled</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Distribution of cash dividends or other cash distributions (e.g., upon a sale of rights and other entitlements)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS held</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Distribution of ADSs pursuant to stock dividends, other free stock distributions or exercise of rights to purchase additional ADSs.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS held</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS held</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">ADS Services</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to U.S. $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS held on the applicable record date(s) established by the depositary</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an ADS holder you will also be responsible to pay certain fees and expenses incurred by the depositary and certain taxes and governmental charges such as&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fees for the transfer and registration of common shares charged by the registrar and transfer agent for the common shares in Switzerland (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, upon deposit and withdrawal of common shares)&#59; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses incurred for converting foreign currency into U.S. dollars&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses for cable, telex and fax transmissions and for delivery of securities&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">taxes and duties upon the transfer of securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when common shares are deposited or withdrawn from deposit)&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fees and expenses incurred in connection with the delivery or servicing of common shares on deposit.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADS fees and charges for (i) the issuance of ADSs, and (ii) the cancellation of ADSs are charged to the person for whom the ADSs are issued (in the case of ADS issuances) and to the person for whom ADSs are cancelled (in the case of ADS cancellations).  In the case of ADSs issued by the depositary bank into DTC, the ADS issuance and cancellation fees and charges may be deducted from distributions made through DTC, and may be charged to the DTC participant(s) receiving the ADSs being issued or the DTC participant(s) holding the ADSs being cancelled, as the case may be, on behalf of the beneficial owner(s) and will be charged by the DTC participant(s) to the account of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participants as in effect at the time.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADS fees and charges in respect of distributions and the ADS service fee are charged to the holders as of the applicable ADS record date.  In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed.  In the case of (i) distributions other than cash and (ii) the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges and such ADS fees and charges may be deducted from distributions made to holders of ADSs.  For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee may be deducted from distributions made through DTC, and may be charged to the DTC participants in accordance with the procedures and practices prescribed by DTC and the DTC participants in turn charge the amount of such ADS fees and charges to the beneficial owners for whom they hold ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of refusal to pay the depositary fees, the depositary may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary fees from any distribution to be made to the ADS holder. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain depositary fees and charges (such as the ADS services fee) may become payable shortly after the closing of the ADS offering.  Note that the fees and charges you may be required to pay may vary over time and may be changed by us and by the depositary. You will receive prior notice of such changes. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary may reimburse us for certain expenses incurred by us in respect of the ADR program, by making available a portion of the depositary fees charged in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary may agree from time to time.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendments and Termination </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may agree with the depositary to modify the deposit agreement at any time without your consent. We undertake to give holders 30 days&#8217; prior notice of any modifications that would materially prejudice any of their substantial rights under the deposit agreement. We will not consider to be materially prejudicial to your substantial rights any modifications or supplements that are reasonably necessary for the ADSs to be registered under the Securities Act or to be eligible for book-entry settlement, in each case without imposing or increasing the fees and charges you are required to pay. In addition, we may not be able to provide you with prior notice of any modifications or supplements that are required to accommodate compliance with applicable provisions of law. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be bound by the modifications to the deposit agreement if you continue to hold your ADSs after the modifications to the deposit agreement become effective. The deposit agreement cannot be amended to prevent you from withdrawing the common shares represented by your ADSs (except as permitted by law). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the right to direct the depositary to terminate the deposit agreement. Similarly, the depositary may in certain circumstances on its own initiative terminate the deposit agreement. In either case, the depositary must give notice to the holders at least 30 days before termination. Until termination, your rights under the deposit agreement will be unaffected. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After termination, the depositary will continue to collect distributions received (but will not distribute any such property until you request the cancellation of your ADSs) and may sell the securities held on deposit. After the sale, the depositary will hold the proceeds from such sale and any other funds then held for the holders of ADSs in a non-interest bearing account. At that point, the depositary will have no further obligations to holders other than to account for the funds then held for the holders of ADSs still outstanding (after deduction of applicable fees, taxes and expenses). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Books of Depositary </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters relating to the ADSs and the deposit agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will maintain in New York facilities to record and process the issuance, cancellation, combination, split-up and transfer of ADSs. These facilities may be closed from time to time, to the extent not prohibited by law. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Obligations and Liabilities </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deposit agreement limits our obligations and the depositary&#8217;s obligations to you. Please note the following&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary are obligated only to take the actions specifically stated in the deposit agreement without negligence or bad faith.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The depositary disclaims any liability for any failure to carry out voting instructions, for any manner in which a vote is cast or for the effect of any vote, provided it acts in good faith and in accordance with the terms of the deposit agreement.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The depositary disclaims any liability for any failure to determine the lawfulness or practicality of any action, for the content of any document forwarded to you on our behalf or for the accuracy of any translation of such a document, for the investment risks associated with investing in common shares, for the validity or worth of the common shares, for any tax consequences that result from the ownership of ADSs, for the credit-worthiness of any third party, for allowing any rights to lapse under the terms of the deposit agreement, for the timeliness of any of our notices or for our failure to give notice.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary will not be obligated to perform any act that is inconsistent with the terms of the deposit agreement.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary disclaim any liability if we or the depositary are prevented or forbidden from or subject to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement, by reason of any provision, present or future of any law or regulation, or by reason of present or future provision of any provision of our bylaws, or any provision of or governing the securities on deposit, or by reason of any act of God or war or other circumstances beyond our control.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary disclaim any liability by reason of any exercise of, or failure to exercise, any discretion provided for in the deposit agreement or in our bylaws or in any provisions of or governing the securities on deposit.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary further disclaim any liability for any action or inaction in reliance on the advice or information received from legal counsel, accountants, any person presenting common shares for deposit, any holder of ADSs or authorized representatives thereof, or any other person believed by either of us in good faith to be competent to give such advice or information.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary also disclaim liability for the inability by a holder to benefit from any distribution, offering, right or other benefit that is made available to holders of common shares but is not, under the terms of the deposit agreement, made available to you.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary may rely without any liability upon any written notice, request or other document believed to be genuine and to have been signed or presented by the proper parties.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and the depositary also disclaim liability for any consequential or punitive damages for any breach of the terms of the deposit agreement.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">No disclaimer of any Securities Act liability is intended by any provision of the deposit agreement. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Taxes </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the depositary and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">214</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental charges payable by holders. You will be liable for any deficiency if the sale proceeds do not cover the taxes that are due. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary may refuse to issue ADSs, to deliver, transfer, split and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The depositary and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any distributions on your behalf. However, you may be required to provide to the depositary and to the custodian proof of taxpayer status and residence and such other information as the depositary and the custodian may require to fulfill legal obligations. You are required to indemnify us, the depositary and the custodian for any claims with respect to taxes based on any tax benefit obtained for you. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Foreign Currency Conversion </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will arrange for the conversion of all foreign currency received into U.S. dollars if such conversion is practical, and it will distribute the U.S. dollars in accordance with the terms of the deposit agreement. You may have to pay fees and expenses incurred in converting foreign currency, such as fees and expenses incurred in complying with currency exchange controls and other governmental requirements. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the conversion of foreign currency is not practical or lawful, or if any required approvals are denied or not obtainable at a reasonable cost or within a reasonable period, the depositary may take the following actions in its discretion&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">convert the foreign currency to the extent practical and lawful and distribute the U.S. dollars to the holders for whom the conversion and distribution is lawful and practical&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">distribute the foreign currency to holders for whom the distribution is lawful and practical&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hold the foreign currency (without liability for interest) for the applicable holders.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Governing Law&#47;Waiver of Jury Trial</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deposit agreement and the ADRs will be interpreted in accordance with the laws of the State of New York.  The rights of holders of common shares (including common shares represented by ADSs) is governed by the laws of Switzerland. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS A PARTY TO THE DEPOSIT AGREEMENT, YOU IRREVOCABLY WAIVE YOUR RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF THE DEPOSIT AGREEMENT OR THE ADRs AGAINST US AND&#47;OR THE DEPOSITARY.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_106"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SHARES AND ADSs ELIGIBLE FOR FUTURE SALE </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, while our common shares have been traded on the SIX Swiss Exchange since November 2014, there has been no public market on a U.S. national securities exchange for the ADSs or our common shares in the United States. Future sales of ADSs in the public market after this offering, and the availability of ADSs for future sale, could adversely affect the market price of the ADSs or our common shares prevailing from time to time. As described below, a significant number of currently outstanding common shares will not be available for sale shortly after this offering due to contractual restrictions on transfers of common shares. Accordingly, sales of substantial amounts of the ADSs or the common shares, or the perception that these sales could occur, could adversely affect prevailing market prices for the ADSs or our common shares and could impair our future ability to raise equity capital.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the number of common shares outstanding on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021, upon completion of this offering,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;common shares (including common shares in the form of ADSs) will be outstanding, assuming no outstanding PSUs, RSUs or share options are exercised and assuming no exercise of the underwriters&#8217; option to purchase additional ADSs. All of the ADSs sold in this offering will be freely tradable without restrictions or further registration under the Securities Act, except for any ADSs sold to our &#8220;affiliates,&#8221; as that term is defined under Rule 144 under the Securities Act. The remaining common shares held by existing shareholders are &#8220;restricted securities,&#8221; as that term is defined in Rule 144 under the Securities Act. Restricted securities may be sold in the public market only if registered or if their resale qualifies for exemption from registration described below under Rule 144 or 701 promulgated under the Securities Act.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the lock-up agreements described below and the provisions of Rules 144 and 701 under the Securities Act and Swiss law, and assuming no exercise of the underwriters&#8217; option to purchase additional ADSs, these restricted securities will be available for sale in the U.S. public market as follows&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares, including common shares represented by ADSs, will be eligible for immediate sale on the date of this prospectus&#59; and </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares, including common shares represented by ADSs, will be eligible for sale upon the expiration of the lock-up agreements &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;days after the date of this prospectus, provided that shares held by our affiliates will remain subject to volume, manner of sale, and other resale limitations set forth in Rule 144, as described below. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Lock-up Agreements </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our directors and executive officers and certain of our shareholders have agreed that, without the prior written consent of J.P. Morgan Securities LLC, SVB Leerink LLC and Cowen and Company, LLC on behalf of the underwriters and our prior written consent in case of the lock-up agreements executed by our directors and officers and certain shareholders, we and they will not, subject to limited exceptions, during the period ending &#160;&#160;&#160;&#160; days after the date of this prospectus, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of, or otherwise dispose of or transfer any common shares or any securities convertible into or exercisable or exchangeable for common shares, request or demand that we file a registration statement related to our common shares or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common shares. See &#34;Underwriting&#34;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the expiration of the applicable lock-up periods, substantially all of the common shares and ADSs subject to such lock-up restrictions will become eligible for sale, subject to the limitations described above.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 144 </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, under Rule 144, beginning 90 days after the date of this prospectus, any person who is not our affiliate and has held their shares for at least six months, including the holding period of any prior owner other than one of our affiliates, may sell shares without restriction, subject to the availability of current public information about us. In </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">addition, under Rule 144, any person who is not our affiliate and has not been our affiliate at any time during the preceding three months and has held their shares for at least one year, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of shares immediately upon the closing of this offering without regard to whether current public information about us is available. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning 90 days after we become subject to the public company reporting requirements of the Exchange Act, a person who is our affiliate or who was our affiliate at any time during the preceding three months and who has beneficially owned restricted securities for at least six months, including the holding period of any prior owner other than one of our affiliates, is entitled to sell a number of shares within any three-month period that does not exceed the greater of&#58; (1) 1% of the number of our common shares outstanding, which will equal approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; common shares immediately after this offering&#59; and (2) the average weekly trading volume of our common shares in the form of ADSs on the Nasdaq Global Market during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales under Rule 144 by our affiliates are also subject to certain manner of sale provisions, notice requirements and to the availability of current public information about us. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 701 </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, under Rule 701 under the Securities Act, beginning 90 days after we become subject to the public company reporting requirements of the Exchange Act, any of our employees, directors or officers who acquired shares from us in connection with a written compensatory stock or option plan or other written agreement in compliance with Rule 701 is entitled to sell such shares in reliance on Rule 144 but without compliance with certain of the requirements contained in Rule 144. Accordingly, subject to any applicable lock-up agreements, beginning 90 days after we become subject to the public company reporting requirements of the Exchange Act, under Rule 701 persons who are not our affiliates may resell those shares without complying with the minimum holding period or public information requirements of Rule 144, and persons who are our affiliates may resell those shares without compliance with Rule 144&#8217;s minimum holding period requirements. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_109"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS FOR U.S. HOLDERS </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion describes the material U.S. federal income tax considerations relating to the ownership and disposition of our ADSs by U.S. Holders (as defined below). This discussion applies to U.S. Holders that purchase ADSs pursuant to the offering and hold such ADSs as capital assets within the meaning of Section&#160;1221 of the U.S. Internal Revenue Code of 1986, as amended, or the Code. This discussion is based on the Code, U.S. Treasury regulations promulgated thereunder, the income tax treaty between the United States and Switzerland, or the Treaty, and administrative and judicial interpretations thereof, all as in effect on the date hereof and all of which are subject to change, possibly with retroactive effect. This discussion does not address all of the U.S. federal income tax consequences that may be relevant to specific U.S. Holders in light of their particular circumstances or to U.S. Holders subject to special treatment under U.S. federal income tax law (such as certain financial institutions, insurance companies, broker&#8209;dealers and traders in securities or other persons that generally mark their securities to market for U.S. federal income tax purposes, tax&#8209;exempt entities, retirement plans, regulated investment companies, real estate investment trusts, certain former citizens or residents of the United States, persons who hold ADSs as part of a &#8220;straddle,&#8221; &#8220;conversion transaction,&#8221; &#8220;synthetic security&#8221; or integrated investment, persons who received their ADSs as compensatory payments, persons that have a &#8220;functional currency&#8221; other than the U.S. dollar, persons that own directly, indirectly or through attribution 10% or more of the voting power or value of our shares, corporations that accumulate earnings to avoid U.S. federal income tax, partnerships and other pass&#8209;through entities, and investors in such pass&#8209;through entities). This discussion does not address any U.S. state or local or non&#8209;U.S. tax consequences or any U.S. federal estate, gift or alternative minimum tax consequences.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this discussion, the term &#8220;U.S. Holder&#8221; means a beneficial owner of ADSs that is, for U.S. federal income tax purposes, (1)&#160;an individual who is a citizen or resident of the United States, (2)&#160;a corporation (or entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia, (3)&#160;an estate the income of which is subject to U.S. federal income tax regardless of its source or (4)&#160;a trust (x)&#160;with respect to which a court within the United States is able to exercise primary supervision over its administration and one or more United States persons have the authority to control all of its substantial decisions or (y)&#160;that has elected under applicable U.S. Treasury regulations to be treated as a domestic trust for U.S. federal income tax purposes.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds ADSs, the U.S. federal income tax consequences relating to an investment in the ADSs will depend in part upon the status and activities of such entity or arrangement and the particular partner. Any such entity or arrangement should consult its own tax advisor regarding the U.S. federal income tax consequences applicable to it and its partners of the purchase, ownership and disposition of ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below assumes that the representations contained in the deposit agreement are true and that the obligations in the deposit agreement and any related agreement will be complied with in accordance with their terms. A U.S. Holder of ADSs will generally be treated for U.S. federal income tax purposes as holding the common shares represented by the ADSs, and, accordingly, no gain or loss will be recognized upon an exchange of ADSs for common shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Passive Foreign Investment Company Consequences</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, a corporation organized outside the United States will be treated as a passive foreign investment company, or PFIC, for any taxable year in which either (1)&#160;at least 75% of its gross income is &#8220;passive income,&#8221; or (2)&#160;on average at least 50% of its assets, determined on a quarterly basis, are assets that produce passive income or are held for the production of passive income. Passive income for this purpose generally includes, among other things, dividends, interest, royalties, rents, and gains from the sale or exchange of property that gives rise to passive income. Assets that produce or are held for the production of passive income generally include cash, even if held as working capital or raised in a public offering, marketable securities, and other assets that may produce passive income. Generally, in determining whether a non&#8209;U.S. corporation is a PFIC, a proportionate share of the income </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our status as a PFIC will depend on the nature and composition of our income and the nature, composition and value of our assets. Based upon the value of our assets and the nature and composition of our income and assets, we believe we may have been classified as a PFIC for the taxable year ended December 31, 2020, although no assurances can be made in this regard. We have not yet determined whether we were a PFIC for the taxable year ended December 31, 2020. Because the determination of whether we are a PFIC for any taxable year is a factual determination made annually after the end of each taxable year, there can be no assurance that we will not be considered a PFIC in any taxable year. Accordingly, our U.S. counsel expresses no opinion with respect to our PFIC status for our taxable year ended December 31, 2020, and also expresses no opinion with regard to our expectations regarding our PFIC status in the future. Even if we determine that we are not a PFIC for a taxable year, there can be no assurance that the IRS will agree with our conclusion and will not successfully challenge our position.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC in any taxable year during which a U.S. Holder owns ADSs, the U.S. Holder would be liable for additional taxes and interest charges under the &#8220;PFIC excess distribution regime&#8221; upon (1)&#160;a distribution made during a taxable year that is greater than 125% of the average annual distributions made in the three preceding taxable years, or, if shorter, the U.S. Holder&#8217;s holding period for the ADSs, and (2)&#160;any gain recognized on a sale, exchange or other disposition, including a pledge, of the ADSs, whether or not we continue to be a PFIC. Under the PFIC excess distribution regime, the tax on such distribution or gain would be determined by allocating the distribution or gain ratably over the U.S. Holder&#8217;s holding period for ADSs. The amount allocated to the current taxable year (i.e.,&#160;the year in which the distribution occurs or the gain is recognized) and any year prior to the first taxable year in which we are a PFIC will be taxed as ordinary income earned in the current taxable year. The amount allocated to other taxable years will be taxed at the highest marginal rates in effect for individuals or corporations, as applicable, for ordinary income for each such taxable year, and an interest charge, generally applicable to underpayments of tax, will be added to the tax.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any year during which a U.S. Holder holds ADSs, we must generally continue to be treated as a PFIC by that holder for all succeeding years during which the U.S. Holder holds the ADSs, unless we cease to meet the requirements for PFIC status and the U.S. Holder makes a &#8220;deemed sale&#8221; election with respect to the ADSs. If this election is made, the U.S. Holder will be deemed to sell the ADSs it holds at their fair market value on the last day of the last taxable year in which we qualified as a PFIC. Any gain recognized from such deemed sale will be taxed under the PFIC excess distribution regime, and any loss will not be recognized. The U.S. Holder&#8217;s tax basis in its ADSs will be increased by the amount of gain recognized, and the U.S. Holder&#8217;s holding period for its ADSs will start on the day after the last day of the last taxable year in which we qualified as a PFIC. After the deemed sale election, the U.S. Holder&#8217;s ADSs will not be treated as shares of a PFIC unless we subsequently become a PFIC.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any taxable year during which a U.S. Holder holds ADSs and one of our non&#8209;U.S. corporate subsidiaries is also a PFIC (i.e.,&#160;a lower&#8209;tier PFIC), such U.S. Holder will be treated as owning a proportionate amount (by value) of the shares of the lower&#8209;tier PFIC and will be taxed under the PFIC excess distribution regime on distributions by the lower&#8209;tier PFIC and on gain from the disposition of shares of the lower&#8209;tier PFIC even though such U.S. Holder would not receive the proceeds of those distributions or dispositions. Each U.S. Holder is advised to consult its tax advisors regarding the application of the PFIC rules to our non&#8209;U.S. subsidiaries.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC, a U.S. Holder will not be subject to tax under the PFIC excess distribution regime on distributions or gain recognized on ADSs if such U.S. Holder makes a valid &#8220;mark&#8209;to&#8209;market&#8221; election for our ADSs. A mark&#8209;to&#8209;market election is available to a U.S. Holder only for &#8220;marketable stock.&#8221; Our ADSs will be marketable stock as long as they remain listed on the Nasdaq Global Market and are regularly traded, other than in de minimis quantities, on at least 15&#160;days during each calendar quarter. If a mark&#8209;to&#8209;market election is in effect, a U.S. Holder generally will take into account, as ordinary income for each taxable year of the U.S.&#160;Holder, any excess of the fair market value of ADSs held at the end of such taxable year over the U.S. Holder's adjusted tax basis in such ADSs. The U.S. Holder will also take into account, as an ordinary loss for each taxable year, any excess of its adjusted tax basis in such ADSs over their fair market value at the end of the taxable year, but only to the extent of the excess of amounts previously included in income over ordinary losses deducted as a result of the mark&#8209;to&#8209;market election. The U.S. Holder&#8217;s tax basis in ADSs will be adjusted to reflect any income or loss recognized as a result of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">219</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mark&#8209;to&#8209;market election. Any gain from a sale, exchange or other disposition of ADSs in any taxable year in which we are a PFIC will be treated as ordinary income and any loss from such sale, exchange or other disposition would be treated first as ordinary loss (to the extent of any net mark&#8209;to&#8209;market gains previously included in income) and thereafter as capital loss.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A mark&#8209;to&#8209;market election will not apply to ADSs for any taxable year during which we are not a PFIC but will remain in effect with respect to any subsequent taxable year in which we become a PFIC. Such election will not apply to any non&#8209;U.S. subsidiaries that we may organize or acquire in the future. Accordingly, a U.S. Holder may continue to be subject to tax under the PFIC excess distribution regime with respect to any lower&#8209;tier PFICs that we may organize or acquire in the future notwithstanding the U.S. Holder&#8217;s mark&#8209;to&#8209;market election for the ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax consequences that would apply if we are a PFIC would also be different from those described above if a U.S. Holder were able to make a valid qualified electing fund, or QEF, election. At this time, we do not expect to provide U.S. Holders with the information necessary for a U.S. Holder to make a QEF election. Accordingly, prospective investors should assume that a QEF election will not be available. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each U.S. person (as defined in the Code) that is an investor of a PFIC is generally required to file an annual information return on IRS Form&#160;8621 containing such information as the U.S. Treasury Department may require. The failure to file IRS Form&#160;8621 could result in the imposition of penalties and the extension of the statute of limitations with respect to U.S. federal income tax.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The U.S. federal income tax rules relating to PFICs are very complex. Prospective U.S. investors are strongly urged to consult their own tax advisors with respect to the impact of PFIC status on the purchase, ownership and disposition of ADSs, the consequences to them of an investment in a PFIC, any elections available with respect to the ADSs and the IRS information reporting obligations with respect to the purchase, ownership and disposition of ADSs of a PFIC.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distributions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in the section entitled &#8220;&#8212;&#160;Dividend Policy,&#8221; we do not anticipate declaring or paying dividends to holders of our common stock in the foreseeable future. However, if we make a distribution contrary to this expectation, subject to the discussion above under &#8220;&#8212; Passive Foreign Investment Company Consequences,&#8221; a U.S. Holder that receives a distribution with respect to ADSs generally will be required to include the gross amount of such distribution in gross income as a dividend when actually or constructively received to the extent of the U.S. Holder&#8217;s pro rata share of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). To the extent a distribution received by a U.S. Holder is not a dividend because it exceeds the U.S. Holder&#8217;s pro rata share of our current and accumulated earnings and profits, it will be treated first as a tax&#8209;free return of capital and reduce (but not below zero) the adjusted tax basis of the U.S. Holder&#8217;s ADSs. To the extent the distribution exceeds the adjusted tax basis of the U.S. Holder&#8217;s ADSs, the excess will be taxed as capital gain. Because we may not account for our earnings and profits in accordance with U.S. federal income tax principles, U.S. Holders should expect all distributions to them to be treated as dividends. The amount of any dividend income paid in a currency other than the U.S. dollar will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. If the dividend is converted into U.S. dollars on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of the dividend income. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributions on ADSs that are treated as dividends generally will constitute income from sources outside the United States for foreign tax credit purposes and generally will constitute passive category income. Subject to certain complex conditions and limitations and subject to the discussion above regarding concerns expressed by the U.S. Treasury, Swiss taxes withheld on any distributions on ADSs at a rate not exceeding the rate provided by the Treaty may be eligible for credit against a U.S. Holder&#8217;s federal income tax liability. The rules relating to the determination of the U.S. foreign tax credit are complex, and U.S. Holders should consult their tax advisors regarding the availability of a foreign tax credit in their particular circumstances and the possibility of claiming a deduction (in lieu of the foreign tax credit) for any foreign taxes paid or withheld.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">220</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid by a &#8220;qualified foreign corporation&#8221; are eligible for taxation to non&#8209;corporate U.S.&#160;Holders at a reduced capital gains rate rather than the marginal tax rates generally applicable to ordinary income provided that certain requirements are met, including holding period and the absence of certain risk reduction transaction requirements. Each U.S. Holder is advised to consult its tax advisors regarding the availability of the reduced tax rate on dividends with regard to its particular circumstances. Prospective investors should be aware, however, that dividends paid by a company that is a PFIC in the taxable year in which the distribution is paid or in the preceding taxable year are not eligible to be taxed at such reduced rate. Distributions on ADSs that are treated as dividends generally will not be eligible for the &#8220;dividends received&#8221; deduction generally allowed to corporate shareholders with respect to dividends received from U.S. corporations.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A non&#8209;United States corporation (other than a corporation that is classified as a PFIC for the taxable year in which the dividend is paid or the preceding taxable year) generally will be considered to be a qualified foreign corporation (a)&#160;if it is eligible for the benefits of a comprehensive tax treaty with the United States which the Secretary of Treasury of the United States determines is satisfactory for purposes of this provision and which includes an exchange of information provision, or (b)&#160;with respect to any dividend it pays on ADSs that are readily tradable on an established securities market in the United States. We believe that we qualify as a resident of Switzerland for purposes of, and are eligible for the benefits of the Treaty, although there can be no assurance in this regard. Further, the IRS has determined that the Treaty is satisfactory for purposes of the qualified dividend rules and that it includes an exchange of information provision. Our ADSs will generally be considered to be readily tradable on an established securities marked in the United States if they are listed on Nasdaq Global Select Market, as we intend our ADSs to be. U.S. Holders should consult their own tax advisors regarding the availability of the lower rate for dividends paid with respect to our ADSs.   </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sale, Exchange or Other Disposition of ADSs</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussion above under &#8220;&#8212; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Passive Foreign Investment Company Consequences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; a U.S. Holder generally will recognize capital gain or loss for U.S. federal income tax purposes upon the sale, exchange or other disposition of ADSs in an amount equal to the difference, if any, between the amount realized (i.e.,&#160;the amount of cash plus the fair market value of any property received) on the sale, exchange or other disposition and such U.S. Holder&#8217;s adjusted tax basis in the ADSs. Such capital gain or loss generally will be long&#8209;term capital gain taxable at a reduced rate for non&#8209;corporate U.S. Holders or long&#8209;term capital loss if, on the date of sale, exchange or other disposition, the ADSs were held by the U.S. Holder for more than one year. Any capital gain of a non&#8209;corporate U.S. Holder that is not long&#8209;term capital gain will be taxed at ordinary income rates. The deductibility of capital losses is subject to limitations. Any gain or loss recognized from the sale or other disposition of ADSs will generally be gain or loss from sources within the United States for U.S. foreign tax credit purposes.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Medicare Tax</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain U.S. Holders that are individuals, estates or trusts and whose income exceeds certain thresholds generally are subject to a 3.8% tax on all or a portion of their net investment income, which may include their gross dividend income and net gains from the disposition of ADSs. If you are a United States person that is an individual, estate or trust, you are encouraged to consult your tax advisors regarding the applicability of this Medicare tax to your income and gains in respect of your investment in ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Information Reporting and Backup Withholding</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Holders may be required to file certain U.S. information reporting returns with the IRS with respect to their investment in ADSs, including, among others, IRS Form&#160;8938 (Statement of Specified Foreign Financial Assets). As described above under &#8220;Passive Foreign Investment Company Consequences&#8221;, each U.S. Holder who is a shareholder of a PFIC must file an annual report containing certain information. U.S. Holders paying more than US$100,000 for ADSs may be required to file IRS Form&#160;926 (Return by a U.S. Transferor of Property to a Foreign Corporation) reporting this payment. Substantial penalties may be imposed upon a U.S. Holder that fails to comply with the required information reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends on and proceeds from the sale or other disposition of ADSs may be subject to U.S. backup withholding unless the U.S. Holder establishes a basis for exemption. Backup withholding may apply if the holder (1)&#160;fails to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">221</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide an accurate United States taxpayer identification number or otherwise establish a basis for exemption (usually on IRS Form&#160;W&#8209;9), or (2) another person exempt from information reporting and backup withholding. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder&#8217;s U.S. federal income tax liability if the required information is furnished by the U.S. Holder on a timely basis to the IRS.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Holders should consult their own tax advisors regarding the backup withholding and information reporting rules.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT OF AN INVESTMENT IN AN ADS IN LIGHT OF THE INVESTOR&#8217;S OWN CIRCUMSTANCES.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_112"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SWISS TAX IMPLICATIONS FOR U.S. HOLDERS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following summary does not purport to address all tax consequences of the offering, the acquisition, the ownership and sale or other disposition of ADSs and does not take into account the specific circumstances of any particular investor. This summary is based on the tax laws, regulations and regulatory practices of Switzerland as in the date hereof, which are subject to change (or subject to changes in interpretation), possibly with retroactive effect. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Current and prospective investors are advised to consult their own tax advisors in light of their particular circumstances as to the Swiss tax laws and regulatory practices that could be relevant for them in connection with the offering, the acquiring, owning and selling or otherwise disposing of ADSs and receiving dividends and similar cash or in-kind distributions on shares underlying the ADSs (including dividends or liquidation proceeds and stock dividends) or distributions on shares underlying the ADSs based upon a capital reduction (Nennwertr&#252;ckzahlung) or paid out of reserves from capital contributions (Reserve aus Kapitaleinlagen) and the consequences thereof under the tax laws and regulatory practices of Switzerland</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1. Swiss Tax Considerations </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.1 Swiss Federal, Cantonal and Communal Individual Income Tax and Corporate Income Tax</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Non-Resident Shareholders</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of ADSs representing our shares who are not resident in Switzerland for tax purposes, and who, during the relevant taxation year, have not engaged in a trade or business carried on through a permanent establishment or fixed place of business situated in Switzerland for tax purposes (all such shareholders are hereinafter referred to as the Non-Resident Shareholders), will not be subject to any Swiss federal, cantonal and communal income tax on dividends and similar cash or in-kind distributions on ADSs representing our shares (including dividends on liquidation proceeds and stock dividends) (hereinafter referred to as the Dividends), distributions based upon a capital reduction (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nennwertr&#252;ckzahlungen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or paid out of reserves from capital contributions (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) on shares underlying the ADSs, or capital gains realized on the sale or other disposition of ADSs (see, however, paragraph 1.3 &#34;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Swiss Federal Withholding Tax</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; for a summary of Swiss federal withholding tax on Dividends). </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Resident Private Shareholders</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss resident individuals who hold their ADSs as private assets (all such shareholders are hereinafter referred to as the Resident Private Shareholders) are required to include Dividends, but not distributions based upon a capital reduction (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nennwertr&#252;ckzahlungen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or paid out of reserves from capital contributions (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of the shares underlying the ADSs, in their personal income tax return and are subject to Swiss federal, cantonal and communal income tax on any net taxable income for the relevant taxation period, including the Dividends, but not the distributions based upon a capital reduction (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nennwertr&#252;ckzahlungen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or paid out of reserves from capital contributions (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Capital gains resulting from the sale or other dispositions of ADSs are not subject to Swiss federal, cantonal and communal income tax, and conversely, capital losses are not tax-deductible for Resident Private Shareholders. See paragraph 1.1(C) &#34;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Domestic Commercial Shareholders</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; for a summary of the taxation treatment applicable to Swiss resident individuals, who, for income tax purposes, are classified as &#34;professional securities dealers&#34;. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Domestic Commercial Shareholders</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and individual shareholders who are resident in Switzerland for tax purposes and corporate and individual shareholder who are not resident in Switzerland, and who, in each case, hold their ADSs as part of a trade or business carried on in Switzerland, in the case of corporate and individual shareholders not resident in Switzerland, through a permanent establishment or fixed place of business situated, for tax purposes, in Switzerland, are required to recognize Dividends, distributions based upon a capital reduction (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nennwertr&#252;ckzahlungen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or paid out of reserves from capital contributions (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) received on shares underlying the ADSs and capital gains or losses realized on the sale or other disposition of ADSs in their income statement for the relevant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taxation period and are subject to Swiss federal, cantonal and communal individual or corporate income tax, as the case may be, on any net taxable earnings for such taxation period. The same taxation treatment also applies to Swiss-resident private individuals who, for income tax purposes, are classified as &#34;professional securities dealers&#34; for reasons of, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter alia</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, frequent dealing, or leveraged investments in ADSs and other securities (the shareholders referred to in this paragraph 1.1.(C), hereinafter for the purposes of this section, as the Domestic Commercial Shareholders). Domestic Commercial Shareholders who are corporate taxpayers may be eligible for dividend relief (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beteiligungsabzug</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in respect of Dividends and distributions based upon a capital reduction (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nennwertr&#252;ckzahlungen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or paid out of reserves from capital contributions (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) if the shares underlying the ADSs held by them as part of a Swiss business have an aggregate market value of at least CHF 1 million. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.2 Swiss Cantonal and Communal Private Wealth Tax and Capital Tax</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Non-Resident Shareholders</font></div><div style="margin-bottom:8pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-Resident Shareholders are not subject to Swiss cantonal and communal private wealth tax or capital tax. </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Resident Private Shareholders and Domestic Commercial Shareholders</font></div><div style="margin-bottom:8pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident Private Shareholders and Domestic Commercial Shareholders who are individuals are required to report their ADSs as part of private wealth or their Swiss business assets, as the case may be, and will be subject to Swiss cantonal and communal private wealth tax on any net taxable wealth (including the ADSs), in the case of Domestic Commercial Shareholders to the extent the aggregate taxable wealth is allocated in Switzerland. Domestic Commercial Shareholders who are corporate taxpayers are subject to Swiss cantonal and communal capital tax on taxable capital to the extent the aggregate taxable capital is allocated to Switzerland. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.3 Swiss Federal Withholding Tax</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends that the Company pays on the shares underlying the ADSs are subject to Swiss Federal withholding tax (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verrechnungssteuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) at a rate of 35% on the gross amount of the Dividend. The Company is required to withhold the Swiss federal withholding tax from the Dividend and remit it to the Swiss Federal Tax Administration. Distributions based upon a capital reduction (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nennwertr&#252;ckzahlungen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or paid out of reserves from capital contributions (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserven aus Kapitaleinlagen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) are not subject to Swiss federal withholding tax. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Swiss federal withholding tax on a Dividend will be refundable in full to a Resident Private Shareholder and to a Domestic Commercial Shareholder, who, in each case, inter alia, as a condition to refund, duly reports the Dividend in his or her individual income tax return as income or recognizes the Dividends in its income statement as earnings, as applicable. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Non-Resident Shareholder may be entitled to a partial refund of the Swiss federal withholding tax on Dividend if the country of his or her residence for tax purposes has entered into a bilateral treaty for the avoidance of double taxation with Switzerland and the conditions of such treaty are met. Such shareholders should be aware that the procedures for claiming tax treaty benefits (and the time required for obtaining a refund) might be different from country to country. For example, a shareholder who is resident of the U.S. for the purposes of the bilateral treaty between the U.S. and Switzerland is eligible for a refund of the amount of the withholding tax in excess of the 15% treaty rate, provided such shareholder&#58; (i) qualifies for benefits under this treaty and qualifies as beneficial owner of the Dividends&#59; (ii) hold, directly or indirectly, less than 10% of the voting stock of the Company&#59; (iii) does not qualify as a pension scheme or retirement arrangement for the purpose of the bilateral treaty&#59; and (iv) does not conduct business through a permanent establishment or fixed base in Switzerland to which the ADSs are attributable. Such an eligible U.S. shareholder may apply for a refund of the amount of the withholding tax in excess of the 15% treaty rate. The applicable refund request form may be filed with the Swiss Federal Tax Administration following receipt of the dividend and the relevant deduction certificate, however no later than December 31 of the third year following the calendar year in which the dividend was payable. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.4 Swiss Federal Stamp Taxes</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any dealings in the ADSs, where a bank or another securities dealer in Switzerland, as defined in the Swiss Federal Stamp Tax Act, acts as intermediary or is a party to the transaction, are, subject to certain exemptions provided for in the Swiss Federal Stamp Tax Act, subject to Swiss securities turnover tax at an aggregate tax rate of up to 0.15% of the consideration paid for such ADSs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.5 International Automatic Exchange of Information in Tax Matters</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2014, Switzerland signed the Multilateral Competent Authority Agreement, which is based on article 6 of the OECD&#47;Council of Europe administrative assistance convention and is intended to ensure the uniform implementation of automatic exchange of information, or the AEOI. The Federal Act on the International Automatic Exchange of Information in Tax Matters, or the AEOI Act, entered into force on January 1, 2017. The AEOI Act is the legal basis for the implementation of the AEOI standard in Switzerland.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AEOI is being introduced in Switzerland through bilateral agreements or multilateral agreements. The agreements have, and will be, concluded on the basis of guaranteed reciprocity, compliance with the principle of specialty (i.e., the information exchanged may only be used to assess and levy taxes (and for criminal tax proceedings) and adequate data protection.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on such multilateral agreements and bilateral agreements and the implementing laws of Switzerland, Switzerland exchanges data in respect of financial assets, including the Shares, held in, and income derived thereon and credited to, accounts or deposits with a paying agent in Switzerland for the benefit of individuals resident in a EU member state or in a treaty state.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.6 Swiss Facilitation of the Implementation of the U.S. Foreign Account Tax Compliance Act</font></div><div style="margin-bottom:8pt;text-indent:22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Switzerland has concluded an intergovernmental agreement with the U.S. to facilitate the implementation of FATCA. The agreement ensures that the accounts held by U.S. persons with Swiss financial institutions are disclosed to the U.S. tax authorities either with the consent of the account holder or by means of group requests within the scope of administrative assistance. Information will not be transferred automatically in the absence of consent, and instead will be exchanged only within the scope of administrative assistance on the basis of the double taxation agreement between the U.S. and Switzerland. On October 8, 2014, the Swiss Federal Council approved a mandate for negotiations with the U.S. on changing the current direct-notification-based regime to a regime where the relevant information is sent to the Swiss Federal Tax Administration, which in turn provides the information to the U.S. tax authorities. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_115"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNDERWRITING </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are offering the ADSs described in this prospectus through a number of underwriters.  J.P. Morgan Securities LLC, SVB Leerink LLC and Cowen and Company, LLC are acting as joint book&#8209;running managers of the offering and as representatives of the underwriters.  We have entered into an underwriting agreement with the underwriters.  Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of ADSs listed next to its name in the following table&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Name</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Number of ADSs</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">J.P. Morgan Securities LLC </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SVB Leerink LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cowen and Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters are committed to purchase all the ADSs offered by us if they purchase any ADSs.  The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters propose to offer the ADSs directly to the public at the initial public offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per ADS.  After the initial offering of the ADSs to the public, if all of the ADSs are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms.  Sales of any ADSs made outside of the United States may be made by affiliates of the underwriters.  The offering of the ADSs by the underwriters is subject to receipt and acceptance and subject to the underwriters&#8217; right to reject any order in whole or in part.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters have an option to buy up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; additional ADSs from us to cover sales of ADSs by the underwriters which exceed the number of ADSs specified in the table above.  The underwriters have 30 days from the date of this prospectus to exercise this option to purchase additional ADSs.  If any ADSs are purchased with this option to purchase additional ADSs, the underwriters will purchase ADSs in approximately the same proportion as shown in the table above.  If any additional ADSs are purchased, the underwriters will offer the additional ADSs on the same terms as those on which the ADSs are being offered.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriting fee is equal to the public offering price per ADS less the amount paid by the underwriters to us per ADS.  The underwriting fee is $          per share.  The following table shows the per share and total underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters&#8217; option to purchase additional ADSs.</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Without option to purchase additional ADSs exercise</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">With full option to purchase additional ADSs exercise</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Per ADS</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in the offering.  The underwriters may agree to allocate a number of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADSs to underwriters and selling group members for sale to their online brokerage account holders.  Internet distributions will be allocated by the representatives to underwriters and selling group members that may make Internet distributions on the same basis as other allocations. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have agreed that we will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Securities and Exchange Commission a registration statement under the Securities Act relating to, any common shares or ADSs or securities convertible into or exercisable or exchangeable for any common shares or ADSs, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of any common shares or ADSs or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of common shares, ADSs or such other securities, in cash or otherwise), in each case without the prior written consent of J.P. Morgan Securities LLC, SVB Leerink LLC and Cowen and Company, LLC for a period of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; days after the date of this prospectus, other than the ADSs to be sold in this offering.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers, and certain of our shareholders, or the lock-up parties, have entered into lock&#8209;up agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for a period of &#160;&#160;&#160;&#160; days after the date of this prospectus (such period, the &#8220;restricted period&#8221;), may not (and may not cause any of their direct or indirect affiliates to), without the prior written consent of J.P. Morgan Securities LLC, SVB Leerink LLC and Cowen and Company, LLC, (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of our common shares, ADSs or any securities convertible into or exercisable or exchangeable for our common shares or ADSs (including, without limitation, common shares, ADSs or such other securities which may be deemed to be beneficially owned by such lock-up parties in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or warrant (collectively with the common shares and ADSs, the &#8220;lock-up securities&#8221;)), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the lock-up securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of lock-up securities, in cash or otherwise, (3) make any demand for, or exercise any right with respect to, the registration of any lock-up securities, or (4) publicly disclose the intention to do any of the foregoing. Such persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (by any person or entity, whether or not a signatory to such agreement) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any lock-up securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or otherwise.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">J.P. Morgan Securities LLC, SVB Leerink LLC and Cowen and Company, LLC, in their sole discretion, may release the securities subject to any of the lock-up agreements with the underwriters described above, in whole or in part at any time.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will apply to have our ADSs approved for listing on Nasdaq Global Market under the symbol &#8220;       &#8221;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling ADSs in the open market for the purpose of preventing or retarding a decline in the market price of the ADSs while this offering is in progress.  These stabilizing transactions may include making short sales of ADSs, which involves the sale by the underwriters of a greater number of ADSs than they are required to purchase in this offering, and purchasing ADSs on the open market to cover positions created by short sales.  Short sales may be &#8220;covered&#8221; shorts, which are short positions in an amount not greater than the underwriters&#8217; option to purchase additional ADSs referred to above, or may be &#8220;naked&#8221; shorts, which are short positions in excess of that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount.  The underwriters may close out any covered short position either by exercising their option to purchase additional ADSs, in whole or in part, or by purchasing ADSs in the open market.  In making this determination, the underwriters will consider, among other things, the price of ADSs available for purchase in the open market compared to the price at which the underwriters may purchase ADSs through the option to purchase additional ADSs.  A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market that could adversely affect investors who purchase in this offering.  To the extent that the underwriters create a naked short position, they will purchase ADSs in the open market to cover the position.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters have advised us that, pursuant to Regulation M of the Securities Act of 1933, they may also engage in other activities that stabilize, maintain or otherwise affect the price of the common stock, including the imposition of penalty bids.  This means that if the representatives of the underwriters purchase common stock in the open market in stabilizing transactions or to cover short sales, the representatives can require the underwriters that sold those ADSs as part of this offering to repay the underwriting discount received by them.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These activities may have the effect of raising or maintaining the market price of the ADSs or preventing or retarding a decline in the market price of the ADSs, and, as a result, the price of the ADSs may be higher than the price that otherwise might exist in the open market.  If the underwriters commence these activities, they may discontinue them at any time.  The underwriters may carry out these transactions on the Nasdaq Global Market, in the over&#8209;the&#8209;counter market or otherwise.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, there has been no public market for our ADSs.  The initial public offering price will be determined by negotiations between us and the representatives of the underwriters.  In determining the initial public offering price, we and the representatives of the underwriters expect to consider a number of factors including&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information set forth in this prospectus and otherwise available to the representatives&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our prospects and the history and prospects for the industry in which we compete&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an assessment of our management&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our prospects for future earnings&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the general condition of the securities markets at the time of this offering&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recent market prices of, and demand for, publicly traded common stock of generally comparable companies&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors deemed relevant by the underwriters and us.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither we nor the underwriters can assure investors that an active trading market will develop for our ADSs, or that the ADSs will trade in the public market at or above the initial public offering price.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required.  The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction.  Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.  This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may provide from time to time in the future certain commercial banking, financial advisory, investment banking and other services for us and such affiliates in the ordinary course of their business, for which they have received and may continue to receive customary fees and commissions.  In addition, from time to time, certain of the underwriters and their affiliates may effect transactions for their own account or the account of customers, and hold on behalf of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">228</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">themselves or their customers, long or short positions in our debt or equity securities or loans, and may do so in the future.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">European Economic Area</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to each Member State of the European Economic Area (each a &#8220;Relevant State&#8221;), no ADSs have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the ADSs which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of ADSs may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the Prospectus Regulation), subject to obtaining the prior consent of the Representatives for any such offer&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in any other circumstances falling within Article 1(4) of the Prospectus Regulation,</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such offer of ADSs shall require the Issuer or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation and each person who initially acquires any ADSs or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and the Issuer that it is a &#8220;qualified investor&#8221; within the meaning of Article 2(e) of the Prospectus Regulation. In the case of any ADSs being offered to a financial intermediary as that term is used in the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the ADSs acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer of any ADSs to the public other than their offer or resale in a Relevant State to qualified investors as so defined or in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the ADSs in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any ADSs to be offered so as to enable an investor to decide to purchase or subscribe for any ADSs, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017&#47;1129.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">United Kingdom</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No ADSs have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in relation to the ADSs which has been approved by the Financial Conduct Authority, except that the ADSs may be offered to the public in the United Kingdom at any time&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to any legal entity which is a qualified investor as defined under Article 2 of the U.K. Prospectus Regulation&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the U.K. Prospectus Regulation), subject to obtaining the prior consent of the Representatives for any such offer&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in any other circumstances falling within Section 86 of the FSMA&#59;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such offer of the ADSs shall require the Issuer or any underwriter to publish a prospectus pursuant to Section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the U.K. Prospectus Regulation. For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the ADSs in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any ADSs to be offered so as to enable an investor to decide to purchase or subscribe for any ADSs and the expression &#8220;U.K. Prospectus Regulation&#8221; means Regulation (EU) 2017&#47;1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may only be directed at persons who are &#8220;qualified investors&#8221; (as defined in the U.K. Prospectus Regulation) (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended, or the &#8220;Order,&#8221; and&#47;or (ii) who are high net worth companies (or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2)(a) to (e) of the Order (all such persons together being referred to as &#8220;relevant persons&#8221;) or otherwise in circumstances which have not resulted and will not result in an offer to the public of the ADSs in the United Kingdom within the meaning of the Financial Services and Markets Act 2000. In the United Kingdom, any investment or investment activity to which this document relates is only available to, and will be engaged in with, relevant persons. Any person in the UK who is not a relevant person must not act on or rely upon this document or any of its contents.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Canada</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ADSs may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the ADSs must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment hereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Switzerland</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ADSs may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility in Switzerland. This document does not constitute a prospectus within the meaning of, and has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the ADSs or the offering may be publicly distributed or otherwise made publicly available in Switzerland.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither this document nor any other offering or marketing material relating to the offering, the Company, the ADSs have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of ADSs will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, or FINMA, and the offer of ADSs has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or CISA. The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of ADSs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Hong Kong</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ADSs have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a) to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), or the SFO, of Hong Kong and any rules made thereunder&#59; or (b) in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong), or the CO, or which do not constitute an offer to the public within the meaning of the CO. No advertisement, invitation or document relating to the ADSs has been or may be issued or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">230</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to ADSs which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the SFO and any rules made thereunder.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Singapore</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each representative has acknowledged that this prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, each representative has represented and agreed that it has not offered or sold any ADSs or caused the ADSs to be made the subject of an invitation for subscription or purchase and will not offer or sell any ADSs or cause the ADSs to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ADSs, whether directly or indirectly, to any person in Singapore other than&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to an institutional investor (as defined in Section 4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time, or the SFA) pursuant to Section 274 of the SFA&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the ADSs are subscribed or purchased under Section 275 of the SFA by a relevant person which is&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the ADSs pursuant to an offer made under Section 275 of the SFA except&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">where no consideration is or will be given for the transfer&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">where the transfer is by operation of law&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as specified in Section 276(7) of the SFA&#59; or</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Singapore SFA Product Classification &#8212; In connection with Section 309B of the SFA and the CMP Regulations 2018, unless otherwise specified before an offer of Notes, the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A(1) of the SFA), that the Notes are &#8216;&#8216;prescribed capital markets products&#8217;&#8217; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12&#58; Notice on the Sale of Investment Products and MAS Notice FAA-N16&#58; Notice on Recommendations on Investment Products).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">231</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Japan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ADSs have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Act. Accordingly, none of the ADSs nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any &#8220;resident&#8221; of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the relevant time.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in the United Arab Emirates</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ADSs have not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and Commodities Authority or the Dubai Financial Services Authority.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Israel</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the State of Israel this prospectus shall not be regarded as an offer to the public to purchase ADSs under the Israeli Securities Law, 5728&#8212;1968, which requires a prospectus to be published and authorized by the Israel Securities Authority, if it complies with certain provisions of Section 15 of the Israeli Securities Law, 5728&#8211;1968, including, inter alia, if&#58; (i) the offer is made, distributed or directed to not more than 35 investors, subject to certain conditions, or the Addressed Investors, or (ii) the offer is made, distributed or directed to certain qualified investors defined in the First Addendum of the Israeli Securities Law, 5728&#8212;1968, subject to certain conditions, or the Qualified Investors. The Qualified Investors shall not be taken into account in the count of the Addressed Investors and may be offered to purchase securities in addition to the 35 Addressed Investors. The company has not and will not take any action that would require it to publish a prospectus in accordance with and subject to the Israeli Securities Law, 5728&#8212;1968. We have not and will not distribute this prospectus or make, distribute or direct an offer to subscribe for our common stock to any person within the State of Israel, other than to Qualified Investors and up to 35 Addressed Investors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qualified Investors may have to submit written evidence that they meet the definitions set out in of the First Addendum to the Israeli Securities Law, 5728&#8212;1968. In particular, we may request, as a condition to be offered common stock, that Qualified Investors will each represent, warrant and certify to us and&#47;or to anyone acting on our behalf&#58; (i) that it is an investor falling within one of the categories listed in the First Addendum to the Israeli Securities Law, 5728&#8212;1968&#59; (ii) which of the categories listed in the First Addendum to the Israeli Securities Law, 5728&#8212;1968 regarding Qualified Investors is applicable to it&#59; (iii) that it will abide by all provisions set forth in the Israeli Securities Law, 5728&#8212;1968 and the regulations promulgated thereunder in connection with the offer to be issued common stock&#59; (iv) that the ADSs that it will be issued are, subject to exemptions available under the Israeli Securities Law, 5728&#8212;1968&#58; (a) for its own account&#59; (b) for investment purposes only&#59; and (c) not issued with a view to resale within the State of Israel, other than in accordance with the provisions of the Israeli Securities Law, 5728&#8212;1968&#59; and (v) that it is willing to provide further evidence of its Qualified Investor status. Addressed Investors may have to submit written evidence in respect of their identity and may have to sign and submit a declaration containing, inter alia, the Addressed Investor&#8217;s name, address and passport number or Israeli identification number.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_118"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">LEGAL MATTERS</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the common shares and ADSs and certain other matters of Swiss law, including matters of Swiss income tax law, will be passed upon for us by Homburger AG, Zurich, Switzerland.  Certain matters of U.S. federal law will be passed upon for us by Cooley LLP, New York, New York. The underwriters are being represented by Advestra AG, Zurich, Switzerland, with respect to Swiss law and Davis Polk &#38; Wardwell LLP, New York, New York, with respect to U.S. federal law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_121"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">EXPERTS </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Molecular Partners AG and its subsidiary as of December&#160;31, 2020 and 2019 and for each of the years in the two-year period ended December&#160;31, 2020 have been included herein in reliance upon the report of KPMG AG, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_124"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">ENFORCEMENT OF CIVIL LIABILITIES</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a corporation organized and incorporated under the laws of Switzerland with registered office and domicile in Schlieren, Switzerland, and the majority of  our assets are located within Switzerland. Moreover, a number of our directors and executive officers are not residents of the United States, and all or a substantial portion of the assets of such persons are or may be located outside the United States. As a result, investors may not be able to effect service of process within the United States upon us or upon such persons or to enforce judgments obtained against us or such persons in U.S. courts, including judgments in actions predicated upon the civil liability provisions of the federal securities laws of the United States. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is doubt that a lawsuit based upon United States federal or state securities laws could be brought in an original action in Switzerland and that a judgment of a U.S. court based upon United States securities laws would be enforced in Switzerland.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States and Switzerland currently do not have a treaty providing for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. Consequently, a final judgment for payment given by a court in the United States, whether or not predicated solely upon U.S. securities laws, may not be enforceable in Switzerland. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, if a person has obtained a final and conclusive judgment rendered by a U.S. court that is enforceable in the United States and files a claim with the competent Swiss court, such final judgment by a U.S. court may be recognized in Switzerland in an action before a court of competent jurisdiction in accordance with the proceedings set forth by the Swiss Federal Act on International Private Law (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bundesgesetz &#252;ber das internationale Privatrecht</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and the Swiss Federal Act on Civil Procedure (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Schweizerische Zivilprozessordnung</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and, in certain circumstances, the Swiss Federal Act on Debt Collection and Bankruptcy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bundesgesetz &#252;ber Schuldbetreibung und Konkurs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In such an action, a Swiss court generally would not reinvestigate the merits of the original matter decided by a U.S. court. The recognition and enforcement of a U.S. judgment by a Swiss court would be conditional upon a number of conditions including those set out in articles 25 et seqq. of the Swiss Federal Act on International Private Law, which include, among others&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. court having had jurisdiction over the original proceedings from a Swiss perspective&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the judgment of such U.S. court being final and non-appealable under U.S. federal or state law&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">service of process to the defendant having been completed in accordance with the relevant legal requirements at the defendant&#8217;s domicile or permanent residence (including requirements resulting from applicable international treaties), or the defendant having unconditionally participated in the foreign proceedings&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the original proceeding not having been conducted under a violation of material principles of Swiss civil proceedings law, in particular the right to be heard&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the matter (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verfahren</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) between the same parties and on the same subject resulting in the judgment of the U.S. court not having been (i) commenced or decided by a Swiss court, provided that such Swiss matter was pending before a Swiss court prior to the U.S. court entered its proceedings or decided by a Swiss court before the decision of the U.S. court, or (ii) decided by a court in a third country, provided such third country matter was decided prior to the decision of the U.S. court and such third country matter is recognizable in Switzerland&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the enforcement of the judgment by the U.S. court not being manifestly incompatible with Swiss public policy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">schweizerischer Ordre public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, a Swiss court may reduce the amount of damages granted by a U.S. court and recognize damages only to the extent that they are necessary to compensate actual losses or damages. Enforcement and recognition of judgments of U.S. courts in Switzerland are solely governed by Swiss procedural law. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Original actions against persons in Switzerland based solely upon the U.S. federal or state securities laws are governed, among other things, by the principles set forth in the Swiss Federal Act on International Private Law. This </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statute provides that the application of provisions of non-Swiss law by the courts in Switzerland shall be precluded if the result was incompatible with Swiss public policy. Also, mandatory provisions of Swiss law may be applicable regardless of any other law that would otherwise apply. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss civil procedure differs substantially from U.S. civil procedure in a number of respects. Insofar as the production of evidence is concerned, U.S. law and the laws of several other jurisdictions based on common law provide for pre-trial discovery, a process by which parties to the proceedings may prior to trial compel the production of documents by adverse or third parties and the deposition of witnesses. Evidence obtained in this manner may be decisive in the outcome of any proceeding. No such pre-trial discovery process exists under Swiss law. Rather, Swiss civil procedure provides for the possibility for judicial pre-trial proceedings concerning the precautionary production of evidence (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">vorsorgliche Beweisf&#252;hrung</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) only in certain circumstances and under certain conditions. In addition, during the main proceedings, a Swiss court would decide upon the claims for which evidence is required from the parties and the related burden of proof.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our agent for service of process in the United States is Molecular Partners Inc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_127"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">EXPENSES RELATED TO THIS OFFERING </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable by the registrant in connection with the sale of ADSs in this offering. With the exception of the registration fee payable to the SEC and the filing fee payable to FINRA, all amounts are estimates.  </font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Item</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount to be paid</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC registration fee</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINRA filing fee</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nasdaq listing fee</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing and engraving expenses</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal fees and expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting fees and expenses</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer agent and registrar fees and expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous expenses</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">____________________</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;To be provided by amendment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_130"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed with the SEC a registration statement on Form F-1 under the Securities Act with respect to the ADSs offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information with respect to us and the ADSs offered hereby, please refer to the registration statement and the exhibits and schedules filed therewith. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the registration statement. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address is www.sec.gov. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of this offering, we will be subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file reports, including annual reports on Form 20-F, and other information with the SEC. We are not required to prepare and issue quarterly reports as a foreign private issuer. As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders and Section 16 short-swing profit reporting for our officers, directors and holders of more than 10% of our common shares. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a corporate website at www.molecularpartners.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_133"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">INDEX TO THE </font></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">CONSOLIDATED FINANCIAL STATEMENTS </font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated financial statements as of and for the years ended December 31, 2020 and December 31, 2019</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_175" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Report of Independent Registered Public Accounting Firm</a></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_175" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_178" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Statement of Financial Position as of December 31, 2020 and 2019</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_178" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_181" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Statement of Comprehensive Loss for the years ended December 31, 2020 and 2019</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_181" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_184" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Statement of Cash Flows for the years ended December 31, 2020 and 2019</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_184" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_187" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consolidated Statement of Changes in Equity for the years ended December 31, 2020 and 2019</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_187" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iae433ad4a4734c849aad6029347be986_190" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notes to the </a><a href="#iae433ad4a4734c849aad6029347be986_190" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated </a><a href="#iae433ad4a4734c849aad6029347be986_190" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a href="#iae433ad4a4734c849aad6029347be986_190" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">8</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_172"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div><font><br></font></div><div id="iae433ad4a4734c849aad6029347be986_175"></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners AG&#58;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated Financial Statements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated statements of financial position of Molecular Partners AG and subsidiary (the Group) as of December 31, 2020 and 2019, the related consolidated statements of comprehensive loss, changes in equity, and cash flows for each of the years in the two-year period ended December 31, 2020, and the related notes to the consolidated financial statements (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Group as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the years in the two&#8209;year period ended December 31, 2020, in conformity with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Group&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that&#58; (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition for license and collaboration agreement with Amgen</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Notes 2 and 5 to the consolidated financial statements, the Group recognized revenue for the year ended December 31, 2020 of CHF 9,344 thousand related to the license and collaboration agreement with Amgen. In December 2018, the Group entered into a license and collaboration agreement with Amgen Inc. and received an upfront payment of $50 million. The Group recognizes revenue for the license and collaboration agreement with Amgen in relation to progress made towards completion of the performance obligation.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the assessment of the progress made towards completion of the performance obligation, including the assessment of the estimated future costs to be incurred, as a critical audit matter. Specifically, the assessment of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes in operational and&#47;or technical collaboration and project requirements that could lead to a change in the amount of estimated project costs, required a high degree of complex auditor judgement.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address the critical audit matter.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assessed the Group&#8217;s estimated project costs by&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Performing inquiry of collaboration project leaders to assess the Group&#8217;s assertions made in the accounting analysis, collaboration project plan, and the estimated project costs.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Performing a retrospective assessment of historical forecasts of project costs by comparing prior period forecasts to actual results.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Assessing management&#8217;s process for estimating total project costs to complete by selecting certain vendor contracts and obtaining underlying evidence including but not limited to actual invoices, email correspondence, clinical development progress, and collaboration project committee meeting minutes to evaluate the estimated project costs.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Obtaining the minutes of the collaboration project committees and comparing with other evidence obtained regarding clinical development progress to assess that any changes are properly reflected in the estimated project costs.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Evaluating the Group&#8217;s assessment of project costs incurred to date relative to the Group&#8217;s estimated project costs. For a sample of costs incurred to date, we compared such costs to underlying invoices, certain vendor contracts and other records obtained.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; KPMG AG</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Group&#8217;s auditor since 2009.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zurich, Switzerland</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 24, 2021</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_178"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Consolidated Statement of Financial Position</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">as of December 31,</font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Note</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,387&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,242&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,734</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,014</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,368&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and accrued income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,721&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,712&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177,812</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99,921</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">187,546</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104,935</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders' equity and liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,160&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,479&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,849&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative losses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,174)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,870)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders' equity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107,220</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,139</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,039&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,678&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,896&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,656</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,191</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,825&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,718&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,618&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,948&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,310&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57,670</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,605</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,326</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50,796</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders' equity and liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">187,546</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104,935</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes, which form an integral part of these consolidated financial statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_181"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Consolidated Statement of Comprehensive Loss</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for the year ended December 31, </font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Note</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from research and development collaborations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,344</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,383</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,075)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,498)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,595)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,545)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(67,670)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57,043)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating result</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58,326)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36,660)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,816)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net finance result</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,449)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">389</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Result before income taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,775)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36,271)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net result, attributable to shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,764)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36,288)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive result</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items that will not be reclassified to profit or loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of net pension liabilities, net of tax</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,514)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,711)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items that are or may be reclassified subsequently to profit or loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange differences on translating foreign operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive result, net of tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,540)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,725)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive result, attributable to shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(64,304)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,013)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net result per share</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.69)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes, which form an integral part of these consolidated financial statements.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_184"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Consolidated Statement of Cash Flows</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for the year ended December 31,</font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Note</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net result attributable to shareholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,764)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,288)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments for&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;6 &#47; 7</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in employee benefits</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,599)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,816&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in working capital&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prepaid expenses and accrued income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in trade and other receivables</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,570&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in trade and other payables</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract liability</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,560&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,383)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange gain&#47;(loss) on working capital positions</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financial expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in operating activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,983)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,189)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from investments in short term time deposits</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,765&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,630&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in short term time deposits</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,397)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,998)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant and equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,451)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,031)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of intangible assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest received</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash from (used in) investing activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21,746)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19,836)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of new shares, net of transaction costs</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,613&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options, net of transaction costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of principal portion of lease liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,251)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,237)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash from (used in) financing activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113,202</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(227)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange gain&#47;(loss) on cash positions</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,464)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net decrease in cash and cash equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,246)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at January 1</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,712&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,958&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133,721</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75,712</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes, which form an integral part of these consolidated financial statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_187"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Consolidated Statement of Changes in Equity</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share capital</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative losses</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At January 1, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179,438</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(89,857)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91,704</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net result</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,288)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,288)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of net pension liabilities&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,711)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,711)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange differences on translating foreign operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,013)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,013)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options, net of transaction costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,160</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182,849</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(130,870)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,139</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At January 1, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,160</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182,849</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(130,870)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,139</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net result</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,764)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,764)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of net pension liabilities </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,514)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,514)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange difference on translation foreign costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(64,304)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(64,304)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of new shares, net of transaction costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,886&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,613&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options, net of transaction costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,915</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">299,479</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195,174)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107,220</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">See note 18</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">See note 12</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">See note 1 and note 12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes, which form an integral part of these consolidated financial statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_190"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</font></div><div id="iae433ad4a4734c849aad6029347be986_193"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;General Information</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners AG, or the Company, and its subsidiary, or, collectively, Molecular Partners, Group, is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of DARPin&#174;, a novel class of therapeutic proteins. DARPin&#174; combine the specificity and selectivity of monoclonal antibodies, or mAbs, with many properties of small molecules, enabling new therapeutic approaches. The Company was founded on November 22, 2004, and is domiciled at Wagistrasse 14, 8952 Schlieren, Canton of Zurich, Switzerland. It is subject to the provisions of the articles of association and to article 620 et seq. of the Swiss Code of Obligations, which describe the legal requirements for limited companies (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aktiengesellschaften</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners Inc. is a wholly owned subsidiary of Molecular Partners AG. Molecular Partners Inc. was incorporated in the United States in the State of Delaware on October 8, 2018. Molecular Partners Inc. is based in Cambridge, Massachusetts. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These audited consolidated financial statements as of and for the twelve-month period ended December 31, 2020 comprise Molecular Partners AG and Molecular Partners Inc. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s shares are listed on the SIX Swiss Exchange (Ticker&#58; MOLN) since November 5, 2014.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant events during the reporting period</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allergan, an AbbVie Company following the acquisition by AbbVie, announced in June 2020 that the U.S. Food and Drug Administration issued a Complete Response Letter to the Biologics License Application for abicipar. AbbVie is to determine appropriate next steps with relevant regulatory agencies.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group announced on July 7, 2020 a placement of 5,528,089 new registered shares, corresponding to approximately 25% of the Group's registered share capital, by way of an accelerated bookbuilding process, at an offering price of CHF 14.50 per share. The gross proceeds, before deducting commissions and offering expenses, amounted to CHF 80.2 million. The offering included participation by new and existing institutional investors in Switzerland, the United States and the European Union. Please also see note 12.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2020 the Group announced the reservation by the Swiss Federal Office of Public Health&#58; Bundesamt f&#252;r Gesundheit (FOPH-BAG) of a defined number of initial doses of the Group's anti-COVID-19 candidate, MP0420. Under the terms of the agreement, the Group has received a reservation fee of CHF 7,0 million. This will secure priority access for the FOPH-BAG to purchase reserved doses of MP0420, if clinical trials are successful and MP0420 is approved in Switzerland. Clinical studies were initiated in Q4 2020. See also note 5.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2020 the Group announced an Option and Equity Rights agreement with Novartis. Novartis has been granted an option to in-license global rights of MP0420 and MP0423 &#8211; multi-targeted direct-acting antiviral therapeutic candidates demonstrating potential efficacy against COVID-19. Under the terms of the agreement, Molecular Partners has received a non-refundable  cash payment of CHF 20 million for development activities relating to tech transfer and manufacturing for the commercial supply of MP0420. As part of the transaction, Novartis also agreed to acquire CHF 40 million worth of common shares, at a price of CHF 23 per share. As a result, Novartis holds approximately 6% of the outstanding shares of the Company as of December 31, 2020. Molecular Partners is eligible to receive a future payment of CHF 150 million, upon Novartis exercising the option for an exclusive license to both therapeutic candidates, two milestone payments of CHF 2.5 million each related to Phase 1 activities for MP0423 plus a 22% royalty on future commercial sales. Molecular Partners has agreed to forgo royalties in lower income countries, and is aligned with Novartis&#8217; plans to ensure affordability based on countries&#8217; needs and capabilities. Please also see note 5 and note 12.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_196"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis of Preparation</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards, or IFRS, as issued by the IASB. The accounting policies set forth below have been consistently applied to all years presented. Unless stated otherwise, all financial statements are presented in thousands of Swiss Francs, or TCHF.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared under the historical cost convention. The preparation of financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Group's accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in note 4 &#8220;Critical accounting estimates and judgments&#8221;.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group is monitoring the situation surrounding the COVID-19 pandemic and its potential impact on patients, the team, the partners and the business. During the twelve month period ended December 31, 2020 as well as of the reporting date there are no, nor were there any, major disruptions to operations. The  Group continues to comply with all local and federal instructions as it relates to the safety of our employees, patients, and citizens. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Group's cash position at December 31, 2020 and supported by the above, the Group deemed there to be no material uncertainties that would cast doubt on the Group's ability to operate on a going concern basis. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements as of and for the period ended December 31, 2020 were approved for issuance by the Company's Board of Directors on February 24, 2021.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to rounding, the numbers presented in the financial statements might not precisely equal those included in the accompanying notes.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis of consolidation</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Subsidiaries</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsidiaries are entities controlled by the Company. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date on which control commences until the date on which control ceases.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Transactions eliminated on consolidation</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intra-group balances and transactions, and any unrealized income and expenses arising from intra-group transactions, are eliminated.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">New or Revised IFRS Standards and Interpretations</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following new or revised standards that became effective during 2020 did not have a material effect on these consolidated financial statements&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amendments to References to Conceptual Framework in IFRS Standards</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Definition of Material (Amendments to IAS 1 and IAS 8)</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Definition of a Business (Amendments to IFRS 3)</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest Rate Benchmark Reform (Amendments to IFRS 9, IAS 39 and IFRS 7)</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COVID-19-Related Rent Concessions (Amendment to IFRS 16)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several new or revised standards have been published that are not yet effective and that have not been early adopted. No significant impacts on the Group's consolidated financial statements are expected.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Segment Reporting</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group operates in one segment, focusing on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The executive management, acting together as the chief operating decision makers, assess the financial performance and allocate resources on an aggregated level, and monitor the Group's operating expenses. Accounting policies applied are the same for both internal and external reporting purposes. The Group derives its research and collaboration revenues from research and development collaborations with third parties. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Foreign Currency Translation &#47; Transactions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements are presented in thousands of CHF. The presentation currency of the Group is the functional currency of the Company. Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in profit or loss.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results and financial position of foreign operations that have a functional currency different from the presentation currency are translated into the presentation currency as follows&#58; </font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assets and liabilities are translated at the closing rate at the date of the respective balance sheet&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income and expenses for each consolidated statement of comprehensive loss are translated at average exchange rates (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the exchange rates at the dates of the transactions)&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all resulting exchange differences are recognized in other comprehensive income.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property, Plant and Equipment</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment, Office equipment, IT hardware and Leasehold improvements are stated at historical cost less accumulated depreciation and any impairment. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Depreciation is calculated on a straight-line basis over the expected useful lives of the individual assets or asset categories. The applicable estimated useful lives are as follows&#58; </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT hardware&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements and right-of-use assets are depreciated using the straight line method over the shorter of their estimated useful life and the lease term. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent costs are included in each asset&#8217;s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. Repairs and maintenance are charged to profit or loss during the financial period in which they are incurred.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each reporting date. An asset&#8217;s carrying amount is written down to its recoverable amount, if the asset's carrying amount exceeds its estimated recoverable amount.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost and accumulated depreciation related to assets retired or otherwise disposed are derecognized at the time of retirement or disposal and any resulting gain or loss is included in profit or loss in the period of retirement or disposal.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Intangible Assets</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets currently solely comprise of IT software. They are stated at historical cost less accumulated amortization and any impairment. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Amortization is calculated on a straight-line basis over the expected useful lives of the individual assets or asset categories. The applicable estimated useful life of intangible assets is determined to be two years. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Leases</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception of a contract, the Group assesses whether a contract is, or contains a lease. This is the case if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Group has elected not to recognize right-of-use assets and lease liabilities for leases of low-value assets (threshold of CHF 5,000) and short-term leases. Short-term leases are leases with a lease term of 12 months or less that do not contain a purchase option. For all other leases the Group recognizes a right-of-use asset and a lease liability at the lease commencement date. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. Subsequently the right-of-use asset is depreciated using the straight-line method over the shorter of the asset's useful life and the lease term.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is initially measured at the present value of the lease payments required over the lease term that are not paid at the commencement date, discounted using the Group&#8217;s incremental borrowing rate, as the interest rate implicit in the lease generally cannot be readily determined. Lease payments that are included in the measurement of the lease liability include fixed payments or in-substance fixed payments and variable payments that depend on an index. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequently, the lease liability is measured at amortized cost using the effective interest method. The Group remeasures the lease liability when there is a change in future lease payments arising from a change in index, or if the group changes its assessment of whether it will exercise an extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each lease payment is allocated between the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the lease liability for each period. The Group does not provide residual value guarantees and does not have any leases not yet commenced to which it is committed. The Group is presenting  right-of-use assets in Property, Plant and Equipment,  whereas lease liabilities are presented separately within current and non-current liabilities in the consolidated statement of financial position.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Impairment of non-financial Assets</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-financial assets that are subject to depreciation or amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount exceeds their recoverable amount. An impairment loss is recognized for this difference. The recoverable amount is the higher of an asset&#8217;s fair value less costs of disposal and value in use. For the purpose of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Assets at Amortized Costs</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents &#47; short-term deposits &#47; trade and other receivables (except for VAT and withholding taxes) (and when applicable accrued interest income) are all considered held-to-collect items and are labeled under financial assets measured at amortized costs, with the following definition &#47; accounting policy&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets measured at amortized cost are assets that meet  both of the following conditions&#58; (1) the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows&#59; and (2) the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">They arise when the Group provides money, goods or services directly to a debtor with no intention of trading the receivable. They are included in current assets, except for maturities longer than 12 months after the balance sheet date. These are classified as non-current assets.  Interest income on the short-term deposit is accounted for on the statement of comprehensive loss as financial income.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, financial assets, except for trade receivables, are measured at their fair value plus, in the case of financial assets not at fair value through profit or loss, transaction costs that are directly attributable to the acquisition or issue of the financial asset&#59; for the Group these are considered to be immaterial. Trade receivables are initially measured at their transaction price. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent measurement for the financial assets mentioned above which are classified as measured at amortized cost, is based on the effective interest method, reduced by any impairment loss. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets measured at amortized cost, a loss allowance for expected credit losses on the financial assets is recognized. Measurement of any impairment loss is based on the &#8216;expected credit loss&#8217; (ECL) model, which is based on a predictive model. The loss allowance for a financial asset is  measured at an amount equal to the lifetime expected credit losses if the credit risk on that financial asset has increased significantly since initial recognition. If the credit risk on a financial asset has not increased significantly since initial recognition, the Group  measures the loss allowance &#47; impairment loss for that financial asset at an amount equal to 12-month expected credit losses. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For trade receivables, the Group applies a simplified approach which requires expected credit losses to be recognized from initial recognition (measuring the loss allowance at an amount equal to lifetime expected credit losses). This takes into consideration past history, combined with predictive information which takes into consideration the specific circumstances of the customer (e.g. credit rating etc.), and other relevant factors such as the economic environment. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other financial assets at amortized costs</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables generally arise from transactions outside the usual operating activities of the Group.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Liabilities at Amortized Costs</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade payables and non-employee related accrued expense are measured at amortized costs and classified as financial liabilities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash includes cash at banks. The Group considers all short-term, highly liquid investments convertible into known amounts of cash with maturities of three months or less from the date of acquisition to be cash equivalents, provided that they are subject to an insignificant risk of changes in value. The cash flow statement is based on cash and cash equivalents.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share Capital &#47; Additional Paid-in Capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares are classified as equity. Incremental costs directly attributable to the issue of new shares are shown in equity as a deduction from the proceeds. The Group has not paid any dividends since its inception and does not anticipate paying dividends in the foreseeable future.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes include current and deferred taxes. Current income taxes are recognized on taxable profits at applicable tax rates. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are calculated using the balance sheet liability method. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets and liabilities are measured using the tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled based on tax rates enacted or substantially enacted at the balance sheet date.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are recognized if it is probable that sufficient taxable profits will be available against which the deferred tax assets can be utilized. At each balance sheet date, the Group reassesses unrecognized deferred tax assets and the carrying amount of recognized deferred tax assets. The Group recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered. The Group conversely reduces the carrying amount of a deferred tax asset to the extent that it is no longer probable that sufficient taxable profit will be available to allow the benefit of part or the entire deferred tax asset to be utilized.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of deferred tax liabilities and deferred tax assets reflects the tax consequences on the balance sheet date of the Group's expectation of recovery or settlement of the carrying amounts of its assets and liabilities. Deferred tax assets and liabilities are not discounted and are classified as non-current assets and liabilities in the statement of financial position. They are offset against each other if they relate to the same taxable entity and tax authority.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have to pay income taxes in Switzerland in the presented reporting periods for 2020 and 2019. The Company&#8217;s accumulated taxable losses may be used as tax loss carry forwards to offset future taxable income over a period of seven years in Switzerland. No deferred tax assets have been established for these losses, because the Company does not have a history of sustainable taxable profits, increasing research costs are expected to be incurred in the foreseeable future and future revenues are highly volatile and uncertain. No deferred tax assets were recognized on deductible temporary differences on pension liabilities for the same reasons. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners Inc, the group's US subsidiary is liable for US federal and Massachusetts and California state tax.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee Benefits</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Postretirement benefits (pension plans)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides retirement, death and disability benefits to its Swiss employees in line with local customs and requirements through two separate plans, which are both accounted for as defined benefit plans. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first plan is the compulsory defined benefit plan which is funded through employer (60%) and employee (40%) contributions to VSAO, a Switzerland based plan. This Company-wide plan has been in place since inception of the Company and all employees of the Company are eligible to its benefits. On retirement, the plan participant will receive his or her accumulated savings, which consist of all contributions paid in by the employer and the employee (net of any withdrawals) and the interest granted on those savings at the discretion of the pension foundation. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At that time, the plan participant has the right to choose between a lump-sum payment and an annuity, or a combination thereof. The annuity is calculated using a fixed conversion rate determined by the pension foundation. The VSAO&#8217;s plan assets are pooled and the Company&#8217;s share is calculated based on its share of retirement savings. Additional funding requirements may be determined by the pension foundation in case of a severe underfunding. Should the Company withdraw from the plan, the withdrawal may qualify as a partial liquidation under Swiss law.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second plan is a voluntary complementary defined management benefit scheme established as of January 1, 2014, in which only employees with an annual base salary exceeding CHF 150,000 are eligible to participate.  29 of the 31 eligible employees participated in this plan as of December 31, 2020 (30 out of 32 eligible employees as of December 2019). This plan is set up as a collective foundation with Swiss Life, a Switzerland-based insurance company, for which contributions are 30% funded by the employee and 70% funded by the Company. The purpose </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this voluntary plan is to allow higher savings opportunity in a tax effective manner and risk benefits for senior management. In addition, plan participants are entitled to a lump sum payment of five times their annual base salary in case of death. This is a fully insured Swiss pension plan that covers all investment and actuarial risks, including invalidity and death.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The VSAO pension plan accounts for over 90% of both the Company&#8217;s defined benefit obligation and plan assets. The liability recognized in the statement of financial position in respect of defined benefit pension plans is the present value of the defined benefit obligations at the balance sheet date less the fair value of plan assets.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows. Pension liabilities are determined on an actuarial basis using a number of assumptions, such as the discount rate and expected salary increases applied to determine the defined benefit obligation and an estimate of the fair value of plan assets attributable to the Company. In determining the appropriate discount rate, for example, the Company considers the interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating the terms of the related pension liability. In determining the fair value of plan assets, the Company adds to the participants&#8217; savings a share of the pension plan&#8217;s technical and fluctuation reserves. Additional information is disclosed in note 18.1.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current and past service costs as well as the net interest on the defined benefit obligation are recognized in profit or loss in the period in which they are incurred, and are presented as part of personnel expenses. Remeasurements of the defined benefit pension plans are recognized in other comprehensive income.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group has set up a 401k plan for its US based employees. Under the plan the US entity matches the employee's contribution and provides a true-up in matched contributions at year end. The 401k plan qualifies as a defined contribution scheme and the associated expenses are presented under operating expenses in the statement of comprehensive loss.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group operates share-based compensation plans that qualify as equity-settled plans. The fair value of the employee services received in exchange for the grant of equity instruments is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the equity instruments granted, which is determined at grant date. The fair values are determined by management with the assistance of an independent valuation expert. At each reporting date, estimates of the number of equity instruments that are expected to vest are revised. The impact of the revision of the previous estimates, if any, is recognized as part of share-based compensation (non-cash effective) with a corresponding adjustment to equity. When the vested equity instruments are exercised, any proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and additional paid-in capital.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bonus plan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group recognizes an accrual where contractually obliged or where there is a past practice that has created a constructive obligation. Bonuses are based on a formula that takes into consideration the achievement of the Company&#8217;s goals.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a guiding principle of IFRS 15, revenues from research and development collaboration agreements are recognized when earned based upon the performance requirements of the respective agreements. For revenue arrangements with separately identifiable components (separate performance obligations), the revenue recognition criteria are applied to each component. The transaction price is determined as the consideration expected to be received from the arrangement and is allocated amongst the separate components based on their relative stand-alone selling prices. The corresponding amount of transaction price allocated to each component is recognized as revenue when (or as) the Group satisfies the performance obligation by transferring the good or service to the customer, which generally is over time for upfront payments or at a point in time for milestone payments and development option payments. Payments received in excess of revenue recognized are recorded as contract liability. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include fees such as upfront payments received in connection with out-licensing of products and&#47;or access the knowledge without transfer of a license as well as in  connection with discovery alliances, as well as fees for maintenance of patents, R&#38;D support and services, participation in Joint Steering Committees and other involvement in collaboration agreements. In exchange for these non-refundable upfront fees, the Group does not immediately transfer a good or a service to the customer, rather the upfront fee consists of an advance payment for future services and the right to access the underlying intellectual property of the Group. For such arrangements, the Group has determined that the promised goods and services are not distinct and are accounted for as one performance obligation.  The Group recognizes revenue for this performance obligation over time using a cost-based method to measure its progress towards complete satisfaction of the performance obligation. Accordingly, revenue is recognized over time based on the percentage of actual costs incurred to date relative to the Group's estimate of total costs expected to satisfy the performance obligation. Estimated costs are reviewed and updated routinely for contracts in progress to reflect any changes of which the Group becomes aware. The cumulative effect of any change in estimate is recorded in the period when the change in estimate is determined.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues could include fees such as milestone and development option payments received in connection with out-licensing of products and in connection with discovery alliances. Upon meeting the set milestone or upon a development option being exercised, the Group obtains a right to a non-refundable payment and the customer has typically acquired the right to use the underlying intellectual property, without any remaining performance obligations for the Group. Consequently, the related revenues are typically recognized at a point in time, either when the milestone is met or the option is exercised by the customer.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue could also include reservation fees that will be recognized into revenue in case of successful development of a final drug and exercise or lapse of the related reservation right or, alternatively, in case the results from the research will not justify further development of the drug. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration payable to a customer is recorded as a reduction of the arrangement's transaction price, if it relates to the same arrangement, thereby reducing the amount of revenue recognized, unless the payment is for a distinct good or service received from the customer consistent with IFRS 15.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of the accounting policy, based on the type of payments received, are set out below. Under IFRS 15, revenue is recognized as or when a customer obtains control of the services. Determining the timing of the transfer of control - at a point in time or over time - requires judgment. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:19.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of payments received</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Timing of revenue recognition</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition of upfront payments</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments received in connection with out-licensing arrangements are typically non-refundable fees for which the Group does not transfer a good or a service to the customer, rather the upfront payments consists of an advance payment for future services and&#47;or an acquisition of the right to the current or future access to the underlying intellectual property of the Group. For such arrangements, the Group has determined that the promised goods and services are not distinct and are accounted for as one performance obligation. The Group recognizes revenue for this performance obligation over time using a cost-based method to measure its progress towards complete satisfaction of the performance obligation.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition of milestone payments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone payments received in connection with out-licensing or other arrangements are typically non-refundable fees entitling the Group to a right to payment upon such milestone being met. At that time, the customer has typically acquired the right to use the underlying intellectual property or additional knowledge about drug candidate(s), without any remaining performance obligation of the Group. Considering the uncertainty surrounding the outcome of such development activities, the revenue is consequently recognized at a point in time, when the milestone is reached. At this stage it is highly probable that a reversal of the cumulative revenue will not occur.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition of payments received for development options exercises</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development option payments received in connection with out-licensing arrangements are typically non-refundable fees entitling the Group to a right to payment upon such option being exercised. At that time, the customer has typically acquired the right to use the underlying intellectual property, without any remaining performance obligations of the Group. Considering the fact that the exercise of any option is outside the control of the Group, revenue for options that provide the right to use is recognized at a point in time at the effective exercise of the option. At this stage it is highly probable that a reversal of the cumulative revenue will not occur.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognition of reservation fees</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reservation fees received are typically non-refundable fees. The timing of revenue recognition depends on whether development of the final drug is successful. If development is successful, revenue will be recognized when the related reservation right is exercised or lapses (as the exercise of any reservation right is outside the control of the Group). Alternatively, revenue will be recognized at the point in time when the results from the research will not justify further development of the drug. At this stage it is highly probable that a reversal of the cumulative revenue will not occur.</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Research and Development Expenses</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses as disclosed in note 16 consist primarily of compensation and other expenses related to&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research and development personnel&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preclinical studies and clinical trials of the Group's product candidates, including the costs of manufacturing the product candidates&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research and services performed under collaboration agreements&#59;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research and development services outsourced to research institutions&#59; and</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attributable facility expenses, including depreciation of equipment and amortization. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal development costs are capitalized as intangible assets only when there is an identifiable asset that can be completed that will generate probable future economic benefits, and when the cost of such an asset can be measured reliably. The Group does not currently have any such internal development costs that qualify for capitalization as intangible assets. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to its internal research and development activities, the Group is also party to in-licensing and similar arrangements with its partners. The Group may also acquire in-process research and development assets, either through business combinations or through purchases of specific assets. Intangible assets are initially recorded at cost. Intangible assets are amortized over their useful lives on a straight-line basis beginning from the point when </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">they are available for use. The estimated useful life of intangible assets is regularly reviewed. The Group does not currently have any such externally acquired in-process research and development assets.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group charges all research and development expenses, including internal patent filing and patent maintenance costs, to profit or loss when incurred, as the criteria for recognition as an asset are not currently met.</font></div><div id="iae433ad4a4734c849aad6029347be986_199"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;Financial Risk Management</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Risk Factors</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group is subject to risks common to companies in the biotechnology industry, including, but not limited to, uncertainties regarding the effectiveness and safety of new drugs, new and unproven technologies, development process and outcome of clinical trials, rigorous governmental regulation and uncertainty regarding regulatory approvals, long product development cycles, continuing capital requirements to fund research and development, history of operating losses and uncertainty of future profitability, uncertainty regarding commercial success and acceptance, third party reimbursements, uncertainties regarding patents and legally protected products or technologies, uncertainty regarding third party intellectual property rights, dependence on third parties, dependence on publicly available scientific findings and research data, lack of experience with production facilities, dependence on third party manufacturers and service providers, competition, concentration of operations, product liability, dependence on important employees, environment, health, data protection and safety, lack of experience in marketing and sales, litigation, currency fluctuation risks and other financial risks, volatility of market value, as well as limited liquidity and shares eligible for future sale.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group is developing several products currently not generating constant revenue streams which results in volatile cash flow from operating activities. Currently, the Group&#8217;s revenues stem mainly from irregular and difficult to predict income from product out-licensing, milestone payments and fees from R&#38;D collaboration agreements. This will likely remain the same at least until the first product reaches the market on the Group&#8217;s own or through a partner. This results in a lack of regular positive operating cash flow, which may expose the Group to financing risks in the medium-term. See note 4, &#8220;Critical accounting estimates and judgments.&#8221; Furthermore, management has taken actions to manage financial risks, such as foreign exchange risk and liquidity risk.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners conducts research and development activities primarily in Switzerland, the European Union and the United States. As a result, the Group is exposed to a variety of financial risks, such as foreign exchange rate risk, credit risk, liquidity risk, cash-flow and interest rate risk. The Group&#8217;s overall financial risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. Further details are disclosed under note 25.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Management</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group is not regulated and not subject to specific capital requirements. The amount of equity depends on the Group&#8217;s funding needs and statutory capital requirements. The Group monitors capital periodically on an interim and annual basis. From time to time, the Group may take appropriate measures or propose capital increases to its shareholders to ensure the necessary capital remains intact. The Group did not have any short-term or long-term debt outstanding as of December 31, 2020 and 2019.</font></div><div id="iae433ad4a4734c849aad6029347be986_202"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;Critical Accounting Estimates and Judgments</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group&#8217;s accounts are prepared on a going concern basis. The preparation of the consolidated financial statements in conformity with IFRS requires that management and the Board of Directors make estimates and assumptions which affect the amounts of the assets and liabilities, contingent liabilities, as well as the income and expenses reported in the consolidated financial statements. These estimates take into consideration historic experience as well as developments in the economic circumstances and are further based on management&#8217;s best knowledge of current events and actions that the Group may undertake in the future. These circumstances include also  the  possible impacts of the COVID-19 pandemic. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are subject to risks and uncertainties. The actual results can deviate from these estimates. The estimates and assumptions identified by the Group, which have a significant risk of causing a material adjustment to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the carrying amounts of assets and liabilities in a future period or have a significant effect on reported results, are discussed below&#58;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuation in revenues is common to biopharmaceutical companies focused on research and development as the revenues are often linked to up-front fees, reservation fees, milestones or license payments as well as income for delivery of drug substance, which occur sporadically. Depending on the complexity of the relevant agreements, judgment (for instance in regards to the performance obligations recognized using the cost based method, where revenue is recognized based on costs incurred in relation to the Group&#8217;s estimate of total estimated costs to complete satisfaction of the underlying performance obligations) is required to reflect the substance of the arrangement in the recognition of revenues. Under the cost-based method, the Group&#8217;s estimate of total costs to be incurred under certain agreements is for example, based on actual project-related contracts and history of similar contracts of other collaborations as well as industry experience. The Group is required to evaluate whether any changes in operational and&#47;or technical collaboration and project requirements could lead to a change in the timing and&#47;or amount of estimated project costs, and how such changes, if any, impact the recognition of revenue. Other revenue related judgments with regard to the determination of performance obligations under reservation agreements relate to assumptions on future production costs and market prices. More information on revenue recognition is provided in the respective accounting policy. Additional information related to the Group&#8217;s significant revenue agreements is disclosed in note 5.</font></div><div id="iae433ad4a4734c849aad6029347be986_205"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;Revenues and entity-wide Disclosures</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group assesses and estimates the progress of its projects with alliance partners at each reporting date. When the cost-based  &#47; input method is applied, the Group recognizes revenue based on the ratio of the associated costs incurred to date and the total forecasted costs to satisfy the performance obligation.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second half of 2020 the Group increased its estimate of the total future costs required to satisfy the performance obligation under the Amgen collaboration. This change in estimate affects the allocation of revenue over time and has no impact on the total amount recognized or to be recognized into revenue under the agreement with Amgen. This increase in the total estimated future costs resulted in a lower amount of revenue recognized for the twelve month period ended December 31, 2020, as compared to the comparable prior year period. The increase in total future costs is primarily related to continued development of various dosing schedules under Phase 1a of the collaboration. The remaining unrecognized transaction price at December 31, 2020 of TCHF 18,983  for Amgen will be recognized in line with the recognition of estimated expenses to satisfy the performance obligation. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Group entered into a contract with Novartis, granting Novartis the exclusive option to in-license global rights in relation to drug candidates MP0420 and MP0423. Under the terms of the agreement, the Group has received an upfront, non-refundable fee of CHF 20 million for the tech transfer and manufacturing of MP0420. The Group has equally committed to utilize up to the maximum amount of this upfront fee for the manufacturing of the commercial supply for MP0420. Any such amount which is paid for manufacturing performed by the Novartis Group is considered to be a consideration payable to a customer. Given the significant inter-dependencies between the upfront fee and the manufacturing activities, the manufacturing costs paid to the Novartis Group are to be offset against the upfront non-refundable fee from the contract (see below, as well as note 15). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the reporting period, costs paid to the Novartis Group for the manufacturing of the drug product to establish the commercial supply of MP0420 in the amount of TCHF 96 have been offset against the upfront non refundable fee (see note 15).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve month periods ended December 31, 2020 and 2019, the Group recognized revenues as disclosed in the table below. Revenues in the table below are attributable to individual countries and are based on the location of the Group&#8217;s alliance partner.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues by country</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands, for the years ended December 31</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues USA</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,344</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,383</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Analysis of revenue by major alliance partner</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands, for the years ended December 31</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen Inc., USA</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,344&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,344</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,383</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option and Equity Rights Agreement with Novartis</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2020 the Group announced entering into an Option and Equity Rights agreement with Novartis. Novartis has been granted an option to in-license global rights of MP0420 and MP0423 &#8211; multi-targeted direct-acting antiviral therapeutic candidates demonstrating potential efficacy against COVID-19. Please see note 12 for the related acquisition of shares by Novartis.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, during the option period, Molecular Partners will conduct Phase 1 clinical trials for MP0420 and, if agreed between the parties, perform all remaining preclinical work for MP0423 and conduct the MP0423 Phase 1 trial for which two milestone payments of CHF 2.5 million each will be due in case of initiation and completion. Novartis will conduct Phase 2&#47;3 clinical trials, with Molecular Partners as legal sponsor of these trials. The contract foresees the sharing of knowledge of the results of Phase 1 and Phase 2 activities with Novartis, though these do not result in a transfer of a license until the exercise of the option for an exclusive license. Upon exercise of such option, Novartis would be responsible for all further development and commercialization activities. During the clinical development stage, Molecular Partners will provide clinical supply. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group is eligible to receive a future payment of CHF 150 million, upon Novartis exercising the option for exclusive license to the therapeutic candidates, in addition to a 22% royalty on future commercial sales. Molecular Partners has agreed to forgo royalties in lower income countries, and is aligned with Novartis&#8217; plans to ensure affordability based on countries&#8217; needs and capabilities.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners is required to spend up to the full amount of the non-refundable fee of CHF 20 million for the commercial supply of MP0420, which is to be manufactured by Sandoz, a division of the Novartis Group. The full amount of the upfront fee is therefore allocated to the performance obligation for the tech transfer and manufacturing in relation to the required commercial supply of MP0420. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the urgency of finding a therapeutic solution for COVID-19, such production is already on-going, and anticipated to occur in parallel to Phase 1 and Phase 2&#47;3 activities. The commercial supply manufacturing with Sandoz will provide Molecular Partners a supply of the drug candidate MP0420, which will be able to be commercialized only upon receiving regulatory approval. Should Novartis exercise the option for the exclusive license for drug candidates MP0420 and MP0423, such supply will be purchased by Novartis by reference to the costs incurred by the Group. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Molecular Partners&#8217; performance obligation in relation to the tech transfer and manufacturing is highly inter-dependent with the actual manufacturing of the drug candidate MP0420 by the Novartis Group, the amount paid by Molecular Partners to the Novartis Group for the manufacturing and purchase of materials for the drug product is considered to be consideration payable to a customer. The related manufacturing costs paid to the Novartis Group are therefore offset against the non-refundable upfront fee (see note 15). The Group determined using an over time cost-based method to measure its progress in relation to the related tech transfer and manufacturing activity performed by third parties, most faithfully depicts the progress of the Group to satisfy the performance obligation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reservation Agreement with the Swiss Federal office of Public Health</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reservation agreement announced on August 11, 2020,  resulted in a current contract liability of CHF 7.0 million, as presented in the consolidated statement of financial position. The agreement consists of two reservation rights&#58; the first being FOPH-BAG's option to have priority access to the first 200,000 doses produced&#59; and the second being FOPH-BAG's option to obtain access to 5% of the additional planned total production, up to 3,000,000 doses, if such production is undertaken by the Group. In case a final product will become available, the initial 200,000 doses, and any additional doses are to be subject to a separate sales contract to be agreed amongst the parties. Certain pricing provisions have been pre-negotiated, but remain subject to final therapeutic dose and while there is preferential pricing for the initial doses, which results in a performance obligation, the pricing for any further doses is expected to be at market prices and therefore not considered to result in a separate performance obligation. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the period, the Group has met the contractually agreed milestone specified in the contract, meaning that the reservation fee received from the FOPH-BAG is no longer refundable. However, as the fee refers to a reservation right, it will only be recognized as revenue in case of successful development of a final drug and exercise or lapse of the related reservation right or, alternatively, in case the results from the research will not justify further development of the drug. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License and Collaboration Agreement with Amgen</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, the Group entered into a License and Collaboration Agreement with Amgen for the clinical development and commercialization of MP0310 &#47; AMG 506. Under the terms of the agreement, the Group granted to Amgen an exclusive worldwide, royalty-bearing, sublicensable license under the Group&#8217;s patents and know-how relating to MP0310 &#47; AMG506 to develop and commercialize MP0310 &#47; AMG 506. The parties will jointly evaluate MP0310 &#47; AMG 506 in combination with Amgen&#96;s oncology pipeline products, including its investigational bispecific T-cell engager, or TCE, or BiTE,  molecules. Under the collaboration, Molecular Partners retains certain rights to develop and commercialize its proprietary DARPin pipeline products in combination with MP0310 &#47; AMG 506.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement the Group received a non-refundable upfront payment of $50 million. The Group has the lead on performing certain clinical development, manufacturing and regulatory activities in the first clinical phase and the Group assigned the full $50 million upfront as the transaction price to this performance obligation, based on the Group's development plan and the contractual agreement. The Group has considered if the contract contains a significant financing component and has concluded this was not the case. The Group is recognizing the related revenue using the cost-based method to measure it progress by reference to actual costs incurred in relation to the Group's best estimate of total expected costs to satisfy the performance obligation. This cost-based method is subject to the assessment of the management of the Group. The Group determined using an over-time cost-based method to measure its progress most faithfully depicts the inputs it will take the Group to satisfy the performance obligation. Please see also note 15 for the amount that has not yet been recognized as revenue.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition the Group is eligible to receive up to $497 million in development, regulatory and commercial milestone payments, as well as double-digit, tiered royalties up to the high teens. The Group considers these various milestones to be variable consideration as they are contingent upon achieving uncertain, future development stages and net sales.  For this reason the Group considers the achievement of the various milestones as binary events that will be recognized into revenue upon occurrence. Furthermore, the parties will share the clinical development costs in defined percentages for the first three indications subject to certain conditions. For all additional clinical trials, Amgen is responsible for all development costs. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abicipar Agreement with Allergan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2011, the Group entered into a license and collaboration agreement with Allergan. Under the agreement, the Group granted Allergan an exclusive, worldwide, royalty-bearing, sublicensable license under our patents and know-how relating to abicipar and other backup compounds to make, use, sell, offer for sale, and import products containing abicipar and its corresponding backups for ophthalmic indications. Allergan is responsible, at its expense, for developing and commercializing abicipar, and must use commercially reasonable efforts to develop, seek regulatory approval for, and commercialize abicipar in certain key countries, including the United States, several </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">major European markets and Japan. Allergan paid the Group an upfront license fee of $45 million in May 2011 and a regulatory milestone fee of $15 million upon the initiation of its Phase 3 clinical trials for nAMD in July 2015. These non-refundable upfront fees have all been recognized into revenue in prior years. The Group is also eligible to receive up to an additional $210 million upon the achievement of certain development and regulatory milestone events and $150 million upon the achievement of certain sales milestone events. In addition, the Group will receive a tiered royalty percentage ranging from the low to mid-teens on worldwide annual net sales of abicipar.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allergan, an AbbVie Company following the acquisition by AbbVie, announced in June 2020 that the U.S. Food and Drug Administration issued a Complete Response Letter to the Biologics License Application for abicipar. AbbVie is to determine appropriate next steps with relevant regulatory agencies.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discovery Alliance Agreement with Allergan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2012, the Group strategically expanded its existing relationship with Allergan by entering into an exclusive discovery alliance agreement under which the parties will collaborate to design and develop DARPin products against selected targets that are implicated in causing diseases of the eye. The Group received an upfront payment of $40 million and a further $1.5 million upfront payment in connection with a 2014 amendment to the agreement, and Allergan agreed to pay us an option exercise fee of $10 million upon its exercise of further options. In July 2015, Allergan agreed to make an accelerated payment of $30 million for the exercise of these options. In February 2018 Allergan exercised its last of the three options resulting in a recognized revenue of CHF 9.4 million. All revenue from these non refundable fees has been recognized in prior years. The Group is also eligible to receive additional success-based payments, including up to $960 million in development, regulatory and sales milestones, and tiered royalties ranging from a mid-single digit to low double digit percentage for future product sales by Allergan.</font></div><div id="iae433ad4a4734c849aad6029347be986_208"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;Property, Plant and Equipment</font></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lab equipment</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office equipment</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IT<br>hardware</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Right-of-use assets</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Leasehold improvements</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2020</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,456&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">639&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">929&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,782&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">317&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,123&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">881&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">549&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,984&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,435&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(359)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(150)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(509)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8,337</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">660</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,119</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9,616</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">317</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20,049</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2020</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,963)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(579)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(856)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,247)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(236)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,881)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation charge for the year</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(639)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(260)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,256)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(37)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,230)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">359&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">449&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6,602)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(617)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(757)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2,413)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(273)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10,662)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,735</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">43</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">362</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,203</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">44</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9,387</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use assets relate to the facilities the Group is leasing in Schlieren, Switzerland. The additions to the the right-of-use assets during 2020 were TCHF 5,984 and related to the remeasurement of the lease liability following the exercise by the Group of an option for the  extension of the lease by 5 years (until December 31, 2026) with a new earliest contractual termination date for both the lessor and the Group on the major real estate lease of December 31, 2025. Disposals under the right-of-use assets related to the return of certain assets to the lessor. Please also see note 22.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.802%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lab equipment</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office equipment</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IT<br>hardware</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Right-of-use assets</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Leasehold improvements</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2019</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,553&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">603&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">839&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">317&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,312&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of IFRS 16 as of January 1, 2019</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,639&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">903&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,456</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">639</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">929</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,782</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">317</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2019</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,379)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(508)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(778)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(192)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,857)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation charge for the year</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(584)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(73)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(78)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,247)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(44)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,026)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5,963)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(579)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(856)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1,247)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(236)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,881)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,493</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">73</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,535</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">81</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,242</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iae433ad4a4734c849aad6029347be986_211"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;Intangible Assets</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IT software</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2020</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,530</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2020</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization charge for the year</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,183)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:87.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.694%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IT software</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2019</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,471</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At January 1, 2019</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization charge for the year</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(699)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount at December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">772</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iae433ad4a4734c849aad6029347be986_214"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;Financial Instruments</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.484%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial assets at amortized costs</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,721&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">173,882</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75,712&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,368&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">95,378</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above mentioned amounts were neither past due nor impaired at the end of the respective reporting period and were of highly rated quality. Please also see note 25.</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.484%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial liabilities at amortized cost</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade payables</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,800&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued project costs and royalties</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,972&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,218&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-employee related accrued expenses</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">775&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,765</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade payables</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,019&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued project costs and royalties</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,343&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,545&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-employee related accrued expenses</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">507&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,414</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of financial assets and financial liabilities not measured at fair value (except for lease liabilities) is a reasonable approximation of fair value.</font></div><div id="iae433ad4a4734c849aad6029347be986_217"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;Prepaid Expenses and Accrued Income</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,254</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,497</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iae433ad4a4734c849aad6029347be986_220"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;Trade and Other Receivables</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value added tax</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,376&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">653&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">486&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,182&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,837</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,344</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are denominated in the following currencies&#58;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div id="iae433ad4a4734c849aad6029347be986_223"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;Cash, Cash Equivalents and Short-term Time Deposits</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at bank in CHF</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,576&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,450&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at bank in EUR</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,365&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,803&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at bank in USD</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,776&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,220&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at bank in GBP</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,239&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash at bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133,721</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75,712</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits CHF</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits USD</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,368&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total short-term time deposits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,368</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term time deposits in CHF at December 31, 2020 contain three positions with two major Swiss banks. The short-term time deposits in USD at December 31, 2019 contain one position with a major Swiss bank. Please also refer to note 25.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in Cash, Cash equivalents and Short-term time deposits during 2020 was the result of the placement of new shares in July 2020, the reservation agreement with the Swiss Federal Office of Public Health&#58; Bundesamt f&#252;r Gesundheit (FOPH-BAG) in August 2020 and the Option and Equity Rights agreement with Novartis in October 2020, as also described in notes 1, 5 and 12.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_226"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;Shareholders&#8217; Equity</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group announced on July 7, 2020 a placement of 5,528,089 new registered shares, corresponding to approximately 25% of the Group's registered share capital, by way of an accelerated bookbuilding process, at an offering price of CHF 14.50 per share. The new shares were issued from existing authorized share capital of the company under exclusion of the existing shareholders' pre-emptive rights. The new shares were listed and admitted to trading on SIX Swiss Exchange as of July 9, 2020. Payment and settlement took place on the same date. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented under the caption of additional paid-in capital on the statement of financial position, the Group accounted for a deduction of 6,043 TCHF for transaction costs. This deduction represents the costs that were incremental and directly attributable to the issuance of the new shares. The Group invested part of the net proceeds from the capital increase into short-term time deposits and the remaining part into cash and cash equivalents.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2020 the Group announced an Option and Equity Rights Agreement with Novartis.  As part of the transaction, Novartis agreed to acquire 1,739,130 new ordinary shares for CHF 40 million, out of the conditional capital, at a price of CHF 23 per share. As a result, Novartis holds approximately 6% of the outstanding shares of the Company. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented under the caption of additional paid-in capital on the statement of financial position, the Group accounted for a deduction of TCHF 501 for transaction costs. This deduction represents the costs that were incremental and directly attributable to the issuance of the new shares. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group invested part of the net proceeds from the capital increases into short-term time deposits and the remaining part into cash and cash equivalents.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Classes of Share Capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary share capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2020, the Company&#8217;s issued share capital amounted to CHF 2,914,699.20 divided into 29,146,992 fully paid registered shares with a par value of CHF 0.10 each. As of December 31, 2019, the Company&#8217;s issued share capital consisted of 21,601,192 fully paid registered shares with a par value of CHF 0.10 each. Ordinary shares are entitled to one vote per share and rank equally with regards to the Company's residual assets and dividends (if any should be declared in the future).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share capital registered with the Swiss Commercial Register on December 31, 2020, amounted to CHF 2,886,841.10 divided into 28,868,411 fully paid up registered shares with a par value of CHF 0.10 per share.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A total of 7,545,800 new registered shares were issued in 2020 as a result of the placement of new shares following the capital raise in July 2020 and the Novartis agreement in October 2020 plus the option exercises and the vesting of Performance Share Units, or PSU, and Restricted Share Units (RSU), from the PSU and RSU plans 2017. The corresponding capital increases were registered with the commercial register in three steps on July 20, 2020, and November 9, 2020 for the transactions in July and October and on January 29, 2021 for the option exercises and the vesting of the PSU and RSU Plans 2017. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Authorized share capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors is authorized to increase the share capital at any time until April 19, 2022 by a maximum amount of CHF 13,177 by issuing a maximum of 131,771 fully paid up shares with a par value of CHF 0.10 each. An increase of the share capital in partial amounts is permissible.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the share capital was increased out of authorized share capital for the private placement performed in July 2020. As a result, the available authorized share capital  was reduced by CHF 552,809 from CHF 565,986 to CHF 13,177.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors is authorized to determine the issue price, type of payment, time of the issuance, conditions for the exercise of the preemptive rights and the date from which the shares carry the right to dividends. The Board of Directors can issue new shares by means of an underwriting arrangement by a bank or another third party with a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsequent offer of these shares to the existing shareholders or third parties (if the preemptive rights of the existing shareholders have been denied or not been duly exercised). The Board of Directors is authorized to permit, to restrict or to deny the trade of preemptive rights. The Board of Directors may permit preemptive rights that have been granted but not exercised to expire or it may place these rights respectively the shares as to which preemptive rights have been granted but not exercised, at market conditions or use them for other purposes in the interest of the Group. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors is further authorized to restrict or deny the preemptive rights of shareholders and to allocate them to third parties&#58; (a) for the acquisition of companies, parts of companies or participations, for the acquisition of products, intellectual property or licenses, for investment projects or for the financing or refinancing of such transactions through a placement of shares, (b) for the purpose of broadening the shareholder constituency or in connection with a listing of shares on domestic or foreign stock exchanges, (c) if the issue price of the new shares is determined by reference to the market price, (d) for purposes of granting an over-allotment option (Greenshoe) of up to 20% of the total number of shares in a placement or sale of shares to the respective initial purchasers or underwriters, (e) following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of the share capital registered with the commercial register of the Canton of Zurich, without having submitted to the other shareholders a take-over offer recommended by the Board of Directors, or (f) for the defense of an actual, threatened or potential takeover bid, in relation to which the Board of Directors has not recommended to the shareholders acceptance on the basis that the Board of Directors has not found the takeover bid to be financially fair to the shareholders.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conditional share capital</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 the Company&#8217;s share capital was allowed to be increased by an amount not to exceed CHF 176,068 through the issuance of up to 1,760,677 fully paid up shares with a par value of CHF 0.10 per share through the direct or indirect issuance of shares, options or preemptive rights granted to employees, members of the Board of Directors or members of any advisory boards. During 2020, the share capital was increased out of this conditional capital for employee participation (Article 3b of the Articles of Association). As a result, the available conditional capital for employee participation was reduced by CHF 27,858 from CHF 203,926 to CHF 176,068.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the share capital may be increased by an amount not to exceed CHF 226,087 through the issuance of up to 2,260,870 fully paid up shares with a par value of CHF 0.10 per share through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights for the subscription of shares granted to shareholders or third parties alone or in connection with bonds, notes, options, warrants or other securities or contractual obligations by or of the Company. During 2020, the share capital was increased out of this conditional capital for financing transactions and other purposes (Article 3c of the Articles of Association). As a result, the available conditional capital for financing transactions and other purposes was reduced by CHF 173,913 from CHF 400,000 to CHF 226,087.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the cash proceeds from the exercise of share options and the vesting of PSUs amounted to TCHF 848 and was all serviced from the issuance of new shares (conditional share capital).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the cash proceeds from the exercise of share options and the early vesting of PSUs amounted to TCHF 1,020 and all was serviced from the issuance of new shares (conditional share capital).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Significant Shareholders</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, the largest shareholders in the Company disclosed to the Company based on the published notifications to SIX, as applicable, are&#58; </font></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders with over 3% of share capital registered with the<br>Commercial Register</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark N. Lampert (Biotechnology Value Funds)</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.56&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hansjoerg Wyss</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.07&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.62&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Suvretta Capital Management, LLC</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.06&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novartis AG</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federated Hermes, Inc.</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.81&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Essex Woodlands Health Ventures VIII, LLC</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.61&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.63&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UBS Fund Management (Switzerland) AG</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.72&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael Tobias Stumpp</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.80&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrick Amstutz</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.06&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andreas Pl&#252;ckthun</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pictet Asset Management (Direction de Fonds)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.32&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Johnson &#38;Johnson</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrik Forrer</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAM Holding AG</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#60;3.00%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt;text-indent:18pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.03&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentages above are based on (i) the number of shares held by such shareholders, excluding any options, PSUs and RSUs held by such shareholders and (ii) for the year ended December 31, 2020, 28,868,411 common shares, which is the share capital registered with the commercial registry on December 31, 2020 (December 31, 2019, 21,228,593 common shares</font></div><div id="iae433ad4a4734c849aad6029347be986_229"></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;Trade and Other Payables</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade payables</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social security</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value added tax</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,825</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,410</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade payables are denominated in the following currencies&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHF</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">556&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">617&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,043&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,092&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,800</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_232"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;Accrued Expenses</font></div><div style="margin-bottom:8pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued project costs and royalties</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,343&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and bonuses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,967&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,751&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,718</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,618</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_235"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;Contract Liability</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group expects the contract liability to be recognized as revenue or (in case of consideration payable to a customer) reduction of costs, as follows&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract liability</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition &#47; cost reduction in year one after the balance sheet date</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,948&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year two after the balance sheet date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,939&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year three after the balance sheet date</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year four after the balance sheet date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year five and later after the balance sheet date</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">45,887</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract liability</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year one after the balance sheet date</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,310&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year two after the balance sheet date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,530&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year three after the balance sheet date</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">487&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year four after the balance sheet date</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected revenue recognition in year five and later after the balance sheet date</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28,327</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the movement during 2020 on the contract liability&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract liability at January 1, 2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Recognized as Revenue</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Offset of costs</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract liability at December 31, 2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28,327</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,344)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18,983</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(96)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,904</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOPH-BAG</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28,327</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9,344)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(96)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">45,887</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An amount of TCHF 96 has been released to offset  a corresponding amount of costs paid to the Novartis Group for the manufacturing of the drug product to establish the commercial supply of MP0420 (see note 5). </font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Current</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract liability</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,044&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,939&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,983&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,904&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,904&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FOPG-BAG</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">42,948</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,939</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">45,887</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_238"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;Additional Information on the Nature of Expenses</font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research and development expenses</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research consumables and external research and development expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26,599)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,314)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, see also note 18</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,251)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,722)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,319)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,088)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(492)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(568)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(683)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(565)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other research and development expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(169)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(191)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalties and license fees, see also note 17</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(562)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total year ended December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(56,075)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(43,498)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt;text-indent:18pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt;text-indent:18pt"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, general and administrative expenses</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, see also note 18</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,383)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,870)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other administrative expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,587)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,231)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(568)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(381)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility expenses </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(57)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total year ended December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11,595)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13,545)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total operating expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(67,670)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(57,043)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Research and development non-cash effective pension and share-based compensation costs were TCHF 2,612 in 2020 and TCHF 1,549 in 2019.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Selling, general and administrative non-cash effective pension and share based compensation costs were TCHF 1,573 in 2020 and TCHF 1,351 in 2019.</font></div><div id="iae433ad4a4734c849aad6029347be986_241"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;Royalties and License Fees</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group holds an exclusive perpetual license from the University of Zurich on patent applications and patents relating to the DARPin&#174; base technology. Under this license agreement, the Group is required to pay the University of Zurich flat royalties of a low single digit percentage on net sales of licensed products, which vary based on the field in which the licensed product is commercialized. In addition, the Group is obligated to pay the University of Zurich a percentage of license fee revenues it receives from sublicensing its rights to third parties in five tiers, ranging from the low single digits to the low teens, depending on the total amount of payments received for the particular sublicense granted.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Group is also obligated to pay the University of Zurich a percentage of the royalty payments it receives from sublicensees in three tiers based on their net sales of licensed products and the applicable field in which the licensed product is sold, ranging from the low single digits to the mid teens. The Group has the right to terminate the license at any time with six months&#8217; prior written notice.  The minimum amount the Group is required to pay is CHF 60,000 per annum (including CHF 10,000 for another separate license). The minimum amount payable for 2019 was CHF 50,000. For both 2020 and 2019 the minimum amounts were payable. Royalties to the University of Zurich are due annually based on a full calendar year and payable until the end of February in the following calendar year.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Group entered into a research collaboration agreement with the University of Utrecht regarding the development of the Group's COVID-19 program. Under this agreement, the Group paid a fee of CHF 250,000 to the University of Utrecht. An additional  fee  of CHF 250,000 is payable under this agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_244"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;Personnel Expenses</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salaries</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,525)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,868)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation (non-cash effective)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,932)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,438)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension costs</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,080)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,043)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Social security costs</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,393)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,869)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other personnel expenses</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,704)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,374)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total year ended December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(33,634)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(27,592)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Full-time equivalents and head count</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average number of full-time equivalents</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142.5</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127.1</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Full-time equivalents at year end</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.4</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.2</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headcount at year end</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.1&#160;&#160;&#160;&#160;Pension Costs and Liabilities</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined benefit pension plans</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actuarial assumptions</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate at January 1</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate at December 31 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future salary increases at December 31</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality tables</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BVG2015 GT</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BVG2015 GT</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date of last actuarial valuation</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.12.2020</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.12.2019</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of the amount recognized in the statement of financial position </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,512&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,455&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at December 31</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,089&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,799&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net defined benefit liability at December 31 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,423</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,656</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of defined benefit cost in profit or loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current service cost (employer)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Past service cost</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense on defined benefit obligation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) on plan assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative cost excl. cost for managing plan assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined benefit cost recognized in profit or loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,080</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,018</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">thereof service cost and administrative cost</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">thereof net interest expense on the net defined benefit liability</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of net defined benefit liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit liability at January 1</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,656&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,482&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit cost recognized in profit or loss </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of net pension liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,711&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions by the employer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,827)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net defined benefit liability at December 31 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,423</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,656</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of defined benefit obligation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at January 1</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,455&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,609&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expenses on defined benefit obligation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current service cost (employer)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions by plan participants</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits (paid)&#47;deposited</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Past service cost</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative cost (excl. cost for managing plan assets)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain)&#47;loss on defined benefit obligation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,737&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined benefit obligation at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,512</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,455</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of amount recognized in OCI</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) &#47; loss on changes in financial assumptions</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,774&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) &#47; loss  arising from experience adjustments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actuarial (gain)&#47;loss on defined benefit obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">335</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,737</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets excluding interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remeasurement of net pension liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,514</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,711</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of fair value of plan assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at January 1</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,799&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,127&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on plan assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions by the employer</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions by plan participants</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits (paid)&#47;deposited</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets excl. interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,089</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,799</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Best estimate of contributions of next year</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions by the employer</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan asset classes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,836&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity instruments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,791&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,845&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt instruments (e.g. bonds)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,671&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,466&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,075&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total plan assets at fair value (quoted market price)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,138</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,003</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,951&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,796&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total plan assets at fair value (non-quoted market price)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,951</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,796</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total plan assets at fair value at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,089</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,799</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">thereof entity's own transferable financial instruments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">thereof property occupied or other assets used by the entity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sensitivity </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31 with discount rate -0.25%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,038&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31 with discount rate +0.25%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,871&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,077&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31 with salary increases -0.25%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,033&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,017&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31 with salary increases +0.25%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,999&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,887&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31 with life expectancy +1 year</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,417&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,691&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit obligation at December 31 with life expectancy -1 year</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,611&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,222&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity profile of defined benefit obligation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average duration of defined obligation in years at December 31</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average duration of defined obligation in years at December 31 for active members</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average duration of defined obligation in years at December 31 for pensioners</font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Discount rates are based on industry benchmarks related to benefits with a 20 year duration</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">In liabilities for employee benefits, as presented in the statement of financial position included are also TCHF 255 (2019&#58; TCHF 240) for accrued sabbatical cost.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">The sum of these two positions represent the non-cash effective pension costs recognized in the income statement, of which TCHF 1,039 are research and development costs (2019&#58; TCHF 358) and TCHF 214 are selling, general and administrative costs (2019&#58; TCHF 104).</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">For the most important parameters which influence the pension obligation of the Company a sensitivity analysis was performed. The discount rate and the assumption for salary increases were modified by a certain percentage value. Sensitivity on mortality was calculated by changing the mortality with a constant factor for all age groups. With this procedure we could change the longevity for most of the age categories by one year longer or shorter than the baseline value.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.2&#160;&#160;&#160;&#160;Share-based Compensation Plan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.2.1&#160;&#160;&#160;&#160;Employee Share Option Plans, or ESOP</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;ESOP 2009 established in December 2009</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;ESOP 2014 established in July 2014 </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An ESOP is an incentive tool that fosters the entrepreneurial spirit and performance by way of financial participation in the Group&#8217;s long term success. It gives employees, members of the Board of Directors and selected advisors a beneficial opportunity to purchase shares of the Company. Each option entitles its holder to purchase one share of the Company at a pre-defined exercise price. The number of options granted to each participant was determined by the Board of Directors based on a participant&#8217;s position and level of responsibility. The options generally vest quarterly over four years, with cliff vesting of 25% after one year. At the end of the option term, unexercised options expire without value The expenses are recognized pro rata as per the graded vesting schedule starting generally from grant date until vesting date.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, an aggregate of 382,059 options were outstanding under the ESOP 2009 and ESOP 2014. All these options are fully vested at the reporting date.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2019, an aggregate of 560,250 options were outstanding under the ESOP 2009 and ESOP 2014. All these options are fully vested at the reporting date. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the initial public offering of the Company on the SIX Swiss Exchange on November 5, 2014, no further option grants have been made under any of these two share option plans.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.2.2&#160;&#160;&#160;&#160;Long term Incentive, or LTI,  Plans&#58; Restricted Share Units, or RSU,  and PSU</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">LTI plans 2016 established in March 2016</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">LTI plans 2017 established in March 2017</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">LTI plans 2018 established in March 2018</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">LTI plans 2019 established in March 2019</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">LTI plans 2020 established in March 2020</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the LTI plans, members of the Board of Directors are eligible to be granted RSUs, whereas members of the Management Board and other employees are eligible to be granted PSUs.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are contingent rights to receive a certain number of shares of the Company at the end of a three-year blocking period. The number of RSUs per plan participant is a function of the approved CHF amount per position divided by the fair value of each RSU as at the grant date. In certain circumstances, including a change of control, a full or partial accelerated vesting of the RSUs may occur. RSUs vest over a one-year period from date of grant.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are contingent rights to receive a variable number of shares of the Company at the end of a three-year cliff-vesting period. The number of PSUs per plan participant is a function of the approved CHF amount per position divided by the fair value of each PSU as of the grant date. While the PSUs are designed to let the beneficiaries participate in the long-term share price development, the number of shares to be earned in relation to a PSU also depends on the achievement of certain corporate goals for the respective year.  Accordingly, the number of shares to be issued based on the PSUs can be between zero and 120% of the number of PSUs granted. Even after the determination of goal achievement, participants may lose their entitlements in full or in part depending on certain conditions relating to their employment. In certain circumstances, including a change of control, a full or partial accelerated vesting of the PSUs may occur.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTI plans are rolled out annually, which allows the Board of Directors to review and adjust the terms and targets on an annual basis. Employees generally receive the grants on April 1 of each calendar year, or for new employees on the first day of the calendar quarter after the start of their employment. Members of the Management Board and the Board of Directors receive the annual grants after the approval of the ordinary shareholders&#8217; meeting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, 445,198 PSUs and 87,906 RSUs were outstanding. As of December 31, 2019, 363,165 PSUs and 81,840 RSUs were outstanding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.2.3&#160;&#160;&#160;&#160;Conditions Attached to and Measurement of Fair Values of Equity-settled Share-based Payment Arrangements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the conditions as well as the inputs used in the measurement of the fair values at grant dates&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU&#47;PSU, conditions and assumptions</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nature of arrangement</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant of PSU&#47;RSU</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant of PSU&#47;RSU</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date RSU</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2020</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 16, 2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant dates PSU</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan 1 - Oct 1</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan 1 - Oct 1</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of RSU granted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,467&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,649&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of PSU granted</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,657.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,445.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price (CHF)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price (CHF)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.50 - 21.50</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.56 - 19.06</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Full contractual life for RSU  (years)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Full contractual life for PSU (years)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 - 3.00</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 - 3.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting period for  RSU (years)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting period for PSU (years)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 - 3.00</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 - 3.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility on Common shares</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.73 - 56.26</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.24 - 42.98</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate p. a. (%) &#47; CHF LIBOR &#47; Common shares</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(-0.42) - (-0.60)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(-0.50) - (-0.71)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility on NBI</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.20 - 25.70</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.67 - 23.37</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate p. a. (%) &#47; USD LIBOR &#47; NBI</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 - 2.00</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03 - 2.76</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility on SPI</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.19 - 15.79</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.11 - 12.37</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate p. a. (%) &#47; CHF LIBOR &#47; SPI</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(-0.42) - (-0.60)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(-0.50) - (-0.71)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend (CHF)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of rights granted (CHF)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.18&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.13&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latest expiry date</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sep 30, 2023</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sep 30, 2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation model</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monte Carlo</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monte Carlo</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Additional comments&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:15.38pt">Expected volatility&#58; Historical share prices of the Company have been used.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:15.38pt">The indices, Nasdaq Biotechnology Index, or NBI,  and Swiss performance Index, SPI,  were introduced as assumptions in determining the fair values for the 2019 and 2020 PSU Plans.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in the number of all issued RSUs, PSUs and share options are as follows&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share Option &#47; PSU &#47; RSU movements</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total (numbers)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average exercise price (CHF)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options (numbers)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average exercise price (CHF)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU&#47;RSU (numbers)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average exercise price (CHF)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance outstanding at December 31, 2018</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,184,663</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">864,197</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.98</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">320,466</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,094&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,094&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Performance adjustment)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,309)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,309)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Forfeited)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,594)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,594)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Expired)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exercised)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372,599)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303,947)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,652)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance outstanding at December 31, 2019</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005,255</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.32</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,250</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.87</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">445,005</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,124&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,124&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Performance adjustment)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,956)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,956)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Forfeited)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,679)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,679)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Expired)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exercised)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278,581)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,191)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,390)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance outstanding at December 31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">915,163</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.74</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">382,059</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.42</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">533,104</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.50</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Performance adjustments indicate forfeitures due to non-market performance conditions not achieved</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">Forfeited due to service conditions not fulfilled</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">The weighted average share prices at the dates of exercising  during the year ended 2020 amounted to CHF 19.73 (2019&#58; CHF 15.95)</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table applies to all share options, PSUs and RSUs outstanding at December 31, 2020&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise price<br>CHF</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options &#47; <br>PSU&#47;RSU<br>(number)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining life<br>(years)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercisable options</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,917&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,917&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.05</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.06</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,942&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,942&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.94</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,385&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,385&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU&#47;RSU</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533,104&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">915,163</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">382,059</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table applies to all share options, PSUs and RSUs outstanding at December 31, 2019&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise price<br>CHF</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options &#47; <br>PSU&#47;RSU<br>(number)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining life<br>(years)</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercisable options</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,817&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,817&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.05</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.06</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,302&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,302&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.94</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,731&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,731&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU&#47;RSU</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,005&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005,255</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,250</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-cash costs for share-based payments recognized in the statement of comprehensive loss can be attributed to the Company&#8217;s two functions as follows&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:69.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,573&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,192&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,359&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,246&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total year ended December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,932</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,438</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iae433ad4a4734c849aad6029347be986_247"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;Financial Income and Financial Expense</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Income</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on financial assets held at amortized costs</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,599&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total year ended December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">367</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,599</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Expense</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,512)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,110)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Negative interest on financial assets held at amortized costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense on leases</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financial expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total year ended December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,816)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,210)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iae433ad4a4734c849aad6029347be986_250"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;Taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners AG did not have to pay or accrue any income taxes in the reporting periods. In 2020 and 2019, the Company generated a taxable loss in Switzerland which is part of the Company&#8217;s cumulative tax loss carry forward. Any future taxable income will be subject to Swiss federal, cantonal and communal income taxes. The Company&#8217;s applicable income tax rate for the year 2020 is 21% (2019&#58; 21%).</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners Inc., which is incorporated in the United States in the State of Delaware, is subject to statutory U.S. Federal corporate income taxes and state income taxes for Massachusetts and California. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2020  a current income tax credit  of TCHF 11  (TUSD 13) was recognized by the Group's U.S. based subsidiary for estimated U.S. tax obligations of the subsidiary based on intra-Group activity (twelve months ended December 31, 2019&#58; tax expense of  TCHF 17  (TUSD 17)). The tax benefit recognized during 2020 relates to the application of research and development tax credits that are applicable on the  2019 final tax positions of Molecular Partners Inc. The applicable income tax rates are 21% federal tax plus 8.00%  state tax (Massachusetts) and 8.84% (California). </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Taxes</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net operating losses for tax purposes amounted to TCHF 58,631 in 2020 and TCHF 33,446 in 2019. The total tax losses of TCHF 157,900 may be used as tax loss carry forwards to offset future taxable income over a period of seven years, with the loss of TCHF 4,314 to expire in the year 2021. No deferred tax assets have been recognized for these tax loss carry forwards, because it is not probable that such loss carry forwards can be utilized in the foreseeable future. In addition, no deferred tax positions were recognized on other deductible temporary differences (e.g. pension liabilities under IAS 19 for a total of TCHF 13,423, see also note 18.1) due to the significant tax losses carried forwards. Given the facts above, as well as the Company incurred no significant tax expense in the reporting periods presented, a numerical rate reconciliation is not provided. The major reconciling item is the effect of unrecognized deferred tax assets for tax losses and deductible temporary differences.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the expiry of tax loss carry forwards for the Company, for which no deferred tax asset was recognized&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,314)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,314)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,976)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,976)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,766)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,766)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,767)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,767)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33,446)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33,446)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58,631)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:18pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total tax loss carry forwards as at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(157,900)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(99,269)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iae433ad4a4734c849aad6029347be986_253"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;Earnings per Share</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net result per share is calculated by dividing the net result attributable to the shareholders of the Company by the weighted average number of shares issued and outstanding during the reporting period, excluding any shares held as treasury shares. Diluted net profit per share additionally takes into account the potential conversion of all dilutive potential ordinary shares. For the periods ended  December 31, 2020 and 2019 there are no dilutive effects.</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares used in computing basic and diluted profit&#47; (loss) per share</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,000,652&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,413,375&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;Leases</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group leases office and laboratory facilities in Schlieren, Switzerland. These leases generally have terms between 2 and 10 years and  contain extension or terminations  options exercisable by the Group up to one year before the end of the non&#8209;cancellable contract period. These terms are used to maximize operational flexibility in terms of managing contracts. The options to extend are held by the Company and the termination options are held both by the Company and the lessor. As of  December 31, 2020, the Group exercised the option to extend the lease on its facilities in Schlieren by five years with a new lease term ending on December 31, 2026. The earliest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contractual termination date for both the lessor and the Group on the major real estate lease is December 31, 2025.  For information about the right-of use assets please also see note 6.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set out below are the carrying amounts of the lease liabilities and the movements during the period</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as at January 1, </font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,545&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,639&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions &#47; new leases</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,924&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of interest on lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,275)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,264)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as at December 31,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,218</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,545</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,179&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,267&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Current</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,039&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,278&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as at December 31,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,218</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,545</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:9.27pt">The remeasurement consists of a net reduction of TCHF 60 (related to the return of number of parking spaces) and an increase of TCHF 5,984 related to the extension of the lease for another 5 years until December 31, 2026</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the expense amounts recognized in the consolidated statement of comprehensive loss.</font></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.392%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation on right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,256&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,247&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense on lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term leases</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total amount recognized in profit or loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,280</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,276</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cash outflow for leases for the twelve months ending December 31, 2020 amounted to TCHF 1,275 (twelve months ending December 31, 2019 TCHF 1,266).</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual maturities of financial liabilities at December 31, 2020</font></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 year</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Between 1 and 2 years</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Between 2 and 5 years</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">More than 5 years</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Contractual flows</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying amount lease liabilities</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease  liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,232&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,232&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,696&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,232&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,392&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,218&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual maturities of financial liabilities at December 31, 2019</font></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 year</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Between 1 and 2 years</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Between 2 and 5 years</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">More than 5 years</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Contractual flows</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying amount lease liabilities</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease  liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,568&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,545&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_256"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;Related Party Disclosures</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation costs of key management, which includes executive management and the board of directors, are as follows&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">in CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term employee benefits</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,408&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,392&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-employment benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,601&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,220&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total year ended December 31 </font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4,214</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,785</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pamela Trail departed from her role as Chief Scientific Officer effective July 1, 2019 and was employed by the Group until July 9, 2019. Pamela Trail has continued to support the Group as a consultant after this date. For the twelve month period ending December 31, 2020, Pamela Trail's consulting fees amounted to TCHF 45. For the period from July 10 to December 31, 2019, Pamela Trail's consulting fees amounted to TCHF 70.</font></div><div id="iae433ad4a4734c849aad6029347be986_259"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">24.&#160;&#160;&#160;&#160;Capital Commitments</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, the Company did not have any capital commitments.</font></div><div id="iae433ad4a4734c849aad6029347be986_262"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">25.&#160;&#160;&#160;&#160;Financial Risk Management</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Foreign Exchange Risk</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to reduce its foreign exchange exposure, Molecular Partners may enter into currency contracts with selected high-quality financial institutions to hedge against foreign currency exchange rate risks. The Group&#8217;s primary exposure to financial risk is due to fluctuation of exchange rates between CHF, EUR, GBP and USD.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group&#8217;s hedging policy is (1) to maximize natural hedging by matching expected future cash flows in the different currencies and (2)  if market conditions allow to consider hedging certain of the remaining expected net currency exposure as the need arises. However, due to market volatilities, the impact of negative interest rates in Switzerland and uncertainties in the cash flows, a 100% hedging of the currency exposure is impossible or not appropriate. Molecular Partners does not engage in speculative transactions.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2019, the Group did not enter into any forward currency transactions. No forward currency transactions were outstanding as of December 31, 2020 and 2019.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table demonstrates the sensitivity to a reasonably possible change in the USD, EUR and GBP exchange rates, with all other variables held constant, of the Group&#8217;s result before taxes. There is no direct impact on the Group&#8217;s equity.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">in % and CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incr.&#47;Decr.<br>interest rate</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Effect on result<br>before tax<br>(in TCHF)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USD Positions</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,978&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,978)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,659&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,659)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EUR Positions</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">636&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(636)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,280&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,280)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GBP Positions</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">424&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(424)</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate Risk</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular Partners earns or pays interest on cash and cash equivalents, and its profit and loss may be influenced by changes in market interest rates. The Group does invest its cash balances into a variety of current and deposit accounts in four different Swiss banks to limit negative interest. In addition, the Group does invest a portion of its cash into risk free money market investments in line with its treasury guidelines.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Groups strives to optimize the net balance of interest paid and interest received by monitoring the interest rates applicable over the various currencies the Group holds as well as  the offered holding periods.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table demonstrates the sensitivity to reasonably possible changes in interest rates, with all other variables held constant, of the Group&#8217;s results before tax. There is no direct impact on the Group&#8217;s equity.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">in % and CHF thousands</font></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incr.&#47;Decr.<br>interest rate</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Effect on result<br>before tax<br>(in TCHF)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHF Positions</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">683&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(683)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(57)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USD Positions</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(149)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(333)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EUR Positions</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GBP Positions</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+0.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.5&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Credit Risk</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum credit risk on financial assets corresponds to the carrying amounts of the Group&#8217;s cash and cash equivalents, short-term time deposits and receivables. The Group has not entered into any guarantees or similar obligations that would increase the risk over and above the carrying amounts. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash and cash equivalents and short-term deposits are considered low risk and were held at Swiss banks with Standard &#38; Poor long-term credit ratings of AAA (Z&#252;rcher Kantonalbank), AA (Luzerner Kantonalbank) and A+ (Credit Suisse and UBS) and therefore any impact resulting from the expected credit loss model is considered immaterial.  Analysis performed included assessing the cumulative default rates by credit rating category and applying these rates to the cash and short-term deposit balances at reporting dates. The calculated loss allowance based on the ECL is considered immaterial.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group enters into agreements with partners that have appropriate credit history and a commitment to ethical business practices. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum credit risk as of the balance sheet date was as follows&#58;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit risk</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">in CHF thousands</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,721&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75,712&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,368&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total credit risk as at December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">173,882</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">95,378</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity Risk</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Group will encounter difficulties in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Group&#8217;s liquidity risk is considered low by management due to the financial assets at reporting date, giving the Group a secure source of funding for its research and development activities.</font></div><div id="iae433ad4a4734c849aad6029347be986_265"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">26.&#160;&#160;&#160;&#160;Events After the Balance Sheet Date</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No events occurred between the balance sheet date and the date on which these consolidated financial statements were approved by the Board of Directors that would require adjustment to the consolidated financial statements or disclosure under this heading.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_268"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Through and including&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021 (25 days after the date of this prospectus), all dealers that effect transactions in the ADSs, whether or not participating in this offering, may be required to deliver a prospectus. This delivery is in addition to a dealer&#8217;s obligation to deliver a prospectus when acting as an underwriter and with respect to their unsold allotments or subscriptions. </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">MOLECULAR PARTNERS AG</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;American Depositary Shares </font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Representing&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Common Shares </font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image221.jpg" src="image221.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:244px"></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Ronaldson Slope',serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:31.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">J.P. Morgan</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">SVB Leerink</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Cowen</font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.476%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_271"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">PART II</font></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">INFORMATION NOT REQUIRED IN PROSPECTUS </font></div><div id="iae433ad4a4734c849aad6029347be986_274"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 6.Indemnification of Directors and Officers </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, subject to certain limitations, a corporation may indemnify and hold harmless directors and other persons entrusted with its management out of the assets of the corporation from and against actions, costs, charges, losses, damages and expenses which they or any of them may incur or sustain by or by reason of any act done, concurred in or omitted, in connection with the execution of their statutory duties, provided that such indemnity (if any) shall not extend to any matter in which any of said persons is found to have committed an intentional or grossly negligent breach of his or her duties. The registrant&#8217;s articles of association contain provisions governing the advancing of related defense costs to the extent not included in insurance coverage or paid by third parties.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under general principles of Swiss employment law, an employer may be required to indemnify an employee against losses and expenses incurred by such employee in the proper execution of their duties under the employment agreement with the registrant.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, the registrant intends to enter into indemnification agreements with each of its directors and executive officers. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant, the registrant has been advised that, in the opinion of the U.S. Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. </font></div><div id="iae433ad4a4734c849aad6029347be986_277"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 7. Recent Sales of Unregistered Securities </font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth information regarding all unregistered securities sold since January&#160;1, 2018.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances in Capital Markets Transactions</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 28, 2020, we issued 1,739,130 common shares to Novartis Pharma AG out of conditional share capital in connection with an option and license agreement providing for a collaboration to develop, manufacture and commercialize certain product candidates and&#47;or therapies.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 8, 2020, we issued 5,528,089 common shares out of authorized share capital placed with institutional investors in an accelerated bookbuilding transaction.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances under our Equity Plans </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2018, we granted to employees and non-employee directors, pursuant to our equity incentive plans and in exchange for services rendered or to be rendered, performance share units, or PSUs, and restricted share units, or RSUs, in an aggregate of 739,750 common shares. The PSUs are subject to adjustment based on certain performance metrics.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2018, an aggregate of 843,192 common shares were issued upon the exercise of options performance share units, or PSUs, and restricted stock units, or RSUs, issued under our equity incentive plans, at the exercise price of  CHF 3.91 per share for the options, for aggregate proceeds of CHF 2,290,358. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2018, no options issued under our equity incentive plans were canceled.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offers, sales and issuances of the securities described in the preceding paragraphs were exempt from registration either (a) under Section 4(a)(2) of the Securities Act in that the transactions were between an issuer and sophisticated investors and did not involve any public offering within the meaning of Section 4(a)(2), (b) in reliance on Rule 144A promulgated under the Securities Act in that offers, sales and issuances were made only to &#8216;&#8216;qualified institutional buyers&#8217;&#8217; (as such term is defined in Rule 144A(a)(1), (c) under Rule 701 promulgated under the Securities Act in that the transactions were under compensatory benefit plans and contracts relating to compensation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or (d) under Regulation S promulgated under the Securities Act in that offers, sales and issuances were not made to persons in the United States and no directed selling efforts were made in the United States.</font></div><div id="iae433ad4a4734c849aad6029347be986_280"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 8. Exhibits and financial statement schedules</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Exhibits </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit Index</font></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.591%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Underwriting Agreement</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Articles of Association, as currently in effect</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organizational Rules of the registrant (English translation)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Deposit Agreement</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of American Depositary Receipt (included in Exhibit 4.1)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opinion of Homburger AG, Swiss counsel of the registrant, as to the validity of the common shares</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opinion of Homburger AG, Swiss counsel of the registrant, as to Swiss tax matters</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of indemnification agreement between the registrant and each of its executive officers and directors</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License Agreement, dated as of November 17, 2004, as amended, by and between The University of Zurich and Molecular Partners AG</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Collaboration Agreement, dated as of August 17, 2012, by and among the University of Zurich, Molecular Partners AG, Allergan, Inc., and Allergan Sales, LLC</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discovery Alliance Agreement, dated as of August 12, 2012, as amended, by and among Molecular Partners AG, Allergan, Inc, and Allergan Sales, LLC</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and License Agreement, dated as of December 18, 2018, by and between Molecular Partners AG and Amgen Inc.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option and Equity Rights Agreement, dated as of October 27, 2020, by and between Molecular Partners AG and Novartis Pharma AG</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Performance Share Plan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Performance Share Plan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Restricted Share Plan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Restricted Share Plan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the Registrant</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of KPMG AG</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Homburger AG (contained in Exhibits 5.1 and 8.1)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Cooley LLP (contained in Exhibit 8.2)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney of each of the directors of the registrant and the principal executive, financial and accounting officers of the registrant (included on signature page)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">____________________</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;To be filed by amendment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Financial statement schedules </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All information for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission is either included in the financial statements or is not required under the related instructions or inapplicable, and therefore has been omitted. </font></div><div id="iae433ad4a4734c849aad6029347be986_283"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9. Undertakings</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned hereby undertakes&#58;</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the U.S. Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The undersigned registrant hereby undertakes that&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-3</font></div></div></div><div id="iae433ad4a4734c849aad6029347be986_286"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SIGNATURES </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, or the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Zurich, Switzerland on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2021. </font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.391%"><tr><td style="width:1.0%"></td><td style="width:14.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MOLECULAR PARTNERS AG</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick Amstutz</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:16pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Dr. Patrick Amstutz and Andreas Emmenegger, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Registration Statement, including&#160;post-effective&#160;amendments or any abbreviated registration statement and any amendments thereto filed pursuant to Rule&#160;462(b) increasing the number of securities for which registration is sought, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.425%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Patrick Amstutz</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial and Accounting Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andreas Emmenegger</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Burns</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Gwendolyn Anne Fyfe</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven H. Holtzman</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandip Kapadia</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Vito J. Palombella</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Michael Vasconcelles</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Molecular Partners Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized Representative in the United States</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;   </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>businessfigure10a1a.jpg
<TEXT>
begin 644 businessfigure10a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F
M9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:
M   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M
M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" $C
M HX# 1$  A$! Q$!_\0 '@ !  $$ P$!              8$!0<( @,) 0K_
MQ  = 0$  04! 0$              P$$!08' @@)_]H # ,!  (0 Q    'W
M\                                        !\-35=L5,0$F+@2HB)2
M$P*D@Q.3Z               #557:13M(*3HBQR,:JYQ4&'"4DZ(N2@^@
M       XGY^DF<E)G2F&*UD]$0K78-YP#2LFJG*D9I61U>N#P
M !25\U5/7T \LGKL,**Q8R$6HW(4ZS1&E<GU0FBEJFYA"E<CJ>PU?$V
M        ,,&4RZ                ADT,PAEYJ@                   8
MZ+V<SX5Y2$0.LD1(2VG:7H[P            0R:&80R\U0(P=1W$F.!UG,["
MS%S.X             &L"L5)N4)3$J+:4I<U*)6/E89\4EH            (
M9-#,(9>:H&K:ME*PX IB6D((Z7)7:5YF8
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M/X%>9<QC*'5I!+E;7%89EFW#>.\[-*O64K4P ADT,PAEYJ@
M                         "&30S"&7FJ
M              (9-#,(9>:H
M   ADT,PAEYJ@                   6DJRK(R20H2X'PLYR*\XE$7<
M        $,FAF$,O-4# RL0*XYD8,GEC*0OQ$CZ3Q2#JRHZ"/$D,]*
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MFJ ,5^<-X58/XZP%3Q85QPK[RQ'B?=O,_4&RESTP
M             "&30S"&7FJ ,4>O.%+/F-M]97*,F6N-9>[S:YKEVGZJ
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M/E/#Y&,W%,CWW+/;'Y!^VK&IE?#Y?3KY][_D.\X_3STPA;]ZVJZGQG.6]<X
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MR/O]=@]CG/GU@[E74M8M$Z]5W5OMYUKAL\S^LWN^QP
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ML'V[L4F%QKV$\?TJ^>L/N'G^"Y2OM-     $,FAF$,O-4
M     "U76/U>Z?P3 6^<AUYWC0]H^:=KWPX?]02;&YH"F@F@>L;-K!SSL59+
M!N'V'@MRN;/GZH!UT]8DL-YU^Q?4>;Q98,K/[W4]A<KRR9W.      $,FAF$
M,O-4                     "%9K5H[?XW*^K;V  !;;6[KKBVZO$E3+"
M.%*X6QW09;/A9_=ZN      ."G-4
M
M         #__Q  S$  !! (  P8& @$$ P     % @,$!@$' ! @$1,4,C9
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M2RRW':ZLIPKARJKCK#@FQBOS9QA6/_IO_\0 51$  @$# @,$!0<'" 8'" ,
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MKR)".JH1ZU1\WG^YE_ =#U I.< G:,G S@>\^X>H%+'"@L?<!D_X#UR0!DD
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M&,NBX=L>_P 0,^>!UTUTKF"CG;0ISA%5=Q_>Z=X?#P_W:GJ)JE@96WXSM
M'OPH]_GYZ[6>'Z)J%>) [15\<M+0R*7S'5PD.$"H?9G@ +$J<-$&W#*@_EO-
M"MRM-RM[1I+Z915, 20 H7DB81YS]63:P/D0#Y:NM!56.Y2.T#QS12.DL3KA
ME=#AT8=,,"/\YU<N(*"X1@5-&$J4&!(J^U]O^?'5GL%/>*:HK=[PB#.P],%O
MJX\_CJIK$IBT B/-C;:74=WIYC[?]VJ.MK'3G1.P$9SN(Z9'QU55=PN:8J9"
M\8Z#I@8]^K;0V6&$RU]7RBN3L7JQ^ &JB]QO+R+?#*(O ,P[S?''EG7#W#%U
MXAO-)#14DTT\LJ8VHV$R1\H[^"(GM,[$*H!).J2)J>EIH&;>T-/#$S_6:.-4
M+=>O>(SU_+V<7:*Z<,4,(GYU9;E>DJHV?=/&B2,:9B/:,)@*+&^"!L*9W+K[
M?6J.(+'2UOYNJKM04]=@,:::H2-UR-P#LV(T8KW@CNKE<';@C7:EQ/::FUQ6
M6AJJ>NJ9*N*IG:FD6:*EC@23 :5,ISI6D'<5B5C!+XW*#ZE13PU=//2U$8EI
MZF*2">)O9DBE0I(A^#(Q!^W512&VW"Y6F97@DHZNIIQ'+G>$CF81YZ#<I0#:
MX&UAWAT.I*#O;^H7.3CV2??TTLRL3 QZCP&JB'DL)0.X>C?_ ,_Y\M;3-)M3
MH/,ZDB>G3WAC_'.J-!(H(TRQQ*697900K.B,T:,?!7E"E Q\E)!.NR.VUE3Q
M?'<Z..5+=04M6M=/M(B=IX6C@IMQ #2&1Q+M'T8R_P!'U:CYO/\ <R_@.A^4
M$J0RDJRD%64D,I'4$$=00>H(ZC7#_:K>*2IBCOS&Y6_E\IVCBA2N0C&R<2@1
MB=AX2)*?E =V\.,FJ[8*5;E3"CMTTEH4,*UY]D==(S>RU*JR/%$L/FLK,9LD
M$Q *=57;%:HY@M':*VI@V$M+/-#2R<SR58E%2-GUF,@/N71[8;8;>\BVJK6Z
M;2(Z8O$]%OZ[7:I#),8ATW(*<.? ,/:U<NUNZUML>CIJ""WUDR<N6X03RED4
M^T:6)AF"1QE=YEE* ]S#89:OB*^U](M!6W:OJJ12#R)ZF21"5ZJ7W,3)M/5>
M86VGJ.OK<9=CW"W%%'4>BTL5HNKMS8JZG$G+WY)9)J42"$Q29ZF)$D0X920&
MC?AGL#H[10W&*NNS25E:FR*6CCVQ0X7IS.<-\Z[OZ->3T^EDC;;OY.=+'435
M%QO$989]%%+2M(-Q/ZR83/&,^Y5W?W]5O\GZ+N"VWF/O_.9*RF829SU:$1,X
M(QX(Y7^_H?R?>#SZ)SJJY3\E5])YC0XJ7!RQ3N'T=6\-@YFT>9/75LX.X6LT
MD,UKL%JHIZ>-8HJB&CA6=548!YVTR&0_2E+&1B268DGU.(>RNQW-*RIM:FV7
M2=C-&PDD:@YQ;=()*7O!$FRVXPXY;'>B$ HUM[&ZYZ:M-VN-/!5&/;;EHM\T
M*S#KS:QI(HF>(^QRH@'&2_,)4(:3L:ODBRFKNEMI7! A6)9ZI9?>TC%:;E#'
M@ )#GQQJ;L:O2U4*076WRT;;3-4R)/#-%_K-M,!*LN.O+_G"9^GMU3]C5MBN
M$,\UVJ:FWQLDCT3P1I+.5P3%)4QN (7([P2%9-I*!Q[>J?A7ANEK([A362W0
M5D0'*GBIHT,>!M#(H&Q' _I%4/\ O?EI*NIH*F"LHYGIZJFD$L$T9P\;KX$>
M(/N*D%64E6!4D:X=[6JB)Y8^)HVJHF"F"IH:>".:)A[2RPAH8Y8WZ$,"KHV?
M:5L+!VP4INLZU%MF2RE%6F>+8UQ20>U+.AD$+QR=?D4<&+"D229(U4=LE"LD
MPIK'4S1+CT>2:KC@:3WF6-(IA&/JA)'./'KJX]L-"*.,VJV5#7!]O,2OV"D@
M']( T$O-J"?",XA ]MNHV'B+M0NUYI(Z2@@-D7<KU$U+5RM4RE?"-)@D+0PY
M[S*N7D(4,^T%6N-\N]W$0N=QJZY8/U2U$S.J9Z$JI[NXCH7QN/F?4NG"W#M[
M+-=;-05KN-K2RP+SB/ ?++MER!T#;]R^1&N)_P"3[=%NL\G#XAK+7-(7ITEJ
MHX:FE5SGD3<[8)>7X),C,74 NJL3JP=BD-%P^U'6UQAN4B$H*4*]) Y'19MR
MB2I)^FR-$%^AN]HMV"\15-?RI8Z.*F,IWUGI2-%LS[8C7^<'IX(8PWOQXZ_]
MP2CEP+=J5:08WXI)1+G'7"<W8W7S,@^S5S[$K]#/R+<E+5TY/<JEGCIP!_M8
MICO0CSV<T>XGPU0?R?[,EM45UPG:[R=Z6>-(Y*./_81PN$D=5\Y>8C,>NT#I
MKA#LGX=X4J3<-B7&X %89IZ>-8J;/BT,),F)B.G.9RR@D(%R<Q4U- 6:"G@A
M9_;,44<9?^\44%OX^I!43TS\RFGFIY,8YD$CQ/@^(W(5;'\=<)]I\UGI/S?>
MH*JYPQLS4U4DX-9&K=3!(9R1-$&R8R9%>/)7O+M"W;M4O%5=:2KMB&@H*-L^
M@/)S!79/RGIY4(&W+W$1.D/M*Q?O:JNV2#T/^8V65;@R_P#6JA'HXF\V'*"S
M3 >2GDY\VT>V*\[8<6JV!E93.V:HB91[2HO.^0+?6S)M]VKEVPK)0,EJM<U-
M<9$V\^IFBE@I6(ZR0HJYG9?Z/FB- <,ZOC::;M4XLIZ4T[34=3)UVUE32*]4
MF?BC1PN5^B9(7QY[ATU4U$]9/-554KSU%1(\TTTAW/)(YW,S'WDG[!X  >O>
MN"^&.(9UJKM:8*FI4!?2%::GF8*,*))*:2%I=HZ)S"VT=%P-<2]E7$U#<9AP
M_2K=+5-)FE_G4,532H_A!5"HDCW\HY"SH6#QA2^U\C4'8G.>'9))JQ8^*F?T
MB%1(#01J/^I2L(RS/(-VZ>,\M)-B@.BM))1=D_&ESJ?1:^EI[52QD\RLGJ89
ME;&<"&*FDED?<<>(50,Y<=,KV&\0)Z3(MVM:R(I-,@])=:AAG:LI,,?(!^L.
M;@],8[VK7V3<67&OCI;O2QVNW12@U%9Z335#/&/$4L<,DA:1Q[!D"QJ>\YZ;
M6G[#$6LS0<0R06YR"T=11K-5I]8)*DD,+Y\F,4>WS5SU-IL%LLUII[+2TZ/1
M01[&6=4E:I<]9)JG*[9997R[DKC/10JA5$,$%-&(J>&*"(>$<,:11C/CA$"J
M,_9ZM1\WG^YE_ =#^R-1\WG^YE_ =#^R-1\WG^YE_ =#^R-1\WG^YE_ =#^R
M-1\WG^YE_ =#U<:QK&L:QK&L:QK&L:QK&L:QK&L?LV=9^'Y,ZS^3.CK.LZ/Y
M,_M=1\WG^YE_ =#U>NNNNNNOZ//Z3']95'S>?[F7\!T/5S^3/[#G6=9UG6=9
M_)G6=9UG6=9UG6?V_=K/PUG]%4?-Y_N9?P'0]>KN%!0*C5U;242R-MC:KJ8:
M<.WU4,SH&;X#)U476V4J/)4W&B@1(N>S2U4*8A'7F]7SL]S#H>F/'5'QGPM7
MT]754M\H)(*%#+5L9>488P">88YECD9#@A61&#-W5)8@:L/'G#'$=3+1VROS
M4Q*7$53#+2M-&IPTE/SE42JO0L%^44'<4"]?T^=9_)GX:S\-9_3$9UMUC0&/
MT&-8^.MOQUCXZQX]=8UCXZQ\=8]0Y\M8]_J8]VLZR-9]VAGS]6H^;S_<R_@.
MAZO%7$=/PK9:F\5$3U'*:.*&GC(5IZB=MD4>\@B-<Y9W(.U%8A6;"GB/M5XA
MOU/%34H_,4*LS3-;ZJ4U%2?H(U1MB>.-/-(]O,8Y=L!5U7W.Y7:2.6Z5]5<)
M(8Q#"]9,\[1Q@Y")O)VC/5O-CU8GIKIY]?MZ^'@.I\!Y:_S_ )_CK/7H<$>X
MX(/VZ[%N(I93<>':NHFE,<:5UN61BZQPJ1%5PHS$LF'>"18_8ZR,.\6S_7V!
MZ]1\WG^YE_ =#U;]8Z#B*UU%IN2LU-4;3NC;9+%+&P>*:%L';)&X!&0RGJK*
M5)!O7#LMDXAK['42%A1R9CG&W=/2.HDIIL#NJ\D3H77Z#[QY=?S91QLKL973
M'ZLD8S[RR[3CX=/MTE)2Q!IE@]OHHD[ZJ/W V?'WG)\O#7(IPF5IT^4/AR\[
MOLSG'V#&KG214T:21J48D@Q]2#W=P(SU!'A_$:[/>!;=PW317=99ZJYW*WTQ
MDDF58DI8ITBJ)*>"%>J_*;1))(S2-RU'<&5/]A:CYO/]S+^ Z'J^)^S7%W9G
M3<37:.]4]SEM=88XH:O%.E5%4)"-B.%:2(QRB/Y,]YD=57NAER5[.>&/1J:G
MEII97@7#U)GD66H8@;FD"GE+DC($2)L\$QUS5\(<.UM+#1RVR!8:<;83!N@F
M0>)!GC*RON/5^8S[V[[9;KJ+A7AV&.");/0,*?K&TL"329Z'+RR!I)3D _*,
MPZ#'@-5G!/"U?7PW*KLU++50D%3\HD)*G*F2FC=::4@@9,D3;L -N ']AZCY
MO/\ <R_@.AZG 79W3W*D-VXBIYC3SA?S;1B5H.?$>K5DIB(F$9Z+ FZ/?WI#
MN39F@[+K#17PW)=]50!,TUGJEYZ1U9Z%WE8YJ(%!W0P2(2)#WW=5"Z[7>'K9
M;*.V7""@BMU=/5R4[)! M.E3 L/,+M$@5-\#\M=X4,1+M;.%Q^UV*FIZR[V^
MDJP33U52E/+M.UL39C#*WDRLP9?+<!D$=-7^Q55@KWI)^_$V7I:@#"5$&>C#
MW.OLRIXH_O4JQI>',<)7.^U"?*LU.M #]&!:J-*BHQ_M#\E&?JK(1D.- $D
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M,!5YG2>90!W!"I!#L/5X*@I1/67*HB2H>@2'T:*10Z+-,S_+E&R&,0C(3<"
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M[QX,K#NNCC#1R*2CH0RD@@^IP28Y+]34-2W\SN DIYU/3<PBDDI]K9[D@G5
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MGHX)*FJF2"GA77)+(VE$7WGWG8 ;DD  DXRWM7D.;5'FM'7*U0;Z(I8Y8&E
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MH'N'VGF=_3:-'W9%;XCIX7YVQ+1'7>/=3O:^Z^(WZ>!^_P!XI!PR"?E.EB=
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M^Y*MDJJ8F[T\]KE3XHWK12<G3]H,HJ^T8/:[+,AIW^21:AJ\CDT[4LCT]/\
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MAV:QL >1&QV(]V(I6DA!%M6X:WB#X=+BV/)]5,8:VDEGN5>*:&%F[UF$@F9
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MV37,P"U^-+,I*%',D,(KJ$UGTD'&BV]AOIY6FUA)K QB\HG$)F3-:X(^[1B
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ML,"6QYA,2(?P/_\ (Q'&MPM@QY HM3F?\VFT8_UF>)A;QY>OO#._3[H\.O\
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MJU(E"?,<4!;E0WK+#!SRN4,=M8(0S2E?C+!;E1Y<K_?69!G?UWW6R2IBR>P
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MKS1F#B?:)1UC@@\7*T@E[^NL3'6-?>VSK'Q^/':7 MR Z)?1NXS&,;XP!J[
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M%]@\ F/"*O%T\YGB=NISQ)-"1B8\^)64[U^R>/2MTF?MXY3&<Z:C9K"[^\6
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M*?R3^(^Z/[._*DZ.B/!:5H#P^'BT\8_L,@A^&G',JHY]V==]^UHRS.OG"^D
M@/V4B.L>M)?F&B@(#G6'6F_$WO/>PR^V9Z1\!@1\HX(#&" XD2$HU$A*-)$H
MGI,3'28GSCA:$CL4D!6L(UT$ C:(QKUTB(TCY_6(G[XUX;\F,4*'-)O)=N'D
MR<ZD($(EN#6?#$Q$Q'AUG37AMAA0^X^!$F;=!6 ]86K7KIKXB*>I3ITC3\_(
ME$$)1,$,QK$Q/28F)Z3$^V/_ .3O_\0 *Q ! 0 " @$# P0" P$!     1$
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MQ@X-H1K2Q0UF[(<VZ1@#4FM;(,CRC:1#\ TN,*P3LDZ>252@QRZ(5"@8\ET
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ME\CXQAHU!&7:]!6)WU#G3BI(5!\\Z>RW$4/"/H  =6[4RQ85)(2     ! -
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MG,SH*#2R4:P5)O\ .#9$%!$2F&#O]1!NX:XZZ&81>= %&@)U1 -^L6_#>#]
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M!^W*P)GM"2@O8'!;P_ED9QU/,DHI.?\ H!36IM4]V@\!-.&@SXP"2N0$1$F
M95XAJB8:BZ#UE0WP0_V.%(XDLTA5%HB##=+P9:+93TP-0GZYV0)#MF *((C'
M_P"G?__:  P# 0 "  ,    0
M     EAIA,E                %$HI@EHH           DBJA8N
M      < !IML#BLSH             L                S
M        %MHEME@             S %-$D$               L  !A!
M         S $-!HIE                                 S
M           'NK@< $( $8  #  #X  S % !@  B   $ %  H H  SX)A ',
M;-(  !$DSC  S 8;_=K&W0L '=00&4Y9 DRC#.8FQ 3[  @11CA  S 9R0].
M+^Q(Y^CUAOMQ= EW]SYP#P@@Y  DMGPB  S F95H &PM/ %C?H$ANV '[=6$
M & $[(  $.EZ=  S                                        S
M                                     S
M                  S                      ,@@@$             S
M $HA  E)@           $&E%AL,             S !,,I----- !$ E,DD$
M                     S !-I       ! )@$9% @  @@         #D[
M  S   -X(     $M#M      &3P  $L@.@0 #X<AF  S  -C\@
M                    &@  S  ,.*@
M     S  IEEH                                  S #L
M   $?4                     S "^H        0 " 6_,
M        S $$X       $L$]F+)W %AIMDI%DL!-         S "5)@
M "0^C73M&     $ @   $         S  BW       !KVVVG?T
M           S  &8             \@       '"   "P       S   9 #+
M               U>  $G7  'ZX      S   "L6#(             &.H(
MWFH %%1:      S   &."Z@             ",^P#V*F $T_!      S
MUCC              &;RX \I5 $MD?      S                     "2
MM8 5F7 #.7C      3                      "H   ]   'U       X
M
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MA4F8!K; -$.%*P%5W'G=3*VM73<E+:"0- P"<BB&],#97 #-9L&;H "6/2:
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M>6O0T8!?A-95$(T7R'T@NP"B^ F61]ES@%8D$;*X)(P4Z0EC#1$(+RS-!9H
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MFSZO53_GOII'HW[8^GUU3IB3._-R3KKE@S?K+<9V_NZV1+AO=9&3B:=DZ&?
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MI-'4(2F  ,62WK$[8)\!       " &  P ;'^#P]AX/MZ$FWP0N!L20S:.+
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M"PTA, 6 %&N"Z3 .3)PD J#5L*R9ST>\$1U'=);;_KG;W2IU"37*8 BT$-D
MP6IR5A(XRF=!EIB)2+"(O  $MZXV'&15;FJU55)S3)J,X!(G=:B  ]$4#E$2
MH1Q5:6*)D8PI:U2@LD*72>5Q( P4< ^L%L7N&7&3_;QT=+IF'6@FD A<,.HZ
M_E%4814$UGH'8HQA"IJ97S4!ZB* F#E 3DJ\]9RF,>%GDC0 * 4 A0@"!(('
M^,A[#P?;TY)5I;F-C(19 &<.NXTI0MAPEU8FE(*A* 2*2(1W&,QP,I-""[1
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MT@).X#=ZR]2'#GE@7!U7NKE;7+XW6SZOO_B3K9]7W_Q)UL^K[_XDZV?5]_\
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M?^]>AQH; %'=Z90,^]XG<&"[Y-($+._EF.\8,_URZ3"9]?N^)UL^K[^$?U(
M;8 +@JY70+E@I@ T.#0;UE,E@L$X03P= %%F)F5=KMXA1<NA5?(%KZ'XY#RU
M/[(>EZ=YUYU$432*/;9G5-]>*EIO:(-*@J*0&0 /Y[9ER1RZ[>G*NV^-UL^K
M[^&!XAEA$0=001[DC8HZDZ5-<!!1<&$?*AHU'9<6;4S_ '+P<"3&R.TRGFN?
MMCD-P4V,QYO;%3TZ=,1X48DP-;<29_[P2"F,AA T.358,X;_ (,ZV?5]_#H$
M13N+AZ$LU<\G'"P)*Y,!4I1)4@\6?L29KH47JH.GA<XX P F88%&.=M<\!2$
MIJI:HAJ];?/B\.$)M&BEH.10=$A/\'=;/J^_@-S$500V54LJGXM\40=(]V@0
M H.)S?P3)T)"G_>"Z412X>!GQ60!%J(&>Q#3T0.N.-$31<:\LZ!.U ?   4
M 51@ "JL#+P$SE@ ("@$1%$1&?QCK9]7W\!^! 5#+3E5L86&X(&2Z!O(RFL9
M<ZWTXA(2#-#S75\@N#T$3BTNHZ*1[_LC2<@_0@WH5P*5SQ]!FX4'BF$!'">
M(,JP"85( ':6?6#A8_-6,"F,RC,KHA0BK@TK.\!]!9\^'1QZ*Z\YFD-%#O\
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M5( <E!-9WR$<I&98)S*J,J8 'ZXHB*(B(Q$R(F1'3_\ IW__Q  J$ $! 0$
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MJD\)!_)X-^;"E$9C8"!\%ZU6L)#O& ]2:%316(::O49,B^8H[+O59:[%!,Q
M 4"BA$11&G/US#KX424*Q0"!$0.>M GL'5\>>1NJT>?"JF92Y*"F+V\C>6C
MB/1I(&H$WU-B'/QR 0K@T2-JRL81&A Y=66(/XI,!B&W"? 'S[#*YGG-=WWJ
MEA0>'(<8]62C)LSI-?I-( "  05AA0"84"VA0 H'DFL!KEE[I-9:01$-4F0D
M*TDJ"\G>9Q88L9];-%J2Q_33@0SO!M@-RA+4.Q+G"7@, #Y4 E:HG29L E/]
M1C%@). KD='Y?9L^@LIB1 817W(\6:_7;DF#.XR"3 ::!6:WT%RE-<*LX"$+
MQSB!$[)4ZY\-2WD -T^[I.+3M?\ 7BK4X)5J@CI=0'F<HG&L@%_Z&IDW"75W
M*S ?"E(B2.#S^)LY!^A8H239/(TN"&CG>D&^)1 PO7HF#/%D& GDXTX?2P<,
MC%7_ .(E9]IY*A4AU:!STS<9U4:>$% >+[F).&]$EP 0_5.X1J=9:;5<1TNP
MTC,A")K6"YD5Y%Y[A?.Z)'Z\4VP+?N='(\6A_$(/B3-RMU-L4"9KV=W% OXA
MLX4'%^[=$B".-(",4B_@T&QPXD)/[-4/H#)YI]+H)WCI_L9004%0*"HP?EX!
MV"^!^%R#*29?:@ 1BCI];\AGFE$/*0!5 WFBL%:"@PGJO^X'BS"LARYL#P(+
M,$75B=,#U4!^B#]@9G&$-JP!0!=QR\U0.EKR@T!!+8FH1L5]_P .!UX 4I>)
M!(P;R46K' U4VI5@\\9@)[=Z9Y76&A62Y. 1%DFK8-4Z?2GISHOP>(W"@B%:
MA0A1J7T2)&0]I2P%\X+*2O*T61<(\M>-WDIDJ%%(/#H6,4IX8I?"G?I[P,<'
M#3N>NVA:P:H6X>*VT=16DI _@!T6<@@X&]]>&I]A\S)(ZJ60(J=,/V[%4\6A
MD:((/'"ZG$3/%J%G4(DXQR!$DBX4QA <@(<8V10;Q;4^.= ,)VR]H*6H#99O
MJ6_XNH]B%Q/".,%:-?TG3(7A)!\LJ5%>?O97J2G+]%,,+8P<(!O53/5)>NB$
M0M<\6^4BMB7FU)Z&\P61D/C!Q>H#-I(42!=9#N 6N8GKT<R"A0/Z L%WC5!&
MJE(]\U ]7)$.CK1(9#"VIS@"U*/(P*M\.L-7!AVC)Q<3*KA:C:*._3\ CH8)
M\!! LP479I,LU14?R5*G3R9C\R@(\60$]!Z>XBC(D*V_[?S_ #^#2U5>)"W@
M\M?'GN/X)5 X,#AU$)SRDD,>TEAV<0"3@?;'BPTKSD,#[BBQ8_\ . 4W-PJS
MD3)G&!$1Q/R#QB?Z0&WB<#/*(WI*U," #)R+W=54+M'*(D C2*=3 *@M"JCK
M-1$WC92"#W[%Q&(;$_>__P!W\LD441!%$?,)$3TB)Z<# $0 #E>'Y6O\]P @
MB2((B-$>(^QW;*JV558!5ZPX?@Y]#DF;$7 !6!2' 4\!6:;>D,X,$XQ1INX]
MA';'7 2$)AB3(<+\48X*\T)CJ^JAJE!?-.WN@DF@LZ#EPM*8-H(/A\.!7QPH
M/R%UZ<1DB0+*@<DEUA._E(!8.%+.]9(\L5Q(J4-?/K_7]EU4%4>1X?\ /J3\
M8-$1RM\ ^R4_"]_H$*[! 5=3WT0B'+S7OK  E(9 %4'OVQXLSU9$A2]6IB+"
M"H7SX$O+C*;M"#5$<^4.]A>4%0T6\L&N=P -5T-M7P\W\ ,C, L*>8BI%2M^
M^"J,VCHY6X!3P''7$<BC0PB 45B(%J8\K -8)!F#KP J8THF5 K!!K(6SE%=
M^4=@@,4.D2Q0+V GL^@I409?P<NO$W=L+(\%$*<.'0B/E((I>ZI9W.3D[PC"
MF)'K$"N2L !C7&(4%N[U&!Y$ (A$V/D_A&F[&!'\<;#1O50$X6M"KZ7Q9BY@
ML0%;[Y*_Q_P!@V), 6H.@=\3\<P+:[T*H@_]KV]9K\TLP+Y>4O\ #'^<)4M>
MX(X)8.(8_>3Q9A"K4! 7H>Z"M\EM2^1\R S4[TSLCN&*T/*WOQW)_P FI@$P
M65$=5V61B1PI ,-$6E>:Z/\ H!@7T$*M0 Y&/!16HS4[/HD&EJE-$]Q1K">X
M%,V0+FU"D:1SD35.?V:ZM[&M6V^[WD@:XVA$3UQ3J7Z"G!P9JTL4H(1U]G79
ML$)TL&C9J1G,6S%J.",009E4:V*+_1??I'FL^(C,]!13P/CG4P",;Y<EMA.@
M?8, WBVRCQ;"'>S^HP90!%6 %E7@'M_;RS<\DK!T8,+T07GRL^:E>B06@\/T
M-G)@(</;5<,0(E9)>Q@!V(9(M$0 NLX;.#5GUA#9H#*10(**6>&9,+%JC?22
A8 & <_=/ZBZ!Y7OUG312UB2>2<"*8 ($#@'@/Q_U-__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>businessfigure11a1a.jpg
<TEXT>
begin 644 businessfigure11a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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MU;)K P;FQS:>.S1<[?ZOJ<7L.KQ4Q2EUZ1+5ETNL30E%TPF%0
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MBWU]RRMK\K5X=:?.?GL&A97& !4H    5*   'K7=]E]?>_^UKV
M Z0[*JEU:PF0   +"68<5/QI^,_E#T3N^SE;6>1.Q&QZ^PR;^SR;O!<GRG>=
MWU_/Z'%R9LFNQ3%P<O5\[D3M_M[O-FNS;O.:/G]]L]7SOSGC(.MR@ $$@
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MQLM<8M+@   "TN    BWWO\ 1_N'M_>]F   !C+BX   %2,2    "TF@
M CDDPG,0OF%;DK8E),A5,+0ID10 8S(    8S(   !#!E7UD  !:MI:FI4
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ML]++J<^.76DG!F^U/$^PE8\HC$DPVK^3GK?*Q;Y$P!4% 5*)JB@*F.62
M&,R    &,R   'U)R>E]D<+L8D7&0   %# 2    ".9P!!(   8R41U?E#HZ
MBU*R  %"H  *%0   "A4%"H !2+>K\_;S18  !$(M4    % 5    .D.Q
M  !A)9H,VO\ R?\ U_Y=]$<KH]SJ;7G>WJV6KQ>3%TF.=WBS;#)'C6]H=;K;
MG4X[\-EI-4\=Z6@B0        *9)_8+Y_P"X_1'R?I    * J    6EP   !
MT9V(     (Q)-#FP?R>?7?EOO7,Z.KK,ZU-%,<KMZN^Q;'5X<O*L<C)$BN7I
M,63#DIS$XO)>KS@    *E !!6R8 I%_VI\![/] ?,^F    M!<   "TM,@
M !MCJC%+$I)BRMDJS%(5 21%E*-7?'^,?M?(8RVU*Q*9I%:P6A$T36"T(FA6
M%LQ=,4K:Z8H52@ *3%8D#ML&;])_+>DI$H)#I\&;,R    6%2X    QF0
M FFPFOXJ=3E7;6C^G_![OS/OZ6E9.[PUBYK9,63KY><Y<7VYJ;?38,\J6ARZ
M_P#*#]@^6?7O#[GT7P^M\4>FXO?ZCTC4VO(-S3S9+>B\_:R3D\^VM;E,^#M]
M;8]"UMJ55XUO\R'+VOG;_FNQJ^@X]SX*]'YZS/A   %*OZ*/E_TCZHY/4 &$
MS    &,J7@   & S@   %Q$FOX ]3C;OH\W]8^%Z*9>.8F.MK,A/.&V(A[W@
MS;?%EE2TV7%_.U]'\!GK:=6<EJQ:SGB<-\<2+;B+82#;'>F],F$66$RIED-6
M96V@S8JS4 4*@':X<_[Y_.O?[#'< 83,    8RXN   !<1C.    4)AX_EP\
M]5[S3+GDA6)3 %"I'3),"?..9VJB\ @(D!,(E,(E),6U7RH$A,%@!:7 "JEB
M( %I<    6E2H   *F--Z    HW.QH]/M:*F6EZ)    5)IKM/H?D5^5OW]N
M=KF2<VO#QY<./:5RQ*7Z7I>>T^AVL&+8D9<&+',C9T\>'9R[>MTG2XD#7VN/
M\_[%60 D@ $D D@ $D D@D@ $@@  $D  D@D@$@B>]]#Y3]0OTO^$YF7&%2Q
M4L  $4E&NTM_\BORG_03M?6>#S]ORT/%M;C;X_-\;U?/><]MZE[#Y=J(RPM7
MH[CI<;0<_J;;=YNMTNEFU]K:=_S.BXWI./\  _6%X!)   !)   )(   )(
M!)  1*V-    *VVW0Y7ZH?J#\%TZ?(G6CQ_,]?UGCFT]8UIV]&>7'RDRW54F
MLRI0L&U\#?#_ --6UVR":)J@$ $@ BTN2 02 !:BY(  ()(M+@D   BB:@
M (G;&EZ;ZKPR<22)()( 1'H/6\YVOMOGORIL4Y'-7G8=;$\K:G>8LQ/54>&;
M:VL>]ZKZYU<DHUNEO?D5^4?Z"])U_+;+8TM?79QTS8-;>UF+>]%])X"7GT>*
MX'L>7X7L@                     *L7Z#?HS\8>S^U^:DD  D@C,C;)^6]
MO!3'DW%JWTF??)S]*^\8;<[DG+6OB&Q'K6O;TW',F6NT^A^17Y0_H#U/HO)N
MGYV+CVMOT>1H>'Z34<+V';^G^>V[&CR_ ]MK/.>N
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MG0U&[SNLXOK><Z?EN ]A\ZYWT7D/LOX)^O\ Z!^9_?0   !4H    5!0
MJ4    .CAH,F+X^V=/[TUMZ=68:)L6@6B=5>MCFI,Z)C$D@;6I^8?Z,_#6*<
M=E,]U\+'MX[TOQ*RHQUKDNV-:S%:D[4S!DAY+)U*WBZ,EEIR6P8\&5>V39UY
M>OE^[OSS^T]QH=F\    QF0    M*E0   4+#(    ;2K\P>KRKL^KNJ9?1\
M6QQ<8>TM?E[UZVC<LOGD4^D<&Q]+ZF[%)1 V.?\ FI]__&=-K3K52U5;4M6I
M6MJ3"82I"H!:7 H5 !)P;/WK\"_9NPTNIE    ,9D    +"I<    8S(
M3(C\_M[F?#70YWZF<_K=9BSXYCTN'(2W!R)UV/)=#UC'EBDHUNWH?CK^KOYK
M>F^%^V=7PO7\EU/,]9R?0Z;I\/F>YY'K>-[&[4V\^?) II>?>U^:\]Z+Q*9
M   ")^[/@WZ[^F?F7WS,    83,    8BXO   !0PF<    &T*HM2   @$HQ
M)(6QI_G_ /<_R19.FK9-:)1-4IJK6C+6V.J:S"90QRR02""2 EX\_P!V?$?U
MU(U=W.    8#,5   !C+BX   %2*20   #&30     1248TQ+S?6*5E)<
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MGP*G#EZQ*SE#D9N3KU,DWX"CDGWYJJR/2<A@-CS<TV>G/_7IE.F*K/2\NV!
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M0TYZJ#GJG.>J<Y\ISGJH.>J<YZISGJG.>J<YZISGJG.>J<YZISGJG.>J<@W
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M5-J&<-$8$E0U@:H=G,N$.RK;-^8WTI(3<)O)"N<IYJ:8?M#*Z7=G$.JF@S(
M;Z?#*BE"E?1&...!I#<]EE,!*Y9Q;J"14FJ;H+9<K$U:^5LFJZ\^H TNKQHJ
MHYO9";1RM5=_E"P7$%;2:'EI'/6#E'E&C.)?G%-.H5=S9!J=NF.-%O\ KQZH
MXT6_Z\>^.-%O^O'JCC1;_KQZC'&BW_7CU&.-%O\ KQZC'&BW_7CU&.-%O^O'
MJ,<:+?\ 7CU1QHM_UX]\<:+?]>/5'&BW_7CU&.-%O^O'J,<:+?\ 7CU1QHM_
MUX]\<:+?]>/4?&.-%O\ KQZC'&BW_7CU&.-%O^O'JCC1;_KQ[XXT6_Z\>J.-
M%O\ KQZC'&BW_7CU&,C<K9KA 2]I/\ETT2M1P/L'M@%"BI3:KR54(/\ K 2H
MW@ "L>8FN+@UB!>IRTW5<Z=-#_..*2AM:U&B4H42=0"3$P B=F$**0K?TR[Y
MP\QQ1NJ]XC)JV9&3LN:;G)QMJ9,RA3*#RJM)32M1@.N$6[9%UE#RV7N4I:UG
MZ-5DTZJ0NW+ 3,J<:S*DJ9N:!IK MZR!?N!I"L+JL,-ONYH?RDL%W-!Y+,S<
M#EZH'.XDC3L!ANU<G5K4\TEBX4;.3L]T2LW(&VYE\*90R$IS8J*%8K7"&\L;
M,8;6E:F<_FW$4PYQR<?;#N6++MHMDYH2M]J^NHP"6U X:<%4@92V7GU+SC(2
MJN.&@PFWK,E9<,,3K;@4J\HD:+QJ=.JN$6Y-RMH69.(9>:6O/,*EE5 *T #.
MZ=%TUTZ>:'+78E[4D)EE+4U+R$LVWFBI(#CBQ1TFOH4A=K2DM.B=EK9S@G6G
M XTBJ39JUH-VY7 W2?HP,HI!AN3L]4],3DNHE=IS*EIK,$Z H$U-(D\I;,S\
MW+F:;E)-8(9=I7_8% P&CE81:-K2CLO+2B)AN9WMAGR0"OE5KCCLQAG*20SM
MGK6MH)E9=;9]I,6W,LSL^Y-,J04G0$D8UV17VQ7VQ6*^V*Q788K%8K%8K%8K
M%?; QYP/[1">JL85I5/6*13:GK$4VIZQ%-J>L13:GK$4VIZQ%-J>L13:GK$6
M)(OVM:\JVQ>I+*2'%# :=?/$NQO>79:K4I0 ?;3_ %<-ETAH:7"$"FFJC2,M
M+'FLG<ILFF6YCYB8D0I].%4.%L+N+&FNV#>2NX[7.<]1IYQCHT0F=EE/KEPY
M\ZVF^M)!%U PO$Z*09EE.;JL?.FC?V]J=8&L809N7!93G!6844-C[0T@^C[Z
M1OEGYRJZ9KSZX 4]L.3<NU+B:6X P5)0%Z:J7YO7"9IA>=NK!S/YRGT<*_JQ
MA%H2CDN[,I=!98_.*H>3C31!G989JKGYY-YO \H17DW\;NNGY7\SF7=\&C&;
M5G2.9NG*/5#]GY"N34T[OE5:F."MSLB\J><!.G$TKJ$<$[G/KSG68X(W.O77
M/O1P3N=:=_+ZS'!.YUIW\Y0Z,3W0FSMS]D%(GW0%5YR(196YZT2[P@YCIY5
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M>2^['&)%0.!I.IT"B:GV1QA1IX&DZ#2:)H(XQM4KP/)4YCR:0<HFQIL:3'M
MCC"CH:3ZA'&!!_X+*=0CC&T/^$27= RE95HLF1/9@90H.BQ90C700<HVAIL>
M2%/9'&)OH>2ZA'&)LZ+&DSU1QA;Z&DNH1QA;Z&DNH1QA;Z&D^H1QA;Z&DNH1
MQA;Z&D^I,<86^AI/J$<86^AI+J$<8F^AI/NB7MN7?<"'+.EY=/IM@8[#LA<M
M*N!IQ#0NKIB!AS\\;QE/JT]4;QE/JT]4;QE/JT]4"4E4Z&QU0E 3YN U?H!1
MHE1U F IR9%;UT:^;';#[F]'@ X%8CGQC/YUE*D^CC2!,.7R"E5*5T81GSS8
MZZ X>W]?LC?!UQGS3_S&>JS]JNC9!>HV-=?WPC/KVGV"&%*7YV'Y9K^CO?\
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MQO"V7/.O8:.:.#+8&B]UPFS+702I%4DZ2,*P+-MA.B\/9'!ML:U=<<'VPC
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MD@7LDA9JIM5H%["V<LQD>@M(A@E1N!:8,[?-OZ.OY*JM#2)S?LZDL'W=)/\
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MMUG2SVEG_ %P,I@O"]*A<5J$C+1,VF6=I#$.^=6M&CZ#AV'KYT[49!:TI)T
MF3/(.B7#\N7K_P TVV'X/LN:)HYW"1#M;LS=O'=9"M*3=<V)>5WM6<BLG0Q2
MM$J^>SVL'#_]+,U$VF^YH>$K0D0^9^Z24N\7?5 ]L@QAHB062:MP9+IZ])2[
MG--JK_X,H%!JKON_[(@I&+A@KS<<[GU5FI'):8Q8()MS]7V3W9V<TBF,I6C8
M=" 73MT_0 1>$ @39<28.B7[QVZ2\><+>B=4*4!.X3!9R[12$%!/GKUW"O#$
MU5%:4R4FK=)GQ#J*Q(CX5X@R!=)0GE#.GKZ6-405-5  D1#D)E< 3<- ++J.
M:2A>0DC@J552D2)+M)F0T#%F)BHU"T"H(>)D*HD)"P@=&EG#E+FBX9\B(=0Z
MWJ5!2GB02N2B93-MC4F!B'"N%PSQ6=*$)"U3Z1^S:(H2%I&&Q[Y:DJQBDR!S
M)N8X*4?(?6+VLO!6#2E1=O%E8$T@W3;@R3$JAQ>E2@?98QH]RN9@UJ4J?ZS,
M;C?FG<RJ/?I,GT@\Z#?HEI9W +Y5D_;\2;@*PK/T>#1$(MP*YG;]$3) %Y(E
MUMA?A92% 1>+0A*NB3?.=2:K<0FWH;YS*34IVC$IY3P"<M-C"D5O:"X?% )"
MG*0[*+#CE$5;1;)LOEPY?II1"4I/!A#%WYQ*I"V6DWL<*8-W*J"J>+S>EK #
MW"T)A-"/%*4\"@#5E[7X#*PEHY*C(F594^T>YD814<\!G,2M96$L$'@=R,E6
M3SALO4?I4T'2+N.\R5FC0QO9RLNWKM8O2L*$[K"T>^QZR](37OL'\&A'IAGK
MF*=@8UTE03.U/U@Y4Q^3.XMS#T6MX_2%H7%+*DG2;20T1&I47)=.DJATR6AW
M*<EZ>FQA2,&5!ZJ%JQ \Q8$DI5FL95(3=Q+JR46M*WMGVDW2T,JDJSYV_,J[
MIWBTV650 !/8SF,+MX\?.@D%\A;M4Q.QYYTNEG<<Y0X$/%.L>Y0).4YTDF9M
M:)BG3\)2[A4H2GS35DH'3/\ 9M&TZ*-A^#XJMRU/)RGYV9N-_P#@^ZW&TFQ+
MD FP$IL#/%JX2J+<*^M4HGE6IM,[F72$0L2D[1F.+35ZV3'Q"0 2E<OM+$U;
M2V58I!Y.+D;^0&1'DVO DW6  59:&CH['(#LR(3M^B+Q*RT6MA-@9EN)Q[Q^
MHY^2JS8P\E3E5II=#J8GBS:4=!+._)6[2I/].X2A*@HJ0:LCH9U1[N'HP4:\
M7C7)"4%)M4F7V@<QT%HK!EP% H+YZAXMT7F.>%=4(-E2?FRZ&3@]1J)2=J-7
M%7JG^AKU/_\ 14]+9 HZK5Q:I6#SN:NN-A88,46)\AY:2?TF<VL,'J.'V'G;
M9.#U&%4E(5;]HJNZ6>8-(4_JN5I#N><S)MSM0U$9/QI5,FLH]%^8:&"JTSTE
MBTE9S-N4RSC'(<KF45ZQ$[-FEC62L8B27<JM50M:LH^=5/4&DC0=K21H.UKO
M-N8*4-!8O'ILY-71*V7[-K$72]H:NKU=C5B;#5ET"UIJ'FG;\I$V ,[38TG>
M<'Z24NPBKRIZ9L) 2Q;L])3,GK8SS (3G"+)M4=7R56TDM-YSK-'T2 1(W&]
ML4Z'F5P>DM-[=6$OH3 :8:8:8:8:8:1^"&E+Y!:9"]BDIO#"VT?)GEG_ *R1
M G*S3\DV%MS&R]IAARKF/)OL^ATM,,2 "K,&T'3<TPUWTIC2U[2,P,YN:1K%
M/V@)D: QLM+5AIO:4OH&R]A:QL!)N%Y8V $V!5QTL"#<U8:?IS!^61:1T?U,
M.X2]05*D,PGG.8!A *>.5ODW(64S9%%K4Z0\MY4[>H3WBYA1JB0 >44U@F=L
MM+&C%IE,RK&29F\Z.MG5&O%H>*,^03[)&TLZHQ+X!2GY25*4E(&>KX6LN!1#
MB:7I>3-4SF)29Q#XUZEV+U3_ "+&#+M:E!5DS:;!O80#U%KU7)L-MW*NMSLJ
M"-A%RE!(EIVMP)273Q9^S[63:2=']7(FP7FQG5'O'KJ4^5*<NC2PHI?F@VID
M%7V3_.RVQE0@0HIG,B^P^W,W!JR5*0?-36F&AJ->1#MXN^J"V2WA (!MT_Q9
M4(I3Q#MV;2:IESA?\:671ZG+XN7GGA 7["Q/UJW>9/R@3?!WF4QHQ1F4W#\V
M=4:\?14/#VU7Z%+Y4_LZ?XAA1SU3]^Z] JJ-LF71RD)*B92F)W\KV,YA'KPL
MM&*47?-,OHY,47:'D[5HQDL\CXL():0LF<D$ ^VZ6EN +#QUFFNS8R:/7PMY
M/F$FPYK[&6Y"GM07; T5#AW5-EPDQS=0^A"P*W[LO%&R?YFQA +$DVVD@7F[
M3*P,J!4J'>+MJSZ?LDC^#/8%27<.3=NT?$FB7"7*)@VV3$C8QA).,;H'YL#,
M3^BODU/69-'5TNRG]9.0TD6Z&?48\0BL;.O\F,"\%IGYP%W.N\6X$9J3,5DB
M:A.X:3T,]HU\Y0EZ3-*DUA+0;F"JT^BS^H1$PR4A)0J8T3%N=G-*)=(Q3I,D
M%14I*A.9-ED[FRH$#ZQ/U=6J$BR73X,FEH<%)2A6,2FHE1-F;-TR9=)A905)
MG4573;<J6C.PI500I("0%5IB5I)Z=LV1'%VB'!%J'ZUCIK62/5.QHV-Q[P)(
MJU0#MZF<Q1AWJ'R;2BT#V,(XQ2SC)JSYDG381<SRDX=]R5)(2 $@ D$2LOSL
M(ET$A*/,"JR;;9BUDQR4I6#(UIV3L,](S]!9]RGE8>V7]76J\K1:SVD5?T:\
M"0L%FUC2JIVYE33*R4A<=(O9=).7@^M22JZP_9]C.(Z$<EZ2A1"T59%73I^"
MT-2<,Y0M+M*@I7FS-Q.G3\!LKJZ&=Q*'2\8/.F2,Y$[?XW,\I6'>2+]-9\$D
M5DV33F'L'L9Z\</#-RDITSM)]ORNWQAXA+X"M5,]+*I9:WQ?$FVX2$A8!<-$
MN]C2ROJGDP7CI)3C-,[S9I;*I6O&U16E)2D\DJMGLGI95*DI4)#E W=(9R]Q
M5YS]+/%5UJ5I/T7E)*J.$ D!TD)D)9I7]S94K#E24GDD)D!5JRLNMM$[6>4F
MI<IA)DL*%DJLOS+.J8JBU(G(B9E6M]9GKX/'^,S'-_!HQ[P@HE95 $LUG4RL
MW4!]"'CEN72G8F"<_5WLXI)XA"03<I1(('*!NONDQI20#L 52"*LK;[Y][)I
M&JZQ12)&K(&X2.8%HR,$0Z")2E+.#L;A2<0IUI_/.9:62)#Z*[<7ZK.Z2+IV
ME";@#/IG^1'Q<PI*L D^:F4IFV8^.MC2ZP0EV)34F9J@V VCVBPEN&K>&*4!
M;(BSHN9U2$H4.UDVNPFTV"S,DW,FVL=*B?I2G9=-JJ4FJ7B9];%<IBHE0&>R
MWI:L)SQ=O09-CE75![9%L:?1)W-C/\/>U?\ P][*77E6=^;:+9,IY6-92+;K
M]#!<K0[WS8/)&L'=O6Q>3_5AIS^P=K6>C/::O9*IO:OZF]J_J;VK_P"'O:OZ
MF]J_J>\U?U/>:OZF]J_^'O:OZF]J_J>\Q59YF]E/*U2;OS/-M8O2;:F]L:1^
MK'MD6+XF0+M-EHL#5_\ "&YJ_J>\T_4/::N/1!L9_A[)!J_J;VK^IO8+E^KW
MM6_P][5A(IQ=AOM9*J@D$7]+5_4WL5S_ %?O,D5O-($OLSM:>[Z$AM8"5WR$
M3:69@)?1FU[2!(.=-S*)7YW<P2!<U4?3 DQ$V2HINEL9)J5ZOV_.8H2?^6
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M.<5P8L,+@ !P=N-PU=N-XU;XV-QO&KMQO_#MQN&KMQO&KMQO&KMQN&K-QO\
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MXF,<I>N#5=FK:H#/=G96$N SPI6N+AZR!9R3:IDX88("LOA+C&$5+OL,C"G
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MSWM>+<0,%?NYYVO%C@#@H+Z/6.M<OXL, <%#_P#SUGJ7XMQ P5^[GO:;YO\
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M!/3-H\:9 ,PRYU1*)UC<]>Y<*-;H]TN<V,C!A;H;[CH:1YM7!</1Z(S-&T+
M4QJRV)$D/E?(C,N//:'&$PDL". U*/C;=G("Z!%XUU5>8LO<E?(WK#$W_<77
M#AJVU%+.L=W@NJJ[Y0%T:)BH^ZPIQT[)-M#0@RXRY,D0GDD"^.85'>CSJA@*
MIBCF5==2]TN]94B)%FG!!AO(+TIT)F\45I346T W]DC5$R\:U"0]S=X6[W)Y
M\+?8F#AR9DAF**'(F*\R^49J,VBHBDXXBYU0<,:AE;;9=[G=9KLUCU@89!NY
M17+:N6>DU'3%I@8ZJB9E+!W$='CC2L% N,1X=STC=&XQ,9T+[4>,XK3D9QM5
MQ1_.*Y<."2:\==6N*Q;+K).X6^!<W= #)%"BW(LD8B:)P796"\OO47-"FLO4
M3]OTK[$:>\W]*T[!>M%T9B!=9-D"\+O<H;MSC-$ZL=&Q<WP.<05!<5O+C0N2
M;)=H#<BVS[I;W'3B/#/8MPJ<@12.ZX<<\J8CO@01:<NTZP76W1L(8P 5R%+D
M721<%PB18C,5]PA=<Q3ELB"BXKLK4!NX6*\6B7.O+5D&+/: 2&0^T3S;PNMD
M;3\?(*YC;+47!I^%<VI7Y,]9V7Y#0H3;?KR;@,N$FUHV=&JOKT)KJ3$D#(;;
MB2+@PY,1$-@O6Z(S,,V\-9H\V^ ,(FLW%1*N$J?8KU8F($!;IIKFRV#4J#E4
M@-EQLR%'BU?DYX.#F3&HE_&).9;DWJ/8G(3X($V',E.HVSOEOW($A [_ ,,T
M6E1>BF_C_P#Q7U)UQ>$B9@1'Y;HAMDVPVID(=&943!*_+;/=+6^06F0TQ+6,
MNE@WF0D:-,%UITVQ;%Q>Z@:B8IKK=5()M]X-RCT2/(2/D=6>_.;%R.S!RJJ&
MX:DC>"^[JPW=N%.EKNC5P($!O0M2 =CB1269#D@VV6GF<I#HR-"<-,@(JU$@
MP=SMWN#\FUQKL3>>'"<BQY3I,@#X3'VNZH8%F1O-P=:4=XN;<E6A0,L:,R3\
M@W31.YH@8BF3'NCA*C8HBKCQ4R^**@O--O"G@%T$,?VX+ZA_$+Z*'XJ?1ZDB
MV/V>Z!%CWCUB6\)O<H:W/0Z8&-&CF^$0TU:3)E1:W--L@:'NG&X'&#2-*<3U
MN$R>WV(DJAF0%R:JW2W!&IK,?<QI#DZ1KNDV*)$V$R"":W8[KH$V)\6*:UIN
MY)8;OG?N42V1X:G$QD.3FB>8=8F(\L,V\@]TQ=$FBX))C3UWE6J= 5D7S*W*
MK,R:0L)^B2(XZVZ3O$V(GCCQU<&TMUPM4VV.M-S8%R !?:22TCT8\6R(>Z-+
MF4,<[:\$DQ]4O^(OJ0X26>XW=^5!FW(A@$P.]H4#+OAUS?#C:$J(6* *YEZ*
MNUT!'ECVF!;+B0FK;3TMFZ AM)&:,LRFWC@YJX^*K;N5)J3ONY0V90RT#\BC
MN26U>C0Y#ON),AL2-H>E!JYP&+==#:MBW%MRX(VUO=9%K:)V4R;2.+)CHJ"J
M,.OMBV\6H5I'@L,^V1'(P2H\N7(A.!(!Q> *-QGG'FS5.%W4!PXN.BW+E;KC
M'D*W(<BSGVD"'-WHB%)T'"5S(&9$!XQ1ITL1!<4]4?B+]*?YESM[UFN4F/9D
MA%=+E'.+H8HSD16BT#CH2'LN/"1D#7WJWM;;7=;M<BF3HS-MA@VCYM6] 61.
M<-XP;8C8.#DTBH1EP<,:A1W8TN [-LTV](W<$;C.,MP'-$]&=$SPTZEL955"
M'75BFQMRU[GP]T6A"VOQSB"CDI_298:BXZ)(ZB-DJDJ9/?IRP-6JZ XQ)WA*
ME*+),Q;@C2.G&D- XLAML=C?>CWN1ZA)?\UWXR?PIZA?%7Z*'XJ4]?MS-[B6
MF;/@,6VY#/@K.:<9BD11I$9!,%:DM9R'A8MEJQJ[W.Z;HYQW66Q;6;:]%(HL
M6+ZUY76#FQ Q&2JS$60J 0)@N6G9CMY;:N[FZ.W7Q9K4<T%R/&:BA-MSX9L7
M&Y1Q],UKP:-47#54R#,O\%=S<K=(_NDW@Q <&X+()S3,1G)9FH:!MW CR A$
MB8)4J)!W2VUB%=++'LEUSVUUR43#)R%<<AEI=&T;C<@@3.A9>.ILI+_.9N(N
M6KUC<:<,(4&/9&VPMK<N+KWV;>4R-Q"''2KA6Z]XK@R![J;! L^IDE&*_$!Q
M')*\+NC;I'BC:8**:L:G1G';!^4QVFFW+/;Y$,E=::5H7Y>F>=TJ^[X&7736
MY I36'Y&LF2;1$W(5F8,N3BVBH7Y2N8>/@YJM$W<=(A[G)]G28TTVY%*7;I,
M>X9=]-2&,Z.8J8"X! :8$FNHUVM%_CCNJTUR>N=QG0=-;[CZZD)OM[S Q-D&
M";#>^4L=6!XU'N$;=-#2\N6.5N?O,N7;-)'F0Y3FE4XK#3@[V>955%M54D)-
MNK7!CWN*%O@0;9"%R5;A.[P5MZHI2+//9)LXQ2\.Z-NJXV/&B4(XJ641'%=:
MEE1$Q5?"N&*^_0_M^E?8C7P(U]*U>;M*:8FWBX7*YSHDXM-A &>TK8"+!.*S
MIF$54TR-H1)Q+0#:I\2)(E[G9MAOSA1"<;N!2,RL7"-B>>)(:,NZH*Y7V^"2
M8HE'!6=8H<F.Y;)ELN%GMDAEP;A:U[B]< D/N#);-,4< ,NV6%0')FZ>U'>+
M9?6+Q"=2TN!;6!9:)K>V@%W3'I,ZFID>I>*DNE_NUMF.O.V<IS$>"ZU&D-6O
M?*&T(&X67?#<C+BN.0A4NFG8\B^%)A%-O4EK,RN^V6;DPRU"9TJEE(K<K(8$
MJ8.@*"M3+'>]UL1V'+"%$)(%M6*:P([@E)4G-(1;\EM"C:D/<@XT&KE'L.Z
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MNZF\0AO+=UA:23;8^91-6GQ$L!;1%PQ54XN+"G)MUN^Z=&S")HTL0.93E-Y
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M<TW7M1/MJYJNG:B?;5S7<^U%^UKFRY]J-]K7_\0 *A   @$"!00" P$! 0$
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MR"A#2&J,7NX(F#[F$:G@$%Q4,TS4I:RA68"^/=]B.$FE(@LB88<D,!<N7*5
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M)+2P&[DFLRG.:\D]V>/7/4W^_C)O]CA"+,4)&%6W"[L;1,55$QI]UB3$_?\
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M2)*Q))$BA0HLE1=A40BIP)*K%TZOJSK-)_D?BFAVP8)9+MD8T<E10ZJF!;;
M<4(J9H3KG7KW."9=7L.DV# VVDDD[;;Z)9]!*IG)3_?:%?\ :?/GS9\_%/GS
MY\^?ER]#J-(I>NY_RW9\^?/GSY\]+J9$>NC[?\3Y\[N^K_\ JS8,&#!H[P1F
M1%<G^3!@P8,&#!@P8"%S9"0$M)8:2["4+_$P8,&#!@P8)9"-*JUXC_#_ "8,
M&#!@P8,&"#55L58Q>HPH.2EIW_TR1*E2I4J5*E2I K&IT*-0V^#&8W0ZFU-Z
M6\3(!L&1@KSVS#HF5QEIA+IT.QO)U334H6!#!I%HWF@DJ=)YPJ4$$U.;"'B
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MEUK^8M<]0[)&+]9W9)))))))))))))))))))))(  ))))))() ))%\,G-Z
M                   )=G^B" #/6[,#HLY\09Q)))))))))))))))))))))
M!,0K[]))K'I\6-NKJ[ S))))))))))))))))))))))4+)I))-R?))+'Q"" 6
M $'H     FR0V("B10  D2DI FF$1 $2PB  !+%U+^WD@     B^E88#Y8>)
M)<GJA%R#\Q ,4$Z   ,IL2@6])))))&/^D&)$ANG((JY%()[(Z)))CE[))&9
ML2QRV!RVVVV\\VGD*PA>'()Z]?()-P[X  3CT !"/5T!BNSUJ,RV:RRVV:RR
MVZI)))))))))(-])))) -9@U#V4CF3G))%)9))4   (I          $MO-L%
M?(M!>:E#*!($0"( 0 A*VVV^ ))))())))))6FU\K!" S>,^%+;;:
M#_\ _P#D DDDD@DDDDDD[X:?_$EO]-S_ +6^VVVV^VVVWV
M!))))))!#=+:)K<BVVV6RRV6VV<DDDBX          )(5%))(+\?ZM2Y-]MM
MMMMMMMMMMMMC!           &U]D0)!'NE&GW;22222:2222:2227@)))) )
M)))))*&DF)) Y=D?QCDAL]]OEM]UOD]\]WQ          ))I)))!&X  !
M"    ,!@ !D   !8    (     ))))))!&E0*CG8;4DDDDDDDDE
M              -$7Q;40Z@TPVFRRV6WR    !    )      =?#6R8&!>/\
M9X*9.6$FBTR)IV         !    !%."B.V]&NS?[*.Q>:*    +P (    !
M    !    !,'2D;)\*DZNO(V#]*=K;3;:Y)))))))))))!))))(,GYVV]P ]
M)(^JXE$) FVVVWB222222;22223"2220*/))))) BH4\#3\X[W_>_P"_WO\
MO=][_M__ '[^_?7[58 @@  ($Z8E"S$F_P!-AMMMAMML-MML-MMAML<   #:
M6'T\'W1&530F[;][;_;;[?;??_;;;=+/;;^CW/?^O4>(R((CM/M< 6VVVVVV
MVVVVVVVVVVVVVVVU(IME%&(G*O-U0L8&QD)))))))+)))))))))+))))*L
M   %-IH!""KCR&M1[G;;;;9?_P#_ -W_ +[_ /Z^_P#]]0          )/+6
MSL)'C@              )    (    !      (&8A%N(_OP    (
M )    !    !      (!4&D>3V@     )))))))))) )))))))))(      (
M$6V>F"2^6756;9))))))))))))))))))))))))))).*\F9@ II54]PI))))!
M))))!))))()))))_9ILTW!(+B^R46)CV1I=     (         )    !EI,+
M^4(&00^U&>F>WVVWQ)))))))))())))!)))))56K[&6($YM:>!*@    %@
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M6#!++%Z#'4TA,E)60Q!$H%+X@6HP C5GNADBB/?C K&1K(*XL@J0,:D@0+(
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M,V:&F'#&'/:LF4>GYBE%T]RD&%OT=IVVJ33W/FN+W/FI2$7<%%((6#.DZ?\
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MSAM,9C-%% 2D)6=<ZQMAB*D*575<^:?U03%X!TO(D8?,4Z"*ID(S@MN'0G6
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M06SU"GEFSDE#L6K.#,;DB,3&?]:M(PSJ@M1[W_M![NV1NZE>-:1+Z%"L0!O
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MCA:PP%H'5S9_5BMDPD!ZVD>(WPIKLW*1WXW%YFH3AF6CI++!<B3_ "Z$"(2
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M=-.DWHU/-X=ZL&?Q\!5QQ1XGYRUX;M\M/S9)C!)[/R_RU%X9]MORUVK>]/\
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M_@1L)W*XO<^:3)E%GOBV?C7_ $O VIB47N/4G6U2&2."Q ,#-XGZ*"LC0P
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M36=TF( *!:V'+4SYELK#L2 6DC>I"R8@<,*[A):R&U&8(B"9E-A1U+EK1!
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M-]]>(X.GK6HOW^*V(V[[Z'9O[5Y!^*AJ^,VQQYZ5FX\_'X_!6XO?TIL,SO\
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MJ">#SLTS@Q4G[/WO+W>:"X.G^?;-:FISZ<\6>#:_K'FWXQK470\[\XWF=:]
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M*\3$NC YZD:XB3Y/* E2L$Z,P.G-(R0@*X(O+V&^VBM TLQC.)B-=+F%YMV
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M>E(2D&<S>>LY]: L &P!0!@CI:E) 1A B,7S:O< +^5K!H8F\=)QZ4@Y!ZE
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MAX<*ZW=:P(:P.#0WAR  "-UD< <*8K43RFWRSJ3M5!& ]\93%'\]$2U%@["
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MSU,]3/4SU,]3/4Q!W2'=H1$;,B &NN)[_P#F>_\ YGO_ .9[_P#F>^_F>_\
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MH6AVQVW_ ,] _$] _$] _$] _$] _$] _$] _$] _$] _$] _$] _$] _$]
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MGJ'X@HIA+3-5UI4] _$]0_$]0_$]0_$I_<=>E>W/0/Q/0/Q/0/Q$R&&XM<T
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MMLZT5.='/M_G,[UZ=!_\:*6GM7Q_Q$BT5ANU-^N82%4E1S.T%Y7Z5*M2^?\
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MF0(8BSY9VA@.XMPG';EC$1H!M@  E%1L$)$'0.NF0_\ F%]HI@Z@10T<S$J
MJK0T6</32Q",CRUM6[8Y?"2FB36 I6FHU@8\)4*T 2)]H6_$PFF@TIO[HAV0
MO=40L8JE\BKM'DH&7!J[-WIS_F7!9.60WU&0*(X='$*O#+]!1NDQ6F<J9C*S
M4])J(:JSDG6(&8 FRQ U(B"EK88>Y"Q:4-4ZJZI84W*Q=316;89;D4,FP35Z
M.MC5Z?7TWZ37Z6O2^>G1UVB%*92KT"AB7>6BZBU*2@DZ4JBUY%]8GKETZMX*
MZ\XLEZA8909#7)TU]I:64[XN<9V#Z>N#6=-U=.S/TVWX6GG"U);K;:YVZNWS
MUE?JZ/\ LFOT=8J^SAW?YF<-4LV8UW1U[LUZ_P!4_P L'4+2(K-K$ X4(-E?
MAH9P.J;K\L.172,G8$&"U4[/^'S+[^#Q+[^#Q+[^#Q+[^#Q+[^#Q+[^#Q+[^
M#Q+[^#Q+[^#Q-9KZ,)JY*UKS+[^#Q+[^#Q+[^#Q+[^#Q+[^#Q+[^#Q+[^#Q+
M[^#Q+[^#Q'NL*AHZ+M>FT13*VP%:=,>?EE]_!XE]_!XE]_!XE]_!XE]_!XE]
M_!XE]_!XE]_!XC;7[7B7:$(LS13HYSI7!4OOX/$OOX/$OOX/$OOX/$OOX/$O
MOX/$OOX/$OOX/$OOX/$P\1)R#8I59Q]QL,=3M1R0)M ;Z(0[LW(Y29RCK=BF
M T5&$EFVT@S7( NVS0_K9E IS*KE@U,-A81H;>_I.6.NBQP#D3[&7<A60J/9
M'@F!3:T(UT6M=V""VF=6)<W;K7S-9HL%LK (E49OW"<K;,RC^?*;'L;?/M*/
MY\HAK;]+0\XVK_F=G)))A"6656$7U7\NG&3C@0!X\?\ <=[-8CC/<W/\J<X[
M/X-<)8*'PVS6@*[?R5M0)LH7ET\LE("R?N4WI3/[J;DVBET26LV^[*;FTE,&
M*E6Z7W<(C  2%G;:ZO&E2UM_Z04=:^6BN^G3.NEK$%J-'L78 @L0:LD&V[7<
M,:=1CYG9X)V>"=G@G9X)V>"=G@G9X)V>"=G@F@0676O5K34=GZ3L\$[/!.SP
M3L\$[/!.SP3L\$[/!.SP1%1L1HJ_8A$EKM#JA]GZ:3L\$[/!.SP3L\$[/!.S
MP3L\$[/!$52?FG^0BB\%=7J'!VT-*ZC.SP3L\$[/!.SP3L\$[/!.SP3L\$[/
M!#;:7758U, ZFOP0(B$B(F$31$+&+W\A:.ZP7;K:WUG<<$4W9SI%-W!%-_N_
M5]9W'!'<<$4W'P5^DINXBF[@BF[@A MM:G7CZ_$INX(LY- :/S :H8+<U,C
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M?;!SI0ZFE#7O9[+6]?#GM_S5Z[]?72>Z^M?7&2ZW<MZT;C/WZT3W7US\=?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>businessfigure12a1a.jpg
<TEXT>
begin 644 businessfigure12a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M !P! 0 " P$! 0             !!0(#! 8'"/_:  P# 0 "$ ,0   !_?P
M
M                    (!(  !!(  ""2"002  ()  (1*0  ""0    02
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MK+;[Y:NSGK^6.[U[&N^//MPR\&KLIIZ"C\:O[O<L:_I:-_WVZ9A<5>9D
M          07S]U6#Y+]1]+LY_$K;#<'M_$Z5\)[;SN;KLQ]4^9:#\%[;;GK
M/,ZO\AZKH:=^\_>^%TSX?VGEX;<Z=MZ/T!\(Y9R  !PQQK3\K^G^;R]'1Y.O
M;GLO(:M\MZ+&O?#J:ZE]S3?;?S_=CJSR?L;%?4OF$$\MZ.:^AHH#YOT/3Y>G
M8WJ?,ZW\SZ7S^?9W-FNX7V[XYRRD              8,HQ$I@D@  DA$D?/&
M?&XNSW>[BSE(  &$$H )(!,(E+YZL_ILP20"8 8S\=>S[[M8
M         0(Q!+,R                             .)K(UH2(V8<COFG
M#;Y$39H      /(.T=TAI+CJ'?.)USM'F'V.9@[8                  .!
M^;9N\ZYL K0<SO'$L:;[      !30U(2 ]\TZ=0[9^A92(CYUS@;6-XF_P
M0PCC$<IG,R              .)4@DI8D[8.,0EF&9D#B9, &3(  !Y17X]8V
MZ2,  P #( ,0@VS"M]A6W)J[3,R              /S#+?'(VL2$^AK+G[?R
MHH_K]F[#Q7Z$V?A\S(I,63*;GJG,OH<@  ")E,#>1V2P    (4://-(T>N;Q
M-IE7;"OM%7=^9D              42-ZG3-GE,3@?H"Q_,.G^D>ACN_3"Y^9
MYD*8UGM;/67B=+S,G/2-NG(   U>5D)\>H69!B'YT57T&X'?Y/X:\]O]=./&
MQSAVOLC6ROG64Q\G![A5VPK[15W?F9              %0SR3NEH"2@XQ&(#
MEE.0:^U]$ESYM?S/DGI&WS(  !J4J8;@/4+,@PC\+?+_ 'BX5U\MV!&=T>_R
MX@^OKUSS7..SS6JYGY%I29%7;"OM%7=^9D              4A.X=\LZ28
M        A)00W"3<LR#$1!L>F:.;$OOE(   P5=L*^T5=WYF0
M  !^8!;<AI90DP         !#BJ9WR:EF0#$0D,I   &"KMA7VBKN_,R
M          /S\+.F2?DF          -?% S>1,BS(      ,%7;"OM%7=^9D
M              4L/:/0+!D.)B28         TF5T)\2 LR      #!5VPK[
M15W?F9              'YS&R#OEG#PR2GN@        &F2!';.198
M&"KMA7VBKN_,R              *$DS/5+$$F          (&5D-E'HF_
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M@J[85]HJ[OS,@             "I1N([Y"S>X!D        %:RNYM EA:
M    &"KMA7VBKN_,R              *6DP.)[)HD]$MN3D        &H35A
M'B8EH0      8*NV%?:*N[\S(              I(34^)("Q0.0        !
MK@JH;$.X6B      $1 ]FNN]AP7"J[/E,@             "JA[!X!Y!M0
MP;H.\      "K1"R9$6,'2/6-L $])F  !$8APF.<99R               =
M8^)W3D  #B<@      0$\(D1-S7A\SLD_ ,'(
M
M
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M&2E'R\(JEBDKQG793-B#ZX4!(2CJFF(')NNF=-PL:?M?LB'UJXVMI@OPO8(
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MHJXS9*B7/EC0\'#*<#088D:$EH'LY,89XB@Z?H0W@#A7O27J</->Q!:BZ\Q
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MHO+!.MHYB631N4$FG3>_I'L]6&$TF:HW.LKT^I5"=%(N>_??? EF\L,4DO)
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M<#SRWCX8$&FIDF_ZJ(A]28DIN;/#-JMR;[>-[?[82C I)(=?P]9O_P"3 _\
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M^W,X[[1V4]ZI[2(\D9XJ6D2/=VC-_&J]66X'GB/-,NF9EBKJ24HNIA%412$
M<R55B0!Y\L0YEE]2_#IJVEJ'%[K!/'*P(YW5&8BV+\K;W^X_J#<@C[-^>&[8
MTT?^\$4\+4T^0D:XGE2]2C!=$D?D&9@GO.,N[94\L<DV:1?)$,5-3U!>HG1S
M>H8A(F1/$C<MR+-?;EC_ 'IR/5 G?X@:FV@[V\7L:C]'5]$M:^,I[009M69W
M20HZ')*A*>:1CM,9(>,'0?NVVO\ '%/VMRT4ZU%?(E!KFDBCC:59C)P^;#AW
M]Y',#GC..W674-;E%#3COIS9R(YHI52*)!I\;LVQY\KWV-\0=H\FJ&FCCKX"
M:0%ISJV4)[;7.S*IV9A< XK^W&0T=!+71U*U:Q.L?#B-I"S.%Y,+Z0/%JM8C
MEBB[645572T\A2FA6.G:FG>9"*MJDV5%0>*,WL!K]H\L9AVJHJ:NBHXRLY#2
M"L9957NG#YAPV[MZ)OMC(NV649^@[M+PIV>94IY6 D=8&96<<AN%+6YVZ8J\
M[IH\LGS.D*UL,+!"$D6-6;6$8"1[+X2=_LQ_O1DL.A*FNA@G9(7:%F!*<?V-
M3#PV_P 7+&?]IJ#L]2TE35ZF2NJ(J> Q[WXHOQ+[C2HW/F#MC+>W.3U=97T4
ML@I9*6L6DA,K#35ZXUD61/W 2VFS;WQ\OY1W_P"3._P=^'.#5NK?N%O9XG^"
M^KTQF':.FR_.:?*ZE#''-1U-<U<7 BA2FTZPZ>U]+GRP<\RI&5&K8E+4W>QJ
M-KTU[<7_ *=\4_:;(JL5)@S&G<4L8EF.L*%0FVK?F+[;=<9?G^4YG)PJ*LCF
MDTZM*\]/G\<=?[_VFRHYWDF8Y<=!DF@/=A;V)U\43CK?4+8I.R7:*7):N7,*
M;7GE?FU(YWTZ**D$:Z6;H+1ZK>>#V1KXLGS^H&64LF;U^>2/'Q(Q*QRTO'8C
MS\.H@&V,G[*9_ 88I,O,<,?:'+J^-;K':EBUF>72OA722/".6.U62S56?9'F
MD>7)714\51!,S*#+%K63003]$$@XI.QN;4_R8[Y8JR)05U(9+#5#-,)N [-;
MIK7?F.F,L[&=H(\OS..6@-/+\DU-+);3'WRH*^!]*[S[[K(YNN%R".@[%R9;
M042QU<N4QI)'$MFEJ3$FLOYL'N"3A.Q594)725>6"HD^0J>#+^-^D:',(YU=
M^$#[#",'<?;CM%DM;F78BBH31FKKH10M)"ZC7^@93.N_5E!4_O#$_8ZNK$[1
M5BY7'32R4^4C* $4/ U/#ID5%'L:3LQ&(>R/:*/M#QJFFXQDKZ.LBS)"JR11
M1TJ1R*9;%U"M=3#R;VNF.UF2UF8YEDS4D1D2"GS6-Y =HS4T+P1ECU#.1BCR
M+M#)\ET\^62PQY3D699:TI;4LL\T?#3A+T#GKUQ6=CJRCRZA[G N7R+D6819
ME5AN#:9Y]2M4RCF=(TW-]*[8[!O'+VMR[NU'1T:TV2/%4]SJ$F6JEULIJ9=&
MP=O\7BP+#D.>Y/OZK^H)M:XN";>S[)Z;X[5]AZ_..T%'64/"CRZICCBSJ\H#
MRI#,LJ:4^F;HH^&,[[$YKF689A,D-+)05,N3F.$S"+]#15&N=72UK:!X1]+E
MCM;V*S[,LRJ3E=+1_)\D-**/AU:4!A:G'C6:,*3."?9N1IWVQV9R&NRR?/I:
MW@A<R:C:%TE#$\&B6GD5MO#:0&W[PWQ0=B<S2NRXUD%,U/339E)(6D5PHJ87
M2$H.IN1J_=&YQ#V!S/\ ^BQ3+2B*@;.A+*L@9ECKD5*5D6WBX?/G=,4?^S7.
MN'5TU1HI+4==3P5R5_'6?CR\2/73!5X:L!X]3-OB?LKVDS'(ZVBGRO)Z&IBB
MIH:/@M&SU9II(R7EJ MXQ(J>P0;$WOANQ.9UL>;R304]%4U-!0/0!)Q**;,J
M%C(BAK#AQZPHUCG?&7]B,X@AR%JPTTU9'45=7G-074ZY*IKZ ?\ U57IZ=,9
MODF99'D-'1]VBI,]ASN5\LFI'X[UM)5R2:]>@#AE!)[))VQ4=FY8NQRY%0B,
MU(@ACM(P1)).(LLI=_/=M^NPQ4=A,SE_WB;@TCR9ADN745"Q=;15%,I$S7M^
MC -O%MJMCM-V>S#,.S^1T=+#3U5?E<V62/'-*(XG[M"$EO*00-3#;S\L3=A\
MWJ*+. ]/0Q5M=GM'74K)(CZ*6%8^)^FL"I!5K+8:L1?[/\U3M'-4S0+/0OFP
MS,9@*[1(NDJR1FCTW>Y&F^NUL=J.R]=G>9M41")(/D',LO+M)9A4587@_HK<
MMCJ?"=DNU-8SBLH**&.+LXV3TTBURR,\HF1@S#2-(8*3?IRQGO8FJBH.\11Q
MT\=-D5+257=_&[54%3Q6!B47='V#2WV!)W ./]GQJ*WM+6UDE)301)E5%2_\
M&;T_$@723< #C]91SU=<#RO_ .?C^S#T]^)(UE1D<*ZL+,K@,K#J&!V(/D=L
M4V64%(YDIJ.EIW(TEH((XF*_NDHH-K[VY8L-O3I^KL/LQ8?GO#%(RN\4;LFZ
M,Z*S(?-202I]UOU!56!! (;F"+@^_P \14]/!?@00PW-SPHTCN3S)T 7/K^S
MM_3%L6_^,C?&Y],:@/I7^& .OGO^Q?/^KXW_ -,7_8:/H-]*MZ,+K]FV'=:J
MBFE[M3Q- T*EHE(9N*6%N=OH_#I@"W+]BRR"&&:90\I5;\/J2/+!SF=Z".LA
MRR9I3,(N _A9 38R6L-AMALVIHJRGR^76E5/&'50K:=^8U<MO?TQ]_[#@^;<
MP^MI/Q38'[%Y'?D1_5_/ ;-OE.1>&GR?PFX3;7XMO#?[_P"B<992UL:239JT
M$]4LKF"1$&I(+^%-7V;7_P KD&^_G^6KS2DHZJEHYC()JVXAT(67;GJ/3^O7
M%K'8[>7^O]SG&:_*-+W<P_)UCWD-;C%M[:/3SQ43QTD,M1,;11)J<^G6V*:I
MBJX(JJ)]44J^  >9MOZ_E9E0%F(55%R3L !YXAFAJ(U>&59E+'](A!%[\MOL
MP.OBO]UOS8/FW,/K:3\4V!^Q0 !;W_?BQ'(^X'_SBPWVY[W]?+W?F-'&S!S&
MC.H\#,H)4^A/+X8WZGX=/[E[M\5QA^7\NURU:S<,Z(8Q>F<>+^UW]KRVZ8S*
M3AT<SM!Q]*WX WXGI;J#C+I!)1POW;N@=?[ \T/D!T_T_++&LL;Q.-22*587
MM<$6(N-\45!34$"T],G#C5B]KD[DD]2?/'F?/\V#YMS#ZVD_%-@?M[ECAH2K
ME5+H"%)'B \KX%O"-/M>$_\ ;C?4;CPCV?>?U4'S;F'UM)^*; _@N#YMS#ZV
MD_%-@?P7!\VYA];2?BFP/X+@^;<P^MI/Q38'\%P?-N8?6TGXIL#^"X/FW,/K
M:3\4V!_!<'S;F'UM)^*; _@NBAFJ:+,(((B[EJ5[*1>P,E[;B_/$E+/ %$\3
MQ%@=.H6U6\K^6 /X*I)9(LOS"2)FC?72K>-BAMJEVN-Q>V'GFE XLDCVO;6Y
M>U^=K\KXWZ_P5!\VYA];2?BFP/V.#MR._*_/^\7OX1\3@W!Y7&/9\S<_9^J@
M^;<P^MI/Q38'[&G$AAE$)TRE"(V\FZ'^B,9>E<E)IKI1)57/C V Z;>[; O8
M7-SU/F?RWVOT&+\O7^Y<L#;4W+TM<_RQ%6U;9B]+)#I@T:E<&Y^/PW/Q]!CD
M2.8MMOU]/S ;\M[>7YT'S;F'UM)^*; _9>8O6Q4TCY?"L]79>'$Y\+;G4?LO
M]WOQ3-,\,;5"!)S&G%0'9)+;@>E[C^Y' Y8\*DG3XK6O;IY7\O3'J>O*_P"9
M15U5/5U=/-1&FBA/Z*<_^J/,"UA;IYC[!:WKZ_FP?-N8?6TGXIL#]OV_(1?\
MVW/U_-@^;<P^MI/Q38'\%P?-N8?6TGXIL#^"X/FW,/K:3\4V!_!<'S;F'UM)
M^*; _@N#YMS#ZVD_%-@?P7!\VYA];2?BFP/X))Q''K(#2*@/TFY#I_KB7@4E
M)40BICG:=Z=AP;D60M>YY7\>!\?C_!5CYXVOIMM;VNEQRP!;SYG_ #__ "2_
M_\0 5!   @(! P," @4'!P8+!0D  @,!! 4&$1( $Q0A(A4Q!R,D,D$0%C!
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MZ*U%?LY#*:93C:3&QYS!;D*F.S!GY%*G>+G#%PDY$3(8WB9Z#%5@\>HFD-!
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M@M&,4[Z F058'NP/I[)V+G8PRLG:RPOR^0RWEW $+7+(&!DMQ 10Y@R.YO\
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M8, [41Y#$-P[%Z:P*U*=;J7)L*C)YS:P)4V,!8S\NVR>YOZ[?J'T9?NC7_\
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MO8F7/7X;H6HP =]0NQ5^MD%U],X&N\ZS.X*GCD\Y,J/]A[3OM^H?1E^Z-?\
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M$67T+:G4JR3"5^':5<780N$FL>+&PT.D8G$WF6KS_,(415L!((I5<==*T[F
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MT>139B$S/CD+A$P=EDM[[CA3 Q0><& ,%>6D6$!J58O#!?AC[<S7?&8@FJK
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MA!BUHJ&@VH@9#I0>CR(B<M4,,Q[+23#2L'33:\!X<BOE(:@_ AGI>^7Y#\9
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M :#" J2(;G\$V5*H5[,:\#&*;-'XHUBUKC-^(HA3!&SF*4!@$SUYV1UEU:+
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M!Q,'@8_-B.*E/("*+9\*57_S/#-&6&/+Q?L_"(6$1)*-6C:'/5)5;#N^?/\
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M)OV.(321? UP7ZD6+DS7"@0_07>6]YE?GSQDZ3_?!$$6!$5( '94"]D>'%Y
M$3EHUFP/(ZQKRL+5@8[C'OCNH&C"NNF]!Y>6+^$@V*A0 %*!3U _/W]$/&0Z
M3#QJ8  44"G.(0<AD,AE0Y210BG(#L!W"\9#QT(S (8@1 44(FG"HB>'$(
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M5FM&;MA.57VR9:A3=D<>#B*9@X&0>6O+4'LB0*Y05"!!ST-=8LF%E['ZNN$
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M%SO3\X'W_P#E#__:  P# 0 "  ,    0
M                                                     !(   (
M  00"  !  !0   0    "        &W/<SHG,=U^!LH\(Z$AKZCNUSR)>Y1>
M2      %B0"T[,1K=QQZJ&%1(-D_(R#63939]O5      &,")@V&BT<0O1KT
MNB$B\RE QR'Y]/""T      "R22U4Z&@@ 20V[FS"1YW]?,A0LF1RP
M  &M7>SFMG8   '?;0\D5I<T#X              $0R2F<$X>   !I=Z;C%0
M.9&P              $.LMM\NLS   %FVFUT6FUM=
M   1]                              D D $       @ $$ $D
M             D$D D       $@$ @D   %(              $$@'A $@
M   $$  $@@ &G(               $$&48 $@    @D     $$@X
M       $$!$0! D@    @ P" X<D@X              $@ "6@',     D@
M-, #X@@X              $D@          @@ \7    @X
M @@           D 'E    @X              $$           $$
M@X                D          D        @X               @D@
M        D       @X              $D@          @        @X
M           @$DD        @D D@    @X @ D$          @$ @D
M @ $$@@   CY$%DI@HE(         DD@       D  DD$   CM$MDH@I%
M       $@$       $$DD $$  @X%!)@LAM       $   .X D@@   D$ Q8
M@D$D@X$ E@  @          $PX!(D    $  &6 !L  X               @
M$@@ %(@    $@ W_   D  .              ! ))   V)(   !) *VP$,!(
M.                (           (       (.              !((
M       (       (.              !            (        (.
M         ! )          )        (.               !)(
M!)       (.              ! )(         )!       8:
M     !))(       )! !)    7T                (  !       ) (!)(
M
M
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MF8$"V^0PMU-F_?AHJ#"@#-C'.(V.)IYDT(7;7K%*^M]=\-ED789[D\>=_3B
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M^ U$H$!@T KQ6H9(DA2Y;/$*U)S%L2 *54J"B-003P+!1R,A0)+4< \ 6Q"
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MTF=F'^O "!#P8/IKD/!SJ=>.OIP ( %L E-,\GGGKV[?/ !4 4BA%-Q]+G@
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M(9.U36I]O;F7!V&,%(_)Z7.O)4I"H&VQ$V3OJOJ_RP9KY^Y_C0[/Z]^2!PO
M$DOSM<JXF'(R@\;D2K&N53 K*U^7%]Y^MRG8#]?'GUFN7*>)[9]=7R?T04!I
MTZG('#$BJC<;0M5T,O#GKH4X*?8% +#G 4X P;E#=])6/@M_5:4!)1 #$]UT
M=[,9Y<I'$V8:7'G^(&:^?N?[7(@<X^'.D+([@X2,O*((&B [I2_T6.V';P;
M@7(WOOO&/7.>$+,>5K%Q*$51PKZ\H*3(E5Z7,?1AXF?X)9NK324F %"PG%4!
M2A;L@Z/7K^(&:^?N?[7"CV6?.'&N %G:K[N7\U_1 %%'"<58/6OMP !,?4_/
M3@!C<R\>!^7^#TZ_]W]>_/?#!,PU6SV_B!FOG[G_  P&:^?N?\,!FOG[G_#
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MP=DQ9O9D][PI$:0TA6??J/W> *?#Z_7^/I^<PFR.+E'^M4Y)C15UM6A'NC#
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M*+34D RF#Q46-EJ4HT-RB4:5PQ/7:M$)H% )-C2BV$>=W3:*<#*593YI7(2
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M'5-/N=/'.\X3.<.S/3WROGJ?'CV].&-8RN,9=ON]\KY<[SS]]\WOV^/' "(
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M"L_*#PH[W<2='',#94A(&L8E@>5.E,TEY<^@U;J]KV:<6(8N*X . T\7/"5
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M'B%W'4X3SQQLU@"AVNTP_'F(L+B 8'A*468S;^;8WM1,M&9F81Z&;\^0Q1:
M $T5."@H5 80T)3$RK9EYQVF+FFEN"5B0@@0&$8$L*))*$O IGK(:?)2%-I
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9N_C^JAW=C^J094Y"=!9UEZWBP !_\H?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>businessfigure13b1a.jpg
<TEXT>
begin 644 businessfigure13b1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X17R17AI9@  24DJ  @    & !H!!0 !
M    5@   !L!!0 !    7@   "@! P !     @   #$! @ -    9@   #(!
M @ 4    =    &F'!  !    B    )H   !(     0   $@    !    1TE-
M4" R+C$P+C$T   R,#(Q.C S.C$Q(#$X.C4R.C4R  $  : #  $    !
M      @   $$  $      0   0$$  $   !O     @$#  ,      0   P$#
M  $    &    !@$#  $    &    %0$#  $    #     0($  $    & 0
M @($  $   #C%         @ "  ( /_8_^  $$I&248  0$   $  0  _]L
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M/M&26'&,_=Z]ZETZ:VD-3F]X_B>H?;+7_GYA_P"^Q1]LM?\ GYA_[[%>'?\
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MZ;GH8E%=T^GQ-(S2>$YP&0#Y6"X.>N >.WZUCZMH5[-<O-::--:6L<>2KD<
M#)))/I6JJ)F3IM'IGP7_ .19O_\ K\/_ * M>D#_ %W_  &O-_@O_P BS?\
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M%%% !1110 4444 ?_]D _^("L$E#0U]04D]&24Q%  $!   "H&QC;7,$,
M;6YT<E)'0B!865H@!^4  P ,    ,P V86-S<$U31E0
M                 /;6  $     TRUL8VUS
M                                       -9&5S8P   2    ! 8W!R
M=    6     V=W1P=    9@    48VAA9    :P    L<EA96@   =@    4
M8EA96@   >P    49UA96@   @     4<E120P   A0    @9U120P   A0
M   @8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D9&UD9
M GP    D;6QU8P         !    #&5N55,    D    ' !' $D 30!0 "
M8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0    QE;E53
M    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(
M /;6  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[H?__
M_:(   /<  # ;EA96B        !OH   ./4   .06%E:(        "2?   /
MA   ML1865H@        8I<  +>'   8V7!A<F$       ,    "9F8  /*G
M   -60  $]    I;8VAR;0       P    "CUP  5'P  $S-  "9F@  )F<
M  ]<;6QU8P         !    #&5N55,    (    ' !' $D 30!0;6QU8P
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M  (# 0$!              $$ @,%!@<(_]H # ,!  (0 Q    'W@
M                                    %8T?4]''>
M             ,SLI6'<\X
M       *CY_L+<Z'C]/O._9;2O>4Y)QQN%GQB:^J>BS&RE"ZW<DN[F6)<\W3
MO/\ 9RS?R(76[=Y=3PFIOG_KME7O,5?0]5>/5\'XQEC<+. T]'>7U/P?47SW
MV&0;N=5//]=L-V/G&LG$^HW!T?&V==\M7U3T7%&?>ST2S?R-;.-],DV[F9_=
MSLKG5M&_Y37'B_2[*O>8C^GH2VQR.ICMIOF^UL.YYS :NAF]M'":;V<W48WH
MZ5O]'QNJW!^LV'<\Y8]SS524/7[H>D^)2#=SZCY_L+<Z'CP
M                               !4?/]A)MW+UDXGU&6V.1R,9'OYE94
M?49K;2L&WYV!U>_CL+-A6_._A7]3T60SK=N=5;T_38O7:YIPC6GIVUT/(8C7
M<NGI>(E5CDT)R?H/=RK]>-ODB*:.M;W0\=8MSS<1K]@=''?F=E*EN;[>2[N9
MYSC6U+T^S/;^75%SO8V'<\Y"JW<AU;LW'TO%U#SO965=\Q7%/TO5QVRG?RI_
M;\\.",]4^#]:V%Z_SKLY:HSHZFW7H?CPJ/G^PMSH>/
M                           %2<_U_P")
M    '=RT6?>\L             -;.MR-"O3>:     F-??[5_%^U]5'M/%0Z
MQH                                   &R?(ZPULZ_)
M     'N(\'[P            #UL^M\EZ%?I?S0#EB=E.5U>Q$\T35MRG55RF
M!<5"_P#5=\6^T_*C]I^+4[?H                #8CE]/)XY]2<</LPH?H\
MX                >R;R7K1ZV?6^2       [.,[*<KJ\B<=EA!K%>J+M,
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M?TX]?WJ/,                 #ZKOBWVD
M
M
M         :E]GD>L_P!7YFN[5<     2+5LWI\]W?8UY?T?FD
M                                                       :8]WB
M_/K]*^?=>8       ]KWC?6>X+Q/L
M                                   !\ZGT[YUJ5VN0       ,OKS^
MJ_X]]6S6&8
M               'R^_6OE]0WJ8       'U#?(_J-M4[8
M                                                   'R]_6_EU1
MW:@       'U"?)/J%N4K@                                $*L5]3
M.WP]=>KRJ+Z7-J:]2KFU4A-FO%=VC$[,.E./A+NXSD,<Y/IW3.O8L*K:M.E=
MN[G=#8/E]7:WB]JX:%\                      ?+W];^75'=J
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M'=J        ?4)\D^H6Y2N #5CTGFK(T6         !6V^OM1YOTH
M            \4:W];DZB]WAZX]7DTAT>=4]ZE7-JI%]^G\   ,UKV6%5M6G
M2N73S^CL+RNIM9Q>UMMP^YD<<P                     /E[^M_+JCNU
M      /J$^2?4+<I7 !4';XEQU+8         IRW4M_B=L
M        #H98Q?=HQ.S#I3CX2[N,Y#'.3Z=V9U[              !U#U1&W
M)M>:K&U(       !\O?UOY=4=VH       !]0GR3ZA;E*X *@[?$N.I;
M     %.6ZEO\3M@                                         8,^:
M M ]WY\W!],Q9H       /E[^M_+JCNU        /J$^2?4+<I7 !4';XEQU
M+8         IRW4M_B=L  4_U^1#_0>?               CV6,AQR
M               F'G_07!R.N. T6+@*Y-JC!%D@       ^7OZW\NJ.[4
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M;T?G,[ZWR0     %8:-]G[]   KC1NL??I   KC1NL??I%?;-=@Z]@
M        KC1NL??I%6U]^<SQFVW4 *YT;K%WZ?T&"\EZV^?.>C
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MS#&IVTSP %.6ZEO\3M@
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M?(SVO/AE9]6S65JMC,L>&8S&&?5F.*8C6W6/J$^2?4+<I7 !4';XEQU+8
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M=OB7'4M@        "G+=2W^)VP
M                  /E[^M_+JCNU        /J$^2?4+<I7 !4';XEQU+8
M        IRW4M_B=L
M         #Y>_K?RZH[M0       #ZA/DGU"W*5P 5!V^)<=2V         *
M<MU+?XG;
M ^7OZW\NJ.[4        ^H3Y)]0MRE< &L?H?/3W3N         $"W:=G//>
MA  %#^8H4'\:\OS0YX#@EPR'E#S.Q <4NO(#EAV(#BEUY <L.Q >!U<@'G#M
M0'@=7(!YP[4!XG4R >1V\0\3J9 /([>(>)U,@ [N(#I9 !W<0'2R #MXO(%X
M?9_47OZ>^           /E[^M_+JCNU        /J$^2?4+<I7
M     !K;X3D4;^8O! "K^Q9C=S;:?%JXC?ET]F69KX?I^';UXZZ^KZ-H\:K)
MJFNAO2WK;X=27T-6&L9Y'5C(:FN#=+?ULYFW.T5?V;4BJ:Y+4U?AA+.SOZL9
M72U0GH;IMS](H'T]^PN57KGK6,#9V2"KKFG/TQ"_NO7S=#P3!^EOKCK6+L\[
M2Z6S+QEV,8_#EQCKYSQ3/Z<&4UAV+-G\>M,J&F&7]WC+(:L?*&+WY9RMAU<Y
MX<I@73WS[F:.;&,W7P[.$ "\OT[[W9+W?7           'R]_6_EU1W:@
M    'U"?)/J%N4K@               UM\)R*-_,7@@!K%[#I=O"-<_5]*WN
M%3JGMVNGLROOS%#5;VO4]A?RSS] >GOQNYMPN_.,7-E]>:HT?Z*]?OF:%$^D
MO;6^*Y5!>FO\>2$=#?:O%JTMZ&Y+*.JV^'4D]/5KAZSI;7^)Y6EWT'L^R+Y+
MYSL8QH=]*[L=M[-P?!\B%=#<,#:V61R*V#LY]+9E!.EOC-S9'+>RR^17G?,T
M=#;E57:M1&_MN;S].MNM9PUG/8/RW/I3T-W&;LMTOGW&T"^G=^]/-T*T[%GC
MF;Y\S1H[T=WJYS?'FJ-%^DO9JOAV,8O_ ,OS]@/,4 !>7Z=][LE[OK@
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M[W9+W?7           'R]_6_EU1W:@       'U"?)/J%N4K@
M    JOCU:J^?\?S!U9>$AY0YCE@.O+BD!V(<L!UY<4@.Q#E@."7#(#FASP'!
M+AD!S0YX#BEUY <L.Q <4NO(#EAV(#BEUY ><.U >!U<@'G#M0'@=7(!Y';Q
M#Q.IDNCWO8LOLV@          !\O?UOY=4=VH       !]0GR3ZA;E*X
M
M !\P'UKY?3UZF       !]1/R/ZC:].V
M                                     !\]GTOYYIEW>,       )/I
MV_51\?\ JN1QR
M                   UAZW+^=KZ=\ZP6S       ?I[H?!^T]GWD_4
M
M  4?T*/KG]/YRN[58     2+5MWF\]W-Q.)V0
M                                           !^%;6JV-SP     '-
M$V35L]W'(
M               "I[E3Y_\ Z1\_UWZG.      $^K6/>S\\]WN3P^R
M
M /03]'\!HKZ'A       "?UK'U*?(OJ7=QR
M                                         ^8'ZU\OIV]3
M^HKY']1M:G; &-A"<0
M         EN3-R           ^7OZW\NJ.[4        ^H3Y)]0MRE< &'A6
M^                                                    3S)),@
M         'R]_6_EU1W:@       'U"?)/J%N4K@ P\*WP :MRMV%C@  $7)
M0  18RQDP 4^7  >!4!#99N%ND6)D8DE)#29$$)V0XF) S*$H((3L  @9/
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MN ##PK?                  -?2TR7@%8EG  I<N@           %:&%+E
M              )YDDF0          #Y>_K?RZH[M0   97#+%9X@  #ZA/D
MGU"W*5P 8>%;X
M    !/,DDR           ?+W];^75'=J        ?4)\D^H6Y2N #AAC0
M                                                =\[,@
M   /F%^L_,*9OT@       /J.^1?4K2J6@
M                                       /1=]!\+Z\/3^=       %
MO4;GT^?)OI_-$@
M                   0K?H]&WT'PVE_=XN-SQ     '-$[#\SH^\3Y_[C8_
ME](
M
M                                         "K2%&P!S@  %#%\@KTE
MA'3MDM(L2D@I)#+ $!)\1@DY%R4   IDN8$8/$E)%B4@ @)/B,$G!6QVS+$H
M(N2@  %7%H@%;$ +'(.6Z9P
M  $=/7^1\\3%F,,R<)(C:LU=,B0DVR-:2%':.L3PPY7IF26&RAKJ5"3$G1!S
ML$Q,8;$FL!TS.E/EP%J%<D,*W+P,:;8&HQ'3.DC,.;3FNY=1J.8<G1MX5.8,
MCY1I*B3G.784^38L\IXN@J8O\V6
M      !KL7"5,; D2-?S80E)'# %A $!/,@I>)R'4(N=0GQ%B4D5)0>1 S*$
MH(L<9X$?+0 (\5L74"+$I!A3N'>*?)D2X BA*P543 DH!!22&6
M                                  !#2*$%-8BFS.&]QIR9H_3/G8("
M<!^E,FPAY$)-B370D)#R=G$;/&HA%S)D^($<YF3E)2=,G1*"DS&F%,T=\A@-
MNC7$P)VB+DP.D;0E4$$,(1L[)>)[&0
M                           1HPY/0          #J$"+(   *>+A
M
M                                        !__$ #80  (!!  #!P,#
M!0 !!0$   4&!  " P<!%!<3%188(#9 "! U,#=@$C,T4' 1(2,E,8 F_]H
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MS9LLC+^O]/VS)%LK_@V[S60SL?X$";(&3ATVPD/_ ."[!X\;GSX*#QXW(O\
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M)L>/@B8+557LH>F0N]RZM889K1(JV,1%"R^'*'$2($0*&'W1 02!+[I%<C/
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M9;\T5UUG;9?<*/!DH\MX>0AZOCA;\MYH2E[+S.EV I$)1L0,N?A'FF6R7F9
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M9N'-B#ATL8PIG [3';_LSV7,9&VHO&]QYF_)E5[.KX3 5?Z;_2KB\;*"4(/
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M6Q_8MO\ ]Q[<FKE_"%L?V+;_ /<>W)JY?PA;']BV_P#W'MR:N7\(6Q_8MO\
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MW%5Y][I_8Y'D[<57GWNG]CD>3MQ5>?>Z?V.1Y.W%5Y][I_8Y'D[7;=MXHO&
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MY9?V% ](PO:D?Y%']0UX>GYOMN3\LO["N_TA"]J1OD4?\"/RXL45D2&6!_\
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M6TH)\\<621@#*P:I)YZ=+2T,MR7FXZBME"\"%J6VYCPZ%86T @I6JJD4&B"
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MY(< *<12%E#330-//7,)5J3S5!6'0UD,-)89DLYJ4.K<;RWBE2O.PDXTK2E
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MKL[W0.QQ_)VXJNSO= [''\G;BJ[.]T#L<?R=N*KL[W0.QQ_)VXINNI/%T'4
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MH>'36R=HH2BH%J4@)K12D,T7X$X'UJUWC&$#KH;)VBAE*E%F6@IW(4AC$O\
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M=M]KW^KW[[#<W^4?\4VJ<3GB5_C8;@OUH(]T=S_C^JP-"#U6-$^):@?S-_\
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M:^;XL+@_:K8;0S\)%(Y/KBVK$/%1P)]])MRAGX:4CU]?EJQ?*8/!W-CM#/(
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M;SJT)[E"G%J2G\E)) ]P6S7<9=S',PUJYC5C.(%*JKKB.))*3KJ"0=+-OOM
MI:>=;"NZ#;BT ^,)(K[MFWGFB5-.N-*.\MK4@GQE)!-E*4HE2B5*.I4HDDGK
M).I^MN,$7:Q4UQ*>('K1FK%/?!5^=]DWAZ?F^VY/RR_L*[_2$+VI&^11_N&7
M%;F,EATK"24JJ@@*!2:BE0H> U!T\.MALW%H:OR">@C+ 'C&!5??%N3<7#Z/
M(Q]?G>'X."O[?_I8[-Q<(H_(Q=).64^XG "/A&QV;B:87Y ]=4MFOBHVFGNX
MK'9R)44>D8>D$MDGQ*RP!\$VY.1,7HTC#U5;Q5_*RZ?L>[8;.1*FKT@CH +8
M(\9RS7WDV&S<36K\@GHH6Q3QC+57WQ;DW%P^CR,77YWA^#@K^W8[-Q<.C\C%
MTDY93\' "/A&QV;B:87Y ]=4MFOB\[33]JQV<B5%'I&'I!+9)\2LL ?!-N3D
M3%Z-(P]56\5?RLNGN8/=L-G(E35Z01T %L$>,Y9K\%-ALW$UJ_()Z*%L4\8R
MU5]\6Y-Q</H\C%U^=X?@X*_MV.S<7#H_(Q=).64_!P CX1L=FXFF%^0/75+9
MKXO.TT_:L=G(E11Z1AZ02V2?$K+ 'P3;DY$Q>C2,/55O%7\K+I[F#W;#9R)4
MU>D$= !;!'C.6:_!38;-Q-:OR">BA;%/&,M5??%N3<7#J_(Q=?G>'X. G]NW
M)N+AT?D8NOSO#\' #^W8[-Q-*/R!UU+9KXO.TT_:L=G(E11Z0$]();)/B.6
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M +,J/I;&SS7W9E_[,J/I;&SS7W9E_P"S*CZ6QL\U]V9?^S*CZ6QL\U]V9?\
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M-0I!LRRDD'I '=")U2U1)%+)<]*&%X$T[K#0\]2;\;MM+'=T1;?C+/Y/)_\
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M9]FPI?9-F=GJ)/W&I5OW].%HI1G$F8:H]B] E*%NVUVBSF0DC3IT:3QUWO\
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M\F56'_\ LC8_UXE["E_F*\C\66 '_G20?^@XF[$<TC]C--4#J24HW]$JHO\
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M\LZZ_P II_F6.U_+.NO\II_F6.U_+.NO\II_F6.U_+.NO\II_F6.U_+.NO\
M*:?YECM?RSKK_*:?YECM?RSKK_*:?YECM?RSKK_*:?YECM?RSKK_ "FG^98[
M7\LZZ_RFG^98[7\LZZ_RFG^98[7\LZZ_RFG^98[7\LZZ_P II_F6.U_+.NO\
MII_F6.U_+.NO\II_F6.U_+.NO\II_F6.U_+.NO\ *:?YECM?RSKK_*:?YECM
M?RSKK_*:?YECM?RSKK_*:?YECM?RSKK_ "FG^98[7\LZZ_RFG^98[7\LZZ_R
MFG^98[7\LZZ_RFG^98[7\LZZ_P II_F6.U_+.NO\II_F6.U_+.NO\II_F6.U
M_+.NO\II_F6.U_+.NO\ *:?YECM?RSKK_*:?YECM?RSKK_*:?YECM?RSKK_*
M:?YECM?RSKK_ "FG^98[7\LZZ_RFG^98[7\LZZ_RFG^98[7\LZZ_RFG^98[7
M\LZZ_P II_F6.U_+.NO\II_F6.U_+.NO\II_F6.U_+.NO\II_F6.U_+.NO\
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MCCD;J'V=0T;M5/4A@O1Z8L8I$U6D3\ZF]B-)&.1.=L[5+BHFV0VT2"(((3=
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M>/6%MP.&K*-65#64EWX::F!U_2=9"B?ILN.64>TV?+*35:]^4P;/];M-E?\
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MRUX@(^[BY=4,6;>=^V:9."[D&[[IOMC+?:Z@^)4O[A/M+,O;&O\ CM5^_?\
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M2,#=F6&*;4+=S:4$#?ON-^*6:MTU5359JP@H*V:&1>24MI8Z=UOO5 RM+?0
MEVN1I)-L0YE')-'"]/5TSS!C":F((LN@:F52KO9@O2TN$-O'88YXIS9]C5<F
M,NR%9L1R4L7V=]6O7HU]'7L]-]U\0YNT?+C4154R4]=51F>*!-E#"DFE%9M4
M98HN]B%D8*07._$V9Q1S+ D-34R/ E2HIHU<&%V=0UVD0  KO+6'332238',
MDG.7O!++&L]5)"\1@C9BT:MJAFU.#!I(OJCUD[MUC?#YS3*9#LJIZ>*3925<
M<0:F1]6D]/7K958V+)&R]1-QB7-HHS/IIZR=*8E9YH(E:*-E 9QJ:1"Q0&[Z
M%;3A*MI<QACCDO2RY8:M1I'28SQ!)+E=8];?N;VW[UOZG,O;&O\ CM5^_?U)
MX>HW;O@Q?^STO[<=7Y_3_KW^D>_C_P!O2&.OTO\ ''^.#CO#![_YL'O8_P <
M?_./\<=>.K'5COX/>P>.#WO@P,=_'5CO?GQXL=7YO2Z_3_P..K'7\./\,?XX
M/I_X8[X_-CO#'7\'I]_'>&._XL=6#W_S8_PQO_KQWOSX[]N]CJ_-Z7?MZ77Z
M75CO' Q_B,=>!C_''5\/^&.O'7^;&_'5W]_I=\_!C_''7@][X/2Z_P V/'XC
MCO?GP._CJQ_5OQ_A@?\ OCKQU>H'VQEOM=0?$J7]PGJ31U$V79S L3"27-*F
M:)7#1[5%J(95*$Z;K($(1P=)/?Q%34T\T"QY97QM9F>>KFK$2E;18%!-(ZU#
MZC8!0 >).F]J2>LI:."@CHIN61,(=<D+\BT;4ZIC.I"LIBNU@VLR&VD]^.&4
M9?G:;*37+49L8DT-JD$@?9F-;7<2?<%;ZON;XHXI5KX7:.15&24L19D8*)5F
M8M&6(L) -Y3N@.(PE//RB [":PSZOF)V;V$3WT2DVW1M]R_<MWCBFFK*"DY
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MM_QXDQ+V*N/M_P >),2]BKC[?\>),2]BKC[?\>),2]BKC[?\>),2]BKC[?\
M'B3$O8JX^W_'B3$O8JX^W_'B3$O8JX^W_'B3$O8JX^W_ !XDQ+V*N/M_QXDQ
M+V*N/M_QXDQ+V*N/M_QXDQ+V*N/M_P >),2]BKC[?\>),2]BKC[?\>),2]BK
MC[?\>),2]BKC[?\ 'B3$O8JX^W_'B3$O8JX^W_'B3$O8JX^W_'B3$O8JX^W_
M !XDQ+V*N/M_QXDQ+V*N/M_QXDQ+V*N/M_QXDQ+V*N/M_P >),2]BKC[?\>)
M,2]BKC[?\>),2]BKC[?\>),2]BKC[?\ 'B3$O8JX^W_'B3$O8JX^W_'B3$O8
MJX^W_'B3$O8JX^W_  LBQ6*Z:"VR*J.2$ L6*9:/(;2E;(%&/*G% D@<!AW!
M?+D;;R.:A7(B+_D[@'QMF?\ @3-?P6=7-A0XM1+C3K+#I@4,,]E755Q(IYKI
M:FD%&:0\C0R0MC#"@P(57;WY0L@//%$$ZJRV]H8Z1&&8U\2L,,8"&WCG5TEZ
M/7>>Q1B<O+0$?&7)-%%%W!FMUC</I6%9N0:T<%X"R=TY]<IRR7[KQ;(E1&Z
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M>/ &6_MF"?;7CP!EO[9@GVUX\ 9;^V8)]M>/ &6_MF"?;7CP!EO[9@GVUX\
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MCGKY$XPO&<3M\>N*"!E.,Y1GV3P<EQ>;974J#;Q#]+"HHMI(NW1(CPC.UL:
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M?ZTX_,6>?_ZS'_M1Q@U[%6RM*WM O(F/4IZ^,!5CV$LSHRI9CF2X9(S(DAA
M2]ILDS'C=MA*G)5XK^RZ4L],@L1 <R6T43N>/(E1S2HE?*D.G,F#G2A#%L#9
M *-[IL-N[S*[;_0<V^-V2?OF9^A83\4<;_<T/\6;\<>T3^L#)OT6%\<>SO\
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M=U]O^/S_ (=[%W7V_P"/S_AWL7=?;_C\_P"'>Q=U]O\ C\_X=[%W7V_X_/\
MAWL7=?;_ (_/^'>Q=U]O^/S_ (=[%W7V_P"/S_AWL7=?;_C\_P"'>Q=U]O\
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MB%FRI,CDYBLK:N((DZR-K9I /98])$B.UW9HE9$JG99VB5<"<SJTE-I*P;:
M-W=SW@&=9IP1-UD>'!28PIBR0,).9I<1V<ARR%"-=87#K;$2TJ28U?D4.]W
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ML(.XC@[C5R7"[R#&AP06TBKQ6VCL,P<^97P8T^PJI[RR3-[RZ28*9#48XHI
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M,V^-V2?OF9^A83\4<;_<T/\ %F_''M$_K R;]%A?''L[_K QG\? ?CC*_P#
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M:9E-_!FQR=H5=45$:R*#':RGQMUG6#K["C3WA8FL0PROL["<(DYG5:ZXT!P
M*V?80)1GLI/[&S"+FNKCF*2K#<FGW<-MBL!7].X^D<5IR(QI9 (PH[R;;6Z<
M0GUU)VCEW[.N%F4K+,YP^YH+&BFL4=E8Q:B+E$Y*N5!(0=E 'CL"&A!!?#>
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MKOBZV##1!(J'4)N05FG-C-_7DBCU@AS"XT^39.TD=LPG0,BG1&$YL:SG8RH
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M80PJF//. :"68U'/U9[6FOGI19Q+6V=#%7-98U-ZH*H/7 M>K<.3%:M/%(R
M6N9YVKG*<U51<;RC)<O'>R<<B7,$4(&.@J8$@%S#;%D%4:64TC)A5&)\LBD+
M%.P(@QH4%$(\JX9$SHT+#PR@2*ZL=0 DV$8$:P'8Q:J1;K9!694Q2L1(XNCC
M3D:..PU@<0G"+G"SK*0U,OL\?N(A(86QYF/V&.5=;!@RHLEY3MD&216LE\W
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M*D(D!P+VQM9<2'3U4":%Q[%\DS&D*)XDD:8L2,I9<B4HU ,0N3WLUM7C"/\
MXEX7^\'<81_\2\+_ '@[A,M*WE6WU#-J[%J>3<NJ*/)M:'R\^2FGQN\:P2?"
MXJ11M\KN!1+?RS)T>;:9&5R)S)97"EFVRO\ -\J"><D=OF^J"Q.7&$0ILV.R
MRF8_'6'#/($R9*C1 M37&CO>ACC!&V5>\;'-&-6N<J(J<8MU^CN#W9TWNAWO
MXKT.B7TW7ZO1=W]Z]W]3O>CY[6YZ+<X:VC;&>]<#R?W2M@-"Z.L5$@KCW6H'
MF/>ZA)O1Z_3[7/;]#JX[!QE!$EA%02CN&K1%%UL?$ZU=16>5CC@,B/\ /36P
MS&N\CV)R[7 UR='$=-P.19-C 4@1P9 XW?<E\() ;HRPQJZQ8)XG2H[2[Q$1
MQ")A\DF8XT>8R-9+75^-XH^"^SJ"05W@R9<6]LP JQ+LRHSY061UE"8R,[?=
MRXQ8@(XAD-6;I2M8U"D><Y"E5Y.6MVI_+X5\B-8U/(QJ)<]^]/K3%*A<<Z_:
MZ=(G5V27_2;_ )F_OK 23H]+L*S<]#HXHG1H8X.*I0Y(S%&66GH37K,F<RWE
MU._(D"T2XB,-6(-PU[O>;8  ?HVYU%KF#)C$CM!P  QQ]'=C[$TRF'D3(>WY
MGG%4"3-'F=0K]/Z^(S7)W3"E=G&91;*36A41AU\<U/I>P<0;GO?!&<Y8K6"(
MYC_5L5>2<80'5B&4!.*5 P^[I&'J;V)N4DE62I]:(QH4NN?'",<[SV# 0C2$
M#NM9PW^*^Z)(S-.G0N0^[OK4Y?!_"/>_?'Y?]_V-6KWMSXSR3-C!--9%PT+B
M%&,BC_@DA2M'Y%:S49K7/V^2.40O_-LY8*T6SNL[5S-.UFC<8ONJR=1M,C?.
M:NVK="/_ )"II\WCM#DP*O$:RH?-R2+82+N=)GY#9VX&$B&>& W1T<@TD;14
MH>\N84Z8H8P&:1\4LL^Z1!XU72#*Q5<=Z,JPD)I74URE=R7DNM%5Z_E(OEXQ
MP\.NP^BJ)5UCLG'X4>?)M,G35=PI&XLI6QFQYZ"4[[-SGV)&HXH"D20_<'VL
M.ONY]_O&&V?WBH-SN/W/UW_GO.2,IUDZ]KX2HS5YR!X['?=/M;C<1R%:M+A1
MZ][J:SNE%W>0UE-J%]%J3FCD11^E1G&0QX#!%Q>7VK=GL<0@Z'5IIQG5@LD;
M%1B;:C(9XQRT3FQTG?3X/)Q%';#@AA^XY?<VR2T(XG>*VYG7G2M*B"[R6-T"
MDV_3+#\K?-ZCB]C0:J%;4T_M+K@XH&9/6MQD-Z*C%)MI3Y 6E&^""Q#-<R*.
M-+C'L-""!OHI&9\R&^D[[;V6RT</$NH4;)C)AUCC*4CD61;B"55&1L:.88CQ
MAM15T<NSGH84>7(*2*S&5J]KK8KW5$CK)LS8D1RK$'&WFV_4;[>J>-9$=\E&
M.9C<R/"C"F,FXG8LEL$QLILZ1EU8,LI)")N[RB,0*/U\VA7:;R8UK4[2^OO\
M8JR-NS=X1\FQQEK(7'5K8O=A6RWY!6(E.Z)N;04CZ1F20]Q%<7DF$+1YE53[
MV)A\@-8W*Z*<*LO:!\L+V2!".8<FME!:*,%VT<\PL)C"/C].FK@K8U9$JFPK
MNZA%#62S3:@\H,XCI4RGD'Y.6MDR"$<$;6L$!VX ;&M&GXN4MKPF%+%E",O'
ME559)M%Q?&"B-&YE)R"E*2GCJC61TZB.==I7*IS?I&;?&[)/WS,_0L)^*.-_
MN:'_ (!QP$>&DD5ED?13C*(A%KXK,=R&Q9,:]GF@5\V!#@;IO1JV<X">E,+\
M4L&RA1+"$;1O0YT<,N*7;(TH]V.=A!$VRC85FIJZ2,:].3FHO#"BP_%QE&]I
M!D'C]2QXWL74Q['MB(YKVN1'-<U45%3FG$R**N@#C6!));"..)'8"<68W3+)
M,"T:#DDE-\V2\S7N.WR$5R<7LRPJ:&92S8&,1:FN+ !(9 ?1#MAD5(AXG2Q6
M:9P6Q>F<Y=+2(YHD:U'Q3.B1E- :1L$J@$I(;2C016Q7Z=4=I1-09$$K$>-$
M8[FU.7"VZ4U4ELOPVB5T3O%?U>6;L]2OD1$]9Q(E"C1Q29FUU<@81L/*Z=FV
M#J"M:A#;(U5@MQSMMBZ6<DX2W=2U+K5O+E9K70UL$Y?!RFJ'J4Y?J])P0!QC
M,$PWB,$K&D$41&JP@R#>BM>-[55KV.16N:JHJ<N!@ ,80A&P00B8T8A"&U&#
M&,;$1K!L:B-8QJ(UK41$3EQ(.^%$>:9'9$EF=&"XLJ*/=4<:016:CQQJ8RL"
M17#;NEY-36[F)L*@I(B!E-G!2+508Z"FL80;)@D$!NB4T92C;(;R*C"$:CN3
MW(LYYJ2H*^S6.ZR>2MAO=8.B$::*Z<YP566L8S6ECJ?<4)&M>/2Y$7@3;>IK
M+5H':PML8,6<@7KRYN$DD14&Y>2>5O)?(G$-ZPHBOKM:U[UCAU05(%T8BPW:
M.<;7'>\#]G1J"]PE\QRIP>6.-''+E, .5*8$;9$ED7<Z9AS-:A#,C[QMAI'.
M06Z3;TZW<XL%M;7MA0"@/!AMAQTBPS12;L4T6.@]J.6,5$* @FL<$B:QJUWE
MX("0(9PE:K"A,QI!$8[R.80;T5KVK^MKD5%X*RHJ*RK8==1V5T"+!:9R<^2E
M;&$)"*G-?*[G\*\/J^X*7NPIUE%KNZX/0DE+RYR7Q-C8>=>2<S.&I%Y)YW!F
M1*ROBLDB$"2R/"C!;(  :A"$S1C:A1""YPA#?J8,:JQJ(U>7#7P*&F@O9U&A
MT2K@QG,ZQ!MEZ5"!BMZIH0MD<O7H(:$U(QO(=5(J*L]6%K!AK30(I( F"3D-
M@X;Q+'8T:>1C6C1&IY&\N.ZF5E>RKTZ.[6PX[8&A7:E9T:#Z?3J\[3M\M7E^
M'AP*BKKJH#W:WAK84:")S_@UN'&&)CG<OY2ISXH+: \0[*BL'$9ON>T,BLL!
MI$N(1'#&5R*6-HE1EVU3KX436K1ZW(&794M382H_J),VNARI .2\TV3'"\@^
M2^7S')Y> 37Q(SYD490QI;@"=)CA/HWQ .K=T0S;;-U@W-:30S6BZ4X=#MPX
M:J2),7O7+H,!095<5\.:&6D8L<=='C0Y$MD<<>0<=G("QNMP8B<VL;)E='#Z
MR5$Z(\M\0+S&BMUJ.-()I0AXK'$>Y(SW[?GOY(FM5XKJ@#M8Z^*..CT$P"$<
MU/2$: 7(0&D(KGM"--L2*@V>:U.&0Z^'%@1!:U'%AQQ18XU(]Q2*P(&L&W61
M[R/TM34]SG+S<JKQ-DA@PQ2;+:[QD#C!8>?L#4(>M*UB/E;(E40M]S]L:JQO
M)ODX)+K*.GKI1N:%DP:R%$D%1?*J$-'",C^:JJKJ<O $F1(TM(TD,V,DD C]
M/,C.U1Y8-UKMJ2!WG!.S243O*QR+P!)D2-+2-)#-C)) (_3S(SM4>6#=:[:D
M@=YP3LTE$[RL<B\-#8PHD\+"CD,%-C!E"8<*ZA':,['M:42^49$36Q?*U4XF
MU5?('$)9,;!D2WJ]'QJ^2]HK(L9&,?JF]"X[82.43&R7#(\K6L\N/3 L"$>-
MPI<* %L8>ZQDB."&-C9:^F'&!%&1BQ6^C.1X3$75%'S("0(9PE:K"A,QI!$8
M[R.80;T5KVK^MKD5%X?'J:NNJP$=K(&NA1H0GN^#4\<80V.=R_6J*O 5@TU5
M#6.62>.L6OB1U >8QHYA@J(3-HLH;&,DD9R>=C6M*KD1$XE'9%C-/.0:33-
M)I9:!8H@I*(C=<A!#51C0JNT,56-Y-7EP8M53U5863Y9!*^OB0R'55U*IGQQ
M#<7SO.\]5\OE^'@42%&CPXD=FV"+%"./'"Q/@8((FL&-B?XK&HG#!6]776HA
M/W!"L84:<,;_ /'8R2,K6/\ \YJ(O#*^?5UTZ /1MPI<*-)B,VTY#T1C#>%N
MA/(SDSS4\B<!@=VP.ACO"6/"Z./T@"1BM/'(&/M[(W@,QA@O8Q'"*UI&*CD1
M>!S'Q8[Y80ECAE."-TD0#J-QP#.K=U@3.$)Q1M<C"*(:O158WD696TE17RSI
MR-*@UL.)(,G/GR*8 1D(G/R\G.7R\+;I3526R_#:)71.\5_5Y9NSU*^1$3UG
M$B4*-'%)F;75R!A&P\KIV;8.H*UJ$-LC56"W'.VV+I9R3@AV4U4PYIHK(QFU
MT1I2V(->Q/(1 ZWS0[I-J4Y5./<?H>FIW,ED2BIWV)F.&:>^LA.FE8]NA["2
ME#OO8]GFN:YZHYOD7R<!BQ0!C1HXF CQXXV!  (FHP00B&C1B$-B(U@V-1K&
MHC6HB)Q*TXW0MZ[EUNFGKTZS21IF]5RC^^.1F-*F[JY$:U_Y2(O&26-W74MH
MEE?!MJETB(*:>"P=160%7G+B^]I&_">].F>]-O;=N:^;&U5G-CULVGAT=S62
MX$X22=XMA*J3QU2*6.6*0(T@$W%(]KFN46@;^;E9&A-K:]L.$4$B'$;#CI&B
M'BD0L8\8"#V@%CE1" ()K7A(B/&K7)SXZ:VK8%I&1R/2/8PX\T*/3X'[4D9&
M:D_4[3S3A*H]77&JVM:UM:6#&) :UGE:U(;Q+'1K5\K40?)/U<!? J:R$^/'
M?$COB0(L9P(A2,*2*%P1,44<A1C(\+.0W$&Q[FJYJ*AY\&GJH4Z5SZJ;$KXD
M>7)U+J=OR B88W-WG+N/=S7R_#P.K[MK^[ [.U7=''Z$73F9(C[<3;Z=FQ(&
M,X=(TVC,81G)[45 GM*:JLC1_4&GUT284'EY^A)("1P_+Y?,5/+P,%M4UMH
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M'VDIOKG'C;$?:2F^N<>-L1]I*;ZYQXVQ'VDIOKG'C;$?:2F^N<(P>98H1Z_
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MWS,_$D$O\6!E("A1@(QK:TJ$C%1Z.4[2U91D+S9S'MEYL\NI.2IQB^.8QV7
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MB1^U?L^I9$:+*. =519-05=A;PH4ACVDK85C8/'#5@""$%DXC1(Q2N5V,P:
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MGF+&Z$QH\^SKEFP4<KT@V;:V9$9:PD<YW*)9-E1TUD1!\B/10QHPA@CQQ#
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MMI4J;NR9(MKJ>2 .1#D0"18O7V,E@8'2RCC'7,:D$+GH8,=AF#(TU5=P0V$
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M\F78QJ!D-]BR+H9T_4-6PA#  \@+Y))#6@UZ"J.'-Z:5#ZR+'E=)/#T\Z+U
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M(M/8I)&S(+:L-C,!1J,A.LLXC?X/CZR'F[1.GWU8]>,KAXCCLVNCVW9/BO>
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M42RUD6(V =JV4- E>6ZNLHJDEW%=BN 1J^^F0]]H[9U/<0\J)1V)0[;#R7;
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MWTO_Q  M$ $  P ! P(%! (# 0$    ! !$A,1!!46&!(#! 8'%0<,'PD:&
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M+TJR33!*<T89?RT"V>KB7HE16,KSO0<I (,6-2_"?RN(!7L'F-H/79#[G.K
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M4!1BX:5$%R3T$2HJ(#JN--@O@!C34!E+J&3Y%(:G_F.7TU+.X0JHV(1L(MU
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MM/B_(P0@"62P\-N\,3%W=%FM&+CLA*SS+QJHDZ=;ZA(''I1_\E6--J88S)B
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M5JQ-JHSJ,T@,<]]);1B:<C$D<CLT\WJ"VN,S:TK:.$6[]@L9.@8*U 4ZDJV
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MP0(&#!=,0$DLSX#^EP1 @0($"! @0($"! @0($"! @33$ )+,^ _CP1W O\
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MG@W<[:^]8R="65)@4VBBS%_1:CA>8((Z:<EL#\49Y8HH.5,Y+=9;#:D>CAM
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MIW [!YIGSH-POQB@12O9Z2;4D^.+.-L"'K,T7E3.H+/V =A0ZG@;#ND4# D
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MV7X.3+?&0HR$-KW#U5B2/59;V\-^#]F**D?"#H+IJ^O_ ),K0.T3)?F4CEZ
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M'R)"[7F"Z!ZA_P"S1@OM-5@XT1[BPB=MHPY1_<9EYJF:LKBGU4!_O>V>A$X
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MW,UGL4FS=1CI&X,QHF'K[!GL+MX\!TE%V=5:*$LZHK".X557.;])U*J+>O\
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M?NGS_]H # ,!  (  P   !
M      *22222222222222222222222222221
M                      0%$L\IU\^^FH8HT]F*Z@(<M&1CWI7B
M                                      1M(\*W<%!I0Z#E7)8N* M!
MU28K6Z4"                                              622222
M222222222222222222222220@             ,     ,,
M                     !L                                 12
M                  !AP                         -Q\
M             !@                    SH
M  3PL                     ,     00
M         #\
M
M
M    "N      G@
M                    6       !
M                                            !8
M                                                    8
M 8
M        $        $                                 #MCAAAB09
MZ                       $        $
M      =\!ZN,AQP1"2                      $        $
M                      3@#X5@0=)\ .@                     $
M     $ !R222222222<                   #N-CP   0,?L
M            $        $                                    1A
MAB               00         $        $
M                                 "20        $        $
M         "               "                        0"
M$        $                 !_"-H!@  >[E^<"      "#R.&1#QAL<"
M+G\  022022     $        $                 -A.<7&IL^32*H8"
M    #L4OG^];Q.7V(L8  022"2 "    $        $       ,<
M        ,   <"               ,#@ !@             $ "(Y 8  $
M  ?P]^$1     #@                                    #@
M    $  \*,   $    "01B",
M          #\        $ "W[O$  $  5CC=O@.2  @   =@/\"1_P#$C_X
M_P#X!_\ P"?\ 3_@"?\ \D__ ))__ (  VP        07<GI0G. 0 ! Q\$$
M9_\ L0          #N,@!\  #\ ""@#L/P$  "B, ,        #\
M$76X1Z?4@$  =@ <CAA\1S   "      ?T5CW.S!/?7C\0;RN"0N?WX^=P
M                $,++X!<( $               #@     (,2'R"+@!SGC
M*S5Q@>-RO_,2<                   $        $               "<"
M?AR#_N0?]@/_ + ?_8#_ .)'_P 2/_P#_P#@'_X G@           !
M  !
M         !        !
M                         !        !
M                                         !        !
M       EJ5M;DEM<DMKD5M\BMODUM.VMIVUMLDMMDEMNV            !
M      !                  #$807[%JDRC&+ # &J^!PCT%YR70W:,LH(
M             !        !                  'H9&,8_.BCF3[J0PAFT
MUGMB6JX H7)4VB#              !        !                X #AU
MT*4_; $<FB3N>^ !D!F "P>B'(8=(';              !        !
M           *D]KDCMLD=MB5MM2MMJ4MKDEM<DMOD5M\BMIVU
M !        !
M
M                                 %        2
M                                                 %(       X
M
M      "I)))))#
M                      "))))))-
M                                     "0      $P
M                                                     !
M  %
M         !        %
M                         !        !
M                             "           !        !    F   $
M  $@ "  PT4@ 00D"  $    "$  0 "  $$   0 @ &" "           ! '
MCR9SX !    V$"RRDP0" "2@6$B@RB$&P&FTB&TR626B"D6FD0DP04" D& 0
M@"           !  ]R@_0 !    $TBRR62VP4V&TFT@R6TRB2VB602FBRR6T
MV26R04"VB6FR4202@"           !        !       P0226 6PBBF2V6
M622VDBP2&4VBR20024&$DFFTPF66T    "           !%6Y6(./0!
M   &0$&BTV$&B6&BT&6B6D4$RVPPD@P$"0BF6@0B F$4R    "
M !&EGQO;7 !                    &  0 &            R
M     "           !    8   !
M                     "           !        !  0
M                                     "           "        &
M
M     &        5
M                     #K      $
M
M
M          $     $$  $ $ $   @  @ $  D@@  $ $@D
M                          D D$ $$$@ @DDD@@$@ @$$$  DD @ $D$D
M@D                                        $@$@  $$ @@  $@$@
M$@$  $   $  $                                              $
M$DD@$D @@D$$@    D D$@D@$@D@
M                                      $
M
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M*%"A0H4*%"A5S7 \0;3I9 EO^G&C63)A1Y$" +$42QRB7L>,LRIP:VV1$LR
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M%"R"-;U#O?'KP%8"NX"N=YWGG@+8+"L%AZOH>[Q,$"Z2C\&3B@94\AT"'JT
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MFJ: N"+>&4PE;,J&X@GI5$,#! P?9A" BH)P,.$FD$Q#!2@%%K[8[>D3 *K
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M^[X$ORC ZH,6?8G^(#L'E( *D 5X@!0@(!B(Z(XCHX_:]C009M1W#"M(:<0
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M+NBM6(_-&E>0J'HI:I%%0Q3IX.%88OH./9$X$80(DJ">!6"H5G?.QDD[AI5
M.(@C0XK6:IMVDE6WIMO#'6-Y1' $(HB".'%/.!I.\-1E%55XRUI40!]$0("X
M#BE$!'A!H M )H<"4$P8"(B_=*V\N7<N0;>*!#!")0/%5)4)2*3J98S.:_C
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M-$FBJ,+02F$'X5093P1:BZPNA2(*M!Z!V"F,"&"'& /:&5D\#D2*(Q#:L7I
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ME!!;D(:K'?\ 8<_I0SUZ'U7 "RE9F(P76O<.BBRU&%9J$0T%2(?],C1HZH!
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M"G'_ /!.T?#\$>7@@V>-P"3PQ%$")IQ]90XNQQ/8#Q&*7@+@!B$AM&*%\*<
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M\)S1HT_8'Y'Z(/R6* %[L^I^@Q-<@APIL%F8Y#:_D B9"C'B$DG=2"1' 0
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M>T-BXH!W@7Q(!4[09=R,1;H1'@B:T!S!QU@,++7=DSWF3H#DS8N1&L0!_C^
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M1=5]!X[/K;UR!JI%JDC0JZ&K:6W.A_)HY9P<5GFX$T).$-^IA*K<4!GA0P"
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MCET]#R:YR^2KK&%M(5(**81#<)!44%)'XH$.ZCCCL@F"$I=5&G=3QTV4&%M
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M!96[B0W@29E)["*T>N2MLVC3K-8P$>KWOG_!1.(5U84(OPI,[VLIA.U&L\4
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MP$" %PB*61<QT5Y!W;09G#8S2@ R&PT_]83U;B2L7T<*-/6;_&FO]0B5C0
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M7OU[1;",[I-LD@J *091B@20DTZ %+!0=LV4A8J:1@-E+!JPC2=J;(U?N.'
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M!LI8-6$:3-3;&K]QPX%6WMT;<2UM8C:UK62+,^B<38L&D.E6KSS;\V-7?_$
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M9@OMMXQ4+6T_E>6R%7-=56&]$KM=UD0%\B:"!88^KTE^UPJ:F M&&B /GO@
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M&1T"<1B[)N28;>:']\>Y@_BPC.;W48,6;,\</1HXNR"CXS>9J2/>R?%A%$X
MX1A6@5K(\1%DZP[FPQ*PR.@3B,79-R3#;S0ZW(>"-.)F=8U:W(>"-.)F<<-7
M<H#??Z82F']I] @PF U+$=^DP=]UGYWFT2#&9#8N$=N4!OO],)3#ZW(>"-.)
MF=8U:W(>"-.)F<<-7<H#??Z82F']I] @PF U+$=^DP=]UGYWFT2#&9#8N$=N
M4!OO],)3#ZW(>"-.)F=8U:W(>"-.)F<8U5&+LFY)AMYH9#N;#$K'(Z!.#"-
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M,3O'\T=+!$C72*H=@CQ\C+&OFX:_&,*4C@A1%7:L=O<]CCF(?*/7.O0Z1$7
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MU*9B@&0BV@D:I94!-Y3:J?:+1N=,1*G1!NV< HN7*[*[-7D#Y0,UW2PC@+P
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M$"MM(SJ*JK]2%N7G=H!?G>]&Z;^!E,.=Z<N'0G^.)QY)4"F\LQMWSIYYZ?\
M;1O:M FKLH">Z
M                                                         .&U
MA:T)ZO"6B@!\E9<HB++E$NPU6P;!GICXB.TC 5TX>KP.V?T-J";GBHAU&N(]
M90UO>P$"WJI3<^Q<5TJX(8Z= Y(N-T0, 3-6S8C!,%"3W,K2+_0%Z @W=V6)
MM<</A#_FOJV\6'7O?9)N@%)35X?^8-YCAZ@\F2H6\5*;GV+JLHUQ%K*&M[R
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M%0M8,DYOJXR6MB68+?\ X259W"QFG 'IYI2 E^NMIK"S"&/:>W:^+Q1BTXJ
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M-\' OK&]B0AHLI:##QA<&)G 'XFY1$67+_KLUMV@3=4VD?=
M
M                               '+*PM3$]U@#8"I\O7J!TE[M=YO"V-
M>2T=---=SLHZ=E;^!C8]X(,;ZSC?R()FL$C4 $03EP?%?BD,.F H /@8;%QF
M(ARV=&[:EN(2X^$](A(BW,50. +B 1\5I3_R,"5LT[N72/#[ 5\$JR/6MYN
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$E.7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>businessfigure14a1a.jpg
<TEXT>
begin 644 businessfigure14a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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MULTCY/@E.&\ #J9*T?U\K]M2[6XXAM,D[TV*&;7+ULB\.0BU?T.>V.;C\E
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M0!J!ZEL?'CZQZG4K4\U%\<;EJQ5J07HC:P"[8KL>H_H6^,.7W \T@@#6[O\
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M+EXV2X.<B[:^;^;^@_B'BX _"IIL? WVQJ^V-Y+9S'RX7)99$?+*L=\PP9
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M^E>^20[X (:=XZ9D5,01T^3)G.<"N?) =@ B)VSHF=4Z)@3@.Z%>H94DQV@
M18U0,H2<@)D#%G(88O4O\  &J!&";$+.^8LZ)V#D-V3Z (B:2$[, 9@^S"D_
M(@<9SDX-H0 5 :R&3.4D)'#($H(V1TDY9A?X!5IJT<QF#L'0,B9,Z1@#M%K&
MQ
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MI7A?>R5M(Y:K#_9W5]43,92,;Z28G_6F-OUG$_ZYI 03C/\ OK\,@)1TY9"
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M>-L+ >VS7S9I2BYNR,U[-ZD'X8ZNY!-NV$@"'-P9._\ ^3Q_<21%Y4;M!0C
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M$1DTYV) Q')'*BR1.LD;C,CH0RL/$$:'VD1Y&5(U9W<A41%+,S'0*JBY)/(
M7.*K8>V**'K%7LRMIX-/>RT\BH+\,[%>Q?[]M=/;H-D;4VH6&SJ"KK<G?-/
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MP&B:JQ)<-T1T5&S Z(:#Q[G+>/?B.S2VZ?+)/*)**',,<1S(PE:0 2DA5![
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MDX _'B:M-7QU%['P8'*Y^&1Y_(_36G,RAL*N>X#L%)'W>/YXX>-XVVN-K?\
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M#\",K\5'CQ5Y>/O7),#RC@.2?FSLN!]P!/S'$6BZ?$V[I&3X"9MZC_2 H/\
MJSP*50!@E>&/</>1%4Y\CD>'?\/V3;1-*%]WJ/M^[<<?1TF"O:U73*MM^G5L
MZA3@LR9V[*\UB..9]WEMC9CGRQGCU:&DL=.K"E>K445Z]>)0L<,4?LI&BCL
M /O8Y8DL2>.?^3J'-YAD5Q1U2FO234>GU!8ASGU:U&"K.D39Z$N\R1;F7#1L
M%$7H:<Q-UN8$$WV1%I[M"/\ ,SV4<_Z4[?/C2?0]9,\QUW48XJL;$0KIIZL]
MD9[.7GC"5DQ]EHY923@JF-QY@]$AAKFSRY9GM2I[^GW3")95^-:PBPQEQ_\
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M"'X3<(H(W<RM%!!$\K##3/%$D;3,.^&E92[#O@MC)\>)H2KG/Q)4^1!_[>?
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MN2W%V#F*\5>K9^)5EC>N6\F@P?%<TI L^3\>)98)(/9"[\<#4;U&1L%EC8_
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M>&/ C\^)=2B*X2-W;^H!5'WD$D_A^8X]=R/X$>[XY;'Y>/Z\+9@8?6QLC?\
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M[2[>N3DB_%,CTV]C<3.,J<^2N707GX?C,X;5F5>!QC @JMMS-@&\Y6I6I."
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MPM"QCF37@-6V$56S9D>(ML.&7&.I%"^8!E$\?;_QU21^&<?X(_\ F.S2&_\
MA_;D]7)^[V]O)]5];F.*!HO%^JY]=Z1L>7+LH9V 4U>21D1* =HJ-1UH\S*)
M1 6/.=OQ'N;P:[0&=-G!^Y@=#Y-^X=)E&4S8!Q93'I"DU6DA$T9)3ZT[?0+
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MNF6?54::]-,L[BQLC$RA >9-;9^4&^4KX=?;7C;^NV._7DIHPF"+85IKTQ5
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MMQC>ZUVNO"N'HIPM_P EXHR67R/Q*L^WA*ZKV)S*9/X9:O\ .Y8V[:276KN
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M(C$V>4H@LQ=@HF2*D4C 0 *'FPLD;.<X\BPQT7D#; BB!3"--")#P4IQ!?8
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M-@Z-8Z05PHXC4,(E*)3VR0\O0@E38SC= W     ( T &@#0''@2%_P P<T8
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M*!  #IPH(7  !@."6,  >-RTW  !-  "$  !$  >   2   T   (  2P  %
M  9@ "&C6Q4  ?I>>E8  -+;#H  "? A[X  %"O& @ 9P2%T4;\\ULAC@ "O
M!(6-@ 4]E;AH  ]4CIJ< *7U@0^0#YD*')"4]_,8RF,F[3">,C4GV7!HNP 3
M9K5"?@ 0'>K5C@!+;W+\P 7CG4'5@ /=!\P(  +Z)Z   "Z^W[  #&=)%0
M!]]J%   ,,:8"  "11"3@  "WP1F@   ,#14  "83264   AH1>@   J3D@
M  6X4B  225_F"  20I;D  "0$GV2    ""00  "2"000 " "2 2  "0"0 2
M "2"222
M                        #__$ "D1 0$  @(! P,$ P$!      $1(3$
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M""*400?6B<KCR)Q0B<"*(P7DT)=+(=8<(CD3ZD:] =B*Y!!& O [8)+\:!1
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MDB&LX_B1P#N +V8 \7@@P9:"^W66:,ZX@-D'6/8E?+&#AXX"-0-; E?GHO\
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M-%.\C_3J_P" "/JAE\OB#3@XQ*4Q2^N,Y<>#.!3BC&YV"1&"'T0(:1>R1Y;
MBQ': (1Q%*HT<\(*[S6/1/YKY,XX$"#G-0WZX/'_ &',E5D@-EV#7]]\=90;
MOQWWYC\N&<WJ69T?;KX=<%3A"^?MG3?7[8XR&H,]4MN+YU@X,0I@!JN)\WA@
MC'H%]PH?D^O#<P&:,42L4(+BK>P(_0SDXH+ + 8,$7%91,L>ATZ_>I!#IT<!
M"F?$]Y._^=YX5J#H&OO^T\39)R76>[UY_C'G?"E08[C*.^O.?C>.(0T=VW]D
M/YQGGCH!3>TUK\Q.3L/V>8?3F CL$ADQ1=F,\,P$]A1F@)E.V%R61   @ !X
M# ?0'.^.0D6S2)0,Z<&&(B,1)ZYZ?/CVRHS-XWWKO/>-:3OF_P#6<_F.(.'D
M^7[]?;CD(>#?X?M[<-0_MST;Q,_OY&EX=6Q @.FL'HH&,X><!3P:8%=4&P#@
M% %&A5AZ%A]#3_+%3!MS!"-++B"BP";*@3M%)DO&(2GWNW/;Z<2G8*6^EQ[=
M82\P5C\IZ_GP\;)7+5QO$31B]XKUR4$SC_HS.KC>#>.,2R08S>)7J[Q[7'$%
M-@E]??/MXNCD"1LK1&PI 6V @Q3<&"L(P%JN(J$G-XX^O;@;[ACP ?\ JX!A
MZF?*&-=^%RT%NHJQR0F<@ A^)C[YV>C\<!4%C'O76\M)XSD\K0D<F:^/S'"1
M\)>N\GZYZ/BAA+CO[?C[8IQAIQEOIZZZ#SKGBM-_?UUH_KRKHW6%K*BJ$ X^
MC*#D6C6C&<I',6" 5E$*+!@^E@[+RIT$QO$$&>6&SIRDG9(J$9K Z,#@5E%G
M:<[1TH.7<2QPL1UI8D%&RLV/ 'FDG#>F:2!+VRZNMER\I%$2VHY+V3J#&.W
MN(V#;M4,'@U[Y6(<:7*>WC'>X[G^ 5)F3UY BKLN&)DX.Z;6B\!R>%3V=<1(
M-B+/>$:8]QR441U5*K6"8!H8:GO#@<6':1PLZP#]59O HBITU&#8IUIG5,N0
ML[-KS!KM@] ; ;GG2T]N ! @8 T'CZM6<#?L@E[SGOF$<9%O*&5I09Z(B:65
M%HL &$P&U0X&X=#$ZL@"@F95F3E5+!A;9AL': =G*($,#)ZI=NU<\/$J@454
M.F*B[$5T3/!@+LRV1S#%0%P-E7!(]D3!A)E[#LRR)Y?9VN@Z @#  ,!]8/\
MJXPG91$!""#QGR(-'##C8EEGD8>!8 [C2N0"3@_&(H&L*L=9 V@XM&@  H%+
MQ >[W0%\Z*=;G84D;W<)A1TPX!42@NN>1=S"NR&@LT2N!GC W38X):0!T$<U
M]2IH,??8IQ\[/%(C2Q;*4,T@#AT[.DB5G4,O0\PGV1X=!Q,F+@EN$RW,X%)6
MLJ (G#2/P7L51AH="-9R([4MFH!E8LHL55]-==\"+)%%8\$H<TP<K<7PD/\
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MMG "E3PK%"Z?I."V23+DF=K5?=QQBYV18O3OZT_/%B'C8J,5RSL4$JHKY_\
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MH72?GP7J>CB/+ *[T' %E!0[U%7:96"O@;0O1:G\X;QQD#?E<]L[[!];^,(
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M+FW/N\&PHT;4+BS=B!)8ID4GX3SA@#ZT@GV^(EA[)P-<HIW'2H,,XRS'@/\
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%_LW'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>businessfigure15a1a.jpg
<TEXT>
begin 644 businessfigure15a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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MX^@N.,R'%T]EO:!SG)$B\IU:)8!/@W\U-G,V)DZF -K)9#X4N[Q%FU3CUFT
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M,<350@V]*,P$#!94G@:S1 JK(91BSJ8B"4]!>1 $=;FTLEV6J9K"])Y$PSG
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M^ZXF?6O<^D%.H*>38B&3_H'WD_L7O[8MK);[UD8@EXMA\VQ$@.KOV'^G_\0
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MP71#;>C <RL7N+C.-OEW^%/$#(SJV@OETL?Q J[HV5O,YWOM<[6J#$- SI8
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M[6I48X<,AMF<_5[B]NE^]:7VX9MJ?4=AOO6$1'BD>6463<_M_;TKZ<7B;#A
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M2S<(X>,X>8.K0Y>(Z#/Q0"IYP0L;#[K:W\HIV@Q2XC),8W!M$DH18[,>89D
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M5,*DV09_+F.H]5!]J23*"^7S:7&QI^ L,7#+EY!FDNNBDZ6O?MV%:6"#?O\
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M)96ON!?]Z@QG"0855Y&<W91S:@6S?*O#\'B)\2&9T(B8$H/]0KJ=NW6L?'#
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MME :5M&*;-KW[?K20%G"R^:XN2<W*=[=M-:Q$/"FD4.& )R'IE.WQK*;@G4
MW]Q2+&\0X"Y@-Q]H$]/YWHQ"$H';)(PN5Z@'RAM\K6W!J8OT5;#7U[T#9$13
M8-SE.E^M2R-FR+I']T#E]^_XU)G4+9.7*/QUJ%9#(H#-E)N1<GUN/Y:I7+/;
M-GZ:#6W[TLB\5;JV46T;46'2P_>B>++=6-]=".@Z 4LC<6S J'TY>AVOU%28
M*2,%S=1<B]S^%8%LLKK)9UR$9K:K[^E/!=Q)FC2,'S7Z^V]0-%G>2;ZY1HCC
M[+=";]*X$;KQ\ZY/L@$9O?TK 2+A4E,B,\4NEAOF&OY?O32+)(3APT9[,;U
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MIWJ,\4ECYM;D?9]#U%ZCE=6%@-3:@(C&,UU8_C[4?JM$9N;>PO;W-,LF56S
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M=KYE ^R._IZU/)@WC*A) X!R%K6+?#_&EJLV8YMQZUF8@*6N.U$K:VQ].M:
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M,3Y%=@.P.E+)A@G#E++*1SD#E'QJ6**20B*8-;0=!\ZBQ<N&Y45'79I"=?\
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M]O\ :WK_ ,^]'R_"A6# .*C!U&_QUH=?^1'2@!:E^U\?TK,P4$'>]ZG R^]
M\-"R<K6.H]Z3ZW#!I.<W;4U(H$#6%M:\/TQ"6ZL1\+48H^))RC8TT4?&\HWK
M$\LCY=+#3\*A=G12QN;]A11&YBH)YM?\5AB?I"B^E]OC7B)(G=1L#H*PX_\
M!HW4S,+]?+2DR-&K\RK$6 -M]=>_2CS2,[:MGM>YVJ*:1V$;-=%%P++OWN!?
M\:Q:C.GJ$O6-FDBDAAC;+'E'( +:W]*G4")--]ZC)7!R%=#<?S6L#&C<Y4%N
M_P Z(%F]1K1 SGY_$5$<S G4_P":W9_;]Z#MEDU.QI=)!;[U,B\F@[4Q*S::
M?P5/(ZR@!B!I4FH%_3\JE R+ITK#Z2FVF]/YOC71Z*+PMNM8?26PV*T0,P-J
M-%02IMK6*1=3E%^]%1PP>HVU.E8<DX="3<VZ^]*?K:D)"7&AT_&HS>.YUWH
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M5AWX;S)-8RQY-<M@ZN,P8#96[U]8>-A)&H"^R5[C]^QK#XF.?[.-G'\P([]
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M:D;7J1XQRZD@_ TTF8 +OVI1D4EM-.E--,8\\$SA0;6Z5A)WFPR,0+EG4_\
MI._J:R0Y[\-+@;VUUH*5%M=3^%/T3MS'RM2$',>HIC][3F/7:C'!(XND;Y=.
M]OGM7#6(N8P57?(!9?( 4,/)([R O"TC9V3?1>ECW J3VG)[V\]*)M3O<9?O
M$VTZ>?I1! [V'QJ,LPYERF^W\)I\ME UJ YLV9KL3_&- YU-AT[FI&$ .A.O
M:G=LRA1;-<FI@"0R;CVO44P9P'WZ6&]"-OO@&_6U*BR2E$1@%W8W%2X<)[)Z
M:_\ @1\Q-^FE"A0\J.OOI(PKNRZ ]/.AI2ZZ=?GX4F$$,"FZ(S"[?U5&;A5#
M>ZG;/)D!RY=]#40<Y@6T)W\JM8',05[=_C06!&0K&BDWLWY^GS:BP)-K45C4
M9CI?TH7R6W)_(TA&:QW'YUPBSYB==@!THYK +[Z=&-F72V_G\[TBEM6WZBO"
M?_@(--A)TZ\:2I,='ARR2%L^ZJ +6.VO2EQ\D@E&6/.0>&ZM?+VS+M\*Q$ID
MY\7)FX:Y5,8(U'4*-OA4&.EA+8H&264*PB#DA?Y0VNC!>WPJ;&XJ>9<3/)GD
MB(=3D6RLA&RZ [>I\ZP&,(B:7&8R.7$O>4*&&9 VH 'DH]D7M3_2'&/B/L(H
MV@SGDX;<25"2#G(O8[Z#]:\-P,LF)?%18=L/@)-9HL1[;-F;-P EC&+V(9^@
MML:G58YG1 0E]/2U%([WMK\^5<JM[(_"GRL-=C49!9X+V74W[U@Y8HQ'A2I.
MK6<=>O3\Z,0(T.I/S\FEC;-S:V&FM6!+-?4"UJ7+I9.NOG3J'9E(%O30?"@B
MX:$FU]3[().^_>N,I 0'F.MK:^^FL'UUL-_=6)-Y7.7+KVW^%3,590JYBQ]
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M-!),%?AMB(S;B#ERL-&70@D:4V*P0D.'>:)YXUS_ %?B#.W*7 5.I &OEK6
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MF<1Q%W91I?<?EO\ .E>#31_Z;AE+K>TUU)L0,[_G4TT;++-(JN>);*IU>1F
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MZ:7VM0MJ-1:HCFS;U)$K#2Y/>_44^$DD:^R]^M28%8U%B?D41:I(L]N:VMZ
MZ4O\;$:TIM\*CL;[W\A>O"C/=A8F,=[BVHI%YKC>EDS2%+7*]_TJ5LJ:#F(T
M'G0)*"XWW_>@B.+4@*ALR@#I2Q2A2JM9>U<$@Q9BUKWO>^M%0"N@;UHQAMK
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M+4B%7!2X:^@'4=ZB?2S;UX>\:NP=<Q;8[Z=::*,1$I8'ITMI6&A1'XJY"[
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M9I'8Z*@ N6[5AOI!X9C,0(,+CT>:8L<.'BG@7%91F)PDF(BCCQ5AK:%F8CF
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M?WU]6QW+?%0%@-/^UU __P"IT\J^K>(76^+CTZ#"W47\N-;]J7"XR09/K\9
M/_\ JF^GGQNE?5\8<2O_ 'RYH@0O_;MEYM]./9CZZC7O4N$\2F #8J*RVVPV
M753<6^V WWUUZT,)X@^AQL:E1UPPO;RM.;6J/"^)9#Q,9"H%[#ZMFS"][_[_
M %WZ4V&Q;KG^O07MI_V@ ^/'K#P^(81+QX^#7,QS80N>YU,V8BU[*+=A7@OT
M,^E_BN'P^,3'83"8.>TB3XG #-)$?OQPKB2S#<C8&O#OHS]*O"/#WPV#^EOA
MIC,IF*2_1X2RW95#$-_J)LE@.@K/CO!?I+@O$OI=XQA9X)/!<3X?X1XHF 7
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MS;^51?W^^I8LO"X5TBRHJ]#RC<^M19.(+YP&&5\F49K\NO7:IGDP&-9.;D)
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MR8>.Q7B:Z',+Z]-=Z$>)=23)$N=@V4 W _D]X_'6D&9KYA91[-];C>](ZN[
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M-&^.M0XF,7S-:Q*V.]QVK,"K,-+[&B<EE=LP84R"R&,Y5OJ*D4B4$GE[CO\
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MDY@"=;[;[-W[4TEM16:XO3&Q'G1U&PH9@;&Q%M/*@JKT\ZC?FZU<42-*UO\
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MN_3:L.3$?M&()U]?GSIB)W R2-$G.6R,%S>MORHF-F0DOD'1;Y#;SJ9\T;"
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M++S(VU[W\ZDD#NG-?+FN1TOWI S2-('7:Q%KT\V)^LY"MD Y<ESTW.@M1D!
M1[,3T.A%&-1.Q#V! %NUJDLH%SF%^O2I;EC?OIZ5<_I5^]-&K7OI?MVI[Q
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MTK7^!%3X83Y>:Q6_P-6M\:47L.I-J=;'+UO06*%80R^T+_\ J]?T[4KPN_\
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M= _QTMYUFUM\?TH4C1%$0 #.#<]>6Q/]J6.Z7S;=*X+2"Q(M;;Y[TF'PT;E
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MY!Z.P]KO6)8M+$8M %.9?9-R1K;]*^L(MHRS!F! 4@CR)H<,R96D=E %D)L
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MAOG,8/\ ZN;Y%7/$NA-NUZ>37N!21B4Y\NE^7I\#3*Y<*K"VYS:$&L0>7AR
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MT=2D2L/N[X^OI12"?XCEQ,/%OUP1VI8\?"NX2G^Q'C;PLS8QGIK[TTHDU/\
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M\Q^ZK%;2YC$/%FFL+A7Q]I;Z'E503N)%EB1H\;D^'YJDY[X2.,DR/\.1U7_
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M:&&@@>VA/Q; !AP78^1J.)?8?C[ZQG?VT;MCK_YEI%_J'QPZSNO]=2!YY_\
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MLHB\E[:R6L31JIY)-Q*54:SNPTJWB12NHH-6]7,B3\Z*>+Q6DGB]T1QRW41
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M']XAMC)'-R \<2\/]MN!\3X^PXEQ;]4P1^TW"[?A,_%XEM>>_%^#6L=Q+/\
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MT(/YTI^):C9.N>GG2QZ-/>FXDL*M;HI?=P)61?B=$[K_ *%"SL$76%UDNVD
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MYYGNL*:8'F3;ER3:I)"C^(1Z2VFI_:*YD%N]GPZ9GCL.7_:;:#4T_.+C0>6
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MJ8;?NO4U<7D=B&ECAE6W%R9-5Q.R%0"!I;EINTDGP@=\FO9CAO X+V.[XK<
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M[XT"4JQ0D=P^DG9O+OFHI^4\A>,Q@N,-S!YJ?Y4D;\N(6_,P)"J:I.YRV/\
M9],>9JXM;JRNXGMGY<<K6C&*\7 S<6TV=.@,2F)-#^'4%TD5'P])KB/BDC02
MVT<MI(UJTLW[).8K,$>7X=;(!O@N*AAON#2PQ:5T7-K+SSS1U1X7"D*>SZCC
MN*X58^SUI/#P&W9!Q19(D)NHI&"SSSL01!'#'O:B-PYE!8YU:1!(F\<T>2/O
M'[V/6DBC012O"[13:5/)EW57P=GTG#:3X3CQ;4;WB-^M[Q'W:4VJSZ!->R$:
M5 AB  BUME]*A%0$9J27_:,Q.03M_=5>@'I33N^,_"&C(&!Z^M:VG16/R 9
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M7,#%^Y!_E6K=5%+U<>>/"/QQUI#'VSD=/QK26.3MBM+.Q4 835L#Y^M )(%
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M?G2#!W]:'B\6,XJ35$N_4XZUB,*GITH!EVH=C6LL!'W.>E,V<Y8[_P!&I8@
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M'U]YM6:Z.X_3,V6>4\,DVCN7AKVZ^\NV%'A>' * )JUFD/"?^8[P_0GJ:?\
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M.*"EF2@-'7F;=XEG5KN*#T<J5SGGT1 CAZT-/&(.UC$UU\V,Z^3-F@'J>$5
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M8^L, -QO;^,8_=IV3;?G+%8B\/;+@A1'\S%<'0>]_P 9>A3*,>,:Y=%O]X*
MY:)ISS;'7Z?638!H03/5Q>GZPQZ^77 6@] >, %H1=M+2V1'BG)K7*:)\>O6
M;FDXU^SC&<]KT_"SUAI0SQV2$#O+:?58O^Z7 95S:C?X8)*G2L:I]'!#.S]%
M)K8CRBT9L\'H![(IX6-.:#J'"TI2\/>;-A\("PMAXHXH',7*8<M(77G%4J=#
M*7C[936XX1VP%7#P7E\G762O449"4&P"\"LXWDMTK8[^VII(T:R=[?O9A CO
M]X$=36,CH*1HLP;OF&1.YFECC&:]Q+]"TN?S].!VDW!$[MBBW;V&YOTHAA'I
M="J8\1*R\@;D6!P6C$E7$ %E.&JL0RYF55K!@E0X,8+MY7!-2Q@&.<=VS\G+
MTB\@-EV[AUX@2&,!A4[SG4$WWT+[>?.Q3[:TZ4ZN!;)7BM7*Z1$7E1YCD%8#
MI]!!YD1.:9/YSH-0.7JZTK-B8VMRPS ! C)5=Y8!=JUJB:G#([RID0?*M(H5
MR0MSCZ-A5MT;H'&)'YP<8L+2G@<*D2T$ZZHCL4-:X3!?=PXEL"BLC /CDD?*
M*+N,8P24Q- =39";6@<?"B3$4FU2H4=)-Y;5=;Z#H7$Z_#"-"#.!J?1'0?,2
M8%_D\4')RHW+\9>.M=+ZOUY<M>=GT41#NXS!Z-=A;JIFV9,38=;\,?GRHC'G
MQE%$'G0OZRTE_P!^CQ\9<!H:\/,QG!@-<![PB8.9-06KLWSB9\,X!]_WE%1X
M//A]8)>$L-_6!%31\?\ .,)K2D:[_K+I2\>QQO.('#<KYT\>3'K!%4;*;R?K
M%X;3CEZ D'6F9H^,*.>G$#:L"M_#^<NR&(HP_P!Q&_MON=<[/6(@@A$"/O>S
M*.&]/J")#APA$T*.R>;_ !D.FLKG@WJ]<S><"62!#QIK]=\Y*G4]5I0</'AX
MN!?&#1)H56CL_C.:B(#9M1IYNYD9 -I+?G<.->V%V=PP3HA@=38Y-TY((EWL
MA?@.LM6/J"DK:!\)VLQX!CZ8CWYV =M.?(:/EUD-N*!A*0VT8B1=0@LN!88E
MGLFHUXJU,'6]?+P5ND<>CWF@3TIYO4($)+TQ/Q[LH%)-4B;<BOEJZ_>HM;!P
MFE6\F @"2HH,T[K%.7J\/I[3"QTILHNJ\ !I%DL?(I-7V\DV:X-!D*QKW# H
M(<_+DJC.,/0R:6,!"]2>ZV$X1J<[,?E-$M46A;6FEQ3CR=;5#L/"H\W%.=%9
MGKLBT=[' /@2.@ODTK)J:F(G\S$!.=.8;9AA%Z,@)=Q5\HIE[3A+-D5TZPY2
M)IEA:+62I\W N85:NKE=11BI;O3FH!) =JD<HF@G<?B0-4I$03DD+0=9'<4D
M;2F#418W-8/O C-P"[;Q&1MPBU0H%)KS5L(AP-Y209&_?<VI3&]Y&YI^BR=5
M/PG)DV+$^B+V>/S@@\$JKM_IDIERWCC8><L%.-=-X\#ET=L[=!\8 A:.?X]Y
MQ_ 2L'AQEJ%[<^>\!< C9)Z<2CE,W0]&/AH7AV9H/I%0E\Y")&$V;PD;(&><
MU29\G-0GL/72Y2'"AP.N#SARX&TI>1)Z7%&P+8P2P"CR)-./UR61D>S&X79B
MH9B4C^$\)03WFPO"6[@QV1*;.,T>?#%[36_3DDE9E'TCCXV-:7\G"^?K$BZ'
MM/:\5\$S:@K R<(<WWFR:6J'H!N>\;'6=:LA\$WE2.-6K$O@*&X]*3QD-:@R
MVXTWV.),CBI(Y 4;T".&\O@A?91!BM:1\3!)A"W"AV&_G=,;>T2WP8X[ G+'
M:SCBP=/?X,AJAA0L:#U^&WC2,NE-!9$L/A #R)'N/?J%8W 4S2='A$?)@UP>
MLUEI+V(QS4 #?DZ(S>(J]B3I;2S"P.&JUL6AJ]@8'S+W*,='A]LFU&TN '#B
M151!H,%AF$0)4;!Y^' ^\!!F0WS\P M8>I@8B%(X>@M\#)^C@@34DS-*0(<P
MF:U5$;J>PW@'<[QL54 %TH1!XRO]>T5 C10B,,(? 6H6[6J0FP95@]<6Q.SN
M["QC%((TUBAB,&IS?N4[G&/3=L$7#X@IQU3<!(P8 &30_>\X6*-I&XW 4D]]
M"SK$;\1J/0!3T%?+)80RJR%K/GY-IBQLP6TZJ7+;A*:^4$=E=10]W"ORZ";'
MB2N02$<OJ_6Q3$<@1#%_6WU:X>S6O*Y(.>@0 .BTO.%NB(K;O3KSK'%)9WE^
ME?66QZ\(4>'.-L(#Z^WV8]*59':<"YK!V6ZQCI,7:'?Q\9"6"G?_ !S?6\CS
MJ\^<:M>$OY3*&5E$X_K%-JMTA]F%)5R L^<7OLV1T_'&-54TA4>']X'V;4Z#
MM\.<AR&/U/?O'Y*5JG$GC*YYTTY-P^C?G-BO,-$DFIT'DN=4_0@]=D-(5Z.,
M9Z_%^$QL9:X$GY#C&!<%/N.J9_+-0QTU^_\ DQA$C'^S9KOICE?Q8EYL'81J
MNV;D06MF2)I66OCFG#";NY;5,SZI?E>WJ' ;(,+*#3>DR-L9A!T/ZY(XM7/R
MCRL#1.$0N&L^1=XMGR!VNJ1-L=2 W>N'4] Z)O$0U8W='.'5QEJ>W@Z$M!=.
M^.(+%\R4R.N*DHQ:*#>W4#>-Z'T9Y2-G(O(JL&&1/HX!0!E+RY$P%:MD+'3
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MS\T;H7E-<X/78]P!;4->:'> BZ/4(;1/9@= 5:/0]^8XCN9PS.F?D84?O/\
MD.6+X0(IYNVOG%7LC4%!$LN!NG\KT+&',P*T@Z9!2Z#HH2('"],4N^4VMOI
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ML)U"'G.,(;>ZCW.[VS8Q*V2QI\O&-2N=I5K=U)@>A&-(#H2]XJ,#4U*=_?G
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MF'QYH[+Y/&(_W M.&8[E4?VSOG^<7FT243DR 1 [Y7W@H3FV+LOB<XQ2K+0
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M3!PX2%5IUK[R.KA#Z]8_4[='#_>.5PEC0Z*ZYP-K!-4.9>C6)#>#1?$';O\
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M1_/UC?(@<M^?&'0;<]8Z'?1=8 X#HR>]Y69SVLUOEPMWF*^39K-B+GDWZ?\
MS#<#MKFWQYS3 O(Y_P#S"N^ 5_8O\8N<#\GZR*X VA/8_66'IAO7._?GWC[%
MT*".X/.*[H)H)\:/G ER B5#_,YQKFCK@7A.LU_!WY,\$Z6ZQ$@[CR%W[P#4
M?@Q?/CWB-<>[E?'O#%<="%QK0M1C;\_S@:0=+I_.;<7GQ_K^\(Y,C $YWU>_
M6O\ Z30O!>M8-0MW[K>(:>A\LZQ:F4E&=/?_ ,#^<:.*J5Y=YU=1@"E!K;K\
M.)"#H4,0>NJCGL(\!QXP15A2].<GN%/-N$_5_P"SGGC)_B_S/)J[PL$/%?\
M<O0)TM_FN?:.^\ V+8?.+XYZ82E)*+PI=6=^,XF-T!.L<SV&NGDB@? 8DKH9
MZ[_G- $1J)Q"P^C&5>'7[P&P T.-U\3  L_].^?WA3?CC]8*3U/K "T)QG\
M^L7\9Z]9N3P-#X,[MVX :#@A"P[[YS^S^<H+WB7?T_=P&.&?>'9>&)JV!'YN
M5=]8,P!%8G^YR1+)ZADA=/.C?SK"80IHXWSAP!3976$8T-8*BZQ&U**W.AX^
ML%0K 0O&;P:541^DQ+[#8'!QLGUC&ETSKZI#HQH3$D.R.OC_ .__V@ , P$
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MWV-\[_.+JI/E-7KZ)^-/?%%D@THLGT7^[/CF*A8(=+B/IUY\]22NNII1;(3
MHLTWLX'*8 H%P(]QS\_?-)KDH*[/1,:8G1;SH!^L'9'"/6;G;PS!F, 8Z<-\
MW.^6-)!8*X 94:!T=7EO)B."*] &)CGC\'RQ0%C0&;=;W^\BJ5B,(09]LU]Z
MG&Q%2-8ME!R-^'HZX.#@8@!!GW^>^W.PVI)(7L$6UN0A*\#;3/*]EC9MAY.[
MP[?(=AH3K'^?G59.GO;TLI[U2'4+PR_T*NE:J===J&%9!1&B" -=J5N??)0
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M_P E)CO\82[JI#UCY\O$!"&B ,L3O=<W-.7-ABOEV )V>RG$0,N "Q8=VN)
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M_!]W/K]<W*J8NWIVZ?OKD2. $3O2=SJ!GV7>E1+XCW\/_MXPI>W3?J7Y_77
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M]<2N=&1JJ/PWH"7\<OD<ZA E&2QA(]IPSJ2$V J_+.WKP.^+2(AU/EZ82O\
MYY=5#LF 4V"[*EI_/$ *(%%>JZJ=YW\SC/E$!=0,7Y_,/^E0 (!4LE4NT9^3
M=Y& >BE98:OG_-YA["()18A6//']\C@F"=TVHZ>_7H/T#TH'N#%S&_S\SC!4
MY J F//#XSSTE@(G0'L:/7R/H]X[$LBJXJZ)8]/)[.*^@0&.AG6,+ R-WB-
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M&*22>Z=8"A1")=E\^IM74C(!AP U.G*>F%R(SD/"+X/LR!@*22ST!H10B!$
M& ;$@<5UO Z37S2$FTH@'SFZ>5PPG471B)0DX-1@P52"630+"+2\%14/,D @
M?K&"/%B%@JD'"RT88WXY(2 @1VDU9\HW>'%PM*14;-0 S(%2)!)D55- "@M
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MH,?A_EA5@&L/S)3PC,?%L(#@W\L4?Q;<\YKO26T#7\2=P+PV0#RG9BZ'2/\
M?"JN!!8$UA#/;GZYBBP614Z"5^7?>/3: :X#?0?3L?K@PCI@JW0$^D,'KKAR
M& +0:YL.Q-Q,X>R"H5%1D0+3.DR! 1 A/$.GP,.[PC-!1,(33*,4[ZZ)P4/7
M3=),(33TQG8951+7$@V"( 'PS>3180D6B#-4^431QD314#:E'PB(8\%_]!@@
M_%R(>#3B.5""8%40^UN3T[X=, 2HJDLU:5*U!.17M8DIEZ"=A+#L%WIDD@*$
M %1#>-L&[>25-EM4O$YKW1HCOEC1A='""J2J+VZE+ZCW&67@@*11!2L4</3
M^ ==[>$(2:1:6M)IQ+^HJ>@:%1=DT[X-M%&YIU+?6WEUC"]!!($5 0C"4WCB
MG>T(K0A&D,$SJ\&!!!T6S ;:/9^>A0<RMK0H>PT@_G@$^U2!6)XI=$C.*@:F
MF-49$F4+<(AMD(DW!IG9?O+P3@!44HLK 15(A>$\4>6"*J"AS3KN4Z"9M7,1
M/0; HJ!YUFD(?*H"&)^AZ-3E-BL1X,+2)1Y-?2RV&4MX).(HJ.U2A"W*?7G"
M%78I -)"8./SX-(&6250=B+\Q%^>^)8*DZ!@Q\Z'XQ^.,VK<0+6UL!TFL6E&
MZLIXE^#@H(@%>!8:I$PJ*'CU?.]7D@7,"4&$Q3TGV]41H 1'Q*-9O3F<1#55
M'P1%*#*!@/&5'I+VJQ6_OS]AO% K1T$*RRP=9\W@44TC3V4U 9-K:4-45HD5
M\)1G7O1U;P68&44-6&-C;?ONM1*TIJ0J$7W/GOAQ)30T$7>W^4UO+X2K$B3Z
M7+GQP -Z6GI4P#XU/=WCFCH!?E]J[_GK7C@D8)\LPFL9UOLPX1:,Z?>_R=\2
MZJ-B;[$JZER:O#M2PD -?R=#N]?'#("!66:8 U[Z]> F390_4;KDSK[XK;B%
M%$!='S1O?7F2ZE) L)M<A2*_:\77HFN,^?GSS7- +$JC<S[\=9WZ]4:12NA^
M*VCYC%X>Y%,H[K/P/[=G([%I8DUL:LAWUKPA.5@ 0UKO>-[X/2H$G6L5Q1]'
ML>)BK81$53,4GOHN-2<P)A+1,2!W7XSJ\9&HZLB OK/<J7ZXX@@0U6QZN"]W
M5TFR69XHBP!Z*C./9]F4*J51'#\?)QEWV9<)/#E^&SQC[1<5H.I VJNS..),
M* NG:.A%K;C5WH-9Y4M:D (0RR(96-A'4TC "[>$B%,!J_ [<$RLO!BJ =61
MH@K=2S\G+!08HFL.I/E@F'W@7($6JT.GO7%QFO&-:E#$Y@F TU^QP*0S$\R5
M"!5*/!1%3O48'MWZ&D+PA5''GZ11+5T"T>!+[E(.FC$3\C>8]4!6 8*$%P"'
MF<)N&-1>PHGHA)]G+8?AG6K7"")HK,75[X@S%48&%6EX4AF>J&6&JNJSXV\Z
M=*F2F></DP(O7%*7"HG0KV(9UGKC+T(1J[0*A6"$S\]@;]NQJU:@[5P@]+LT
M+<BF 6RHO0&6FG [FGX"0X *RKI4,!!V22:<& S/0/M"45TMEN/ -V!5#VNJ
M>%I/> >0B#L(CM7I"EZ)QB 528(KH:!VR[-T4JHDJ*V=,/X:9=Y8#Y@:T7R>
M,E_'/KB/W6(]/Q\8,8/"E0!V1FP^VMGT9CPP(<B@JRO3.OG_ $TC#CL C2GX
M?H^>'H2$@NR0"1*GTS.-W9"=7'L'+N7CZ+(J7C)\F/M[SI<2E=Q#ZO1YO\SF
ML@ 86)UN]>/?O78 19"1<Z/GSIQV]'#5L#&!,90+9\^80XVZEA*A^SOI=^>N
MN)?!;4K[*S'_ .[R&A!J.+9O3WXS9P]ABH.P5Q\G_N^*/2I(BDBZJOS0?UTK
M B"BRX-#2LLZXIQX(A70=)ONOS:JY@J08\)JV$_JW@X-A=0[-GGSC?XZ_8E-
M#V&ZF>*];>!7(@,^OM?*^=\)X10$:] #U]8Q,\,_14B @>0F3[.[I*%44U[G
M75\?A^$X)(4 %I6C:;D.AX _P-0$P=,3$/N1X J%,B'8FH9_E[Q55,%Q@@BB
MN#"PS3CQGF*J*<(&ADSOHBDFTB!!::T##H6;Q(ZC!!*S+IK5KER<3#"18OR?
MW) D#B16>!N,UM;#PG)I&#%<ADD&C&O7(P!*O:&HRG4E4:[3F""F:/AGRR?&
M[P#M7ZD"HJ6I TLWC<3/@4GIYMK5 CKP,1>"8U7 K@O#,/RJ0N&GH!-D8GV4
M5050,$%,!IDXC< 0?LB>_NS]F(H#/$:X =3=&%ZSA1EU0,TA@2OL' (!Z+ ,
M'.V_#EX;14<=-7T H;*WLY.B3(6"B$I[414^FQ[*FH*X2!^0@+':E01NKC"F
M'YHA-9J\@%WEVTI52\!1,G"1IJT5[[@(/%8LJ%8I1$U4#YV>9P>4B[]RG<0F
M=N\D2^I0>Q^>QGV>"Q?Z<@"C,)53?D+P%U[$HQ"(R],T:F"*1 77 E8OS>KH
MIX4)@%N@B^=%/UP0M=-(%@- M*%S]<5CF7&DZX*= 0@;;PIHM&EE)CM@W$WB
M>"H ,62$$9DZ=7>, ),!#4BDI-B=FI>+U(C7=)^4\WWZ>"KW 2&2#.YWK^WA
M KIV4!2_/\'UP]D"*P'4CW&V"OXY$/4DD*] :YE[[3ABL:21;;NF66O9>%&<
M^ N(@9,_W7DC@,C)1H_/G09^N9F"$JJW"[ZO^;Q,:](._*W>WK=^'FZ%J'_U
M[\4'QXKN7/7?I>W_ 'U,4U,# 1?*3_?U]O"0LC#% 7/RHVW_ #P&TA88:=3-
M?\_T0V0#+Z=^%[/RO 7F2"]!0-H[?IO0\O;2VK+T!GN=;. R%(::6E8=[OI,
MX<?*$#3H'''WW@EW4P:ZG<$U-^.N$%*=( :0["_0?$Y08AI:11(SO\3W>7;A
M% ]<(.]=%[_/#;8$G8"OQ7._3?E@;DO !AZ Z!X\1"B)($+)YVK7Q,X., DZ
MGJ/>R'YR/-L M:=[JRETEQ[>-00A;%  ]' "4>!R>H*"LJ[H*%[OQR51(.@A
MU1.W&NAH1C05!W/5KZ/YG?'52BQ0;FB"]])GZ! <("=Z4RNF=G7LHMMLNCT@
MP>TLH?3QH1Z&:1I\J;(=?2 H@#) T-8+QKN7>,WL1Q3\ L?(XH<2 .F('&W=
M41G9VWB955@T%,T1+MWX[$&2RQ"6*"5*EW#B5IZDS<NWHXN(\PF O=  %&2(
M"E*'&:M"II*/QWPX* 1HTF"D1N'%7DHALZ5;5$0:A8?@A/X0A9- ]/#A0"A!
M*],@HZ#J=<-P611I<I@A,0$UXSC4:%$Q'V3OR?''-6Y!]V"1R.QBX #B :"1
MZ,.CY 0O%,2*)9$ Z>Q-^?GA"],$P&5L=NS"SN$OS.A2[ JD?1)R@U@I"-E"
M!@E5-.H]"$"J1(8@.SBU>*FV-R0#U6! -T C J 44D(JS<ZN=VJ)[?CE"AY_
M!)S*:9JAWC   W G$A , %1$+DT&@=CEP9<"RML)32DJ\B%8*+5"$]78)'O7
MA02U)IXM?Z ZWM=$; (K?+??SD<XET 1@41V%6[57$Z#"J1WU]>8H0O9>(SW
M,G4FD[/M_C.5  SN$.P-GVA;>[PR H*BAC\/TS_X!WN0TUE>*+VOQGSEQ"T(
M%2_,TGP_/&6=&"* $2[GS?GFJ]* ] 88!9_\X(X@7C!U[-R>=CG ;A0-(CZ>
MC.__ )S. &$(M >O?;F<"3152(KY,]^9E]Y"Z0-3X7Z:^[P8H"*Q>P22>-Q#
MHX/%.'<.7MO7P'>#QW-@$&NQH2FF"W-G.G*A#L%?#.GN_J#2RFP.J=W8LO3P
M75.;$AF>'1VQY1%%:4AQJLI:>TQX@,8AC%B&,KNXY.F+F9;= +*Q?)22=9Q!
MRL(['7K'%/OSB=0!"EL(QTR?.?I]:<"+M!OKU5Z)U0XT@R2 ;='7YR&*>U!0
M47LF" ."CA![X2]1H"I''UNI\%,XD.ML(5 #K 02N-7A!.0FB##1DGT?1+P
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MD]:55 3H$[DE7Z['BJ3W2@.ZKX>XSYNFT[S1[0]KJ*Q^N('JH:(UK(U=/?\
M-(GT @+HT!UX1 O;H2N)+:)!C#87FR-88F' &OLG??7-$-HH]=9V\:_3Y4#[
M 2!DQ8ZE[$XR$ 7LM"8-7QSQL]8&7>NB\7Y)'X1)Q>N9>=?05VG;6S\&%,4@
MZL1) #DNLZXB&SF"JDQ[!=/OG""(+08];C:JW=V=$_4,>"<)&3&3TU:"#7G
M"8"B^047,\F6= 5!-&"M SB:6:"Q:(25,@X&&%7FJ52B*-!<,?0+?B+C1$6H
M#5CPTO 'UIA!FW1AW"?DU)1(A&.P1FT44&#>H%"A8%H/ %L-&,ATHA,T.R\'
M0T4&AO8J.Q!C.^ M=@0%V*'B.OUPLD)U0%7(D[P!O'0F7 *%<4[A-_77&6-0
M*2I 7H&Q7ZFO \J*%)W P045B3MQ]60 *D2F7KJP<YV$9!&Z#'YC1&/,>[!%
M7D:"HN804F@= HR)DC!BL+$' 418#58!.[OVV8,/*P!V7!M14BG5 X$2,00E
M/6757W9)$* @* P* P'M<WT<Q9'60=>EH#.V+@ (I8Q=#I=?>E\YEAW$79O1
M=OZN\G-2!"=@8FW5G393@;"^F%D#A^#MKNKH?LL'$E?'693OY!@APE.OE[?A
MM\[Y@E@AHRI^?)GW'@1A*0*>Z)5:!%>@[8%0&P$JGAV&6U]>&J*]6_K"8)+)
MMD]C1\?/E=/@ZX] 1"D->V'<:Q[]WI^ WL^&R'4[_G@GP!3+UI_'ZOSW<E!T
MDC/6_/@9^'MB*B14*0F3]GXSC!@!'8'9FV69][V<J51CX&NAW$G?7N<&#3$"
MU(.H^#[9UZ>)4$2>#%NEW6G%^)(A4!2!9KUZ%Z." T3H!DLJB(=X9=&\-2"4
MJ,^!=_I>*U;A@!Y#P#]_K@U3WJ"8"Q!5'S*7BN+6=ZE01/BD_?QR@%FLQ41
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M).K57K-LFL;Q28\G9(#AUF]#CYR7"Z -G1]?MLSR<5X Z=P.C,0<!J;WR:H
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M-=!O7^;Q:@:(5@3W1.#WWG45/D*53&[Q4113H5]OCT4;/F\1-7<?CW^]>O\
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M!=*@FY)A0X,G1RT $G1AL]U:7FVVO65!(]1H+@4.Z95@K6+&B[O!C#78H,D
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MHT*OWU#Y[^/+ I-507 GJ_+3ND]Y<1B@$H!+V_QW]Y>)D%QV)@ZN]5G_ %R
M1%GOK^;_ .SWG8QYOY.IW19_?7*3V'7 L'UW/8?C@&AA1D1*GM6_?_X)5;N!
M3#I?.J^>\;LA2S["_P#O\G-%A%@&1\_>_P"NN !4OI^O]_\ V]O%73 8 ]@^
M"YU8/O*+0A!8! 4\G3]QI>8.M?D3KOZ_IN5PU0@5/?GX>\8_WRB4=*:L$T+;
MU??*6-$7FF>DQL&']J<  ZH2B;*8K#_>\BAM*5!(%I7;.RGT*H3JZFQ5L.T^
MIRU2[7.4>V???3Q0>[*6P-BI=P\Z9P=L([@EICN,1SY[G!G:K$!$0CRK]G?#
M3K(K+D0@Y>%FSB&!T!-JM1$G4=X*G,0(L/TX-*%/<&=O2Z5HZ:A0ZGG:XJ5&
M%VFHCN&=S"V>VB#:L$"0 /L.N=:B%)VQ]& "7!G&F1BAC"L5TU.YZ</P*@&J
MZA]LK+G#N?Q*>I8E4&JS7:#5AHI1I'W-3^.-K6U&0&I9=0W-G)'DE  L,$*]
M"!^#E,5=NJ4!@U&_#Y,X+&I$%D*!TA[&=?.LJ%DB9#\&G;>\X[0.($#T)^9F
M^S%U@ITV>:.DIADY=-U*!!(#@^ACW^9'6;&2A3 1 .=FAE12V%-F##VN[^^'
MBBA Y^4EEI=L[X P.;*W:T)X,5N=<99%\'3:WPYB,GX2!W<;Z@^-&MO^.6QH
MJSZWO<O<L&]<7!85D@#>XM%J4^WBPH"Z!&H':'5[1,>$&HB(Y\B=WNYWUUP-
MUF""/\*A<^^, U2D=&@+K'"94YIJ\<I5!3Y"PA"UXUG5/0H A$ LMGO 5RW(
MI=1/I"%E>SBH!,5!? 7U7SO@J2M.EN )-N>^Y>.R-6CL(U*WKOI.N, *@*#,
MCI1PD2+P E10@AZ@/RAYP95L6TA0(0)>A^/,++ [K<#02+-.M]X_K0U_\=L]
MCRTD/:YW?+^YT\3Y"GD'[K?&LWZX)H95#Y[K9GS\)P'B,ZE][O<^?C^.4H)5
MVQA_(>D^7]<_<_\ ?^\Y??5-BLP45B_HFXO%+=VFGM5^/-CG4XK46Y-\]D?C
MSW]\$ $%DB_#JU6*G5W.!0E@20*8Z#OIN>\_J$B&%OT=SO\ H]2#0.@[GCG>
M?:=YRZ_G,.CQ^?/WR!$"(4HGSU0?XR[.$K)#I69F@GS^._5*CK(('5X(2<-&
M%(ZC\/T63@II&U4/6C"7^3>(V0= ? 5M>P_/QS!#,#K?%3_/G?(I%0UV9V:Q
MP7\."-*1N7L]-S&_/&]0U 1&TZ*>S.Z'7+; (Z)KQ727T^.(](;5$^<+GX'X
MM:VI^B!)(,@!;G)@.&T*T]%)-UW[XT0E@$LP,+VOM%=";EW:4=P8';K3@,K5
M4$!41M;_ $;T#$!!UOIZ$#U?5X^(%8CV"!@!Z6N]CAB3- "#\C:[T;> %CFB
M+(Q(J9W.^H\)5C#TG3^'D#I >^ &30=%;OPI^IWX<9SNE=""XU"YW.OD>$X7
MHBA*#HCHWY#.9D@"3T!5@CT;#HLX>@B5$H=%VP_L]MXY.ER0'[B#LK\O?B))
M% "JZ*?2AYN<?47Y0BM8A$^_P9J@B5CJ YM1GPR&YP3O4IHJ]06:MDWYXS2T
M=$+Z]]ZZZNU%0. "MQP%E6?"?/95"1$2]] ^W)"\-:SA)^P^*YVSS(\4([@Q
MNOF/L_K@@,@9'>NECOO]$XR@Z3_31OOUU'8:-5EHOTZ_QF\"0MH0LT--)<D-
M64C?A6D3X2 !U]??-DT4E;0!#-54,/#G>P+#3>UH'1V/97DD2\@492 A%%S@
MATC"L^@V]=R'5(\+:;HM<SK43UD?\Q5P-8"7ZPZ>NB_'%"J?>!@C2K.^BE+R
MZ$!)!7HZP>DQ-,X%+&NX"_GY^OX.0,$:[T1ZT^L_<>(&)%W')38Y?[HQ.:Z,
M7JW_ #LG0]?EX2JI]0W]A^>DW]\H8UQ<KB-6%"4TSJ__ )6*M!1ON'^.='V!
MK>U'^O\ GOAJ_C_9P$0,B4C#^IPBWX,[)V>3G7"50)F?WPS@$$_4'_/[XT5Z
M4?6^.O7.N+4"J0;U\CQC4*FO2Y\GX/XXR)^PNWS3GI"7:RGO.[HK%+UCO7UQ
M)E! \4J3XX2.]L7MKV_.\L_/>GX?O^NN:VC8T(1!I"N2<V"#4/?H#F*BDB.6
M>!3Y2^\8U/N6=O\ @XJD;@0B2"9*]?+P,48#$%A3X=/O>.6$U4,E2NF*C"G!
M:)P=#X&R?4^^0N)'020&_:E]X&)MRM;!N_'QQ/+NT2J6I;#M\Y"00XN[[QUJ
M&N.)$"@OL"]]\&1A8[2OVGF9G9V\!("S]D/_ '7 ,&A&O1CWYQ%L&B^.J?L.
M.AV47H?4ZYU>ZHQ-#$TSXXVHE ZMK6U;:WB5-J?HS&=_O>0+0I07;KO\O\\W
MAA"2K+$XH-4K#X/^7S_''@B"0\H]_P#N_> 8*89Z2Q.G0[_'7$RW3']?\\ ;
M;6-].$$)KU^9\_"\ Y A3Y:%W;'@Q ;V9W;U\\\GD_Y.)0/2_6_\'_EY#4RJ
M*KG=[YE*)H#IX"!UX?Y>.N0UTO3;WQG7R^%Z^9>(FH"@6('ST7C6:=+-SZY'
M8LE]EG^%/WPC A )A-C' *ESB @\O;V&?CC(,@#"2"1)_7>]\85JP%:E0 7.
M^^?ZW\+SJ_G_ $<<0N[Q 0=6?/Y[_P#W_\0 )A$! 0 " @(" @(# 0$
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M.4N\4:=,@DV"0ILU;%QEK+I@4*.?K:&=F>\0C,@MHR,'=)).D(.T0A0!F62
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M: SEQ[X20BH((T$HPN=/.3)5 !=0@1J'.8?:/FSYH@!I&$:JER&9>92HG)N
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M E2143-J78N,@:F2%C4!76&>?CJUHJ.(#3!TM[[C[NS.B!%1"32Y&]F?HPF
M-Q0<%5JVLI<F.(+A1@(25E^<S'F66K-8>I6'55,8F>)V2C*EW ))K0;AG%N8
M20G1B#3>#&>N-/I6RA8N)1WYGV"N _;@SB(T(QP$E8C3 2(@Q51R?@F40:!,
MJ3)QN* N^!DYN[DH25XTR9%=M50K!.DQ>N#8PBE&FHD5 K!?/ @Q["1FZ@4*
MP)YDX($#$<FQ7([C2G#$A)D"AJH*F9)=TX=(K"")TKVXW?6M"S 2M9# B+5Z
M<_R@6X1 0&% 7P[..DU(166,E[+\#RM#>D)BC2HL*C=68N2DB5,-^'CK3P%T
ME@V>T7#W8:QPBB-YIJ%0$-0!<*XLF/8JK$-#&3%?/!]1"C0("QN]N677->(F
M.IK>!$R8_,.85M(7>XE5/AZX2;3#)7-=C;-EGCD\$1U+5S'A3\B8Y 2VJ:'C
M"6DI-RXG$&Q^UDT.G5@G\[$')A4$##O F%=M>2404H#09S!ITK/&.84AD0!A
MN #!^-'IH%3H5WI[];RW>1*,E0*TI;5DQF/G@6TP1YFES4/?>\\-\<DX&2"P
MK-_+C:,$8JF5%VF8Y9EO+@,R $T6LI=R_P"&/)!DK)FW$75SIDX'E$160RO8
M=]"_GF:I^9]D,?O1\/$)2D2K[CD^S%WS/1@B+T1T[UDKZX&3 @FGC(6 X;\+
MR(63)<S&3[PMN7A $:4<ZN6G[P'1R& BF&FWKN6;_P!\5@3(^35[O?H/3..3
MP$[QTOBZINMG*CNY9(DQ)K7_ *\$9C2#)7-JFKU?GD2Y8\2.'4&<]?$1=]2"
MG9>5V.).)L55NTU&&V>_?$-@!GUE[[3>S/%\O4-^_@_KCF&UL\3^;_[US!&B
M,1MJ8H&ZLRG,)S'K$R9I2ETF,CP?B)7  $AS!9=;AR!3!!+$,M(.S @(BE!0
M"%J9$%6V)@%"K%)4)1 14 J"Y9P["HB@D18Q! +S@.&G,"* @6)D((1X! *H
MY*R82T,7SF<:JE** @.Z-#N34SLQ38,(A0V;?2?6> 3 [*%JS2$F><P@*7GI
M8"JQ3'KH>4_!#H)"0D7%,G"%8: 5@H3(@ Z)>4OO!H:F4R*7 48%MV8[.%\"
M;QJL( &4,!L2*L)K&;RJ^)\%=H5/LP<2(U*<YM&5(GI\\54TLJ#(85J5SOAI
ML*18FK55BFH;-[Y6\'"><KF8)$F;K'%=3]SR6TK0P0F]^22@FG%"M\6%J_3!
MS"V$!$X"E@=9^'ED8,TPZ4RJKWCKEY%1J"*(#HPV3(8O%#067*N.D%A]#-J]
M& P7A0@9<PINJAQ\RARDZHA&H27.\-(XE R6,78>C1IC@@'HIM6U6EN+AY%0
M$DGV*4N0FJ3W$_2(4#*,%2 QW>"ZRP-A#DH-X4J#&+6123J(% PL,G'LQ,12
M1,R-A4<!22V30>:F4%P,\CR- 1*JN%##V>LE[4:%*:UZY90R.10@FE++1P!"
MFK4X)(DPY,+^K=XV',LJ(M;DS%]2#=F8<517I@" 9(TL$N$M#B&B52&F6:"S
MWLS.7L5T-1G:MP&H;.C@%H11C1\]9QT3QAY#4*8'V[SJ?":.,J IVN$MA?@T
M??!9HM*.2M\YF\%T<HR*5=@RUZG_ #OD% (,Z</AQY.JIUQ>B2/1!5FL(Y<3
M/#7![*UZ\CU;@='+##"C0;*JTUAW,<)L)I5(U9'<V;R\OC4U2C&)\YQ\.Z%*
M""Y-ZK)U^9.(,[PFZ.0:WG><<?6!L0#-J9\F+9DX5>.88B:Z^?T;>(,U3X+@
MW2JKO>.FI[Y@YI0*DV]]$SLXR*Q6'":*6&GO=\@Z2*LC6HY)A4CTB^;3F9(G
M ML9FE"* 4(:"$IB7&JH!P$D0N55$FRD=8O)=HH4F%%'0"JKPNZ(7',2F04I
MAP3+D=RVA6A"8J+Q7.QY^I#%3(51%47T03HP;R@*LYM7B,M0(N&1P>SCMV@,
MY%*;CC+"&[Q[A$LBBH-N: #CBN-#V,6**R !"#@?#/A"<O0+@Q* ' %-W@1
M5H*I0=0 +(**<(0XJ>44]ZT3O4YD)7_!C0B(5(3XX[,BI(NB0(U&'X=F(0EA
M4E 800,+.3]!K* &*2K'.AQ...KC@"T$$&%\'& !*9H!,D*J0D=\1A9"@;1!
M0(#/([UDX%4_BR=TH'2L:] J<L^?G7((HL7. 2/%M@#B>8%(:$K+GCJA",\(
MK%RLTNIJ<(/"VZSN2SZOKN<20Q,0V#<I "SP3@DGXUN7+P$G(&U,%Y!89 %N
MC/#$HRC9#-K3LQ2;G#EN-9E8M8*9N<FD>52Y0,(D,E,_M.2PEC#X&*"Y$,C@
MQ:'#BL@\M,/!5V'(FGSW)BP!X5A>COWJ9%DIN,NCG H*#LI*T7A[K-&5\!"4
M!S05Q9LTJ5T*X8Y-(X=GF-$K?P@2CFG3'@(B5"RCKNL/)@.#,"8P;3\3M-=<
MR5BL75:B^BE,YG$]K41FT4P]CE:YO3PL=84(F2=RST=7';$$(4,DZGSACP_>
M@.GD.^]O<P%X*Q, N (?>5Z4X9$@Z.RT\N,ACC\!2XPDRF##J7ZSQNJMSHUO
MNR_\X$80NL%<:PVI==7@N *U9RO:$P_CZIF(E6"[BXT3]:%80@0[R-CTXBW9
M\!M)1:J?"#HGC/9WS(*)46>%9@)Z *X..J V(EA16VN_6B8Y0!EJ2Y0ND3#U
M"/6T0T1V!B.(RI:=9])RC3+1&9RLQ/QJDRQ,F"%*IC%&T_YPB2\-5AA0>!^F
M:O&3*B+)G%=#>J.+R)HA@L,)))5STJ!RE"#?96$^Z);BMX( RRT@C:I!P)ED
MG%)FFEJP)M5>H/XX'%H)30AL1,(B@05<A1Q&^Q(A,DN1>$L'3 ^2S@!<+3?
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ML-?/@ON$94A4IX\9,7IUQ(=1J<)3/ ICXG! P(2V3_WP>+GAW EZ^R!#%/\
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MMUT1 RQL69-V&]YEWS 7+V/!<K@<]?.5B&H-$K$>N_W.O/#A;%[,V=4I</\
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M.'VR]>/CB:AU1<IZ8SNW1S$2)")@F&38C^.8$"E %6J$-)<$\[M%52. A,$
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M)Q$&TS]+J2S.;R( (IL=,ZV;]8+*YX[RPJ:R( FMGSR6Z8 3/.WXZS]SB,*
M^H@@YRV&[FR,C=M1K.%Q8SGK7?QQ@\JAB[@/9%I.WO68:"P^#?ES=^O9(7)I
MM%$E]7L\<:M(,,2#L,8=;Z9<O,+*T083M#Q)/'*^F7=+7J3<O4/CD0)1S*N$
M8$D(W#[Y/C6!0H3(J,)2&?V5AV '+@S.O!CN]\D=J.!5J/1^A-< <@V,JH@>
M 2A+AX)')%!0%E*G:84^^ QS$<5%6 ;)M-FN)1(( M="OZ+_ !R.&$!L!JNZ
MNGNNGA5PE05I0VA%$S%-H**'R19!UZQ6<55U?J+<B64UC50HP*/%!G3RH%I5
MHS"B-,$^(E%F0G*D *-W+(@Y),R87A$-*H+(@ NU+$8JEN!0>XO&(:T/$Z#/
MH6O-5!"!4.#P*!ULXSR KD<=9&:)UP.K;BSB:R2&&P*ZXER$Y1"7DM?1"M@(
M(3F"QSN7#!")"BBX(*861*AROP4$ CCFP^TAP 2M@H,O7+Q&BV!(@ 3+&H&>
M1P^6V'<&<H*3;Q3+$&"*2D,:P&KC@A%#H$<@I%VH$#B0M,:="NLFX&L <H@
MUB"-M/2Y!]=*2B-DBJIB9OQDW:#=2&,QGIO=NK'O-@QPU+G'C7S7)PX?F 5P
M45!D:??"N>@.$,TF<),XCG;Q:9"SL[2D-X+VV!B4A!0W8]^FQ*9]\4T4P"W)
M@VX]C-]/"8!4+B.PYRW.]9]AQ =,+DL\82,V&=\1(I K,M+\4J=%O%H[9E1C
MLSBT4?Q@,AZBQCEQ&36#.;Q,.FM81.I5$ZQ<LX$$*2C&4-'#G%M?O@&6.$7:
M2G='YVJ\8FBHO;KY^C3PPD2[_P GO..L')+DJX,Q87?;^G,@S$9>&C?/77'9
M6HE$PP4M188RGKE%W5VIF9O>9G?&T2) E<E=IKWF.^+"S6]?+P^#M=XY10)+
M#$L=O6OBR\%#DR#[JS+FZTYYG5#1$(1QT:&*TUPN,P2BB#IRUXAPI=)%65#V
M!#$S=LF>%U,X_1@9V[G7O7 WO HC<:6]!D<O0<QR6)KI9F*[SYX!!_)#0I,I
MDF&_7 <P]9'5G\9ZEXCKE#*FO$D'%OD\C0Z9G+P8TM^),\O!! -<:F+6=ZX
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M,>\3F18B1LA;[#_W7 ,<WR#7+<X@E/G, IA><1M7I2"J>R:XT$$ 6I+4FO\
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M %^>2$,89Z_SQ#97\_WQC4>D%8A"X8=L)YN,[UR869J%"$)]JYJ_)BN21)7
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M=&K@D!4U*FF7HEWC!2(<7O!1A7+4IE^O7GBJ_P!ZXJW,QB_W?!$IPS2;=?\
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MQ,Z8N,<0%W(I+$#T^4N&[SR08J!"L(>**$U2)=CVQP9!+H#%,.2*< )8B2%
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M=1'(%04*)ALTD#Z #K4C(_#0804QI($+X(M!GB!8,E,M-!$)5@I13?@FA6#
MAC2!-ZD+0,X-#@ )!I#KV;8]<NK4%:MB ,6[-4LYE"))&KT?(0^^M<@C=["X
M<OCW#KB?>FBBN<(/O-7SG@')#P%?C2&G=]6:;TV%7^'6<]Y1Y9V%6&/>'K,]
M/5G).>+=T)#%01DI4[0C2BJ$W$UH!Y<-!;+1WZ]L<OU.3XRKM'G( 9:CGGW&
MBM!(L2J(RO*1!ZJA)95Q2F1+DS)A+9"K,!2'+U81)%90Q\!P_DEK 0^#%N;Q
M@.#6BRBRM!L@PHH@2"-M,DD)<HG4*_5BX2[7D!T/Q<5M7RRJ5 06*'3)*-D
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M///'KB#?]_O][CPUR.QDWK Z]:X%$ &JD&&1F0+^-\[H,>3CVS?7^>/KR<3
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M$B!RJ7+/!FE++#9%80(K1X=9 02PHW-B%&.+!M@391E%,ZVB%MSR=7N1 PX
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M&XKX;DTWTZQS#E25 VVXRF3!3'CA\8S!W@GW9EZ'K@,#DJ[FCR76\^]"@3D
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M>$ >15: &0%+R2(!O2=DI,Z17DF,Q$D6:@8@!-9PV,W;]H,<_' U6-9[RKC
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M .7]'E@] Y:]8N'KAA]&_._YX4BR9SI?]SSS[Q-YGG^?WQ0FWX''YG]GN.R
M52(A@P,KC&,Y@<%#H@8*L*J)*D,87D%\5D U%PUJ,N-3(>,JB21:0.\@OW.5
MJ#<;J6I:XQU]\5/#ME=NUSW\\,%!U2/Y(R;S<Y':LR* 92H/@'6<W@W(LA+K
MQDP=W.1@<,$[@.%!8-'S7.O' .YL](/V,S^E./<SM"B;03+#H:\<?B6ID,EP
MYBM&-YP(=/12 L"I)KR3BA*T"@5U5R(RNY%%P"*9&F0,@DI&"B?:T.A"VE#$
M9AS(Q+L)G4 #@P:Z76:\ HB!SX%;;W([QR"E(*<'D8CKZSG;DH2###)C.[]>
M^ BT,KY2@!FA%:KCEF,<9-6#DPKOK&^ 0:B9B([4"8OF@>R>X2OG-\!@C"!G
M[E 17>/UK.-3?&.GG"]\#LNPG?\ W^]\%&$5@N"JS)UC+$S\<&2$A)!@#[52
M5J=/'$6I-_Y[GES+].!I5!T>!7RGR4UR;LI?P9\76<IZSRP"MF =F9G=F)L/
M:*"C,= '<Z4ONZB.L+!>R*@EV%+"XX!"FH34D7%!<,Z>TJX[,FVKE,:7&?/,
M!6+18Y$>NFFC(,R)JN1L>(?5J(8?/$CBJX.%>JF-7L(+!11D\(-J-;Z.9:\V
M!<@C"L#U<SAP1BH*A D"H*-)CDUT,ACL4&9EB]PX+M$S0EK49"3."/CEBJT&
M:@''H6W%MY"!-61*@G-HWZZ+R:*T(*8&@)B8*=W*<8@C6%VZ"O ID+Q_T$+0
M!E&)\@F\\1,=&*L%2@&I[72',2<2PM9P7)==/SOL9KLFTQ_(>>)8NF/J^>L?
M/COA!>UGU_?WPFF#PM)O\ZU^<K5L@Z3Z:[[_ !QQ>-)XN+[\O\'$%CI+]8?[
MC@J4<'DN=63'Y]Y@'DU071B31C%_7_Q48TN<7Q/SK_&N"FG^Y_VYYN5[-R'U
M/YQOC9RBE!L[_79Y>]2FM<90R!9T!&XAV\4'471(%-XO>NYQ.U[E2-R.#H7L
M3\2BB&1.6(%&83SF"/*6#("J&?(<0K'[>%G7,&P73$OAW[Y$+;]#BEQK%>YG
MLXMEH!G( @M/J3QWOP"K1(C]>;HP=\#)%  " 6C*-L;;3'&]J)7P@JPLQJIM
MF0VQ0 D %R&#Q0>@PWA(8<@1B*&&'GJX7VI($QS#504X\(8'#(T@(I]VZ6:?
M ]\*)H00)1H %%+G>P6HAM!5MCP1:0O\&5JR9:-+C)F[T8WQ-)<51V!U +J,
M9XFVI3S IL]TS"[E.2'2$6J4APC@A3?%QP0Q<5NKE719,9X09Q":93*+0F>X
M[O*A@"Y-O=-N*>OXY*'L'4-Z_OSP(%8)==?/QWUQ!PZ?<?KLWO@C91Q)<NEA
M<.;C<64167]BYA1>]=U,$C.-!MP)QV6H.S<,:?DO[RJ)4@7IN.O/1/S.67C-
M<M&,LCL\D[XX+ A"4@[.@Q+/CDO;K*>$$4 T6.>N#_ZP(I!01")8/!TPW[!7
M(0*06"BB--8R2 #JH-0F)&8PSCF( 9$8H#=>FWUQ+,\!YTC0P+8V:;QJE$;%
M4 %5,Y>M/* K3@+AA;-T/4)U*G2.2;7&"^.TZZX%*L4JH6"2F4\@FN6@J$R@
M,QD,95=_RVP 0Y0*(&6#>QCKE2TL J)6KD^\94X3%0&T<K%Q=9-&)JH]!6J^
MTA@<DLEF$@9ZM91;3_5AKSAJ%&"L);8(.L?E]I)L"HX4+/&+/RN7%*&=&YGR
MYO;/XO,QL4]].+K6G.N^X@)9K,GIQGJ>#'PO&*D^W7XX.+I(DM+YZ_MYMB9$
M03SO>+AQP=K2G=%S#R]>69XJ%%6\?63'7WXSR#FN(9OCS\<$?P/Y_P#D[M+O
MOQX_'\ZZXQE==_1OZ?KBBF0<T]9DWG3-%>1PHEL*)&*G\O/&S93 X4T(/=^>
M9 TBAB)FMPUG'E[P75437,DI<=!J7!W#5540_P#C=S^[&RE @""],UB3J^.,
MVE$U+VQ!$Z&N#*"$9!%$]ATKZU\\( )NT(JX$5)=/\RT%52K*JV+7=O 0#P8
M<D4:*ER74G'$6H8FE\Y0QW?=./4FH1,LN@Z,(\<$AU8-@$4H78,CGD*&"!$X
M<TYMRMR.^(0-"!I3@!")\.^91L IV4L%NG.^^"&10J56BV2>^OG/(49],&45
MIB,\)WQ8/2Y7G0UC&9UNV\:F$%1%8)BA.EUGSPVHK$3-!30?';YQ2K!W <C.
M)=;RR\:A&X,-6L=Q\Y4\'!PE-!FHK?1\[?IX4%IP$=YA\?Y^2E 0(&59XGEX
M+@A4P3J&NX YZZ#/,H8,;T>AS-9?/, <X;@K@7D!Z$D6?+(OU!SD.9ID&/:!
M*HN52Z/' =@+L"@C:A;,9Q@XJY&. #N "&3=SC,?6 L,? '0CA.WA&XMI<C
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M[B\45D%,H, LSC&>%0ER^K_R\;>P,_+=_+K77 L 5#/$. R(" ZR@_D8\ 0
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MD9'4B!Z5N;&JK9@-4A.?G^GV::5PH1BK24&NNSQD:!%82ECF;':+Y*+<9&H
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M78H)M7F&\SSP:R%? H-+TD>7PZN4 D^ #)]9],+Y&&/T$5 OZ.?RI:&6&#.
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M8-EX#7 U]]*/87(J,,)H/C'@'(9H@H-8U7;Y;G9FH(:K$_A*3@%G@ J#?_\
MA!5MX-Q:6S]Z"*A3Q-(X0D4'?$DO!>8<./(*Y4"E?O:$HP43-#NRR0#%K25-
M40GH!K4]'>ON@'3[?8!0%Q Z6C"#Z9B@6Y$E9<5,%?D^>8%F-_>((%R[ZTK2
M%$F889;X\( P,4:);0@T%'/'8>K9*H==%0$\X@+O$\T-8,0NM"AX!6=0:0L$
M\@; 4^B"%68E K\]P2DWV%O<.%B&>R'.\&2Q.'[-^(HB8A>,$\W32FD7R!?E
M5+I&.K5[1FP!'S;VVBNM, B\\X;HR'41,4!58<%[6"#J@>XFN X<5\=]L3!%
M)!B^$-/&!AN1#]\;#Y-]IOM1@J!Q1_A]]NK&)@&C44'CEGB[:"@C2HRB_0=[
MX]8.QT86470@9.IW@IG Q=SP!GH)*BL;EA^M6WI]?!6I"AJ\-YM=[^MGJ^6!
M!2:*_O1]'_GV@!HX")>C]^O];YS9^!^C]'2+I\A]]@FZ7HY@_?S_ /,5BM>_
MR!<>W_/M[@()3(Z7L)C_ )/8^KB^HEB"_0#]"^?="$"@BR0H=''OGP# I&@"
M$:_\_?(6*VX"@H?T^;#YZB:,I%0>!%6_OX]T'" -4!J)#3E%?'7BC-438$(.
M/4;XQ"1JA>AJ_A6_(8BV*J)P*R@R'V/F 'Z=T*2R#J([=?*^M6_V 0H I@WC
MX/KWK7/PJB4GD5 Q,ERP*F@1A#P*^)14UWT0+DB#RH\7\%#W08Z^-D+FV8G7
M0]:?SQ)2%[ Z/A*Y_*+@V"/!  $I_IA86EE]HH 9"U._>^:MB*O4[T5N"WY5
M$, D10.M2G-0/GEA]T4 RNE2.E2=;XL1@3&(X+)DD]-Y*52KW(N#M"@$;6>#
M]&L8Z%J5Q_#F@@:#0;5P[U0'PJT]L8)ES-WK[30[&=GRAQ('C,#1RONG/V#
M14Y622RB8-EF7M.J;!B%!B(.#ZCW=UQ)E%08@#DMA:='KU.W:\>AHR%F%3JI
M2/YZ>["U@=ZQ$&4 ^+G!6B"$ &O]"S5\,+PK8*(04@IVSOB5L=8D*P@%>L/P
M15\H5G-Y0@((.#1KN FO20= XCXI,(,P@I5LD,])FZRHF2H-D2BP]!OHX1LC
M5405\EB*>Z>Q =$6;/GD Q=8%WJ36D<\O<T,/6X=&RBA[M>0@& +]M1*^WJN
MG$(4&&62I9/"N5*@SB6.A;(]5X\! C1;*H@PR5\RS$-&DR)#0#5L?+99H.*8
M@CN]2@#TD3K-'NB6P%33/%>.JDBRVT$]V/7SLQ*FLH?5FC.YW<32HR8)N/X+
MAL%MU02E&Z!^?)N$*0QL!%8< "!*_=9X(#+1 =0&+_O?\^#"33\,"++#"9#/
MGBL"X>U\*(.(P_G/,%'H#3[$6?X?HL\&JDD=Z&.T_N_O]?<"FA0/%[<?\OW-
MJ.NLG.1V?]?S9WPZ1( 5&S*7GX??V4P<9H,AOSF?XN^/'AG0.T5YKGW[<*>N
M!5@#M8%.&/B.Y[IJPKBGX?S#Q%$4S!JGQL4%?LSR-TPIIB 0LEW0>J11@PIC
M8D"U4F^2?TE*RPG!0VO^?.RE<! XE05TF4YH'UBS<<(HE5YP?OB0K6I=X5:9
MK1^^<!D!:;]F!:A>>/=(3^FY1 DE(>!3]36E)8@C $Q&!F2($*N\^\^>)_&Z
MP1/]0&Q^FOCU'YBP2S$?Y8?V?K99(FOPXS-M\/ZV@G,(UQQ(BZ@>^CZ@L$D1
M*8];XG)(P$#9%2!1.FN6J7DAHTFH37Y$GA%(9(!MBN#(8;?!FO6,M0P^J+2?
M/'-;B'2;-$3X_N/K:$PA<E5)CN,\G),G4T#X8^6'_ :99(#J[\H<IRFA'D7Y
M:1#QYEE4#ZQ5D"RD'EA :L(7 J<46_"+Z/47OS0")/EC=4>':ZK,A(% 0  U
MU8X0+TM,(E4\:@CE+I)"!<,)X<M-@4 N LU@I(>/I1Z5CU4[:WY>>*331J30
MVZ4IPO0#*7 9--(4AVA2J!B,4%2+V@R91B'\=+&9#6=CQZ61TF(&&_H!1@.+
MH,=IQ%#E&@,4)@: #)'%<0ZQ2<R0*RH:00(3!W!9+J&:A'P(*Y(;!HB'R-=)
MKD4WPA.CF L<IQ.8?B^'U% 4,%:R(#!4N^8Y;8L1:H:"H,WQ$F4:*AC&ZK.S
MX56ZGLJI&(O1Z1TI/9B EM LX(Z\AH@/KYN%I]5]]@.>A"R/8-7");F!11\9
M!  HNP.^#9*H;&)_<" ;+Y;%W4CX)U:OS\G?0*L-%/@FO3^^D;_7?1!C+J@_
M]>?QZ#FHM*]U>SXR127[HHH'Y+&K^,OH>%!NB61D?OY^=\KA"#0@J=I8T^77
M^Z9&?U_;3N(\QZ_PKP:L@7\3-VYWZ/IO2!,&%AB=JX,[OC41_C26+8WYMEGA
MM%91E/E*F?Y^\]3VZU)(3(3?J;/GDB "$KS^P#]<1N>-P[CKCB5A"95G/4DC
MQZY!CPK-N,B[L_@R0_ (';CGK^ZK]XD#D&P4>;4+,/3D3[W:*6$D$0"!#!:T
M=04G^-?43Y&TX"@@S#, 7Q,=8P[%<GM,H'&86$JH 8O#Q'>92T*GAL4G9=2M
MA;6$*H9QCSRD^Z(L71$.+U\N@=/] Z,<P9V-\JZ[#?*8KJ:=,\A\.%882"?U
MJ<7RY,1'!MS"1QT.\ SXBN GHCU'KUB+S&I4<7 X9"1]L>*J4KZ ">%+G@VY
M U<@8:^UC+Y&&CF#Z\V!%*@443Z;>\:!)&"'D&P EHFP-+>JJGN]:OH@@0Q!
M"B&)L(B%UQ+$'SJG<[%A>-8H1"PAKY)OS2HVH9;0#]8[BW4I#H7\L33R-*CS
MB*2 1$&;OB816;)!I=68JGYX#=)C!62KDK1VOD]0<+94D!0K$6*>?3+)"!"0
ME " YX]1+/)BL$'%9M&KYB(^ TJ8TB@5^-3RA@4WP 80M>-9(><RFK;;>D$D
MB1GF=[#QN7D.QB5.$?4;4:1+)$K4)@D!4 AAH*9P8YA3XY(UW)=4"J@0Z"^+
M1%F%& U*A!CC#R",YPR:*F(C+8<\'O,S<AH$ 2!7#,\C<D]./M$6598_Q9BA
M6 @OC!0>/EGPZ"@A)_B2W\-]<WKP$1<"=!!7-\X%>Z,?31T*E3OL8B#.RK6M
M0+"]3SO.09^B@&*;_D.>?0]9 -HW:^_B6&>DD= A!C/O,N?"/@(QTP:A')#,
M37[X@)@HTUA/MT.SZ>D2?+%6"NVC_.UX0HDE6OR<#^7[D\[; ?I1-XE<#_CT
M4  CKO$W\_OYI,=&:."7I,?[A<^>C9-BZ(BL06Y]^;Y<]3"\N/%^8F\]:VR4
M8"T'#0_U+.>"A125@L$*<FX?N^=1J(@:&(#:A3GSR[<$IMM13HO\?VN/ZBRR
M@!>4>N<7,2G@(#21AUX<J9JA 36:%T9GYYCP]A0U=4>,<1GEF_P8.LK(Z182
M/H?(1 0^#2V@M4%]@[*Z5*K&ZM* 9WWL!G!C-_@'H<TFQP((G^#I]_2']-_[
ML11@I0GROF?*B)+4%04% 9KGA%PHM2_,J!!U*^>$!8K4(@_(B@ID?:3!$9P^
MJ$!!KWS)-101(,3ZDOP">V!PTPIP'I!FEIXV7"N<7X$FA1>+Y?[-@41"1=JN
MP#>D%<M36!H@-$?"1> J"@8@PP %?..!7MF!11#& 6/F>\DVD(@<) +ZBM M
M@AJ"$_'&_3MQ)L0*JN:7 !T<;5]=A!BQ@1$"/1J9\@O3H-)]^B8!!I/=.N'6
M-*5*J-%@ 7*7S.&@^9< 0_"0F'I/-,CD3 MQMQT\9:^:!+U00A)\1)(%64 ]
M3&"Z\OLZ*;,H:AR)J>^XORJC L! >*^#*"I/)!%@Q*2-GA"UGG31JQP&;\1M
MTAA78@00ETC-=YR^=!["INA%=6Y=T'TN0+$!>[%"?U7#C7P?0KX"';@X5,#%
M06*7I24(J_()*URX%KXL@A&D-F)J2K /%3* :ZAUJ@@R/G3RV^U.JY#)HJ0A
M;YPFA(]*BF@!+Q,GK!Q*HF(*#$ *_P#)?5%?3BQL=8>KKWCNR97I(&%*OWX_
M.>+2 *5KP*BB:>;YH9(&B2:V'4E8RH;X;T%$T 8A@Q4CF[?,@X1BKGU<WY<$
MT>^3X4!!(DF3;P?^(^S7"  O0-XS"?V>I05FI^D?G/OW\IK*HE(:=RN2'<]2
MX+-4<;L8WDGWGAN(@] '^6$B_P"(>-FY@6 _%-,S<_QGA9U)E 38EW_7/R^,
M!F,8S0!^3YSV-XM>1J<<1GS'SLWEZ$P*XGZWE]"NP8D2K%YVO^/SV]H)*&0#
M(>99NSQ<0$3$X4S>#;XUWA27U)J)%.6L\;4NP*K$,!:?\SW&SPL6K GVA?WY
MXH#'(LE!38S1O NX.!B@P4!@JK^/2!*9KHQ+#@9"$;MRT@-DX21HN^%W,K5(
M(L1"75[SBQ)"P%,$,6I_$]6 T7& 01:82OF<F^$T0T,2(R)N^W$J;D$.P""
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M&^1DH :M@NX[4POWPW5T"JL@K"JXLZ\GM=.@OQT^$-1^_/#T-S&;A:)TY?\
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M,*@!,@4+P#P,:+4$&D99#0 \P+P1/E5';H#X/*9"L8E *,9)R9J6O;0U@$@
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MJ/\ A]J9A2<D:-@V#?U_0E2 R4.E "LSZWQ8]PT!@!X/28FS?94' 6)*3/\
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M-R(2P53XCF87"BIZ?9_,/5D<7G<,1524]0!T,\PA/6A'XZQ!8C5Y("T/[T4
M4(:S,#A"3.@!PZ>R/#V6'IH!&K THD9.'F>4:X$3 $4/I FV@':,>%+%%Z*K
M9V4/0702'4;'#E@(2TS;4@82C,!5\;(]JY44@#4L$=:?E2_EU!2WM(:;.*72
M$]A@1Z- ,UK:2;$C5\@N)XT204* ^3?U!C.FW1I:""VL1<"T!K7GPKS;1S6;
MU.S/U58-=SWC9BK "# QX);FL@&"#FB+]8V3V][CX&RFQ>6JX!!,4XX$W[H
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M!(0*7 ,H%.I%AMG@:5V(*^6E(7]<L%VC+BH:8!@-C %RA$ ZCVY/%2T1H(%
MBI Q^!S9*BK RU*G8=3Y:".&!0&Q[_I"_IZDHBA0V5%6EP-\EG'H,%MDFU^Q
MQYDQO?4[R](1X?Q'*G*ESB&EX21(E= 2-#TP 5Y"C0,:E^A+!1O?,H-4Q8I3
M";84;1M?D6GX)K#"P%N >3=-;.3Q-E7D!SX/ F_+#<5F.P$$D-&Y$(#@E$HE
M\0?UHA!\.8AA;\8*HYH@K5(KB*\PJ@,]">:9Y@#I)"LH!G@Y>LE%>/\ D('-
M2'FEK11CM+CB;_2>M((XKB12 $1=<-5&:6]Q0J1')*O (21",&H$+!D@P2$7
M",@"U)3<[-:I07--$(@ :085ZZ6J@>9&^,G.\'*:U08)2"4X%9V0P-I^MC1-
MN %'R<(X.@4]_I5DO#Z0T*@&EV)GQ3P$DH9/^9?(0PLPD/=<JXT;.U2!OB0,
MULU@TC!IE<>($Z), 1B@'GP'T=,C!H.)18(F^7@%.\"NGJ4+@4MW89!:WU(%
M5SY*-KD9\&O'(!%4)"=66:!0I$KZ>*I[-^XBBD0U IX&X%$*]DTU0?NG>W#V
M5(H4HS4K0X*CP5"Z-?N1XG0K2  1<+A58Z5\D=<BA0T6(5@.V>I2@95]*ZV(
M7]UG@1Z@Y4IP%-Y_ 9R/;.JH+UB6CO/\'BRUH(U@!,,R9,QIX22SFJ#(0%TE
MF[\#V \F"]02]I./R9Y3'J%)1OR0F7LT\HY5@'<J3-$;S_GUJ?,$NM%;IA<]
M3@I (U0""9"DY\\9T]1!!,%PL>;>WS[**@!0HBM,<IQ^^8DH*),0NA.7[GD"
MQ91TPZ?<=T?GJBQ82"_4+%"Q+GKJ"&#4YO=B3OWPPGA>@& ARA<DJ 0SP:2Q
MT:C5'M!)( I5"RFC:?:>C3(7;(VUB*)[MYZFTF0[H#70%ASQ/5$J7 %R8V$*
MB^&*DP!!?ZB#<7GS7"@,>UQ-4> 1@S)QVG:A[_\ @JED=-6:I]]X0@%?3%\[
MRP?R&EO&3<D[C4>1*CL%,5> @PO50XP$Q35@35>-F4+JB*I@UXKK8&85&H.T
M30.^F?ZWY.QN[#^\,$7B:QPU32PHKA$FP'8L/8L62%LK"T4*26KKQ<P0JJHL
M0#L&^7CTW3M12A,.J^YK%Q7H_N#(^ >5=Q6H=7PJPWP.V1C!"0USD/MTHI0'
M'F4*;P0%?-+P*_F(D1)C*2(4T%)3P^EBDCB3Z7_"I^=(HR>+<D<Y:B@XP!2%
M LABGA4YA+-?!08*(403M(K!E&'3-(AO5U\1/ZQQZ:CP>C:-@SPZ)0D^*J#'
M#@2 HRI4B>0]0-Y2@+-C+P@JW9@#'E^03>)Y//(%DBR=:@>.<ZBRNH*XB#3$
M>6:1T"A@Z5H U/>8HG)#51!=:E\%K%2300E $?AYU!)Z#5NH6$04'EUU^H&,
M"CL$^OLE;\6I?MP4>F#Q3-]UE3HQ5I :#T)&BD@1<,">OM?$Q1$0'!BDN'!?
M,BM?)M80_ S(0]8C( 9 4J#+9PGSS*%S6-3]-)0?_;SRO$IHJ:,EX'[WP?A5
M_M*!5M15+R9Z2@TRT@65&3-:M\Y!44 -O5,E8?OT/" )6BYB\@1G]3AZ6LC_
M  4%7*@J#R' D]B 8H1<CE GT,$Y@2L/") ?6 W</>&GZ:7.K^!!1 F( *N:
MV6/4\%AO: T09,Q6SGY[X,NM(A;*WZGY=]?"N.3!]&/['<[ZP<X%U;H@5^0"
MH8Z!8&6UT&B<F]F VLPMP"<0,#Q\E+M9"8W MR;UHK2XJ5SB#)0T/YZK)%H&
M$-= 8K\-E6AL&^R4KSZ+_ 5HFXI6=I(:1>MAYD.E0"2N(&S9U@@P_-I304?
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MNYW<)3)"9T0D9MZJW1K7 -+%\7[\+1; X _*(V[U_H4:AX3>:IU* :8DR(@
M%9?Y:15*_G!$21A>FQ9:W4JEV15()OYI*54@ 4!EO("GG540EZ U>.6H)H4%
MS%(H[&>21B.I@: 0GM0Q;$0 B@&$F/ JL3=D&(..PE.0&_3>AI:NR%CC%T$J
MQH!@$@K,QA\$_F56V43QH"133TI?X#@E39%L4 _)5C#1 8G!:<3/P9Y.J*P^
MPMA4^5($9Y@4+23E .CV?I3PK1@@X IL>VM=)OA^W8W"3X9@[G^O!9_4L;+
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MVCV#MP"MK>EJM*E'*F6T4*",G "7?+]CJ*?LZ\G2.>8(>=@+0<Q[I?LT\2F
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M7T$%2HZ@381:#;GFK+PDR "430$?\L\3I*%:(2Y51/[?[Z$U>D+_  D^D?\
M'8(8!DCC"O8<0_/STLIP,*QWP)R]<"V;?M1LMHH_V3C/&RJ64+C!D_@Z^&]=
M4$:]&!6'45$\CJS$JK@F,QG@+@4O^9A'^?SQCHB%8190D5TKWGWW8:@FD 4C
MHE!^^#&4[P)2J%^;AD[X=5  J_!.+EIGFO\ >Y(EA2+C,([F7SD!4M% -5SY
MY@/H0 8VI'] $_OGA2+Y-&*K<*/GMR>,<!"9(A(":\;A!^&KOS@!S71'@B)D
MTT%B*8J=OB&@B"(P5CHJF7_'HZQ<)<^@5-4;OOT4>0%2A4._O^?2EHA!GL0X
MZ-G^/ 6991<8L7A'9^&^%[N)*N4H09;^\_']X0K J2CQ!0Q/PKXJ$&\P5JJT
MVD\Q,(1>&$-Y"ZW/SW<(9561LE($%Z^D1T46!H)L +Q9YNQ+Q2KI8%-^@]#.
M$SQ7P;$O0[ZFY.Y(!'$INC1+X)V:9""V&X@0*^^))N\(B40U5$/SQ+Y2P=$O
M%4 <,U414O2?%>_H@ \K;EJ)"[ ;ZT:><!8S$?($L<(2L<Q&!1]2<,:I:;X"
MBT4,!)(5,)="ZW"!")@D).K+T9U,5Q-39(LHN1"!!:E3@\&UWS:FP$C%30$L
M!!NW[A& H?D-U<R+;6 @DC#C7\!^*S23]@JI[<]/E!.L"JX+\AXT%X"I2 ,]
M /0\3$?$\!I^"#FK.'#4,!M94:X+/'O,XP&W"L$#"B1CD,TD"$ !H"JN'@[3
MU"*":APZE^^BH#!VHG #L>TBB0ZP>M<*ZA"ZX9F1Y4 ,$51PZ$;ZMC%NM*ES
M\2YY?H5#\OL%QT@$:#GH1.+T@124L#1/M>,A"8* ($=G5OG7Z5XA(F"%4%BB
M"YM,Y%( J*IH(YS/%@E!H_:>\<6;L\5V,'B]Z7^H/HB=P*4#652T_P @&^'P
M/+5^TN6OW%/AYI*6"&=,98,>D+>>4%.J6(HC:TK_ -B[%H1;*@'?C=[A(QUH
MP_H( PF$FF:LS(4')514#'<1#-5T-*E( *'02)9OS&LZB#F3_CQJ=B@NM.L=
M_LY]\]P :@(_02;$*!'R!WQ$)&'ZE5^NYXZ!%8./],7M#_<\Q5:E4VQ!XAT9
M]?&4+)\*OU:LMJ>1B$0&LH$S'4D\V#*N ,3K "HIPY:CBN=2, $(; -^>I<9
M$:'DU;W0*SOJ'\J+,>?4Q%OY7\0A1QC]LSJ33'Z<\D=92T'[&\YC\_/2?2IY
M<E9W@_:?/-0C() #C3&:7G\]4;2@?6"T P1_[])!$@*2%2XD_P"<WV6)!8^@
M%UI88?U30X*:!#!H\$ K'YX&H A*# [%N/:R><940CFMF_4%NFZ3.\TFB8#=
M$^FR><C$MRI1"-7$;]TN0=E0H3"S2 MTG^F/%'*X!O9W7PP%6T^E5)12B2:\
MFT:EH$0Y--, GE(+A&DI5Q0Q38@>B]$!,-6!1"/!? J"?#0T;:(0A=3U<F2V
MJ#Y#Q&I\%U %&.6H"-!,$%*\6ZX ,%8]-2V(Q#.BFQ @-;Y+,U?DQ 1! "2^
M%HZ\D@8";0NE1@<0@X-%%J$5$!VAV*V$)3%2P#T"5HA.2"@$_@0<?&ZZ<$1,
M&V%5';@!DK20:/L5_N7-H,DDNDZ-\S-2,:=6*C$(15\'<]@5 8BS -"PHF6'
MA59H.BI"6 &FT&&92&*+$AXPR<J-!26KK*LY[-EB;;T@4$E9\\W7 MP!$%C0
M4_/B1H$*(5%CM8QHE\(R)@8E<+<:$E;JSOJRL(Z=,&&]D4T0DT : LP-DJP'
MW?S4C)0(4;A5LZ"'C61("MI306VYGP]:[JTE\+I/F ?]""4-K:5CI*#47)'P
M71(#1QH*/PUK9^B= %(Q-+?S?TV+X][*84J1(10[-?<=N#J&FB8JV??1,KLR
M?1QC#\[_ +/!H1"0'O"F'9PIZPT6<$ZH84LU5T;,,*1K4.E$5Z'YSQ*7&P-0
MC0-E3?L&"PQ=M2BJH#<P\Z]E2M38IC+,8 &)@:M"R9,98CVWOA2.*LB8C84I
M\F[T[2!TB<+Z0B;W\\.\PE^J<":P_O@GNP840Y&VA^'[*8@1VJ!Q (OQ;?/7
MEVLY.&"8.XO%F4#P"F\K=#ZM.>HDF#:^R-!$!.69'R&(TV?::V97\/GIL9A(
M ,8H;\4_WR^2G.QJVNHH*53^D\8%A<61!0D76<NIYZE$TE"N(1?AL/SP3&UI
M$/IF(,G1\4MH1\ 46BY0$3Y?1!V:@2)95(%.7#"0W%&@HU"_N,XCJJT&*"J!
M%#04(*ME\J"LI0T_P5ZHI'Q*XIQ1&A*(0@HAX?)#'*%"J4H,IY;<28JI!H2@
MXLOHDR&6R -%55K /3]X!VXH1,@N](FB*8D =HG5 @FB>!MH5%$HEA2R8&X^
M>(GF%*AM"+J*QNGUKAKR;'6=23M!D*624(-8E%KZ.Y0)@:=!&4E)YFG"?Y&9
MD-E!\@!D%C(0%5="],[R1U5.2!SN0B18%.83:K:1%05MB,PEZF-0**!/$PZ1
M7!&-\(HBASO\M$*E:1;T)XG$"R@"!0"<N)XH,UZ 5-+DQ-F/HL)H*(< A>P?
M_P"%5(M$  0P?QG%OHX)5YMUZM$<!./@_9+6&BD +5&V>I0,8(U02*B-7KY-
M9Z(*LH 5JV)O&0"T*J"A5WKV#?&BH(RGD#H#U8$G;Z+<HPD!8 0/1K47QFU$
MHE!*K29H<-,3UYM*T+WJH1ZB/D^IL(* PJ[2IM[Y1Q 92Q:"$H>?\^"L5H"<
MP#U%Y6.>22_?1&5?W?T+X=G>X@XQP!4@1X34WP,!KJBZ#6P\Y2B61P$   #!
MH'IR& =D, +I+4FY]B64R%6'YIDG]>)9DL%ZP;\$T+O].]020%"F,3]SY>LV
M!U25%9T8D_?#*BVD(3:ANJ$IL/3%=O ,V&;M$;/&4P(@!6  Z'^U\\^BA&&3
M"Z/_ /<\Y>I$0BFL"_>!S9[L&E(-;G8#^W[]\(H&_0$H$-*B<G4//-B 6^HA
M4C41U]OL8H21!$02UWX6C1=; Z$K M:N0>)2FH*K7JF9'[]]0F!##! UM7\_
M^D%4JB# BW4YMG6PN%\8M'$@I74+_7VZ(ME1(%+ QK_WX=E3DK$,1)C9DV^L
M-K)64?1B#"/^?/V"DDCBT!F3A?Z."@#GT:S;J(:UZ^@@,L2T!%L"LL[OH=%&
M#XA(TC@:EGMVI359JJ.A (&#CYC<LP5 @+H /I9OV;$I"UJ&='!5^/T0W=),
MJJ $I955>(0DDD#85/T@8</,FB=/I&5B ;5%.AH-61K&"I< 4P%/*92@(  <
M:8*G L]\ 6_M3I4GQA%?$ 15PT@M!ZZ?V<)#3(<L4$"44&?LHLH8 7= P10N
M+D4?*3%&E6H*10IT%;X)9Q1*$"W4")$I5K\4CZB(2/(MH)I@  O 5S"("PGW
M\ +.3A( '@PKKJ$_5=GUH4622A(:!:<G#;9.4N]S!0 @BJS074P4,IFXF<_4
M$N!+?\^+:27] C*<(P3XZ>$AN5>PH $_T_;X632+2;1!.JNK4WW D-$0@$P!
M"2&?OD>2#(#UE-VO@*I3W H$B_;!B\%JD]0<EBZ0!PC.@^N,!.'IDHEE3^V9
M^ K1?OZD5@C8.*98THS# &C@D-1UUP\SL02@2"3@[!3 OE-V )&&-?Y#K\#Q
M-XF RTB(!N@M[AZHA?8I208/I9)?T!+5X4B")\E;-\1Z&+@+7X4_E^#.+(T
M:RK4/4B01)"3G/$0*CB,57]\^]%E#A </H?]GA@!00);/ED%_5^SS);$H92C
MJA6%:W[YGM$GQ$AP\6C]R^(N%J$<#'8!;?\ +[>L @*1&53O5^N>IL48Q4L3
M%YM5G]]27BVG.M0Q. R9_P"(<QD,AJ!4_P ]0Z>I0D 04T,Q_7B_S4!QI!%*
M/Q=[R\N^)/P18ZPL:3?H9Y*R-M 56-% TJ=\(C*6"_24M6W+; ]NA\%_1@:'
M^N33RDK6+J.(K\HWE\<,@S(SL2P/Y]?7&6V;C#LJ_?Z^?060*30^ V[O,?+
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%A_X__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>businessfigure16a1a.jpg
<TEXT>
begin 644 businessfigure16a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F
M9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:
M   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M
M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" &&
M CT# 1$  A$! Q$!_\0 '0 !  (" P$!              8'!0@! P0""?_$
M !H! 0$! 0$! 0             ! @,$!0;_V@ , P$  A #$    =R?M?(E
M/7D !1//K(=9         'T?5G$H^ <G-<1P#Z/D [+.N7Z/DY!S7S
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M8Z<KP <$1*/7L+73*DP.$X4#DH0PZY,FJ66 #H-%_L_)D/7D !!>?2==.8
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M<O;9KEYO3<7;B/NI9K$PWC'RUERZ^NSR2Y;4S=SF]9@6.GO3$R\F\/M\/R
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M@@#@'($K&@ .L^SD  B.I7&FQ+.%7I2?DJ-+5L HHO@U@6VTSI"3D]L;O6
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MO7Z!L@10CY98 -"E]A:D;*V "+F+!2Q3:V+&Q%@   U%7'FYJ?  *\*OTM5
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M\QM,GP   0TJ^6PK+    !K6L0C<.P "O#7AJUTKI9Q)MY8*3+L
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M,MFV1I=Z&=J4I,NP         %'%X@&"-.5AB_HLR!%BC2=@ US6#R[B7(
M U=FH&3@VFN0  /":'35CED67@@ B17+6P;,!7@V'3T&M"WJGJ,L<%7&+B45
MY#QF;)8>T\1V'@,V  4<7B 8@@IT%L $6*I)Z@ KM>\GR<   '@,"=*S-
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M:R_'VR? VTWMK8*\R#VY=NC%?!1B@[ ?G8X5KJD_&+[&4PX<K$?!@Q5V</\
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M6BE;=UDI5N+*@N+*@N+*@N+*@N+*@G*U3@Y3QFB/!#$.D!21/;ROC0DIJE#
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MM4BEP9<$5\)7_GZ%!3DHU7PEC&2!;%AE6KYFA^94=.JG;!DZD>)N5B"<_8?
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M"'BM&ZHP2H0WO$J)HM:C0]<A8:J!I+=7H[6>E2HF.GBM&[N55H^;7Z6H]R*
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M5-5S^H_Y*E]QZVY\7&K&SY&NXBMHXCL"-ZG/I:I_*_"P5P,<NEWGT\D9R_\
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M9@4,S,,!QY#HP7;P7;P7;P7;P0S332Z5VA2+)();6VN3N*$VDNXMN;M;=&1
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MZI?:"/H^D:I?:)CZ/I&J7VB8-!I99ZAJADO-&2-0U"/H^DZI?:)C$Z:&90#
MI PV8'./<8Q&E@%(JU5-63A15+9G&EH30J6BU)2DZTS0(^CZ3JEZ_O!GCZ/I
M&J7VB8Q&EU:F14>M5PHJUM;:^F/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?
M:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^D
MZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/
MH^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"/H^DZI?:"*+)7(EE,QG*RJPO8
MR;HF352YU*"6^L)2>BQJPZ6)'QA-*4D(%1.14(M5:98(%F8.^4V<Q+I*I82
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MOUAH:&,-#0WL:&AO8T-[&AO8T-[-7V0@_P#L/KY1KZXT',_[P='=;T9XS/\
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MH_#T#[E7_E5_:F%2)*B5*EH<FTU 22T8K(M^JEV?R",6D-]U+X1&+2-U+S;
MC%Y&ZE\ C%Y&ZE\(C%Y##ZF7PB,6D;J7PBZ,6D[E' (Q>3N9?"(Q:3N9?"+H
MQ>3N4< C%Y.YE\(C%Y.Y1P",7D[E' (Q>1N9?"(Q>1NI?"(Q>1NI?"(Q>1NI
M?"(Q>1NI?"(Q>1NI?"(Q>1NI?"(Q>1NI?"(Q>1NI?"(Q>1NI?"(Q>1NI?"(Q
M>1NI?"(Q>19]3+X!&+R-U+X1&+R-U+X1&+R-U+X1&+R-U+X1!HTC=2^ 0:-(
M'^E+X1&+R-U+X1&+R-U+X1&+R-U+X1&+R-S+X!!H\A_NI?"(Q>1NI?"(Q>1N
MI?"(Q>1NI?"(Q>1NI?"(Q>1NI?"+HQ>1NI?"(Q>1NI? (Q>1NI?"(Q>1NI?"
M(Q>1NI?"(Q>1NI?"(P$C<R^&,#(W,OA_>,#(W,OA_>,!)W,OA_>,!(W,OAC
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M1]YX%^6,;H^\\*_+&-T?>>%?EC&Z/O/"ORQCE'WG@7Y8QRC[8X%^6#3*.?\
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MD!H*YQ"P:[3"%3!5.44YCFT1A:1;S\IWR-H55-DV5A869XPM(LM78S?5ZDU
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M< N\5YS@Y;BNQ*7Y_/=Q;6>UXPDZPY3@$?=BT$,:V3EN !E/9"ES5%9-8X0
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M3CGK%S6YFFPV&JX<@. P+6QA)S*&4RRHJR-OGMDV5M+-"YTY:RJT9\FHZ64
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MU=*?@?5%O5TI^!]46]72GX'U1;U=*?@?5%O5TI^!]429AFRTK-SO\B1[?+_
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MX*)F$JJBM]("*I/$A+W0:.HJ(=I?TE[@EYB DW,#[;RP]O)<AZZ@:RE!; L
MZDH3XK_#4"N$"4R):*Q^C(43U*8UB?YBHF+.GZ.]]FA*+T@UDI-8?RE^=_\
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MDLR)CJ *$[KJ!K7C>8-44]9N'M@3T5RAE.!?=P(37*3?<6Y\'N>!24EMQ8<
MWU><LS$\%?:2#[N<&>'2 DFM5>\"J%2S,>\\@+__ .1:@0Z4*^V[M=5E[0&X
M[P(\O;[(-(0')"F 5?<Q4A%=2!>[@>88\'A4XU"4H)5M$2ZJF#%;,2Q+AB#<
M?>T6A+/567JU.&^%+J.F^[>ZF+7PJ:$EB%<$J6;MP*55%:_JZ7\X%)=GED)(
M=P0:OTIE![^#^5_&YHM*"]5*RRDI%PWJRJEU["\<"Q:_A"IR@LHV1+*EIXB_
M:)4;K^(;G=Q@4F62  J](5P%S@D W^0O/A!9S%H3]&Z5#:56>K=7\)4RB16B
MTHJA12L. 4 U=\*)%V\PX%W@TA-4J"5%JGL<K25#CP:JQ^3PF>__ *:JQ9D)
M8EMFE9+DM=6Y7G_!_M'ZY'],?J5%&(L\F\?5IYB''4G,-8<=2<PUAQU)S#6'
M'4G,-8<=2<PUAQU)S#6''4G,-8JRJU?=K.[UN=6IY]-T;*3NW)W:K;_1X'WK
MZO(ESRX0$2@4$5'E@A!K#="N(X_G^$;*1=<G=9M_I-9+[U]4WAW^$;*1?<F]
M_M^:@LMO;N\*VZU\)1*0:R:H-_VW\1K*XJ/$AS&RD>2,WDO:#GU[W_B-E(WK
MD[P(._R)K,-Z[>ON9C&RDN2R;PH'?>Y?CNK?:YMQ-_&-E)X;O%_'?X0DWUG8
MI !#L><5)7W/$%>(>)*:@/'DFYN$"7*3P;BDOM"3N^&\J)8<D\/9"D2E$E50
ME2-F=X7H=VX^?XP9<D\:N?[M3SX5+F@RY)=ZMX8[_P!VIY]-T599K#=99=6]
MQ(8/Q^Z/A"I<E5Y9ZQ4XF$;Q#$W*'$ /YQL9#@LC=  %>[=\.[68M[0;X(EE
M042FL.==O:'93%C>'>$29*$I&ZHI;>*KS5=OM7"\FJ+G),;*2&:K<&&^[,]6
MXJ8E+FJ3PY-"9,E*0EP6"=ZNRMT$ @A3IXFY) O/G!1*4SU35N&]R\C?>+A<
M7$%$HI*#5JDUB*_.M6=W<;U]T"7(2S"7<_$A7B\3UB7)87F_VP)<D  5;E!0
MW_M)35!=W\-WM'&&EU4I=-5%6J*PNJ^'GRC9R>&[P2FY;%DNP<*>YS\;X*)1
M"4FHR;DBLS#@UQ%QYC@><59;*3NLMZPK"]PQY^5UT*1+4Y< E-5Z_P!TI!(K
M,2 ;B1 E20D)W?LWU]YTBJ"]9Q=<P+,2(J2F(W&-7@IO!X&ONJ\F:-G)8C=8
MD'Q\""X*=[=OOW6O@)EIJ 50)9)1O<"IWY^T\7C926:YO+:'X#>N3>=WP^R-
MG)/3Q=J[ F[B 6(N%QNNC92 0=VXN-_F%5A=6:Y1)'DY;C&SDL!NW )&^Q !
M)#$*<>(_& B4"XJBYO'<S5>%9G9@[.W.*DG[MS-O=*2@<^221&RD,S)Y'QOX
M4E(O*N%4LW!KHV4GAN^?UAZ:G&L_AW6X-&SDE[D7@@[WF&-U9@2 Q(O(YQ5E
M_=O4E?B^TD )/'DPC9R1T\0?%Y*K!K[A6O8,'Y0I,M2@I54D?>'(N'#L6-X=
MV,;.3?X;_O\ WZ_5<*]]T5)7W?$%>/@0:P85F&]>P #Q5EE5<U:V[?6YI>J6
M=G#G\# 1*'"J&%7Q\K^(K,2'+$\'NC9R72=W="0G?X!'@^U?5Y._/SA$F2E(
M2X-PWJ[*W2X(96Y??NM>\&7))!-4D,/'Y!@XK,6!(<WL8V4EFW<]_AJ\:SM5
M !#L><.GJ3F&L..I.8:PXZDYAK#CJ3F&L..I.8:PXZDYAK#CJ3F&L..I.8:Q
M_:!&V2Q!^C'"_P"TK^Z[_*FAO\-O^]PK0FY2TI/D5 ?G&UE8DO.G6-K*Q)>=
M.L;65B2\Z=8VLK%EYTZQM96++SIUC:RL67G3K&UE8DO.G6-K*Q)>=.L;65B2
M\Z=8VLK$1G3K&UE8B,Z=8VLK$EYTZQM96)+SIUC:RL27G3K&UE8DO.G6-K*Q
M)>=.L;65BR\Z=8VLK$EYTZQM96)+SIUC:RL27G3K&UE8DO.G6-K*Q)>=.L;6
M5B2\Z=8VLK$EYTZQM96)+SIUC:RL27G3K&UE8LO.G6-K*Q9>=.L;65B2\Z=8
MVLK$EYTZQM96)+SIUC:RL27G3K&UE8DO.G6-K*Q)>=.L;65B2\Z=8VLK$EYT
MZQM96)+SIUC:RL67G3K&UE8LO.G6-K*Q)>=.L;65B2\Z=8VLK$EYTZQM96)+
MSIU@*2J]*@H>P@_E_&4[Z[_0G\U?L,I@;V/ ^<;*;N7'?O2]WX^P>T\K^$;&
M:20UZ6^T.?A8NQK<F)?E%_\ >@FL(F_6+_F/Y_L<82A2G8.P<^P"-FIJS7>\
M.SL[.[/<[<84A2&=OB"Q'$%B6(\O\!C\8V2W8ABSWD!A=Q?AQ'Q;C&R7?=P?
MF'W>+![V%Y9_\#C 2I3L/"'/L OC9K:LWS#^3MQ9[H6A2/%S]H/X7<_V:!]4
MK^H?TI_C*=]</Y$_FK]@3JLK9@.X+E1<7](N8\+[SY-"9R6EA1/"8E9YBO6
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MI%&DF2@I)!=5:[W ?[?]D/\ _\0 :A   @(! @0 !@L*"0<'!@L) P0! @4
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M]1LBHIJ2('/> M%N''387,NFDUC4[.Y15B]HOCPBZ56NK>!](W9%.,+4K7+
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MV$PU7NDVXHJ/*X')99Q8ZJV5M]_X@Z@07BSXBS!NED$\>U$CBDY-]1)1WV.
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M /@5/NG749PTMN5PW6#W(WE>;[TFPK%X6CA$SJF&C=GLGI68RN3P>/RF1PV
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M?EB)M ,4/=GLH(7?<RF/Q60RN&P"F(S+V&*R/(*8S)5PQQ'8'VC1*#)T;'&
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M372)U^D:U_>JUUMFXM^VMA]K. R&.H_BLYD]T#,.C-'$ONL:K9L^+S77IX5
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MJUH%* *B@PB3 UQQ>_)),MX8A*=V@=V9?-8O;;>2W&RE2#WS& E+P0YDU;C
M-GJPVC6^/F>O6M+S2;8OJF1?S#>T\,+!;=>2HQ?'8K;A#MIY.HCK2QCC<,C2
MM8=E>Q)7KT1V*L7IL9M?#XP&8;K-&<H))>CYJVY.>"-5'!K=3I"ZG&WOG2%S
M\W3IPWUX1Z<4IN;:UUK7M-)J_&W<%"72M68OU;'FM(BOGUM8=XD=KQ.1NEEL
M<:F'&9]^]9Y:K@I!I-D(M>M8*M[DW%Y?J M[N.M,S.A.*0L5=P=6PG%2DT8&
MU3J5/6T1[N#C)S<_^O6\\?+K,.V<QU8P;(U,T:E:W(DWTE;A Q Z6+U^FPI
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M^,S&+7S+&'P+F/PML-+O@@A5,L_([9+)196^3J9%+@7C>N/(UYC0Z4_AS/\
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MP21>T@EBM;T]K;^G_P!6+^&\X)!Q_(L,+)T[$:IF$ ,DY&LK1=QE0+5T <Y
M+2>O59D$7]ZZFI5ZF44>[!]>GA1C^-I2'N6R1\L^18[#=L8*AXKF706@]%N[
MZ72OT;ZR@!E3856W%D1I'Q!F&-O65N%,U1[>,W8C%L:O<A!7BQ3#ID(=JN3H
M0.M?;M6.Q*@*JL6.W4G2LJ& WDK-2\+=*P!\Q:DY;<EJ1;EGAPUN[+XP6/RF
M!%C\:?&[:-E;Y-AG(J=T!/<>:!#AC8][/MMKAZ-[49*LO5A^E&R2$%ML+.4&
MP$.-[TA&3TIRNYM6,OE,GT;R\OMPC!&!9&RDT[?&WNL @>2+5.*I0' OGLT!
M0Z!3GPI%.Z@H(V^5F;L7PH(+*RW5(7E,%F@2W7J+VNYOR>V?^N[OUM^?E[,D
M<?E_SH^H\4>Y\GB\G]'XM<>'CGRS^/AY-<.$</Q</%\W\._L;=FJU*Y[&DO:
MZ_<U)5GV/0XJPY')!>+AD9)/CGFJ.1\/=\U8R"!L.)6S3A>S/@!'G'A88[NL
M8$M6PTQ+5CR3NV: -#%9'>H1'!4EL2\GF.S'CL1C\?(0(VIP:QV/92HVI2CU
M$QC:(T1IQ5M-V#$DM;$M#!."D5SB%&5\U7*U9!AF^*]>SPZIJ*#9SC09(Q;#
M"8+WHW%.H7WI04!IS9T/AH;$Y)H#"=G5<B3H2')L9."M]'-@[ARA&;C$RMV5
M8CGL4)8.06L>OEW;.FQFV0X)1WMZKE&V$HBUR?07*-2X[R$=38PH2*'#%ES<
MX2$I8F<+D,0.QF!N$*KB'1Y."1@@X4R06"9HJ L8:*$MTO!=V:+$E6K//P9C
M%VR^=Q[=\(DGC\:)##G16Z"95&^HY4^6?,PPP[C,5<G(8 !A4)08>=F2CYD=
MQ9/NRJIV:8R%BY,5LUC,K3-X[)K*,,P-4%,B7+6;QP[P-D&4(.I@7 (ND#Y;
M,8+).IMNF@#F!>C"@"TLLO4*2J>X%,A2XY7L>YV\HYU2,%B*#%0-*(Y-[*X5
MO'((A22Q@L/D >"XJA"[),66^=.&AFV(XW9=5=;&A_%XCUK)2FNOW2%GK=3^
M,#84);W']SZV' LQ$L00R8V51/76DT4M^#ITRQ5F'W6LI1X#F47R/:&3/<=X
MKGQ;@.NT,^0,J:M6!]NC:BHNV!PFT%MS<S[GA?#N,,M+L4#D=N7;QAY#X='8
MV4QULQ &FI!G+R&4_!RR["@;U6M0A*:=:$_B8DF0G)K+L8"ADRL$8QS119E:
MCP*Y)>3)$Z,4E4B_.M>M[$3BQ<>]+"AW$FE3]Q7%B7OVXL5EL<?&K<IKRIC;
MWRMKKI5M<*RX1JS!OPT4&.E1C'6M!CI6*TI2D<M:4K7A%:UK$16L1PB/%'M?
M9"_*\7]U-L^UCW,>+R>*/%_1^+7_ .OE]IF?ZJR/ZH;6T_R:P7^ZU?:\>$<8
MXQ$_+''AQ^?A''^B-<(B.$>3Q>3VUO%/E_%_]&+7FS\TZ\V?FG7FS\TZX\G^
MSS?DGRQY/)/RQY)^741%.$1XHB*\(B/Q1$1PB/\ 9&O-GYIUYL_-.O-GYIUY
ML_-.O-GYIUYL_-.O-GYIUYL_FZGE#6O'R\HJUX_T\*^/_P#'7'D\?#AQY?DG
MRU\GDG\7DU$<LQ$1PB(KPB(CR1$>2(C\4:\V?FG7FS\TZ\V?FG7FS\TZW+Q\
M7\G=G_KN[];5Q>6/D?"#F)8? IC<'FLT:4Q9 JY&+TQ"#LB'4UZ#FQ>3W5JQ
M\L:VVB=[H/;NH8F!2.LT)MNBZ/A%BQ%R!J5*%U>$F[VJ_2):H+\#S ]9"F$S
M VO!@H9:L0#:0^RM<PZY%8KP%QNXRY%F*5R*EC)S8-XZWBUCFULR+M,KBLSF
MTFC :66OBMOLC4RSI3,A$-8*IC#CBS(I)2>H*+CB;0IF,98Q,>^/K*&.HTE<
MX)F8H>J[@@,0$T1U WN*L%%:A:<1WK:=;X>QX(99KN/'\@;V8J&]A>QMW8H9
MA;W=P686#6]9B8XS%ZQ):#UN,C[(\5E<6\WC"9/#I.F!406%_O\ "L2KCJX>
MT/RM,4J[=&*'?#0T!J+2R&U(S^>=5RCF4EI?(8[+";Q>*$F8*:^;R8<#X3Q.
M4R3-<>R:PIRH>CE%00Q109(8R^(?NO6QMO=4XWKXDR@'LCB","9>HLV;%6\'
MN??!NT,1819OTITIX+/FLQ"(-WLUC&;M94EI=1S QC[IYV,!:^ZI6&VT,56$
M4>J;N5(LQ=:MRX-O^,,GM<"N*V[ELTN%$6'<R^437.3,RL0PLL$@LH;%8ZD#
M0LFL-W)PS<9 3 LXN)!&I,.PM2SC8F_!\AS32]<$6Q>X5%$=M7*>%+W:"$#"
MR]((.61#NON,V/376HK6U4@CRMBP];:%\RP1V>H,9<:-LM04%80[!@5F#M#D
M?&M6ET<&.!S1-JP@Y%BS++N<R^#3;Q7(<B_;"A1/(DH0KD,#)<06.0@F85Q.
M2-A>E?;>/R,9<2S4TEFR6-,TQDJ=X.<<(K##2H1$7&O8]!0#(G-8B0?\G[(7
MY7B_NIMGVCF4R3(D\>@N5MQHT\! 7!2;E)>?'/"M8GQ1$VMY*Q-IB-9++XEQ
MAE;$=7PB&V,R:^25D2T.<E\0RF')S<RMJ'5I12UFZ7IVT%FT1K)!PA7[FQ%E
MJ9 3^%S&'(O=P=RKTFF612M:]Q4ZO+2+345Q$M$4**;?PYG^JLC^J&UM/\FL
M%_NM7VDVM,1$1QF9\41$>69GY(C3'@]HLU67H[)6D7L>!C'DDE1Y))AY9<+^
M.)(2<KJ=S+S%>;J<MZ386ZA9"I,$<5"KNU"S/<5*>%00NM >[.5EB:A5",%C
M,$(.H:7DE>-V\<4EZ!8,FR)A9E)M1Q?AUE7$G! :58'S5M(S"I::7&2O,,E+
M6]I/]/\ Z _X<9AV'0TRN8D\8U#FYFF85 1E@D"KQM0 Q"OQ.7D%-^ JWDMH
MKIG'8YNYFEJFO[I1P &Q+,]DT?&MG -;*+JN_>C)D"G&$_"E[1S5F;XA1LEW
M*R[4<V2="F[?&$@63'C<B9>B.1+CBV@;PTV#67MQYO-O-?;Q)2C%%KT'6Q;U
M'%B$GE&.LWF(DA+>YI2/=7MXJQ,Z2C*.A3OD7UL8@(L^_./-EH$"ZX:\2DM-
M[UZEJUY T]\-:@XYM&PMGN1U?KU+<BS5,?4ZJGA!M/PK8,8VSZJ$]ZRE5J60
MJ\Q;CB*7Y3WQ1S$[;H24;*3N//TFQR9)J@'P+F(D\&)*FX.EEV:5MT[S-;1'
MM-R?DYL[]>WAK9&?P6.RSZ:VS\AB&/ 6][;(R%63YZ'*=5T8R$:2Z8)YE>')
M)I$69XAB)VMO&C^%X+,I29;*!9R63V[C0;:<QY\7&3C(A%EQ&=<;*8P%5RLY
M-JF18N99:JT9O&L,XO"#;QN$Q!B.-GW,ME0XW,O91]3&K+>!C[;VCE!M=M?;
M:[-(J,S%8Y.>Q+[1PN[6 )IX?$[]6/?;[':U6/FLNB]@1%!UBQD5@G$;)RO'
M35K($5&!WZ-['QU-V+*KY\ NVR$I&&=1LBUI#7(+R.HX%1\=*-=M(Z2K<M@<
M. XF=;ZR#52W7G/XNIA@!+#!*+^Q^ODK47IU@Q!K0CPI-IO6T^]<L6)!!C4%
MAMP58J1FF4&1-2/ 4 .1>I,K:C]Z=-JX[V7MC[9">E62F@(ZVF,=CB RJ3.2
M47='5P2-) %T)F<?W AY S$2\L'KCD(3#7J8%<A=,I.G"I H9D,Y+,SBR6*H
MB&@F^VQI1G:;G(=G>IE7T[+U799<,*AH$M;M"Q3+L!'E&:X@X0WA<"=NYH9T
MF/AL=K/T$FH-@?OI,P3&6H.X2\G(8<VQQ<3V/9.[?KFZW=Q&=RMF"'8"NDAU
M\#)%L5W-S4#WV0M92#$CA:U:7T=(R"HT!/UQM@6QN<@BY[;;%F9L7<O+.VC%
MJY>4(QH[T=-QITN);5I="F87P)FL[B$LGAIQ??KC&9I[%(D2?7;*P28I.87.
M-L)Z1>@&J6 .:5M?<0,97%-NI9;&H82M'YD!E<QE/ 23N7FE+F3Y,D!E@X!C
ML2R!<=T_?G*ZQ^)<%MXS[;3]&2HX;<NY%[*JJ)-KVM@\1ULHD4EV+TOW!65X
MJ"C$&^^:C'BL:<>'85>2H9D2@LH'+)TC']>^9< W7IXQ V2CP6MBW8\(6M>#
M0R6P'%UR'!@\QD6:+UD11++*8UUZ4U,E9 !3Y AAL5Q[<,^^TZ'O1 ]S)N2E
M\@BHME7'$'!H567$A<KK-\J/"DHM7PC'1[;(DJ(TY*4(D?%I?KJQ)M.I(XS/
MNY!1L:HT%E$KG>B\9*UF4KSD:J67!3$O6-UV5V(Z5!U!8Q@CN\LQA,G6X,B]
MB\<D 2QW<T=9M)<94[V?"NO2:LEN<3\K=&H"%N>M:36T)8K$Y:[S ;B5(^N-
M7&BS4H/NAPN1/1@S2[7\6MA8L%-@ BBY.O,E7ZJ9FQ=NT55<C((\@6+BK8PH
MXS,^]DFU/',^3R^U]D+\KQ?W4VS[3(WPZ"^4RM5"^#T'#5749;Y> :,FMXJ
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M4L-@IP6"!<M["@D3'DF.,?T3KV0ORO%_=3;/^2S/]59']4-K:?Y-8+_=:O\
ME)F:Q,\?_0'KS(UYD:\RNO%2)_HUYD:\R->9&O,C7F1KS(UYD:\R->9&O,C7
MF1__ ,\OS:\R->9&O,C7F1KS(UN7A'#^3FSOUW>&O8ZRN#R36(R.X2@]C?-,
MJBL:Q=M;F?:ZQJQQX+OXDHK'QCWB[:S+'-/"U>7V/,<';>Y5]J;9RG@+;BZ
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M=%FMEV>XBQ;6Z;PAL<A:^\ZS6*'DF6*9K"X["$/=<([KBQN&)A1L#I2W)<I
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MJ^UW"[#%B3GVUFK#D<5A7M\2EBN2MN:>K%H2@_&8KPDDTX<*\96VN+*![-?
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M9;3ZW=JKU#>3,+=N,IX,$?,0<A'<M;5B:5FT1K=J"CPW\6ID4#XJZ6::W#C
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M+#MXBA,&!%9;%70/1I/L5QU O"[%+EJ:E1CBO4ZEYM,3-K3;C_![(7]<8/\
MNIAO]%]D+\KQ?W4VS[4!\&2+K8_.YW*19#,-E5\-9 [M,W#?2<L%GE::;YTF
M^J!)CA(@!* ?3KAMD97$9#&X3WFP,5EA9;LI9*<\59+1EDU;F+W%XEB_/>8)
MPX\L\/X<O_5>0_5"ZVSXX^+N#_'_ -6*Z\M?KUY:_7KRU^O7EK]>L=?)-X^F
MXRPJ5/'%RY%KY+P>0I<<8^%AH8,H3'EL<F.(TJ>X"<\KSQI[G"C>R:@<OT\@
MKA!Y++6EYFN1*&[M #:/)6[$N (AVF+V%6E5@36L].?+7Z]>6OUZ\M?KUY:_
M7KRU^O7EK]>O+7Z]>6OUZ.YD'%4D@4FS#39JKKAI/N>)#$FM*<9M%8XSX[3$
M1XYC0;'=3^Y,.)"F(\Y<T8B,?!E[*L0U1F!]R!@(.TR4%[Q<L<!'I:;1IB=K
MY)3**R\6S[P<H7-'/DKC%);9#(G.RP9SH=O' Y9M0$!K6M1Q2->6OUZ\M?KU
MY:_7KRU^O7EK]>O+7Z]>6OUZ\M?KU3.Y/-7P^5RQTA4Z^Z7\8KDR8^*C45\&
MR\%)H(N?A9;H6!:YK26DD/,WH@=M=O/(*JV:QEL\W=UI-0\NH3G<=#O'+"2.
M7N%/"@6.WYXFO 5JQKSH^O7EK]>O+7Z]>6OUZ\M?KUN6)_[.[/G_ ,]WAK:&
MZAX!S<F-IL3,;>2HABE-P-;:S[>8LR/.1@7'$8> XO6J;-EF*&I1>!$N,![V
MUM84[1Q%5L*P+("V]B& [>N#*WW=2Z3Q\#C!9)":@P''KK"R4C0/D\H\3NS*
M!IKV1&O!0L8Z'8]MM[18BHQ -F-QXIAO<&1"] QE)>6[8S$2],#N(:C'+%.N
M;F/&0VCNBRJ&?VF\D=5+:^,WICGL3M]G'/Y!3$+JWQ&Y<1C&K Q^,4R%(:/C
M6&3T,>ZPK34.;QH\6:<KES*"\&H8=UC''=(51_+XK%W)CL?EG8O<[JR=NE6]
MHM-:%L2D:]D+^N,'_=3#?Z+[(7Y7B_NIMGVC2+47LLX JS%1F,O>P34D9*U.
MO<1Q3:EICJ")0E?+2U9\>G-M_<]F 3D-Q^R OC%D!C7HB@5_,N8DA&V+6'CU
M6U:@7QSA!G'!SK=2DTF;:S*?@S<N(VL%7!+85'>$XV^;%DE@-#S-0FQU:]7#
MTCL:)W-[@AH:*G0826CVF7_JO(?JA=;8_)S!?[K5]J#$VVWEQ8Z7]OY?*[@2
MV^R[&9R&--0N'1KDPTD:".)N(1,ID#W@E!_>*E*T(VS%%<=MW-V9<G&G7='B
MT[+9$N,S$FC![G(Q2K^%Q 3"'DZMT85[@)9NF>3199B9_',S_D+'KB6,ST6%
M2=JF%9ET$06/XS14:I<;C>+G@Z!6M9.6PN (L6*TNR V,RAFQDW/F<?1Q"H7
M<F(CQW5/"PE^":>=RS#$W\&BHO[U//"JLU($>/6/QMD#"\(9@UH]]9S61^_,
MJ<WX[RV4@JQ_R01"#7A058C_ " \53;N5;KF\4UCLQN/&[?/G"X_!7-$GPZE
M 4),9')DF;BL;E52I67KP<]%02F%%3)+X53=C>ZV#.X1<(^FU@F$R5%N6'RD
MR-6S,! #%2B'(IU$:F2-*BRE;^UW+^3FSOUW>&MHY#!8S;F0QQ[8W$G\+9')
M)NTR.:S_ (*4D0U,>T"R5"-!NP2QJFI2"R,!9K6MMH;-/BTF<SE^N/<C:##1
M,-@W)PV1RF.2 R981F&'ZX\I^D4(3 Q].Z(+@=?FWJYE\%M8H]HFQ&,NYB<Q
MEKXN,QE3H]>KK;F) 4:6!1? ]FB@6-<75& 46)5CH8W',8M):CFV<SF[.).F
M;59+B-T1MVIL80JR]CXC(CXOIL&&%CDFM+"_UY_@]D+^N,'_ '4PW^B^R%^5
MXO[J;9]HZQC4/"F0"L4B6.[D27>LUI,A7EL_O*U2WX5L:_&!UXVY;<.6=UJM
MXS#+Y[;60+B:%Q^3:>VV]D9QH'J!KD)1"W24#LT0S-*JENJP,L#ZEO>XW%X>
MQ^!66PV5MA5',$]D'5\@\E$QF.G.011OT$&;50ZT#X$= \./< K<G\.7_JO(
M?JA=;9]U/Q=PG^[%=>?;7GVUY]M>?.MT7G /48P+XDT\7#2<Y#(#-CDW@G8O
M)NQ1ZG=<UZ2P65E*=0G.?B#6,S2" 397*8W'-BQMW)$F([\!DD%<L.2RJE!;
ME)88;,G&&: %)B4C3EW1JB9Q^7?Q!38TY6,6]="PZW;QQ3TH:0<][+$H2+2%
MM=D/4+%.;7GVUY]M>?;7GVUY]M>?;7GVT8N-HH9NG+-?"+)5D0BYH[AIH@!&
M/82H><TA!3K'Y8%2U.;G@6<JM+!;]]2BN*-!JOW2<.G4F.L[VEJB?Z,'6ID.
MV, 98JU%;5F90RS*\(,-PUUDAG[FJUUGFDY%#'+6#<.W]T2M8I:TSR>XX:\^
MVO/MKS[:\^VO/MKS[:\^VO/MK('8Q=<8[3=@=K8Y7),D+'O^,!E:/9*N*&Z?
MJ=M<UHQF,JVT0D+J4OUB$O0&40)@H?-4D\Y&\@;!<%V2"8)):KKY,,=,5[66
M97"TD?F6<K%A7M*^5RH4E;ND.5&N/NW8)\5U.7'O6J[6IPW?#'=U!;CTUR@Y
MIZDWK7S[:\^VO/MKS[:W+QGC_)W9_P"N[OUMC&MG87$!K%9>MUNGU)-A<]7*
M '/5H2O2*96@R^+FZ=K<EJVX3&.WA('E<PEF:9QBRV4R-%\DX%'LEY:5EJRP
MX#6H+<5!+W-5>JS%BJ$, F0V_=_)UE_<S6[O"H[*P^OG#YJ<X!FD76(F8:;4
M"$(#*QA76#01:VGW6AYE?)9-Y[P9ET6R/2IP>8SF=KN#(Y$E%E5QA/=VO(,"
MM )B!/+4'/[Y/\'LA?UQ@_[J8;_1?9"_*\7]U-L^TR&+%D',3=]4JL9''6I1
MY.#5Y+&4(2A*C/%9GIEY9L*T]2G"]:S&,Q:^Z\NYC\8Q-Q*'1V\N,JG9F7[
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M6%:\[A5LF;#6!%BV&*]X97-R=<M!]J.33>M-8.NS<9MW)+9?$/9V"98AT16
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MQ@M<GNAS%!Q7^#V0)_\ M@+_ %N'DVGMC_YEO]OR_P#X1\O_ +__  M?^_\
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M_6C6*Q#C\*Y',8QW,*+'$8=QXW'+]RVT[S4B,>,0^;_/.C-[B,.D6N$L5=S
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MQ]M7-K*U$JK/&G/<)3>^6<B.D.@YBU)F]=8G%169LDB 3%_.DSMJ]7(,WO\
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M')M+MB!K>51@IT.7*D42Z&W E,O4%I@<'Y*!U<J]?PMP>!1#NTPEXQ]&X.Z
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MU<V5C@%+J#R>/M*!_1\6+%BQ8L6++R=[D.O"+2'9$4L@=1"E*$;YU[9N#!Q
M!,X"GP>58L6+!G>*W@1X@SM$Q#CG 7_.;FY3<W*;FY3<W*;FY3<W*;FY3<W*
M;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY01=XAV%)
MR6!0Q((-H&XVJB71A)BS$ [Y$28N?C*O'B,=4Z#0!&Q)U*!$!4@2.>8LL=F9
M@@/G-M:)5*JY@V SX(F212KBB7P-8/V9'T$?SKT;'EV;&^ ,<<F"--\+:KU4
MU-J<]BI$@VG$9:LI(U9J_543YPP*ZC61/M*6F/ZS9W )<*0A.O6)T?((AK34
MP98^H\/"N)K!Z!>6?)M*HMJA(U2JV#"9E_QR0J6YAPR)_%PXRUI,%(IR8K+"
M*B<[ U%B>6K#RGS)Q P6%24I>$LNJ]\S<W*;FY3<W*;FY3<W*;FY3<W*;FY3
M<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*;FY3<W*)2)[Y7\L
MNFSYM@AN$;!>;CQX\>+>W V?U#* AFH"7\&+2R.)LRKJN1K4E$76:=-K@)IB
M2K0F=C5::P1#C%KQO9$;J8#E](A^14XRGQ\CHI/>"K4SX50-E8Y$UW\J6\8L
M<#D2986T/*SL4!)NU6?N*:N<:**M0Z[JG* 10>DN/'CQX\4X].I%2TOT.?$$
M* ]/L?X_KYQX\^G3I^ YHOBK"+:I"R64RUOL8X #$!Z8]./PITX\?QX\1B@!
M[#C-:UEY*]>O\C XHZ%9V\(C26J0_3?T:]>O7KUZY? RQ3*>X,D^=(A<>&8Y
MZ<3/#&8BA&H2?8W/+7KUZXV@SX46";21#VHS(:%IO7M[,B5OJOHQE&$88CV%
MU%>8TTSAA;SDU:TMCO6$MJL!A>-3M#!O#VG<=)2<W/*,3WFX;J<54P*/7N*:
M;=(7$'UOX-1<EU%$6L@[\2"X:(,KG@<"EKRW2(19&6,TL1(6-IT$PA-O.]%?
M<M*2_P!-S6FA= F,'X-I'62U+X$HH#,UK(X*-!#16FZ2V>6:2#UQCB)%F,!8
MV4U^-<B(MZ@Y;<'"D"CDZ)^*K[:A@H:YDMYIG7D!!4 ?%%87I&@V@">CK;LG
MJ?$'/DI:4POBE,/H#S77"><]7 %FSTH"GDE#4E,4!7K(K6)5>@P)YHWP%SG/
M_K_&^+*@0@#@ERL/9:E.J1,W1K24&9R0,ZGW]Z$S<0B?CR&]W(M>,3#13%F.
MS /"/&-[.#]R$&PA*H= ]06P!/+MP$< &"Z7K5@U\0#$\L09E.G4*-5C$ 4
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M4W-RBY2PX12)Q$2D>(X9P8#@"V8V#DRIR9F5LLGJNL.3<V\KR0, @<8,  &
M .!-S<IN;E-S<IN;E*!/N1/Y8CA3KE =T"LS=8O@#=EZ@^)2B,IJX#AP-TL5
MMJ*D16H8A[Y*N\-(2,EX,<Y##HT=/E,5 >7PEF1OL@KC86U8PM(QS?42,U-9
M2^&4%[9,8L*M7+%U+HX-AT9[AD<Z- 34T#F.@]DF0T$VLP?-A$?H0>3&-T5S
M5IB+&0;]_ =E]>D'E!VNJ&N>Q0L-:E-@+0L\\JEQ!WI0!?J@0\%N0%<H:]!S
MX.M"@ JK098S4H-3JM4W-$O= (N^8 ^UE66!51T)GDWC?E6_O?'P)=ZIDM<
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MD!D[@ZS=]4W?5-WU3=]4)A*'->]P^Y2-$.F<*+<WN<A1@) H]-/CB%AG(>8
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M?:E5EK LU78!!7/(33-&WAXIGA83XBK1Q>X)J_MDU_<--(_W"&NQ*):>#C#
M!&S)O!:>>,77$J^1]JB3#7HQ$(V2W6UXT"K[]IH>$>- RH4VHOX+?IYVX,_4
M[8T**7311 /4'CW -XS%.-[9.A11#^ 9*X4FXY8R,L@.K+)&V0[1)O>*&R^)
M($Y# VU5X\4D05>*H@L /)?H,Y:&+U7<T 58$H?&7=U"C];8NG0#\?H8 -@
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MA7RHX@7=.;JICA>J.$+C%^U*-T\6+$83TLZX =(VI#?2<$%TU-]-!F!72A&
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MZEYYK_A (AW?(P#(J5<_"BO1(7]6#%@]9@MPYHES_/A>TU)%6\*!Q8&5QFI
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M;:[;;;;;;;;;(I;*;9;:[;:;;;;;;;;;;;=@ #@         :A9*M4#\(@:
M          (5R#XJ        >WA)+54JGG$;9++;;)9;;;,PCS6+4
M"0.42%@ !JD)_HK[J:)T  %@ #@          !&J@7@ $4@ 00$ R26"@  V
MVU6VVVVVVVVVH    6@ R@  0"4R22$$223I_='M))))))))4 "  6@ "  "
M #    #D  & &F4$P       4 0T 26VFVVU@44#I)"C))*$&@0D
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MVVS^VVVVVR2R22226224G_\ _P#_ /\ _P#_ /\ W<'@5MXZ86<_J7__ /\
M_P#_ /\ _P#_ /KR2222222221O[ $LY!Q4L] ]22222222222+K=Y?OM]_;
M;;;;;;)+;-[;-_;9-[YMMMM)MM^0""0 2 D     4 4P $@ 0D " $$    D
M  &PT T&FF      4 "$ $@ &    #    "<  4"" F4VD@VT@< 4 "0 $@
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M*;*232;2;:!VW]VV7))1)))(())))*)))"[""         !0 + !* !6
ML@  !6H !99  9)?33!!  !0 +0!(22 22223"2221:22;%8(3* )1##0 !0
M!(0 #))H))))*9)))#I)(0  "2222222223222233;;;;;;;;;;;;;;;;/_$
M "H1 0 ! P,"!@,! 0$!      $1 "$Q05%A<9&!H;'!T? @X?$P$$!0_]H
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M1 *RIA\MC 6"#(N"Q*J$"%IA0 6+FJ.:HYJCFJ.:H9>%,HAL6*:R:8;7R_\
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M*DW.Y4FYW*DW.Y4FYW*DW.Y4FYW*DW.Y4FYW/^44(!*,074U>57\A(D2)$S
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MY..CW?\ +(ZGK63U?7_R#E*80D$L *P7>/\ 50H4*%$Q0H4*%"B*%U0,DL2
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MP &6X0&( !+ABD-X"#,R44FX+65 6@""K9(A B/$DE-X6M)0-!)5H"*15ZX
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M@01(E:(0*0RJCHG3 P L9(D$W(NF=&20HL6J14Z"E'($+&2J0H1.8B04MI0
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M"A-3D2L2M5B0$4 B$@4315L9A0"!, @Q(0F1>"J059E,RV;U)KEINM,6JW%
M$$$9$\P6&) BHP=D6V$2Y<$9&\BK0H( 6SO+(7$IE*#**P GD6N.^]%M+&@
MAR-<F;!8RX2X:%& P!!!SW8Q.4-@!0-FP!NB8' ((%@"@0G4W!01A %< '%,
MQ894$00%!7"  *<R"GK" %5@P9(4S?6"0 1 +64E9R%:K @F\%Y60B$"%J,L
MG:X0*2C5"I=EIQ2TBQ:@9;"))1,JJFHS>1Q"E(8R$15A@ .0XG$N9@$G"KA"
M5D*0D1*RM<&%Y:*:(3-4!!RF)606K(P0CI;I4A)598BBXPS,9F E  3='4NJ
M,"-$@,SQ3FA )>*C"-C4!0I0#F" (69+@J0!;Y%^ "05(C))DQ&Q)&L%B^M
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MX^:_N/FO[CYK^X^:_N/FF(V-V[S7]Q\U_<?-?W'S7]I^:0(0174P@WO;PIQ
M4B4FS<+QIZ\5_<?-?W'S7]Q\U_<?-,[N.K?K7]Q\U_<?-?W'S7]Q\T*#)DE:
M,:WUFEAE4$S!?0L[U_<?-?W'S7]Q\U_<?-?W'S7]Q\U_<?-?W'S1->#6Z?7P
MJ;)#.Z8B=]->* D0(.3V;5_<?-?W'S7]Q\U_<?-?W'S7]Q\U_<?-?W'S0I:.
M9+.@$L\SY4@C@7R[ >M]:_N/FO[CYK^X^:_N/FO[CYI5"5;N5?-3< N)(T!=
M(2TYBU2IEEGMMTXQ4DW(99AC%^NU2QF%PB^\Q%YRVO=9IF6<RS.9U_XXZ/=_
M\KCH]W\5==@N&#$6VUU*$K$7<C\<GJ^OXRPP6Q,3$Z3>)R^U79@M98XG,0>7
M^4RYF<$R$;3U,<4E;D<1%N#;_$40! ="DS+,3/QQ4!QI8@>-FU_'G\M#J^E%
M+DPP5F)+(G<?7BA*NWG4VR)D7P7L8:$,I+AP-A.[KFE)S<!%4&69D6ZQK%KM
M1F1FQ-UABX+=#3_CCH]W_P KCH]W\!AG:](!DU%U8)Z\TQAD6\I,1-K.'-MH
MU_')ZOK^)8F260)P(S;5;@'5HM=2W.),FBN(O[G^!G,?=>'#3"VM@;V'%F9@
MWOUQ2RKI@- +$3W=9;K_ (PNR$,PL2Q9VC2=4C%Q;3:;%YU,F;',+$/Y:'5]
M*0@5+38,$G+Q:H)(P8$);@ZVA2]^,-2(%R80F M:0E1 G9U)@F%R%R&X-[Y)
MA-_^N.CW?_*XZ/=_ A26#5S'@4@2["3<B$IB8TM>_% 1"WO"!!:,+G/2/Q!+
M8RZ&]0;'8J#8[%0;'8J#8[%("XA&;6LHQN5 A8)A8O;1-]-O"@1 0DX).M0;
M'8J#8[%0;'8J#8[%0;'8J#8[%0;'8H1+!X$^'/6D$+;WWB;QKI)KB@(@>4)J
M#8[%0;'8J#8[%0;'8J#8[%0;'8J#8[%0;'8H,@2D*H1BUCM*_P!24);H3\>.
MN: H!;<,U!L=BH-CL5!L=BH-CL5H=7THH3PG>#Y-!#9")<+2RPY_LYO4IG@A
MP =3$V1'%*;,01$:00';>_/_ %QT>[_Y7'1[OX##,#PX]J9*P2ZSW772E5+F
MWD1[?CD]7U_%;!M,>-:@&58ZS]WYI2S$;W67>7_ 89039U^/"]+.D;0X-KY]
M:65=_P#$A%ALCR+QY5D,%DM?!IEMY\TW5W_'0ZOI20),; *ET0I9CN%7*(66
M')8@6VDLPJ:%3<-\M!D21,"@D&_-$3 LW0A$&9$4/+>:<L7);EC.G_''1[O_
M )7'1[OX!4 ED@<>/&]%DD6 E2,F]M-#6/)S@%F"-_QR>KZ_B*+,3 3:]VV\
M'G0!,,7(#+$PFP1WMK_C*;9=70U>+:Z:7IG#-@D"\9AU8G+?=O60WP3-V=9=
M5YTC_#WM?G2]KTR%V;CA;8M<(X+P$!-T@WD/ PG$G,WTJ4WG WSKEU?/?\=#
MJ^E$5340UE".]2A6A0N]XMOD\$W*6(292;@(3"IMB)G2:&J6MJXOC2TR9C9B
MO+_CCH]W_P KCH]W\"[&^^/&F$7$<)C,:@E]RF$7$<),,6<@^7XY/5]?Q=8R
M*C=LAZ0Y,Q,3%<C0[7W]Y=:2-9DD_P "2/%;V"ZVOX:XI(8SALMYA-F\XCBD
ME%M[<W[[_P"+$(1%29PA";XO.LCG-BBX6\NEM;O37K>DBW;IXW[_ (Z'5]*.
M F0B\0@0^&WG1%0-H&^\WO'3H3(4B$C&MY2T6M8UC>M<%U+W6%IME;K-]J4E
MB)OXZZ&6_P#QQT>[_P"4 %N21(LDA))).3?\%"A02$Q:Q-1"=JULO@ VCHS=
MY0 $$Y9OI,;&GCO^"A0H22D6)3)6 EU*!NL4NJ**HC"3D<C\5"A0L5$%&!LG
MA)>6KC+2&*9[BR4M(M 7F>7_  *%"A0H4*!M\26F.2C)=O*^+NSTMJ32TMP!
MT /K;_%0H4*%"A0L5@HP-L]V[2RK>5VAGN.S2V?%9'EU/XJ%"A04"ZH&2$"@
M";B=1*15(B0E0O'*5#"Q88GE]?"HF(WU(MF68(UEMK2C)K'CGS,.'2DA3:W_
M """=$^,CWI(Y4X+VMKIY^M9:Q>+9AL);XYJ$F?#4B)G,3-K_J -2%O.@Y+/
M<-G6@D[6N"DO*$SIJYG&"+8T7+18O,7@,7FUVH0W%EB^AQB&^NAO1<&$P-[D
M/-YS;&VE96D +81=YRZ:=F@0*Y8L:WY^^=-DDEA!'$%9Q>;7XYKJ<QCD'S;&
M8K#6>2#"FO&\5&]W,8-;#G$]=N: 3*,NE@(E6>?+FWB)@N;R3G$C]N@0S=MA
MQ9/C8W#G%"%#[]TX_P"X?$$$))1(Q,$QF#:OK7M7UKVKZU[5=,"1D1A($+A>
MZR]D+IT1,3GJ/"+A144D:IO@##YDVB%XH!" S?6%$QD1'9$KZU[5]:]J$D%(
MD)-A":\K_ 65!;=;H6"5NA8M-ZO<L@2@R)2290;LZ)0<!(+!!8($0RU3%Z##
M(2EF$*#+<8;$E@)_P&TYPUP%#*2A(14"6U)"4KD" 2)46$T"N8@%X"0@MB Q
MNF5B;F0D 1!&1!$PC<?'\Q902@:K*%@E;I-K3+!382R!DAE&!+P@F4E* V@H
M@P*\D; 0<"44 JCN3O""612)>T3(*_(/F$+3)<$CJGYYHL(D1!-E&5Q(]_"U
M7IW)1 &$90A+KFVQ0"L,2;D#K *RYQ&W_86(V]QZM2S;N;3Z)]FN2!,.Y]Z^
M5Z"6.OI4HG3]Q/?QXJ,<WZ=?"_2I6TG?O?FA+%CE0O*07S;BA/WB?1/3-1$W
M$6CF_P 5@NS&-)B9ZIUOM?,S=3!>)F+O2^)*^IM&<WV)Z4-DO)%H)9>4]ZP6
M=XQ>/'6^*0O#C,G@QXU*8D=)\0OMDG-=0&\V=XWC;YJ?&)EM'7FD!LSC[;_F
M7ZV_"S60,2V+ 0@20)"1:L@E!+A"(O50,@( I@,$$F. 0"P2K0A6=91;Q;?"
MQ2S$GX:/*_P41"8RBXB$@#$*3:T$I@ C<A(%T@HQ)D1,V<)^4HD3 *$$I(*7
M%LE8J0V:084<0(19 /SBND(8$L.@@@D:AU(IA84RV) A): ND5=WDV I>$!A
M?%2 3!=&;[B8)1S'YLYV.5T0)&PI%@1A":DF$D,PDC))"#$@'7#6-0[6 1FE
MN8B8"J6Q@DNUU2(/:H,C\CX*H)QZ'_8=O^S%FSZM2_8VCT*59ERR\O.]3\>4
M5)SC7'Q;'>E57?TQZ5+?'\\?&I;^1S\M2[6P>=K^/&Q4I/-\#?>Y;PJ7?1/!
ME?-6I;WS?O)[U*?>I[M2WYS4O70USI4N/B_7?QJ7T-QVX*E^@^M2WX[VOOX_
M]B 75+#$)%T2<R,R1K4]CNI/8[J3V.ZG$=U$,@ZJO$[J3V.ZD]CNI/8[J-+L
M40D1D$8I8RZ4VD9B6J;;.U?VJO[57]JK^U5+A_\ E5_:J_M5?VJO[57]JK^U
M5_:J_M5:]K?_ )=:]K>K^U5_:J_M5?VJO[57]JK^U5_:J\7QOIIWMO\ E5_:
MJ_M5?VJO[51RU C*KLA;0#K-90!2,K$D;\.FN=*$*4F(FT:5$U7QTB6I(WO
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M!5&84HF;BA9EE9Z7ZK*:F89IV"20# &] !)D$ X22L-[QB69+4  "!   &
MP!T"Q7][6SI+(/K_ !9Q\2\3%<N]ZY=[UR[WKEWO7+O>N7>]<N]ZY=[UR[WK
MEWO7+O>N7>]<N]ZY=[UR[WKEWO7+O>N7>]<N]ZY=[UR[WKEWO38M@NX.@5M
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M 8#  8#P[0     ,;J=L " !   <!X\N^               8W4QX///L
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M=J <0B$,LC"(@8QH+E8)D1""!,I2!NDR -0BQP$00PJ/72 E415H'";("9
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MQB$S.6-T&I$)2;U8!R2"XEGC)G@F9O2)I@.-L2B8A9$)E%V566DH81K9(C!
M66]*W<%())"!.5%BI9;TZ0  N H$!1 P53&IDX!,B2B1-;#0%9HD($YX  E
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M/%);Q 0!*A))+D]M")$LB2)G"/$N9E\*.AL<0EBD&049&(%9&+*)I S SA"
M1P1[@' +9;$V!7T%J<LB/A 4LX6&,VQ=!M8(<# K"[<L* L JDPL Z(N")2D
M!-R9)% 2>WQY]8=OG,.[YE^><YX5X=O02)1(@DLB KAI,RJ1A; D 8P0*&)L
MGK2!!IBH(AN)KLC$K'0R1CQ?SZ]_C7'YNQCBNZC".AMG$*6$;DH(R XJX]5@
ME*W55QZ[DL@S4MT";.6+T\&5J 46X646L$ A(7;5*L!( C+>6J]+BR@"B= D
MP(G)N C"* P%!Y:%VC$^YA&8N R*@465<V>W&/!.L"="EGI#DD"2&((0%)I)
M-[E55F[>@W61'"0>&1D(5Y& )4OF9221<2,64X6+GZ8<8Z<M^.?SX_O> 3Q!
M RDX2S#J88=TN7+EQY<N7+@Z0)PFE$&]P**222"+)$0C"+15)S5]55]55]55
M]55]55]55]55]55]55]55]55]55]55]55]55]5^*KZJKZJKZJKZJKZJKZJKZ
MJKZJKZJKZJKZJKZJKZJKZJKZJI-ZH9P#&9!F?5^,LO+RX9?CTVVZ^?H_Y'-:
M]'KSKX]SR?#GKXT9Z7^/+G6?0_L\_ML'N<,;[]>>1O6>D;X_'K/Z4U/IH\\_
M\"V/E/M^]'GE/SC_ 'L\^.QSG,\_\!\)R\?UGIH^R>__ (__Q  J$ $  @$!
M" (# 0 # 0     ! !$A$" P,4%189'QT?! <8'!4*&QX?_:  @! 0 !/Q #
M &"XJ83YWJVK-FS9LNJI/Q:A9HODT';MV[=NW;MV[=NW;MV[=NW;M@--* 5A
M4.00+@S/W*()OQSP!@*9BHH D&\"W E)8%LL$2"(0OW2M%R"K8K67['0&5 !
M55H XU<!S8@#[@+MU8"X2X"J1(U&J6*KI!6A:!P:^[8D!3DG8"'!86X+=BW;
MEA R,H0 79 H%"--Z6TDTB^ '8Y"%Y7I;ZRT<X07 40K6"-4QI7B1@-4"0#P
M %4(*RYN%=%CY'G+#-?CV[=NW;MV[=NW;MV[=NW;MV[=NVB]K<J>.D'\QIFO
M@'W5CFF5K8M%(RWAT.SN/Y_AX0LE\;JD]91=C:N6:!,@4TT49>D@8=E"O;;K
M!206C6H,4?U"L =PY85Y*KQ">DR,,?T7E3A'>5:&A:()/^:8$9K*S"#Q"VN[
M;)R<9)O7==:YAB ,7E([S0AY,I1J;T.M469TC08( 2]V/:SBF6?Y#V 5ZS M
MRGVJO?A#OS=ES6*GO 6NNA,CSND'#5 ;$<:(/6A:_P!4Z6BNP![/%?Q-V.(^
MX>QX_P#D&*I[QEVK0=0UC*2<-E)(>]/())!*[VB;R&C.B3L1B3L ]7CO;:\@
M-IJ@TH*XA<.,ZA'F+=1O?MC"8(GWP#2AZ$L$<:%CXQC_ !!>$SNA19G+4@@H
M?6?&!S=O2'*R 18H^3"C6_/GG4*@V278B0AN4%&<$ARX"98JQW"E3P"4%@%H
MNZ(& P,"6J1C8U46:-RM8":64='P.U8&@ $ 0K*Y(\E:62F+GE1H"D %&$EI
MAN(*HW:!;3:%;9\@K  ",@"*U@4,G"LEXMSD!L*Q= 4V1I.484%Y[IQM?UZ9
M!C2M3Z?^_P!8RBEL1$MIM45:!MN[@9@PK+QYZ ;+8$I)=97J&?K=EFY!I&)@
MD0!<R "P  *(L3*R#>4I7TF![%!ZQ1W>0E8AGEP*KM^I:<!!M!NA_N(BX*"L
M3.FI+TBQ8 J!%0<6;>17P@WKM&]>LF5Y&?IM,GK-ZS8F!WH1_P#A=WIK)F\E
M9NF7;Z]>O7KUH(W^[(E12T *QZ1@<V(VB\RG$FFG>;<^/@P54]F+?<>=H<)R
M0*M44ILLQ 5Z+XT#&AP8\L 6+0H6W0Y!P#D0!04GV<X"'+&Z' <1Y>KLN,A*
M;A(^))T9IC6[-:6"&"/M 8]":J;A$JVW"=T7/Z@C*#@(&_.@' $'Z1GT3_9]
M$_V!%P@F'=0&@R$/=/M^,NA7MIP9Z*G*-#>*;4"1HO8"+]>J:=>(9Y>SB.X!
MQ01D?1/]GT3_ &?0\/6#!@  (     *#!M-FS9LVO9^?%*(YV>2@^T61@*H?
MC5)VV2H%[OPF$T. [KR5VZL;_, Y>4>^,B\PV#GGAG'H6L'@.4?@V_@YL0&W
M-"@]WF0>U@#>_P! WQU*F^ERW692!WKIN3]?=_B(FDL;3+TI*3>$5*9@.+!'
M^6&#A3',C"FFE H0^GN2!;YLY902Q*<Q>'TC,ROAR040RL3F6A=*/&W+YA0%
M;-\060>186'-%'YE0EED&R2,-![X4@>/FD/&^!XK%(F 1VILV;-FQ_. JLT4
M"U:&K?SVOA"+<X2[1*$__H4T3")^Y*8<#7)+2I7? #/),O-/]ZYF1GDG-Q?E
M]/-KQ#VX,P_JYBV]2)O7KU2A9D_#44HCA%*K#5)MXV%>*4M=7KH8]@22%4^/
M0UC6YB 5;9R<7F480Y4HHI:ULRAHLE1&+HA9P4!."$,C05%0""A+!,8! &)+
M%*6$LWCB*%8P#CA06AI"L5BG\,.E:4'0!"K1!#B\-PA+Q6B F(2;J+P$T@(1
M'SWBE=K9[2*H&OL</US2_P 0<J+\"08!KBX5 IL%9M1=9BXXH@(3GGE^E%%8
M(+8JM?\ J5\0T8"Z*\(9QC"MN2<>(!RH5HE08MQ3CQ;BVX\]7U K) )5QAA5
MZZE,KU1\DM!O&$E#SC$@H$2$.7SB%>7#;,F, M)O"H?8K^4Y9S924EH.O7KU
M%O1(% 0U6_<JC09\JN <KPFORERY<N7->FT%F#5985<N7+ERY<N7+ERY<N7+
MERY<N;6X)I0ED#PG=5)$B1(D2)$B6%T_<++9Q4"8HW9-9U1ZZ3=XM<^?/=O3
M!R?NK7)['L_VQRS(-X1%?/;^!5_GNC;(0NLERGXLM[/GSYZF TJ8$$C:05*7
M5Z:&N4<%'SLFB:$TOGAW<D(4DR]-=5R5H(QOAC?;-,9//CI*WUA)XM4F<!;?
MHT:-&C0 ! GL/,040%V8YXMAA[0E.&@0 *COKUQ<9B9143^&XA;'V;HT:-#)
M3,?-M07@40;)HRHZC:;WEU0N%#L)H\UHN3T()X#<.E3,K% %R6.K3Z3+I%/>
M\$ZIF(6N;$;;6$7PDB,J5Q:S[F<A _AF99FEQ-5LG:(^/CH'SNSA"?(Z#ZZH
M"(KN:E<\UO%OX),C1HT:-&C1HT:-&C1HT8"8ZXB$@8:+0I0V7:-,;,R43COH
MTJ%&"B(@B9$<B9&-65557*K>KS79HH!M!"_O4$,ABTF"6<Y+/:A^57@O*H(M
M*T957+K'CE LY:*V>F1]+<?2C(4&9)3"P[N=RT2%0I=PQX\>/'CQVMI:-. '
M](L@K6&G<;7]]:V]1_,9)@PDC#-:X*C V.5N7V]9,>/'CC(P!0( M0M6KJUZ
MQ]J1Y%R(*"^T ASUJ$1"U,XF/0#D8_"E.2(NKPTW4P0>\2XS;T/_ %6C9\D=
M@&]0D4 D .7I"\& B:?(2RI&HO\ P:)DW8.@8P9_T+R$(EB<\@,:;H7D;,95
M;>GIE =*^"9B  L"Q0B(HC9C\08Y:LQ B7TJ^!4(3I%2/NU\Z"),!\^=-)XO
ML$&3*@\G$!J=RYA_%)5 BM=H6T"^!.W/[<_MS^W/9#]0C)HI_;EL7_I*\_@*
M\8>W/[<_MS^W/[<].$!%+&"ZP&$5J(*&C)DFO)0E+$E,VX%D]#$ZU8X&HJY,
MH?5(Q+$[*1DR'0XT7U/_ "?4_P#)]3_R?4_\AS:!JE-T(NCTBN41&^)(#8U"
MU(D8P99Q[*">!:*-(8A8S=/J?^3ZG_D^I_Y/J?\ D'Q)"&VA0"J']6'2EL"W
M?;1"&1/AOT%\6F/DHIVHUI&%BIEUTRV#-H;#BY\DW?F,1L_!9TAZ@=A[\,P5
M/:P0GT$E&$86(C%>#E9R[I\2!!5NY+ED 0+-R\W'#1*C I&X</Q!CW(I0 0D
MT?@PDT;9$+D7SQ!3@_-MX2>9<6S&$@**EA_)#.Q&[$;L1NQ&$ J)2-8S)!Z<
M^<<+>W/RLP/V(W8C=B-V(W8C(@"5P!P'B*XYIQP<RSJ>26=3R:4_U_5&]50N
MP* <SAXVS"YFK9I Q_94H0E9U/)+.IY(RF3GS.C+.IY)9U/)+.IY)9U/)*G0
MC%JI.LGL3/Y0#CHO29RK!"H2-&Q:R2K*YR2ESS;Z-1Q:SJ>26=3R2SJ>26=3
MR1#6W+/HNV?@ UF?T++#,,(2$AUJ=_#< PRLEOSMIZV-]M%N)(*?W*6:F9;D
M--XZ5LO$E<5EOMEEBQHM^23(*J1Y $,0L?'T8@+%JGS=-B*W4 9*]_>HQ [D
M(2S/5/OQ17QO&"$U%]+F7ZF 6#^?]Y1*2>2W[169UU1S/LPI X!^B5'0\$HZ
M'@E'0\$HZ'@C]8\EP-PO(2HO;4X(622FL'-=!X)1T/!*.AX)1T/!*.AX-E/&
MD38G'CT2VULC5PSE!:C+LW:@S*V%[4'6]7RRWJ^66]7RRWJ^66!> * "@4&0
M5#B%N!E--[S68O(BAC?N,GKN&PM$\%"AD(MM[3#><;>KY9;U?++>KY9;U?+$
MMS<MS9G>B1A9)<XJ0$T9"UFEE;V#MLI].XJ:Z99S8$JA0G1HO>H>3)+^L*:@
M CY_<]L@CD@Q3,FDAZ\P/HB]CZ[WWZJK;E F@Q!3K/OYWP3(!(3$DT174
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MS+HX%6:J4S&<,M#L B)-2!)T.2C*@[V<&G.UV'"_O_CLB-3,511XY0+Q<C(
M+S#L?"D,<7S>>%=;M@Z$\*WRWA[%1)VFI+E[#9[9>MU,/9QFTH6H ^.,R<[!
M+! W_,60#$L939@.4!^/@[M>@&"DMJ%^YJN[8'2$ 3I(3\(,4:SI+FM&"C9D
MR:?V^M[B)C>X=&5[7"GL?W'P8O#2@<L*3X=?14,I;MQLW(@9Z9( F^9,K6%3
MCEJD:PB%F %9CY1IAT\4.6!+(MTUEZZG ORSKGR9EF8 )&W[*AQ#,B"8B7]6
M="Q6V 1^A+P8P6&));:1D<)<^72J%GC$45K;IQZ#>/[8S\MQ^Q_#C#C.>#"
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M(MUB5;?&I<2 _3L5FMWA=B3/:%(,_ W)5@)Q,C&7?Z)"UM,6J6=1 @Y:P_\
MO(:P0%L@5P(+$%@T\<D'H+CR]KT]NB(/=X0QO@)KP!,7:DD^S-SL;L]^LBZE
MAKZX/P]JL9E[10=W4VBOY?0%J!VI\-GAB/\ I@.=6VM=F6GM'5C"K[\9*^2S
MSF@C9@@I3!@\4\G<^?=CJ%*B6Z4B3QA-^[6<&(9&(Q/+!2VGU9E.R(F,6[AH
M@7M="VLT7OJBX;$#H@E%]59LKF:"Y4J$;15%(*E<[6ME=EEYS+4LY69.I+'@
MWQ/Z-)_'#WV4V<3*XT@GT*T1<!U=92P+H]B=0/020(\9]V]!DYS8IFY.91D*
MN$FA1N(R@?!);0\')'I%,)K5YY<>(!UZOH# ,\N3<<N%FDMT@#'W*9#W9F_?
MY*I1EJ L(IWL T$D MU7E?R)/VBE-&6\W$T?%OQXRV"3O$$/ZXG)T(]4OA"F
MS$A*:J3;F73^(E2^-!86CDM$0&5)+Q?Q1:&1]I=H=P9UL67S "EYH$KPOLQ*
M"L@E@T@EY!_#&4B0B6-CD3@G79<7&V*HBVS@ '8GL4>Q0)_H( 954 !E5H.,
M<1E@EP+Q%T7=75-\&4%G8K4*U8 R"HR+/8H]BCV*/8H]BCV*/8H]B@:A<B5)
MC.(PK$(4$)8)XQKHJZB5W<4",]BCV*/8H]BCV*%#]0T*-7+E \0P,#^;-KD-
M^H(1[M 2VT L=,X9/G.PTTMS*K\G4(WLQS)8Q7!90HYXDLH=B:AGT/TC8H)&
MP*;A&$)'W5J\$]?9EF0/0:14.Q]1LDJQO^JQX11D;1521Q9+NLS@I9 7'G(3
MH6ST*RVJ>BAF](.!B:5[N<'27YG?P '(^A5$8Y5T;OY8D"W"$\1,FO>L6U^[
M^UD]+0D3,(&B=J.Q(5T;X#FT<:9?!<4#! AD3I* B6[I%;2.(/+TM*25(^PZ
MM?)RI6H(KW!!-V :$(EF4J!AD3\2=X&0B$6(4@4."H 4*#9&74PWA8L-%&8A
MA4 QW;D"&*ZZ:*GM@)[D![I$BB!L51@IQ(UAJV!2.K*=S6,.S&B>XB_X2'=%
MP: 0F2;(FR"=F?6IY<&Y&ZI3:L$'EI>"(5O*A\FU*$$^=1^B$'FES2>>(EV]
M  +H5)M2"WCM#F,>,U/$.ET%IWLNG3ITZ0=)U?U.G04NRA%':?QCXE^AC;JS
MZTN)F@V$3)'JU#4-0YN7%.$LP68E/X#ITZ=.G3ITZ=.G3ITZ=$NQ060RRMFZ
MQ!TZ=.G3ITZ=)-Z2KO4,@H0%8?@208YE\-RYJ]XZ=.G3ITZ=.G3H*/4FG/S"
M%::"ZA%BF#JP! (6!I2CF*.%G2H@P*&,@B1G&#&)BA195%6*:&!P# !N8L6+
M%BQ8L4<: (-C$HI2052"[HF  (!Q4!'_ +068VHL6+%BV0-_R#:3RFJ#)^>:
MD! <@ _&=.G3ITZ=.G3ITZ=.G3ITZ=.G0B!%6@0"TVK<T,5RGNY?*@P6O#ME
M97KQA88G/@?-^LE3 /V$W5_6'_R)J%,"D58S" #3*;6I7[S,T!*5D;1HX[;B
M/=]R0]KJ@(YAFM\WK$F6X'[)M"'J,P S#L^51."8G8Z4LS%0N#TMC Z>_K/5
MQ3/A"855@\MXWT-T5+2+H*MR'@N@3?H\TV?%R\@K@FN%#W;\%0_)/@C0MGOS
M0:@$M;W4(GU0=YX_ T% ;"SM!RPJ\D;!N+Z^C4]+57C1=@!$AIG\O0_-@\=[
M]FM*$8#7P:0:%Q9"OE(J6R2Z3"!@FT$P/BNW&PW^.]LKPZ=.G3ITZ=.G3ITZ
M=.G3ITZ=.G1*P8<" 6 *M#5K \-_2QIZ/AE/1\,IZ/AE/1\,IZ/AG8?#*>CX
M93T?#*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*
M>CX8 $HHV"D!:P-5<4P@Z.#$3P54('<",K00@N",!^2$Q.93 ((X(5*)ID]=
M$-([E2# 6;66:2!Q2EA\%L.3R*2:Q=.DWYHD8K72(2B"A82-DW=TBV+W3-O*
M6(T*Y>X J6?T;:!XD0XY)>:\Y\9%R^1XU]Y//AZ7-IT5A9^PY;+E%K\9!C.0
M\4 @1-U 6?92;(9MW4%ELX#L_63C=DB<I3DE6[)&NG%B=679>PLHH1I"JKZ*
M^T/4$E><410')ZI A34B64&LV  553D7+RR<49FDA7ZL&[ U<?2HI'I**9)3
MXU*[M\2S16<Z'I*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*
M>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?#*>CX93T?# EA49MI
MU_U>&0*Q.5B]((K9&&'.O.UD7 /1NR8NJGB3[>PE:.3+2V?LC1"FL#?WQYV>
M&"<ZQJ([3TY?F7E*42YU$4UYD&+%AE6,[.LBR,#35""RI$+"4D1>0PP8;T+"
M]R8037X'R38I?!/P,<"3V:+)5-L\QE5HL!2],715N#)C]3W@?2/W[]^_?OW[
M]^_6G7!&G""$/V#7[]^/0HXTZU7N40E*4><'AM5IVZO@X9U,:&PW@?OWX]/G
M,X.,+Q4(FD"D,(_ .@(-A^_?OT3*;/P(?*OI)+MN^2OXK ^!7DLSF58(!)>R
M?OW[\:55N!C<Q2\%"%-A:M>L8\%&B'H2=O*DMUIEG9*4BTFP3TEBUW-R:M6K
M5JU:M2\6!6@D0BVJKB\$JY60<W/M5JU:M6H<^XZ$((H/BRC#&,?H73$<V!LG
MJB[**.@GNIWO2;.3Y3]-9;Y@@4AUR[K"I@I>4**M;X<@3)[9"4!JL:1?M56H
M=[T_^6_K0RTZRDU!_0 Y>O\ ""JBSJ)\R-&4E:./=/)]B4_$I5D#ZZF]8\A
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M)O'5B)38#QNK)2)),SQJX4<$Q7@([CR0RT@ ^Z?T+YM? ?MN+>@0A3#KE"O
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M0H%*KY:>J&)\B\/]&S[O66<H$6C1S0D^9$2%I)3L3KC@$6U1:P#67@6-*,8
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MA90:.+^1-Y(99DQDZY<\H-$5@XRE).B/X>T1**J^ELK\4I^ $N*P()^"R^
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%@DH9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>businessfigure17a1a.jpg
<TEXT>
begin 644 businessfigure17a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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ML5-@2]^KZ<S:$WIP  !CYQURZ=64CVNU>7YSB6UVS-6D;T.G;M>XQ.Y7$Z(
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M:U7+=+4,-F&L5>.&QL_>'9)>\9EF0 !CE&Q!3-Y-9HX/,DJTV1C?86NUQ9S
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M6,QS-/L^#'.(F3E *&6HPS!,XY#-/@PS[,DD  :]+B0QGGP?1FGX8YPDF98
M
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MI-<!(9;;0RWY?;8'N.4VK.RM@@RH<^K5TK*T)&IW^-@?9;'066/QX'['G<K
MJJUB'T"9#))ZO+_$/Y>G.00W6!DR#$M3EBV,M4B?;O\  T5E#G=VM[X$ZX>Q
M'F7=R/K\I'L(9G2Y&P9EXHO_  L)R<+EKO$C0DM?]0XI'H[T)7YL)C-09\N<
M]6K/,.$/_#V<!'M !WD\.9'?Y'6_<_BX)[]BYV,L,H'7HX)^/5'&+?\ X& V
MBV)IPWZII@W28E>C1Y>JQ&U)CBD10P01]EB_X'Z[]\<;YZ&^J>>"/:@U6)%(
MMTJ$W)%"T"1 >M?;"/\ @ZXEEM)8Z7V.O V//5<ZBB6?N59J^PED!V-DJ=#
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M XH8AYQO4,_-B85K==);%<KL!)RQ<BM,>6'Y,G[:$X^^]*LO,&8SM6&0@:(
MEB*['LX=U&[0!^BK@'Q5NC:UVGIIMF8^^MIF5-AE\D5Z6TE8 EIB/ >E.R0$
MQG7XW/D:CTDHZM%76EOA%O'4AI=O"-[5;@B-ZM8/>]6D%O.BVF59[1)=VREZ
M-%++G5Z:UM028UJ.)?>VD)*T_(KZ?:@ ELNI<<UKC-Y%OB?NHSZZLP/>(N 9
MU+=P'.9T>Q2K';Y3BFDJ1');GUY].*!/MZ8$N.8@&OY$@%'4U!!:CNI4YK7&
M[\+3 \KW"1#L0:$B7B*NTO&(B0+\<M%DN%H*W4PD$X4\V>97BU^ISYLA&5#9
M C8_W6A#J"474(D*%HF-:JK"TPGD!LBSH\["X^1O CTP<Z9--RE)7Z5:(2D;
MY_!60F)'#T8EMM/[?J/!1OM\_?JA-[],R"OU,D&5.,?"GLN1%.XI^-'U&<T_
MK?I1HPJ.N%3D3'JEN.QO-Q(JL^!!WG9@\01:G6_=2F/[.TO)>U+C^G2/[8B.
MK/5_=ICZI]#+>5R&_+M+%:!QM,BQL?26FD9],[@-8@V1Q&G4ZC^UB'TO9+C^
MG2/[;1&5FU?W98^J=^PUE?@O$;+Y&Z\./LR*>Y7V]G4.I.BR\(8"5*5-;DF=
M[=-1VLATHD71"YX^I]RN@GF8<"$/:\#M.%'7I =VJ.)(/E7[;"GC]5E1%6(E
M%EIFF8LB*SSPG\8'0D,2I%; REM,M,-_O9ZV,MH0A^GNR169K3D6=5*G;CH)
M!&.MM11O6*D-MJT .W W%K]O%RJAQ,*^ "<&H84EX6NHB+B./\9G!!3LMM6I
MW,[4'KFW/FXFIVMN7(9E")%>YQ:;>P*YO>YLIGF-*2,K]*K%75X6.M"+6-.\
M3V,%O/J]<SD=J&UQ&W2*OX^O34F=!)5^16N86>Y,C.5WV3+C<_J+(D)5*Y7/
M\''=-Z?G)9W)/.HQVT>QFKK_ ,LV?WMQCKJ\CD5+Q"]+UY//Z1IXE[&I=@7K
M3MMVQI%TVO<:R;6N,:<7C$[W,3OU:\=Y8:/23LSY"1T<B!JSTR18WDIGSH=B
M:KVAX1J(4D*R/*6O->2M^G3[ UN3*,NHQ1.)"=<NCJ,V?CD<B'7/3%*N+QF1
M[GFM>D:D2&4.R3KJ,=L:([F[M]-HLR9>HIYQ>1B:EXV[IS_%;:5X^,2YDBO;
M7CU1]>?A2?JS4O1D>O\ MXR.2WB4:1KR<82YCXG3F/UO:\=IWKQ-+3K;%5]&
M1P7MXS"2WFM?3S6PAS'1+3F.UMM>*J+6\346M8U6VT8T):;Q##;?GO7UQV&A
MS'P>G,>JOKQ5,3O&Z?I&,5OV\9$I;QME#?FI.E8\.2YDBO\ N8]4O7GX4GZL
MU'T9'KVT8P,TWB&TH_Q*7VR0CA'LLZ5&F6,^,#1>K'HF$^EH@%HG79!-UOM.
MWQ4_KKL4Q5;R_:27DSTVP,+F=5/D6KG=3 *)_*1443,=.0+L6NP.[VWUM2D_
MS');EU6UNVAWPZ 6+!:Y#ZW[K,+K\B V2ZA]O 2.M*995U^3$;:ZM+9PUT><
M"L3_ % LW&']0,2MA^LO.C*D<D66O_NQTXJ-*R^OD&I ?I3)<X(ZXLN['ZO+
M).H[$N>B5T";\-SJIA[$]:(-F(/52D9RLW]ZRF_ /U(M&7OL$[4R!U%F>IOK
M"G'4=6F/R_YI>?08Z1)@"I/4S39*/THG$/ ^JE=QZE>W+:0\]QV-XT,&LI4V
MVO3HX>^R] @R%*'P%XV,&LZ^W#]JCQ(L1/EN)%4EH? 80XRR]CP^!(TZ/@/O
MJ@05K9'#XS2A(I3;;33.O"3%C3&6:X%CE50H:TR:T"EK>@09#;XL9)W\2+BH
MT92OB1-Z:'#V-H%C&E(0AM'[D:P!*L)AQ$:^UCOJ)!B0<#[4,]I X>WO<:/O
M/B1<4,'+<6.'N;8BQ8R?"?5:\3;^)$WDD(*EL1!T" RD6,0TV,&LZ5%C+U\6
M+FQ\#;ZQ8QW&V&&?_CO_Q !$$0 " 0($ P4#"08$!@,!   ! @,$$0 %$B$&
M$S$4(D%182,R<0<5(#!"@9&AT1 D4F*Q\!8S<L%3@H.2PN$T4&" _]H " $#
M 0$_ ?\ ];'25$L?-1-2=[HRW.G=K+?4;#?88[)/RN=HNFCF;,I.B]M92^K3
M?:]L/15,:<QH^Y8,2&5M*GH6"DL!OU(M@QN(TE([CEE4W&Y2VK;KM<8DC:,A
M7M<JK;$-LPN.A/AX=1XXCC>5M*"Y"LW4#NH-3'?R ^I4%B%'5B /B388FX5S
MVGK*ZAGH3%4Y=3Q556CS4X"4T\D,,4RR<WERQM)/$+Q.]KF]M#Z:C@+B>FC6
M6:B@"/)%$A7,LMD,CS3I31B,1U;&2\TBH2@8)<ER "1F_"N?9'"*C,:$Q4_,
MY)GBGIJJ*.;?V,KTLLPAE.DV2703;:^*K+*VB:B2IB$;9A24]=2>TC824M66
M$$A*N1'K*-W9-+K;OJ,5M'/E]74454J+44TC13*DL4R!UZA987DBD'\R.RGP
M.*?+JRKI:^M@BUTV61PRULFM%Y25$PIXCI9@[ZI6"VC#$=6LN_U'^)LF.9G)
MUJG>M6<4KB.DK)*>.J,1G[-)6) U)'/R1S#$\X8+U QEO$&2YQ-/3Y9F-/63
M4PU2I$6N$UM%S$U*HEBYB,G-B+QZMM6XO+F5'#F%+E<DNFNK8*FIIH=$AYD-
M(8A._,"F-=!FCV=E9M7=!L;?LJ\PI:)Z..H=U:OJEHZ;1#-*&G=6=5<Q(XA3
M2C7EF*1#H7!(O@9[EC93)G:S.^6QK,S3)3U#O:GF>GFTTZQ&H<K+&ZV2(EK7
M6Z[X5@ZJZ]&4,-B-B+C8[CX'?#YE1QYC3Y2\MJ^JI9ZR&'1(==/3/%',_,"\
MI=#S1C2SAFU74$ V^H:1EFTA6=>5JTKIZZR+]XCPVZX,DNA'+-ITL7*:-0(<
M@%E/50!]G#U!$BV;N+HU]WWN9XWMMI%CX=<2%S*J+(8QRV8D!3N"!]H>N&J)
M.6MF >\AU!20RQFPL+&VL[7Z==\2SO>Z,P!B1ELJE=3-;OD]!X'?&N8RLJZC
MI=!;2N@*5!?4UKWZD6],"H8+?27LC.Q+ $*KLO@H!Z;;80'=M1(:Q \OIM*X
M>< ,P55TZ=/<NA.]R"=]_'!DD&AV=A'HCN4"&S-[W,4[V/A;ICGGGVU>SU<O
M3;[1'O:K?Q66U_NPY<R2 2\L(BL-E(N;];B]MO/#U+VB(V[@DD %]5S;3T-K
MC4WATZXDEDYI"L;:H0HLN@Z^NICN+CW=\"274Y!<JKRANZN@(M[:6M?5T\_7
M J" .X6 6$LVH7]K:VUA<^=K#"J5O=KW-_ITU5#'##&Q <-4WDT%F@YB (Z>
M!N19EL=L=JI^RA"]V[*T!01'7K+%E/.VM&#I)3<-XC#U-,KO.DCR2/3"#E<L
MJ@/*6,EV)[R[7  ZVQ3U4,=,B._NFHYD/+U<[F*!&-1[JV;O$W\/$X6MA3W6
ML2U"#[._<BCTS]5^[S;PPE73*&"ORU_>PT8B/M3)KY+ZAT"J5&D^[;IO? K:
M7]WW 5&A)4HY:+0A#Z=M%B>MKE^I%QB61I7+L;GH-@-AL!8 #8?3B(66-CT5
MT)^ 8$XS;C7)\Q_QA$[22M54LM-P]7\F4.]'43TD\N6SH5#QQ1SPM44K2"T6
MNHCN!(H/SUEPCX '-;5D,TCYG[&3V(.>=M&C;VW[OW_9ZM^[[VV,XSC(*:BX
MG@RFOJ\VGXIKXZF3F43T-'ET$==)7"PFD:2HJR[<D2".-%BU'JVG%3Q3DTG#
MU)1-7-4E,BR;+ERHY<1V/-**K26?-37N@VCIU:"-('=I>85*JFK$_&V2]MY4
M%0GS56YKQ5+F:OE88RT.84Z#+%]I 955IQJ,4)4QLJ/)[JX'%?#L>2FD[0TM
M(U'PY&O#@RYH5BGR^NI)\W:6M5>54R5PBFE$KL>8&Y<F@A5Q5\99"<RCK(:B
M"3DT'$:TL_8*MIH7K:15RRBGBJ8F@:*.H4&.*)7I:0A]#F*0C%3435E1-55,
MAEJ*B5YII" "\DC%G:R@*+L3LH '0 #Z39)Q$G%7;\MH?FFEES8569U<&>--
ME^;Y>L6AA4Y))'=,SF 1.?%HCCM?6_O8X3H,_3-<RS+B+*DIJVI@Y-/619C3
M3TU-1)4:Z?*:++Z=;P0IJ:HFJ))'DJ*C4S:;@"'@WB<U$L@IUHLR.4<1T=3Q
M <T%3+F5=F$T3T52$N:BDBY"-3KI17I0_=0<J,M!P=FLRQQ-EGS5E,F>9'/-
MDL><O4F*"CI:N+-*\522J4[:9H(FIZ>3FRI&99 LCG%/P;FV6QQSY=2@UW9N
M+**9*O-)Y::2BG,B\.TDJFH/[O'$(M*Q:6@8DRNK%F&6<*\1T^E#2&FI5S_+
M\PCI3642K# N1UU)7.L5))V>/76R0^QCN7!$IU,KOC@SA;,,@J\OFFA:%9.%
MHZ7-KU[5*OG<=:CK[,S2+[.EUI')"HA1/9K:YNG!7$:T680T^7"AJ'RK/Z2>
M49LDGS[4YA7B?+-,:R&.CCH(M1#R\IE9RJJ=3M@\(YM\\RYO'$T=6>+:.JAJ
M17FR9%\TI3U9[-SA"UZL=^!H^=,J ?Y>(N"N*/;%*5:',&X?S7+ZS.6S85$F
M;YE45M),*FX8U%+'5T\4T2=U33K+H9$6--5!P3F,TN3PYE15"95%FN8U-;0O
M7TL204\^41T\:P)EDX IZBL35+3QNVHEY9 HE=2H"@*HL%  'D!L!].POJMW
MK6OXVZV_'!@B-KQKMTV^_P#"^]O/&A+,-(L_O"W7XX:*-[:D5K"PN.@P%4;A
M0-M/3[(\/AZ8Y4=K:%L1IM;;3>]OA? 4"]A:_7UL+#\L<N/IH6Q!7I]DFY'P
M)-\=-OIZ5[VP[WO>NUM_NQR8B0>6MUM;;RZ?&WA?'+2VG2+7U6];WO\ &^_Q
MPT4;&[(K'S(\L:%[W='>%FVZ@"UC]VV.7':VA;'3X?P^[_V^'EC2H!%A9KD^
MM^M_CXXY:6MI%NZ.G\'N_P#;X?44\7/GCAU:>8VG5:]ONN/ZX:D5D62GD,@,
MRP,KIH=7?W?M,"K>=_NQV!>T)$LI>.2.1UD5-R8M6M NK<ADL-][C'S>H8WD
METB 3Z>3[87DY>@Q:O>\1ON,24#JQCCU2/S2@V55L(A*;DO<. >\I%A;WCTP
MT AU"HNKE \6DJRL#?>ZZ@=Q;J/'#P!:>.<2!];%"H![A"AK$GJ;$7L+>I^I
MX?R6CS2'.*JOK:BCILGHHZR0TU*E7+()*J*FT+&\].NS2AKE^@.!P7!\YT2_
M.X^8*S*),]^>32-&\&7Q.T#\ZD>7NSK5<JG*<XJ3*C!M[8RW@3M-5Q!2UD]>
MLF1U])0\O+<N^<)Z@5DDZ)4B'M$)6!4B2=V#-:*35X;T/R=Q51JH'S68SQ9[
MF&1Q34=!VN@#4--'4]MK)^TQFDI2'T2-IDY3J5[]L?X-S2I>)<MA>9/F[+:V
MIFJY:"ABB.9&9(3%))6E9*>5X66GD8QS2?;IXR5#3Y;14JQ4E;42T6:QU[TF
M912QM(E"J2M'([I&A+B)0K^QDE,EV51Y<19!3Y-'E5325\E;39M3SU$/::)\
MNJD2"<P<QZ6265A!4$<REE)'-CN=(MO]1Q!G==EE7DM#EU#35M5G-1501]JJ
MWI(8NRTQJ2S21T]2QU*I &CK;SP_&U0,JJI5R9CQ!39S\P?,@JUD6;,1&*D\
MFL2+OT_8M=2'Y(8!"C*&WQFW'PHZ;(*NBIZ"6'.\LK,R$F8YB<OBA['%3R-2
M"3LT^NI=IFACC(75-'I\=LQ^46:C:FD3*8>1+D>59W)#59AV7,2N9U#P"AHZ
M;LT@JZR,J&$>N/6#?NX_QKE--%+)F4Z0M\Y9K0TT5'#F%=)(N5&/M',2.A5H
MYX4E5JE '@CWY=1*H9A0U]77325$"039/-1Q5.6U<3__ ">:BNFY:X#AFO>)
M>7I%^N_#?$U9G=?FU!59934+908HJAX,UBS &JDN6IP$@A/L5'M)1>,2WAN7
M1PO_ -/!*8)4E4 F-M0!Z'XVP*]E*<N&&-48R:%#6,I4J)&)8DE+W47L#@9A
M-W=>F1DYNEVV8":/0R]VVP]X>.K';I+'8:V@6!I 6#D*P97O?WP!IOXCKOOB
M&L>%0-*M9Y'NVJY,L7*-]_+<>N)9C*(@0!R8A$+7W 9FN;^/>\-L&<&G6#E(
M-+:]8+ZBQV)/>T[@ =/#S^IR'/SD@S!&R^CS*GS.F2EJ::M,XC,<<\=0+=GE
MA>_,C7[7AA^/<W JNR0T67M+3T5!2&DB95RW+:*66<4-&DC2KHJ)I.;4RS\V
M65U'>46 ?C[-B\]1'%3PU]5\Q/4UT1G6:>HR(R<JHD42\LM5JX2L33RI%0 (
MH)Q7<4U=70U674\$674M7F]7F\L=%+4H-59#'%)1V,I#T:F/F)&X8JS6U:0!
MAN,*QJ,T?9*30:/A^BU>VU:.'IY9Z=O\S3JJ#*5GVTZ0.6$WQ59U)69_+G\]
M+3/)-F7SE)1L':D=N<)C P+F0PL1H8%]14GO8XASW_$%9V^2@AI*J0R-4R15
M%=/V@L5T76LJ)UA2$ I%%3B*)4.D)8+;ZC/N'OGN3+9TS*MRNIRJ:>:FJ:$4
MYDU5$!IY >TPS);EEA[OB<1_)_DUZ3M<U;F*03U]=4K63:FS'-,P6&.3,:R2
M-8G,L4,(AIXXC'#'&Q&@G<K\GN4<JGI99ZF>AI(\^@I:.40-'!3Y\R/)#&QB
M,@["Z:J&35S8BQ+,Y Q0\+4E+F%/FE1/+F59391192DM;%3.W[E++(E:"L0*
M5D@ET2R1E0P4'2"3B/@NBCJ15"LK"XJ^)*S2>3IU\31Q1U2_Y5]-.(@:?>]R
M>:7QE>5QY3E%%E$$TK1T-%%115#<OGE8HQ&LILG+YFVKW-&K[-ML9/PW\V9A
M59K59I6YM7U-)!0<^KCI(=%)3R23(FBCIX$DD,DC-)/("['R^I.POY8#RR=X
M-I'@ !^=P=\)-8Z)2 _@>FH?['^OACFQ7T\Q+^6H8>6./WV"WZ#Q_ ;X21)!
M=&#?#].N&=$W=E7XFV'JH$^WJ_T=[^FWYX>M#;17'J1_3$-2^L(_>#;7M8@G
MIT\/I2/H4M:_D/,GIB\QWU_=86^'G^>(YT?8LH<>\M_Z>8P)8V-E=2?(,#AI
MX4.EG%_$;FWQM>V%8,+J00?$8:2-#9G53Y%@#AJR!3;46]5%Q^/Z8>L+GV9T
MCU O]_7%-4&0E']X;@^8]?7Z5#EW:E,LCE([E5"VU.1U.^P Z=#<[;=<5>5"
M*-I8'9M&[(]KZ?-2+=/$$=+V/A^VQ\C^V&'FR*C.L:D[NW0?AUOX>'F0-\-D
MT6DZ)7UVV+:2I/J!N!]^WKB1&C=HW%F0E2/4?WM]+AOY+,H&6T]1GRU%5754
M,<[01SO30T8D76L/LK22RA67FLSA ]T5.[K;C7Y,Y,MB^=.&Z>MK*%3:MHPK
M54U#?W)D9%YDM,W1]2M) UF=VC;4E/DV;U<4D])E695,$5^;-3T-3-%'8V.N
M2.)E6QV-R+>.,JR/-\\JC1Y1EU7F%2HN\5/$S\M;VU3-LD*WVU2LBWVOC.^&
M,_X<=$SO*JO+N;<1/-'>&4C<B*HC+P2,!N0DC$#J,4U+4UDJT])3SU4[^Y#3
MQ23RM_ICC5G/W#&4\ <8YU42TU%D&8*\!M.];"<OAB-KZ7EK>0FL^"*6?<'3
M;?'#WR*9NKS5G%40IZ*F TTE'5PRSU)/5Y)83(L-,G1M)Y[D[<M 7/$'R5Y-
M)E\\F0K/1YA!$\L44E1)40591=1@?G:GCDD *Q2(X4.0'0J=2_2XI^4_/9LT
MJJ?(ZE<NR^DGDIXW6"&6HJVA=HWGD:HCD"1NX;E1(BD(%+LS&R\ ?*#6YFTM
M!Q"4.@#LV;\M((G;8&EJ].F%9K'7'*@16&I9 K:6>3-LKB95DS"C1GL%!J(O
M'I?O=T'S:PQ5YG04,*SU55%%%)_EMJU<W:_LU34TFV_<!VWQ09QEN9W6CJDD
MD4:FB(:.4#SY<BJQ'FR@@>)OB>H@IHS+43101C[<KK&M_*[$"_D.IQ4\39+3
M1J_;$J-7NQTOMY#ZE5V0>KE?2^.+N.,PCRYFX9BT2*&>KJJN(&6"!?&EIVUQ
MRR>+O)=8T'=C=C=,A^5+B&BKX3G%4,SRV21$JDD@IXYH(V8!JBGD@CA[T0[Y
MCDUI(H*C0VE@K*ZJRD,K ,K#<%2+@@^((W'TS:VY%CMOB+;Q\_ZX>Y9M774U
M_P <6P/[O@.RG4A*GS'E_?AAF9S=F+'UQ;"CO#$5N8FK8 @_I_?E]*:Q1A<7
MM<?=TPUQ"]O>TG%L=/\ ;'3 DD2^AV6_6QZ_=_OUQN3ON3U)Q;"#<_#_ 'Q2
M6YA)ZZ;#Z64R:Z73_P .1E^(/>_\L9I(W,CC^QHU6\&8L1OYV _/%_08LO6V
M_G@V(M;TQH4;V_W_ &=<4S%J>$GJ8UOY]+7Q7DFLG)4KW^A\@  ?^8"X^/T4
M5W8*BL['HJ LQ^ &^.':JJK<BRFJKH9*>KEH8>T1RKHDYD8Y7,*FY7GA!. W
M>TR#4 =L4$"K1TCP]&B#L1U,A)YESY@]W[L!=,5AW?';;?%'2TE//.\--3P-
M4R<VH:&".)JB6UN;.T:J9I+?;D+-ZXSG+<NS:DDH<SHJ>OHY;<RGJ(P\>H>Z
MZ]&21?L21E9%^RPN<</\,9!D',&2Y729=SK<YX58S2 =%>>5I)B@WLFO0#OI
MP2B]?#SWQ-)&T,R?9:*0-\"A!Q4F<4M2:6-9JD4TW9H7;0DL_*;DQL_V5>32
MI;P!OB>*6":6">-HIX9'CFB<:7CD1BKHP.X96!!'F/HSU$%-&9:F:*GB%@99
MY$BC!/2[R%5%_#?'$L5%#Q!G,>6S1U%#V^=Z>6)@\168B9D1UNKK%+(\(920
M>7<8R.&,Y1E[06(,3<RW_&UMS=7\^K8^EL!%6.VD#[L1&\EF)(39 Q)"CR4'
M91Z"V'EDA=)H'>*5#=)(V*.A\U92"/7S'IAZNJKW5ZZIFJ2EPG.<N$_TK[HO
MXD"Y\<7C3RQ/,C05 L-)@F!OTMRFO?TMU],0B(M")]0@+PB<H+N(-:\XH/%A
M'JTCQ-ABAGI*FCI9Z&1):*6")Z62,W1X"@Y94G>VFW7O#HV]_IRRLTC$^9 ]
M #T&%D9<.R2&Y6S>+ VO\1T.%A=SW=)'F3;\1B2E=>EG\_"WY[X2#_B;?# I
M23;6MO/>_P"'G]^)*95'=8W'75O?],*-!WW/],+&K;@V.$DN=!V8#\;>(_3%
MO7%L6Q(=",PZJK'\L:V)ZFY]<+*R^N&$;7(!0GR]W\/TPE.[^*@>?7\O_>'I
MI =N\//I^1PL&QU-9O#Q&$I23WF%O'3U/X]/SQ+ %/<.WDV_YXCLNWGU/Z86
M,+WU._6V%D5QY$;$'J/[\\7&+XO_ %MC*:6.;F32KJT,$1&Z7M<L1T/46'2^
M^  HL  /(  ?@+8J:6.I #W5E]UQU'IZCTQ-ET\?N>V'\HLP^*D_F"<=@J=&
MK0!_(6&L_ =/NO<XCI9Y&TB-E_B9P55?C?K\!UQ)E\Z'V=I5\Q92/BK'\P3B
M/+7*7=PC_96VH?\ ,P_\;V]<+E\Q:SE%7Q8-J-O0?KT\?50%"J!8* !\!C-Z
M9W"3HFKEJ1+IZA1NIMU('>N?#;PQ?&H8N,7Q\F^24.7<-Y?F,,4;5V:P]KGJ
MRGMM#NZQ4Z,>]'%&BBZII#R%G:_=MBBS6JH5*1Z7B)+<J0$J&/4J5(9;^(O8
M^5]\1Y_220^VUPRV[RA2ZG_0P\_)K$=+GKB'.*4RD.)(U^R[ $'XA;E?/Q&*
MO.H%2U/:>0^C"-1YL=B3Y*OWGSASJG4:I%E5OX% :Y_E:X 'QM@YZ[2DO".2
M?=56/-'J6/=8^8LH'@<56:\R-HH%90XTL[VOI/4*%Z7Z$D]/V?*=PIF$.9UO
M$D$*2Y95&G-0T1)EI9^5'"[U,=MHYI4U+,ETUR:7T,1JQ<8OB^/E+S:LS+BC
M,**H:04>4RBDI*4D\H$1(\E3H]UI)W<D2D:N3RT%E'[,OSBORO4*24<MSJ>&
M51)$6Z:@IL48C8LA4GQOBGXQIW@M6P31U '>-.JO#(?- SAH[^*MJ _CZ8@X
MJIC.W.IY883[DH(E;_J1@"U_Y"VGUZXS'BJ 1Z,O'.E)_P R6-DA0>/=)5Y&
M\ .ZHZDGIBGXLB1;STDO- W$+IRW/F"Y!0'R(?XG'^+*TSL\D,+4Y]VG6ZN@
M\")]RS>>I=)\ N*_B*:J@:G@A[,D@TRN7UR,A]Y%LJA0PV8[MIN!:_[/DNXR
MR\45%PK6:X*U)*@4,S;T]6LLLE2( ][Q5":W5(V 2157EMK/+^G5)IF-MM0#
M??T/YXB4-CD ]<!>4?3 D#&V)$\L+K5K^&)90?V:CYX@UO*G\NY^%C_7I]#K
ML?'#KI=AX*Y'W7PB!ACLX.%/+V.%</B1#X8B+(3JZ8DDU=/V:V\\4@8L['I8
M"_K?^_Q^ADTI$DD/V67F#T9;#;X@[_ ?0(Q8_P!G%CBQQ;]LX3GS<NVCF/I_
MTZC;[O+Z'R29C+5Y!5T,LH?YKK E.GVHJ6J0RA?5.>LY3^&Y7II'U7$T])3\
M/9W+7:>R_-E7$ZO:TC30M%#$ 2-3R3M&$6]RUO+%A^'T/EBRZ*GSG+<QBA*'
M,:26.IE'N33T;1B+_K""72W\4:1_P'ZFXO:XOY>..'*2JKL_R>FHE=J@YC22
M@I>\4=//'--.Q'NQQ1HS,W3PZL!].6%)19O#H1U&.S\D:D);S! Z>8_3'-VL
M-SZ8D1U2[;CT'N?']<1:M7=!8^0QJDZ<MK_#_?ICF@7##2?$'"T[R7<[ G8'
MJ1Y_IA:0W[W3!BC(L46WPPJJ@LH 'I]&6GCE-S<-YCQ^."A@\2R>?D?7]?NQ
MK+D*FY_(>IQ.K+8-O_,!L?\ WB'5]E2WPQJ?KRS^&&D4J0!N? #>^!2O:YM<
M^'EB.EL;OO;P_7!BB/5%_"W],  ;#8?0AE>"194/>4_<1X@^A&QQ'G,)TB2)
MT)V8J0RCU\#;\3\<:AL0001<$="/,'$M;#%*L3M9G^\+?IJ/A?\ ]FPWQK'I
M@2(?M#;KN-L))&W1E-C8V(._KBIJ((5#NX5>E^I)] +D_=TP*JG9=8GBTVO<
MNH_$$WOZ6OBJS24R_N[Z8EZ'2._YDZAT\AY8DS.JD0I=4!%F*+9B/'>YM?\
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MO903;%'F5!F )HZJ*?3NP4V=1>URC!7 OL"5L<22Q0H9)I$BC7F\CJB#WLQ
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M&&QX)<PDKV;QFQ(WQ2N%A4 V/._GWG'$8NMF;8[;G;W>&*B>>6)%>61Q&NE
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MEG,"U$M7/$P*3E$>-*>-[QJ_$D=&98K+''&!'#%%!&NRQPQ)%&H_ACC547X
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M0E%A("0S0U)B<1 P-(&A%E-C<H*1)50'%S5$)E!@9'!S=)*3HJ.RP<+1_]H
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M34M&0T4/ZVA*)JJ2[^)2ZY$D%_*(3,1'>>FU_LJEPN7CU-7PCH88K_V:,_\
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M1D$G_P!4 'ICZZS_ $G]%UI4[QSV(Q^2*/>4MK\F+8)?A!C24T?IZSB/;JN
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M.M!0/S;=\QK,S/6[J0GWCJ9ZTZW1UMG^S0YC6?IUX<KXN)FZ68H-7L]UKKV
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MC* X.DNG))(--7>*I HP<L%O-^2DLZC<&-$UI_)!%,<*UO)2-X22R-")_%@
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M/0X!V$@$M*=GU40$;FE@RV!LRX8@ZI@>R?\ )1<V>0B1+N * )"<GD\\E%R
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M#BB0.:T'7W-^5H/JA/\ X[__V@ , P$  @ #    $
M                                    G>^    9K)    00(/D    /
MI$\P  $W<+"   ^+@6   66:PP  M )]U&  !(F.30  ), ;@   >.JP   $
M&A6   ![>9P                  ! 1W    *X*0    B]30   *.NK;@ !
MBRG6P  ' L*>   '1=;Z  /*K":0  /=,P2H)V\-(-0  )W3260 (<8$J0
MW96KNP  '0_N%R?H5.^(31"))(I>]TK\E$W(U)9 _I!   (9,N]0 +GFOQA>
M! DZ_F+Z[))()'N! )()-   %[W1Y  !#9')_0!":/%2P  O'6H$  [61L*
M   <6WC0  *<WD*  (@!Y#  !+0A[0  (S]&(    4[RR   "A^_0   4UKH
M  !+9SE0   =3L*    !!()   !) (( !)!!)!( )((!)(  !!( (   ! )!
M    ! ! ( !!!! !  ! ! (( !!)!()
M                                                 /_$ "L1 0$
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MOBR*$<D( BTJND9P"+#/"[!* /"KEHB=(2&IBPPA@&!<_C7[JA+0<J1@:I#
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M7!',DB+%6><RX'@V[NQ$AV,M0<8TZR/@$U-(R<#@!R8GNZUQ2A'XK5!E"JP
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M M3'-,;5!] XE_'(X">2<D H%!6WW4QP+\AR'%3DH<("!GAI IE4&*RV! "
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M!8T<CSW>\#W@'/TO'89T4VZ.C3'6,G ^JR"/U.S2;'#'@A]DRAI1:'MA[YH
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M(?"C .!$,QH0*[%Z;4;7@Y(AL<V(]F.SC,+, :\J(36 6<6!-B5"6WV<@..
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M2$D<-B5@?MT AK8VL/R!+U[4;5'R#UOYX,R<8"=*99KRQ$'/)KE3OE<S4#%
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M .K)[7+ECA.@"(@0<&7>I>N8WGI!$0-:JJKWW^235$/* 'U7B,?7OY &$H>
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M#J<]W):/0T,& 'X8T*J&YY-@"Y<DW J\6SBA3#[%-76AB@IJ%1)!H&4</0*
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M#"C3" !\#3D$0P  /(J;]UU^<X/ ;"2G9H_K<Y\3A@% T?+_ (P+=08 10@
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K82BO[S?7":X_'E1W* $,+[>J5>/C,UTOB3BRD@' C0/ 3EAO(?\ QS__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>businessfigure18a1a.jpg
<TEXT>
begin 644 businessfigure18a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M_3/!PV^1V%CSZX_4C)0S926VED*LAD2")0$<*4!$0E4I $1".%&"C@3%4\!
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MSECS71VDL%!:*F;*BWK$0B&1("C@1R) $)*.1*BHS$<*61-(1%)@)D+@+D!
M"-H3)"P^+,DPG ,DR2[*=+D&;36XJT"L2>5O5KFP:K*@>@EB@BOB.QE,DR3)
M,DU#ICH3 =29)DF28)@F+"RX6."9)BS0FI- X&P0)(8V*N(0EO5C-KO[V_EH
M-L$78L6?1':A':"UT%LK+8A1B(RJ Q&"E"HA$)*,Q*JI9$<"6%-(003 3 6
M62&0 ."9"6#BS#,DR3),D[9P]/L7-HHFRN>K9R?HHZ+SZ&Y6J"VJ; 3]'7B6
M0EM3/7RK?1RYIQ8)DF2:,R34.A,DP3%F0Z)"#J$+'4F [2:6:A"8 /@."8LP
M0N-@'JQFVW=[ORD+U2-0L5&F/UUL>=VFIFRMD%400(U")PAD1@)!$4*.%)(E
M$30)9$QA !!!<A<A<@9 29!D( <$PS <(R3!+.JT1%EEU5K.P>T,'L%D471@
MJQ,D_2ZN[*7-6NNF^&/7 FK),LBMZIMK$ P.FI-28HT"$G4.$XL#)D. Z$T#
MJ0(8 .+-"8)@(58N/HSU9QZ[8^@^2BMT8$+-GU1ZNIEH+4C-=;(5B %%(E5$
M)"(E(L1R)#$JLD@32)R$Q!(A,A4!<@) PA@U)A@(- X)DF29)DG1V;9=N?6$
MRKWIZMR;>+-F;IC-<]((Z\93()8G1N>ZJK*;!KMBY4(,_$AS2EKJ^0->#:+J
M )?0.&8)H3(=J=0AA!"$$,@D&@0%@@A#XLQ( 0,/JMEWSCZ)Y./L66FUGHM8
M:JFJDIZ:45:M1L93H0R(@$BE) B*HY$D*4%,0F 3F$$$"%2%D $#""34&2 ,
M#!D.Y,DR3!-&8)H' ^U<,.T)@0 71;(2S NNI,DV)BC),AT(%"%H66T#DF";
M V ".&.&3(,48&+#!#8IT9H0(((^),2 ,]5LFY^^B^49E9JS:F):V>EBJ,R.
MJMO1D05H:YE:]$&0PHPJ6*E*I(4PB4E. 001(5 7("0N0, 9,DT8 3),DR3)
M,DR3) *VB^U.@NHYR(65 6P-BDR,2XT0&)DF28)NN8(&,%F"PU#B0*S4@8^"
M:!T9J'2G2P,8,.D.@=0@AT#I#H$$GJMDWF_0O*-^?2S*C/4&JHCIQME=B"1$
M(D41ZW8BD1 (I$D"<*F(3!DQB<@J F0N J0$@2  Z@R0)(0,DR3),DR3! A@
MQ\@4%[5]OZBLOG_!=MFB^/JGKF7)F*T$R5UG\_\ .Q#B9&]J-Q0F81M9H' =
M!L@T!J-HDN-I1B#(01@1L$P'%(3"X^D. X""0 ;! J=0^JN+:W^[X#4M;37&
MRH-R'=65$@0$(0Z0.Q/>C 1R(V".1- 0 0I3&$,"3"H"Y"X 2!@!)DF2 AU!
MD.09#@ E(2=%MK+/]1V^QOOGTJ8>T]*JX\2OI(W7KZ,;%TC%>C;-^9PH-EOL
MK\6>*Y7Y'F&^RFG=G.KZ_+HMDF+!)-!2RP2VA,4!#:C:6 #AAU#M($$!(0=
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M. '7.<<ZA35O3Y.5Y^HK2]L&_P">?M>DZKQ]7KCE^@D15SK%@.I1*EJPE7H
MP@X&@VJ\;]G+L*B]B*)XS*47J]I4WUE96R1+8ITO:6TKHQR!36EE(0= A!]3
M.=U>3/0\(F!.85 08205 24(((9;LS:9_3;*TL4R2!;(%=3TABV<V;L$-MIZ
M+Q= @K+$LK>_- ;JHY^=/K/1/P'ZF=7ID/*Z4?Z^TK5V8_ZOHVSGUL?I^&N^
MY_FF6^^^+S+I<R5T]$=F9I59A.7SWT/D;:G=CG']\R;/*2#;YBVN=WY]@]J>
MM+MFV3*C,JLR\M;-?BIWO03C/L[[Y?>54Z+EHL;V8Z*RFJ:D+763"(8.=GIY
MB%+U7;U-EV^>O0YM[Y=C\ $-6%E%OU:(J5:).>]6&AKLI<?%@9/4OF]3CCT'
M$+*DPE$EQ22A14DPE@7%"1+:V-83>JZN;Z,@7R1*VEV!<$<@A<&:K!<G/Z/3
M?\^_U8T[:3TM4T]6)]_HM?9ZUGW]/U2]M\IDOW'X=R3H2FM_@N?NAXGJBCU,
M\.;9)4\Q0F[P\?H]$-\=+KRNB\WJ;>S^@J';\YDO&]U='.[:1L@K,%!;M7CO
MW^^!7"K2VF_JW#UNM^9V5K QZG"!F!?8K*61E?$SH<+8AHB8G0(%(@^UA1FH
MH# B;4ZDP$)7U'YG7XJ[_#+@!%!(6P*():%,I<4$4! " E0&:*A881L3(NV&
M%\DPB0>7]#Z%_@?]2MG0RQWKA=GZ4<[738NUT[@U:NM_T'^8^QMRU59G\\.O
M\>F(I>.EPK.Q>D76>?AMOFHKOY-"8?4'T[VQN9UW3VPW<6-U\FXO.?2Y2CM!
MIBMO,CFS-Y4][O4M?J & A"KV'EU3S)T[^Q=.X$:PK*V<-7#U\;[.7S1=D"H
MT9I&R34(0VE(#, "!D@0=" +Y#ZC\OK<.>@\^$0LN&* UE/"XH" 0 (! %@
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M7)#@\/+W2T\3*0:RL;;VREA.15:=1,^%3[T_LIG_ %C<29.TEQMR*[73BO\
M7?<S([MQ37!VU%JCU4W&MZ^:NETG [(C-3,V>O)-KVIKW$%VS%NHL8PVS-Q3
MO#6 3/LFFYE<S06DB+B/BKHR/'EU,$LA$*E*!LLKX(CEIY4A[*,C_$>/D7T7
M^%]*6:%9;1=CAV46'863+,*Y*R6,(EC\M&<">AH)X_XW6MMU6+K\ML^UM7D\
M<U_\J)D#L>Q7.!0P1"9@OA*TJP<D_"_%>A[W_73T3*+7Y-XY6Z36L/6TL_.;
M;4E^IVRUJF4V^>+K _Y95RTG2(VIZ+(&9OFZ!K&;#M-M(C[U+>KK!EK\7:U#
M7Z*OM;"&W&MM@KT+5(,:$BQHK9L2J-R(\Q+DBV_,:=CO#W&*J.1VWG%F/'$B
M@XC]9!C,R(][5_@MSQBXOK_TOKH,)A(3,J$,-J2[$D5]\XC;<H7\1QIK$<[L
M$_K8Q&[&#=,6-9(X(H[SJ"\<V.A5IM(VI"6/N<#'=P9*AGP^$9]2OZB>J>@Y
MKL'\-II+Y (-)S.<'R08_ESVSCP:9L3>LE8=7-5A+1=1*W979:PAF6<@[:5M
M+TVXD:R9,FPQY85;:3ZV^V"3.@Q[!V"Y!LY[E54-VKTN(3GM&XUG72\<C$N1
MHSJ*V\V*2F5GK&L9KQWO4*)K4B9*?GRUQ<7U_P"B]>GYO.#8N X>L>V5F1'
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M,![U<_U0>S'%[%5%%$,&T.0BBQW$VA\FA!W(YVY]&R3\BK^FO:1&X:<-C.:
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M/R'#A.(HL2VU_2SH\T)QG$1<?1,/A'>L+Z@4B<G +^:0$@,A,LF4MH"0ZO\
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ML#?3R_S]]"&4DC02PY_P_J**W! A*ML"P7;DQSG\1YT%;5I \7+\/]#05SG
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M-ML:LP=Z .\!+>2D;#O8/+8>9!'L:=PN-*K.TF</&NG!QHY<N2 +]_;(WSS
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MSED5O8T9R ?;..JG\Q\Z&MU9@25&['88Y\O=G5LNQ.:1)'9'S@,RQZO" 3J
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MGY!QGRR.IJWD10RDZ-1!#[=#&Q'(_N$;@[MR(U4)XM@7R<3#4<\V9,9\1.&
M(R6SIY'.U+.FK&L841ABVH%RBE3(C*P.LC. <@[$G(H3IW/A*C",FEM3,<L<
M$88+N&RQTZLKD9PM231-')A_V@72G[N XQT_>"CGL-\<A')'W2Y?1H!0IYZM
M7CVP3[:YYC[/V6PN#<Q!XSJYNS\U\&TFWN;Q*G/D@WY*(YT")F1@W<R*6&[9
M,H9>N20,X'X;5ZS%F)M0W>%M/[FAF)SCD=+!!G[D>[>RH]:35 >\. 'U]/\
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M<_Y5)&V<CE^-$D'KCK3R?=49/G1B8@C402#OY'SKBG%+[A_%.(6MQ'$\D4[
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M29%'+;&H;;\\J03_ (L5,J$7(:- (PS(0JI[,F ,@#GDQ\_+ U#)EA MV4Q
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M,C&Q'\LD?CR/HS6?K-9KA?[5_P# ?_<E9](K-9])]%D%:ZA5P&!;8'V2P4E
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M$D*2!H&SIFBN $ \6,;UPR\X_P!H[B/@_:7B7"%-AWB1O/91VG$+KN^;/,Q
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MG%(D1H;9NX>R&" T/>,PGBA0YDV!U>6K%<(O()DD]4?7;8CT2*A13)NDI5,
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M9EV?;!]QQ\/XTOLCW4=ZQBBN]'T75NLZ;>VFZ'S\U^'E[Z<8'*I-08LNVU0
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MXU(N>>G R?O-DU<DECG:I7+2L<XQM5NQ'/J:*ZC0MSR -/"59CMN/KYU(?"
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M"N5:^0ZU.KX+>7U\:0D/Y4&Y5#NM3)X2!UIK9P3Y5<C0O/GSKA\PADP^0K;
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M7G61BLZN7*H-G/\ A_G1/05[O1JQ0.:^%$8KE\363Z?#M1.6KKO1]U 9YUG
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M1.V:Z9S2Z<>+8]".5;8Q][S]U' .W2E!()QGG2KL3^?G1/(=.OQK;-#GL/\
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M2K]*O5^R#V7J#4=F6LM9:RUE\ZR5EI>7>-MJ$[S/'09!)GSY5"$D D)/L@D
MGRZ\J44("Q8Y$E91:8 FD95"P'=22GF H2)%!Q)"280I6B5$9ON)'WFE!* 2
MN .<UF02M$0E 2J3$<8)$7HAL1=,*[M]3\:A,Y+21W><>59FPXEH7,JF/9(C
M6\WS=.O2B$@A)("B+)\+_=7U5X4GA[W@:>6V$6,YCD&[4)Z\[6\CK$&8IM+:
M L!5P<RY(D'Q@ "PT &E9F^2A?2^M9D1FS#+UD12G$A12.)02E4"-%*R\R!X
MZS'*K21(E(DB=!X^%#*KNJ!C6+UEJ*BHK+66LM166H[+FHK*>E0>Q4FH-0:C
MSK*>V]8J<H\Q^!I(K04:-U_P_"31/OHZT://MUK2I[?GYY?3_IV#M'7_ "N=
M/I7O67$(SAO>2 0#Q)"1WHFG677%+.3]HEL22/J2A1)Y^,C+-Q?D:+#GUR=T
M%E9=4'20++2H!/-4B0F+"!KRK#MJ:2IM0&@(7;,J1<*ZD&1/V<O0UZHZ4'@3
M(90A-_:"UG\"#_2L0A2BVH)SY"2I%A/"4R)M8F;UN7)*LB0)95N@H$'*E4IT
M L2"+1/A19<BR+G>$ %!2@+5F#:DJ3E*1^[!!L+5N72X29,N)<SI*4A,)%KI
M4Y:.%(5E(-XO333B7&I0(;W@4Y(X\Q!!ZWYSS-*:<WB^ +WBDJ2Y(EN !EO)
MM!C*/:U%Z]5=*%#(!E:#>O[0YDG-Y0DFXF5'S*\.HK40A.7?MK L!E#>57W_
M !UKU=W*I.42&G49I_;%<1//49K\S;J5897UL(3Q!G+_ -KA4J.EOTY46'1,
M)!!<)ME*HW02(SI('$.*TQISKU=T)"<@G=-()D:H>"CX]W\*]7>SJL(&](5-
MU[P+X?\ ]D@VC@YB(894A:3E"1N6TF/M#-/XC_+BH[)[#V1V3V17SSJ:Q?='
M\0_ TFU3\]*60!)M40/$W-*^%'YZ4545]:GZ!J>WY^?S[#_](;4/OHFK=>V*
M(CM!JW7LBHJ#VGL%17SK]&.V*([-:R]D]D=AOV16+[B?XOR-2*)^>M*.97[J
M?Q_E2C2E<J49^>M'M!H]L5H:'_T\=AZ=BJ%6-145'TXHU% =D48HU>HK3Z)^
M@1_D8ON)_B_)56^>=+45$I3\>@K2W04:-'LB:C^M<Z%1:H_7LBM/CV6J*BHJ
M*^?GSJ*BHJ*CPJ.R/"HJ*CY^?GRJ*CZ+3+K[K;#+:W7GEI:::;&9;CBSE0E(
MYJ)TK:7]FWI=LK9B]JOX%E[#,HWN+1@\2C$XK!-"Y<Q&'2)R(OO%-%S=WS12
MEIB3H?:((3?3B(B_G6S=GXS:^*:P.S6',7B7EA"4M)*DHGVW7!P--IN5*60
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M3;5P^S=F)6IWT?=Q.'?QJH#;JW,H<99&J@VI-U:384I)!\>M(NH9KQ3KN<!
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MB>%*DR%!(C,)BL0M['JPSN(  Q3^\2CV@!P\9Z_A6.6[ZZTTCV(X$]%#*/\
MM0C3I6*?QN&=W#02QA\J3(6HEP\UIOP3HI M::4T_OB]N'%!*TN2 J"+*!"Q
M:XN#6,*0IG'8-91O 0LM\*T.#O)< YGF#9432W5XE.=?$\T "H"[C9/>4![2
M#K'LGPKZMNSF93G-"2$A(.F=77P&G.@X,Z2V%)XA )DDSUTO64]*QJ59$D:
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M4B(*7"$S<12'7&@Z);6V[C,8V6\ISIA*UYBL*TM=,"$D&::Q;Z6TE.Z2VTG
MC=Y%&1B  H9RLE.75-E$\^M8E]QT-.J+>0.XM(9@A0W3;B>-07*IB5"$Q*;T
MC%OI3(W0;9.!;R9%9E#$)0%<97;+FX;*\>M,XM]Q[#A1;W>(<Q2,@2<Z!AY
MXLW$51Q<(C0=:_M\]*,%BQA/1#"_78QG$-8_&.H5P87*"&V51JXN9(]D7K"X
M-*6E)7?,.GWBGT^KM[L0;?=33"EE5^?\Z::7EW82256ICT?Q3BP0A4*N?#WU
MA=F'#I",IF2=/#7^M8O";Q00WPGJ!%>B_HMB]KOAC#I)::*3BL2ON,(/VE<U
M$3D0+G[Z']E?HBZSAV7ABV\6TVG$/8EMPI4ZA5PE6;ZO>.""AM,0"F\ULG9>
MSMD8=O9>&PK&#P38^I0O$1CBI5UOJRE3:W'%<10N"K0*IEI>\<PHXEN).0<G
M%(^L1E)YJ ('C:A8D*U'7[QX$5:*2#-]*4>5ZP:"A%U--;PY]]B&BZT([J,I
M(2I:KE(,CG6+]64X@ONX3,W=Q.$2I*\0/81N+I0[-E*S9(,T"O\ QSDJS.#3
M,2$9E 91/+* GQ%84*6]@!R9;<4>@XXGXQ2FV\.YB,9CTP'BH-MF0O(+)&4'
M-]9$C2WG6)Q[+J4IPV'2@@R7W4)4J_)M*IR^9K)B'9RJQ"QJJ%+(^ M'A3:"
M0X.)*,A+G0E/<S>.:PYZT5%NZ5%*N122".NE9C-SJ;GF>M2>1(YUAL2ZAU'&
M5I40%),G6TWT-$ S3F&:7;* ;Z6HX9X** F;V/(CSTI;:DV6F.DZ44\C0\_G
MG5^E"15^T4A2D&4FQ-TGYUI_#N..J6F(R-0DGOE#A64FVA'WZTC#KSH64IC>
M/.%/V,[>1/A)(S'SYTXA339;4&U++"&\I5Q).9<9!'%F)T3HI(FT4^API:R"
M<IXAPYNZ1PE25 7UX9CG2,.ZV$2VAP[HM%)-@<Y(-P;*$3:;)UTI6&=.:R?_
M +@B#;ZYL #3D;&ELJ1"CE"0,-8F 2VI1*28@3(@FTQ,"L.DK:Q$ )WCKL1<
M7M((UOS%##/9""GBRM(NL0<BP3 "$P(F"95R-*P[DE0&C[BPE, PL  \22)$
M<QH3!H,.-Y?JTKEL(A:LV2ZCJ4Z<7V?9L-(PZ,B5A28^L61',$R/QC\^V*BM
MI?LD?QC_ -JOIQ45^':AEIN<C:$9K*A(3(Z'P\*2PR$% 9:"%7* D93YCPY4
MO!LK<:44(R-(<0&<B<ASD&?"(C2\F]*8:4I*E--E2(R%202F+@)Z"=!RHLM%
M)2II!05%924@@K.JS^]XZUZOAU #<-$#- R)MF[W+VCWNIH(0%%649HRE4"2
MD7"9^R.0\32&66IW;:&YUR)"<T:3'F?*AAV$J*@RWF5FS*R)S'-WI//-SZUN
M&8@-(@Y9 2(^K[G_ (>STY5ZLR5%19:*C,JR)S&1EO:=#!ZZ5N&M-VW!RD\(
MONXW?+V(&7I3["<&,1M%:TJ]68Q+XAI#:C]63]:M/[3*!">%/4R:Q6*<VAM+
M:>U'R7'\9C<2^5*,F[JLHOR2@  <JPB5.C-(\OUK:#(<2,D9A94?K6R=E//8
M@6^KU*KD6FGL$O!O-*93G&GQU_E3;KK:!R,7'\JWJXD^9/**]"MG[/VIMC#O
MXIA+J<(/6?5+'UC<C, M)LI&:%.)Y@=*8Q[BTN;O"X)A!<SE+>$:2DJ//A2F
M2GEFS=(BFL1F6Z<02XEY*D.K(DB>ZL 0/JR!"1HFP%8?#MK*5X=P.Y5 K 04
MNHC1PI7<M<]X.[[0%.K2ZM6)4M.';;*=TL3+KJ;E38U$JN8L/,TM_>*4X4]\
ME5NI_"=??6:UJ"NOQII+CCG V7<O$4CF >9M /CK6)?Q##BE9&\2V^G>-MXA
ML2R.[N\BK)W)E TC43-);P^,S*P<(Q<9G<(K*G.8A1PZB8,'_IF_3E6'PG[1
M.+2XPEQ$'@.>!>4IU4<PBU%_=MJ4TT6<.W9@*$.%1U"E'BRBREC[5O"L(YD<
M=<?'K#;B"7][QF ;%(5J9A*4B.5/JP[ZL^'9+"([JYG,-3$VJ#O49)]6P[.9
M"4D@.NE&;,N+*7-^+A2(MUQ>(Q&5(=<65+)<RDV2/9D"+])TZ5,F]>5)TOK6
M!9WCX^RV,Q\3R^^B*B*C[Z<:#B2E7NZBG< 2F4+E0ZVH6,*U%O?6:@14BIJ;
M=@U%1V1S(TJ*BH[(^C%1V[3'U3?^Y_Q5V1_E1] =D].R*BH[/35.T%^BFW4;
M+258Y6SWTLI3=1E/$$C[668I#:VCN7 4E-E)4(4E7-*@;@SJ#>:;S-HMSY?G
M6S\$O%JTF01[M*<>>V4^MD$I )$\OD5LU\XWZQ1G+J3I_6G$M!(*A\.?Y5L#
M8I](]JM[,0^G"!P.*+RD%Q+*&TR3D!&8]+@$UAO0OT/V%@-F>J.X[$;<PBTX
MI>T675,'$.7!8<1F+2,*1PEL)SQ[9FEN9UJ5"4YC)2V,J1T ]UIU.M-WX1_/
MW=:R#!ME3I"<2I/[,=]EE6N>+ NZ!!OSBFV',5]<Z4M8=H!*,]FF4#V4C5QP
MZY1))-(+2V\0&\&TM++04%N.N-OE(LI[+)2HSQ%N.!.I,4+I_&FT!><E80EM
MLN+5!5PBUDIN9/ZFFMT[#"=X\DE3KF4%M3ZD));P[0-_-1Y]T&*<>2AL;W"^
MM.MY $I6I*<.AP$H843*WRB+E65142F8%$X+&K2R<.,!B<T)5QEAQ1TSGO,*
MFQ5W>O6L.\YA70(43GA2I4IQ"D*BQ),@$6CG6->4N)6'$JS%/V@ M4[S]]:C
MF)YB.E-7:>&JDH2J/W4JN?=(FLN'P[+3[_UBW22AL72E*#&=U(NI,ZB4R!3[
M^.@AHOALRHK0RB'<PU2&TJ2E   0)*@.\:=65+)425<\TE7O[4GYYTSB%L+S
M).MB#HH=#^1U%8?$(Q"9'"H1F3K'0@\P>R)HT.G6EX9G/F*!>]Z7@05$I5 )
MT/Y4XTII64^[I0CG7A0'*D@+4I&9.9-E"9(\^E--9#)N>4<NP=A^A%14?0@]
M>R*VF/JF_P#<_P"*JU_R?O[->WYBM*OV_?\ 0L?GXU_:K_9VSM7 +VYL7"I:
MVK@P7,2RP@)&-PXDJ.5(N\CO ZJT-;/P[N*7E*%</"1!D$&"".1$1>E8YK9#
M1AO,]I'(>-,X)W;F]<@0ZJ9F,JNHG\!6$V Y@V-P7,N\4-ZX#=*$ZI'4J\(I
MC83^V748'9F[WZ6BL(>=2RG=-]]1=5PA70'O37HHW@]@85L8KT<]'F=HI2A'
M]X;/:=??2V$!*R^M\E+CKBAF<+7U>L#E6,Q.R\9O,1_=[C7']9B4J4RTM1Y@
M'A)5J$(!/E6%:8?8?>:V,Z4(D>L8K&;EL#[2) S*/1,Y>=,*0LMHV9@\,C'N
M-R$.XC-EC532E< )'$)X^@I:MK;,RH>PN% *B]G4PG$(=61&93BLP5EY9C"3
MRFENNOKSO*SFY @)0B;G=MI 2D>0I'U*$.*1)5G6.4H2,H$ZE*UGB'/+%+4X
MO#?XIM*7,R?5E!M+;K@)XFRA,%38%T+*;$!()!K(,)O-XM/K"VRWN$WW:7!!
M+Y'"DA/=;G-FU IG".O<2$K2A/$I^Z4-Q[6<:$<HXB=*.(0L\3F*8<2C<EYM
MI*O64 R''D*4%H<Z&,T0;&:;QK;"2QA6R5.0E6)<:^L4H] J=V "4_:5)FD.
MLXG$)4G#/MX@RG=-) 8<4!!>S*,LA(E2Y!$\4B]9\!#B%,/E*5J++C;B<RDZ
M9'<P@B;AQ'CPFB<I:>PR3*EJ:+*CG)5%TR "I+B3&D@^ZL4ONM!&Z+8*5)SA
MRZCF(S"+#2.1F;TZZ4<"'%"]\JU!/N$Q1GQGL I _E0-;+(WCE[E'".O%<]A
MHS7XTH2.QYE#HA7_ )5ZB0;.?=2V'4+C+F!]H<Z>:^I6A).](U'+]T>)YT"X
MTI5U-+%C?B^%,8Q*D2EWN67O+7C6_(TAU*Q)M;7D?*LR>H[(%145%ZCZ$31%
M1V[4_9-_[G_%7;%"HFAV^[Z8[(^B.SP.A\.7SJ/.L9_9MZ-XK$8G%M,+P3^*
MS*6<,K*WO57WF[TF;E(L:]+?03;>R]H[O$X=;^"<7]3C&$*6VM$^U'<7U2?=
M6S_1['X=II+6S\=ZLA.]6L89TYXY"!?K^-8?T%Q^TL'A\6WCF<(MU2B\QB&G
M%K:1[(X#^T(OE)L-;UZ.^BV"V*A8]9WNT'4A/K+R0VTL#5E!DAF_=SGCYJ!I
M6!=3^V++ )A)==0 H]$P5$_"+TPA6'?SXC!^LH9*AD>4H89I8U4<MHTT\":Q
M^T<1M$(;6VC#X=ONX=D\/W #+X1)YDT&P-!EY\/"9\"((-(=Q"""C$O@BW$X
MI:<O0I5*"GP(O24,N-[_ !#2L+?5D!3;\=XH9)SMSS(EN3:-*]<=XE)#;<D!
M"LH6XAM-D)25R$P/L@&;S6'4?6D$J)=<S)WBI6I*E"$KDS$&+Z)I.#1@$[['
M&'QQ-88*!5FG]KB%7$3<(NIS4P*;QV+QSH;4^MIJ%<9X&D*(A"RE A(GPGI>
ML5N6<.4EY.,Q67*G%%! RG_IC0NN#V7B) GPIME:@%[QII*CP%UU+>8IU*)U
MRG6AZLMXD.K4I:%#%HPP!0A*@4NNMO*4G,@GB*4@ZE!L:QN"PS#&9G')?<"@
M%-!I3? 9A04H]-1'OIO%.X<'=J2F;A61)6@Q!+:B,R%$6E,4XO-,23UZ]?$U
MUM7.H[)J;S6%>W*T. 9LLR"8D4QB&GQ]62%"Y0KO#QZ$>([2([%"#%?C1I0D
M$ Q;6E)*3!_KXUBPV$9U,[U5@#&AY%1U@=*2TIU>0#C)/*!_3\J9;W+*&RJ2
MD7/Z>%$]*2M0^9H.7U$4_B(X6S?F?THNK^TH^^DJ4;R?C2'E(_>Z31Q)RF0)
MY5ZPY]JDXEP'6?.FW L=#]WSX=L5%;5_8H_W1_[%=HH?0O\ 3';-34]OW&O#
MM5!U2%)Z* 4/@9%;5Q"L-LUY;<!2H9!TRATY21'05A$LHPS:&'$.J;0%8G(2
MK(XLR)/2+3U$&C'@1T_E24)F<L3:WS^%)W.("58UA;^'2TVE&):7D6D@9=VI
M!4$+=2X#/"5*^%?W2P_?!8A;H.B%)2E8BY2HY@)'2:;P.&<<+(QAS(G>QA7B
MVW&N=P I$>?OIC9S"1GP^(PKSALTYB##"2-2MO5.74%V >2:]74IW.O,XR,T
MXH@$/N=WZOV6VD7#2+?:(IUN'E,M'>?6E#9^U>WOZTTO#X)#R6\JW6T?XEX<
M2^(A.[;/L)*B$B.)6IM6%V?ZU_C,<I3;"C++/MN)3SD]U ]IU7B$UB7%XY[U
M3 )"<.C7<#*BQ[RG#<A/M+5STFD8=M>'4PEP+($H=<%BZD\4=,R92#>>EZ&$
M:P[3C.,4T^VN%!>'.=;"OW%$:CVT=U7G2,&VCZW?M.MJG<Y)"R#;ZS12)/#D
MU!O.AK'-[AW=#$#$(2GA(S?5A5]V<UY3UDSKSIUS5/6@,K?CK4\S>O&IC6C4
MFAUI)M6S&G%.;[*4H2DB38*)M Z_A1'*CV:?E2Q::T-$5%*2%BXI:"@^'7\C
M1L9@3Y"LV:M*%<J=0I-]1UJ:"AEB@N*4HF]7IL2::!2O6H',QYT>W:O[!O\
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M\Z>7@\5B/4L4C%L-)A<(@%S4)@JF4_O]:Q[N%P[J<-A%8A;<I*_62)2 + 0
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MI29!R*(5!%>DCFTUXK#NMMCB:("VT,!05))XTI 3PPK/;76L$SAF,0WB,5C
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MF40D1^Q1:5=9%;72VQ@]VO$!Y:EPTV0-Y/-TWS-I@6'0WFC?QJ/Q_.@8(IR
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M_+QI3AF ,W(QKTJTY$Z>/.E%6;*4FU74HE2?C3<9"=>5J"K:1?G2HB-*C@$
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M-1'7J-:;<;>!#0S'VBHS'OTCYBDM(S)SI05Z )3((\21\:+670)D] *++BR
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MEA+20>950TX Q@)'0#8 >@&U''R9YUI4E*QY*2%#UV4"/CYU\[]F$1H%V/\
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M3 .&RJ#'=2E6VA"6AN1T ":=;@M+5%#G#:T^%*\G3S/O9YGR'E3;S@3-OKJ
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M2B+MTRG*OMI,!YM/%;?XB7\ZBI.!X.>-/)52I+[+3[+[P>4ISK[!+:D)"=1
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M*;NUJ=5!DL27TQVWO>0XULXTZX@G2EY!&"G(3D4F+(A79NXQGDO,N:')#'$
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M=63]U Y*?4'3^\4Z52G'4A0"4N+U:0?CTKF,FE?5K1G*1R/I0P:SFL'W=/\
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M9/M9$=Q#H]&E>!7_ *B*U.G..E'1Y46%;$5I!K<"B4TKPG;-7UD<T=G%*_\
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MV:2MDI4C(RH'(&=_]#GYTW)2/8RO3W71[R?@KF*"TI 4:%;T#2W,>WB:76G
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MG4E&G_" 5? ?(EU(2'$+2M*M(SJ20H'[P/C4F\WAY$FXRPV)#X898"PTVEI
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MK^;6VO.D[?$4?DWKSKTHCSK>MJ]!2OW4 ?W4!1(.<FM]^M)V SYFBG;)Y4M
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MUG[A]PHI0A+:&_!J/NG_  ]3^M7$?.MS&EL8PG)Y_$GH#1"'2A2=].D$^'F
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M$^IWH?"DY%&A\?DV-=H58W/9963_ /VUNK__Q  H$ $  @(! P0" P$! 0
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MZB^H(^(IU/0QEC 6K%OM=_B)Z>TJ8?\  )0I#56R: ,B"%!1V0.P?"(S5P)
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M*[?F9@IJ0Z]I1W<YO:M**&;NLA?WO\JYBT!H[18)$J)*F+0N$X'IS!5A@0F
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M:U';^69>]/P@(ALKRJWNAXNT0-YEL@;OW 8.@_B$^\UK"GVEM^J3<.53&O\
M(-='BDMT+)YR5>+] ]3[]^]O^*8067"NSVE2R^;:_$SY0O*R,EY/Z3-058_F
M48.>GNV/2'?4#_BO2IT>CJXA?N>5K3GE75J(6APF U76_N8"$YH#DUO=<=\P
MV(I0<$5=0N73:05L"%M];[?W*0E.K!K%\@Q =$'CI:82*[*S+WTA%,A.6(7!
M=L2->4L7+0<+;\*C2['VQN.(A%):(90GP5,&A5XA-TZ05>5R>1;HCUN0"HUN
M%%GAPQ-"&LJL!55%D#E4/-@,W3@!MD*EB*4RN]PO7()"EJ%%@*H,T4F[78Q
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M.9D/58TY<"RC&(2BTHEB=!0ADBB)3>2N'#8.72R2,4'Z'8;WP2B]:N.E1?@
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M6*6WN*+74M-#3[B,U9Z'6!5 B[MTE_X"J6W[1*VOE_<<T13NF,Q:KI"]=?\
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ML6M(9HH-T0>T2,'M"A?L3JY@@W/A#-WTAC*C_P"SJC#BW@7%G3]02[!,6_+
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M$&$R=(,SDA=&5MMSRA[FQC"@/7;BKM <5$:#5$(D 4#&3.._,H0HV&&5SKS
M K8LZYY=_F94"N5 BI$4[@B84H$V.H+]KJ8I)D!2-(B)50I.[:%HY+^X-L:%
M=D!RQ>+6/"RQ7+@<TT 75]6$$A:MJ^_-QM<A)BU8;JTSIL[1U,V_%SP(Y&B=
M81Q4C8#R80$%=T9>A16(I8(+W2X#07UHN#$+X8VD?UDXE=B@3E"Y,K\QJT :
M:<IF+%+=@W%I#R X)3>D<^%WOOKBI@L7%WR_/,2J>0TF02N1C'*$U+JG'4QF
M$ZQ&EJT%QHWQB"]D5P7-&L^+A R"+RG3DIA!"%,'34V^7ZC<1GXBSHUTJ)R4
MR\KUZW*AM:70T_\ L8"XJ6#@R3>&7]_* H-@4!724FI4((*<CWX>;EZG%#P5
M\150P 8]I@&'CP,4$ 6\GWC+,AQ:9S6(,L=6X<H,]/ZFUM3:Y7RL0'A&R-60
MM7M]U#6:=,3&C%VOF]PB#G#^HF2XL7T,+IUU/+;-(S,)UEW&9IJ67PW%OS4Q
M(40'H9A-N(0L;;7N^DS3.E\U4$;8ZHQ1Y0!65C^I6 =LPHQ6OS$35I-D0!6-
M13(9F,'>!A__V@ , P$  @ #    $*I)'!J_JG M2)3D(2D4GC9M@@J*<)I
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MG8'QX1RE3?T$TKO6)5!YK_/)^(KTT&*IR- HC$.2K76^5$@E+2C1[T,GKR)
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MINY[FR3$GCGR:^^_@_CKDD&UIG0/QDW-%5PV7T9C</Q,D7P0[L](WN'[??'
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MF>+IWD$&=4/W'5/!PZU7]\$/[F'XSZ\FAXC;!"AHH!"9MZ:58X&31,HA5A4
MSQ\*0SREA"H%B*#$1$<DY4I,$2SH!9EC0'!9 !EN28(L;$6G+EF#?  "9XH*
M"4,,"1)+ LHA$S8 FP5" DYR)BE-IH*R@%AQ ,^4N,9AHKI*0)<1YI3TW3.-
M$(!# '!0)!A (4!"FSME9>2!J1(C2.$>D?F2'A5_&OY'ZQP29BU^#UF]X]')
M'K9'K/[USU'AZ\G[A>9GZONZ[XQFP8DE&*,K74!4F3GT8PSO<=P_>]LK=_7?
MXZ2)EZHXDS"S7>OI=C$EAT\%V1>X^/9@O*^.3U<8ZIQU^XSQ$.1^C_->2?KQ
M<PTZZ_BO'B)BD#(NI$J_/C=3XYGZ86(-5W/@WYX84JA !)4$)I)CXXM]W94D
M%BE 4!22,"XR)F(4J:F$H)B%!;@=U(J$"J$4FK=Q#E)-/$0A<3"(,Y4,T;C"
M:$ ^"DD9 $E$50PS93BD&,!)A+!0BP#W,->' Y*U?J5C6E:_GN,>LE<FM0X
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M*4$#)<K ?""CP9Q6&XQ-[\1P2* E.AC-FBT((61<<'7[@;I@@<(<5'(& H
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M DU@ IT#K@R2U.74 -5@R1D04IJJTF#97Z=D\ 4-1 B8H (10@@/($N(2BA
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M_2-<DP;)8]V@]H]/QQ+LO\?IG[WQ-$14S_7BHY2\[A"&9W::S7UJ3)]\??\
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MC 2Z+PQ*8]6@\1:,$)L<S\29OURQ&0DY+K6[!"<>.I(J@&"U(6"1NJC!QPM
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MAA%J'%GC^N63%MFOO7DOZ$\01!.#RQ,<G D$SB#K@\$(9;(B0VEXR@CFEUM
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M'(_Q/\$.!(%*9%@&K;^( 4X( .%P#(A0Y(Y:$ 2^#&[!D;*":M0&83C5GO5
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M\@0D*W$IN<[Q96M\BHR,B!E$,@D:A4L<%;K$-8B9G9#0^OAUL(05,YD_2ZY
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M:\&8P1]481ZAXI1_50U<U/OOUQWK!A?/7D'%O3'+".5S7K^/UXP!E\DD??\
M>G :+U;^<O(^P8OK$COT^N#.GY&/K^?.)Y$Y,H;)"5J2/'S'"!$&YJ(7$4Q>
MI;RL\%)'J#V5\_XKQ5@0B0E2,,+V?.'?"BI&H1B6R'(A3OQ"82RF5;H,BA#>
M7?*V2LBAV((P3;%IAY(+S: >@5#']!?)19@DTA!G3(EJ_GBB8!2D;;E9:\K?
M7#,4BJD[H<Q8QWF^2<[!BF,SB9O/1,\D'@G'4X&V7,G+DG",BKL=D38?WP?&
MH+F4<GNW&M>8W4F0C^L1JX?J)Z,C,N>\!G7,?GKUZOB+9GS/CU743N>+!9QC
MUO@V0J-21X1AWCWP8^S[IF<_N.?7\_CA D@MZZ"=^MQ\AA1AP1XOM;<S\<:8
MTFI/O,-D1]-E\-,LP(;(_P!*K&-<#P,C*0U8I"Z+0SP*&BZNS1C"32R0X00,
M/ 03DYZXHEBNIK8 $K( 1618C@8VJC1V81;@4 O)$2*24(5GE !*#' G8E4
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MG@D/D9GLF/H5X?7(C81!) @5")4D#,A4FN51)8@B) CECBA@K!*A  %0 "I
ME0X[RJ0P)2)J'(E8X+BC$(U!.IE4PUQEC"S-YGWWYP2\$02%[^"_%G_>#*K3
MG'1[+K=<[=WEJB^SU?)4#,8+A7/HC55D[@C "1)"O=Y$P9^8-&A-%O=!?;N=
MA'/'"=TQ7R=Q<SGE(3&$M5F+^WXX2PARSAF19]D0G?C Q%2!LWO4UOOC%HH/
M4MYN\>/IQ^MH2FA-Q)5;(QPR9$-F!9W,Y8^\<4<BQ++F1ZE>IJM<GP0$0L$"
M$(R1;6#[\1E!,D>D&<>OQ3H4%3;->:<U$SR.@D;Q#==/WSXY!8Q,&7Y^O3M.
M?>^*12K#SA/W'_C78)!=V%Z2\-,3CBK\?'X_\7IZ,M-T0PMG95QR56ZN63U<
M#J>N3P+:2<]1G/=P'1?&:0& ;@S,SB[0OU7(+ F=?E^,?,<3("3)G;NHO_G!
MQBVN'N$)OZ9CC&0"%0Q;,E7]?ZX@MT(,:<VF4-9[>;-@0W%9A%\^GWQF!+<)
MW=]:&\\S E .S4#)?>+W?)@8991,KZ)@EB!EZX;(P4:\K/U]9SR4)GUX_?7T
MY*TU.^HT?SK=UR-Q'>)W[\.^+))A49G3&9P_9P8G)W_'$0D^(F\GS7+"%O\
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M; &)6HC'6K]LY\<FSZ(H]Q#3%+!U,)*J,+*JE8MF6%M!O? 9$IXF?ZD\E8>
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MWB=QU]9;+Y-RE((R 6FEB3=XY"A2W MH"*[Q'G'(TC-$HF?GQX,\B\E=C5-
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MRC!U,9@[I(@,W"PQG <Q"MR82  VDS""K@:T*G'+8E"9EI[F9;UC49XB'-8
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M?S'!B+34$Q\?Y^4E@QYZ\5B3Y[KC!*G41F:<_;.N!,4QDB\P7V8D2>"DYDF
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M3,G\3HKXWP"(9S.A7X+)B8^O#1 0@@W\85J*B?CF ,VZ-:?E*SZP<01#N_\
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M"H3'8O?C$0U)AA^Y7?\ /?(RA,@.Y:-;O5\JR6)K#-I-7C?O7&/!4JE(I=P
M>=\J@5)+2(B0L"I+_B&A22%+$F2D$ZJ7U?"7$!(-"S!#4HFXJ@Y-"(T&%I+<
M>YJ2?8N@B"9EP)+!HEQ\/%6",F0I$$EG\T0SGA$VP!@# :/)8MSQ<U!2(9'+
M(&3TD[XT"D,D9#@LFK'ZC7&3$D+>^Q5"[6/6^$1!BG*'#B IB4,VT\@J+4$D
M&S*73&^G@"*""A@9)<[((J)XDA22S\I(*#+*5C?'2I0T!L)8( 4(+N\V/(4@
MXEVV?[.&H>1 -2R#",P&HG4L_$8K K"\7.=ZSWV<4A9U 05E6$'@6YY6$+F2
MSXNUO!G3M:JC") A:RDI4I9>JX\@(RLLM8F;6+GT<06#R)D>2*:^%VX$2H<@
MLV=T(3T/+@+JQ6645(1H[Q,X0D"EL"4:2!+^8GB1@9-NC8,=5[.2!@8C ! /
MA^6_/!9<+8,45<@I&Z[WQ:LI#"I5W7S,,ZG40J6*RA2*Q)JX9<[-HK9RCR7]
M_P G 8R!5BV/R*B43A*X<9#4".D#<=;EG4PW92T:<5$7/;-'C+QBXGZ$N&M=
MS'4<$' .81#,;!9,3#WXXF6RX"JI#,4U<^?JVI09F'UF3,35><\,(B0YRO7G
MU_?$&49?:-'?Q$$XX@+7E,V^H[^.$D,$*J09Q6"+@ZO')$"(B5GT9_W\O NH
M3 ,23O[QLJBA@J$UH4JJ8V2S%5??%9DLK#(RJZS,!"XN'AL)<CMCO=3Y]<$R
M$6)2CV-SY<=/'61!5H64^INYEAZXK!3),7"BNS3>3LE+&Z"' W4#OX9=Z<J,
M!$C&A]?)GBCP" F84#9"3%&,,<3>1! HO(()\ 3,3-<1P:4+ F"&@',&Y,'(
M%A4D*^96*)\XY BHI (5UY?,?!R9ER(QF^<,D7# 6T\&R6+I8S(R@2CBBB.4
MA(BL?5BX2XZHUQ2-$8-!R"K!Y1F)EK@&:04)DR(L%SF;'/%137*$99$85]2X
M<\ E%0)DRP]?)DSP*R"0$$EQ';!BY^.3D2)"F"3(Q@,1[S/% ;(>L3D6^^EK
M1QA!!65B:B&FVWJ*Y%41AUC"L*4ZNXXO0$)$B2E8K%,79O@$%EF_:)D]7+$0
M%0Y<!8V$QI4:N[-<"E((09$$S/#T7DY$$)5N382B7:9-U$X0#HQL%24G#_,<
M0DZ5F ?-J/.^%)"66 *5+6PM>>%"0LHG,^W$U]-<F829+1EEQDU<U[X3Q9AB
MAC+7Q/<FL<LXBB AB2+)5R8=FN*,H2P40)(MB(JKJ.-$0D B#;:3&PKE8^,]
M=T3XTU)/!\.4TC-#LE+]1Q=6PF<Q(V@1OJ*EFN&(9% #FDB5$+-,01P(#,H"
M%Y&A)V9Q)Q-0 H#62AD?+"RP$*!<&KEV(*FT945L"BGTR0?-)[8.H.&"8-@L
M/ 1-2?\ +0CE1H4#P6K6='F919*BT4-$'WDO%B:X+&9!$'A4+[MU0<;&E%<B
MRQ[!B]-3Q8 7,RLR!F9F2.I].0HV)6.*?3+M7WQHD! JD5(18*K374*9G&)"
MRHDS),$S!5<4L*22Y%>&)J#.N""LZ9)/(U>I[FY3A1HB(3Z 7-C4$#CC3D4U
M_ KZE)PD  !!%I S.ZAQJ'R6I']5DF.E9.0B$0*Z6S>)DBCXAX) [J)-8RN8
MPQ-9CBDE A#"D6SF%TQ% QP*H4K@5S(F:])@B#C@ I#:LU*RB5@,Q$["8/-5
M@A))G3/F(T!MD"C'>:O4XQC?&;;8E$"L>)C-#WP+' B I[(3$..NHKBR4,0K
M K#)(K.EEX##+H(N'!-X9S#Q'DI2[\_\ 1\SQDYJ4H@U=7V:GUQW:Y3P8#R>
MN#(54QL#,)>;Q ME<'(M!/181,+\??B*EBI!00X)AN!B<9J+!%(1-YPZG]C6
MQ CLL^'0M6Z>SC4"4AS!%.%^)B9SCE[$D*U;1#F6@/\ .2$,7"D BEC#Z@KS
MQ@ 7MGIILDF(G/$IDLL2%YHP)!&/KQ'%2T(&W$S,LFXF99N@J41U55E8*@CN
M>%1B99E*8EJ-(N:V:XJ$IEDM%.X1?T3-S9I2<SNY5<9BIZY $$Y2%NAVK#9/
MQ<D7G)%LBK5T03GF64XB\ 7-,!22?ZX,@"AF9 *A49&F)O@DL'#J'RJ@5BN*
MBRB2-I9E@<$,1NWDB3&(($J%84I4@0R8XT2JE&4D"HB22@LA74\DU!(/9B*"
M'$NN#)0$1!88K,H]C=*\F<J)@)!Z)7"1YY!2,E3 K*)(PN)OM>-"E"H#88!D
M)$B^DX= D D"P0*!!D)M@R(/E@3(H4,$P%@F66.7[&9@-#BO@EBI[>29"Y7+
M9)&"-@B)GB @8B:3P@E"R+>89.('0T5A-#<"Q"YY$%HPJA@\MGM(W4R%4$[J
M8 (4$B)N)K@AZA*E*%)19*8O%AK *Q X"JS+$YR<3DH9*LZFX3,3454\ D9(
MB:3Y@*>)C^>(DDB"QF)F!HFYL(5#C4E!&*-LC$,)%*2<=R;COZEE$)()89>/
M, FY*QV1)2+/9;9 (!@1 #- A,VGD37$PN;,(C86U-D$/78@%@=!?1)9 &\\
M &KE$)ZY%8!!H</+T T*[0J0PG5FW@I6G0@S?<T+V=&7*@9BAF 1+D&1 B?L
ME6D4\DP9Q';48N#CS$Q"6Q2,J"S*)$X88X@("3T+ &I85AXB1A@*E%E96 TB
MP2>U,3 *(9<[%PPMSW5+N+[)[7;J,5Y(LHC"LVYGL 8/)X.3E@T*8SBS,>/,
M\%0V9"4&4HFF<9R<8.55<958#KH*C!!R'3<W,":.ENO"=<> )L;2=JYK;"MU
M?)% EQ1EHG7C$N91>&S; E+N8%D*)U<T\8S)!,R1#NL2=+XQP*( >Y>YFX,9
M]<4" $N)!J8D& 4OXXRD(*[A/Y?.^%(0E &!RB$@-$7>;Y>!@RDI=OOV6YC1
MDB 2?$]>D\1NN*;JK-7"XBDJ(U[WQ& *D30W3<]564GC-9"@2[\OS88[+XA&
M0RLYE+RS\8T0%2$LD*^&9GN6I_P 2*,MD)IC%(]O)%:]L9W&0=Z**X!.!9R.
M937[\WPSC1*0F. F,_6?AJE.;QIVW!$QXO@(S% -5P1F].([;1D(AQ&@B!I5
MCUQB((D&D":A;+GS]$:!-*+>T(M1I_ZD0:8L"RW$D$!K:5GA< - $"*,S57L
M4VR"EBRRDK@F)G.7D_2$N O"X$RR5,K..!4 M&$JPDN$?CW/)^#H %0DV0I<
M2N@XH%60)9A@5@8(4AX@475F*P#(+2EI:HX5-EA1:!M&T8JD.(X1(20BB6T
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M'' ,,,AK$Q'CA8&RGVQ,O=]\!-BQ,^?U76N!?POT.$HER_@^O$,6@-'/_\0
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MFZS_ $1[7D(OR0;",Q&9)^7)<5$+E,SM5:>NNGD)O&,Q\@GM;RU1PB0B[UU
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M;"(;8)*1%0A%\##&Z6MUW51);63B9"H(&%39:@ 6H#7)F-X8ICSZ'9R#HYY
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M%]_WQ$:8@Z%J4 JWI*QP>Z)(FO*AUBA^W)A21($HMF$Q ;B.XXUJD&&V(M$
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M'HVB/XX-1+;A\K"M;-QQCW^^8_?-<3)F4*))"PTG9D+,<G$MR^(P25I$@!/
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M8N##*)DN8 FHY,Y"7"X2535D9<9U['"!N22)C!KQ#R&RE1G"(!46<D6QN.+
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M$+=G!!D61:R *X-.K"Q8-1PAC#E]"L46 .$,AI:YE9/@7%@5+"&O%0)7P&"
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M?$LK,5 W41T\;)3B$.(4Q20D0RG!2_2"PK0JT(>$=0<;2&:E$4&RKY.,547
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M*Y,AB^Y*U=YC'?Q0L*%S5^9KS7D*)+Y,I(C!\^(?.'3"X>%3A*A,!9=EQ?\
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M8G$P:X)$K)GN<H/T@CUT C*C8UZB5AQ\1AX"02HR620S%Q+-/']1 ![I5;*
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M-3)#>8HKXX=GI#,Z^?;UR)VGDFOI/X?'$VG-&(_A[QXE.3,@.1!6"@\SPEB
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MA8AO!/C'UWJR704$"(U669<?'SR&5T#![%@6\%,I/$091D#@$C +EN(>&0K
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M//9@!5,HC0(A8 H!D2<O!"02P E%0!*J!+(7R"Y9 $AD; FKI'#EK@:_BU%
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M$XA9GWH'[F##O_T'-@.*;.D=XC'FN!/U#'?[CAC3*]7;UG]ZY%^,1J/I_/\
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MR)&+[J. 8$:H90%F8=LP^V90"R%37>R55;#YC"W%A)?D)H,IN+Y"J04*E*N
MHE:6)ZJ..( 8LCV20!@_%X"V0LFGM8Q.@+3KBTB4R< TVK;(/V.5TRA)O (D
M4)$7BWBMQN$@**P%.\,%5R?VP0 -A0#*LPSFL/$XLNN#,H@1L;Q!R4W8D1*
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M$%@:J0\MVI;4YY"1B7(X7J)O<FZWPI"Y-$&5E+'^W7!1(9(PR%$NMH!<YSR
MH%%"GSQIO>>2C9A1HP^]LQ<$W3R'G015T$J&!)BZQ:)@8629>842_*UZ0!Y0
M8H?*N/3WXX.P \D=N]].^T  IDE 8F7L/K'OAR5",)AB)F58K5G0\#!2 -""
MP$"69(_$\ ;:!D((E4$DS+,Z@Y$*Z,,%)*3&1(WT1/ L(V).HA$%\;CO@P@(
M@C:)68K8DN.1.25+*;M!R]]/OB.:4'!326S!JIG$SQAH %BQ<$RP6I.= X(
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MPBE5OKD@I.R:2HV:\K)$AD>3\ 76DZ$R#V$;\1I0CQ-&6XL[(#W/ (A(JNR
MO%F"8C=\*\G:! @8%[)6X8KC1$@)5+0$L=M,SB8XXJ8RM$( D$5!%JL/"(2
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ME'_'?MX!P!"/@9]^^-9'KQD>H^.M1PR2(!-)()X61R8F.$*"   H_GEQ5BR
MI#2.*8R4\ 8T JM*UPH"B!!['\O+D \2[RSF?/,:*3.\=\6^062^O>-3R"IH
M49F+2RZ/U>* Q B_W_.*[*S5O?GT<:30 "DF1^O&:E9R^9^WC'$R+[>?',!
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MJM /%,LOHJ^.*.X;Y>B>,OPAJ; JALI$@P'Y2<($CIPI'65.R3O;:<*T25*
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MZUY^[LXM*'2#C[^*_OD.4+B^/+_?SXX"3R(8:N][WE][>7KJV<?4^_/Q^O\
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MW5XY5;]KFYP'G,"_EXF5U,X0%6=?6B&M<H8T]_&'&".=SISCAFT9\4FZ#BW
M2@&B<B8ZH32QQYF==/P<1<J2LR_!NXSNC<S'$Q'+ES'2:W,C ]SEUP8\,SEG
MB'ZO8\)Y;C/?EGKW,F-.1LA$GYG7SHWD-1,6/$U#%5QJV_3,[6^-R!L[*XR&
M[=7.T3M;V#IU7V[/O/&MG>F8=9=/!+?Q/&,_<OEZ-\G^<[]?&],_WPO 6^WQ
M<W9_KKD_CQWZ=7YQ[Y.:=PWZQO?[ZU.,7<^,Y_MQESO'&VY2,Q^Z?'?YG% Z
M#A,@C+28?U0I;69)M3*2BX+VKFILZ0YE0$Y#CXL+=$M2F!J! ',YSI@0@@C
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MY;7MX98\/X,%/8 CH(32BJT.%!I-HJ+"*H%Z-8,O%!"@;5TR*S((;L[X<Z1
MHNBN@RP4S,ZS[E70ANS"LL-6<Q'+0I.;G#5+MT1[Q+I *4MP#2@S(4FUK;/E
M%(*8*@90K--<Y&& I$FRB8Y!Y2VL7=E..';<RI%H@;NK,;(CBT&,:<;N&BXH
M'&*(ZTHLE$130;Q\6\"0*#Q5$/2NQ5DBN8AA/G)DI<;"EQ"3^'#$C929O&,#
M?X&0H#7@<BM('HX;H3**YC"P)094VXFPP,/>NBA(,B:YR'=XOS L43F02 @#
MR:*CB4,-;PGAV0F/3XVL&5$%BXCPL9V @X%C0LR H4J7/NWSQ4HC)F(=22-V
M_KB.3*%R43)$CGQN\H@4TA2D9-V">>"W'@H !<X"?/+<L73CWBKUW]:>.%*X
M$ L^=PUOK!JC_E=A9^P" #%(H=A+51P J)HR0W$N5$ .X$'2Q]*EA5]%V5]H
MS-# O#(LHT@=.Q^".(SO@8H"(E:V3I8CW=\H:ZBE#,?&U1I5@1<T($ +)376
MLMXX=5JC ![4EC#EZ2J>-2]IGE@ TXP45>)LI'4 S 1&^DEK76?.W_'\^AK7
M77  )"<3D3CC7!@YFF'XQ\&\3F%A^GKY\8^.2R=_W_? O\#<("2 'P *J4*W
M^1! .$ @KC%N/\YR^6:[X^P_7]]_W/$<#-TUO^]^7E^?[9^C_7+ )2;WYQ_>
MO'01G'77>=ZNR_H>"((TU\3/6>VRY]\K]>O$N_A_]X9@EQ^-]_&"?C7&"TRY
M9,QW@O7CKC&-KYJ..NRW^;@O U?,J[_</E%P3;R%M;;L/MB^IB_._<,/E''7
MATE,IWSV#C/A/#\MQXDQCE+IOS3'K6^[W,/&K@]0R-Z76(XGF9;P7'M@\/\
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M-!;95\7@OP+(BE#:@+H9=QJN(621JJ6:SWCC2*Z%($"*"98>YG,RX$) % "
M#,"+XO(Y(RET%H:($H-+XY)4](#"=QD*O_)ZU)=A5JLEIV$X4%#5G$GE 2/@
ME-B(I45$F)WC'[%.E:",/;"_-#>SA,8@!LN1!0]TL\XT]3%*FN_(/5_6>;TI
M%R*Q='GID/'$$S@#3"!JUAEM#HXP6MP0K1:+<[Y"?BFIJ4%CB4V/7$W1'/V
M!)GZXY(YQ//XIU\')/Y(^/YM?UX0(VHBX;\^9UF?XFYUH^[B6/?OUJ,$W]X9
M>_PE/GE$4PAY/T>'!K>9CA6&C=[[LUA#SKN3BPSG>+H\.[;<^?CE.Y0-:G3U
M,_BYUR9,=LGZV?7ZY3J[GV==>_06O$5_C_&]?RRGA$^L7\*2WO\ WXXK=8P+
M^ ?1<8D_F+E[%G5S,ZTX[(1P\0\6_P OMUZR?F< N@3WO]_FXV9SQP6B+\CL
M\LQT?? 7P[V=/[DWY8QS5_E?OZ"XX"BIWGO.\/G]^]BX()T^C1Z\B:\YX#%
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M+G7 :PI'8?&'%S&W"V8%F'%!3--NX.(#;RHG E\I/9Z>&;@"CG:8L-^)/FF
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MU>CWW;T+/%_\[]'_ ,^+\_OXY4CRQ4V43!M+FSKBUN!AF@Q&KF@=>^.O5 J
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M1N;U?W?/=WDY+!%73N'>,Z#KS\W7B2?^_/\ SCU>.O#W^J^_Y=E#/4\ZZ/\
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MP0TUOW\8QYS_ (4Y3!6LS;'SY'[[]'!KISY) &^4_P 7M\P<'24%Q-7+DO7
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M[.H]8=^&^?Z\RLQWGK_SW+LO5Y8ZSGK\X\^>^^6F4,DB4+2!2(MR[>!,K-D
M 71B';/-Y,4%AZJK9XLQE]\'"K&8AY[PO][X3",*EX+,O"&YZY)$(JA&5PXT
M];[5X0!%P8I=^+YFS=W-E0(&Y,,CVGG!DO!?=R6X)82XQ(UWCC7@"Y4+:C _
M9]<-, F#HQDO?6]:ZSU49,)[G@Q??,A]0%(@3*IJ+G$UQ!B#-&1 VGC]X_\
MA#'_ )?S]\%T;^=_GO&-<K)'PW\D_'YS<\-&8NYYQ\_[UR&LJZO7M'R9[?0G
M!4HQ['63/>O&]^.?-CX,"V_R^/7(&#F86(*.81+9E,4!I12&O2.0R]?>]FXB
MN11VI@9/#Q6I&;%PY'#KY'-UP?WZE1/_ (E8\V7>V-C.$I+HE62N+V^ WF1
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MV0J45*8I\W']T&S1S(L6&)OU-9\_X-I"ZDQ[5GG7 L P3/\ WL\PWQ:A8:F
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M.%78[#Y8%1.A>-JNU57MJK>\K?;_ /%*N@L7UE[]_.3%O$=3_O\ 9SQ9T_\
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MS&#K38 +9D#&K;I[QVYY:9CK74_[-?7 *.>FR.M$3N'Q8$WE!(BUPJ"!>8V
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M'.'7QO3C5,\_O]_O_+QM(IM;UK#N><3D]MJ0QR\1@^Z_8MA5DE9%G)GZ&[.
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M.+@E\[XBL$"Z'9AO@N"W$1>MT1I,6*U0@]+0$1!@$"0,PTR:JC7W#&WG456
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M1M1KE(! YA>0-,N02VF-!?;"<(&@)4Q(4$SDQ:#T<4@ZFT)C)UO[DTT>O%
M[H/CU)\@\9*@ I4TC&WWJ>>(![C:B/:S:?X>^.6S>0:\S$>M^N*="2!8^SS.
ML9PYXFT,E.D%O@CMKOIXT#T(Q$OQ^?D-<>YFZ,"0,D=N/SN' ;FBY2%<6^=F
MXXX,")28H?6?AI_G@#$0]-YZ<Y1WC$G(X$ =1QDA?$RLIGQPT0LUMAO.#K>M
MO"Z<2"6@]F,^_/'F2C8%4WESZ1SCOF3$E(&#I!Y@OWHYD%(^P9&9R]8EO7#D
M&%6GQMK )H)UCBR&@X%#Z'KR9S9OA]0X7!8;2>9F]EZW0#4P&?BCF:+I.:[A
M!IB>PGS\^\Z>>250,I:ICV/&2B7=IG+E=2'^.&+:S3'8_?P\265F+VO[DS4/
M,>+C$#":7:!=#@JW'B<7/0V!ZWVXJ'SEX2L@0.:_)-3[\Y(8I,U,.'&?DZNN
M* [4E%<=?K&OMXLH%4H+\GK=[/@Y XK B7;7KSKK\JZJ#!0Q(QC^L[WR5)9^
M<W!G2/Q"UR/*8WD3&>]IZ_;>9"N!%BDW_F:_!RVNJ@A&X'+1^T?%G(R (J[?
M-<_XSTZ*IC]LS0IKOIS\/ ZBL?9@COWY_?,.*;H$/3=]]3S;)"*DNVZ;6F,_
M,MY46#&VCC([V;[!^@B68:ED?G'C7O"<$,X:@=G<M;B[^<<( "XR0,?E#NS/
M!C@,"Q*OY"5P9Z=\ 0PB0SYF+F8(9UWP="C3/JO=SY^CD 6I%] &M_UYNBTF
MP 35JE/S\-?'87,LBNB5_.:'+!D$8T:?L9"?'CC.'<[@N:I9'.H^^ J1YF"3
M"^RZA73O%=4 O8=ALN]]<K, &T7"=E\^/%O+^"@"[,+T/S8&,\=WHL4(@#%A
M*E^6^"XC)*6 8 O@1DR]YRO<$"(NA/!^![F#E3#>UKWB9?*=AXO%$[#40=RF
M\_-.^&69@HM8X.00HSZY1' RI2@ KF9SK?CE MJTB!51MUJ?XJN(&8%@E2S?
M&V^*EHRS8!,%,48X==:Z%5-&H1!K>&A:#?D:NHPK]$G&BU6BJ<J$(J4LOGE5
M(2!07/:KVQC+$S+19D#4&Y;[7<L;@71&,E](&%"E]H&E$C;<*L@/F(C^",3X
M7A<>?L$=BH00Q" ,"I,8[93/FOIF>3^Y N0P/BSM_<E!@3#F96X?*PN_5*5B
M=CT6J(LY<WP<T3M:QV^=&[)>'4!J0S1L@#<(W@MG5:Y3!+VP=9DG*DR)2 N*
MJ4]?8\='T2*RY@J$[QCQ>8:H P836:%M:J?7%4)9MUQ%<;>^\G+*I2X&T?O,
M'%ZSS?2$ IG%#Q$3'9OO72"8Q*,P"?%[>=8VNTFA+1"=8?SPJ8T <EN1ITA#
M)W#833*$$'3\3S^\R@0.%:96PGSG*4T3@Q(*(4$'YAXR8#D_ &A@'#?&^[YR
M<"SDH$@%R2[=?6.'4X"B 4<$&N/)1X=S)0IM*1%3$Q#W%O#7-VQ2-3L*RX,$
M<O""L@J*I2B7/[79M:G,A*9)!R^M>.(3,LS0P-]?K&:O!SP2^B:D]>-[SM #
MJ/1ST&O1_#R!%R;*YB;,XUV>$YEJ 1,:\M,*'Q/GAA,8T3/A>[\%)]T0,\W+
M5=]-E]^-2]S4[S5UVGC6,G#=.M+F>@\U\M[O<TVI9Y'5'06GE#FK]3";N+_I
M3-QG@QBMC;O,=U_8_GBQG0 FRA&>O)K1C/"(3.4\J/9/IF^+NRRJ)'LSB>/1
M."R=ZG?>&PZQ83YX@$$@(K6Z'5^/?CBI>HI<QK5G'HZJ\""*<M&/[@#DN//9
MA(>#=V[?#O6?H!I Y2C7ML+WN;]P:(R1?,4+,&,?KD$+6I2EO>\ZT3.M)AD]
M!QYK;?2,#&>26"DR7!M<PRW>^\<%$C(#:,DQ!\;NJ5Y ]:)L4PJXR9OXKQ.*
M-*-D\9;?",?>.245(6,8$Q;W-[ZL1ZL$S:B#\P\6[UQO1A+.:ZTO4T[](CJ
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MS*LSA1#/:Z'A\)E[-@!G;%>7P9%\R\@<0C<4J9];[AXX*&PE7\;MKY?<WQ0
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MTT:J%UN;@6$ I3?Q!@R41Q<C5@6N1D;P( <.R 134@:ABK1Z@)501<W@5&R
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M5O!,M,*,\@(!N]VWA_O )@I0BK*17MXEZA0*561*K!#.N$U,6JAQ6O[].=H
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MT[TB<:GP\JPWP970\:XP;&9B._6/KDQ#1@*A5Y7@* 11R<=$RS0P9FDKD1X
M[+HKV-&W-WUK@U:LPFM37CBE%4HK!95>O4[\O"!  ($HS[?%LZXP0]-#4?[=
M^^=9PW*"0Z,EH7WQQ$4+@>T[/'^]\ @"J#8#7[Y=JB#$4=O8WB4\&7D"@'HY
M*!5+[HG^7XZXU^# P!=)K]<)@&D _7@5 T'2EBR7[WWQ+LV$ 0# )#77&N@:
>8;N\!B   0"?W.^5J-E&8?YX40'QQUB^+F>>?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>businessfigure19a1a.jpg
<TEXT>
begin 644 businessfigure19a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M
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MQX2G)3H/=U>D]_4  'GYZ;G;.DX]FQI,.SX\6RQ-7+#\].Z/.;TFQ7
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ML>42AEG[3?ATV  8Z*'*7*^,0WYWB;]/U  (*<7&<?9&J$OC##,5,Q.JBS0
M#D@@9_$1\W$HW#5FZ,I-G'80 !@'G*:TLY%6EB$:/L8B>B3IP
M
M                                                _\0 +Q   04
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M8]H90'3$3=/R%1[OQV3)'TQA@590A]P[>AD ^H7>#6%EW+M=$7F>_EKX=/\
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MU[4<EFU  .T? ->VS;:N9%\"WT J)$=X3)*[!@Y$:@:4+#VF+\%N3;&M"_I
MD)U4TJNP(CD+H!N!<Z686T\>&#(NJ1];:31QZ760=<UG%[L>$@-P=N PK15'
M;<6#5!NAD(NJTYL38CM$C=[<=L3%56)XK1F6,]8JL2 0Y ]HD@V\?+UV63JZ
MFQ[/6OV-%RVXW!OS\L-V9[A2[,Z75XB;  =M).  '+OPNL2B?0=+N5)YZ#94
MNMM@I75?QQ+HZV;7&SZD0)9"3>QX$>SRPRS,%&F[01+N3:TILVW'40JA3YXD
M!=G?3V2L#$Z3K47WT>*_:PL1>5VV 6;5?2=;64;!ONGGQP&ET=DLNB'7I"
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MZ_A?ZDD*"QX 7.&JM5UTC2=O'],"1)$*'8$6\K\\-&Z\1_\ (;CS_P#.-OF
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M.;-O-;,39W) U'2TKL?=EBR1DJG#@-!PXZ?ZS8::#3AIP\.F+"]["_6VO3!
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M_7&O/CSOQOSOWWXXIII:8ED/Q6S*=5-N'F.M^>/WK49OAB Z68_KFQ+M.5E
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MW#^.7EY\/UQ#64\P&1PKM;W;]EP?EL>/06.N+G[&=$L&=5+&RAF S'H+XO\
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M446%R3<DGVZJE2IBR&RL-4>WPG_I/,>?' V34EK,T2KS<$G3N6P_6V)=F0M
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M#EPEAH1'(XE*D-LVG7AKN$NI;BC81SIM>*Q6E*[N78KRJDL3$=5W+M<:F-F
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M20)([H/+668R<QAU)0)J0@XI7L:PCR",986(U1$^%Q*G3F1R@F-H]0&&[J-
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M(I/U*N"/UTXTB 1%/A5 $4?DJZ*/].!%,!(OJ#UXIU8'8TK\W(>L3JD<LO\
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M<0M2+)Y*Z,AWZ:2>U#'=BDJ+!2:2G'%56*>PV].64B7_ ,[_ /_$ "L0 0$
M P " @(" 0,$ P    $1 "$Q05$@87&!,)$0H='A<+'!\4!0\/_:  @! 0 !
M/R'_ *0HN'()[>Z04 M)GU/YB-[7?".X,1AB1B#56@%10MPRCZKOH_XAEP(&
M^14!+^*G@Q\OEX> C>$_(Q6Z"@2"B"3745AA27AHJ5@Z)4[$PG ';WR"8>2B
M=)_*V$A)IN B_BR]?,@(. CHLCC$8[CB"@4H@]&.L-LYG7RJ&>GW07J'!:>4
MV835H("ZP2*UDT5?#05U@LP6(K#D5K4'$8IB0/I.-E2&&Y=)@[)9 :Z]I(9L
M;@*60 "V0;I;%2;LR:#K+]G H^@B(WY Q-"H%6!7RJ![=?X$+DV3Q'_^GEMG
M?9TI28IUN&F86(X6@M-"E$V;7%(^A 7<HY.Q^28XU0?A0#!U %J'AR2$@6HA
M8F=-G'!(8$?*50 + +<*:%(N?<='V B_)96T \%+D'(H%,(W1D>P<B,U1W@8
MJ8V4]D (3H;AAXU?O0@_VRYJM6>6S3(6<-S$E]RE4AO"-]F&H"(G R,V_F(8
M"E%%@5)B JF(G3+0_%)0F]")X-&G\9@0P) F;F<&3D[[5;)/R>)'CT8XD_U)
M(SD#A5[*@:JFIVSM=ZZ6% .-T, WKK%/3O\ 7^I1AAI9I;SP0@UN#7W#W=.I
M"0WGZ4!@+>B=B(R(5?C8I1(IVZY-WU,4F.R6Q[4NJAUD17"$)8-"U9P27MG.
MB*9KP# Q;>U,<MPNYM%%G#8EHX<KH3NIJ:-FBSE&C!' HZH**KQSC#<,6OIA
M\F"-6?E[L^K5Y!*I4T8C\59PKO014$6!@AT7A.*+3S%3!>FM(1EIL(-\EG0C
MAEJJ#F:I(*1X,WDWKO+:K&(B1W>;/(:)S M3%UND-,#5+1"R3$])RAYX<Y]^
M.U:VLG0I&C%/%,U@'R:\&#GL SJ^ML\-H;Q15Q\G@,U(G6B6UX7 K#>DH7&D
M>V @8+N+)2K+]=)B5[:UN\:0@^:S#BEMW+AA08+9S\)_CGQQB-E-!KB??H<F
MW(%CD"TTO-<X_/P$6F4Q2FY!56YW\<J?'NQ#&-"K6W[E#XA1^%^ 7"(J?W-D
M8K%K:7IQ2D(H25K:._ 04B]8B KH8<I%055FQLG1)YTX3M&%C'%9.!#(=Y ;
M_P#)#T*$@:/3T'S,W^4NBT(-[0U?6L @#T!/Z<YM6XC;WZ=>>\7:9UM"[4W]
M.STYO\IM%TEO;-7LUCO*=%0Z&G].S[W@!4 =D&UY7WKW_P#<&GKV@1( JN(R
M=D.;)BXX^S3 #US%1VD3^N,?D/@2@_S(U\@)M9/$%?TWC4-1LGQ,P%H_28!M
M<" +AGD*0]&X3@_Q+Y@AP0;M*.ZVHB7 R:'WID#:R./RH\WLXC)!OS396]HF
M4P%^!5/D<8 [\0,J\57S61+F@EZ92]=T/F,(:/ '1Z.[X[(8TB3*VZ!!P/G9
MDW9L==2,QYLNE"H4%TS2.4WR)9CF 4@ JN>V,-N:?7O[#!_ZXBN) ;\AB 7!
MP[+^@Z"R)\Z]@.X^)[@1_BH>HC1D[E$(I:;)*HS2Q>CHB4VR+%WX>WT%>K'=
MS&9EA: EY83Z0;#(+LI^N]2&.9SX41(5-,>U)XY9 5W6*\2*T].TC5;\42)0
M=HG"$(RMZ$-*2@Y][75U3+HLOQ44$ R2 2@H!,A.-8FM-<U6J B:$I:08Z9]
M0S ^ T,LT)QUE+R:!1LFJ,I!X#!<K!D*ML8 W(BT/@3EF&LD)" (,>A, *Q-
M<653B0( :$G!!-&MFK D&M8:]:=<'84? ,IG%2= -DT2='!:^'3!JN&VVDN
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M@=/$P>3]60>5/[C_ ,,)1&(,2%1<JX/!.B'-O4=B/C0?'&M9?]%7D]K!_3@
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MX,__V@ , P$  @ #    $
M                                         !W44C0     .   H63;
MJ  $,4.10  'SB$0     !"3,0 $R52:   ()5#D  %18@?   /[>=&
M      );+?4                           +B  ,  '@  ,0 !   ,P
M-P  +   90  H    '-%380 -@#"L0 ,X'T^   $$$&30  >H'<,    *U=(
M<V (V'F 0!+!.\X4 !TZ^[SA.-:"@J:   !8=U$-"  W9#WS762#2."R;Y#)
MEK25<+]J]GP   "QGH5Z:V&\Q": (:#)9\0!A+ 1"R !GLL/M0   !FPR4
M)!6 &  ! [KD@  /,@V2   "Y>1@     #Y(D0 (=4JQ   ?)@(   ))9,:
M  **AAR    ))/-X  !;LW0   !<$8(  !"X_8  !(+UC(
M
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M4!I@# T!,I";,,5323 3HB:(&:KL/<R*0FDKF6CB-HM-&@3HO1OW3)$<AL:
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M^.R -E2A /Q"Q9$LOE'2*Y.=81W Q*( 5$W%Z8X^*A)_ ,JK #*D#ET/)\$
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MV*>.0$%-AW".C6)V$_?= Y8O0;ZKJS!\QM!"P5/'16^!X 1"5 I80N:03?\
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MOTU#O[S7ZN_RZU'7MS[^9LZ ?+9_O!Z9N- "'UW=S^OYU/\ O6$QZ<?7+O\
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M9W@]^^&<I[(VGD3S]SB[PY0#2"KC'D.YP0K@%6(54< #5DWT\(=,PVSPW&,
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MX_<O^?>_SROE^O/4?S^?GSU'Z_\ W/\ _\0 *A ! 0 " @(! P,$ P$
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M7>P;OI1>R,X]-U>+F\+U90_>\'C7O% VP$4 !"E%<#8MN$'85AK2 C$9#^F
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J4QG S7?U4[S>!'Z)M:SD<GI5N%E0!]/_ '%G!^[H/)U<4?NF;.D^7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>businessfigure1a1a.jpg
<TEXT>
begin 644 businessfigure1a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X1YB17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(Q.C S.C$R(# X.C4X.C(Q  $
M : #  $    !          @   $$  $      0   0$$  $   "%     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   !''0        @ "  ( /_8_^  $$I&248
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MK:?]^C_C1_PM7Q)ZVG_?H_XUZA!X9\+W-O'/#HM@\4BAD8)P0:D_X1/PW_T
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MC:W#:%LSN4I+("&R3G[O/4_G75&4>579S2B^9Z'+7,>GW+1M+XJL_D&!BPG
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M 89R5_VC5>U_O?E_D3[/R_/_ #.%.A:$.#XLMO\ P#F_PI/["T'_ *&RV_\
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MP<<8Q@8P.GZTZ/1K>.2)@\A5 "Z$C$K#HS#')'^'H*TT,23^U]/#1JUY"KR
M%5+C)ST_.KH[_6L:/P]##-OBN) I*ET8!@Q4 ?R K9'?ZT@,K69-.M(?M=_:
M"8 A,A Q Y/?MUK+.J>'E4LVF;5!< F%.=HR>_Y9K4U/5[*QG$%RT>2NX!QG
M@Y'^-9HUK00"!%9#.<XB'.>#V]*M8?F5^2_R,WC%!\OM+6Z7%DU#P]$$#:>A
M=FC4HL*$J74L,\XZ#MFIX9]!FDB06,2F7.PM"H##CGZ<CK4(U[154*JVH4<
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M/_/-:/M9_P">:T>SAV#VU3^9_>5OL-E_T#;7_OV*7[#9?] VU_[]BK'VL_\
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MO_K4?\)8/^?$_P#?[_ZU%%%D*XO_  EB_P#/B?\ O]_]:C_A+!_SXG_O]_\
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M   "H&QC;7,$,   ;6YT<E)'0B!865H@!^4  P ,  < -P S86-S<$U31E0
M                                 /;6  $     TRUL8VUS
M                                                       -9&5S
M8P   2    ! 8W!R=    6     V=W1P=    9@    48VAA9    :P    L
M<EA96@   =@    48EA96@   >P    49UA96@   @     4<E120P   A0
M   @9U120P   A0    @8E120P   A0    @8VAR;0   C0    D9&UN9
M E@    D9&UD9    GP    D;6QU8P         !    #&5N55,    D
M' !' $D 30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,
M     0    QE;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D
M;@  6%E:(        /;6  $     TRUS9C,R       !#$(   7>___S)0
M!Y,  /V0___[H?___:(   /<  # ;EA96B        !OH   ./4   .06%E:
M(        "2?   /A   ML1865H@        8I<  +>'   8V7!A<F$
M  ,    "9F8  /*G   -60  $]    I;8VAR;0       P    "CUP  5'P
M $S-  "9F@  )F<   ]<;6QU8P         !    #&5N55,    (    ' !'
M $D 30!0;6QU8P         !    #&5N55,    (    ' !S %( 1P!"_]L
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M[7(BJ;^9UJ?'MS1]UU-WQ7+3TW%>!DQ>J:>W]O<+M@
M  6GYQ^F\[\J]KC68K?KQY+UW"Y<?58+\W>FVKFZS!/HN'8 "9^:?FWVCR#Q
M_P!%HK]B?8/SIH=;HL*/7))R5E[.I@P9)63!T'1YO0[_ #>;OATF7'K[8_D3
MK\KZ$Y>]YUGP^JTV>'M'IE<G*9<'0:FY[9I[                      ^)
MN]Q/GOI<^T_2OS/I.)R8$3$F.+VL'I>KF]>T-](!+PWP7U+S;SOLZ9:_3OTG
MXEQW+[FWV-6R:P,&YL<VGCLT7.W^KZG%[#J\5,4I=>D2U9=+K$T)1=,)A4
M                   $P"46*A6J,C)1$@!!-:A-(@E,@!!5683;%,8#)$D$
M !:"R)*IL@0A&E)    (Y(F%1*01"2)2CD@"L)A,H)@L,1<7BL+63!"LHE:+
M2,2Q$)D$(L@M4F.2 !$IA$+7,:+ "PF&$'DNYHPK3J+XX<-/+O*7X^D^FQ.O
MM.@C'@R7Z.7$WK],<C>B9$H    CGSOT^7I\ENAU[[RMM=FB/%.@P[.GS:_O
MO+Z$6R2:>U/G;H\_ML>735G!:OHFIM]]69-;X2XR'SETN=TV'-HLE-5?#Z]J
M='5L'I^#;I$0R;#QC;U-%ECH(KS^2G0X,DG+?UKF[BU8Q) A\Y];F75OU.OD
MXC)@WDV][YW1K(",23$5/$]K3\VW,&NOAV5:Z:^7,Q>HZF[@R4F8,T;)3D\N
MKLZ3R>>OV#R.K'KDE    $='S_U-#S?8UY&.>VPY]%FIR.7'Z+K7Y7+3Z>Y?
M5W>*TDYUC^?.KI:>^#'$Z#)B^I>5U>OI>93)A+R\^?\ H<_S;9UYM<O*[.O]
M&\KH0J6]FPYZ5M$)AXAO:'GF>D&^*5>W0X;]!6/=>5U%HC$D ^5.SR-?=;6>
M^T=CG]G%]/\ 'Z:X",23$BEV3&4+B$36(%$531*5*35"R,B4    1$RRDA28
MK55-M9K:J4:$H")(H)5328I-L,KR\5A,IBV)J"LK2*3!,(E6:75I)58(Q) $
M306I4MQWNF%@& EF''B_)GY-^;MOL[&@U]2D9*QAFY]B#BPYXKT.YU,J=;BU
M)&6VOP8XTXM]?<LK:_*U>'6GSGY[!H65Q@ 5*    %2@  !ZUW?9?7WO_M:]
M@         .D.RJI=6L)D   "PEF'%3\:?C/Y0]$[OLY6UGD3L1L>OL,F_L\
MF[P7)\IWG=]?S^AQ<F;)KL4Q<'+U?.Y$[?[>[S9KLV[SFCY_?;/5\[\YXR#K
M<H !!(   )E)60  -]O]+]*_K_ZCE9LPN    ,9D    -^=A6?EO>?4>A75;
M>MCBT:T3JVQ36V)CY<6:MMSK;.*)E)BTQ?GE\_\ C6/#H+2@K%(4FU;Q6LJU
M3:JEDY*VK=187 J4B:S8 "PO   @DF?4NWZF2R@  =_U.]Z1V_4VQ%0    6
MEP   !M"?K[OB?']%Z5Q]'S;ZU\XA6C2[6KV.OL^3='F>N<KJ<WEQ8SWO@^B
MV^MM236X-+\</BWY8]I[_M9O4[>ETN3%K7E-+S\VFYEW-CKK[&NR='4\[SO5
M=#N>'^9^?WX]<  "H      "/L?W_P!G^O?:?5@  $R+"I<    8S(    2#
M;B)(K, DBI0 I$QI237X=7\H/DGYOG;W0B8J2+S+OMQ-?3MC#L\FY$M&:\ZC
M4U-GDVM+K<;+7&+2X    M+@   (M][_ $?[A[?WO9@   8RXN   !4C$@
M  M)H     (Y),)S$+YA6Y*V)23(53"T*9$4 &,R    &,R    0P95]9
M6K:6IJ5   !4QEX   !,-N 5K!1;);.*L6K:*,RM10G&"]/YP?H_SZ^;[>+:
MNV/',V3.2*S8NF.>OAEQ-J=]ASQD:+8P              ?8/ ['ZC>/]9;6
MPJ    6%X   !T!UP%7YX?2_G?RGZ_S'38=G=Z&?S7M:$1;]O_@_V+88LPC$
MDQ7I_)M]?^6?:OG.SU^OT.(S8;:TY#:PX<NOW_-WXF7%YSMZVSK;5GUKS>MX
MEN\[X>]1YY$@            #OM7/_3O\C^I9ZWJ7    H8C,    23> 33Y
M(]AY;A^QI;/2RZG/CEUI)P9OM3Q/L)6/*(Q),-J_DYZWRL6^1, 5!0%2B:HH
M"ICED@   !C,@   !C,@  !]2<GI?9'"[&)%QD   !0P$@    CF< 02   &
M,E$=7Y0Z.HM2L@ !0J  "A4    H5!0J  4BWJ_/V\T6   1"+5    !0%0
M  #I#L0     826:#-K_ ,G_ -?^7?1'*Z/<ZFUYWMZMEJ\7DQ=)CG=XLVPR
M1XUO:'6ZVYU.._#9:35/'>EH(D        "F2?V"^?\ N/T1\GZ0   "@*@
M  %I<    =&=B     ",230YL'\GGUWY;[US.CJZS.M313'*[>KOL6QU>'+R
MK'(R1(KEZ3%DPY*<Q.+R7J\X    "I0 05LF *1?]J? >S_0'S/I@   +07
M   M+3(    ;8ZHQ2Q*28LK9*LQ2%0$D192C5WQ_C'[7R&,MM2L2F:16L%H1
M-$U@M")H5A;,73%*VNF*%4H "DQ6) [;!F_2?RWI*1*"0Z?!FS,@   %A4N
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M%EA,J99#5F5MH,V*LU %"H!VN'/^^?SKW^PQW &$S    &,N+@   7$8S@
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MP^7:B,L+5Z.XZ7&T'/ZFVW>;K=+I9M?:VG?\SHN-Z3C_  /UA> 20   20
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M/Z ]3Z+R;I^=BX]K;]'D:'A^DU'"]AV_I_GMNQH\OP/;:SSGK@
M           +LV/]%_T=^+?9O8_-P   *$X2+$$((LM5!25I6K%A*(U+^5^;
M]K=AO6UJ3"LK75J55E>R2""83.&)S    $<N0   21C3D0"2"2 !87)J@D@
M$D3L^KZ'Z/Q&:;    8#.     "PF&(\ZV=;QC:T]E-X]9[6U>7IDPS27-.H
MQ;=M*^=;NK+I'7Z^WI[4^C-'=SQ8    <2:(    H5    * J    4*@   '
M0'9      C$HPH\9W,'SAU>-2N?FKXIM9WJ=CBR=U3)Y]DQ8XMKL^MI(=?AS
M0+8_N;B]O;4R    #1F(    QF0    QE2\    Q&4    SFZ     !&))B.
M716)2K"@$D%H1* "0     QF0    QF0    M*E0   4,9E    ))N0
M6DTA9M?\[OM7Y+LVJ*6K6&6$%:D+2BZI&%-Z6M6PJJ1%)BM;4RS5569.KO?6
M/QC]2RM?>                    Z4[<     $4E&LW-#\=OUI_-OUCQ7U#
MJ/.>Q\^[WE=SAVI.OFW7(]3@V$#H>?E:NSPOJ_!]AQO19.;WL63!CMI8,V;2
M[W&ZO0Z5VIT-1N\[K.+ZWG.GY;@/8?.N=]%Y#[+^"?K_ .@?F?WT    5*
M  %04    *E    #HX:#)B^/MG3^]-;>G5F&B;%H%HG57K8YJ3.B8Q)(&UJ?
MF'^C/PUBG'93/=?"Q[>.]+\2LJ,=:Y+MC6LQ6I.U,P9(>2R=2MXNC)9:<EL&
M/!E7MDV=>7KY?N[\\_M/<:'9O    ,9D    +2I4   %"PR    &TJ_,'J\J
M[/J[JF7T?%L<7&'M+7Y>]>MHW++YY%/I'!L?2^INQ240-CG_ )J??_QG3:TZ
MU4M56U+5J5K:DPF$J0J 6EP*%0 2<&S]Z_ OV;L-+J90   #&9    "PJ7
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M^3R\L,?FUS1OS=!6]+J)P!&/)B>L>?LFZEQL)^C=7C2E, 3IIHO<\*#@/SE
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M=>#0:(24+J<.:)FSIEY2,XI)2GSL!6D<%)UGOAR66\G-FH %-6B&;-?9_,J
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M3*E)NFJ!4QPM:=V_=-W$5\8X=GJW:$^S1";<GUI4M*5%*3C"+;GU^:#'"=J
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MH\8X3W9.AI#XH\8X3W9.AI#XH\8X3W9.AK/^*/&.$]V3H:0^*(X3W9.AK/\
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M"3E.=))F;6B8IT_"4NX5*$I\TU9*!TS_ &;1M.BC8?@^*K<M3R<I^=F;C?\
MX/NMQM)L2Y )L!*; SQ:N$JBW"OK5*)Y5J;3.YETA$+$I.T9CBTU>MDQ\0D
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M*7.4B&-&NE.,6KSBJ9M$K^ME4-#K6LD68E*7=HL6,]^EH*B'3@5WEKX$E)K
M[6>T?PB,<13V]P24R4-$M+/*/4I94)2/K!DT2 NL39.?G#O:,HEU$8JK>CSI
MJ _BT+1B89ZMX+E5?M)S>UE%<P!*KUB?YM\7CO;XO'>WQ>.]K?@I[V^+QWM;
M\%/>WQ>.]OB\=[?%X[V^+QWM;\$=[?%X[V^+QWM\7CO8E*?.4E'61WMC'4Q]
M:BWI:NZ]*C:U=UZ5&T-7=>E1M#+6[Q:Y/43 G>V$5)\(4ZAT3(38HYK-'[!D
M3<"Q2H"9!^2?6T^@_)/H/RSZV!G\KI&,>.W=8HKK":XO3/[0Z0SO!UYB1_\
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MF9KZ$6WL:$CQP7ZV*_I<.F(3RCR$J)%1YH79:V28_&EU7C)@3G6,F>4;'NB
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M/Y]=^W[H_GUW[?NC^?7?M^Z/Y]=^W[H_GUW[?NC^?7?M^Z/Y]=^W[H_GT/\
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M?$37A_\ D#T?MKVQ$^<#YZ]L1/G ^>O;$3YP/GKEXGS@?/7+P_G ^>N7A_.
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M"7@<DO\ 9CQ@PB_U47A>_7171717171717171712?$7Z?97?C)_"GJ."NM"
MA5/"BHJ*E8K;&\5U[9].OPUS6WVG//7-;?;/ZU<UM]ISSUS6WVG//7-;?;<\
M]<UM]ISSUS6WVS\]<UM]MSSUS6WVC\]<UM]ISZU<UM]ISZU<UM]MSSUS6WVW
M//7-;?;/ZU)FM;>.OW9^'XU<UM]L_K5S6WVS^M7-;?;/ZU<UM]L_K5S6WVS^
MM7-;?;/ZU<UM]L_K5S6WVS^M7-;?;/ZU$BVUI$1!PQ<)/A]U7-S'C2^M7-S'
MC2^M7-S'C2^M7-S'C2^M7-S'C2^M7-S'C2^M7-S'C2^M7-S'C2^M7-S'C2^M
M0X6YC#-K[J7%A\;PUS<QXTOK5S<QXTOK5S<QXTOK5S<QXTOK5S<QXTOK5S<Q
MXTOK5S<QXTOK5S<QXTOK5S<QXTOK46%N8QP7#NI<?:I,;<QC@F/=2\'QJYN8
M\:7UJYN8\:7UJYN8\:7UJYN8\:7UJYN8\:7UJYN8\:7UJYN8\:7UJYN8\:7U
MJ:DL0(XO,EG;)34LIIQ+@2JFKH]^BQ,=9JNTE<H':2N4#M)7*!VDKE [25R@
M=I*Y0.TE<H':2N4#M)7*!VDI.$FPO$N/3[U;?TUM_36W]-;?TUM_36W]-;?T
MUM_36W]-;?TUM_36W]-.*BZLR?PIZA?%7Z*>O;T.1<!8*,T,.*38/ON2719;
M "=P!%S$FTJ5>TNFYF]6>XV6U#>5MDIV$Z].A$XC69AZ.XXR!9U1,KBHO35S
MO5ZW'WZP6VVP0G;XEOV^3OO2J@M1V B/&8F>9%SNH+8CM+5VODO<O?8*VH8;
MHP7UBFMP9N!H$4H4YHSAN*2DF=M3SMXHA5=9]VW+7?<S#M<)9ROW*1 ?&2V+
M:N$+.]'G%$T%/TF''@E7#=HW:KB+5L>WM(LSI,C<M*;K;;":U1L4D"\#K:GA
MP%UU.AWZQW;<H_!LSU_5+F<22+]L85!==:*$XXB$A$(@V6!.*2840R=RNZ2S
MLNVR9=[7+GQV][W2'#:5\E%QM2WFXXU@33<O(2XUN,EC%?PW:2 CQ&D=85V"
MIQW)&:8B+LH+>4LFO,M6W<8['DG*N+0DMP')O&&\\A+$BR57AH_+$"5KX,*W
M01?Z)7RX0=S+XL7B\Q7[>,2/BT#Y.HRZZ+YB#9XY1$B7#!-=/VNR[D+[ND6/
M;[9<7),"3;X[0L79C?$7$);K9Y\FHDUZZW.6:?#F;XW0"T;I@K6BL@OJ+;*W
M)<>)V06]P5O%%<1=>%/V!FPWJ\OP&8TBZO6U&%2 S*7!HTCN&+\SPFD4244]
M^FW!QRN +@YD42P)$5,PKK%=>M%UHNKV-/B)_C7373737373737373732<==
M-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=/'737373737373737373
M1_%Z?AKB3JKB3JKB3JKB3JKB3JKB3JKB3JKB3JKB3JKB3JKB3JKB3JIWXR?P
MIZA?%7Z*?LD1&2<DOV\C%]U6&RCLR0<D#I1UB1-(2#AKQZ4K=I:-S+%O<LVZ
MBTM[R<N$MSUPMEQ;(<]OWPZCCSEJ>P4P7-BR?AJ]0&-S>Y3<Z].M;,<9C=XG
M[H&I[[!"JQ)T*?BTW&DCG0W&N$VI<'BK=9%2%8K+Z\Q(+$7<S;KK-D69R5&D
MB\_<''W\5A$^VFB1I@4R#[Z5>-ST;<[N>W+MWT[:Q/FV[=%<+F^<)I\5FJ@3
MLR-N:%%T2!AG-<I:JW76J!<AN]LW4P+1F=N;S<20W<K<^RV:*$=L01ERWAHT
M<%$)#37BNNMTMLM0QV]S>ZJQ)%*2^^;]UL-S;RJ@12?4W)%L?<%''&<Z9"35
MBE+ OC]@A6N%89MJ::MCCC[E]E.1%B0Y<I70_P!' U@ADVWGUKX*_P GMR@P
MHS%YL<T7]T\GUPE.@^&]70<WFTZ9,D1/&A<!MO <:W17T[UO2_3-T$:[VBVM
M&R=LT=H,$M.^9)-Z9ES0HYI1;7()GK0JW4W^0,1G=',ND"YV)5EO.P'0C16$
MD6ZZQTRL%&D21,5(FR)!4#QZ*EW\MR>YF[-S+;96!C2MT<^V#;94!C1R&XZ0
M$!'F%<Y)7/<)@B)6Z2XW&ZC9Y4N!;H%EMUN=;E0T9M38OQ0DR'VM,V._QQS
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MS-2&'45O2HK;P'BSTNHHDJ*VG%GXJ[BZV\B89E:<%S#'BV57HUIX4IUQ9,=
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M30W9B:,HINMTQ<5QM7&30M&"@+:9:O[@SF)T:XK;U8-F.W#T:QV5!P"B,$3
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MQN-QN-QN)[JVA.G#P3IP\$]QN-Q/=6T)[JVANK:&XW&XW&XE9B>ZMH3W7/\
M">XW&XW&XW&XW0Y_)R2N<0T^675[*O',LO(LO(LO(LO(LO(M/(M/(LO(LO(L
MO(LO(LO+X(M/(:Y'BJ8EF67D67D67D67D67D67D67D67D67D-U4> 3:3'KU^
M"++R++R++R^"++R++R++R++R%U)4QQ5D<.N$EEY%EY%EY%EY%IY%EY%IYEEY
M%EY"A+::FJDTS3Q&F-K;VW4W"7B67D6GF67D67D67E\$6GD67D/PO]&'02G
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M$II,C=.W![TR#V0<5*MQ-HM%6*$,J4>#+1ON9 A$(@\'UEY14VBZC)DF"15
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MMFLLMMFLLMNJ2222222222#?22220#68-0]E(YDYR2126225   "*0
M   !+;S;!7R+07FI0R@2!$ B $ (2MMMO@"2222"222225IM?*P0@,WC/A2V
MVV@       __ /\ Y ))))()))))).^&G_Q);_3<_P"UOMMMMOMMMM]@
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MPULF!@7C_&>"F3EA)HM,B:=@         0    13@HCMO1KLW^RCL7FB@
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M2R2222K     !3:: 0@JX\AK4>YVVVVV7_\ _P#=_P"^_P#^OO\ _?4
M     "3RUL["1XX              "0   "     0     "!F(1;B/[\
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M<+0>GK3$1C(.&"8R&F^M\U"V%#"1LEUL3$$=:47Y=W%G5+S]59LM@.&03=Q
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M2^A0K$ ;P!0<TF^A!)%9,$$C+/2D[,5$ S%@8%]%,#8._!@O9JQI[TJ1Q!K
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M<ED"Y)V)OA@.H9@LAIN1ZK:@TR$#&=S0*&\34$MR8%L@&,P@$8A+UE3ZDEK
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M@(*#I)NV2U-$-0@ NY5UK"'7_E!*&[%3DNP$(:KTQR\VHK,HPG/=HZCTJ.M
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MK#G18BV6_%S+O4BWL+*+"DY<.LA:"@>""@2,6F\LGN&:2@'EE%A@ML.[Q4S
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M$PQ,K!0PCIJ5"0B819F2:3B+U:_,HA+&$8)U_#4F?4P;9A@E>72A$7-<#!!
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MZD_ZD_Z4_P"E/^I/^I/^I/\ J3_J3_J2.I])O]//I<>%UV:HPH=  [3^I/\
MJ3_J3_J3_J3_ *D_ZD_ZD_ZDWJEN*5@9C4U9HG]27]2?]2?]2>CU._?^$_J3
M_J3_ *D_ZDZXI$-:5K< T5O/ZDT?)SS]<_J3_J3_ *4_ZD^]^MS/ZD_ZDU-O
M>0@+BB61$D0-")O55[L_J3_I1_J3_J3_ *D_ZDOZ4_ZD\#!KJ&VM\9D67FJ1
M#1PM0WKZ_P!2?]/U^D_J3_J3_J3_ *D_ZD_ZD_ZDQF%T*41&M"PG]2?]2?\
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MI)%[?U(E;?V!^OM#39MP_P"K!)G"] (7G%#1T7M_\=77+?G:*%+?!/\ &_O
ML''\_P#.GJD%+'!URZ=]/C2>J?GI&B(I ,JD%7U<?,&/R!/P7/?/S/?/S/?O
MS-0Q[#_C.]=EQ^<PTQ7[:P)L^U\7/?/S,:^OHVW9!63H5D4@-6CT=%[SWS\S
MWS\SV;\SWS\RU52U<UY[77V@*@#MYNQQ/9OS/?OS/?/S*<4U+S->13--;T[?
M_,,,((U-';X?S RK/E7KU^K/0=&_]@2Y+K;'W^W_ ,PPPPJ3H@$14+#&V?I,
M['+XE.@1QZ0R^E&#!\(<Q&G%:@9EX%M+-"PJI)L$J*6WZ$6'J"JEA<0N55&[
MU 69:D+J6Y=U[!07= $W0J!WB-EPWS59!N9:"B---8$ =)O85:E85S@.GXF@
MV M0 /+Q="@P, 4 6.DS9H@"G"$2A!922;6 SN;*#8ZI%EIUM+W-J871^EI6
MT5;&DL=+"-_NB,THPJV,C7%+<M05$!D59@<#@Q&V6E2T]0U!QV$106Z5JF <
MH:0IP4B$0<21U<CBU_!"MS=+_@NEA0N[HMA7M'X_X5[5^)[5^)B4&=MXZ5C(
MQA[=>L]J_$]J_'_"O:/Q_P *]J_$]J_'_"O:/Q%JR4*%[BL@K0LU=Y[5^)[5
M^/\ A7M'X_X5[5^)[5^(,#2T*'!4$P0%+(74=G4"#0@H]=+*I&DK4+APBPFR
M:C<GX'3#8- :!T/_ "&#!@P8,&#!FIBO8E[Y9]^7_P 1@P8,&#!@P9ANE="F
M>0$OC%*)_P ]NR6K11T?DX/]_P#/V[=NW;MV[=NS9DPT"L:.KJX)B)U!\;IF
MZO2/#%9L!8=+T>U2NVL/=$VZ.C:JMN6P1*,S Q5VA"2/!K]>9M'#@2N)]_I*
MR>,Q3,23_A[\[R. !&).@,L$@J7QK",K/F''RS*I#EF-T'E%4@D4!>7O+V8<
M8@"&" ;T?!3Q+E>(>\Q>4!(!=VF F")[59FJQ2R0QE<8!Z,XL4>1-G,5*VT;
M)D!#O[EE+9;<B!=B0R,H.4"M0M%&GG!=EO)"HH03$C\*[5]=6+#56HO?DU=U
ME@$SN</F9W.'S,[G#YF=SA\S.YP^9>:LOY=?K,[G$9W.'S,[G#YF=SA\S.YP
M^9G<XC.YP^9G<X?,SN</F6[G*\:XNY;O[?,MW]OF6[^WS+=_;YEN_M\RW?V^
M9;O[?,##I0BFPU";8"U%1L;T^090RM$+8QA"E%K>:-:TEC9V7>^W2>_I/?TG
MOZ3W])[^D]_2>_I/?TGOZ01LPYJ@*P8NN?NSW])[^D]_2>_I/?TGOZ3W])[^
MD]_2$>.0IU$'1Q==#J&LT4 <&"S*JG6K!8$7Z5;K8#<]:$T3TM5!6$L%519.
MI>);B&;=IVT"JK%1,)&#.M.6>[AD=<2^L;I%W,#"HL;8+-:AI@KBAC=[WW*W
M22HNU!&SG;35$@82FBK1&QNTAIF_$^*B0R^C\;: 23 S)@CH(&% ;)0N7UR]
M34^W,[G#YEOM0#K40JH1:H&Z<53O;'6@.@8+K1#4["ZCIBC\?::*LY!0Z9%Z
M$"SH&*@Y27+34%F H6PA5LN! +<CHG2RLG%=\N:&L3-;<Q6$M5K*&ZZ_.9FL
MO0VZTT:&-5+TEZ92EL*:JA09 V%V&@%"J$  HI %!TT Q,@Y_@-11JRZW8Z2
MC+EM2RK1:#&@[XUF7J;%)=:&A5V4]6KNZ]6VW5\@NV;J%LL7%'<D5!V&O0"E
M= *NHD#J255FBTFP$#I4I&RF]#;ADCU+MZN<@JA:D!%W>IK%JO2 WUBG!9M@
M=<RPISV+1AZ)A5YMZ]K@RQL)G:KZICZJZ_!A.C)5X,5I'Y_2KM'1/@]J[SJW
MF0_%7^,:O5E>O3V/MJPUU+8X5WV[G%YU=&[RY):Z557,M*,:NU4=94'7KER4
M8+I7YN9->M;N;JKW;=5[C$[OM]#YZBTH=$#I&G3S8FE>*K+7IV9\>F#0OJ.R
M^7.8F77=U_FFJG.>NNDNK']/34^%9^IU)5Q?%KGH>I\[P=S9H606!0,]WH**
M AQU;J@M'*'3*$?5O^'C3_V/'CZQK_SQ=CYB%)HW@%!FB*7HK!2N/JOVUUZQ
ME5HY:ZB=F]--KB-0UA^H1]%3X)?9^\OL_>7V?O+[/WE]G[R^S]Y?9^\OL_>7
MV?O,!H%#I> [7;HV[G67V?O+[/WE]G[R^S]Y?9^\OL_>7V?O+[/WE]G[P;)F
MP#C&3IGY;WT@&QP!8TX *01H$P/OV>'M&X&&3(V3 U1K(KF S*IESDE0+41;
MH1<%+>Y5O!IDX:QN8%1!K#(';Q4P0-_":+>EB"TGQX*T T]20%"3+S7@P?44
M0*>&$0_+TD4+- !M<W1"UEL1H1ODV-LJ+G3&V&$<-FEU^?$INY(!J7UM?J?/
M&)E8IUKKDCBCN R+N\6V@9B)"1('<%*;<*)7$18!8W22EJ@B^EF!(51%JI6C
MWQ71T2!N)M$I'!\A@_Z&\%(<6IZ<$DJX56C' RD.'T0.Q?0"<!VKG3%5JXJP
M%"!0R1PH5E*F$HX[,/H@D$5$) JM;H+!+0:4+91OX2C?PE&_A*-_"4;^$HW\
M)@Z^1_V6?WX2S^_"6?WX2S^_"6?WX2S^_"6?WX2S^_"6?WX2S^_"6?WX2S^_
M"6?WX2S^_"()38;$PB=2@ZCT^]0-32CPGCNN< "7W<'F7W<'F7W<'F7W<'F7
MW<'F7W<'F7W<'F7W<'F?-P>8MEK2Y#_"OO36,9QV33O(_N7W<'F7W<'F7W<'
MF7W<'F7W<'F7W<'F7W<'F7W<'F7W<'F&%J%4+L+IG;N7TQAONX/,ONX/,ONX
M/,ONX/,ONX/,ONX/,ONX/,ONX/,ONX/,(PLO7@TLO35TUE;O"(D004*P-A%/
MHD:<K7=B[ 4#(:1W#I]);/6P[S&'<P8=B7F\F,Z\:9[45M+N[R-N]W=WNS1Z
M!,F!U#.!ZUK+4!J&PTC=V'1O-F;BFUSHKC_7WELJRMEO>C5T&!U-YBUO:JM+
M5U7=>K*:M&MISZ2C?PF80&MMW1&#K1>R/J"+B<-)- E.<QUO V^6[<#J\7Q9
M3+=_)&!*I$24"$S!( T4VFCP9>ECF<9>PEO>$&&!D@>H$<!U@U&>*^T351?5
MO"M$5Q]FAF/2N*2($),>R;5M%L'+6IR&U:$,7:F*/\ZWL;K$[.8-UL60A6L7
MY=GF&E:A=I2BK/0OQ/6/Q 36H("BCD.B)/0OQ/0OQ/0OQ/0OQ/0OQ/0OQ/0O
MQ/0OQ/0OQ!",:PY>R584:WIGH7XGH7XGH7XGH7XGH7XGH7XGH7XGH7X@%4H&
MF.!**%@;QFW>=1DKH3#=F%C;_P"1))))9/28^5#]$(17K/U7>N[_ .*2221K
ME"NC4LH;3=-C6W[G7K_Y))))(V#5ER"]+#;KI\RO;EBO;EBO;EBO;EBO;EBO
M;EBO;EBO;EBO;EBO;EBO;EBO;E@"\IZF"U>_29V.7Q*]LWT/UHYQ+9!R=TH
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M3$6-B,%"]G5BN5P\5R.YSRGD#&*09A",QINLR 54]$:A(&7K( A^6^5*U 2
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M.VL]3/4SU,]3/4SU,]3/4SU,0=TAW:$1&S(@!KKB>_\ YGO_ .9[_P#F>_\
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MCA0P0!#21$0UI-<RB@H@   !H 50=#0A# "H-6R@<')J-Y;:W=U;;:TMU?K
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'N=+!OG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>businessfigure20a1a.jpg
<TEXT>
begin 644 businessfigure20a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M/@JPEQ@                        [.N6Z3L>YKH@Z_P#@/C%+4W+@
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M/<4     9O<I))GQ6+7!\/H ?  ^@? /H        %[7G7=6/ZR[VE)\,
M                     .W_ (SK.Z3B>Q#JH^6?G?7'G>)
M           "^+WK]_/LWZ"L&/O                        "%[]-R0I@
M0"OI9%)G@                       !5]9S\@Z3HK-BR0
M           J^5%M"+*"(PZR73+,                        *BJ.:<.A
MO+-BR0ZU^EYZFYL.ZH4R2:MF4GD??2,Z'NW1W,8VZM5K:LG<??4TR+/H^_L
MYZ]              "KY46T(LH(C#K)=,LPU@YG@8?#K%F>U?LW/V^7)),Z/
M1X5P6_30N%5Q>+7KMFZ+1:^(Q*W=CM/J@              5%4<TX=#>6;%D
MAK!:5K[KSOF!.UYL8'!Y:D655$N+LK66,6VZF?/##ZKR3'V*K;
M      J^5%M"+*"(PZR73+,*QK*#@\L2PNZSK:$)G,M(G$KIY/MU>6QCTQ>'
MF+3JCRJ58.VV2              %15'-.'0WEFQ9(
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MR\Y>>9/<$^.W[FYXX\7O++SE[CC\S?\ #*PBKY46T(LH(C#K)=,L\8@
M     ,HN            *BJ.:<.AO+-BR6C/#7^P@/&&QQQ]09>8WGSU84;?
M"M^IQQ]'J+W'/YZX8^MF>,KT[89OTH,O%&/O(=,<N?ASQS8-FM)EYR\7Q G
M     !5\J+:$64$1AUDNF68535<\FQURB5/'J?'7R>X_/'Z1+8M$1)AKR>^R
MV79/6Z4               5%4<TX=#>6;%DH_<:XE1T/OB['U-EXNQRC^S7(
M]6QLSQ78Y8O?%N/L;VZU^.2W'*3ZMD<V:VG/%MSQ4>>NV&33EC+-6S/YZE]\
MX>K&C2       J^5%M"+*"(PZR73+,(E$K4V.&/S%9GM!+AKCNB%.YUNCPU8
M\<5NS<Y;-[ALW               %15'-.'0WEFQ9(
M      5?*BVA%E!$8=9+IEF                        %15'-.'0WEFQ9
M(                        5?*BVA%E!$8=9+IEF
M      %15'-13J+6=:-X                        1S;JFL"=/"M:R@>Y
M$P                        *WK:/_Q  V$   !@$!!P,# P,$ P$
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MX\%_"OP@VAM&6"LK][$M%+*%[/3IY19Z9 UTC!T61Q:]M?0,;0_'ZW\ZF_\
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M2RQ5.ZDG9*F*6')#&I8NP9,UC;*EEXW(0:X[/4<'^[S@R.T<8,,@,DBG*T2
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M![UO1<^!DQE6CBVQLN7:;TBUD>S+U$=3+&T._"H6CW9?)>PS="38?^'X%?\
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M<'LJE,)-H1L:?)/$M26X3'YOF</+_P /P*_^KS?_ *Z?^TT6-H?C];^=3?\
MS/\ P?P6)O6+T\BWR^4'C_[0O_NFK_-J+^H_\*.1XG26)VCDC97CD1BKHZFZ
MLC"Q5@1<$&^*[:^U-IK&NT*^IJTB),:32756(L6RBP+D:9R"UNO_ )SP*_\
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M:AE*G,=["5;GJ6(Q#&.UT[45/5TZ*9.U-/ODB>/(0J9)G.=]YE*E1P@&Y_\
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M&*6GBFH-DG8VS=MP;89=F/[(N*Z&C7VEJR:HDJ)S!/3RQ;[@5'WV=<@Y$?\
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M5:Q4U(9[O'3AH3+OZ@+Q98U6S\0"G0L+87:E/'2&LG;>(<N[RB0K/)?(K4R
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ME1N"*2<*LAOJXS9A;*+!@JY=;=<"W3IIXO"'G1^JI_R^*7VH_P!/4_VB7Q.
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MB 227<$W)4&^MM+ VL.N%FD)6S([Y1<LC+P'H">M]=<2-S$:.&OKD70^MO\
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M7Q2,P4 6%V]UW<R/EPN3=EU)6,L3KS!)ME^7D.X8;>RWOEM&VG0*;<C\GIQ
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M73KP^=^C$39]W*F20%CNRW$>(ZE5])Y7\WKB1X4J,TUXU7AECB&;=%B &CT
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M/*R4U52Z;R-X^)/,S/':]I0.EQCM5+2O)+!4QS*MII:=\C/!F.9^N?-W6YV
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M?/*^_D,*9I!F9(A:V\&MO.RXH:"GV93&&EI]VLLTM7*F>^>HJ#FF8L>69M
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MH%["U@NG?SPNHO@$YK9=+>=?KW6_V#?_ %SQ^^V ;^+PAYT?JJ?\OBE]J/\
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M$1( $Q0A!B(Q(S)!$!515-(6)#,T0E-A=).4HT-2<7.!D;.TT=-0@\,'(#5
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M6;'-1+!K!<.I!%U 5&3H+IC;L_3(;MT1_=PW$L7599&S5=* 2RRA1R3$ _\
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M 2YLR*TM80]R%:S,A_\ = Q,C_;P"FLDH6IAR,:E +,Y&(]=T#$R/]O$1)3
MC$R4SI$1$S,SZ:1$=YG7X<$AP'"S2T&%IM62S$RU]-!F-TZ_HCBOCKEBQTPI
M,&["9,- U[0"-9*=1U[^@]O,4Q$<<IOE]DSS%(#$K*)(XG20&-.YQ/:1C68G
MM,<0A\Q,PELP._=,+/0>7[^Z=-(V?EZ^[\=..GL:++D.@6S J*5' LDO=@"D
M="U^&G%BA:K69J&HB>,1.U0DS=J,%J&@^>!UTDHC;K$QKVX!#F%(+2TS'7<
M+,C'3M.X8B9C3],<)0;K"JWN&UH)C?$QM(RV>:/6-)]>VO%S'IIPZ/G*HYZ#
MY9UU0[F;H+:4>8(#R=Y+S>D=N+V*L4*]6RZ0D;(Z[1UW)*0%D+;KV@I M8T^
MB>/F ]\(&]3.X28>-3V@M,9#F1 S([9G;^G^Z/\ Z> _'6?JI_XJ.,7_ .'4
M?U5'^&/R9*G<*W=M5DG+5#095*(UWF&\&B/TR(,F9CZ(X''6$U,L@4'/,I8]
M:M(_#-!>KMOTR+)+=PO#KY4F3;+K,TS0N;+=\5Y:G84+'2('O.WXZ1Q23=AM
M5DU#66-QK*T0XA ;%B>PBLHDM5S$:\S32-?3X\4E-9??8*HZLA]>(MKM;3YM
MO?K['62F4B,E'P64:>2)X91L.J9U(KD3L79;7@M!AH!RRC;KVT+;MCTC7MVX
MQX/9=MW6H;6!J*R%K=I#"E0^T*1B9T'=V&=>_KQ-.SRCDJS'*#./MMJ]H*S6
MG3:0#,[61$]X"9\WT=N.CL\FY:KUBKD%VO<Q](A@3B51M=[,)F Y\3,[(_F_
MT<4,;:5;K+<)=*&F2,R].N8F%RK^D#U+3]'&00<Y!%AE,KU;I6HA0B#.4\RU
MAD@<Q$00^7F?D^OT<5Z=A*<8=F@RRFO%T&TX$6&MC7%*V\HYVLC;H,3\([_1
MP5"R-:K)(LB0/N&H$@FUTBGS&Q#:K9VLB8_*$O9:S'KPRI=D,<;JD[%5["CK
M5ZZ7\HS.96<UFGL&6AI!$,SRRUTTX55>.&Z0)8#YJL6OFF/, CW; (P\L:1,
M!&GNQI]' 56,JM37QA4;$8_IRLG(JECHD=R@@2F&BW0IYYZ3&OKIQ%5K),J^
M.;1 ,58K. A$)M/->U8@(S/,VEYN:7K_ '<=*U94V6<>R\F,2JK"1$#*M9B(
MW[EG,0.^.TMC61_LC@*5FO% KE-F14NBY$H" =*',81AJ)SIV5,*YD:[=O;T
MCBY5LL$%#C>4/S;RUPI:[1 S4IZ8GO+V AZ[@'?,SH)>G$U+1+L^P;JS 5ZX
MZQW*P'O*_K(^,<6D&VQ5%V)>VO717EAH0J6VF@D(A9M*1F$*[@0Q,R4Q,3VT
MT71L]7[1-B#G)1;"P"4;13V(=UHBYHP ^S.M$:? >$5;*LB!+J-V=8UC.I2D
M@4MDS)/1>"884EKY5$,S\)^/&7IV'6$%7&9"TOH;LC^17YRVPR?Z(A@Z_IT^
M/'S=<FE=YB3)R^DHU!T\QU:UD62P?T%&D_#W>+--D/SFRF93;J!TS@6,C)<N
M(<O=ZP;#[R,>](S,_#BK3FOD*AKK\I7S5"WD(P(S8W!.C-/5GKWGO^GMP[']
M5EVL<+Q1T2A!BFFF);#.X;PF)G2)UVS_ $\.H7+=QVR036KU(HIFVLG<X&C[
M=H>:)W>@\V9F9_IX&G=?\T(>%E,TFVT-LIG84*$(A#0/OV.- U^.DQ\>*E)-
M(3A4L(FGS&M:<L:P_34BGZ(](B(C_O>+O?H?^Q__ /)?R^*?_&7?U5?_  X^
M3"7DTJ]B38(G-W'E"Y]XTB9C8TCXP*SF2_1QDKM(ZMBK6<N4HLXU=48+7<A(
MR36#](BPRW%^C^CC+YJ9M70HQ3Y;PA76J5$V6K)0P8\Z9^G4=8'TCZ8B>&W:
M?*L7ALJD[&%5CAI^;J!L=A/<.FV%#$;H/=I/&ZG7Q=NOUR;*'@IE5 +E=P+N
ML24V(B.RU=XT,S"8]V(GCJUQBJ<$WF6%94K+%D4DR5[ T*=?A.W;&L\9*U4B
MOE"3:58++6JKE+7NYB%IC<?/B8B +=Y('69G^_2GD!15PBQM\KEY)K+@"<CH
MB6#I+HCU7(R7:=8GZ-8X7;J<RK S#]OB*Y8Y*HEARAD%"G L8U(=9@ATC6=.
MT:\$<JJ;[&0BV >(:K)9/-VH7NDY"9:,3J,>8P'45>GT\7;XV*N:6=KF[\DE
ME,".2CDB91)(&?="!VZZ:?\ SWQUD(QPH7?#'O5D(LN(Y,.HK[1C096,RV0F
M)]C/8O[>'W4//)KJ9%5%[KZ; 6Y,U@^L" #EPT!F=5G$ELG2"].^L\!D:AVK
M\@^MRFMJ%/-:^@QQI7 ,MIL)B?RM2A+!\^F[\J>*]VC'6K1<$3G)C:BQ:L.K
M%81 #&O.2&YO+9NT2<1#!TF8UGA-P!SDW!;72$V&E#"4R:_F$AUV=F@+)F=#
M[$N2W:=M.&6*)7,>4WY2:QM\SD76V*Z9(?9"%MJI8F+$Z[](*5QVC;Z\!D:P
MV,9/6I"1J7ZU@UV'N!9GH2(8YL<U@;M)%A>7?&HZ1IQ6;6)6*YV0KBS&Y.PV
MP3#.2<+&P<-3.V98)SWDYTTUDB])XN9 >A)->UMYV7OL>*BG<55ISM*8_*6<
M%K SV*=-8XMW:HU+H*O@XI*@VJ?5.;9/DL"3+9(@FLP8]%)B"TB9+X<,OU2N
MY28O).;J*_1MFRY *6N?:52L+&3K$1>TT#M/Y7>9CA>125J]]\49%HTQ+5UN
MK%@D1,2U5Z//O#\J##1TC!1\>&MJ_/RW*L&VL-RNR;#IUF8&0EA24Q$D S$P
M)3&LC&OZ>'7EW\K*;#*88X;Q.YXI6LC2J2(8EPCS#YL>7O[TEK/#\GC\DG*(
MF&UC?]]I99>)JFPB(!:U# QRN8J(#368T[>OKD<Y*W#T(TY+HT+ZT50=D)E6
MU@"V9\LC[ON]O_IX#\=9^JG_ (J.,7_X=1_54?X8_P#!_%T1I1+X^W'^SV4_
M_?Y?%/\ XR[^JK_X<?\ TA(@(3 I QF"$AF8(2CO$Q,=XF/IXL7KEN!&U9:^
M [C#"UB)GXZ1I&[X;O7]/_G,!^.L_53_ ,5'&+B?FZCVG\51_ACQI/T3_=QI
M/T3_ '<:3]$_W<:3]$_W<:3]$_W<:3]$_P!W&D_1/]W&D_1/]W&D_1/]W&D_
M1/\ =QI/T3_=QI/T3_=QI/T3_=QI/T3_ '<:3]$_W<:3]$_W<:3]$_W<:3]$
M_P!W&D_1/]W&D_1/]W&D_1/]W&D_1/\ =QI/T3_=QI/T3_=QI/T3_=QI/T3_
M '<:3]$_W<:3]$_W<:3]$_W<:3]$_P!W&D_1/]W&D_1/]W&D_1/]W&D_1/\
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M83^R#[/'35_S"?V0?9XZ:O\ F$_L@^SQTU?\PG]D'V>.FK_F$_L@^SQTU?\
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M;5 !3KR_+S&Q"_B< QMZG3O4:!UK"<C4I.Y5L=26$W)0RX1&LAKN0H3,^\2
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M19;R('FL-8"]HIW%&KDJB8$8B=(@M9C6/6(TU[QQ2*I[4KEL83LT)&]G-.&
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M'OP ^UUF2$]9B->/F?Q -2G=96<:&/8"X=$.F&FI4B+Z\S)JAT&$*-@@+==
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MND-XP$".[BIDE>*ETDOR+P\3V,C8<_.363*IIOIL5:^>WBLK-VV;$K73Y4[
MKE.@2Z=LCET5ZZZYX;%LLIKV:'5&-CFR3SW1<-4L%,VZX1*T-V:Q!;I7O")X
MQK:W6IZAS06D'M7R->8VZA4G701C(RD#9 RRSK[,!,H\VV)JY569?>S=VC:'
MYFQAY#HDYFQ07<DG!CZY(N\H[*%44O7')3#&6A%G,L!)EJ3#*^H]2@@-&V=2
MW1RX#9H4ZSJ.D:3^C7AN>R&7OV;M^PRVZQRP-IQ&XA2N$K M(B)Y8#&L]BG3
M6>^O'A3/7*_AVOAL96BVP?$J\ADL;0AR\M=Q*5BXV\Z9BMTJC&%%)$,:[!*?
M-WR)*SOA*\2\JG%4KYWKQQ8O],RX:#F%8^S45[)+(\DWMC7LWJC77F1H64AW
M_9]ALQ3@ZM[PNQ!%&%I](84]A5[C.K?$P75#/,-X#(<PQW#,Q'&/\>90G0ZO
MX8IWZ=>Z30Y:I=D1LVYF%$^](FQ[Y'4=TKT/=W]!XS?C?QLNSBE71L5>3DSO
M8_#Y6N'3;IC10O)^P&+4)D *;(\F"'_TZ>(O$",C:Q.4#8W*#NG.8]BNEQ0M
MALD5'I*\@JRH+&C5'##!H0!-UF9'@\BWQ7DW7K63QOAP$5:Z7VX*:HP-<-@
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MVR3-S0'4!V;M.8TM!DHTF!C]'&=QYU*-=2,P[+8SJ$0HRVBMN3=7@K,P.^3
M*\2M $^=9[[/+VXOUAI8U(6L7;1>LV2=6R,M'HG4Q'EMK@K;.K <.LM$]=9T
MF-.,%9I:,HY&F5BJ\CD'I;R;%2R2Q!;HGOS$B4";D::M$=!F"TX85-4V%TLK
M8MX>7M6J@RPQ;RB% 742B-R5K)VZ-FF[05D7<^ 4MNGE:8%$[U:2): 4R6C-
M/7;$]R^,<5MZ;R0JL%,V9-:1>8+:M+M5[F2R($9V3.TSC87K'IP52_.9#"LL
M5ZS^H&L74VX;30>L1S3;!&@% ,RTS5J,C,[=>+MAD'7K=6FVG%2]->1^^,<*
MF$4-.ISAB94TM6#V\L[2"!]>#HY&M64YRM:UDR0EJR6R&;8 R I BVS$&$Q$
M]YUTTB8XJ8V'$A(VZ]>Y=ZJNNE9EJV!M#LTI"->99.1170?G(Y]W3OQX9#*U
M,J6,HW*N./(-G#V;;O=2,LU8)/"=]14F/+=9$QCEQ(R>W77)^#\M,TETJ]2Q
M8ZEN/J%CY&(SH(:29O5Y:S=8,':UF[1 O*)D,AH?#L$4I*E-#)V,O11=+-*<
M$&JJVNV-XH:!$+>G7I)Z&SS3VT[QQ1J5)Q&2O903E* -.+4/WN=E["-46$V-
M-KHIGLZBL.NX3*9TV=XFSGZ">6V@MV)JN9TZ5,I\M* &>:ULZ@QK_P"2@2'S
M#,SPQ+K*)N"@%!417ZLF."',)IR / &2)MW3([]NZ0@=T]N!Y9$N&>0),!:8
M1)%(:Q+#B)_*A>Z=)_HXBA@8QS&XV_?T-=YKU6F17BY620C4K551(@Z99[9L
M1J<;=)"=.%4GTL9>RCL;6O5#K#3YUAG*?C;%F=Z7UA\K#<&V1/RL7LF==-8G
MBQ9.QR=\#JE 5X*(\Q N2VR<^I%$%MW3^2(QZ1'R93^0_P";_P!/BY^%']7J
M?Y5/R>$:56ZNXVP-IDX^H;*ZJ&X+74N,12TF#$Q"DM@)\TQ$3.LQIKQF?GZ]
MXA1C+Z$7LMC\4C'5QK+A<,K*KDWJ=^H1SH@V-:Z9C>^.843,SKBE>&_#X55K
M7D4OS.+@KC5L8^S8J'9#V:("=8MRX!#8N!Y:][)(AX_[0<15:N?$.+;?N&EY
M)RLVG^:N)G')"42 F,+,AC6(@)#68D]>,';M%C,FMK.7A&,6K)UZYH7DVND)
M&N5.3TL"K=,18@9E9AY3'7A&3R/B8(J9_(V*.(HU48\2I4X37;,$H ZP0B*_
M/A*MVNV'G,3RXF2GBUEZ_A:CDO#V(EBK.'KADL98M NPAPW] 6ODC',-CMV@
MB^8.&$41&D#QD/!HJH%F&O"CG*M=>?MT^83TV*[-QVU#6Y(JIGO@NG4&HS[3
M?.JYGAWC>OE2Q28\-XI719"K\VY$4N=D45^=.J'U8=%2T#.81$$JB2G\J9+7
MCQ3>JDG*KG)3!W*\8@J9A$<^4G7>NX^@@X3BU)5JM,'S73)$,[HB.#6+L7CZ
MV-3?8Q$MOY62!IX^+1MY-0UH@3@A!>Q?.D=&-*!TG;KQC;&3I86RS/WN@JOE
MN,J5\>*?G)-FNQ?5KM5@B#J"RJ12FP78VS 1&I3QXCGP[<MYEP;\72PF/PR:
M=3(69B]E9T7%GHU5U.K<]JSYK"<Y/*@)D]SBVP6#I9:.7@[?4O(;-HL<[=+:
MU2NI1]K(1/4/-C)4()"9D1DY[<+>S'W5V4S&ZJX'5Q+S##%'!:2!=F#)1W$O
MA]$\.8.5NNMNK)2ZRWF A$S"1<?<I$9GV8D42>WT&.T<>$ZZVWK#RNKKEA*-
MO(RZVL[M*;J]X(L+I[#6VNH=#*'Q[0]@QK$Z<%Y\@,QK[1H'NT@9W'H>_2/=
MUF=T1^3Z?#C%T@RN4K46NY(M*&-L>^\$IC5Q*7.L.8WW=LP7QG2>,]D'LK8+
M$W:6JJK;CL;DMG)R&8QKC76H5G+7&Y4)4G8FN/E]KS95S"W3X=HU<=%/Q+DL
MAD1RA9 DQ2O;^1%E*&"-5_,UF2JJT9#&P.T0CEZS.WCQOB?G+%U[]#-6,VW%
MJ20TPJ+!LU-I%8L/B16[0BB2&=D:P.L!,\>&;=]%_P"<,-62]D56[V-C1N/7
M.WG7Z9B8$NW4CSKV:D>LA(2,\4O$%DE3X;H'377;9MOO^(75"ZK(U+!L:7SF
MN8.-TD>V#C9,Z+UF/CA,?A/"B!HW7T\C8\058N4K1U56*LV*/M3K!:8.U5>)
MCEGZ&.L%KW[(QF4\5(/+]4WP^W+<VK2QZ[$)P-IE.&0H14U\-8JSH>V%KA"Y
M+F;-OFAOB3"U<%:\+Y#"6FW4,<QMVADF4EU<R'L"(T0MH74;5!&[<N2]1G6>
MS+*XQU6X=W'4DACI;>I1S9JW*UU6G2O*T#;=N[-@!D84L@0R-0.8]* C4PF1
M6B_8C*Y!ZJ!8^LJ7KL8X1FS:<]VPC'S[8C8>Z=I;O)''ACFU:)LM)IHH(8)O
M;90;%5RM"72O-3".6I<X15#%*."F=8F($BC+U,=E!\.HJY>7YB_C<KD\M?N#
M4Q527!##KUU6KQ+ E*A15P%13)0, H&-.(X'P_%FM7=B+X.L/Z=?0VQ%%MKV
MLV&M"0U%B@B)9S#T&5#,S\.&IULW:MN6I<C9L!0BH/9C.^)#_P!6L3INB9U^
M'&2RJ+;$%466-]FB;-8)F*Q,KQL"UR^TB;0'SQH7GC7=QB6WLA<K83YPL59R
MSU5#I\T@2^CNEKNHG?RQ+V6X:SU3N+;/;MQXM+=D\C.VFG[])45L:9GCD0@1
M5$5)9,E(D(1S3UF";!3$[=/DG\1#]:9_A*^6O^,W_P"N3_E4_(J!DX@RVCWU
MF/7L,S']\]N,?:5B\A"[="IGJ<&$MK>U.'A,>]6<C1H' SH4A&GEF)].%/\
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MV'7UICS0FN/,V0,POJ6!$P(ZS'CL,!T2\GA+62>S,VV.L/8NT%:S"2D32$G
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MF)+76.,-2R--=G-P*Q#'F-+D6E5;"OG&R7*14OXZT?X(IYI#))=(&O=(#V*
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MSWXRU[(W4KLN$ BJ":'.0M:)B.3!*K[D;.;')G=J<24:R)$7"LF5B-]I3+)
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MTC5"O+<B3DU$L!D86 Q)]RTVQ!<94[-Y-NHD+;'"JI;"DI&G-HR!.9:8Z(F
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MY8L68A^6,LT.(V[HUXFXG'9UMRW=H7GOATQ\WZ7%*AG=*>4\02I<1,I.M,L
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M54P^-A:IR"A;:BY#W4[# +4CL6*Z&:*GEG,0,E/PX=E+;H5-F'7%*9&@M*1
M4]C)*8B?(+ #VACI,Z;M=>*I?.5T*6.W5XR%M0#3 IY824QLB287M!4,:^:?
M2-?73AU0ZEVS2L$MAUSY3"46]<G$1/8M-=.^GIVG6.#]TD292O=#!6)^061&
MV"D?22@?+!:;HCMKIPH: K=S>;&242#QXL5S*#3.9%T6M)ABC7N!R&#O'<$A
M(3KQD[:\I.4R&0N2$U48<LI 7@(\E*EDAHXQ4#L<T]HD',@>D\T$'>(X=:\.
MS1LHJIRPD;EV,=78:=$6-@ RY:M;9>T36/DJ*D!$]"[=YXHJ99=%>-8-KUA,
ML\@\LI+<UC2\B@7&NXV%'FD9[^G%SP>T*U&]3J#@O#]C",NV:^6R174ML5X.
M3R%M*E&M3,DO:ND:H6Y6F\UP.G&X>M641M'>J8&)](T'2(GX]OC\?7A61Z*D
MW9CT->]U.RC)G#)LXQU(C+:F->4Q=F9$BYT%MD-('29X+(->L/$[,NM?B)N4
M*S734"5Y)3P+=\XD(*77J+*8]F*M9G739 S/$U?G.ED<G;O;L@JQSS%V@MM<
MV9.PR=(@389LW1M[QWW1'$X\K5.;A P:X/&K+5EJN'<OG0ML1[LL7$R&L>T@
M3T]V>&NJYA6<RV:O63RRPJ!CZ-%&E4A$12,L9W4BK3KK@.0$<PV3&GY4\8JE
M8ILZIM#(8]ZL=><YEU5?8^H9A6B:U>\O0#!39CF@#'\T]ZQTC6!I#R+MRP0@
M=9E>M65WCJ"?)3.FNV0!*%\W68U*9@=(UF>*F%N93!X<%X*5%+\A9/)LL )W
MD5U<VW"8;M6M5<1$Q(YT#3UG7B66:(%6MM$::&;@JA(G.L$4<[<$[7;9?,#.
MLZ;YVSZ<7L@QFPL2T@459:B4HY:YIQ'G,&GN%03,Z0/;9':->,MB;N-:*+!>
M>QRK$Q#((B XF)B1^!JG09F>TZ]N.H<OV4.;"V)Y!B$[9-4EOV-B/>#=$3I/
M;6.,/1K66R>1LNKKV,Y5CS:39"-U>NV F#A+I&08:YW#J,^G"K-K*TL=3YHT
M[];&9--64W%A054UE\;G>8RVCJ+A/VQGLCUG7@<5X;36/G,R0)=2$;PLK5V7
M++H,'J*F9ZKI+WA.]T3NE)[>_>.&$IM.P0E!/9Y FP\VLY:Q@10DG$1R4 ,"
M(1M'X#Y8XQG@FZ_$!8Q>/RB\L.1JU<U>LV%AASQ]Y7;'+3$%-F4F2WWAD"-:
M0,H*=HCQGT!4NVZBP1$5[+4G-5O/K<Q1[3E#-!U41P<A&D2,>68UCY)_$0_6
MF?X2OEK_ (S?_KD_Y5/R)G:U<_04:=]._P )UB8])[^O%U62R;K-LB9?8FJN
MU;<) PE5A 5B;=NGX(1$2VQ.V(C=QI)$,".I>[$!$S)3^C3O.O%0F!920 )F
MMD'"VQ$@<J\^Q@%V(=1\P3Z^G&'R>0K9F<M77-IR@NON+* D657)8F[,KF8'
MLEIP$#KMF D8\O&1Q]*C8FLBW%DYK4VZ:S((=96#CJ\WT858#A+6>LF):]^(
M,07("4[IT@Y^$R,SZ?\ IXQN4R&'9%K'M6BT8M2MVBS8L#[-C1FO+DNT06G>
M-8CX\4'.RF*RNM@%7,9]_1)N@2LI<P%W 7N8&Z-8YTKC=INT 9CB*UGQ)CT6
M]BK%+PY!+NL=9"H9UK)$X YFD[BYD<I<Q$S$2(3'?@'U05;65&&,<0],XGL$
MZ<"4R0[8T%NZ-!+>,3Y?TS\A$1Z;S(]L0([BDM!CT&-9[1'PCX<:SIMUG;KK
MMU\NNFFNGIKIVU]>,=G[./K'3FO4NUIDB6FZKG+2P_PA@'IN9$Z3,ZS';;Q.
M318IGCC17K RP=L7Z..$'I^#0H3T"3TV<SX#,QIPG*)BF8-%86Q$$H<%%##.
MN,3H&^8'EGW\S)@F'$:S.O!E3E;-2M$V$A%>"A<*!O.B6ZQ!>1?)W;-L3JSU
MB/7BJQ<*:##*/RA&!B1UG8$D4S_-&9F-._:?ICBZ'2-975<1<1/+TL5>9*6^
M43T'G"#1)<EL+<(SOB=-8[\$!KA!GM(71O$1+OH,Z>?3W9U_MX:^6*3$,WH$
M9V@6_<DM9(TQ&V8C6?-,CI!]IGO'%NQ5315U[9R-ZN=.OBFJW0I>-4@[#ENU
MVRQ@/:NJ@)F.4(LCW>)MKAA-$=";&NFOX.)+65Q$]I@NWF]8^'"; J9+>;LF
M(*5[!F9WZ^6)T]-.\[H])TXQV5Z7*5[-E[G5V,&+^Z)-O);$K>(26I27*F=/
MANTUB9XH/QC<I9Q09$*>*R+6U3R3Q9 =&9R:3<O36.66V=9'6/7MIQ<LSCLF
MEN-LJLKQDQ7J6XJ@ MY.X.8Q4Q,'#-2("9K)AMGAC"8PS+22,I(M(@8UGOV&
M.T1^B.W&OZ.-?T<5K3ZCPLUF$ER]9!@>HZ]I_P#C@,_E!:;IN/)K$S6-TS!-
MZ<I\RQ(HF!DOY\1NCTCBCG"QIV!J [H[ $$URM,"?,.W?)AWYD1,Q!1I.WMP
M&0!%A;^AJN)9PS:V7D)^6= /VFI1!3!>O>8^CMP\X8<%K$ZC&ND:=]9UC3T_
MN[?VZ_)E/Y#_ )O_ $^+GX4?U>I_E4_(KD=(@:[+!WR:1L" ^]T*"8V^L^T8
M?O3MC:(]IG77C(U[RF#:O5AK*>(\L@TD3F(CUV:1$E[\#I'EGM$QPFJTVJ\A
M+&P0PLWZJ24%Z:,+0>\_'X<!D22P%O@;D(!E2M7LR3ZZ-QS[BM=ACO(R@8\I
M'._O.G#8R3UA>55)52@_HUMISLK(?$0T@2<%KSR_"F7\Z?AVCAE[EY-F2!;"
M36Z1;7M7 &R6%-=B3W3YF-D61NTU@8(ML[>+STDYG3+>-;34@L%N:N#8T>^T
MI"(B1_\ VS$S[W:RT=*[67.N98J*:0D1'R$P$17 ]^D:+KD! 4>5<%/>._"B
MQY8U_,)XY(&[4A$3"##W3YA;NQCWB!V]X]9^'"L=(U8M"U0O+:=6%6/OL3$O
MS"O-$S\/=GB1:ED\P7K,^\\X6!)S/>2G?I,ZSWUGZ?7B"+=,ZE,1WW1KV^'?
M_P#[Q6"H>UUJ]*#APB"H!DF0:^9A.UVJ@?4/>F9CTB._&7QYXFQ*BVG%NLJV
MO>4FWDV.XF<E$:,9,2<[=?+,=]>,=9KD+^L;LL*Q_(QA=/Y%N&9.382ADMP1
M[K#@B*9T.8B.,5D[(KMX\5<Q62V199RX:Y5<9AEE@#/:1A8<PA,H#RZSZ\6<
MHJ]C5T,CO54HA,TF#8<GYS2MNT8Y.YH\YJMK(=&JH$9$=(X[<\=NL1J&G?O$
M3$:=_IT^/!F@:UCG66P[M%:JL2+F'^4QI24 "QCUTU.9](TUGAM>^5>K992D
M$!HJ;?:(8?\ ZH'S#I[LD7;7XQ/;CF,."VE,KDN\ZSLW?I+W8[>OT\1;.E]X
MVF$5-=@+;**[,0IS>5H#-1F8F266W?[PA)".FO#3O7$DBACN37&(R%J*,,,9
M RV*=9F2*4I#?"5@6G>=W?='%W('8G'PQUBS:JUW->YLM/IQK3SO:-84B2E*
M&"CRQVT@I*9XRV21:=+Z\V(8^.HLJ; @&X$@;C2$%,;="W1/>8D^7ZQ/#;]M
MV.K"V^V4TI?732AY"X5LD5V&<N&1[.2):&=O/S!&=8XQY8^Q%B+-EJY!6ZM
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M0HG3Z?\ XGCK[&A1N'O$QNV#N")$1* +34-8$==/C&OK,ZG<><3$R,07O0(
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M-C"/S R8.0[Q[3DG7*=8GO!I+;,?"8W>O T*X[OPA20F)$;3,I@U DN\S^;
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MN/-G%_LS+_\ %<=C+.+CM>_O90Z?G]\^OJP?\F<7=DVO[VT-OS?Y3QYMXO\
M9E#_ (IAB,LXO[/7_)E!_BN/-O%_LW+_ /%<,5ROB^RBY_R90?XKCS;Q?\GO
M;0?XKCS;Q?O_ /+<O_Q7%O>SB^Y_^64'^*XTOE?&"MZ#E=$"/GS/OQYMXO\
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M#*Z"W\N; _R8?51\6Q%1<!\JHR7/XJ\O,WW_ .]I'KP.9EG&,8)L"V54._\
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M<2<2<319;)-E^=9'EE"<WS?/LIH=%=09O530H<@HJZHEK930Q\KGHD"H)+R
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M7TM/4Y715,^74=,S#RZM9'6GC@1A4$P#QD4FK2I5=<@%@9I-+5#5IA>CAHY
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M7U]+)"P1)8):*2GFUQ">*<75TNK1:2X:-G4,<-X+X0>TUXHD9[:>I&G?YAJ
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M((L3N.X8-5([QE"TCR%3,1N0B:#OJ9BHYGQ=FPCR0F11<W7M2Q:K^,+6[#$
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M<U/4U$1&;ZH8%FK*:3MO"(_#"5YD01C%3^44E("1PII* K.2=8FD#W:WXJ[
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MF#:GFC-[1V9B-2@%6OARZSQ04,IJ:"F.EHZ2JE=.;4/S #-*JQ:(>8& -EL
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MAIZBH2BUL(6?D(RA'[#"_6Y,[&":">?,Y,W-72U,\%4E=-2K0SR13*]XTFI
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MSWE'M*C^NQY[RCVE1_78HTH:^BK'1:IG2EJH*AE6],-3+$[D+?:YVN;8_\0
M*Q ! 0 #  ("  4$ P$! 0   1$ (3%!46%Q$('!\/$@D:&Q,$!08-'A_]H
M" $!  $_(5$0]'C<J;/4+_X[-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-
MFS9LV;-F=];ZE"VT@];"GX*:!T:7=[Q@X0_\?1HT:-&C1HT:-&C1HT:-&C1H
MT:-&C1HT:-&C1HT:-&C1H+T$8;N_+AK>4/\ RWG+]E]/_*P/(QD]!?J2QSY
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MB[?*I+!16&Y#$ZQI1>$@'1OQ& WZ.V;TB#HYZ=864?P!#0@^%<L#:>)?O$;
M,B(($M XVI%P/)FMC4&N3L#RFSJKII#9 G_^#E^R^GX18$KEKGT9'8T&BG7?
M7+0^@+/FG?7X\BB[E12=HPKR9S\1]W2Q@:*JB"XZI")0,SNHCWL2MH^QUH2&
M5E!LRI:8UGX]O0YAVE:%,<"'1Z*&]Q.MTX/%VNU/3P>BZ 0RKJR5 ^UZ, %?
MRLZT.*]4;,A'&VGRPF.$6QQ[$)4XH'6BY@IFSE5.P,9G5S4+L EN5[#VN [B
M-L!1^4IJ)%1KY?.?01N"4]"_ER",3]?C!L#>M3;.CULVGH\V,L8_>,9GQ(BQ
M":D68(XTI:8I'4US_,(>E0M2\A4;,1P'([7^3!*PBXW4[P;$5?W:R"+2T%O3
M!$'5L\_SY5VJ[5?*NU_]+ \\+'7\?H"'C?;\?V7T_P"(W"@]SH& Y#6-E-YX
MI2@,)-5O_<P"Q%@2>\7/WS^N?OG]<_?/ZY^^?US]\_KG[Y_7/WS^N?OG]<_?
M/ZY^^?US]\_KG[Y_7/WS^N?OG]<_?/ZY^^?US]\_KG[Y_7/WS^N?OG]<_?/Z
MY^^?US]\_KG[Y_7/WS^N?OG]<_?/ZY^^?US]\_KG[Y_7/WS^N?OG]<_?/ZY^
M^?US]\_KG[Y_7/WS^N?OG]<:C2\/[/\ 'Y;30\<_A6?PK/X5G\*S^%9_"L_A
M6?PK/X5G\*S^%9_"L_A6?PK/X5G\*S^%9_"L_A6?PK/X5G\*S^%9_"L_A6?P
MK/X5G\*S^%9_"L_A6?PK/X5G\*S^%9_"L_A6?PK/C@!'!)<A)A*@D)8@'_C#
MQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQYEQ+1U3Q170(+^-6A
MM$X0Y52X4"J_^-RY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+ERY4%
MI;NMV@&F4&4/_DMU8/W]/Z+<*.5=)0]8('6D!3SAX+UV-'?EM,HIB5/YP4RC
M1*;GXN7$+\2,!,*]_$,J!^$W:631=6*9R  ^2G-*!G1[S]5&0:! &H8;$$PL
M)F*BH3C1,4(A<Q(-9UOF/$?A'"*C*KJ<HY:ZSRT]37D;5E(1Q;Q:_P"O^[6#
MKQNMY5M#5**E(3=V# )QR()& ?3$=Q!E[US.AGF5AEJ%6'"?9,=!JK7.\63H
MA&"+YFJ@>:L$M)JN3J_/R. $92H!DC!706#3==Y*LI&W5F+B1,<_>F])4=Y1
M0.;272Y$;*)!!MWSEUH  G$<XEL\R+]E,O\ V!W]/Z+<.X&?V)Y.P7L%U&@6
M6W$-.)Q@%);^DQ#WRAB2T#,@6\%A! ,YFS!-OK<\  +-844ZXV9&F;EZAL<!
MH)?4RQLI,'16FY=$6# I'0H*10R= N[_ +#9T"_AF5QL4B+MN<&&0/\ O5@\
M<Z?H#_@N6<-P>X^64>9_N-%+D;L4:+L1, 58!F_\&4%IGN@&8J5* -X8+:9!
MF-<-DS%,DM>$%'AFB*NO&G3F?:N/IH'=FI8.P4R* GJ_X?@& U.*Q!7YP=$H
M?2 1F[&'"MRCJKK82)Y8H NO*6V XT2WP8"'_8[^G_R5NK!^_I^-N*X,C'G#
MI(R$"G%?\#QV&>M9Z7W";?JFYY]//D]?/%H-ID1KCEID5OQO$MS*-I\HW/G^
MUQ/3:IRB>*@_SYP!"&^*6;BF_</G-*\ONR0AH-!^=;S[#[?]LSE+V_W9N"J0
M"E^MOGEF#X$J: NP>.?YGX%9(!T6I.@]S"2JL1:^CW^,=?I&/\<<)E"!O!\P
M/83/&Y\96W(E<;0S;T[:Y4T$2* NZLX]O*;S>1=;JZ0CJ>0@]!GCR(G>OQR8
M]O-GI7L%/"0'I@]AOK=_8QJ!6W9\-P=?KW*3?,2LP)XUJ;*)1-_2(7DZL]WC
MZ,T1Y4)M$1"CV!Z7!0AY>OK\@Q'?6L*#GW?8UEY S^E% ]11J79V-O6_"EM:
M/8A#QQ1OG1":2G*,"9K7.'V)(M%)6LZO1K )B[@E(#^M6#HD^7J&\^8?T*:+
MZE>A44$HPY\BHQ8\/?* %7X_]Y17@<7!H?- ]B/G$2L<LM;O^,@<*%&C0H4*
M%"S.(BE&F8I*!147&XK]@&,<07"Y$I5Y^V]7\LK/*?3_ 'OUO :5\:OE\3YX
M8+Q/I,M2.=-I]FQ]\_HY^'@@8=4W\G@\SGG_ ($,"C1HT:*ST(=3?,"$ @%S
MOZ?C;A$<!.-0M^V#F7Q(RI^B#+E[ A?KD93_ .&U,NX %6-X1@6 5O6K]0LR
MC0JI M0#8-PWVTXD/C&>##-"T D;Q\^<*TXCC:'Y/6RX0A52AM?V;^ S;.@"
M?)@'/SN&)HO2V@MHG=)@8H$Z%*;D%-458FR@\MG8V1%A4UK'O,!?S9=,=(;S
M9"($-GV&MNO'C'6S@RJ[JTC<K1T;52:7D&PL\*4Y<9>5+G;'^=F(>>Q8<.6K
M'**8#,B67"HA&+)4+K+^D<"7S2#PP7C16Q\/*S.]VCI2 MU*).F 4RO6UTZ_
MLO\ IC9X)S=^/"_G,%/1!W/G!U0>SR+_ )NN!?Q>B*? ;&P\^,I)K ._'^3?
MO.*)CD"8J1L0X1*RR4ANKX "\'C'JPU5&R/, 9EO#)[)5LLN,!3P>L$3YV!1
MQ P0/1,*_;L2@0EZ1-B-QNH0SG4ZUKG]OZZP?V3?*;T/,MGG!47Y@(8)[5#P
MJ7WJE;GCC%S!>TW;D:G/^U&2$O@2PXCGQ(<5'343MYKP@GS6;N%)*7#9J<&O
M>?!T K2]CI6T//3+8TAL(F^*?ETXK*USHC>Y[]G3$Z>J8/G2Y38\ZPGQN0+$
MNO&LI(0-+U=]3W[\9+JMGQ"./YXZ?Z'3<T_W$=7.$/!C_7U9?QOFA42PB(R_
M2=M_&1&"#H3&J@&"J*!\<P=R0&A9JSCQ[F*!HM3CYL/JHXXQ"C.U0\!?B8-\
MQ0G&8NHUI[OVDWFWLWLD#=_3LX;I@;J.PZQM[<OO%\0-V+3Y![AOW\9LO5+8
M(]U( ^O[99/00?$>'I[F-1I@SU2GU]?U#._I^-N\2@\=,!NEH)4.C+>K(H4J
M6%$OA3*B8]08J4L@0Q(2,@-8*H*%KQHW+0/8C2:$[2U41*X,T()*.BZO/MIO
M/+Z1Z-W8:B/SS03JE)M!9 ]L33BZHQ*@0.SW-.7&NW(?:1%-589.H1'QA/R-
M<5-@ XUT?-L_1Q+FJ?I\A=J*CIBCGC U#Y!O=F];E20 D(S4 ;KL1W<0S-AD
MTEL?0/"..ORK9).8B@7#V[<DA:;TU-YYS1B:293T%AL\ \BM0$ZLDXK*%KG3
M&J"E;5)55SRT&0/SAR=/)B=P:%_++:3P:R12*O2FTO/\Y,>-T@4@:+]/.)V1
MG97K7^;ZP/RF5NVU>GMOB9Y_"8WU;</]M&<R8H;+L;X/=^\#0!8B2@O5\ZUX
MP32[7R95! JW.\7FK-@4J@6QEC,4*W-@JB=8"H][N=V9UPL/#&P# CBR6@1%
M6#N 0/)N+8=*DPD7<8/LW_76#P7W(E!IJ%[OF!X8.@1CG_<1^ CQV#UIV>O"
M+60:Q^.D:$,+QJR=2XA@1K*SMRU>K3(OE-&(+%Y$1>1+^ :2>"9Y6H.HCNI\
MF"+X<8L5O))R[M90-9EHMJNC#\F?LYEF'/*]-D>*B.SSDFX'[OQ>T?8D1,CB
M,2+.CX*20*$RD%;J*M7\H=V?.0H,Z>#^ OD4*9H0W08)MY)R.)_;W^#I5[:'
MR@B4E0$N 6FAYY?EB$7=3]_ E<B9BHTJZ7+I=IN^(7E^S>40-&($KH%I1-"U
MCN(W.F -D$WK0W@6DFGCH@(C\K\8<B,2U[LU5![I>Y4,;?!@>$;--C?&']!V
MX5M[(-/9CNPK=6#D.X\\*><,*JG['@)[_GUW$,D(IL FE'R;!\&285"-S16;
MY5WTQ$;ED1"T\&>.GDS9X!0YZ!]+H>/C.:_%]W]/QMTH!:TY%5I_Q/&'19^+
M;4B]6W1-+@12)9#:NF-K06-AG)D !RW30C1J$,%.'0J"+M:"Q01;AQW$M]!&
M%GM4< _IT<#E17@:6FX,EB#=M1R'RNFPUD1Q*\/02<!_F1CF!6? @J">N[V=
MP%#OG;: !DE^FS$<^34(-K>'P!A=Z$QJ'5"NR:^[$^!B(A4@*04V.;65"2\R
MJ$B.D<ANN+9*.,\)T9'PCP<&U*RUD/E=S%7Y/-ZP$4 2'QA(\Q%^>4'1+,JV
MSQ_E>\E%?QO36@&SKC?<E\0:!@UYZ]C3ZQVJ%@7@%V4\LWFI%UN+?$Z0Y, [
M5$RIM(@_Y-+C)+[FD1RS6B %#&0+H&L':79#2X4]"SLTG)VF:"4XWFC4#&R$
M"K8G1,4_=\@J77S$--^,ME7B(QV(%;:.6XDQCBN]%0X@]L:EZJ-F[ ^G6 IC
M-^97C='DA=!W-^*O:A#&N#5:M"Q"_20-5(AYZ#_76#ZI^8OR3>^:WBN#=NTZ
MANB1O"V*(#85EFPB!@04B\*25"12)$5KE^ R?* D*55<LP%5[%JN6]XB8"_$
MOT- 37N!Z,592P5):=25;!I<<=&R!MGXM-/2]%:/-@31;79R1[%="^4*X$/!
MBR1R\)1/-U!14P7%D-"0<<A"[WPC7]T 6AZ-NG;'B?Z!2MP4(HA0CH28-JT!
M+;924!6YVH:F<!]$$/#4<=WQ3\EH^3_;/$8 )*&PZWA)2M9#6-[V=YIU#A2L
MHTCPV6U!L05+F)>CC@<2)L9:I& O>9:)$3M,Q(\B A'0 , ,Z)#*K&&/&YH?
M$]9&>2F$O$C=G'E#^P<A:C?Y'@@P:72/F7P8D%=KT$WWXV.\P1["._EQ$<KA
M:QA<9V16M$C27D,(%"H4L(J0X!6A$Q+75O#^SO@%*+O+1^L+TH(!R<=1B!8R
MT41K:'2#W<.(#'?01X=4,='-/P.[^GXV[Q\K>0VFK]4OC!H?!D]1VU [&;7^
M84,SQA>5-0C4^#P8N[B#%* O41)QMTYBKC;!07P'0:ZAG#D?0>9"+^I):VC6
MWVMI_;P]P;\?;*[D[-I: Z>HWLS3>/(Q[ IY.LI:+VGV SQYWK#M,"Q87B]I
MZ(H&\T4FWYT(,-EG;FL\LGXO!7@B1VOMCB7M GTQTC3T<)9NTYE=. 40N1>N
M'OVU2'0"1Y%B1</1G7QZ^,NJDB] /)_E\X'*17XAT&A[8(I0;8'_ $:N,:A.
M;##0XPXSPJYD _(!KNJZR$^$E^8_V?+K"\#2>!+LC2JP=$# (+)K2.$BU2FJ
MX)IE#5HE^,HMJWDBQT(.&RDVRSPN063T9N\K1YV', #7KT>N!-E7 ]- )H(R
M@2<=%,:+$MB8FA M$!C+FV%$'G'V.8HZ@ZZ4 "C2U+J:X=*^7)B5H"4#(S5U
MC0*519@!G]=8.S@!QVSL<3J,5*%JTK$Z031APG8ESZ (-HC:@A /Q+TBI,+V
M 5E$ &@5GQGKVZM#YP=30M7PI*@$%'?N?.VHT,+U'.]>"RPXL1KB04U'$=XE
MA,J4[<WHD,4G&=1W,DU9C)F@"H&Y#$7(6.R.N F@M!^NN&\-.-0!'5.[9M6+
MJQN8<LJL%Y;@9*-H6; I&-0@Y718%\P28+!DSG #,@&H>K@ R$QP%81Z^R5$
MY*30HX1ZI*W'DNX%'#B.(\&%0E E#KN:7.7K#%9"1:C-FT@K!K3EQ9D*X-DN
MB\.%QO*L*3KIH4=RC%Y$V59-JZ?D3#)*]YH:*]="U-4=ZPNP,36)WYQ&-&8*
M(LH(\3=+2C2W4R(#(BM 5D K[ATX]&%NNZ\'@_V3'HBXA$TCL-);28ARKS*6
M]BU'C)ZR/3]:?-X'0 #PPK'(*&G1E5T9Q[90WMZA71I:.6:8M+4T5L5V,0H8
M+O\ +_X?]C^'?T_&W(OIP.NI/M&/2Y:]"(/==01V4!^6$4S+AHV4_,?O60!F
MGH J:+2OKF;UU$%=A\&7[FG-$:AJ&G@,AH-+,K"O4J=J"I'=:=Q"$--U1!<4
MH>T82Z]0@STD+)(34<&;C[7I3H&-1-EQ61,-,,$H^76 Y-TED08"\YG&/B1R
MR6ZJ'2M0IA8$ [9AQZSI=81,'?("I?-6B%RQ[?<_\&HRN=81[FFR"[$ )ODC
M9QJ-P;0\PX7>(T".[KI2J26T]FLYE =8):O<:GWD5@Q/E7@L+JNYZYJ*NS;3
M[\X\A*A%-?XM4>1.PQRPVP42=4 ..KO);#1@1X](L-AC.V482#=55SR#7<61
M=#)Q"-=(*-ER7=<*[%DV@&FD;5 QT7W*-&2CFE3[(*_R-:K2TR/6 1K*MH@6
M! PT3Y JO"#:1YK5PI(6JI6!>"X^22PH325,[$U,1>2ZLWD!!B;!*E=21X$\
M!7Y?UU@_!R+YL6H^U/*DP3*J&]VHYCGXA0<^C6B1R^( (W9V65JLTU6VL<GA
MD:^AG''$!\Y;X7&@MR?NR8##B K5*R28- #D[XS%+;,30S;$<K:<1 #*?]6A
M JENBMD4.LDAL-87M&*(0HC\3"8()FT*@ %4.!\B+C^E%HF0)W84":XU35*5
MJA$#(9V311A*/-!A /+E%U.6E6!,!JPTANT16 J9!<0$:2!:T=-7M&4&.QPH
M&EM#R+&X@S[IT85:"0A#9C8H/1JTAY"4.O9W"52H.SH78JH" K'>07!-E';(
MW.FPLZ= 7=B%M9:2N>101K$78O+HV&[!$!HK00[#8OO*AO&A;P9Q#TZ4+D/7
M"XL=@!-F*"N;PQ6K;]7IR#ZP+) %#S#UI&K4UZ85#H51"\\=2LNT'F!S"SH(
MT33A*:/3.FVA!+@JQWKN5C#G8@5Q%U8HC:QE3T/4I;1N.VH5#*WQS^!E[GX.
M_I^-NH W9. ?::%=^C+E+1@%-0[)0-Y,A=.#5B0(]IZ<;4^+2&' =FWK;1@D
M18:,"-:6F=@\,,R-"-%-IU)50KF]>A@/*M.-V$>,OC;\,5>B@E/9KDG05UHN
M)8;"$^&>)&YN+"!&(:5'N:<S(-:#;06!PWESJM)(Z(;:*3R0%\T&\X V+&G-
MHH"Q/85-TIZ<$JJ?C0D\-+NP.-F-8 T$ NOTL=%L<BE".@U4+08E*J(-,S>F
M:7SW&H#=ZV-GQ+O4N\.X"5H&T=_DE0T8;6(%8(6NTWP/$R-<\:14MU36LWC,
M1.''CLA]R^9F"Y],@;'VHJ;;03&"J=PGX_9)TQYY$AE.!-<*N)0LZPFQ&D@;
M+W9!B0%HQ(6QNT8/H''\Z%05J+5:7=+@0U+I$(Q1T+!0- Z-ZI*% 3T'.C%1
M/]0<@J"+1ARX#"5$I30.CDAX=99>:4!5*T4Y+[*0V?0IH34TP0/(+$S;H&N_
MZZP>>H4253TP;8<RS%!5/L"L-XAC> 2@^],-"M(QF!K18=!"-;PELN"2$"W;
MQ= .HE!KJ6RC#TA"3G%#-9BIF*S)4OLJ<U;K%  =. ,6ZCXH%"_Z8.RF(AFK
M#E"4G]&4X?2+K!<(ZW6@W!F.-MDPZJY068,KV2-U+7A4] F',M(TM!-%E$Z*
MA#[OC=J8UEAF<UT$+-S%G0F31JW^#<>GV8HZZ&3$&J*X,G&KBA6T06_1D'.I
MCN):(P*:<#IT.[<,[HB.72,%W##A"^\X6L+J)[),B:L%*M=2PH3J3PJ!#(!;
MG"/Q,FU=LDK9(B=PG6&F(UC983*=")7>V1O]5/#L+X";-E<WDE/(92A(3RAT
M5@A=8!+XDBZ2VW$G %L]@FB1O@=9NOZ^_&LCRZKH4F)%B<DZ,\&ZJQP[P-WU
MBL[H'A 4)S><9K5A(+A:C!C6*U.")YDH!' !U&M:[?\ R!^5_#OZ?C;G=@35
MXP;T&N<+O#>*3< 2#J0NG,8Q5&4C)[K\H:K-9/P8WEVX.GF89Z!O"NKK%G W
MD)CXX23R$9T8T@A+<H5FWT20\N>,XFQ-DM=>75T,"WTE0JPK(IBDXNLBC["*
M$%T0 *+@-+$,:O4Z1\NQQUBJYA5" @NO29VYMC%-CP89&4PPYUB##;R9?"(<
M O8]9\5K_!;A%=/W!+M2*D(K(L<MVLUO],T*6I@[]8QH0ANQ("/6O&-I'VV:
MHV/C\_1E.U8VSA*='KO+AYX!I B^E._Z8.PD-Y'Z!Z#2\KBP@9 [<$2!6! R
M<=$(OV031C3> 9J^?^X7KHCJ%%,>-NO*0<2*@2U2SP0'I5\+ UT76(=+5,0Q
MK"I ".YO">!J[=:SKOP,*Q:R6-SK2M+:P\P^_43%[-Y5E+,7>FZ9I%1=!%3E
M;OG<>AJLU54_'#&_%:6O$7*/)TQ$3IW9H-MZ7U$[\"T#H-@)_76#N-R?MW6&
M[$65Y(6$84YAD!7 #J5S0J98VJ7.+&.4J!1AR_T"[)HH: =X5G*A)"NY4GS&
M(-T1_P!]I*I)0%C+MED&VX+D,<RD;O4E5Z(\00PVIQ9G(P*@"MU*U;,6BCHN
M4('!AT%CM=D20]T8\QH)($E$>KD^\VX=+\AOJ4^!]Q=H@9C/)VC95CF&]B",
M6_D *ZD!B9;VB/;FP0NP<0/<A-,!$3"\L%2 H  #2ZMO-S GM+Z)-%PZ@-@J
M)E-&:)#DZ@#9@7,7T\EN\3'6S4;DG:AT/)4BIH8PA [K#1;:AY=3-INB!JBI
M)C91Z!PQG*Z=,M7$OO!:9 (#9*=F&*\J(AA,G!T9/&&@1[3WP@Y$@T)1NK07
M G#T%T*^R#Y?.L7>7.A!SP71\E>&2RRG7P\+$K;!@X0EQ&55$WY^3G7-\<VN
M(36AN+>;,H-N8:U %)-7#)IKIO,_;]?AW]/QMVU"\:ZEY0AGEWD$2P2W ]"1
MY+VV24H> 8ZN"0EJ\93,=#L/#1SX)[<W)#F"3_SCYU3+#6RY00T4_39BD@ %
M][%V1=NFSC)&>% -L(5^+U.'#WN-H8"MUV"'3@0-([,H[>?@*U@6)Z%&3OA.
M"0@.0)3\D4Q<"NDS8 .=JR@E,Y%3P-8)'CJM52H&L*>8502R+9N<M$9((.*8
MBWL \/B8U<V8/3/['0^3/%\M^;NRE0_(@+<B%9N=<2RE2HD$]13HK+DSE]E@
MI3GO?1,9Q,R=AUKJ/M/NX+YT'H2UW*=L['"K )0(V:M3A1>:P\&74FP%X<'0
MBM<#B G4*:G=V@CPN;$H. 470?5+DX E>[/CCW%F B+&T 0<(=VD"O"#+<T/
M5.[,F8JD%/"YG-=1.#4P%BD[O<T7J<H,!8D .VAOBFM3.G:$"^ B\<%!3UPB
MH-TX:&!Z.('34*&T>P":AK4_KK!U1@Q12DBQF)L[,/=>T->:H'0#I)D>F%&D
M2(04-8%C55A:F)K/%Q/]%Q*NT. /#6!5=HR=C::D**#FW(S@ -9X"$@ A/H3
M>ZC.8;;+&T*2'/#-.(L&L!_\W(B'8<98C4[,*[$#1X/"#X]6X@+?.+IZ4AH@
M5#1J73NJ\8/F(4^1+@NT+E8FG7:6*0,8<,5%2.V%XD)?::,P&>Y[MBP'M[)E
M2HCY@)5<L5A*,*1SLME-!60XT<X%UHQ;\L:#Z&H?, 13JB$=38)@L5AT"F^5
MS^T8&%0 @ &0 L=@06X:>&(AZB![--POATN+HRT5N_6N@0,XLH9 5Z"/Q, F
MQ%5)) VE#KZS8 Y&T1/IU'3#9AD'NJPQ0=@#<)Q4R"&A5&C&@Y,UW]3$"=@;
M[O$6M-L@T#8M,U+%U+PE\90 ,'3W..Z27 APT@H9&@[;C"[8>6Z-I4=9V?X)
MZ_OC?G\._I^-N" //O6([U6XRC@_*T1B*>IY%B=F(Z)^M5FPNWCM+G/ ?=EK
M3R#UIX.#97DH_EAO33B4@^P#G@@!\M&M9 &Q$JMM4\FT.,TU\LJNE)T.KY3"
MBPM$ G;$,Z1=WFD=R@@;-6$LT<>X&'RQJ!?4@O+LHFQFWT06BCIQ2#-$IL$G
MHEIV#F:.6-[KA1_%RTP;F,?HMF,+$HEK8&>_L*Y4@=V5 1#V&M)M7\@T[D?E
M<Z;D[L.9O9H FG"?( 'KD2Z*H^QJN]N]S(F(0H2Q#U<U0#MZP;T?5RES.B3X
M8JG0G"\:H]87<;UC,1.9BL33Q7Q.5]8V? @+0[*RFIXQSD.Z^" UU248GPMH
MQTE 4U*OA\ZW>O,>BH-F<-(BUK=DUWM=\'K45_\ "?2![J>#"(5Y+5EG'G&U
M%Y]GS)!@))<:5?[4H=D&K?MF>^R)U5B)GN4&.9J(%$,KEP4( )_76#Z]';D@
M_@O_ /=@=(V@=QPJA:B+,KI:(67P< QX#U]V('CMMUP2/-GVK-C1("A$;88I
M7]\<&K TJ^))U%MK704=FCFX,ZX-/0D0VVAG-_#R?UL02#*RT2*[34AAVO?*
MEGG *0KRRGD-XB4KH%X8!MXL@2*T-P8);JQ-+8Z\RB1W\6=ZQBE[\A4M+7/(
M;8EQ+G25:*#, N='30=O!G(AP# +X[#O<06!,J@NC\'D'05!R&C21*\" %3(
M@7 KZDAND!!=-JKS$.YB-#\B&Y?=0=8T%>[$?<(Z."5#$5HB$!H0SLR&V6-7
M-'>3QECJ]KFEV%PAXPS7X FRJ]I+O$FT'?'E+,H%I/1S\_&;!H2V9@KZ )X^
M3 L]%#Q3;R1+! S@G!2<:9!4]<5@D$ 0-1;LNN.!4%B@W4$B2)HYJUDLTEM!
M*$@4JES:U=*0L7VC0H@944BEN\'33^7X=_3\;</W9]"&.P"?EO*O(9*:W+2O
M TN#HB;:-YKY2^<&I.V!$Y1)Z6G0\F;L&6W#\E'NKW<I6G Q0N$X.><X.\7+
M1\#/]B,"-:A&A)=&[$VUBGU[U#$QH7]V/ -P:*C\+YY[9M/TJ4/0?G 8;B#H
MR)H!""'76'<@:M4FFB$>N'TTK$6"5F  N- 1 ;=(O#:\T+B[K$DBJ@'A *D!
MO'2G:Q5Q9!5M)1A?7K5Q@@#5(/%F\;-@L!M.4OQR!"V##[1-1_\ ZQ20.L\P
M_(>3*TO(9OPV=O3O/*2-!%4/?]E'"@%0I%!0]%7Q7\\EN]%.;95-?#K@,[/U
M8B\FG\QGI[V!T#9KMDCK/#TYW2-:3WHL;,"DPVB[Z2?T%O&)%$V5TZE%*@Q;
MDI-E,21$1A@:"YSFVIX2!TH6&C1U(PU)JM:  &0Q$;6'HJ+5RZ+X>5'5C1X[
M#T>9##24-DEHN]PO@%_KK!R)J@Z-@+>M%< H#TVQ.IP4[P8$OADDZS-?0PAP
MF/8@A5<K1K8,)@II>GU%M@-*Y"SO9LV*'3,$8.S-CPW2""$9L,]]%7OIF_G2
M'@34;]&F@HCX[R7(16BXQ4/7+7%I-H< @P^WCOC6/0 [Y2D.]_OK!PV[F:FY
MT,B\7 WJ) 2B^8(4@)#3"JW*NL4H(JP+53H.0,5=.SV7HI).!8M.'CEASKMY
M2K;;$1O9%4!SBOT38XN "0!.DR1;2]F"7.8IMUW8$2-87<G#QIL?/3SJ<<"5
MIH" Z17A>(,,E(OVBTVJJU; ,#0U.]#=A40C5K2@GGRR\;Q^Q$ OF&3U#1G?
MQ7 #/ABT+NR+\5,C 02B?_G#[RBA0R:7519[-O\ &.4R"BKC@W^4G1'!P<J+
M JE5D8^T.0;\F=9:_(?KFF"V4,;(T] B&'OEH3A5;,RK0PFII?** 5!;I7\O
MP[^GXVZUPI]P+XVH>]GG!1@(S0'9-B>&SK.-9#E_M(UU?&&!^I&0$$+J]>YA
MIC$\ .#RZ\]5^X1")(QV;DF4P2YK! \J%YC-I% /$D>>'CQAJ0<3IH"-B/Y@
M#$CE!".]RL[.QDX8=H&B%.S1!^E\=P?XTTO?(KG8BUKD(5I6VP-?(.RR(VDE
M!N4)"&32G,8JXVZ7?0>TD3SB(B522[>+4$L5&HIF8W@!0"U +P>=[8+X'^X/
MSS:AA^.D"T+N O+RT)1-&VGB?Y93>$5 KT[./O)=5T0==L-WP[TN _JZ<-3(
M B+P%O<N8$4C>\==CJ/!=8)DNU\*P1=2,MX9JN01/-7 )NK)^6+D'Y4%'D.1
M$(&11C%0 #4!Y9Y9TG>)**50DT$E]0[A#FV@E4RDGPM6)]:!+79)KK77DY.)
MTYSYF>'V%Y/3AK5;K\D%*8QFF6UC\(JM+-/4_P!J(KURH.'0TWL3@T)7T.B#
M1/ZZP=$)+IJE,DU0CB./H%?G;0T&!XR!+XX.\ "0C*VF$[X6!D00!AM),AP;
M=J(4!$@DTSP>ESAWASXG).Q+.CU8*%D@&'530D$ SHYMVTY> /-'JU;@6L-@
M<;S>X#Q_QX;%%XYUUS.13<"<]O"C7\]*":V/VFB!T%>S>O\ =]X;7AU*!"5K
MLI&1,9E#1XQHJ7H.;GJRHLXT%I8S+90C-7H>?PE(L%1)?!I*&8V;F%C'[:+?
MA2JDL8=PK1%6ZBC9#!N,%8-SK1.>ANH0W) >)'J(VQMZ3&QAA2I1':VFM<3>
MW N@T 7&>3QP89:I]'I:PJ!2,35QSNQP$"Q$N1+-5?A %8"["9M).ZXR4J13
M03(@9==90 A$:21B@Y?C\M8& H2DU\_(N%0[!C+D(PM*C@HG41.CV"Q#0.L7
MHQ@P2K?(L*^$!H76^.^UP&;OS*)BMT:AT#O>]_AW]/QMTO"5#0![(\%'EP9H
ME$2 :)X)MGYXDCZ==HG#AU0YC%M;WLTZJ%D H5N"7.X%"E)$:$4;6X='M_-P
MB^"@?0S8\1+V+ZFN_>,%+'MJ0-O49W \$*Z@29'8>ITX^'JQV36&=#8:"X2T
M+<!R=E1XAO6:<-1VX5IZ_L\*X^1U$]P3:<Y/!4J\D3IH1]FX_&2P%Y<_;#;J
M-$,8K[*^ DLRZP#.="RD8)^QSM1UFN14PD:CXB)]9S8:\"XA*;OI&2$@$V=C
MZ''WA@V?D 11P$PCAZS!*C>#HDAKW#D5"/,-!*)2BSQ/(UWNE7T"/WW)>F(*
M %=]!@Y9<A:&5L:#H$+S)*\D )T&E*^S-X/SBMO#8V>7[<5KF50C@>RX+PN1
M#$0).B.;UOCC,XZ0=>E35R[*X;J=J )W3;N%[B%,,X@H$0X=C N88GGBNO(@
MF8PFP%*UM8!"15;F"+J_-A/"2_+--3^JL'\8) 3!>"^O>/4X!=2'REG2M:$Q
M,GSH4ZH+;0PS'T$"S>LP6JAY,ZCW%Z#GGZ-PXP/):3;]6)AJ*A0$@-2+3@"^
M4$ED5L$)ZH$#A#B[S0-=*!$B[Q,NW3!)A,3L"51K><HFUX1E[!O^U$"XE% 3
MSM7 6D=L+ -'C=#S#+"%">+35+_#AC[08W- =R!U&)"D4"WNPYF;+D%(A0P<
M@-;ELPB$&T%CIV$\+5P6%;V=4N-A01OW9B,&T6CFD+H!EU29HQ&\7T#S8 !H
MJ@KC028V<L0[,CQCCF'V( HP#S(9,;MA-3H59TU78F7PX[P0JCZ\*E3%-M#1
M!40 9_L7*M8L ' LQP!)7)8W<$";LZ[HVY(>WR:=:M+4^"$Z6)HVGQA"NZ&D
M])X[X[@-MY*MG;;9<HY(R?$)!P,N/'Y&#A\S>BGURPC-U/Y*'L'^WJ&NKL_F
M>OGW;U^'?T_&W2,8]- N:)%7LMR8<=T-@@.@^(_&-\2 %6VNXNBI3"G< (CJ
M;&-:#"N\CI%7Z?KCF4PSKV1>@]!^7'^RQ$!UN F6S3')5HW)1H\4@.U9S*:Q
MUW!>'80@NMB"V]=_+TH+1=KN)<O&>)AIWIR?'#('4WPHM-[A&C:-"L0V];XN
MSX,2 UH5 0#F&F*GWKH098K'[T3%2_>VJV  *;DJ7-Y P%M*LZ!NQ&#ET'[(
M]?K$0V-#"@"ZD0-N0$.&=D -I2]F4TF1M0U$ZTP-ZPH<FGY.]D:=:G"-!YQ_
MBRSUV9*$DY FQWB:_P#S-H JZN)4 AJY-A9.MJ$]'CG76:S:+BZ AM-=OIK#
MQM =/6/[63.X1,PP@VGR1X*SQ!2SL+8&8D0UDJ- BHW>N5X#&LA>@"Z&% L6
MXG%$P:@%U0?>HYWT2H4JFDK*>  [?6)X?!&V>CB^+5BE1%>_O+3_ %U@Z"FC
MIV4=#KT'LQV(ET,4^<Z: \[YE55W$7R/'6N8;L?0-$#9D-!YK%L$'@%&\A/S
M=Y.L'G6'<IR2*8[(3!Q1A-5:B7,BV$I Z810@T*6AE)%00#G^1!C!"U:2'>G
M;(>LTDK'0KM6]W07%?)$R$C\#MRL@KL;<7OAY-\_<R$6HBL/_P"/Y8SI<H2Z
M7;5;47*S<#22] ?*V*$> /9#O)[4D1[#^DA,@1J@=S:]2:"+'24?L_6"#;KK
M,-)N.U+-/O-HFD'H*G?0WJ7<P)XY0?%,6@*R.Y,S(W4''Y8+X:IQ>\CW.OBZ
M0+8A7WAS A#1@.@8=1$U&\CP^G.(%PZOT2@&>J.]H@WFEG1B./;'W(TX.="_
M'WA)5U,H>#!.@LXI%PVTN;*V'O2^\U$B:J_07$; R%E$R CXK!U82I(M =A!
MI;*H9FXM4I95")1*_B]Q,X!?CP:A>>"'C\._I^-N;-0=#T_:0@[28-FBZ""!
MKQ1X@8X<,*ZM:A.U>9AT1(*:!MJE@W)%< %L!K!O[;P$]KD@0#2Z#G.&5TJ^
MU71[6\P&P&KP4A'PTBIRWLDV$&RO$6U0'#$=+ZVT?2GD*ZS5DQ<:-F.PF$!*
MQ3(2/ 1J0>0GK+@N!C8J42Z:*D8Y0/S_ &NEG(&!O,D/0%VA57[Z/!,3**H+
MB&2AMP/3)K(8$HUWH\F"2=I!ZYB?>64-#*#6&-1N&!Y%(CQ4-H/(NARO"VU+
MXE97H/D[R#X>;4# ZBP8(I2E0#M<?F5Z<WD-4>D@3[0GW@\L\=WW?/SJ8,["
M6L2;76R(-F6Y0Y((+6@%KJ3$60=U<@+P:"%8("QYG<>B90"O%:.H[;*39FMV
M+6&>>V IT@RGN8PV-9)Y:R7@J+K*X9XA-B-H];OF.JPJ_6I" [)CA5&$L\6J
MZCN9X+FZB175E^??]=8.038WG9XOG#;(:J<8$2I VCW*1H&-/E!UHOW[S< +
M%#[)38G$?3AL)36%;42^WP;<1O.BM*49< UZ%##NDD%$0#M$H#HUY\3!63+F
M\<(AP=NC,X7P446 *J"I@@GH<[A_V9# 7P$ F)#(>9;XY!*!U)D_'H 1\U;1
MVX!$$"["=NZ*4VG<28@A?@TG!A7[PLJA$KBZY46=G%^@";V9+/[VQ7]"@%_C
M2-\@3!G*YP:/V60@U#0R\8:T2-AOO/#C@,+A4/7LBL%-:?C%'+I,)6D@ J'!
MW62Q1LT()"B \U$[45F2)MP* ,&ZLENTR.=$\)@QK(1P0-Y[(9/BM\5A ; ,
MLU=JQ],TR!400\GG@K?.1W3H"WND;#>OTREH[DH>$0 )]XZ#P6='4KI;KY\;
MQ(D>EUK]_&"23& (SHW!OIQF.D7F9;IF'BW.8T/*P%+W?-R0@IX !T?+RJJV
MV_AW]/QMU 2K7GL\W>.XFE<"=7??M\>UP&@LWW!K/H4K6E-K>H!9$D.S21+'
M'GL\07X+0H AM9FO$YLL(N[(6&@PO<<&I2E@^F"-[*$,":B"J$%I)PMY%1!
M$)BWH%SB3_[SHC[E; Y\K<D=$=M4 ;V[Q^OLJ:O+W\G?S@\,1XGM]O(> 3&;
MKI?@??M6#83!7M=10Y,H.@4N+BZ\*4:^5F0$JYMXR?8;:'!:/0LQ 2#HA Q9
M0-2DRX=&_'D#S&P@ &;/ FR,K\&UUX8X1I$DLO(:;1B&/DL8T8VHN(&S'G!]
M/.I,":60!M)B)/DZ6RBB0)KA@P"]"<=0=@\'G*Z1WK=,7/[(17LO!FEJE1-
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M1HR3P'UN/'MC,J\!#Y4M+E8K J2FEY#UK[QXC'$W,JX\A&JT'R=;A$(:1D7
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M>!<O.C5%9:V,*7(J'=98(:>-DGP:D;+2VR;#1.V1)S!0@J03=:ED_P#Y*_\
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M,4;F5ZE%QBJ><Z\NU?\ L]_3_P"2MU8/W]/_ )*W5@_?TR8P_LOX*DX,H?\
MQOOW[]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?OWPI(NPGFIBNF/&5
MN6K*5S3%OX7V<#\=YIP2%:O_ !__ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#HM2F=
MS:1$%5,__]H # ,!  (  P   !#MMMMMMMMMMMMMMMMMMM\![;;;;;;;;;;;
M;;;;;;;+                   8#@                  '"R/A5XXG]Q9
MU3B>^@  8#C&[V"LQZVF2,IH     '!NO:PTIW;U[E!LTJ8  8#@2 VHV]CI
M(\J!)@    '"02"2 20222202 2   8#@   #X" "2 2       %DDDDDDDD
MDDDDDDDDDDD\ _\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#5;;;;;;;;
M;;;;;;;;;;;0+MMMMMMMMMMMMMMMMMMM                    P(
M             @!_M6U2Y            P( 'LR:DO@           @!\-Q!
MWB            P( Z"0JP90           @                   P(
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M_9@(5=$J9G-(@,," F2"_P"&4VDTD$))8BL*" 6TFFDFD2PR!$^S,24<# @
M                 " /QG!A&3+HRO7/     # @&U!ZM!            "
M97)O>MMC^@JK=     # @!'H5A\            "                   #
M @                  "                   # @
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MC/"DW)@R30!)0B*"RF).+2*9!$:I<.))0D:N)[B,/-G$%!8";.P'WB+B*0
MD")(7OA4T$9!/&#N%L"I(<C&.,,$301(10",4I$D"Y4C#8D"AT4LZ!CTM+Y_
M\"BLDT;@*8L(O0=3#G @1C'J*7[G$ %.@*OV.)" 5> ?8Z<&1$=GGW^S@!1I
MU?FR?G@B4T]_7KG?^;&I4A@5@*4& :D[G!R*##::$=AW 'G1.(VUH(4J1#;<
MZ[XNA>RP4009%K(:O0ZBX-E[-SV(GO9GSG$0!BKP9\"BQ+1SW +!J;/,?/\
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M(+P(72P5@"!J@L.]KP1AHNCH3%25:,REX&*H2C (D!@$:#1*NB/0@92 %@D
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MP/":5&^V4A8"@5EY5-0LAIL!ZL31$>(SRCRPK&P,WLX8BP^"KCIU("("+8
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M%<16I?2G"K#5T$5("0.IOCX.".66"%M': Z\M((ES (EJBDHLIPV5>>R)5E
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MY4"D!*6KA@[@%["FP'!A2O<Q4%&])7$T7V@'GS4Z,B%@'10!=2Q[Y)T (B*
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M!" VE2*$CX'$-LC TU$8ZWMM+G 5#0L  JBT@!;%BSBY$X0)/@Y.STIFIB#
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M9%M3(/3P$,#RR81FK46$Z"RKS2CM,^50P0!C#.^8*/;( 3(BVG0&T.)VY!K
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M"WNE1!8UZ4YP_B%!%RF&4EX&I8F0A8K[(** 2.D@#LM\%0U)R+4;7* :PB"
MNWZ?K/?U5BH@GWBQ$.WVK#[<R1 +B0M)#9Y?^&"A0-T$Z?E7I[(<6L^T)&+%
MQQB>-KUAH Z:/-VF1NI\\F;+R,8'L>-]9=3A6F$0JB&== 5\'1WP-A% 4RTM
M,ZV^_N7J3N&5K'< P>3+P)0D-N /DA!$'E9L;H+$;'1$[RZPT(3(#"LHQ+T$
M$#Y.&A 'J%9T(B+H-O;X8*C"@U:L3([\>,G$II)>@5E\@,2]$DX&50 3 F(^
MAO;WYY(D,J ENU ]Q2GFXS(6;MW(T=0<G9NH0FZ2@IAPQ5.SD(=@(Q9;,DMR
M\70;!+!'!I?0NLG7&_H9P,(*A-6*2)O"FQ!BEK\".&AK@[]$![) ^L:0-Y!E
M,YH  X0S"AA4A#NZ0#51 +B'FW)94T,4@ 8****5AH*>A*(%%#[8FLY2#.-!
M:I6/0C$XM..DE*V:#H&"L$MUW== =!5I--.L;BB8!"@,$!T<>$",SC XX4V1
M&G*#94!@M(/GV.H7XX(T8<K77'%O@A '0$$7_)168"-4Z!IKJLOBW.-X"K7(
M6!5*&9XQX+CDY!B;,^:%%*131'3!7T#$B@HK<.3@*E<V#2BE1F>>7\/:W9$!
MD#5$=3@G5,S2_P  %-)@G$4:H'G@H03HNMV5X<74.Q2,!:JA$/8,IW([G)ZA
M48HP <OV+7*3FC#H5QY-P<%K2I' ZH_Z)M0H 5D>J#]G[/KC/YL(@E@ ;0S#
M@42L $I'8K'%#NB^>H')< D)@JJXLO$Z7LG1%X0"G@*!6"B1#()=&'%7=ZJ(
M24> 3!@I"DU!OPU8A"6>'0J"XE#6Z>DQA7#3,L7" (F 21TPBZ.B%!6U(<="
M,V"HJH,7X&13\P']=E/C"$GS#PN<_'J9@0*U,5Z\5$5L68FLET'.R$_$5YCX
M TERA(+-6C"&1F[H:%@LNV]>R^/G['"B$F"[WO0AE[WQ)P8LK:+T3X:S4KEC
M,EMQK9+;*Q*!X"H^FV9JP ACR.^PLO+-#D34> I.& 51KL6A$F PY^L]_56$
MB(; :#W"!?#37C*@7(/H^1?A/=O'4@T*L[J ZB8(VD.#@&H$D>$$D-E7=WB]
M>T# :,MM@[YN6*E2AJ%+(!@49U%\\=*D3?MA,EZNT<ZXK H<Z3$I&.9T4X;
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M$.,A:*C2D*0FH'1%&OU8Q$:KN)/!SI%^$ JE$NP.'&CN^(U$M5B:/%%?WA4
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MD7OE8>P)D2"MWN]?SP,EMJHH/0-:"1CXO":5%)H$>P4UD-*/QX$(!,6KJMP
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ME@<$((J&Q]2&)!7@[4*W'$H'N/8,?OPF+W@,=BF)=)$F^.= RT-P^/TW['$
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MG0%*>E(X6@SO1 64Q98%4>A"8PC$' 4P26(1%9" &U0B ;G(5% G3HHU2/%
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M!3PFC)1I,R,([HM*M"PL0,P.,\(F.O 1JO3 &Z:8)HJQ%)+ PXF17O&B5?\
MHBBM>-RJ%*Z/J6,*>0T"_1\P#=A0A+ <R(?"$X;/G&BM&$F%FDT@?@LUCVQ$
MMLYAX("J(UU1XT4>"X T1!0*K"TY71RRF-28"H"P2NX<(X$\U5T#2>EIN>$Z
MNBH$5!/'V@F)3*CNFK%*O7EB4%D$2%?]3^L]_P#J2LHK?K/?_J2LHK?K/?!B
MC'Y1"P@Q#$>D_P!GHT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT
M4>JH @@$F@Q33ZJ=OT<B!!BD(U!_LTR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9
M,F3)DR9,F3)DR8VR]V#4UB(H%J'/_\0 *Q$! 0$!  $# P0!!0$! 0   1$A
M #%!46$0<9$@L='Q@3! 4&#PX:'!_]H " $" 0$_$$2>"Z=YH+ #T [YO#YO
M#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO
M#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO#YO"*JSMNW.%(&[
M<^H156A9K^EB@\&=\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3
MA\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3A\3
MA\3A\3A\3@,#*%68"%BQU*'_ %51O-5E#8!CNL3!G,BJ9O*+5)K.&@1!1AZT
MXGYY>EN+E(' Q0@P-8$&_="( ;./1:+@#,88?6"@,W5[I0.(JX$4#BJ,G70<
M\_ $BQ9!7:*"G7VE[@RL%)!:5 ":E!5 'L34EC?&7#6= $+2%7PX%]!5N'%H
M79)4HJT(U1ELGVDD^'5L1%!-\<YB G>@6XTI33.$01$01&B.B)1$1$Q-LY!$
MDL>T$/\ PXFX?R,$R,'Z#Z]Y25<IJ8$#=\8G/S$76*"@1$!5-,ZH%0,&Y*-=
M/5Y/<Y8@&SJJS*R":<$C_P _&H%0!IYD0]AW9:[*'4S8B;9P4(46C5!B"+1#
M7.3IKS;P 4C)N,<>-L%7Z^6<I@"JB5%&J#9I2,.&F4"+F!!9>& 8"C+RD9Y9
M+-U #/5)Z](F9.E'0UOP#&QI)$(;@M2CP7Q;J59_KT]T$<D7_2WFI4 ';HZ5
M1%E1Z5&@'4C848@!K8+G!^8)KP A6Q*$'/%B^YE1>A*(I=)(,._)U%@K%R%X
M4[4)FBL\@QR8!PQQ.J9]V)%IYHH%TVG#(@0\>Q3IBL N#Z\*,@L3>-6!5BP"
M42'A%G,ITC5$H+0%!Y"/(00E>2@ 6L""^CQU!*(+R40B@T>.\J($46*$1DT3
MSRQ?+C$1H$121$XZ.$S& E&(%N3O:R4,L;5A2O17M_"DY8D-J2LV"+8B5BVO
M1V#G:+:*R9/-FAH\QTF.<$< &;A-\F'9O.5B&EJ:!2UWDN<5/D=L91SSQ.WT
M$:&<FSX!A><*P-3A)'J$4I8(T'*J-8 PD^%\"KW\?>]!T*$F*N@B*)$41\B,
M1^1Q^?\ 5K*)),3B[\V!#3XYI6YK &7,O5;*\!L*]V&343H4/?F$XV>JZ,:"
M K$WE+8R@-$&Y!A)4),$MHU57 D> 6HWC)>,.HT!O9_AN!S(8DC6N.X8X2=M
M;G,&02EG$@[M5+QA2E8E 1WD$0V<QZ5)..JZ1$\J6BKXI:JS!C]( #BIF@[0
ML=:6 U]R<0YT%$8(Z%&AR"CG*/';ALEC0QIKCE87,)JB2T%K2@L+68.V3*B#
MP*0?@D@H3^55'7Y(E7RQ@DUH>@/%!<]@\ZK!=&1NE8X*QI,L@@Y:XM^0TB)Q
M!>#T&%'4*!X*7P JE42)?5:I(G)A#"&@YC=#++"7;M(1PHTJ448(@HW"'(8F
M)[TN ?JQ-7'1B+E:TI914J R*';).<QIOPD1OJXI0 "C*2<6,(!#V0QRQ0<7
MP %6*J_Z6\TK_P!C4J'E%\>0X-TZ[C; R( +\J&Z1/#PS-($&(!$Q30,73#%
M T*EAD_,P<O Y"608& PD2^KN84 (8%^*I+"SJ (A#B>;4F](5EFE58'&QKR
M$*(DP4PG! (N9!]C1U4[RN"Y@R7(J)GDO"5/\Q$.;1.AZ#EWUG\ YTB- %!9
MV$AJ8'U@JI!H^>[2L$9K74GM["G-#-" 0#A"$W(JL6H XS1$KL2Q*)H*:B/)
MC.3'OZ4JSG02/5A&;.*+ 028KDB'7L<2/R)G$F9FR4@>06\1P#["#MS,W!!0
MZD20IXC>Y)05;3#P!<<8ID7,*AS7K\.#\_1J2D-YX/M20C5-@3L\WO\ WW]U
M]U]7_DJRC,7=KGI9XM+?/I_JFGP3/1IP@"!$>?S;&LB21&D,YA;_ +RLB2>T
M/']X_CO[Q_'?WC^._O'\=_>/X[^\?QW]X_CO[Q_'?WC^._O'\=_>/X[^\?QW
M]X_CO[Q_'?WC^._O'\=_>/X[^\?QW]X_CO[Q_'?WC^._O'\=_>/X[^\?QW]X
M_CO[Q_'?WC^._O'\=_>/X[^\?QW]X_CO[Q_'?WC^._O'\=_>/X[^\?QW]X_C
MO[Q_'!+B7RD^H@JA\W%/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/
M<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/
M<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/<_)U/
M<_)U/<_)U/<_)U/<_)U/<_)U/<_)R$QK2&L\V?<[0W"G.@(*K "J^O\ P\>/
M'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>.>J%-!:"U"[#+]1- @Y
M3"FJA8*H5?\ AW3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3I+*
M %3I1K99090_ZD@% ?+[?W_HH,"$(K+)5]ZB+U!COM,(687"EA>\!'&@6DFL
M[N5X#KJS*(:E@9%X(N+>2$Z Y)%@-J\<>H<T JH/6G 2H>.>*LA0..,3ZX!$
M!11'2(\&$0!( +#5@*8,Y81:BM8 "B*4@/I1N+?_ -6^"=K53@"6? :(W5%!
M G2BQ=Y&)"Y!]1?]\* CLZO(K!O !9*WBM Z8>_P8Q&\#CQX(E'F*YY,CELG
M#?B<+3)N6#Q1:LR6'",70,#@+)G-HY-Q(Q!!.($Q$[9R1?W85&%# U4M*_;)
M$/7!,H #PM==(%Y38? &E04*CA;S39(FT8A4)CD(]) 0 95*BRTGB9S=$K^[
M. -)P*#_ &_E]O[_ -% 94B0A;U^73+ 0"P2A5+62P "?(*]AQT3 /HH$?<X
MK3<$' K,4>,>L(E//HA>D7B/$-:.' -WSD:"(480(CBC]( -H8-? 8V8D1C
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MX]M#U$BHJHE*^(UQY-7S3IU%4EFG)]GD@R+I<Y*"8*(ZP&Y&.R0*)+PWY2^
M%:%\@9R7HDFE0FH94(+(J\MY 7%:8QZRV&%4!!) %&OZA0'/11J+!#6OM//Q
M[<;FU8LPBGA5$O,"*M" @,<>"Q8PFHB_D&"D#(Z^B3=5Q<- 6Q$X+,]J((M3
M 0B1<^W;2%;8:\6E9<6%E;:E:AB1 1H'@N0>&*>!)PBIHS@6NJ!DD96)!6WG
M /./1=\A234+AN$!JO5!%!0ZJ:'>7*Q#.NR2M0 6\_W9!K:#24(2+1X1O/4B
M3 "QH6MESQ^AX0B"&;2%B'+)SK2B;PR]JX'DY@11S&0^Y9:L$7/ Q06A>S1B
MJ)5<DU3;B,0U("FEB0"T%2<"9G?HM>_SI^M'* 55'H-^T\%03L7T(NO8'/1[
MDZI-FH7CP'GC3E$15EL!!7([R.(9DXF-2(V]K&BA[2#0D15#.GFYYA@DKU#L
M0+#K3E%)J!J7P,&$'/T,T)V,+$-JPM/%_1Y?;^_ZT#J$ 0&D4<0:1'(5,M(&
M- %(((BI4P>2-L+$$C.DT@'U7)D-=2IJ39V>W4+&1-5#[@[(A"1309)GU@CK
MQ_XF4($O83!?&YX$H)=!IO;U!;DE43D\4>7CGT@0!N@W30=D.*Y64J!<:U(K
M@9J""IRL3-&4.;7<X0\I9&] ]0[.ZNK!$\QEQ3AZT@=L9M^CU.5(& ,Z).R'
M!C94X<[!$2DL",CMP""#T]G:+"A\S-O@U$P80M4AW)*8O&\IUX&IE F$@#E[
M..@*)#*E2S2T:=BBUW#8Q QS64?D OM5P#C9(_( D D20I"Q;K<W*>UF4A.=
MSO,9U%62#I3AQ*Y_RS7U  JKPUGX@-9J<CE7A)5?ZKXY+$3DSW_'"PM0A7@!
MNI/#MY=G<L(>][K\O9B')1#A<*>&0.Y6FT9#2..2?$:X)@,#3CG#4QU9A..B
M1_7"@+&2H%\5PO\ E_A>):2T&RA"NC0@V#^'R6W!M2+)L X\) 4AP1V+300$
M*2TRZ56V4%;47R#'S/0 &-'$[PBT?\@-5$DX&(RASGOR M_#U+Q=X1DW21X2
M&0>7MWFAXXI<*F6 <A@W8W3*PPN(A?DO!E%9;F0PCE;]P>!+?5$%*<FS$;&2
M2,B9LG7FG@4[H XE$5"IT159Y%EF6""*D 0I05L@TB^(I>.(0!0GZ SO((;T
M6N*OP'&(4%\7I5*^8:397@%1I0XV<@"T:66](<7%M4M"LU<Q57\),[8A.DI5
MCPJ0.F @+"JPJE?15.)& N21J(&<GCT)ACP 3 >GY7*X*9Y2!\4<%6!2:.N(
M@90W;3P(!3K1T@%Z*,9*QJGZ[. VCOXB98];;+X$SC8=$&?'/ICD$@<5K756
M,Q+>-6,*(XT^\X858)5%V'W\$/#]/+[?W_6@A656J4WRJQ]D>O,60MU)Q'6$
M*\&>-)T@[+5&BXH@DO>=P2P(K:KRN<**:B75D+%6-#R*< 7##=C5W'OP_P!D
M)9X=: H>#3NJE@!P&+I\DU521@3^GM"R5-0RRLVY-=*FK&B)0P ]4Q;A:HWC
MZHD6*V>?M>0;&TJ-R-[V2C.I9\$,P&O' ZP#B>H :UFBA6& +V+AR9@<XUHN
M)^/%VNQL2! @?( >.()MV\L5#BA*I=)AA9%8_([WCP\9$*\'.9&2&_$$E457
M2+P?).*I-3XA"1E0!#ABAG&;:BJ=GR.7I9]@0]5>I!2-@J]?4FIM#RL"L!'&
M1J>89<&#HZ0BC99!#U(PK6A1+FR@(A.I69Y&59#IBLW=8:+K%EK<NP#7)NHH
M ^$)Y2S#EB8M]MN!Z&#-X#+=_1L ]$;J?ZZ^QX?_ (TKSK9KJI)1^N@4! @S
MVI(CS-^QNYT"2(_&-:%H'&O*V#C$-58H !9[:)<*"F#S$J4"6'@5*_UIXVD)
M].4835R6#48]#]E2);@**2D\?A,9!3^,1@5 ^3PY03+P%'@W_P!4H.Q&]AOD
M=W&VO'0SUA2E^H71 (Q9*EK:T_-1 UT>0&J%T0\=<].)4\*<655+A:RCH3VR
MN\@$IGM9 J\;6U8=Q,AB2VV"OJU0OB0V53#B.: P&7!0]?E2'22<S'IMW-18
M1(!?9V!(DV$*@ ()$/X9)%M65!',1&/FG1V1^PDF(Y/O+[AUU$'VE8:DXJ*0
MCPF'$[/VF: PHQR2\3O+)<^,"TP#80S@"7<\)L[I8WBZP0F!"L6.LZV/#.E'
M8!W06UJ:U,<ONI [3%E' @BB44->S6(:A84048T<,3$XA,1'O-2&I33E##!Z
M 8)@0&A:I(P%;:19BD0[R^W]_P!: ML$$%"#(AI!54)>82F,FQ;),P'YJRET
M?0/MLCRY?:UP]R3P#4ZE ""BJ$0E/30*I;I1J*,P"P,X,_ZN!;V 55#':_EU
MN(V:+U@ !67UED?.[(04$/ZT[)?WP40$$%%0@[O/B<H)@"O,6:3"6%-"YE=)
MH4':T/OY N>K]*,>"'I#Z*")Q2_ H@&,',^FP\ =8JKG$X=<0%_A95,\%E&$
M W'Q"4Z-2G*[KP4/LT.M!6!6OJF2(@$  @8I_%<6P8K72#@WJFE"$ID"N-%F
MZ?-.W8Z!%38=52"EA)@9!S2A# A0Q)1\G*/<V1;:&2%Z T0Y2GRQJZ@?1FYR
M!GT?0=4>GMEARJ N2*J,+P4F.A)AC*=610OC\(X"<) \()"0NLO*7I")'#PV
M/,=$:X>3DT#D>S^'$0=^8XG'&6T;RKQ@X0YH3]?P@3J.P*#]8H#98$4HGO#?
M"YZ')E+3@@(09D3(*#FOK"*UC#OND9"@$#5HX^]F*A-J1RH?31@&EL<U"=D5
MLZ::8#I,OFHRL C\G@CZ<4RK6XE=I+DQ'Y5I0X44TI6B'O!:4XA< 0=2@I8,
M&K<,[/2&*GIP="B@\ARGEP_-""Z4&0<W7A$4%FL!FQ3Q^(Z]!X7 7OGK*W3<
M5=I(M6FJT-97I(8BV(0*@"BE8$!AH4 >6^(: PU/L%7J (I,*4#B+ A8!AT(
MII$O%3!6$"6 5KQ\(I2VX* -DOM5%8TWIE)?#A9NLF$@O&D<84X(Y3$1"H%(
M1:IM+2DH@J3@Y?JQFFG=2D+?%T(' )1^E\$Y'^4?ZIM?(4 *)E='9]J?L*E)
MP67# [&]397*CJ<J3 @471$9.@V/%MA+HQ%>N<U+%:XBPGA3:-!IL0F)4/4>
MM+%5BL*Z>#!7UOT\OM_?]:!^8_JAWAELW_0)BQO POBU?-@@TOZAEN-TZ_0A
M!Y7%)()B8L>/5,P#080J46OE,9FF_J%PO5F!X@F =:F<9EYK.&U7(G:(S8<4
MJ#T0E90LKEG'L[?+/,+"JOJ/KX??%W52JPGF>A(:]:[0FN*PO(8#S(!(]U#=
M9-L)#:!<[YHFN0(-7]'#4:7*BT+;ZO[UQQDH)WJ^6XNN/")@FE'K!$1;I+*&
M\"?YBMXAP;KPZ,BP0@4K0D/'!,_0^.$,4,VF 9_$(SG/:4 !>!83$C4CX&A0
M?!_3#UIM&1,UU9CB!O*<M*'2!<YSU?-GD#"AU%>MF%9)Z$EC0$5-**B%SC04
M<K#";RN/.*Z$II3X:+4-J1?A @&C>2H2LFLZM3MO/'* V2">&_KQ#%6@W,M=
MWLV:KH!R94Q6KL:3X,9@>6(7E4004 '*$J/ZP4!>N0\,","BUD.&HDL$ &>?
M(=!1A(E-*X$#Q$*C68\-.%Y_=F$&</%YZ)L]JK%*2R(80FJ1<L85C0<-$+27
MQ%R""=/).2  )'D%]$"IS\]!V!-0J3UM7";23&/R/#0@=A>WO\@A4,XD] MO
MYZ0)@VW)S@K>\P5&_C 4 $((#P":QUM8*.A8*&A&B# 6J =2HN(H6]''%1@4
MVKU6X0YN%=>'VJE&01K,,@4^JDMT246FBT2*/E*D>MKUJ00H^"!,.GQ6C+##
M6X#0Q.)G#@TFU,I^U>,.6,%$JU)"Z"WJAX)<P<M$(H!6*CKX 0X\2 O8KUMB
MIQ<J$DB'@2=1,V&C"*T43DA>W(&V8I+&SJ>('4 *Z7((!=FQ!&V1!C%@."E_
MRL5E/H#91I[W=7T-L#"'AQOBN,73![%4H,YC.UEDA-WE;0>2U1H:V_F[ I9%
M#)X2A-X""J7O+[?W_6@,#_VXV5$V@2)->:YRH3'JQL0NC3\Q @BP@0'B59*G
MTV+?Q 9P2.Q$I502M<,X(PJBH$6O+.J((/,F[A<6W]%VGY<N)?N2NV#Q4=T:
MG,2L5P3;XFJCCH*R?'TK':P4:2$#XT.0;PW/K&3IXI#$\!!&551VLZL%4 7X
M[2.#Q+0E>%Q '*ZV;N17Z%]=\K5%N9.GE'MC;F] 8</07@#^ 1?9< "$D3BD
MXDEG(!2,"B'[I*CH JLDA!4QM<F03G$%XHF9>] >=4!!2<1%.2-!IF\?#C5$
M&+C6,E=J'H3,D'= >8I6H#T26\U24(WV\9@,PE,\8WHAN^7H-)A37@,V&*D6
M1(03W9K,(>+P7\ZSJ7R5U^FN/C"0(5>G1\B9BN$$!^VB71:>\ "!(JD"43,/
MUX++F9(;N,)NA@"*F#X.QIM+;B'&XP-OU"@-&(?-#4@6@2@/6\&(-RVTA:!H
M(H1+9MA$)!>Q!1Y$C.^A7L9%<E6CJU:YR&?N Q4$#;ZX T% JXD'I&Q)@"1$
MN"+ GG(;"D4DPVO. 5! 1HA+<28].HO%&I#VLZ)Q:"E$5>:] ;IC;5''BE\=
M.A @LBXLVXF 0RHWIA(@M+,5F>'<MN(TII0(C3/Y] 0JV]R2>UY;93I0EYIR
MAWPYO&3BY2R,2ZTT^DFX03L)Q@:6N )$02_\V!!J;0$\#3H0@U@3+: !.3"4
M;)D'4 @(2@ ZWE"QJ-7I%@0&/KP36GH0]\MB^NR,$%BT8:3I[A2<!O8L893H
MW;_3OQ.BA.4YV$=5]8U-]40 ;3&&1K*IY8!:\O()Z*A= ("0GD_>'#<W$IAP
MYQ5;6$!D]4=X2Q(LEP(NYA[+ I$+58G-G11@!R,5.95J*F1\Q1U:0BT:9T&$
M2Z*'>7V_O^M %32X-HR]J]O98 TH<!T(E2]AZEDQA+!IG&6)16%55B@#D\&/
M, _BN_-U/,V 0VU0:@[%"@[X'Q=WT^WE6Z8;TDN#;C+";Q @>84HJHT"PK+)
MG+@&:"UA M'&B T*:L-PE?4#D%M5-V,OG1$KP<8-%TWW3!,:!Q;VH1BB6= 4
MC 1 :QR!@ZFU3JAVV"*LOG/P&<5HD:D!V99_G0IXL-OM ^4%2@*5KO\ ;/%5
M6!GEE !B(.G!M:\\ '>#CV+304/'VF=+4RZS ]\*O(\ 6#%D<3%(9CW]XVOM
M$\@L^U>%0P< 8B>I;0,-(;H5<VK 2X&2@@<U6?!EO;PD(M?$,<I (8CSI;@#
ML<,%5P(R"$Q^[8<37$QQO+(*<-3QQ9V7"6..;Q235C$D"(TO&!H@8IV8&M@>
M#> AZ-)"FTOEY$1B !ER.-:H _6Q0%T-)0JS<(07!:X=O$&Z,P<$XR)N)$#;
MZUJ'2DHR.H[4IA%FTFI1A8AR,&@WXLWS@A K3P'D U0[A:S7#Y23PABIN *!
MWO<R8J5*T&%0+7K7(G]$X:+NIY>W]#,D]#D45'6/-- 0"U&,F=,E>Z2D<?0T
M$,K2%"&@U"2*+2(08,M.D\Z=M"JLA-M=(?*PK*XX=AM#DPTPKJ@Y*1IOTR/S
MNA4AXA<%E]::Z2:+X$]1IMPVAL^*ZV8VM<C!9W,D@@J.S#L% !8?$X%Q20PP
M_JUY( 4/[WT9JB*:&X'YS,M\A:THBBG;(F,@,GJ&$H=+ T9ND%RLJH8GBT[D
M$L1B((;X1,PW)"ZPQ;2"4T=DKT=!D"  Y?\ A64@Q=>3XV+Q<* -BUTT)4")
MFS(PFGQ4H$FI=(_G3PD 3%SMSDZR!SA_>3E#D.3V#94,J'@FLB*4WU&BBR8(
M[R^W]_UH+"/!M0J<[FE@X_)*#076Q0HEVN($V<\$*$G4 HT,'B[L 5?8H>'$
M_A;H+$\2ZAZ5V8)Q8\J8'8%E!FE(G(YLD9 $&)4B@$RV,7*.',+3:4=3$Y'=
M*#0H4[TN"C)%8#28I.-*(,3PB':>.6JMIPX6F4Z\"IA8AH39$T-*;41+$K$L
M0UJE)BP0VD=8[-38""08":&9\L))S*(JZ3=A,<9A0<Y'^[1I-064D V>":2S
M)1G%8.$G&7Z^")TQ1AAW#BPQ"NQ84![!HBBNJ09BBB+X"J 3SGN 6T"+RAFX
MA3_2!@BEZ,! VN2#&01Y'$EQV^2M"U""*\D*D9*\8QO*5Z6EX(IT9RAE(,))
ML#;,J.(W1@?2,_-B<FWHK;?F!D &KL$4JC$&G@OH64M M!Q_:<SQFC*A--(<
M&1K<1NHK?'/%*T8= 3)H01(!/U"@*^)L0B$+E "X6N#V&FL@%0\B" 4HDQGQ
M\BE1J9N$LMIE4[1FF9P4U]RP9@I@I@!)WJ6=,^!Y0SJ$<"6"\EM2[H@?R15:
M1#YFF"("Z89/M7:@194D"#^[ELR$RCAMY+[%*3_B(.G?G)/UGFDE>R@2H8I7
MW,-*QJ&S@=%>\^%"M"&KPV+8! ^7615EO0.$"%%[=I!ZP!>RLOXQ@!,&1)UT
MI:J'#\L;PRR@>D2=@0B*F/# 3D;T(0;3V!NI(^Q #%*#WZMM/0C!'GQLH<_:
M1)JP45VBH[R1E&W;=>9 >29CTP2UPL,L&J$7X5L?F*/"[BI'SP!A8P  (45<
M6JBIY!R3"\'FT@78"2C#R*8=*2HC0.B:QS,G 8(99JIJ5AU4@XN\"69:J3]'
MY![ RI2%KJ#0R&M&0IR@>? %X: J8R?6'*=6$/48L50"#Z/+[?W_ %H"PK7'
MU$FV0KBGJ?7!-&,*UAF>$>-_R3%%&D(X-7&K^:!FN,1K-G\%@ML HD(B8+N"
M8-F+624X<"^V^:%>Z@D/ U(Z\T#&T M1W2$29K,%&JG*G86L:*&>Q$4J/FW+
MHE!<YBR8+3U&BY$0+!!.2$;)&-P)-042*&71=U;M+"+4:H]/IO5F2K;(,6I"
ME)XVFQ 8OD^9L39HRJE$D!Y-F"!1 TJB BA%5V.[E  34T(D(.)V=:TQ7!6)
MIN0#$(T[85 $(KH)C&\@O6B%D2@UHZ*;;LX>H\NLDAQRS0SVD%$66J+&Z- )
MH88#/ZS-8\ E $5<I[I[JV.K!>H9*)9#P>_L #W^9;YH!,V(<+&@01K&EWO4
M4&U_A=$6N-#(%CGF2(-W7Y/P6@D^T\Y@,50$)L X9]E[IR#UE2)!0N70\3(5
M ! P9HT1$P#Q5/8%_4* EHA$CT8 8"H^@9.PGN41EN6@RRA5H:.0/DD9A4'$
MBX P20V$RMG@4H%4>U6E0)"*GN4W(7$F8R)XA_X'Q 49!$WRA*Q(!DN*Y0\D
MC^Q$0&" ^U0TZ#1"T.M9V::HG&;I(]#A DK3[L& .<<4@$%J.PATE*AW&*RF
M@@.1IP=@L-+6E$*]A $83PQ$OA-/)54:?O@"T9G)3*I8-$IU\8/-2V S<!(#
M<6\7$,G0.@X6;X"U+L"5J+R\D$$EP-,$"N /*X]TC'JXIX/H4\LI[]J1$"3P
M6EQ6U8C302=M;DTJUK0A5PP !(PV.<%A*+ X \XBA;-('!LI N\Q,2%)T/);
M($?/O/JZ<)^DP).5@A0QW@Q>A%>&>D6UKLWAA(>CW7AIW(/ENT%E!VD,.%WT
M0 X_+HEH9A9!PCO!\I67E2WJG-%!40,KL5SR 0@!V]Y?;^_ZT BVV29N/JR&
MWPVD^4J]R !U:@3DDFJ$"P\[ #C)A'<"VDP!Y(\'BJ]Z1ZQ"E'?,ERFSK&^
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M4,J%K@ !ZKH?P_& "3*&1Z-C^*"P))'=5&HR<9#5G0S9+ <@_E3W6M(3K1H
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MB.4+.Z-60J9:0<+G!64/9Y2@R#V< 9 I5&X#)5T4*=*6$3)*CK%,"*C5NA&
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M($"! @0($"! @0($"! @0($"! @0($"! @0(HUJ] H@.*"#GGZL@0GT@ND@
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MUMB*\Q3]6K=IB$808--DSY=.(NBQZS572?>E=HP$(%;+C$-)J$U*A1:#5?\
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M<+4Y<$8"&@MJ_J;V6,%0A/A5J-P>8# H-!= GSU'"I^?P_,E*A6!9V9=HA'
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MN=!K$)I)0-+4#PK,Q(8.^0=83FJ;JK3PJ0]HX"ES()$XO),BPK,0"R.10G#
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M?[>+$DMJ 2LB3J'?BPP@/MKA$U5P+B!LB!^OU*Q(X=+%"3.6N\&G- _4WLC
MLEBY)%2O'4)N%81+I#A9M9&#+16KH5,:!1BAILY%/BF@5L !@6RHK]9<I8#_
M $Y5HVP PP&9B?7<G U488)1ZCNY%0CK445<V>?D$8&&SAID?;@$AHC*Q#$P
M-.<?2@\T.XQV&NOWX0W2M@6T,(FUO C2M.PNJZ%V-/-92LK(C<UI'8#B*.)H
MI&([Z0A,6_(2*:(B]3.H57M.0O (2N0'9_:.',@\%XHB(]C ;"![XJ,[))!3
M1. XJ5Z)N(16@LXG$5$2T(4"._P%\2\3$14O+RZZ!B$!RN"50"@*Q;;I$\%A
M23,*HE;+2:,@ C@U]XH^*_X0(5 UU#I,IDZ9 OR(GXUB2.%DD)2%F&"#9#KQ
M%J*3 3C0Y!2&4K]GN^8ZF& HE%Q8II.07O?.NM+1Y(]9C/@O)93RF$::X%#@
M+ISPP-JK722&&8$LD20VES\Q[^02.9O""E&09?&&""1X_ABRD$@(R,D-?27
M\Q%> "U:QC"J"+;0D0+7"5!+),&6H(K%F1Q&@!ER-0 O@#$&!AK:$GD#!U#Z
MK%.HLC%A6B<Y*]/AP> -[0(/JT!"ZA)@)O(8Q:9H RE]+7OAMJUE@H;5.K
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M!9Y!-=_6WLZPT:=U-M:67SD1M%C*9?M> T;P&CH;-J>HJ0!@2**,(HBW.TP
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M)Y%]O'L_H@PGJDD&C")U.*NWV I((0=_K;V6 Z1VD=#1$CLV<PB%0"@! $$
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MZ=.G3ITZ=.F=MR%2$<W3 1H*?XGYCW\@B1T!'NSDR(47I#U]&Y;Y%R&@RJB
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19,F3)DR9,HLAXB\O#^HG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>businessfigure21a1a.jpg
<TEXT>
begin 644 businessfigure21a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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MQ  < 0$  @,! 0$             !08! P0"!PC_V@ , P$  A #$    ?W
M/IA[@             ^9Z9#S@                       /&0_(2ZU#\NK
M=5@    -UC^^@='/-:_?%]8G->SA^O.4]G(    !^Q%(N/Z<5.S]?9*/_ 3Z
M1\_         '@UCB[*MNU>K'.\^OCG'QSBH[](         G]6W^F3Y3]+^
M.7XY7>G?E9<:H    !^LM,MW#]>,PZ^;6>+KY.,X!)1_1*Q0(    '[,T6Y_
MJ/4;3UIE8S^;7ZG\V         '@[SUV=[1Q,I8]6WY9Q$^_'6F5C>@EDKX
M        LFG;_6'\<^K_  R_/VR5_I#/P8    'RR'D]L/7+R>^     'Z%U
MJP]U8&;Q'OX?Q1OM)          \GAGR#PQY9\,         ";U[/Z!OFWT#
MY9                    #/S%S#68XT=B]%Z.L#-<.#A,9=KV*R<8Z^LV\U
M-B[%',]9L3'R+,:*9T4XY1-DF6HR$^P.6:T;6
M96==S.C+\9VS.+,:<985DXA?"\%0,39J![8;/G&W&9&%LWDIQL[&RF2%**<S
M;F- +P8,<8A&>6=H6.QH                      !43:B+)0BR4!%$J<,X
MY* C22!&,2;(BB5(HE0<<^1S2-)($:20(H\%9
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M9I&'XI3CFQDW+R<''1DY:).$B"7!!8S(9Q&@    H1B!VL,H->/@
M     #H]CUVFSYO8*";T0A-&'1TQN4C#B"(TK$=+SFS7;NCCYFW1GDI7M#B[
M#D!H)/ @B**!7[=JLI!3G9'<0HQ,1DW)2<)'1DW:Y.$AB9."8_7KAK%AI]9
M   !FYQC."NG:,E#W             .A;UVI>=+!GQKY#D814=,:!(PXA2,*
MU&S,]MT6GHY.5NYLGL-)M<#<.)KZ+"3 (4I9-QLW<Y*$'&*82,7.T#BD]"[H
MJT2<)$DL4SQ[CHZ:O$I!1H    .NA<36C*#(30S<@   "")T        Z)/7
M9UYU @BOF\D&1)3*];](E(*=[8V"(LX.GICX2RZ98*E&=<;!^O%7Z.*SQ=AF
M";!5RIEHC)NV2<(*_P!\-%;>?DUB^0LI!3<7.VN3A(4FC(8J>^FGIT2;K%9
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M8Z+S:Y>KV3P*?)07">9&-G_>-FK3)0HZUWCY%I55^BS/#,<S7NY^S360
M ?,R X9CY<CP=?3L(#R>#R>QG)HAX,O.S1J0     !T&QZ[6Y\Z8=?V;2QK?
M;%9_*5VP5Z[^D=+R^/5FDH;.9&"^WKQ:(RP4N,F],DX3T]:\$L=&W"!N'.T=
ML.3 ,=D8*X1T[,DR"IR4%2,8M$=/<*)L&D2U?&.6SYM=(NP^T/:),YQ&@
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M0/UC9Z0+6"$)L$*30(@EP0Q,@A";(0FP<4^!(D.3 ,CEZSJ<19N20ARR&
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MYC/8[/GKD]2>%*R_6AXL1\O'O+ZQ>="L%1J'5PZ,1Y#'#."6@K1?
M                 #VQZZB_9ORKIU5^C;)1/L7YO/4L2A#G,._3SSSP 1A[
M$B >2!X)7K7\U^U[)<?G.(VBC4AG0F(<M)R,(C*,.P3&@            'D\
M    'D\       %9E*Y/1\WR-?1['D\ 'J     "-YNV3Z>'PR!\SZ 'R/J
M  #X:]M6C9OH3+5_=#+2>(P^1Z$*?H$?G@:J4XMI FPF5&#G8PTDZO&FG$,_
M.TYAAQ2#-.(X[P    \G@\G@  'T/4]3V/4 \@\G@\'D'@  \G@ \G@
M\&5G$.2<<YYQB$(\TDXY3#12MGL78Q<G"SEM,N+$9V3Q)DV0Y'&B%2+R<0ES
MD@ I<+9>N<U6M#.K)8C2B3,].2:\4LDBM'7<[*',*H1IR3#SN69&0)7SM@8
M:&0Q5#GD80I?32#L4     <4_.XEC.#4C3B#,X),QH_14S8H9UT.>;V7TA#J
M4=KB%.L!VK+P=;2]F<&/G9 W ZG'..V!OP #%*9DRN$.6TIQ9BID\6LEC(3D
M'+/4YI'%]*B6,H9SB)+:? ^9#'V/L?,]CB&@%C     /)4R?/L>3R>3YGP.8
M>QZ'J>I[$,38*V4@UL]#R19RB0.(>QY(TE3U( LH
M  /_Q  V$  ! P,"!0$' P0#  ,    $ P4&  $"!Q40$1,4%S,2%A@P-#5
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M\09F:4$5MM"K;0J);@[*;:%6VA4WMX>0BX0R&/S,9=%L[ &ANHGYK])5BY?
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M:L(E%DW;L0^^M$X WKKCQ10DQOTI9W1F&T\>0GQVA"1BL7C1(R4&AB 9T?@
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M]-/G[&'M7;P[FJ"B+9\ZL@A9/HH^STDNH$WAMP-\<+UTT_9:&D1D;_X[_\0
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M"QC1%?D1R VM:\B*)QS5%1PD(5%=RW1.[$EOP9 28Q"#P(X**3;3P*+K9LN
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MP"41V4-D?=85-6XY85(DNHI?%]_^?VX_=_AA?[_[L?\ UCH5-_<OT_Y\N/\
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M&_<5CQ;*_A1[5OM4?Q9"^Y'^I[GL=I<6EL3VXNERNU:HN*TSJG3=,E;(L5<
MR-I^U2KJ))/TK)\8TK^*=^2<[FJ^!_\ =4_^H1<5+Q=/\RE>P<PQ\RS]TW_(
M, $D  DDV &LDG@ '&3B)2ZDF%5DJITY*E,10E)B/A2BF<PHA(*+J( )(%[
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MN%N%N%N%N%N%N%N%N%N%N%N%N%N%N'\BYB1)LV(CZ965>D27(C(]6S8:(KT
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M$?VODS9<5YSL,SN<JVE_>L_?#M,EKCC/]>;^.D^5,%$__9A!A^7KM ]SM_\
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M69L6K;[(^&S/3VCX:^^;%3?,EKN4B>,_'R\4ZK?9'PV;\HM]D?#9ORBTJ5'
MAQ/@,&J%JL\!&/ Z61R[F2$(US3MP17MP5KMW.QLM3,)! 9'V$>2I32D<@Q1
M-S>:%$&A]J5V#^W5&(/F9U^R/ALWY18S>GPV2*O?DS'>:9UZ^/4F[@G5Q6WV
M1\-F_*+?9'PV9Z>U)[KSIDE%]=RN"-J/#I^:NY-Z8+Q\:V?"36P+58IB>NI2
M^MX%-!*7-TV_UTL1N*[TSIAP2WV1\-F>GL-5U^)>$R6GUXG4A\+(]FKFS8<^
M3)(F]%]B0KF_JW=7^S*I7CTE6UBL0CP)L^/.G1BZ4H#(DHT5H3M%"G28@V13
MU"*,4PH&H-Q<+0Z93HXXD"GQA1(<46X8(X&(P0VXXKS6IQ<JN<N+G*KE5>P6
MEQ:K#/40J=I(HWJK\T56I*8-^5 G)%5S4E#CD*2,JX':Q47"[7_%M)_A:G:C
M_?SOX1UJG_>D/][3.Q=C^\9G_<\_LR8\T Y(%R.49$Q;F81JM=U*BHO!4LP8
MVHQ@VM8QK=S6L:F#6HG4B(F"=B;^!A?^I[,7W+-_>0>S#]SC_9[ QE(<6D76
M:^.]!OS:10JF+F/YJL,_'=CPP6UYG2VS00R5 >R';.&Y\UH\5)KMTE=QRKO1
MF&=PDS9,_8C>[HG[U.S/-'C.F''$.X45CD:X[D&N T<O#'__ #?:CLD!)'D)
M"$IQE5%)JNQ<1[\-V8SU4V'L<^5=Z=@_N*)^_F]FCN; AM<6\-.:5S8P44C2
M.,I$(J,YZ$7>]'8H_P!EC::L:.&.*%&!&R@$P3'297KF0Y48UJ*[09!;FXX;
MNKL"]LW[\ED^_3_)?Z 9T.5'EMC2CP9#HQAF0$V(_3E0S*-SM.3&?S#@?@03
M^:]J+_3O%Y;!E5"@U:BTV[TBKANW%Y*THDF1,$\$^\52J E6.-)PGR!TR"+?
M@=\N:]\H[6!NO*<26A&7FIL=&#G3!1E82/4E5SH@C-C/.GL)#Q*<:;AD:EHY
M!39T8L=SW,>V24V*$&HW-5IWO1-RXXMRKNXX8I:H))JLU1BK4D#AL5&:S8!Q
M(-7.WN1ST"S.YN"_:9=V'=)GP^;Z>UWH,./-FB#+.ZI2F5"4YE/4T(XA#(Y2
M*@RN:]Q\J/:51LRX92ICW29\/F^GMW29\/F^GM(74E]JG&;+<G;-ZE,J+;ND
MSX?-]/;NDSX?-]/:8FI+W"B?9TS'?M'%=;%>&['AU<;=TF?#YOI[=TF?#YOI
M[1DU)>^-,7OZ9CN)"X+K8IQWHFY=V/!+=TF?#YOI[=TF?#YOI[1%U)>\ ^$Z
M8B=KU(AD1/:2W=)GP^;Z>W=)GP^;Z>TOI)>Z:=-TV6GVO' V]?*N^W=)GP^;
MZ>T;I)>^;%3?.F+Q(GC-N7Q+Q3JMW29\/F^GMW29\/F^GL;I)G<B?9TS[5?[
M>T9=27OCA7=.F(G<V]2'P3VK=TF?#YOI['34E]YQ5[^F8[S3.O6QPW;DX)OP
MXK;NDSX?-]/;NDSX?-]/:C=))WU^G8YIDIV"=*JJF8RY7;MSVX.3QV66KYB+
M4),B;W[,1=(I%;%QZ;>J1& 3%;=TF?#YOI["74E\2\)LM$[L3J0R)9'M?(5<
MV&!)4DK=Z+[ A7-]I<,4ZOI]1O!4V3'TZD@VJ;L$5TV4.,US6D,V,QS7D8!'
M:I\JXC"UY,%1BVOI=JBS*JRHS[W7UO>([:>^.T%$JU8 Z)(VHK2@#-<TXU2,
M5CG8ZB8+IK:GE=3SUJ:^[<.KSS5.,=AQ5*96PTPP-*  31Q:7!<6JR(K0OF/
M&-4:J,57)$A1:"Z"S9*-,J-0=2J@<(7$F4<E1!&4N1Q@&ITV4T9"1P2(Q8YD
MRO=&,J/,^ZD,V8**- QJRW9G$!1Y2GDXH1Q(\(50E".P+=8IH!5;D:U[;.T:
M/%@M5*5@=E.JDH@\8U$J-3/D.@4=%>&74(86*!LD! HKL2C<EIM.I-#'-",4
M392OB5,B>N=GSU(TH*-ADAA,9\-T$#]N0@U.]6BQM=Z1+=-H8I,FK O!,I%.
M+.DQ"PFR0TQ(\4T2>84*J20ZBF?'>Y$V>-J-;*SJ=S)E1' ?3;CF:8=$9'G0
MMMO$R'>,Y!L9,]>K2\T@\=!*E,9V@>8KUNUJGE&I$FJWOBG-*I38TN?2H8#$
MN[4YSL@EAJ16(-B;+$V_$9W#8K]-;RTRHQ9[:6F9]#4D)PH45L$NS&#*G;.-
MK9507"=#8,TUAZ<5DAQ@G8^*V0>=5[SBK#@QFS(H;MA$*EULTJ0)M.ARBTTK
M&P4P9M)E946CIT=L_:]24C3)$+5)DF4M3J$68)]&5E$CTD=$$6'68SWQHKF9
MZLK= *SG.EM,6.\3-/,*BR*PKW54L ;J@X@$BO=*Q<CW.C-1&@5V".TD3!F.
M"?T2[CG*C6MO925<Y=S6ILU23%RKN1,51,5ZU1.NW?<;W\7^JU7SR8[<:_5W
MIF,-.9K]MO=VOEX644":&)3\5::IZP4-(P7!XJ8URK@WV+J@]N1-^RL([IAT
M\$0L48AS4<J-.Q5Q4$C.0CU>KGO>Y<7E(YSWN7%SE5;=]QO?Q?ZK=]QO?Q?Z
MK2$25'55:FY#B^V;_6MWW&]_%_JMWW&]_%_JM,7:H^"BAX+KBWX;1C[+JMWW
M&]_%_JMWW&]_%_JM&7:HV"1IF*ZXNLD+#V77@OY%MWW&]_%_JMWW&]_%_JM$
M194=%0 \44XMW-3^M;ON-[^+_5;ON-[^+_5:7C*CIC-.J=.+>G,W]M;ON-[^
M+_5:-A*CKA-BJO3BX(5,5[:W?<;W\7^JW?<;W\7^JQO74;N1/KXOM5_K6C(L
MJ,BI'"B].+[FW^M;ON-[^+_58[MJC8;'%3'7%QUIF*=MY4_*EN^XWOXO]5N^
MXWOXO]5H6A*CZKJQ &Q4.+F*=2 U5YW:BU=1R^)MA '*C(,(V"8FN+<P;48U
M.V\26[[C>_B_U6$BRHZ+B;<IQ?=B?UK(T9PD=F1<K"L<[!$7'<CE7Z?*@31(
M>%.C2(4P#NU-$EA?'DB7R$"1[%]NWJGSA(GT12Y59?1"N$&>WD>BBD)=TZ#$
MNI)2:0SYIXI-G(_*$)(PB#S+.!.HNN>-6(]+:+3FQVG,&AT:3)#2B!BG2:>K
M3ITD]*(=P8S8X31R&U0.1!4JJ4N)'>."0TNJ:LJ.%932KBX<%X5>D-%_F_/K
M*]*@-V.+%RV-3"U+DZ.$M'93*;R22:^O@FA>^?*VUF#XR1).>*KAN:.!LKI$
MQ",E#2V$NJ!B3 Q+U&C!!1'/#6ZC2[S+3J53!!(II+6R8.5G0G0Y5?MFIE2U
M]R3V-4=$2+(I0(D,RO:$U#;-(%_2N=43BEYVF()1MPZ-C&8;UJDA^E6HE9#2
M:U/2GN)$IT4L\+)=7@A8QC*S!@T\[7AG!$.+*5KCJ)&!*VP>1;Q@J4T=/KDU
M!GH*PQ5&%!#4]&6-R\\T\DD$:-3PP6LCS]GE2W#2,5F#RQ)X:O'%7;C17U,E
M)<-QX]=/&%7Z>)(^C&>:F:S"[<@G-BC.H#-4P=1M4H<*D1JER<""YJ)(G;7F
MGP=M9*DC%#+'#3!DPA/(TRRG2#"5H<N.-X4%0!0I--/4X$25(--,()X<6MN
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MAKCU81Z!).[%5GW;EE;&"I'*Z11Y%/?VXC6N#4;Y/B3_ *)[E4:EW!K A/%
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M9+FE)&F@83*XYBE1]^MI$X1F4A-Y$H%0J;(=]"2(9!T-#,QWX9.W-GHT\?\
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MR+I6QT3 !@Z)=VJRU3=(T.R84>@X=0-%#ZK2ON=!T?WG%VM$[M0(Q8F&]@H
MUO!KN(5+P0DTG9T''NC)+3.A2=!1.K>,(LD:H--@I1AWAF)8'Y(F!"G4<.L5
M4Q6IF'R*5RY=BB0WUZC(<$^%!(B'82J>IHR.=/GPD+%H#)@XK3BDH4UC!],3
MTB4$E9@$#L !QB#71YSDR.E4B)(%1D%!UX,&P$7<F(@7Y.]680!A%]!QV13I
MZU%FH-#$R@/0<.F.G6U$HA1VMMO!/00Q$+<V-*TY#\MZ(SU*6R.*$%QH4K/9
M'/1)]'P-*"8D%NJ];/<[X$ 1)AI^NS$,B,<[[3=77,4FK_[8JF#*V,R&MCGZ
MY [7X<"6)[CM2@4J@A((A)!=+=.(,QM-6?" +:%E7[!]W,QY6?0N/ABHWMOK
MS%;*TPPP#&24D;JC[)#%''X"2?MBCJC^!R-&%A*RBS(["7^",]UUF2Q"@%5H
M D6=1SB8V#FNN4P>$TCC-_C(I_LOX4BLWS)FNGP6#D?C+O#LN7#"(K* X@C'
M*)@K.Y 35"LI&BK=A]^'( _748KVIC=3)N#(3@'%_F)L['DAY,&SU]?X:]\!
M6C5M9'RGGQB\H-B/3R&,#(S]'D7(*'6D^\??/T>4/S0F/)Y''A$3^CR_1Y)J
M*$*U8AJ1JQ'THX?0J$VJQBS4IPQB2N"0@!V(!^S%NSKM<\?Z/)UUQD&V7D@]
M<_1Y3&N&(,"5>V4H#+7X0XU!*\-8<"_1Y?H\K)-0K5/1.,[$\[:F^]5+V&.M
MP%"7UO9Y-N-51@B2[U!?8S]'D5ITE;C&:[][B@1M/98XP*9H:U7@0S5Q0BI2
M]1/Z,344DNS;/Z/(G "XXE?_ $@9^CR_1Y.4YM,&DS @)>B#@2T12#BULKY9
MQ M9M ON^1F&3J(Z&Y>/^ S5.,)=!/@A@6/LC(+[. P;NPU8 ?BLCU H 5&
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M2UU:*A D0DPD=+@K> 5*V,03 !D N E2+"%@,LK>'?\ LMXP0Y9E:6R%0<<
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M6!D$'@(*3"X+L#*I4F!A1(=$$9F)U%/D<UV3N37&*;GZ])@#_FO,8EX0&B4
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MGQQ*2A@RZ0E<=M U*7VB_!(Q"-W,7C%=]T;HD.AE*E!F[=$'<?OMO)P4@=C
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M:*Z);;;;;2 22222222239/K22222222229!@    !EDJ     ("
M !/!=          - /\ _P#_ /\ B#P?_P#_ /\ ^AMMMMMMMMMMLR"AMMMM
MMMMMMM8                    ""2R \B @02T"4R0FT
M        " ^P"T2"ZR6 "6&0F"                        "  0" 0#@0
M0"0 " 2                        002"2R"82".22"22"        "2
M 0         6    # 0-  (" 8           "22 "2        "40022720
M?220P06020      2               0""" 0"T "  ,  0" 0       0
M            "0 002"(R:-R"XR#&22      000              $&  @
M+$4%@ 0"0S        2 0              42B  0$T(&@0>B0M" 4
M 0             !$" "@ ,$40 "(@0S "0     22"             "$ 0
M0R0,DWB22200%01P     0 "    "         $ " L"!VT@  , FE"!
M  "02    0        "D6R & 22*R2"22IW2#\     0"2    0        #
MT""00 @BL  2,"]!B 8     2  2  "2        "$"23F<R2NP2>21^20A:
M     "0 "22  "        265# !C Z" (0"H  X0       00220" 20
M  #&"#P^(BQ#22&"2Z27,0       "0"2202"      #T"%?\.@ ,   @"\
M!V0      "22   20 0     "T"-0>-R2"21NR2&"5:
M      26'B 9    !8 "D #00                       "=A  "  "  0
M 00#0"       "020 "0         "#0        0 0  D        00" 20
M2         "$0 0"     0"  #@        ""0  2000       "&$DVFDTD
MD@DDDTFDV@                       "" 0" 02  0  0" 0
M               #Z&0  E6:@/ZR&F&                         #$&"
M0"" 00><"PJT@   "2"000     "0        #,0        , 0 2   !200
M" 0" 0 020""        "00 22"   0 0     2  "2 0 2"0 2 22  #200
M"  00  ""0 020       ""02 ""0 2200"0 #B 002""  ""002 0
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MV[=NW;MV[=OZEC".<#<D$3V^ OQEGI#?(:!B6O[80($"! @0($"! @0($"!
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M79\W14A5,"!0:YZSLXZ==(4MM:@-&;&([FV.GZD<'&G=.+<Q$0%:WG"<.P:
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MN)CP7SN?3T!SDF?Y1RELAE ]#!&FRG2*O@_ZT2<P1/=GA#0GO7EW^?@D@_\
M-ODQ\$%<6!,@F170 5-C-%>3!RN<&+4HC/0,W27C'[%AH'XF5?*7T$:]%.S/
M^E/KJ$P)).DDGM,:/U5?%_1Z9Y\RUFD8')CE"(_+21,Q)6/.WG;OIE9M6>W\
M^L80P+BH><P7VSZ<P*"/81;TF8^\WGZE.1I4+IM;'-$8S!JJ*X4@BPA4B8U7
MZ4ZCU0HGX[ATS,8N_+%%9R!<YZ&=K7ITY$BD"+@V.QV/6,W:[=#QG;G-Q/0,
M>TWC4"?'5VCGB7.OS75=(O\ @(EX'* !5 T^B$FV**N&R0G$A$I@,C5'0AZ@
M-.#KLT_KWX]*[CG2B?;Q<20UGZT422;>P+)ZTBP05"V#&F+$*@LKE?005!9V
MH./J(,"X*XT+$LL@$#0HU1*1(^67%&M#A)G.<=NDN^<[F;ESSW^$99C:]+Q_
M?IR<'C]]NSH-E395:GA<A8ZP]"**(\.1!'B'*F5]GB Z%7NHM!(S<[K*D*BL
MZNLC=M20,;;JQ/Y9T  @@ JJ  =:SFN_Z4P$ZP#QZ!E4=H($-=8AI)KVR9^!
M=V"YC.(,Z;7CTT4Z?49ARVL8;0Z;W6M^#Z_9C91\L0&RXE*<<]-WF3MIBL(5
MAV^%+-FB'>-;&^.KTZ&KB<_F^_H,[S_EP8_NN=$(<>[L2W]]]WKZ07_F>MO\
MF.-B'P<GPY!W)W[.'<<D0=)79L8 V P ;'U<N=.[=LS&^6&#K(!C'KQ*KQ&E
M3.L0F*7X?QCR+^=-S.E;<.P;$;=C+NN6JND%&+OI41.^%>2()<FU4I8$CA+T
MZFC]5?XO]>A"Q)B!X)5]@+*:28[RA2):PK4 5\L"*E)*PZ[;9Y[;==,K-JQY
M.C^DVA)M2W!S1>F:P*.HZD'9#E&N?(/P_#\>BYM#80%W@@6!9+.?649 5D E
M @PE#")Z=,D&HQ(O'^)+H'1"=4]3!A3B\D6B=LF#IA4!I! /0XRVB(+I#9!%
MUC79>>@.^4./EL (X6P+L=D]M"((13!#'9J>W3UH+H4RN[2'>"PX7G1#<V\J
M[2W?_>OP?U2V.3'&VYF4V72U7&6X ,\! .P =/@"^?>>M/7MC@P0^#FWLY!W
M'K<YP[CDB#I79V, ;!TF<9=URU5U?H)PZ58-PW"W9SZ4 5!DD0!NBX9V]--T
M<.L7&@&:E$=Z0(20';')?#'WA^-DPS]2;;5EB/&:"( ,(@FY,.-X_31*50B$
M88](0K?RW@<V8)_+/YOTSKN#+AW^O?\ ._PC+&?Z=E-X]/@V,8QC+'HSK.-0
MC"[R!J3*MF.BZ]I'.@ZF=PC"SIE*BRL7-F0@8-,L53)IV\V_71'-S8'^TNY!
M'P!(Q ?""N&&(&*#7#O2LO1N9[QU%LZ-D5E<"L8;0[%)@96*2*="ML>A7$GH
MA@H"0+#]!!_@G>;,5B7$U@X-@LA\6XK0S@V7FDV=.FZT@T$,?J:? +.'&->
M53  ^6[6HHMJM'$"YC;C9WTJG>JXO5O7/PI1S(3(G+QOBRQPZ_WH3._%P ':
MKNR6B6AN8DB\4615HCLT1R;(CL_TZ,]Z\M^<[M:Z(>Q?0AXOOS?@ R , <B
M9>KNS@U03C B<+,[(_7,VQ\""7OD.2IQ #J_"61WT*?.ZTE0 BSWY1D.=!"Q
M.FG"H9PZ!A0(1'HV?JO]F#(/L;^;H=A[_!L\CQ8-->R#\!.BB)N(G7)V<:-1
M%(!-;504&KB^"7Z1P")4%J7Y?=81& /1RU3W_K?7(9KF<I<8C,'3;T,YZC/3
MOL[H"!%#N;P*%@%%5DAZ*I35*O*M7&-^-+;)=M0'L(WH&F?H_FKE]R(=3K9,
M#C*I><2'J3>(BVOM$P*1F!Z+DG>#BF94+PU]%'#6!&WM3G@^C^Z);&<3TDNR
M).4;%W$L.7(0W?=]!/B!H:401A M3Z.N)4:2R @"'S46+@ %#%6"%@LYL#LX
M-) DCL9#M:WZY]#?"]K*5Z;2T1I+9WL_&N2! 35?YQ_6CR!32$00QMB_?8@!
ML!UP!GG'PG49NRSP-$S=@BW=-N?B8(#M3]'CW_V]"'#VM9OY9 +/2U5W56 &
M>Q ]@AT]!?;-N.5FW<:89U[K4%.0IX)^(Q$W&G7;LX?KIP\!S@.V-4K;4";$
M"% MH7:NQ#(W;7GY?@"X$2@[?Z[..VEJKNY?A$S._P!'9^O3GI^@)/("K *!
MN/"Y92L&WMV;$ 7("!#](OX0E-,%OT  -+?.&Q">%_2YOH(4C,'9"@1>81++
M%*7QJ'$$&>FGN;$Z!IIA21-OH._:L@'.# ^8X##5"U>=AVA?8F-^>_YC3$WV
M3-5"%/NDB?1 I]O]UY$D:?G']:/OP"5T)AA1(5_=* @F26XXF:['2R[:]OFI
M2Y,/U+G[SK2]W<T::0^#!W??YHL%E@L-WM]=$>8*TO$TH_O!!A&^##8-2,"P
MY\TQU_J_[-8Y?!]].94P!2P,!G )@V#6.7P??4.7Q_W6.7P??6.7P??4.7P?
M?6.7P??6.7P??4.7Q_W6.7P??6.7P??4.7'29?;/Y]-8Y?!]]8Y?!]]0Y?!]
M]8Y?!]]8Y?!]]3#+GI-O?.L<O@^^H<I[G\;[\:QR^#[ZQR^#[ZQR^/\ NH<O
M@^^L<O@^^H3=]IGKW[9]S6.7P??6.7P??4.4]S?MOOK'+X/OK'+X/OI ZO3H
M=2\Z9T7Q_P!?_@N^ 5Z 5>P&5[&J G1'PLE1YF!%RO3%(&00IA#A:B;B?3X[
M;X]\?W^/H:4'"DZ42>'4&A43>6Y5,Z;0Q(MM(ICG8)O[MT" )0IPL@97)^9
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M>/'CQXQ37X48'"@(EQ!(:NDR?'C+0#.R3E$!9L%@4E2U N;'2R 0LJ( #'V
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M*L-I[9&F0<0( 0(,$07-)?C5R6H=W>?S2)59AFYEN/#MI5Q5YL_.P)N*OD,
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M  (" 0,$ P$! 0     !$0 A$#%!46'P(#! P5!Q@9&QH?_:  @! 0 !/Q#
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M\)?R7&16E-S>R4C;W0 VD  <"[@X0OJFQFN]2+PN.!EA?5N;=- @G*XX</\
MB.P7Q"JH(6,IPX+7 /\ P6CH[P5EW?/I_)B3(9ZR:2H(7!8%8>>'  XG$_\
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M\%*B5"B47$OA-CTG7 \CK  :SL %RH$ *]8*Z5T>AO\ KA^QNH0RE$Q'J,P
M< %L# G)E(I&!!1$-'2)<3PG >GJWMZG&X[>KU04X3C1$9>THB[+6ISS*-B5
M"DHD)ZCZY6"6&R1\FATFV9=!)G1)/9)#M0%$1!8H@@2CYB(SR3@*(*H@;58
M>5PB#=1(H@ %2@ KUC]7K*0:)&!#9V2ZCIV,JH7JH+.X.!$B/2B.W-/J;X"R
M%BL%@*K/ ;7H.^0C")<1$]<=X'JZ5]B%?]0_M^W?CF=]+UN%M8+5-VWPI]G-
ML"(_^++T'; :()!:3R(Y0*O\Y"2&F+/IZC0X:!S1](X$<4.F)9J(J %0$1&F
MPG@T>G7#FYDI =N13/U].>]N))>!G@Q/%'*!E-Z:7U<A#ACHS8O*465@!CW-
MBQ*U*PIL'VJ9$\'G:.@.W(:VF*P&IRJ(DXAAH 466WB&H !H-':IM+'8K>T]
MOEX8VT5LY!WK4)VMX8@4^>W1]>5JX&,0U--3-453R+ABQ2['W19_32?WAR:P
M#8"@!@:$F(KQ>7PSH,0\FHCZ.E0,?K9>)JM7&)RC-T)G]$')9'*7.E7N('-
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M0R ! 0  "!RA04W 4J)_;X.W*&PP$](U(]!\Y;Z'['N(%8@! ,>5R@J9ZHU
M=%"W7+/F!M!NU&M70])\/ 0TH<K0;VCTZB U"JP N"EPKC4AL0:0O"?\5?\
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MCG!VA9UA";NEB'@J *K !57H VKX#;@YL*O[%>P=M9!O@_'K7QX!(##@:HK
ML2*H_@">!@AQ\1Z_8@8X/<C[=,=PO\LQ"V__ --Q^G"MT,H4] Y,%3#HURAX
M#&!HR1 QH0Y]$5MS"%0OT.D J&Q"A*KAI0C_ (53VO?64R8BR+'_ ,YC?E3"
MD!"5(Q4=@% ILXQ"+TUD2:9YGE_8G+8.-L9U_EY57F( 1DH/2NE D9PAE!/I
MU61A(1?FKVP5*BH=1-4M6MV&L2()Q4J((E0$X ]X/9<U4J6$)$"81E6D%3SJ
M5$8+P9* N]"M '-2HYXM3C.R]\3FL3*CA620"$XMZ+!+S4J#ED@=*@6210%
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M@4$$  4& "H@ J@<)D]%]^J."Q:/4;Z3 5 *4 !55@ 55= ;71B29!HF*01
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MV];!?^J.66<>H65PK,O90O,YLF!P))7!Q[C;1?<=0 <!*NN^!_PDLVS;_6V
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%9)@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>businessfigure22a1a.jpg
<TEXT>
begin 644 businessfigure22a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M /$/5/$ (% BA4 >HOBH  !%"IZ'B'JJ
M                                       'B)IYYC[7#,W;L/;Y>(YF
MW+-+'S18C1TY/>SK%V^7K;"ZE?-!7.%TS_=H/UW)(BM6KT7&W5U/$!5
M
M 'B$>IWX_3T&V&R>^-#!9=K%-H@MNMBH_P!S/CM#373UU;X8[3TCGQ(X;,SU
M<*2W<\"@                   ]   \
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M&9%"_,,R46<J)>Z^$T6TB#'33%Q]OO+O,*"[3OZ ['K2A"D.Y6%M]XZMMX
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M)%.\@#/4QPJYR-8S"L&UQ!*1 "<F=IT3^,_J[*^GF2'U\5(8D=_6\J$CG>Y
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M<MFM*41XO^YG11.VG#^-WT\3J.3J8]'-(%S<IK)M9/C&BRV-?VX0ZIB4$V?
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M939'TK=&X#2MG58.O[8P#-4V+U!:QLBX'6-E]0.L;&,OL^Y0I]5N^P>K;8K
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MMSIRGZ,8:^FK8:FMK:3-DDSU<L=HZ$99F'YCD>.9HT:J_.4B,8R'ECIN%"6
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MO>/C/=WQ41%(I89*I?8J50FA%9&D?FJO(#>X'B"[DWN<"KF$3WDHH8K+%'Q
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MEG?0FMN2)?QNYTH-SMBL[9Y'JG$3S5#1Q5$EHH9'2U.TJ,2X[NAFB<)("58
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M&7]6AYV6P \V)W.*ZDX<D(C[O'+&)EZW.II!Z+<_U388T>S2#20@O?4S'4S
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MFCIQ,HT:ROQ6ZZ;Z3SU6Q+"T4LL<@TO$S(X/1U8J1]X.--L6Q91J+6V%R38
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M/-1L/#B7LMGJVX66R;QVT@)IC8_%IOS\K<_/$_9?.VCA9,NE+A &5= U,/\
MFZ]1RZXF[,9_+$LLV7N\BV"1KI'"4<N9[QPN0]I#$]/^:9A UB^JVJ2VX5;-
MI%^OF-L0]FNT6K4<L-.A/ZO0K'IXVON?3D,2=F,TUA_8W9I%4.0JV4 > ;\K
M\^E\3=F\Z$ZZ,MG*^?=MMT\6/S!VAFG&K+JN* &S *O?L?.]\9CV:SF?A1P4
M$X0+=WNMSZ;G#=D\ZX*0^PSZ2;N+KO;<?%UP_9?/8W"QY14Z5Y:0A'_RP_9W
M/Y*3@K05"\5D5U.E>[U^+'92@FRS)8*2>)H9$DF8HUKC4UP=K\_T?\<?:?\
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M23 "0_[_ !JI,6<1LRLJA=EZFO1+$SX/T9Q'I#Q3$S3O/%/C7:7%S3@I"TH
M2.6T>'=W&3EQ> ^#6Y(KT9]*,3AL1C&XICIN()B>#2<;CB*N'PTT!D>? X?.
MBAAR2I&6X%M37$O2+TDE]&L1Q6.# </5WX?)AYL-B^?B(\)B)[%9D*,BR_NU
M>^5<C26\:VK&^D&*X9CXIL>K.</Z+R\3FP^#Q4C82643M$@5'C&9F4J><P&4
M7T( -2>FW$<'AN(MCN'8+US"8+!\1@7"XHSP287&3+$J2O[4<ZW#'W2-1I8G
M@'',9Q/&<4P'$,%%@\7PUL.W^[S\^)X<7")8KN0/&$89K::]"-1_[\& PHQS
M<2Y0]=?#^JM."<WJ^<2".U\OMJ&O:]2\!X3.V.>;!12-Q/E>NYRS"9L/^X;4
MV1HMT9,K"F]&.!O@OU?)@(Y,*)_6%5VD=Q,5RF02LYD#%? ;, 5 %)Z.<%C$
MBI@(D$N 7AD@4R -@E)(AMGV!._M'O4OHEZ/S,'DX;$S9<.M\\JZ80!<.2JR
M!6=$55S,+V%?[/<(LX]32TG$%XH^KZXY 0N)]K]X+VT\-CM4OHIP&:/E2</C
M*&>><J))5!?$L&GO9Q=)6 +QGPD@:5)Z/\(E&*5\%'EQN'P^$Q*#,JRX?"@"
M"*RD95BL,N6WG4/#L'A\1/BX8%3$8F."*>34F1,,@C@5@3:R(,O>U8;T;X)@
M\1/B\+P[#PXC$K(DDJ WR37YRQB^6(/[W+"WH\$X:W#!P;U91PT *,*'?+E$
MO-"WOF*Y_%8G>I^$<.Q,N#FGPL;RX!63",;_ $2.@C>.WLM&R#*48,I'2L/Z
M,<"PL.,P\'#H8X.(+EQ<7C9)5N6"V9R%"L2RY;93[-J@]'.#88J8L#'<823
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M&-S$C6R6&SMN3\+ =S2%$^BCQ##/J?$&-K]9#<JH[4YA1OH8Y9DTUN63-[Q
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M7,PONYOV ZT)W>1CD6Y-HSG8\M?_ (?C#9CMH!UOL:)*+F]:$6EC&[<R^A#
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M$B<W,DYC0^-W"!C):P4$M9$3M;3IKK5R+ODAD3/ECS JH'07%KJ-"P ):VI
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MGC6Y!.2(>(E8@-Y,VY\[:UB)<3;#/C,2D8'TCQ1(/<7,+VS/X+#N":PI@G,
M;UH1XG/B96D#*\JJ;+'(#X@-BM["PVK%SAY57/+)'$UD5S]&$%LS>$>*P&ER
M*Q&+0SJ9$YWC!5(Q8<L=&UW/77Y=F::9V=AE#-HOB*Y![*$7VH80B4NS$YME
M1-+]M=;?G2H(@MM$'8!;:_U^-!66S$6L1ETOI0*LXOJW>UOE60W+=%V--*/9
M7[JS4I%7'[.:BU%J %ATJ].PKF5#ENVEF/7O\*>2[%+L"?:/4"FDW0K[)49A
MU%^OG60/*I+!H^6<\9'A;XW&MSX2+;>1H((5 10;V41QC*B? ;6\AH*>5CG0
M'Q ;+W'3R1?_ *C>LC2Q9O82-K9MF+[FW7:XOM3A&$<C7Y2[=F(V0#J/K&N,
M7_6F,) !,NJCW=!8#^&VWZ8T5R@$>>0-G+-[(07\*^;'?RIQ)+B"XC49+[C:
MN8<BCE!V62QL+AWO[S=0NX%))*1B%/,.HOE 4GLA8;+2JQ=0QR 1@,&LT@9K
M6-]Q;50 =;^0HHOLD@D^%A>VA4]M3>^OD,M];B1T5C])&#E.K-8AKV'A&F6V
MYN#>UJ::.]N;%MK9_+IX?E48+9R7B:Y.77V1T!\.]]2: &8DNMF-K9F]D?X=
M+G>WGUI5&?=1H-$)M\1X=ZGYI:..)A<DWTS'*?N^^O[0II8.#1888O#X23&3
M<ICCCRX9<.@O*HLDA;Q9 19=/>Z5A/1S#/)/.<?AN()!A9)FP/"G=L=.8]5C
M@YD615OJ[E)#'&I(4UQ'A^'P<V'Y4.+'K."BQ8PTX'K&',C.@BG<*BFY3.AR
M(3&ZDJ+UZ >A&(],^,R8:[8+ 8-.=Q'&IE:6-&OE@B#*5,LQT4D,JA69N@KT
M=]'N'>BW"(>%<.SF*-F9IIBAGF=]6EF9$52VR ;!=!1;2B?T?VE#%'AF!,;O
MZFV)9,7&EP"2A;#O(>BYQE0;,QJ;#JVC$*VUMM>UJFPCALBZW_GM7H]Z+<,P
MF'PV)Q<$>(QA1),C+FCBERZV4^!V&GC==*P2@JMR;#30 7^6P &@M:@$ %JN
MH%3>,6WK34#>H5=U?(MCE*LV;;7K1\&'! &;+K;\*FAYR!,Y4D"UM\V__6L,
MLHQ$D5]+#Q'338K?O?6V]JG@ B^C8L1>Y_D/*_QKC;%\>[L+%DCO?X6_E^SP
MC"PR\*P(ER@L#D5FNVCW+-_Z:* =3_UQ4#9P,$BW:R9G4C-L; MKET!8[;6W
MJ83F3U7.XGFR\Z1\I%MB%M^[B7W>IVZWK$0QQMZMG]8R1!4MHJM?Q>SIKN;W
MUTM46$1!T%]QY_'I\*$*5D \^W2N62X8&Q'0;?A2DDV;4]!68("7 %OY5+C,
MUU7:@WG0>LU9JS5F\ZS5>LWG1:AXB!W_ $,0HNQ &Q)( !.@!).YZ=SI696)
M (.4V8 BZ'^(7\)^-6U^?Y^7G0L.MC4[Y%98TS,=%%]LQUUZ[]ZA14!CL"[Z
MYO=3+IF4=Z!MF%_$L=@Q.@)V?XD:9?G4#$JC2:*#H#[39=+@;FY[5D1!)(MP
M\HWW.2^P7SZFED66(YO"B@HUAK;J6/NCH!3'FP*4LL<9^C2^^3;XYNM<4-^(
M8HG<S-^ _#;],'+CCYLDALQR+&I -^M[WT;;2UMZ<LSE(396&5B 2$7OGZG\
M>A-!,D(($@U(B(\)(.AD8'VB>EO9H988$RLTHOFD-_:DZ+W.7?3M1?*N15%R
M%<YCE*D]CY]NEJDF&0&XO(3J#F:PT%[#3R K*#JUF/G>N4N:X ^&MJ5-?C\?
MQH)=EUN+5%#F)8]#K_=&M8""\LTQ(<\QO.RWT ^6_:O[4<1S?26+!SW,4& @
M:!""%M,2[D=&);3,.V6I,,V"Q"XO 2R0Q9A=HR5D@<^>A 8W^'46KE3S/F,T
MF(EQ)N+!YY9Y/JDC,[M:PLNM>@'H=@O1?!KCXWQK<2XKP_">O)BG7+AW $K0
MQ1(BY;.Q!,F=M,N@--+< 7M0E&4DD6"ER3I91J3\+:_"N-?VB\-AP4QX)*F*
MX@DXA6/$12K#E5OI9?=YD=M$L0"UM+5BO[2/2&?&P8CF1X6&#*9,-AUM%*%/
MT@<O=OI!H!>R:6H>D,7I1PXP8#!22#$BS<_(T4<BKS'0[JTJFV0DC^$UQ'AV
M+@Q4D.+P\D,V8MDD%F8?6'ND>8TZ;UZ,>AWZZYL[ROAT@=/I#'G$C7OD&8KM
MU(O:CPDH!EDU46VMF7MY5"IA6QWKF>= D]:R;$4JJF,(>( 9"Q<C0[U!DR2H
MMM=23I:XO2QN$BC1[C0YB- .]NE1A[R-<A0+*18_*YT%NI'RJ?-'&70!I#8L
MNK6O_"-FUW/0TND&JDOEN3;PK<:CX]QTKC9)Q[WW5$!^_3[/V/S^=ZX+#%+P
MO#1J&DER\R9G.55C1VRC3>_:UJBFR9I)P6Q,S%,.5D)"Q+VMXE4"Y8^0IIIH
MS.(GTETSNH9LOS\2DZD:W]G:HO"-S?3Q$Z_UUH&LU9KU&XV/VT\D<(+N0"!I
M6(Q;3$C-X>EJ5J5O.E:@U9JO6:K^=?.KFKUAS=SY#^=7%<0@:=H'2*+$+#S<
M^'G=DC;F*H22X5@SQ6;*"IT8V(-+P_$B9Y(QA\,W,GD3$*6=V$T7+6-XK*<D
M1U&9F/A4@ UAN&XJ&;"M))&PAM>0/)GC1.=]$H)/AGYBM(2;YEU!TIG\0 WO
ML>M+$TF<-9<K>WMHNY_TIR!'X0,V=1FZ6)V!\][=Z=;3QG,OTEU"D^T;:9?(
M=_E31@?2^TP7*B^Z+_50>(]>PHNL2*)+ABM^7>PWWDOJ3URW M\Z8"1.CKT
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MF/E#TO\ D\EN):&2'^CD@X;@[ZL?-3Y7$]#Y0:L1R35,CK4E0AF2H>8U",4
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M[%5X0&P;Y[I>_P"-OY"-AX[X,0[%5^REB?GNEV __(X<+V'K6T;_ /+U*/\
M_7X ;L/6H2"?^7Z4V4=3_B\8XW\":_3O;_'E-W@.O^0=>F B]AZ[44UG_'E-
MW1[_ .0>_&ANP687U:5TY_2$,?>3EX"VZG&W83,9+>L,>>TI5#X7^;^];J0/
MLP9(^P>9.BD DYW3(2?! <ONW[,*K=B\Q5CN0V;P#3]]!N? 8[O8;-'.YLN;
MP;#Q)\@VP">QE:'/]'\^4O='UF\AM]F++V+KG/0)G=,Q/@/\@Z^_^W$A_@)7
M7CMJ4]H*0'?D-LO8:C]'$;R]C:R!W4,8SG--)HON 6%&H)MSL-CMC]&:I?\
MWG ?_AL1"3L9630S#S<ZYS3H-8]*-E-$VD@;\]QAI'[$UX"CE\]TUR>BC^0<
MVZ8_0+,?Z_I/[OQ^@69?U]2?W?C] <R_K^D_N_'Z YE_7])_=^/T!S+^OZ3^
M[\?H#F7]?TG]WX_0',OZ_I/[OQ^@.9?U_2?W?C] <R_K^D_N_'Z YE_7])_=
M^/T!S+^OZ3^[\?H#F7]?4G]WXRC.6HWRV7-**&L?+IIEGFHC+?S$DJI&'=0
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M +#PY8<J.+*Y//SCV'*Y/(?=@N\@IUC'<[I/VV-K^[$FAW!D.TC1,TLOA8;
M*/9Z8)*O/5.>\]KF._(,X[J <SO]^%CI^(]0UN+)%JN?&['I]'"$V#WU,LEW
M"6Y-)(WIOX(NWV8F:\3ENZ&9"J7\%4?>79ONQQ(&D/=M)*NF.)2W/@[<O$H&
M)Y7P!P'(A75)(UM<CGE<L=KG???D ,+ :F0OW20LG=B^D3;Z"]W?FW+$D;U
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M)>%/3U4Y$]3'-?5Q ;;+R5; 6'WX ( -AWBVZW_=B@I8EO:>0F.(>ME*:48
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MA7X@8990$&Z\K;&YY8FKZC,ZXS2SI(TC5TYJ)98*F6LIR&5],8IZR:6IIUB
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M8D V)73$+DG?O2,?'<Z1TQ)=)C$M@[,%!:7:RZB>Y&!]WL^..)HC8!RJZ[A
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M-L00-B!IB#MAE(JJV@!V6?VPJBH[?IQ84WW89QD,</T')C/!T\/^R.(I\_\
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M:E^7#3@GVD$$$:UAP7/ >T=LG?\ *KH"8D36:0+="L\UI"N([>RK0HPUX8Z
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M5#P&04\J&YN;;8;0S8!:(@E4,FP=8.AA_-Q4<\O/$\GR&/\ <]?7\EG>2;Y
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M_3)R,CW_ +^,T^U"LE'TGHZQULC(@!0I-K-:@>\JHI'8!P<2@4:F"PT%>NP
MK2.@[H-6-*=Y2S4.[5 #2?*#3L)C2'P5*S7($:->;V>ET"'(A8"' 0:2PMT@
M;!-?+ ;OO=UAO=".'#E'@ F0\BR"C-0#2"=^\K,1%+DE0":@P)>-Q139 X@K
MYX).H,9<8%VVX4WLP[TNC>:U2Y(>2&X?SGXC/PL< @!)1="3B7A,*<;'PC5P
M=GT-\PT0VM=85Y;X^0<ROP(@;.02D\D&Y@GJ^A^<QSR&F1T:_P!,!\,6 0:
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M&S$DFW$,B>YR8K'3_#7Q5AW1EVFA#Y=VV^=YKPP@B?3[O0;>0ZHT#T0\7/\
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M)^QB'IFQ&H2\'X]V>,-Q1=A&S39R06(B9#UB*VM$]!?Q*4VB0!L"&M)@Z A
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M_P#,1.".IY@&.!-?3__:  P# 0 "  ,    0 PWNM5MU/
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M>\^OG&W&,W!_G_V_?\]O5T>O";7S$-*76*P0KF8'*?W5$ B*BIY.P>7!Q7F
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MQ\<PR8<E%'/J)G/&>9@-07(Y<%G]!S:6K2Z2 5K9GD^IM4Q;YSSW_5_O/?\
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M7RSQ>N%AV>NS_?SOC#*JBR]#3XFO;>_\'/,^T\^_ZVCNCD0"H0@>EKGC"X"
M.A$P)=#<K512# 32A#@&WQ$97I#8=@1A6,Q%2>PYHV1"^EB@<T&@8=IFBRBD
M$EY&CV#E(J)&,!:IY&*NE>K$.,LK54LL;E6]"?4BXX&0+>&Q?CS>%0%=(A';
ME5%ER)*6\S%JL. !8I9FI1I#":93A@8%4!V6#H  2:  *E7AD80 *O$ /SLJ
M0@/,I%9D5# ,U!0--J%%%940I#;:GB%0%547!W%! !1.J:;Z ,<M(0V(E10F
MN%08.9>.@'EIE&* >K)>84#AG#V>]>N_.]R%$3*0?#['SWZX*3A@(BUAD@N,
M<86H$J2L3R6%B%Y'="FT,FJ;VU-5@D0*M5N0K;YZ<]&W !9,^*?FN-F7OOXG
M!6C0W.I$DD25*-3BSY[BWB216BOEX%1'4"LN?*LM!3A57+<,>_0.3QWP&0S$
MT?GYZ<6 80!];[=^_>>*^^?\'3EP<C.M7JZTW4SR?'>*+LI$08!%'A7&M 0*
M<K@C"@X@FI$E@2&3,*GFXH>!73BP1\8('!U)?V2H%GA !GE7$5B!)4#F):<M
M["R'$4SVDAI4$U\$7YD$,J0B!7/.QC$D"G,$4XG!$B1JU"F 0#S0@"% D>RB
M@I-"UBM4LWHPQ.$,/@V@J4MS#A$^.5)L_P#4,R:H>Q;85 Q(1B@TJ*,&,3"T
M<5A!M$2[H3,P!?1*G$1$,860C:DC4*'K6;VLXC6^7S\-3TSXUQ&;E*&-JP8\
M&?WX[/+-1&HLJZ<[0XR"E2GH7%SLU3I>>!OM'7_O#&J>SAZ^/Q].!F%[#K^.
M#Q7'QK@5F?SYYU+B8O\ ?]\K,.'UP\@@ >OKY_/KQH),[>KZ?<YDGU:^OX<J
MP<^#^C^N&&!&2RXP'9;9E2(>Z>)K^UD)B)^J&) NQ$4;NK5'')A $V(?A3D!
MW!R[3F34!1591<57)$.K\(.<>A:B%:H"58!3(C3E" .FV#W45$VE.]C5<"A@
M0G4*MQ%T(<*)47DH@$5&P#;!QUYQ#1X"D87L/'RZ31KC((T&$DO!(Q<D@L!-
M-4#$G&,3/HBAE)1UB :A>%)D8W!,9%$ /%$DX<PM<C*BEC,Y*OL[VH/ H R(
ML6<8"T!TDVI,X66>A3W<Z.=,(:1R"3(,J;"NK@%!X)P=W@3:&>3(2=4"/A3>
M4<H,O-)*= PO!WP"25E@ J(65T QY&SV0 44$B&!=%#&2IE:T%F%$0P&39@)
M,:2[-N-!/'^\4DL7R%X& S%X4Z6.0X:WR(TX#'GD%T^?/IQT-2"#JH"%JX$S
M'+2P*@2)6:MT\^%XR@6<YBVR%$KE*8X_\TH"DNS0F^W'$"$SA@&\Y?$R>^.^
M7YIG3.<BRK/(=]<#,'2$SI@,7!7&(\=;U?RGPW_B. *NH4>H[!D=L-<3K)PJ
MLUA "P%!F2CJX*R%]5"FO+2;0,F"D$7!A^ 8 P78%"0!U%9Y<+0N9TLT FE.
M<V@H8 %"-@NF'!(XFBNI0/ HP^ U0DPK$[A84^1"A8JLG "Q"&R 4FR9A/1
MBE8 &.9O+$@(M$@MH(A&')&,>E+0J289:<A%"M D/56'J*?' /'9 P1HEA&P
MCLX A1% 306 "+&EHSV8WJMW<OTY=7A0*2DBUR'.3AU&,<K";2!%$<@QGJJ\
MK -8(EN",P"(S KS!.[+V!0841F8I7C-B5:@,^57U)C^+S]O3^^!F</[^N#@
M'7[/]<4=P_)Q7+91,V_U_'"O3P7?K^>.)K;U?VV?&_Z $7VWP1R<5#\_,?H>
MR$V&%+A'5U5>$U46D262!O/B7;29I%P5[,P*P&?U?^VI*0#6!=]CIPB""W<
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M?OZ:XTN*_P!_YQ9F;SA^WQR27>1Z?VGWSP(E(%""52]!GV.)5LOF$#FF4G+
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M 4+:C-\\>0-BH!"3=$$!,J=1:.:R&!=42$@G,R16K 2&0#,%.5(46<SP!K8
M25J',50KS1:@#T @4<<X$81O8"VCL'U_5PT5VN ;0%4*8XM%QTZ)$X*(:ZY+
M,NB.8KL-JK)<$'B9).6E%PKDY JE:9X!G466%3'L/)@,4*!M#@B7$A#K3W%K
M,/OVDTL%&$J5+R:MP(/66(,NH&=V(!PB/,$$=PS%J8%C1WK2%+1TN%,V/H\*
MC%H@4Y%8!9<[8GGC'56<I-)4(2Y!@:\.I4 ^$ &=B!2L4XSIW<93."J'E@N6
M\S6*0,FJ8)G03UC.)(:"Q\1LREBW.$@NYY]_]XU0[^/>_1'KUY#*J^7POO\
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MJ B.1/'87_C&*H7*)AWEOVRZ[X[O->F]I2)8S!14(IA($T?2IIN"RM5 ((9
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MQDU 5X!F8D6'J!D((:7N.^V_5_67X29E=2OFSYX1L8=9C8A54(&IR=),C-6
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M'/.\8ATP,E4*H93)G)2%'>%T=8C46. N&F(N< IK@N"VN@15= K,N*S.A<-
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M$2+#SA1G.%JC>,5TA)&I)Z24:>._4MDDA]M& &Q4P>Q ,$H.["EB/)&6HQ1
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M&'/U+9?01>PP </11Y_%@$8#P*.EBJ0!P49!Y*C>D5T,J&()8!P/NN"J'!Z
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MSA;N'0B2W2"*3@T2P:RM,P#QJ38SHQ<0K?!%G"(>LI'(6BS0HL<$3:ID*/-
MH"P,;$YD"O)PX*8(EA7.!Y=@BU2PB;%J>)V* J#@,HS&XQ,>_  :!0"(O=*
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M-T6<H!J1.;G)%_FH+CK(# 0POMHT8-4:D"T7 F&((I'#8P#$APLQ-","H X
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MT]C^7D[B8U"3Y\3[_3+K3]M?\\/?#BC]$I^_9]\!.C69]Y,^<9X@,JWQ/Y.
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M8Y1Q[/ZXBT6R;Q]>/ <9QIL^O%_-[]_O?+6.IL_WK]^&F2,H?:_7KF0#W?\
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M)/0,>]MWG6N;L&/1>C>]$W."B'[W^_/*HH$BUIG%D<8Z[Q3F%,L9@UWG'O\
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MU']=<+;>7@F8JBXHP<N#6,LERL!PX,D@P3K8K\LH%8- *49Z(1G9'%8(+$8
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M&.&Z*5@"0V0R)XTLSR_P=*.TU6\)5+4YK )@(R5QC!8*W,QQ;;./D%GH;!J
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ME4S6L='R\"LUXO[C]SSH7T?]_?GF'#UZU];J9P37$',[S,'K_4^.^ VI]/\
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MH);UD<K,8^7H8\U!B1WG^Z/KG_P;^C_#R67*9;5P#,KB5U;MM)*$<+!,US@
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M.(DJ""X8&5!#)SO?!.)I!14LDANE^8"Z<?.$@#"'&1<C+PT@>#>P/&?'^5R
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M%S"$P_+/ C\H*>\K.F;J[>/R-"9&1"G3&5<-QR$-/3XU<;$RA1DX"98EU,*
M#>&IGC%7':7I MC%'N7B43+%E\N^#/IQ.$,@KE1"B>.W[9X@Q>%C0DT,[G7&
M.#3$ @59,[M#QCF+,8V#5[W/BO7 ]L"Y($(S5GK'8<'GVHBI"H-"4D+MZ_S_
M &)]'#R4!S"%\<AX/L<AX/L<AX/L<AX/L<AX/L?Y0=@_/(&B?XAX/L?X4F#"
M),9/W/$MZNTP\G@?;@!@Y#P/R#_)Q!)D/6.3-V]F:8W]OV',>#K,+ D^IO\
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MMF1/+I!P@216H%!3()L-B#-([WJL]_+[W_#:?/H13_1\<^F\YJ$GEWX(X_D
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MX@*:_P!:M *HJ): 1@[SS@;9JZ7D#VC8(L:J!TY(84!6CBE5&S\5@@*B.V*
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MYEG$>O!HTXX$K5Y>?;JX"\.J0/[=>GKZ8_G=(&A\/IZS^\Y.WKP7\?&P_K"
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M@U-?7 1R<6 &HJ:#C0HV1XH0%&[JL,G]VZ?PG0/JL[J3W)1W$(S-G[%<$P*
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M5I11@J-:AHXI$Q,2!E@Q#?94$\RFR<AQR/87, A![MI@^KP1190@),G@= T
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MSHNJZ4Q0NQKC7)'?'OWR86[BBIZ,D)HWZE]\ (K'-4_97_:,HW7MAT(2)/\
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M")S\>8D2MX)=6I&,'!8Z((!%NY2]4"N!%'S4U6B//^5PLE1[GQ_1_EPN(),
MD)MR2*0N@0= >8OE<+.DM;\W^KAMY>[_ ,W[9P@Q7G=G+KZ>-Y?ET:$OCE/.
M^2YJ<SMMOC_WG" &+OLY]?0^^&F.GRCSZ+QX?..QOTYOY=(/KFMJU*OF^?'G
M'M:[Z_'V_P!ZSS/&IWR]?WWOTSC[.@*K=0*MN@YN3%>\- M%X ]&H:<9/%:G
M&:3ZXHE$<!UR1AL6-=L'B3Z6FV($2T%:PCGE&9%55C &C%I:ZV91ETP%.NL)
M $8%(JR2;E(QTA+'H\)54"&1V): JF ]DK(>&,PB@#VQ10@BX3O1(@A':Q6]
M$4[O-Z$5813">ZIR42R:YB_4<A:._P 7(J4RA*$ -*>G%E:.BN*]9]YY<^AZ
MF3HI_?0IC63UP$BA TF2X0VC+?(B 4!L'J5J;G802LSFRJ&@IH 8Q=RV;%M4
M@&H+T7#YBUQ=UKRGX;T7EQJ'58=DKXW^0ZUE;6')ONT1(UT(IFE6U2H!:L*Y
M4&8%AS3I-PYKX@+?&]%';0JM-,HS>#KB#5[YX]_[,/7JUFG?^3F?\,=$WT>"
MJ< &ZV8Q^%!H\+,0@.JJD14+MB0BF >S,.WKB+NQY:B2EJ<T/B\$$J.[24!"
M\89<NN@"B("]8HW3;/.JSS=SF%W8#K =[*UG=#=\=88 ?#1""[ \E^FE"O.B
M-;/3>^_7SDE>1PPT/Z]L=I)>?;4OK_?9O+$)41?3%10 T@!0L </C"P ;Z4K
M@;L?$HK:DL)=-O=8D 4GH)3-KFQKR<C^62!%B*+3^XB?Q54Y@QU484[6I2\5
M$DNJ\(\P<EY0,L*04L\[&%%Y#Z-L#@N%&Y#=K8#:J$)9GT_A_/AWY.N/7K%R
M^DW/=FN)4;!1G-&0(0$%C3)#4!V;L40%&&=915EIJ4D*X*"(CK<(L42&G1T2
MM!NHVS @(,>[72N>)CHM@]1)-728 IN\TZ^-I_N#739T?[,D\WOT\FYB#IM-
M=H7D/\\Y3ALE*;^/[Q/)+H]-<9'MK@7_ "_J^N,+!;[?&_;C?'OAPL];"?@_
M9@4'SQ'E\=_J[R'FWY]_C6%H @<H@ %55GO,?"#")E$*EL<@D@"?X3MS01)@
MV'<=J&5@I5G-EJ1A0"8T[-4A>$LKE6'%$U\MP:!&TL^!Y6X6;"R*XRTGA#PY
M*@ /!#@(P/QL4?I$@&Z*)1P/>2LU=EL3J*R'>([=7ZOS 4099QDHF S:S@U,
M+2K!<$HAD0(I.SPJ'7F0?M0(;W'RRB:=#NAV( <X7QM7K8P05I%UB&B2Y*(H
M[\[S[SRY]#U,>VLC5&:K(@ '.&>05/Z2KQ>RTJ"L+'.((ARQ$0T#B8E(@()8
M$>LE*H7$"-%6*&8)NTQ!:<Z<#8/7D"-+@I] 7X-45H<*.D:5A)MH9Z"@E6GF
M5(PPB@*O8TD,:ZV*K%_D +H3B'##\TLG"46I%G&*LG#7?CJ3G>3/S#??QZ_;
MCPQLX*Y7:N#ABT?&V.ST!2JB263 7)Q4"L1D"*0H4=,I-LC!,L2E,$L")Z""
M4H&@G)@C1 M._I.2P)F@PC47<'_D?1,="K=O+[?CGA_U4M1AQL045H,7=2+<
MB25(H RW6&E4AM39@ IA"\O3O;Z^WKM-B&'ZH::D+@.[A7B?(ZPP2[0 9CR$
M_M A25<+DJ1Q0L4P@WB%]&#5B4[B($!47HBZE;F>$A@7K48H#B"RYQ5!*0A3
M#)U1 P*U$] $T41:/5ZR*4E[50@8W.!D1!D1:*6"8.,S-0>4I>435KX^G\/Y
M^L\X3NE @KIZZA.,!B. FB>/')9Q^L<KR=7L@&<EHH$I;E^".D74)0;6!<1=
M#/668)"+.N3*\OYW_>#YL.(\>-/CK_<F]GWWP3PV:W]OY[S=KEZ?OIGK[[XV
M<ZRVMP]"_P!^F:[M']3($$]*[_O]97<X^OV8*!N$Y-?W_6\X^]#7=\1ZD_>^
M!&GR7K$" 1;+8N*DY,NEM0(:!#FNRN <1V;D'8(0,-NETI&%B)A(U88/GY:(
MD XTTF/C<8!L**!X2WI96XM9R((D"-1?,K'X9U/TZS[CE"@B=W&BR9SI$#P*
MSFS0&1X'%Y#&](-=4- ]()8]@,UCAHC"-L(3F-)ZJM/3J<_QS1-1>N*4!1H(
MM-G4["B&83D8X@4 %106B]/D9]YY<^AZF.983P8: ()H59 2=V<0,Y2E:"I%
MNS.6=4@6Q3JB;LNBW5UL#N- 'DZLSU$JSM2UVB[TX(0V<Q:>^]G%U\85@Q5E
MS>(5L(K3X'AQ$R<H0$ T+E?C;01UK6NE#:)+ZM@A4HC%+#?1G=T@C;U=GXWZ
M3^:,0M=I39*QR%JLS9/BC.$K0S!@'N2E,D+%&[%([G4!54X%2FFLTF-8,(OJ
ML*TU"D&E%VE5]1U:AG8[^T%PLH@::5"I OA@0BMT+$@D!)@PJ1-(\3V.I.=N
M-DBO/(]7L^0UF@+BT@OGSQ=WI.L%1&"@DWR-I7][-XU*Y!U:20(=)!B -RP?
M29 $GJ(N =(M0%BK)> D#$,PCJ_G P*P8[W1WHDPDV5UFCN&!F[S? 3H#%2>
M!2OE<#@%:R3SOOQ8,@&W@!6\84IFIJC4:8L@N;<!R[$:!*W ,%H%QHDPX.)M
MJ&1LH5QW%@[(2B :!5#2LSZ?P_GZSSA,-I17&YY\OSK4V:*4H !0(,5 "@)-
M \@[38"B=;&*OCAW_P Q0Y0]\$<!Y];Y]<KQ^[A>DGK]XPIR:G?.#Z3\/_'#
MU7;..1[XW#SBG-]^S_OSG"$2SZ_?0RB!76OCK_F2>(0>7[^YC6M0TZF!\ =X
MEB0HCG3%)PGR8%SU*?N:'=@30"Z'/>10)4H* T@*F)M3AK2Y%M"$H4D+O-BR
MDG0$0(!@FL,M8.PTQ JRG9;0,C8FJ6#^5U7AQQ0(0#/D/Y8D;\L10E#F.ZX$
M$[ &F2IC*AC:1*8RE5)"8-EQ.9Q,@-UKG@5E<_@0?C^4IC<NBMI)MD++Q.>)
M/4AIPWU2V5%D >)KE&H0BG_XE35Q[\A<DA8)B[#G(WX@FHQ)(Z)4+Q[ 2ZLT
M! ^\\N?0]3%Y@;IA%6\ET]/&% +?C* R(@6R"5^SE8PJ56T"@F(E5>5HMON,
M;>/%7!'A,OJ]S?S/'XR<]CG(@FUYTTB IX/QD3Q>$(D@!PA-S(B;'+T$K;8#
M29T9%%#%\\=D;@1R2R P/YYM) ZUDL4QQ[H+9B$M)!#483;0VJ&K-)$I 24R
M:*ZF0,1$J1HJYJ89/()'2<W?2+I<H) ,H&QG!&C9HTIAE4+']IL>=:=;-8VJ
M6ZL($VB=KT1:-W"&_ .Z3>!PB.B^R\==_P#SW<:DFZ]67R$E>NN7D 8M'48'
M32+@77"HK61%2G58@W+@"T&&CS IB<XC%D?&B;G\!-BC;A!8<F_D0 "II*.4
ME2PH'=96B-\2!V4)(12!/!H<F+D3 C'*NX6Z*F40<,,C.S" =A!"T&7JS$)"
MJ@UK"#933:(E'0A>3#J P6:#4WD8N;14GAQ6RRV%BPSZ?P_GZSSAAA&WN,D^
M$B&!8I:]L!:WW[G6Z3&-S" #C^!C?G2T!54 ;H1!AA6)E?%C=I$D%"INK!/9
M@+>!06ME:U""[*:;CI*[W?A_S^X_K]YO7V>V 4[37_?UFFV)S/'MO6<Q2O6W
MB;^ZWYN=ECQ]Y)[YP/P^_<_]P&[RY &H$5"KA5*!@"0FQV-N*=7>41>?JYB@
M78C6W!IB!Y=!%0"<&UQG  SJG56QVTJ<BL#;25)3-J 88"#S)_ 7/:DB 3B@
M(CGUDT ?$KCIYBHT8D=@NA<9"DV%Q()$!D+1U.7\6FEH%)R&'.D=M6M,LXP)
ML6!4(UG6:=HL8B2@K*=>IM0D6Q#8E-[!""$6NK=F>F)(+"50NPJ)4M[)("B:
M'83 N&RMS0$M$F"F"Z?),X.Z"#.0Q+[JP)5ZB@@A$H)YD>P](=0*'*M7[SRY
M]#U,0AJZ0W ZT577YPHG\48:D0)YR'+9*QMC%O)5&)./-]K!A$=F<X1L8_+L
M@B=C" D6RF]R-:<_BPRC6U_W:P[SV(%F]1*UO.MD]GR<I<)5)G!M*Q**.7D<
M8LI"&LI+-OP"L9+HR@8&DMY-<X><A?@&BC, 2ZWN6T$=L%M"+U/21L7;#A3;
MAH'B#U:GF?)".N^\>-D( ZN^+ G,]7"L!V0=(["DI,,4LRK?I70M")JCC&*=
M$*FS7OOQ\'.$H!/HA8DAFG$@P27=ZVA*;4%*&NR,J4C*Z$0;4'(Y"R7BQ;P@
MY<F"R(VLEUBPA#T(<@(:I-*:X,T&[B=2O, BJY>=2PD*:;Q"'" WK7+2B"'.
M+EH**4/28.5#CBH4%Y;$2 *!C2ND X71]\HMU[250%D*C0!#89 %K@(H'!+L
M<#14-#8L.KK074Q3V%LI'NP!7#2?8"N&KJ-IK8F?3^'\H _^FOO[ZP0Y\[QY
MD#<B<ZJMX>0#KCLL TK:SX#M20!A,C#4S.^6IX8Y-K+>2=Z?&-X-_$ \13.Z
M.XV[ ;B$8!H]@(6^>0@FR,.^--/R_G.HGJZ)ODL>'7^Y%R==CIX7D?\ 7#N]
MC?\ W,+MCT?[HX^S!G9EV]'IS^_G)FDAH^#:OO9C%/6F[3?15-A-,J!41"TA
M &08@\^'@<(+*&QZ3H A< ?>"JQ*%T/;>&%HP;T#;.(9:>"-<"\)GDA.BJHR
M'^<?M!2<$:(AC3_: 0+A*"!88;*$5Q0))UEA1PE1/Q:JRS,LP<QS&T<81*U:
M9F+-"1,^EVTS4,;B6UG,XIJ C(JJFZ52PN,A0N0&FE>N18&RT? +5\I5"L"]
M\E',$RX"48U1%L*(DQ^F$1D+MD;$@!0N1$K#RX 0;B3%Y=>.A/)AW9,%2#SU
M(JKB8K8]!@ 1/]-_-P4#ZIAL_'L&1S;R5FSN2)X%P3V(/* VXB72)(,EI#X,
M/P<DS0A8^(HQ:E7ZFHW#97H*9^/:7_*<89YG0HV%23$P'7^??^B77VN#ZF!P
M7SX^ZXAB]C*&BM5,X&E8864C2C.[<#5J";=BGM6W+A/BG=B68O'FKRX;>&0@
M@NT8$ "AC/I.O?TO+XWEA";4N8>>M_[UA/&I65Z:/+N<'OA;B>!""76%-Z0!
MC%5@!(H>@#8Z;4H@4=@NR(Z$$P<O,W;K2PRN2E"[AJ;M@'EX"L]9YK3NKK@\
M$0RCICZ-3(+=5FT1WLAK=+$+"W,012C%A3##!P P(? 8*[=+;2DE, ;0",B0
M::=, N/+4@S"TM&H>T0+ANUC<MY8*&(70T0RS6.\M!8:D"F'TXV]0#%A! PV
MZ71,IB%6;D=*J\UFDKM&^VH#A#1M$-1,F-PQHH:@ )@/1!\"WUO\DJ4$VI_6
M"!F[1[##Y_6]!C@HBO,?7'[\_P#^](D2)$B1(DE"I63LT2)$C1ID:)$C1IPS
M-&S1H=X:.O\ @U%\MR@"U)<1. 5CWQZ3#"@ 3V^WSYP0GG.'".71-DZO/023
M>(]H54:JO[Z[YU_*1)'@?_V1(D2),B1(T22A0'=[O_\ CR),B3ZW]=_RTR?4
MO'^,^M?7TSZU]?7 OM?T_G(T^]]WZYG\I&CP\>^[]&?C*S-1\D-@!WKGXJ9P
,"!H: =37&OZ_C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>businessfigure23a1a.jpg
<TEXT>
begin 644 businessfigure23a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F
M9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:
M   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M
M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" !A
M <(# 1$  A$! Q$!_\0 '0 !  (#  ,!              8'! 4( @,) ?_$
M !P! 0 !!0$!               ! @,$!08'"/_:  P# 0 "$ ,0   !^_@-
M773&[U.%5&RHG75QA51B5)ECU^4)19K  $5U&\\IIQ+61C6;VRR\+2X.RW&;
MK\[)Q-]G:T #UQ355CD-[7L,:+63-W%BU^I]"W-+F]PXLR2O9  5I8Y;U*=S
M5F^A1X13Z5O7QCSFYO\ TJ9)7L@ (E?HHC9XVIN1+K%>DNTXR/*)]B;DP+UC
M8=T  5US76P[3[^2[/3Q74;WPIJUUC*D6QU,@V6ILWI^.  TE.%2.+P'BG04
MX4DJS]/&'J:<*8W-_ K7.];Y_L&3-T "A\7SZ+4:O IQY'7L\",7U12,J;UQ
MY'9S2[O0 ,&JG27*939N  >B8B-^W-<>Z !XQ,&UG3SO:<N  ()JNHG6TY?]
MD !3-CDK6O=-L)O@ 5%9Y:Q;F^W%66 !6EKG]_5FRRO9@ 0"WI,E7-KFX  H
MS8XO/VPL\U9]G;VZL/(IO/5W^2MKC4[G6.Q-;5]2.1W>VHJ %&<OZ9\^_&/I
M^2Y>!.]CS=>Z+JNE?0O'Z/XSTBDN0]#E^XYCZ%^Y_+MS]+YV (=1J_@QSGQ)
M^]U[G>>7V$2KQNA<3;U??PN?L[51CD?(/IAKO0_HIL_?  /AASWQC3'3]=T5
MN_4_511*(R-U1<YLV&HK'3^==C\CK?L3O/K( 1:];Y5W&#7%]\Y^EP81<IT,
MQO*9F-JK57(^CW.Y/;G.[/-LUD_B,>W?Y=\P^@J%\\]:YL\[]DC-K=95%G79
M69O[.ITL[/I/T/QKO/UWYJZB[OQ<>L])PEKO$/G9K/ >?_0O4X5M]]@6<?\
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MT9;K8TX<3KW^?&)D+/G$7;OO/-[M,'LWTSY\V^1@ ?/_ %WA_#NM\0@-&O\
M&:]-%&KF91$:$Z/O=)>>5WO=6P]HMF]TP',.)YW\S-3\W5[:TNC5Y440BI.X
MF'HN.K-ZTS_5NF,KT7J++]'  JK+L>RW52>9C[^Q=\Y2>B;,L79+1/FD  4]
MSW=0FQLHA1>T=4Y-5KW8V9=^ZX^T-ESNTN8X  KVWHN7,7@I[?ZBF[>@DMS:
M06QSG7N5Z+.)S)97G@ #5TXW$&%Y+>&5WW,5CAYY=Z&#6>?ZCR>ZF#(LFYNO
MT  \41-%8515TQ 9;0LN%I4U6-$[5(  T**WFFKZHKJ7B6'"T:9LF*M^G]
M-8BNYIJRJ*TEIR>%HTS9U-4O/-( &,B!(JZJ*PJB*$O+/B;1IF=Q/O2 !512
MAZR+(GQK3+/6G=G3X  !^'-J-<0Y,@.A"8@  '+A@HV)$R7FB-HGT%JEL  %
M($ 1E)CR-XGP1D&C3.#H@  P2-FZ,(Q3Q,0RSW$K   ! CS/:>HF1D   $=/
M28A^&0:\V!@$K-@  :<P3%/:8)Y&S-2;$E(
M                                !__$ "D0  $$ @( !@(" P
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M->N7I]+HSZN=)T^U%0:6=*FC:;9EO2L)+%=/7;MFQTH^F\4==:^]&9LE>/\
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MI-*I!%7!POK.]YG'Z3=.1$3/Z(WD?I'B;7M;GD,AU!X<^$5=4CC4?( JQ/\
MF9F;Z\<X4(JUF"W%V:[UC9[D]2RK*S3$DD[Y1)F0_F8;O,\>A6:WU->KY<T%
M6G/@_ EQVF0[?(-+"@ZF/BZ:$^7M<VM<;F?7C?)-H:G91MQ/]TKD553/A$M;
MI=(>&S&//CD>2YH!75H)3OOQ;7JOGU:6NKGIF51W,NX%HI%(,:L5&0S@MSGJ
MAPZ5:**/%#UG+?\ OWIC]B']O%KG6]:"1T8$I,!^-+)ML-N^42E0@3SW.K-]
M%\]-YRG@<Q:N.O$?ALP1*LJ'Y21*55T/Z2!67S#^5WG=G<)I-=2@^*>XK#/T
MCA1U('ZSOW_0'CQ9YCUNT5_K*U%7\M1 F3\V:0R.?L&"_3CG2MZY4?5;$CS7
MX6A1K#G+/7+=/I''N[(V8.@4 *=WZ3<>C*:W%SEIBU2^VPEN*XHSM>H*TDK&
M0>!$<J1.I/@^,=V[^Q)((UW']@^9^7!L[R,CP\.)L3*"I&Y? >&0?$<%2.S
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MO'HFW'.T/F<1%1DDXSWXMV[5ZQ+;NV)K5J=M\L\[M++(WS9V))P, #P5< 8
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M^[L!L&9F \KG3 _/2X\<:8&]Q^&*.=Y8R'[14Y<W4BUQ?QZ?+&;?;&;P&+^
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MDGV*RF=VYD8S: ,O738CX;C#QR)[ZE;[9A\_HL1H01^!U_._L?WQ#"TS95T
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MI"NNI&A>-^%)&FQ[MTT-&3J*[ZCC9.XW>+#&63SY9+3&?6*#^+Y5R^=<5&3
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M=&:5S83&2%BL%.S^,/J@HCU[3$^L=8ZF)[?I/:?\NB>"S)83YS@9D8G]9_\
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MF?<0_P#G/_3J2*J&<YF/- 3/YR$3 _\ 3K88 0?N2,2,8],#Z1CKC6L%1[P
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M4!DN-0  +4O<6!'<1$PC*?[:IZ9(?:NE-:ZLIA0 64O$(L5X86!!L\2341S
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MB][FQ.]AS-RDK1]-74U I.]6"E7%%LY[[GJ@-C)SWC=$[9[CB>@X]%TH-@[
MQ0JY$/#'3D(GBSMFHUE:1])0QBY\AE$CLT'2!VU?!#_V?5[5(G,5OV7[&)]
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MUT2KQ4JFSQRM8R'/P)Y<8WPE4%F%AC_ZU__$ "@0 0$  @(" @$$ @,!
M  $1 "$Q02!187&!D:&Q\! P8,'AT?_:  @! 0 !/R'_  V-?0N&#A(H%PZJ
M7E4P@R/8 7<)J^WLY67#.5G3!MWGH09-9Q]/\[K*TVQ5G#C%$#9E.]GC0D9-
MY<V#.>;8'3'K= BJ[,)*;C%^#8"I79)=/)P7S6 9$6.FJ\#D1PC](->WBU7$
M$1Y40O+T/,)F7[0_0=B(AK. (KY^^ )5$H@&'1*9VXF_9E$)3LRC';/=@5"
MKHJH*FB/DJP;KQ&]3)L8@>J "K,(!+W\(,PE6OLP S7N8/Z.TWC2'TA0UDTN
M2F.UQHL8]RT&$ !7(Q[ :4FAWDSK-T DY.UQ$47\I(KKJ6\CKY:2/".DLZ@-
MM9Z+-G&>_2.SR9XJ#](Q'-Y#L(:'5@6\TT5@CT+01@V! ;-7 U=3+.$\M=@0
M*7JP((,?!;7:T94P@#B*C^0$/0AZM)-@D]IP.;DTE0<L=#]:<D+6$*1XCA'9
M%87[?%^D^2?.J@12<6/NC\@.W^?8UF#>>B=(>4,F,F#.)$&A=Z"X ;@/MHZ6
M6M/P"X<AQK1]E^GIQ1NP&\.>$A*Q<*)Y&EVQOJ7GC"^>A5<OG$"&)UY4O15=
M&@J1='588'&)5@(3#V?@X<RQQP):PM3B!Z]AT0F@";D:!1"8UM9O0R-MWQ'!
M 96*D1 U"5JB4L_S2.<'\R%)@TT$P/+@N,1Y%*4T@B+'.;G#]C007NS3+]%,
M=!<9;XEJDD*:2TZB7 L+!;%_W+%.RQ19VD>C8,W'K-<V*_$25!YJ<:R>?,'W
M8S-S%[I,B!6KYXG0B"E\]CU OD"I+Y2(G&SLT0T9Q,$[1;6M-\8ZV<7-<@XM
M"Z#%QFH5.V/4&I+@OE-H,$E"M7<"(CE$@MFN;K5W Z31\"S)Z(,#CA0GY=P0
MOCO31<IZ\JH]NB( >33328ZR[3TX=)GS5Y;6IR%$16&WDYP!LKN /1VJ!MSD
M\7+[(''3)I'R0,Y8 5" "JZ#;@_N$-XV10?D'7G.Z+PZ#R;>0;"X(@B(E$V(
M\(]CY*\@.CI IR!C-Z:\&BW 1= 5 AXW9!?Q(5HJ3E$XD2%7S;*>D$(]'B!^
M;FT&E (EV#%/2@QEAS"T0I#Y'Y!][T@HO6$09!OJ@"Z23TH?O&]/IY /-N"
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M090@5#Q3'^0<T$5BE$%$*Y6&?!I*=T'8)EHVQ_\ $28A&"QJLT9 N@;#4 -
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MOA(M]A7\X/&.]:L?B\9I:YR0+]RC&#Q8 (B98#''U!8NO;'5LFPJ9"2:[-Q
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ML!H(5#>3VR/N3>!&WZ,&"_:!#RK'6!IT5134SQF=)HC &1IDG:8QI,;DX7T
M(N:,@$$5V=\KT6$ @J)IXZ4WNW#@ Z$=LM-(2ZR;L1]9] KH>Q0O+G!Z"?'F
MEL5&./,&2 YESSN&?"*@0UA !"#MW,%3M9*N)1A0K'] F:Z(>K-H. SX<-@G
M-:E6VE)'*1%$6W3B">5K124B@%*!H3.3K,NG1*5Y#6HODR\#;%U?6T$9XGQ;
M_G5J NQ<J^]2\S%$%L#BY*V* XHE.:@F\ >2%(S;G12BE48+@?N"X9$9+>O
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MM)\)883!H0AR2X.$"@!4.M>DM0><H;1@X] 6-NZXWMAPNZH&0,9-C)LJBO\
M=SU  A#C0-XD"\N!Y A9AFA Z+7(, LJZ$YS3?3=HE<G!V(N\BH-@.U<H>6(
MWZ4.AR-1;D8[YY73_*Q"L/(QF[(>>VB$+PJV&!5(V]#HJ08H[BBHG!H][&:#
M#?44B0<;$F/_ )M__]H # ,!  (  P   !  ZN""@  ' V2@ !8V44<  )\<
M',  !J#R   #DA"$  0[*'-   E(OY  !H  6  !4  #L  .@ "L  2@ ",
M &O#X@  %-%'(  7G>=(@ #ET4\@ 6XMUV2RI$]-*$ (UIM!H #:+R"] #*0
M,)2P"JY/<_0DT[ZPLTDNQ:(#0 2;A4&P  ^O.MG  LG@OR #V/5<5@ #;^:4
M  #PU+P   UZ]H  !"FYR   OM%R   1F)L0  6L8;4  #(:2D  "0DD0
M F     $TT2   4&$P   0  2    2"    22220  0 00
M                                             ?_$ "D1 0$  @("
M 00!! ,!      $1(3$ 05%A<2"!D:'P$+'!T3#A\7#_V@ ( 0,! 3\0_HIL
M<@5 5P5<&@KS-X/F$"F2 8Q; O,:6I5B !*:R;A!0Y:.RX:#=BT1$E$3B"9\
M*,QCZ*>=G,,,S0]81,E28R(F^)B66$!0*AE 8SKFR$C0(%H! ,!58 XXE*E
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M'&&@YV5$-.<[(S^L"UB6D[+%PCYUP. DO$$04@P39&"E8F\EW2N#@R@9IFL
M4V!0Q#[;,P%YK>+JY];;@428!D;Y$7$(DI59G4^DWS]!A;0Z-*K@!?7"ERU
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M>(%MNWM3Y6UG=KUG5K6/2O7N7NZ&Y'C@&O/QX6N12 7^NY(OJ$I[-GLX SP
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M\EB==QSZSG[]=7/UY[W<2QQ"[^_C'%=9S,8#M/S[EQO:)O\ .?QD]?\ O7]
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M%C/ZQ\.=>^,E*)9U"2C(H"Z)E!4VB&9)@T(AC$@\IRWB")6S6DH(BJC1"5<
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M/_,J:_?A2Y<_'^ _O9MKW_IZOZY^/_6?_\0 *! ! 0 #  (" @(!!0$!
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M440,QD#A\;K,**C=!;B,LA8\I?AD'2-@&WZ#"ZLCAF/+3',OU9"BP 3\/6$
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+W0T*.6?_ &S?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>businessfigure24a1a.jpg
<TEXT>
begin 644 businessfigure24a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M\
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M*WK#U>9=]"]$)H>]C."WTM:I:SL<@
M           UI9[9L6P          /.%M>+&UK           T0;7*QL4P
M           /.5MQGH\U'#MKQYU[6DG'G7]9^\9       \9&^RC'H.U^-<C
M\QGZVQ^L?N0       \Y6VP#&S3 &L4%KS*^3?H/ZCEV'^@_(/2[T?C,V
M      #A/PY6,=/%KSZW3N[6K-\_4H+VW6O[Q/(XN3;PQ-"#';)X8$C!89G
M  8LR&,]*K9BO"[G7CE^(]LC<J9OI<W\Z%&G]M; .8Z1S&2.N9TRH  !C#O'
M* >(WR;]!=3XQ^FA^,7E^FOPWZ"^F\1D3(D$+:.Z        49ZR*!=R]7'K
M.[]SR]":>]?F'@+F\WBNJMK7^.3K&;,6;#&OAU39 N8   ZD$U=^0];'N;U1
MUH9?QG+6Z64]1Y?6#M<;%934J N8H<F9MR6H     #P(^'?J7M_/_KW:CFSU
M3IY_[E^5?1KZ=\-P)7ACC=(E8       !@[576GWMRIOHWM]/.CT-B:52<58
M9_XGR>TWSOERBE8       Q%"]6WC/8X^&S&N/U]>OE'U,SL+]6^5V_[OP<S
M])YW[VP        !YL<'U>@OPW]3V'YCW.!Z7%]3/T[^&=L+%0
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MC2&0<"<V/1       ",$ .FS;K$5K^;G]CT@
M
MAI B[S#W*<?Z7._<9[4,O8TW^]-N/?7DUVX]M>>/?IS0_.V,=9K3?@]WGTD
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MQG"?I]'X?AR@ $2[',\@_P!G_EWT0_-GW/9GY7]"    %1EM$4.T<YQ'"2<
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M <!YRXVV1SB:,6X"HRW   45[KR-@>%]=-0      #S;;7ZQ)C8%B/'T4\;
M   C9]F-[?)F?$ZP   \XVV_+61D1.Z5Z7&  ?)J9+'=&F]FZY B78YGD'^S
M_P N^B'YL^Y[,_*_H0 X351FW&,\3<%1EN  &#MUM;^KSMK//]H       :2
MLVRQ)"W0#7\V ,.9@%2>M\U8'DO2U(6AU.?E*EC)5K    U49V<8[X!3A<8
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M &?^7?1#\V?<]CODGTGL2Q?>VH   J,MP           U<9MACOD\!""MC8
MK7R'M.S-#VIX,10Z$CZW'C/'[>3N4?G&<?5MR/K<>.\GL9:_S^K!8C/([5T_
M0?FH $>/TKPI/[C\EGWGNWG_ ,T?H_$4.CL3]6^/<!_._8B])H]_/S;6W\9]
MI8MXEV.9Y!_L_P#+OHA^;/N>B'\N/ZL[._8/A^]?Z3_+    J,MP
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MZ,\AF"-G0),8,S!8C%(,\Q>S$S   (D:L,[J, "M2D6=K&.X 1DT^9VS8F@
M     ->V>8^C@,*9,P9)BQF*U9IEG:MK/P       #\* 9'(8<RAPG"9%B;$
M(QGFRGK$Y   -0F=@6)X 5Z:NL[K,=X &HK.P;$W       *2(^S(V(RS("/
MGX28DC$39CI:#%B@                    C9W#,
M                                       '_\0 -1   @(" 0$%!P,#
M! ,!    ! 4#!@$"!P 0%2 P-A$2$Q06,D 7-3<(,3,A)"4T4&!P(O_:  @!
M 0 !!0+_ ..\AO#ZW2N+K6QME8K'(SRP<IT=GR[=JT)RHQ6UF:P<@U AF3R*
MWL%3OVC.F4:^N;;;[%+R8IUI5J<_1?03;DRSV.O0VI6/QQR*]L3ZY/;E]=%V
M/D&CMNG5[JRJ>H6[0OC]%::[9XM^1Z%I*U<J482:SUZQ";\BT2.9U8$=<%KM
MUS8;UK?*7NW:VJMHY#;]68JK1+8+<ZSRA;K"CQ6'HUGK^M[IFS<7DE43R)6+
M'%( 0U6B'2\C42!C8>2E2&[HV),QJN]TUV>TNU12;KF:]P&]LU?K,#:^5T*I
M<3OV]G1V2QV@^Z(&%_564WD.C+=BVJP!>BME:L^&%ZIJEDP=;+[,EY#L-E <
MV9!6A5;98[#861F/R8;R#2%N9+K486K6UUI')+R%1X%TKY+ *2T7!%'<@TA9
MU,W5#K4-NK%GZNEK%IE>V#YLV$2VJ RJ(K96K/B'D:R[U!U=ZA7"H)X"H?#S
M%_&3%])QRTJZ'6K\H\052V-:!?:0'3^,>89X3ZRPEKU^VX;(DT4U[^8^2\9L
M3]D(J+"ZKE,^I[ER$&=6:);Q>0:\%;QR[)RF#QF1(X@*Y0R[XZ75\[B#35L4
MF7*[+!REQ2MJF_#@&;2PW 6OQN0T2!+'_3>@UC8<AMHQU5O@16(KB0%; RY<
MV$&&L_%^FFO'8!=SL7(56-L563JEO'<?"Z70??F50L)(X84N5EHL3O1Q)Q#C
M6.:]V3>;1#S" E74.K*EQG,/$$48N0XA3>;3X A[-QE'IIQ[90J->+@O[_H5
M]XE6UR<:'9L36]%5HAY+XN K9O%";*<CDXR./7^GM=$*;S/58J@*X;_S?1T:
M@BKM5"P'^FTM:"RY[X]KJ/-U7;^[Q#?9X/U+XI1)S)!-F<_'W=5HBY'YM@FQ
M5N^U'=%VLQEWAC56>+DP;^.B4[W2W<5LU;.E>%LI7O5S"JU]KULA4;.T:)36
MED\$!4"/C2E5QC8N/*C:3%"=6A7P(U0K;=&JE=/D"BS+<?Z=+D2I2277TYS<
MX(5D$!3JVL([&/&-&;-"*152J]7*+5ZI-0.'$6M7?52O69?7Z+5JQK%5T4%>
M;TBKO%E?HU5JTWZ2\?8.[B5=]Z5Y-&PK=1K]1#1H5-:735Y.0[TXJH,;,^FU
MMF_4H%")<FK2*OJ8>(>/(>FG']1="05I$/THXOHR-@(C5 ,U:-4EVLE+K5LZ
M64RLIDR\ 14!9Z15KC'6*!4:?)5N(TYFK&KUYLEKM!JE5*9\6T1PR[@3X;[T
MFKR(+%2:S:L(*ZEJZ^5$JG<@UM(M$(J%<*KG<2GOL!(K6%_1%4^G%'&=)1DJ
M4:I'C%'J?TY7>/JE5BY(])=/T7XU^9;UQ&]55V@U2JE:TBK: /N-Z=9&"Q8O
M3 ?^K<H6!HH3<768ZR5;\97];6ZS\6V)\XU_&5&7#E,FDZ7U>=^8X"L'(7*]
M9%>\=<L=F^^NF(YHY>S.VN.L;8V_ %TX8WN_"FXW>_7MQU[V.O>QU[?PN/K2
MBXPCIE]GO+WMY*Y04\=AL;#RE:917_+*K*#^H,U3NM9 . ?Q-8X].MHX]\^W
MHJ3,</U+\]K2F$DP3)Z*!$79F1DR'!N!;+9!*P"NN]?-$P[39+AOM4(Z!N2-
MD0 R7-1_J:M_*0WBORLA6:T_Q[!!R;?_ )TUWDZE8:ZY[R_TPRSUWC%U$1KO
M@X^!< -R36"Q?JBLY$GLM=%RPM2!;%':*W(NR]2:DYL5?Q$.<$9GQDA!FZZ:
M:1Z=MW+[XYG[,^S./Z>G,:9K8[2-7-UEE4-$6'R/;*N_5AF+"2.1^%9&C!?F
M"X228.V@.-'G)$WFWWZKD2H<;0^#7JW*#[(O;<6OVY>W"WM2:<8,C6D_$;(L
M4*O,9T1G&#\R ?AXP(&GHFZ +QR9Z.WD^+V230Q=1S0R]13;PY80;O$>_$;3
MVK^*+&O8Z\9'KYE/$;WNX_C9G@D*@6%(R X;: +JDG9HUGF:'=ZW"&#8V(?.
M\)/7&@,SWF7D"G$VS,/'QHU%-XI;,&9/$;CNM0*:&/\ @E:CXQ:95\G110X0
MQ7,8VI%9M*VTB$X@]T.IZ$]*PL C^?/C;.)H9M,]-YYA@-LYVSC.=<J)YB00
M9,;:8_M^'RCQ$QW9+&\,TXD<6NSYY C%X?H$M#K'XU@%*+"BK#'$=P5&NJW-
M'(-+Q&D8#;0QD$30@V%7LD)G)%\,Q0H^^C)=+OJ<%)GKVXQV1S0S=3%##::[
M8VQ[?]<X]O1$/OZ; 38ZWTZF0+Y<PU\"+,0^^W0<4L>N/[=A+-:'+*>!## 1
M 5%V8SC/6LT,FV\T474,T1$7DVKCRDW;IA_3IQ65#3.'*-2"O%--$/'WHLQ)
MNQ7QX[/[^;M'IMK9U84>N@?>$^U3-]R(9^FF1;$%C:1Z1^)ZC.(;%TIV<&HH
M3\)Q/\;X*.!F7V59'9$&&];8QSPP,$=64 SBP]9Q[>LQXZW&UWZU!BUS\I'U
MK#C'6-,8\#A+ADT%XV=BQ=PV(>R]&QO#VVNNNFJQ*_3OFU</V-JBZ96EW@=,
MVW]OP;,L)8C$59O/M'Q_8A>D8,JM++ Z9-L8]GG/47>N%%?'7:>S'LV@BVZU
MCTT\;"P?)G2WX06 .] &2=?.P9,:,AU ,MJ,BEQR4CD*5,HVP?SL&3/+96,-
M8RLUM75;7&?;CHLP<&%BR'5+MK1/IL _'/TAN&I.>MS8-"_P&S715#/<LC;$
M<H(H-Q"=#!2S8 M/R65<%9%[4-5+I#3%T,A@V#!$ZK12(R7#-@=Z=%O)^GR#
M7:!(.,H3JM% ?EN:P$Z(/I*=CK''I%'UHACP[8 "M LU$?/2RLCJ#0*ZO7;[
MZ8DT1)-4@_X#55 V@VI(.^WT GUF!"'7!!H=!F__ ,J+?J@C1KP(5GH\S1>)
M,\@TFB=QS]0MHI^H&/Q(M&R^0?+A;CKO9=[,.%F<X: 9WG<!Q9V;1:$[/X<0
MQ[XEC\HQ@RB)UF;?"&-,W(@W.GQ,T,B**=$Q%[O3M.L/#9)N_2\:[.2M0LD,
M]PMSF,!";O':/S,O)\3CMV,V@S8N>2 XR??#G7YB1YII-]2#YC^H(=M\6 ?,
M.[F/2#9F;\K*^EAE7$E$><0LTWO$=-3PR]3P1DQQ)0(>I58TLT2^"'K  ^!9
M%$.1MD8.VFZ!?)GN0',>J<3!&%(FLLJ\:;6-2#%/Y>60..L.5N==&8$FW>@.
M>L2:;=;;CC=>]KU[VO7O:]3D0"Q9.&Q/WLO^%%+'/'YGP@_;[5TH^D(>L^NP
M6DF(!L]1@A029 !SU@07&_R(74@P6(L[":[R=W_#\YR\#1#KK&K:&].=2]PL
M=\&$XT90RAZ,-^H<&CK-#6V@$![_ -N&;W.T1KK608]S(''EK-&1HY@Z70,-
MB?&S>+%$R5^O?Q*7<C%CU(@]\K1%I".,GW@F&6_ SE%KDHNNR%&;5K;;K2MZ
MZX^FML]%5_!1$ZSXA&J808B&&(>+R&K$=.LAY%QOJ6Q7@;=91F?,1()!AH4T
M_P 45;MI-& TU+*6NIRN[[%[,+7GLP$YR00K8E3SK2\D0U\J/>"'0>#S;*A(
M?P*ZUJM9%+@U_*!9>HFN[O$?4CP?$TCE;#'WT#\=<T#:0^)H=JL7)'$3I7N6
M+'GPNZ>N>,:]7L(=$_K#HEP3I 6],$B";D[S_4Q&D>ED-'QX7N<ZI-FS/WN,
M)YB*_P"04*.:-BDU_P!Z\XQFOSS:#P;,V.NN]FABZB;^P>>T!Z!C/Q22?%G_
M $P >,R'.8!K8>O;CV^8W_DLL30O3**#.?IU=IM*F#FTS7ENVZ]7 N\#!XL5
M$E,\1SB.G)C<E!EN*IHR5:"YJ5:U([+(\80M*[WCLL[4_K#KW-,]8TTUU]W7
MKW=>LZ:9SX7_ .Q;?=Q5Z<\J\>G\XQMC"-9C&%"S&(EH4$.BI?'-$F6P3]K=
MR C'P887U*?B*SSSJ_EZCND.66@7_8Z">]HOA-BO_F-_Y+\FS*!'#'70-*"O
M6XQ/V/P!#)NR_P $<]M3^[A3VHIHIK=Y;_\ 8MONXJ].>5>/3_D%%1!P6DP!
M<%IWBUP,F5"3?WZCBBAU[/DQ_FO*LBYG,QI<1D"9CJ3CD_R"RH015(DL46/^
M19=I(<!>>R_9A6O^/7;=PHZMR1@T945,<H@0#CC6[RW_ .Q;?=Q5Z<\GVXZO
M'I_QR9SK'7BB&P@<<C6;SGLVXZ>N0JIO W_DOR"?^0:O&Y*W(0NH0OBN/Q73
MV@M6#)!VI_6'EO\ ]BV^[BKTYX-LYQ@6_6\@EH<<)TM*,*B=PM"%B"H6$ B]
MXFRB\;63:7I=N,\T\^Y:9DKG'L/NE=K?^2_&87""*F&D@#Q_O6WCN)E<U:(2
M034O:G]8>6__ &+;[N*O3G@V]N<0D&%V"\$[BGUZ=@0H[+QZ?\4F^D6D^^^P
M5-1?3R;SF=T4K"7;$!]3J@'.&ZZ>VGN,I&UE:0EL?F^5?&Z#BL<T(XE92KA<
MAB>-Q;:@SL:O5=HLZL;ADJEK%C,=35S4S2V^6_\ V+;[N*O3G@DUSM'C+V2B
MW2<+#6B_+?2_9>/3_B.8#3V%;#*1-Y_()(VUP"UT/XPIXZZ-GT:J7LLKE@2D
M=O\ R7XCV40<"P+((V?^09>1<;*/M9$^=,J>CT*=H2"I6+-D_K#PYS[,$<S4
M^+>M6U-:XNU_^Q;?=Q5Z<\$FFLNGT?;Y5#[1GJPK@QX:7LO'I_PL3X5HB:69
MG;/P'C)>19T#1^90ZG8S['IVM_Y+Z%.@,V[')L<%A-8# :5>G0IF!Y<FF1!8
MPQ_(5XY*^.+\S\MVI_6'AD_Q[_=P+_T^U_\ L6WW<5>G/!)G&L9C9U9);K(7
MNOK4WQ%+%B,K'!M:)D7?SA!4O6;&IU=$,0!8X+*A*CM]AL HXBHAA)^"<XA4
M/A>\HN.JG[8)NLY]F*Q8LV(5MG&>2^JPV?3EO;(:A5K6C5NN:5ALU<Q=RK-A
MW^CB<M9/HK3P&#+/+G8@"D*W"MU#7"XC+;X9/\>_W<"_]/M?_L6WW<5>G/"O
M4*E.#UJYI"&"$O@L"TYNL75'Y!A=_3_38D6.TF20[@U3+^)&V4VPCKXSCJ,V
MTY9RS//AH=[CH"UEMV8/BNNN\;+EKO([UU2-7[L)V@9OA,!,^H%KJ)QXF-D>
M1,[%@XVH4V)7AIUMKC;52C7)=35JX/E/I&MS*6\71Z*URL65?A0LQU$/!!UK
M%%'GS72*)Q-5Z^4DU3^L/#)_CW^[@7_IV;FY'7&U)Y:479GT_P#V+;[N*O3G
ME7CT_P#CW4@Y==E)9^*]0'YKT?M;_P E_C)_6'AD_P >_P!W O\ T^4/7W 7
MKGI_^Q;?=Q5Z<DGAAZUVUWQY%X]/_CVBMWUVT2IR4M97?4FT_8IL*MW(W_DO
MH*LP+YCP7N1!Q'F!R0+/N9D=OT$JL0Q!8UC^6#&LGRIBRR3S_+.>AA+9@P@1
M]O "%8H1'".R,)_"T90J0U;&%L$G]8.N3F"YG3+P59CK!R CK1ZKDVNN&'4G
M^/?[N!?^GRAZ^X"]<]/_ -BV^[BKTX[LMAU;<1N&K([R+QZ?_,K]7T13MZI:
MC+IW':>F::\QK84EOS#W':>H$UYR9W':>FB>_P <7<=IZ[CM/02:[;1=QVGJ
M1->,'=QVGHY+== @DMTV#[CM/246PB%]K1=$U#5K85(.U)49-EXLII$F_%U?
M@%*XLJ3#<;B>E!S_ $<OZ^CE_7Z+\>=0\7UY= 9PUQ^P)6\24A,1]'+^I*4K
MFC_2:D=?INJ&ZDXBHLT@'&=55;+ET2R#Q:V7;9_<DSEXKV5W?VY5\@^SN[E/
M#+97??>D5\D>T!;R5[V%?('6RODKH1;R'L+W7?>F2WEC0/=7=_9(KY$]N%O*
M."]E=Z^)E7R/\)&-<1C?,96O"]A':]YHWK7N-1I;H]FZ1GNT&+N_P.@K#A@T
M)M^\9@%APSR\:=RJ3+O\ D G8P$^V?)F(7V7G3]UA"O,N\D,W32V:K3TUEW;
M'>6]L(=?B4M1W ?@.9 +-/*PB5X:V2=H-FN,;,XPMB)@76IA8%YBO=\X4].&
MSH0A5'8#)Y,;YC@?V;'0(Q\)=NF9C5R<^R'V,72:,5^0U&-J)KQSOU8&3P)E
M3^^S,>6P0K6<BY>,K#,$@/$BKBJ!KTPJJ=GB./2&,ZM*V&X@HX(I8L)PD-;5
M0,^F"!:RV  %6!G@#,Q T"T!CTP0+&DB]>,K$\I\]#KX*ZM_5;X  -6)VL3X
M%@>9_K&<7!&HW_BMML::I;+:&(>.34.>A.04C"33EBI2YFY55P%,N0UJS95R
M0,8''R96YI;"XW40N.41(T^>0#3F]><Q6%)XW#D1(.LLKMBT\%J>XKZVM:&6
M<:""$:/M;-14P6";)<9%":-9GSB']K8,3^2*\LWQR(GVZGY-JPQ>_)P,N/U,
M2=RB<G 3$;<C*==_J)9FMCW\2*3]6V.*2F<[,#/PA^/%L/0''BT1@'Q^ NE7
M\7(5TA/'*8DAAQNF9NQ>-UX,0O'2(,.QJ)VD4_'2,A?#15JLJM)M:\A\;.LG
M.;6A0PHH.UVW(!(3U?5FS'&'#A\%Z16ML:A1P(A//:T@9D6PXS2LL&T@$EEO
MQBEV+FH:N3+#C%(P QQ>@]P"D!"M=*P!'5 Z='*+GBRN;1I5$P1__BFBA<Y'
M  #6"?\ NO\ _\0 5Q$  @(! @,% P4,!@8'!0D  0(#!!$%$@ 3(084(C%!
M,E%A$!4C0'$'("0P,S5"4G6!H;1#8G*1L? 64%."T>$E-%5PDI7!1'-TL]4(
M5&"#E++"P_'_V@ ( 0,! 3\!_P"YW4)WK4K,\> \499=PR,Y'F.F>-,M26JV
MZ? L12/%. ,#>IR"!Z!D9#^_BKJ$]C4[$'A[JL<IAPOB9H94A=]V>J\SF =/
M3BG)J]RNEE;51%<OA&K,2-CLG4B4>>W/EPFJ21UKS68T[S0D$++$3RYGDV\D
MINR5YA89!ZK_  X-B_4:O)<:O)#/*D,BQ1M&U9Y>D9#%VYJ;O"Q(4]<CB5M1
MFL2QU^76AA"XFGB:4V'89(C = L:>RS=6W>0XJ7Q+3>S.!'R&FCFV;G3= Q5
MFCQEF5L94=3Z=>*-^:W;M1O$T$4<4+PI(N)2)"_TD@SX=X PGZ(\^N>+)U.+
MG3=YH1UTW/F2&8LD8Z^(B0!F ]PZGR'%.U-W,6M1:&'>=RG!B"Q/@1;][-AW
M/7&>FY0>N?D274[5FZD%BM%'6L<E1)7:1B-BMG<)%]_NXKBW$LANSPR^14Q1
M&((H!W;LN^??Z8XT[49[$Y2P%5+,1M4<#!Y*RM&4<_I/C9)_9;BY/<[]7J59
M8HN;!+*6EB,G6-E&.C+Z'AK&H4I:W>WK6(+$ZU]T4;121229V'!=PZDCKY$?
M)->JQ,T)L0K8VDK&77=NVY4$9Z$^@."?3BG;WZ=7MVI(X]\2O(YQ&@)^T]/L
MSQ!:KV037FCF"G#;&!V_:/,9],^?!U&B"@-NN#)[&9%Z]2OOZ=00,XR1Q+-%
M ADFD2.,>;NP5?AU/J?0>9XALU["%X)HY47HQ1@=I\_%^KTZ]>#J-$,BFW7W
M2@%!S5\0;V3Y^OIGS].)K$%=-\\J1)G&78+D^X9\S\!UXKW38OSQ1R1R5EK0
M2QLF#EG9PWC!Z^R/#Y@^?'?Z1FY M0<[.WE\Q<[OU?/VOZOG\.);5>#(FGBB
M*IS#O<+A"VT-U]"WA'O/0<-?K=UEMQS121QJWB#C;OQX4)_19FP,$9ZCIQ1M
M+<K13!D+,J\U8SD1RE0S1GU!7/KUXU.W8AY,-/8;,O-D <;@(8(S))TR.K':
MBGWMQ6G6S7AL)[,L:O\ 9D=5^U3E3\1QWZGSN1WJ#G9V\OF+NW?J^?M?U?/X
M<+J43:C)2WQ )&NT[_&\Y9M\0'OC5<D=3U].*M@&.,36:\LLLDRQF$X63EL?
M @/F\:]'^()X:2-72-G4/)NY:$^)]@RVT>9VCJ?=P=1HK)R3;@$F=NWF+[7Z
MI.<!OAG/%C4HH+M>JSQ 2*YE9GPT9PO)7'EF4GIGSQ@#KGB"1F>WOG@D6.;"
MK'T:!-BG9/G]/S;^R1Q%>ISR<J*S#))U\"R*2<>>WKXL>NW/$MVI!NYUB&,H
M55PS@$,PW*"//)7Q#X=?+B.2.9%DB=9$;JKH0RG["/X^[B>S7K*&L31P@G W
ML%R?<!YG]W$MZNE1[:31/&JML;>-C28\,>0?:9L+CSZ\:5/-9@YTMJ&<OL/+
MAC"=W8KN:)CN8LPW+Y@$8]<\6;%J2X*%1HH6$'>))I5,AVE]BI%'E0QZ99B<
M ?'BO)?BLBO;"V(Y(V>.W#$T85E\XYERRJ2.J$'KY?8^H4H^CVH%RS)UD7VD
M.U@?=M/0YP >G#RQQQF5Y$6,#<9&8!,'R.[RP?3W^G$%NM:R:\\<VWVMC D>
M[(\QGT..OIQ)>IQ2<F2S"DIQX&D4$9\L]?#GTW8XDF,=D;K$"0+6>5XFZ3>%
MQ]-GR$*KT;X\0:A8LI;G6_2A",XCA=,B)!,J1S2R;MQ$B@[?#@EU(/3'$UF"
MLH>Q-'$#T!=@NX_U0>I_=Q%+%,@DAD21#Y.C!E/[Q_'B2S*NIUZHV\J2K-*W
M3Q;T90N&]!@]1CA]0I18YEJ!,NR=9%'C1MKCS_1;HWN/GP;M02K ;,(F;&V/
MF+N.[JO3/FWZ(\STQY\2VJT&1-/%$54.0[A2$)VANOH6\(]YZ<'4**QI,;<
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MKB?=R"Z/+W=)=O4KG.U?5@O'*LC4:+SOI\,GTRA*_.YMB+9XT(9<%4.UQN(
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M-%-SH;'!X4-58W!R@I)$15"5L]'5\%1@9'2 @Y2BLL+%_]H " $" 0$_ ?\
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M!&=KE2$8^Q_W?+/L>O$U>>$GFQL.OQ8RIZ_G#*]?T_BUVU8IZ9//5R)043F
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MB];>];FM.H3FMZ(U^"&) (X($_Z."%4AC_L(/K'A[^G]#_7&F?OL/ X_"_\
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M\:F.%<&@:BHU9R$2F'M"#][#J66UN;9S" UV+9*QV <KL(<(M!<0N&+V3*Q
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M$8UV)!5FX,G_ #FMB<?I$_?,*<V?4B*2]O68Q=<.+(QM&:LG'K9IN58FKO\
M;$C9 8*LR=HN4U#=!%GH:+*SKO64BQ+QE30*/J)+/0HG_-UD<U94RO4MUE5*
M@M&0*UM=S'8$"TGA7I +9,:&1GLU@9GK@J)*P^ Y2B#!2TKDI 6/>R8%0F8D
M*X&&.9('QJ*%LD2?4JB,3.]M>M;5:K6"^LRRFT:)"V?7\XI$-B9G4QLZ<<K-
MZ3KL-8&:&3J:#F/<LIT'7;_Q1G33<(SJ,?DI78LH0=D^*N#G+6=AO^#2)E$M
M/UCV!J7]'5E:LA28=*"FX 6D&=2 U@YLB)S*("1*"Y=NW;.OTGJL(7*IE= F
MTX&PHIMK 8(V5H@_G@(S!$:MPP,Q,SI^+]_I'],_BGA:MNFW7C,3TW#!#KMF
M=-PS!#^T9B8].F,L6$(6D!8XW-6H%+,I$#81E$ !$)")%,1)#,1ZQ/4$,P0E
M$$)#.L3$^L3$QZ3$Q])ZT^_ZZ??^*0^FO_[3'_9,_N^ND_3KTC=^[;_\VO\
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MO%-@_LK)^TN%<_,9 F<#L$BA^0LPTE(XXXT!R/<U[5UZ]= :C!.L6&J0J"(
MWL'>8#J45ZG\%LW.1=%]DT>;#B7CX\,>;;"+!Y,:EL3^)(6H4/D^<'J:*I5,
MRRK7KW[!^#4N5H6-2&6RO#B"JH&LRV%JOSEG,>A5JZFM2.S-E/D:U3UBV"FU
MRA]NK8K/X^:M;HVG4K==DI8U)RJRA@0Q+6*:,"Q9D!1/4T F66 5#GP$;AK
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M !?+KH>S9QD[U/;L@^,#+CF>30#]GM+1*O(&&/\ XL"$P+7<80)P0QQ$1K,
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MDOK,RZ-Q?SM9_;TRNEC4\@T%\FZ2,0QY+E6SZ;3VAIO_ )T[YB=-)(9ALD3
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MB_2/9]GTCT](Z"&HK0FO.]<,6J%IG^<.Z-J_WQIT"9FO#8.6K5,K@^0MTDP
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MX1$[_P 5E5!K#*KM.>6N^N+Z[&O0NY3)RP&W28^K92NRB361H+2=LK(^R/\
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MT]U=TBU9?S@GXQ.D_P";K_?3NS_ICW/_ .*=?[Y]V?\ 3'N?_P 5Z_WIR/\
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M$SUF$W,V^CCE]Q)3\3IXY"RQF-;VLW(5:ZY<B^#N7,A6KNMO%I/:^::AK<Z
M5@LEDBFN,X5++]9+6H'S[->)95L8UDFN)K,,B*R)\TL%*1"NI+_+.%$(,D"A
M9F$L 3T]A$N#7)C!:200P)*/3>/UC A9REF;[0IC75\,0E/<%MG=5G&9B+*H
MK%*5X_"+3=!-6Q5FL#9MM:]:M>LBZW:YU69IE77$SQUR75%5D4JF/DJ:X>6
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M(OK-4V ,PW;#,951H(&M51!<:@W3ZF4L89F<DQK6L(FN<TC:YIFUID9$4_\
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M[4!4"H2=';01>4!^8Y@X3A$Q]3'B08,$%2K'@%*]PW7F4Q  (  ^ T&%VC
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M,^S!^S(_"2%8![H2!&+@GL/(XYG3"M=%Z&QL+#-#@19@ITAL'"NUA!3&U#.
M5I.XW7X3?)O'/P/)M/GM0UCBE2ZF<L-*T_O_ (C+<=WH!)(@&JA76:\Q;SE$
MSU<CO$'*&+*=+\?>5?JY9^L;<M@V+FGNA=]R8QMKO$DSO\G;,^R9%<J$<O\
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M48]B!"-V4S,<*_<-$O#S(AG5B4O8'-,MGTA>P&/)&G!> ;(Q;30=ZH27 @
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M;=2$)C8 10LK&B]A&41W:\##&T)5YB$Q6*P7OWB1RN U,/R44'="POFKN??
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M>@5#?[@FC.=4<Q>10$!E#2;[ZTH'E0;_ %S,MHL#/EP51",/!#80E,5<WBL
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M,!Z''R)* K_B[G_)C4F*L"Z+AI'-8;M(;\7/*D-71K>9$(PG(9F#+'*2SP+
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M"CI%3 C_ ,V#(CX4!Q__V@ , P$  @ #    $
M                                                       !ZDLS
M\@U2P6[0Y%\R"I?HH90RK"7UD>2?G096P  @^6*,HVFIAC17QY:I"\:#[H)2
M?L*1&\K\5-L0  9RXS3L]R!UF"6=J-X]# %(LLFOOFV$< @5,>0
M                                 "           !0          (
M             0)PP       #!RY@       *0!1H          !//>K)!!)
M   (-HXR()!(   (  H%A!         ))47I( (   !Z 8AY!(      !%Q!
M((        *ZLA@       <(P]P         0F0          #E^Y@ ! !!)
M))?760* !!!:   &F    !2     &2OEP !#7A( %3RF *8/I#2       !2
M;       )80  !: (00 !   *8&Z2*        2 :           !14)9X
M   #0$";"       !3(0
M                                            *0@(. &@>    !W3
MZ_8#P     #%+I0$&      +0KJ8).K0    !NBZJ/!@     (T  U#&
M  "1>VAQ/X@  !:!07J7\30   "("H#?R,"      "8)     P  !: ()  !
MT@   !0! (  !6-      ! (   +O@#0 !(    6@    ((   ,ZYMP
M     !R! +0!      6@    (   !%(       +0   ! 0!@" !      6@
M  !(   .P       :      "0   0       6@ ("#0   ,0       0
M (&   (0       6@ (90(  !3       + *8    "   + 3      6@ (@0
M(   @       ((!    )P   !00   &  6@ !:0(  -@       *2    Q%P
M   +    !&  6@ ):18 )D        ("!0)T]&P     (  !&  6@ (1#0+W
M(,PZ\;@  *0 0+3MP     !:  !&/P6@    (           %8
M     !&&@6N0   (           !: 0#IDGNM10 ! *+A&&@6BP   (
M         9!())!)!)   "+!(21'O@  !0())) ( (      *28228+:!2
M   +  *     ; "!01;+ *     + 181*#(1(     ; !#
M        !( !2*   *0 #8 +2      !) !11"        )) )"<*   #0 3
M  "0      !81((1"                    !8
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M(2$.@(>_FJU -(@K@R0@:Z6&5(1,XAJ"D*0"E3V3V".HR0BB4!4,0DJP&N$
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MI0;M,3U$!L%5&L"QHCB%.6S);;0*Q ;8"X9M6" 8E-Z0C192Z/-H6Z2%(!%
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MANK3RXB$Q6-T_1!9J,;0Z1QX0:OH(.<1!4(*8P$119=LT0B $11$PD&!Z6"
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ML7 [F3T"$QX 'J%("Q"DH7&Y+'5,2&"M3&5R6!%"@,30A!T-ADB'Q$@:@/4
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M$1H;JB@K51DUE&S"7J4!*)K8F-Q-4Y4R H)R4=_%L7PHJHL5)(4 *8DXV<:
M+F0K*"T#DEE"N0$H44RH 4=LFS?74CH.JUIVJ_(/3+?8==R[QVM:E\%'T-J
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M;G6L86M#A)U+]2I$]1 H)6KYMA%5H :&(K=5'DVW;P.85.]@N\>J]$AU5Z
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MT(](^$RP[!,/"+(]P<N7CD+>:(#JS77-T"((C10$10>*((B&$,5R: &T4;$
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M7O>=X8)_*#L$-Z\^<+US/T]^O_?H/:8\"BB])RH!#        " !H T!H/D
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M!Y$@KGN$.!SN0-5L%PCUW**XX> BH&'4,^G(0TIC7A1]DK5CO.!MU;%C5"9
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M@R,N'6#RP/6Y(:W?@<J1^G@J>2!OO78!=1 O/0^C:#1, -PIZ555M4J/@3B
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M^\V'(S)!H/FE[%9;P4)MVQT?]Y+$3> Z!HH1-<FH7+=\ALOF-&=W,("8VFG
M1JF'8OSZ,:>81ZJ#-J@S/50*CLB6N>S1F/7&9;9G+1VT.A.-1HH:2*R -Q:I
MA2E+W2,NR+&!=B8LZ38<GZJ-"PL^ -E6Z:9.Q#;MXL^?4($0V,C;A!J 0,(H
M=.N[H+]0NI%!6OI<.:P40 $#J0!P!92RW4;LN!?$X  +C,.U,D!P*B!?M(Y:
M@]2RZ%L6J)Y2"*:F*"XZ5=DX*RD9!2*2RCXQ<'ARSF:J,#04]L&[7<]'%P?T
M]'IT P!^\88]3-5!64JDKMLZ1,6&N2LL#3&$?Y%*<HV=%DM48X$4Q[T$-A9
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M>K37OHNYNP9J<9%$U9I*QL^5$/D ;)4'ZRC^/</D 4XV</<>E8I^Q33)(^"
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MJPB#!V#&J<BZ"U8@&291)H3I(((90+VFJ^5=^9CM=?E!WH][G)9>>("Q""0
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M'H'B(RW'=<MU?)%6N4)B6D9K^)O/ LV:+ :_85R%'.S0XR"J<;4-@WC6CUV
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MZIGK48>CE-VAWA9"JT(!-8/]P93I9-A.D4<H:(.*2&<!Q$L"9$/Y@+)QIVO
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MLU_HE"Y#[T (9G+^?8CWBS/P1*".!;X$V B3Q*)#IF4&HP43,KPH..8WZ@X
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:<OX6B5GP5K#2B K/W(**()_YMZ"#:8>/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>businessfigure25a1a.jpg
<TEXT>
begin 644 businessfigure25a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M2>UEZ8/QJ9[WMX7QJ[![W<;Y^'?]/;L99@?$1Q1CV,LP
M   !3WD/F6D:W1;#8NRQN^KQGC7SGO;Z/C4Z41 W.\/W?6SW<L^3/ULAT7<1
MS2U.KU=?,NXZB*-5SF]WMOQ1&FT]7GO>YM-O8<&.&JU:&3]??7ZU+,>UG%^5
M?K1A+>UZ2(=3S6V6]A\0U*IK;3]1]"ROK8                 '4P\_R,4S
MW,_4#K8^?7QPY9RXHQXXQ[>7KP8X<F67),]7#S^3LY9\LY?$1^RYISQ_GX?*
M.2<D/AC],OE'+.7!&'9R]/B,>#''+^UD                 =/#RX,?,
M                              #]3DO6P
M
M     (+-@,Z;N  "#S2#K$\F[@                            KZ?A)!
MO8  --(A,J;:2<                                        # &2/D
M_3O      $.FC&H'3+H',            5D([+,&T&? -6-I!&I6 M>84E0
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M[ZU^PJ27WW%@   40+W@                   KNF>4=\UX_2NY9<R(
M-'Y'I:A6J]\NATGWGB   !QGG6>C                    /.EEZ+,1Y>'6
M,4>J!D0   #B\L_Y]>9Z+^@#JN:[\AA[E7DC+*5+   %$B]I2,ZY+)8L  %4
M"P)6PS!II8XDT           %$TWL0 *O%D#(@  'QAEJ^OO4NUEZ!.HT/KO
MB$2=CS&S:K882]4E#E>B  '$>>1Z)$?G&:V30  ",3/FC&!-N-\,X
M    80J(FZR !5XL@9$   I9Z8>8VSH^O%ZE!_TSA+'?-.ZQT(/[?E9!YG>R
MGX>TQ\ATP  ^#S&/3P                   P9K9(  *O%D#(@U^A<R_OXZ
M]1N5JY[>:9NM393<ZJ2:EK*WZ0 @CH=)MFEVL,]+H;8\GT@  'ER>F)7$ATN
M"?9((  ('*ZEZR+R9P              5;\/:P\3%6ON5HZ31U J^\K3':K^
M\BWZ?I'5L   "(C:#=0  "J1:DY 8(C8F8 T26\P^@ 083F :=+MPV8
M       \N=E0J#JME=C::V<*WOUO7#)5+/-CD!\GT ?!]@$[F[   %#R^!'A
MJ!O9J!,P!C#)@T8B\G8A L$ 5[R9(G+$           !\E>20B0CJE3"R9M1
MKQ6@M09 T<@$ML"+B/BRP  !0LOH0^8$D$U8F8  &AD=$VD&EA@"",F;A+D
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MXEX @TB0CV)EGY']HR'ZH_+6;X#LLE3M3R
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M5B7KE<W*E:Y:W!(Z.F'53L#:7$R(PJ00F+:\PGF1X&40C$>Y6V^Z50%P[_\
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MTDCJ,_$=1P\D<8!D=(PS(@+L%!>1@B("2,V=B%5?%F( Z_T,QF5S&8R)&?4
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M&8@XBT1(NV)#G((]*C0)#U<+EJ/5L^!3J+.;*U:ZV6^:P(8Q.<_OE"ZS_BW
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M2,.,M*#,JOBV9R'V"O9LBWS+25W_ .+8IB1!@S8K?HFI%'F2>_"V3EO @9*
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M]M"GG+5#K!5>7+C4[1.W,CJ)JA/.=(,F.YJSL',-BM%HK:1?@[X8<K,EM9B
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MT@(Z1*<R@<HZ04]9B.DSUGB5KG5F 3KRUYC$ZM/PZNG73\L_#Y<: [W='O\
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M05VE7"8RS@G",K'+.,\RZ9]>/\_X_=+&+2MCG,!2E 3&M80@M:P&2-C#*8$
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M2LV^E+CDBDO/14E<".NT(@(T"(B9F?/^93%:5+%I&;1!8"+#9^D,XB(@R/\
M7(M9+Z]>.WZ">WV[.ATPZ.V?>/2TV;9_9IIP702I.[22Z2P7NF(VQ);(C708
MB(U]T>/F!+%+9*BZBI,!*5G'N,)*)V%_I#I/$+MU:]H(G= 64K>,3^V!8)1$
M_P!?"=$)_)_T'T8?0>G;]#X^C]/I]&GI\>[A?2JUU=&#A/32L.E#9W,A>T8V
M0R?)[=-\^2UXFV-.J-LOBM#75%@M??JZ ZDZ_P!9<-,5+$WZ=8A 8)VD;8ZL
MQ&K-!\1NUTCQP'1JUT],2!?22M?3%A;S$-HQM$S]10.D$7F?/#-Z$GUMG5W*
M NKTM.GU-8]?3TC9NUV:1MTX;]$OZ?\ 3>@?IO3L^E\?2>CT>K7T^GW<$JK4
MK5EGY-:$*2!S,:3)"L1$M8\>8]W!UDTZJJ[->HA==0)/=&A;U", 6Z/$ZQ.L
M>_B%5DJKJC684A8*7$SYG0 @1C6?,^//![  .H<L9M&!WG,1$F>D>HY@1B2G
M6=(B/JXZ J4*-LAT16,*V3[PZ<1LVSK.HZ:3KQ,)4M4%I)0L!#61$5C,[8C7
M0 $(_8(B/NB.)$H@A*)$A*-1(9\3$Q/B8F/$Q/OX)=6I6K+.=3770I(',^-2
M%8B)3IX\QQTDTZJE=07=-5=2U]89@A;L$('J#(C(GINB8B8GQQ-N*U>+4CLF
MS"5]Q(^(VR[;U)'Q'C=IXCCM65:[*T:?DYI62/3.L?12,K\3YCT^)X6AM2JU
M"M.DEE=1J5MC0>FLAD VQXC;$:1XC@B;5K-(T]N9,0LY-&[=T"DAF23NB"Z<
M^C=&NFO ]*I57LD)#IH4&R5[X7([1C;(0QD!I\/4/3XIUA=JNBR$%N@+"EN&
M"CW% L$H@H_;[^.JVG5:WI]+J,KJ,^EI,=/>0273T*8V:[=)GQYX(>@G:;!<
M8](-":&R1:4::2P>FO:<^J-@:3Z8X*T-9 V3':=@4KAYCX]).@>H0^(\26GB
M/V<.%=*H V)UL"%=(P^===71 1U9UF9U/7S/^9=)%L^-?HT.9'^M8%&O]7O_
M -?'P6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P
M6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P6?LEG
M[KCX+/V2S]UQ\%G[)9^ZX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+
M/V2S]UQ\%G[)9^ZX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]
MUQ\%G[)9^ZX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G
M[)9^ZX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G[)9^Z
MX^"S]DL_=<?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]
MDL_=<?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]DL_=<
M?!9^R6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]DL_=<?!9^R
M6?NN/@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]DL_=<?!9^R6?NN/
M@L_9+/W7'P6?LEG[KCX+/V2S]UQ\%G[)9^ZX^"S]ELQ_YRK_ .F<\K>SF]2,
MPC$=[UPZ>YW*EKFGK]'9NVBNM-/9NUEAP[7;&WA5^P*FG:R%3&55OM!1K]S;
MDYWVKA@WMJR$*?8<8H>V05L0ASC!94<Q"5HBZLS@$7:^11H#6*ZE>]5GHV4-
MV=1+-JF=,AAZ$/AB0^=AJF/Y=IY9.;O#BZUEV?\ 9A+OE2R%^1;7G%79[>*^
M.9],#"*6& =&(]7&4I.Q-FIDL5S=C.6&5&65D-JMD\VG !GJ#^F,6<>G(%90
MX( 7*?4)+>G+D$=[)7HP.+Q>/1:=:Z/-"<MFJG0R,XY(7L#4QPV:S+3HVK7#
M7-Z[$U5K:YL1Q;;B+168Q]P\=>$ZUJHZI?4I+FT["+B$-782MZI:N0U7)[2T
M*)B/\]-YAH9NYB\JS+U<N#!JTKB%,K\N6.693"+*I@EMI6#;,D6\+&DB6ST\
M!>WJK<UKM8O)?C4C'5(MOR6(\5+%NI,=L]&R24VKZ(Z1STF)9"V@O&KL-MEW
M%^]:MN%:SM7\I>L9+(6.BD037!MRTXUUTC"T+D5#KMW3\[!V'-:LL%EHRZ!7
MLVN=&/R&.Z3MPS/2Z>08?HVEO /5MUB<5:.WD%W,/SC9YOK6DL6MC"N98<Q;
MPMF.GL?AWVUUV2DHZHMJ5; -%RMT_BPAK$2!JL(RX(J>T%WJF6'-T+9_0PJQ
MVN16EG2<!+<"]C/BF>,D-C+6<Q:RV5=F;=FPBM6$;=E%9+UU45@B$U-:T&E+
M#>Q6^1E[/$__ "F=J<E0BJNS--EF;E?H+MP^*TU3=U.F-F+,Q7E$E#.O,*V[
M_3PKN'I1UW!61UF@KK6&Z])"M\QU',TG8H-3/2=L3IP-*;"(N&D[(5)<N+)U
MUF"V/%&[JDD&, #; [!,P&9B2CA-4[" LV!:=>N30%[P1LZYI3)=1HIZ@=4@
M&87O#=INC\\>6##WLR4-2OHU-BDUP8Y:V6[]QOT=6L@3W^!:]YP**Z3,_3'*
M"8P* 5.(79L9?+VZ-RQ8R@OL=KB:JL3:J6;"ZJU$I=O(TBMO>-=$20E/'M:_
MR\2</E,=F,ARHQ&1AU_+3B+E>D%3(5#J)3BWY:;:+6/(+5Y05I.+1*<OIEET
M<V<G<P]UR^M5O-6N4TQS%@Z&.M(BS5N/R-CV,]6\.N#4E1W+*HTXDE$LB!@_
M"8B8Z^_0HUC_ ,I_G6-'#V(LO:LM^"BCUVV 8F_LO#,#W-H$V4UQ<JBU'8)Z
MMN[UE-0OA% \HNWC0NXZOBLA[-2$<Z*NVUJS!+Z0Q%:>6U&9R=+8$]/=;@Q@
MN!MX[ER[S% P\[2Z5[%42J)0J6]4IRMRH+=^D@()DSU]\1'GC&Y5(&M.3H4\
M@I;=.HM=RNNP ,VR0[Q%D06V9C=$Z3,?,)+0LE(+4UIIKFU25N82EDTQ\#N(
M"_KTC7W?ANV\,Y:;U?MVP3*DWMR8LJ[A2T0P/I6IWK!A=05274E3-NWBS5]I
ME4QPW<JO+W?9*FSRKVUG*AR_6'6L0V/QB56H3OM19(NO!5"3%I&VODO9+KV7
M+&5++,.AB*3F7&I43ZH'D')17);".-++AV[-I%NXRTOQ%S!W<+F786_0NOHV
MF!953HWMX/QUBU68IB,@B1D6[H+<)1&GYO)8/$XLCY2O9G_E53=9_@W\::>(
ML558&Q)#TM+G-*<7GWIF?4D6%MF.J486MGYYM.%<X_)]<M,MT[*\AB<@H,G^
M,^1Q]RV@-M%.^N)'5KMQ%)L@>*L-$SVR=-7,#\G3Y6Y[QZ;]JK7/*&"/E#HA
MBNG;LH &YI_*"[#L5U= NF"K,@QFT^,7E>5://3[N-Y>^4].$O\ .E>M[61;
MNU>6_9PZRL&*"PQ-X<(&;"+;GIGJZU.GQEOQA=EVI]J1['C/5KJ,FJKV-7N@
M-F2!&1LU^^ZY5VW*R6#JU2NI4"N<_G,C@BLE3C(+4$V15#I5TK";&L*DUP6O
M2V_''Q:_5P8OYF;'+-F]ALC;P!XRLUT/PMFO<4G'Y>'*;2IW+5.J^ZME6Y8W
M@WL[52+$["QU_F%]C$T,?FJ'+%96/37M83VQ=1=[JQ<Z[@RMC&36KU\=NJTU
M#6$XLKLN9+H^5K*97*#F,UG>7G%=N)H>RZHU\;0[6C5K4>ZNRH5C+W-,[33;
M8LM+T+A:@K?V=/\ #'^>97_NZ]_[9O'*?[M8+^ZZOS)>Z;$$0*4P567*4Y:6
M$Q8N6!0#($C+XH^O3W?A=9L,!**ZF.>YI0"U)4,FQC#GP(  R1%/B!B9GBFF
MOEJYMOL)-9>UP'+1+I]-PFH9JFPY@*XVNC-DB$:_4DHUX^4G_P 0;/\ NORK
M\RQ;,2,:ZB;(!IN+;'PCNF(UGW1K,1Q84RJZHZMTMZW$D]1<,D!"2&,']68G
MSK$Q_-&.9KL4!L/:!L+8 R1;5K$F'.D>! 2,O<,3/CCJSR;SA%#73ONPQ^_;
MNTZOLF,I[=Z>GJV^R^YT_P"C\+<N9E;@!@3(D$R!C!#J!P)A.D^1,1(?<41/
MCYGR@_NQDOX7%;^SI_AC_.J]&YD:=:Y;$SK5GV%*<X%Q,F0 91,C&TO/NG:6
MFLC.E"*V9QKIRDN''0NVDINE7G1XUX@OI)7/@H'SKXXRG_=U[_VS>.4_W:P7
M]UU?F%7"ZROI5IMKI"B-A;V.LN6V'OE9] =JQ$=37[YG772/PW\?UFUN_I6J
M?<(V]9'<H-/65O@@ZB]^\-PD.Z(UB8XKR&67%:;F/N9"E7Q\J0R<-D(R>+5C
M9;=L.H*B[N;>AS+Q6I<WI35B0@+%,WVZHV V38H6FTKBO,3NKVD2+4GX^,)B
M=-8^OCY0J8/N6A1S_;B'Y"TV]<9NY:Y7.9=:?,M;I);1WS.T($/<,?,-R*R+
MG2Q]Y45W2Z3AK^A*WUUK6<-<N%G @6WR4:3Q;7L=L_)=KGTFT6N.$[6ZB[0V
M"$Q&TYC]:8^=DJISM6>>KT,59A2R&.G<HA>I-]&D%-.UUDF>IE OT/<([;3H
MQUB5 +"IG!^+)!D QPK>1)%=0FN8# ^D?'1WR<BP.G-];JG:/QUOLW!%@;($
M?;I?N!@K7J.CHCR.[QZH&=1AF*IY ,2NKB(R96)KHL$\SL,3 E%B) *J.GN=
M(:,F3B-X1I/'+ZD9X83F$O)LTZ=)M;6G1!\MIL<#F2JR>I?2,9M$M!GQP58;
M3]"YDL8U*G4J08LZ59D=9??ZA9[X4;B!<;B86V !GGBZY;%S>BYEJ]4V+&%Q
MVUUZ*\&(;(T@0&)+W_K3OGWUXR,J*["XBP28T5+(]\A_5/O^K_LC\,?.L8]C
MGUPL=.";7+8V(6U;=FOUK;T^D\/\H@V+\;M>,EA<7C\54I,S<8XT7>;:2<FM
ME%(5&6T\O]J^XYV0V=[#+5WO<FIR+;)@37K\SY0?W8R7\+BM_9T_PQ_/W<@-
M.[D2IUFV(HXY/<7[<J&2Z%1&H]5[--JPUC<4Q'%NPGEOF?!5ZW2Z3^8,9./7
M>DV64M&E,L/K%596(;/B.G)KCS,SI\^*!9"B-XM-M(K:(MENC6-*\GUIUCS&
M@>8\_@0H[% ,+%1@NKFEO>3D]+ TL@30G;;3BX>3Z6.;TD=Z167&R12*VYE^
M1QW4RUS#6<S716LC7K1R]:KV<>.#@G_0';[<0R1V-VL%/2CT#$V89DLYCNTJ
M7G1.$R]K$D_6J<=.R54AZZHTUA;-1B=9TXY3_=K!?W75^8QL7;%<'I0BPE8H
M('+KM8T/4Q1F$ZL(9E9#Z9_#F,LI/<LQF+R&077]7TYTZC; I]$27TDKV>F)
M+SXC7BC6>6(D@NXNG=2M,0W)3F<D%3^26HRMZL<86JU5VZQ++L&)]%X46*;I
M8O'7NVQK!U)K8ZHV]>;YB-M>HB"<\_.NP(F=(F?JX^4"\%:_3&QS];**V3IN
MQ]Y6WEKE@-'T[$"Y,S([@WQ&Y<B<>"CYE!==UQ(/EY3%$(ZSFIZ<@OJ>-@0)
M$91K&^(G]D<"II6IN4S-5N+<'UA,FM(!(S_2:!H.L:Z:;?J^<8G344,O1DCU
MB?-Z-L=SKKK#- &-8TC;XTTF=;X(0JJW(+-;7"H71$,;UV:(?O1 L;](T  .
MH?KUAD"<:SI8L=XV\#85VX):VL%,H0D#*!'MPVSO-I$1&R2W%X7.0IJLRG=T
MR/=!#!Z;PW!(E*STC>N9E9:1N&>*C>W7!T!8-*1';VPM7"3%0CH(B2H@---(
M&-(TX8J:BMC;OM(X]4:WI.#[J"@MPMW1$[@F/V>Z9CCOZ](%6^HUO5$W?I';
MNJ6R6=/4]Y:^GZ_S-]]&HIN+CFW),?9N8/E$+BG3:,KHJO'FXYAE ODYJ66X
M^;1UR4554T9JQ'S/E!_=C)?PN*W]G3_#'\_8R.0?%:E47+;-@H*02J/B8>P2
M* 'WD6F@QYG2(X*G3&U6O8FYD(LTKE=R']E=NMR.(R40Q8?DV6QEZI=JZ^9!
MA#&Z%R<_.8$3I) 0Q.I1I,C,1.H$)Q_UB0E_1*)\\1@W\O\ )^6KHRB\?F;V
M-^3+/OA=@A!M@&<TW,W9Z=]:K"V-R#2M=N;-3*6"0BFLG?":ZP2J&-:XX6L8
M$()SC8YDQ$1ZV&9E[R*9\_ARO_=U[_VS>.4_W:P7]UU?F @,G6K162EI5CW%
M-EC2;JILBR(7H K(=T1^DW3J,Z<"8%!@8P0D,Q(D)1K!#,>)B8\Q,>^/PT4
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M6]IX^]1L7B?C;)]K+*85K-9G7K6FUS,?I-U:7EI$KCC#\F9AJO\ E#^49-/
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M=MEU9NHLLV&E9QX@->3"8^AC=&T9*(AWKC7C$:C ?R?5],#MC]$/ZOU:^_\
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MD9C4J78LH;-DVR1D*A&OZ@EA",23ICT_/_EJF5F?9U[%086;-8PI9&QC[5H
M.NU<@96,71:#H^E42(Z9#N+4DIL9*YN:3NKELE<RUD"(1&178OM>Y:O3K"@*
M @I(M-2GA755?KDC.6^9%-H97(T&AFKJB2^]!UK*YZG3(H5'PHDI-$+/U<7,
M]:LY'(N9DJ&2I5K>0OLJ5K..PE'#5K=FNRT:,CDU!6>U>2LJFP,VIUW,2ML(
MP@IM5*M/(.RU%U"_<IY"CD[%JW;?>J9!+AM)>UU^[OF&;259<F1Z1;.*F,QR
M!K4:20KUD#)% +#W:D<DQAE.I,:PB8TY)C"(R(I_F^0REF#FOC:5J^^%1!-E
M--!V&PL9D8(Y!<[(DAB2TB9CW\8W+HM_)K7TS57-5K6/H)/G"QM^E&LRY&0E
M16+HEV]UL(=JDV]%<.Z;5_,^4']V,E_"XK?V=/\ #'\QEL9:OE?SC*)L7@L.
M!W\E*P8K>5I=?=%&K.X5ML7"4L1;^OKMGV3D>:J7-*ZN&K\YTZ#JMMW+]3+7
M'C&0QE]3EA[2M<LW'K#%)M]2AVYQ;A$MB 5,WN<WL7/_ $:O7.FG3^C/8.I'
M(_U;O=_KXN<L'BK3LR[-@I&?%+NBM%JVEDMWE8-\ H&'!IWG#)U<;MWKB(K\
MYY"1'X0M4UW0_P"S^5V''LCZH P_Z^(E&3QV01'Q0E->A;+_ +(V*MBM_P#J
M3_\ ]HXYD]IX5US*]2TJGD;;J"K.-G%XRO=9'Y*<BCM5LBX@J$SW+#T+0]W&
MLNP=JV:5 E@6K%-P/=  MEG&9!*',4!EOL35L'H$$0Z1[CP=ZUC[W\G1DZ[Z
M"R5T]]J1>MXD]VN\G@58XV[EB4S&NGSYB)VS,3$%I$[9^J=)\3I[])\<?C+;
MN6\I4Q/,>,Y=R=M_XLI)F=O302C(5N5UXS6;,+NTL<[.HL5LZ6.@RK)=3KB9
M?YGR&+L28HR5&W0>2IB&BFXAE=DKDA(8. 9,A,B406FHS[N*QU,!A4OJ0OH6
M5XJ@NR!*&!%@N77 Q9X^,-LZ^[3YOR@_NQDOX7%;^SI_AC^$?:&2H4-TK$>\
MN5ZNZ7,A2H'K,#66MF%KB/C9, .I>.!:AJW*+7:Q1BQ9:3I.TPF1G28F)TGW
MQIQ-ZW#"3#5)T5 26YQ; _2&L=-??,EXX"]-QSXM>G%HIBJ]8R[^H:NWQBJ#
MK3+;H:L@):0,X+QMF>-UTW_)9RBW_HR>D[GG)HU]QS/4J\O P?K;W%^(+0Z5
M<O,.I8+$H1W<?RC<L:W<GECD8$V93(VI;;O$?UP]I*'614L ]/!%5IU:Q'&A
M37KJ3)1'N@I6 ZQ'[)^:_)6#NK;9E9/6AP@EA  KF9&5D6K  19H4:QQ>JIK
M]1JJX'46I:F-EE-BWI2N' 8_2$D53$Q,2!3$Q.O%ZYE,>_'L"H-5(G7K5UO&
MQ8[AI?0(21&J4K&-^_:LX -HQ Q\\G<QYJSGKP90+M:_RORQRUF.8J.+!:G!
MC\R&-QS>9\+CU+%J6VDI>M]%IK"Q7*Q(Q5R%!Z[5*[75:J653N6^N\(8IH3_
M $3 H*/K\^>,06 &ZRJ%4Y4JI+P0W+3>JCIDK"7K55K+Q\N<+,BBY1=TG5.B
M+WK9%7ICS;V.['QC>^8Z;(9R&X'V\_.;F;9P;$CF>TBS)4=Y6NP >ICN)=@,
MICL8VL%A[YR.(=E@L M,D"UBG*8R43OC4F23M1\0$>_CEO-6Q4%O+X+$Y*R"
M((4#8O4$67"D3(S%4,86R",R@=(DBGS\^D&(JY1]X;,'5=C[D5TU;0,KFJ<@
M'?4OR=ZQ>CO=MT<=OETTGR0CPW2MGM_:O06W+:2?.S(N=KS,J?:@:<O)ZE6#
M1H"]0$IQ<] IX:NI917ODB13:=6*U759VZ0UE47UB<N#]4JBPF2CT]0??QS+
MCL[:Q]ZU@LVO'KN8Z@[&*?7=A\7DQDZCKV1D6K.\Q<D-F1,0&=HSK_/^>:L$
M,V;7+>275KZQUK+.E^C0KXVGYCTK@I\QXX0:'I> )4!FEH,$2%03(D03,041
M,3,3YB)XF,]S5AZ38_Z)W06;Q3_1"C4Z]LRGZHA/$IY)Y'YCY@F? Y#+]'E7
M#_U,A^2WWW!]>B<=)%^K'%1',W+:+>##!7+E>ER;DAQ#4Y5)/7B7VLIS3:Q?
MM+V-9L^U#&@D*W753@A:$,TPS;WR@\U<NV6H9-JLJQR\%938LN@CJ]GC+C&(
ML:=P!FR).&[M=)UXM1BOE)YIYBSKFUUA4R.1H8VAVS70-\V68Q[&$?:=4:XP
M(0+2$O<,QQS5E[O)F$Y>Q]U.-CEL$Y@>8;^)@4]+*T4W64ZIHJ6WA%_Z,%E+
MK#P9+(V:?F,F0<MW&E3NIKU@$QF;J#F(983_ $@#:R=?'B0\3^M;I/Q3JM9"
M$,3>(X)-AC(B6*#3WRO<,3[M)@H\_5\^ZND"%4LAS1C,_P#C(O-,K'4QU--1
M%C"6.7U4]N1Z]9%NK]+:FLTKR\@X@LU%C$  B #&@B,0(C$>Z(B/$1'[(_#D
M/[#;_@,XY'_='EW^Z*GS"4%2+'2I%><16@K[5"SIS "8%U#\:Z:C^S76>(G]
MOS?E#_>FG_NIR[\Q+08E/5N)KFZPMC5J!D',GTU$!E/IB(]7U\)M'*R)A/'>
MD2!;(58:D6 )R1C!BN"VE.L:_P ZY3Y>R5J]4K\Q6[E?,6\;2L7;V/Y<CM?:
M=FHM*S_++,"./J$6O2.R=G84(XMA\HORI\R5EHRUO'4^79;;Y3HY+&5!4O'Y
M1B<=37DK3[](0FSK?@P<MP2&@[I@L0_E%#8T_*G5+MZX4Q]9W+]>S:.?VR39
MUXTK\VX-$?L37LK_ /13C@ O\U8&X"RW@-FM9= %^T=].=)_;I[_ '3P"AYV
MPR_3HI41:#TA'N6OM8](1IKMC0(T]T<?X[8K_9N_\+Q_CMBO]F[_ ,+Q_CMB
MO]F[_P +QM_'C$;HC60_*]\#/N*1[;= S]4S&D_5Q_CMBO\ 9N_\+Q_CMBO]
MF[_PO'^.V*_V;O\ PO$[>>,04C.TH'NRD2_HE$5O27U[2TG3SQ_CMBO]F[_P
MO'^.V*_V;O\ PO'^.V*_V+O_  O 9CE[)5\MC&M<D+E62E4MKLE3U^L1*#4R
M) XD8TF/S&2KS=S3J-+F:K2!2N:.6\/CZ]7LJ#NW9RY9KGF<@O<YAF\70S([
M_P FV (Q^#&IRMDDGE'6%5H!+';8J4K.0LV+$K$H1637JLU<S2):2DAN8P1X
MKI).4K,:^LBT-JC*?917V54XL\H74D:Z\JR]4&@02[J2^.K"=K-EN<AD*-"'
MU+:TS=MHJ0TXKG,@N7L7!E$>9@=9B/,\<C_NCR[_ '14^8)6:M=Y!X$G)6R1
MC772),9F(U\Z?M_">1LU+]JLD6MLS12MG:UJZ66'V7RUR %:U*+:,&3GME:*
MZFN8(<1 U\JTG#8L4%A45#,GCJ0W2OY.F#;*YFI2C'6NL+^A;\)Z59G<)W]^
M5A*Z70&SW36"I UR"&0XV,D1!>R8+<4Q$1[^/E LTK->Y69S34Z=BH]5E![>
M5>7H+:Y)&LI$M1*(+42B1+28^916L8-IW!L3!IZRX37C:1'NB5Q]*],1!Q.[
M72.&)($B--T@LDZ^N'FU\[AT@0D9+2 &(B!T\1_.O,1Q@*3<XM6<Y%L,YT9C
M*\J80U&X[(X+=DYD#BLDAR3&K'>NP<J$Q&4P4\3:Q:LEVW2KO58R&$RN)3;1
M:$C0^DS)TJ@W4L =_4K=08$ES,Q# U^&/]4<-L6"4E"%,<]S9$%J2H9-C6&6
M@@ !$D93.@C$S/&(YW]M7*\\DT;ZPI-Q&0JGD:W.O8TJ%JM2MX]>1R2[KL>"
M<0S%J<%RPPTCO/0> R.+;UZQ->@NI7=5L(LU6G7M5;52TI-JI:K/ U.KV%+:
MLH\CI,3/PQ_JCBSE<J]=2A4&#>\P(]N\Q4L 6H#:UKFF"4)2!N<XP4H#88C-
M_GY5_+OM9FMC.13P:\!E69%%["EE\Y"IPJ\;.;7;*ID'67=:M"(I+18&=C!,
MT6UK:"["@< 6:S:E@18,% NJV5JL5VQ$^M3E@P"])C$QIQ\,?ZHXK-R;&C-V
MQVE*M3HW,E?NV.DRP2JE#'5[-RQ*JZ76'2I)"E"C:R1&->,K>7S =R/E"RE3
MF^&Q3L6*-%&2IXW 46/N5*A(QF/MOQH*0_+-K[[A6%;OHF0OX8_U1Q\,?ZHX
M1C\K=[>RY2[![:=RRFE5?8[-%S)V:U=U?%U'V_R9-K(,KH8Z#$3GIMD,WRMB
M[&9R5AO-',66O6SPF1]ET\EF;!YZWC9S*J(XB)J#= %K*U+O(*/5\[?S$Y'E
M_%9>Y?H<S8I=_(/Q_P GY<NI75[$\DIN0.L?-JFHQS))'3*;L6R2"I&L6L<4
MLCE:KCN4-!6Y%RU7ZB(3>3VMA:FBIR/Y0L,T(-\,D9@](D90YN0RMMD6*3\@
M5EM0O;'LIM-^'7D!&F [,6W'TSK=G%4SE1=P3NJS=:C*8S'Y**]6XQ Y"E6N
MBEDUSB35%E;(64QXDATF8\3XXY'_ '1Y=_NBI\^DJU:OUAHWE9%79.6L66*\
M'T.Z4]-A%I26%%A2G*,0M*18'Z1(%!MEV6!VKQK.7=@68^K=[WVA0HET)Z5/
M(3D;DVA/J-^E'HN3V];H^SVUD-HRB*I5'*!U<Z\!T^B:F00&O9&V0.)B8\3Q
M\H%3'U*M"HKFFKTZM*NJK77NY6Y>(Y!" !0R93)',#J13)%K,_,PB.E8:,LN
M=P-4AAW:P"2/:+#6L]&=*="G^N.+]4UDF56X^C. @X$D*)4LA<R'4)73D]LS
MZO?,SK/\[R63IXJD=+(<B9;%6"EHT5W\Q;R%8P3=;5COHZ]56QE\%L8E0^@M
MX@/&19[$O\J<OEB\341R[D,_^,$^VJLV8OY*FV+V1&K2FJ5.BO1Z67^UBTZC
M6(8EO%MBJDWVA6>:Z(DH)NF*BD*D&^10$V"B$P3BA0[]63 :\'S%E^6<HOFR
MMF.5LT=&Q;P*\3.*P.1=8'E7EPZV6MS!U@MVKG?Y6*D9/*;6-94K]NBKG+V5
MI^S;7,/,N2ST8R6H>W'UK"ZE.JBTVLQM8K;$40M6HKM:I;K!J%K=DL+C(6L%
MAAY@S"EB6.Q1OKUEV+757"C:^RQ2@56F>Z9](##%,@DH<03Q6M9GD;F'F/)E
MG;^2SC+6?QV"S3\A=PZ\>K)8A.(Y@C&QB:Z%*PJ<=9RJ+&/H+587%QX/:["T
MN8+,V\Q7HJ7>>3YM'+?,BMELA KC4+D$-N$(E;8LK!1JR?P*72P5G/5K!.JY
M-.,RP8;.5JEBLP8LXBVRS0'J];IJL1&2HN&LTVH8PU]%E_E[V.JZ7-W*>!Y<
M;=3?QXUN5O9=K+)@,C!35;?"GA\D@XM8NL\[V4J6MR5]V%B8CWZ1$:_]7X&X
M7'<O-NJN(J.QN:IYJOCUXW-U++307,M"P:_:>"J[DWHJ G+KNDNQ4=CUF5=Q
M5[M+EZQ@IC/Y/)<P\PIYD;;PO,N)N4K C7#!-N,8G(6\@RG8:@\=6KXHZ!LJ
M7[ N!;?GL:OEB9LV<CCK50@P>6[2\NK:P]=F5L<Q)N1CNL.(=D;!0T!&FS$5
MJ)T[#+.YOX<A_8;?\!G'(_[H\N_W14^9*CKVWR-8K;2K+68IKB>R3/>Y<^_7
MP,%.D3/SOE#_ 'II_P"ZG+OS,'%3KZPVZ3XK6%U7%6A2NH(.:0#'JZ<Z;HF8
MCQ/&3&WU.OW@:]5H/;"YK*E L<N9!ABB5B1#,QK'O_SE84ELUW-0U:GQ&Z4M
M-9"ML1]<K*8/3Z].,,V[1QU>]C;W+-+'W49FQ<G 8O!6697F+-5V6$*?:R7.
M]]MFM:J2N9[:PB<C:9"3#\&'I8:[=7D;2W-14BAU<2WHL#=&0M=G8)EBYXH8
M['I?3GJN.^YX)JZ\5 &[F+%27XV,6QV&$"S.2>_"#S%C,C_)Z.WJ8I=C,S7*
M!I=/HL/NK/LW;+O8.)QV5,Z]P;8Y',-Q H3VQ[6*)6+R?<')>)64(B(\]3CD
M?]T>7/[HJ?,FNXV]-,@HD))M4[%%B%NE16%Q]()NWSH4^)],#KQ4:TS83 (X
M-ABPY63#E.\P])%TMFZ8^O\ K_!@V8IYK7[=QZLFA=,;)6J#SZ30)Q:S32K7
MK.>"Y/0('J*"3W3I:S)Q%>LRE+,+L*WSD8T>_P"6+(^SQZ6)KFRYTRT0,;3C
MVHSM8XLLQ]=-NZ"3*K6L62IH>^(^C6VT*+1( B\$V*[I"//3+W<<^LS%*ICL
MB7-5?KU*5\\G67$<K\O0N0N'3H$V37H9Q-5?3*9#U:;OF8)2XKG*FW+,KMP4
MH:*E*&5G 04^>I$QXF/3YCC)U6=+<%P2T1NZ(PZNIPK7O]6Q8L@(U_H_SBYF
M\'.(F<8AMFTC+5KKXL!&P5KKG3N590>Z9DS8+XF-(@1\SQ&(SPCE<LR<2E%;
MEO%65]:SEO;S41$Y#)M6*NVPCI83+"QKDLC:W8Y<+"R:<M5"RBA8QL7:J*DY
M0,A>/&KBI+[8+7*+BS"U-]E):ECW6\JFC^'<R4PMV:E>;:W5T*!UT+-&P=2U
M6V*<=<F*>LAEH62I[([B+/;?3<-9@,2=NKBL7S7D,V-B*K3[GEQ>+V8ZK:I9
M4Z8PWVM5LMOJ+(JZ!J4I4O-_:W$79N).A%M5K0*K9#(4,269MXL:Z;C+IVE5
M0:N&C6G'LMJ.HN\;]!F.8U83(RTW8Q0XBX**V0",AE:N.^G"+#%+,1L=<5]>
M9GT SIS)[._L#D>EKS*.Q=/J.W\J79Q^5#IBSR?<C(U8&9[B/(Z<6(R%#.XM
M=.S?HW+%Z@J$5LAC\7[;90(J]JP3;#L5I;K36%Z&[QK=8;D]O%/!EA^8EYNX
MX0]DG0K]U6JDA5F,G:,;Q55X[I,+<T;+&"ZO9JRGNE]$JZ;@O:IU K UJ5)M
MJ\][,SAL-5%!0X%>JUETK))!O+?#8: )9!MTQV=99IAE79:@NBD[F'K86R%6
M_9O#%OI$J&'!5QHNNON+@SJI;"V;7Y$*>:9AEL)2,XNA#,7?8&3JX@QJ.%\L
MT[VV(*.RFLNV"+3*96!04\/QRJC[-3'T\[.2E29F[W^);RM"U4Q)H(.J:.9!
M8^P\U+3TI-C%)6T^)KX^DX*JDG%F_8%%L*^23S+B<"=#9C[[%V!9&2 U7*EE
MZ(ER&3)@#P%]A];,#3$<B5&X-$6(S,XFXNA>#$PMY/>Q;VQ*@<FM-Q -L4^X
M2LCXNDJM=I/QM]F-O4\@I:K->T"*UN(+HNL(,&U;E6PIB7L EN'61.# ;V21
MC;.0ME2YHR^)I4:_6Z>&Y?>=!>1RQ'93M7<MKA@KJ[[)(? (KM.L]G"592KD
M$N.F5@C0FNU32KX@,U=FK7[SVF=5-+KM"Z=(:;NU>M5ECA$#C!+7D+EN;,5N
MI537FN9:T1=-4VVDLR':%D$1<5CE6[-<1<UB84J3XSV.L@M=S!97LV='=TVU
M+52MDL;8C?K,&=.VM5@=9CND/D-%R$1^:R']AM_P&<<C_NCR[_=%3YE_L1RA
M(@Z3(F@D7B!12D UU&=AZEIZOU9(OZ.N-ZF[=V_Z^F_3>>W=IXW;=-?F_*'^
M]-/_ '4Y=^9B/_LY/_T5>,S_ &JK_=U7^<7L/>ZO:9!,UW] ^D[9,Q/T;-"V
MEX]^V>$<P-FUW]=F.:&QVU&[&(S5>MN5LG6.GGKW4]7K+H3XZ?JH($LB$XNC
M7HXZQ%E9/J]KDIRJ+(=6NQ)V1L$8%UDM0VLQE=R&+,HX=RQ8?D'4[!=5UIEA
M97F6.]'(]<BE'::=T SVG9^SNC':=GVFJ.,H,NREB<Q4S=.\Q]M4$09^OB*U
M\E#7K(56+IX2CVHUUK15VG"4B!0(WH==S1IR2K/?H[NNM=J[=QOLNWE&DJFM
M_>6$ZN8D71B^]*;@XX7Z%%C$6F65(L=">M4;"K2&U7JM5GH80,$6HL(4T-ZV
M!)!H8&$R,V2LWLXU+_;<A3*^$5*9\Q657<PRHL:T$)V[BNYU:;N@;7!6A*62
MKBV-Y=EZKV6NYFRF;)"L[=_ _BXZ(V0)@J*'K2(&)JMP-@6:Q$<)SQW<MD\R
MI;D3D<G;4Y[J[4)KA7:*:U=/1K F31"U+GKV++W$YSB/BI?O3:Z]):E)Z#^F
M&U.8Q6;'>.PMT][AJ>LZQJGK+_RFX;KPMYBDW)GE/:1T;P)*]3S+4NO8UTE7
M9MIFQ,2HJ_1NUNH_M[B^L>MO'Q:S2L4\+0U,2G(]+'XAMNTF^RSC$@J"%X74
M!:J]XRXFFR6C42E36+*QW5S-6[%MMNP^[9N(:]MFY9P%MCC7-/LS@7<M8S95
M.H5#I0Y!U#0WIC+.\S1&RR^U9DKB/RMC\AB<KHX!IBL%JOX6HZNJJ-<$Q+D#
M';G"@.&V,LRK!6RQ^/*X'9X<LA?3D;TXP(KPU?<V$P/Y2ZUV]<W5:7;(80<9
M5]?J;\QD?:EOJ'NCN>PHX[Z*-(Z:^WQU?T>KZ3J%KZM(/'V;^0I@H>8,95LX
M>WVMFQRUS!:F\[$7Y;6<.E=S.DAM?;84%=3D64D^RN3RF/FR^ZE]W(4\=D+:
MUXAN0N89^%:-]B<<Z^ZF^H]BR4X[BZD&78H2/T7&#PF1NY&PO&UEA>6JQ$5,
MI:[N,@VRT;";#T/[O?";U)U/)Q4+MSN$$# YW(6C4R[G,KWC.CNZ:JE6K7QN
M-KQOB)DPI5%LL%MB)M/?LU7 3^;S$XV;$]"B9Z6*S:Q.JW*KCHWZXM&);2O
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M "H0 0$  @$# @8" P$!      $1 "$Q$"!!,%% 4&%Q@?#!\6"AL9%P_]H
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M4&-;$BZ&K!AV#6'!2*1$!L*+)2$F8*;C)R "% D"QWA$<1/TLU!K8'HJLY$
MCVRJH)5@UQ?6XW01Y'O"TFW@J+4R:(71Y7Y*.=NR"5(D-.3!&07_  6_?OW[
M]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?OW[]^_?
MOW[]^_?OW[]^_?OB@YF;)^0 ?5?_ )FC[]8QCR<NF NY 2 T)HC6SE$05QSA
M$04SO*E8C3QZP^1F[]F32D<ENEAZ Y0SNV#@2.#>R249Q7YKAAJ+YWK1O0$!
MFAUV'!=SNG(K @,6#BQ*\[.;)D]NI[[^0KEHH4]GS!UXU&7>,WF 2<*;&61/
M1X7<^GOBM/7?HY\_Q, H( T4A )1N8_NO\I'WS28ON9!8>C,S75N6.O4 @N4
M-=WU6I_4?GFE\OP[HS]UO8OMA,*7\;;&IB8A#>9VT[_;L"P94[4XTPD>QN,*
M>_Q4LMOGFD>ZC6=(]>\PD_:TZ71H=JACQ#S73'X,&2;,WVXQ>I)/<2J4=/L*
MPVZN<V&Q0:JV8D%.K0$UUA<EW&>D0'&WJ(SE-Y@3!J#WKL #/?TMBLB^"Z#9
MRV,1-+L=6SL"-5>\/NW;[*O>%&RNO9EP1YKX/&A+IA*#G>9;]6[FPL69!'K8
MBM8=61%+:,.SC9PBQKHDNR+:5"0@].COS-6I?&:]H=TH:]#Y^#WA2E&KIU5C
MQ WY'SHH ')66[C@U>F:!O<":.1*>WY#C':&)C2AV<3&(G8$C\(RA>R"D!;5
MQ&HMB6\PY&H3R,%?S6^2;PJBI5'7]7[_ (OL#S>8K<SPQ#8.$]PND%)U[(B%
M0[K0UAULD:QKH"E=G0%RHZNW^7LPL%!L%O35F.8<8&"Q- ^ %VVJ19?+7>
MB%4:>P%A^; X.LD>4BEH&G @('"/<->X:<E4.] @V@(X6"<;@'%M7M!D3XG1
M@DF$ # LLI'C3,/S:KDY'IDW##G"HPXA<V7>LV$46H(33[34+&W9R-#):)"J
M8$JS"I:KW\ 5:&"T$VATP1*RS#/":G?A#':_5^_X#M*R/PEWK^7@%PT04Q4$
M %&D"]!$6A#(9ODXX%-]!:7C[A.A1ED0KSN*QF0E5LQ@!J&XJLAK$?HKVC84
M"KAM4RT'P.^LO+CMX+CWU9H,2&^1XTPFZ,V9;>JW\?XS:BRLXH)$I" HN[(W
M$E FY41LSJH8297?<2*WD-K?<-99(B(^5RH%HN#//\QA,?$47A.TS&!?!B'&
M,0>D\)]6A8#$@,T360Z4@@<@,8Q\_;%, _C#LV&#8BTB:F#P-H!">@7M,TTD
M%AD9D'^K]_P'::"">,)1=J%=22TGCE1@S4=^VSVB7VB!1;&\PA6]Y,7DBFSX
MYB_ @($HT8U5J[Y0TSF(0$FA8@C:A]H?+%)7""((SK. Q;'U7<0!07M""JJJ
MQ;#BUS5Y< >5K,S.BXJZ=QL:&)A$PL\@$KD:@73D1N)&^ZB,U1(>K2XH)%$U
M/)2 EP[C&X86C84P\#P\&F,Q%K/,N!MV@#HUBF4^<DL?+8Q!A& $-'7;K=PG
M%&D4?9D!8F58P>(KY+:7+ G@WCL!EY#1.AP# O $_195 0/)8N)M"&F=+@&
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M5-H-<FT$N;A-C/C8.,T\>P4]&?&]\WGD4_5!X@?W @I"Y2U<')?*/6"Z@AF
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M2/<^T7H&N%RZ 9I!TZ:7BG'%J3_ZW% ('H)/\8?_V@ , P$  @ #    $!=
MCWNPH0E"4@ $                     !C%NSG^%F\]3*F[J:0
M         G !0 <H?+T4S45]9<                 !"222222222222222
M2222222222222222223
M                                                ((   )(
M                        )   !(
M           *        (!            !!( $ !     !X+0     !)(
M          )( !    !D          8 !            !)  ,!)  ,@ !=Q
M^Z   *  (      !D    ((   !!  $  +9-$    0 !       (@    !
M$!   (  ! @4.Z  #)((   !! (.   ()(  ,((     *8J&T0 !0()
M !,   !)(  )@   $   )(    !(  (       P  !  !)'D!) -H  ! !
M     !      &@   )   Y= !!KB          +  (     #0    (
M                !      4    (                       (    -.!
MP   (!(   !(             0 !    I^!'@  ( (   )(!
M*  (   #=.[L   (                      ! *SG0 !\P  !(     (
M             !QSC8   !(   ( ( !(    ,            +FT9()))(
M !!   $!   -              )!())!)    (!(   !)  (
M  (( (!((   ! !  ,    -                        ! )(  D(( !D
M           ):#)");")"    !  )    %            3* 101 !5+0
M ),JH ) MH                            AM ! J:
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M * <!)'NZU.1OG=&UT4+#R.FNK375"%%W_7'7$3N#2-HD,=]9 7>QOA<2M:
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MJPAFZ"FDN!9X!QRHJ!ESKKJ<+P04:1N8IDFH!?!3\^@8Z6W0 3_!!,70N*O
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M_\0 +!$! 0 " 0($!00# 0$      1$ (3%!44!087$@,*&Q\&"!D<$0T>&
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M < @Q! :1$-XU&1H=4  %4@&UF&L  FJ*=(*$*;-8,$G%#(H$IM@!4/@$0"
M@D%4G(4B\QG#CP0(W5 "+#62 B3RI> -K-")VFVGD@PW)4O:J$S X@X$-BIJ
MD&!('1160-$9]<L0- IJPYZZ"#813FPC.NPFEFU7O([C)M;%R(>A)+T#2)HD
M\P5.N JC0:6"%A!!VS4A.C6L> /\J!]2K!RG>85^ID$L20DUN;3 Q7(:VJEM
M-9TBVI4O%M52VW+:YFF4N*CQ@^I'06Q&2MT[:U5N"*-"Q,LW)*(2!&H%8")
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M)@"! C'@*PBERX$Q;5IO0:P8"$"V *1!"9:5!A&]P+I+6TO&61D^*2$9(,!
MD(I^S8Q#E!!V=A^$ G(@8,'RU.APG]#*5*E2I4J5*E2I4J5*E2I4J5*E2I4J
M5*E2I4J5*E2I4J5*E2I4J5*E2I4J5*E2I4J5*E2I4J5*E2I4J5*D502"=7R"
MWD >7^F=\MGAS?!2>2!=OH=;&D69.[07N0I!@"M#>G*,MDDA1N4N(3%B^3S>
M2ALC>=PG\YWO?.A072S;$KW+\WCR5W #([;:)/1!\=F^5+$)/N6XXOV^)K*B
MU&\Q!&]*<K'9L+5L2/!$(M[>Y$5+^>AXUJ*][Z5V6\C"<)Q_Z2%]1SDVDN;
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?HY0SJ16*EPOAUW7P%5(%OFD 2ZIH>^*>AU[Q^E__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>businessfigure26a1a.jpg
<TEXT>
begin 644 businessfigure26a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F
M9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:
M   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M
M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" #'
M HX# 1$  A$! Q$!_\0 '@ !  $$ P$!              4$!@<( 0(#"0K_
MQ  = 0$  @(# 0$              0(#! 4&!P@)_]H # ,!  (0 Q    '[
M^                                                 'SDWM*-F-0
M=K7WHU-JZJ6N*LR<3%S&4\>3,N+*               !AW+BQ#EQ[6ZVQK?G
MP[*8,V+LF/*N+)5I                TAV]2YXMKEGP[ X,V',N.Q[TOJEY
M.)OFEMV-3:                U VM;4/9U]3]G7W<U-K37:UMLM;8QUDI]K
M.)Y,           >*.A12Y*-$W$T<O:'A+VAXRC9B7K/27:%%,6C>MP5MZE5
M"BE50['HD>"*U,E$@          "E1;%HIYBXJVB)BG,+YL6SVOG
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M<GWP;N.:9;QQ;'OK[5+J<ATQ9P               .(D 3.UH6[WOR'K,
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M8LM^X\X&/=+N%AZ7;*6N>NR:N>N8\EGM[C(?T'QCK, =E(_#OUV;3
M')P   #O@W(OH_K/RO\ EO[R^N7UM^>=7EP=CJ #L<'!R<')^7'USR[[Q^==
M\V6ZAW:CX_EP !'S6UKX[CK>T[4A[5GJVKXM[P[D;+T1/5O;-J5*>YC_ "8<
MFXLUP5R "VL'-6QK\]DK>Z1VF)[>XN']!\8ZS       \ZY.L2 !Z6IVFH
M %3H\OA_RSW_ $Z\?^C_ *<?3/P]1HT!W=3U+WK;$N3'-1.9,66Y*S@'-BM6
M]=Y=+:R33)\!O1^@;H\#S7T9Z+WV.XCL               $]O<7#>@^+\2
M             %1H<S@[SCG]4.B\5]-/:.PBS+4Q#EQYFQ98R8KX7!6T@FP[
MT]"[:6JD_,7V_P"6<S=;[IN-Y)]$1O#]B    ZS7SO0 #M$^E,@      $]O
M<;#>@^*\2 MK1[#$:_*WYRW2"1X1/O,4T34S%!6:^T1-;>J)&T 4T34S I8G
MRA6S':0 %1I\IBSH]M /./#?K/[']0< T-W-2TKTM*]: BIC,.+)+Q._&EN
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MMI?(?IJ(X+M/AK;H             %+7/;F#FKMV>O">WN-AO0?%>)
M          =\>62X7MUK\1CTZZ3Y/K=U?SZ.Q:]Y_0_4_+ZO\;[Q?//GGMVV
M?CGU#>G6^]Q7"=F\=?;                $]O<;#>@^*\2
M    JM#F*WCN>[ZV[9VEQ-L<GPMS\O>[^$[6P[5%Q_+47'<SUK8
M       ">WN-N?L73                  !WQ9_2F;"YF0J3QQY>
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M-F!*W((-O6.1VN.5]=FFM*(E0L; L;@!03;KY^S:XY7U[-A*I=D'- +]FO\
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M-5QGHZ1P';#:[#JO)PI"1+6U]3'''65];5B.Q5:FKJ*A%?+E+(LTCJI(N+J
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MH!#2Q-,X]K!<BCK9@.O;%,1J,6Q'$<6J;M4XG6U>(2CF>)5SO/PQVY<XC7V
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MAB%(8@AB!:Y&W E]&= QZN2L5;W,I!]8V>&1+!TMF-AJ#TNM=";,-,RFS#K
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M".T9>=[<^JUC7$L&X=C9@6$AXAS%3;B$=)!ET642Z$W)-B!7$ ^)C!.?*5)
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MZV7OA2(Z]%_.8^*J;?W@20]<IVP[>_=W$\H@Q*&&5O\ T]:>])@>SQUHV_\
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M/\]N//Z:7XC_ #VX\_II?B/\]N//Z:7XC_/9I96T:21AV,[$>XG;_\0 41$
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ML%$9$CL,=5KZ\=M6.>T<>W&P4H8!1 .8!(FUY72/>>,^_'MQM)XGAZ.%BI1
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M!YI<O+$F8N7(3UDG<(&*HBS36L*L;J4B5*]( PXR1;DO.)< 2 A05&:5A1!
M_=RXX"=Z&0*C4KQ *@8)W3CQW6%->NE*Y04*5-TSLJND1^M'HX6322I2;^1
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M3:VJ=Q3RZ9];C#'*C>JZ"M925NZ,JURK6RVE3M'4%2BZVDWG70IAYZR^8O\
M55[K,.I0A2=J_+A "<<%N*PG#++C-D.N75;1NE36-T2$K*@X<&P# 3CLJ"<3
MC%E%>RI.ULNRHB%7 MKFBZE)7  2(A><&<75K#*;N1NA2[LD))2"0DY[-XC
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M/M!Q2WWFAKW<:_1X33\[RWZ50U'65[*>NS-1K%:IQ&I?N:P(OAQMYK#QU,\
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MOX2?_<>F%*863HRAO4VCQB XF?'59'2J5B4SB&$M#C:O>NHU0.TYGU('XC[
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M"A8D'O!W$=8L\RMA=U67DJW*'5U\1NMIOP<;KRJJH[K-9$K0=EJI/%7FWO\
MJ<U?EX[=G6GZ1XMNH<IWVCDJ4+21DI)S_56DP<P;:/\ "RJI[K=<CEC0PUH(
M14@=9YCO[P2KBLVI=.Z*K(U=6VA9_P JH\0Y]^$*_<6JPVA*=H<4XCO&%LL\
M+ A1A.T>"<3W#&VC?!+PCTL4\CT35:M7_,5*.1TXZR[4:N1^H%G@+:#_ $5T
MC!0_I^JY:X(5R"D*VJ0'HO5!NOOCBEL,H.4J%@*/1U) %-04-(W_ -.FI:=L
M>JV@<2<5'B;>&'Z1E5B7M%^#RUM4JI;J=*8MO5*<E-T8P4RPK)3ZH==3@V&T
MF\I2DH25*-U(S/Y_)M4U!?5O"$\U/_L?M'V# ?XY24K%UQ"'$]%:4K3W*!%F
M*9EF^44[#2BZXI*D--I5=)V=I*01ANG#Y:#ZU7[,_P 2;#_0G&T.I*%B0>\'
MB.!M44JV)//;Z8W=2AN[<NNU;H^CTBWJZME+@',7S76^MMP;2>S%)WI-J[P0
MJ6R5T#J:E'FG2&GQU!6#3G>V>JU115=(;M33/,_M&U!/H7%P^@FS;[S7U3SK
M?[-U:/X%"W_T_M-Z7TQX2HTJA.DFZ?1-"MANO2*MMIQ=<I*G&TOWPA92FZ5)
M@E.%J>@HJ;_A:&CI_P#MZ1AH][;8/MM6Z1H:!!<TA74M&@>555#;1]"5J"U=
MB4DVTQ^E'0M&%-Z):=TM49)<(534*3Q+BQKW1U-- 'S@SMIWPGTSX1.3I*JE
MA*KS5$P-51M'<0R"=8L>=>4XYP4+.O-LIO+,<!Y1[!_/+KM45*WSC@@<U'\S
MQ5[MW^AT'UJOV9_B38?Z(]0-KQ;\4KAF@^C,>CNLY2OM<Y$CI(VA[,>\6.(@
MXC>#B/2#A9W1FCGL7:&D6>.H0#WI -M!OO>#3M0_H!Q6B7JMI#-2Y20%/--K
MUB$+U@<%U*R5" ,;5'A-X1U0NU&G-*.).:>6.MI[FB@66I3BK[BE.+Z;BE+6
M>U2B5>VRWFF^>XD=4RKN&-G=(;F4Q]M6?H3\9[+*4I9O*)43O./^B4'UJOV9
M_B3;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;
ME51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51Y
MY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;
ME51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51Y
MY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;E51YY??;
ME51YY??9;JW.>J]V@3WQ/T=4UYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)
M^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)
M^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)
M^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)
M^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)
M^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)
M^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%M4WYM'J)^%@A"<0A(/4D"W__Q !:
M$  " @$"! $%"0H)"@0#"0 " P$$!1$2  83%"$5(B,Q,P<R05%A<9*BTA 6
M("1"@9&3L>(P-$!28G.ALM$E0U!38W*"P>'P1&2#LQ<UA$5456!TE*.DPO_:
M  @! 0 &/P+_ /,?N=U@YKRG*.'REW,JS>1Q9'U K)C%=-Q+6##;*.JS9$ 6
MG5/S9XS63Y?]TWF[W3;F*P=JW/+#J[8Z@2ZLF+:AN5:2S.NQ@:Q#=W3,Y@2]
M4Y/F6;WN@V,OS!?13\OV6TBY;QR@RKA9.  9&Q3?8!?D]Q0OI@_<-;H;1+CD
MS!Y#->Z*%NSRGE<F[&<V.QC@, O96"?G7*8+>\4*OQ.%*)84U4^HR#Z_%9U?
MEGFIG*]S+>1:O-X8\3Q3KFXE]2$@PKG9=0"'N.E)Q(D)(%@DN,NO[S>;<IC.
M7Q06:SE:FFOC:\._^Z'=<B<A"O4XTZ+"?R]FASRY4Q&)S/-&7YIQB\WB\1AT
M+[F,0U/7"_<*PQ855&,$(:[REBV"4#MUGEF^_$9ZC7YAYB+E5\WZBZI8/-QT
MME?)BUT:J=U))=BIUP@$NZO2:MBASW)U.I<98Y<ITK.3R/H?)ZW7Q6RM1&8;
M+YLDHR9/HH".BX=VX=)_T#Y9R"+5R6VZ^.H4*0B5J_D;>_MZJM\P [H6PS,I
M\T%EM%C-BSH<I\T\EYCD[)YE#[&&.W9KY&G>[=9N:J;%9:H0^%K.=DP>A1"V
M$LVI%D5)MUHMS&L59>J+$QIKK"=W4TT\?>^KQXJ<AX;EU^=NS4JY#+7!RN/Q
M]?%4;%L:IMV6M3NMK08.;55(/(3$4"TM^PJL6$3: =Y5H:N7B$Z:$2=W4@?&
M/&1T\8XSW*E=Q=_RW7I/R;F]-503O!+5UTL)F]S%)T.P0KZ2=\+EDMA@ +2<
MH5'MV,)@0LMWO=IS.V=WY.D^/P?Z"]S_ #O*^)H9DN5;V4NVZ>0O(I);W$8V
M*ZYEWOA/MW;I&"V;1U'SN+=3.\B\N8"A8QMY7?8W,U[5CN"3,5D])81,K8R8
MW%/FA[[X/''\B13J_?'7R_=LK=_7A$(\NVKVO=;NC,]NT"D8*9UF1\2C3C"<
MP]$/O?1R1D^7[]F+*AL+M7?*([5UY]*7F65S#!B0B9G73;XXOD+&T.7J^*QF
M7<S[]67DV8=A7WGW'(C %'=1=9+RVG,@$>"-X^-WCG=5S"5N9U99C&<HYS(\
MV6*>.Y9HZ$8T4<N!,@>0VPM"K)(!$68[EMC839/D+G/E_"T,SEL/R#C^2^8.
M7+.7KT9_$TZ#9I9(]]28ZT^?ZYVJ&!6?7,D\R?\ Q,RV"QN>-EK.8)55BD!C
M&XZ0N8S%HL:P60O%TVU2<@#.5W(5'6(9<Q_->:GJ9[GO)6.8[[I& F:[9E>.
M6,1X0CH0=NN,> !=VQX?Z"6OFW#9/)X&SEZ"+=S%'"[. ,I.$YG?H9#"9W)C
M1;!<3XJF!18VER?RYR;[I-SW1^7L[-L,GBKY>46X*FE4&%ORCYT()8RQO15%
M39%<U6*\P].EOFG#5.6\!=+G+K+F_G\IE/=*=;59U=:<!FI&)QXCM=*S%X++
M0 ;UI!K.9FT\559?K\D??3C-99,1S0=ZJ:\G$=7:3B<WQ@M4^DUZ>ND\<M9+
MRSR?B.=RYQDV9.UD^:+'/UC*^4'@='+8>IC[8Q2M!TDD4CVA#*P>8OL60GW4
M\'E:N/0_(TZR\+6<Z0L.9G,"UG,3,<IC/3->FW9LOT%G1$I8H5@/F\C^Y#E0
M:P?<SYASV4YD,Q*$6J6#LB/+>WX&(8RX539/A-1R2C7^4PO>/4(2,5[HWR 2
M(D<#[Z1&3""+32),8GWT<-6+5DQ&WK!!C)IWCO#JC$ZKW!YP[M-P^,>' '5N
MU+(,8:EFBPEPFU8R;%@2S*"8 1)&$:D(Q,S$1'$W3N50ICKNME84-:-#Z4ZO
MD^E&C(Z<^=X'YGOO#A$6,GCT3:$65H==K*FP!^\-$&R.J)ZQM)>Z"^#@>H8!
MN,5CO*!W,.=  =?693X",>)3X1PBN^U62^S,C60UZENL3'KA"S*#;,?# 07$
M;7IG<XZXZ,"=7KW]1$>/BY?39O7[\>F>Z(VEHV*ENM:E!])\5WJ=T6_ZMO3(
MNF?] ]"^3@K/73VX"9F_JAT0!6O4(FZ[!%>TMY3.@;9W::3P@'VZR#M%LJ@Y
MZEE9/P\Q F42XO.CS5[I\8^/B:R<MC6V8+9-=5ZJQ\%!PN1E0MDX+J3 :;==
M\P/KX QL((&J)ZBAH2+$AMDV@4%H:A@PW,'48W#K/G1QUZ=FO;3ND>M6<MZM
MP^^'J*(AW#\,:ZQ\/#)FPB(2T$NF6KB%.9T^FIGG>8T^LG8!:$757I$[QU_'
M<A1J>?TOQJVA'I-@LZ?I6#Y_3(3V^^V$)::3$\59YKJ82Y218AM2<U%4JP6"
M"=)7-J>EO-<%YOCO")\)B.*RF9+%TUL2LJ:SN5*X'6TVJFL$L""3I$"N51(:
M> \-K>5<;W%>&D^OWU;K)% R3Y:KJ[UPD1(FR<1TQ&9/2(GAEROD*3ZB=_6M
M)M(;75TQWLZC@.5AL#SCW%&T?&?#B;GE?&=I#>A-KOZO;0[;NZ,OZO2ZNWSN
MGNW;?'33BKMR-$N^UBEMMUY[R1G0HJZ,_&-L^$]+?I/A/#JU?(47V:^[N*Z;
M:&O1TRV'UE <FO8?FEO&-I>;/CP+:]ZF];'=L#$V4M [$1)2@3 Y$G0,3/2B
M=^D3.G"Q==J*)SBK)AEE(2VP,[20N".-[A+P)0ZG$^$QQ- <E0*]$D,TAN5Y
MMQ(#)G$UX9UHD!B2*-GFC$S/A'$MIVJ]M8G*R96>MX0P??!)J(A@QUC4==8U
M\8_E+$6%+>AHR#4N 6J8!>! Q9Q(&,QZQ*)B>&'A\'B,2;O!QXW&TZ)-C7=H
MPJJ52<:^.A:QKX\7'GR]@R?D-._<6)H$V]HR&QWC)1OLZ-$61UI/TD0?OHUX
MFZNE4"[*!JS;"LD;4UAF)&O+X"&R@9$9%6[IQ(QH/A'!9@,+B0RYZ[\H..IC
MD2U\)W783W,ZQ,Q.K/&/7P[)UJ6+1S$-.Q7QV=?C*MJ[1:Q#%).&D$/-*R/4
MZ\/ 6+W+F8@YXYCYDSV:'F'FCFAU>;^071#'UT5:@[*]2K7$V;1TV=0M1WBF
MN/3B52;/Y1BLM3Q+\I75ALQC7Q6LX]#4-N7L)92<C?M5(-1!0?NZ1F0E :AY
MVO&6NDVB;N;:][RU0B>W[9BK(7,)5M7Q<Z<C7704SEEYHKKE=:[UX6Y2BB:O
M:XT.2E=^96K6/?CCRC$_>YE\=U7#5@ZH*)]NK0#M;$Y J/<>FHZIE/*;SY?H
M3Y!*P%SE>FZH-'<58Z2+F*[B5TIBMI+J2+A5S"I<;!FNXK849"U"\74Z#6KQ
M]4,5=37A^=R.1C#[K5&P:E)18!C&8V:JXL6;"ZS26E+.,<6/IS?=0S^%R950
M=70QB*-T'/Z3+;$HZD+B2&&-7!::;M>.8"+EQ-AW,U6HJG<NW,?UN6S34&G
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MD1$=>P(,93:1E"W(=9KN[*W(UZ@Z0&)YNQK\G41IZAH<P4^LBS6#P%,7.XM
MO02E7@H:U.BT.D:$0RAR;BGUG6-51$Q;SUSH4Z SZG.7V]J(W=&P):<!;MA7
M4]5;LZ%"GK-#"T)F"*K5(H$K%FQ(+*_?(%E8E:UK6M*_2?@&,>LEF,?.0S$?
MVSQ5A-7#JN5>7N2J:WKDA,,W@,V>0RV1!W0WPVU3V(7?_C5F!BL_8B(CA52Q
M6P5FKBJCZ](6W&L\J'/.V)YF65A3L<:L?#,?1=2+7O9799/OZQ:\95[T\OD-
MRCF$R@6 ->_9L<QXG.XTGCY(FU( F@ZJ;LI=RSZMAY%4A=,NEQD"A6&?Y2C/
M*IS9M/$N5793/ORU;-XOIU"ZMU-=J5,!$TGB_'4Q5;[8F;*>5V4H;WG/#LK9
M5,Q:R">8,JJ]B!>72'K]L"]6*873IMUBKN@BF<RM<8E9W2YO;Y:[JP.3S".9
M*KT4,+DUQ6]#3Q,N3Z3N;*A#&49I5TF3.GA%8W&8>U1Q,Y$"Y>O3V.*=%^B5
M5-H(35LJ%^-:1N4)5IW#9LFIB[73.<91OKQ#E@'+<7,R%BP62IX_$X"OALIR
MU04=;5N.R1*LR#9M)3*,E;.W4.T(2R^O(9&A99D<)E!M1%BUL9S&&,L<K<O6
M8F4^CJ*Y8='>F,=4,F$&L&1Z3@7K1C*^&3D;&0J55A$Q3LNY1JX0;J*,JBM%
MM>425W=KK,P%O?W/JJ6\DE6113L8"OD*,-9D*','93>ZN1R]?&\NI961UK"K
M@VLA5SUT;8BK(6"K:/BH"*6/IJRE;$18K6K5RHW$)Q'/F6YD $U64C:\;>+O
M@NJMY4FUV+"+2Q@MB\;T_(VE&WCK:[/6$+:8J<X7<_;3#G8NW9CNJ-D$I\FV
M<4!-FPG)S;3TN*X!6PA5Z)5]V+ZY*H9U-7FK+9KM[@A2V5PM5+]8]K46UC=I
M+38%U;TG%MC Q,72ITAPT UQ+Y?<OG+(\Q%2QKRKBQ-:CC[2*5:RE:282C2*
M45-@<<TY EFFOE>8)=24P264IH8S'XEES86DB-VS1<Q4Z1U$"EWC#1G\$1^'
MX?@\XO&=?FF=OS1'%^U!;D*9-.I\45JLRL9C^M/J.GX^IP64:/XSEYW!KZPH
MI*82/_K,WOGXXZ7Q?PE_H+WY; 0S.8N8C4S[94^4*<?#I<I0S2/A>FO/P<83
MF2J4[L7=398(SIUZ1>CO5R^,;%,W+F)\-2B?@X39KE#:UI*K"#CU,KV%BU1?
M,:S&?S\3'Q3^'E\M"X<6-QUNXM4^]8U*B)0',>, 3-L',>,!NF.&5;-.+U;%
M7\/R]E<M-M:+;LYEL=7NJ;6Q05=A4-]NL#6=RIHPYAHK.5481K+,X_R/W.)P
M&9J16=:S6^KS -SH(?VF.!B+2#HNAVBV5=I*D;.Z2".\RF.HVGKL9ZQ872NV
M(:.)QW,EG"UY377BWS#MJ3_&,@5#&MFOM[_N7&FN]-; U6'WG-2J</S4UHL5
M.3G$C*6GEY-:-9MELUPQ]49?K#&NMOK*KS)R=# V.G**Z)M,FZ::N6O<NISJ
M8<Y>,+'%CJ\VJ]5[/*(7V:E83CC1$27)Q%1JV\_S2FDM:.\.GC0LGAFYBTYM
MKLW.!45Z[)6A5)C"<8J".D!/BL[$M7C<5:;R;2Z$VD39068R>9KY=F^<)D <
M_?AF5*EE;I0-3\8758^WK5 Z"DWL%&$[IW5&YCKTY!O,F(P@2(7*(ET%!DH.
M8G:+9W;2U 8G,*JX0+L8,>:;%PSRL5=U7E7R.5GH#V3]UNY&5D:Z#E:E,KZ/
ML"+-P'AEX*M.;$[#82S-=/'3CZ^&Q^:EW?\ DV6=W*LE7J=K%.5@\76"M=FO
MJSDK52A%7&5:5-M>XZUONNL9#!T,VL9H!7Z2E5TY 5,;-QDM<KT:I4>^.6%Y
M>I*,AD:'*^5Z]*]6L!?I95=M3INC..%=1IV:G4;5I[A);A[2^,UWAQBJD\OH
M3D\[7P%W%5BS.^GVV=I9:]_E"Z.-WUGU$X6W!JKU;D6#96%#-9;T\4MM2,CE
M<J6+J0I]^K4H5WY+)\YKZLOJXYK"&JCE]:7F NBT$).NA+>M+T6Z^"":R[/+
M=++=?+"IU.WS'E9Q:QI+BF8Y%%,QEK'$VF=@2$*ZI8M\+R]:V?6L8;.W\3-G
M: =RE8U[M-I"N("&Q2O5TOVB,$Y)G QOT_ [U-7O_P 4;CLKC(F /*X=Y;S4
M@I(!'(46[K6.DB#?)V*T,65@& NVMN2OE4#M$<R8(%MRPUX+=Y.YKP%@):;T
M%K+=U-^YNZR"L>YC-UQ+YYBSB9O7>I1'$#RUCGQU/.C+Y"T"&15+_P 154V1
MD8D&57AJN7#U4VDV)0G-Y&G!#B0H4CZE?E+EXITFS6ENLYC(#'3,9<OP:U-:
MEP7]5/\ >'B?GG]OX'A,QQ6KF>^4(4J9C7;,K 0F8U\=)T\/Y#X?P(Q/JDAB
M?FU\?[->,M>B=#11L$N?]J8])7Y^HP>*U0/%EIZ:P_'N<P5Z_6UX355&BJR5
MUUQ'\Q(0L?[!^YKI.GQ_!^#X1,_-''C&GS_@>=$$,^!#/J(9\"&?DF/">.9L
M#$:)Q^8MKK1_Y-Q]S3T^3M7JB/FXY::PM[\<JQA'%/C,SBK!H3K_ /2=MQK\
M<1_A_P OP[-*TN&U;E=U6RJ?"&(L+)30UCQC<!3&L>,>N/'BI;LTZU_)U*B:
M<9:U75-YP)0586.,8@2?T38'6V[Q%KA5*P80\"=2JBL0TZN/$DA 2-"CU.SI
MQ,?^'K=9O17Z@ZAZ>OAA6,!BW2YEEK>I5$H:=QG6M2P?>GUG_C!"42,6=;(0
M+R)DIIPSR>E5F_:-:J5&TE[LF#!NN8FXED1:,G-<%E9#/58SKA94PTS2:O%4
MRLX^E6H5K;4@RS%>I4B@CJ,F-&.&GK7ZY#U821J$A44APC#,Q=,\56Z?;427
MZ"MTM>E-?QW(E>XH62B$@ B 9@)D>%2&,HKZ'D_H].NL(5Y)ZODOIP,1 >3^
MN_M(&(A/5/;[Z>(9DL?4O'%:S2@K*H;/9W-G=5IW>M+I4LB66L;U@P=K!@N&
MUT8;'J0]-VNY0UQVN1D^AY14WX6#?[:O-O?,R^4@3)DHUX8-[$4+4-:IS.L@
M2DVHK124<E[[4:414]>AUO0,@ES(\/[>LA'=2!6(4L5PZ5UE4U[X'2/,J(36
M"--!2I:X\T8XZ-+"8VJKJUWPM-4 &&U 8NJ0Q^3%8&N% #HM76;(#$L.9[=V
M)HL1%:C3A9('0*N,)AXY"YC0EA1)K9J].1E/59LF-T\5NTQ-"MV7;]GT*P+B
MKVLW9K="!B(7V\Y'(2K;[SO+&GM)XH7]>A6Q[,>Y.,53H]$&XR\W)U^WM2CO
M*JVW6R^XH&'UBW=$JW6L]9JEF;F6;EO(6[#=L-LW+SB<YIP$0$::@E0#&BZZ
M4KCWFOX/<V*L=U$;>\KL?3N[8]0S;IL18,1_)%C"&/@CBSW:KET?*%N05DLC
MDKR"#J>8<UK5IB&[O7N8MF_U^/ @(B( ," #$" #'J$!'01&/5 C$1'P?<+^
MJG^\/$_//[?X?WI3\T<>\9]'_KQ[QGT?^O'O&?1_Z\>\9]'_ *\>\9]'_KQ\
M,?/_  0_,?\ [9<6XC_/VJ*)_P!V7]2?_:XP@SXP%N7S_P#3I:V/K#'W++$+
MZSU5K#$)_P!<]:3-*O\ U&0(?GXY"YHR'N@9R><.:'7(R6(/,.O4\UDNA<.Y
MRZ[ETNM6PU?#RGT3:]:BVK-< 98W.\[ 9(480KN1Y#]T#FF_6#K%%:]RF4#C
MTBJ+7555L3U!M"Z989 4*8O:7'+F*>KE7=E.4K7/&3*O5RIRC%5[E&(Q6/$K
MFK\DRK9-/=.@:\6-&PF0CHED\\6$Q.A\NX[F/#ZKM5T5N]YBI8?R5>ZE]MC)
M!->WU%YFHFFB+:7H.MYH"0X+RAR]C+V']T[E#!7+]-&0#'Y'&\P8@\O6JV56
M+DO6A# -&0VO";P"F5S7CJ ?,.;5>R]#(\O8FY=QK\7F,CBX&P95PW6ET;"%
MW1&(]&%J&@O4MD1)S/&)QE;$\Z9U=^O8R,W%=_S(-1O;J<T<IELA;:^BEL_Q
M<)ZBECU"6N(U&5<Q69Y*O.SF/Y<OX7$XJQD&9'"_?%EUXR)S=0GG-^C0ZHB=
MM#L<;\F/D_HJ$NL.)*[+<3;IX[W9<?8\G.?1JY,L-RI7L8_)S0B[:=1LUV.F
M>SMV'6,=<69K9&X"XY3>]K'N?RS@G.<TR8US68RL;&M8<R;&,*9(S*9(BF9F
M9F?N67#&GE'"8:X7RL!3:1S_ /U!XYAIS/A2YDWA'Q1=QM4B_2:)G@?S_P#?
M]O\ H OZJ?[P\3\\_M_EX_,?]W@BT@M,E1]>OP]:-?"8^'3Y/DXQ.NFA=X,1
M\LTGZ?=L9RG@L/4S-O=W66K8ZHG(OZGM.K;6H7%+-/23NU9^7)<&C-KY,P-[
M+UKSVKLT*E>QD*F1GMLB;.G6F75[LKE-J#\QVV1,9^''9W%*HV5EC!K8K*U4
MC_\ )SD&#7J/V0842)2SZ([5[EA.WS8XR$)Y:P:@RQ@S*0K%4P'(FIT65S<V
M)B'].Q$6!@]8%T=:(W^=Q;C(8/%W0R3ZMJ]W="N^+UJB,+I6+/47/6?3 8"L
MTM32$; F!\.'T<A43=IV@E-FG;2+Z]A<Z3*G)9$@P)TB=A1,>KPX@1'; 1 P
M,1I P,:".GP1$1X1\$1QDE5^6L'73F]?*RU8FDM64UF2TNA"8&R.XI/:R"&#
MF3B(/QXK5*^ PZ*M)5Y%2NK'55IK)R:^CDEI 5Q #D%>CNZ?QD/-=NCA-:LI
M:*]=2T5T)"%I0E0P"E*6.@@M81   Q$",1$>'W*MN^-DG*PE2OZ&S*0Z<6;C
M1UB!GSO23XZ^K3XN,^O&J:M=G)U&-ZKV/DC74(8TD_>Z"7J'U^N>!_/_ ,OX
M+P_MX_(_07^/'Y'Z"_QX_(_07^/'Y'Z"_P >/R/T%_CQX[?S:_R OZN?[P<3
M\\_M_ Z-S(5DO]?;[^I9T]>O;)ACXB8]4RO2>*:PR=5UUM=)$@CZ-EC)7$G(
M5W0IA^.L^C"8_-^!U$M4Y>I#U$L!H;@*1,=ZY(=P%$B<:ZB42,Z3'W!1+50\
MP)H(E@0\U+F(8P%:]0EA)#!F(R(R0P4Q,Q]SKW+5:FC<(=:W8363O.= #JO,
M WG/@([M2GU1]PDV+]%#@KE;-+[E9+0J+G0[1*8P3&L$^!/D84,^L^).G;JW
M ';!'4L)L@,F M""))F,2:S%@ZSYRR$XU$HG\!JEN2;4;(>H&@;42P=ZX>L2
MDTRP//7#('>'G#J/C]U8M<E1.*02+6@LG&(2P@5!E$L(5B3"$-9@!(YC;$SQ
MWD6JTT^GUN\BPKM.C_KNYW]#I?[3?L^7C=K&W3=NUC;MGU%N]6DZQI.NDZQI
M^$/_ !1]("&/[9CC+:1K->*]S_\ ;V5R7_\ ')<8.R4Z &1KB<_T'SVY?V-_
M QN7J??Q4H?>0[&GE.2L#4SC^\+/39BA:"]4N(4J4#W&X0ANX51NV',3S)D<
M:SGX.S]S/EVWRR.^[AKEKFVK?R76*WBZ!(JGF>D*3N8_H]"5V!WUYCH].V5R
MWS-&2/W2N1*%.U0S$CRU6Y9MEB>I@[F/K7A4O*-M=Z5VDZCY0.2AY'V&_=S+
MDZ%?F?E\[7+ON@+?.:NY0L;2RR+:F8!K,OF+?D(7%3AQ8BWB:..Q=.&)JG8L
MM@B#FK'\I??N%.OA_<VLV<9E\ED;^<#%6LCDBYC;0A61;D0F^L!884KB<A:J
M#8+'2"658XY(K9FSSBOE]1<\6W:NS&%:NHJ[B7\L8W+M;D+.2-&]=F<=&7L>
M4+%*.A<"!ZH,R*\O6YFMX^Q3RK+>6SWEG'$BY&4@Z-:SC[5_(\O9*TY!G%3(
M<KL16115 O4._9'W<AI.L5@K4_\ B2D9/]#&%'S\-?/_ (O(V"CY12"D1]83
MX&/S_I_EK-NOHG-06L:>>DMIZ?T=?5/P_=+^KG^\'$_//[?NOI)>^K6J!7G*
MVZ4;L@QUZ=N/P6(CX,ID=1(WQY]2NQ'3E;;06*_92ZQC7F V)Y>Y2J!=R"0;
M,[79G,/18-MAGY=AC*2VG!=)EN!ZQ4J'<V+3V5%L7@N<:*P7?A:0(_)64576
MQ3ECYP.0W('7TAK*XC&\44VG:92MM?4J3D"W9+$Y6H$LL\OY-VXNYGH"5C%W
M9-AV$!(&ZQ!U+#^ _P!\?V\7<"=J\',U2YS[<3B*F&OV,B9QD\SDJ_9@ZI&.
ML6#KB+JZG684TMJS]<CQFX\OYA^*[OW/[%C/E73E<IR_@LVV\KFF]4:OE[&U
MFLI&BLJPM6-R%?"-:X5NLRDCXY<S?*N3S7,?:<K<[K?S/>PRJ&<^]BOS%ARN
MW</4.NJGD\FJ@M@8BRZHD<D(G;[3J+@9K97EJY<E5BSR\-K.IJ>4<EC^6KST
M#D^8%4RKLZ]RO2/K'NJ'T28QQ(CI:#R<BUF\YF>6Z?NL31P&;MXRB#<YB(Y=
M?<+)7T6,0-:WY.R"[&*J9(J2:UFO8?/2-X)<O#(Q.0LX/$V,1F[<Y2L/FNYA
MK$B,7B[#)P>?)JI69/#$KK5G9>=R5W )<1Q[J&6R5W+1DSQWN3C9K5J-6:MC
MRP=,\ECJ_=8F<@.-QK]2336Q)1 B.8&S(3$9_'!DKW+W+8^Z56P^<YHQ>%QZ
M\A0PM?DF@=.Q^*8<ZH^4,JL*UC)SCVA6B8K*Z"I6L<0>&YBYI*S5Y?Q666_(
MX.KA5\QK?GF5GV680,+D;61L>35[KR9N82G3J=/(Q,M?*N,YA+'-W,>$Y@L9
MKFC$8SEJER\BQAZ6 5CV3RYS%W[*.M:"/HW_ "P=ZTNW8+R=V<"4Z9;*YDK%
M6IAZF*Y4/&L6I:W<VXM4LYNROFAOG\<8BFB(/I"L6:+@O'CF:IA[=G$QD/=%
M]R_#'D*6+ID^<3DN7+GE.3>VBV+@K,0T?;FP-,Q!<$"]5%S6.2R%R[D<#S%S
MGAL;E;V/A]Y]3$L.,5;LTJ2*\9)HZQ.E5 S>@(6L9(O'F&?*N9R5BH7*9W^9
M:]9.8J8?'9&_-;F&_BZI<O8G(5<M4J[K3^7\A3O^2%1U=?,F"Y4,[V1YCP>+
M]T7-)Y8YFR./BO<RV+^\+)F]UF%TJ:K*:F38RBC(=HE=V(VZ'LX5ALED\KA:
M=CW(J3\'B<7@$]IS1FK;;R<W2NK1BF#7["N%>!J52QW9J:61]Z,[L&U=_)8U
M5'*\B6;[L:$$U5$+5$+-AZYK62E>/W1>B.E(Q8KJZX-5!J+R"66R;+\^[)B:
MBE%CCG?[G=W')8EC+ T!JCCKSRDH?U L$XC$2$1F!PSV\X\RI9F>2N?\[:$,
M9BA*G?Y4R+EX6O5D\1+$3<#9WO5ZC[ZAV)E,'!"%DLMEL=GYP/(-[DWE:G@@
M=C.=[>8I4W<R3D3+'N9Z*VVS5:I=W'>1E*%\[OAY[SOWW9/'S1]T"[RUC:+Z
M(QC*&#K9*F9,"]4PF0NTC<IC*2N8;*+="C5G<:]Y=<:MW)3DV6@NY*IW65FH
MUMU56T0*M5K=*ECD9#'F,].ID>QJLM@J6,7)>>4%'K&8+]$Z\6Z)^SN5GUIG
M^B]9+@OS;H+AJ#U"Q5<:B^"0<@Y"?T&&L<8W)#/C:JKEL?S;(>CLA/RB\#_-
MI^"/,#,#B#SH;9#,%CZTY$2 .D!]UT^KU 7Z,&S/5 /, X'PX;7L*78KO6:7
MH> M2Y+!D6*:ID$#%F,R)@<2)1.DQPU&!P^-PR7LAKUXVFFH+F".T3;TA'?(
M#YH;M86/FAMC\&Q;?.U-5++#9G^8H9.?TZ:1\LQQ9N-\6VGNL'\>YQR>GYM=
ML?-QBZ,QHQ-1<N_KW>G=^>&,*/S<?-'X7NBTKYX>KDN3@K3A,=<RL5K7,QV,
M0K);%)(.H$BYL5([>'Z^$^!3IQ5-ER56W9G%\LLI16MDY?,>5HIR",> =&#8
MHJ[>N-Z![3M@)Y-@1+2$5LULW5LI:78N4,C0H.7A-Y9@:^0N54T[#L:M9.N(
M2XVJ3'4D=-='Y0\I916KV,978%C#Y>O=US8L/#/5CVTANOIY45,FA<2@Z]C;
M(B>[S>*&>KBJ%9"[@:R0S 9#'%"\W>K5 AU==*Q>K7-+'HJ]BJN(?M7:96#>
MP6T_*5]EA=G*4A6C 9RQ-B]AG2G)8^F2*#%W+U73K-KUB80UM+,Z)G=Q7:[-
MG*+.+QV;&PG&96S75B,J\ZU3(VW(IL"G5[E<H>=J537=(+; F8QQ636R#NO;
MSH<M)K6<;D:=GRPVD>2KUW5[=9+D+LT FW7LN *[5:2+-9TX0QF1M,[F<Y%=
M53$9:[8=/+5KL\WLKU:;6Z4':RPY& )(,L 4J"2XQR9S&^,G4Q=Y-I-*^^A7
MJ9P^EAG9.^JL57$CE&^BI1D6UR:SPTCU\3DLQ8*M6[BO3#8AUE]BY<;":M.M
M6K Q]BS8;.Q:EA,SXS.@Q,\<LXJK4RC_ +YJ^=<JT_%Y6D./9A!VFB]5?0BT
MLCLZKLF0 NB@>Z<4J=7EF,M9O)+J6KF%Q6<MQCZ.;R&-IT,LYE:M>.[Y,62<
M?-A?1FQ>35-9FN&*"6!$U4UK[^XN9T>6DUK.-R-*U&8.B6237=7MUDNKKL4
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MN=QJ[EVQ-;(TK%I]I3=#,P*-UNS2>^!+MKJ5D_:#Q,K',W,[%X6CATWT>9D
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M^K)D<LK)(Y-E::1MZDAOATU"FKUHF&PCT4%T_-X"IT%%54M*0KF L3"J\!"
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M@5H#T<($H5"_,V[?#CM"Q.+*I!*.*I8ZF5:#0$+0<(E/2@DKB%J+9JM<=,-
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MW5X8F"4%MKLF+4NB]$%V],.<Y%A#[@N(%">Q1S:W*A1KGF4(C;^<P,L)=G^
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M7Z/53N2V-2[1GO1M]&"JQ5 JSU!>ZOA0$"U1MZ.GRV^ W8UZU$*1= C_ $^
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MDH*"!3VC@MZR.<(.WA(:]&#X&<%,*N)ZJ6O-9U+R7_+N1ZDOFX"GRI?0JO\
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M^4^T^4^T^4^T^4^T^4^T^4^T^4^T6*Q9 V&K#5@UVG__V@ , P$  @ #
M$                                                 !O9GW0
M           !;02P                R%"!0                >XN
M        .P&PQP7>S*Y^HZ           !]9D@           -"G!M<'7X)[
MLBL        '\!88OHT5L)4                             V4W+O_/V
M#&ZV   "                  + .22222222222222223O_ -
M       %VP108                 %  <  4U_,TT*+,  "G,#"Y!
M         !@% 8E@ #7'R37?\0  1M%@#=+H             "C@%!#3$ "#
M]V#O ED "UH@  !:7   -C&]0*;;$0#./E QDP  AC)G,FNH #F4    &_@
M &6CN[/@F7P)JN% 7(@ 23ECRR95X 0+     !^,  #ESW)GER/@"K'E  L
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M=@  "$_@   6Z5F:Z#D !DJS@ T#XYM M\F0LC?@<2_0(4&\
M  $P3@               !S O_1#                 3@
M   3'ASADDDDDDDDDDDDDDDDDDTDDDDDDDDDDDDDDDDDDC02O_\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_Q  I$0$! 0 " @$$ 04! 0$!   !$2$
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MQQ0[0T-]O1^7QQ!$'04&.X+6?'/D.WL=+3\D:=D?7*& QH8^F./P\I-$"K2
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ML#D'Z-00$Z6(U+<"\%KMP"$7"%[)L'8'D$JX>V"4)!"#T!7%&6@1!A1XV';
M">I5D(AT1(*4O92+=1E2H$V 1JVB!.)-8Z9;W!"=#&T\EO%+N5EB$I(@1"XC
M^.1/1C"#*9UH+D8H*&E- RH*1X=B[ C+3#@Z",=H!!]2Y.EMG+(@\ABP2<%W
M2OG*"%<>.YLX)VSC/U ?N.DP'7^*PP  *@!4I/*%'M15JJOW*X128"&;?4,_
MCD#ZC;,8&HR521_NB5* /R"_R?'^TY46#%$!CRKS([R[9D@?30/0*AQBRFJH
MJNX!Z # _J9Y*>1Z1['X3'@G$(9->KUAXS96E[\R_+R7WXY7=3^ ZGX&_?WZ
MF*"I1Q&(Q,2E%.GAS22 L:J-&K4 PHQ@B'&1C&8&1T5 K5JNJ"@OR/S1\E;>
M#!>, *::Z=,HA>Q!"4"ESP-0_846HC:$>%TAAA,!/'%YT !8 H%&%6'1U'&A
M7 ^^0W3UA8P  .)G1H(>U #TDD$,(4B]6@N5"A610P@04X:@!4X>W/;!"UP+
M "%(B*#P "  E,J6BMIQAF =,E& 11H'> "PA>8% (0(0"$T:2R)4UK>!!((
M"*G#0>U5@/:F U4*6%($^QN=?PHLSVIG5;Q(1 _[:+V!(##CQ#FNG1>N=5"_
MV2N%+WKU",W%>S=$?/W!"$(?1"/G)9Y!Y)G]*UG^<%@_[F_Q7A^A8 GPV(J)
MHQ.+0+9CGA^3':*>?I0@4(/82'\L/? %YJ0A=H,!("+0\&.,;W(3"C0IOISD
M8=0% ,\APJ':3.(3MF# !0Z !0*'.A\9,\"M,\$-T(MMC.JC!(\%!L[X)"DM
MT%&D/@T"P[.04=VY@<G=!ERMXYJCVT&1D+HI*D;Q*Q4RJJJBJZJZKJ_0#3L/
MD*?S!7B,.0/0M_&_ROQR-&1_;*_P/_ J]/\ ]W_@,*O&)@H$FN^,P'R:E/A)
M,5:E-&/JJZY"=BT%V;M?-SB0%]325<J1/!T> P P [Z),R89A>!Y.K 6.H-C
M/0=[WAL90(E$IN NS XZ-B (>0.)TIR3Q)GX^. NID"=GQ^0O5O>\# ((('2
M 8%GL=W@     ( $ / &!]&C,<D/B1@,J$R"X,_B>20I*5";PM#H=_X\Q/YG
M]+38HB8?-+$ZCWWG)S:<VG-IS:<V$K/!.Q[=Q+3J^9_8$:%X7_']_L5P85_I
M.((XG. 8N$B*^*415 X(@B(E$T1Z1\C]4:B# J #$'1$^'Z#(HPK0"I$$)"U
M!9GTR6:X0%6*P-60._H"5P60J 2+R^@>+@ZB@J@E "Q%Z",3[$T!6R*I42F4
M8XQ^HR$ I$"@4"!0%E4#>2J'=EK-3LR2O.F(C9$;?4[OL\>?N ;X;ON2?S4X
M3R9 KB8>GOP/XY3)F,!;+X#J^7$4CV*/Y&/U!(*9GT"&$[!1#9R@3[9 ("XL
MVZ>!X5M.> <[KEK:]X&L!N,%(+0J,!%2M$! >G4LRT$BH'B**="@13 Q;&(>
MQ):7I"4C:30!@+/L!2## DM0GYT1TY7Z?B2KO9 2E4V\1\"GX59^0#^'\_WM
M$#>OOMZ*1E]@"_X_O]5+?%B1:0X\P1SP0 V#AP<$_*"NP59$3W"<X&'2?)Q9
ME]!9S>_[!_\ >>*TY$"AM5&*$%-(!7OW#(L4* /%)@!U;3W-ET&- L:=VD&8
M03"/=P.DX[ .,4J,"AKA&^:=PD $C2)&719<)TKDD2HJ>1D\F7>]JZ$HIQXB
M%&-U.! J@.1X(-BM4$$,O=C*(1,I&M5O!AT .37MU/9%!J3-6N%9]V@K7<BZ
MC20X"@,$TB8@0)4*(B:A,L2:E%-:F<9\B+CB%*D*N7!5L!Q:PL^$6S#AA=%G
M6&B!74H*E,S%'3T  #6H*#@ 12Z1>)0AYT 3:;Y&PE=%2@1.8/L/2 7ZN,0!
M!/,1>O8O'-!1;&0$;S8#X0\!4&VB%^Q:'X$X? &5@?7!8[2Z3[5@E+1RH0<6
MA@]GA.(! 4(B"(D1'$3$<3@2'*@J3*PWXO71#[5T7^4"&'O4;% ZCU-OJFI$
M'83QP_4& 8G/NL[D\'&>(E^*)_&A_G_7V@<*HB&NRGF2DQ)#DD20(@*4&_2(
M!F).4 6V&5*Q24((+BLZ)IY<,2CX%" HG*=J5)5=%9PM0I7O6@:8Y% 0B@8&
ML7%D(D+V#U[Q%KAM Z0V)0C1![(,D0"05!Q\GP;P(T':9 MDLW6%X0$))%-!
M# :BADJ; "E-_P!Q$;$.&C9YD:*"C$N $1<X@H9M Z0K'0@401!#0:!XJKE+
M3*SA+7OE:F%DM(0'>Y)(+X%D8"N J0ES@F,?!M02@LJ@"2<%!4%AP$88!2!J
MB!](!Z1IL^*)F/'^7I3%P/%%!*PP[F@-Q*$P&\B#6A?%@V]?59&07_']_H0$
M$J0;")NHK/(C$L"V5BG$TA#C((H^<0<C%]$WW'\(U>\%,(P1Y>_&1(./,9.Q
M8F[B&C$-!5'TAZ/T<:1\A5 'RJS??%>%95:M# '308*32!0(@DL"1. /QYHF
M%;6FS;3O'C+30VH(*D<A=)N*8NK"*H, @;EPXFU%A<HA>QSD D*(YPH6>8%*
M!,: !,;0@*NL(5*Z<22R\Y9(9PPP&.ZZ>#5;$@/(NG>AP*P4%+@'LM>QQWS7
M) E&2"\9QAR!.1N6PM7S-B H0J%0AV :YTH^$T(Y:.LH0@;]X+NSL1$BH11,
MI^AF2"@,1HX0RD J)CT%+#+BX$%=O(#-<T. >)>_HE$]DX;[?%J",S_\[D&]
M=@:BF$3@J%IR].,L&,>QCZ]D?Z>^"'NEPLFI3&'A+%: /#K1GKJ<@%Q@ ,(@
M$*O! \9SS C]#_<_R;OW4 (M2&4#@P%&1T\B>CY +*-%,W:V%H0+7!H#D!0H
MX2R7+3 X"VI-BU8.>VXY"@91 )C 3&!RM- P9IHE*HUJ"HM"@58!ERAB7#LU
M+D0<.C4PS2Q !CF0H0M+J]@8,"F!#@D)@5"! *>(B Y"<1,M"!.D3HBQ7P#!
M5"ZJ+I5,T#24B4*)4O0W*: P"5% 421"YJ8HFY8@QSI\J@A50XM8&P+""5!2
MO/\ =F.PW ";T>@"VHRMA,A7H</AZJE- @4PX7N,0L( J5;:E"&:!]0MKZU\
MX' !(X?JT^_8*?Y[B1;E)WZRXN@VN-$!8@X$)\;1W1E.4F$MK"77ROH"_P"/
M[_1*(]./$<0X3G#BMIVR@V:3)9Q<=P)#0$BIPJ<+RY/*7I85M$FXY4TLS!+N
M !_H/J*8ACTC!^% _' @ W62=5Q@)Z->* 829H2K!WHIR@(V #IE<4:2U5X3
MT&4BA@!,H%AXX ^K/6-Q!*RI#B<DAN99 ]*!4NJB 8QJK6F<3 2HHT2IL=)9
MUEI\ C!QMT>S#8012XCED>)BW>-P>5*@!WCA00H*ZA2T%U1@1IA.D)$ @C%;
M(U<DHZ?(4*=*(X0 [7:7:E@4ZZ5P=OMY6FT'HBC*N"H !3>T,"2*.J65%:PA
M,IF@144L94N46H6J8D$(!A6Z?4(=)6"O;P*KTFN.4L >ZI%(,8DC% ) :"(>
M#VVH"LTL-;;YHB-"23^E(JVA?9:VJAPKQU5)&=]F8$8GIP7>(! +81ZTWM.+
M8%:]9$]BJ?'ED_H(.)0L(/?*6(B)'4X1IDL/*0 M:T/(L^HYND:BZ\K579&
M\71*N6$BY+=M#:4<EK4TEX$#22&B&$NO2[H$X%98KI3A$(LT)(FL"6(>!!&[
M9V # P" *] 4"!-;,]6+JE=W:0P#+<RP%@QWC'0"F]%M@5R!P4R16&U[AZ(
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M^T)Y5Z :J"V!R>88AU[/0_\ .WP/[T^-@3_4[\J^YUR4C6T\\8 .#D    "
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M 0/8Y2P5U!EZ#8*A!1*\@;<'  X,7,$?(!C#FW JNX8 P$P+ :'(@_@)T#[
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M1!P)IX_*_$0WF'@/*0'E3C,@I@H><$T2(&B%E?;JA*/E34:JG+R@,;@QD+"
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M", 1(YW.N [!D"SLF%V .1F^ 4 >\@A66(* P*LMZE6M!.?BIA=7)P?)>VO
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M4=\:+-X2UVLG!H^.L+Q6>4.%YPP!+I+!!LJ@75(1N/H3U(U!4G$%55[6^O\
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MH]C'ZGXIKL$PV9Z^!!+WG'2>-)GD$:-@XP$(9!=#A%OAZV"82%R O(G+%>(
ME3QKL0Q8T::!H7BP+!AK$0%1@;='A.*GOS 54*R>DK^+E1,1%3E[C7T<@J'3
M:1?-\=WU.3]R?]0_V_W_ .VYKM1-<=;21R^C\G'H?0_;\4O\(2PEJC'!!;M^
MV8,F[R[!N<\2IX:+)Q7"I+=3SI4[/X!+4AW#_I\%\E7M8X"64=0*:D'-I:G)
MIP$ 88#VL!"QVJ T+$\1E;,Z+3GE VHP:XQRD!+D9@<8F6\15!@ [*K+*%!0
MWC( >B&Z5<, <0:KMX":"R("E"3.".MP.I2$V:2P,.%G[:$'8Z1"1"P\$Q I
M%LMA,"FCN;PJ2FR#FL/8)1]!QO0IRCQ2V($J1(O! <%PL[(!817569NP+TD)
M@X@E;P4Q!99\)<#>)V.:.%?5*B^ 3H:AC!"P-YM.S?0%K?@ P2Q\1PRE![@X
M*%VI#@(BT 14Z DVH -L'190AWO1(Y)4%(1F&8 22*ECW8?HG[)."V:7X*_Z
MQ]1R@B:1%P>ZE/H/']%&#9+/25/4?/Y=9-VD%6N&1=3I=2\%$10((#10B(](
MB<9 A$B'HO0ROMUK^4'""56:;K;T,8/%_P 7P "Z *;VCRXSQV4+/0$RN8\
M)HY\*E^@C\U$S!)$0J,?8<OZ\(3#>"]Y'3>S 2@GUK4!8%* N-(L&H.,LAD6
MM!$DHE8(I$5V2J6^]FV#:$30H$2),K,$1HV ,"M7.*!M$24 !+!&&CJ^*&6;
M8C2(&,8*,(BBB!.TB"61,&%IT@YP9,**,BIA#LXXOH!0@ 42  *JAG?' UZ*
M0A51 D5:AH!0"/RQ1JH&*]B\\L&2 R:!,0P4=@*\+RG111?.'P*TB<0) (E9
M4-*/(.EH8)!D82^8K* .(!L$JXDF*!B[@#?%X?Q[ =%0NAD4:4W\3J'UD(A"
MP# !PGX$C08@(K301Q$)KK8H\V-W+S(AUB +#$%J8L'^-3QZ'T/V_#JALGH/
M*!I$;LZX@]RGO74DP!%1/ 8NG*^@S@3$SB5Z=9*LH'(TI>-,D3DD82YC *F5
M$ F7$#4V-FR?ANNS:Q6]UGFM]W>2<XH(HZPW9K9WQ>4: S''LK0(A%IRA"@%
MC"$%("B6@BHD9\P K0 !N&I:8#6TYX95'N&M0F"R@\NKX8A*B44AJL>PP74C
M-D24=J4D!HJLX*C U (,RO=& "PK.,:DH !!+$ *.HL<VZSU&VE:EV(]'! L
M4M *#!2-":HA8A9. B@A&J7KNTN;?/ (@(8SPE <Q/BC@BD906%!$7D66N52
MG?%=A1(X4@HRB&:!!>+%*R)!M@=IT XP&@XW1"]AO8U2@7:ED$X=$!"6##"#
ML>5((,%4E80@:0"P+KPZ=B]A"+4AK1K\T&]T'@!@ :P)JU?U57V[SKDT)_F4
M#M[>3)QCG4D((DF"47L^?+C *Q"I<?' A$?Z>;;3A*UQ<)@@L@QLBH AW,=Y
M4)XKTJHO3E;\!RP5DO@7]@/T_-&!&BS6EGS-4*^N'*(F1C:5!.IFNO$=!)L8
MRPI$(3*AL40M "(H"  "L\!##,0I2J!5*U:DRO(EAW]D&R+!IDO;#@4C[1%O
MWN1J:O1+R1B-1X3*$(B(1-1X@(0>!C*C6GXT>*2B0@GT $+56THX@2L#+0E#
M$N0FBA1!*3> ,24B]=42A0,/>I&'?A%O;Z(<(L9CU@8(A!$ 1(HE:K!)"J$T
MHI9.J>)4)/?&"6L$0+=#5%!VX4!2V#%2% XSM$3C!U$1F JNG4V8P]^+3" P
M87%1?QC1$\) ?G8)"E%R(02K#*DP89?.9,FLV)J[ L L^#BE?. 4 J8"SRA)
M0F>QZ?(M\C^''H?0_;\:C8K!P5$D&B#@9DKZT06^&/("#AE1QXC,'7"_ %;?
M0<AY\A.'S@  =!#Z'XZ<F&2^YN%DNRV,G$@2$1>Q (>0!18>3P+9H8]"((R5
M2%&0CEH7!6J(1AH>@"T(Y'G42 ZK045CV(U4!(  ERJ+V+#3!")1Y0,@7Q8Q
M< E^6\B0]P 9X0$P,=WI@;M%3,4 0&(4(05)A-543QA&=F-$="B@<QR%P!"E
M54B5J4!H<._8B 02P540\#VOCC$% P48"0"KX5)4(D']C"!I;%%(H\3OG481
M@*94&Z4.CC:BP+G 2W=*L&.#^ZFH$^4154CN+&(M,#$)0K0URI'2.&DI<@5J
M,1[%-OG/Q0CM7V7K[ZOHZ[Q0EGKFU>R@+%D6!EQR%+D1G3 HP14F!?H;T6K%
M-5@C_I&B'DIEGR]]P!R<-!6(185O%.,"!@]62J@@JCH5E _*)[1T_1GOT'^@
M;"&65E+/F6>%AYX7B$()KK2<2G0H/$,W<\Q+8FBV")G%2<@)M#0@%&DL'D 0
MMH&(00A:03M-,*/L .BH=1Y18B<!C>H"!)9=U!" 0%"-.#42Z@PI2@CHFL0T
M0%%L *BI8(.'T$[4 +K!?!@OB>>$"$5"6] E3*( H17F"#'I!"Q!F"@;Q!)A
MU0 "[;"A2@CB0 ([3RFA("&-1%X!#@Z,A"!E%!B"LH$YY6FB?(2I)2/Q-$-1
MZ-\#0?)8Y>N&8)C +T2**PJAR4S"49"P%$H<"F-F$<GPZ+0/*%'QC')5@UQC
MH./<!X:"X+ T @@_AQZ'T/V_$^C>'-5;JWCU%!9#>R$DH:S"!P02F5EQ=@9C
M!ST&8UD*"T7X8G0P*%V;H:@U$.NT0\CQX,@AHGJ0!$VT0@A%@0:5"3H2IJW@
M  HP6$P$.,02Q2"N,G<N?4%TKYD':DI)$$%$.@N +86F/ 9Z).JVT@J\[#Q1
M @8T8!L*8.@[!=6! Z#0<,#51@-%%/1!@^J,KR"!8:3?!2B* CI'1((H0$$.
MF#[:8CM.Y'@DJN,D0V8$]FB,[$24:.40L!3K"TI'BC2*)C8($"R "*"M;R@A
M'*# D)$&A@4\K@$=%8*4B :5D "P.EK K0 F(/85.$!$3D J0J&/1E152^,I
M !I=B 18"JVHBMTS-D+O$59 5] %E9D?.NL[L+B#4G$6DNT9)J^#IJNP <QH
M@B(CTCB/L3$]<=);O:\E79X;VU[Y<H<&"?76T'HTZS)V6E#B1&S;.(4_?]['
M1J.ADQ0?T"(YJM47D7M:W$O#@  8K44*%%K'#WTJ8]5# /;FH0>'T2_[$8>M
M7!XQ6ME4#*O  ?Y=7^@Y98!B(T3Z)>/JY(2R@FIZ(5AK0 ?#M-1Y9*5X@T ;
MTFH)):Y.RA5-7@)U"\]ZK=@X1OF9Q6$)@*6!X*22?-A 8E<KD.R,%M]&<! D
M6Z,CJOSUW$A -&0T"'@R 4B>0$8&D"  8 2@JM;VQRAL0KGU*A.?($55)5C@
MH* ;@@[E%0\#%1D'"3 2A $,!(,R]E/6*%NU01 8,Y!#Q!"@2#Q,!>+@+8 "
M@8%M,"*/RN* %N>6)^+DR\5ES*<$+J"9S'N$9W#;K1BUPXQ'E5F@WP8$H54&
M</??X<>A]#]OR=<$I"A5 S5J JZNOXH!11$3V)$_QS:[=D7 6^,"S&5WFPZ$
MLSXSKO;+Y+O%4IT,ZN.=-,:-,<#@Y +.S4@]^_!G0X!S)B89\P^UT+8]3BJ;
M*"?  O< $LAO;0@$@!EA?E>JE[3&F<[B=&^1"7ZP^D AR^D2;J 26&'B/?MM
MJ;=='R:/Z72=G,4H:1@VT_5?\O%#"C'B20G6=23QR@<%3N-&][(2V!#,X&B4
M,,/)V>U'ZIUG T(?(]&M5L?\^@>8XCX)VNY'LG>536\^=!&]A#;8'18.A=Y@
MP .X"!+(7UWO8/%0X$0TT#TW 'Z#WO-<+;9YC]H)UAE.93&.I8(%[H*:QEF<
M";76&&4($%*A"[+5_#WY$8#M^$T?.CBG' *JF=S%>!E-6:1648H WD"($@<
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MCJHU:@EGFT>P&_"H"%U0X#=-> )\^ZB@8E*07MS6<TH!I=WY,(D$:9% 1D?
MIHLI6M<V0_:-S$27XNE320\V7CPD1.\A*.#&&>\9\/M)O%VVRG4  50?DPH"
MNKSVHW;X3F$'/#(YMS9&KOH_)G$3PU480#6IGEQ#8OB.SY;N8=(Z7O*IO$]P
M\>>XS; *9YN4XNJ$8 !,@#0XJZZTBNP%+3+0=*6<' &N/A?'8UQZNJ5)*-/[
MOA:D89]* 03PXM%&"4SKKJ37A9:JA^O<^^$98G&KYC^D#PO1/$WWEJBZ!#]$
MX@D"?\)4+RY6+R70TTS(_P!NA@(]![)$I9@R,!ZK.C"#73"'.2=X.UC?,%][
M)T@/B7^XO0 5Y@DR"Y\\OO.J.X3@S%<;\MZWMPV:4X43!N& ?(D'\)T%.$!6
M&^\NJ8JX*@]DUJC* 2DUE"*3/T3'0 W3.)7(V((P9/9X8_ID2Z7X6[[5LC$Z
MY).4RY>Q=<&V"2P6^LOJDKT,!35AP=HF&4E_N99T\J1PG5UB,7(L@')PE?FW
M#]/ZR_\ H#1EK)3$BM,(4\\7[><1P*@EUM$,/1N67GQ0HR4/"$I_'(P_AXA<
M6/C#&&U:ZE'M'AY6PKZ>0=W9H*TI%'R*?)X_9C_H/KV0X_,A7=G<538.EPVK
MF\UPZ)75VA,5(W!A1&\UE!IL%K3F"4?E,FU3:[=/83"2O4:DH;8.F;GD;HFS
M\_-MQ5JH3'#:!<J">(L1\R[AU; "&97H.9HC4Q,;*>-ZB.IN3@"F!]B@*L#J
MO@/JX^ W&X6R:J7GNJ-VZG<[/_/?@<K2="V5XX6_#  BPX6 N@%A!(%86P?*
MV:<4,J1$NP3SQ<8:R2AM$N7O6X+ 18I*W&HIX-_U^4H(J0[LYN72&,.=VC_7
MTNWXP<-64-00#/W*;A &>(#0H=L9=^A^M"-@0IR",QGV'H"5..CA*0N2_P 9
M<8]OJ[Z^W5.H/2K#'E6Q5GD "1H**[MY"L%*JCI$Z]6GHUR ,$Q"!C4&%+@^
M: _! M]W-:6N8 8<>,33>(PI2X$G*HZ8ZI!0NT<ZZP6X JP.#5 K: OX :B5
M7P! *G.E%5UV!"HF&]R]Q"(/%$8U6L:/&1QD6=CC'KV9+?04-%TTF/'9;;"1
M-O5@6OX>FQHCN[6MHQ9D;E6AV;!;3'#=+/)HA0#OW=XOO>861N9.#[T+A=;:
M*3/NKAR$-@+T<ZTT%5 1$M<"@-N&$\J$*-1.("@1:[JJ3H4O;$!N / &! C\
MZE:\46M$4\XND%7\ &B(%11\JM5_=6^BM3] 8@@H/R3M=$R.IH%=4 5,#*M>
MBAA$DIQ6DHY_ETC@FVP907F)3@;8H%A7X!US0/-  8>U)A'T)T6U+,G<B1]D
MXC(1@.W86U:7SBJ<<OB*/XXOV\JV<;=E4Q$B(VQ1@Q *( @4+H\KYSIJ!T:+
M[2W>JA'/I2WFZQSR,FWADG)-WF3,5H+ ]9+T7)C#!F"9%M=30-IBCR]=P?0#
M-Y4+\@$WG<=-BV\$(BP#D>\Q('Q2)S2/ !Q6=6RJ2.5N1_HLXKY%ZLN!;J;$
M[O%.0Q7M"Z+..JY%F1.,ZD'02&P<#(SA9D:V+CF*YJ-[(D% KP%?P%?^AT5@
M]D4&>]&W9N "DH8:4A ) 5- <)F-ZNZ !)QU>#\. !CQF,:(35B @VLB.21\
MD!7PAMGV=? 97B+3?1P.(6(#T04=\.]/>3\(W/2/?# 9HG+[?)"DV^-Q*:&2
MU@%\[[0#7F63Y\DS(<H-7W2BN@SYDK036ODQ:'IZ32;0 2 R 'S3)2HDE4\K
M'MPB17QR<Y-XX\H/JBY+T 4N/L8[8YR6(B4H0.:I<Q>3TP$)?Z-W*Z"6J8H
M$,?U$Z^N#9V(<[&\3:'U*X92<;=P[I@(BYS!>*&,<HEY]A1O Q#"1(O>/YH*
M?2_$^#6AVW6ZG[C+(F]M>SA!?_O<O>Z1 "E@*M@@7@ $  'N)A%> IX8'YB6
M?%P*'1$&$2 (L 1/R)SM98&2B"<4X^,JJJJJJM5>JKU5\OL552N=57A#KW@
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M$XQH.%(4R3"9 )>NZ5PU4?A$1#P@H%""D03\2"]1%+5Q\B4%,'T15I(<" &
MIW3]#/LHGA*8R7(41'H 2%Z$1@E*DG4*D$PBE; -(D(414(B1$1B9-B#]&W^
M3""D> 76,'R@'RX.<"SA7RII/KPG=PK>A14NKP4$$9 V5Y$ LK!O%"Y9[8B
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4%BQ8L6+%BP^=Z%B&!4I4H?(;_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>businessfigure27a1a.jpg
<TEXT>
begin 644 businessfigure27a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M/$<;FXV/+]3&R>[U?6?1[3;>PZ>+P<NC=5W^1?%=NUZ+?VW>=@
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M'6?S\\[],ZX[C7^C_9?*YI(  PBB$H:(UO=('3=RY8T#VB%IS-T]SHO6OO\
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ML')U[KVX[WVC10!^F66@%;(<TIEPZSRU^41$Q>*7FZS4;UE8FX4MN;%E
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MU>I\<]9\Y1GUEXAN'Y0].N/4?078^]^L7 D@
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M<G/P*<:C<?6]B\K;-I<S<P       !5>O[;F?1_4_J8W5L^B[6V#40!,EC
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MTO0+TNU+V&LZHRXZE:-X8LNW<60#C?E<6H6C/*O:LO$XDNA,&;H#!F$R6,
M    U[>M7M2J6C-,J$!,6>+5JU:=:MTI:^TO5+5U?DIN?%DW?BRC&1DI'B>P
M  *V0Y@HJUZ_AY&1"0B?J63"O6B+F+M2^%,?)@3$C6?R6&C-3%S'D9<+!%JI
M:M:M79..^%*,F)F)L5;     "9+&      "E6I1KUG(G$/<SXFI7K-5F.F,^
M)]@2\3?Z7     %;(<                    F2Q@
M$:88                   !FDB
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M,2P4<Q7(090M/AQI%V!B'ADUR"2ZS6H)C#*Y'OQ\'7VH@9-4KR$EQ<>>KTQ
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MXF$Y/ASP4\PU!;+?*\0](;Y@IFQ@^4:G)&IW\R?<;^Q4P\FQW"4D@"P.1C6
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M-JK5M.+JU:<:0A#2/>5;J^$V81'-#%<64264/P_3M+CR*W$F?,GY@)B-DR/
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ME68J2@G30C%>XRHR>+^(Z4_FA+BUVIQ M64Q_J9;C8]6RFD::=PH2/M 8!!
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MPQ(X+@*KLQAZ0:7&EQ*95*-36)%.4^ZU55$2(467/FM0)*Z+(1(C*CIF*ES
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M(*Y4I[BO-<>":=&U]D @=#C\\\NC'"/ S">B?S?[3;_FERWEGXJ./SSS?O\
MA+@9]/5/YO\ 9K_\T26RL7\E8^G>$)1M4.!D1;^L]P_7ZA#6G^9$:H"HQM.B
M#9)ZG H_!M3TI/%,FD2%>I#XLI_*CDG9L5FE&2PD] N1$81U4I/2I\(\14D,
MN2*:Y(B25AN)4*6M%6ITM:O50Q,IY?:+BOLLKR/';EWPG@>=$;0_Q-4:9PDP
MM(6EJKO*=J[B3J"S0H(?J.HV[0B,GQ4,9O1Y3]$L\3\3NC[;KL3ANGJ(]EMM
M%1J"D$[9EM*MN!?3\ZJ0S_\ (<!<+,CHJH+J]7>]Y5)GMMD^/U5CX#'YZO\
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MI2IN4A 25*7W RXBZ[J"E&X(])+/#R#!7 $6/6$J6U4H,0(0EIK('FU/M)0
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MG&5-@+"PT Z6(M;Y:8R(]D?U8_B!C(FULH&WW"P^0PAL(OUO:^@&VVG]?#;
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MULRLV?U3KT-K'316.4?!)U<N#XK5<*VW2-/B;''+5FR=>_\ 6V(.K92.EM_
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M*01S'W;'E16!]IYXC*D;(3F=79M"CBN5>57JM.J\RW/FOETI3ZC2+!#+#?\
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M7@GP2I;256]HJ/7^W>->'T\U-:C1UN9B1/Y5U*9-AEE<L:EI5BF1E!R*RND
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MHD(/=<92K3$7A)$&.U4^,I;G#]/=0'8M-2A+G$U71ND0:8L@PV'-OI&I<EA
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ME2%:&^A!/EKH<!TZ @GU,Q\U^&EK#3<CXG"G"%6RW * 3>WKG2PZV^'EAPD
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MVVOVX$D@%@Y _P"][?"^MMK\9F%S<W)N?4@WO]^O'-D&SGOY=S>^V]];]NW
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M0     !H - !Y ?JZG^H^*,/J=H,;H9L)E/;VVA9JZ@O^])"U9$OGE4<>-<
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M+WT_'@Q,'Y>F;ROL?)CL"._EP*63-E.47* $L+$OJ OF;:VX>!@6M8J+96)
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M-^]IK_$-+%Z?5LC :MD4^2ODU)8M<D'L1\-@(DZQF-Q902M@&SA3WU&O;7S
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MX]JDOFLA-P1=?=*KD!'V#[]>!/(.4-/FKE;C?-?WO/>P\AMP:F0V]W0H=O\
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M6XTZ;ZB(2&_5]FG?R' @!MUVS6R]'FF?JZM/+2_'(]VS:.5 Z=;%<VO4=O\
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MJ2T71[A2XL+#("+J;G4DYO=7]XG?B:02<NQ=LB%2S[DERWF>Q_L)0A ^EF)
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M5P"S8L&BC492=>6Y')73R?*M^C[*:^O,&P./7<<0CSG3,;I_W@_LQ_C\(8K
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M*T)1W6)?(&(<89Q8Q-2CDTXZ2LVV783-F[895?61<34.I7948 [4Y,JCKO-
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M['3]$S(;MHY I]8-?9WK[]>_CLNBO2M9!&6N9:O<JT*R[-\PJ8EEQ!5H;8K
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M49 I8"4ZVJ7H:N=6\&/7<4]MNSU"\2[GXP&'9LM9LH-[ZPP<0L?51ZKP</\
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M)(0E JDMBDA"DPM<D,OQE>@JHENI@2Y:TT6AQ4X6O="7M9)/JXW;63S)(.4
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MLRPYY%*Q7B'GV=M^C)RMS+X1^4L0NTK'J4..PB,O?9J:GQZR#)==(#\I("1
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M$S*6IB!<#-L:/HU:%7'<U4I%Z*RGDD9#'I*(3:YJ3$Z^*Q]<HD8.%54REB7
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MQ2OI(:]Y0=VZ/ 7?HZLV8\4<IPG %W[9UB8TGCUE%S(\H.N/4C/_ -&2./\
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M*?*([^*URH];ZUU 6JK0+N?7,8,7+B="D-LQ,SIX?G:3Q'C"=TS ^,?%(^U
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M<S\]LQ'V%>J'^(G/[?@LK'N)E=ZQF/."-1C&GUZSP52N<0V*I)C]%G+D>_\
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M430F B[UE:O1N4XH..FF;9&NOD4&ZNQA6$BBPLY4V*U['V+5.Z 2T)3\G_Y
MW*U1.;]%0R:PC=U-42G?&V._FH&9,)CS""#O\/$:SQZT%'[_ !@)3_WF.-HR
M C'S1B(C_M'"\=0C=8L3IKIX$K_M+#9]RE1WS/SIT =2*(XJ8RK\C45"X*?:
M87M,:?Z;623"_2*?R\G]0X^(_5R73_C,_!C[,-T'5J(7OVSS8]=#5CKJ10,3
MN(8F0B!UTB> P&+P%3<M=>&9BP;KG/WI$I,:@=.M13/M";6S$_:C02S&&K7:
MWSR17;19I_PS!EA.OT0Q??[RC@+V/9,C[+D,T&S5;[TV%Q,[2_-*-5L'Q+*8
MX;C\DCGUF2)QH4K<AZ^]-JJ\-&5K2"\:7KF""?I&9B3I=IV%=Q9 :L?VM!?A
M\0R*:O:12X^)6_(!R0QT-J>]G(;,ZJF)B1E:Y&8F)&8D(TD9CNF)CRF.Z8\O
MR()]=#B'V2:E;)']4F,S'$",0(QY",1$1^J([H_(QUBZ;/6]<BO6KJ.S=NV#
M6GEUJ=5>K'N,H\HT ?:88#$SPC+]JE"BO68-C$=EA.'(IM'O5?S;!]7?RH^:
MJX[J5 O9YKHWQ\'=$_\ ;BU@Z]DYR51CEFDDL@&=/\L271$J(5]\%J03K$QI
M/PO^K(Y*(_5UKOA'['^?P+BY4JVX2<L3%JNJQ"F$LE$:^:![")1FHB'2269!
M.HE,<1T6+Q]*1@X Z5.O48OF*Y)RIB%K-9RKU>\)@MF@ZZ1$<7UQ4C(#DXJC
M<C*JI6@:ND;F50E*Z=>L4J;8>Z7L2RVUS)8ZPPH'02G%XZ2! 50*:-;4*RA8
M"JPSRO"A0.<*TQZL!:T1&(86L5GB=888@Y.D%,"9TRF(K+<%FI;KN766T^EA
MB2*H7CJDDN_BCAFXNE;QF-2A-*I?KJO+2-97(241:!OK17J/.]N=Q=_BGBFR
M,)B.9C@%>/9Z,I;Z*P*3 *9\G=6 #F3 4R$ 4R0Z3.O$Y.,=0C)3&V<AT=;K
MIB1Y<ZV^7SYU7ZN?'WAX)\/=PP,?1IT :R6M"E515%C9_M&"@ @ST[MQ:SIW
M?^0']F/\>&/1S<>]DR1E5V\DSGS(JYQ(:S[^7R]?.>_B.@LT\@,SY-W46C]?
M]NLX^G20GZ!GB)OW*=)7SAK;[;_U1)BE(S]?K=/S9XE5-7B/3G6&3OL/F/*6
M,[NZ/F@,"L/FA&L_U%N/[VG2;'_MLMJ+_P#U_P#?X#-%UHX_",/'XP:YD C*
MX@;[QD9[SL6.8!G\Y:P#V8XZ6M1&]D!\5BW8*86ILQKLF8B6N;I,27B 0[HW
M3.L0NI?4I!6"Y:6*DI2;)]E1B>LA)>0%ND9+PSI,QQC,I7G8L[::622/A"S1
MM.!+88,=TDG=%A)::@Q?=W$6LQ]$\9.M([HL8Z\G;IKNYE5HQ&GO[YCCL[8K
M-@)9A<=O6>IUS,*P+.8C7>DI,"UE<[=?:44\?&5DC]/Y1$_J>$:#_P"["I^K
MC<,P0_G#,%'_ 'CN_)T,X@I\@]ID_96.IS^P>/ '3A_>V(U9_P!%>)[OUN(?
M^7/&!$=S#I]G<]=:UD[V[K-G'T4S,^0#/KH 5P QI,1'G\!&9"  )&9G,"
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MB]!@1/\ :WS&L$?^R'.LS^HEJ^LAX!W:*NG).4$@J5+*ER@*/$OGH9%UR_\
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MU '_ .F(_JQ^Q_GPKL_Z&RY*9B693^D$(#T&LP?R/1C+&_?&0./7"O9IR_\
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MZY2(<ROO=86MFH7L:O )+*XU%W(7$'FP53C%4\=BLGS4W2Q^K;SEY>NCI)K
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MSK&373;RK/:VQV8I)K)7C9$MC06^>HD#"KO%K7V8B66O_AY#6XKK(RXCF9
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M^^),II*>LM,!UFQWCI++#E+>[=$@QX"XAEL;N+ED\%BCL9!;U7G%35++2K)
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MSSAC!'6SH8K'0S8(2+D7U':SY,L=OMYRB7<JHU #L6AKTDW;Z&^]M"EU2'5
M=%.!XCT6>X[(&5$(C$3P0G!%Y)I/7]O38\.N .!^#IC3VX':S3$*ABK0<4R*
MI/;@"P\R@H;=M)@-<^V/<W:6\D@,Q*EX[O<?>?K2I(AN:GO?PZ']RG:F6OV8
M!3;Y\K/%9V-QJ2D9 6+.&,+NO:UH_P!I.) 0F$U/R1(#JPPT>8RJ)&ZH%@!
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MC3VH2:A&Q.V7KV>@?A1'N?66Y*[MX#-TCY&:N8GRD'5\- - ]6ODAIMN71C
MTP@@0NKX:C=E.$R85<6;V)/T3WB1%$'W Y'1,='.J9QZ5E^)/_1]/S/+P>7P
M=<(D=H%:4CX?( Y3,RV":93$V@/2X6(I3EP\E;K!-F#;DIJ77*RK=7N^BP0<
M$HLZ*/N$TL<M&EV0"QCDS.N.5,NS[ 'HD[MPM^6$D'! %\(L[/.X5NHPUY#%
M55>55^[Z^VXGW2R6Y:.'Z/A>>=1;\#]B\7QSG HE508]?0%HP1?Z N.(^Z^8
M*Q;@?@95.!ONG>I[E%7-(42;1NT-T##8J6@*"8UA8$T1F#Q1(IE6T%CM-:8*
MT=";R_N_3< JM0,78ZH8FDJZ@ H207@<<"XW\H4V#B;127]ZU_D)^Z\GHV!_
M^W4G_LX9K^N)IGV2PCMF8&O+F_$\=#M#8P5(X,.BHBQ(UBT& &^'%"I*+B,)
M1.4S:2O";]BA4S*4U"$U0 =P(-$@!<W#8!VF%[*D@0F-S<2^[=L(M$1 .]IH
M(D4)2!0;04UA[V)WO)AOJ:B<;3V@^#9N1$C#+,\!AZ-!;Z;;1T<IK[E-M;C;
MC8"1CVF07 GT!N=633DP(/F"C\UI+6L +M"XNN$<$C?2ISXG<?8JV@K0"M9#
M.W=A/A&#[B'B3&UCP;H,TN@:#*E_60Q0.4^YOJ%0[H>^!>N;S<WQ.ZS6U)FS
MPO9T^<0^E;1D()W<O7@IT>1P;O1QS@+KP&.Q3.Z_7U:0G2"1VF7KKL^D8)K[
M"KDO9WMB(HZ32=GT?FW^$AX?S/OZ,VJTB%HV $3KAE'/A4OAW=MW$KY1[@LO
M)IX=)1P82^*'O$RR-"F\#GV$^&\B;RO5]%#_ +(\!SSW+Z2)6"=<77<Q'(I>
M9TEY1,4X#H^@OXM.I]]SI.B.N)55WNU>SZ_"\\#)*V>-Z1TI7#C:<]>D*.+L
M7A5N1PK$+!O>)ZZ8)0*)*K%,Q\A^A>-#++EQR?J'_;VJO'.UWX]]AQD[SO&U
MZ%1(8E[3Z65*N5KT+3798<Q4W[#=Z9MH@$U(Z.2, (\JJW<H)X:<$*MKB!-O
M ),#9!\DN,C5JC04H8RV!?[)\=8VD3G!N0<X);V8AY77_P#"!#-S]G]&/]'^
M&V?.,!&M3JX"C  ('*%0/8[]Z+^SOJP'B'KM?L9UHU>&)R!.)//*]858JHB<
MY59!$I%/<(H=]D$9HG"HM#^F L11%:JR5P1UC&@<2")6^0]QX@)5S+5#=B28
M>ZKU1;N2Q<@ '\@Q'LW"YWVZJ_9CEWO;'[..>0^Z,.L\G$0 Q.#E&!/ME_;3
MPG' 5HHA5#.B#;-1 +)#GN5/8]/KHK0YX#?>K[]GHL-@(%'%$JZ#;ZU+N@'2
MC7G0=S,.B I:1M4'J,R=2X1^Q5_U@VN7Y"]M]9! ,@06NW"U;"7K/,GY-F'<
MW7(= .N=)YPZJ#1BV_4_RQ/5^*_]U?O[(<-?7,!W95AZK:48Z[_!WZ!S8'TB
M4I2E.YU/R8QNUKS/<CCPGK\+S]*@;&)+==36+7*ZDI"J)$U,<(<XIOY#]I8>
MR<EF0H&ZH%,1XY:/!ONY$B(!>!8=9<0G*0HF&,"+B5,6Y"U/AL@&VMWLI9:;
MZE/93[(L77Q_-62Z[=/Z*:155R$K8+:"TF^@;N2-&PV'?8_W@'@H)?:!_K-9
MK#34 5L6;V]Q"/<P+&_#^(U/K5:G(._L$^XWZ6IXYP"# 5@);FZ!40JE+0(E
M!$PD<)&+Y1..'%Y.*T<T$]V#VHA,]6B$&\LD'![@T.%60K##+J]N7AI):RRZ
M5@N4"D?H^$G2+)IP$ PANP@/ 'T(<.CYGT"  ;D2YO1EE.39G%TJJK5VKROH
M;2CN)_Z,3@"D"+);2DS5?3@=.A/#OW?7X7GZ"DB@E?)?U%U?.[[MC3+X&:$)
M,US"_":Y>#+SO4=V"1"1R7).E-V860)@!:1/>]_FC:1SL@@(]$1@2+8MJP.C
M,91IQ8$;VCD'6R#D>@< ="&O\"0Z6W @HROMJ]HEQ90(SGHM^,(R"R\N4+3N
M<N+CET,7$6=2T957;9W1^OY1(?VN(5ARZ,AL$B*DNTF_6,+(!8,!I!@3B3(<
M_4&93\QQLBS;+$V<)LT70# V%H7O&7\X(@SL&Y6)4@CN=<U?B/\ +!6G.N0Q
M]8^KO9,">QO7!]>X0?LZOP_2P<?*_8G\^SBM^Y3N>KMW=/6':PGH( SK"QUB
M0W&H5$; "R 8RTN9;?6&JK+.W0K#=G5I #QAD$,)W)B%Z>9Q<(!77,$G=W48
M*AW0]\X-)GQ4)Y]22P1T%O1,\K!Y6#RL'E8/*P>5@\K!Y6#RL'E8/*P>5@\K
M!Y6#RL'E8/*P>5@\K!Y6#RL'E8/*P>5@\K!Y6#RL'E8/*P>5@\K!Y6#RL'E8
M/*P>5@\K!Y6#RL'E8/*P-I(1Z WU7^368?(6_P!D#ESX;N90C3'=V7=TKL-Z
MXV"'#R(!\.8QC$[E2;(0YJ,A'(S[?@&%YV2ZXXU_MY#S4?MD$%HCOT/R4Q'_
M "KH+M)93;E!Z-[[;8'JWO\ ];@$:;=$?8SRWYSMJ>6_>D]B800-O]05HV-%
MFC%N^VJ94V!0P1"B8*G4#[+A[@]-&\G:E>*&G$X3T9<H,"N(A^S0FC!P@$SI
MF"P3$@D1UJ6/-PR!H.*<K#&/!%/29"]I/!*LMNX==.=Y,&=E[/- >7";HF\V
M6*,<?E[WY?YG0 AE1A>!XTYY B<6GV .E#LR%DHQEY0+. I@6-D)!SI7D=<2
MXGP6:V0X0W5998X(?'FU1* Y1'-SMY?3A$SPW#\"H\@%8]0Q1YWU]MR8.P8E
MNPH*@J(TP$#-^XR@,'! =M30D,\1&DZ\ 6B!/0H:Y>C'<*C9\J8E1UISI6]=
M/!X'H5 &"LV7#'B:A'&8A(.DD"6M:B.'."M<;'Y?UI&."51;HV-"RMXY(08B
MK?/X%.A2)G5V'[$L]E.G[_S9!U+N(6O CXU:XG'_ %^'2?9-)U-9LMI!NI%E
MW(7BJ8T/#1M=P%-YTP',S!8B$@<$  ]=?SBQ;M6@</HP-D,=33>'P"WG/P:!
M*].*&N;=([6N+%M':CM--P/8BA(PD:] (_+$TZ-: YU*G%<U,/KMQ2L. LL#
MNBJ5Y6OW?1WVHVQBITY$1QV)==#QK)A,D!9U0#<;:G<&KCD=.B778J!6-.H^
M'A,N,''DBA2/73\?=NO D?J28A$U+.A_Q63)DR9,F3)DR9,F3)DR9,F3)DR9
M,F3)DR9,F3)DR9,F3)DR9&P(5N@ZZ#^6.%K( #&-;Q#.!;<3%I):04G73P5B
MDKLN%8M!BXI^0@8[I%X&Z!SF@-A0J#S9<.8&%17K8WL"EKZZG:1&"[PCZ5\P
M)8@(&)4CRH1$<=@0CKUT6Z;??3)3I#REE<)+8V@Y*;26JH"%J( "FW%@3.3N
M5XN-)ZG""&Q"-#S=B#]E 6[5@#SG%P0!<BYIA:70&4( J@8A*339D <Y1% $
M;/.A$_=5-G:P<Y5)P==QE\4-*P'<Q7(O3;==L4->5%_G \ZSF&[J :B8%@ZA
M2XK7)U:1X\_X)SH^;T'U]<!6[C/A>>2^_P#17:-C\E&2O_#6!5=AU$$$P(]^
MZP9MHC?#38Y=D0@L@>2&]'"U4Y*E.F-7!"-M'*ZB0!4->L?*S@0-5H)BVXF#
MVMHJ_?A$5';.B=:%OWA8+0A1DLEY*2WS0$%MDPH3LCYDVZY5MAJB/?"#O03T
MD Q#CAD)!/G!E$I.RGM_BB(9/K Q)HB#@S@DV00Y '+)BQGJAEHEM9PD W[I
MP71TFVC-#FEE&HW2J6*K"KZG81X+:)D561O"Z/-@9W='\ "]BCV@H=ND4%'@
MX9 +Y,@>=?Q#QAX3^? PEI"/-MXM!/3MNV>:]P;"S9H@J%)FR /31 ( $ 0(
MAH"B:11)BB%V 8*O-OJ%,AW#4.-_#>X*$PB*X6*?3YNVH&74 KBCFDF3);5"
MR ;41\GD>AVZ<!)OQ'?MQ-4VC\G878JB8G<-HJS0"TDB9-J4C?TUM$-\1#P'
MY *5#OFA8"TJ+OB?22)X=%T5-?K$SW @P%/@<I4.N;5EFZB_?E$V0)325P\"
M9];R4HL1U-]DM7K%DP^4 80:8H>PE "_<FRH%=IQGC^8Q1K^@.&0N!>))3(]
MJ7KNPC>&2O09#<I[ O2&51W3[O\ BR(=0=!*&-"A5D@(@ 5U;!!(HN@%@B:=
M??Z7\Q2O&B&M&4#DG8E43>6O5$89U%T/E9)RP55)A/9RP]<T"(GM!B Y(1:&
MH!6!C]12SC2%\#:NNA83)-4^/O\ V2E+7D!I53NNI2 CZ4.0! @L0H@@30MA
MAWJ$F8_)HPYT8]!NBEFWE5B8NBCELB<EWC-^P9<P<5POD>!/FW!W;#^ZYETG
MQ@.V(+1:.#6U308.Z%&YC,$ALHCHY !4>;!?QR/J'?0Y8$3.;"<R?I0\@SQZ
M7^*T(6PKRN7FO[Q13$M!M90=%89V=5E0!TYFH&K[2QR=B#R:#!I"V@G].\W_
M -)H@>:*&CK1G/9#Y3NUB-U@@LO0#]55Z%='O<X&U&@Q7MBLZ#1_5$/"D^GR
M MU!,V>U3OG68]&^')GE4//ZW%W(T"9Y UV=H1.NT\X10GA#?LIA%".4<^Z&
M>")<G:F7IL/.1#A:7NM;^EOA5CFZ6<H%EL06VR9>S[@S_;D;MIQJIO"G\/>?
MN!N/SXQ[YUZ>N:+H[Z??/^T ?V#?X6<^;KG#Q'#W>/%SK,76CW1ST,=7A)H)
M U%H5U18'D?P?"\\WT&1[%D4>=BTSI<57'E(Z%XEU(4BA$08<C1:"]QYF3=@
MUF *,1"@H @A+U,;#[]U$P^DD& =)S/4[H:Q[19/N"((C51 7$S ,_Y2%43)
MRX8&E-&AS/@ !Y"4R]CJ%5))29@1B>+E1@JZZ03:=8X@>S2ZC7@;<KKQK%7,
M,)P G?,*3I.;>?/Z7;RJ8:/1'-";&/8 JA./\1T"I>D9TGI\>3=TRA]KWUPH
MJ#D< I:4!Z;GD'#0\ZJUZ-=TV\PFK?ZY " G("/W'3C-0[N>Z8S2=W/<,
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MZ$86M!2NK5?8;(M"Q+Y,VUVZ"SP?)3..%-GJG'0B-)F%H&CP,G0HQXS*B!&
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M12,"3*H&R!O9S7DP/#V5#/&>9$00-\T%RU):&EX=I!_P'8 PR'ZZCI#"?H8
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MS/?[<SW^W.]L4<4;W?\ '/_:  P# 0 "  ,    0      D@$      @
M                @##(         8@     WY1;40$F:            @%Z
M0     $@ ':<@   %%P>MBV[?\            @!?T     @@@JF    %^'V
M?[L5.9@X           @:0C    $@@@J5 $@ ^H!&9I0R<.Z0
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M(_@ !( 3#R"@                             B/ +"4(+&,RX
M                     $$$@ P!NL GL@H @]AYUZ(             @
M   D$ !6SD D@  "-J&?7[30             @       $  V*P  $   <VB
MZ2$OX         ?G  @       D @ CD      !=+I1HO5        !>EP @
M        $ @  $     #XI!X<BSE?H%L   "M@@ @
M$G"#<5(5*"I#O   '[/X @      .,^Z:B-\0\   #"6T0KP0'J;"X   !Z%
M8 @      ^  D"ZAAWO   $]J.;I%VGAEA)   %\M( @      (7;Q?,\$!J
MP  #JFV#I>@&SW=^_P  !T_Q0(      (9;P;VXP&!@   /3&JZ8!5/#N!6"
M0     (      !V5<%T>0                          (
M       )))))))))))))))))))))
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M@N 5#Z1U#>Z,GB%.SP#Q^5789SVSQ;E7!S7.H#:0Z$ 4RWE"UB () P!8AG
MG7R_E:OW5J^77]$@H*#!JO /*H!VJ!S-E'*MG EDB)SLW #/B)BB4455%YLS
M3#)+4(Y3#BQ 5@ &T1XY^J.-*1EA\DR-'(JC':_C%L[(8B*\AQB%+,#N),@:
M/I_F1&4A6D%8  0 !Z @?U]%,[- JHKA6!JR?.G#EU(Z.D"((H0(*$03GAGC
M;Y]G4K.[^.4ZIOCV<I[,[WC0P)77M PJZG1SS//KS_7.SPR0BCQY!40@J<IF
MF];W]O?#026(VQ5_2)OKU.#SM46118,D:)HGAE/?E/R=GW/)RAM("_@*OX-?
MC>" 0$\(E$_&\I[/[Y$@1/S:?<QYLL@E=A5?F,_WRGL_OE/??7SRH +3O0'7
MM!^>4S36&]OH]_C@E!-/R)\B(CRGL]=G?KE+*7UY_KE/9_?$ KT"N*P[0!7X
M@WQ>88:?!V#?7G@@#? .014C@667W^UXZ)4E441$B@?A>;0Y(%1#$!862)*\
M6T;! !JA+=""$$Y%@2"-066A8!@8(";^H(=(OL%>&N;Z(UY+G=286#LRP7 [
M3L)4]AUG .Q"P'_*^U5?+S"0:%9U"@L$L11/2U-HN?\ PB?&?Z'FBP-)1W7.
ML'B?301$HXCTGIY$()"PYK$R,>X B"(B")TCHGPG[#^#J*#0BE"(T)'A-40B
MB$L,+HE<GO@YXF-DHEB46C1!..Y7P2H0M\81$-'D+7V";=[2): ,1_8@X@GI
M+R_ITWKOR."["$/#+""&;F+]%]')<^Q]AXZ]M $P>+:(2\+!AE[*'WYL'*"2
MFX%#$EJM #AB+(*<AVQ8?(SLHM4&D*+2M!0$"M(0<$HZ\BLBN*PH$I2AQ;0H
MPC?8 -0,( 63A'K$(2VVU"#I"KPP@J; ,8;>"J,L@(B10H!X8U'6&@AE \(B
M6-NB42(0*5!H7'@ (,EK9B0(+>4GAQ\*LPZ!TP8HFA<E!-8K(PZ2A)AB>.'5
M0&1EX&RU2J7R3B36J+VV(H-%<.'I:@3N!00^B43%\]0:K)81(($=T"2<W@D5
MUT\/0!&&C'8B=NTP(5B*0)&@!PD/:GI*5E:(K+\'3E02" &4K#,C8PAQ6 F,
MT1#<B!#.#!()>B4&AHJ3$H0'M6%32U2@4($!5(A%*]WI0"3!54$*8JZXLT5J
MS:Q79W:D'3O!D F5B%L @T31[ <R*C=5*88"#X#Z@^0$_LG%F@A4-ZY[#:'R
M<>+*:+@G4M*-4>'!I2HP:!R$T;$X-<PDW;RS5@( JPRS2=O.#>\N]?:\B2K@
M$(P=C$#9TC]07.]BM&X<5 D'%A76H3R+"_8*&$$1*(B>QQ./ST@#6HT( 55>
M%:"@I,#;I&WKA9=Q@HMN)&-)5A'DJ=J+6"%GMK]B7W/,8# %0Y2EHP]F@\!D
M$P&-?3/0B+$I$6,!U9_<G,3@%([*!BP0+'XXDHBA- X &D1PL '+M@Q= X@;
M@R(2O9Q**@+)H$ *'A.V)PL 4)$8TR:"")%GI3@V9M&-HL>"J@"0:T%MW=AS
M (%5VPH.,0%]'@5%111 S%)U_@!TH.>%B*')=/-2Y5J''1'>_A_)U2BU!J/B
M"+^N+?:0H?*+_P"CXXCY9$Y$&3P.@0JC6LHZ "4>"LT5^@YFWQWDIX&OB#>8
MEX*)87TP=!)$<9IG4B)F@9XHO!P&*H#$2+[HG&8UWQ/(HBAJS@-],YE01+[A
MKQ:/F?\ O"\523H A^B"1!'L='\<G CLG!AX4$*"ARH@2,=I"\H7W^Q%@$G\
M=3#%7)1'M@I7'1"I# N)@   " 8 = ?I@L8:L8!VKT3@ODB,">0!@D@^@@8#
M2!C)2V,4IXSAW#!!4*11 1F7O^N$GPDB1*(8%6A2JKG0Z@!Z!0&8 H'16=\%
M* 1R+"!$ +KR*'>%6# (D0<.SSWS5;&/86Q2@= @.\__ */@CTNF.]9URN&K
M4"GVP*_/^!A@& &)1!!,)H/4^G9B4T-O2BI9=!&E=#PM@P=B\5=!',R0)'1D
MA_1!6';APXIKA0$/;D:L$;^EW<\(D<@@\7'@.Q4 DV*R/AKR#:(X)2Y)<;"C
M0L4ON,O$#*0PF(MH$1.R\=UAW)/Q8@.41\_1:1H4">#T.$ 0(GAV8P,#$+R@
M!5 XE+B12HQ5%C, \!<XT'1/POB84\)H'+*8&&,!2\!0W1$JGD< (0K_ #G^
MH_Y.*_E9@.7M=+O;;>/'2BLKUAHC5X!,!2@U0.R3)46 @&LF])HM4'FIYX1#
MT_,E#/)0\*!:/L&OPQ_')\_'3!7P-#BQ$'[0B)P$BY9-<ZC5P0C2B]! I(+^
MG8:2@5[) L"I4OT29B*<HE$OTRQR\5(@LWB"L*[2B$&Q'3TLM%%#M%>)39U)
M*58P5D+B',V(HBIM X,"M?\ .$!RT(C,7+$P#H[>%]),%%$8@RYR;P18MUA0
M+ .%Y8@03I#PD8&0'*JJK5U7M?;^@,,OV"_(1(4:='ZI])03'B"SQ@&! >V\
MBH,^^T"DS%Q0)4L19)7B<SD(ZZ%:49NN*4*8HU^\%Q!"/!M*L&=GBSB5*I>&
M$%18A/%_D0X+Q0%6B,@=0CQ"('>]V QJ-5[&(V-XVZI)=B ,K* /"J!6,)(W
M1U.A.C_G1G7R?A(GV1B>3'@S!=E88'6Z_D:\"P*":BF!00L'V< (X\.@P"
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MZ0Q.JA6+K7$0 $W*U1Z$%G24>34:%08C"H61Z4C+ $$5V9C$@UA @@]*P(8
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M>[(:'Q=".M]YL& #\K555>77)=B>0*9PH/-BZ.F@ &]3+@5#G:L>!2$:7(D
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M1M2Q<@_*H0-$K6+DU>^,_6H%  JJ  55< -5P.0*.P.YMB\D%3G_ & -BT'
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MTFP9!!!W$!X\7V5[C:BWX8VB:/-^((2SH 7=77 <#_A(U!P 0  _4H% "H@
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M</9=>E'*?'%9^K710/O&W37X,$W\XQ=GF.@!(W2B*[KT,9V-BI<L2;*1@(G
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M1L(8@8 =H$8M#E(T!$)Q4-RMB5BP&,J7 AQ&JZM>U0%7M4['RFK4O05)&I
M#4EYTO $1 %(RB"1!1!4Q%;CPQ"B1$%E2 "H%C@4!53TC- B!#B)L:7@8QN?
MLD?AD]T/,XN)DT3 100(46!BDY2B(&O8PLC$4B-:)SJQ9!E$D&T?([5%Y:WD
MU-42@ J3L(*O#ZD4ST@>@@00147EAED$$!!@&54TJV(")40)CV"+T%R!UP42
M4A.FM2U<&$H#P8!"8EB5G8D>5<X8 FH46F%'B[+L5X&%*(#3\! IBH"IR[?=
M,;"7L"[AN  ,0R)E/2S*E!2B@\5LTFHD:[E*DB.AHS]*81O8^Q&BO4(^\K#1
M"WQ%31$ J(#P""LLR@4] #(  !\_,N_F]^J,KQ_0^% HG3I50TP(4$XZ L=8
M5H)) 2@**W=2GWID6) T1YXB0G")@EIO0=<>5Z43QZ22.(OEP)B   @" !@
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M1Q!RVRHR/45_92:JJO:U_+_A ( $"HQ!Q$Q'$X)3$>2:]=(L%@2:KKN@& L
MB)B"=@\=2(VMO#/B@A>G>.^ "G9Y'1%\'"AF1QE4,H70I0_^!:Z"<AS!#A ,
M+@";SA,I*H65"(CPY1 .AR6:QDDA)XWHD4"3-1L"[\\K*U*!@ S[7\Y'@A!<
M(8)%&+C85\18%.)UORTX[".2;,*)+HZ@.!+^A!"@=((_"&?URKVW_"<P:IH+
M$(780=XFC&"#V&/0A#TFZSM%E!-\DG0?X2*O^\,V**#3U<X[,<J$("ID-I0'
MIP#) PDE0,+6"(#>#@7.X-$(,8HU<F%XZUG#I'NPT"\_!B_5\D"6ZA!>5]W
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ME'5"@YE:2#4%+RF2H)0K#(*B@)#A  @(G<FZ9/0$AQ9"$MT&;FGM.8Y7*0R
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M$"7 2!TF@XKBD3ZBA#:!!V \G6$>]5X2=F:T0$5P'M+<RM /4-.R-@0 VB'
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M; ZCTRKX?KWZ\]5#NI&9<DD-,"'BS%=G7W(]$=D)VQPEC@Y5+LIV2_#C(_\
M4(?V?S]$>@$<&506WE* J&>U0=0%ABS!=&!O_P":'1+6AIVZV'G<'YN\L,%B
M=F?<1PP8M\_HL5>5(OCR2U?:CFE D,A7M$CKN5555556JO55ZJ]5\^C/SE%T
MW>'TA8\J7<A4,;V>T+_9NRMN-DTWGJOS\>,RY7T1#*@4'1!TS3ID0^V;8T]-
MJK5NX5T@<$"Y8:-9?&4G@W2<F8M2#CW[]JH H8BAC1/3O."MWA! ]#RRJC\>
M1R7%",#Z&   H  JC  %58'7!9AV<K%7(7' '-YL_KU-PHI-_);?I<\]%S)"
M#^K&.6J*=+\_ .SF=Y-C5].$8-AES% 3CC;"PV<MO!FW63')3+7/$&.<PS54
M!5^]='?TTG>%\D# S33.&:@[Z,D XVSH!OX&W?![PQ;U<[: 6D<Q<C%#L?*V
M7K"H")@9!EBY\(]<AD7+ !J'>$>>Y!WS_@V++::.#6%?4W"K\Z/TBPGVCAE&
M:C.YT!S3'%^HO%#?V?S]%<(E+;4SR$/"$>7(09Q"O!!R1&@*X?4GD.9&!!V9
MH[;! "H,"<OLG//[:=6-""HI"J.0G;\>76O2/<:\%[I/L3,Q?(8833T4. :"
M;2M_V>E5P9CZH2#SJ=XHBMQ0\<').)4:*%*Z<,-,NUY](_@+*$FRIK)%HAKL
M%0"L>L4D6;] 48Q= %@1P18\+20/0_($CZN !0 "J!C^K+,M=HP\!P^=BMX[
M+T'O5]/Y+;;)+M78HZX/Z2?8?\43EBM)+T4Q+J$).7I+FXVI;I^)C:PJ'6;5
MMSEW@]!C\ G[IX0"&EL+HX("H@VJ.Y&K(CN'[?/+>,V3X%-TCD#93D=_UJ-=
MADD"8^A4VM^SCQG.*0UV6[M6-A*L0'T*4X>RED37.O4?L1.X< :7P#3%#Q3G
M(11GQIF4W]&AIC=R5-&+XSH06>$5WC=<]8Q"R!E-0X?^MS^G^S^?IW2>4BVQ
MB(,XM]L(R')._@GZO#Z1M1$:I,,(ZNZ%(2 6&9K"8X5J4S(X584I)-RHV.P)
MDJ47Q+VV_86M8N$7U\7-P>(^B/P_^.C\/_C]!(-]J#CV=6]A)/1J;+\11'!*
MD(/Y8"$ 7E-VH>OK_P!?4'I JL3R3U40E<X&SHD#HT\8(A*H8TZ$^]-0-\Q$
MI Y0 *H"X%WZ$WZ,B*A\Z+9+1NO+>!]'\EOKZP=+)#O@D(L99E(*B!XII-3)
M!=<R7:;;H+V!4'*81+J.6+P)B<2.8INA86N M7KP8/".?;W)@^D][%/?9%F+
MOM0 PV6LP*#0P?GHX(P1EU<Y/Y-<'VN*C'#* OA9<GI:ITV<2]B-QP"0X/RV
M77:+S#E#1]H!1X])H-5AK5$P31M,=.O2^\ <8'_16-R-+R@JX_S<^&TSF^?^
M'P*1FIB<3#01A,LHB6RDT$CV9"]-2_B1F&M^C!E_9_/U/.<TF3[QMC HZDT=
MK"^3_, ,8[)(G6>6=*BFS!%0 MB_JD: 0UDN%>P'55"J%^Q?@TWHGR>]!V%L
MP )&$+".T)V]WB-<O=ZN28L%=IO()2$S[11YY,U##;O/'5O^Q_W4\!J_=ULN
MU=1=]@"%,,=6@R">.J!V(4"Z@GA!%%!)/A"QP'Z*0U)!(DV)GZ"!!J10*"*%
MQ"-\D*)I)(%HZE2/;^_8>YX($U8*Y*/<7CRKQ< 6BKSBWR",_5J$:!*DT :D
MIYPP A(KFIBCE ZKX@9HL/CXQ*5]OFJ@ 1??W&Q74N9,0G&V4O>IDY9H\9T[
M]2G<.K$ ^G^2VRD/,E3Q?V9\ )PT!(Q'73=:P%N(_(-H34,8)T/A'9YL3$T$
M*5B1,#[3H.I0AX]#Z1<^OX\97?.A^IQ_<AL-([6TK&0II!@I>QCIB V-*-,B
M.AEL<><S2$,EK)_&B/C0*:O$N/\ ;\%)5N=H6"M;>H?I7X!@MJ^8(#.,F3 !
M4%#ZJ:Y.M"F8@E16GFWX!X80N8,T&$X/1C9C 4I9O\*QV:$M=Y0*J3<=*J-$
MH%5&@9_53SI\@K=>6<5!9I_0Y0!**?99W1C"*8UB#%W2D^T0=*,3BZVN*@<?
M!F'(7 F2ET@LVXSPMFKH4& E,@%%HVDY,C)?!XL]UW)+%UPNO4\<8M4-WP*$
MB%#4A$L'*FG*SL#)C1RVBL$J:1KMAF>*QVU+P0.G)SL1Q3FB&R@\(*&YT'%'
M,6P )/HF+! B  E5> '5>!C\@2/BXH!! B*/HJF88:H@"$8-&O4RD\9\_P""
M[&/&M;L4Q%6R8CJM.4O*&GK0]NM%.W/I@M')C!,T^M$C?!Y,)5F06"<''EC0
M2O.0MR?8:;,1')&T1VQ]T88F-^=]8N)8BBJ"8; D'>)TK9@Z(?HZ#N6B\HG3
M:<V!VZS>9$6E.><_@%$'6>CYQP$MG.FL(O4K$')>%^AY$FI^: Y_9"$4J\<$
M1(I",8"54+@5'E_&QW+?I"YORLYR:L_Y _6OC.9-#[ /J_DM_/2MK)#IX.<6
M<LQ?^X ,DO0,4B!ZGEG%5R(4M<-,\UKPO'A.8%T M)F$XOZ#Z-FSH@*G+7K:
MC)14&\D^H1C0]\07?WC(ZJ6KT2.V#[S)M(0N&&#V?_OS.Y(>IJ4V7Y\9JVLC
MU=+5]S9U:DIP^HDW+.*8PN/IB6SIXQVHKX3BPE[&"_8''VH%,#PQGC29I)>0
M'Z5RXL,)K&!6!G1L5/3\%MA:1M.0YSDCW/PM3"2E$$44\6;;%#^ZO=#+CW#*
M=LJ%B"+9X\O"3'0VJZF!_C1S9"1Q;2:^7 3$(T2V7#M#GF!GH'#\S.DD@SSP
MP7Y688F250N?IK4*OU__ 'L*4Q/L(-ZX$30);MF.FHWY#2!^8-5,T?$#4X29
M !S/@2>FN:@Z!?(E.>24\<4\7N,<V=A7S*(SS+_8LNY<!V;>B2 X1J0? 5AP
M0.'H"\!7X"X]CM3W7P3$K-2/@A!Q$X\7KNW)?I)(WW"N9DJG"1&)Z^BH;";*
M(G5I\E[$+B."*1F:F6 (=#6V":X)3=\]+<Z#W/I_$4*W3$@O_JI@_2(5K3P,
MOLV:/#U&3$',+#<X#=641JOM\LHL7VR*TH8T %T8*DCCL% CDHC[@%X3D\AP
M41M4>SAX.'.3U-&!O5B *E_Z#/<R!A#K J?]_81[1S5+^I_& >C%S6@P:QN2
M%&'+$UX4&[Y/4?0MNPKR3IT$>KM88P>'R#+8*4I*5R'AAD1#L*>#^>/WS DT
M(9I"S?[=P;TA!'!RKZ%L[%M#8M8!, 0 %$*(B(BB-/I_DMW5Q\CB<29P/OT2
M5;7_ +W4VSLT@@E'+EWG,UO+>B(0-@%]-)7&4)VU1KF(0(1]I,0\/W3I>(19
MLV$<P<+2QMYM-^<LA(;)":0 +^CDOY90TIOOM]%7V$FR->)6<.=]%V.HWP"_
M25[E2V5P@'PMGR2GYI9.&@RKTZAN!MK@QQ/^1)W/IZ$!/%S%W9WU.0\6IZ0+
M>FZ^AAQ9'EZB!IL:,:N2.BY2Q4UO*B!+(#":WKFB31B0I,'MFT^T?M$LC VL
MNZJ'G7=U37][\3VCAZ:9BNIXR8G7OWP/+SJB$6&95_*X\4]4AN6^"= A.PXS
M\-ZWSV@3O-0_HBL@%]L)3E(@2D8(IE5! 8PPJ3:&[ :#^\QQD5,@P$PAXHV#
MVWB'"2]0LW3%;'F8_6%%3\ #7#B98= *A7P5E?V/+@4R!$A"HBPID)??B9HJ
M!\Y?WW _E+F"*)I\"=EJ 2)O1X^;-T\!SS")<!9 FDB<0&+Y;)SF O)J9*6U
M/(IOBQP3#N$Q#P^IBJ!8S,7!C5RJR';.!4>P@P?\:36BXAH,XS.UWMY7-X))
M* G="$ ,@)) <22N>*Q(J30NIJO$"J//(ZP138)$,D I>!F+CL(HBMX3+73(
ME:+*I)1A2'C<9]'&5^C#>UT0.!BY^H12@#'X7""+1>E%.I!*2E"%[('Z7-B<
M@19EKL5!;X6-Z6(5&\!E;4UEVL!58_Z>)$D$O9$1=1/&$ 2J))3)%%M!N N
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M&JG,51=T;04TVW"Q AAL'#T67H.S0#2F.GL?A@@=6VID^0/5$3J+*(1'H('
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M+%A\4P.R*!+=-D'0<E\^+M>T_5CX5AHO-4>?295N]#DR=!K@?@=E4B*_C,8
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>businessfigure28a1a.jpg
<TEXT>
begin 644 businessfigure28a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M*^>];U)J:OH                  $2/*(VX-TCY,![3(?*L)[YF_/?P_0
M         #1HUW*D/:8[7OGAAN-5?]B]0=^SOIA9>0\]J6[;MFU<SGGNXN+D
M@               #SW*2($>TIK[?LZ%9N',J*\/5YW_ #W ^T[2X]_=3$R@
M          !T#R&-C#?PZKS1?-Q;XL7:_KH[;W$^^=4S/GL%KHWPP\L
M           0\\HC;@W5*VN6]?KUJ)5T["6+U<W+?8\]K:Y1OUA98
M  Z)WBO"7G1)$1TD0(\2$CY(# &?(F9@YCD,4= EP,&9P  CA(P
M                :VFR1Y;FO991>A'2NC*%JD>*^+],,6L5.]M8AQW3(F0*
MX)L2DK8RIC2Y2ES(FQ+RT        "@KUF^[-[S\S,2?4U\;S*^>SBBJA[UJ
MU[=S!>^<A/J*Z"O69-35F//9G35&/:<UY5#JJ,%4[?BX[=RH;EOM&X^+D@
M                         #X/LQ_OG4.-YR/>R?I\G$?IW_&,]<QUCL'(
M<OC'>^<CW%>^2#SWKGX9CST    :P&SY_/ ;6' 1TV9-6CB+!-S35,E9(C E
M@E7$])*5$765(?1VRXBG".&=.$M(BA%B3$9.<]$@     "K;ENT+=S3'*QK5
MMW/HYO'YZDM/L$KIRU/OX=?WR84UQ6JGZ,AXZ!F_/8773+Z*HM53^&5\]SGG
MOV2&FJO;ENDKMN?45[28]\   #JG2,N  8\[9R@ $()N   8LZ)(@ 84YC*
M      B-5,NIJKFNB/54]8R+W@);1['JO,QY[4EVW-Z*Y=3[A??.1[BO?/TR
M]/N+]\_##U>=_P =_P ]Y#'^NR?AS^(_5Y>]FZ !KD;&GD2;$$!)48LZ)=QI
MP;$%FF,,B<!&#*'>):1L^SM$?,(30P)V#H'4-E"DSH'2.,SA*B!G;-N@
M                 8TR1"C%&(.Z4D6^20ZQ%B7G5!]G7/L&;,*=@SQ@3I&1
M*X+".N8DM$ZI$2LRSR,G.=LR)90
M                                !'330VF->R[SZ/LQ)EBUP
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MGKZ/VBC_ +D:I2)P?E/.\ ZT=C'HWTC*9O8/YN^B9+@YH  '5,&=8KD@)MF
M 82QL\1:V&5NX&<OZOJ49&LG-3=VZL>_=]$^?R-3"\?GZPQ..FV1T5EY?7?3
MT  :^R3ATCWV+6'68^T\+V_/"4H-T*D^%QLGQ\@>P?SQ]&[#<5UXTZDZ.O*:
M=?GZ@>IXD>A\53C[ _-GT/W+=P      #JUT>:4[PMH?)D15;NN=W)X"4_5"
M!9UN#F.C%+]5S/F]-4.Z12-$F5L9/HA%,U>G<"3=S4U    "I"B\7>;6U6_M
M1P^7?CRK#6=CW*\?NUXW)[1PTW=1>3^@]W^U^8>6J@0RQH(;C\]<N?(
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M]4I0_;FRU@      'G^;)Z_KM'OA23]_ONB.IWG<KE;N",8>>GE>R4:R7KQ
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M8(=A]%,<SG0-7^8G'9[IH/\ KWR-8VZDN3I:'UT;WIL)&Y/:@    !3&%PM
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MI:B'8[:U4KO;F0W-G([NT^_:XQ:U'7\MXVG%[WN1F:\V'6=)9F5U5N9G:@
M                #"E1F<.4_#MG*?)CC@,H?9V#%'?,&2(C)+B,&0+0
M  !T*<;NU9'T]                      PA21Q';/HP!BC.&7.B18FQC28
M&/,.9PBQVSZ)R6F
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M"7Z#XZ"#[Q/?TXV&]K"4%C7%*4H2NQGD(3VS,V%;Z>Z<F+;PTV7?9FAB)A
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M'D]JLUAFYE?BGQM-N<&0.==)'?A\BO(->@YGTZ8W]PS4*78XZ)&)*,M7!;?
M$7YV5BW.TJ91/JF3"(Q1TB838F@5\IZSHU=8!+ZM7UD&JQ=KY D3"[P+5PLO
M[%LX"3#']#:3;P7RP0[5^Y!.=OHL%S#3[S7RPR[ =$91;JFP3@;[?5+892:#
MP6[M+YS7]XZ? (X3.A.)]QK\^@VK]K!>?2^O(BW>2]V*39=T4V/<!@(S&^Y8
M;17ZF(C?)[*O\565"\WVVUTULCO=H:[N3)E,'8'(,E8L6KH:K-\N5/I;7&R=
M39G^$@93YR;(DN;-=+5GWPTW&<;8^N^%NE]0=W"P!/1WUY*5DV_6PT[B#$B#
MCDC0K3.&1.9HVQ6^F[@O6&1D3I-&R)DFT<&;0%/_ '/6*T033_&,Y\^+[^;.
M,Z:F=>I84T?5 R?/U$.\_41AXQZYJIT6=AD=2_/-C\^>;'X)<WY!7K/T:C"O
M/&#9:J\C; $*; [V*F;VYNSF LCI=)6K#AF,A9X;J_2[NMU:RU6+X$*0[<%2
M(+J<%-3GFRQE]R[JBWM-M5,N#)7GG5HEL_,*0_JQS_.VJ2QXDW1>G/-I,.N:
M;;_E>G3-M_QZ1K)^?Z4C>3:NIL[;*/KFAA)AV2I]V(M?0@#7=:O%IW"?\/?2
M4?"+GW=B;Y M!']""(!(,W-]:MX>8KSY %2M5%X[?K:^-[I;;/XMIU:59QC&
M,?4XKK@V[?(MOTLU>Y9;@ 1EAZ#E=RUDVK?IS?:3WKG&=LJ?3I.=OB'1-9/B
M_I5MI-D(^=MH/OS1:3PMETJTZP4HX*>!.V)DJ=;RC'I2O=:G]+RJW8J'R6%V
M"?77*Z135&[2:MH_SYHX]8H_M7[^Q.(+X"./;K!]\_#H,2:*AM-=E NT;&&/
M64)$&%OJH%UBW5C;X(%!%U4 :=%.TTTBT]'SH9 LKM>GCE^X>)J>$Q S#([I
MK);**D;FR5>O_! JLKV4IO3H"K<L"QH8WP1B%P!(EJ#-I-5DOQ!A^QL-:$?1
M7P1I0D'/+UOT*2FU]041]%BH?Y\G2;N1S5C7]OCB:JIEJX#UC>)9L0F"$[:R
M1[[9VUUQYKOIOY++%!IY?O[$X3_A[UVVQIJKUS/GUOFV]B:ZPYB:>N^/F&\?
M>LE4&>Z]$D8\Y1\]M^_00Z4A3[R^NVNN^M@H,F9.A=$EYX]5CX.%KJ=>I!^^
M(R".W\U:A;&?U!03D\@Y3[XDI'"(-HPO"S!PHH9HB(B2(A(!#(#=/ZO #BK4
MQEW]BE1[1UCU1T!["F&H5H7A,J?=R"V-$LQ6;0BLK6Q!\]MRY:=3;@P%K 1Z
MY+?O[$X3_A[U;[;;0ZZZZ:^O.L?&2-M(_CWH<7$O"H0<L%=-.$6C:MENY6TT
M6DGXX\C*'EG-:+EWD<FDL>L\&\OX^N<_AX&Q#8:^0M0YROZGQB2N4\^W)3<<
MXI#M&%X8>*!IIOK)H43$' *7 ;%_5:N8$=,<D;$7>N:YT0_=_P"O&EJ3!^",
M,+@B>GI1I,S;$0 7Y45FUUQ1?:_0*]\$7$%#B1D65:<UWL8];&$Z"H<S$-_E
M/Q9;%#+-UY\$T= B: !^EI/9+$-896=O8]+1?5@1=LZ"'N;9[Q!$5T&[1'QV
MR];ZAW6WXDK%JM1[:_?V)PG_  ]ZY_UW?KT)MNCI07+RU HROHV'P:KL><R(
MNF$+'05N!51QZ0QV5/E\G%Y^T'WVYT;J%K0BQME%3/!6?IP1NNWH)WYZ6K3K
M"X>=E9#7#RB+\YQC#JS)-8-&GPV&7J"2*7:?>$8"^*BMKA5E5]24-+A0G*-$
M!C^/ N&\ML$1#BWA99-2GV*L8LLZEIY9>< D6B*/$4?W>BRO!E*N@W-X<;6E
M;1%&GY)"=L@592/.&N$^U& LRL53$1%%=8KX6]Y[0F"MA<:C467E24<W);=-
MK5/? K:%=53*$5M&CQ^/X>KYS&B7E]#& )#Z/J;MCIXLVQKU*JL!G42<A(+4
M.^,\OW]B<)_P]ZJ_]27S;?33RR7VIU/R[EP/YV)6X($/42V++]7M\D(;_J]>
MV/\ WML]+1&7-7,SWN$[;:ZLL#?-X4<1UB*IVQ%SE,$^<UT7ITF6P#@(^8WI
MR4VK"=ZHCY-SZ/QVH19J^*#+)O30K I%5PEPB6<+H36P\^H1U;(;\[J#YJGY
M_4$!-WYE7[WNKYUTA Y_+;;K?OWL4I98P[H,0'G$_P VQVL#;(IHINOH:/[V
M'7V4U9L=CL,9J;GA>53#J=APV,HRS155_I-!#9"XJ-7UVGJM:*UTK:".<E$F
M-.CJ=:B'#4*UTWG1"AAZ-Q5^H7\NPYTV;",&I)6LUFPL5J6N:Z57A3PR$"4P
MHE:N,\S_ ,GUP7F%GAM6:,]^+_)#KRT\MM#T94-M->$5=8)=H]GT ,C:44&9
MRJ&SYMKKOK]91HX>NUDA\Z+9M]JUR741<)%+'-IY)KF2-6>36;1O9!\9^98_
M(["%MY#/"1I]\TN,$9OO\<D<6916]8NFQ9W7,PFPH1<@)6NV-M?'K?X=%,$,
M04TZ$L#F7=%7%2S!@F>5<W:(OZC6RM:.99%(.A#6:%E$6ZW:!Z63;<=0S^'[
M5I=.KOB=3K0>$_X>]'6V?<==<:Z^O/\ _D''FV(/C_I2?]T1Z[QQRXE3+)CX
M%NT!XL3R#31@QB E?K10])8I,>C-A@"&262>1Q>UBR87HBXG8?(^8$I6PYGC
M W4$<]8*T/>7L)7,-THC\Q>Q$:BJRMA#/OVV3.("R,""3D3%S^41A(&^\6YS
ME?Y89,R-KZPE!1^G/&$I:A1G.&GK .\PR#3DP8BK2B-<.K6B#?5?O[$X3_A[
MT+_UF?J_:1HT?-U<BBC^9W_YOQL=JK5T4#*ZI?9,4*V&^ZS7=@.,TC-L&^=C
MK>PE6H/3F["22 ?/X$>6/?.9[*;(O1>G.C9(VOF/^OO6R';84F#4H8P,A<5Y
M05<ICF*'<B6&/$,7EC@S"TNZN5FD]*$KE7IZX+L0R^[?O[$X3_A[T7_[HOUZ
M7O\ %8L8QKCS/YWQ?R_R9)6:ZZZ:_<L,6=2[2LD;(_3G2R4<16/D@[RR19_,
M;@8:+"!YQ)_.=J)M=PQ]BBOOSP1DPL4Y:[=O7U3S6+G";20((<.%"E]QU]'"
MO5F.2*2'(TI"1G*MHB-?*(&0=,N B7#?=OW]B<)_P]X25L7M##H/%Z62TIJJ
M%3TC29CZ9TU^-GL E8M?'+>-_NGA:'0$B$";-Z>F<2A<_1BR00;S;K@- (?"
MQ8S("P20MFB%2Y\&HM<&DBBSME6MP!%]N0P.&<8P0S&IX.\WI))'%H:O2;22
M+*QIHL!4P9\F(''\U*&DB\WCTEUFKJJ;R6N)Q8\[J4@9#56)IZ3SP"Q;SP1R
M>8DCVV^EH00(L#<VIBF#L!5R1U:W/.>T/;K_ $(C$/:KS!ICN%_SXL[C;6@+
MGK/<CIT5SL2,[]<;_P";]ZN\<_ZXW_QIV+K<Q@U]NVY7ZXW_ ,SWJ[X)_7&_
M^?KC?_/UQO\ Y^N-_P#+C_49TQ+-5W!K]%]>VNNV)4R^7SY=!_$80<37USC&
M<3*%\WGR\#^(H(H>/N=(KU@9.OE"[(D;51;UVU?C965@$'T7WV>H74FN75%;
M73-WS^VL,57=RC;,0K-M;%=:NL@Q5692TOWVP3)MTG1Y):@#:Q+59E=E8TZR
MQ-;4H@K#\.-<LM@EY<+[C):]ZV_EY-LDM^3Y4_1,IVE:M,9*+!^J7Z852L:&
M(,2"?V-//8T\]C3SV-/*#IK\K>QIY[&GGL:>.,:_.7L:>>QIY[&GGL:>3Q?^
M<>QIY>+5K35('6*U[G!T&C%LD%GJ5RQ_U]AB="K7YLJG4KXZE]O;H5<TAB>)
MI]272@*'+A3@CYIK?X;6)!H.(W#-FQ8D&1M+,MD:?>CCCBU=,<*%7SJ-&?#T
M)<4.5T  3&UZ7XW^=8-LXO N^&UH$4,1WQ,M5%Z&J,@'OR\S8I\WDJK\^Q#5
M8JY3)[(%T(:9X+:=3?V.,8Q]'LZYS]5YJ6]R41<?D'G'X,A$8\YYJNYR+]AV
MORV3E<U!VVWHA?X3\\(D#L%.)+F:H,,C1*!*+'F@;96,:,85J)4/REC"DG-(
M0:;[BW^^Q!@9@YK*N?S-(1Y93UQ.1')5D4LL-81P9-I(A1YE=3GF1I5L07RD
M@]F&I5\?PFI(C Y5H<Z^9&K(AWKB202.M@0$?>Z462&AM4AL).KCI'PA#>WS
M*P^4PSYA*7M;HO'UN%T#*J[6=X@\4)BY5BH.Z)]H">G*A49)AJ;[89%D]RBG
MWG#W'E5[BO2H#6+L\9Q&R;_+6SYZ-I%97<IH3]GH("X/+9GV)F-.2V:F1(G1
MA[+^(8G1+%XW0Z^9)I>:G-#!>*@3C2ZUO?22Y5:+3>V5[W.*WU>>8"[UEEA=
M?*JR\UN56V&,MJ-::3:ZV'')<T<(?S8@D7EWE"+II:4.<S7VN:9%LR T<J]U
M86)!<:_9!OO$C0F08QC&/XUD#$T71<T1PRD<R1DP,.=*SME'.4R4,/E219.N
MY4)$ 1RNN%%"<\7C+8.;+XI/T<KN8K+SA+9S6/+*XPQ#2EHJ<&A+@@(^9(88
MB*(O(\7\L1+XX>9J(48O,T@$">J"(I?_ *__Q !;$0 " @$"! (&!@0("@0*
M"P ! @,$!1$2  83(10Q!Q4B05%A$",R0G&!%B!2D20P0&*"H;'P%R4S0U!R
MDL'1\0A3DZ(F-4145V!C<Y35-%9P@X20E:.RU.'_V@ ( 0,! 3\!_P#5[>G[
M:_[0X+ ::D#7RU/G^'&Y>_M+V\^X[?C_ *-#*?(@_@0?HU .A(!/D->Y_P!
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M^WU W;<K?'73^W@1](.Y,DS-H#Y$D>6@7L/QXJ1&-&+#:7/D?-5'V0?[^_\
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M/SX$:CX]OG_-V_V<=-?F---"#^R"!_42#QT4T []AIY^[:%_L ^?'27Y_O\
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M&43QJQ]AO-)8CKN",5.G?5'4KJ1M8X'(G)8^.60ZSQ$P3_-T T?_ .\0J_\
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MT5%=8]O43K#VO;T/9O8/D>W'@IS/ ^ACB18MJ1SAN@4D9G&Z1"7612H8)IJ
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MF,;_ .+\ID*7\&M4_P""W+$&E6ZK)<KKTY%VPVD9DL1KHLRLRR!@QX'^(_\
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M XM4[-)REB)D^#^<3_-7\C^!T8>\#B]@,??<RNKPS-]J6 A=_P W0@HS?SM
MQ]Y/%;E;&P.'D,UK3N%F*K'_ $DC"[OP+:?$'BO7DL2)7KQ[G/944:!5';4^
MY$4>_L /W<8S'1XZ#8-'F?1II?VF]RK[PB>2C\6/<_1=J1WJ[UY>P;NK#S1Q
M]EQ\P?=[QJ/?Q<Q]JBY6>,[-?9F4$Q./B&^Z?YK:,/Z^+F,HY#0V8%=@-%E4
ME)0/@)%[D?)MP'N'$/+6)A??T9)B.X6>4R)^: *&_!M1\>(HGD9(8(RSG18X
MT'[@ .RJ!^"J/@.,1BUQ\1+Z-9E ZKCR4>Z)#^R/>?OMW\@NG\7!C<C9J7+]
M:A=L4<?T?'W(*L\M2CXAC'!XRPB-#6Z[@I#UG3J,"J:GMQ=QV0QS0ID*-R@]
MFO%<KI=K356GJ3Z]&U"LZ(9:\VUNE.FZ.3:=K'0\28G*Q5O&RXS(1TQ%5G-N
M2G82MT+SSQTINNT8BZ5N2M92K)NV6'KSK$7,4@7Z(8IIY%BKQR33-]B.%&DD
M8J"QVH@+'0 MV'8 GW<8W+\SI%8DH27[5:A$)[AZ#WJ].N9%A66RS1RK6A,K
MI$KNT:=1T0'<P!AS?/$DF/K)R_8GL9: V<5$N%R+3Y.LJ-(UBA%'H;L(16D,
MM9)(PJEM=H/&;RO,%H0IE19JPV(5M5Z[5WIP6(#))&EF-&539B,L4L:S%I4Z
MD4BJVY& XKT[=OK>$JV;7AH?$6/#P2S="#JQP=>;IJW2AZTT,74?:G5ECCUW
M.H,E&[%8LU):=J*U2ZPN5I*\J6*AK$K8%F%D$D'08$3=55Z1!#[2/HBEE@<2
M0R212#R>)V1Q^#*01^_BMSAGJX \6+"CR%J))3_MZ+(?S?B#G+F.]-#3I4Z]
MBY9D6&O#4I3V+,\TAVI'! LDK2RNQ 1%C<L>P4\+%S!S/D17@JY/-9-@^RG3
MJ6+ED+'WD$5.K&[JD>FKB.(!?-N*F!SF0ENP4,-E;L^-223(PU,=;LRT$B8K
M*]V.&%WJI&RLLC3A C*0Q!!^FK4M7K$52E6L7+4[;(*U6&2Q8F?SV10Q*\DC
M: G:BD]N(JEJ:&S9AK6):])8WN3Q0R20U$FE6"%K,JJ4@669UAC:5E#RLL:Z
MN0/H:&5$BE>*1(YPQAD9&5)@C%',3D;9 C@HQ4G:P*G0_P 3'7Y?B2-[.0NV
M79%9X:=18C&Y528FEM/M;:Q9"Z CMN777@9FM4;7%8NK P VVK>Z[:#@@B5.
MH>A"WNVK$RZ=CKWUL69[<K3697FE;S=SJ=!Y*/<JKY*JZ*H[  ?1R?RYR=F8
M+UKFOG^MR<E26%(:OZ/Y?/Y#(K(K,[U(L>(Z\:Q[=C-:M0@,R_=.O'K+T$\M
M^UCN7^<?2+?3[,G,MZMRIR_U!Y2+C\(]O+V8O>89\A6W_8;MKKS5Z5^9^9\:
MO+T,>*Y6Y4C<2)RIRE07#89Y!II+>6-Y+>5G]E&,F3MVOK5ZRJDG?]3,6N:9
M<1+A\"_+E 2WHKWK/)8^WD,A&T5::OT8EAM4D$#=;J-&\DB&2.-BITXH^C^"
M2[!EN:\O>YPRE5^M4&16*MAL?-YB7'X*L!3CE3[D]GQ<Z]BLBL-?Y RJX*LH
M93YJP!!_$'L>)L'C)M3X<1,??"S1?]U3L_[O'Z,X_7[=K3X=5?[>GK_7Q5I5
MJ2;*\2QZ_:;S=_\ 7<ZLWYG0>X#]0@,"" 0?,$:@_B.)L+C9]2:RHQ^]"3$?
MW(0O_=X_1G'Z_;M:?#JK_;T]?Z^*F/J4017B"L>S2'5I&_%VU.GR&B_+^-]#
M'-_*.%Y:YOY7YNR0HXWG7-<MXG*J(K$DJ8#U7S7'=RD1AKS*K8K)6,-8'^>W
M%3%'(%?0^D/T8\U<T83F'F3,<O>%BY;Y4PV2P^9Y=?(1IBX^9.:FRE&K:FP&
M7>K:HXJSAE:OCXJ,MN*P)X\Y7\%/%)@>8?1[F$Y/P>2:OS!+%2]$F$.*CHW+
MEB;U5S)SY-F:$*-!'XF""+)82>[4BE5LE5E%:MUYRT:\W38;DK$039G'\D'G
MBQZ/KDM0)R15J4KG,'^%*$17%P&2P%%:]A>6:UT06,AB:4-BO Q@26&6/K9/
M)>AP8WTF18[(<K/#EI^=I>6\;^C;U[M&[_BNQRM+B,H<'+=6C((\B*\39;$4
ML:SM0DQEL6A/%4](GHSI<Y#*XR7E+#1T.?N:Z&&O8[E6.I''R5F.2;5.E9N)
M7P_4LU3S*T#/+9AGR-9)[BI&*$LD)]&?-/H_Y9PEO$\RYFPUGG_.9C%<SMA:
M,;8VARSZLL8:A+E!-7K2QTSDLW<YDJQX2&2S'ZDH=2")NE >6/2WZ/L0?1Y)
M=SM>3*<@XODKE['7(J]]ZT='.^$H<_2'6D)&7$TL/OC;;N=,NRUEE)D$?/D?
M+?-'+_*V:I<]<N1W>7>28<-8Y;M1Y]<U8NU<[GKW2J&/"RXLK+!DX&C,N2A7
M42!]F@W8?)\D)R!B*KS\KUK4,F3_ $WQ^3Y?GN\V9QWS=6;%/RMFTQUCU<J8
M-9*:E<KBH:ME;TEN*?QL,@SO.OHRAO<RCET<N8NK>Y.R^/QUO"+=1\C6L<Z<
MGY'"8C)8^/E/E^O2O8_&8V_,I=\M:$8DK9',6YHJLDM#GO"U_27Z<,E6S6,K
MX_G+&\^5^7\ID<7XVE;LW\S'D,6LD<^-NS00W:T<VBS5!"\K0):0%4:,XOE&
MOS)1HQ<OX/%WLIZ/>>/2EGJF=Y=K3U>5LID^3D]58>SCGJ6+*XKEZWC+^>@H
M"MKT,O!+'58K$O$?,WH;AK\P&3&\H93/-1P*9B:2G8PV STT/*TM;/-RD(>4
M,M-C&DYB99PE&ERK+:MB#(U[<-**2KQZ0LIR%D.0^5(\$V K<PU6QD5G'X+&
M:;ZJ8019*UD,C:Y>P^3K6_6D:&>C<RG,D=VW/9OT[L%5(XVY)SG)6'](OHVS
M-.'+83&X?,8.WS+;S60@RJ&>M<ADN7:<>/Q5*6M2"*S+5=+U@#MUY#Y\ESX+
MD3F'-/!Z3.2,A#S-B+=60>#Y[3#S1KE:%TX_)YG%T,-S)R[:D6/Q>.R&'AR,
M4D])ZE]8XYHW:WSQRGD9LO1Y;]*^7Y)\-Z0OTLM\Q74YDNW>9\9)@L+3=:MV
MI4;)Y.Q@<E1R:X3'\QI4&0HWX9[4\=KQ?&8SG(&0]%U^MXK$#FCQD\]2PF(1
MN9<U;EYFL639SC38'J8NS-AI1+-<Q?-]W$F*.'%IBQ8,DO'+N7]',/(-:MD/
MT>%A,%SC!S+B[>"GL\WY;FBWXS]"LCR_GQ1E2CCL=NQIL1KD\?%!X7*BY2R'
MK"#=%SIRE7]/^ S].?"XOD?!9;'K5N8C"KC:4="*@OBK,M>C1KWK<LMZ2PTL
MMB*6T^[I(RP+$J1\S^CQ,5:Q%W.\LP9#*8;D^GS+E>7>6+,7+^1-'TGULO$8
ML"N,Q45ZQA^48XCE0]2JMWIBF9+MN&226OS%Z'QS%6EM2\A2Q6.6*E+-9-,'
MM2'(T^:<P;%C&X\\@M@KD\W+LF,6W <!B9,C7ACK8_+UK*RV),'SKR)-2Y#I
M93(\IWZ. P'-^#6#-X7P%['6)><YLAC<E$?T1YFQ2R7N6V@VQ9"#(56GDR<3
M/5RDWCI.:6Q+<RYY\%.+6%?+Y!\78%$8Q9J#VI&K.F.71:2&(KLK!4Z*;4V1
MZ;%_T%E,C!B,;D,K:$AK8VG9O6!"N^4PU87GEZ:$J'?8AVKN74Z#4<'FK#);
M-2:R*^S"QYZ6U8:**E#1EL^%7K6&EVI/U2!TR--"-&).G'Z18#?CX_76+ZF5
M4-C4\?6W7U9MBM5'4UG#2?5J8]=TOU8U?V>'])G*T<,DCSV1+%C[^3:H8 +?
MA,=E),3.X0R!"QLQ2R1IU-S58VG;:HTX@Y@P5E=]?,8R=-MU]\5VNZ[,;T_6
M#;ED(VT^M$;)_P RLL;/HKJ3<SV$Q]>O;O9;'4ZUR,RU)[5R""*S&(A,7@>1
MU651"PE]@GV#N\N&SF&6U4HMEL<+E^)9J54W:_7MPN"8Y:\74WS1R $Q,@(D
M"L4+;6T_2_E4#<>8\(%,C1!CDZ84R1M$DD88S:%XVFB$BZZQ]1=^W7A^:.6X
MZOC7SV'2GXIZ/BFR-00>,C&LE;J]79UD7VWCUW+']80(_:XI9JC?L9>O"SJ<
M)9AK7)90J0;IL?5R:20R[R'@\+;B)D.P!MX^R-Q'-'+;5/'C/X<TO$^#\6,C
M4\/XK3=X?J]79UMGUG3UW=+ZW3I^UQ'S9BY<N,*HM>,;)VL4&Z*^'-FIAJV=
MD;J]3_(FC:BZ<FWVIMT>T ;S_&^7<>?$TTUB1I9Y9)Y6TW2S.TDC: *-SN2Q
MT4 #4]@ /+CEO#-S#GL3A5EZ R%V&"6?3=T*^NZS.%^^8:ZR2JG;>5"ZC7C_
M  :7IL3!S'XREB,/?6/)5ER<EEY:G+]G,>J(;MFU7IFM8L0/_"9Z%3??>A%+
M=AJ$#H\6?1#F*%N;%Y+-X&CF8<M2Y=]5O+?FEDYBR%)LA6Q"6*U&:GO$/AXK
M%PV!1KV[=>NTY^N>&CZ),MD"RP9?%;H*W+SW3TLH8J%WFG'>M<1C[4HH%0PH
MK)-DKD74H8WILLMAW**R>BW+M%A)&RF'09FX*1E,EIZ%&<BZ>A8S$-63$&ZC
M49(),<EWQOB9Z<,$,_7+1?X,[2+>@L7*M*3'VK[V<A?3,4U2AC^6_P!(IE;$
M3X9,B)S!K%&W<2V_J(D>N5NL_HPO1-*DV=PD3RULK=PH;UH?7M+#\NP<SVIZ
MI7',*A?&VJRUH<EX226ZTM4B,PLQY?Y&R',6'R68J6H(TQT&5LM!)6R;[X<)
MC3EL@9+L%&7'5'-)9#1AM6XIKT\4D,2+[+M=Y4I5^?,_RY#E[V5KT</S!8BR
M"]2K;MV,?RO<RD,$RV(]QC-N".M.A&V:#<J2 ,L@O>B#/XVW7J6[M!7::]4N
MK#!E+5FI<Q];Q5BO#1K8^6[DU90\,%O'03TGLP3I+8AB1)Y+GHGR^-CR\M[)
MX_9A,EX&ZM*')Y"6.%4QT_C9TK4'..AFJY.*:EZT\%XDP7(=T<U?8]#E7EZ'
MGSF#E:Q#G.9:V-R-_'4#BK=+  QTKQAN9/,Y/*4KD.-I8NE'8L69&I^&::(-
M+:K4PTK<IXGD^YSW)RY?ARN>PEW+SXO$9+'92'"6/#+;D2ODI4GQ.46;Q%5$
M?PVVML9]>KVV\4?1Q7YCY+YFYRP^$YAHP0F];P$4EJ+)T*F.Y9JT;',8R^27
M&T/$3W4NSS8@PUZ@1L1?K2I.2DHR?HANUN5^3<I'#=Q]S-7,-4RV1S;+3Y=7
M]+:\F0Y>FJVV@4P04J4+0YR6=YECN6*Z)L)Z;7^1),8>9*%F69LGAL)2YCJO
MX6[1AGQQOUZ%Z"6MDZ=2R)U\=%:@GAZE5TJ3I')/UT>+_0^>QK9G"9?$),*[
M9/&7J"V"G4$#6ZTD E,89"XC+[MH==VFFX>?%ST4XPF0XAJ6&5\9B(&BITI(
M$GR6'R\65BN6FJ6JLS13]+P\BPS0VHP1-#:61$XD]'-TKBX8,O3K4Z4V/O3T
M8Z60>%LC3YA_2":Q7EL9F>R?'R$PS>L9<CT63Q%18))IM;'HSLRTI*:9BN%L
MX;.X>R9,>[ZIE>8WY@@EBTN+M,#/X6=)!(LZ#>AA)V\<S<CW;D\L=#JL<]S4
MEZU;K)7KQ8K 6,%1P>?I66EL"2;UE1JNL'A8&8V6@WK&L)E.8Y;7*7\#;66*
M"+")ET6NU?J+(,EBY,;'L]M5B%</N^RV]-8QLUUXI^C>>I%3IC+P/1V<HOE-
M<;_#Y+?)\51*AQETV_X!6MFG$9H9(;,E<&QX:9#:D*MZ-V;%5<<<C7+5N6N;
M\#U30U4S\TV(9_&K&;!V^&Z;+)'NW6.H3U8^X.4]'MZZF4BIYN&E!EK3268/
M5[M&:[\K4^7-OU%VK+U(6JM<B42K5E$OA[=>PB#6GR5TL3S-B;5\O'S)4K5'
MEK0]&2JD/+6/Y?=DWR2!V8TFLIKH )!"P;:7;)\@9',5\?ZPR>)>WCI+,<:5
ML5?Q^/L4;>-@QDT=R.AFZ]Z6R8ZZ2*ZWDKA&>BU9ZQ&F/Y']7YJIDXKT?AZ>
M5L7XZ:UY.T,O*F/Y:CJK+)9E;ZKP/B1(_49D<0MJRF9OX_#Y2UA,KC\O2*BU
MC;<%R$."8W>"0/TY5!!:&4 QRIJ-\;,NO?A>=<Y5Z46-GCJ4Z4X?%Q35,=D+
M6/J0Y/UO4QJY.W1>]/CZ]\):\#++X&2RO7>KO9M5])_-"X9\:;9EO/?KVSG+
M$=2SDA%4QMC&58TGL5);$=RO#9F$.8CLKDXXBM=; BBB$=7G+F.I--/%?5WG
MCQ4<BVJ..O0ZX*JE+#3I6N5)Z\5S&58Q#3O11)<A5I=L^LTQ>'GKFJ"O#6BR
MFR*%J[-_ L<TMM:BV%JPY.=JAGR]6NENRD53*27*J1S-&(MFU18YWYHM++'-
ME6Z,M=Z9@CJTH*\=.3&>IC4K5X*T<-2J,9K5CKUDBBB4L\2)*QD.,])N0H8J
M[4L53?R4]3)4*^2FGKB*M4R?+M;EAX_!OCII8G@Q=6.-),7>Q7C&2'UPN32O
M$@QW./,>*QQQ-'("*@5RL:Q/3H6'ACSE(8[,15K%FM-9JQ9.DJ07(Z\T23JB
M%P74,)N9,W8R4^8ENDY*S1FQUBVL%6*2>I9QSXFPLHBA1'EGQ\CP36F4VI&8
MSO,;!ZO'^$#FPR&4Y.-GDBLPV]V+Q#+DUN1P16GS$;4#'F9YEJU]]G*K<L[X
M4EZHEU<V?2!S=;\<UC+F27)+/':L^"QR7.E:J5J-N"O=2HMNE!<J5*\%R"G-
M!%:2/^$)(7D+T?2!S5CLEF\M5O4Q=YC01YQK&#P-V#(IUX[3">E=QEBC]9:A
MCM3F.NAGLH)YB\OM<09K)5<N,]5G6ME%N/?2Q7KU84BM2.TC/#5CA6G"@9VV
M015T@C71(XE1545^9\[4LX6W7R#Q3\O5GI8<K%7V4ZLL]RS/!T3"89X[,V0N
MM:%J.;Q*V9(Y^I$0@BYRYFAR.3RL>6G6_F6@?)3=.N19-6[5R-;6$PF",5[=
M.L\"PQ1K%''X= M9Y(FFYRRUJGD:]HQR37L;4P<,L,->A6QN#KY$Y>?&8_&X
M^O6I5HKF26&S*T448U%G5':[,_\ HBC9YJ\!RY);LQBC++F^G)07)6<\VS"<
MP/6-F&P35M/$T:2) P(DMQU5B&FG$$[V:,U#&SVLOU+W+@GFK\Q\Q14KDLN0
MD2Q!8M78Y,I@<E/&.I?K59[,0@6-988)/\K)6EQ#4*O-F0NX[EZPV6LQQ5<W
MFIZ].WKC5QV+N\PCPV3EC$*Y*[66=X*[V7:N#+X:JC5.8KE?(8.A%-:L8JW%
M3CKOD:K/G;26IK<2VKL<TM&QT0D4$BW:]6ZT4!>;,15W<.,GG\A5SG@8O#HB
M2X:.O0>M-);S,62LF&_9JV%E5(4Q,0::32&8)T9#;:**:%EBRF;_ $6I9-Y:
MCY/(38;;I1F6M5CRE^C5D0UO$F:7PT5B5][31EG +*B C@\Q<Q54FFL&E:CK
MCF%I$BQ]B!S!ROF:M>S*I-N4&?(XM[4D<079':2'H]2/>C1<UY^7(TJ[UJD4
M5L8R:*&0=*>Y3R[R3&2ONG-@R8RHT<<IAJS0BS7L&X]:*6,Q4.8\M'4Q]5I(
MY'\!C*_J^>"VV2NUK& CNV,_XSKJPA@M&6&7ZL@>'FCDL);FAVT,WD+N6Y;J
MRV8JRK=6-\2D-L6I*HY4M6H\C/9DL/U*D]J71$GC9.I'"O6>[#+QD>:,K4L9
MP0)6FGQRW%J83P5MKDL%>K6GBR\EM)>GX21YI-4Z4:2I&*\$_C%E7BSFLO?@
M#O/VBARD,5K&2D1VT6YRHRRL:DT]3KPFS;KAJ]F=-G4!:.0V(4Y=SU[(Y7*8
M^[T6\/UY(O"UST88XKLE98IK!LF>*RT8C<U;]&E.S">:N9ZH5E_]2[=6"]7E
MJ65,E>==DL8DDBWIJ"4+Q.C[&TVNH;;(A:-PR,RD      #0 =@ /( >X#_[
M,O_$ %41  (! @,%! 4'!@@,!@(#  $" P01!1(A  83,4$4(E%A$",R0G$'
M%5)B@9&A("0P,W*Q0%!38X+!T? (%C1#1'.#DJ*RX?$75%9@<).4U)#2T__:
M  @! @$!/P'_ -O9'^@W^Z=@K&]E)MSL";?'PVR-IW6UY:'7X>/\6E6'-2/B
M"/0%)!(!(',@:#X_Q .8^(VJ'*RL!6&+EW,C&V@ZCQY[(Z+1NWK.]+9RK6+,
M1_R$<QSO?9B#/31JTJ>K#"S"P7(P6PM[7B;:C810K&)9L[9Y&50I L%YL2;W
M/EM'%$[26$LJK;);*FAZNS:+;\?+8TB"8B[<)8>.VH+6^B#R.O795I7DB X@
M#DJZL1W3[I#6U!/,6^W9H%CA=GOGXO#3P[OM,1^[^)Z9@DR,5+ 7T N1H>];
MZO/[-I"SPR\.=:A+!F606DC ]Y>7[OAM'2QNH[LH)C+<1BBC-:]E3VBOGX:[
M KV.-$SJ99,GM6!<V#%O%#]':2DC59 N<-&N8.S)EDM[0"\QY;2"!NQJ5959
M!R(%E:_/35LUB3X;- L<<S/?,LO"CZ7MJQ.FNGP_AS5:N<STT+,>9.;X>.QF
M)B:+*H5I>)I?32V4>0V[4W%CERK>- @&MB "+\[]=DJ<JY'C21<V=0U^ZWE8
M\O(["J;UF=$=9&#%=5 *\K92-!X;=K?B+)E32/ALNN5E\"+Z?9LTO&,<8$<"
M*21S !YW9M3\-JR82NH5LRHO,<F<^T1^'\3Q2-$X=.8^XCJ#Y;-4W5E2*.+B
M:.5O<CPUY#85INK\*,N%R%SFN5M:UKV'Q&W&;AI& !D<N&UO<_V;/4YPWJHP
M[BSR6N3Y@&X4GQ&NW%XRQ1$(A3NB4DBP%[ ]!\;<[;5DPD9$5@P1>\PY,Y]H
M_A_\+I&&0NS+&%-KF]V/@JB][=>7,:^A5CX8%E+<)GRY6XAU;56OETL"?J@Z
M'8P*/>.@NUAS[N;N]/O/+O>6QA!(MF MJ+:BT*R7/@23_7MP!>UVT!))&C6
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M@Y4W'/7GYBU_CY[ D<B1\-KGE<VO>U^OC\=KGQ.NAUZ>'\=I&T@.0%LOM::
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MU]Y3J.HV$\#/PQ-$9,SKD$B%\T84R+EO?-&'0N+74.I:V8>EF506<A5',L0
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M'J$F$BH9ZN.:*F:7/[4#*7]H[&BWB9J2TV(04HEJC3J)$J*JE5JT/2BOS8A
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MM=\.HY%53$0%,Y&26:-OSIS)4*7CD5VCF<YI(F)C8V[O=6S870L[.T%V8/\
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ME@O?MP@&S%>RLP=F)-U+'0$<P-<X.TE3*K36"DQY\L.1LY"JI$I8&V4D^ !
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M)K:BC6P44#QUCB=B&5P9<5D(-$T[@7L0UHE/6#,$_& -N<*NX6&[$Z%_W8Y
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MC8( HU,.>;R5N=\\5=MD*6-37 ?Y5]^U+8")\HBOM^TT9&]F@8WM\;8[.XF
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MVFM+"FP%?M84]4I\6Q%=M56WW$]@FXU5&NRXU;[;:M<-(4;VKWS$R2U$QW;
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M;I_$]/X^CU)TK/39R/='F\G7R;N>436MSEQREZQ7O4$I\!CQ7E-][H'I:MU
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MF,Q_E2ZQ!?[!'Q4(M>(L>,*_#47NY=/WZR,S_&/KPQ-UW=HN-?GQB1 $Z_\
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M,#.H3/D83.@!NF?3$EI'GI'EXN675VFLJ9H].V-#E]8XCU>6NBR\OW3XQM!
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MDK-LMT 7!([P2/,5M+=<Q"@0QM&+0UL1V=H[3$HK5G+RC+(,V=J1N9J'& M
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MPE'G9/(0SV4@<JT#]BU]0&Q:N-AK$34 RZ'W ? K?W#[+H$DZ3&(#\;#:_\
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M,;<\BY BTDR@@R!E2AP7B0=AFS#:*OQJEU@10>#[8'+RH'LR_P!$5#-8C,*
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M[- "D0H9H0OM%1S^ 4S#V-&I;=X">$HU&CRS"];A"U2S"H<P96)R(+8V0 I
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M'/Q^<<9Q.+D91V(C]@N9<!_?)\J'HP*Q.E-_8C_. K8*:!+AAX'M@O*6D=H
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M7)-#&0*9:INB!14D6!4M8K8Z<Q*((A@#5(>:P[X8RY.B-ZA>/;";D+#5+:\
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M=4Q&I5\%V;H6K:B5@.\69H-<L^:N!_\ 8?_:  P# 0 "  ,    0
M                                      $_D
M@@#"             $D@"'1R                 D A4'(           $@
M#CXRU                 $ HDJ@         $ D$   @( A @  H
M                  $$@ $$@$DMI-%)!I        #B%-)3GRO'"C@
M                       $%SP@":F@?",      $@$DD@@@ DD@@@@ $
M    'D@0H6<D.Q7^=Q\    $   $  $              &"+@_AELDRTJX$,
M   $D$ $D$$ @@$D $D D                      $$ D@@D D D$DD @@
M@ @
M         DD@D@                     $DD$@@         @  @@
M                $$D$$         @$ $ @      @               $$
M@$$        @ @$D@      @@            $@$$ $$         E>  6-
M     @             'G( #[P     #(SCK8%);(   D$@D$ 8WQ2W]N $$
M6V7 258     #Y(D%X%@&8   D$   4--Z&U@   ![ Z S F       &1DH#
M270    $,\F):+ B      M;W ;,4        K5 $=!  70P$  * &H 8
M   #R  !C@       @%' D%' L-Q"D  0 J@')CU$0 D MXD$.P       QQ
M1@VFZ 2S.ED  0 I@D&RR-& @Z#H%'3@      ;LPPH9]L %)4&$  0(8X#
MX*]X#[$Y@'Z9       $?I $64  %YC^#-*,/4DE6?N   $I) LL8
MM&6 X5E   51;9H#  P0' !2]E ST7"[K0       "@/87H' %3M  $ ' $X
MH<    )I<PP F$R       RXN D-.      $ ! #8@R      %H?"4#@
M   K:K B.I      $ * @ W@      >XC#QBP     1P'9@G"!7 2#  $$ 8
M0,DLDDD@   #S8 P8      #RL46V._NE7PP  D@$@   $$ @   "FWK*-H
M     O=*/.Y$BK        @    $     $!(REQH       !WV9Y"KK
M  @  @@@$     '23=E7U                    @@D$ @@DDD@      !@
M                      $$DD$$$ D$
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MD],$MP#(3D)#&'DBJ%=9X#"&>@2>F+1/.$)1MP1IL$_(=[SI!*E9)%F1 GK
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M6@@LB@:F*5B3%V"L3 (*P@7WR&1PP*H"Y<7GGNXC9H^HH+< =6!X.WVW\?\
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MI=+[4X^L1<*#51B")V< "! P#H/;ZS"WK5!XL(\OH:CC@HL2)[Q'[+>.=W-
MHB =T T$/?@4E.9L9</+J?9KIV*.#V"8@^JP%@"D+!E4@I5#A+I EATV$X@"
M'0<X6TSRBO\ "+_)Q07/8O\ *!G_ "<-L;)?P$7R0-2/[ @@8#5Y T4BBR@R
M^^@T]O\ %"8 7E'<!$58_.A,)'@^2$&,0!\2!@73L$#&XUV@.5 !H'_DF)QO
M<%8V)3B#'C[8=\H'Y/0'011*1VJ.)6'$H$Q0$SX\0@SDP $,(HDYD:;PL@4Y
M/4$ Q8+WB@,TA57:I$]!8%,@,8"+5.E)H)/J-WY>2/>CQH'ID35'5"/Q\?DJ
M'ME=I]VN?5X#UU:&/#\LI+$SK\:(=ID]P07Q-\O0*\C'(D$CC]HKI[6;PD-[
M>42&P =DU555555:JZJNJNJ]^K72Y1$&TA@C@]CBKE,[0=\J/Y^B"  H-Z-M
MLT'@'(JUAJ%NUZ^@H4?3805C&8O?LH,NT^CS!PY?3PB"K1'BVHI3#UC&T8'>
M7I#%[&=6;*NN1P<P9$$\N,BIXE?"6/Y%T*DVK7,9;@7(-/$5Y-WQW%Y*( DA
M'T2@AF HR*:D(FDK@Y5JZKV1!,*'@<=?1$X@*N(E"H(-&]3ZA=M%JP"G-3D6
MB)(#CD4P)-]B922.B4&Q-PX"HZB0*$:(+1@= C=TD(1<9 U@>"C7S#E%8' 1
MFX0$3!('KKBQM>-IPL=Q9A+6H@_N(H 3HF^V">>PE_8(0"^NQ&>U(G8ITO&1
MF)L9FKT:Z.#-)L,X$PK-1KGD0F^,^LT8,Q]$HB=B3[\EH%@:!>?A?QUZ'X"8
M1>[[O&IWAB))3F?,*GBJJJJU757M7ROH3@<AQ0 +X+9%,Z8'OO?F8OF?0W*!
MTPL)S+G<4#FU7HN:Q-TV8[@UZQ_M5R'IOUC)YU VG<75555555JKJJZJZKW^
MEO3*<=TO),>UM)/H K*'K&/)$R.)Q"/F#9U#P2UM'C/5YFDBV/4DE/37(2\%
M6[VH%V :\B\<TC$7HOZJ%P_10" H1$$1(B.(F(XG(Q"83\L.L@(1:,;N%;H<
MU(A909TYM%% %>$IUW1A'GN(?@<6.:J.4<A9M4-]2AVC5V[-LL,%.R-HB'8G
M3Z4JPOAJ_<2WHQV\=L\7$9&,I;P#1WG_ &M7Y5U7RNKWZ5 4-:")X0'DEZ05
M!V-]P)_<XU;M1\:@N>/UQ&4XP-YY0)[KQP>#IL%T7 5EZ$\ '2)(YS<^#\2+
MP5(:#7WQCP4WG^VP1H/O,FEQ0<)&$@T#0?(*'QZ%]1KW;![&#TA[7%6O$(Z
M7>@R&(BB(C$>QX"H JH %5< #57HY5M[<08IME&*!Y*I8Y>F%K_2;6G[)END
M=)0\X*;-'T -&$J]$C&J^6@^X#$O*905%57T4CL--D8>9_338X@5H^*R%'>T
M_B"6J,+%>!@\ ?JVJGXS:?O^&7V>0P3J&>#U]P28+Q%(*$!0(@"@1 1$03T#
MJ(1$;!WVE ,%0 R0Q0(ZE[I2=DX0A6KPB#[7#=KA%&R=#/EA?<X?R3(MOPA*
MRQ%#Z10!96\/8="W U;X@,9X4  1<=Y _KX:VBU[<7TF+\7($1"T2,@S1+@-
M>%\Q<*Y,V(A8" ^;M/V*TCL T(LXW^0\*:/8EJ6-"&BEQ16)U")D'JVX.$4Y
MO%*LX&,  \E[%9(F!/*@IP[$\ !ZK]"/!,\:<C0^6]B0*)V[R$!3HCJ)<?>$
M\QIDA0A150(X']BWW12"82*B[6'G>:PP(+E*0E<> >I-E3]0T3PSD/*FNO@H
MY+32#]>/):Q-D<+7G$P#3)S-<P+9)>:6HG#"RUBV(_6!'+=W2"(D(C4::C0'
M"!AB3P,D]VHBJ<;JU;'\;H#W(K>("6+2C=$?G.8%.)2*&IB@">JC0V*X()$@
M.C"56J@%#E;A@0OVW'M4#N@GDD,CQS D0EO,B:-[)TGQD#<LM!O"EP@ZB) Q
M,%O!Y-XJY@0,$M6!5#E&O-@M2!OLCLD'Z@$ HQ%(YZ0N&BC^I-TIT@?">( )
M1C%*.KZP=A3,NY0%=Y92P26?WU"EKLOP<RT^Q !JOL%%1+^YW(ER2 3TH6Q*
M).Z><W&_77;9)+&5IJ(#G_C'7%;'0ZXF3@0,$CLO*J^_!3@\X/4 ,HPAR897
MFDLT4(T!KPJN!JV@'!QA'H2X[:8A<X"<2$'B>6R4AK]14M>%RIW78@(JHBA^
M@1'.Z=@IC3(0!+2X723I%)'V%Q"+HWU!7"PH P/31F_YP$20"HP3L5%<-N4!
M/V@UP7@Q7I?,ZN10OU';?E6<OML9D@/JB#(HO"*Q._V$"6PEO8"'PB<55@KO
M'^X;R!2U=Q)[0?ST^_$@R(5QTKBU#08,^@XS0(#V((C[)./)XK1GS0_E?Q>.
M@*O-)Y*?YZ/?A$]%1SH9JVP.A?U5ZGG=V8(CB5>0,VAJKZ(Y2W*#',&&!3@L
M@X.]0/%#Z9A&>O* .'4>"*V<!:IIKASJ.,- [HJ71F5;+S.#\*/X AM8T.N=
MR23D>T6D0'%$O$S]S3O^V:8KT;")EQY0OZXPM,O <R?5PK5(&<\X2J-#"PJ>
MQIG +?.6R1FOXFFH)P0*68]<RD#M98V!.#TK\!:S1S6-\AL9J>._5G2P"B;C
MH-/&26QATYLL]*O8G);E!,"M/T_(\JCBN#H+PIS*%$-(8^<565MFWF_*KBI8
M#4)7F"L)4#PGYS^AC0*7638.R-@N$TG[W&88BF+D&G\E5[7)S)AX:RVI]F91
MKP-R!;R>OA42*Q!#Y HMJE;7@3EN^\#ISSDD@^_*-P@EY.U B?DT KGR+B$R
MK9YW.#A1 &=$(X?@01X'7<6=9LR3+&O+:_0TCL&IH&YA?K J$0(B*(C1$T1T
M31Y\H>TYD;$1$ !$$ELUU36RCJ6-QL6P)T1$E(L3!"YJ#I@0W<R'270P[BF%
MY]-3J>?8IBPM%<1$_0SF#SRD'+<-=FA2YGZ>=-X;&\R0A>DP*X 4XW-O5(2#
MT:#%E$W)I&DLA 92TB\MLTF>%BS8::<&6G#A5]02H.T^YU9%VG '1@CAC?!J
M0@H$\OCBC2^06ACJ/AJ[K?\ 2$4RYHR\2+9#*L1<.R.Z+,Y,>R4E%5M"20QL
MXEKP?ILJ&D!@&*E:9!>_&QX5E>L(1IBIL\8",U-QE1X _F+DE1?&M*("3KD!
M.*8W@_4UN^%?)P:2[B$'*Z)\O 2U=Q?Y:3M@+E0R#FGLC9HB'[!&*PM3#A1:
MSP-XY(3;5K+E"K?1+B:/6'NV;L(CVU93I:I%!YD4R,S:W]"H)\-_ES65B%Q/
MX*'77Q$Y _'Z2)#\(B:E0O 4QR)OP*BTA+F;4J>&40>JA(>).U6]<SS]O' P
M,!U+'$&Z7F3LYORQUX0&X4#RMVR^7<Q,_( 7INKI9Z%7G#FCSE$@,%0R3_1W
M"3VX@(VN%T')^4WHA5XJDA>'9WA;R-N'W)@, Q,65Y_1X0+2.\(#-,+\,,Q9
M9)^D?%-!Q2:R)/7I7!$^19[P4,/P>=R6<#U?$UR(B'RS\^>F0(ZF88&VPN@%
MY2B79)M9@]))/9AN4\RQ:6?_ ,8YGJRVK/'4W/5P=;#>$3()G# "       @
M3_\ &7__Q  M$0$!  (" 0(%! $% 0$    !$0 A,4%1$&$@,'&!D4!0H?"Q
M8,'1X?%PD/_:  @! @$!/Q#_ $]_=?\ ;/PHI'.@Z1YF"B&-6,*6*3075T7]
MM-$MX3'Z*%^WIL@P@AY00^Z?L']QY,$K!K%?%H>R<7>,1*YMM;9:07;DC,!\
M:#.N# @CH2 .\W-5L(0(J&@'EMU<_M$5-K,E A8NFAMD,#E0E%H81$WV..G6
M"&T>2 ($M]FI?9B"+9"I"0A4=G[.I]4JU( YI)^S<Q-H0J!>@)NT$*+I+TZ$
MD*C:NJT;!O$.,-1H*36LY&JLV8BI,4T6/._*(WMX:0=,!8Z/B6S;LXV=A K"
MI&LB+SR?K1B/A'\..Y(Y5@"P]!@A:"[&P!4EQ=^7/+;;(I=C;IE#4QE W)VV
MJ"IYH-?.*EU9(IN$ -MRK552"0*1U:5P85J'.ZFYL%**:.LG07C>B*!"4@OG
M"@LZUJ?LZ_!?G:" I4,=^YL,UOB&KJBHG8#I9,"P'T!H %6["IH@S%"@;/A!
MK)T0'SF_FU"*56"V9X(@B@:B.TD%!912%3:D!=MAP#>30'ZAK;_KV?J8N:'2
MBR$]: !3IZ(4XP600)X"BFR"/*,R*)N;"H0$700</!0!/J$1!3CD> 5(@Z#@
M8:'=5 =VP+:K*@1R#1W)((DP6/F!*X<+122M !I6(!N5B10-;.K)C)<2$D@P
M*&@*1VU&E*A5E+J,F)HH:*5W1$X#%(U"A44$EPL$RB;->0+&%00C7'<AS &
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MVMC< -81]!,6D@*2M/".57Z/DX=T9&,-J $E!!%$1'8B(G3^DDC+P,^]76O
MX4U&W=_12Y:BEUCU-Y_Q&3WGI?8,H3(J+-VH/>8J9%.3<]M[*;UFT:%#+I-,
M^7[STOTTA\)?S]LN"@9Z<OL7 D1==8A+&1J430)'-( ^M.FPOP84U9@&6T ^
MK-> P\LI>.]"/00.2+H+TY&-C<QL#JMG1M_^*V8!0H@3AQ;8J$80:4(1Y9H1
M$H1(CO!TK$9;K3!Z$X4UA!^P=PM1 C6X@F..\*")SN]<+34]1@EC3S"7!P$K
M#17!9P8$14:D %@8@(\52J!.5SW@' $% J/:Z"4#%PC98,)N.B- CQ*^8R[
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MPD/ #<J]!? .3L6&!,P28P,H1!\ I,6C)=!V_8+KR*61B,'%L@"U,E]]L8A
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M[D/LD;BUX#V  .@#0!H#0 &O2:(: ;0Y3'L1$ICU/)_D_P <X;#Z'SR>4\A
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MCZ)+HU]X>GVA.>-Y[&E+D$6TT0"AB>8M&$B6+N/E&*\.'6*)\JE:HX+,/..
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M*I"QBEDH"8T(-X:43G!PTE::3Q2Z-%DM4B@K&+\%(I:\PA7:@5L"FL@C&M[
M5J2OJL5#@ ,8J[&20B<Y ")6$U: F@V,;<H0<Z?/"561 SK1$I(Z1K*X[H'+
M4A>DU Q!2T(_*H)E+LL''Y-?*.!2Y#,$@#4R"0L14Z*P6 ']E)9#P @)S7D6
MIJ2JC8V'-!* X@+.$*B%V.!Z!,,L8(# !!Q(">Q/2'  B YC]0L<>G"X><;=
MLY]!<C"Q,HP)3D8"NZL5$"=N@I@<W?CZI#Q1(GB%66UKA S,J A_PBXQ^T"R
M"@)!'25P)T"=ZF,T+)-%@&@#7"JR LH#@$" &FL],% \7D(@J\,:O"B4#0"6
M6\-<JJ\0>0PZM;"H"8AWPAT75!;) 'N)-1JJS;46J_$EE0NPSU45M\H(G,2
M0/=:KY$-XX+,+NR(J:2",,I72=Z%>]Q.B+$I-\+854@EZCC$_P!%G,AB\@2H
M/ L1!2( 0(&@. \?_,O_Q  F$ $! 0$  @$$ 04! 0     !$0 A$#%!(#!
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M>%-O^8^X+:=/;E''5^RS=&= _%2MULM==BZO#\Q=;4<^F@C4!6$A601=P3M
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M294G=AQ,""92\J2XR9'FE:NL:VQ>S/V6D<^?,&'1=E8^+<]/S=_5]O1,XT6
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M@'K\$%94"!2Q(#@O%@VTD*)!KTDY0]A,R>SIT"-;%W!0$\00E?\ 0XT @ 1
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M= +%$2+/";=UVQW%_CQ4/2]J%+259\T2C$ < 1!<O-DN\!<+W^;A%[T$:KM
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M;;J[,&8IM3 4'TB?_,KZKI(J#4_D!\/2)QH'A\'1^^\@;@\VQ KG6F@
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MP2C  \>/HH<^E&C1HTIV8&K'GC5V_HY\"=S@*&(?]8 P)$POO2-@Y:NOK;'
M-H3<"EE46 HQ.,XC@8#@  !P  ^P>L1"\K1;/<)KV7FAU<KM.ZB@D^#GLHPX
M0(DZ@/*;0,NGP0!L\@VP"OAO:(.J6',WG4\'BH);HZ#I'!%];%H=[KQ_BPQ
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MF1<H7<^ZIQC+_&W#V.Q<G_I]C:RP06C [XU?]OPD.*J>51N;PKJ5.;^+\Y5
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M-C# OD!KLDRCTZT6P9<38<Y-E$HQ!8SMZ;]^&ANQ".TS@4^!LP+O@HA8& 0
M  /Z<=2F>6$U&KRRM JR*?F?2V&&2&!H]5A 0'L%86X@4!8N)T$B>)]SF:[3
M]X7 O <%7C+YPYHYS<GO$_>2\)K$W%"1_P#6)!WHHV_JI39Q%"BU_O:$-;5,
M_<I$ (D/325\E6,BD;E\^FYBX'F-&QLXB;EH%SD87?UY] 9_YEEI$J#EK@EQ
M6/FKSF^,7/J'RN<9HQ;EP,W$^]MKR9J90O#K@!EM:F"T$Z8!]-,)<F9C_P!@
&7S H;__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>businessfigure29a1a.jpg
<TEXT>
begin 644 businessfigure29a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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MSKT>EH7\R>N<X]\?8N=J"_6/C'6_=Y>P &N=HNE(>/A$_CYV;V=F>Q\59\/
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M!#"MB?D]  !KG:+I ?CS[LSO[^Y['Q5GP\
M          -<[1=!'/OPQ/UY3C1C+#BH'M@.[/!P=,XZ  Y.V'(.I\\XZG.7
M&')RSW /F?/..#L=#N#Z8SP<'SSCEGJQV9ZL=PS],.IR=,F!@RSCG&>QV. =
M6&3!DPY.[(Y.IP<')U.Y*_'UD?GZ:YVBZ ">Q\59\/
M                  #7.T72N?/SP>/FXO7VGL?%6?#P&M!Z38X
M             ^9HZ;6DY          -<[1=*N\O*L/+RV@VMJ>Q\59\/ ?$
MIDNP  $!TK)"/*1P&C:9-L1$B]XKX[=>@7M'94QA]#DOD]X -$C9,MH
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M1+<KE3[,+(SQF8(^;K   I<N@  \9Z#N<@UW@NK8F=Y3!C-&/.A>9;H (\4
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MVR6X        #7.T70 3V/BK/AX"C#6@\VKK2S9V/7G.,,<9(\A(CSF8-QP
M    :DGE/C&Q&*T8Z33ECR?IZ^<Z'S/.94OHE0     -0B&E;GK)(?,R9 SW
M'G+$+?-C     #7.T70 3V/BK/AX 5V#.& *K."+%AEI'<PY8H     ,"4:8
MHZ$\(J2,@AF#[D@/*7R     #XGE/B<%1$ ,F5";=DM,@>8]X    !05EN/B
M^_L"QHR'L2*@P ,24N9(@9:A:@        !KT5F>$KTW9+(         (\>$
MCIF20F7      !X?3UQOIZCDSGAK=\8
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M"R2[76Q/K3U"_L;6>NKCA@$N=/E ;;@V]*#"W!2-9B)@D]:B45ZPQ@X3UOH
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M :DO+<F2O5=!*ZY_L8CTY6[U7JC%U^&M!<Z(N#:A_J-VOS:3IT VF/Z)NY$
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M2V6UN^VPT".LL#[Q]1=<!#%M.90;(CRHJV2W$:0U+C1Y;!9F)3#4ADK6S-/
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M/+_DZ_'A')&UXR)<U1?'%;!M8_+O??E]+=>$<D\MXR)?-F\<5RHGE^KS9O\
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M\.4YFJ5NGQ)2J$!'2EU1Q!4]*D4YHZA57%1-]H$:0@_:X0#U5.)M:GRZY)Q
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M0BJ"H!;*F!,=XB[.<11,2X:E]WF1UTY$=S,4*IPB)%>I]0911UHSUOM1UAQ
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MY/\ IYOAPLR.E^=>4!-?#=\I6RKY-^J;)NGJG"RXZ9KFO)ES>&[]?R_4WO\
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M]_\ ^;,**AB".(@:>T%1);W7SZ_)4?"#[S\I?3*GN\51K%-JO;SCI3QQ[.#
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MV-*>8AU$VD8[<RT2@,L&<B5MI^W%9$\74:(.*#;F0#^O(A 2,R0  5,S);"
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M'*8UQJKO-"@MJ;S.6HF+5H@F'H91 R41[8G6?%M%O$XR] M$D/*'U-5S'O
M64P83_1&4[U^O)S?A<F]T_0.&*DL=%:R]45V>D0%PV<O<KTU*24-8MT;8'0]
M5TJU;!XU$CN*X7)8L1:TW% I'5<U%R$1!')V2@YUB=L;219#20L)4\-LP4;6
MA!CH4>A1H7I,>D_/Z_45FM8L57+K5H!]6[&-:/+D::C&<E)#Y<AJS)5J\!<M
M6L;7JU,(B<O\-"M;57T3^4-OY0_Z _O6F_Z,G_X<?2S^V_@^@_\ #9_F1] O
MI\L\5B.X!0D<RAJFJW% _P "V&!%,Q,#]Z=-NZ.3,T)2[>%?OZ3OCLC=M""#
M\8'UWP8E,1KI,>-J7R0$,\<L:?PPC3>P-OJ)?A[]T?A'BNW$U6G97LE=BRR6
M+Y/D,BO=J]N[]G&SYZ:>NG@G9P,WO48J1RY?+U5[!$-134"RH5*20P*R@=)C
MV^LKUF;_ $]<SQK4Y:;V.*_D,F@JC@-//"7,<2YK,E<D<>R%D1%IL@H%F:QY
M5V\@U_,*;]SF3)S [D3/\'KR"4:QI.FGC:FZIJS'5;".?V<:;CTCU"?P]_IK
MZ1XK^3H:ZR/'*FV9@@Y9](X51.Y[)/T4, 4ZZ?CIX(LWENK<:-1BZ=!*KA8P
M)KIK) H%!5H>2U-$@6TR]WJ/KLF9*[B<UU/D>*PL;M.W?;D FJT6A+N,5B4<
M337NF=P0$[B@=F^-<E4)1ZPJ;2#^-/NT]RY_J^N^"CTT\:+?R*F)XSW%Z#_$
M4?C$_A[M?")QB&M?[..6:LW-F=!V+]9:R2] B!F==-(U\ C-5'UO+S&E2.RA
MM=SJRE#]Y;M#(4E\);=HP0Q >XED1?J;E-$@-HE[ZALF8 ;*_<J2D?6!F?:4
MZ3H)3.D_+PVA-&S;LO'D#'\ VJ3-WJ?VST1PQZ[Q88Z%[=-9CQ#:W3.3!D#*
M;';8UJ^&0'5BX*5P6GX0N-1T]/Y>*O:X:W6JE/;B84N!FL>FK&-E4I5_7=LT
M])B)DO3Q:3?8@P9*X0A1$X8X]VYQFP!^(W48F(CY+B2F9^53(]/)1$Q697R2
M%$NK89Q'+ZME.[:IK0DFK*"F&3JJ(W1'L%UW!9#,XNH7!?MNQ;5/J-GVK%40
M,-DAG]N8+)8>V'2$E'@;D=+YWMH:GAEN+M0EAO'<.Y7#/I^$:Q$E/IIKIX/D
MQIXV51%E460[''S$Z2"R9',;G%KI*A5/%H4.XY])Q]'(4<3:O(446'A1KR,D
M;3;QB9IAA@D2%(F<01PN"F(F=(HW.F:E))I2VO>JIA-(G+W0VLU7HM)FHN8)
M@I@RA@:3,#I!OL8'(Y&C2/BNL;CV@RL<^T87&V&D0S^U)8$*XTY9#=&L6XZ:
MS$5MR2"3QUF%D3O4-1X?E^$3/X^GXQXT/&'C=%Q9$[D=I4TG20 F1RF32UTX
M15)+TGEA>GC'8[)6HN7:RB%SA(R#W-8:T@;(@R"NL@0!% ZBN/;$>GZBW3F=
M.X0:Q+UC:<Q\,O3UT%FTO3^7B57T,YK@Z#3!$7TW&Q[-J&JW1$LGYK9MF!+<
M41'@-O3=FMDJQ;'UJF-9,UG&6FL2*9XX_E/K!3]V9^?B5X_!V(&M8VV7QBFL
MLBTI_$(4/QM?Q+[GS*8CPPLDM$U&(_9O)=FP]QRL@EHR)"J:\"0_?F=2VQ[8
M\)=A*-9=J")5H40FJ;JQQK$Z_#6PTL]P\AQ(BQFW69VS%>[C9RZZ;([P6T??
M14,Z<C"$2@6#K&V?XAU/[L3/@["L3;[0ME@R&@R*S(W^R#/AXS&/Q+=M_P"W
MPN$X]E%;5PU1*JLK@2X]?BVS$%B&L>BQ*9+6-HS'@47ZU*7RQDZ E1;%EIH!
MLV?$*2WL*?6(EFR)F!B?%2STW0JQDT.8JT"I129:H6 ]_OGB4QJ7+28<QCH$
MMV3K.V3IW,/9S08P],FEF-8+<;7 MA,8Y83\0=?AE&N\()D:KB2\%=K87,SC
MMD69=&-L]K(<FT8)W!Q&$3]YF[;_ &^$#6P]K')M*BQ78--]2N2H_B?>; )4
M$R/HN"DV:CL H*/$)Z@P^$LY$[#VR7:5[9*2< (I*PU4RR=1-LZ>P.78,S Z
MS59TKBL?6R%=Y0]59=:A-JFY>ACNB$J,U,!1A#2C0.79.L[2L5+&%MY*,;,^
M8(*@S?24LMI&;0$HUC7591,[PU8.Y<27@KJ,'E.Q(.>6^76.WX]^V-S>'C((
MGYGNVQXK16PUNDNVKE2Z:K:U?B'^)MID"M8^GM'=N/4=@%N'5./S;P;96YDI
M6MLO&K4T6*JT-F(UTD3;M'V+Y>()T#Z_4&V]C\=(55/[W+#+,8J*]RL^8NJ&
MO;-Z'0O@E"Z[&O)HJ5M,A*,LY6/Z0QDKNH4ZKTKC<IB& SM^2/.*&7Q^-MJ<
M0&)T2XC6RL12+)TGZ#_PV?YD?3EG6[N"[JF$CE9::F$L6.749!!.X2/N&*JV
M>$28#S6BQHPA":DHCI]U?)-=2I%NJL.W8 #;8JI-DR\["00PVIB>6N*3DA7
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M[?IV&O:?=V>_N_N?P\?AFG2JBD::7+C\X*L<EPY5S4M>T]D(@FS%J=0;Q1$
M/)&ECCZ54R5JJE7CS^J'<M;"^Z5,S4G@[229$,+=%CCU& WQI:XNEE-XCKC6
M_3]5?= R)[ADZU)X.WG2( M\NUU&1T\.A?3"F"%U:4EY]6#FI%R<E[2:L\9+
MVK^RSJ9\GH<;)UT_-A6WS#M]_GU;_1__ +QV]I][_P""_:?\YX3!],*7!W&I
M=/GU8^"F/'QW8B*L<LMW,^S1M-?'ZG.^-*O-TLI/(5B+6F?JM[45C$UR'2H/
M<=S.H[1V<.FI3.OBO)])<<L1;.Q'GU NV<KE[5&L*^-W>U4<H:#7Y?B:\<^
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M LW1 3(QZ>#'\V\)M95&D8SC*DB=09&8KE$JTE>H!.GXR ZZ[8\"M8B  ,
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M!7VT.Y"E>84OR"RLFQ[]I@Y6Q<#UY5H5*U*M'4..9%>HA==,&WI/IXVG"E"
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MOP$$[I[IRSU7B.F.C.ELHO-8_-4,$%9=O+X82?CV?IJYE&Q3FQ!"HIFO:O\
M(QUG3F%09WR+\HG2O4N6*GLKX&S1QM:MDA8Y8640U]@H6R*A.97EC)CN%KB?
MGXQ,Y/\ *9TQB<JS%5.\PM+'8RQ4H7"K!R8^OM8 ,4AGP  2@9@=@LTT/PW(
M]3X_#82QBK3ZV/7@Z5:M42-M"YMY,:Z[5Y)9VZN8IR\BX:%(7"H'%?9ID\Q
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M:Z7Q*^13MDPT"]G,E+=ORY%*/3< S&U@ P8(#@3&"B#48L6>A1,;EL$6 7S
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M>:$Q6I54A\1U7*:V+*DG^Q L%(6B-TS,D T]B2J-CQJ/)AD,WZ\07&X-T_\
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MG+^L5;Y@HTK?!-E^(^Z=-@18L35=3E2R]X*HQ_/!D%Q%&RR0!,\TBX$GT=I
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M<:Q'EDI4JYL=;"M-T7\T\=!,$DY*M<@$ML&;-U("76HBT(AX( #JD\X0.K.
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MV&2_6B5:6DM,6+BB^_;/L!9LR3+6<I"@B^^$0LD+:Y[Q48:% ?\  (H\KD!
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M%;7I2*[J\A5>#6A@$I*NJA19;(TD6$"V7B4C'K"&V8@?H:^DDOTK1(4T?Y/
M8-7P.C-K3%N@,%VGS;+I]:QX*0.6"\55!&:QR"UB;ZB=&@9YXB>R"S )!XUN
M9KPA3T0I$<H1B"F=(.TC_P![KDTHT*R&4GPL0'/!6%*^VYY-V+$;FN.6IFV)
M6:6!:I9DNL;O<7?0T)OC( )[<97@!6\ I4U2L82Y) "VN75.&"!YOBEHV%+E
MBE%'.=K%=1\DA]R-O%O_ /HSTV.Z:W'\EG59<)!LZ(OM%+1#,TK1$+V9>B8
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MZ<7AG@NVZOZ5PK%.R'Z"P0Q97H/28T_64PQ>EI!CR&GX#;A(L%S^"@:0F.
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M1GZ-'R"8 ,(IP577$_8E-VF.WW8:W7P1FOR*$0D5S".THU =P84AAB>(@ V
MP?T@4'<"97SODYB78KP*,:K(PLI&-B%4*KNNO<7E-B'8'LI;DK;('36;?&A\
MIPO3YBRB("J&X-3K(D%Q$',I# ] H/X_HG__V@ , P$  @ #    $&
M                                &A0
M          !\*/Q5;>OA$    ++*GOL,8   (D0+@9.ST-   #!0OXK^0=M
M    IOAS73IP   SJB<.73F.F  !V*!< /L!'      ( )(!(     !)!  )
M      -10( !( ((     !(!) )(     ( (    !    8*
M                        F"_1K)!/VWRV@3B324M1Q3$D,\=C%SS_ &%+
M;)  "@                                   #T42
M       "            -"B0  !D@2"20  0          "    8%P 0  #T
M6   "R_T02" "   !>M( 00 20  6H@&     2"@  #$4@N20  00 !?O3P2
M   2  8D -B0   #P40  "=X%"   0   SD\!P0  2  !I*T400   7"P0 6
M >B      0 6!8      2 #3 > @0    04" #D:D*2   0" 1.(@"    "2
M ;#$H(2    3"P " #, 0"  " 0!,%< 0    "06(=OB20   "<413.77@
M    "2AR0  2    !<%A?X      <B@ 2 2"0      9%#FP       " 0 2
M0      $4  ""0       022"2"        0"0       "CO+P,)MO03Y]MJ
M#NTG\3.OE(9OUL!B*L*_N0$ '                                2 D
MR  "B0           0           0     2"   "$6"  "!0PP20      "
M 2B"  ""  2"OP2    'BB0  :^NH0   "0 ""D%<0   "  !%IK"2   " 4
M  ",A\VR2  "" "/@$QR    0 !Z"+2"0   6BP  !@=@     0 #5E!VP"
M   01S#ATP    !L60  *(@;2   "  /#K :0   0 81Y\\""    &"P3+!*
M("22   0*.P@H#0    "+8B*2B00     4!(*&D       # 3U4 02    1"
M@          "B T2  0      0822"0        ""2        4 "  2"
M   "0022"      22" 2"     !$E@  ""         "20         "22
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MP)N; D8 U[ K7KX1]S3 %&4RNF)1E=MF6675FK.9J^@WG9?P9*Y"C T@A=C
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M20'M-!H=K50NA&;K'=FB\'=N[V,6"#N!L\3NCR#J*8DAV!%8[--^'6ZX' R
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MD+X?<^0REI4BRBX%M"N-:7*7?M$:M09<8H@A+#(R@"%IR>%L22 AS.5>R&0
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M=4'7;% &2]R0"8[P!)B (?(H\4(9$O!P>0(L=;"@E&EY ]"=R[3  *!A"\[
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MR/(^BV*TW35%%G##$F2V*;(*JM-CF#K_ -ZM!HS=1(<== H6EI%43[D8K?<
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MJ0:)&(EULPO* !0"(41*3C]0-.LN)L2F*$XT@]%F ,<ZDSD+2!"ATV5\BRE
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MC[?J7\C[O<;P9"0L6DSE( '5A@]M./<8I,:,4(!WW+5A"@R5*$R6<0)0:KV
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M*8LXH!4_.[ZB/!):4N=WU_5.XT'P^@YG/V5L;#3H*:;P$2I;N$6-$$V&N
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MVP'AS@'1//X1; H\ H6X!4(@"KP+A]+R2+NW2SS2/X^9FH8GN3F[+].W)O\
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MX&IFJHJ.+0@Y&ZNJ)HV;JM@JA^1M?<]0UB2!"E4!!88>.A_  )?/7USX._F
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M#J?PBJGX8UV6<@MB)P&W^,VI 2"MW4AH:-%IVC3V5(N48]RHP$0L!!* - P
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M+1@08^:N$_%FS>F+70QLS!Z8^0J#Z.]*H0&=*@1<K+Y*W(4&VF!?VM .6*M
M)PWHV56 C!EJ.:K,+>0/0S\ 0 _ *L.5?W\FSG"_@\\MYO@<+[Q^-R,&Q?*4
MA, \T; 0FSW.CV#^ +ZZ*OXAT)N>9 ('$!!_(%*UK",$JUF.BS-$/J,'S0JR
M62M'56< PBH LL _!F)7GK68GBGJ7XPXV@7= /4^J13%' ,R1(BB4&VJY?6+
MPX4Q&X'-%' $0^U*@#Y"JJ8[9R][K(UM^GY ?F6'\R %98Y4N$ B,Q1>$I)D
MA;+!2)B4!K.S?7&8=**JM4BV#@8\QII-DL FRK->^O$ /:](D5/\#^S! QV.
MPDG'8"IQE**@#+1BN9=ALY8AP#]@ _@PN/R7,)Y0_P"OI;"LJL3G3/?@7T2-
MM\^!Y>3$=F5_C4'Z*!#:J4[6OHP#HY#%@C?>J+GC@"AC&S1:8D_SDF++3L-5
M/CT66X1'5K3\NOM[X%I\&8V4S7/(R%[_ " !M7*#-F@EOQI+.0/N0T4-P5E
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MH2)M5_MG'; /M4X[3)O6KWJTTY&-X5O 4KEOG>])E#V)_4592Z PQ, )(=M
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1V)"M/]NB\C^ <47\ /Z)_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>businessfigure2a1a.jpg
<TEXT>
begin 644 businessfigure2a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X17.17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(Q.C S.C$R(# X.C4Y.C W  $
M : #  $    !          @   $$  $      0   0$$  $   !K     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   "S%         @ "  ( /_8_^  $$I&248
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M.,]47\J/>'>GV?\ 7R$BFCG3?$P9<XR*Y.X_X^9?]\_SKK@ HP  /:N1N/\
MCYE_WS_.N[!;L\?-;6C8CIP_U3?[P_K3:</]4W^\/ZUWL\='-ZAXFDL[V6".
MT618R%):3:<^W!]:OZ-JQU1)BT0C:-\?*<C'U]>M:#0Q.VYXD9NF2H)IR@*
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M;YW(#I-@>MK'T _(8%6(H(X<^6@7( X]A@5)15W,0HHHH 0J"><_G2>6OO\
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M]T@ _G0DFKMA*4D[*-SU//%)FCM14F@9I2>324'J: #-+GBDI>U "9HS110
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M8VUS
M       -9&5S8P   2    ! 8W!R=    6     V=W1P=    9@    48VAA
M9    :P    L<EA96@   =@    48EA96@   >P    49UA96@   @     4
M<E120P   A0    @9U120P   A0    @8E120P   A0    @8VAR;0   C0
M   D9&UN9    E@    D9&UD9    GP    D;6QU8P         !    #&5N
M55,    D    ' !' $D 30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $<
M0FUL=6,          0    QE;E53    &@   !P 4 !U &( ; !I &, ( !$
M &\ ;0!A &D ;@  6%E:(        /;6  $     TRUS9C,R       !#$(
M  7>___S)0  !Y,  /V0___[H?___:(   /<  # ;EA96B        !OH
M./4   .06%E:(        "2?   /A   ML1865H@        8I<  +>'   8
MV7!A<F$       ,    "9F8  /*G   -60  $]    I;8VAR;0       P
M  "CUP  5'P  $S-  "9F@  )F<   ]<;6QU8P         !    #&5N55,
M   (    ' !' $D 30!0;6QU8P         !    #&5N55,    (    ' !S
M %( 1P!"_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_\( $0@!$@*. P$1  (1 0,1 ?_$ !X  0 !! ,! 0
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MUD]B:9>YCT3)8FQC<O7  26)L8W+UP %)B4P]I&9>L  ]2^-_4N3Z?IP
M      +-=GQS[S\<@ "2Q-C&Y>N  DL391N7K"0 )+%V4;E:T "2Q=E&Y6M
M [EC,LW+%FNT !)8FQC<O7  26)L8W+UP %)B4P]I&9>L  ]2^-_4N3Z?IP
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MOM7;#:QUR[E&/B8U>RMH:_5:XS]EU*J_:?*\14%FNSXY]Y^.0 !)8FQC<O7
M 26)LHW+UA( $EB[*-RM: !LKA?8MG><^Y  <T<4T  +D1TYGY4[W?Q.7G9C
MBXGT#TG/Y/M^2T![-\K  4FGT?X7]@=K"VP &55V.U,     "Q-5F9Y%#A,]
MFFC7N;LLALXV3X^*!9KL^.?>?CD  26)L8W+UP $EB;*-R]82 !)8NRC<K6@
M ;*X7V+9WG/N0 '-'%-  "Y$6YD "&W7*: ]F^5@ *33Z/\ "_L#M86V  RJ
MNQVI@          "S79\<^\_'(  DL38QN7K@ )+$V4;EZPD "2Q=E&Y6M
MV5POL6SO.?<@ .:.*:  %R(MS( $-NN4T![-\K  4FGT?X7]@=K"VP &55V.
MU,     <".* %#D4 !4LUV?*_NOR$A20K"DI+$V,;EZX5A22'9UG1]3DO40
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M53M**A>1:3J&'0F-KDLG*J[':F           +-=GQS[S\<@ "2Q-C&Y>N
MRK0=GN[Q[ZA  %Q%M( %PM@ '-'%-  "Y$6YD "XBVD "A>1:2 !E5=CM3
M   '$L     %JNSY%]W^/!0J"AQQME!9>N  R[0]EZ'\=^G@ !<1;2 !<+8
M!S1Q30  N1%N9  N(MI  H7D6@D =R_B\JJ   !D-JY<2.)TR@*E"I0%2A4L
MUV?)WNWQ^A0%2B,]\V]^F^4]*  [\,ML7Q0J"A=1;2 @E<+8@D!S1QB:2H"H
M+D1;F0 .:."0*%2D+TQ:B4@*'2RL'2.RU^S,3)[D55A!W+>9V+XH9S8OWHD
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ML=J8           LU6_&/J/@H  W=Q7J.R.>[$ #F<   <CB  <CB  5":(
M Y'$  Y'$  )YS'"  $Q51>F
M                                                   /_\0 ,A
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MG5N M;'$)A4"=)D!VYD=O7-I/$6#"GEMNT1_NR"1S0I4!GY19054LH9KZ5+
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M#!).[ OI<):T877>.2QYUVD O&;<_<^92+K&R77$"\BG5S8Y#&*9O_/M.?\
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M#O&%J\CR?BIAS.DAV-1MY6RY/1C,\Q<#\ICGJFCIX**CF&JG6FTR)*'9Y-0
M.*B1):BHEBCV,4L\LD<(-Q%&\C,D8/\ R*0O]-V[$/M3F'QO+O[O'>Z>MW^M
MAC0<((ZF:FCH\PJ:D0U+T[U;9;FN6U+4R4]03+..+UN6"6,2[%)"84:ZA06Q
M2T532OQ3T4X/U60Q1[2BJLWGI)XS/L@\T5$(YHZF)>,ZXW1FCAT<Z1&U$%2B
M235W"*OR>3-"KI$:FK@S"&BH2#9J;*Z2-XJJ4W=:.%IT2-65RH OCA#F%+7R
M4"TTLU6:.CXM+7U$ IYJH[5WB&R#,P2FB98(S(S2%5M?2%QEWMCE_P ?HOM,
M6*CV14?SYOK6QP4J1!55\0J(Z.JK,N>&BJI)A3!:E)HIMAQD^QA61))3F8,A
M74 '6^]LJS&&J:KRB/-*<Y7!49AQ.N05M(&JM.NDRZ>)Y(\Q6MC>4R/8L\*D
MR;[D3TN:C+:1H>":PM6/+%%&[2U\% L^DU$M/EDP/H:U6;':33'3LN8(^D\4
MR_)=*5<M/'2SQ30YK+FM3M*[.::P8QT674LM2L202+#Q.H>59C,NJ^S!&#:Y
MM>US:_3:^Z_=MT]W%5[ RC^#,/MG*RWJJ_Y(S'ZM>4>@]XXSCVPE_E4?V*GY
M7 O]$\@^3U^MEPL,*WTPQ+J&EM,:"Z]=38;U/8Z,"*($L(HPS"S'0MV'8)MO
M'9[.-A#95V,6E#=1LTLI[*BVX]T8**=1*J2PTL2HNRB]E;=S@+G<;C>>SA8H
MU "(B6U:="JNG5TZ;#=?<3V;"]\11+"@1+VNS$G>S,[%G9CNNS,23N'ZE4>Q
MZCXO/]2^.SWS]/*G]JLL^,YK_8<K*O9,WR=F7V.7 Y6:^R8?DW*?]MIO/L.P
M/F\^'VIS#XWEW]WY]AV!CHZ/.R[VQR_X_1?:8L5'LBH_GS?6MYPK:U5A1:RJ
M5*8ZJ95J)E6G;LP@.-D>ZEL&JJBSN:JI+2 B1N,3:I V]@YUW<'KAKWZ_GU7
ML#*/X,P^V<K+>JK_ )(S'ZM>4>@]XXSCVPE_E4?V*GY7 O\ 1/(/D]?K9?UB
MH]CU'Q>?ZE\=GOGZ>5/[599\9S7^PY65>R9OD[,OL<N!RLU]DP_)N4_[;3<J
M'VIS#XWEW]WRLN]L<O\ C]%]IBQ4>R*C^?-]:W*JO8&4?P9A]LY66]57_)&8
M_5KRCT'O'&<>V$O\JC^Q4_*X%_HGD'R>OULOZQ/['J/B\_U3X,=+<_E;VU'?
MQ5NB_3^=QLJ3MM_%&\KC9TO;;^*MY7&SI>VW\5;RN-E2=MOXHWE<;.E[:?Q5
MO*XGCI?0O+?RM_9.:;^*MO\ 8-_WFZW9Z^-G2=MOXJWE<;.E[;?Q5O*XV5)V
MV_BC>5QLZ7MI_%6\KC94G;;^*MY7&5QTO&)ORIK^A^8[N+-T<4DN?SG6&_N]
M&-G2]MOXJWE<;.D[;?Q5O*XV=+VV_BK>5QLJ3MM_%&\KC9TO;;^*MY7&SI>V
MW\5;RN,UCI.,0_E;^UV5?\*WP;36_>]?&SI>VW\5;RN-G2=MOXJWE<;.D[;?
MQ5O*XV=+VVWBK>5QLJ3MM_%&\KC@UP<EX24^9T.7U48DC:AJ7>>)HU"(:A;#
MGG46+]RUL>I-G7PA0?,_WL>I-G7PA0?,_P!['J39U\(4'S/]['J39U\(4'S/
M]['J39U\(4'S/][%-YE><T]33U!KJ%A!403E1K!80RK(5!U;BVFP.^U[XD\R
MC.GDD?C]"-<CO:S[M;%K=5UKX]2;.OA"@^9_O8]2;.OA"@^9_O8]2;.OA"@^
M9_O8]2;.OA"@^9_O8]2;.OA"@^9_O8E\RW.9:>C@%;0@THJ 6YQ#[>;:BPON
MTCFFY-SOQZDV=?"%!\S_ 'L>I-G7PA0?,_WL>I-G7PA0?,_WL>I-G7PA0?,_
MWL>I-G7PA0?,_P![%5YGV8Y!09GF=96TKT\66U,4@A5FD'&-$2L%U<[2Q%QN
MW;[[L;.E[;?Q5O*XV5)VVY__ !&\KC9TO;;^*MY7&SI>VW\5;RN-E2=MOXHW
ME<&.DL?RM^CM5N[_ .+_ %P?,RK,W6#,X<WHXHJVDHYHXY*:<NJ\5A4:M+VO
MS;[NB]L>I#F/PW0>*U/W\>I#F/PW0>*U/W\>I#F/PW0>*U/W\>I#F/PW0>*U
M/W\>I#F/PW0>*U/W\9-15V3950Y48HJKB$ I^,I.(5FLS-K$3HS)U5M+$G=C
M:UO:2>.)Y+&UK>TD\<3R6-K6]I)XXGDL;6M[23QQ/)8VM;VDGCB>2QM:WM)/
M'$\EC:UO:2>.)Y+&VK>TD\<3R6!>PN+'KB]['L7W7[_^O4>QZCXO/]2^.SWS
M]/*G]JLL^,YK_8<K*O9,WR=F7V.7 Y6:^R8?DW*?]MIN5YD'LS//BE)]=)RC
MC\.5V>5PX_1'/OB7]Q#RFZEN\?HQD/M%DWR70_9TY4G[?<#'^H&-M6BD2H1I
M_8NN1YMEI+D+H,0 )'.O>XMHZ=]L25LL9>/9QM+&[ A3(P9%BCEN% U"VU"L
MSLJ+:]S<#'HB53:R1:(S#M8P=9:6\&V CD"F+5U2E&*N I;?T8IIWF,BR1Z&
M39FX#JK"0$[A(%>ZE2";:6W$=<"E>5C5"9P[1U&A=*Z55=E&X4"Y.[5TL22=
M_<_T ">A6;^$$_1?%C>UC?W-C?YNGHW][?CHZ=W?W>=]'9ZW+J/8]1\7G^I?
M'9[Y^GE3^U66?&<U_L.5E7LF;Y.S+['+@<K-?9,/R;E/^VTW*\R#V9GGQ2D^
MNDY1Q^'*[/*X<?HCGWQ+^XAY3=2W>/T8R'VBR;Y+H?LZ<INDXV<>C9:%V=@N
MSMS-(Z%T]%AV,/!!(;O%&Q)U$E1<G2%N3U[J I[( !P*>!3=88P;:=R#HMIM
M;HZGF]'4[NC$<4<0(B18P3<A1:YM;?WAN'8&X8"JNHJH!<ZFL.J:P&H]DV %
M^P/]#(,P.6YE#.U3)30'6M28R]G39OH618P2Z[700+&S6;K7P,PR9Z:F>JJ8
MJJOTRM/4-1R)5DS995PO'53+%^4LM88 DC2S$KID)0 J)<PR*=:MY#3R.\06
M3:T<LE34!<JIX*5:"HTVHVIJU)&F9C%K6S7D7F8&8\&V7,DDI:+=!!%1%:0P
M[5!1VFTNE+*ZU7'3KVK;!B%%IMGS3FM;E<F414E ].#QJEG%/%2R031HE"T,
MO&YF0)43[<GUP.YTL-]N:O*J/8]1\7G^I?'9[Y^GE3^U66?&<U_L.5E7LF;Y
M.S+['+@<K-?9,/R;E/\ MM-RO,@]F9Y\4I/KI.4<?ARNSCHWXRO@G3U5(*>H
MEICF+5=+-4M'4OM:/+98EE1(H[".>6H6XU ,B:KZRR:<39%E%,BP5G&:*L3,
M)6J0[2%FRT;381Y9=6BKI)?6EN#M@[-=!IMB;@SDT4%1(4FIY,R@6')J.O:8
M5U/7J)->I(RW,D(C(9]2("=; ,+/')$[Q3(T<L3&.6-Q9TD4V96'6(/_ ,MC
MAQ^B.??$O[B'E-U+=X_1C(?:+)ODNA^SIRFZ3_JY'E5/FAJ.,SU$ BDH84-/
M''(3)73M3J7$A%D1K,=/.(N +VQ#P8I9I%T5.82PR0TQ58:6%ZI9)ZRJHGGE
MCVA1:&"2D:1Y 2X21 Q!N<4_!>DJ85D-68=E0+)(\8,PFG:LS&'C14AF6DT4
MB B,=+7U WOZ6D/%T1Z]Y)J26?:K3(:.IE&7/7Q0Y?*'+U!U+L)5T%[W9;'F
MX]+$($<!6M>45(XR\2IMT@]#*>K=! YT$PRS'5I5YR@L$)Z,XR>FRJ'\_4RU
M#U]92Q:HXD@V-(T8,DAOM-HPE7FJ- LQ) L,/P8HXC'M*K,!&#6;9^+0#:K1
MY7Z(M/0W<B:"4^M1LY&X$WQ%P8I*I8Y(Y:]5EBH"AB@CE6+CE)-4<9KB9#LX
M(]F%F>,Z1JYH%M_S'NCH/='<['GU'L>H^+S_ %+X[/?/T\J?VJRSXSFO]ARL
MJ]DS?)V9?8Y<#E9K[)A^3<I_VVFY7F0>S,\^*4GUTG*./PY79\ZFX15D$2QR
M04E5+!3\6H*N:(+59>N@H#'-& TH56.A)20K $'!X:9QL\OB1:95H1'J+!Y6
MK#&N@&9Y"674-[[,@EN<6ZV*KA/F=14S5<?%Z.HFT+MZ:,\9CB0 "&.>1G*H
MUAM-*J9+68VQ([RN\LKM))(S/)(YU.[L;LS'KDGIQPX_1'/OB7]Q#RFZEN\?
MHQD/M%DWR70_9TY3=)_U0S+U+LO1U+,O1O!W$;U.\'K'>-^!)*#<2R@Z2MQ(
MX.@W)2X/4DDDKT$DDBYP))%ZF21>9L^;(X];._9[C^;OOT=3<DVQM)1HM+*-
ME?96D<;*_3L]_K=^OHM?KXVLU[[::^\WVLE[D:2;ZKW*\TGW/-Z-V&9GW.[O
MT]4[-T]/238FPN>DV%^C%9G&85\<$53,"E.+1B**. GUI8;R-$JF5MDHCNW[
M%Q:Q.%K:I:9Z19G$$DB2NMSJ+)&T2KKZO9A&(V5]F=W-W#D5'L>H^+S_ %+X
M[/?/T\J?VJRSXSFO]ARLJ]DS?)V9?8Y<#E9K[)A^3<I_VVFY7F0>S,\^*4GU
MTG*./PY79Y7#C]$<^^)?W$/*;J6[Q^C&0^T63?)=#]G3E-TG]8J/8]1\7G^I
M?'9[Y^GE3^U66?&<U_L.5E7LF;Y.S+['+@<K-?9,/R;E/^VTW*\R#V9GGQ2D
M^NDY1Q^'*[/*X<?HCGWQ+^XAY3=2W>/T8R'VBR;Y+H?LZ<IND_K%1['J/B\_
MU3XUTES^3R])_P"([O\ *QKI.UY?&?\ M8UTG:\OC/\ VL:Z3M>7QC_M8UTG
M:\OC/_:QKI.UY?&/^UB=Z7T+RW\GEMQG-+?E'Q&_[K_T_KC72=KR^,?]K&ND
M[7E\8_[6-=)VO+XS_P!K&ND[7E\8_P"UC72=KR^,_P#:QP3HZ3-,]I<N*2PB
MMBJZ=IA-K,:O32:R$T+<Z;@;Q8F^^UL>I+E'PC6_,G^,>I+E'PC6_,G^,>I+
ME'PC6_,G^,>I+E'PC6_,G^,>I+E'PC6_,G^,>I+E'PC6_,G^,3^9;E=0ZR29
MC5W6&" :50#130I!'V=^B-=1Z[7-AT8]27*/A&M^9/\ &/4ERCX1K?F3_&/4
MERCX1K?F3_&/4ERCX1K?F3_&/4ERCX1K?F3_ !C@QP.I."\]5+254T_'(DCD
M691S=DQ=2I%NNQOV>4>7V>5G.6IG&65>622-%%6HL4CH+N$UJYT[QO.@"_6[
M!QZDN4?"-;\R?XQZDN4?"-;\R?XQZDN4?"-;\R?XQZDN4?"-;\R?XQZDN4?"
M-;\R?XQZDF4'=Z(UN_=T)_C%#3"BHJ2C#:Q24\=,KD6++"H121<[](%]_3RI
M4K#(YCJ842_-5J765'8+;==7?TC&SK^VX/$S_P!1C9U_;<'B9_ZC&SK^VX/$
MS_U&-G7]MP>)G_J,;.O[;@\3/_48V=?VW!XF?^HQLZ_MN#Q,_P#48V=?VW!X
MF?\ J,"]AJ-S;>0+ GLVN;=ZY_UZCV/4?%Y_J7QV>^?IY4_M5EGQG-?[#E>9
M[^F&4?Q5/V67E_CRNO\ T/*./PY79Y1ZW?Y0Q^/*DZ'_ (6_]IP::7B"2@)$
M5H[$1!]K,T@2VUYHWH>=;G'5UP+WGJ*B)I(MH_-D;1*RHMP((I I<1.&.IVT
M(D6J2VG6-)N*NJMJ'KLCP:TAC4#2_%@]IHFC#BTE[2)*RL6$>@'%+*\B3[5]
M42JMI/VN<A,HU)%$+KN(T NA.D\ZV,O*,99(K1Q,L8C@!NRJFJTTP_9EEOO'
M5:0NT.NX7]2J/8]1\7G^I?'9[Y^GE3^U66?&<U_L/.R;S,.&N?\ !]N$^590
M]3E JHZ-9Q(H,E1-((HT13TEI&5%!(+%E '.6\WF1>:'3T;5TG!RJV"9CZ$L
M5*LW'[V-/8;MHIZI-6T6S72X(Q'YB'FDNN<E\@DIVR&E2LKXYW"2)!(C.C!2
M+V958@L!?2QZE68$$$@BQ4E2#T@@V(/>.['F>_IAE'\53]EEY?X\KK_T/*./
MP\XQR*J.T;JD@O&S(RK(M].J,D .M]UUN+X*L.E6%Q<74[P>@C=O'=&#%*L:
MRM%((7)5)C&XA=E +(DMMF[J""RJQ8 W(\[L\H];O^=0T-9F=7#0Y?32UE94
M$K#30+JED*J7:PN!954LQ)  %R<0Y+G-1.E-!E.8S5$C5:1PQTDK/(] =-:J
M66S<4;FU%B1&W-.\XARG-:B."6'+*^2&JJUH*:9:6783UKMI6ECF*B-IRW-T
M:NFXZQQ6T-7EM7/05]/)25E*^SJ*>8 21/8, =)93=2&#*Q4@@@X&/Q\Z3)<
MXBAHZA\LKA!F%-/644NP9EJ:2F&JHJ8]-SL84L\DC!0J$.>:0<#),Z,U)3C*
M,R:?,*?CE#"M%.TM72]L0(J%GA_\2VGYQB7*,T@R^/-ILOJHLMEJI**.LDCT
MQ-5Q%A)3[SM%=6CD4ZD UHZ EE(&&Z3_ *O!#@_EF=QYW/FE1-!%E5+1S1B/
M,,NRI)'JJOBQ$U;F<4M-$%!U(" SMS ;D8CX#G,:8U>3YE3U&TSL95'EVH5L
MU%%+7+14]3F>94=J5(Y"ZR)/%3<6J$*[*4/(D9I. 7HA65-+19[#-%'"YIJU
MLGS6GI:FMCXYM,OD>H2-:68&BEV;ZZ@3IZY&G,E5(/,UJJMJ&*ESNBEFJ/0Q
MZZ)J2K@]#8<URN?-J>7:RVAKB*>FF1TIW73(%NP#W7TG.G"+,,AGS>CCCR[+
M:C-I<TBAEK(&HJ:D2L8K3TKR2[?9.5:!7<QRJ4+'JL1>9I425$=+Z.4(FJLS
M-!0+Q.KM5TZ993YS)F#,644JIEU0).*SVF:9>+AKMK%5YGM73#,9!FU!/3Y7
MM.-SQ([)$)**FJ\K#Z))%63-):GB*QZVXK50RB1I N*SS,)LNJ'BK^$66P10
M4+U57.E-4534TL=;14,E,:6GD>=O7:Z(PSG9B95D];CT8F\SM(:<1C-1/FPC
MX1;:E$+P4RR9)F5-EL9BJ620.DTM0I=7T&SJ0RB-M3>9YHDF+\(Z%:&D3-%K
M:\Y;F0%-79/6Y?0UU$*1E6HJ )<Q@,%7%ZU, PLG3C-\MER?-<QRJ=TEERZK
MFI'EBOLY3"UMH@;G!7%F ;>M['HQ4>QZCXO/]2^.SWS]/*G]JLL^,YK_ &&*
M)H$K*-ZI-I3)54[5,9Z)(%F0S(>XT>H'' FMX+)E.6C)<LR&IX*99#19_MJ#
M,H4J>#N8QY>15S9O0SRJ:U]HC<1G@!169%6))%1\5%*E-%D'H5PCR>GR_-J_
MT7X-T^?12^B645^9I/,]13&EEV5>(Q55!2+-8S'!4LJ/4L548X1<(,KR3C67
MYIF^5BB6"&@X5<*<[DH9:[,J259-CEE-E^5R1S"HBXS*#52P104=BQ$K-O\
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M7W,:^YC7W,:^YC7W,'>?_MA__\0 6Q$  @$" P,## P+!0<# P4  0(#!!$
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M8O-QR>G^#P=#%YN.3T_P>#H8O-QR>G^#P=#%YN)H^1G5_P"D)M?PTK'@K_\
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M<!8%BN9"Q!L@0"[,=7A 6XMA/[5*9IZ./\&L$JH)JHG:[TIHM9VMR  &6-F
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MJ^B]>.O/*/>U?1>O'7GE'O:OHO7CKSRCWM7T7KQUYY1[VKZ+UXEZL,IEBEC
MJ@9(I(P=C>Q="M[7WVO?"]664JJ+IJCI55OL>.E0+\?BQUYY1[VKZ+UXZ\\H
M][5]%Z\=>>4>]J^B]>.O/*/>U?1>O'7GE'O:OHO7A.J[*4EGDM5';&*PV/<[
M)-&_?OOQ^+'7GE'O:OHO7CKSRCWM7T7KQUYY1[VKZ+UXZ\\H][5]%Z\=>>4>
M]J^B]>(^J7+\RJ*2DIEJ-LU5$Z"2/0C;/4Q4OOTW6]C8\+6WXU3>1'3+YF-4
MWD!TR^9C5-Y!>G7S,:IO(CIE\S&J;R Z=?,P&FN.TCIE\S'7=3T)DI'H9W>G
MFG1F6:+23MI#NN+VWXZ^:7]7U/30_P!,=?-+^KZGIH?Z8Z^:7]7U/30_TQU\
MTOZOJ>FA_ICKYI?U?4]-#_3%=-0YC65%<:F6G-3)M3 :5I3%N"Z3(LBJ_"]P
M -^-C0?K"3^ D]-C8T'ZPD_@)/38V-!^L)/X"3TV-C0?K"3^ D]-C8T'ZPD_
M@)/38V-!^L)/X"3TV-C0?K"3^ D]-C8T'ZPD_@)/38:P)"G4+[FMIN/';?:_
MB_'Q=]B^<C^V,>KLHO;M9\S1?YCLJSO4?TJD_F$P>Q&*/O3_ $NM_FY>RZN?
M:^6_/S_=KV0[/U]EU._ES+?I!^ZD[(<1\HQF7Y1K_IE1]ZW9)O*#QLH_>V-A
M0&M>F=(/;8CA2#;:Q&I?:"<L0#9 MK-JVG Z=6(Z"*01R;618940@L(U97::
M6+2S7*F^R9D1%:1[VL+$X&6!GV,<Q>43[&4C9A8;5!@+21%A-I[EA(NI"6"&
MW'%53I (FCD+K)M19C&64QL!O:)FCLP8$"^I=X8<":Q(4%&T",BRTHD;6VMF
M?:RH68V WA1N4 #A\?X@ G@"?D!/U8L;VL;^*QO^[C^*B[[%\Y']L8]791>W
M:SYFB_S'95G>H_I5)_,)@]B,4?>G^EUO\W+V75S[7RWY^?[M>R'9^OLNIW\N
M9;](/W4G9#B/E&,R_*-?],J/O6[(>#&UDVFVVC[747VESKU'BVKC<W._"5-1
M& (YI$ &D!6( &HO8#P<\EAXF)(XX:IJ6!5IY2"VHW<]UJUWOQ[OG<>ZW\<2
M32S$-+(\A&X%S>WA-OE.\^,[S@LS:0S%@BZ4!-]*W)TKXA<DV\9_$916<AKH
MI3,\,)U+,4+69=#:594N6&TTD"QL=_@P*S+&@@:>>.HK-,AEF:F=:@F2@J(F
M2>41]O(J3$%=I)"5L]U%U$M9E,HJ6<PNS( VTI9'GGTY?##3K23:?[L8*I7,
MI8IJ%C=UYN.6Y(RUJO!2]ZBCI2*<Q[1!36DTLM/(PJ.4G5M&V1.D6ET<TYA5
M4#Y='3TC0@\HIY=C'3O%(BI2-')RB1ETS2[4GG!FW'C;<O91=]B^<C^V,>KL
MHO;M9\S1?YCLJSO4?TJD_F$P>Q&*/O3_ $NM_FY>RZN?:^6_/S_=KV0[/U^Q
ME_4W!/3"&=Z<UIJ*>6=DF?:4]%)&)56-;:99)ANN+JNJ^JZVQ)D^60H(:H34
MM2E;(T^HOJ-"->R2AN&2K>3M:W!VFMFNHMB3(,JCBG?9R0O70K%EE-5F3E4-
M6H?5=5U<UR$(9[JHOJ(!Q)&\+O%*K))&Q1T86967<01X\=3OY<RWZ0?NI.R'
M$?*,9E^4:_Z94?>MV0X?C<JRZ&O,VVEFB$;TL2[%$<EZJ4Q+JUD6538FV\BX
M O;$614\KKHGK'C>* J(X(VJ%>6IJ*5I9$UZ5I8GIR[."6"NH8@W.(<AIYXP
M_*#%LZ,.[(#*))34UL6WM8E:?13J+(.)O<;[_@->TJK5;O)3R2[00(::>043
M5<<='(&U3<Y=C(-&J]RMC9<?@*(!(BM4T@G[>T87;+%R"&I91$QTWBDDWV#2
ME1N0GAF66P9?%WZ>2=JRIIX[HBP[.F*7=S<OK82+N4:=Q/"V'R&FC*:YZP(.
M4[5]A$-:TU!RTRTEVM)%(>8C,1X<1Y%33JCK)5JKQT>C9PHXCY33R3[>K)?F
M1)H D9.:+[@,?_-W#]GQ>S%WV+YR/[8QZNRB]NUGS-%_F.RK.]1_2J3^83![
M$8H^]/\ 2ZW^;E[+JY]KY;\_/]VO9#L_7[%/G]3#&$DAIZB2&#84=3)&!/2"
MQ4:)$LSV4\U7)"FQ'QGJLS'11HJ0JM*$U7!=JDHNGMK.25!&]M!!+;[^#%1U
M15\\\M1&(:6:72NVA0[=(U [4DKEBJ&W/T@%_#NW8DD>5WDD8O([%G=C=F8\
M23XSCJ=_+F6_2#]U)V0XCY1C,ORC7_3*C[UNR'#\:&8=RS+P[EB.'#@? =X\
M1WC&MQPD<&Q6X=@=)WE;@]R222.!))XX#N.#N.;HW.PYG'1N/<7WZ>YOX,:W
M&FTCC1W%G;F7XZ-_,OX=-KXVDE[[22_CVCWX6.^_A&X_%NX8+,W=,S?XF)X\
M>)\/AQ4YE65B11SR@K"+)H1(B>UB*[F,*7.S4)=OS;CPX%5.L#TPD81.ZNPO
MO)5#&HU=UHTL1L[Z?BW=A%WV+YR/[8QZNRB]NUGS-%_F.RK.]1_2J3^83![$
M8H^]/]+K?YN7LNKGVOEOS\_W:]D.S]?9=3OY<RWZ0?NI.R'$?*,9E^4:_P"F
M5'WK=D.'NB+OL7SD?VQCU=E%[=K/F:+_ #'95G>H_I5)_,)@]B,4?>G^EUO\
MW+V75S[7RWY^?[M>R'9^OLNIW\N9;](/W4G9#B/E&,R_*-?],J/O6[(</=$7
M?8OG(_MC&F;RJ7L/T7Q?X\:9O+1]#_KQIF\K'T/^O&F;RJ=#_KQIF\M'T/\
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M1_;&/5V47MVL^9HO\Q[%?U9=3F69JN35N8)#F#0/4;*UPL,:&1W)\2H"Q(W
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M_,=EU3_D.N^2+[Y/<8[/U_C?5V0X>Z(N^Q?.1_;&-:>_3@/SE\7RXUI[]/\
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M+KVV N.D,7(C!2<S&L9@=EL3BKNT.=J4,2>0P5',X[#5<T_. 2K>+JYJR>0
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M@,GM+!S6K/L0$SV$F(*4@<#,QUQ$[M\:X<=&TE >DKN<--.4K1TM2S2JUN4
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M;?=<"8*2A0,L&9BN"(BX(GAXBF=W7K9<Z]*[8" SL2=>I8>$3V4[TDI91O\
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MZ.R(#,;N[$Y\7JJBI4L5F*>3X-FU#[-FNX(J>F2R3%+JUH@L%T9A6I3)1NY
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M7R4G[<UZK<5\E)^W->JW%?)2?MS5AF2S=+)UVJ (16PLXU@-@]XLY_9&YQ!
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MCEY5DK!TL;F7X\J^*NY)2S:W' 3#BTJR,+:$2^JM1N4Q0LXHZ]+]KK?OG?\
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M$[Q1<- %92,_R5NDPCKGO=_2_:_NJPR%-%P5%)JAX<7+(HX2(>N-TS'5/XM
MY>-IBU:>C+/DQ,BB0E<JCBWQPRN9">K?P3([]TZ4KL/C^6DF&H.CCN F\/,*
M/7WGP#OWS.[A'AW;HU;CHB;!WCL%;=84LFO"P\K$H,H&-ZEG/I?\+<(S)24;
M](QI*A5*O8KV!KJ$>671SDX28E!;U,F9AG\.?6*)Z]$F,?4A)5AI$J%#P34
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MDU?X!7F:\EK?%T^9KR6M\ KS->35O@%>9KR6M\73YFO)JWP"O,TS[EK> ?\
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M<] E)]F L,FPL4R04WEB#3?<(@RB*Z 4_0GABI^P$"JVJNZV^(IU?-_OVND
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M     #__ /\ _.-L(=MA[MOYML#ML5]L=-MLMMB=MMLDZ>P       /@ ,
M!& !^  N  *0 'P !P  (  ,"#;X !2E]K6/@ !P !F  @YC%/4P02Q@  P
M    "GP6  !0'<K4/@ !P !F  A!U$NB <+;@  P     %DA4       &/@
M!P !F  @.L$/& 05Q@  P     $           /@ !P !F  @  $   0 !@
M P     $     ((()! &=_@,V=QKL4=CE))$)))I)(:]5TDDE)))(@
M/@ !P !F  @  "  '0 !P  0  2  $770   (00  /@ !P !F  @  "  '0
M!Q  0  2   O.0   PH@  /@ !P !F  @  "  '0 !S!*0  2  "      "(
MLR0/@ !P !F  @  "  '0 !Y2B0  2  "      N&&B /@ !P !F  @  "
M'0 !P  0  2  "           /@ !P !F  @  "  '0 !P  0  2  "
M !) ) &'(X)'/   ,  ))!.++(I)*0 !^  +K;;:@      /@ !P  @  *
M(  '0 !P    !>  !@]0        /@ !Q>F@  *  (  '0CQP   =5?)X"GV
MP  !:50<JO@ !QP6@  *  (  '4TWP   ^=?PTR      Q)M%G?@ !PYR@
M*  (  '3Q9P   =1>$4"           /@ !P  @  *  (  '0 !P    !>
M"     )))))!'S2?K;;   *  (  '  !P    !>0 %__ /\ ?  $  @ 8>S]
MVVQ @$H 0 0 ?$@#  $ $': $<X32T       ^  !  !   H  @  =  '
M  %X  Y?,   &_+A)B^  !  !';PH  @  =  '     %^+0(     '#>3K\V
M  !  !%; H  @  =  '     %^7$(           ^  !  !   H  @  =  '
M     %X$ (           ^  !  !   H  @  =  '     %X  (
M  2)));;;;;;[;;[;;Z;;?;;>;;:#;;P
M                                                           _
M_\0 *Q$!  $# 0<$ P$! 0$      1$ (3%!(%%A<8&1L1"AT? P0,'A\5!P
M_]H " $# 0$_$/RR:>Y\UPO<^:X7N?-<+W/FN%[GS7"]SYIT.V3<UF->#7'=
M_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=
M_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=
M_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=_E7'=
M_E4T9()D;MC#_P"-@<CQ0#!8L:W97+Z1&"!GK%E^+>=UK'QKPKBT@MKB7F7X
M-LWE(3/#H,2F_72>[3PO6=P/8PW[XT_14"7>'%5@K0F][:VF?#SBTTD3/'C]
MX9SNI#*?;T!PSKWF/'Z/99+QS?;WMZPI(3>+;[.,X<_VD-/[G[?=K>I;G_OW
MO;-2W/;=_P!J&YB(F>+!W<:<:C<7EO8@TNSC?6A#F,:_1J&)AAPQ9Z_G FX7
M<D#[-$)N"D29SQR&0"@ %4"H=87=-P0;H(NE=.SH4\]P-_J@<)>P;0]5T.X9
M)'I"A*.,P@%6L A:1<OI@<CQZ!J?L>R.)S&+UQ+&;[IX7F/B=$!@T\Z^F)N-
M.\OZ\\!8_102'@\DN)7"F\W=;WYJOMN*WDN,LS%A>(6G=2$M;)T=.1DH)1JK
MRG0X'S^CG^UGWCZBDPY9TS;X*XGL5(U]CABUL7C.N6I<-(MB-VXL=N+4KMI8
MR2$,B$Y-_>M*;6<$V(+Z\=_>=U S);_33KQI3EUG ?S]"%@<CQ2 0 ( @0H$
M041$11$IB $K%5%)0G5B ^L*6HDIHH)QE2$7%# >S004(M"BXQML=3K5$ %'
MJX7B6J\'*5B:M?VMN#,OCT!#E+0GBAD-YIE8!/4I0D%)'"F#P4OPJ"T\6Q8M
MF7#37A>COLU^\QJX35GE\;WZ<\IQKAW6Z?+K?%?\._K[?A0FC)P)W;<N,P1$
M,[/GSY\^0+0N"HVR[@!E)!-OSY\^?/E#P8E(2CI."+ %65V?/GSY\K\"$F V
M-9@,7E,D;/GSY\^0V%P(7%:!(4084<41X")1A0ES8">.-KSY\^?(V14L:*!C
M-TIOB-=GSY\^?(YV .H#54N4$2Z)G:-FS9LV@+A)IKIA%4KH @4+%HF6[LFS
M9LV;+M^ID#$D+G,D@8/QW$2R(CN1D>C>B<QH09!G86;Y(4O0W6"L?LIM@--U
MBA E-^=NQWM&$4;(1Z >:#W0\H4!AU5!.BIH@I8U="P='1#74B84DAM=Y"Q$
MM$;<-YZL*B84D*3"3"DX4OL*?;G!4)4Y1R)W%Z;+IE2$(LJ!X%"505HG)"3(
M2QO*SEW*@$--L8\F4&9X7V%;)565I550$H*T"X%00+*4#ZO=22^&PDT5CF S
M&Z! %/!=Q.Q$1#" -_,%C3-D4QIN@BD+#S:JF$ MJ"45DE)D64!D%]#PG);5
MAK","UD=S4K5-FL4"%W9%Y!!!#F ,:PT"@RIMX4M*3@R<:+8V!&J%&?!5N28
M*$0FKB<,DNL*""Z3T%2%HBE9>"(6M!ZLSYJLXID0)03+JAGM[B+NP?$XH!IK
M#?0MQEV& !R@K!R6*#D8 B0#TZ"/BS 6F1(W4B;3%$8!D %W')%"6 JP4BD:
M3G"3QJ%#6'"9O#TRD:TP1V]T,ZDC&003X[BBWY0(19*0!<)"9)*A.(T,2YP@
M)((LIJP=#H# .Y);U,I)$>3)>P(G>@PI4+&LN) 19"(47CRS^R"PG(!(*?7[
MM+'.!-5](+DD K(0XQVQ/R;OT(DRG(>J- "8J"F!"!B:;M"4.W4$#I,[$ DJ
M!V! %@4<>XDB E%#D-G(3:2EPQ,PDF%N5G6%N0<H?'^*D'$0+4'8SXB*81)<
MMD!%F)8NMQSCFD .LKTR00Z@).J7O+Z<T6I38J+&DQ)B$NEH7T$=QIQ,13A*
M:?-Y$A'4(ND-R LYM143Z+-R0<>\M@+)"C&A&D#\HB=,IXLH]D9$04C"#AM&
M18,MLU@4">DR!2L99BVXL"@!%"\C'8M4V"1 @C<TJBECW8[T2,YD*; /&I17
M"A=)$B5(D44Q@.3Y@/A28B3 BI?9$PY2V&)5@+^F[*>8%:9D2(R&(?3S F;_
M ,V.H9$$R-&<Z3(B%9C)<%,(;J]3H105G;TR9DTN (L;KK.09LB67X\JKJ#7
M4S DNLJM4%Q4G*P/"!8NK2E*$@4D!$%A@8F*.AT0'!+:8,0#"E#3:PJ@(L$3
M@6E"4RD=0=D02!  ;C-+.$VI0<*= 9 44*%+T:%Y? YEFIF;S0Q:5F8@"G@#
M1J7%<X& T1$T:84MZDC%6")9$PEHP>*#=G;EARO+,S4)H\00$"*,@#-,E:D&
M;HXQ"$"C(P0!3^0++U,5!45559:1^4(T4HJ]K+>U&T=V"X@!&1%@CE2Z2OTY
M<QXL#E5*K01.%DTHTL 5! $@*9G10Q6)-D4&(0,B:-?@PA$#$("P6!+41".A
MQ!*,"7*169/WQ$PLJDA(B0HYUT'=$,'?).:L:$?DS0Z I!2%,+0C^@U+64T2
M,(!@H2P'B#8-8PBC,,S01!3"!5W 2O2A:H4K!PK9@P@N-2F0F'*VC /Q 22D
MN#8^$AJ0H*$FEI0'H<@2)"KC"E16&F6BU=<)2JDEBRA+))%5& "F!B5=: 2!
M1YT(PV;3-FA1CQ>,J"61P7FIA8+"W(BZA.'*Y@I@S>X_+!5UA9K(!$ <"]8.
M=*7&2S0P=8:@$ZL 0" #BCDRK-@ ILL V%P4EJ),,)(J0I(EE,-11F$!H8+6
M46MA+5GQV%6!: PF'6D&\B3E_%R"-DC>B%N!$B< 0LA@18I+)9655NK*JNJW
M5UNTO;H=,Z*.(M7M$Y7,VQE=R<F-1P)84H0)E*8R "!1M/HL).$E";&R3@Q3
M</2Q0DS+:TL6H5"U6SX "P  "8#'YQ"#D'G4&X[%0;CL5!N.Q4&X[%0;CL5!
MN.Q4&X[%0;CL5 8(I(HPBB61&$=$;CHU<?\ 0VP#!@S6H/<T=>4XJ#1F'-.0
M4I9ET1-4@<:JP(3,*"%!0C9#!@P9<#=/\:3;Z7%HC?7<<*(9@,N)1"D!N#8P
M8,&2EP=C"\R)$AP2UA[ C@0F0%D<)%H$8E*%0'%2@)56Z[ 8,&@N"Z(2<1)#
MQ*%%".!.(8!H( )4&']HO7D0;T8=)V0P8,&4D(JB 0F0'"$M5D%J64IIE$"(
M.ECF& @" & $ "P%@L; 8,&EUT64LMIEZX+S4(+/2L),NH27DFJ]".2,HVXD
MGCLA@P8,"B)1<RHGA5+I"'53$&9>#,0S84R"R.P&#!@T.2#/**M \"B&J.A>
M@ D15MA*OIH$JT*F>#Q*L )78#!@QF4*LTG2(PD"K01Y$KLV E2,+!10(84Y
M)1Q@M0UU/'(5A$  @PBIEO8(ZR"02,H)"EL#")L[!S-$2) ,0) B12"4610%
M"4PAR$@VP&5L"-D3XM8 (+D+?2DK9<)%B70[+8:(SW'Z1YK]%VR'!3Y90A+M
M&5 BM9>KC:JS/6%OL9S42=(E"&P<DB94A@<CQLVMJ:AD-2M3K)&E2OT3M<H;
M8U($H;!IO^C&(%BP 1$H,<=Q2,1;>@7/;+8ZA 6LUD$@6TFU&N$;2#N3()2U
M@4-[HRQM&P9@WLB"(DC9'";FH1MQK+RUTB(2FUM%NRT*M$D2Y,:"$2'$$%*0
M(!(B20[)2B(JZ&4".2D&-]!,SS9%1A,D6!F#@9E.$V&W  "0!/$M)@QT",26
M) PQG-A>@") 9 Q,4E((88NHSA5R*F#!@"/203*IEPF/5]J"+*13:@PH*)>F
M3OAA!:'./V^>L;*,E#4Q)BVDK %ZABQNB88G=.)J\EP)24AO2)BK$,5EIM,E
M_B*5(74 PJ)#F.<7C-"RT;&)RD 4 "A;B7!*0R&9;6(U:+;;I2K%:WL4= I=
M+0*)60)=4B]6:1,B72XES)S-3)ZO-?HNVOHM^V#8'(\;9&':/R! 8:H*@%30
MAB>:#F3!K09H875UU&%:RFD%G #"]RW?C.*^AW5QF@5%./!4(N#B0,D==*13
M>8!Y.%-/1X$G59-9N$AE;3I8E @28%Z$AIXC\5'3 HBN0=D-")O0N6K_ -8
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M)9AN(EL(X](8F&##!@I(3$3%XF8O$?@>:_1=M?1;]L&P.1X_2(V\'D^*<]/
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M$ZD>B"5%%UMLN.W@KB/X"ICKY.T8?6QM8/)\4YZ>!Z7X6O"P,16YA%D81!@
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ML_GL4LCCJ(PG$;E+HLSRR2J6=; KE;M>P]%4Z%4W*M!X*<P$U7RVETMF.J]
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M:_Y6O^5K_E:I5T,!6P4(H$4($S344^("@0M!NA6)BO\ *U_RM?\ *U_RM?\
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M5K8FR"(=>5ZPKB0\6]D^/!EX/"&"CMG[?N HF/750#I_ 3M<!E"JD^F/M+9
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M?4.FWCOTDB\U 8$*-4B^FK%\XAPX<.%#HQE)#4NQJ$:"#EPX<.'"FFC-*[@
ML/-I_"?E&?/?TIT2^'?K1JMY^_A_>"+H%_W_ #;SK_M99O3^*[/8O7?TK#YV
M^_\ -O.:[9X^W\=:_#;K._?;SNZ6W5_-O6NV>/K\L5>J6CL]3?V\:NZ$XV;3
M5T2Q^T^?^5XMY\]\>M=LW_FWK79?'V_CQI3 .MAUA!$H',L.'#API#,)U"HT
M2ALGHUG1CS1?^FL38ZL,?U!U"@ 528 :+# PV>+UZ*@*J $RK !FK8-6MV2X
M%R)-:L,CD.+UZT&*(D#@ ,+!):29HD+,%5Q.XS3["@WL^_F[]M_@28_9W>>@
MYKGV;>;!Z/ZYW^NED"5F$6XBYP8*";%V$@YLPJE02T^TR%+N1Q?_ -":3_B;
MO!35,/J>RB-APPA?M"JX*#N9\.&]GW\W?MJYQ1 H1[P77-^012+N!-'%X9(4
M8K_BQ'IFGCHL%U8 N"I %<@V/M28_9W>6!5 (!A1@8I % %JUD#L]E[Z3H2F
M^)HD,*NOTD4N^N2N?Z2\$1<'H.:Y]FW@B,LTDX(@"P40(]I8%9-W@I! 7#E*
M_>QB;$V_#5_@36_3,8/1_7!^TM",E[:,]9BE@,)P/"<AT9R-3_2HH9'HV"@7
MU=A?]+D%'X;5+(@[(XGB.*\<#7F9NW)9E+++>C8 PFWK896E)A*M)G65@FE2
M&1D)DLS474;UR9) W(2&Y>HF^%+<Y):+JEW7Z":XDXYP2DU&](6+RB>I-"N%
M31NM8!3!R&C-2Y!X$]>!_ H7U OCC9[(8RFQ5L'4+R7R[C4.H@%!*Y$RL#?9
M8_&$%4/G)Z.BP S<GX7=K;-7:+Z;RV,$-M4[(%"8G)*K+% *&]GW\W?MJ@/!
M 9)<N,2 A0*9LKNH7&#UT6R0DL /QG#P/T %D7U-YTL#('-^;;[9R;.V&9,?
ML[O$^2J.DW0\;*(]'7 U:"U&NY)HZ+VJB/V Z#=8XSRA!TPFL_XY6<<56*CE
MJ/0<US[-O"7C]5YZV@6<8401R V1$CW*A,-[3G@,Z E<2P#\BY"I&L*.#T?U
MP?X1(7EA)Q#/EC_U "F2WYG9X$X-21BP^"@>"4SU-6V]3.#+T]R;QN, ("2]
M,^KI:V07(@*6 2M1H5X?N($<QH9'^CB-,&_63&1ZA-\\B$ +7E' O0[C(!$@
M&D#QCI0].TL@),HD@'=$0_7?MEEZ)F!%@OA= 4S4"DP'+.61P9; # DBZC@5
MQ$FYD/R<2B#*'4-0.> WL^_F[]MPW#_YLKBGL%(D9U&5J<E'+GFMU%?R,,GS
M\  1.14*'*I5756?MB8_9W>00_:U#28L$((%ZA@;Y.*RS''_ $G<QH/L9AK)
M7J!807%;XL%555555E5NJMU7+7H.:Y]FWA)?JH%K*II?E&)HU0I;2B)3$%).
MF ?5*((C$07F+D"<$F< P>C^N#_1+(@ @*04B H012K';,'R*4F_Z:8>">U%
MKCIDB 58)7@(+(4%@LUZ9]SC>S[^;OVW^!)C]G=YZ#FN?9MYL'H_KG?^F?4P
M9:BQ97 U4!O5B;<3,)%A?"*2X));E#L".PS-[03FS:)L[-( H#A2'Q%BD7DM
M%\4)AM+)?9BUN6S*$7*OQ&[(NNC+(G43(T@2F&5$+3=8EKWTOBIV!789S$P)
MB;3O:H(D)Q)3DM)FX_AV:DP_1?'3;?I#AKK\Q%V9B(NF;1F8(EI"Z9;(YF,Z
MX8W1"8K\0!I+AXDG:2<E#-)AA!D<B,Q-3)4.?>I#\Q/)J;"T4\EU"HF&Z-O_
M "_AX"4D)T2"$##&4N8[=NW;N()_E4OP(65G;5\\]J^>>U?./:OGGM7SSVKY
MQ[5ZMM^NOG'M7SSVKYQ[5\X]J^>>U>OJ;^"OGGM7SSVKYQ[5\\]J^<>U>K1?
MKK=\Q=C)BOGGM7SSVKYQ[5\\]J^>>U1RY%DOTU\\]J^<>U?//:OG'M7SSVJ6
MK4,RS&V*^<>U?//:OGGM7SSVKYY[4QNTZO:O09/ZJ^<>U?//:OGGM7SCVKYY
M[48^@"BL<KX]Z8>>Y<N7+ERXB*@ JH@%U5@ 75L&:/>?^<]RQO(I#Q0H9Z.P
M]*RP61JQ%J&%JQ,+(8),*"EBA%R)D%F]Y)3J>+=I,"0(!4"(@& 0!!H1BBP"
M)L#R&;92&<R#H4NR9W6<KF_*=5=6EQ%1R*#;(;OT6Q:D)4A) PHB0V4%-P<E
M,:Q8EQG$J,N-W=H @,V#,!BS '0#!5R;V2Y)%E?<#.9!S2DRTQ(H,ED925V*
MI$M?D2X@<#(!W V*0ZRHJZJJJM50565":7RG5L,GYWZWS06#M%CMMX:6R_7?
MGU@]:AM8VM?CO=WH'!]-''EH;S<_][T\_HQC7KUZ]>M2*B /K%J"+/7MUG\S
MP]=Y?VOUVE^)BH^Z]:WDZM_:[9;[W\\UGU,P7]K/K=V:[Y_M=Y?WAZF=W-_9
MKS[?]4UWU_:[R?S->7]N[SK]]W-993++9WW'ABAQ[5:MB)@\JSZV?FK]=[NK
MSJ/ =/>K\]-VOYMJ[Y_MO*L=))P4]%K\=':UWU_:^>OVU^^[7TQ7GVQ?IJ7)
M-V.PO$Q/C4?=>M>7;L_E:[Y_M>&="_37GV_ZII$8*S^+K1HQVB]>N^?[7_.+
M]-?GINU_-M7?7]KKF][\S-1IU@6@/,36\!8JZKG05K%E)E%U"HYS_LSUB8+<
M#%SD#-FV'8(VC>80RE4@'"\;>B,0!2CLX_-F4 A0$$(C!$LC9+-%.0:%17PE
M& ^P&]GW_P"-G@C]G=YZ#FN?9MYL'H_KG?@A$%2!0EM0; 2($XH]<Z'!34>0
MT?3/KR]R'/#/#(+^@O/6#G[:37)E4_72K1)Z&>_=,ID<L48 N"UP74T81"6Y
MCPB%:C"$53H>-:+K0JU:]A(,KC.&/'%7&:1UCGA46!HH2,S:(*E0 !56P*XH
M55WKYA\D,+X845;P%EE S$3$9MUM0*3121"!6&I HB"B F6DI2 A50!5 :$!
MPP"%K, )DIA0WL^_ZV>#"=Y%BK!Q$(JE47+_ )!$LIU=@'=.NR,Q,- #Y#68
M+RF R )^U(_9W>>@YKGV;>;!Z/ZX/XVQ43!I@AV>@DQ&8V4>&9"DQ-J!S=!%
MBW*D95H]%: G =S@^F?5TA'M]=:DLQ,89H$03!FAEL5#YJ]MQCC>&4U>7X#=
M3J6QSP<VA&&BR@9W8.5 T!A8*DCUB=N./-"=.$<>"(:_V-M<]A, Q&ZLIGF;
M?_%!T@]YO"'G]!0)##R1N#B7AFK+C1["RPU^S[_K9X+V(E-AD]VQI^!+80P@
MPALNL51XD@P3LNP8?VAJ8G9BD['6'?:A^SN\]!S7/LV\V#T?UP?A#(>,N_6B
M$JIT9'^-P5\=4\,$X/%+G2DWDI296?-M9 U/T*NPJ2;"GN5&@UZ9]SC>S[_\
M;/!'[.[ST'-<^S;S8/1_7%^  T8!L$(A(@4(P*%FKBWT1;B.1<AUFI7+.GEM
MP],^YQO9]_\ C9X(_9W>>@YKGV;>;!Z/ZYW_ *9]QY@4SXEM*,38JQ4BDI3P
M%)KO$3=AU>;GSY\^9[I#1X(V$DB2>5(D2)$BH-#2Q!;@0*+K&.=(D2)$B0$&
M72^O)!A4DWAO?F2)$B1(!<X@C!M$B<,1B&>9(D2)$CV40"9' DB6()H[8&Q2
M0QI,<R1(D2)"<:2K'!$6D@(9UQS)$B1(D8DL?%M "D+$7B7;F2)$B1(J)F([
@BA(9"&;,V$NR/!O?F2)$B1(9I82()(;A?6__ )A__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>businessfigure30a1a.jpg
<TEXT>
begin 644 businessfigure30a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M !P! 0 " P$! 0             ! @,$!08'"/_:  P# 0 "$ ,0   !_?P
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M73ME-2V#WZ:AVL?N&<Y]_''R1<<^GZ!   B@YZ.P"'#3CK \FC&Q%V:N;L
M:8;B>C'$3D1G8H+=BT>OF9 MZL"@Q5V6PC5Q#G_4Y^>K69!JAI9$AUT
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MZ[(,,B;*<+GZ2@       I%4T\V(OC%&5*1X*9<%0   $?FQ&;-8-E/!:F2
M /A] /A](Y)%+8MS)%D7IY/0  !2*IB"P-F,690\%N5BB78        (3.+3
MH8@LNS;CHDFH    $5'+1E# F'+XZI)E     .8"$2\+,L"\.[S80    1Z<
M1FREL6I4)B.I@
M
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M3LE;.Z/'^X3L;7MQOX%S,C. EW%L$7W.YGN=S![HT6OW.YA]G&_*^YW,*N*
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M4I(D0%!38H*A%F-RHK&R\$-456!SDY3!PM,7)31$@-+B_]H " $# 0$_ ?\
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MP\3/ VE42TC%*B2G,9=F@CD5DU'6/,1=05LW"=*<$<0_E1!FSY5:&7, E]W
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M'<1ZV"\9[Z3P 2+NFL]^DBY^!I45]!YVU?4/;]?=CBIX_P L"1"V@'>U^6Q
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M.6$+\.35&CM)%9]@)50MS34N_P#!0;CP^OXA_J/Q_9V-KV-O'NPJLYLJECX
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M(F?"9[7.1)\9.B:B/<++[1DSW<RSAGRD0'>?Q 9\*HU%Y5[W6(2O6H*EDO\
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MX73Y[++F);7:BW%"VZO:FDC)U%V9DE5"L Z*QGZP.?VSU9U=;F"&[QKF2K!
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M"TF-(_ BC6G #>R.2K5*+>I:N2NXM%CBLVBL%7Q8&\["*U:PVKRQVO, ]Q#
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M7GGNIY6D(52B 50 5SE5CK@2 A7Q-DMU<"V2/:19I8=LDI8-KO13)^H$P%
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M'<6IEY%W^3)@,3/9!Y-TIFA=<]*@O!4B?-Z0; )@"V% 7CY5C^)%<X)#%L!
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M\=B,2M',,#9X'.FZ-!&&2Z%\_P!"!2D+3O-;7>71G[%?GHF9?4M2PCRP#TL
M&F&G45C): VV'C 6@.*=8-)L#"## +-I=--7+-E-<8*;BRP6B54.2$#,V :A
M6&O>!?1:M8;'3(N(8G(11H]JBD1\H%=7:3[/D8(S*#GD.-18AH9-C=)"(H1B
M/2A$KWP!236,BI0+48RT$2A0"!J%5UJ\/+'V;=G>M\,#;K8E?LI& Z<>$@8]
M$0Z.M- P&<$8GS2XUF %@:9WGY_0#\7\*=8*!PLYL)0('0  G"GB;&=Y2\*
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MXI!ON 2%[<HO,GHIM%7X9<PY8,R(PPU029V#"8<90.DUAYXMMF6ZBY'0)J
ML6RP+&7$G72;-Y#!;6RE()W(S>:3HO7\[B**+7H1;N/"7MM=!C)H!\[SK-?I
MGUY.52 D,MW>HQT:&B"\>X0ZO"0T.@WGX.[@IU>,&@+TC:TD]8V,U@T:CU!L
M&&5P,%I.'GPD4W[\;"/2'LLFO98'1VIQ$_3AA4N$L-/DW].5P9/.[HQM&:G,
MS5;=1FF^JR\\&=6)*[\1:C>LYH4G6T_(S%$).'1H):1D^Q\* V]#DGJT[]T[
M_?.\6_5E SX>@OJ\,*S197Q?G"MF%$MA.B?8M6C0CP]=2$JUG_R'^S9^=])K
MYA&L@>.O,<72,U7$B;^<P3[ZR#)H':?-BQ*%(F#,\!$(0:*!%@.NDT#-+D&^
M/7!K$A*NHFI:.(B$7'] @K0[_&^MJI1,4-H8C?'=(=J5>; LS0Q@=$%!IF=$
ME:]JJ@0:/6 *ZYTQITJ>%H&O?^/EE:M?+(_P0++2>M,LPX9"UZ $U#24*4@M
M6,V7O.+EI^2.VEK(\*BXT'U:G@*0G302?OZH&5B74+H;$+\V^3"V-C65WK!J
MGH/"@ESBM>P(XM?0/7$(V#:6"("[T/CT).XZ1D:G>O0)>A;\.ZELG0OW/Y<F
M1TK29.[3CJV>N1_ &@6P(;;T"-,2 'R<XL0V]O58?Z=U&AV#) :<1(LF4Z^(
M"&EW95X"/4'D;9MJJ2B(G(O$."4@*T'AG1*=49G3\1]/RC<(]N.T(,.M(:*<
M!<__ -!S AB:&,EJE(6SJ&$2#QT)@O2D!_$*_4FD"GZO^A6%_>"DX]QYW Z
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M\5;M\)SC UA?^^<OM^D9I9K_V@ , P$  @ #    $   )
M                       ) "3\"     'M      !;3       (=
M   !#""(+ (  : \3<  !A?(!,(  $D7IN+>@    !)) )8()00!:K%'$0
M/!DEPC  (41O$)H\               !()((    ) M &X    ! (!(
M( ))(9)(  (      ! +V_UWWP !      )>    )&/@D1W> )K[PS7) ((J
MQ<;42 ($22N6LE.0   )  ! !() )(  /KEC0(      ( )   !%B5!   !)
M(!!  ) !) *=0  ,!!     ! ((  &0&C)(  !) !!!   (( !(  ,10!
M   *!) !=@. Y!   )(( !  )    <*FM8 !! ( Q)C  ( 4 $]Y )(   )
M)  !( !!8FV(GP  )?.\]Q@  $6'PE. !(  ! ! ((((  !&<G.@$  )%WV6
M[X !(#M=P!8      ))))))(  ) " ( (!!!(9!) 8!( ))(!)        !(
M  )!  !(  )( ( (()       (()(         )! ((   !(()  ! !!(((
M   ((  )          (!!      ))(      (       ()
M
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M7!X5^43ZGTZXZ1J5) "Q0<@ML9R\5U,O7S7TZ[Z(<5%E&8A2!U I<@C$
M$ P : ^ :JJ2)!#! K*V#J&/T3?&54R6L@P+9VQE?\'JA<R<>X$U%!!^,=AA
M3,UQD*\D(H@0"K *ROM@%>X!Z_\ WK__Q  L$0$!  $$  4"!P # 0     !
M$2$ ,4%187&!D? 0H2 P0%"QP=%@X?& _]H " $" 0$_$/\ C.?\\]?/F_\
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M4)4GXU""(,6.S)6D@-9I(LF*E0A0>"8Q *"MKNB-5>0@L@(@;K^[/R6L$%=
M8&#I&2ZPK7(.XT9._8 \F#D$9*&A#-VA2T%<*H,K."7>R(4RSX'-[L#O0M"V
M<A (0"B*=-[T"L"K@#=>M($CD4%,%T^Y@[//(H+[>J1IK=4ZEVG^@!ETM2_H
M5\^=>7X?GS;\HK^+)&28J(>J0I.-5L/[7.$FL3J:)>6-I2-!333)B'RK>*O8
M7)H)(!NH8%N&6,CL=F$<(G<B"0 ).1J8T151"=',"1@&XU31":"!DEI.:4,0
MAM8#!#F][LK'ZK;1=X5NV!8&VFF#P)DE."'@U^-E_7<VV ("%I'22)G,R00L
M,5A2  2*7!2T2" F(10(7PV,]@@,4#0:*P"-Z]$ !%WVLJ[:CR7"EG/!8*H-
M/OB-\4K %1 " ):XD\G$B'IAC(+P 8S#-%)XN",BZ6M7N;*- -A&'N,TU"(U
M!10@P3B+^'D/$,-=G"#(@FKO.N C# 4Q@%=*4-D7 ))!.!P\!3GUB*F0QV!!
M $%C08CSX/MI6,CC8!=> ?%Q"(U$=AKU$X :<!(Z8]2D&0I6JZU@",&C51E(
M-80A$S-&&B%$$!)&+ A'+Q'1W0)-8IQ&,;("(#2?9ZBUH5%0'F"%N0@<:AN@
M#D&*F(YT"Y&&[9$+D/OBQN*OU1C/W(B0"(L=D9?&T)N)CM0Q'+$60?1!B@ID
M4&/9UK@B;R&_?UK%3#@",-9+&FNJJJR G+-%92'2JJJJJJU5RJN57*N__!:&
M[JG9[^O\9U3L^7_'V=4[/?YV:IV>_P [/?5.SWU3L^7_ !]G5.SW-4[/G_I[
MZIV>^J=GR_X^SJG9^C12TC&2L<Z4') ?X086 I*A 1H+I'!C$%A$-A :E.-?
MF)09L"F17NAY+KU^\=K?==\W>L]R8=ND3V4\P=!2'),=8^WV6O:9MQ$GLCU=
M+VO;<=Y^_P!UK9,*H2QI1>8%VAUKT>;$VQQMZ/'QI:&",)1X?#!C2F[;\.<O
MER[UFN7N9W'^0=*J2M5*KR?'^-UH     -@" > 8_"@D2CQKT>3#P/;%UX*2
M PA B!,/+9Y8VTK:]MH=\O?-_:H.P9N"9BO.#S \:V..3&TQGEA_J-2P )&&
MY&'S ]BFE*JK5I:JU]57Q[G6 @1)%A%#CI=[#N:6PJ  3@ /8_('&MWGMPS0
MM\P7P+EU"X"MN"T=]\A[5[=&# @(!X!M^),7C @@HP49D'S!W#6.8))BD8VV
MI/)39TI:MJU:M*TS5WOQE#V#G!9HW;L'S!W-*;MY\6''R.$ V'R'A.NE/)39
MTONUMK6T\<KO?B* T)MH#:-LWH-[!X-8Y@ZQ8 << >0<$]IG@Q)MM \E-EUZ
MY;S53QRN]O8OH2)P(B.VXH/8=P_$@B)1$1V1PCYZ4HYZ.-Z!]PO5WI55LJK.
M51\U;U: V)MM>%'LOYCHU@# ;;XAV='Z.M!D (GH@?<+R7>E=VJOJJ7U6>U=
MZ 1 1$<X19,\*G2.M, B7)@*"88!8#C1I3JX&2 C!1+E=]>#W7G=4YY7\T\Z
M5:LT;X@'T6>(=%1#&#; ?8#P T8H3":"V#X 21"A(UF P80$*,5%4J2=B: R
M1-"')3 Z)!UT:22AE:[BQ^Q,VE%0J;IG@=MW'.$UF;3S=O:GW]=%0%1Y;(S+
MS.N_/4>W[?YJ/;]O\T8 56A-U=O"_-OT?BE\*E\98ZHR(W\UJSG?F>)/C AJ
M4(.CH&+4X$B:)$DD1E)1P^EQR=FG\68D#STV$(N ZEM2=H\'B9 IOJ S1X"(
M H1!/V.F]QWK?P/9_P"C[]=Z"8/Q!P6")8:;<C/!QWHDQ)Q-OM^A@A$E1LKD
MEBIXW:)^4JO9AS6B6FCMCIP/+%7P*3#0V3XJ!@A#NH]IH"*-Z<[,0Z2D;4M#
M!C&@02@ HFI+/VS5.SO8$4@5&,OHR45PZ".)5$#]B+&97<)NQINHY\>.?P?/
M?Z*'/^^VBH-*+Y(_KVTA*7),G/&PQ\>/T259 5DE@.\> *"/R+]C_$F%_23M
M0M%@R#HL$V"!TD=;4X0Y4#H7[/T.U9VS_"9X!AFE9-Z, $B=*JE?5#PJ5X^$
M$:!FJP,UGFAY4M:Y!_8C?/!M_O\ GOU/I-5D$!7=+Y;;^^J\'NSUQ?GOH(V+
M<*Y,9><5X+,ZAXOFK[FWV_,7C,6(H;L!8<O'T[H4*!VPPPU8 *N-3K?8$5@4
M4 6Y?H9V)8TAZ8E\+=;[:7A=9JNT2D.QDT48  )!%$24792C9D_)0T<T*0NP
M,9_0:%B4&7/YL"$;'U5&U)".H**]83+I1("1UB$'A!/BK5X&[$"4$!4*8SZ*
M4_5=9D$DZ)?L9M4X-_%SCTPOMWJGGY9_C;UTP,:OBW>#:[F<;3G4.:^>WMM]
MM3-\ /O?Z^'T0;H8/<?UGR'5)<OD/S_O&J]/G3_=%F2/5O/?R;?D>("8.75V
MOA="'797G0+.W8T=!EBMO&6"ZZ8!J:#*4N]B\,''E7&].7&3 P!X QPT+%P
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M  (" @$$ 00" P$    !$0 A$#$@05$P87&1T8&QP?% \%!@<*'_V@ ( 0$
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M'^CY;#)R(\-LF;KS- '[42D#E8 J@+A.#6NT3R6TNP&K6&WA#@ *<L-GVQB
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MC!CL)7PD'7W??$=9GOA8>+@IB *S#.D:!B0\_P"'LO*NNGN7#_$ V#P$
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MUUHL7(_UQ"&BJ;@5$#>RV;>%A5;!1H!B%B+@SK0\1U5"'A+R(NYPEA>G3R%
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M?L7J(:S3@QT,4\UT.]VQ7GC-54S741_)/5I HNOG*AWFS3\IPP+^E!] )0@
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L14IR#*9X2\W)@((),MAB*;JE<0ECJ.\R1P:_1^=_]ZXKX&._GZ!/2]1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>businessfigure31a1a.jpg
<TEXT>
begin 644 businessfigure31a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M2          !\.!P.1R.(.1P.1V '75A5O/O31],3>YSA&+FIR2+
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M\5N'U3.&*S<C(O+A.SIEETB*BOY&7^A<U1&4WK]$R<>_8J7NO D0
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M?6P<QV8+]><S$&+>7'BRH:B&A)\VCCDSK''KMI''%CW28LSC,@[+HFDJA1I
M ;P7RI"66 WQ[SZL6(O;CU%E)"Y/2 \8QC7UDIE6F*_7='R*"B2K,_VBUH1V
MV$2?! P 8G_7_\0 /Q$  @$# @0$ P0'!0D      0(#!!$2!2$ !A,Q%")!
M40=A<1 5)($@(S R0$)0%C-2T? T1&!RD:&QP?'_V@ ( 0,! 3\!_P",WI*(
M1K-T01''D +C,$>4,/YF/I?^8\-IE-/&[4\A63($*W[BW )2ULO+?OO8['B>
MDGIK=5+ D@,""#;Z?]1>VW]%'<7[>O%=/CT8XGRB$2G9@W4]//[BRC8^I]^!
M.+EL3&UUL(O*N.^8)_O!MV"M;M<;<0SL^*/&M2,R0Z[V=R2N[;;)>]\2/0 =
M]5I!"XG3$)*2, +8. .P[6;OMV-Q[?T97*_/C2\VD+H2(@"L@)V+$>06]P=[
M_7C4:U*KIHBLHC+W+6N2=MK7VL/^_P#19Y73%(4$DS$60MBH3(!Y&:QL%!V'
M=F\H];<)+)'ETY'3(6;%B+CYV_;0P2U#X1+DUK^@L!ZDG8<1Z7Y5-1-T7_?:
M.V1$66)-P2,B?07MZ\/I-(KW-0V&0 6Z'UQME_S=VM9?7WX&CQ'J 3;F_1L5
M-K?X_>QV:UMOGMQ4TTE+)TY,;V# J;J0?4';V]OX3(@5DPW=<E7Z0QW _-V8
M_GQAT<95,A<^'/4S9A/U) DJO=C'OD"@4##8Q^4$?LKB^-QE:]K[V[7MWM?U
M^T$$ @W!W!&X(/J/LT^H\/4J=L9/U;W] Q'F_(V_*_%=+$)E1U<XIOBRKW)*
MVNI/UL1P9UM;IGS%2_F&X0^3 X74@#S>C=V!-^*">,RE<"KOD%:X(.^=CL#E
M\^Q^7&K312S(L>[1!DD:UA?+]WYX[W/;?;^$1,3(;[.^=O;RJI^M\;_GPM+"
MC!@&\INB%W,<9WWCC)Q7N;6'EN0MA^C<7M<7]O7["0HN38#A6##)3<'UXFEC
MIXI9YG6.&&-Y99'-ECCC4N[L?154%B?0#BFU^BJ?B%J6OT>L2!:A1]TRU3/3
M)+"T%/ ]*T$UE,"%9FI8I57,VFP$MN'YKU.!GFEK8<*,C,2K#'"ZN?\ >6&-
MB=@A#1VVM<DWUWF7QFGZC3ZCJ4?1:BF:II8I8H%2*1&,:N(V$S*Q4!+L2YVW
MR(/P=U!*OE+PXG>673]1JH7CDN13Q3".IIXHKDGHXRL5[!6SC4!4''UXYQYO
MI>2]*&JU$$M7(]3'34=-#C>6I97D7J.Y"I"BQLTC;M;RJK,P'"_&].93&E,M
M)H%?''A74\\RSNSH03+2S3QQ1"*U\4*O, 3G?$-Q#S-KB]=XM29_'J) [O%(
M@C\H6:G#;4Y;-%BP5#)D,%8V/$7Q8GY8J::;4S]]1RB&)Z0.D51!3R/9M3CD
M2)O+%&&+=08U NH99-QXI*W\7$\<D52!/')$P>-XY!DC(XV92I!5AL1O^U_M
MOKT?/>KZ7-#3'0M-M":=4'BB&@@>&JCJ,O-+++-YXGQBCA!2W5\_ YRI<U#4
M<Z(IM4/FA,5SY2B+?JBV[;H1Z!N-2YOE:DJ?NN%(9C#/X:JK"'17"'I2FE0@
MN+B_3:5/2_J./AWS%J',G+HKM4,+5<-;4T;30HL0G6$1.DK0J2(G(EP*C%6P
MZB@!K?96UE-I]+-65DT5/3P(7DEFD2)!8;#.0JH+'RJ+[L0!OQR[\2:W5-/\
M?5Z=36JJJ7P4-/(Z-#3)(8PM4TG5SGL,KHL8%]UX3GI/Q)EH& 7:F"2@ES_A
MF)48>^2AO;&_&J_$6HH?NV>+386I):REIM166=NNBU<Z4ZR4C*%C/3=@S"8>
M8&P"V+?H$V!/MOQ+)F"8F*G/+V:V-MC_ .O;C*I!'GD)_E8D[?(W]_G?TXZ<
MI(:1V/FWNU[;WW'H/;BGL$QOON=CW!]?\^*NECK:2JHYAE#5TT]+*N^\=1$\
M3C:Q_=<]M^).7).6M9H8.;=*K98F$M/1PT3"8:G+&ZPT[TSPSQ-)=I%/0:2&
M8&5"Z8@@T^H+05DE,FGZW(=/U/4Y7TPH97II:I:6ABAJ(I.HJM$D==@CQS-D
MRE'=W>7BIHQK4&E0Z)I&KU=/ILKZ5%5"AZBRFI6*I6&5X W3J15-4NRS2.$C
ME!,J !!\..0]>Y7UFOKM1>DAI)J 4JT])4O/XJ5I8IEFE4Q1I&:4))$"<F+2
MO@>G<GCGGEE^:^7YM+@>&*J$\-52R3ANF)82;J64,T><;.N2JUC:X*WXTGEG
MFG2:_F&GGY1AU&5*!XI:LP>0JHD5*BAF:,K4M(L@D$< %0QA2P5HV'%)I7-M
M/3G46Y7K1G!IX>=5JNGCIDE/X*6.D,<DRKE2QK-#=GD0L_5C4CBG^&_-^MR4
ME/\ =L&@TBZ9$GBJV=JAFC3J-'&X3]<L[F4CHF-33Q*JR$LOGY7T4\N\OZ7H
MAJ#5'3Z;HM/8J'8N\C8J22(U9RD8)N(U4?L)IVBNP\WFQQ_EM:_IZ_\ S@:B
M_P#-$ !W%S<_3V_._P!>&KIWV50@/YM8_/W^@[\4S,T>YN02-^_TXU6*IJ-+
MU*"DE:GJYJ"LBIITOE#4/32+#(MM\DD*LMM[@6WXY=BU&HU>D2DU1-+DZ,GB
M:FJE(56B7.:&=9#>225MBDI!NI8G;B+6JIG>"OKZ%4-?J$537TLT4!-+2Q4J
MTQI3)))##)-5U2Y%EE)2-XU"N'/&N:CK$%/11#5HS4RT\]%J\5/)22)%/99X
MWITC!:FSI*@0O)D<Y(9'#+< ?!BJU2DUC4-'$,CZ944GCJEY()4-)51="*E8
M2.%4K50L5"6)D$:RH<4:]N/C#H]3JW*BFF2>=J#4:>L>GA1I.I%C)"S/&MV;
MHF0,"%.-RYM:XY66&*IU5AS)5:/T:9IH*&>)726JM(&AQG5HPZO'&I*IU_UF
MU^FP-!S+U"CRU5 \*4] (I#=*J68M2#5S/#(@;KA?%M2+(G5M;H+<J>-5JZO
M5FI*&"2759I*6.5Z#2DGJ(UKD,S22G!23(D?3D=5NL#Y @2!SQR5-K51ROI$
MO,,;1ZL:<BH$B=.9E61U@DGCVPFD@$;RBP.9)(!)'Z!IB+J=[GRLN_Y-[?ZW
MXZ3EF4H;6L#8=MAWVO:VUNW'AG.P)"^N?<FY-]O3_P \10+&Q;(DD6W]/L:.
M-RA=$<QMFA90Q1NV2$CRM8VN+'@1HK.ZHBO);J,% 9\19<R!=K#87O8;#A(T
MC!$:(@+%B$4*"S&[,0 /,QW)[D]_VQ%P1[@C@(^+6[@V*G_(_P"O7CIJ3LH#
M*+CUWL/GZF_TOP0P&)2Q_>%@/+Z>GOWX@68-YQBMOE<^WV:YR#RQS!5TM;7T
M-IJ>0R2"F(IXZX,XD,>H(B?B4+BY)QE\SKU,6(X/PFY(:IJ:F3399!42]5:4
MUE1'24MW+O'20P-%TH9&.\19U5;)%TT&/%#\+>2J)"C:3X[\2*A)*^:6>6+#
M9*>-P8_PJ7/ZA\UEO>?JD"P &P      ML.P^@]/M;E7EQZJOK7T:@:JU-&C
MKIFA#-4*]L\K^56>P+R1A)&8!F8L+\?V*Y3\-X3[@T[HXX?W ZMLL_\ :+^(
MRRWSZN7I>VW%'I.EZ?T_!:?1TIBA%/&\%-%'(L"]HNJ%ZA2^Y!8Y-YFNV_\
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M!ZE5N;>O$];I=124.EQ5E!J%%]G4RQH]5351K:1%2&"65<R9,A&F]@1+N,9
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M97IVI\3#\=:QKWJIV1F5&KN:\['(L)6QM"<!5)L+R'Q6N5!5.P_*VK..V*R
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M9G2-9G3;K/[SM]O]O'TZ_('@=D>V/R1] ^GY?,^WZ=:P(Q,# 1,1$>R/H/\
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M  "         "  "LP"002 0       20 0#J@@           20"20 3X
M                0       %#4         5    " T*S<         <@ (
M!AE[#[\     #O3YH@ [BF,*)N8   26JJ89-$!A\ 2       )-!$P!8@
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M90SR.#0  (   8# P ^1 +;B"%Q@)% "0%]0>>F/@,^=4SOI0@- -V*"OW2
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M!%%/U13=&-6*V0HS#:,;,*T',W##<AG)85(XF.J._++PVPKT8.DH:)PB9RP
M5!  JJ "K4,!O\0I*X64"*(\-\QI+&Q)S74)^!F;$GRPV$Z*GY&W!N"YC 5)
M-%B@+@)ESZK?;9Y3WQ9O"0!*)E0#$)&M2GGTG)!3$Z_$.!2\3&D "N'2:OAF
M7L=[7$ ZD52K"DH>P*0" 8^@P_[:-L;+'6$+3%1U<%U$M*1Z>S;#_P"3'B*)
MHL"8'Z%UW:RZ(T.I3?%&B)4(M#3>^74#(*BCH4,", .C^&T6:/J":Z RA6:T
M-->$B6")<^3I^]#)3IJ$V5XX3&DU.76[*JI+@M%BL272;Q7=#\-A31I*#/\
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((WC_ *[1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>businessfigure32a1a.jpg
<TEXT>
begin 644 businessfigure32a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M8?@ K(=P-!O*O$YM$H]#43T\%IF0&8:B5"45C&-QO'X9#4)28D!+" "HBTC
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M,?BPP YK+7S^"U:/>TT^2]1SR2[V'*5P)A2:C)""PC(#,<[T>-T7;Z.^6C>
MTU8(?VQALUNQ:P 5Z6$ ')\,=O..L]M7FDC%/DO/*I0EL[U5R*E.0#-=ZEM=
MGD!$4?7@LBS?X/8$2/)+S!DP9/1,P #  !@YD+Z)$9 P &0    (^08MD
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M4)DM:H]E%&SO=G;O'#]4?__$ %P0  (" 0(# @<'# X'!0D   (# 00%$1(
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M6K-U!14G&UK5>Y'=5<XA,1Q]&IS#3L6<I4B]5!063&*Q=MB#N.A'1QI;L;D
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M7VMJ]JL0PMVHS*BU7H):S$Z[>/2C^>..9_X_C_\ !,?[C"Y"\<KJUZ^5AK(
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MK>+YIKL*!G2%/I4E%/K/N2GOUXPCQL*:88^M5L%(R1=KIKBK:WZ-]+KI9/\
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M!\,,=4P)0E0,9D:)YBT+<$SCEPX$R54#9B/AF/6>@_A>N?DNGAZ^?0?65O\
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M&'4_X[_G^'__V@ , P$  @ #    $  (!  ( !! ( )   !( )!(  )))!)
M!   !!()    )( !           !))!)(( !)!(  )( )  !!)(  )(  )!
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MRJ=Q6.8T-Z-<-.F]X'F>+>0>@"& EE*WI?F:HI76>W%91.627V8HF"1R(<8
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M$J+"TDFN"*)W-/61(:2P0-1:PT+WG/20%@T40D2*/!,:ZZHK1>=QJ;/K) T
M50;%4Y<./7W/4]0( &F5PVV;CL]P9-Z4M]0)!V62^SL'GM%*; 500]/IV4DK
M:C_2 XOB%;L+OABMB:4SM0T0_90]?%4LN5W 6%FE8QFH;?07G))P\]!$69B-
M19<DG67T.&FA+K(#B%IBX5XGH#%FLR/4[$=AO6,N2KM'":&K2L\:&\_,SZ(1
MX[]5A:?VM=B<A[\'_3UPH6#./(1ID<5>M#5_",I5OU_[0]:R!PDJF9J5TV-I
M5V4HQ.@!QI*UY#5]W!Y.W5Z@ !%%6FT3E=-]I>+T /%(FJP=W58<1@@\WS=L
MT<CJM00$" 5@2!43#CU]SU[;9ZX,"5I7HR^D@3>H*!Z78/(IKEK?2 R\MPF!
M@AP%_NH#'(U*$+7"RX'I4"-C+P!LD]5UU,2&933[F^PY!\/1!U&7^?>&<&?.
MIWU:B?L*A66-%/**&)5MPB!9:W@X\C*-],B A=<$$#_E"2WRV5N] ,X4#>&/
MP VS'<4^@J5='+K R1APS !@O\\F&LP6$"?@B6(#O:R+$$D/2*/X11&&A0G'
MK[GP=N'5"CV(;[J>2CFXR,;82SGA'YLF,99"]P!SW^Z<9^F?SGZ9_.)V(YVT
M413$F$O2MM+$+IDO;AMJT%9PET[+)E.^0J9BS-9CW=M<8]?Z8^S\@GNI\$>H
MW!GA^:S6;M,6":]& 7 A87^@\"!T(J*\&V$!0"Q1+<SRV0!$H2#&&+\O6@3U
M.&'#;*L_UO\ 9&D"K(HJ3<I-9%DC%#VQPHD=4$FC1ZCY^>@E$L^;4:^@?6]#
MXF4[+)[+ _TC]<<L>P3/OM_M<W-1A0"+6K8TD" U3CU]SX.VN#;./O<Q+_'P
MKML::/5Q+GO\H*C>KND&^VZ1=6)A_P#LSZN]GW\8&0($:HE:L;A#$I<KUOER
MS_09+:G+41*^R6QM*&0"#MOSX'5,P&UA 09B1#LHN]KKP!=MQA&70CE\I&WV
M6$TZ$?$$%]Q5O2\F>TXQ6SS*]3Y3$.*3@C0X!QF6A0P8!!6*<K&)) (0IB:Z
M=<D51PW9BA;> 6!=_ APNP!T;#D$9W2[T#R-1AW3(JP9YQ!&IK[ NL>SA5%V
MV 3E@3N#06PB3>X]\JL-3CU]SU)^K(02J&$',*43II-@70M2V=->9K!L*M=
MD&)J#4V1.F;,9.JT;/" C'3.AH?$;D[W+.NQ'(2"2C9%1J)@TKGIF5I@'B2V
M%QD<@(M1,S.X0_PR<4W4QX_K'XS]8_&?K'XS]8_&".IL&L2@:',-(/;#P-)R
MJ+(V)1=D8)(M N#NV><8>1_6 ' 'VUB#R#]]X!P!]@, + +S"7[^>''K[G^&
<A\3@-(FO6X' !I6-5FZR:Q/_ #B./7W/_'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>businessfigure33a1a.jpg
<TEXT>
begin 644 businessfigure33a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F
M9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:
M   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M
M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" $6
M HX# 1$  A$! Q$!_\0 '@ !  (" P$! 0            <(!@D#! 4" 0K_
MQ  = 0$   <! 0               0(#! 4&!P@)_]H # ,!  (0 Q    '?
MX      8):;+7'#=7KUB.I0'B>F1)CMZ\NG=^;2O?.DO/.I7>-RS>'&AU9[?
MCC)R2SY[7Q%F\OS:XN>XW=K:?.T@7NK
M 8):;+5W"=BJ]ANO0QC]]Z$EST:%]YTEWYM*^\ZE=^#)=1O+3YKC RM=:[G]
M7&Y-4M?1FH\"&/RUX]HY.'+/:_)L=KOQG^,[3=]\;S/E.>@"/#"4<W0Q9'+4
M.P<QF                      !UY:M=L3U.J>%[)B.S\T\[9^5X_HOH.$^
M@;;BFS6>4<3Z'QZ1O?F4LA%5&YZ=? 6FR.BY]4LL6ENX>GM\(GH=!+[B>2Y:
MTSK?W:UC&E++U*Q/0_!Q6_[3]Q\O;2-_\7]N:@(2A' 8L6,2A'P8O<.1"\*'
MO                     P*TV:O6,Z96'$]:Q"CF.A)=>=3J8Y2R&)6^7K[
MW3E>(W5C8[F^\Y1H^T5EQ>[3YE- L?>:E"4M:EU>P@>MC^&, !^(>S)>6>HY
M2ZT(Y_<8NM&/W2JFM]CNID=&WA]6^<>25\3CA!Z.6(=\QY'QSJF?(8<CWD.X
MC**&1@               &O[5O3/9C2X(S>!3R&$4,]X4+SCC'IT[GHT[OQF
M&K?L/R=[5/8IMUWZOQMZ>^=<<='XOEOE'Z35IY+ZRN[F^82K7PE 9K>H=:R_
M    <T*GN4\E>VEE;@7FN0[:;%1S4^ZW(OM2WP];^:&"5+2 4?(/!B]:#(H,
M+BG\BLZ)C!?-#T@               #2CS[WUVIJ'I5;/MS6_9J4/T^Y)I K
MZY)UWJ<C76K^?)>U%P/;H?L=T\ZE>^?3O8"L\Q/>8YQ.%WJ^OREGZ\5L5@\^
M(_0  ?J/-"IV):W/"KVH75NJ69OU?ZA7S&[A3W4N^;1ML\W[;^C>%P(JN[65
M;2Z       'R1>C*2           $$8KI6N35?4=H<MR:6,AHWMU+#.;C7L_
MO-7YHR #SJ=WJ&T+W%$=CNF#T,CA,V.O)G^6:XZ4*F1EL!3V_AKXF!)<'Q@
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MP]H&[0YE-NM;<<NA:UZ'YF)O_3H4,KVO"3#9Z1L2]7^2+ [1HGZ
M     #I27&HS1?;NQ_;/*TI7VF1Q9;9Z$]MDE;$5JPO7".F?0_9,_P">YGZU
M[K.G2C#] /PVD[5R3 J^R5#QE;'['+YAF]0N'F^=45YSZ;Z%#)=B%?L0K<\*
MW/+6[$*O=A=[5LGH<7V&PTTTWT7_ $&=5^<TG;5PZ4[2Z$(:?N.F7R)]!(RO
M<Y[=E0\^XE]2CC^S3H>G:9*'=KR_N65'.\10W'^OOGM9?<^=@
M    :RM,]=?2%Q<_PKW*N.]BI89Q=:Y^QAA-IL?\Y'+/HI?3;.+4]EHZ]Z8
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M-Z#UR,-FY[@>;U*W_*/2/=I70 &!W-*O-_;4KNK:)9Y9;NGW".Q[ W\Z8^Y
M   UDZ1[ N%L/")TRW-A0_4_2LC7NJ6JS_%1J-TKU;'='>."K2UWXGIG4FM8
MQO>>V*R/@"5<YY@B#+]*ZT*?9EARRXV>M>L(IQ_U3]J>UQNVV"++'?;-^YOD
M5X.R\ECVSW:1\3D..:GCFQQEGS-ZVC/SE[XW\]/^?<\WFJ@#';*\B+5-PI#R
M7MM0>+^G8MV;(<$\<^P5+TLQJFV[T'XSMAU+DG-$/P$";QR"4M:Z#0WM/F:
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M,^3EL!Z&X\V\^K<=_F799-A82%/B>A-3JOC]WQ*PV_;[NOD_81N7EK[C*
M!Y$+6G]IR'%XVF*28SLPAG=78+7W'3<SFS'(FXB YY8ZZ-R#7%WCRY5.3M'Y
M":PF(L9NTKK4WV6&V*<:[1!6+SN9XK-QU:9/XW+G%I9Z0 $![!-H?]#5X(Z/
MDY&S>P;7?.>O[,.!X,           5(PG5M56G^H8XLMNF*YU_/:F.XKJU@3
M>M$Y,E99QJVW^3I/0X?ML][$U#8YLO!MBFW>9<FN,.         !QE$^B\PU
MT^@/*5H>?=-Q>?(81-F8>S^#[>4T;>3Y']K2A3J\<LT(30U?6U],-Q9[+(R:
MPD^T!)DH.A4?S5>Z=OVB<.Q=Y>-XG.\/2            $266UTQP/8*UXOH
MD;VFQ^3OG/?*R]EQ9"WFS3,UM6K<*G+*<_\ T            KWN.A0/M&K1
M5L>FQ)G,!T;BR\C):_MN\Y>MYCUK;1@12E-6.$=>L9[_ *3;<DDP X)G/*
M             &N&3K6NVZZ7\Y*TX,I0OW:<\V/8'F^04[<    8U7N<EH6P
M       'PAPS2]F6<  #1XGLY"&R>,H                 &(0O]#U;T=CN
M2AU<G;^=E9>_?VUR,=I]P\%J-G<'K/K4Z0  @3+9W2=T[M']"W'_ #_ZU.D
M          !4.$; 1AG@                  *<3;WJ6R78NKE+;S\I+XN5
M8_EZWCY"X]6G2L-A]>L+A\!/.*P4XXK"33C,-Z<E+^>KL'H"#LIF]H^B\QVJ
MZ#RT          ?)%U2G*=.H  ,?C+W4>2#IQ>W"(               H/==
M&U@YOIWFY6'CY27'\O6\3)7'Y&( _#],EH6V-5[D>C)3_HBX[Y\FG&88
M      4GNK:#ZU+.I)I5IU(!K4NR>M+'TX1CZI+[LL;R6ES(LDX
M      %2KW<-3&S]9C_,7'@9:KX&4N/F:8   #\-INA\OVH:'R\
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M5SEL->U/[                      /_\0 ,!   00#   #!P0" P$!
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MHFUN;M%-4)LQJ]TZ=*F<_P"@%Z:7"FQ=A&[WI.IEB#0<7+.6#!@R**B_:Z"
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M0%ZO^T18ABJOWB87)$)L2!%BPI4Z0I"'-;9*4N+2>Q4F^3O3T#F]9Z2,Z]R
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M4XM!^D?NVS6(S%G>/"YJW!&M#%8C/47,4HFY4V0;'FJZ1J.-N(UI#-(P7A/
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MCL;PV(\16C7IP4X^&S>(']&E>*"H/_B /+3X?P<"QEWQ37Y/T?"MIY<?I%X
M_;PZ[=O"JO:'<T\3B\*7_2^+XO\ RA=NP_-$+OKNO:?7'Y7=3,Y%8V/<CM8_
M'S+,Z@] 9Z,LJR?2Y$/T!\&XS^F=D^"TZG^#3P?UJ_/C(_\ #V'@/LVW5;7'
M2KYI:?\ OHK;;RXWDR^GPK\C.VDX'A'/]/W++I_;U]OP:; ; :;*FNP&V03A
ME]S*&^_P.V(DX;?+/A*C#^LG>'[ =@NP78+L!MOKNO+O)C(XZK1I?I2F>OS.
MZLP9"LE=I -5XAH8R=5#CJ.]KL05+*W1E+*P]C*=&'W':9XI)[(#1GFK&B2%
MF41NGB3HNC=?#KIKTV+Q\UP720,\_K<7+UE1 LNNA[RE#KW3ZW1AL9D0R1])
MRPX19.NJ_(B+N^97B'V<))T)V5UT2'B#*&?5SW0_,C"ZN61^L9&BMP:\!Z<)
M&NU2(*9I R2"0IPN#QMHL84AFTU\1K[^A/7:E +-VK7Y"6N=8B0UY%XTD!<<
M09?8!UU^;IKKTVM[L[V=EL/\).S:TU_&4<>9,CNEEA8R%6O"J<^WDL?&DJV)
M[;S/QR1J4*0\>A91TW^[3M\=_P 0R[QW4NQT6E?&XVK5AJ4Z\MH(C\$<8+MQ
M!4#R3R2L$7JW39=>%>+0-H.(+U .G73PZ:^'3\3LDWH^)-Z,3C)L=B[=+,9B
MC!-8MUHVNTWE=84EJVB"R*&X283W&;5M58DF37F,6^D=?U[+II[M!MOOBI<W
M6HT:EDUK\&0IY;'S+'SA'>Q<PLUFFBU!>N2&CE 92%?B4\2@'>;<W>3>Z''/
MDLMAJ5C&6KSU:U2ODO0VJ7Z IS0V9DMQ6Y9F8&3F(84$3O6X2&,FW_9'8BM1
MRU,QCS5BGIRK2GI6R'2ONR=WY87?TMW996=YAQS<8A(B>;F=_;=/"9+<^&_2
MGFCD$\E4U:L8F->A#6JB K%:MO-?M1S/J\:3SSK5C"012E0=J@^-(FCM:'A8
MK'*O0H?:/:-?6'@=K.\F[&[D4T><WAQ=">O*RV*TEI&M"37P6I&9+)XET91R
MM2IU\.NW;-VBY+)9B'"X;(-7P-""&Q!8QMT_Y5>[!'+Z5/)7<:*B'DPUB=8M
M)#(..319'>5VDE=I)'.KR2,7=C[69B6)]Y.VXN/APV,ESV4L)4%Q=*XL2\J-
M*BG7F\#'1GG8:KHK-RU&GK;7MS]U):U#*Y&.G'5ANMF<E:L=?C+TNOR8(K5E
MSS#!QRQ.J:\(X0JJH\-Y\[B^QOLZO;P34[>9Q&[)640UF@%]:&1R*1J(II08
MY/1?2UZDKSXU'4$Z[;Q_A!]AV^]?XXHYN[N[GXD7TJEF\7-77(1+TT]*J>E5
M#;A^8[2*9HQP$:JNV_':ZRS'![C<K(W71?2LVND]&DLBA@E336.U:X2"SDF&
M#P(>34)@L-D;\WIN7GL7;4IXI)[+M*[$^/5]=![%&@'D!MB,74K\!Y:<0'CP
M@G[-=-1[^NR5Z\BE>!?MT&V^6[\T9,JKQ1MU! _9]VV WBR>ZMP-'S)L>[_E
M5!F/+=?.2#BZ0SKXJRZ!_5<$'IB,UCLY46YCK"S1G02)X30/IJ8YXCWHW'OZ
M-XJ67K^,==#IXZ'3[=DC/$58$'V'8]"1XKJ1IK]'H3[A[#M)!T.AXN%0Q^S]
MVP,@ZC4%>H.GA[.NPNVE;4L&^J5&A_5H=H\B3T:,:^T$@?JZ_OVAFYP/30KX
M_?X?Q7X.>)66]O+FW34U*53&5W/S6R$KS6=/8>335"?HRL//;M_S+W=\(,.K
M?D^ QM>+@_\ [F047K3_ &\N2M"?9R?A_!K /\,O;R\)]NG-R'^.W;OK_P!I
M&5!\J6' ^SXLK:;;OYM\#)E;$(//O8/)8>(CY@RD0JSR'[*KS@?69?@["[@R
M/9M4J%N)J5S*XYQ]%99/2(P?^[M#9T,<DD9\8Y'C/VHQ4_NVW2EZW:_M$4Z_
M=JC?O7:6*.>*2&90\4JE'4^8/[B/$'Q!Z[9+&RXZR8GU:)M6@E\I(_?_ *Q?
M!Q]_@=E77;M8[1:O99N9;WIGHMDK'I-;&8O'J_)2WD[O'R%GGT8P5HTBEFG<
M*S<$? @XW7;LG_"DM;T;P283?S"XK!598S)4SV):X,?3?^;K95+<EAD6?0HE
MR.1560?*0*C%TJ]H&XMNTU&MO9@I+$<;2E1?B52B#B=EF<K"_"NK,%<D#RVP
MO:=N'G\I\38O>*I/D"S+#&Z3UX[;)ZRT[%B*.&RW3HL;EG'6,,-MZ]\=TL%-
M#4R^\&+HW>%F-22P&L+&1J&DBBXVC!T[H<*6\%!Z;;V]O^)PF+L7]SL?-O%F
MJLFL%>]'-CL<(EUYUN28_+S1HFO!7B2.677UHP-=NP'\(FYVIYJ_NGO-A,?B
M<_#CY,MCK.'DLMCLA3@DCCM5W@MR335K=82QRJ1-)'/%QD"-DX2$/L/M_P">
MP&RKLHVWW@@K[S9V"I!Z-&MAPL77\X\2R2.H^:LDCEU4=!KTVDD2%2TLB1*H
M[QD=4X?;Q<1&GW[+F<%K()LYC:XC@DGU>267F<L=(8A6AG+3RGI&C< /BS*
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MW@/5;R/GH?W;5DX$UTT9O6U]WA_%?@X*IW:WF^G\=U.+]'T!N']O'MVO\?\
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MUEG'#(:L^G'"YT!XE/B-=-INQW=^5)X*V7WBQ].>M4IM4@R#-7%:O^<C*/\
MG5L OQJW=1G9D70\.W:KN/>[.-_MX\/8QEJI4JY.[\6^D(YCMX669GQMRM89
M1'8C>JT8>1">"571PK*1MNR^Z4>\E&UG:+28_6?TF(P-/"9GA9:KRUXCQ31)
M.5:6-0>(?,.V:S&Y^*S&ZV7PU,$8LUY[D.&QZ8N&S=BE!M26TMQ<<L+KUHQ0
M2KRCQ"334$8+(8C%[P19=\V;E)K&9$CC&9 25ZUNA<BJ2VGDC1Y+,D]E$E@J
M0V40"23T@CA!&0QY@W5IG,0UWW>GNY4Y*7%7;6/FM6[59EH1UY8DMA((*YG%
MB6KRS:?@0+H)MLWD,?+F,I9QB6[$-Z_/-6YQDFG*32:H))&+2R2.3KIQ.YX@
MI.NW9'V:]JF\W:/NN-V,+O'A,G6RE&XN=?'9#'08.M'*K2Y&>W-%"J11P<>B
M<?'9UY**Y?3;=KL]W5[,J&3WMO/-F<]4IV<WE=Y<RPL7$LP4Y'NMC>,:XZ"V
MW'Q01LQ8OPEST&V6R,^7RF1RMDDV,E>M7IB3K\I:G>=QJ?(%]![A^/6LRTK-
M:Y >&>G8AM0-[):\BRQG[.)!K[ML#EZV\V[V+S]>.2+XRIP67AD4K)%,Z RQ
ML#Y"3B,;>$D95QT;:.PT?=T##RU\1M)99P5 X0?U[->J8RI:R-^=*M"A7DMV
M[$AT2*"%2SL?#4G3A11U9V51J3MO!V\4<IZ?%%NFMZM<:0&/+VD:"6)CHO-K
MQ0DCN:$#CXT/@P(UV=@\DCJBQJ[NZQIKP1JS%A&FNIX4!X%U).@&IU_%F)6&
M5EZ,L4A'VA21^W;<JL9(Q.W>=V9W8^)9F+,3[R2?U[0)X'R'7[AX[6TH[R]H
MUU;3788LYGK(K-7,+O UBV_ 9Q8!XXU0=50JP;P/"-MU),3HU2 ,Y4R(HG,7
M-/)X@[N4T0*. L3IW5UUVWMQMJ^)CCHH9_%8^"Q#^4R<E[')J]_Y>?DHSF)=
M' &A'$0#GMUJ^-Q1RL=VQ-)KN_\ (R11JG^6L2V2E[RGB_)Y!R8_I)WG[VWX
M-LI.%WJJF3BB2_0L1Q_T;S5Y(Y6 ^OR5U_1Z[;[4Q<QN1J #6S3LP+KX<;Q,
M$U]W'P[8'LNWUWADGAQ^-A4U.6+#V[M>NJ<SB"$ LSR!N!CW%/[=MV?P?=ZJ
M66Q63R.9P]-:&0IWFCJ>E6[!]%G2;@4M#7A5SP:!N)U777O::?Q1 ;H0#]NP
M '0=-O _;_$[B[T2[F[U8?>",,\5.R%NPK_Z1C[ ,%V'WEJ[N8]>G-5#Y;=I
MNYE;M)W+1L/)%9O01IF]V;2D<%Q9H0STP^N@3(UN%5U("7(X>/31]IHI:\LL
M$\;PS0R/%-%(I22*6-BDD<B-HRNC JRD @@@_ K%6#*2K*0RL#H00=00?(@]
M0=NUK,+O4NX^]H93-EMTX:.2T\5S&#N6:5X-[.8&KV5U_F["$=#\()!!!((.
MH(Z$$>!!\B-MQLY#V@;@TYYW5KAJ_%>3^E%DZ:*HF(\1S@(;:^T2,/([30R5
MY98)EX)89&BD4^3H=#]WF/=MNSD.1.U*5M(K)UBU\%G'@/=S1W?T@OMV'CL-
MM]NRWL\[1_0_X;[I8K>&3'\0I6;<<D=RLC'B>&.Y6DAL<AF[QA:1HN/OA0W7
M;?7\!3>:SO5;;<7>7=ZMN;>M&:"+./>^-L#7D;5Z86*"9<JE?5EJS<Z"5HPB
MS]\%V[0/P(9ZL&&D[.LK!!;K48JF<AWFFL>C9:VGK9BI;KQ6!1>4EA)C^7R0
MO!RG#<6M+\!>W-5Q\F4[1((+SMS,M#0PCSUHM3TCQL\MR%I61>G,L11HS=0O
M#L?P(][ESWHK;XX.7<Y9N=)DQ!8CW@>I&>,P#&<MJBW& X.?Z6:ZGY3A/J[/
M^"+N-'F8[<&?WBCPP:)YL&WHDCS\'#QQ'*\*3QPS$'F*L', 8JDJ]"NZF[^[
MDE84I,!A)HL/Z-\5QSXJA/\ %\:)RT%1IH':#AY:]Z,AB>\26Z[!=?\ K_K[
MO@52W@"=HJFOYP]/HC_$_P##:]BL7DX&J9+&8_(U7BD@:O?IU[<30RJ5ECX9
MXWT5U)# ::_;L/P'^RI=Z3FQDMX!A?2S<&ZJO6%507YGH0R?#Z<M#7N",+Z0
M(=(A9^=MOS^!MV7;V9&#(862_N.BHD=O&X.&O9QED1]!+#7O,S4K++W9)(I7
MCD/?:#CU)@_ X[$(?1>/&[PSB" 12J^\5M$N2 :&S,L*H(Y2>]PU^5"#X1Z;
M1?@F=F^+WEDNOD\WGL+6L&2O@LCZ,*S,#TBM7*ZI8N5HVZ!>&!I0ORKL"==W
M>P7LRK[T4LGB-T:<&3%E9*NLMF>C1=3Q&U7H32R5HG@4%XVX#P, 5T.FV"HK
MS8(4'Y-2CCZ>WE#AB4^TEN\?OV_":WQ&"W(BW<KR\.1WLL<J10>^F'HNDUQR
M/HV+'H];ZR\X#U3^)I[^OLV ]NQT\S]@'P4(ZLUZE#>G]&I26H$N6.%GY-8R
M+SI.%06/#'Q> )]VUSMYP6[JK2W9QL^9@ACB@'-)Q]#DP*L:"'B1K#.L:Z(W
M*C7Z0(VPV0Q6;PV+S,-M8DRF/K7TA=>(P^D1+(89'4]YHB3&S!>I773;>?M4
MW&W3L6J.0R;V<G4Z2XW'5)K$X=E#HC2LL=:,LK*=6G[H/4:C3;M9[1,=OINE
MB7P>3>I"V3*Y3=Z5Q'>DX82\,ER-.DT-:5=8V1C7)<-UD'=_&9>)64^# J?O
M&FVY:<H6Z3CAEJV;%=E\P8IG7]P&P/!IMVA8:_V?;^BY!$DE<7?CC#23(S5Y
MH6E:012<#(2U=V,,R!U8<(/3B&V(WRR^(E+UY(VC::::2M)%&T4OI'&)HV;0
M6.6RN5T69=.A&C#78[^Y(0SU8:=&&K*1)'#$U^(03BNU8SB2*ZDMEY$;CD6X
M\\32I&_+'#MD=Z,AE:'Q;/#5$1^*>_$DHEUP]$X^MU:5E^4A/%/W.])U3@7N
M[=@6[=G"[J7\K<C:&3/V8I*R."&-&HC+'+H>H6:627@^DJAAT(.V\3=U^OTM
MNS%)#D<]*/S(BJ1$_P"M+S,!_8U_C6\OM_BNP+M27'RP[B;P6.&C:F/\'KTS
M:+1N3-J<9,[=%J79#Q5F/2O;;A_-S]S\(+LN$T-C?["5^"S!I_"BG$NG-BU"
M+FD1?"2,\,61T'>7@M'0K.3\#6YVJ1T6?BK0SRV8D/7ERSI%',4/S1*L$/&!
MT)C0^(_$[#=]EW9WE^*+\W+P^\1BJNSMI'5R2DBC:.O15=G-69OHRHS'2+;?
M?#%7&7@7H>&&\H'@P[L4Y^W\W(?;P$^.P)!!!T((((Z$'R(/M&V&R8R%?1R/
M2H0!,/ICP69?<WS_ &-]H^$;>X]1Y@]0?N.TV.J2=[E<!/G&>#]@[O[-GQ0Z
MA)3H01WE]HT\0?\ #:PO"[J?%69?[+$;;IOIE)8-=.?6?]<3!Q]^G%L(??\
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M1]Y\MIY7E=I)'+R.=69CJ3_R'D/ ;8?"V,S8X5XHJD9_*+.G11_1QZ]&F8>
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M"<P2XW&SB4Q2KIPIFIHCS((I=?DT0+%/H1SSZIBBBAB2&&-(H8E"1Q1J$C1
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MH-K.Z./L+SJ,SU@XXDX2+-5@>H*'BUX3Y%)&&GAM/NMEZYUB6*TOMAD ;_\
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M4Q:\RM(?YRNY/ ?TE]1_KJ?=_)VC?60CSDB<==-0G#J/=X;&"0@Z@:Z-IWO
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MA^$ ;$DDDG4GJ2?$GVG_ $=__\0 5A$  @$"! (%!0H)" @%!0$  0(#!!$
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MRS@?-E&S_IC?TAC+LXH,S7^33#B 7:"3J3+^@?.'SEU+X_TRS*H+,P51S9B
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MIJ_K(]/5.XZI%OP+3_U]5^O'_P#XX&3T8\[C2?2G?[D*C[,)E]%'YM+#?O9
MY^M]1P %%E  [@+#ZA\&2-)4:*10\;@JRMR(/^?8=QBNI6HJEX"24MKA<\WB
M;E?O9#=&[[!OE8.)GT+X]GK_ ,,992\:3C2"\<1VO\N3F/6%YGV88\\ =N#O
ML>6-.D^'W8"W'PR?@<\?=B%]#<-O-/F'^Z?W>]F=((9.(@^*FO<=BOS9?4>8
M]N&!BDZI(*D-&PV(L;J1XJ?NQDF8C,\OAJ#;BCXJH [)D\X^IQ9QX-X>_+U*
M6F3TVEG/M(B7[(R1ZS^)KZR'+J&LS"IU>3T---5SZ!J?A01F1]"W%VLO5%Q<
M]HQT>Z09;TGRJGS?*I3)33[,C@+/32CSZ>I0%M$R=HN01UE)4@_T#F&7K6H&
M4A*B,'A2=A';');<QL?:IZR[W!97CD,<JM%-&;VO9T/R9(W',>C(NQY'M&*3
M.60".L!<#E41KO\ \:(;_IQW![47$51!.-4,L<@^8P-O6.8]OO//#'M)-$A[
MGD5?O(PDL4GY.2-_H.K?<3\'I!!KI4J .M32"Y_LI;(X]C:&_1]Z35+*$7<Z
MM*CYQ-L00K!$D2_(&Y[VYL?:<-\!,-'K&WG#[?#U]WP2??Y8\3[[#4-]N[P/
M8<02<1-_.7JM^X^W%1"*B%XC\H74]SC=3]?V8J8S8W%GC)!'J\X?7CHA7>3Y
M@U(Q^*K5LO<)XP63]=-2^)T^_6;3"/\ J(XH?:J#7_\ L+_ S3-<OR6BDS'-
M*J.CHHGBCDGEU%0\\BQ1+9 S$N[ "P/>; $X&X!&X(!!&X((N"#W$;C'3?W0
M).BN;Y=3THI,PA-/4G-* LT=7 S<(T,J5 #I'J^,UPNC%H^OU;H3EONN9C39
MSF>85E,U519B:4)EPJF6/+13(8[TC-&P)G!USZE77( VUL9%[IDG2?I+29+E
M&231T7 FJJ_,:Z4*8X(DM\1# )%+-4-'"#+(+W)TCGCW0J^FI.BF=4TE3%%5
M9CE]12443M9YI)ET=5?.TJ"2S6L._'17/<SZ$25$F6UG$%7&JU-)/'KHWD3S
M)@FH,)4%U#A@60V:]A;-_=<Z1YEE%1E])'1Y;6SC1^$Z;BB1(K'6L2,7$,S[
M6F4G0+V%[''1FMAK\@RF>*M7,&%#2QU%4'XC/5QP(*CBG9A+Q=6H, W;;?%5
M64E#&9JRI@I8A\NHE2(>S403[ <'IGEM1.M+E239G4.VE.$A2$GO#N-3+\X)
M;MOA22JEETL5!9;WTL1NM^VQVOV_SVJHX*Q=,R]9?,D7JR1GYK?>INI[0<5&
M55E/<H/*H_2CLLH'SHCL3XQM^B.6&TJQUCAN.>L-$X^O2V-;,+<65E[N/*1_
MUVP%4DA8]3=H2,R'VZ58_7@Z%.XX;^HQ/_<.!552BRU=2!W<8M]K:C]N'J:@
M^=5U)]=0Z_<RX%9.GFULRG_>68?4[,OV8I,^FB(6LM-"?SR*!*@])E7JR*.W
M2%;M ;EBK5:JAG52'6:G?00;AKH2A!]=CAWM'J[=-_:>7VXRF'7.TQ\V(;?3
M?8?4+GWC\ &V^(B#N,5,6W%7]/\ ^7\??)QR]XG'K]_Q/O1-HE4_)?J-_=/U
M^]FL.BHXENK.MS],;-]>QQ'(])41S)L]/,DJ_H,&^T;8AD6:**9/-EC21?4Z
MAA]^*5.)40J>1D4M]%>LW[(.)7XDDDGINS_K$GW_ '7<_BI*;+*"@S2JHL]I
M,QI\T0T3E3# B2):JLP4\;5>*&0.& +.FFU^D/3;/ND].*/-ZF.>B$D<WDD<
M$<,!FB4A92([,S;D[N5U&X46%LE]U?I-E:Q03-39E2PQ)#'%61Z'1(T"1 5$
M&B2R *#JUE@-]\/69EG6>3SYAI0U$LM74L@U<7B7T@2OJ)%[*@&G2JVL+8?+
MH)(V5(@I56*LOG7 OW]8GNQT,Z;IT6S-IX:&HJVFIY:-X)'2G76[*R.]]; 1
M2(&(TW*W YXSG/Z[-ZV:MKYS-/*QW^3&OR8XEY)&G)5'K.]SA8:FJ&I5LO>V
MP.)H):=@)!:_(@W5O4?W8Z,Y_GN5QYC3Y-F#T;U-*7L%20:XR/C(TD#*LRJ2
M-86^GG>V,E3I'TMSCR,R5F:9CJ^.EJI9)(Z=+]:::1KI#$.RP%_-12;8Z,]%
MZ3HY2A%/E-<ZCRFL8;L>V.$'\G".P><W-N=OZ 9$?9T5QW,H;[\5-A55850H
M%3* J@*H"G0-@+<E&,I14R^FM\M.(Q[WD)=C]9M[,/''(-,B(X[G4,/J(.#E
M>7,;FC@]B6^ZV%RZ@3S:2G_Y:G[P<>3T_+@0V[N$G_QQF630O$\](BPSQ@OH
M06CF W*%!LKD>8Z@=:P:X..CLQEHI(SNL,I6._H2*LFG]$L=NP6&*GJ]3N=P
M?T&*XRV/ATB'ME)D/JY+]@PW+X5!DL;4T<U14.C5"B1$C56"*?-+$\V8;V%K
M"V^&R+,ED,7DDLJD=5U7J.AY&Y/5N/DG<'$?1K.)YIHHZ-EX)L7G(A0WW 5G
ML'-N>FX':<-E&:"K\A\AG\IOY@0D$>D)/R?#[=>K3XXI^A><2ZN-Y/2VY<27
MB%[^B(0UAWW(\,#H?0PP\&=I))V6_E".5 8]J1G;2#V-<D=M\5$9IYYH"0S0
MRR1%AR.ABM_;;'W^_P O7[Y[>_$;:XT;O&_K&QQFD>NE+]L3AO8W5;[QBH7K
M!O2'VC;'1F?CY-27-VB#P-_PG(7]C3BEZHJ)?ZNG<#Z<UH1[;.S#Z/O]+NF$
M/1"GIZB?*<US):DNBR4$"O34\@TA!6U#,!3B0L-!*MJ ?M%CF]?49GF597U<
MAEJ*J=Y9&/I,=D7N1!9$ V"J ,4^7PA 91Q&8 [\EOV ?OQ74B0:'BN%8Z2M
M[V/>,0JQ@?3LZKJ0^*D'_(Y8JGEEIXDGEX4J3)4(8NI(-(8;GLU@\K'OMAA'
M6,:IT J:<#XQ %XJVT_&@6#%>8;SK]XVPH#2H'Y&10WJO@ * !L!L,9@@:F<
MGFEF7UWM;VXHY98)HYXC9XVU#]X/>&%P1XXZ#)T9.2I5]&33R156EJ^=/]):
MLM\9'67^,1XVN(XF 54L4%C?^@LXIFIZMI;'A51UJW8)K6DC/<6L)%]+K6Y8
MR_-6HAP9%:6FN2NG\I#<W(4&P>,FYTW#*3M<;83.<M?_ -2J'NE5XS^THQ^%
M,N_^\I_^8,)744FR55.3W<5+_5?'/<>]24<%#$8H 0I=Y&+'4Q9SO<^ LJCL
M4 8K/]*F3NGF7VF9_P".$70B)Z"*OU##\A\&@H9\QJ!3P6U6+,S>:B#FS?<
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M+\;F-3Y'1SS_ "E0B,=\C]6,?K$$^ .,B@,]?&3NE*IF<][FZ1^TN2_Z/O\
M2FUJ$]NJH^K3&?OQT=_U8G^VJ+>KB''2"#_0*Q!\9%6017[2LLJE?U9 +?2/
M?[U>.'GL_P#OJM^OI/[\'%8/C >]!]E\0/<:#S7EXC_#W[X]?OY<^J$#T&*^
MSF/L.,UCUT@D[89 ?T7ZI^\>]S]6"?>]R7IY2]!.D-149E!+-E6;4B9?6O
MTU+IG$T%6D9MQ4C>XGC!#M&UTN4 (AD94=!J215D1AR9'4,K>U2#OWXSSHK5
MYCFO26:.++9?PS0Y;29?63YC4TK974T0;74R014TD=2 Y5XT+V8II:P8XEZ*
MY@*O,)G;+,X2JJ>D&FGK9IHZ?7F]%E]/3YR3Y-,HKZ62DFO&(R5CGO#4JV$Z
M-9A3P9I121Y7G,];3-'3](JZ:H3,:35D$64FFBC6%W:%JB)GNTYAX,\CM U0
M QBZ#9M#04F7F:@K(Z::ND=WJ.#)7-F>5PTADJI9LNK$XV53QO#13BF,PHI!
MY.]+*@OT7Z/OD]5GE74O3U+YA+E_DM7K-16>3TN70TLR5%1)$DGQD\6NP)$H
M"R2=?8=*H:"?HGTE3-G$.7?@>L>>9FX8C>*(R4SJ_P#6"I2'A#<L]E -[8BK
M*/.B*3.(Q%42R 1UL&F)V;S4AE)&E8PHL#N"UNW&39+E]!,(Z>],)+>45+NS
MOPXKL3<GF-]"H!=B+8:VIM))6YTEO.(OL3SWMSWY_ ]T?HK'G>5S9H*_-*:I
MR>CFG2EI:J1:&MCBO,\572 A'+;CC#KA>J0R[8:Y?4W(L"3X7_A@6L+<K"WJ
MMM]F(<T.32>5^1BOAF@J,NKJ75PY)LOS")J>H$,MB(YEU*\;.&2ZV<:22,HZ
M4Y'DL=3!2Y?F(CKH*;C2S34,U1!44U5Y3$84:GDI]*#J?&<6\BI/S71B'IY3
M^1O!/!6/4NE6/*EFIXV#5&?C.8W"I3"-7B4+#=(=!<&01A3P\=,ND66YI/12
MA9!/%%4&=UT<:K:HJ&F1Y888X:&G:-;([P1HU0Y:65-5ACA15L,>N,Q\12T=
MSJ>*Y(5@0!?4 &*D;C%)T5S_ #(0199E==54ZQA8I5B84QT^>W&;3#?7JU=;
MSKKSQ[F'1'+4R4YCF>7\;,9JFHADI\TH1JR]J.:2 QQPU"M9G*\0S@==2@0Z
M1=HT2%%CB18HT&E$C4(BCN55  '@!CIWF,V=9I%D.54[U9HFO4FGBXLKU;"P
MBUJ"5CIU-FNP7BL;^;BEDS/C/00)-+5,IIHJ>,7>)H6+2"-%VUJ$?4?7<XZ,
M9!5]..D]%D-/4P4%;FO%2.:H20TXGIJ9Y2LB)9UXO!(Y'0W8>6,@]RSW3NBT
MWX,K,MI\XR>1CP*K+*Z.9J*0[_D*C@5'DTGRE$9$3G4-BV.C'N?\2+\*=)2]
M'2AFX&7'XNJJ2AL6F^5!#J%@/RDG,:5W;-:VCI8_)\OBBIX$ZJ)$H11[%'/Q
M.YQ75DTE[.UB>5]OX8:61#S/UXR',T>RDV8<QC,LLH\Y@M)I2H ^)J5 UH>P
M/_61GM4[CFMCBNR^JRZ8P5491M]#<XY5].-^3+]HY, ?A(0&4MYH8$^J^^))
MUX8=&!5N1!O[/^^$FW5QU7 !##QWL>\'M&(<SB=E5T,6HE=>H%=0^T#Q[#AN
M&X,9*.'4@H2#J4\]NZV&R7+V4J(F3YZR$D>J]Q[",3Y!&@UQSOI'G*RB_L86
M'UC%92&E9>MJ1[Z3:QVY@_Q[?Q72B>R4E./EN\S#PC72G[3W]8QT;@"43S_*
MJ9F-_P"SB^+0?6';]+W^E7_H?74?=%CH[_JN+_:3_P#]6Q54XJ1"K>;'413G
MQX)UJ/UPOL][I$G!S=Y+6XB02CQ(&D_:F+Z@&')@&'M&*P;1MZU_>, D$$<Q
MA'#B_;VCN."<01<632386+$]MAW>.&H3(I:G#L1S5B-_4;+OW#MPU!6*H8TT
MMCMYMS]0WQ+E]9%'Q7A.CMTD,0/$+<C_ #?&50SGB$1-PVMI8]4$BX-M5K[=
MVV)Z=FI9E8:KQM<+S &]P2+=6U_&V*BF6-.(C,5! 8-:XOR-P!M?:UL$^]]V
M#OZL>YEF-?6>YUT5GKZSR^KJ,H(\IVU<..6:GIX78>=)3PQ)$[GKLR];?F3:
M^HV \Z^UO7?%;FD-(D92&HKFEE6,1T0B=HPW.68RRQ)'"@W=M1;L5&.)*VFA
M@DJY9XTIX8VEED:_41!=B5%WO\T*2>P';%-FE)5TL57!(PAF3B()HI:>;2>1
M:GF1)D)&X5HPQ%C;?&7W=#)^:?3H;L?Q'JY'QVQ[OM;FU+TJK*"3-ZR7)ILM
MH<RI<KX[BDI6:$QLIIU(C9^-$\BLX9NO>XQ4,50$'K:K^-UZP(]N*23C4M/(
M3=G@A9]PQUM&K&Y &YO?D.?P95B>*5)]/ :*19]?F\$H1+J^;HU7\,54U#//
M6B@8FEBK*F*EXA'$:F25A!(1\^, WQ3RUEUCC=M/*Q&I5'K/(#%74N[! Y*J
MO/OOV^WL'=[<0T\U0;1CULVRXFI)Z<:G *^DAN!Z\""*J3A3#Z+C9TWWTGQ&
MUN7;AT1*R15&E%*B,=R #2/8,>YUTVR.>CI.B\U2*/.*%#%'#4E8XZ]79ID:
MCEOH>2TEG@?3-J!*AP??I**DH5T4E/%3JS%GX: -(S&[/*_GR,Q))9V)..B_
M1OR',LXSBI2T]17UD5 IYQ4K3LSS#N:<G2I_JUO\O'X%GR?I?D?3#(E1*FCS
M*.:NI]-XVXBO"]4J; ZED(J4%B0>*O6OC(.G>69O035-8/P=-2+_ "E'.J&1
MM);^22<Y"UC:%@)!<><#?&==,:O-*F62/5% 6(B2^ZQC9+_.(W;QP];-(>LQ
M)/M-SX>/VXRGH/TASF+RC@IEU,?,GS'7 9?&& (9G4>D51>XG%7[E.>JA:&O
MRVI;T 9XC["Z$8J<NS7H]7"+,*6:DDOMK'Q<J]C12K>.53WHQ[C8XHLT8@;]
MV)XH<XI'I)[;B\4GRH9?DR*>Z^S+\I;CU3P24TTM/*NF2%VC<>*FWU'F#VCX
M5/,L>I7!*/;E\DCML>?CB&2*2011E_2!;8&WR0.8-L3@1?5MM>S'M]8Y^.(^
M0*OI=-U8$=G:/7VC$-?4"8<5N+$1N @4CLN+=OKQ/F,J]2>(+&7N)4NPTWZH
M87N#WG[,9C,99@+@QH.II^=S)\?X?BNE!M5TO^[O;_F[_NQD?^JJ+_9?;K:_
MO]*XSY/23=D<SH?^*FWVQXZ-?ZK3_;5%O^8??Z6P;TE2/GP-_P!:?W\4,G%I
M(6[5'#/K3;[K8J%U1-WKUA[.?V>\K%#<?]\*X8:A[1W>O$$316D9MW4]2W8X
MV+'[; 8H)(HU=)CP[L'5R.J=K%21R[Q?;$Y70I4@CF&!V(.)' A!)"A1S.P&
M(I4C0NY &VY^RW[K8DJNHW+25-O&XL, B%9&:!*C2NH(_(Z0;^!V)Y@[B^/P
MJ-.GR*DT\(Q>:>1:_P!VWKWP),JJR1-$U Y86>/K1JBKZ-K7<\^KSL;XGRNH
M1>+%IJ(=.O7$;Z4)ZNM>>HBQL+]O=B.&66>*F1?CIIHJ>-6ZOQLTBQHIORZ[
M 'NQ[GN19ET$RO\ !8SJIS")CQFHZF*%J"CJY+&<Y>I4SQ*S;,&E*2$<7AAB
M<50FFD>9V,C2=9R2+D^ Y>H"UN[!ZJ,QZB(K,[MU555%V9BU@ H%R2=AOA<\
MRG@RU'EJK%#'%,\CPU*?%3RB"&6(- &GCDE81H\ D4LR[]88;.,L2-YI*K0L
M<_DTH>"J$T<_",_#DIC!Y2AX(,UWB"\,%]6D7Q09G5QPH:25)*68+,C$++$R
MN 1)$?GC?;8]HQ[O^6YAY73](=,U135M+%05,JQDI234\C%1*ZBR)/&XX>JR
MZE9 >0Q0Y8U?4(\I$-!3$/55,AT1 7#<'6>4D@%E/(7Q0SBJIDJ5#+'/=XE?
M3J6&^F('3L;HH8'<V._P<QH8\SR^MRZ62:&*NIIJ266G?ASI'.AC=HGL=+Z2
M;&QQE'N<=#,EIGIZ;)*>H,L7"FJ:^]952H>8XLGY('N@6*W9CI?[F-8F:9C5
MY,6R[HY090N96:9I$GJ8F/E.7(%;R@.R#B*\FJ)8R$N>R1M3,W>=O5V8I0%I
MX0OH#[=SB< PR \M#?=BC N,9=EE3G^<QY=E:B>L9U22*^DQ!0"\\E__ $Z)
MUVD%]MK:K#%%[C_0VG>.HK*>LS*M!CDDEJ*V=(34)8ZXH8#%H0.+QKJ-E N<
M?]OJ^#3P>1Y%$K[253-5,.Y7 6*_Z"AOTL.UOMQ[G'1B"&E3I/F4:RSS:OP3
M!*NI((E)1JXHVQED8,M/?\F@,@ZS*16Y]%&Q#/<WYDXH\VCJ#;%?04.;4<E%
M7TZ55+,-T<=9#V2POYT,R<TD0@WYW%QC.<LGZ-YS497*QD1"):68[<>DEWAD
M^E;J2#D)$8<L93*\\D<4:EWD8(B#FS-L /\ 'VXSGW/L^S.O%33PTL*20QB9
MIZE$/%2ZGJJ&9NH$W Q7^YEFF7Y969C+7T4AHZ=ZEJ>$3L62/K2 2,B ,J7;
MS2#:U_A D&X-B.1&Q&!5S@W9^)V6DZPQ%-";,7X)^6NY!^CSO?N[,0ST\G60
M_K;'!$-2&"N'ML=)O8XK84@9%OUF6Y^;W?7@BWXGI7">'25('F/)"Q[N( R?
M:A'K(QT8J!+EYAOUJ:5TM\R0\1#^TR_H^_G=/Y3EE4@%W1.,GTH3K^T CVXZ
M,&^5)X3S_P#7?]_OYY2^5Y;4(HN\8XT?THNM;VKJ7VXR>;>6 ]HXB>L;-]EC
M[TJ<-V7N.WJ[/>#%>6(GXL$4EN:V-N5U.G]U\(D+1:BW6*$D<0#K ^9I]6][
M8 TP*HZ_QC>;(T9 ('T21]F"-96TCI&(2+AUV(\]7#7N6VM8'D=^_4IGBZ[>
M;'\H</93^UO8XF:R)9M0UR$ECUP2U]/T/1/(X!DY@'PVYXK='E#Z+6VN!RUV
M&O[?M]Z"IGICJAD9-U8@'JL5Y:EY,,)GE4C))PJ9Y8Y#*LICLXD)NK CD4(%
MB.X7QT5SN#I%D&5YG#4Q5,LU)!Y9H*ZHJY(PM5%+&"6C82AB%-KJ59;@XZ1)
MFT^454.22<+,6,/"<2+$_#$J\=8I7&F*5HM0C=K:3\H8HLGZ5S9=GF7YE4,H
MS#C0T[YC6FO>&DDC(@2%J:31'*IVJGEC.O8I>Q!S.'-\RR*7+ERKR>9(LKTA
MJVDT334M;32SQ4ZHY5(4B@9HY9Y(6:ZIP@;D34682U.?5S99*R9U%2Y?Y%%F
M%+35D=/34\X-7),LK4Y::680F))]? 34Q:_"QE4-1299E]-5F$U-/1PQ5!@5
M8X%>-+,(U4*JH@%M@%ZMQMCIATDZ+T'1S-I<UK\MJZ6:BJ:?R):FFJ9*Z5XV
M6.ECAC=V=S)IZVFT5M;%=.*K-*W-W@H4TT],[)3PTE/U(RK.!&)=_C63;K&U
MK<L0Q+!#%"GFQ1I&OJ10H^[X<\,=3!-32B\51#)!(.])D,;>VS&WCC.,N7+<
MQS++>(DSY=6ST;21D,I,3=4W[RA74.:M=3N#BGKI*=>'I#H";7-F%^8![N[N
MQ49A),AC5!&K;,;W8CN'=?MQE=//5U<%)31M-//*D4,2 EG=C8*+?:3L!N=L
M9?[B&815T>9U'2QZ"K67CALHI76>G?L6.IEF )7S"=&AA>ZD&V(U*1QH7:1D
M1$:1[:Y&50ID?39=<A&MK #4386^#& 9$!Y%U!]1(QG\NE^&-E4!5'8 %  ]
M0&)&O?QV^O#PSY5T?HH5,4CT&54B2Z@P5^%3)JX>BVGK7W.UM[7.,X@K#(&&
MVJQ-KZ1J[K^O&1L*?3Y0Q7M8Z2= U!-;^BNH@:N7U'%%F#SU IC$B@"MZP8D
M_P DJ. OAUQUCW'8;8]UN'359!.%W>GK(C)W\.6-PA^CQ"1]+'1^<P5=)/<_
M$SPR'Z*N"W[-\9ETRZ/96L<E35N1-J,2PT\LI;3;4-@%6VH><1C-_=/R:HHJ
MVCI:"NG-32STP:;@P1?'1M'J-GE<J-5[:03RV_%*[(;HQ4]X-L$EC=B23VDW
M..:^(^[\3F-&*ZCGICL76\;>C*O6C;]8"_A?&4U[Y57_ !X*QL33U:'FEFMK
MMWQ/>_>A;PPI# ,I#*P!4C<$'<$'M!'+WN>QQDL!HSF-%O:&M,D7C!41H\=O
M59E/BI^!7P-E6:/I'4#\:+YT,A/5]G63V85E=5==U<!E/@<54>I=8YKS^C_A
M]WOQU$T-Q'(5!YCF/78[7Q'F,(4&5'X@YZ0"K'O&^U^["9A')?BJ=S== W ]
M$@G?UX.81CE$QMLI)7[=KC[<+6P$J2CZB0-.VG?;SN[V86"-V!(Y=E]C^_&?
M:T:F=&90T;QD*2H.@@CD0.1^ 6[L05-32N):6IJ*:0,KAZ>:2%M:&ZM>-EW4
M\KWP/=PZ4?@P4GD>6^7B'@_A<B4RWMIX_DM_)S46WU7X>OK<+LQD?NT=*<KI
MGI\P2GS\W9H:JO>2*JBU;Z'DIP!/$#NJLJLOFB2U@']VCIRPD"U&61ZY-::<
MLA)A6_Y)"Y;4O9>36_SK[XJ?=GZ35F6^314>7Y?6N@23,J?BF0=[P4\I:*&5
MO2O($OU5&ULQ]T7I;495-0UF=3/2&(I,1'#'4U"G;A2U,:+,ZOR87&H;';%3
M)YS'SY"=^Z_,C[L=$:'RG,#5L/BJ);CN,\@*H/6JZG\#;\17RU4-!6S4,'E-
M;%25#T=/J5./5+$Q@CU.0HU2:?.('9<8Z/>XYTGK9):[I%F--E?ECR5$],O_
M )A6R3S%G+R%&2"(\1KM:65K;=V,RR.DR^NK:"?-814T51-32 P%07B8K?S[
M@-SY=N,D]SKI'GL4-51PP)E\]^'7S3HD#HKE&=%75,X!!Y1B]K;8]SKHIFW1
MKI;F]+F^4(\29<LF5YY$#-2D\<+(L4S6X4T\36:$J)4T$>:;GX0-B#W$'ZL9
M^W$X-0-TFABD!\'0'[\$:L9!FL'2KHY!(6M**=<NS)$(XD-3%&J,PO>RSH%F
MB:Q!#$<U.*K)Z6J'64AM"H'!.H:;:3Z-]O1PF1TZLCF25G6X+$0MK4N'TV:(
MJ@!%@8@C6)%]\4^70T\_&C:0O_*;!BI'\JFXS[!0=FV3?9>=^>/=3S.*IS:@
MRJ%P_P""H9&JM.X2LJV1FAOZ<4,<>L?)9B#N",96-UVQTO912Y:A\\O.X^AI
M0?\ 5^-7M]1_%=)<G,@;,:9;R(O\JC7\XBC\JH'-T&SCY2;\UWZ,YQI9<MJ&
MNC?Z&Y[#SX!/<=S%W&Z>C[^A0YDMUF4(3WA22M_5J:WK^!TBR[RRDX\:WGI;
MN+<WB_.)[+:U\01VXRFJN#3.=]VA]7-D_O#V^]/%PVV\T\O#P]\^\&;OOZ\<
M3>]N1!^K?$)N%/> ?K&,]3511R?U<R_4ZE3]MO>O[Y]^)-1N>0^TX7LQFM5K
M<4Z'J1F\A[Y/X(/MOW8D8RR ("UR$11S8DV  [V8XR/+AEF7Q0$#C-\;4'OF
M?F/4@L@^C?M_%>ZAD/!Z99K,J66N2FKUMVM+ $D]IEB)/B<=%: 97T:R++P-
M/DV5TBL/GO&)7]NIS?Q_$TI_"F5+2KUJNCU)P_E/3^=&ZCM"7*-;S0%.#25$
M+%9(R+>&.AW2,]&JZ262%JBAK(UAK84-I $;5'40@]4RQ$MU6MK0LFH&QQE^
M:Y9FT0FRRM@JE;\VKA*B,^C+3N1*C#MZMO1)&^&BD1=<B\-.UI"$4>MF( QT
MKZ?4&3TTU)DU5#79U(#&)8+34N7 [-,TH^+EJ5_,QH757Z\A&G2=3RRM)*S2
M22.TDDCDL\DCG4SNQW+,Q))/;C)XBQ7'2.N%9F++&;PTJ^31D<F*DF1Q]*0F
MW@!\'W(>B>49]49GF6;Q1UJ99P(H,NDOPGEJ>(?**A01Q(XU33'&3H:1B7!T
M@8Z:>Y-19MY/5=%X:+*:Q7T5=*6>&AGB/FS1 "3@S1F^I5&F0&]@PWZ4^Y5G
MO1?*SG#U-'F-'$T:UAI.,LE(92%1GCF1"T)D(3BKM<K< 'X7)?7^+Z09:V5U
M:55-=:>:3B1VY05"G7P_!21KC[AJ7Y.*2<55-3U Y30QR>K4H)'L.WP\]RUL
MNJA4P#33S/KC*_F9O.,?@#YR>%U[,4E4M5%JV$BV$B=Q](?-;[[CLQ(@86/(
MXDC,9L>78>_W^7J]^B;5! W?$G_2!BNBX]!4Q]O"+K]*/KC[O@^/O*NHX0<A
MRQ6U?DT>E#\<XLOS%/RS_=\=\3R6N@\YO./@?WGMQT3R<RR#-*A/BHB12*?S
MD@V,WT8^2=[W/R?Q'+?"UA>70(]O7UK=_=MVC[<:#:^UO6/\_7CI[D7E^:Y'
M,%!-1:AD[>50CK?]"5O9@1%0% TJ@""^PLHL ._8=F.$?^US]MK86J;CF"1
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M[PJ[QSH%X]*60H9H'8$QR*&-F'M!PE;)E*TU/G%1QQ-*T,&9K"4AT]40)F#
ME8JJ4DJ'4"&0J#<,V \C2178L59%6_8+BP'P+GO. 2#<&QN#<;&XY&_>.S'1
M[W3,_P F<)62'.*(((Q3U<EI(M/FM#4A6D! V(?B*1W<\=$NEU+TLHYZF"GD
MHYZ25(JBG=UDTZP6BDCD4+=&TL-U4AE(WV.,\Z/9=GU/-%51J)98G'&4:>-*
MD4JT8KFC FJJ6EG=*D4S2:>+&C6)7$5=G/0_,1"L1INC^6O1Q3TU-2*E/F-/
MY+''-7">2$R9AG&:5[:*:**I6HIF71)3/#=TRK,FS/+HZF6BKJ$RJT4^7YI
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M(?8X!]GP:;5^E6;PGM00G[I'7;YI<JVLN?5[$4W_ --F^3%BJ+Y?!K*,S?\
MN5LK7L ^Q9#!-[-V?'X(Z-7RF[D6E70>G8D<+(W]/LY^JFU7#H>5>/RC_I9V
M[4\I_7DS_=R'=LRUGTXGBFNK2R\Z%,OG-O\ F4.F,_I77PV_O/,^T^T]_P "
MR1L4D0AD=>!4CO&V39+;ARWR#TAW3(/5;O'HMP\-C:K*%OQK[A:0?FV_E /H
MW_</#+(@@@@D$'@01P(([B#S_)K(A(92#F.!X'/@>XCF#W'+:*9VSMU\H+8[
MRX'8FR\)EXGZX<;6\.DR!F3.!_T5E.U!(/<_!OJLPVDK3 HZNT,J'T)HV*D?
MT@1M-@,TF5/I!#E$I/97$JBM)"1]::#?1?6(CS\T?#)B7?C>)8GB_OAM6Y%H
MG_\ 3H:G]W#X>+ 9^.W6K\PA@U*FKB>TYTJ,ES)X^ ]NRR1D,C@,I'>#Q&U*
MG72'$Y&@F:_AZONYJ^K0:DK6,G6+7V_(E&=D[>0!4F[=MX5#9HW37TT8[DBM
M26!2AZL[QLC-(#JDU1QAGR/#:"A@^&R+7$3S8A8N2!9:RJGFB&+6,S*5169\
MGSS RY6JMJTBVK<92"LIU3R^.E!QR\6.2CQVDEP=(:ZR\'2?7+K SR+*"JZA
M[.6QJ6HX8MYD&M4M4<P7OR5V8<?%6!\-J$U:ZMQD@CCG?5G()E4:UE![2OGS
M##V[&2[<@@4>O(H)]PYG[!LE#HYA%O'<1FD$4"+G#"[DY<\FD(]H0#+B3EM6
MFMP]6LRPQO-7U:]S*R O%KX!]#9KJ'G99_(^,\7J])Z:T^C(DZ XMT-PMY[<
M_3 S2ZZ^)VZE::9I!IJ"K6N-'2-=IBSC-L\#;'*\-7&Y<,I2XQ#!&D2+B<E>
M,W.S& NK>ZM>7I9]W\(ZOB5?4R9FO:B.[MU6/I03#B,_2C;5%)^<1MFDH*,;
MICBK5],5]5_E:C,$E(]:LYU<]ROF[$3QS4K*\]]'-3G4^W6(I-M/QGB$D?J_
M&5QX_P"CORGX;,(*DUMP>UN*LMMP?;HCE;/\=AKCEHS+Q&I):4J^T9B%P=@D
M/2#%U0<AUQY?ZTPE;^MMY?'\8(]N)68A]T<D8_#;57Z1XHF7CB<TR_:EB2:(
M_:IVC@Z2*EZDQ"G$:\8CMUP>&]FAC\E:B7FYB6.8#-P)?-VQ2*%DL08AA-DU
MY$(9)-Y6:2O(A'!AJT,-I[7I)#V/;*_93^LV>T^)S#4F&QYH3WW+.:J?>D>\
M?WD?!<G1M5*D3A] >CN8&(DE'[>;7)GWC1X#Y$=J Y/&>7<Z^E&WU6' _?W;
M16H3V)!R[T<<'C;VH>'W'OV^-ZR\&(6\B]S'@EG][S9?;DW>?RD4$KY5;^56
M7/D&=O(R?N2Y?NNWP"]$-,6*1[_AR%J'))_M;R<G[QVPW%ZS:9Z-JM=C(]>O
M*LA'VZ2I'>#EM3OP'.&[5@M1=_8GB65?P;CMC%I"1*E"=(-/G=9G7<5M/MW\
MD>0[]J-!<M-.G6JC+EY"%(\_MTY_#2P[#IY3BU6866W#E4KKD0IG93S/-(^9
M'$Y#94Q#$W,2$%88E2*,$< 3P+$^TG9$%M<1JQJ%%>X@)55X#1+'H<9#N;,'
MOVO8S)-)>Q+$+3R/+,YU)8E?7)Y)2-"PIV%4Z@$T@'+9#)*65G 96\W)CE^Z
M!X[7,;CDKRP3898KRUHW<B;5I>O)KTZ#NI5&1\&8=^TV)XG,UBW98LS,<Q&I
M/"*,>A&G)5&V3MFWJIQV)C.?B#P9?LV=L.MR5H[>45E4\UO5?(\ XY!^?=M'
M'$T]ZQ/QU.SOISYL['/0H[S]@V%J9$L8HZ^4G(^C^I%GYJ^)YMW^'\0:+$$,
MZ>K-&DJ_<X(VQ]8HHX$3%KD:Q0QK%&JP-N$TQH JYI$IX#B23S.V!B+2=]4%
MJ1U].:T[3RL?;K<C[,MMW:KP68_4L11S)_1D5AMK?H[A98^%94_!-(V\CT?P
ME?\ L,#?[Z-MH^+,/T<M'4JVG^CN\MK.(8%5BP_%JT;V-S67=U<06-2SP20+
ME''.ZCR$\:J1)DLFI#V;%.8EH\.O2UZY;NK3Q1V%AX_HGDD 'HJ53@%V&'KP
M^?6]0^I4E>)?ZW]FU:0C*7$))+K^.ECNX!_LT!'ZVV+7D;3/U?JM7QZS;.XC
M(]J:V?\ =^4,:GQ0P#$XEM5J,<2,D47'=SR2.P.\D3BR)DH73F=6URA-)!:A
M5I*TDD;:H9EXJQ0^W\#R/?M9JU(A)%"WD[$CK'')$W:CR9N;:3DX'(@Y[=2>
MG*+ /F@9H1ZXE'DRGUM66S;^2O4 Y%V,I8^Z+/A[2=DR^,6OC.&U?:QH:.WI
M!U05ESAZOQ!C5]3LGGL&Y7*+L':G:GJLZ\G,$C1ZA^MEG[.7RU*G)@P(/@1Q
M!VP^_P"E/63>^R:/R<P_VBD_;MUD#RF&V8IP>_=2^0F^SM(WV;,GJM^#;8$6
M.J2BL^&2<<S\SF=(L_\ LYAVZ/X6./QAC])YE\:N$B7&)LQWH9*->%_9/ER^
M'4:5F<212MOXU\C#H'YU_1)]$9<=K%^RQ:>[/+9D9CF?*,6 ]RKDH'<!EL5B
M;=HI(X99MEWY[/'+Q=1J#<LQ[=E#<8V.4@[LB,O_ "=IGK0B>*2!Z[B;MQ'4
M5;@,N.DCQ^W;JB.35LD^3;-MTV>OR1.94-ED5Y9>W9V7F(V(]^6Q)XD\]D Y
M/FK>[+G]FQ#=XVK'"W6:P8DZW)(<[.^TYL),^*@'S5&2Y<1_$4F**A^+\:82
MK*/-BQ!4"V*[GDK3!!9BS\_.8#,H=AA>)027,(#,U=H-/6\/UL6=$1RJSUBQ
M+K'K22(LVC6F2*#\>5ZY/YNXDU20>\3QI^!(]NW_ .(L)_\ C(O^>V5?',)D
M8\E%^MJ/N!D!/V;!E((/$$',$>(/?MD>_9Z&&(ZPR6K%R1I7WDLD]A]3%GR'
M!1IBC4 !(T1?$G%:HYP7[M=1]>7$+)_XUVJ55X+6K00C^;B5?[1M@N&@_P"=
M6Y[D@\4JQ[N//^<F8^]?DQX7A^[5V1I9IYB1!6KIEKFER!8CB%5%&IV(4>.R
M=%KN+FS86E;HKB B:".-+ E$01&8OIKB0*"3F57EM\\KG<J^[2W7(GK2^JRR
M1YY!AQ&L*>X\=NLZ6$+2]7WK#*,39*VX9SP2;2ZL(FRD*LK!2&!V2:."237Q
MZO$R2VU7AY1J*,UN.)LQHE> 1MF-+',;1XH*1L5I)'BRK306)XGC.3K8KQ2,
M\+ \&1\I$_.(FTD8*)>GM;]:K, T2(H1 Y\W>.<R5SX#('CM9LP8;;3"<1"W
M$ETM/##;D77>@WJZBB)+JD3>Y=A^!(7Y?NVM52>-.\2O[.R@D^[6K_?MB=0\
M=_1LH/UMTS+_ %@-B/63\5/_ /NV-T<_\SQD2@>'7*L1_$P[5EYI@N!3V#]2
MSC-M:\/WU\-M??P[_AQ&EI!:Q4GB7/N+QLH/V':6E.ACFK.T$BL,B&C)0C\-
MG,:;R,L2I!&>1\1[-I))>R672J]_M)V.-O-A2X54[%R6?%*$;0RV4F%:O-7>
M83QS6-S*T"&/4^[)7NV^93F:N^J3M(PW9)SR#D+O%/=PS'?MNFMPT*]35.SR
MR(N\T'2JC7EJU-EK]1..W!E?B1FA#*2.!R(YC8M&V[S.9&6:^W+8D9LY&6H^
M'@!M%AU9"RC.69^.[C1.6\/<&;)<N9[MH;S8H$1?I:\*MIF7U'S.60[N'#NV
MZS >TDD>>?$%<^T/MY;-;U!#$F<R$\4(''[/#QVOZV\DN1@7U4XC\<LSMU=9
MHVFRU;L,"VGEGESR]OPQQS6((I)2%BCDEC1Y&/)8U9@7)[@H)_A<U#$:\=JI
M873)%(.'B&4^<CH>TDB$.C ,I!VNX1%Y26OBLV&PZV"ZSUO<0:Y&X#@T>IS[
M6V*OT?OOEZ5<U[*'W&&9C]ZCW;/:O8)B=2M'EO;$U.58H\SEG(^1"+GPU-DH
M[SLN:@EF"KV-1+'D%R!.9[MEDPZVSU@WSC#+#O)2F'>IC))K2^$T.AU](.O9
MVBQ.@2N9W=JJY&^IV5RWD$N7/+,,CCLRQE77GD-L;J'CGTO9/L-M9,ON;8^\
M[84GYN'"^'LDEL.Y^]5'W?)IH3&(,55L,G,ATZ=[VX&5NYM^B+ER;5EL86X-
MX$Y;5(;N"7X*'6\9%FJV"&O3RI2,,*J)C<PD@W>(0#?MB$GD5;*(,I;;I0H@
MOQ=>_P )_1W%/B):%2U'/5BAP&.S?%U8#9:&MN)4DDK2"KE V8\_;'\1Z*X9
MBF*0SRXY<>"WT=G%W"<2>K!'%8P+'(8RE_"L5FZNB4XI9)8HTD9XHE@;1B71
MJYA%BE!>P_"L8WS31W(VQO<=4QV5[$'DXYL1F2*\T3>59S(YX;=<O78<.B>0
M1+/8?=AI&XA$[V;+CD <AQ;(<=M,6)U,7M66BBCJ13)8#U2Z]:-@IJ$4;U]<
M2ZNV6D[*G3M-TEZ+1"!H!O,7P)-(3"H(XR!(CG3O&DT&0JO!@<U (X_*QBOG
MYU:M-E[4E9,_N?;(\F[)^WAM-%ZEBU%_1D<?W;=*ZW=_DN?+V_.H_P"[;I1B
M?Z;&!AL7[#!:L50@>*]>:^X_:'X;4X1I#%#(X11FS:5)R [R=I\7K4'CFD9Y
M7ZQY!9P264+J[6M?-!*Z2,N.UBI?@ZC8KPB7=6LE$PU:<DE#%/<>1SV;K<4B
MQ;E] CR+[YN"LV3#()YW,Y\MND&$VHYGOW\8P&]2"0ZHI(<+Z[O-3@G=RMUA
M B$$MF<N6U[$42] ;MNU:B2;"Q7EJR6NB_Q15B7.1B[IB($C,%1%C\KD2&V1
M\1I6L7@@M]%+-.&2G$_5YL/PFQ4Q>\JRG2TZWYENJDG"^\2ZVX+EBF']=N-C
M)P2A1^/>K-#<Q:PN+3VW!#OUA%K4I!2$TK;V=&:-LH$CV*2HT;*._D?#(CF?
M8-I4KV8%:*-I"A#ZV"@DZ,P Q&0U>&>>U[*98.HU5>Q431JMRV3HCG=LM[)%
M$%?+CI20J,N.9D:B5%A1J34,PV7H_;X[38?<@16S 8]I2"K<>SQ_MV4P[S=6
MI>K>3)R:7AE&^7CF",^?'V[2PUGEKYL]>25,P)'C.3I&^7:T=Y7O.QOV6WEV
M[D[,[:G6/T4S/'ZS>T_!+&KF-GC=%D7SD9E(#CVJ3F/=M(;$LTEVG:8&29W>
M7?UY?.U.2P)9,]J-]""MNK#/PY9R("P_=;,?9^29V.2J"S'P &9/W;;TT)EH
M&31UG6"X'=*T('F=Y <N!QR[M@1R/$?E[75^T+?2X"++CJ"XG&O#_9M\#QR(
MLD<BE'1U#(Z,,F5E.896' @C(C@=@,/+PT;J_&&%E6.JG)'+Y2NC\QU6;1)7
MYD1.B\=!VPW%;=6*GBUFGVL2IQI%9BNQ%H9]X%"K8A:>-F,$VH:&R5D;M ]'
M,3[,6)E:,NG/J]AF#/A>(09^C(P:#CVDWKPOVH_@Q;5_^<IOPEX?V#X'C](8
M=3:+]<;TC[^1]^V1X$<#[_D C,$',$<"".1![B.[:K:GO6,6I1+NI:%J7SXN
MXQSZ3(DT?-'8L#YK@@[58^CT$^#[F:.>>Q/)%--,(SGU544&-8).4K'MLO97
M1Q.T6(5:BQV[$4<FLR:H 7 +%4 #GCGV2W#V[4FW5*QATD+;ROE+'))(K9-E
M8U-H(!4@:"./':'$J3QX2D X54"6UL?]<WT>F9>X1A55>?G<=H9\:M+-U=2M
M:O!#'6JP:\M;1P1#3KDR&N1M3G(#5EP^"*]4TOI/E:LVHU;2Y$:+$0($BC/-
M<\]+<1M#TEP"537Q&QN;=*7**6/%'SDG6K7"C35C7GW#@5S#;!)@(HAQ>3/^
MJH[R?N&V%S85)AX;&IK=7"Z]O$HH+>(6*0U6(JT,@.<BCS=;1AR0%.V%C$*V
MA\0PN#%8-R=[+U29Y8UDE$>;1-KAD#H_%<AGSVJ04O*R6[,5. .Q6%K,S!(T
M:5O)*2QXYGASVGKK&T=FK)-#/'$#(K&NYCET,H(94<$;Q>'MVBMU]['I<+KT
MON95;G$[>8ZN >SGW9CEM!AMVK%$]L,U.>N7T.T:[PQ2(^9!**S*P.79R([]
MKRD%3\8W.!&1R,TF7 ]Q[MNF-B4Z8:^%49Y6/)4ADN.Q/N4';"C+]/;K_&5C
M/SA/BDCXC,K>)C>R8_W?#X<CQVEGE9(TBC9SGD."C,[6<6E73$6:*I'ZM:-B
M(RWB[^>?#/(<MM#$EN\(-67OV6M0>)?)S6)K$S&**G6JQF:Q9G8 NJ0QKJ["
ML['2J L1M3J8?8_QC=%DMZ<'IWYK 4-N?GU:2O%-7>'SD<JR3+,A5M?#8=(8
M9J4E9L.GQ 5?+B]\WQ3XHDJ[G<Y=8ZUR&H+EV21)V=JBW*%ZG?DUO/'=K2U_
M(,Q57B$JKK$14JQ0<6U+S&TR4HK%BUJ"L!'EPU><IY*K+EQ9O':.M,@2=-#.
ML<@?2DBZB&9. [/G+L]BZ)12M8;/5E:(:MUY:"2*1TYLBE2"%S8:LP#EELDN
M%UC:KSQB2*ZH+5W1N]-/$Y<B"%R.8/$;--894DD8:W(TJOMR /+V G:-HV@F
MS/;F@AW22RIV=>D@=L<B^0S(SVBN,]UI=.XB2(0FE 0=1$I\^*20G7RS?[-E
M?#K$\%?,>5>4[K]U#JS^[98[]GK<_I2Z GV9#P\>>VJU8A@'\K(JD^X$YG[
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M:U2Z6V+^.X:R!Z5WL38E6F'G0REC&9Z\@RTLS%XF'>IX# .IWL*OSB5J'73
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M?2V(+<FO2L2]G3",O#CRYC;!DP2T$3%)K.^O0%6R2H(_FZ/QT2.\F;Y=K2A
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M2\:NK"2)GC=74A@R,1Q\?@*L RL,B#R(/,'9ZN-XIBL.)B1F@PM)8*M:W!S
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MG=I;&>I1MTKP.7$;&-8+T6Z36,)Z-XQ8+.UK#0"PB65O/C@R1H\N").$7)0
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M\(#>SB!0,$ G#N^?H?@PN*?G>'V& ).V?C%.(W#O47P'XP#\Q\!O^'.LM9X
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M$3 G4^,7 37%]C8,^AD]\K'MA<<96DSLHFC/2O"OL<X_%#5[6TH %F/?O%0
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M$B\ X <1CRK>#]HR;N^']Q_ASYP'Y][WS?5TRHA>1'55>%RXU?3[+1/Y/O\
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MK$8_<*84=HP3HRUZIF!2+)@-!R'#P"I>Q#FE0-UG+4=);UPN\HO@IC>DAU$
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MF7)-?>/4@=E$V^!_4T!6/[4!E:Q!Z:8&CP-'_ ,"$&DA 2"B^13#[_\ PJ$
MI& (ES_O@YP?[\7'E^?U/_ZM?_\ FPM_ 8 8('4J&SZNGY,JF/"IIQ*&15TF
M1?H+ .]9?Z83M$W0,SXD;'&*+3DW>\NAPCX%GA!R+JJ_G23MRX85MCT:'"LO
M@>F^6R%83 4[G1TP5$]H,S@FB[D)&SD7,(9VE9C/4#PQQ=B0P8RO"<BR+2=V
MR]>3=(M'L#T@D^"%OL3_ ((:YP($T+>(G7F,NSAVHV%[EPW4"!SASF_:\>5
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MGP74.XCAD%"X6V#NHV/%5_\ QX42Q@FS&[AW,QQ_JWPK7@?"YQ_P)'X8
M"!/^.__:  P# 0 "  ,    0      $P,*+"$;O8
M          3 B,UZ3UH9?  %A!M                      &F81GY&Q'K<
M] 4 "!0!                     "Q_XQO_ *LD !>3#-0):(*"(
M         *IV*=?#L$IH   *LCKD8971:8                )@@GZ:G@&R
M8   !-$L: *       !            %1]J  AKU^<0  2&;I)P"   !6
M;,          !TX(  *"!!3,!6(IG/)@&!RUC:SP@!"           '5=5$*
M[J -,(3+,^T>D\)Y;+_5G               ,(<=D@@ )/G5: VK/(0#Q[+3
MI                !O[64K@ &[OT9,M#<4  U1MC$ 3P*            !6
MZ@ 4  !>=YEP +.B0/JZIQC)-QV0   ![       $"H 6B!6P7HD1@2W' (Z
M>D3=:M[J"   /=.     !X HPE  PCR&QOY9E*P <*1+!S\=-4@   -H%@
M  &!C@W!#55=(1LNU(6 !STFGHH,O5F;P  CU80   !, X!#):I_@=L282MH
M  1>:GL (55<0V  /A3>    0 B!B3<#>+)_E[2EP  15^3P !%KH1B   !)
M4   !E@Z O\ 0T63JEL \&$ &0+?*  "QN@ZT     !     4  ![,4(=)@,
M>$MX " "8P   )#B'0 !G@ #    !V   G[B$(TCT3T   0A]S,@  ([3W0
M KXRM@    ,@  ;O"Q__ %2D#=@   #5QZP  T'IRI/IG!@     &P   2JM
MD#1PY>@    /=B+PX)MJ-Z AV/I@          !42HZ7UM+0    WJ<%$',;
MK0\   7ZP           ##'%3I(X          D2(Y<L:HH!.
M  $5+)*(            ZVE0%G!( 8               ! R
M  &P   /                  "$T*Q   ;@            =
M        ZCG&^"T            $(  'GP               !:^8 $R $
M         Q)!;B0                $(X    G            XIL
M            !KH   &             RJ:                   &J( %N
M                                     .,>
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M.T(@/U04@32(C@# P)G!.D^7\N<39Z_9]7'U[Z\QO[.+C[\G]9Q>G/G3Q\G
MY'4K;'@*NDX/C@A%HD:PNP83U.BS!C'VP]+/@C?DXQ$-PQ?7=TL!GMEJ(\$0
M]/-=_OO+CM^G^ </3$ME?<_;S@C4F^:WX+-;)O7KCY/\BT?,_47;YRH(T%GU
MA$=T/BZP[;O9O)_(Q=^+A)!;O8&J;07(/4K\N "#M8;#2A*;(;XM2A$LZ!+\
MH*S]\J4WN:MNWB;T9'PZYUQ.?EBB:=E-/&1XC?$<CX<CX?\ 7/I<U%$MFE1T
M#@X%THP1489K+FMF.8[*0"!(23)*@9T\E_(5B.NZQ>6V_$P5,*6:88]7F6L
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M!Z]_M7T#KSZ&<6O8_O[]_3@7Y_U_?OE)3Q.=>_RUOWPZ #L-]32]"\1'G-@
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M,,?5N3Y8N5!01 A1S&,/#IK;UJ=)I!FJ&N"J&@K@,8 %@(!I@,4"1=C:8"?
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MXJK5VED=,/ "LZ I RN2-!2GF&W:VACA _-@V54*2Y4F6<.]O<M$$2(-UX"
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M^?\ OC_UR\FA'CEN\T%\93;7;QL;U89SOK.(GCKG[]]9XOVT??WWFK7TBO\
MY?AZ9/05U\/OSWWC,T<UP \0I4($533LF.S0BB^<:$'_ .Q"$(:H&IG.5I(H
MV;BH 3SL20PBK, #8-6N0J%#5[1\ 6UK#D..?TW IL+I$819 Y+J_--Y0EMC
M.JVA44>%:69D*F(W#ZD=_9CA&Y!BH:)-"0I%!U^2YTSPM/\ '%@8@+LJ[AOF
M+ZST7W[R D(!NDFIP'PXP"V[#B)+*L82)'OC#<0A2;QQ6+P7"&3C90+H!=P
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MG7VYZP!X](W;UYV[S99N-@+0JNB4Q-)<P;K V8)0 /+VJOJJJZT55A Z _$
MX)[?A \ 1:<*:!,5OKBZO0#V#7/@=?3>.3P07% FB%3PSIK"F@^#7OSYWDF
M-H.O3>W@YODP]N8\)=0*Q!"F#!1A8-Q!ASE+M&5>1FGN@@2H"N@%!DO=&H''
MAA=$$TC=.I[14LB)T/Y4$1!$B)1/".DQ0ANM 5?A$UQ)E#KKU"DY(;)8$X+K
M*A45&U;0Z>O:<:JD@*DI?L_OQD2[ HW94NQ#6S>Y=3!$U\?3]$@X@.8'[08
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M:CR(A39SIN-#N94+Y @50AXS9R>5("5H9T"/ ]ODOC0A5< HUU7$>>=%5OA
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M( M-H2H<PI?? 0T!3X K],<VF2)0HQB:>$O^A%T12H5!KD:6JE,4+F/QIYE
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M4_\ CW7@";^M7#.8%9P.-Q8M& LNLD $ (4%0U1JJJJM7;_KO__$ "L1 0$
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M5+H8D'8TM+S*^% B+B#6%50' H#%<F%$AJU:9-[,,1&HJC,#0FD>KQQ(RMG
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MT?MHU8BD$15<\Q?Q5 FGWLAQ!13Y!D-8P(<F4#90,I3L2"K$0$C*U0[HH2Y
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MR-*!1%$R&NQ+\'X$9.#1_4"0@4*#2)$3I&\O"$%9 UM$?41SF\#BV3)+<0A
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MW>9](+C?UJ!5@*PK#>#?)QJ< MV6[HC@)03*+"^CB?;./:'E\641&:P0D!5
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MZ<IH\A .')/6+6  SB:@^3]&.?<?WWP$X0,AI!$[%ITG%#=,-A@DPX0B 98
MD1J NCN I%RP+!!)1$J0<F(8(TZ%3@N A=EB7(V]VM4 P*^C$"-E\$L!$_MS
M7-+!3:V[+A,B<3Y/+4LJDP;" KE1PL"!B&.L9VG:(O*6PS8H9QM)L!CG6_)[
M'P_F?VE<1Z\/Y_[R)AWW^9_.^6>U"Z0#6+ZCQ>=&M?;'G6^3P!I\J[*#D&NM
MP6^#E 9-@GWUP%%3T,?<_.\+S7B'CM_/.^:@S&SX!JUO =O+*)1$"]; ;P-S
MQ1",M6VR :IC&' 3J05Q@7"?B*8&<      ( & # & P?T@$!,(!$\(X>+#
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M10Q28-!$1W;SKYH^H&^N!#947K1*8'IQF1%/U&Q3FBDPM!>$])"KV@1!TV.
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M+<Q;81&YD :GD@5 0PR:CX)5#%5ZET!KX4'2">2#_.*%&_E4"KN7!I'H@31
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M7=6]KAM1T5?*_P"OXUZX>UXVZ[FG^\>M]_S:_P 81R*4I,-&J214QQ8A@K,
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MYH2)'2E"_ GF^ERTU_R?G.]^?? !KSG/H?GWY]'[</\ ;Q^3+H!OOR/7W_\
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MS(AU4FB>5B9"+DY:8P4,G>F;A@$0"MK;$8#%B:+ (5H<CH10T2X%4P\% 58
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M,'@W\4HRKHOILZ#BZWB4RK$NR46IL"'$QJHYBAXQ(U492SPL0Y(RO;,"4$@
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M(E2&GM#-,5\ P@$F0$A2A000*%@50FV T.,E14S ARZA*BXJ="9/D$B&/+;
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MJ ]5 5VN<8(@ZA!\CVX79CC$LX%U.N@L=6"8K/!ST^GM];\MXB_-Y++2$E-
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M]]F1;AF+_CG@RP<2?XH(%5_1J9.@T&WG#(60#$E$ %FCD<AYW#VDUTQ*-B^
MS:$5A10$%0E&6Y8'3JM&F\EGO8ARY/ QMRYL:M^$[ 80$H;5-+M6N!P4#*H,
M+I @ ;L[08$558B:VT>/LY+CG;K?(\N5\S6N<!;EX0^V6+21"\9FRMR$P@TD
M1&FXAFE R55@"JKRM\.><%0 M82OFX@\@^Y?YPS<PB4P6@NCL,;@)12&&][
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M&=KK6$(ZXNC_ 'FP<PBM,)I<>6F5EBASP JB C8MPE_M! ;I8^<E2=>&,E@
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MS9"RL;4\)<"H%0J\!95Z#;2&!A\-6=I2#8KCNN.&%QZ*W5P2AHPP 5 !56
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M",I#SX#%;:6-)VWFC6/W+AYW%CBP<"I:E HSLUC4 3D8Z",T"/+X5@*/#><
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$X[__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>businessfigure34a1a.jpg
<TEXT>
begin 644 businessfigure34a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M7CHX000.2^0L269XM<6)     *E'-@OJ59/8;>? L^5L(E-Y,$0P66+>%H
M   #%8MVO5?ZOF,T98*?Y=K.O,P#!]6W[>JDS2W.P       !JI"Q,YZ"%S:
MS*FG&2,H:B9(RQN9M0    !A2"B=31CUGJ/(9\T(VT_L\YCC13UD_@   %&_
M0$5<[A<GQ1H7C&EVI5-IQQ_>_H'OWF9V7G\+??S,WY]=L^,=. %<#PGB/6?<
M^Y9$                            KYTG3EBG;%/*/YXI="<(GB0Z)TNM
M?KVD/1Z3%4S%SA7YB[G/[F -9-2,D94Q)YR2@  5K*5D\%O#=
M 5 ,L6I                      !X2*S=2*"P@           ,.5H+7@
M          UG:R\^.C6..9'9ZJ\FJ6>U\8      B<KJ7A.2Y8(F0L&
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M7ZM>=OWJW2&"]#=0]?S>       ,3F^\MA^      *CF++E'.(DXDXL&
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M\9AL,CC,6]MFW "$C=343!FMDTF^@    %8;5*\:NU77#Y?OLUP#G]L872
M    %=24#>BAAYB>2P9SA]00EOO.=SF"+A_+\9]$T;3(LC3\;K:D58L,I;TC
M'Y6(W C(O.;0    #DYZ8A,!/K)>5++1C+QOJ+S"S[;*2O/3DMRZ"=2Y7I$)
M7HWKU6M9U'LT/U&B9_>D]NEYROU!YC=/LG?@  -/P0.TYIKZLNEZ<_[OO!$%
MI^>-4IZ7]^;2[?U+S)C-/#,(       (3(;*E]5T,]N8X%\K9>B\]L:C4N;5
M,K7;;-]-JNF4;A&VW/H&L:FC]:O3I7Z9U_4N>\K]V_*2#=^BY*8GIV-V   !
M2<@/6W][T(Z:I?[T2.D-=BHO:)?-FT1[9"4RIAC+_GYI<+7_  _?WNDA*?/8
MVLH?8M"  <\JWYBMQ,=JYSP?(>;%<V+ 2/YV&ZIW;D+;OO!8-[J[5=2P<1O2
M* 50(R,J:(>8D,\I:8DP  T@^I'6#[D]^PAH+&2N.ND;J3QL_FA[.WL'[^[J
M5U+&D-$J8\,3?/Y+&7-[_P!_81)S   !II%1-AAB/28"$2>R 27B'B5C/D%D
M]$+$J$.$R&Q@  I;"<'I%"<+M1*=7MM;O1=!^H4'9-78Z \XN^R:FR !^'Z?
MA^@'X?H  .=1)!MI6PO:<NCJ>4D) -T*O%]#GV7R*6DW&0*X'44   &#.8!T
M@*BFWF\D-EPCFP=%RFI+IG"M9;0K,7".?Q<<L"                "N)8H_
M3]/X-9/P])L!&!ZR+B?#.      &A$:$CF1/@:&;2:"2V?A$!^&@%S0
M            #G<5^,X>(D@CLU4W,_2:"EALIU-)N      (/*ZFF'Z1\2:>
M U@W@W<I^;4;B=3
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M,1MM,."JN&XS,O\ N')F*!';991""7_KMT:-(YRV5_\ 3B/Y/(*I?M9[C,?
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M,9*4YTYS:O'FL1D..[<<@!+G:F*)J8!&C8 >!WG%5>9.M:0J:BPM470L,HM
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ME?\ FO\ _\0 1Q$  @(! P(% 00%"04&!P   @,!! 4&$1('$P 4(2(Q%3)
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MJZKM.R<4KFGV^4(Z.!1ILRY7:=D 9<G/KEGZQ$J_5@[L5_NO3K2!:QO9*G&
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M:RG0]0LE@&IPQ(\U.2:W+F1F1/@R(,9D3B8]/%*E4QU2O0HUU5:=1((K5DC
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M$C\B1V_T[<6\K6JW*5!NI+;NL1'#"N]HX5W%[,W<=.NA!U;W)W;5;:VGW?\
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M&P'*\1D2QT!F\KTRO4CR>?BA>N&27T_[MP4>.;9H[16;-Y-NK,.    .P T
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M; 25%.L?4?4H\A"C:VO+F3O3X'#S+B,A*LF.J.))K&/61PT*$,5DMJX!_#O
M8KH6[\8OF3Q EYYN4+>(L'#(]G6IY6"**O456\G8ARC[(9YI&Z>\>9=)=\BH
MB=-=O,^-GYHPUK#V<7D*R6#$Z3PV<6S1302++$Y1KH61-ZC?&Q&Y=="K:,.3
M\'/RAB3C(,=D;C26)+=BQ+/BX@\TBHFD<*WF$<:I&B@;F9B"S-J=!S7S3S[1
MYGQ=/$X:9,?,*^E=JL5P9!VE(LI/=@::.F(TT TFA,0^/(60@"QD\A!!-/\
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M >+5*G>C$5VI6N1*ZR".U!'/&)%^5PDJLH9?HVFH[\       : #L ![ #Z
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M56]U_819M66 L&MC[P5$3T7(FPEB:^Z+=<7+Z,=7?6LAXK52U79*K%6TJ"*
M<E@R)=IFLX[6*8Q)@PNL_2(^LS/Y1'K1SZ>C5L7<@TKTJZF03*AV DT"V/YL
M$2Z=O7[@,)Z&)# :F)>5H4#8Y(V%0P1\B#E;0[6@MD2)1_G#'<,B8]0(2GT_
M1U;B*-*L,&^P\NT%C)BN)G\YGJ9@$1$3,D41'UGUD^[TZRHW;5>EDEU)@7;-
MH!;76HU"8QY@," V2"Y\B_O^\>H-):R:KNA;) 98N#^AP!S'</?$?=VS'=_'
MUC<9KYMG?W-6[11?IYDA[G/JW"A=4IB0+W=]TL%M7,[TS-2&V7V*JRK>YL<?
MYW2T^$.]XQ&9LZ]<F<5VZ_=/MK-'D5<2I))J8ACZNC[)M,^J6R4QW3=J(FO9
M_1OF7-^.5+JI58ZYX\A?I(56MAW=U(UW$,5"F2@QA1CUB!G^BAO\GG$-XU1Q
M\M6\.62!L%<BX+*$Z =\:!G C'MS[R$1Z#UB)]5LIG(*3-G.O\CNMRR9A:%R
M:G)]%.SK4VY-Q-@DQY%UIKV_;P]*(_$EPMGTO>XSL)S4(?:#9G$9E7*.G$7*
MVC;KWFV%78J/"W443WU65K0*)H$0E*F)OZ]'G-%%<J,93=BOJ<<\^?JV,5>)
M%U&YV2^E9?F5ND4!L HREY /A,E1QZ+/,E-L'O6N2TIL:>-5CD,Z?LB]F*%B
MN+N7&MG96K5BOWN]]0K=UEPRP6" \F_1][K(T\C1:''*EH:S*FCGSD]]NCVZ
M[6T]:XL&VH?:!DJ>KHV'S8IY=1_N%Y%:ME]TFLVQ-*LE0C8\?00?XX69AVA^
M_$]L#,?U$\CU^1:/$+'$[P:>/RC*K^[NYEZVIF1*O9S3O+NU-)-\Z-NH^L:6
M V#82_'Y!M\]CDVMRSD^Y7S,_?N:]9-,L;V*#NU^.4:M2AGYX5:3-2Q88^DM
MHW+%DW&\I@067;$272>V)GI$ET^D3/2>D3/YSTGI_*?7(-+E7&AW$7.:\+Y/
MR&K0TJNPCDU2EB[="[FY6?I(RUMS,>U<R#JY^C*^Q68';-MX^8N.YP<US<9N
M1P>EG[.?<XP')'-T:E%D6YC7G=H1(^+Q5(B*[A@JY/%K8;TCX<?[#<5_P2E_
M5X'=X[4L6-+(?=N&T*YVUI*'YKZ0^T["\HFU!>9H]0'HI#)@VA'KC>[R"F5G
MD%S,KZ+1T>VPO(L7X]ZZKDTI'VN4I;7% "A0VP#HBQ8;XXZ*Q:.6=?5J7]3R
M[!H^W6UZ2; C5[_,3/;5B9HV$G87"_=(1-<0[A.6)K6?:-/I$/E 6>T>OW1X
M63 %W#U'Z_EUZ^JV>VY-T:BE5J[9KJK$-9"5I4L@3]A$,+ZR?0>LS^[$1']!
MJ: L4T"6Q9QU$P.)$P*)^DB0S,3'\8],;E9-#.8X>QITZJD$P8GN[3E8Q)1U
M^OU_CZRJC=A^+;Q[;[%6R%>+J#7;!2[*GU9?6[IF$J)+8=$JD2CH0L+UB\9I
M.?9K8U%=-=BS,2Y\CU)C3Z?:'D:9D*Q^Q0S"@^T(_KL+1T^:9%;WM,?><"7?
M9R&#DY[%K'-I:%GVK/RL]*\CV].XA^GI?SGD/QBO\EFKO>XSN9U]Q7&!HKVC
M7FV$E?R:U7YG.7&>?2+A,\CKO14?<*^26%[-OCQ)SB9\YHT;^C9H +%RQ@U<
MH2TI E]RGNH=+=1#&6ZYK:@3'D-:OR7D>S6K4<Y[:VQG<R'."UIV+FBFQC:7
M,[%G0FF&79H45I+VSKW@/48DTMK.F(F8B2^@Q,_4IB.LQ'\_I$S]/X1U]?"_
M_>OQK_#=[^KM[2O-!7[8\9QWU_;>6MF9CFINZ2O<3V%$ZC-)Y= 9Y:U2D0K9
MT'TR@FQ6FS54HVTUM5YZZ6=PH-E<)[U+9XRA4D @784!^[/3?_1NU[/8"C+:
M]CR0HEK28-N>)T_1+RIA8%#?IV-D2@@F(,6IYD;O<-T7V<]-MXV;R:CX%K9L
MN$F3UL7"?8$&L-P^0B9(]\ /]1D^[K=%60I-_'5^%<;*H749]WV662]$ @NC
M"ERN@_B#U_89/Q P;-$V5[6?8TLS1>^KY&9X E9UK*:MSH+4*4MBS3'80RP2
M/R=@/]VY=B_H7;&EH,2!+K^ZL]L>*J!R1C7K)6FLJ6%+6"GS-_$8419XI3LZ
M&=6JU+=.ZOO-"-#S!9&SY^A+[D,2@U(Z^49'\2)7-B(]!<BF-0F5D:,]+;U,
M,V>=E0%$"^K;$,275I>-:I-90R2/IZRU4$OK"+4:+*M>UH"BS$I&PQ3*OB5Y
MY<B!K&/8=@N^#"N:8\GK2T,JZO2=F0J+&>,-K7D'8+L1-JE;6FY624]T^5M>
M((5-\?>82/JQ&L3=:UFV IK#0,@4++^B58_&9&?BK!:0QEB?#$*4@26N5^'K
M84>148- Y:,+U.\.^@G+%C5?AP,$%>\H*!#]7A5-?X,",>M#/Y#R#-SUS*[5
M0MG:4AI]W<HX0&A:\A*+QQ/1,=@&!=WW-]8>CCZ*];D^=KY76OQ8VV-3<R(N
M+BWES=SP;%(ZXLF]2U7&HLQJ#@+5)5FP\;5?7JU+F:2#]Y7OH7;J,0 R1^=+
MQ8M@0,3,P8EZ^(@\.U.4<+C5W/?9M,/?9^+>XEO9>=;S(=QJP8KG+N&&M23H
M49SM<4 T$7J_CA(,S]9M*9^86G4*6=8OW*61FLA4(S*US3@;UA2F YX>8 BL
M-F*2(]M53,_-J?'<CEB+?'G<?+.U[:JJ\YC+3+!6_P!8K6EMS] & C7"N'O>
MRA2\*;<=P*?29QO'4G]+*?)5\FF\B8A%2IGPS.J4P2S4";DUG8[/.<+'*M6#
M-CYZ57<I(5T>,IVB^F"J<_4"S"\4LOV:;U6GFIS,<>RJK+ *S;Z4*:RV4$\:
MZ./Z**Y<NVJ+\(-"C:GCV2F,[,R]JO%6I[3+SZ+I1>UB;Y[H.MM5':-@>WH6
M@,</P]!7(\G8J^S9I4PS>,-U]G2OA6/RTY=9K)7>"Q;/+K_=<FV-91!X6SGV
M48F5S88XBOBKD;5M=2*U@#[VZ1^ZKW 92UHD0V03$WNVG3\*[GW"O9S[>"J,
MO0TRTE[=72JS6'KCY=;VXYIS\P"!L4V)7)]_17C,SGK/3^G%/$SJ=OYOJMSK
MMC0H;6E56L<^U:KYHUL$&7AO\@M)7D9]HAFK6L6/(^"^P9T>-V,7.S,CC&=C
M*ST9F=R;/CCSW>]38X3JER=8NTMKCZZE?WFE0(ZCO<1)0!$'=ZT<PN,[([U3
M=Q>/U,>;.,1W;V_3T=*BD[R=%N?0LKS,JWH:%2W8%U.N5/N[V7%!ZKZD\AR,
MP.0\:^;Y]/7T\_.T"J:%1LHDZMBR)]?)!H*0[U^93 !A]O7U\./]AN*_X)2_
MJ7-.^T44Z-=MFPTNOVK4,E/2!B2(I_=  $C,Y@ $BF(]5<3D6_1'XC\QT$Q;
MP*]E^D[%;;$[5/":W[UYU>BMLR0665YL7K#FH5(O2H8,"$Q+ZP0S!#/^J8^D
M^MSF2<BLK5L:U^O5MC)]!77$*%VPI/?[<+%R\J^3K +\I@R8[NAL[_VJ%8]3
MDMY5CD6 GD%7B NGD+^,3>$]Q&<59B+"C?4"4,8EZ#\33"'!W]?59/$.&?$W
MAO%+/&]F>05.;+UHRK.PFYC?);6=&KK[!*OPB=1=HDM3#DF'D69#WQR'C-GX
MNY/PFS^-4\$J8NI<?M7^17->FV_8ML;R#O6%'/'VU:*M1,$PR-C[ Q*@]?I!
M5JXP7M;7V4ZVE@H]IF;]G U;G'T[M:H+&)JKU*>:BYX*\PD"<79])ZS\/.45
ME:%E.:/)*>D4W#G-S*MG#M!78&>310%B]=8I+;:TLLLA2%&8H7T]?#9W(>3<
M?UL<OBEA17S\WBUK'NJ:5+;FL;-%W)-1;02N#!JXHJEY%!P:H'L+^G(3P?1=
M5;\\K)OT:FA\LNZ?O)"MGK19\J(($6C\CZY. )"8M']M.9C$PN5L7;T<7!'(
MO&M3UL&S=41.]KKK)1.E>8ZK2?;I]&%:6]WN9;/TYG<X_P IY70CEI99@Q-]
M;=#*G.>^R01<T$WU:0N8WQBS1INLJJ%8KD]WN&-FVA&EG<IJ:09650RKM4</
M8;:)M)>C+MZH;\XPO4$ZEDH^05H3:: @P*H=L,Q+E>[B[M>I3M/S=*NQ2R&V
M"?\ HW4@9R]@$6FS1:>=:?TLJ,9"(D)+^BUH*M:L666.0Z"_^56D*/?_ *;U
M[W&9BG[WV8HJ<9*^@:O@]H(/94MI<9+[.2^Y#9%=YN=:17J<F2Q-O0K:FR;Y
M!=G;18/+;1MY\,[M7 MNBJ@EUJ94%5+&C;?X2^:VL"V 4=AJD8UK/=Q<MT@E
MS1?JJWDT[:_<7X;HUXRAKR4HU&3*JSXY-IJN8Z%5*-#DW(&Z!<X;QA=5FK\T
M0RRV!3JJ/LH->NI:LVHO4J=AB#7ZHKL=9L+IU0?)3W%+A2$-[IZSUGOB>L]9
MZS_']B/(L6/?7RA%1M"8K+-: 40^:O:<U4=O41AB)^LRPF0<C$AZ.M6X_*O:
MW"IO982BLBH^?[7NDXB8& ^K22!]P=O3O[UB>;=VJM",^C9)["AJ;/DFN)0C
ML #!O1I=L 11$@ON\J__ %)3\TRZ%BV-=B*FBZG7=>H]_68.I88N6J\;>CA$
M2@/(,%,=?5TAH>\SR; >]4A,Q:%G[GG0!M=/Y^.?,,CY/L&9[P[B9\IIUY\B
M1\;_ &BVGV_N,Z?6)"MTCI)%!!]/ )3!=KHT$H^86GR;9B 88I7]J5RT28)1
MUECA[>G;YI@ON_+Z?3UTGZQ/TF)_*8]7CQ:C*TZ'MX=Y+EVV*Z]/S>SHTPMV
M'C0SJ?N+$U,^G":=>;#O"D._]IPZF5?F]CBUS;O?I>' *NJ[=;0K8UUF=6)V
M-'OZV?8UYJ#>E+42U(^+RQ$SUY/GXM'XCT>$#C8=O/K_ !$I[JVU=XKFNG45
MBVM^6W&46T@S'.K^Y:M5KR&L%>4N_P!,U;7)N0V>0!9Q;&9O.^3^\S!P"V/E
MRX0O*70OEXM_5K6K.C4LV+"'K#R!-=117HV>(\?U_P!'>,QC9EW;R,W4TE4<
MVJ[VP3=M53=]K"8_[) (>YK  ).?7PX_V&XK_@E+^IC<:7!%3J>/DV^0&J(A
M5.QTP*#@/J9!H:J67"[!_L\8ULF ?]V-RG2P:%CD&"Z7YNK*8&T$REJ8!Y#T
MBXI4-EE==J&Q5L"%BMXG#!^CNY->WQA>9:?R!@<8OVL2O:>I2RL!>I4S&A=K
MV4U 2VO9JM7V]TJA;3D_6/7M(K\QJ6+43>?6&MA;&'4N"EQ-93-C*._[:XVW
M-HZ[<JY-:%DFGH6N\3C3Q+@W*OF;6;^&ZO8JVZY=MBE=IV5IMT;M<ND/J6TI
ML*ZQWKB"&9];NK5!;;69C:>A66V#E3'TZ3["0;"Y%DK)BQ$X"8.1F>V8GUIV
M-/\ 1^RFBW1H1[/(U4S[M?%<KD]6\?EUW#[)!:19EA),0+ 1\R=I9X>=*,"+
M?R/VM[7U<2XS,4-S0NMKZH9].UGT5[Y3[/V[U6+5[&9RI59@->Y2LR(M^N-K
M[:U?<<-?)>C55?M>T]UH<#H5-?4BI>KIUCUJ&Y9WJSD>W6F'1GB<-KZ)LX_F
MW3X]6.[M4\)^>5'2#0V@)NTF_P @Q#*_*ZU!#LJ$>U>J_P"!GN1L7^^:8._K
M$SB.?DZ>QYDP%7:T+&;1FO,SYSFU5J76PP(Z>,/!T*?S*/6)R;F61Q7'SL/C
MW(LM08.]HZK[5G;M8;@EJK>706"TCE']PD1=6_ET_+D7',C>XIPH.*Y&%>==
MV.)Y')=;D1ZZK;?-'S=]<*^%FC6&FQM?O?[OS@3DB*X]9&H^KEUG2_7HNG$5
MX<6\S)V;^4>KDK_S<_6FG\QK?O?99Z=[.GD+U\+_ />OQK_#=[^I@)?4=I>T
M=^!44U:$ENZ0>UJ%:L&#?$O.S'VWF(J:??IT&P'V=P@_PLKV"L7AT*S'E9FM
MJ*NO5I5P>1GY$)N@]=8@F%37%4J$ Z#'K$J]?MIITM=@_P#?%:\VK,_ZXT+<
MA_I5,_YOIV3N4$:.>^0(T/@OM:HN]-A#5D#ZMJNR(96MUF*LUVQ#$-6<07I.
M=NV+.SB;VQ%'CFG5S"EV!+4R5?)Y+82XY=7:T?:Y.W[2.I=J-M_N6*N6?6SC
MADK7HYZ==$M#1#H.CAAJWME2_-18/^3^/HQ=I9L4P&SN5:[$P(]SE)/$RA^:
M7;F9@VG[C05+\W?JX%JUOS&2(9]=K+:W5HI^\-C8BG(K983,5"=1QM!X'G(T
M"C9%-J[=Y)O:&3CKX_51GRC3H4R0D+5XF52LJ"T:$R^HT&%FYN7528J]]+[>
MB4)^6*C/HVK'1=4B\H\D+;P4J_)C<5KI,?(2T_W[A.S6S^0;>#QWEB=CDV)Q
M<G?.;M>O0N?*+2ZM=]=VI4RMR:%Z[E+84VU+[I0\$DN><<GK9/*^/\2W%XI5
M,[EP6:=NYR.O[X-C8S<:XUEG(S7T9R*D@8H"Y8JDY21%?KK/TB/X_P O5^QG
M<[TCX';YIQW#L\DNZ>(.]4IPODQ;_(E16I*#BW&]36JX>+C>_JAY 59M5@KA
M? SXY;9P)G(+.KP>C?VM,N09''B3HVZ+/= >9=5Y0.%PJV?8(*ZV92 #XICU
M\./]AN*_X)2_IY3H4GE5NTN/Z]FG9%<-*O:50>==T!/T+Q-@#^[[?IUF)CZ>
MMW3Y1<L7$<CSUW<QUZX&E>L?*]*QG6WG9)SK=9'G,DI0Z1"R2FM4$>"2/TC/
M^O\ E?2H9T]/XH-\6+T?ZISZUN/Z!Y+Q]GMN59U&XBBMURW7P]B'K+LS^0U*
MW<-FKY_&Y-L%>^I/6MB6DCSU;!M&%U]"BV*&[EC95;=B;*T(=<R;+D_A,;6\
MZ^CE?@V5&NRB22T"FUHWF>*G20RS:;XV-\2%#)M9(*$V$(!$D7:!3 Q,_P /
M70-*N[QZ&E0NSVVQBI.,3%:I3VU&^2:S5^,!^T+?1DUFLA9>FZE9UR^Q86"5
MGAD:]>[^ JDSRV4V,X&YE)R]+-E&EH+KT6C?JRMY0V/19\:)#8BW-%9LH:*J
MMNPN^&8\*%]E0:6@%/1:NE=;2>]-*RP%VC5)1ZH<CS%CJ:<T:MJII+K:<H36
MLUGG3<[O6-&M:95-PH.RM=X5,E0R,' S^P1>1Q[X5\LH5E+&G4YKG[=+7SBC
M^V6C;R&6XN4K#OUB:=F@I:RDHZLZ]TFCE1<,J54(JU<;"X5FZ%7.RJ]>&"0S
M;T']UGN"4+4E&=037%,]L,\OV>OA?_O7XU_AV]_3;TK<S%>F@W'VQW,/MC[5
M*#\V.<?:I"X^YK3!8]2*/5"ER2GY]$M!G+-2Q5N"FQFZKY7[6D#%L]Z*5UQ"
M@AR96+*^,'4X*1CTJG35":Z8F ")(Y^XI,S-C")C6L81,:UIFUK")C#(RF9]
M;][Z2"3I8J)_T4%';LS'^CW6BQ)?]ZM_HC^BYFWTQ8HZ%6Q2N5RDH%]6THD6
M%%(2)Q#%&03($)1U^V8GZ^K_ !S01=$N+VE96=HZ%V+]G>Q(I5FYFRZUXJY,
MLM$VTK\FF/\ *-"WT8[^TG0JH5F-TD.MAHUG4EIO=[U)IVVM190NPY-NNA%<
MK<"RO=K)2 N<D Z;V3/%FZ+LRSEX\9[,>DA.Y<Y1;,EU,^=&45W4SNTO-HW;
M'BH>2L=B&V)K=WK%TZ?!'V- !M(Q:M?-PDZ-'V0:+.25:CW64HI_)SHV:]P*
MUJ%7+EBNFH5CW/>-@U<::S*)!!G:2,W+]MMZ-8JVS\EI5Y<%H;?O=07USNHK
M4CU/?G%@&I)K&V/:6<ZS4NVLW0SKDH*Q1OTS[7)-E5UBJX9&5N2^NYBVH:H^
MHS,@/[26V'*0H9B"8Y@+ 9*8@8DSF!B2F8B.L_69CIZLAE:U*\=.VVC8!+H[
MPLI_?" +M(Q^DR#EP:6Q!$IAQ$S_ '!%QF5IZ-"6R%^QE)"X[,5V]1M-SQ9%
M^XB2^PQS$7+0=8+VQ!W$/(+>I\NL\6AM@<B[17G H'KON6BI3=4V]&_=5.7X
M+&@6[F8&C3T)FK[#M[H5ZV++]?%37R+Z<C9,"2<5]-RTM3FO%(F3+LKL*+V@
MBQP]_P!0B1/I<N4WJM5+>18L5;-=@M180ZF;$N2T)D&*:LA,#&9$AF)B>GKX
M<?[#<5_P.E_2CCBYK$H8KW]8+)]E:QWO\>%@N+QM_P"G-)??8"!.2R\^ZI@=
MEH)]36QLVKGK/M\OMUP)MD>L]6,_?/[C,^DST@V,.(@F'U]4$1U\>10L:3?^
MS[J_,Y]'K_I]N&K/_B/\_P"G%V0L9M#-Y2V>.[B3IS%S4W92!\5M!<KU3,FU
MTU-#,D;UA564VT"!>=:%G8J6![T6D-K/#_MI>LEL'_V@*8]'27:VB!M;+K-:
MVZEKS^59NCFP^2*IV^YOQJ6;FDV!_6KWC=T 0\?KW;>7V,<^1,G!)]7:QT?.
MA34RL@\)16ZKQ88.P4284^S0"X=ZOYA58.M#<2SRNS,[-;D%3C^-&QDI?DQH
M:0WMQO&Q"J-]ME&E1^UEMFE.9[=M6O"$BU?J[>RN69R<9W(+TWB;LY#<X=6V
MM"59'NBCK4'.4@(H9ZK"F+5W2[S!/7]I\+^3_+:OZ0?\8O&\CYOX_P!=^633
MWW32\O\ ]!+9D^S_ +4]?Z)F9B(B.LS/TB(C\YF?Y>K-;%VJ.KF\18FVZE5L
M!%C<WI[YS@JK?*1LY] P\B'B<HM['MB Q7G][V-=T*U:,FN/Q(!@C)%->J1(
MCHV*2BBL#"(Y/LEG=]_]%J\_KXZJ3;(C^^R1C[%+C_.:X^U2A_,F&(Q]9]54
MV?K<.#M7I^GW7[K3MW9B8_,?<N8(?_=P,1](_IF\K,N?Y1X7[>[L"THSN[(V
MQ/.SFHA'C*\0[.G84XK7DBLMJQ1(]QB[8\;;6J[S!&A?>V[9JUGM\IT<^7D0
MYU'N[?U2B*%,[ )PL9'?ZTKR]&W1OW#X_8IVDKKM^6W>-ON/I65I>LUV!=-U
MJK:+'<#420!*B+R1D9]/=TL_0R&:31W%JH/N63W8M?/2?7?6*E$Z#+K[(>)
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M\3L\06CP_##G5=9*7U\:FK3A@) '7Z3':?;^%)RK[/1&S!^(BDI"2,R^&?.
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M54521YT*93)/D_A8:H90?=Y(D)*8:;>\1CM(LO)OOA]NLMLN*"DQ7+[#;'@
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M,L@&FHX/:QDDXV8-P_N#+5IN[R-)Q#13&[\Y1-MR7BU"BQ#$) FSUM&%$#^
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M3!U=@,;-BW?ZQJ5 4[ >ZZV+L):X@$$_!"4:_P";\%;MCQWXQB)2*_S2(&*
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M$^8[+=;UO>ETPHF+:C58P7%N9;%^*TI4"#)M!E'"OR,)"D9IWX<"CDI;8'R
M!:HE%:- 31M[!A#K0@9"<3._]FSZS+(D\1"]VE)@"R\ JYG0J5O_ /-&HN5W
MI)0=MK .(=\4 NF-!'L04-A^?A1_XV7"_P#_V@ , P$  @ #    $   (
M        !    )(                   ( (! ((     )!!( ) (     (
MF"8         ()) ()(     (()() ((    !% =R !()(
M              ,%Z1N !)!(   )(
M    !!             (            !+H                      (
M           ;0      ! (           !            -K!WJ0 )!) !((
M           ! (      "   ".FC#  ()(  )!          !))(   !0
M   /#*L      !(!          !))(   >IV*       !        )
M    !!((  "55K,       ?F     !()    %?7:     ( !:K-;L
M7!1!!)   (  !R5Y%0  !  ( !"#Z?@    L.)4@!!(   !)   <_P 2;@
M00"  "$@     "XOB7@ 20"    2 "(,      " 2 !0* "2    !XI("
M   "2  !3P 00   22"  X< 00                2  -@" "2    "  7D
M4"" 0      D        2  6 @2 0     ""? L 0 0     $W@       ""
M"T)CH02     !Q,O$)EU   !A?F4          (&XL1,L2     3XH01IN"
M !MAAK  220"   1I!:0" KR    2 "020" 00  "P%0@ "" "   " "
M00    "000020220                "2"2 "0      " 2 ""
M           2"2000      "2 2222
M
M#__$ "41 0$! 0 ! P0" P$       $1 "$Q$$!!,%!182!@<'&!@/_:  @!
M P$!/Q#_  (O\?:C17[=:0!57O!%T@KTW0" Q?'7MH>0<^A!T_B9RK(:@P!T
MLMQ/"7N/@W!EWE J2XV']_1((L.W44+I"17GD+,+XS?!!OT@G^\^DQ'5U301
MPYU0JV-]\H[Y)P^,&(#:#2+,;G%E]4#(N"9S'=:B:(#>HM.==ZN#& 0A10E1
M(;U7)I>-#ZB1"! 5!_HA\2#/( & IRE55T,&8FRP0%6"@.$ #H)JO/TD /!7
MA^(6 IJ' FUR6NB#.V/,5^ "8   ( 0     (:XT>(K[\@.@,T=$Y\8Z'LCE
MNB%H'#K/+7 8_P DM:'6?X4CEVX #*JA"V6LA5# @Z#"(6?3*D(5\0PB!ABC
M9>/&YO:SG6_/$,8HT1$41$4?Z3XY;30AO$(G ] X:-Y2DB$DDJ\%5.O<95,H
MEY'BH%$P@I!UZ"A!("VK"C^B#YPJZ1M 'H'<,-KNDH13!4(DDB"=7FKR8VJ<
MIWR#[,+4=!^5=KI*J0#1_CX8HTXXP#P^"<R.FXE3#XT,& ;D&8&D#N>(U7ZE
MT40H*0;9462BGWNL[][C,K^DB^)2W\3Z"A[4I)5JC%J$/0 ):CZPH_H[7+:$
MFERTNFYD<A8Q!A K+"!RQ5,TP-6 XT4H!8RHH(DS-IUKP_($V' I-%0X$,$6
M[I1*/.0G "PWR!?=S7)@?3#^$X.G WG\8?!%7SK\@4P5=0_20B'+.$)*EN,8
M'$7,41H>*DML#O'S\^I"<"H_1W_0Q@G0A>\ 1A%>V\?A(< F A'0C7%"H495
M6 55?*KW[JH%  JJ !Y5> ?ES:B_3?ND9^QE\!N'.<&(:<*WIM@_XTA<('11
M%8AC75L-J1@^40J.HY5&[#S/CJ;T)MMF%$2/5D1@R5<$1[&P(6D"AFF".+9*
M""H/3[F[8"R/\)H0@@57B+5>S"6FBI_2J+\?8%L?E"UGU[ZBU/1K 'A>CJ4G
M$5KFL!AXO"(%@M^@*,=!*B(Q1AR@%J&VN6'G%\P"&+X84/#=&F%KZ]D$>B<P
MQ/,)14H 5FJU:T^,)7UMX$-)$Y6NAUTXO5B1 IW2 1J(+MH(D">YDZ&*SQ\[
M62MFOF=9<K=EH,$PZZE3V-_I<MNUTTU01N([FAE8S\]O]?-L3I9;DK%(WL!H
MOCG<,VX"Z&C;V(4"@ JK  JK\ =7' 1<F8LBVE.W*>0>6N,#[TT8G7R7^X3%
M-T$[OBC+@1J6H!K*3;'N.)(B%220V9QX4I-^C>(IZ**PMAWLT*ZVD$FTAGAW
MOA+(>Y))!Y@ /K$<V!RE""I_(8*&3E?8 WVHKJ42&UCS[0@J590O607FB%,)
MDBFCEUS%0MXZP-GVS4M5BKOJHIE3Y_1'H$'&W:K]"SW-HA 4.0C-0;R8&D0I
M1VV814EJ(/#%1;\3(G/.=0^%03261'PC #LW):XJ[F<RX1#DE$]3V$7DB[]D
M/',B('[Q1OX'JV5F+1@L1G^@L=Q;?UHYK3?_ *>8,,;'A2:=K4A53D_* /4A
MC#@I; :]C-VL"@)04(._YN+:IW<$/!, 8 & :%"@]+8],^<U21^5*K^U^BP?
M416%,LVIT,0G\-60X;(M03, 4$ JI0 %5AW<G&)2MT<+);.&EG5U N-7S'H$
MA2KAUA8"MOF <5FZSR*L2#0E,$/+$57>EFY=7ML%L:",D/N,!Y22RW*)5WI:
MB1E$G-KO%0O!C^,>UAHZOV[Q)@X:FU3H%@@ED\Z\:U?.HEZ(:D3\,E-#X0=:
MRK16);*0B0%<#&6J@0JJ( 4/$1F!Y59U2<*E!P0<#V*0AF /)X9@-&4F:OB,
M <N10ERZ#_.]!.I^NN#BMD*0J"&R(EYNDC&@%D-J+X,*S-RY' :P]H"$LPS=
M88(8'HI#!/""5:#/DCY*%/4D;=+E24>\DB$$D%18-4Z)1Q+?>5$K, 76E./>
M*#H#++,/;HS 6L[NZ:3!Q>LV$Q?;H38U0"A94AC%%0=)!=^"ESR"O=S#L+ 2
MM$]D9KV\^=, GG1HU9$ZXH!$6CSO@GF<3T:DN]?"DCI!Z4?/GV B137\IG)Q
M01C3GUA >Q<L-AUT5?\ 6Z) QX<#X\W1:B% \4CE,;PT(Z'6H.'@FL02 (,@
M IY" P"0AXD"E!#YP%4Y[<@:-L4$R1:T2^A.P7A1*"@B34(-0[DM,CZYPJ2D
MDP]M.Y?X@S#P6UC%[KZV= '(= ]*%7L5'2L/A2@D4^W >J>TED$L$3PJ&_2%
MTQ"6!N9\!AI4>,\/+X3GA[=HF]PJG@/E074!U,,.Q-\9LKFJ?J9^.;.XA0D5
M]B&:<%W%FH .P=]H09112 50%0!5#@-\8) *!\)J)X*'08A[B1OCEFDY>0%:
MFE>'"2%O2VS1)4%D$_-HVTXH*P]JH"K ZKX#\N/ B<-8YO.QV4/C0X+H%(+4
M(==RT$(_$I'!&($X8+@#8AD&HN?9GL4Z@?P0LRSP=,*A*J]YBE!21Y LJ@6*
MD6ORJZ 090OWYE3W+#>@3Y/;, @CXA#BW@#5!Z](UD+TV733FBDD!H5%0=2@
M=9E$>$HX @Q??JZ-I&SHTR598RBE-2?[3&^'$I/8B=V0!  #9Z !D$2 @UPO
M\Z?H%=\Q6%[S.F[3'[V +OB&7C)-7$?@#7B!014Y71;L=]##T 7_ *CK;QQ?
M8\K1G9N9X][DN<2I7/Z+.F[1O9P+O<$![#-,P]?(,1C 20\J76#[%\0 ?S,=
MMHFZ=Z<(">1V!+] 5U0-W@EV4L9]FV[?0JTCD"WD>.10MA"@/!=*_P"#@'@\
M1(<]!SRX %0@ JH!7+:.>79R HO $@CQJ\Z &CF&=ZJ^($'VK@%A2O;?  "%
M I.X[_\ D!0LTMB6)J8Q8>/& HP   ]I8R$@H<ETZ!X$EF3$>MP183I$H(!\
M4(47<!:]Q\L")8LW+. 8^*+/>NJ$^(^LUW[RQ*(9V/\ ]W2UX#YJ6H(<*$K@
M[;H5?<R5PVRPZF%"'FKZMH'3JK!E&WJHE"8'BTG6.EM?=>!*X>1H1R4<]"[^
MB=L12'*Z6Y2@9D%!&S+T2OJ+9^D?3&0G<.OP#_A1!-YA)"L;F.B/+1_E)E*J
M10JJJW)2H)YRWB'W!1CU=0+9HYHS&+\#P?JO>:.&GXX/H2R& :V90/J"8"
M(@T1%$1$8Y-92EDW64*<8@IX?.0]_P UT\!4[-&%@,=;0Y'T)?N]DER_YF1T
MF/2H66")L&U &7XO3*90=O"Z 52[-!#ZPX<0O3'OK)A];)1N,'[2J!'BE4$X
M\PLB\H@$$!'&1,#)"8"V^IXX]1&4@DT$2+>TF /5<0G924*XIHCJM[V-I$5<
M40OZA:"^F\2/?!1HQ.B>1_.<4_B9$T$FQX8;%[H%:=IFD!"$Z#GAP
M"'\OTEF)O@M'B$I,:09Z8Y:C&D()<      @ < . <#A]D.NWS\2_),$&M ;
M]>8I3(VX&F)NW;/@\G,288V/70%;00X@E#EH0DK_ '!;05#"][Q',\//">3P
MFOQ^6)R0FJI 4(E0O5_]%?_$ "01 0$! 0$  00" P$!      $1(0 Q0! P
M05%082!@<7" _]H " $" 0$_$/\ P09WKT/\LGJ#"94&![/'ZN(ZU-"X""'N
MY@N.T$:#3H&LEN%%2E),2B!Z4'09X3TRY*(:EA/V$M#0N'A_H>YE=C[I;^V4
M_P!W<HKP FU2J*1Y*S$UMQR2;-%Q7<'$GCP4#)OY0Y6L)15#P%!%L%*-P37T
ML_LK^K>>'(NE!JK)4@DN6P7;&@QEH!,'S*5V4AI'NR 0(?Z&/?HR&ST/+%;D
MN',(\#%20^13(A4>+KD*+3!$4PE9]NAB9HBB:0+G^#)G1*()Z*1 H 0(& >!
M^NAFVC'!6MHCH"[)6>&U8L@)0B7'_==L<PVQDM(?^*MA<I/UH0!#&B!(@'&O
MOL=2TC%>Z 7H^E71(*ICI^"S5@*,BR2 0O\ I$VBUM-[&!!,HPRM^!7@0!4A
MP5)BC(7+<=7(T;RSOE<FM@B(T:W^B4#;_*&Q5#=X%Y@JJ!IN ,X$Q#<1?=\S
MDQ"3 ]R! ("$P0+N54)\*9BZK10N O'3A*JLSS.AZP8BQXY4Z+6$*+1$<\E!
M F4*F[W _<S+3% &AJ7S0:,:@/BQ5GDUH4G\V$J%.H53\LN%1?'[ P) "@\
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M^[TKTH_T?H#A6WL:B!AD: KIBI.R?,HP1'6R+J'T%&BHT1!/% @Z(B.B/)
MX8H(# "-F*G"Z?YNPI?0,E&],>W^AN3:P/P:DP9HK8ZQ2B]8)    $    (
M & '2.C(JNLJ?0HQU426Z[LE5-%/O)-&!.)C@/,VF=:#''*+I,TS$ %"V?N[
MC\<X 2\+(V)#A90? !9$.K%4ATBI,"1SIRE=,J"I,C8 J'ILI#U(%G: IMG/
M, W#.L9R%B?X6NQ%\I8"0*\=N5VK6-.+C OQTDRF+RO7TARO&71\SJ%$$E?3
MD=SVTVNHG$TB?'K#^>@TX3P[V<QKN[])DPT#1?1@A A-FS$ 15JH?!G=9.*
M+Y& Z4A :5/6,("-@-#:!,,C!I!RB"*&A*%4]2PBF@(150:;S0ROM>$EIJU1
M3Z.>K14&*J/D) JCCK10:Z6CV: ?CJ2*4B1I2C?2]FV@_P"4ZL?1?A_YU3$\
M D%56*$JJOQU1*C)YX*XN\[KM2C^=GGU-+X]A*_0M@']GFZPW^.%;K)$Z,Q
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M"* 624"O6T>;_A_[[+7?UXOS'B5EW'\X\D2V)'BNK2?X:TP['[PTD[LQ*98
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M6D*1B%U(@JBPL]2'Y553%H EIRH $D;>T<K[C6%<ID"B%<0ED[10002*+IJ
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M^&["666 ANQ'8S-,<H.=U\1JDWUBK-9AYQ3%!^WT\#X3+0-;@ZGPX2P)7+O
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M&4^OA@5@"!$3DDRI,2^#ZYZP;97FZ7X7[Q5=B9!T2+S+<M-Q#C%A_&D@9RF
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A -K5;RH$(]M1PHJ@A6[_ ,WZ+",8=P.H[1@5,=3E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>businessfigure35a1a.jpg
<TEXT>
begin 644 businessfigure35a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M !P! 0 !!0$!               % @,$!@<!"/_:  P# 0 "$ ,0   !]_
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MS9<TK+),<0DV\*9*@)D;:FHA&RT3\E6'KN
M                  1^OS4B1HYL2JS,?V#^>SX@YT\NFQL2J#DO),7
M       #\'P^'P'T^GP^'(?H              @F;G>/';>E[&<MS]I=$C</
M$[%-,W68EB;#K9U^%VUY15A+,GF[T7*,J#MB5T$           >='5<'\0=S
MA+9T;*R97FQV9%;]ST!=Z1<9<(             !@[%OS"YAC\'ER_I_%H'7
M[VRFRM:=:JFF;5+<O'A.!D6!)8UA2&1MKMN2           -#:^W5Q![[T/,
MFP=9OYV_%1*3JS]<=P0D[U_+U]SO*-C-BXX   *?J2#Q.O'E^9XSA*3/FX@
M //PUW-YC9\YCX8XYCJT4=[UT/?>[YYS^U<7E(^O88\E;WF]</M7?
M*1*X/IM.=T &JFJZG1T'#<5-#RC+W[_-5YD;EV X]G]T>;([%L6SNR[*
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MIK6;CFM1:RSL:\G"_BJ;M92V-C:?:89&VL;8QJUDO*,/[5.F1R $7)*I'[5
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MX5[N>Y5H^7  .I1?YJK?+[0!Y,=>W#4'<)C9#3(7UIY)J,L --C<DU0-3C;
MVE.V <9&B4@   @ )KY1";<?*\B6B<I78,19    K0AQJB>E1Y@E@95.V)9N
M+4 *GF+>O&T;9B^"?0?<S]7OR5Y_5\U(Y*=YK7O*/I76[V1W.VSY8X/)3BD;
M&=QN4[.U]   U+U3O\YS=7LN7XCI3J6Y;!S<%56];=Y"Q?U'[.Y7RIKCJ,_Z
MAR_/ /,,]/ "($D.V ?@PQG   " %:ES>>:9QO-MO=NZ-6]Z<UUW^OT$X_"
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MDER83,78_OW,4:NZIJ<RS<V\)Z?Z%O(^/?-;H^Y><E_N._\ C<'WFY]I=W@
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M)?)I";-$T-$C?T          UB+A/AV3H'3,.98RYR'Y,(1,[1.2$EX'Z
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MMFLT63%^MD9_&TU8=UP<?Z'!M!LGDJ58P9.HFVK$16LI2RO.(4(VFBP6CO\
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M'PZ>J1&7N5T*^K0%2:_,F,M6XJ4+63//5%R(-4G56@:+KJP+(/BC[J=-K$A
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M^\R:]_C*["WO_A[?3CR\.FW8-.GTM-3^SUUV^_U_G^?'2CUW;>^\2:]_C"[
MWO\ X>WTXH5X?L#F ;.W^2X]-3\,EFR7'OKWU/S^?\-,#SCS5RC9YDCY8Y@R
MN"CM<M8.]:7&VFK]>S6QF#@AF?37[R.&::.,]M@D?;IN.OB3X@<D<VKR-,.4
MLI@+&$Y-NX6*S5R=3)27L9D8KM*)+@DIT!YBK;\UD3:!9K4MZT)8U8K)Q)!6
M$DG15C%O7I&3TR&.%B:^\*S*'4:%@K$;M1JPXZ,>NNWN#(WN?>7]H??][_\
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M5W9I6ZI>=J'V[(+1T/@.=RQ//011X3\5*^H#KG),JQ[^IRJ XI5U+-:V+F6
MS/;ORU/N69>NNF0;<4HI*CR+1P^:.Y3I_P#DTZN6C436Y&RX'.JM6VL:NA-8
MOV+3/,Z>%5Y:O=:#%N4+-8A9ZV\NS7R]/"GX?9#,K&K5M^.>ER6GFY+3]^WW
MOL[D#=7H$RE[27OCP*8+70R#^)F9QW ^(QU.5<+^&GZ Q3S>4/F@O% T;JK+
MW25K#T4=1.W6NL5I70D9[+!=O71TS#G:RL_^4%3R.M+4Y/3J1\.;^#7^<,17
MJV5558MRSU3;U4K'Q$L5HMUS"?7&*/+<[XCW_A_E<F^*%&]GXY\IL;/:K:@>
M!.T?EKQY1I8*\^+0YSTM>B+)4W6S*O"3'@;.>*Y62,?X>:>@/O=#36H=1'.R
M9Q6OR)^?970T.05.-L3-VI<)YN,".V#S49?J9NQ3_P"T#/SS^'3,HM?@W"U<
MP8=PN1MM?+;:K=&Y5K!*1]SY \=GN%0P8K9/7_R;<VWC%@:]//\ B:K2SI4:
M+4<:]I!C9U:Q/L%5LZ.DS"T;54G$NOJ696N%=/" \YU>';_,N.7N"KXU1+CN
M-^D=W"UD:]F[:4S*@O(BML57J#Y@L>V6)]M8D53W>LR[P[@]G@VJ/P5YW6RL
M;+$2KX.IH<HQ[E;/5?KHKT:N[?SXM74U?PG(OL,!(F5R=ZOI:CG._@Z_*N+I
M;DJP?B=QX^,J72N3L:/L[6[I\TY)E7;44E:6=0T:E#YKUM+<NL1=W$MK(H\K
MM<H:'./AEIYVG\W]_0S]W;O%P_DMJO:9<( XN:*TCHL98D<^X*ROLK!)^LK*
MP<?GAOX=6^'%;&Y+4=S#6J[%!%](\GM]F?<7@9Y@B6)W UJVOJ;),$U(1565
M@;TY>'S^AR9_Q_V=5>GX=VKPYOPZLZW?N-?)L#CC:MVF#8B&IG4N7#IMH,-4
M#(<*H-7RO!P@SN?PCY;QSF.IHYG+[?Q V;&??=E<6U<303=+&=6LX-_9]W@P
M/N(;6GW/D]<'=%&US%W%N3\.Y%RK'KU 5=Y3GY*S'6!.2YGA;9.PT-(<=S"!
MA(]M]YP,%RW<Q/A/R'#3/)/AL\K;>.'6Y7R]6)R*I:T>_C*:WS&:F)6 AJV+
M1E%J&N\8+6LR]<QY]3^$_(+G%%?#_+X_;XKNXB^/Z7-=='*5:Q6*N-=&2N?(
MLY1$AME,-N/ *%22ZKF.0.XG2I8J-7X@Z.T%SXG8=^ER'<R;U"A[J[<R<6Q0
M70O#?4VG0*:U1#,RK7F: '^*YNAR3>OYN!D?%GD?*\_B)\7SZ-M]S/Y1=NY6
MA/(GA\W9G7"(;,+6 J?7* 2[Q]IQD?#BMP#E]?F"/B0W;CDU_BMC-Q,.FOX@
MV]\]E?(;8I@^F.?A6%7NL.FS*$@P8^OQ,^&U;X?<OL\JY+\4>4Z6#N.XO9J<
M?H5KW+5WJ6Z7)[ J3736J*.P#4$1GW I7<#9GU\..1QB7N79'"^3'J<BP<ZJ
M-_0M);D6Z%77J9AE'S&QCW6C;&JONLSWR21^TYC&Y=E_"CD7'\^E\:>(<@>F
MIQ]D\LY'EY.;=&[OW^-4:WO*?C9,5*WNV&ZPOL<SPRV!+D-KC>1R/!UJ]6_4
MRU\NP;6 T]4J!,H6%HT!_&IC98F#=TE?<)@7[L^M>*O%/C+=Y8WC7'J_-QT-
M#F-*G:W#TZRN07LQWNFW[UU/?:N6(X@CPWL$8I5[%<G%V<<P]*MSNOQ]?QFY
M-^&W]+<9B>"V>%+LYZS=:OOV:>!:TR>E87M1CU-<RHUJ;9$D.;XFA6W'Z**/
MQ0Q\:KJA>M:UC-!V[6X^@?=P=Z\+:<UE43GRG83*841C(>KR/A[F?$;&<KX3
M8]+E*-_YXEEKEZ=+%!P\85K61F=-7'5[2Q9QXZU**[*-6N5>_P"'Q<C[M34L
MU+%_OP*&UQOE7'0QSB@ 6%45<SU=C>L9EBW V?VBU*U6YNQ7&%&,1P:SGXG/
MT_$'.X]\4U\HVN5KV7X4<YT../3BVJES08_%BO9N $5[&3"LQE&:*&RQX^-=
M]/'4?%[#!GPUNUN?VM,-N]K6N>$_-]K9XS4V]%'S'7ZCK_,+'';53-=DO2JK
M8"W[409GT\KD53!K_$++9J7%4OB0SYSQEN,_W;*G$-38K\^IY-'9&D.Q0RM4
M/?/E]FEY*:WB?%%<HGXE<KXV/#N6IPOD69RS'V*W,+.M)8:]_,'2L;"@IXA3
M1Q;W)+CZ?8$%H%!&PYX'8S*&POE?!\_B')$X2@NU="\[!:@]/!M4EC%EOO\
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M4X[I?*]"^$TK+UPE-@E1849C8I$T%7%);U'UB=_+>/KGDH0S AFI57.LLF^
M&TH-@RY37_@I8/V.=^&HB/Z>B890( ,F93]($1CJ13/](CZSZ;4PN6<?UK**
M4:3D4-6G8:NA/3]K,%MF10'48:R?HF2&&]DE'75U:7,>.6\W"D8V+M?6INKY
MOD9"E';8MI0E363V)<7X32ZPLR[9Z6V<<W<K<"A8]I=++O5[L5;'3KXG> S[
M)(?N7,_:P>I+DHB?6UQ*YIT\?:RMU7'ZU33OTJ[]FVW.IZ('F(\_F8LAN!7"
M# #;9 U*$R^GK8V=C0K<8H8_+=SAYNWKE.H-K2P[95'%4_&GR@\A)BE_QX4)
M&Q80,SZS+^MRSCV?1VH@LBW:UZ2JVBN8$O-3<3O&^O$&$G864H"##O8/>/7>
MP+5@<U^-MX7'ZUBZ^N*=[3Y#C)VZ-?&@&&VR?M'1W!V07VDP>JH[_6OG4>38
M5J]@ UNU53J4S=EJ1,Q8;=&&_@*K%$A9:?0*S(\;R _M]7.-<<NIV1I\?J\@
M/9SK56WED%G2M9OL8-+2:-Q1U?,8FN!\#4F)3WQU_0YWPSYC2NK55OW;5FQQ
MR*E#!MZ+LT>063'8*?EP,K66,A4,M0M#.E>2[1G+72XCS4>-[UYN;A<S9D+G
M!TK*_+ L[4VFZ=//LRAT5-&[1179V=S)2'4AI%F?#KE@85W0NT8Y(ZQQ[Y:K
MV%RS0LV6)'7G0\*[51JY[:A,GIU$)'Z_JJXL_DN(KD;NR%8C-*J&B9L#RK4-
M66>3SL5^*M'3S,5T8 2$P7KD=@.68EX^*4K-_;IYVC4MW:J:A>)H^W6[J3/<
M]M/I$]HW&+KL(&'$>N-<ST'X_&]OE=!V7@+V=;'G7M9<:7^;)FK=L* 'Z(!#
MJ\&+8O+"K8CW*06.SQ:MMU5:^/MKX]*+34IG0U3K'8.OFC+).QX239JGW"LY
MM4[:U@8J\A;N].M4;E\:9HHVK5=HN"E:R?\ SA39(STBW6/\)B>O<+I\9="Z
MQZ5K/6''LEO'K?)INZVU@25?.JZRLB3MU*6E9M5H]PV(:UBX36<,U+# M=JY
MUMBKRWCS\K!/Q;.@K6I'4S3G]P;;X;V*\WY5^L]+!?:CR%]/3JN3 WJR^8XO
M#E:8:F0NC>L[6(6XFWG,;=";PI4,UV4:T,TB<+?'5($M(/E>+RWC^IH^W=;]
MC2U*C[7MZ["58;X09)]$&,PZ.G<J/N.(&8GU97G\SXU<.G6OW;?M]BBV*U/+
M)87[CR%TBJI5)RX;9.83]\3!S'IMWC6YF;E5#IKO=F7$VQ0^(@O"_P 1$26=
MLP< R!D@F#'J,Q/JOQCDEU&+%CCC>1!M:5NI3RNQ>JC*C/[W.%I7F&[W B*Y
M7%=33(X[)]:)/W\I8Y.75V](YNI[*61=AA4])YP4B%*R*6RBQU\;("9&9CUR
M/AN5>A^QQA%%]X>J_$\+H=YS2(6$;QHR==-XY!8IL65*B3GNZ7\'/Y1@W-G+
M%Q:&;6U*C;=0:T]MJ7*!LD/M2^VU_P#VQ?:_L+Z>M#D8<HRMFEF7Z.987AWJ
M6A9B[H/\-9?C"P,"$B+K,O,Q5-2K:<HF^&1FSF#=HI9&DC,RCG3SG_.W/PT\
M@'VB:UAKT,^6MFP-:XM%EB%S94HJ\BR8NZ'+<"E4+4MX@6;6G50D]7/9XK](
M&,8(FZDS[+?;,C6+^,0>AVL_C>MRQ??W.KX3<Z&UZ,57VCTC+0N5$G5 4B'X
M!L:1.7(+(.XAQ]IW!^7U[/*;-2OPO"%>3;U>6#:HEHS<SPKZ1)K9].F,/O6]
M%M4*RF 4P77IZSKY<&YD.Q?Y>/"?T7M5:%#5#9//LZ0$I]N\O+NT&UZTRF[3
MO-4<F,3V3!1#[FGQ;8XDY5HJX4=IN8ZQ84*E,]VHLJ[>1"")AIB#8#?(EG4.
MSL(N5:N;NYG(F\/S+>KK96)I4;6B->GUAO:KSQ';Y(\/FDO!#9@"9!3$>K^I
M2Y-ALJXZ4NVV1JT2#%AR?-$:;1?*JT1'='D,X41+9 &7873.LY7)\301K7VY
M6<VIH5WC;TTUV6V9ZY Y_;1JJ98]L7:Z4#Y8"0Z3ZJ7?TKP/9W_F\T[4Z=6*
M]B,")G:);I9"Y',B/VTN[M1U'OF.\>MK<QM_)U,BC[CWM^C=38KT_:K\UB+1
M+(O;DE/XI@V!*%2+.G80S*]-NC5X]7O:MS,PU;6EEKN[<TVU4FVM2K7+#U%+
M+M6(J6!"W V$ME7B:!SM+J\OX[8/CE>Q;W01JTVEEU:A2%JS;@&EXT53&5V&
M_N(9^&TA/Z>MWDF5K4N5)XZ[)1I4^.Z%"[;2>SI5,VI)?M$+$29;AL$1P+ 4
MV%2;![?6Q:JZ]"S6X\^Y5V["+ -3F6<]?FOU[; F06ZFO[K*YGO3^3($OIZH
M\Q/D>=C8VA=M9Z"W+E3/L1<JLF#K,43RZ6/!*KDJ C)55ZF-[(F>CO?<HPZL
M5\BOOM)VE6 (Q+=@:E75$Y9VMH6+1A7395)J8YBUB4FP(GD5K9T<W"S^.;"<
M9]_0U\R$NL6*56\F.U5DVU'M"U$!1N F\4!+8K^$@.;&@Z_4NXB>(/Y@O5S-
M3*N1=J*TE92JN?2"[%RTVW<<%=%J%CG>ZF*CK:K$]GI_(:_),F,RDK,9I/.Z
MB(S"UP06>B],',)=9FPI:!_\9A0*N^9_6^8UGX#N.U^5\!Y+G@>A9R[::_&+
M5=FE0M4:>,P-;0><6'T=73U'!4JS["O51)^15OB;J7#;7'Q9SMU/ESW77\K=
M^E[[]NN/LOEJTTK*77HKZUKYG;&]3K)!2@*(Z9F?R]6*K-3\$;?PIT!S-"Q>
M8=J->LVIJ5_/FTNV&4Z\7?K^)4O=BA\T#Y_6).[H9.GS=WQ6XCSCEFE#W17?
ME\5LUJE2K3;-,6-8G%SZ\H0Q*0]W8LC+8'\0KJ*!4PYG:^+.YR#X9VLD-#1M
MZ2N<6+E';H:*!S5IQQHX^TU]AS;CJIS1%L-#Q )V>#+RUHXUP_!XMG8.Q^T^
M36<="P.H-D&H4CSUF5Z[V'3=: _?_C,78[U!S/)JEB8^+J\)Y9QS.Q4\BU-S
M*/1VR(\UV2&OBCI<0RJQ$;-"@G5UE6K#.X5=H#(\IDAP6%M\D^#NBF6N8<SF
M\$R\.GMU['=1+IY&T;OL4QWKL+=^,2/*8PK4[L@:@?&'FG.^T++O)\EY!P[Y
M%2" ]G ^_P#?=2LH[O&"?Q!L,/[/65PQ%GC!54<#R<%\%J7*$5MK,VV:MDW,
MJX+;6_1NKBLK/1<N5*.59AMN:#F3).^(FCH13Z\LYH[>H%6836QFED95-*;9
M$E7:Y=FK;GQ"35P+(,3ZL*(YQ?I%Q\Z>ORW@G/,4;]JYX;VAP^IGTV\;Y!17
MGL@<R_%5KXO(?:(&^V[J)=#D/B'R#3+%RM_GEFO:1D9A.U,/#;G8@Y%)[76*
MN>6I;N,"+FNR*54+$P"AB>WOG7+=M\<5?N\)XWAJ;&G<TZ-G8XKR^IR18VJ
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M0<4H "?;<7^0TU';?;4GLR_8H7-UZXLO2K[0]PU,.-8]Y+@OM]?!^QA6L/\
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M5MJ&^!$/%]_P_G]',,K]OC&K$W&';[<^U-=+M>I#5E_ ID-=%5I*9)CI/"
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M*1QFZ%(;:[CG^[:WJ:>P6541(G5@;GDZC,*M5A\4]TL_N0?EC]Y/['/\<-\
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M@A@4SU!E?O21-\G7\_PYZ>3ZEZ5*OW6G(#[GRU#F1ALSXP:G\2/PB'K$_O\
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M/NF(Z=?6PQ9BQ;,70-; *# P.BTA,"'J)"0S$B43,3$]8])_X2_^B/U)_/\
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MKF5B+N^("9&/I/3UN*4 +4O"TEK6L8 %@&>X0  'H(@(Q$",1$1$=(]<7_\
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M&P)0%</;$N2B59;[NZKWKQ%VI.<HKF>Q+!&5)R7L>F8A:Y*(O.6X;4G#_:J
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MUFJH3AWD(7?BL9,C,B70"G\^G2/5R?"_]KZ=L>\M]*G1$)_9OQ_P^LQYI_\
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M&;WXHKG+J_,&%8FT=>U$9FAXZS)BM[CEG&>5YV!3T.-5^.6P=QZ_H7JEE/(
MUC&#G2H9[UM1\L^L0H@+R?0OI_H>)"DZUG(#E>.SE5;%&^V\[C@C;]R/@RO\
MIV*\79SV6TT8)Q5P9)"28;$\35R;W'SX,+/'3]X4G=BQ"!^VZ921%<$.P;9&
M1'-B&29276?[.0HK.OU[#L342FQE5O>:E=K:3E@_.J0U,V;RB*&5$0U<M>(!
M!1,^KU"U4LJI4-EM3#TK^??R-/D&6O/S>FQIYFFQENK<9>F[389C7BY%,;PU
MEQ9ZGZVJ5'0TLRT_/L0JYD2L-()$).5TV-38A3K$#->'+7YU>665B78%;0^&
M76KRGWRN+_!\*+>FQ[2A9KZ;Y^)P<@.#]JBT_!FHJY&WU?<@132\EL&#'I@
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ML_.KE+1TRDG@VQ>SJBJ%*UYE-!J'HI(75$ZYJF402R[A8R"D:C:*,W*6=0O
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MD:.:%76G8E"W6U7;62#[PF'^3N/ZCF66#S0DB#QY^"66K)A:.=T9?7S=0'2
M=S'/!=25^H<-.3HHEP"%?B.E()\;<BT\ZD,$X<E;!V<*;5[O0%#=7288F>;.
M]9Z_Z"BAD\>1%FI<_CND3^!;H8CO$GT1KB-*A2-[TAD*^!7 -Z@S% 5% ]J
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MDV++4/ 8\V=K6%&;S\\C-5_L 6$ 0O'NS@-5S$L##2U%<>!L2L1]M$F4/H,
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MKH,'3TU)T[[.%;*>Y@UZ2=E'6[P$)R$*4-SG!(6%IYHZU/D11$QQ4_DL?L^
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M(_2^U'$KA94F:M2"1D+Y23(A<./I.WN'\"_*;9SZK[G.\NK2M:F,$+V;2'B
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MDVY*EPRL/')O-22^,/!-YB=7^*$48GF4,8+-Q5T#_P":/__:  P# 0 "  ,
M   0                                      D$D$$   $$  $@ @
M  @ D$@$   $  @D @    @ DD$D $$$$@@D@  @@$@D @ $$$$@@ $  $DD
M$$$D$ $D$ DD$   @@@$@D@@$D@   $  @ $@@@D @D@$@DDD@@  D@@D$$
M@  @@$@ D                                              O[$&D
M@             $D@@              #7:H0'@            _ RD@
M          @_IQ7M            GB3WI    @ @D   @$$DQ,1J+(
M $ @ $^=/#@     @$@  @  D$D  $$        $@ @$               $
M$ $@   $@      $ $@D$    $    &RLE  $D  $      @    $@@@  P
M  $    H"NNH $@   @     BH    $@%(MG8P  A(    8$     @ $
M$D,    $@ @?8X]MD\.(    #@  @ @  @    DKH    D "9 %CJK;-4  '
MH S4  $ @ D    DZ/    $@ K  D](K&!(  C**&P @   $@   @4-X
MD $    6.V&*   "_@8   @@ $    "_Y    $  $  %N-850X   4]H   @
M  $@0D%AX-X    D@$  $?Y$[CL     18   @@ D%@W:VB8    $D$@P%(Q
M)%=2PN ['Z"@  @  %@W= _@      D  @  %@  "P\8$#O#X   D  S1E&P
M$       D    EL        2E4    $   $DD @DD    $ $$@$%X @ D$
M         D @ @@$ D       $     $ @@$          $$@D@ @
M   $$ $ $ $$@            $D$ $@$         $D @@$D
M                                  __Q  I$0$! 0$!  $# P,$ P
M   !$2$ ,4$00%$@,&%0<:%@<("1@;'1_]H " $# 0$_$/\ F<H% "JH ?E7
M _OQ\JC3Q[AX-?(USM$D&L.!6BX%JX:\(@B(E$T1\1^1_0\&8UN,*51& 8C(
MG^A#1]'K.^Y,DNCGP6O"^&ZFNT6^Q$/1BG:46J7#Q"1L;KX=X 4A\Q8YU4"]
M&% >KGYC='/F YHE2UE.GCQL3,4QE++,H1<\*?EA]%FB0J!XK"1R5)S$:FZA
MER]KR(,T-J9 ^+A7LX#M-?<%S&*8BL4$$4 BUE;J4""O@R!13GWJ1\! 8] A
M ,@^C% 1 8 A5P%92@*/"V,(5)@%&,@B*%_H#\A3"HW1,+B3$X';G BR##I:
M=5; @011N97#<N%^X]LYN<%/6K +F[X,"@Y5/,4=K?!1X$:?2DK2T3<#%F_U
MPQB(E2M/=@0YHCOFKC=_*%8Z1+NX_D-5P50^Z4,.MWG7YNV19NTSG]S7K:E"
M)OULA6G4V#&"[5D\*G**<\OZHY#E*FD[%PO6W*^ZV8\0@;8[8\+A<[VC<()S
MBX"0WXHL\>H AXH_"*T:.H)0H^(7,PZ"U-+#]N !TEZ)1W&O'-]^C$X/1P)D
M1A%89"+U+#$J8HDL15"(@J%4&T.58ZK"XF"BY$%:Q 4D( 3X)A\&?D]01"02
MBFBJ.%B8!5^ ]R@E! X$!D^N !A& 4,"0)(V \!U%MD&4BJ !  - Y<"IY*E
MHB>__#P@!$")@C1"(D,N@90X@#B"$L85RBHJJ_<VP>VG1D9MB\R;'&CI=%UL
M2S4)$H\.&6:6@'57PZQP0)73$</<#I2Y2*2606]<,0AYZBFZ*O(PI(B;'(I'
M)AO:\2JPM[L]\*,428A9[?\ !;P+$M<2B/\ VA]K(-#H(.>J*\:3HUTUQ5 $
MC<[RZ<R@!>@"_A)$M<.D$6*>84@IU8*,;D0]<Y=@'JO:C(;>A'XIXM8 "Q"R
MM2@"']1_C$^8X_*N1ZUY]DT,6?E 8HHD"8@<2Z:VEMEAZJBA#P!R\VG&F^=P
M_4ZV$[QSF-W==:%IH@RV+)1N\H$\0;DJH.0*D7DX7J$2(%@4"4# T2_!I?60
MU5+T3 <2 B I-(#['GW8.5%P?B2"_P E/QRVWM7((B##\ -V'[Q3.F"$-!@3
M26J"':)8"P"3 +"%BI:_0:$V+(E," 53!JSM7BCJ(>HGR8T6.7$I@TI]5Y%/
MK-3MNXN*H@CJ,9;<GJ>S8HD0"4B HRI)29\GPC\4=.A5&@P@KD   M1S8!0E
M*(I;7/RD&?J1'J"!*P% JH!=<.HO5!"1B42B(EQQ_:7+-E0XUHO_  C]5Y*G
M3LH*HHCP:9]ZZ.616UA15AV>T:,Q2+9S*L&B_O@."[1(FL#-7-F7CT$-A14>
ML-X$1'BY(D*F@M2*4BBBO!XXC7BK&!C(,(:?>5MT F3(6KU'?H'[!^3]0*R3
MG(% X?,610K@F ^FVPU@CX,<DD279]I<8^Z*$C8(JS0**.S!.7<$K%&.$YH,
MG QZJ9T=)4KC G\KA;0HA2@T@$G##W=-4C65$>QRJAX:$ )H$41$B8]16]00
M0E(VT0B,>,J-F3LM->(H@6!3$P^]&0:(,?M,J(E&BL*%2J!^5AO,(W1&FC4)
MM8*H^<X^,&#$B,08C]V1'I4%]I("5;PFI5*3.29(!!XB9CHIP%.& 66 ?OA;
M6(<,^-70\-766OH^#"].M0       @ 8 8!@?H,0F[ B8 *4H0TD%MYU^1 S
MC3]!Q1:ZER'SQ#')S<HP],N Q)L26?BD)X('?"6ND$$@(3]!B#BX.I! %'8&
M5$90FDB4%01'*Z9O4"TBT!/HA;DLOQNF@BM39T+:BA:>V(3)+3Y1(<QNI3SC
M@%B5A0;D:K;)\_J:W5<Q#EOB&")#T<#4CV110!/T.+L02P/Q(<)ETHX !"55
M"]:BEI'&:HTT+@1M*4*B!]S74K&A*@@!2Y"^<2U@YKD0Q"%.W$LD'*%;4/3-
MJU%D)[4-AR?@JE"_O490@33\8A^0=,>#E"@7#X,0?!8?'Z2;2?E<1B#P2I/%
MY@>T3LUG<=KA?WX3DK!5%S% >#)PE?@8>VAA;J8*]U9'>4KN\C_LN<@DB5_2
M?3B[8#"5*NI;@UR%8/>2=%17#9Z_5E:.'!FU"%!$PBMY"3E_3DGR 0 1 GAF
M1UJEL$; KIQ=U6:&CPH&1^E;'!ATG%2AP=-%$A2L@=5/7 24^E! P]@H1X3&
MD3CKD@QFKO=]6R9N0^XRB!8D!/I9%>G&:OH N6)+JBG2>3\&I'G*TYA-VA-L
M,*5IZ=]P>B(<,J  "JH!J]0<#9>1"*[@,K1;""R!)[$;WV0BWE+I4'I2$P*L
M?*7".5[8?:[(\!L@2>:'\'^0!_/)CI;&+8FR*%)UMQHA?:.TP^(F40$9H0,2
MOHF>6V2V'/EC03MI,P8P0M$I5(*MBL<@EJ[19*J:]Z2X:M MC;1(Y(:-<Z 0
M\R)XM]>+22U3DD4[<&X=1-3#TL'GADA$>&RL7X^G[,^;R#.3&<_(_6_[#WHO
MQU83B8B(@*)JAP3.XBC_ (J>Y-!7CR&.E6NL(,1@@GES&9*F$ZP1L(-:7/U!
M4QZ"OW2X-C[AI'U5&469H!7B1MI/0^$)"4#49W9J&#"6$P=5X  ZB<Q5L] A
MZ;7H/_X.J9B]06G9E<PF-2Y6$ J*E^U,$\A_G_$/^O\ GB1^&T4+0H4"@SKJ
M"*G\@%#016CQN0P: V@^(]*Q\<4B/%5?]BG^569SVD2H2B!8B@6<="/P!/XW
MBJB%,>#@FFPYZT2XPA\"A'%,Z@A$N[[[!SF[ HI70%)B6H#PY$2'.4CPU00/
M28S T4!T*7:<?L91KYC!44SUN 1Q(::ZU8DGHY+@C;+B$Y(M"-*RJ$L)T?D0
M?1#BS)*XX]B+$ J]XDEL"8'6!8"Y]C!3*IJ^6DKD)%>&%8"!8DG*1$:.B_HJ
M J@!5< /5?@.!D&)$*$-)" >A=9@#D6$6"*=&!9G(E,81RZI#OB%-LBCLJ(7
MJ,<9> X@A&)$>*DD)"<ELD2BJ\> _L _]?;,>V(#ARO32X$*%/WA&/4LQ(4)
M&F!4 V%*'@Y.A-$5@4( 3A*5JBX"/E^FWOZI;>402HM95HV&X$K"11T^9WYQ
MR*FZSWUX9M8<HP@D1*CBR/O" <&(0U X-<:;RKXD!@-$0WQD313HN$=*09*"
M%P5*^?MY1'E1!"EH%V2N< #C10) (Q,1(ELWP#&0VA& #'[$B@VC"B8Q\9:4
M(%^C%* <K0J(6(%J$8G2_8,X:& M2[ &%8+4'-F2E+4/(Z1P:6$,KZ&..*D
M&]7+  P#<!.P0#9715%.2!D"EL!7T$BT:><,!HT!1_(!!_DX        @ 8
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MH%'!A7*U!Y&*>#L<(LK811#W*.\0PBW,'Y\BDZY)= 31S+A@X.3.A8A_P;
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M9; H?&1*!;WT+!0 V\K:F C%)51I?8@%XYR_'O\ MA$%3\WQLOP_[?2@ :
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M!E)W:A4"C@LG#.3;(Q!@K5GHA2@'"(B9XJ#OW(I!79*1F\L8- ].H"J %5T
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M7'G*G@,W*52J$5Q[>P%B+K1A'C;V'33AX8IJ7> D,.6N#."0 EV!4+%1B0-
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M$2JYD!%$%)_%+9A9/KO;UXGV>BO3@D\B7S^42@9__\0 )1 !  (" @(" P$
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MG*!>]95/=)X5SB_2K@G=.V2B6H:4=\UWJ#<3)Y&-/P:<FZ6,& $VE=5QK'?
MON0;0:Z>=S@-KP,"C86$MRH3ET;[UD[&*62/58IF9XX0I?5<TC<:F!0)1X5(
MJ7"6KA3O=G V2DK@=;X"BTMM4S'EE/TJ6+LEI  X31%)-B*'(>S'F VH>(((
M* %M4"V$%M!\1 P00#8B-/B<^A/\W>%B15LGGSF1+3QNA9Y#C(RYT10 8Q1C
M<=EJ^X$E]MD=E&'V<.!TC@W'5W&6ORXL*,0H@JHRJ[56U=KPKU&VD399*78!
MLHB?N#+=#CJVX^;X0+5.?5 794T\VB/0Z=F$)WB8LCL'2=!5M #1'I]]V^/L
M=@#N0K*^KQFV#2;6G3A^(^2,C 5N%H!$Y[LK3K:;SN.=EPK<Y03LCE8#!3%D
M02%DM2,>3L5BO51!"J1]+:\%HZ1*P%45I34LA'LX*0114%B0L"X;C0'P3N@6
M332OB&G0B;W6/QK>N+!!H_35JYM2A>@S^$!S@)J(JJMS&S\%RM5S2:D9%5A(
M2ZCL#,>T;QY4 Z$5#/92U$"F8&4Y-^03BS"#0XHV<^<"@4< 0EF_'NE-H!CL
MGI*YASO4Y/@TGY%P@(+*![-V#_E'&E+6(K1@'6_NJT9Z5,S)\K_M6 Y*Y@K@
M<2?8\\WHR,7(*#$:3[#A<$53Q;""S]Z""BM]Y";T0D3T<,@0A(0S50H0U<*2
M0& @ZVUKK1Q6C^$*E/V!,(XPVR4"J$IOPX'NPGWUJAQW)=9@^KG>_P G]Z(B
M4EV0K9.MMW6E /"0\S/ L61X#= S0$#, 4:41E'BHR;GS5C+ J%6^7 1K1[:
M:8[B6;S>.Z&.R!(^!@      #@.,[E!L!=_B@@W) !=V69QX7"_+W_\ 8A;)
M"L/^.U_8F ,0B'!T:UM**IRC_C0'_E+&#&G28F(F7L/$FN6WH6<089[[CJL_
M2/@!;NES4LKB=:&"5$.89RK"E]^7$G(<X,B0_P D+ 4_,?F"4(/:SQ:KD\^*
MC632Y"0[03!\;B(X?&C!<L4AEM9%I6[L,0DB#<=0994<TH-N-9/:6[+$N<85
MF=+'L+@P\0> . Q-5;W"@W33:9R,F0LYFDPXB+GDCH_1I&ES=U_#MP!8LV-L
M4'18KM7?#_L<!#6HW8+0VQM-:GW#=ILLJW@;>DBXLZ4U#CNL>L<^W#968R0>
MZL.A@X8&;187Q*),#SP#%J%O?\RO"'@HJI:%O8VX*GJ='BJ\18%2\S2%J3-[
MV1GM*VL5WZR143RWW&-(4K*(9M8;> R8%P3O3,011==U=#K>E'6^QMN./!Z:
M;4#8$S81GLR:9\(("?-"E>^D@M(TB$AK9Q)\(^ OF=!'D,0U'#C9'85RZ58E
M'D'4=/<'*)W%N*%J4JW[F1\@X.!5#^2D7AEP(@( QTBS"V/O1D2QQ%I9!5,2
M"Q):OEBX2?<()QY5S:Z&PN6>1QN5^=%$;;T#^#FL)/WI/LDNL"7O<13(^44+
M8(I":8+^J>E624AP'G'%SM[1TIQ4+0,"947&M'FT05MB/Z3M:'B1?F9==O:9
M!!_6;N (1&0RH!@Y9/[&@;-7UWJVJON@GP:'0=H06='P%_[W75/31#GK(9J3
M7SC2-"'VU9:CE*ONP!U7SJ5;TV8$CT?**C=K#PTC'7B[Y#F*AZI.NMB1?+XQ
MK/BYLJLT'P;V3F\F545BP(XW/F?Y8$K-+A+""YC4\U$GM/9(M4%9<+9#JO$_
MG$,+N2D@Z@(TAID8[.\]1V%C<C5.VGL:T\21:5D&D)%R?92WP'F]B81@?N$1
MCDHO"]%S1;\.[<CLJB,DRA)P?*1'X')#):/PU[U1T3LZ4A+2^SC SO!Y$J%I
MZ:%9(JV2H8LH0%'GYZF4:,W?X19P"1\&!2ZRZ) @PHHKH3T('T6ITN4.]-.L
M. Z?4M\J=L,AZAW#XY$-  ]E2FA_6UJ;52HHUW@7PC84@[]#Z>:6!V$!!>JZ
MKF.O+CDHPBBE:JX><G'L:!P\8,A*F#">;'18-1)"X@G24(2;0 =6]\/[&%/<
M%A6[!35N%* 9&_K*')48YCE6^,)+0"]18Z\40":+E;B<C5FMCAY.V0_P63J=
MD,UD?$1$ 7F ?9@[6HFRMS;)]8&_I)&%5W7#FQL>"T=@'P!NGNLC;Q+-?7>C
MDME"&50%GYO8P1HQ:@]J\1P1$FLX:(O1C\BGFEDM-T36IOU+ [@6ET</^*(V
M,+^U0QJ0#$EA+]GIT!LL790B**1C\R H"%+BRXY4:"2/A-,UVF?;@<M$0 -K
M3DVYV"WV:0+0SH@K4 %^^Z*K<%PG\@P/O,Q/Q^LJ#H/R91VT*AHP>*@5$8 R
M-!KK;0^-&'#(:+0=@<:D6HO2[YA.LA*#X!GS:@^+!^PG[(0\FG00"+.$#:Q#
MX!71]@W!2**X-%SA.\4!2$Q@WYRZ\>1YW'1FGF!)OOUT.-EIPJ.?>O;S91Z\
M"BG0+&AZ>STRC>C??YU6_O6OURY9&$8+(.'8K8JHN@5,9RT.:6?L0$^F_K;_
M .J]+8JSTZA:$8!;VL )2NJM51B< 4 6:$$18;T:;<+46V'%XUMI0]HG<->[
M>,CK,"&[@R.8O'0M0H@J6ZL5K&D'3]>=H*+A]Z%K0 @EIGTTNPDKK$L5>HW_
M # ;%,N@/I+OP(M*Z$( *"\MREH3Q*L* >&Q+EM,CCA!-B)THW/9E?(JJ:-Z
M.0W**3N#L*)>K\(18XM!/\S.E.BZJ67&%]3'E!T=N%ZV:XNFPZA@BY*Z:A-A
M6' -0I3P%XHF54XK5P.&TCJ91E@$5*$2F)X=MM\*X@#I[53?TE81+*(L=A(Q
M[:949<'!<P75NDRAH(T\YN1ZF_Z^: UGG%/8HN/D"T$DXB8^AH8,^(7S8>G6
MFECT-+69WQ^P+4@'CR51#8TG,F=07TD4/B-$9>!;W:=<O3),2B)(Z52>4,,6
MH34@2 @L)I%%^TCV*;X>BMIV$5&E=1M L@QU@4&^&*YB6A(CPCB[(4F&B53#
M P2Q2NDS$A2S/F'%/5@M0<H7U(*K&WN8>1<._P"(UAPS(#6WXY8%4QDA$7L:
MES1T(X/RW^S.^Z 9?CSKM)6=VR:.=CSR%1;:7D,M3R)#;6<J,H*RWZ*#8,3<
M%J=>( \1<76L(JY@%!>/;MMCV7.Y10##?#2&<N/G3@%F^'HJFX'1RT K0IPA
MOP642+K"Z)]Y6I69@%Q2W2]%6Z4;0!%PA6IVG+=Z($ ^4'L.)M$$:(AKKTOJ
M1#[M?<Q@'Q]93$:A) 2[LD4+'NR3OYH[*6-TP$J1#:W:NK]D(IK$K&U,DP!_
ME(QW(!][Q76[9H ^ARAO*3GR'6)Z#8Q#2UE,IT72* J%3/KBO>@1Z880?ZG-
ML]*C+<\S$OEG4)-X3OCW?24"=C<1O6 !TNPN6.S,*X" ,OZ8$"V!9Q/-JF*4
M-U6B4#!.'B5+&Q* CMP[-O"I-A1E  8C@X[Z))=I;&1M>DRX DCQ-)U4Y #O
M7].\"M;10I)'GQ*.0-;P6#1M&DY*+9." 9!]W-,>N9;R*C&O/Y%S%"ULLS(=
M0IV=@PN"/'*"X]E[NJ*V^_C.,B%80A2/3IQ''J7+!?/-D;K--(6(>V;KFZ40
M 5P'V0>,Z)VX2L;@K(91LPXE+O<I#^XUH]8P-A<TV=NQQ@% ! T5+@#79(X3
M0@HBB9K$:\K-,=H-1S0!4=828(=>2GXED&N 2_-,-0089/\ 0U[2#%J8$(<0
M(%QC".K*\933U<^+>A-)(JV$7"(?_&BK$E.5Y:N3;0I$1XD.$#HVB:CF;I'1
MQ9_Z@0D>A+G5F'(P&4C\E R*0-B,$TB(B:1$UR(..%/4J+X.* VJ#S6-[7O6
MA%:P-'4J-BU/4K(/SVH3R8">D$FC1=W;Y2C!*VMH7R<7G&=N?R145]4D#/>1
MV!%;.^890$@!XWZ&A(*@/6FX9*ROL"SHNUN,L>YIR+)B$!<#@ 6#QI \X19U
M%+_<)V0$AT[999Y>'AQM)W^NWA:<_H0"?O=CX$+20BYL+FJP\=06,7@UFJ7-
M^08J(L&S0("0I B(@B4[X$^36+ DS_Q?7%^\?0?.*$X#;;1[T"&]6)6R.AL_
M3<!;/A[Q*\I>]A:,PH 'S5[E22I6PQ7K)3)D8SX0$ @$ 'L01_8Z86*!:K0%
MKVM=K[>\GRISKFX]K-K\V%;N'HRJ3;NL= Y*=V9L,A0,'DIE\<=U+ 0<I'%$
M01I$41-B/3R#=AU&?VT%2Z02U/O0>]"J;QLXJU?4^<?=6?3Q7U."Y$(W*.=>
MXX5:MAP0(?&WFDQW<L#$ R69U1C7;Q,!QABM7+N4(P(\&!MQO<Y'Q[S[7D8Q
MU%BSV6BC#.! H:_,H3QE"*L',"&:H$U1@M3/(;T5_);P)T[I%@F^A#IP8/P%
M2_#WO\<#N@C1*4"4>M(TR=-L(J)#3X9<!*ME2E9_23@8^$[HB@NRR=.\P=_B
M"F2PBJ*@'"#D$IGMRFW! )F0=&ET-B2U;@2B:(42/?Y &7N4 5W3NJ"W$_0:
M28O_ &)IE0W*8O,A&U,X115!SP0!7$2-@:8LA]U:A)13OBBW0T4'(VA7'#\[
M( M<C#*&<GM#T)P7;@[BZV/^I8*K$(GP6RA>B;$X+&+0X:@;1@=HE*="G@P>
M4H43(L?!;2D_%1#>;QB@1AN]4 &M6!2,#$P%6/SS]FQ^"CNE&O/Y&=,42X5A
M7UX2Y.1,"?C4L?Q7,30HCA$>FP*DLUY M95;9%R5@KF,N'\(HN1O6*+;>8DY
M8^MNJ"C7?;I&^*B_660EQZ'8_/\ TD"=)X\*3#+/>I@YM246#0&YE2I2).2-
MSE3_ (UAA[BNPU73[T;.M,53HT]&S[:"BNZAF2*UB#:/D%TSN'O?D- D%%7X
MYOY$$;>CNRP!&<UR)J.6B%-\+F]O@-9[FVU28'T)FBY2F!;X?FUE " 2M?"6
MZQ,\>8>OH5A.SPZ6&1&9D@%-W ,DJ#]\.?Q:&J1$IWRI6(]><!NW1R)#'TX:
M_P"E$2&/J?\ >8?-Z3D*.-.6\+*D#"@YNJ-SK-9:]T+H[55!&WLU@FJ]WEZ>
M)ZEK#.'-Y8S-O^(*N<E7 K;E*F,[M)IW3B3F&$%^O+JS(?P'OZO@R34@BJX
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8<'UHE(FP]F/370Z3_-W;40EV"-*?V?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>businessfigure3a1a.jpg
<TEXT>
begin 644 businessfigure3a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X0W817AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(Q.C S.C$R(# X.C4Y.C0W  $
M : #  $    !          @   $$  $      0   0$$  $    J     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   "]#         @ "  ( /_8_^  $$I&248
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M[.,_+D\^]2\MQ'*YSBD/VL5LSW:BBBO'-S+U(ZL)\V 0Q;!P<9W?-ZD?[/\
MGI$K:UY,A>,;]XP%*=,GISZ8Z^]<[XZU^_TVZ@6PO BI&SNL9!;<.S?X5RR?
M'&6,*MQH@)"'+)-U;MQCI7H0PM:=-2A%/\SL6&JNFII)W/1Y'\1%6VQ0!N2N
M&!S\O YQSD9^AJW#_:HF\N;RS$/^6J8R>_3]/QKS&#XY(+"0W.C/]M!^18Y/
MD(]R>1^594GQ@UK5KN.UBMXK"%FY:,EGZ=,GC]*M8'$2=G!(<<-5D[<J1[;9
M&X:U4W2[9LMD<=,G'3CIBK%8WA74I-6\.VMU-*DDQW*[+Z@D<^^,5LUY]2+C
M-Q?0Y)Q<9-,H:U:M>:3/"@)<C*@=R.:XZSTIY(6$SO 1]Y&&./H:] JG>P"7
M#>0DC+T)%$965C-JYQR:9HD@%A/90,P.[=L !/K4OV2*P,LS6L#H5V*44;OI
M6A>1WIN3.EC$\A&-S**6T6_\Y9)+.-67H0O2GSA8P=.M+[?*UE9_(#DIMP*[
M32;:5+%#>1()R23QDCTJU;&4K^\0+]*GI2E<:5ANQ?[H_*N%N])FCUJ9661(
MF<E).W/O7>5',@DB9"@<'J#2C*P-7.(?3K"SF,]W''<DC;N902*7^P[&.-?L
M%I:B)F#LA4<FMN^MYC!Y*6<;1@Y"E>]4%74F.QK"$)[*!5<XK&1=QFZU)6M+
M/;(#M!5,9_&NCT:WU47#+<J;>$#^''S&M&R-R%57A50!@ #&*T:3G=6!1(!;
M<Y,TI_X%7EGQ-TFYAU6*\B6XEADM]F[E@C#MGMGK7K5(0""" 0>QK7"XAX>H
MJB5S2,N5W/EC3Q%<[X[D!V#<;NM/?3=EVSI'&4/&WTKWX^$=,L_M9L]+MU^U
M@B;C.X=<<]/PK%/@Z*+"1Z/9LHSR\>X_F>:]K^V:7\K-?:KL>.):6"W*PM G
MF?>Y'2NW\,Z1KMCK%C<Z?8SQ+,R[I=F$:(D$Y/IBN]TSPM;VUN;=M*M#$7#D
M21A_F'0_-FNMB#+&%8 8& !VK"OFRG%QA'?N2ZMU9(C^S<?Z^;_OJL+QAH\V
MH^&[B*"2>25"LJ1@CY\'./?C/Z5TE%>/3FZ<U-=#%JZL?.>I6,D$K33(XPN6
MAE4C/X&J,FGZ.EJ)I+!5!;E=N"IKZ'U+1[*^GBN9K&">>+[CNN2,<CZU@ZAH
MBSWDETVD6DTTG#-)$&W?4'C\:]N.<1LKQ9RO#/HSQY+?3;2W:XCMU8284_*,
MUMZ;I%Q?VCG3;%I40#<(@.,UZ'8Z.\-\EVNDVD4Z#"O'$!MXQP!QT[UU%C$T
M,>T0QQ*3DA%"C/KQ45,V37N1U\V..'[LH>'8-4.AV_\ :D\JW.#E>,@9XR<=
M<5J?90>LTQ_X'4]%>-.7-)R[G2E96/$_$&F7-IJ5W!)YH_?,RR,#\X)R#GO7
M/0V%K-.XN(4=U[XZU]"WMG!?VCVUQ$LL;]5:N=O?#,#6:6L5A#Y,;%D SD$]
M>>M>O2S1*-I+4]>&9144I1U/'/LEJR^7!:QD YPPYS4MK:I-<B.*T5KF0[!M
M7DUZ6?"S.2ITNT52>J)M/YBNAT[2Q;O%)]BMD>)=J.(QN4>@/6JEFL+:18Y9
MG&VD3GOA]I^K:7-<VUQ#+'9GYMLBXP_'3\*[V@9QSUHKR:]5UIN;5CS:U7VL
MW-JP5DW6@QW4KN;V]C$C;F6.7 /.?3C\*UJ*R,C+;1(S>+<K=W:,O1!+\O;M
M^%1C0" G_$TU$E<<F49/MTK8HH R[;1OL]RL_P#:%[)ABQ227*GZ\=JU***
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M;&-M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                            ]M8  0    #3+6QC;7,
M                                                  UD97-C   !
M(    $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:
M   !V    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G
M5%)#   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6
M "1D;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $<
M20!- %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M    #&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !8
M65H@        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP
M_9#___NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M    ))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P
M  )F9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T
M )F:   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!-
M %!M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1
M" !E ET# 1$  A$! Q$!_\0 '@ !  (" P$! 0            8'!0@#! D"
M 0K_Q  < 0$  04! 0              ! $" P4&!PC_V@ , P$  A #$
M ??P @<K%P59/'6+2+)-@OPN6WKU6/#RX/);*L-X  P.6R&R+._97(6UZ%U.
MK<Q]ULTCY/@E.&\ #J9*T?U\K]M2[6XXAM,D[TV*&;7+ULB\.0BU?T.>V.;C
M\E  %$=KJ^IDMRL:_$RK)YI)44V>#HYK+OX[9U5TD*=:>1+-9(  KO>[:*[*
M=^DGUL'@R7]#-EZ&?+.M/K?VRS"S)5E:#3@ #3CH8&=Q7_!R*1[)3,VUR&.Z
M$2,>ZO.SOM4  4?LXU33L7>LK*\%\5SV<)^59>BS-?GMZ#F  P<J[0+V[<XF
MYLOP4*D^QE=B-3K9J_=K/0[+JY2+;?,Q\_#L  \]/>.1KO=1KNX_98/8X(O,
MQR*)D[&*Z&;./N?Y/T75R6W3R.R  UT[CJ]<N]Z^Q]+J\M"BQC93NG=7EI3+
MTI<''\U%-E/V=\]XP #JUI Y6&Q(F?Z  (IGQ\%:3*/E  %?RL,NP9,E9< !
MC[K8#*Q6=#S@ "L][FGFHQ9##0 #JY%:;[-:O.X0 !6710NGEMMGF)X 'X:V
M>@Z78'AMODX]X '!?="-OLY]I=4  (EL]CDX\?-1(P %/SX]62<>A>^A\^*[
MJYJ;"Z[-2TG%0NPPJV;X:;/Z,<QN  (_DLH38QM#-_$CM$BMK*Z79F-=J]M(
MU42\6\FIO]/.3W4BQW@"*;"_^<#[V[?)^8\_M?YMK)#CIB;J[*<[9I1W=^F'
M=R;!](ZK^A/X;XRV^:P  >(OU_YIJMVT6VN&Z6;:^_7GK8OH_P"-[C1[U'4:
M>>A0KMB:?UT^<.PW]\1ZL #1#V3UOSL]G]LO#SCQ"6Z;4TWO=GN[Y_R^OO3;
M?6OL^EK+M/1=X_/N=];/FOYS &(OMU1W,##W7>8?50*SSV8)3LT<Y*K+K:AW
M[NZ?-O7S6VC]'PI\'%556SB8'-;YY])#UTGX<!6G%1R533%=Q5>C7/9]^>>V
MDYC90!J!ZEL?'CZQZG4K4\U%\<;EJQ5J07HC:P"[8KL>H_H6^,.7W \T@@#6
M[O\ 3>9GT+Q6D?HL/3#K)/S<ZE+\U7!EV.'I6_/#Q/4+POH_4#YT[< 1Z=+\
MXO=O>-(/2_2-+^KU4:QZCL5S=?'C^ZW=>^-;&&9NQQL?WE^0/F'Z *LF1_/#
MI-1(\>7N6UM"'*^:5Z63'EK+\K8URVD*[=?*E^#)MCIYW.#A4\N>MT7TOS5E
MV6QY;B@2JVEQ_P!K2\-?)U"W6OL6-EG&')?&DG]BC]/JC^>[[_[F)9\D;JG,
M.%$<J)9*3.R_N9\^<PV2Z_//N1A^T_QAR&:P6\9RGE+]1<!1'H.EH3K]=9G.
M;'#9F*OR=G+%M[GI?&2B'7%2[/4+YC[Z[N W'T?)JEZKZ7HO[=]"5;T,;$5C
M<T*[M8Y4@MNC,N/EX^.5195;[S%ZQ?._A^]/CWEH'7K3S9ZG2W1 F6'%S5--
MCR'%?+<.2#R,5&["+B+[;8B9K<A9]F]3. &E.^UD3S6[!ZR9 I.*+9<=T0)5
M=RL-8R\%;2L%KQ,V>LOW=Y[9<RH'BA]7=/H_ZMM:WSV[&8+N.ZD*RTS,?)%:
MVV#6EA:?#BL5O] 'Q+Q\G@V ::>L<YY=?1G#_%*T#V&MV/XC:4AU,&VN>EX:
M39U\E+XX_9=+/;ZB?.7;[$\)N (%N=IXD_6?UIV<.6L^@ASS2R,?)IB)-G6N
MQ=:^+EXV2X.<B[:^;^;^@_B'BX _"IIL? WVQJ^V-Y+9S'RX7)99$?+*L=\P
MP9   (7(Q55+PYS#?1LZ-:43/U;J2+'=,\62?QLOV  8?/=IWZ/L?)WZ#W&]
M_E6MU<]!V$[YV-%-A)GVCB6%AM]._!=-)X%@  AVUC>7WT9Q%Z\-M]6^_P!-
MG=3([V.[YSV["\=L]I_/-U9G/S0 !!-SM-#/9O98[GCQO+GC>6WNQXF#V&_V
M/XWA+5TVMW"\RX+]  /PC:E:UI5U]M:F)JG5%H4K9]E9ZN[0  ,6I75:5?=;
M6-42JE-%G46A;=8U*Y=4  =<@JE8W6U?=2!59&BR"T;+K*I64*_H !\D24K.
MZE776UP=2JP:+1MK9UMTX.94  812N*TJ^ZVLZHW5,J+/I6S[*V$KD%0 ,81
MPBZGZ8BJ3'5HE1Q$J5[(  *_.TI"C$DQJZ:DJI7@5E)WS] ,$8XX"3G14CYU
M3E/@^E>^20[X (:=XZ9D5,01T^3)G.<"N?) =@ B)VSHF=4Z)@3@.Z%>H94D
MQV@ 18U0,H2<@)D#%G(88O4O\  &J!&";$+.^8LZ)V#D-V3Z (B:2$[, 9@^
MS"D_(@<9SDX-H0 5 :R&3.4D)'#($H(V1TDY9A?X!5IJT<QF#L'0,B9,Z1@#
MM%K&Q
M                      /_Q  J$  " @(" 00" @(# 0     $!0,& 0(
M!R ($A,4$!$5%A<Q(28S</_:  @! 0 !!0+\ZV11NO'M"@ID$^5,3R[O7 32
M; I$9;V]#&SBN=?F*'GC*@6-QFOGNR$C8SW!%!&7:4@ ;EZM0Q#VA&6LGMJ(
M=9+=ZY# "W!99-;# E>,\T8T 79E/808[*J.5R"WU^S;!=F4TX^*T(YK"O['
MJ+,L/LNI,(B)]!H,WBNP)M=L;Z^*[LFHM&:[M"FM(J_V'4[,8;VC2EK,NVH
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MIM$&J9'D_P"K G[07J8G#?\ QH-BH&]01F89=6;GU@OJ#[6">GI32B^H-I"
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M;CVF8*+DV&%J(F.7-8GA<6O\>'MQT\\HS1PR.OBJDCYX(*DJP*D<018CX>T
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M]'\SPJU97K!,PONH8=^(_)I#+&&;Q" J#P=L4?0CH]#"%JUJZV;ZTIG-./\
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M2R%8CP/#<A<S+=H413KR2ZD;JTY(=2TZ>I+)IT1FNPFW#9>O%-6C&Z6*61'
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MWH,?Z=F/SXKZ#6B+&=C9[^P.\: ?U;6W,?\ 4!\CQ<T*"5<T_J9!]EF8Q/\
M+ON9#\",K\5'CQ5Y>/O7),#RC@.2?FSLN!]P!/S'$6BZ?$V[I&3X"9MZC_2
MH/\ JSP*50!@E>&/</>1%4Y\CD>'?\/V3;1-*%]WJ/M^[<<?1TF"O:U73*MM
M^G5LZA3@LR9V[*\UB..9]WEMC9CGRQGCU:&DL=.K"E>K445Z]>)0L<,4?LI&
MBCL  /O8Y8DL2>.?^3J'-YAD5Q1U2FO234>GU!8ASGU:U&"K.D39Z$N\R1;F
M7#1L%$7H:<Q-UN8$$WV1%I[M"/\ ,SV4<_Z4[?/C2?0]9,\QUW48XJL;$0KI
MIZL]D9[.7GC"5DQ]EHY923@JF-QY@]$AAKFSRY9GM2I[^GW3")95^-:PBPQE
MQ_\ 9E1=X]V7< C:'Z+>8M3D/[QC_<E9/&2VG4L2'X0U4<,?F\KQ1_RESVXI
M>AS2X)^I?U6W>@ [5X8$IEC_ ,2;JV6V^>V-4;^L>?+G*>@\L7SJ6DTBEOIM
M$)K$TEIHHV_B>K]7/0>0>R94^LVY0,$9PQ/4W*ZK+%,A26*50\<T4BX>.6-L
MK(DBG:ZD$$$]N.<=-JZ1S5K^F4?_ )2GJEJ&NN<].(2$K#GSZ /1R>_L=^_T
MN1O5DY Y?&G;4C>*S)<*]F?4?6IDM-*?%G&R-%SDB!80/8QQI^A5^9-+U"EK
M$?K.E61ZM)7SAI)%Q()HY.YADK-LDAE3VQ+_ $[@T7^SQRP)G>;7=<EKDYC@
M1*,,B#X26#%,),?%:\6?@.)/]G;3OWK"\7,5K]R>]8K2UHSJI(/\*&S'BIM?
MM]>]=6C[_42]CQJ'H+Y#M47KTJ^H:9;V8AU"._/;=9 .S3UK+-7F0M_$2):S
M$9$<D9P>*WH YO?4_5K5K2JVF+)[6JI9Z^^'/OPT%"VC,1_A3"! W9I@/:-?
M_9^Y-C,)GU#F"UTR#,.O2@CL8\5VI2:2%&\/8F9P/\3/M<4O1UR+I\E6:IRO
MI:3TW22O-(DUB598R"DK-8FE$LB, ZM*'PX##! XYA#PW3M9MKJLH[DX+$AO
MG[RD_CQZ;(:WK_+MM0GK]K3)UN$8WR0UK CI22^9;!GA5V[F.%$SMC&/H^B.
MK4,NLWV57U"I'5BJ[AEH(;/7Z\T?\KN8TAWCVE1F4$"0YK"6S.:^%=90ZRK(
M-\;0X^L$J'(D1E."C [LX/&K>A:&6])-I6LI3I2L7]5LU9)I*VXY,<+QR*)8
MA_AB3INJX5GD(WG4?0S>BC5M*UBM<DR \-R!J/8^+I*LEE3M\2C!#CW2Q]DT
M_0UI"U5&H:KJ$MTK]8],0158W^$<<T,LLJKX;G>,OX[(_#C6O1?S-I]TPZ=5
M?6:<A_L]NML4X/V;4+R9K2+X,2QA;WDE/<+IWH9M2UEDU/68J=IQGU:M5]<6
M'^F2P;$"NV/>$2L@/NRN._%#T2<IUJXCO&_J5G[=@V337/PB@@R$7_\ 9),W
MS'DFET]%TV&EI-<5:D/LK"I9LLWM&61VR\LKGWY')+''@ !QZ1*<%WE&W;M*
MOK.ESU9:4Y]]/6+,5>:N&]XQS))O,?N]2)'QD?1CC:5UC099C@?]S\AXGB+3
M^B=X?+;2/# [C'8>/Y_EQ!U*=F.Q@N$)WCS*,-K8^>.X^?$=B"?!BE4D_9SA
M_P 4/M#'GV_3COY=^/'@LJD*6 9O=4D9./@,Y/X<$XR3V [DGL /G\.(Y8YA
MNBD20#L2A# 'X''AQ?F"1;,^VY7 \PH.2Q^ [8'QXFZ<T+(2._YY\OR/!4@D
M? [?QXVG]<<8\>X[<8'?OQ@?'RXBTPLH:1\%L':/(>/M'X_(>'$]>0DGQXJW
MX9HE$CK%*  Z.=OM#MN4GLRMX]CD>!''X\?AP2J LQ"@>)) 'YGL.,_#\/G]
MW FB,AB$L?5'C&&!<?Z?'[^))!$A=S@ ?B3_ "CXD^';A90WO$ G_KQ:C$4Q
M"^Z?:'X_^OT>5_1/K_,5"+59)ZND4+ WTY+@E>Q;CSCKPUH5+"!B#TY9GB$N
M-T0="'X3<(H(W<RM%!!$\K##3/%$D;3,.^&E92[#O@MC)\>)H2KG/Q)4^1!_
M[>? 4<$9XVX_9[WAX>'"QDD =V)PH'F3Y<1PJ@B[C=&$^![J!^?<<>E;E8\L
M\U3M'-)8IZV)-8K22G,J-9L3>M5Y&^V8;(?9)C+PO$6^LW_1Y*Y U#G#UFT+
M":=I--UBL7I(S,TD[+O]5J0!DZTP0AY"TD<<*,A=]SHC<NZ$O+NDC0J5F>W"
M+=BV9IT5)"\XB1D2-&98XP(5.-S$L78MW '+EP4XY*-OZK=(98)&&$;<%#QL
MW@K>R&0GL02,Y SOSX$$?$$$?IQNXW<;^'ECC"EY$CW'"[W5=Q^ R1D_(<9)
M\N.8)8YK'LLK=-!'D'/M L6Q]Q;''I6Y?@NZ''S(I9+VD-6HS]SLGTZS/((A
MM^S)6MS>RPQOCL.'SLCQ]#3=-NZO=@T_3X&LV[+[(HEP/ %F9F)"I&B@O)(Y
M"(BEF( XY/Y-O<J79[=N_6L/9HM4>G5$K(LC2PRAWFD6,/TND0NR/NS=FVCV
MM-E]7M!Y1M216C+^2EL$$_TY&#\ <\8##([@^8[C\/+AHL^''2'AP8>!#P(1
MX\6E'3"'Q+ _@,\<U<MGF#0;NFI*T,OLW*I!]A[599&BBF'G%+N9#_([)*,[
M,'P['Q'T*$BQV4+># IGX%A@?KV_']AD7.#QNBR,':WDP[$'RP1X<6[5H_5F
M>0H?$9QG[R,$_B>(=3M0J$60E1X!P'Q]Q;)_7@N]D[W8L_\ -GN,>&/#&/+&
M.+1L],*\TKI_*SL1V^/Q_'/%4L#E2RGXJ2/^7![COW^_QX>JS'*DCBU6^H:4
MC#I@D_SC.#GYCL0?S\OH#L1PCK(BNONN,C_W\O#AG"^/&Z(^('Y<36;$28AG
MD5?( CL/D2"1^!X@NV(&+)(^6[MN.\-]X;/Y^/#7)K8Q*V1Y*  N?C@=L_,\
M?VE(B(YY43'NK(V,?+X?ACB'._SSG.<G.?CGQS\_'A"S*-Y+?YB3_P SQ-!U
M#VX]4+C9(,CP5O-3\0?R[>!X8!693]G(_$'''L_#R_7C([=OOXR.W;[_ )_]
MN*L]6UIVFV:!1J$VGTGIF+'3%;U>,1(H'8=)1TF7Q1D9" 01PG$@QP:\3'=@
MCY*<#_T_#@5(9!@#9C[2GO\ CG.>$HQQ'.2[>18#M]R^&?O_ $X>K"QR4[^>
MTE0?P'_3'&4$?1")T_Y,9'W_ '_/QX5(XSF- I^/?/ZYQ^'&YOCQSAR7IW.U
M2.&V[UM1JI*NFZ@A_@-+ANE9B/LSU'D53(OLRQY=X9%)8/:K2TK5BE9398J6
M)JUA <A98)&BD4'SPZD9\\9X]GX>?Z<>S\_']./9[^/RX]$>I5;/)DNG0LHN
M:9J5N2W%V#F*\5>K9^)5EC>N6\F@P?%<TI L^3\>)98)(/9"[\<#4;U&1L%E
MC8_ %#\.Q&,_/QX?F&8X;>VX?#L/R';]./\ >6RPVOL'S5-K$??_ -@.$UW
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M6N>E;DVG7:Q'?&H/MS'4I1S-8E;R0B6.*.')[,\S(%^9[<#TYZ$T)9]!U9+
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M*G5\4D.UXJ@]$2L6O%DOC4Z_J*=UU?@RO6+.6&JA1-*LF$0;(FQ<";/[/-L
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M>QPT5RZV+-L%$QY P PG7>6HSJ6LQML:;8XM8F2?"KE&NSSPE7.5P<>3^]W
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M.8JOM\Q>Q=RO6WZ;?,FDO+[IG\,<VSU?E_%\NCHW%G7M5S)+4N&5L!@3M(#
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M!R[67[EJH&/2&O=LV%N;RA\]*PO;/Y5E/;JG'AFV1>)Z8!-Y]RRT:F<G9^T
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M@>8[""PG(<(W83N6KA>8/QM)I!I%56%?,L\S=K&W9%O$C%/-U<7%V' S@NO
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M;'0<[4[H!7F&#3,(>)9/!J\LBAAM0P%]*$OUCDL#['GL?209K0[_ #QF:Y6
MSZQJY+)7RW?"7PB*A0@7QTLKP)0]!=9NB%D#].4EV1O:6E/)9B^\BW:LME&
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M=J\A@ [!^V$]_"9'=@O$G!G$<F  ,):,D\DX2@S99\==;(VC;#1@@F*(D@X
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M8/06$%X*^.6$1!LWW3F2#0SGNNB$P3?W+\N[:HL0XE-,JGQ?^&_)I<6)_]H
M# ,!  (  P   !  5>TS$  #IEQZ@ "?9Q5/@ "+X9F<  01R!N   >#Z;L
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M"0 2 "2"222
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MVW]D/YQGGCH!3>TUK\Q.3L/V>8?3F CL$ADQ1=F,\,P$]A1F@)E.V%R61
M@ !X# ?0'.^.0D6S2)0,Z<&&(B,1)ZYZ?/CVRHS-XWWKO/>-:3OF_P#6<_F.
M(.'D^7[]?;CD(>#?X?M[<-0_MST;Q,_OY&EX=6Q @.FL'HH&,X><!3P:8%=4
M&P#@% %&A5AZ%A]#3_+%3!MS!"-++B"BP";*@3M%)DO&(2GWNW/;Z<2G8*6^
MEQ[=82\P5C\IZ_GP\;)7+5QO$31B]XKUR4$SC_HS.KC>#>.,2R08S>)7J[Q[
M7'$%-@E]??/MXNCD"1LK1&PI 6V @Q3<&"L(P%JN(J$G-XX^O;@;[ACP ?\
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M8/\ JXPG91$!""#QGR(-'##C8EEGD8>!8 [C2N0"3@_&(H&L*L=9 V@XM&@
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M 0(& @,! 0     !$2$Q $%187$@@9&AL?#!T3#A\1!P_]H " $" 0$_$/\
MU8*:] %SNV2]!IR#7N <$4U3-41@5'2X:EFT$""4\$SPR.&8(%BE3A@5!2<
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ME" *M!-+"> "@.%CN(11R5!X"K(2LU]0)"YM!SI>(S65A^02A6W,#DI10A:
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MOOW>^$,+(XOC_N?3.7CL#!UEAXS^;Q(N"F2YR^+].&(!0;Y4V?B^'3Q6+D.
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MY]][]?\ !B]R_;^^>29\Z@XG\UN/5X!B?B;_ !^WA.[W_KGN5\];\,=??O\
M\ ZST'?[]7SQW_7SUZ<\S'[U_O/Y_P  F*4!I/=OX,_Q0CXQ]C^M:W,<^_[U
MZ_7ECH^Z_OKZ=_\ BCO'MY_O[F>/^S-ES//^[YYXZ>_ZU_WZ_P"&OE^O/4_?
MWZ]\]1_?WY]WE?+]>+<O^2O+]?'/4_?W^]\]3[']<KY]/EX_R5\N[\_/OROG
MT_?WM\O*^?/WW_E%-/KSU'GJ/*^?W3]>_.W/^:OGE?/_ -K_ /_$ "D0 0$
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M:+S:7EKU0G?&B<\YI;LQJCNMO*S2XFR!TX8A!+,*A<(JPD06$X=/@/"#P9:
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M6FX=%#47ZE_@#XC$_P C+L_*R@L%@6XS#XY(*$PK8DA5>Z>DNYJ_&$8&;0
M$1-V\WG672"0:U->[%V=G/,;H[*E$O+'6DX/D-,P%BY"R\>^#:\9&N]((I3)
M2[Y=?P@@V'5HG.PWIUWB'0P*3CA?>.2@T GS1O*J2F*%Z%CDKNT_AG')B.I!
MCR;$-%@PX#[<CV0ACR ,*-(OO?N\<?UC[PF<=T:C9U7?US<H:V-\(!U?I^^<
MBPJKW+])PK>=28U!Y#?::UZN]?XPEAE)I#?MG;7OG"@HT,^.>S_WQK&5^ANX
ML) MT%0TBB:!RXP"?9=("Y+A$-"''P.VU8A3AB)3!KS Z0,O7X#X%28GI47Z
MG@PZR#((U!41E2LK@YB1214CB-M&08>X2 N* K2%A#8"FZ#4K6CD(8ZK(L&"
M7>EAC0[B6= K40@H18:<5M^;GG'59Z1+84"Q_),-8:YH2 "A#29%>\71SX5R
M_954(!DA*NYI5]HS+);%>VPVVRAV!JP%N3,1O8#%F>PZIL)R)T$H9R@S%QHU
M00CN0J G9.,\%2QP  \ANR;HZY:.L8. \WL+$&]:(,&T!X9@ "H#3AA3SY,P
MP>F)*!DFC.] $#9=\CX3(B6[&!FN@8MQ:"IX0+YC1 LHTP5"(MG>Q;S<.LTK
MYU(@J)H0!<<RF.?-.]M^#"P+ $[)3_OQ',@->/&#GT+QTMK=)\184Y):<02Q
M!W"1G !5(F*2W2]IC$@<:EMK-EI5Y(1V ]/4!$YR%?+J"]!!V2212!.."UME
M9X0%O-HG.#!)IY@%W * ,V2Y@?4[6 U3PX#JF$BZF!GB=#;?YL "(;EDX0]'
M7#IT1+BG%SXN>MJI""!VJ:#V7# 50%$=S3!H/BSU3&3 ILSP^X74]2# 'M"?
MR>38SF,^YK 2$H 1/@#0P->W:<3$E4,=GQ.?1MYUFFETDG$YY9ZOKV&4$ZR
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(1+\/_LW'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>businessfigure4a1a.jpg
<TEXT>
begin 644 businessfigure4a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
M))\   ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F
M9@  \J<   U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:
M   F9P  #UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M
M;'5C          $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" #Q
M EH# 1$  A$! Q$!_\0 '@ !  (" P$! 0            8'!0@#! D""@'_
MQ  < 0$  04! 0              ! $#!08' @C_V@ , P$  A #$    ??P
M                       $6O6O'+=-1T,S^#Z=:;JX3,>S.D[?8\:2
M                             !T?7G\S?4.<:JY;& "[8$S]07+.E2VS
M>                                 'G=LFO^'.]:9VJ.G6@R7GU#[]G
MV+TS;?4[0=^TXG8R2$S,R4D64<AT":D2,L5R9<EQL,
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M6I!8N<E*]:M/A3N4]:]9+'^,NZZAJCE\7+;-WT2UO/\ KQIVV9;Q[
M       &!@Y/S)G8[+D$-GE*-5S1GZ+%K2M%+L*Z(46 9 W7       ,#,Q\
M>EX^?XC8.G[\]#WYS=FX ->\CC_S(=2YO%KML ;V8'-?HMYKT'Z5IDLXXSOG
M5( 6&?)U"0@   &G<.7I+R_I>R_1N?;79K#:Z8O)T9KFP[ ;)KNX\^!D%0-2
M2#&2)0;!DR!CC(@XSY.8       &%F8[OV)=/[=H5CZON' D93Q3+QY@ _/E
MT70M,<UB<GXK]*_"G6K2M)<;])/+.F[@8+-:G2(G"8LY"VB"D&,P1(W].X
M :,87,:"<@ZUDM[T?URW73;>DQ].L+F/.[G/0\3A\O>_1^=>NNXZD!!S('T8
MDFQS          C4_%9V'D,?(BZ];]RV28S,USL6IR?7M@MO6]TJG<-%V3YY
MUH ?EFZOS&LI-BUH<K,V[F NV^-37W)8_P!M>?[YZK:AM?FC(B3,V0-?3B)0
M8XZI)C=    CM*ZUV+U.XO)^B6<PO, ?)0]JY,BR+ML8&#D_/*=CIG2E>5K>
MBD.)04LK:RD>5M5YEQ!CE,(9(LXO     JW8M1C68P&%OQ=-^J\.P/NUT+5W
M.R(]SZMN^YG)>[P[+X&Y]/Z .E[\_G/Z3S[4_*XR[8,S%>O/0]><EY]ZYY/'
M?HRYMT#>C 9S4HG9 #,&)+?*_/DCQM^  #'GYP>U?)OICSKN?H[K6_CA4'(J
M/E3[5_H!K^14PA-R($R+4.J1TGY]G 8<XCO&>,R    5UL&J0S+8+SHZWP*1
M2XD+QV0S\J-@(LG(7;6RN!V[;#E_:Y3A=G'<\5U:RF-_-7TWG73]4 &T.*R7
MZ<.6]([=/5$G5,\88R9FRO#-F"-D@  :=S\-XN]S^/\ V_X']G[3V96J<B/G
MJ>JANVJS]^+QM7=?K]F_+-[<R)) HTBI\ E)V"[@      "%$U *BVS1=*>N
M<$J*3C\W(CQJ'+D4N+@8LF12XF2K7?'BOTA@I^&V.T#JP&DV=POB5O.FZX9+
M'YKQZ]!-=SWN)HFZSN/?        \P-HYYJ'OW&??+C/U3V2K[EN%^_."K2S
MK?O%UI7%SQ8-OW=MJZ,7&FZL286<,@<1BB6'&8PB)DC@+((J=DZQ'23EW$9-
M?P5X;9%NFO6\\SS%F1YX==X#_;\7CIZXZ5R]^Q%X4R02HN*LW_1;C_T'>>F=
M$  $>N6\EY]=_P ^@        *HN6^7Q6TJ>]89%B&>O,?\ 7GZ(OZI45RWM
M_&D=ZBP_'NY+5WJVKVN5VS0Q9I*"+%K%*DS(V8T[1@B3@Z1F3,EOEA@&',P
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MYS!F2,N   "F_%KP#YIP7U$WWLGHYD<V    /.9ZC9VSL&9(Z;E*72H
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M;+!              (I(L^3VV:MYZ['@<7Z\;MX/->R^E;?.(]\
M                        #^'YX.CZ!H'L."_A_0;&XW(?IVY9TG(6)%07
M+6</@^@2<AAW3,'>),                            :JY;%_GIZ+H5KP
MY<3O6NSYKG/'O$>_'JKJFS>C^G;A3$F'7QUSE/X7@4,<9BBZB]P
M                  #S,VC6_!;H&CVE#E6["E_-4"D6*/R$'U;U+:/:7F_1
MJ$FXW7\[!+BJ2:F&/00RX                            !IAF\-^;'IO
M/+!C2+P@3N:B!R+%"Y&![AZ)NGJ1I6YQN1$KXEQA#IDR)$9L
M                 '!6GYE.H\WU4RV,^#^*?2MI19/ZF.4=,E4.=6%VQ B4
M& (^3TO$                              $#D6/#7?-)\_\ 8<%T?5-R
M\+E_=/0MVO;'S@                                  !5LJ-&;MJ^($
MX          #_\0 ,!   @(#  $" P@" 04     !08#! $"!P ($!$2(!,4
M%187,$!0&& U(2,D,C3_V@ ( 0$  04"_L#)L2NCG7U0D[$I#IW0RFU+HS^/
MV3_4ZS#95=L .0K_ $6S9@IU^L=.O]'/?0@/9CGI\$;'L8?_ $3U+,L@5# K
ME@_I(F,NL\:FPR:;*;)CRTD-%6S=#%!OGI79I+ R A'8N='Z"P*YN5M<-6!7
M;R3)=+N/X2=SU._L3.=1" KT72Z-BQKU,=K$<>A@$Y1Z96(8%NL\RG%T\D0)
MZ=C699!W0JMTS_:^K':7[<<;)B-*K"WD:]YI:<05&5VI2;-K;5UOFMK@;TM[
M28??#Q+G](I#S]/@)Z*P6"U'E.)F-$I6CAUY\HZ17T53)U=T)5FE:!J#1G*?
MI50HRCD?\ UN<E"%30CFJM6^Z<_EFW=T^,W3>TPC8)$Z BK4N5K]?^Q]4"_*
M22_!I^V+&[/EJ:Q^IA'YC#M=.#?/2FO2ZZP4MX;O1U!H.GY$OH$]RTE/N+\/
M.C=;Q.!N(@1A,Z/^'O%!B)%-DGHDLK(&*TBL 5N"7QO.3(O?\J.U(>R#3U'%
MGF3N6K[H37:N5>:GH  U$(2W1U" 94_L2HRD:&]"0RG/6/Z%98+N)Q05QZ:N
M?Z*R*0/H0UU].;JNRVQI(?)7IW+>Z?P)_:94'G"WSL;_ $GS:^8SC./GT^'F
M<XQCWUVUV^CXXQ_%N[9GVUUUTU\DABFQ%7@@]G_IJQSJDU>HY_.R6G=SO2"N
MI=$"[HOJ@SM+1O4R=/\ G6(K^]QT3F\@]+?ZCB*X18;QM1GCZS]NTQ="-6Y]
MNP29UWZ%5N)!!F*."M4>%^G:U<:W//S#T&&&H9Z5<#[:=)EKA9'F\3_?(DJ0
MFL(9PIW?RQ/I6AI0;Q:?1TQ^I\[5S9LJQE/HXEU>TBF,9QMCP0_+ALAJ1'[Z
M?B8W[+%FMM/->KUY[[JNCR6]VE%%F_1UDT+"I(OV7WL0-4W9=^DF;W)\GK(S
M=1KV(GE[,(5X/VAYEM!N[IU_>K;JWH/<]TR< 6)=2,C[,G4CFL>_3)(XE\G,
M:"^U>I4IZ^VVNN^NFFD6G\",C0ELSZ:20H,46@ B7'"=8]M"<VM^CO:^CU*L
M\IA\!K^YJ*1)9M;$*4R2ZX2&W:3"@Q9SG'Q\XB>_.7+Z].O5IQHCGNOXY=-;
MDVY1/=EK<]9A;"WIF[3;BYGO#?VY2>EBJ<HL#]+?)#]Y>KZ;QP?7VEML"*T^
M+ )(3.>V73122Q:=%YU=4N$_"9%WIY7;\I0-R+\TT&OWK+H>J6A"!J\4 4-5
MA)+8@E5CCTBT_B%2U$-6BDQ-%?J??J@J"BFGKO0 $<:FY"A0QF.#F$:!7J2]
M!2%UF1C^CK&=MNF"K!S6K ;>J@NN3?ZX^Z>=\V-2KG#!\?CYZ6IK6BG4DGFJ
MI#B3IB;'36 P#5FR\P$(.CLD@:/K9F"$KTTZ!\SU)@^S@Z"<J61W2C-^U]9,
MN)"P=37Z#12H<'^\G]--(M/?.,;89>:)S3,K*PM0%^UBY)#<;^F-P1R6NN6[
M0P+U!SL43O6XQ=VYVR07I2Z@:O3F^DN4<I?IQ3 +]7#87QA;F ,U+SM98#-K
MII"OX=Z+=BHVNI6[! =TS;:).;[#/C]DZJU6"Q6*W%J1G>H:.+=RS>FFTWDB
MIP3PXUVSKFF\&(1ZY5AIA?S7I Q^TUB"MKZ@POX9T80;MA<Z=1):6X^C$8=Z
MW0B]43OT>[)+C_ICTZK\@3FV^WRZ@&].(P7'!6%E!?0TD;Y9Z>B4-2/1%6A7
M8&@(O2ROR>/TU?T>:X3Z@N5@7U6[,-*KK8-,@GT_;2XT]M-]),;21Z[?''Q^
M.//GUQ])(MS^N6U(<MDFN'>9TAQH[SBQ; :<O$Y$5N9,,6ZTO2:SJ:O9LE$8
M 5OW0XHEY2$BQOFP0-OK(J+$LN%!5QG\M+WWBJ.H4L_LX8ZFY]^+PT1-VO9L
MR^6BNT4T<F+M6A!<KSRUK.+BP<,?+ N@1M7[_F7S["_/Y#1JP;=FYQCHBM8K
MV*=CZ.4<WO=&8X((JT/E/G2W1EE0*%YAT15^*]^FJIK6M(*W;KL"D)9ZE#F@
M:'RWSI8NR;<I4MJOU=T*?<D"K8IT+'&%J56YWYT#[0JQP(JXK%D=%67-2J7K
M]$44^9B=@X,2R[BQ--(Z5[FD ,<SMRL%M+-RH)/-^E07)31!H0D%-"#)V_[\
M1X?O<]]TL/-NQ2R[%+][-7R'?,D5D5B:6"'6O%9*:02Q2:S1PR[03:-"UI"0
M/,%R3WZCQ,#T/QJY*_J$F_\ VLT1Q$G*C>F]L/2K:T%4A'\'O8$Q:(+($^\L
MD,4=>+QI5JK15%)%W0WKSTH,S43@=)56DV!<6I>9V885U,_!R?M+=J06"?6(
M1_1JW9.=VJ^O6N?[;A>H &-M-=B3!-&3H0<8"O\ 4$L7;DZTD:U ?9ETG1 ]
MA5RPP#VE*,T#'15$$9QV#GN^F.MH&?-^O(L0ZOV)>E*_JVC?=PQ@:P"FFL1M
M4/P9P\_!G#R:K?\ OBQ2.U8O)\NF63.7WPG?ECN2UH)MK-N&KBM=AM>U@7'/
M+%'K%')<SI<1*-+ +ZIQ JSO!5K5=?X;=#B:FKJJFLU_.JVR%<02KFN=E'5K
M/5F7HQZE7< IXCMYJRUZRE.]UE_S?IV@R!99R1N;S>"&20[S :PL 3@E&9:C
MXHJQ$%;EHE3-6.*K=F!A1ZI[8GPU?+7R/*!%XO2XH!&8H\*7!]H?PU6&W'#F
M)\ZZ"N)*@;33B2I&5+<.72X AQE9*W*'*A54LIK=-/7/>&A4KS?0:J11E?"\
M6_VHF+?-BT0BJ[5;<=K4G:GCDQ%KMNO4+$*_]\GK^1313Z>[#UCGJO)_DMS#
MYUWJ2"U2?Q'!Z:4=SX]TDV<:.@KA=D%_EIT8RH?D"[/14T5@#$+B,4KD58%J
M 7[W/RMJ8THF[K$C(A%?8_)+->*4[U=<7K,_35 ?$$Z&NFC5U\4AUZAT=()6
MA_0$XKC'2T7,M3H8.^MKSI48E8?TM0NQ5WY.MRVVY<HF8^E(TM48] #+!^U>
MBFFI!=&9IU=E> +Y\<?';;7777;3;4A1GVG&4Y8/-OL_BOB)#12T8+HN]#>U
M)2E'P2;?.1K>7#PD<-Z?W=@=+'P^'OR[OIQ3GHWJ9.G_  N[!*81T&LYM9)
MC%-@#?LR5*LTQWE80_,X\G/38A3 @9A/<@KL!8LC*5XC^E&-LUN-C*PN7GE>
M=>5><5U<>.Y&/';A^(*X<G5Y@,%7MN.4Y:"VAZ+)']O6./7=JLCH1!U:)5-[
M$&+$(^G-5S[9'26;B**IT@\P^E9L^_J8?I2)GZ?3$^S:VO-]](M-R(^/&MVE
MOKFQ!B;#(NYNZW:>^,V:^LNYP+%-J0H;Q_L/RC$\*T);:W!Z<JQFL#_:NJS
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MC2BWN$F8FUFR%*.K%MH=?F(.*PUG:-J-W:),LCV5$LMIV:(::O+/.L_PI_\
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M:.4>>W8?V66_SL4M7!61"6G<.O0]S(?FNO56'G[1<;_J,S*BL[$*J@LS'H%
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MN=J+$A5VVZD_RMB10CLH-PK$7]F(:TQH$9-6G92#;;P.QZ>/AB60RN7;O[O
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M=@RZNJJ6LKJ>DGFH\N$)KJF.-FAI14.8X.<XV3FN"J7ZD'P/QFM/'9XIS/\
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MTT4TB0U8@?F0BHC5@DHBD[<>L'2VXMB^ ?Y?9B^+XO\ =_.^+^7X.+_SQ?\
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M]QQ7Y*V65U?1Y<]5#3430"JRVMKS1R<09?&.955L,K&"DG@.U,]-&))(T(D
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M03&[QDKNI*,5)'38VVV&W%#5>@U455Z/!4F$EEBJ59X2]C@SJK(6P:SJ";9
M7!&W&IS5W;#0Z.II(F>KHJUX:VA@N5+2HO*J$#;X!1;O,<,Y=\5)XI.PNN.\
M3S+2TRAT+++4!I H()[L(E%[>!8;^/':GLIJ.K:F]=1-3&-X(4Y<LICERB3
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M:/N1VJ!C<+=_^T/WFN39?C=M-A:7G%FN7S9;*5/>5P!<=VS)>^YW/B%(&F(
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M<5_:6CIP5I?];F\"+B!3YE]B_P DV/WQQ554]9,T]0YDD;\E'@J+T5!X*/\
M,D_8NR=;H5#J?-UV&J,9Y7HM9232Q/ITZRAC4GD21RD6L"R%RJ<P<IPYMVT[
M1ZC14=109T^GOJ\9,.F4*13B/3):BH])KZZM"A36ZK956&F!6. R.[F5\A]$
M<AC)V#!ABRMT8?\ K<$;@\-*,"D<8C5K9]XL6MT%ST4'>P\>O'.5K&2)7< #
M+)ERMTS ]K;:^Q/CP97,G-OW@01Y#'H /(6L!Y<22YR!\0H%L4'0!? ?CO\
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M(HT,:JP[]1GRS]W =W_&]U^7$"$Q2%8ED<2(+.+V!#7ZD>('#H/5<R-(Y3,
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MOYR0-RR?_EL&6_R91\./]+*'_N]5\K1?Y\S_ )<5/:R5@5I*98O]Y,W-8?)
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MV=NY1N_GZBHFUB?2>@D>]+U_JE%?J$6G]0E+5_#_ )BTR%[V&?BA^F=>:_\
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M/5%"5I&M6O/MVX98[OY?+H(=OG_?-N7ZCYO$FC@*ZG$N0ODL(ZK@!$U,:Q]
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MM0@IFECFB2RXP7L15SB[52SUE4,"=G/6>^+K?'2ZF"TDJY:<)G+,N-0]F26
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MBHT:X_BN6-M(0F563K6K\20[RQR"K]O>8IZ/0F'DWJR+3 Q6V>K:IP[9Z-;
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M$4Y6#<.BC\4ZY(N^(E6$BW1/U#^;UQ(@/9?='Q-!K,4(NBLIFF9HW0_P9)4
MQ()3Y74'.B;KKVI]GR[E_68*FYJ$R4V.%=-W)N)#LZ>YP?FYV;E:1&?'\M8=
MZ9.<=Q !87.=6G3VQ7.(R6C5AUKQ2;_=58FO8=7UU[((*L=/*\BX>S3-(Y4U
MF+B&S>:V'[1Z<M@Z+F+AZZRRN[PZN)5A32$HNTJ.M''1,/H5*!JPV_%/6Y8&
M*0D6O!+$LHWON:) 96/P]E&T<O%:$AP_A,W:1SR*2E039[$M$L:G,&A/9#*Q
ME)@W?2?7W-1Z%^%$.%F1Z79:(]3,???2>(W-(8&85M1P'9I:0RO*].4>/$V_
MS=R5'2I"]/=O6M8N3HCE3KM$<[],>U>KGRCVCTR/0K!H9K(UUX_I2G^HY']>
MGM7Z;V)RFM(]IB\VJ.ZQV %2)>D7#8D>TCY\X]ZS,T)3G\U+<KUZH@E*]5>=
MA6GESY?-'X6CWB>7]OX?EZ+UWK-+<N5:\_K'];WB.7M[?_3]??M:;C%$7J.L
M3SK Z]<\Y^D5CIL2TQ[S$3](CT)P%X.P_7J.;E]SHM-96K^7:O$P2?\ C+QS
M^Y4456<.N,S"?7XQ"<[=GN36;6I69Z.OG2DQ?IZZS6.F8_<#P(@:8SL?LN;7
M;M[-:I:0598G*>5AYX+4--+1_P */$S\P*_O-_H_T#6NN01M/A[KGGV+CGKT
ML^D_@*];><&G/E6T-=/M:(_5<A+U&,=;7(2]HK2E*QU6O>UN45K6(F;6F>41
M[SZ'8CR=*F%# 9NR&L%!8@ U,.9O'6*2M+"@E>=)(P"G/J,.+*7HVK>C_+P;
MU.*U7>8;LQXEHMR8YKC(>.SU_8CN7[E9F/'DX88[/D=B24[W8BW1)^WSZ^S%
M_D[G+HZOEY\_0,V-_%G1:$-A5"-1'S60%%WQ' KW^^810?;#(.EJ7%]I69K[
M^E+4;6M70CFA:IQ3#L2"S,2I,6Y,Q*U+,<P]?V%;%^Y$V]6!)PP>H?)L&2T@
MM5^J:=^P^?7 >NMJ]V8Z.J)CGSCT@L38RQLZM()EKWT%*FTAVB+5N@*Q8NY2
MU9B8LO4D3$Q,>ES5=4L%PL 4+5D,C:-/7R"O>+])RSVB<ACFUOL[^WR6Y?YC
M1X=(SX1&+*-)N]BK7B/YS@'TS2"UJ=T??7J,XZD%<B]RCJ2DVZH5OM@7MHE(
M\$.BKE>5^RVO!I57SFU>3#Z;=+19COG[5)-6P;37HK>=L=V'"\)KO40X>IHL
MPPU\11*Z#BAD-.NY%,]K2Z+@5+:/XF'#B$,9HDG^:XF=ST[JT1XAX%<#Q(QH
M:"LH9R6(L79S\S/@4J:0]H77F-]LM1U(6_F\_&!'KA_/7"DTW3A%G,8[G$.B
MG^S_ !PX4-OVZ"P$12:C"XA"#$?9-!HH$"?2!IF*LF-*!RE/QQ:_&!MASSG%
M>)>#]+#Q%;8]0="=<1IH0I\<_2,%>\E'4=FOJ[VOE9S:D&X3AOA/]IV87W%<
M3A76PC5/H53I0-PZ[:>V$%Q6 S"])-?R@C]7U<]+.S*.Z?Z.]$[2VRTT=07#
MJ#*6NA:[:]&=3MELJR S4Q\1J"ODT&3GZ$HS510,?L8IO4#Q#HN_M>YD<4):
M6]Q8P0XPE19=RA-KU!$RXQ+MUCEJ!-.9<RG.BH1\1<2'R C8NS17!<VG&\92
MEB?,.JZ)A#A?G: <NU%IBL?Z&6R@QE8K7F(9;32EYC^KU1])F.<5Y\J]7+JM
M6O.T?']VO-N"%$FE-;5$A4!;CY]J_OW.Y6TCZN?+V/,V):DBNJX&APW^M;?A
M/^U2T?-2\?A>DQ:/S]-YN%>3U5!4Y_(M6G:N3E:%X)'*EK=!!]'/M_UXGW%:
MUC>2BV"D1SN<0Y+0=8_&Q1=8NGV]_M/I^/KF!/09H;IM2_BG@'+\+5OTVI[\
M_O=7+EZSYUH\!9UNBO=GMFD5KS'*;T&7VB8ZK?-:O*M+VMRZ?7V0)OW)J%EL
ML4)>*D^2;%Y],#6ZNF"0.O*(F+FZJUN6MDC7Z,/6M8R9+SR&DS7EUBO:?NTY
M=-)M;^IX]IGY&;Q^N;3[16)F9_E'O/K>UV+=9M'8T6[6_."-$[<?V5%T4K'X
M5K$?J=0VRK)##=/<'H%F!GNKE6O.QB +];FUL\MI17^M]%0$4^8D\\MDMU5G
M-;FPPF'62RTLRE<YO2LA4(TR6[I&NSFKRP09.58#8_>O0@T4\%I9X(F=GK;$
MP!HY@WMG&3ADZ_RE@/=9 M?E'50=_P >O]7"FJ/ZJ[V=U1[_ #!88JHQ2>7X
M6 <D<O1@+M72,2O(;0Z5)<,\XGJBE_:><<Z_6)Y3SK:MN4QK(B_BVF,9]0<6
MZ*2RP5(H:=7O0=.\2T<_>E*]7UK7UPW/Q#<W[+<+9B+ -=CA[M8[BW%OZ/M,
MJ:7@9^9:X_#QM$EKF(]$USA4J;NDIWX\W+,7ASAIYI7@R4_'/>W[<:82,L65
M\BI%%>$@$-CUN2O7\)89("A:5FOH>DIK[> D+A!C/E_$)BU*TZ35J>B+%-;-
MU9[4"B35N$ /FF8LQ/M3UB"C$VO)7I^BPO<M;@PG"@[<,9G#H=>=DQ9OQ7#2
M1,YR%:8=Z+'8$G->X&Y^L</Y9S8'#+3&/P39.5V;67XQTAM,.%!)ZE26X74[
M7#\7O7N1G4<,$9!$GFQI)ZVWA)QP7\-JWBEQ*V>>^)MG\!JFMFZEX%01*DK<
M(UHYEM$L3/RULAH?HY5XH<U\G@L:FHR]BU4P[XW#N+EFRM<[#'Q)%;$U,]O9
M2-P^KI0R5Z]EX$]UDL0;*\1PGA/:_$G#=^\"8)L\5]<.+0I3[0-<(AN(KAN2
MM1W#Q&M1>9E,L5_S-=A]9Y+1D7CN,XFBSCDU%ZVD@Q:=DK#LUV;VM81N=&:1
M:1]_M?)Z8RQ9S:O!&6"KP=F[K.T_?4V=@E3YWPP"I]*PZ$9"?S9L6)[UN[[T
M*;UKU:^(T^"-9*;MZY.D4=C;/9\+P[!6O#M.9Z0P17NT5GV8FGK]F^%TL_>V
MD0,O;XWG645\I9>%["5FP4V+W=T/(_A[Q'8#05[W[L_9U59>X,XJ3G5HM\"%
M7X6S.FP>O5*UR>< ><3IZC!\VU/(7K:\=)^2TU%\.XMC1L0B]<N,/K:NVK$6
MT%1EAKP;%SJS6[/-NM;#M2ZTGBWK/WL<\L9ND#OK%L.X;\NJPR#*(D5((P34
M($P[QSH4=ZS]/WM66M9!>,.5*[$E8'3X;+U!D3ASG/V'DT,*X>OEUU)68^OH
MMU34/4++"A9I]*,J%L!D,_[X34L._P#O1/IOP6P-^"Z;.<[!*D\9Y;HDZANG
M[AP]RG<'/S5ZHY_7T9EDHUUUQ$.<YKU$$(15FY2E)>8H,8Z5F][WF*TK$VM,
M1'J^D1D-,\2MGB.6)6%Z)T%)[,R7[O9J&)+).?3T?-]/2+EWEX5TNUX#'7S"
MUWEB."D5X^6:W5$0];<^F1UFW/T"RNP@:K<Y\*6JR/I:G54E_.JK:9B&+.)5
MNT"H>NUP4N3ETTM,?J$5]H"@CM*HAN<D#J1QX]%4UJS;ZF98(,(:?6Y+UK'O
M/ZJ,:#0$P$953H5@E1TLT\P-10$6M[25EDH@!K];DO6L>\^B/:38$4Q6#0C+
M)*B#2[!QK K:]N41)6#""./ZQ"5K'O/J;ZN@KGTA5IVQ&B0(=5$NS#3%B6^2
MHP2P#KM:8Y=ROJ%0OJW:L9X%5^[6#W+F6%30J,5N5R>%<X:LVI6U!2846M'<
MIS_SEIQ[ ANL\^D]><$IRGG2EIF*4)SZ;5DD32>F:6Z>KKKITU4FA/L,^45P
MH_LCU]H[52Q$4FU"W*2*TYTY%MT>U)CUK_\ [!CE_;VYZ8_OGE'K'_\ XY3_
M ![->?\ AZ$CGU7^<W<,8Y.GM]N.5(K'3:?FZ[3:\<YKT=/1:"3-; TGRZ92
MUBA.[:UPT'$6KVZ=SG>W5%OM+VZ>YRK\E>7N)#0'Y/@6\K/L;YJE#'V=;7CZ
M$,G-X%?KY_4#$QUDCI_60?TZZ6I_VJS'_CZT%21,$5?=6O$_6+ 9**W_ 'T]
M($:TW0.-!VFY46&$DD#E.()#63'4+39'3^==Z_\ #DI5)(_0.TVDH4;UW36$
M5K4 <MQ"!9JR,:]U5<=7M,D::=C,I7K"1ZZYCR,^>*_BU;\/XXYWNG5?(8X4
MP+BRL5D4: +BO,,SLU3EDH!6@8SL*]FH8DT0,0K:S Q,]@-6&!Y\^8$S/#L3
MM8G;9B)1I7786B6^N9.M,3/.S T\SB#.:=(-]CM7#HRJ(HNN7>S4% CB&^BB
MD>2RN<M!$)VV5D;6!!N'4@5FYF=[($.L?69G07_^$1,S_*/1G#P21 KUW@0[
M%)RYQ'RTK[S[S[_A6.=K3%8F?5R)6'0Y5K74LT(EA4+<?,%F 5N TCK>:R84
M$"2:]5(N.WO&QJ<:3C-IH[&OB@'PUGES3=S$[Q&FV&>(>)93FI@!GQ4 W\PQ
MYJ)?R9F8K(4,C>T+7:$FEXRZ%/B1K82_$A_#JWI+7Z$\AH!F"-U5I+%X17D[
M?V/HMLU;0;;^$?$%UB0FO/G%X<_:57);%+EG%372N$;#GBWRU6C45(]W_D]$
MN_D:Q#T59TF%,Y5,ELI#-X>X9W=6[C!=: MRL/B,-A62^T9]U0*D.'N,+9*R
M.KVWOC=<_7N!:,IZ_#IP*ZM $ARSE9"R?LBEA(%69 S9>Q!"[DHOX^$_%VG$
M&:!VP46^(\-1HE4V]#,\-QFT-)"!<@ NU!8O?2+V2+L==7EZY-G<,'$N1BI%
MR4M#6U]!-O!XG<<>622ZY- ]CA^506 ,H_ HRT3G\LC^$\.H9F6W+7$S'D<4
M(:X++9&"[F9P FQ:G2?G6=:TNHTD85 BJ*I;!-=D 938T!*!>N&OFA0;\Y(;
M5.=&**MR,-CAJ6MHI:X1$Y?*0=+Q:L?YO:WU5'M?XGQ&UI+;N'Y6NX5<][$S
M<;B'AL8H<+E(K<\D5\\Q0IQ4+5*!F\Q"9R;K.+HM,#IKJ,YK#ZN3KK4MT,$5
MV8I/#SB]H*L$E@Q7IMU'7CEWH?#F45W'\33'INZFQM)K15]M+VV;.UZHN(=>
M2)@*BI%(KV*#GE'KB,_DV)PK+&>'&%6[5\^VO 3M<2N8/ES8@<5AMQ<8A#)<
M'F+N7IT7DO5^X@W#C@(2D\RJ L45<[XXI'F#Z9[O9Y=8?>.FTS/K](>FJ^^O
M;:+PM;$S5MN5,C5KF)9P'OCZ/8O4DB(N6%^JWSTJ/ER]:8&EW==C8'^D7]FE
M%'-[JS=+<XK-H8^BF7.4.JSH'RF (?#6#KW4&/MQ/@&=N,'$G0,,'XWXNT=0
M@](O-CAK4X=JMEKD4C[ EHVA 9(OT]024\GN6GV]<:G"-:^1Q+A<1(]W5UR-
M\S/X@%<D2(EUEF$@@U #,=)^-%%,-2FSC>2S:D(W#D9N2FMPZUB=*V\0W<2:
M_1^]ATSG0DI89H!Q*4;DPOX^?"\+-U78T(9/&3$++9":CG"T.Y >(FM #1LC
MAGB;,V=_K*.M*SK-:>0#X?$<RTS_ "VH@@Q\^'(UL_/T@8;WZ-2D2)JV[<)X
M7 ['#W$?B_9R,=AZA%VZ4K%/.&K-XM4DUB>)],YR.-$7-PEP:36^)I";X;X8
M&\GP_I.TOV=%>^PRT=E]D=!-F#4)Q7G[&WI%7?17%A_M%?5<R!;IS+T6)P"S
MC&%3L2*\T-Q- 'KA[MY)2\,LF98\BQ.%KZH5M=K/G]&!B:[/$3/=Q \)G4OQ
M%FB1D=PZ5M(P+Z%6YM'E$)/DV@ZJLWQN(\>:53!3."RP[J2111=>S_FRIEC
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M:>5(*6M>U0R;KD5;7O,4Y1-K3[_Z\VH7K:[&/=7='2E9M>]<^\RU6L1[_P#
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M5(,\6K% ?"Q+EO%ZS\UN]Y$13I^[TSU>B8>P^J4R+P?EZG5Y7TJ%64BJ>DM
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M FQS=%M'49Z;/Z1ZQ]\Y(B(H*L\^PJ**@!6>5:S:;WM_S(K_ &S_ /"?1?\
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MD#_)+$(]>Q!U$$T:;FXR,\PZ1S1-=</Q4!PI-E-\JJ8HDF6H6X,@IK=PA/\
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MC\*L'"\Q%E:=A]&.P#29># J\1PZE?T,PY9E(^NA:N9YM_JT)N%\O<CQR]X
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M$.RM;(AK+Y-%YFLVBO :$.L0V(A @4MZHK%IU<K!#)!TAZ"NJ:UG%*#W-3@
M_1'K"KES>!*YG,HK+R,5@P[GX9=@A!6'VD>&0)QG0HL&Y5 -N/VZ7=)=!KO0
M7'8@XNJ2HL4E2<#VF.Q (BW29 _($BCT+6VQ%ZS5?9,E%.'H691R"V09K4M9
M1=3N0Q%:IM[L979I6&U\ -F&>Q@I[-+ 4L2^DL XB9+,(@J%S4;K:T81J*1C
MH)Z86+0K*:/#]P(D"T0),7Y[BT(IB3!:8,5< :J"%Y##=&\><[+#4?"08&3,
M4Q[S5J2 7"]CF4;6%5!$U.#X2)_.LX%[0*Y6DBTKP=DC.X"<'=Q8S,@YJM@.
M'O'\1>';0_JH0)[P/CF]YI=5+-Z$$D)4^!Y,=Z7S[P8"$( 8B'B[:HB*?K8#
M(PLN(K_?8;64\<=P0_+@ P4N@]&%?50J4I@D:4A)F$HPD/;4BARB E6 3>.?
M4BH/L6?J7V'O5'V:ZD&N1<>4IWNW)>JXM>8,& (7E9"=$=@RQ6"X'#9YV(:T
M4GXH1[QA-NP%"$%HPXM?_HFY^DS=Z)9%P-BHO23IK<"E$NB3E $OX7$=*THC
MR8IHB@71766:=%#=+*E!C4E"GAF Q%(1NDARB[#K!V0MFOM5VBK\N$X"KKU-
MX1W[Z)R[_.#1NY<#:(?)-LTL3^5O+WWG_-Z6?["]=OVAL2N(B_,SJS3 L 8"
M.R*\;W#;P F%$*^XK/PL/3,84O5US#X>Z8O,#4 :(+@J_NNET+KB"T95&Q7J
M,4M)R!UB)7S;MO$B$P0 RE3XE>&%$\1:6X^4SC(WJ;OT##R")$\2,S8BZFFQ
M[JZ>"">U::YVZ&3A;&A@=H8"23URL$;>8-I*VPI!Y^?Z01L'#O6INN81 P!5
M1T<!(K=D9D5E9TR5;QSR$"IX/A(-7@$1"))XDG6O(?U_27#<Q0OZ/+$CD;S$
M$XG%7'<@MXP3<CA*63AV-(0ZU*W)J]=B0**X?%Q( ;NQ8$_YO"RH0L>7"]X<
MG!<FG%PB!K'%="%;[\( 9^D'-?@45E.633#>^]M_& J,4D<K0&S:1XG"# *K
MST&DP4')D="&)4!V]71=I@UR1 -CTQL LBRF:<TU/S@I$P=D0<9L#?*!M-#L
M>0*)@[X0:3\3E&E*T5QD?H"MXY(A""XXPEHP!6!?[8BN.2'QQ.2U#NJ=GP?+
MY7,2&^B+E-S6#CN F++B]GI]]8W'T.&V:055$IO[4XN7F855!A2>X/K118ZQ
M8N-* S+5$[9ZH1@:II[,7F+N<C][ANC06_!D'')^,"Q^3L%S(<TQ(\<#-RB6
M^#5U[-?3LB11!@?;4*%:1ORJYSOLY' A )LXL]U1'AE.-.W@7Z,K5:[F%.1&
MY;$PA:,!G@L 6---6("B:>:E"_P0D #/3[E2F'A<;1@-.F0.H>"F -^5[HEC
M+A.<_&*=X0[Y6U!6I)M 6;DC$-IH2+YQ1E1-BO#04@OBQ!1O4 *#1E@-CF^
M,R1LZ01RPGK3GW*^H>T#"].I2J22%,<V)V_+P&&_34 +%-'^"R?9:'#670(R
M,D *+C65@+^[JV*Z<(  S"-E)6'*50=H3"QUO GY:?\ O&,G/_1%T_9_O'1V
M$D(RD5PJI40@O(]I"&MB%844*LH8(^""17(N1ZWR2^X-8(@';1V.YOL>KR7(
MY'/ 1DZ&R%<RX8B9S4U6-O(!L/[@KG1GX3 JBG_L")&-0*_3 1+8"1-%>4QP
M9%V\V$%0"JH2IJO:NUY7GQWP"335&VVU";$<U@7"BRB:'DL94&_*!"P@G9L
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MH*9(J @BX]X(M#LXY]5GK/[W7ZI.NO\ @>C ]!%'0YY/V=>NLYNWGLYYU_\
M1[<#0!<@*\<O/1_H]8).PPC)<'$$A^3$QP_,]MC )R8$$GPYS%VJ<N-<=IU
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MX.,+DHD]^G,[.ZP)_A2;O?\ *_<'_]H # ,!  (  P   !
M           3;<                                  0  *@
M                           'OD^200"020
M    #RW#" 0"2 "00                         <%G@, 20002""
M                    *  >                                  "<
MT<                  0  "            :B<"0.@              8BD
MA&"00       2@, !T "^"202     9Q02@ "  0"0       !P(( "3C81
M22"    !90!! "0           )+8?X !C^_M00200   )F  7 :,4TF""0
M    0,V'+ 1:O@,"2"2   "O@=R,  $TVVP"      > ]?K(.< !<2" "0
M <!R\H "20        0 0Q,)C< 6:\        "&BR;E 2"202 " 002""*=
M0?Y   *@        "\7.C!T, 0"  "20  0  CS\K0@#N          !AU-8
MX6"&"0"V$    "%\V):!%'",@        !0    8 &TR$@P     '2" 3 !@
M " 0 00    3(     2R"         /*Z-W@=AOCH"2""    "8K:@  P 0@
M02$      3.OX 'SS<(22000     #[@ /4@"0STV       9 4@!AR @0 0
M"0      X   &TR@VDPT        !@ , <@               (04
M       \ .!                 TDT              !AP
M                      "(  *B  "
M#&Y6LB 0"0                            ##^T" "0"
M                #R 0:0""0                              8#B<R
M20                               2\0
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MQKF'9RH]":][_P"<-B]QDU$7F\\?T3)9%L33I6I.M/\ GKZ%A!Y7)N#$5UJ
M55'B$3O9"C'.-HD%0C41TIA3/>APP=!4X!0@P N+*C#1#T8[CID=8Y'Q 2Y!
MUA5*5LT&(F87/*F$ 4"@1$QG0X=(M!4-V\A%-.N43(U$HO-2SV+>V^+\D(T\
M6"\E7H5V^ J]8P8FY0@ M6ZX#WE^=A!:6@@$8$4ZL0UI4I6G4(R@8DF2)%BH
MUZ3HEJ (X$2Z$$2Y [@T"'AR @B( ++FK*5L5_!K2!NF=_IZ,'?T(*@;5 /5
MT8SV!P+2$&EAFRJW?85X;%)-5^ CPC[;RAI2O!>?C3R?GY:\5GOZW^0<KY=U
M=NUY?OWG16/.WQ/XU[8*6*7F//O^7\XIF^ #[ 'WUG(UKRUW[^<KY>GGLX?M
MUXRLE9S*R^<$">B=Z'F;F^_H2, 8A.J=)MKDRW7.*?W'."7*ZH>4"EZ;:!3H
M40.7%JNMJZT;\'C MX";&U!JFX:$+; ($RAL@HV*:1L#R;6+(AL5S)$#AHH5
M%Q.LK;*RD1#16FEW<>5;K0CL.H*#1P*R,E_HP$;P-^"_MEG[<(]?Q]YT!N=@
M]&J]VZTF*0KY53W7[-EZRN ,H@-(YT" 72I*$7G"5J:*!$>'Y1L)4)2NM-"9
MMD(*'PD4' .@ #H/H==[L((X!J/!8!@C**C:F'PG#X>/L-\MH+O%\+34LI4H
MTC5I$5#A<%+2!Z5Z%2@=A6C PD*O,1Q$& XEYKBZ%N:):AM:':\ASO$KT+UG
MMB\[3!!J[1*1>>3_ 'E"@Q3?&I)@(*#+]:D347=P J:HKF(1@*3  ID#B,RM
M6.&\L%$ BL78 6D#T.FQ)=:OF:N:"4 %'%?0 Z FJQ^& ' (%VP.7:U[PVB%
MI:%!=!10*D669*"Q1H]B/8B)Z..U9E3^&Q->V SI&%.A5M,LC<6@?5($K!DF
M?D(NF*-0#2(R @:U(SUQLQC>TF@+'>F*)%$TCI'PCA]81?+H!#]LMO<?*9MH
M\6V#T&YHT-KE/@:I700 ?0L$YV^1,L-5_"M@&)?QL"#GW557:M7ROP-&B>!1
M(HH10$1'R )D"S2!ZZ!B0%<M:="VENDI6@)8#6+MR4G8V-J*O)I-8"[4S;^]
M5"!U 9 %D7@+ UKP:WD0<2@+9X"[@J"NCXM:QRK1G>Y&7I#Z@2H*0($MNKH<
MV0"I:AM3U->*/*F:84T!7EYCAZQ-$6L[$!;)111-*(SU"%A#8U O!057,!9M
MAD$I1-KF(@B"E-@Q8_!^EL1)&@ P-D5&7AQ.!9 @= &X  %T!@O(BB4<AR+'
M3C=IDG>J^^)C.Y5_.O\ V!"2.$^@AOX ?27$;B;ARG/DV@W"FS'P05AL3!*5
MNP? HWN'#P,93T<(,VV9 "00!*(\(84@+D2NM&]!&BF5(MTAV$I$O'^WUO9!
M+1#&'@,%W,F$H(6\K@JBT9O!QH#ER@*#(HZ5I4("!=<V40A.2D.2S>+ND"'%
MD%2>UTB*;^'%=Q534 9M9L^KNM)]K%4#5VD?@;Z!@6)!?)T)R$>''C"V**%3
M.0Z.K4T..3>0"K&,.AU5"Z+&.13;='(B"&E'I$7<++#CB @H"-%X*)O!AEVP
M%LY:!4=PMA(-FA34>Y(,HKLSB@#FGKH?<O<*5M"ND/:BE]/D\F#%MZK.N&OR
M9PM/_9?^CTR*!*E'46>S1Y?2E=SV^)0U%8%B?<"\UW2A<A+!"YF(/@*$7C1D
MRO!BQ"\54185T&*)-NA4A5: (:.,!CW1H-[!03<\*9 @,M!D!"0.NJ *KE_(
M.)4$FABEQ*C2]NM]:Y5.ME><:+:R0MN436[MUHQ)M\(NB2!R&*IH,Y Z-GB(
M$$+(3!H)L;YU/.M<:RG!>/V4Q0#R(-/7S]]>+WE((:6?=T8AT_W_ +U?.N<0
MY'B_:S^<YM<6_8K^#*$&;D;KPW_.*&4NO/?F@GXSDUPQ^S/Q>\KQQ?VY_%R,
ML9Y_O/KXSB([K^.;XG8[->3%!>JGW)_S_=7_ !,RR2$3BDH"JC9E[*<)5"A/
M#:D)SZUIIW0E1,+CH@@0887@7@7H7%X%T52;T&]2TX"]8K%>0I]QM[.![G"&
MY0B" 5$9=)W*IU"(*(J"DVL!4-RY;M06U#A)I#<=#!DE#*L865%A0I@LCS?.
M'D<B+&880( A[S-:JU<=6'*>5Q$+T$Z-N=&?BAMJU3N]\FL"\N^"=#6:26!2
M#3C5)NBK ;B!I,I\/'HT]$X3UQ>*2E"Z%]%0 U.3J*F!(@<B/OTQ^CIQ$A&?
M 'I(@W?B\'8NM3(,'!$$ "%05!I!$32(FO\ %5EV!O\ "D#LW*HB3J_>^<&B
M]4$NP'DY#U\]1J)-0%WH$3\NL)FC4WLL:7]Z^WC= :XB[W-WYUXSVINF^8K:
M^">WWQ:V'*_('[3.0PT!WL#\&>.]F-(PUQY=W;WBWQ=E]$J3UKOPXI$T#./3
MQ[H+[&*3>W:/9?;GT\>T"[9-J*[73WKV_--8UR'*ZUR _F']?\B9M:BW!&1\
M873-ZH'"EP#A49 H_-T(AB)0V &35OPJ;R2/8,>3OR4RK4H(V#5% *+)O6WX
MJE2M>^FE+$)$"AUK9(91;IGE(8BOY5*&J,7G/L5\5N@7-',#$#U*FA\JR:#7
M[ '(\'B?H[EPZD<&+K&.AC(J[OZOF"&#:N 4T%C1L?YQ#O\ '<)(O0@'*Z5]
M.=_;O(4];!-(OV7_ &\0P(X]$$(%;ZGHM])G@?0IQ0V;Y*>=Y&BNB":VB/,.
M^M3$6GJ-!M 3B#/Q0JXJWT+[P'][]&:M5I]$DBY,IDA;GWN:YP71.'R74+*V
M7U(K06-;OFWD,:%^ HG+C!5Y=DN[-!4,-6PN.)\Z#E:2Y(2@R:G\M' N$G4E
M@=7OG JCPRM!$R&]BD (7.(!!0(B(B41-(FQ-)\5@KP"_C-OSC[(>P@#H Z^
M JTL"/M2Y+81O JRQ"!Q*"S$LE>!NRVHW"0RA"<C\$81LG*!^NG=V8;J8.,W
MC !C'Y#_ -$PBAN?*H5^A,(33F>-$ (B"H:\@7,-%)!J, #"^C94&.X4Z"H[
M"9')J(=9%L0*!CS8>Y5$N*90@&M6XSUP_G5%CR9[>,X$)3 @B"?-'P[X]?EC
MXR/A_'K/YU[_ "@O!?; 7@OM@+P+[?YGH_-#%Q^3-1GQKO\ %I"#3Y0QR2;"
M0I"H4IM@%V@[P T)I1'S%-::>DF-:0Y@@N[7K"Y$[!::!"D2 )$I.CMA*<8]
MBT?DD>H"?DF$U!;P%?E86UZF'@ZY(&E<3"=[(>LXEBD,R\)0J'[M&:8" HP+
M2D.EDB2,6:$<NXP1$*)1)DZ!<INJ>'-!UXMPK;4Y+PA$,5WFZ:JJ:G-=CB8+
M](I*/U,D+@*CR%*()0 \GHX &!629Z+*5,1]<.L!43@LU?)_EHWK/T\V4 BX
M0T"&:M9Q?#S_ *_?$4X M4-@ F]\^/YEA0] -=CO]O. /(#HG"N^GW(]-ES0
M]MO'<-/?RWR63$-YXC0<I"#UMN3$%*0SM"=^"7JY(GVX'L0ZAHQ/2V@4VLH]
M^CGT ,Y T60#='[)HG77H)0^NIOJ;X_:G3QCT>W4A0'KM-W4URX4&O-=&@1.
M=[^T?M@"-L4LEA7XH>LPTAS=?*6G[G/,G&18<&C^GK?_ #_,C\KH690-P:&\
M&3UGA@<:@4P_&9A!-UD",-V/IM-A@@16Q.6GIDKJE-?(KD:!RS9)0HY&]_"'
M@_O_ (?CX0\? %780P"/""WN>'U$-Z-\^OOYP,  !  "1$(2".('D^>"&E9=
M=[GC@/?^<0T7W=>4_C>WO.7<0YYX'C7]VF ISN/)QL..>$?<F0]N.>?1QW#K
MLR%A>.]/'M7\7T[R"]SEJ:T>M>N.37.(=7IR>KP<^_\ QD+]_2=.)XWX])@-
MO.GWCX//KKL, LWUWYYZ?WT1J9!_!QVQ=??7_+#(>O#]H'>O+.L*+O7KZAK7
M.^+?29'5>=$W&6\?WG'2^[]'V<4/4SV+LO1$%\CUBIX @FHEN!T09*FF2J3B
M(/((E!H^+U41 CN3\#IK;395840$.$T, *$U*?KROOP?AX9WZ]R85-D??6EW
MP=>?7C#U!QYU12Z]-^,%2)SI_/I>GDSW'%[X@^.K/7HF>X[\[A?'A[GUH( !
M041(B.D32/)B *!VUA6M>7VE]OY'[.T%/(P]6":5*8N;<2GH&2\:#E.<#[Y7
M[/\ +W\"$3;Z9"0>;=\.<V8ZUO(JM[<:%@?_  :_WGF\\\[ROGC_ -_G*G?]
M,KSX\=<3Q]LKY_O'WUK?6LKY\_N1_;ZXNR& 8:MHN[XB'(!="UAZ&KM&4:C&
MP%5O*]!$'6KZN\&"HV-VW\(E&W':U!$.BL)<P)Y.LTZZII2G*!&"C(B_H9E
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M]O>H'ZY$X5[EYH5A".L,V5$=5$+TS24:(H^13:@[1!W5 !U7'P*@5<3MBZ!
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M9P!"-D$KDU .L3-EHN!:C-Y8#_/=M1Y]T,_:G1;?VLKW(G3O6=+F3ECE0/\
M:!-91(2!C.P7UZ7JN1G0B* J!M84-AQ@ )\@S7$0%#$^%UKEQBG5"HZ!FUQ
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M=323B%E4! V 5N/2&.P$,8X:4N&P<I(0!$Q#ZR(:,H/1O#$BBH+N!+A$8QN
MJ+ E2@@S5XPX>)G(D;XSM'3!U3LFWU(S: -2A7: .FJ\ZAP(D; V^%L\C&$]
MZQ/#[8Z%[?X?R=?\X%@^(&D "BQLQJN>]P_+MVQ%(HZ(XJ0;0@("%)R0"!%$
M!'5*J'5!G7#JHW03I3K;HO7#C/R!4[</<TG4RZ1D,H0BBL!19L<2WCB(-8J"
M8%,!NW!"Q4#N>1<C.-\3EM=T:*2EN&B$,92R&/NB(14C4R9[,"9IVP-0 (8,
M@=$@DW46:5A*L,ZT_=*O$:[!CI@X6\2RM95 -B"T)<=( "<M-H06,*6VJ\J^
M^_#OZB/J/(^CU,(1B*<LR-_4.$<4OV44H#PB>SR4WY.B^[=N: 223I%!IGW1
M'*DL!72CL0((&@=B)I$B)I&G^*PED7E4DUD2@'P\T^C\''D27L0P@.H<3.1K
MO-MR$CKNJDJ$0.7N2 *15$.3RSCD_P %!+'&/4BO8H800!<J.P&W 5>5@9'M
MX'/!_+1+EJ/$=D'6VF@UU([@).R6-#9)@C@II?38GB%E1H+M(-N4W&.U\)8H
MI!Z J0B6F[^3$-'*:$S=#DC&/&*&SS?HTX,H%EST@LF18   $$5'Z'JZ=6*3
MDM!U,'B6Q3-#Y@'98\RW[<0JR(A0!X4A+H*SE S$-8DO(4X*H<7.^ZJ15P4Z
MZTHI3E&(>1:*I*B:#720111;P9)6XJ91#+@3>,8X.*MAL 7J*9$11$11$B)I
M$=B/)X@J!M4 ]7C BA,]6GN"/55\&KFD@1PO1[U0,T>&[0U(U-19JQ$4>!*&
M;FJ"P+J>!)B; &!*Z%4?3&WQ;8B:* I-$A@#Y@7LL%+)(  \D"03 49"*!I&
M%*& P0"7,6 H#(Z)I#"W2/2>@D7M$/0<N$XCK8JD1-.)0I9406YAV1HJ%+RR
MB^(-?;X.1C39@\<42 *(B,?T$MBQ$5%! [,*DR%9740]Y1$.]Q!5ZE NAU[4
M3T!=3&KJ342>KOOSZVX4X4"*J5C@SH7!GLL_;$*"F2$(8*N340(P9 M)6'\&
M <@/HW&,J.=5#Z@X4:@*UPS.I& 8NE,4B53#Y%*P8ZT54/@RD:JU-X$6@-QW
M>T9 Q(L/++"] M+<"N;RRE0-3Q-Q>\GUQIVP:B*S#0E'$#\0(,<"!#=, $\K
M%H7B@;X!5JS%5*;3$,)29HP)K-^S@0!YQM,'0:ET#'8-59SX-QE^:@74C5<C
M3L?;Q]N?R?!^=O'^OW_\_L\#_?\ /]9^??R%\/5R1.$>(O5D#>R6&EU:'$10
M\0B28]T1 =0#NMCD,D(< \?[T+LL01/@':D):S5AW'VI[9X5[OY_U^^<\^,8
M8B)5D.: ]].W/+\<8HU55M6MB6NZBB]1CK_'^?GY_P"^=YLO507J"%)OB#!X
MF(U E@J[I"!0,5DCK$L"BMCV9H[F/P!^(10] Q%K[Z -RC4O*J[6TI6"B!@_
M0+^?G_+K]!<DYR@$#8@(FQ*8,#H\38.@H&SB"^):'1(>TK9N@'8#O&2H3H(V
MU#:[AT36,J7[HW^'[O3'@SQ[@#2=&QS!'1F1J[!0/T![@OR)I555:I TH["I
M02P34@ WZ 0 B$'B <<9.&J*Z[AZ8Z#(E.76V7J&">XIMJ813Q0M:E<W4LC5
MV-9^RFRT0^1A1I7U 5"O@$I/A*7@<<T6)RM%,D(5@WE@BPCOL8FDB*(X,TUA
M M6?I ('Y#"N]18*N$!'2,ZX["/C>AIMP=?+J'H @W6-U-@U2D2-*DI4V:^
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MYK3#R>B7#N/<./ *::7Z'%E >9950I7(* _#!Q++"1<0&' "JPQWT?0RI<:
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M<])F>NQU^06'! E%2$_"2:AZC?"1(>PZ5OI 1WTB:E-6^3K1"&"_&KAV68]
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M\6A.\&5R7AWZ?T)Y'A#3,8:$^X0NT_L][UX;F5=TSF3V)%^A@Z?HD<2X1_\
M.DZ#H9Y>-#RD!%Y0X+*E.0D5IR66];B5KX<:K?7937."U;]6-J> A90'A<=R
MYF*QC%CU0*VX6GD+A0;#NC'[?VJEG%&."'T9%MA[0%!9:7V7XA52[PM(BG4#
MQ&J!;W)@?F M($#$8OS:*I<_$6#/'!=M$,1_<-3!J4J_%/MZ_#>-/9'XWWH
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MTS(&/XA."#4T<U<@,#-S/!:OS@62I(QC&-?;^%"\CTPY <'=)F<6JR&?()'
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MT8@D+(%@]!\@$8BQ<+.V"&$D@9+"P>@&5[6%'DA7@0-(H=6M0@3J " @&"P
MG$[!-?"PU^*5+"X%%3NU5#:CH 64DGNH$XJBNLZS,](;\' /.,'+7+4$L/M,
M6[Z6\<8 LDV3F$L^$ OX$&ODABD1GI 4.>&&#O3^_LFFP*\+-U&)@416Q^0$
MMX]BA%!=JN#D=JWF^!5D"X6]GTT6\>"UY,K29.ZS>0T23F'OK3!_R(R'T81]
#,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>businessfigure5a1a.jpg
<TEXT>
begin 644 businessfigure5a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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MQ  < 0$  04! 0              ! $" P4&!PC_V@ , P$  A #$    ?<
M                                            6W+:@!6B^T #FCBH
M#ZHY/BH            :6;W2\F58<M52NS^HVG%0               8[QU6
MW4^', ._+B[K["J_&J&K^VUF18KX.V$&W76R9%E:;;S3>O7%==]J@
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M>\3^LLRJ  '- "JEK2DK;=;;^:.!5P#F@<5<T8YEQ]5:4EUM[QY+O9?S1Q4
M !"9Y/V;?.]=])SGLO /1Z[E  4*]=:=E*BDNMJK:]-7)W4J     QY.NVM)
M&D5<N+UVW8MH-]8[;NPJJTS3>:2ID8+5#E\R(_G[TG#:F]+PMWNQWZMLV<CZ
M9Z/Z?J*H   ')"$^#\53EKYW           !%)Y3R<>U_=:S&,=FP?&3]J(4
MODZ:@HU]Z'5VS+CJ[+L1F8,@C9KMBOM&;'2W4[*)ZT.SR6-F    67J*7#F^
M++E7-:#BE5'-U*O/@Y&2P     "+9<7S#]*\\K.AT/950\UT/H[YYWDX0)V.
M4K:C-ZT         P<\X)$??3L.3CN7CC>33&J9[+&DSMK9DG:R7?X4C-X4B
MZ67         *%EY4IP#D!5?8K0:_>D>)1[TW#RMQWI$V\%ZZ   !Y%^C<!*
MO:<ABD:3576]5*P7'S^@GD_HGCK[-\IU^>'[A^#_ &/-F"9R #FM.*"H
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MQ7VFR29^T'O'S[F^VY_[([T'8]$BV:^W\P       LY$9@QLH7D
M            C"7%\KO:O(-B,^"UTK;J5MRL:<UT/LUY5Z9P#1CC.RRJ? V]
MZ3G+'J-M O">N5O;^40S?9374D_'DN_%>I[)>G^(@
M           >;W9<EKOZ)P4G7V7RM(2UVP]1O)/49F@S0+>I<E?DYK;K1Y3[
MK.W:^60ECSQS@G;+V(STO8[$>D>,@                              #
M%<V&#9\&+)L38W5[.8H,P >>^]Z:X8(TSV8O.OI.OFSP?TK?CI?$XNBYJ_+'
MRK2]+8+-C/'?>3                                   #RZZ#J;S?EC
M2=LO-?I^SW \?WOI?P7-3WN^#I<6:#N0]/VM]<^??NZT
M                   :;;/=4%+=V-;IQR8MJM]'7.]E8=?MYT[ORB[S->
M
M
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M-?"<_BV">YC9)%?/Q2PUQG<%!6X-+B3+7TU+RK*&\(Y(DL14?/D)G/*Y3W,
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M*O46(/L$4K:[69 6VG3KUX\>OOZ_K_G5FG-)-V]>XU5S'V4B]FLT<BCP.QR
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M\U O]+@<SB\GN'O6&*RMEO\ V?V].,GA\OA9>PS.*R.)F\.SR-*Q3)_1[>-
M_P "I(/E_) :G3ACIW5^\^_B.%(T$UCV3^3B^E)\3[E_R?=Q+.\O0]U![*+T
M4?X_YTTXIT;=^40TX))Y//:.Z@]\CGNHOQ8_9KP<3B,;_P!<9$SV!XT,;WV4
M^Z6<]%]WT/OX^7:%;IC<%3CT\)KA-J8_$@] ?ZQX/-F9^@]6$>2Q5(E _6&X
M'-F:^E-!+\):L+ _;H%X_A#!8Z9'"8ZR/-X5-6;[F77[NHX%'E_)=,?=DQED
M^%;(]Z!C]5+ \/AJS?H\7\7>QC[+<!0-[$R]^"7XQRCNG7ZIT;X<12O"VJ'[
M0>JM]H_O\>&C2RID@&V1>LD/O][)_A^X^*M]%O#]W#+M/[N+TTR34J\4@@%I
MY0\^U6*]E'O5$#@IOD/F0>@.G'K=B22&N+L"_P 5GG:W%&A6=XI3'L4/N1=@
M&Z8+]Q7A+]ZSL(E%?7%/<8+$C;I(Y&7<O:!B$D UTZ]/#3VN'NV;4+AIHZZC
M#K;8;%/;O,C!QW^JH--O<((9O'RXD=_4K"JQC"8W&MW0 2',:LI;370C370Z
MZ*!X>+VI:LU[8R%Q'C(NW:-.[VW<::3;HIVC30=%'3RXGO7(38@6P)6ALT46
MSV<>I%K7?&ZJ-A*::] IVGKH=#P;TZ&S7>P[2)=AKP21PP=K)VD?:F/1BD"$
M?[1P=!]$GB"S+:FQ+SD-)'?OP[AMU(CC&A.SN;NNA*=T^(_G%K&1VI)7,TT7
M;Q+#*L8C.Y5.J]71F70^(4@-Y^/'R<G:%UL68PYA,\<;*JS-"H56+!=\>X =
MH(V4/Y\'%Q%V/;2A#=2^(M(]JS*=3H=N_8_34%CIITZ\?)U?M[5CO;KD1BD7
M715# !S'YAGT&X_#A,/"H(:>>0&HU+0B)0(&T(V[$71DT]HZ[O%M>/DF$[NU
MEEF#5%IG=V:_-H_:(PV(-'0@:'PZ:GKUX?$Q2I,LT\\KS)%$9F[/>D43AU1%
M"!.K#5F(+,>IXCJI'9GM!F+SI%&RG3:!%KMV^>IUZZ_AY:S]OE?.4,[2C@GG
MHM+K6LAC6M5[,$M6U5GV$/V5BM-+$Q0AEW;AU&G%&IRYS@PGY)M287F(*7;E
M#*VE2S,R]6'+F9UBCR0^I3G]7R 7HHE\Z?//..'D?&VLMEHS6?L9<?DRUI(F
M0Z-%)4R*3!-/ H4'$7,&,RFARW*W)F3=O;EGY=I5YI-?K2X_U,D_G::\0X;T
M=7CK/R#A$)\?4[V;IC[DCR)4<5N0O178T)Y+C4G3HN?SVW^SZ[^SC'>C#T6R
MNBIR32D<^"O=RMC]8DND$>_7I[^.8LCZ#_1XKPORKRY=S$2D_)M''5+\\+C7
M06Y[/:5ZAW>/;2]KU!5'U&N2].><N&2ORQ2Q'*=,@JJ8^G!)=[,^&Z>:!(4/
MQKU$T.FDA/CDL]G,R^_+9G*9)O\ ^9>L3(/@L32=DJ_FJBJ/(#C:OU5_4/P:
M ^('ZN(GD@<25Y)*\@\)()'A<:>&CQE6_;Q1](_.-*(U9<L<S08!9,=S#!#G
M*4B#Z!6^LLRKY?-S(0-0- 3K,OHTYJU7)8F?D#+2>&6Y=[6_R\\K-[5S!SDS
MU(O>:#G3Q)\>.:?1_GN5H(\E)ZKF.7;+!:?,N%E]<Q,V[JB3NNLE"P? P6U3
MOAD1Y"#_ "![@T^D?'X#W<01HJFQ,-8U.B)_M'\ON_SY<22-*Y=SU\AY*/</
MAQBL1ZXDEVY+ZGBZ_P"6LMXR$?T-<?3<^&O70G0!FZ<7L\>R-##Q_)N.'3YO
MI9L^6^>4=X;OJ@Z^]O(?O)^TDG]I)_6>,?R7S%D(Q.*0I52-?6LE*M*+;[P)
M/G2/,?-]>#RABX.E_G/!0/YI7[2UM/F"59>H^SC^">%FZ4^=\+(_D+$4M8'^
MLSG3]7%OD7F&M&9Z\$&5K#KVV*L1V^[XZ]D-LOAY*K<,K(S)(C(ZG1T=2KJ?
M<RL 0?@1QCL[8IH:ME!D,<_=DIV.^ OO@=M3&P\A[.ODIZ\9'$P>K_*N(<V,
M:3\[$?\ 2*#^<<P\2@\G\O,E=&X5F1@Z'1AX$?Y\.)0L\?K$8 =?RZ#_ /(/
MM\3_ ,.%[PVG^K_AQ+#%,O9S1I*FNNR10PU'GH?/AZU:1$C>O"\<?Y-&C4JG
MZ(T[OW>/GPZU4+/((%*P['9MB[:_AM;PVPZ^7L\>JU)%CUKP.B)I#K&C!8R.
M@3IT0CP Z<>K5M&'81:,BQ,-BZ-&OLQD>:+Y+X#RX"44[@6LO;#L H$?SPB!
M^9T^GV8U[GT>!5K*@C%>$1AQ($$:A=XZA]-/:'D?'AJM9]X>O"PE8/)NC4[W
M4:*S:CJP'0'QTX6M60J4@B4HS.A6-1L=AHS+H.ZS  $CQ _G%FY.D\D%:*-V
M@K>M3-*[(-IUVQQ[0QWL%)U;NCIP<P=C,L0UE@JS4E).LWK+]D4?XQ2=#M\5
MT;@Y<BT8NR0I'96K)M[4S;N@>90$,?9(YTT9]Y4$^[BC:GM]J[QQ)"DLT*[6
M<R,T4FW4@C:%(^.NOPX];MGM^VDZ+F(:J]C(\94:@;/9ZPZ::@]YVW;SIIQ\
MJ6B\8%>#;-<GI)K)(#OC)TD;12-F@Z@=X^6G!S+[8U[*%9R]E'+M*81ZLX3N
M[$:0F4GNZC1>I/EQ5G]9KQ3[&C[5-Q1O:4ZD$>7@0=#IU'XG4$$$AE(964E6
M5E.JLK#0JRGJK @@]0>,/SQ1Y@A@P?I!DD9T"08OG=$,N4Q@]F.OG47OYG%*
M=/GV)R--1N225.Z,KB\IRQ=]4NA71D2Q5MUY!/3O4Y1N@NTK*=RQ5G31DD0]
M.J2!7!48[,>SWOV\<MRV<M;CJ52H;8TLTTK;*]6M$-TUJS(>D<,2]68^)T5=
M68#CG/TH.B3\O\EV98* UAR',2]R_EF'21:+>U2Q^X$(Z:3S+WE9%.LEJ)GT
M?74*Q=@=6+/M?1CJ1N8R,IZG5C[7O#67L;W1%0Q+W=>^^UNX0-=%ZZA=-KLS
M.HZZ=*LDMB,H9V#(VI/0LRGO#34:Z^UX== -"/ [GB7MEE:1 ='#:MJ ="5/
M5AH-7[S;2OAIW6X!U /XO+O-&6Y9GD:@\4U*UW,EA[T8LXC*P'H\-VF^L;;T
M)43(%F37H^FJGFSE+%7L7/SKR1%)%B(74<Q\MR2&:YRM8F;1)H6]NU@IVZ06
M.IK>R_=5U@_%0==?(=>(T:>54'BQZ_!?,_<.+,@=PB?DHNX@\NGBWW\8?&G)
MV^S9NRJPJ9[D_@(H$ZMU\ S^ROWM]'C,97U]TKUE[#%U/FZ=8= 0O3MY!]*1
M_$:^R#]8L3B,/?SEQ*./BWRL-TCMW8:\0]J:>3P2-?[3'NH">),G@N4=:V"A
M@S6;35;&<MH)*E63P9,?#KM8H=1OUTU\9).JC(Y?*9>0RY*]8ML?HR2'LE^"
M0+I$@_13C0?@I7[N.E$U"W8IR Z[J\K1Z_I*#L<?!U(/NXBYCQ7,2K2YOK)'
M8("5^8Z,:Q6H6/1?78U&V6+ZS:%1XF-?;&>P%S V$CG*6*EE>THY"#O5KD/B
M&1AJ%D"Z;XR=1XJ60AN,7DYL79[:/YR%QLM5F_)V(3T9&!Z;@"=C:=#^:2.,
MWCH:S0WJ)WXS(+VM9O\ 8OXR5F]Q0^R#UTU7Z'$,IAD#?1]EQ[T/C_B.)X^R
MD[OL-WXS^:?\/W:<9>SV?JR+)+$T_:G<LRUHOFD\))BCMYZI&G><]#TXBN2S
M14O6;SU8WI3RFPA5#+8CF9 K-IWBD8#=ET+GR\N)VTFR,G;N[OBZ\D>_N=OJ
M#J1 PUVC3<$T^;+'W\/-<6:*DDDH]>%.6&4?T,036VJG3N]$!4#R<].&O2/?
MB6.Q,J279*DD<DZ;MNTKW*ZQCL #H8Y68R,VAXHL43%B-R[^MW]\;,&*,J2;
M%\-8]YT)'0LS%O/BO;G/JC+;DGEGCMF["Q7;6[-&*LL8&M?LW 0 ^W\==>*,
M]D2XKM+$TOKD%KMTE8%=T.A0JN@*LO74ZZGZ7\YL48++]H_:*_9F%FBE:(R0
MDZF*3;[2']?QX:C69ZLG9@&GT@"]%4:  $>87:"/<?MX-"OV_;_. F03-&)7
M$+3*-!*T6NTOIY^!(!(U'$$$=9&2/7:TCRG4Z]Z0[F]WGPV-K,[O\Z.TL1VF
M02'L^WC.H<+Y;OI>_CU"OK&=&^:L/97J/RK^)\/#]OCJ3J>#C*NF@[9&$DT@
MDCE9) ;!^=7<OT&T'=\CU'7B.-(D2.,;410JCJ= /B>I/O)ZG\;D/FJI/7CY
M'YJG PEJ4_P?RTYW-RME9SHHWG4C!9"0B._6U[.O(RW(PA60\9K 9#!7;-6>
M)H+%25HYXCX!E^DK>#(RZ/&X[KHRN.AXY@O3<K<GXSER(F'-<V5(LUS'*"!/
M6PTA88O"[@Q:,65!M7$T1B"8FUCDTXDD2)2[L%4>9( _:0.%LUY%!$R:,.AW
MKX=>H(.GEKT\NO$=:MN>3M>Z6/=WA5T)UVG8W@?HDN-?#;TXCEKU96B:10LG
M5.J+KW>HZ===>\-#IM/B-C#C=VFZ*$LRR>)T&U=X.[1M#KW3IT<G</HQ\*-J
M@>[\&H]XXU'O'&H]_P"#E?F*?E?,0Y*-!8JLCT\MCW :#*8BSW+U&>-@4D62
M(EHMZD),J-IIJ#Z0>6(>5>9K-*@S2X2_7K9KEZPVOSV%R:=O5&X^V:K=I3=O
MI&#<>K?B^"?I']@XA^:KS3?2;YF/[_:/^?=^"[_T3@ZN/7NV\L!=O'Z2U_Z"
M ^>C>)'P?W\1123RQPPH9)9I$BBC7Q>21@J*/M8@<9VRG*V.'*N,D'K\\:3<
MR9"(Z2/*ZZKCXW'58D4]\ ^P0/:DD_!RQR!S)S6AM4*T5;&HQ63*Y"7U6D"/
M:[)B#)8*^![%&4'HSJ>(/1AR9BU'\(^;Y+UCSK8.)1&NGEVA6S(?M/9?9Q_!
M;T1D;-.94/AZQV[$_;MV,/\ Z?!]&').<CEK\K9_(P9=8V>O!E0K5[)4:[#\
MQ#(OQ:)G9/:,;*#Q?H7,7=LX[(0/6NTY6AL02#O(Z^[R9&'>C==5="&4D'CE
M?*U[<+<IYQM^*R#;:$[GOXK(-^1DA8^Q%)(="OLASI[$CCC)8^QBK]K'6UVS
MU)6B?W.!U21/>DJ%74^X\8%A?K7<!,>EE&M4&/\ 17(1NT7W"0#4CX/];@@J
M2K#1E)5@?$,IT(^X\?E:?YU9O_IM_A_=P%5U*LJMIWEW '0CS&OGQL3338F@
M.H&U= ?>!IH#\>"B-U9%)TVZE03H?+J/#X<:#4'0:@: Z#4#W#W#[.-B:[MB
M;M0==JZZCP.NFNH\CXCC8FNNQ-==VNU==WAKKIXZ>?&U020J@M[1"C5OTCY_
M?P%4::*HV]%[H[H/CM]VOGI_J;QZ'CD')1^D#!08J^PDYEY7%.M([]9LQRL]
MB."&R['K):PA<59W.K-2>"1B2IT])UMKG/W,[-T6M?7'PH!M6.#'UX:L2*/)
M0(]1\23Y\>FSFW,68,KR#R]AK=G*7N79LO)=CM"MV6-K3JML4(P1-D;H3<&K
M5M&$3ZMO V\<L^DT197$8>:W?Y5Q&+Y7O8?$2Y&S<NQP<QW(1MSF>C[CV:RS
MF1*T?9F/'Q&)E4[6/%>ESOCN39L+=YE?!4#D;^7SG/[YE<QB+N*F2&*C2PEB
MK8ER0M6+#.\]."*&5O:8J-4XKY7G'FRQA)*4S9FMZ,I99[7,<F6DQ\&8JKD1
M8KN\V1>LHMRU(34J5VW7)HB5EU\#RQS/CN9L14S6'D6YC;B1"&:+7>KCN3).
MC!3$:[J8Y%;O(X8=?'@$$:@@@^!'4'[^*F-R6;LMCL3$'G6![%F:26.O7I4T
MVB6W9L3,J111]HIW=YB?977C/>C&O$<I>Q6)FBQN*Y9#T8J63EEGYCS9B[06
M]FLKPPU5U9U71K[E=BA.&Y,Y4GJ<N7JF9F&%2A:L\X<Q)<#F*Q"D.RBU"8M+
MC;<]EY((0L)D55[,1O)WN,5Z..4;4M[+K+Z[RI<Q,:X27)9&Q6EIY5Y9H;&O
M;"JZ@,D7J[V-661G548<1I- TM2T&2W3E>M8C<:.DL3;&#=!XD;@VFCJP<:@
M_@]( 6UR'Z+LD^ILQQ<T8)G.NK5<;D():J]?$1"=T4CH!T_%?R'N4<3]V"K'
M^:TA^UCTXQ]?UN]3K>4]F&,_HEQN_P!T'CF*SZSF;K#V(I/5HQY!*X[/0?U@
MQ^_CD6&*._?S=A=T'+V-GO@'P-IE,=8?;KO*_G::<3SRVIYK4[%Y[,KSRN>I
M:25B['7[3H/AH./1[RE_"_/+6LDQXFA'Z]F)P=NE5#W:ZO\ 1>RPV;O%(A+(
M.JCCFOFB2Y+6Q>*@CK8&J?5<?2A<UT9($D(GEC2)@R;(SV:DG;J"09&9CZ_5
M"J2^FY5.BHY]I@BZ=P$AF/=Z#4:MH #I\HU2-=Y\-=.SDU/7:0.[U*MT8>7B
M>G7BOD EB%ZLTB6$*S1/&'5X65G 8G3N,'B==K=>Z01IKQS%5J>D'EG+79J,
M47-?+M(7([T ">OU(06E@E \0T:2:(^O92A&A949UX!\"#IX$$>(\P1\1XCC
MFL_*N&Y;YE\;%B!\3DF^M:I:]F[?G.@<_9I[N*-EJ=VK:7H8+$4G]4,-P^]2
M0>.8ZZULS=5!HDK+93]&PHD_^XMQ3ZO)%Y2Q.-/B.HX3HP_5P?$_ZMY3YEN\
MH<Q8OF*AJ9L=8#RPZZ+;I2?-W:4GO2S69X^OLOL<=Y!QZ4H8'YKDSE%NUQ7-
ME"AS'C+'326&Y7C6<="VUX[,;]HA.Y-RA@-1QSOZ-L9SG9Q^2DN9/&9C#B?Y
M*RF)N&G:J/,HZ[@"LB;D0F-UT;0@L%=N+7H'SV8P&?7F#F6OF.:LK9QHJYVW
M15O4<?BI':.K%M99D-L2MZVT;#4!459 &;BS_P F&J>6Z^-I9J>/-):];LY.
MPKR4[&Z/8:D>.2:.&"",GM$E#266D]J3:2HH>@RAZEA\3G<UD<W@<3655Y?E
M2M0QEBZJD"[;7'0UY[<L99NQ]9L3LFH8O(0-<!R[B>6L7#A\/3BI8^NK+%6B
MU[-0[,S]6[S,[,S,[DNQ8ZL=>/5%^A)+&OS>U(WVH@C.NBC3H&^G[^,!D?X.
MY*.\*7RI4DJWJ&1QTLYC%^E?C*RQ/(0P^;;;)&'!74:=#H>*/I"P_+^-HK@\
MGS%/)/>QZ6<)F$.2CY:Q%:8F_%4F[*$S=K"1'5*V)VV*I"H5TXRG.OHUL<ST
M;B\MB[660SY#/BA8A GC&ZJXQZ=E\H-#-HTTUJ$E--8ED8<<T<_83-9&6<UL
MQG\?3>-L+A+L%6CRW-<[,QMD<B/^L;,:%G>O!/&._P"RHXS67M\Q9>;-7J]2
MG--!6KK6HJXA2*K&T:;FD^<ED(8[F;310B+W5 !.@)]W'I3?Y-QGH_Y0<KZU
MA,!/E\I$-=]?(<RVO716EU\)8JL4)9?(.OX@XE]H_9_=Q<]N(>Z"/CEA0V>Q
M^OE)(WWK"Y'%EBUFRQ\6L3D_:96XPO<Y)YPD7H\EG%5F/F8C("1]FK'\'HAD
M6?ESGW&Q=RZU6O<$@Z,U=89XVCU]VY6'_JGB2NDS12%F'9JX7:=/RFWKX'J
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MS#/2?9ZS%&-Y3+^G>5)I#B.7+L5"'EK(9:U<RU:*2Q0R6.YCAY?M4[6/K9:
MO7K6>TK2R5[3R/;GJF$&LD\G',7/4J9; <K<H3X#)<Q9RUD89I+MLV*&#AP]
M/UR^<C5QTXN&X_=KU*1EKLS]M+)((ZTHXFYI])39S#<J0TN2Z6>L\MYC.Y![
M1S%_&NV,S$&+@CI/6LU)ZZW8[,5IEL+9>IWX2\[KWJGI2Y@N+R!FEQ.'K\L\
MV7:F&R1EGORW\7EI+%ZC;+W41,;5J"_7AKXA)UEL9@S:?Q)A^#0<:#W#]7'A
MX=/P<JXRACJLO/?-,9'+6%E!HTSM$O,^<C.ZGB::O^4KI,HDOSA6B2.-D;NB
M8QYS,W^8LQDL[E).UOY6W);L,-=BESI'#$#[,->(1P0K]&*-1^+)X_:.+?7U
M=_)H%_6.,!,(,UC9#X>LK&?LE!C_ 'L.,G":^1OPG^CMSC[C(67]:D'CE5?7
ML'S?AUZS38^'(UU^L]%RS@>\Z;-!QX]>/1!F1C.<(*4J[ZO,$$F(G7\Z0&6N
MW_N)L/PD/#X>./F<X2232 9052_GV#2 J!X]]XR$7RW$>'&:R&4O7;4TBV(V
MAEDJBEV>V"C4BG[*&M538=#'771F7?N<M/+N+ BO%:?#SO:2:2 W*=7'=H'[
M*-VLM=O/$64#<*V/J5[# *Q]8B$FC$J>,[(V ]%F4:;YBWS/>@JU4;I++4U0
MN0OCL,$4S_H2*?IC\%P>H<@8JNW27-9B?(;?,UJR=FC?83L(]X/ 4NRH/%V5
M!]K$*/W\<U,/E40#PJ4JE;[UBW$?[W%+_2%/DH=C]PX'5]?>Q/[=>&]H_;_J
MX$J596965@R.I*NCJ=5=&&C*RL 58$%2 0=>*_-/+?I"Q_R#Z1Y?D[,M3?&U
M.=4AWPY"J\1@2AS;!$4>13&3",M"1,BD-,R;7>2Y_P G7#\A2T+4F*ORTH;6
M$OXK-U\]DLQA;;<NB^F">O>-F:'L:<&2LP05)>R_B[I&T+!5/%WT0<C7TV34
M;RJR9:.;U?,9*OZS!FLH<W=@M=C83UB Y/\ C<,<FJP2JACV[$TS')'+6:C1
M;&.%2S#=7(U\GB)9L-EJ]\*\9M19/&/6N":2*66*8F4]M'*ZR!M>']$W*!3'
MK7&=Q[XZG=H16<;S)G*-R>OD[7KV16[<@NK9N&]<_C-DV)'WRZ'IHH ]%_)"
M9#%Y"'#^KMB(L7%5IU[EV+%R?(G;'#37L:E@4\A:QCSRR4[5R*:>.5^T+L_7
M\2"">W/'5JP36K,S!(J]:)YYY&/@$BB5G;[A]O!Y<P?)L4>2](MDBT0LM+D;
M&6(WSM_NAXSEID9H\-0?5>T+/ZPZ;U3;(-AYLYORG-]V&>Z(*E"C&:V&PM%>
MRQF'I^4%2$: R, O;V7':SL!KMC5(U_%;J%/PT_5PWSE.-O.!RA_1;P_NX5F
M1E=#HR,KJ?<RD,/VCCF5!/)2S$0^9RE5';\VS"H25#\?#[U;CEW+M@\Q3R.A
M:*-S':C'])4F'9SKIYZ*=ZCS9!QS5A1A\F37(DQ>17U[%V%ZQR5IN_V8;PW0
M%MI'CL*-Y\4+L^-O4\C5;;9H6H+<#?\ BP2+(H/YK;=K?FD\)GN0>=; NIF9
M>6<[9[-I:N1 2LUI5 '9SMI W51M=+$;$:$Q!N)>7N8+'SPK\K9^33I=Z>L3
M^&CR[&CCE?S+/J6/B6XR.$RHFI2\VW:6#Q>MA$D#UXZU..&![+]E7C*PIVFW
MLU8EI7<JO?[HX;F7T48L^LQW,UG9:[:I36JR06G7PW/+'7C[+7KWGVGS5@=#
MSCSAD><LGZ]< KU8%,.-QT9UAHU]?9'0;YI- 9I=!N("HJQJJC"8BQG<G6QM
M?IVK;IY?HUZR:&>=SX (GLZ^TY5?/CG#*U\CE%KT/^J\173&8\ ]UHX.DLP_
M\V0=#])45O/CERH+.4BDDZ5J(:]98^"I!WE!_2?3[@>+UHW;EJVW_:)Y)0/<
MI/<'W)H.*_<BL3>Y.S7])_\ (X4>/P'^J,1CI<QE\5AX'6.?+Y/'XN!W]A)L
MC;BIQ.^G78KS*6TZZ \97&W,+E,GALC$T%_$9"YC+L#=&BM4;$E:=#]DD9T]
MXT/%?&8:GRK#S'F$R=MLEF\EA*%?'6JU*.G\EXZE<LWK4EBI<];EDER=2.M0
M055:**R\EI6:,#_FOR"?*/;9_"1# K<7F9^SR;#!V:6(.:>JR)4+Y%Y:L5J&
M&2@)(O7*LD,C)&\,\A]$_,!N"G#>Q-AFEEK)*DEI(3=-G"08VC(9*ZM!9S,?
M,6)MT5E "UYYNW*/5F55]%%YK)KCF;EO:UK#8^M*CW+#3Y/.Y+)8G'T9*].&
MS+0>2YC)',U[L8_49ZUU=R.R)%Z,%M05(,;E/E#,9#"<M9'L)5DQU;%7,WS
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M4>X9"X/W3\26K4PTFMVYA[IK4\H_5)(PX"J/!0/N'\D#H=>&&A##P/4'W?\
MQQ(/68NW4?.QC2=1YCR<?Y\/LX5F5E96*LI#*RG1E8'4,I\B#U!X^9YHA4;H
MX,_!&%[Q"1Y2)!TZ^"V /\E#W)8I8)'AGC:*6,[7C<:,I^(_<? CJ.G&'YKR
M&*@-":.'*XA^DF+R"]K" ?'U>0AGKGS 75 >NP'KQR]@.7\Y9R'-/;ORWRUR
MW8Q<UVL>TR-R2>257(B U[&J9 (^T;?M74[1HVDO+1R/,$G-4F4]:VXEZG+,
M*QKZKBFN0GM\@L@+>LS3$HZ2: HFJ]=%T@M5J7)M_P!'&5ECY0YDF>3M[N8W
MC%9UI;BSV;L&35&3^.0C;WM&BT4)[EQTN&YQQ5_DW$\N7*?*OJT]*IS/#!5.
M.:[2,:O/4C?YUIFF[T-EMS3$,7*]=/2;ZGF\.O+F!R+9#F+E U[EC'UP[76J
M0UO4[;B15"FQ DD<TT,,A?0L-FO0*I8A%4LS':J*"69B=-H4=2VOEXZ\5ZT/
M+D2W\BJ2Y:1=:&/)!]6U'^DVM/!E^BOEX+J^I2>>6S-)8G<R33,7D=O$D_N
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MFC+@'< 5Z:Z\48\@L3B+LHP;UMI1:27M&C:0;##H1IJNNA;IKH1Y\0120R3
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M2K8K$4XVHAS#>F@BGR32RZ]M8EONAL//-N.]]XZ':H"]/Y.SD:5,Z6)U5_\
M9KJ\GWH@)'WZ<5LE1MG;!81G^HVL;_<KZ$_=K_.I)S5C>R/&!3*-/>O7C^&4
MWO?]1XDYM>52D@9U.AT(/B/ _:.*=V"['VD+>'1T/1T/Q'N/DW@?QNSF06ML
M#&T999([(5#K&S#0)(Q[KK#\VD9&@<#IIU)%\[V1K 54D:!6*=HS!X=BS:]3
M_3;5/C'IOZZ<)%;5]J-.!VUZ1M[ZQMN8/5&IU/9'7JJZ==0W3QDBN3(-R3N!
M')TFV;Q.]2Q')LTZ=DSM&J?1W:[=%XTR&LO>E&G145%*F+=$!V+E]HF6(/TV
M:E]=WT3Q%%86LR#MHV>^7))3MO5WG!9R>H!,>NI]K^MPT=URX<NP$\9$976,
MHEJ)XW20OY0J2X" D[MW>"Z_](]DVXS&1B P50.S;YTEXCVFLB$]FNB=F@!#
MGP=23DO=*2R5S(= .S_)]ND2*VDC-\X=R,K#O*1^3/$':"%.U8L^G5F4(WB=
M-RAFT(70'4DGQ/4_R0;R;J/W<%/-3K^\<):D0;'TE3ZDG7]OC^_C^)R?7KG^
MVG_#]G'JN[\G/"X_2VG]NO'J5CZJG['7CU*S]0#[77_'CU0C\I-#'[^]N/[.
M-*<?BSSGW*-J_K_X\-:?3;"JP+[D'>^]O\.-I\6.GQ/B>"P'1.GQ\S_+7;<=
M*O)8EZA= JCQ=VZ*@^T^)\AJ>+G,5Z9F E,2?[.#YM1\"_5V/O.OW#AYI'))
M)Z^/4ZGXD^)/"S.OGK]O]Q\1^OC'<PVJQ"NQFB\XI6).G_AR'O*?@=5\M.*6
M1JWUW0/W@-7B?I(GVCS7\Y=1]GX-#XZ'3[#QH?=_-;2[JTZ_6B<?K''J7P'Z
MN#6UU"+O(\2/9'PW>9^"Z_'3A:UJ-M\4CPM[XNZ=/=KYC[>!%9;\K/:/Q6:0
M?[NX?LX2G(?8M3Z_^?+K^HMPD.0C\+<_V/I(/]]3^_A);R^VL4OW&)OUC<O^
M[P+(_I8Y8OB5WI_;CW?M X5T<:HRN/S2#^[^:>'&_P"L ?W\:(? D?;QV?N*
MGC8_Q^X_\>-K_'[S_P >.S/GM'&B#Q;7[.-X'LKI\3X\$D^/X>>O2)FN7><<
M5A,:U U'EY?6]4N429[$.9R#U9YZUTW(W9:L077U6G)'6DT-J?618^,OSWZ0
M+G*<\S9.C5DS')^<ST$F*P\]._C?D3F.IBWACM>OR$R7*4TCR3B*,U=&,2L.
M_P <B<RY"U\N*:F0YDBDYPM4DS>+,7R=!57'XEEO319++M)6IS-/),D&)6>"
M-$DV0"0ZR?R/,V2[6?U:,_-UB5_2G([[?$1CN#X[O?PH!8!F"#S<AB%^)"@L
M?N!/$]1H9A7619YM5!CB674%U5U'?C3<2&&H77:=0=-./4[0+CU>76,!G[O@
MK*64^XZJ"PVZZJ"? <35)(8DF<IMD[/0 G=\Y")QKW=.ZC)NZ]"X'&.N2U;$
M4J'O1G5?B/I1G\UUU'&87(Y# W/D&_\ )N2L4S)C[W8QV#!*-)!\U,&C+.%:
M#5U81E^TVDKIQ2M<RY[*4,RZ<[U(UH9:;#>JWK!:PD1GAS>2Y@R[QST\?822
M"1:E"EAA%()*<=9(E7M.*=+FVA+A/4_EVYB[8K#EV>_=OX;F+%97FU[$NUY(
M6FI7;<(K^L7I+D4]-<5MU2O-8[,4%NI1I)D7ADR"5*RWY(-QADN+"HLO"6"G
MLWF#,NJCH? >'XQ('B0/M.G'C_*L 5(/0:=3\.!7[?KU2'R^B\WQ/FD7N'1W
M\]JG0^K(.@T '0 = /LX]67CU9>/5EX$9'@QXT_S_G3\#0Q/U9!K]8=UO[2Z
M-^WCLI%]B=_LE E'Z^[)_O\ &ZPOC'')\8W*'^S(-/\ ZGW\=M]:*9?_ $]_
M_P"(R?MTX#*W@>OB00RD:^'1@#Y']7\TU/OXU/O_ !\]S<,3DXL)C\%D^9<P
MV,FS4]'&/0A:GB8I3!ZS-/D)X(C)8L@PU*<1>Q8<,R+TZV_24E>?*+'RCS!8
MIX'%XK+YZSKBZEC$T,M4-U3/BK5J.[+-5@69KE:N)&4P2>]2:?/%*WS/6Y93
M%Y&+Y1Q\V4Q65/J1IY*E!#!.UR.M%.UZO1E6?LZMVW!%%9L12P)WU.G\A-)V
M,,TW^RB>3^RI/%J1I)26.I.K-\6<[B?V\*0&4L-5# L/#4 ]1KY:CIKP,@WK
M,T[(-LSV"541B5!85T[D^PN#&K]WZ'3V=#Q'D1'$L44#@0N[U]71RK/$L>YV
MDB9@R;2Z" PH-Q339Q=N>L[%$?9*C2-MW;O;$2(/!?8BAC7PZG4] =.(5W2#
MX=>*5S)TJL-?Y(FD$8.CZL"=S%O *=/'PX^6KXZ?(UH#\TOI]O2'3BA?ENF0
M2TYJO9A2.VU[Q8G7;N1=--.OV\>CGEO%<PRY+UZ.PUF@():+2[4P7;R;Q7AS
M%@$3HMJTL4$<4&C3AF4<<]X_U#.2:49,;VZ"9J4D;1^JM*J3^K#=J'$':M D
MJDK-'$L@T)*K_?T'Q/N'QXQW(_,&2KM96NE2/9NA6ZY@DLGR$<>TL@/D\P13
MY>_B]C[V-G-:_5FJS>22(>_\8F&J2@^1C+:_;QC?11+%2@R?.6?Q_*5.PHEB
MJSZ3922(@-^0+(D3D'\G\](NNCQJ>[Q_";D;E)13Y0Y;K9V8=+.=YAB[5K'O
M$$3Q[U0^6Q*T8\D<][A[GHRYPT7,XN3DK+OT^4L0 V-D8_2GA5.S4:^/:5T(
M'_:..;?1[F.5D3((\69P%C1JV<QWSE?:WL"VBF3U9CY/O>NYZ++N[H_UIG>4
M[60S$?,&$S\_+F9^29,':LQX^KE(;>-:<VH5>M9DA$5NG98RU;:2=T,T<D4B
MGI;]&^0L3YDQ\Z9&.KS+B,3A>81-B:%O)Y&KBZ3T'E3)M+$M2U>@FL=O(E&1
M4:4,J,T:GBKR(M;F#&Y=\YD+./P1LO@<)+#!MQ;6L=%BWKKDM3:GQ<-:-FK8
MUT1([$AF>60@#^1S,G98RVWUHQ'_ .XP3]Q/$IUD;[?P*-3IP6)^SR X'>Z'
MW=#^W]7%4Z2:^[0_>&!X!Z ^\ _K'X?1K7ENMGJ%6'(V+EVK5KQ0UI*HQY#R
MR!9\JDW\8CBHS]C=AN4RLL$D'9[P9U#>E=XVYDD5<C;R3Q1UX'DM0R0FNU>L
MD,E=>TBA,H,RO9$H#*XL:K))[7')>4Y3IF-;M;U7*> R%TBQ79O_  6VA:7]
M:/\ ]?A65U5U971QN5U8,K ^!5AJ&'Q!XQM/&7)Y;&5%62C@D7*7/6%CD%<P
MZRP,5;4QMNC,B^R6$>@UUXYJSS\RYZ]F'[4)8DTJQ3R=H8*J=V&).@$:[0'*
M#Z;,69B=?P\K<[Y?E9C#"4O8B8GUS#6_G*DR/TE[(,&]7E=?-08W/Y:-QQZ2
M>6\;CY<5S+R[&(^7.9Z_K%>%?8H7U&ZQ3 _HU()=(O"-TGC7NHH_U_=KBW5G
MK_[6,A3[G'5#_: ^[BQ&4D.OO(/P93HP^X_@!T(/!&GAX'P/^?=_\< : GS/
M0#]YXP&--NRK./FHBLLQ^ .J1?I2$=?<H/XG)O-K\JWC-ZI6FAF;<]DU4FR5
M!Q7L0)8QTCR1IN46"TM:8M7LA0L@!"L.9\]\OWH98Q82E2IUL?0CMR)+:%>N
MGMV)8U >:>9IIY#WMIE[-3L11^"AG<QC(I(*&0L5X900T:L&1=?%H@X;L7_/
MBVM]_$S/@O1/BX=[_*'.^4FR5Z9F+334:Q^;5W;5F5ECK>)\)''@3Q(N[;T)
M]Y'D#_>#U'N\N/G/CY>6WXD:Z>6FFNGTN._IYCI]IZZZ=.GAX'[=?L4,3UW
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M):')]'U*68'42Y*4)ZWU]\815DZG29I5^C_W)Y5&ZS;C6.U,\E1XUKU1$RV
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M&@[L4,:]R*)-%11H/,__ -&O_\0 6!$  @$"! (&! <*"0D&!P   0(#!!$
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M&M6(UB[=^JQJBQR(O9&KBJN_=MZ_Y@) YXL7[VR^ _OQ+/'#V=V<\HT%V/\
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M)#A.D>4,0KU#T['T:JGFA^MBA3_BQ#44]2NJGGAG7SBD23^J3;W_ (HFPO@
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M8\H)C]$6BD\0IWQ&\56FI+A@2KQN-+QNO>CD3FKJ>8^K:V)J;U8JHEC4LWL
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M$9F2H5(YP[NQD82)&B$LQ(5%52H&!EF7AV<4L>IK7-WMM,E1V5UZ4^7C28Z
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MU34&E61:9IY33++;B+ 78Q+):XU*FD-N=QS/WP!/($^S\<EPRZ02UQ8#F3X
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M+J8]75.S8CXDJ?\ =$??QS(9!3'TESY6A_2">_[>\?;QM/\ \XXY3[C^B?\
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MNRRVY?2.!ZE?I,!T6%V:A%3M@^(D>J-FM*W<Y"1"<R4\PE,%OPCI^.KS72]
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MV^ST_#JG)?H7<XV%S\13S_\ ^@_@M/E.2FNJP['5LGX+FQ5S+)M)H%CZ]CQ
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ML<7=0Z.;:RP/8RU>PMQYV,J!E,FQE"VXI/(!_P#AWEXL8[+-_88*O6QF2L/
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MY<[GC_XI5AL\F4]D%$M>^?3C[#/QW1_AT9T@2!(32D8;<4C"F=(H0 SYY0'
MWPP00S",6T.\\9^6.A(  &>;P5@:!&.5E:5ST['Q?!ZYS4SE1LK!X3M_$G<^
M%@$7R-ARLS>4##R.0'P'<>/+&I>8XG7&>C:M7CIC81>ZOPZ3SRO279 %9U>'
MU>".Z;Y'\U.O[)QK5ZF?V'@:DY\/:DS5?BB:BX-CVC$A3I6,DK,YBI=GY'/#
MN!@"8J!MF@T=,]MD@*T9)F' _P J%Y.]'<K1E5Y7ZN0)ZVLAQHW>P-HQ^CU
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M$RS$11(2D:1[_M#Q)O$+5AA#)!D85D&51RC+)%54!-;XQ=ZNUVG#&)2V*$H
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MJR0,4"'XF3-FAV/VQ'5&0N2C@*2*)HP<W;:[6U\_NX1,2 F_LQB& ^FCV^?
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M$#A1!NIVD\(V;(Q#4Y7KMKZ@N3!]<I^G"K*6DY-W O(3>)/HC<4PY#WVHT\
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M&;P#@W:VXH+96(#_ .&?_]H # ,!  (  P   !
M                       !DM@ # !,            "-'
M   -V24L, =L5@           #.4               !WGN?7!"].)A@
M      !FI/4 :< *.Y80    &G]-, A!9.5H@           "R6,"S5AIG4.
M=   !(5@KTACBB,3Q           #=$9L &=02UX  $  #<UP^HRXE*8FT
M         !)/_H  <:M#*(J6  !=,Q4'W\7^1=@                  %\S
M$:A[C  .DZZK+>K4,                     !G[NB4T6@!STP?;3,@%@
M                2   9\"P%46 !RM3LI&CR4<
M )A"P +8  /M8*N*$!+ 2                 !C0Q5.FSKC@  &A'P%Y7])
M 0  (C>#'S2, " 0   2=9+84;[(    #7*# @!=X9@  +.5\C+P1&OB,
M"IR/9        !]L(@%?UYM\  3_ (G#P@^GR,F   $<( '%$[R@     ;_[
M;P'4)L    #$            =BI@TZ^%3     #+MM=[ %    ";W4"@
M    $]LVV*         #:]M8 ''H   FQ@".,  G      'J2LY'&@
M  #8   %    :2?!N? 7NX     $DD@@$2@            &(    W%FD_\
M+'8!0       !(                     (0," %08,(0
M                 ;\@ -!7'-@                              !'^
M   +QVW                                    +TM5S@
M                        'Y C.
M
M                                                 /_$ "P1 0$
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MTT<>E=[.CCLFOE!TV"?$'/H93:!$^(<%0G!""#M-=.&)U"3NGBC<PKT6LV<
MT3.3+78W-QBYXNP% :1ZG .[C'C00ZX@WC6UX/&%1..0S. Z/+$K\9SDDCSI
M9:G(0%6^?0&^GPX[)$Z)LZPBJMV)XHH-D<=YTRW6L.Q].N!!TS6!(,ZIYIT-
MVP M$AB%"M1MKXI=B/)*.)!V.UY/]YQ2J8*P)*(19%V1?8,;#YJL5V&V$0TA
MQN"9W(863$0K#[F-)P"UM!;C!R6"IB+!)LIAO]23$R6Q!04G* I]Z+Q.=-59
M7==$3P+@@0,J)"K B--(HAA0H;?[>$<2*\C'""J&(9:6Y)= 5CH@FL$)D"2P
M^X P LI2VL&4>XU[HNP[L+[[^D"*E10UJD(H;165(HB0P06K41NM92MI)*#F
M@E,A0H#8-DO 'ZCO#"4O"@BHJ*&1("(3#@6=#4N$IL5Y+"THLZC<6JCNV;2(
MMV7O@[WO3WP070%C#%$L46M4ID7R!K5SGSYVP*C5*BG:@N23@^V-8$  4H\,
MTCZEFH2D"8(7"1PIIQM\ P=:%K ^ GC_ ,LAX/MCSE\A_DQTLBTRJ#D2F&+T
MGATM(7?E8& DV695IL"TP AM%)(;#HTC=20M^_@M#5J^QR7_ -]9N.$-(\-Z
M2Z:1172M\"T'9T?0_+MR,+Z?=%2-:,@(D"A"E5)Y3BQVIEC9 J +$ *;0!4N
M J>7!>:*HN-V#8 $1C<1E&C.'D):D#.3!=D[[NFJV3:OC"+8S2"&FS:F<568
M\11;;$XSR)P"EUZ6F07=V1("YQ[M41IK2"5*+2NI;>1[/:-)PFL5!<.\^$FO
M LMVJA&WRM:3VW'_ 'K&$<(/M(4!N)'W,B"C2W.> PI!Y,:=FV*TRT4*ECV8
MBQT0F]M")19$.\"">N4:2H!C$.!CHOE1 0:%@BIHA'"KZ$+D4%@5H>'"2$_D
M8LYLZ:#,4+U!#G@"((!H?W '=*RTYR91I/:7)DO,$2!:CG"#D)F))<C2[) 1
MAM)NLVF!3<3% 0JYTOH=H6+4(1L'E0L)V.8;FY84! 'OETM-FB (#=! N #0
M:>B2H!@PO[!!V^3B:* )@"#AZP$MTH)"NL*<UNSV@,PV3&\%PGT3BO\ -3UD
M.U8E"H;_ "<F4(<';JLPO#G"?FF4!A>I%,!6%4,F*540&44%(XB"L(*TKA!L
M(0K("TP0YM)6HX0@-R#0,B1.FE-(,+$2PO/[13H4B6OR-&[/!>D(1P>I5!RL
M_=4%+AKB4XOUSR )T6_0<'N><B #%RT/<H@H,+RN533.5VSP;7CC1":\$%FM
M1Y*6X@ 08;503D#YC;P3D,T$V-4A$L@<SBAAKTF\ &@%>< X G$ GVQ!Y!^2
MX&^P!H;#D//<RQS#$5*1^M(J[#!7.':P.2 G:C '@V46I0K B=;4D=*<A7LU
MK6P6JEY@H\-A".E.SLG;A[],.T=@#W>MGW,MYQ_P%JZ@$C1P>-^'NA$"A)%+
M!#OE$Z30:3V&$01 GZO#8")@!'82YV43,$'2]06@R7&]F*-85D%9#:F9PA,N
MKMU@@$.]AD5BF19'1;_<T@]'0E&6+I@J &8G"ZIQ:1LJM!:U5HA7(X< 071
M <,,[$K>#('@3RJJN++R",BB* (Z!Q@ *Z' JL!V7@BO(:C%/[A,AYQ# 8VS
M8U9T'"HHY0HJM?W"G04!5:4',0@+HG^NK%6RM6*;AYRK0^4OX<I0'+=CQ\D3
MVFLV!J*RH$*TJ3(4$4"]\T!NHKKV!$D*X>H@)L^1UR$E15GR,AA,A:X [=N&
M#H'!P*JAZJSU,XYS6.A!&FQX3R,T\/6"6)+8FIS?$[\9Q0-XC;N=75)>!U<U
MR=AOUU_.'.<5P;M8(3PR%A4J6QB.DFQP@?L:9(HWS"?F<?YQ0=.)XBEV0[/N
MS0> /P8FW ?18,X:D<P2/ F4 I!0.[20M=#FG\4!<4EX31F( ($#0' >,%D5
M9;"E?2_EA&Q+M<.2W#I'3BBXOZ]X$.W8=H@.CC&N=_G70$(9W5&;G*"$JZ4T
M-Q.,AV#$G<T(5*H,JF!0"<PWT$V.Q"NI,-\JNC""!RG%M$BBAYT@B<B9R+LH
M/E_NBUW/7*/B%X5 0&HA2N+AM96MJR@JH!5:XQL;T6FT:.:GK.\:VA05E8 2
M!"28HTB0V=*.E'9LHF 1"\2H5(-Z-5.\. P@_  _6;G#4,!T(@U@X*:;_P ,
M@$!$1'8B1$[$TXOQ?G3@@NBGOP5!Q"(S]<  B:Q>I%QP493N+@7;,R1O'C)Z
M0IDCKS;H%Y5M%Z0NNL 4K;@N01$!)B(H!A. & 1FJ 'D"B>QQ_N';>>'J:&
M<&T )AI0;8\@8E;$%';%$;OC6ZD-\'713AAQ]X:%H]1>3P4,PCD6Z279Y+4
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M/"Z7AA[D&[M;>E.UO8X'$:'&V1452NI/X@N-OF.C5F"AW.G=R,WT'0!\ 'X
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M#/J&2=N144"9UH& U)HFCD87#Y$MI<#Z!C%(I1C*</LL9]/Z-"UI.)B=*/\
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M?J#<\4AD*5!E8K1]HN+ *4& L9$?\\IT%.XB^FL?)PE"*:]X_P!B^._#^G<
M.SR<)]2GCSCJA2H;)V+YX/3+1B.Z"X:W7!H#7-J:F/1'6:TMK@HNU>#/L>C0
M?!T?JRAD-B6[,F9%:Q>(6]L/( $(9TO7J <.:X)=Z(K6 %$OAF;7A&DASDT4
M"4: @9W#V<%D&TG8"["4$Y:@ 8*HV12(P"@0->,-@:*8L%P#1"DO">Q.:50*
M%"RFI6E5(0Z 7_0 #H$Y$<,V-IE.AGB.$I$62:2)!P[(ZQ)C]!)]RC\F)<2_
M(C6G_#FN"P;&4> BKMP% K]!70P&.B!OR"JI_71?0\\L_5)/FI\S7YPE <!
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M;ZMWO-^'K?AV:5= PZVH8W"-#@_4T5L-*<7$'Y#A]O#\^WC"*:3E<CZG/S]
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MVHT-:H6#7^Z%O'-A4B- .1W; 8*)TZT0582_ 1MT(U@/UQ\'P$/6: 3PR?\
MH.F4%3:G&M%6#%&5S#"8X6Z ,RDCNQANYYKQ4)D:>'#!J/VAKMNR]>@<;\SW
MN' ]5YMZEY.3'*-V<KY&%>97JX>FNU._ETG&][]\M1>[0&>;5]L'Y]I$]XIQ
MYQZ_<'J^&YUI^,X+3Q$SKE&<^/[8Z;?28.>#H^X>^\@A.[_85![D],2YDT#
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M7%+ (DPB:2/A^A.#BMV*ZA" -6:7(#M;@\B$27ED_P#/&NHXMMA.;/>P<2C
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M"DN8'I21H\^!)&Q$K -2"D3D'I,)!7X-!74!BMG00M>-#TFL.J\8(<I1 \M
M'OCI:$4PJ9T"5R#P,?\ 26"O%.!,MWDH@H$;"C#HEZVS94[!;HA#","R&X:V
M*CQH ,4!$-C0G&5"*Z11ZL,<(08&)=$7!):A"08P-5#5K9"5XT;V=YJZ9#C3
MSAIQJ^X7".,EC :1Q@<@2;\#"6A2: !Q_P!)!IKSN4';(Z3JB,5;^!^4(]#3
MA7'<M80I8\58>A#.)-23TG$]NL+OZ;<D?4 SM<W/M:O?.P=##7@R1B6*(H8-
M)Y0UFP3X%5:0OU9-5@!_^&?_Q  L$ $!  (" 0,"!04! 0$    !$0 A,4%1
M$&%Q(($P0%"1\*&QP>'Q8(#1_]H " $!  $_$/\ T@IO*1, $9T*!=#?H7,Q
M:)$ "=*D'3O!D&#1<5(ZK=1JZ_-M+[:$P+/[ZUR\MJQH#?,7MR -;73*#->K
M,&Q#TM0]9V5AB"H1C8B"FF(FM4TI^A?PS7O>55QYA^,7)X1<7PP]/7O[9N:G
M5J-Y(S^?.17[T_X7_O<,KGE61S=HUKQ_AQV>6'X]*5\%?O\ 4>JL'5&)Y5!,
M#1,;RJS@OO#B@XM:%!I:0:R17,O^#?"&/*@N(!<\'5.7.'_DA;L5E349UQ,Q
M;=W2*A(/^:(M"R/AS:.+K#33>W_^]2SSF[W!(O>>R.3>4'C!D/-MJ=QJJJU=
MJ\KY?T$TNBUG5#1]W?A9NIIP%HX5VFG>OGB_#;V?GF%YT/Z8FS5V"'[!,T"W
MAO\ 97],9!]X$'V!R^P9! SP&?LZS]ESA/$?ZCB6\^\3=!)K5/WN2#NG17VP
MNX:T><^?Y[<?;^_J>7$P(?8;I:-1VX:FNN*P?QO1]=WO1IHH!?F_TV=K8ZO9
M24W:1W[G;H@$%JP#%PYE8H) ^M(VAG0NBD7\U>9B/31@&"6II?/[$9Q^QY X
M+'S1<-;%QDJT0]G"196^ !,R#;U?1YS$!F>P2#"PL&NME5.V5R^"DF-X".@?
M*17,]N3/XY!M1X)ZV'-?;5$#L-.5(RQY(\HG8H9AQJ+J"*L!*0E "'\PJ\#Z
M/YVYX'!/,8K4DB%T2-<4T-XN-$5O1V3!X0!N-0F5!8+6L ,:,<K!BD(4U)B>
MVI")1".DD)KHYO%47J$!A6H15@ I"W0*"@2Z$T#$11$1B.D3D3I/PX[NE'G9
M7CGDL=!= FA]VIRUJG@_);PB"V7*J?\ #QV%1!*9NPD;J-FJ<,@ GLA&TF.A
MOB'?  \U73M1M^P\7$B(<^'-8Q*RD9QMRH8&BJ+5#H3%ZN <0ICB1#;(,&G]
M M&0/*!1X3K.)-O>'2>S>U5=F*J6;BN>0CU2NA&DYB(B"(T1V(FD38FD]$\"
MY=J;L"&*95@M3@EG,?!#-UGP3$44TSG@MF[?OF@>9#G'_J(X4&WXSL79K\YW
MHH(YH]-P O08] *A1VA2,#LIL<.!9_8L *B_&X_,,%,9JD7P\;]XL#_1)X^8
M9RQ!?NS8H-KDE'T*41;?T$U).$:/K0CWTS[\<3->Z7GSN<C!N0!#K:-KL3=F
M8MNMVZ(^XN-CT>3#6:S+ELHG"6;VI/#D-MX\DVDG9FW9+F($!S7*F%$(CB\A
MS<62OMR P)5I 938X"89-CJ$ZLD(1CK+([L*IEJA&&<:[#WA>)B[!A0:Y3.?
MAB+D?:R)4@"I8"NT7CCM/\CN?9[8J[57RMS^/*>$P+&Q[T3M$"TYP2$NO/ /
MP,.\HJ<04A!#M 2UON,RP[VD=VVSQ_K_ )_/YUFA$"J+*D-<:-! (2!I;7H[
M/:?8-&C+MM44!BI+417R"'"&2[!)-@0%#!02"J@$U4S<E4;<#"G=&QIT:*%H
M(T3 ZV0RW-.>FR'-EP78S0URHB=M"#@!+7RW06FAUMT"X")X!2BSQT%U;C$M
M!SBUO> 6=GD0NZ\8 >!C 4 R-2%X9/[B.T;439CH+E'3L?@V@PV"?S_N$$:O
M]-W8 6,$(*P- @I,Y9$;P-Y17U$YT!T%,M=T_0Q6OMI5H>ER5<,=;*#@80TB
MJT"K?DM861E!%&K/GB%>#3+'"@(AF*',3T>J<\$J4?EVF@+S#X,!JCQM(#AU
M6436Q$0I/_X=T&PID86"ZI$MF[*!PM7+<,*[9J<5$#0#$^QVI$[,I$5DT>])
MN+X04AS<'*(*2?52NOVBQ.9D*2D0]ADLWSCVQ)-SG?BQINV9AQGK_P!90_W?
M;'K$K4FU.DB"^C3VR):*I0!X+ @5>@81U;((@2ZCO[[*UY)Q3- N;VQK#5DO
MQ.?&(/B:V)[H:%V,-[6[!'?TRT],R%*HAQ4RE[:,W3+@!#]<YV6GR%J?=B]P
MLV1KHA3[8&H:J=,T_FQEZ<"ISL"$!\Y/2%^\)8&-/@1H.MH6^+Z0GS!=_'*#
M2>)W$/!R38 XS%"6P&L>0F\U7^^"G"GPIB%?L,)*J$]WP8 6\ #<4".P8Q)%
ML^B64NL*&ERZ0LGH$0D =&:'B75 H9 U!V/#ASI7($#8FP7!TWD,%MB%$374
MXUWW]CUT\Z$WE"7EMY'32'Z:OX[L!=O5YZ29@,F,X+O=>N=>:IC<3.FB&J/!
M",$CD>(Q'$F#&-M/;>[SM@,%T;\,T!(+E^[\RCO)] S8'9["T^@]'\&<NOI>
M&"<H'JLOCOXP"W27OEQS8/,13*?)$))S^T7.2+"'K1QH/>$-^8R,Y0I O5$&
MB$8=<4'D;Z52RI];(+!Y>PAL.2))8@<N7@UN[^&N<F ^,JF^7O2V$&;/$T@6
MKDC)!" '^J-=K13]9&@V0;WRL/ST'CL^F=L:L+*(HXXKA1MQ]:(@P68"H JH
M %5= !M5X,*A$ 7WOMLT*;#$:0H**G8&MJ;#LV8BHZ\KG\,3P2TF%"F[=8(6
MW&P LD*K:N#W?N L9SD&S:\>U'[2?2!S9BYMQP\IV_#SM?*O]7";B?D4K2E@
MU++1Q!XU"UI3@RU0&TQ9,!+I7D]<)$7%555555JKM5=JO+FR(UE\E3-H9V%/
MQV,2<_CN+85L5==3F*L!]##;"TLP$/I:9-!-=PV[:ZNH$=K;@4M,P>"C8:FX
MDB )G1:Z$)2=IY?RFA>"BG7!)L%13D!B0$2$.@:1A-1SBG.O@+F<$_'>[F)=
M)L%5J.VIM1BS!=%^L4GZ6$.%A)N$]1F.U*RU>"Y(%L_'W=R(KC1O_P".#P(6
M>@= G.R;=A9HBC@\-A$*0"T)@.KHY@*!^C(F&0B%1TB"/28HXQ[1?4!JX\E,
M!:7/A@SL-Y@,IA6VMVN>\J8A''<'B_R*'"0D32Y.?.;CVNZT6 !WBU^ #,DS
MB,5'C[#CP&-I,FJ,=[L/;NL%LUB6 UROBPS@M *<X,+N^6."KU]G37[:\90\
MXR.!@U5\0INE+F+T0!+K9X%' SV-L ^GRFA3@R!^!YX]\C#%I9VK_3;\;R1=
MT^5+=[-=P' 8IXHD,5$:K[+!*#ST8'H&A37E#44$DVT#RZ;S,88KTCHW7+([
M&ZDPK#8GJ+DS\UER;"/B1H?UH:T8-0Q;- I)Z?/YFM'7*I B))H(M65!*PB(
MB+B4=*R7QU 9@<BX*X+DT<$\LND/)E=C&JKLKN[%[]L*=P%-(-V&P=7>4=G#
MLG$?TYL!#/#1. @S<9(TFT*TQ9V&"-QPG)&I-ZI?(8,\DII4TOB#BVJ9+"-F
MK0S3':-D>JUM PHH+Q[=FJ8N@N&%G!5<TS;!W+%7&)1,>PER!*(</B5D!F1$
MO!,*056J$A*LH2"C*L.@4AU9*.*F6W3*84%*5C$S:2"H"J KM4 VLQ.!Y[K]
M=U $6?3R/D_OFR.6M(T1OLML?\N,M&I>_GM2]><__,EJ."&L 67BXEG.P'L&
MO1FQ\QTU"#IM%31?;U708*A.5UI"(IZJ@LGA,)=L[&^[-W!C![A7$ 626*M&
M,Z.55U!52E">YN(5-B@^12830%&-(Y]M/2'MFY^0^R@YIN@L^%^ %&O;!?:B
M\L/]\=3RN^=_)^C@&H6/E6B*)G\#&U$1\PCI\24R_P M3$H8PLWV'OP0]:Q-
M)E!O5%TS+;DF'%8&NG1D?0I$KBVM2 &%@E#0];>@88T/V&4,AK<U89LY42"X
M%L)=D9LZFQ:!(%(KG"@Z:!IQ A'4DQA1N5AG%55GOZ-\+6^$37Z*.L)#"4FV
MJD"*K, ?0:1\)FU-+SJ-)\S]I.P"Y P*O[$H8*2]8L J0T!FGA?9-[UE?6-8
MX\U,E=P-S$0Y2OD8YL5M)=G0B"8A9#8?!;0+-X4^('4&5^U,F8>2B("<<%O4
M&DW<DQA+*J7M4OW5<YGHZ:B3'056+Z(7M7+2IIJP.VOG&;K1H2;X!5NO<YP:
M(,/)NH4>3=FG6*"X$\H,_8^WQ<T..L,E$U<)6$E'$"$(!$&(C$1TCL?18=.#
M&OJ,^]D^@^S#7D_]+<456(+GT,K"3$C@%QOD516]./B!KYVR5?HPG>PJPNG"
M0.(B>;3LG2M9$X:%+H0N'&(KA')K>97$8/AG1<3?8AG&[M56#("5LI9DV]'1
M/ ]5'$0CE1A:M04!">%()N7(.)/.QERHP[ZVY EY=!-[Z.)/*AH>W6'^>/A)
MODV2Q$*TS[L1D702AFML7C6SF*>%&RB$XHM4N)6BUANZ43>Y.E272@-=4R4>
MK+48""9^JM13:'/PT$\ME&.!&H-,X^N42 LB. ;%Z&I$0II%FM0J!>M@8G#9
M=,,\D15YMP;5@HIN*A/9AP*M'$I:02:&:G9)2SGZ*"GW-CY=E57#$\$,H8VL
M#4(9/"C66@>%6,6T#$]=7>_ES!BVKZ(,XA<XT,A/K0EZY%!KG^T%T3SW_IG7
MZ&"'L_83OTFJ?^DTG<O&0%^S])3.']')A*#V(N0?(UC >7ZUO8##;FY%[L>"
MP#Z4H514F6V>8+1E'@6193>)HO6B,&#T\&@5AJ="ZD2@FAF4 +U^*D!P$@#2
M,6TBEQ,Z59,'6<4B4!BI"$/""/H(2*U9*:ML?^;P^ASJ@+ANHL$B#QJ4-Z)!
MLH,I@73W0F,4VPC%0!68?=7)NMO3([5")"F?L3%J,YK%P;7DBB.LV;AU"UYK
MV'HT&T@_@' HH[1#F-2*')A^*;]AP^XU'2."H@9@2&D(+&5AF!N<=&AX&UZ9
M"&!G,5;^"H800[D D;LA]6%Q=3.@.%S@#*M86-I]QER@>]2RR[*/ 39Q'V>(
M[*!$95O"EF*9=P\H"4>@H(>4<#J5AV.(!0/H3L FM\;6(#+@ JPQ 87.!)!H
MKFAP$4!4 */ "J^P"XW*FM!.EB(T:=$MWU : Z$F;$V\W(P.K'860&=;-<@0
MW;U7,+4<OJOC8D\CHZRTB#9!@$6/'L"!"E9H[8L<42<"( A-R*@VAA9J[S+Y
M5X09TA*8E>-]RW"+J>$U%;\3W/(RT1H$@H%2@!M@!MC#M+$)^RH!MH#X,5'U
MF##U%[6*H?:&8CIGN4N)0*1QE\-5(WQ*:9*0JHF)O4F4^;XDS3H.AOB;IAM:
MLHRHZ!%IK"V?)1&]A)(H&:EU'+:)B1(HQ6(K2,$,AHL9WS<!'9""FX#:+18]
M6R?1,H6S7A$@06(8@T(+* N9>Q:Q)(@03$6$LMM-U$QP5+%$:C2[@T4("A"U
M)K%0QALCK3^#=%!&$/OO.3C?2TA<4!MO'ZWXX2^"U@,&F1?&KYM@6Q99]"5&
MVRKJ@<'0U]24EIWG!65;;A(&>+([8ZRQ)GZ"(,/1$ 0U??;QN_5V I& T@D<
MJJ[G/T1%"CE5JONNWT]Z&+]Q#CI0M6KIKM32K4TYMI2[S6KL"Q6[0N'S_83-
MM"".Q*'9O'"URF?<C^GX:"(@B(CPB1$[$43QE-0P[%;C0WLEAN3_ )(WPJ5X
M1$4<J ]P-N-E83<AO*(7838!#0=3(F$*4R7E7BE"^@B9".!UEZN>$L<'45A_
M^CB0-3'/.ROEA"DQ=^SBLB53I&CISV.U)ANMCY#=!]!Z3LL.]4:,<$,4= EX
M4,XTTF<+(?:/E7;29<*C@\/Q"HL,."I=T9=8-(B\#>9[QO-S_,='KF-GM:B:
M6@ ^AJP"UO:T**95_P!:J):^"#(1-(+%M#OR?V)GM-,:I$..D!*X** 54#*2
M/P",@$Q\?G"IL'F=#.FI0CAC?\AT6!B4\SKHN8K04 F@NS1QA7<6&R1F7HNC
M _67YIB$SNH5JUZMON^<$N$2>"S<UPM;_P"\I '0#K? 2;AU]LRF+>E &2='
MDUC);!X@BJ1Q,59PO6N"*P"H@@ N 0"_R/YP'D0S%=9@8)IM"A]&J7/;T9C$
MZ'3G#)D2N50I7=G&ST+N,FW-0;_!4B:BIFQX;3R:$1L R>_(B.!A;=3!^@V?
M28=JX@F FF]=-Q%$EA:.8?(57=_=$KT!/*#'B5+Y]F%',#]"%,!<I(+ Q@TX
MD4"G+E,<VK?TO7!.UL(V-!71;5;'R!I<D:%AK\D_\[P>M.GP.32(Z=[*.'XG
M#AXIMHT!LJQG)++KD@>O(2)R8B$I*2*/ H5*"  %>!C1*']K")"N,O1B*YSL
MVB58&&T9IO<\@YL-GY>FM"RX"Y/)-*YH@39$HR[A=U"W,R)4,A8D",IS6E*B
M<,KW#V NB!RVC$PTP*.%00AM76#(SJ*E^Y+<(&)I@M+M!!=E'BG9^3=U$H:&
M>(+X2&:" 1C?LI/B0]GZ-!HV"#0J=1LGAK48^I 0#1$1\B1'XP"0:4!7(;TT
MT<W=P( E@$': PO?GO $04BA(>"VG['MB H  I4#@+8'1P8,+@=B: ( S2@7
M)D*E%3*H@KG%A4$2*#@*L#P8NJ1))E7*;5=CKVSD[Z]GGWO]CVQ<-CL20^2H
M?8Q!42(J11TC.DY.'..,4#4\-!.)5)\Y\CCW(T=MAV6QWB"A-J*KY5VY:JS_
M )(+/:S-0=K4_'=DY@-8H_:^=?PF6C)SSC +$X4F-AEDW4S17,PF,=@V=CLY
MCBO;*X& W B'P*A]OP%KWEXB8\+CST04]_D\/E O*C8@FY4&<:0Q$C'JAAW!
M"'?1[A$TB(]B;$]QV8@H25%6<5:ZZ]/;AX8HK1;"JL- ]$ 1( (H4!E#:X38
MICJU"$BI#T*N1GSGPL8E26C(H<Y3<VZ)VX\\(0\$904Q&>.K"(HB(Q'2)R)T
MGXBVLV#X;E(_9-(F&J(P' T,T-;5X4R\C(C/F8WR&*UJZPI%+H=@=)E!4CU2
MP"'86#G)V!42 SI0-#(!P') %"2 +(1D!W;:H"3L()2' TD-'W Q[A>N\;@_
M(A]CE>P5X"X91P#N%U%<!U!0,0#,@&9/6TI,<RF/3E',[^.K(R[-D&3[M*8+
M8L1$OTP5J&A2,JSJP&3+P193Y*X8I0JFP@TCOZ(.'P0W!K*_@ G- */ !5]@
MP".7WUBVTHV7 JY?9OVH[J-.06Q3*H*4H@[-GDV?F#BY/()%<QS 1IP!B,9B
M[D]47_H4Q6J[F[5MWP6"*'2NK%(2+05SO#[+O!B:>[KYP.D^1/W3B(HB)R)$
M^1]""792GM=Y4SSG")OMAQS#P!Z#9G#5;.C*2;3[3V>[C$QJ9=2"1>H1 F+E
M:;C]]_@ASE=XA4B$AB>Q, B/L7BHKYR"\-V&M#=-@Q%"O2V FKQ@+)DHWE3A
ML/HL;@_#^_W^T]YSX[\8C3<1;K=[1YFV^=&;M>)9Q][!?]#SEZ K4&>-C4?A
MS5MW@J>S!"=Y[JZKO]'C._#T2/&W075F+YQ5-%>04&3I'N:R33K5/L+(<@LP
M    $   Z ( =!K/]_?]S^:X]05@5= <KXQ$E$I2DIY/)IW[?A#+A P*Y,ZG
MI8-TJ8<)*51W*SXM8%$BJ?)I8Y*U[8^N/"T*K>#)$W>+0!2).<9MX4.)JMUP
M2I*<VF;O0*ZWHPX#A <O2J&5H0F<.XUC UHU@6DHB0@(#$#$1TB4>?R8E:=4
MD593K9P+(:%EP-8BYL4=0*0J !5>@%<4FA]:$/I(6Z2CC*&B><8Q2K#=N0*<
M7XC0Z ;F!YD:X1JT$UF# WS ! B+832Y!$B5';=3,@6]V*1()-+'0_+H-XBP
MIY"%T6<0Z*8 (''/Y:IPID7*?*<_(Y @9QHM>-!E9RSY9[?4:P"C]?T\."@A
M/:22[;W,U)< :II/R^2'+!(I1C*</N6,^WX *@"J@ 55T &U7@Q$1=@A\:/3
MW*<.B&6;A8!1K:#@) ^*(G#L!VH'.3^29,+KP!.^3<XP,@96!=6XGA@U6]F4
M;1N^VVFK,-LRL]_H Z2$+TR)@2>.DY-+LFH:G?F5EO&'TD'O@?35V0U$$4W]
M+,$*C,\P+,04!R!$^1B?BM9/\")^=8 0->R;<D?7HV7#*/&RC Z,0T5HA]"Q
M:B $&%4BI6(@BF1XQ@$(QK2H%0EP1!!YC(\6AZ#LO\7#M$0$&F'15@>.B>)2
M)A+0)8<=^"."(:85&WP+E"GG,Q"B56@U<!^]]PHGO"OC%"?B"7JI/)(1! A"
M @,4 B)$01TE_-@FD]:"\XI]"9O(N_YS=AA1K!$9WA75F.4P3\$OIVH.MOW^
MUFYG<90H.(S"M&M,5-_5DU#7!I;,7TN_H\2XR8_QO9!Z3MUS>"#(Z8B(?5_B
M^0@=J18R%C=4!@@G9!NF?UJ6#&OL7M$[50!C,/HDB=>ZI(E09ZMI[ :Q%SY6
MQ0?!(7YG&$%B<"J *$ *A@#:(!M0S0FB?*$,T#X6A0\1E;+!AE2J0*T7#TE6
MUB5H4E%!GK--@WI_J]]@\M"2-"D+PT48"M&2HIH*YTUW37KCG\,_IA:Y\OTA
MG)+G)0P:H:J[557;]'CQX.(<6O/<NB65PN@\CV".<@7$;2B0R%98P 0PQK)I
M<RYP*:GHB1+>ZR?[@X$@AP '[$X"=6I\OR\I=:J44*A0M5-57:JJ[?S=<Z3H
MEZ#\C%P!@EDIRJ$#&4QI@)#,I!<@AS\!),PV(CV$M.]H8@$'9VW#00['EZ&L
M!BR%XWY>,P-FM*+@N+$>$)-6#(9U"MLX4S9+^;B5NG"P*Q3#"OZ1@YJ:A":0
MXP#@_@/\Y, ZB9>93+"SF>FY'YL4TC2Y63;;8I]7"^CY )#KJQ-(JQ! 8J[L
MJ&D2+:3'9E*7N !??LTFDN*QJN E623Q@3)?<Q/N""!0/I528I085:!O206P
MG,;?'TQPJ_\ (D;LZ%H\X20+3-!7Z2?-&AMS&TX0.<F+ G*Z#^3-+5'*OEG]
M,S7$T-+SP2"(M!8M.P&!AP=A+L].A9' !CX,R/,#O=2I"?\ @N_@ DEOI 0K
MSY%@J!V \"I!$%8SFP%!!+H6A0$  (>JF_) ]Z>&%K\6H##QP^/9?2..,33H
MS>[ EV*!J41$;)$!>F$&PY!<HQ78$J'X&*GR>7X,)8G^/&$E\DMU<UV(=[-F
MTWG<MM9LZ'41;,1HRIE G]?XXRBTFQ*3$RLED#-RF@.[Y4E ,<CY*(,'RP>:
M3$_R0N<QY]64LXL7!T#U/S[, (Q0[&T_1"-0"I,45H!(+0G0"BA4X$./.  "
M )TAKT CIM/%%?8N,G4PI#>K,*"H@,!)14 +M6!.VNOG'CN1@?Q%R]26.PQK
MW!C+.&#1\A1(9 '9VB0F,$X)1T+Q#6\!^OH"*!0B)L1-B.Q-F':@[EVR55(*
M@PH!9PT %=\#R:QINA5.E4H:,&,1/3=KIEU-E?IL&U/2H3,M^A+#O/+I:I??
M&(2:5W+,H;P-KP9I\OLU;P@1%E@]9,M12!0;XS<-8AB-4B% (,-(W6>)QB>"
M!P161R\^@8"*+/O'R&CX[*!2U.%D1 !&,0 #_P 0UY&UN-5*&7TZDQ]R7V&T
M[;+>0%)!9EFRDH1.'C2MEQ=!9@6R_IF:-[RK&)CX,1;P.T(!&;$P%]"#;UW@
MAU3'A'Q["'I8FR"1ZNP/8L-,W<DG\ 3P%"'_ (G1B1C P+_!>IO2R1ZEA!I-
M#R*(BB-$TB<(])CIR4P_+)Y3!WBX .%2GPK<*HJ6DDDKY20(9@5(@E]EO=U<
;!$TB>E"M)!A(();0WB8@JMVJDP !_P##0__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>businessfigure6a1a.jpg
<TEXT>
begin 644 businessfigure6a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M\
M                            !YI/75U,J-/#;2[+HZYIAIM8>O<^/-UZ
MK%,C.OT3:,Q]0EDQ8QZCO(   Q9C*B0   /+-ZI*)T)VYF.O1])RRCT]DD5*
MGL3'FFDZXW4I<6TCJRF5%J1'329MDN='J8\@          #@/@Y#A.0X3E/D
M_3Z !Q'T?)^'.<X   *KNK:U+6Y    X#Y/@^0?1R'P?0/D^P#Y.0^C',@P3
M)/HYP                        57=6UJ6MR
M                 !5=U;6I:W(
M      %5W5M:EK<@        =:TT28:?PMU%-IEJ.RQU )9")S.V1VA1<8
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M9    /E'7?<-,M? ;#,\=DQQ3'#ZC+\>A5EW:VG:75=Y?#3K%Y7*\5
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MV>TRK(Z%\33RL9MWO7\;_H3-L;E!79\S&XB=>;HC)KC<&M,DU2?HEB)F
M  #JMK>@Q&AB\S(>OW2LQTVMN6T?G^=YO-=A[_\ 8.D]U\]UCP;Y?\GR+1=I
MT65UZ,93&2C$;'W!Z;MOI[N/=P!!R<  Z\XS7/&[F?#9%K&/]+NE]F@TX7H]
MRO0M7<4.]_3.B=S]ZZS-P 1*_P ?U!Z+RGH'WOY+A.=U.8<[^CJKW/E6UO-7
MC>/W+.BGH:]M:./KR;&[!8V%V'TWX/\ 2<TQ.P3C&94 5E=6UFVMR
M       -#3L]#XLIO6R_$\^"W%_E6X^7],JK;M.Y?%O7.RZUV0S^V^RW2OI,
M 0DFP *2QNK>-O$> ;2UO9#D*T.HXXI6C.R>CW7^KVML&X38  $'RF(IC8]9
M[-:3O=-[%K>OK4;IUO9_J'63=-)OS5MKEMAD   !65U;6;:W(
M    '0?!<=Z>_.N'_*M#-M[WK_TCD,NPVU]JK[?O5;MO:0!!R<  X(\5;C<#
M5]E@9=6R/E3P[CL&RNM^\G</J635K^#DX -6CY/I(        C-6E)J57X1E
M&:D             "&4<5Y'<HX+0F/U3,\UN6V]\2E9>N;7V5Z%M7IGUGL(
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MW1V/I7:CH^U]B\INH  Q2#DD-\ #"(82,WH !JT?A^I         'PC*,U(
M            $#H8?QIXK\^UC4U_AKVDPPF?B6;Q'HQMO6_0O>>Q    :$TI
MH:E.14ZG&91+@                             #Q7T;Y=KWEOF==*H]S
MMCZ=75'#][\WU^<7.5     JNZMK4M;D                     #0WV'ZO
MV.9I=/81'5*)LV8O0HJ%CRJY.^1$4[Y';5%E  '6_'Z+!L9C>R^<WB95\H
M    *KNK:U+6Y  $>OL1T5L<SH#L2CJ\F<ES(K).Z1%H;B48B>:8]!T?H
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M,-4G>HL@IL[)E;$5-/"\9=CT        #'J4-/3KX1P'(0PRRV
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M ^RWD;L                           TWOQN?'L
M
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MI!S^MJN2:WKN"0N:HL#/G$:[KA/'-;UUX9.N*VEB. 8BP?\ +R  \H%_V?\
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MT5>O8??W==5M_FJY/"O+7/0#_,X\M)S9^X)UPKPK7W>XT]/1TSS3S.JHH!Z
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M6FF!K+D4FD?(6#;N"Y\@@R2??JBK^'8KC>9I5PBJ4M\4D9Q'N'RSKGL2?!&
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MOBD8+&\=:H'R8!]@21D!7SU]^O2_4W>EM- :.IEAMT\\]-<UA!'-YD6:=)W
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M/B.F"@(.8KSK-X#D9F$O,)/SR3XAT/88H;!9+9-ZQ;[714D_)6GYT%.B2\E
M $W@;L=!N.<OC+EC\-GXBO-AD>2U5\M*9(S$ZC;)&RDY_JI5>/<K>)6V[@>Q
MZG,7''%D%/ZK%>ZQ8Q,\^=R-+O=B[#G,AEY9<EN7NV ] -O34W&_%<\=/')?
M*[%*Q>)HY!%(6.>LLD01YL D*)2X \M332U$LD\\CS32NSRRRL7DD=CEF=VR
M68GN2?T_TG\07NW362SV>I:W?&S3&:O3"..4T:+ DQ!Y7MEY&7QD;0"!G/$O
M#W$$M'\;72[37<6^'.9IC,\<#.N\1_;AG/<XZGIJVP4ULLZ5%-+-+''3QS55
M$S\Q'1U#2*%;HDN#E67;XA@]-7R\4M18+A+:*"I@AJ.5%Z^[0P_UDJB2%80Q
MEW2+N3(.>_EDZL-XO%HI9Q1T#2HP\4CHP1!V[XZZX<L,EUJGNMSBHYJ64[V2
M0D;6SWQD?N.K9P5:+S=#<C&Z6ZE@,$:TDSTZU-7NQGG0,DC)2J"#M8 RN 2=
MA75JX!L%IN?QO&M;5UR;O5Y;A5R5?JN\;28 X&&VDJKOO95)VD$D_P"Q=ZL-
MKXAI/4KK2K41!M\39*34\N,":GF7#Q2#W@X/9PPZ:'#-69+[;A>)_4Z"JJ:(
M*SX:HC@((,P.1XA@$)A3C(Z,!JR7:KHZ2YT212U/,>1&E)+!%&4ZY\O/IJWW
M.VT[T=)<Q))14LLU040;E:=P FY?/:,@'RW:NG&4<M,T%NH8X:4^'/0N1]0[
M?OU88)[VYHX;A+2)DF2%'V;@>^.OG_#7HXGK+?=[SPLS^L6^CIX[A3R'JU--
M/+LEA+^:SG,RJ>H97*]&/Y26011O(02$&X@=SCW9_P!@?27=7I.+[A!;PU+B
MFHQ6%<J*FI>'F&8KVSR'AB+#VN7DY[ZX"$5327>"3:9'5W&>^=G7^.N'_1[<
M.*5JJF&>GH:2.HE@-5,&F=ZB(KNBCIT*G:H8;I&=1GHH8YQ2^B"PPVF6DFJ:
MN:YRJ3\:*QBY,F/#RJ,.83"#[22;WD&?E5)&WA[T034%R%5=[LD]+#N,<%N]
M8II*@_-Y\I*M$@[M'"6+'IS O>UV2V65)4MM(E/SWYE1)N>2:=\8#33RL\LF
MT=%#.0@Z*!^4K/S6?]F?[.O*7QZ>G%@FMT-4*^C:J:YQSR0M;1)^/1PBG\0J
MWBZ4[-\F']OIUUT_GKIKIKI]&NGW^S1UTUTU@:Z:Z??[-=,?A\3^CZQ<4U4=
M=6>M4U8J+$]11R)&9XD]E)E>.16* D)( '"^$D@*!_S762F:)[/67.T2+'RI
MWAG6H]:0]VD6J215E/Z\6Q1^IJSVBBL=!#;:!&6"'<V7;?+++(Q>6:9^F^65
MR6=L#W !0 /RU9^:S_LS^&J7SX\D=IK;_1WXM18X!'/\:B[>L,9)7ESZMZEZ
MMM54 YO-R3X==/O]6NGP=-=/O]FO/737GKI]_JUTUTUT_M^L_-9_V9_LZ]6V
MINE/3PTMVK;.\-?25;ST/+YE1#32;Y*&3F CU>J'@FQXL=NF0?=KIKI]_P#+
M73730^#IUU_PT?TJL_-9_P!F?PUMM2+[)=C=ZYJ-[:E"+&>5\7QSK4-,;BO@
MYWK3H1 <OLY8[=L:Z:SVUT^C736=9_E\'37_ !UG^0^#IDY^#IKIKI]_MUTT
M<:Z:S]_W:Z:Z?Q_M2L_-9_V9_LZ\V>*]T]/3RUERH5IZ^CN DME6U'-(]')S
M%IYI%5N923'PU$& )4Z9'?X>GW^W6?@S]_MUG6=9'W^OX,],:Z:SK(^#(UGX
M//6=9Z_\-9'Y:L_-9_V9_#6SQK?)+[ZY<C+);4MAH#5L;4L:5#5 J4H<;%K6
M9N6U1NR8@$V^>LC61]_MUGX,_P ]9UG[XUGX/=KIK(UG[_O^#/W_ ':]_P &
M==/T2>IIZ55>IGAIT>1(4:>5(E>64[8XE:1E#22-X40>)ST4$_@X_3ZS\UG_
M &9_#]8I^>:7GP^M"(3FFYJ<\0EB@F,.>8(BX*"3;L+ KG/X6-8_L"YVFVWF
M&&GNE'#6PT]73UT,<Z[ECJZ5M]/.O4>.)NJ^7?((^#.L]M9UGZ-9_3JS\UG_
M &9_#%HMBW5[X** 7>2B6VO<-GXRU"DQG6F+_P#9"8F3&._GK.LZSK.LZSK.
MB?T^\7NV6&"GJ;K4^JP55=26V!^5-+OK*Z3E4L.(8Y&7F/TWL!&O=V4?!C6-
M8UC6-8UCX,:QK&L:QK&L:QK'Z%6?FL_[,_AB]VQKU)P\*D&\16]+J])RILB@
MDG-,L_.Y?(.9E*<L2\P=RFWKK&L'6-8UC6-8UC6-8.L?Z_!C6#K&L:QK'Z*R
MJ_1E5@"" P!ZCL>OF/(^7P9UG6=9^#.L_!G6=9UG6=9UG6=9_0JS\UG_ &9_
M#VKNW[1NQMW8&[;G.W/?&>N.V=9UGX,ZSK.LZR?@S\&=9UGX,ZSK/]LR(LB,
MC>RPP?+I]?\ XH?_Q !+$0 " 0($ P4"" P$! 8#   ! @,$$0 %$B$&$S$4
M(D%183)Q!Q4@(T)04H$0)# S-$!@8G.1H;%RP>'P%E-T@B5#1'"SQ)*CT?_:
M  @! @$!/P'_ -RE4L0J@ECL -R?=^R5#^ET_P#$7]DJ']+I_P"(O[)4/Z73
M_P 1?V2H?TNG_B+^PVH7TW%_*^_\L2SQQ*S,P[OT01JOY6Q\9ZE?0FZ=;FX'
M^O\ 3%)F"S#YVR[[-T'N/6WIX?D:']+I_P"(OZLD;2"0K;YN/F-?[(95V];N
M/J6MKY(9!%$M[6U-;5U]-OYXJ<Z>G3]'YL@75L]E(]UBVKTQE6<4^:QL8PT4
MJ;20O[0]0?I+Z_S^75YP*>9HHX@_+-I&9M(OU(78]/,^.*WCS+8V--&XBF8%
M.;*?FXW.RWT^1\38#QPTN9Y?FTM9/FRL9(W,49F/SKO[&X-@F][FP.PZ'$%4
MJTRS2:.44U:MAL%N[/)[('F6.,ISO+\U:H2EG5]!M;0T:L.A:-F $H_>']L/
M&T;7B-@3WEOW<02R!H]+'<J"M]B">GC^0H?TNG_B+^K4OL5G_2-_\T'U!'R3
M?FF5>FDQJK6\]2LR7^YACL\;?FZJ(^DFJ$^[O I_)[>N&I*A1?E,R_:CM*O_
M .498?UP01L=B//$N9I'+RPNH7TWOU]WI[\5M8K22F" O,L9LG3F.%)0?NZC
M9;^M\<029W7Q4N94[/"P YU&I*F%U)!1@-]B+ ^/7QPO$G$,=1"'BCB%U#<M
M3J-MB6;K<^-L4G&,4#PT7:+3S!3RY%Y@C8CIJ)N 3[\9;6-60L7 $D;:'T^R
M=KAAY7'4?R^1/,L$,DK=$4FWVCX >\XXISLPQU: .D\T3R\U0>6C;'E ^97Q
M\Q;QQD^3'.>9+//:RL]V;Q _OC(\NAK:N49A5LM-0OI"._><AK*HN?9_RQGS
M95*L&7R35$)F2T)CE=823['-C!TL"0-1(]<4&=5?#SST4L!D8'2FUV]"+8X;
MS*JJHUGK*=J:.06^<N"WV6T^GGY>F.W04LW>GCD<NIBB5PS-8^0N5 %^\=L0
M5,-2FN%PWF/I*?)AU!_V/EH[1NLB&SJ;J>MC]^WY7KL-R>@Q2<!\55L*SQ93
M*D;@,G/>*!V!W!$<KJX_[E&,RRG,LGG[/F5'-22D742KLX\XW%T<>91C;Q_"
M%+&R@L3T %S_ "&'C>,Z9$=#Y.I4_P B!^&E]BL_Z1O_ )H/P09!GE3%SZ?*
M<QFA(N)(Z29D(\P0F_W8DCDB=HY4>*1#9DD4HZGR96 (/O'Z_-5FG=1'?F$:
MKAM.D7MU&^Y__N*C/J@V1F611UCF1)U/J2ZLP]#?^N'J14SKRX(8EMWA$KJI
M._>L[-8GIM9?)1BKSBFIH9IU768=6LDJJA4ZLS7N%'\STQE.?5%3Q!7U!EO1
MU<Y BE/=Y8/</D#[L5M9DU+,BS+&99+:=-C<MTZ?Y8S/AR*HE6OI28ZA=+E?
M&V(.,:G)ZF"B"&61V19-5[-;:Q]? 'KBGJX:F.)ED35(BMR]:ZU)%RI7K=>A
MV_#QRO$LV:CLTT\5.)M$9B=@JGZ&I1X-X'H<0)FV;455EN:1".H@TE:@@#7;
MP+>3#??QQ+DDV5Y<4BJ/QJH8)"B&][]6V^B,0<'9FYYD\_)1]Y7+:=NI)WPX
MRBECAGJ:F*N6@$-.&0ZI4?I\\3U4GV3;TOC,YLFIHH<RJ((G+:-#;!SW=2WM
MZ6ZXR?B*LS7,K+#(*759"%.@*.EO#ICB*6NH:V)J%%+S,OLB[7QPP]0S0-5$
M).\#<U1MJ.Q MYCVK>_]4^"K(8,TS:IKJB,2KE:0M CK>/M,[.%D-QI8PI&S
M*IZ,RO\ 1&.4D4=SN?[G&;Y7E^<PM29C31U,!)(#7#QM]N&5;/&_[R'?H;C&
M4_!YPS0:G%!VMR;AZ]NTZ-]@B62(6\]!8^)QFW 7#&8>UEZTDO7FT![,_P#W
M* 8G_P"Z.X\",9#PKD^2QZ:&C17^G4S 354G^*5QL/)(PBC[.,XR++,UI7IJ
M^DAGC<$:B@6:,_;AF4"2-UZ@@^\$;8K?@IS85PCRZJIIZ&1C:>H<Q34Z>4T8
M4\P@=##?4>JH,9)\&V0993JM52QYI5$#FU%8NI-7E!!?1&@\+ZG/TF\!GGP?
M9'6P%**DARNH?N&HI5TCEGOG7!?ERWD2,?18+KTL+XR'X.,FRJ>.IJI'S2JC
M(:/G(J4D;CHXI[MS"/H\UV4'?3>UH(E( .WEY>GNQ\)'"M+F.55.9QQ*F8Y=
M$9UF06:>!+<V":WMV2[QLW>1A8'2Q'Z_FUX:6:L1#(\$1)B! ,B@]%)V#"^U
M^O3"<2OG>:*':7+Z2G+6B28B61^ADF=--[#9$'=7<[DWQ+Q3F>65E534U=+6
M4CZEB62SRQW\!)8R6'@-6*:DS:O@^,)-2B5FBJJ1I.7%5P.I',&K\W.IM<K=
M6-CIZWDX+A6G22.L['4N>Y'43*HMX $$ M[L95PS60YDE9FCJ\-*UXV=P5?3
MT8"^XQ39]5U6?R4=.G-B5R&(]D*//P&V,[J\KAS:A[L;R+*IE*6ZCP]^*_B&
MNASF&H5WBB29"EB190X\!Z8I:F*KIXJF"02Q3('5QT-_3P-]B/ X+*" 64$]
M 2 3[ACBB6"&D%4-,DL2N=(WU(N^]OLM:WO.,NS,YY1U2R124ALR\ZU@5'TK
M^-L5-/6G,:>LIYTGHH=$:,K74<L %3Y-[QOUQQ-3UE?10&CD=2RBXC) /GTQ
M'PFR954P\Y.W5=.&"2/8M(CB15W\=K ^>.'\KJI:>J@SNG6HC559(78,ZO "
M J ->YZ8GXJJJ4&++\O6CIXVT7,>DW!MN2+XH<PS-!-FM;%S#H_%RVZK?JR^
M%\<'\05V89@[S O#3VD8#Z.]@ W@6W%O'$$\=3$LL1NK>>Q!'4$>!'ZED_#&
M=9X"]!2%H%.EJF5A#3AAU42/[;#Q"!B/&V/@XX5JN&::M:MFBEJ*YXB8X"S1
M0I"&TC60NN1BY+$+8  ;[XGNR[>']L+#=M\>PNV':[[XA.W^6*BY%L4R;W."
MZK_NYQ,VH;8C4EK_ .6$\,<513RY!G4=,G,G?+:L1(!N[<INZ!YVO8=2=A^'
M0X02%3H)*AK;%AU \[>-NGZY5Z32U&I=2\F2Z^8T'%/PCR,PDJFD'9M1>X.^
MCJ;C%+2913_&.<SJ'I8ZEHX@;=]Q]%;];>-O/&;U=3G=50P41"Y<Q CY-UTL
M" R2 ='7K?H001C.N'JFL:A0UR%H52!HS-:5;>S(MSWO4=<9119E10UE'FL_
M-I%0K'*3N%(M=6/CA:&/)LMJZG)C)F-75-H:1=+/&&]!T'F2<-!59;4TM?F
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MC1:II4CJ8U$<VH7"/?HRWM<,+V\<1P9IE$4N7+5T@G;412 N'EMT"RE>6TA
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M;P/7%;POE5<$$T3=P@WO<M;SOX^ZP],4]/%2PI!"-,:"P\_>3YG\O0_I=/\
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M1XQ!^-K>/,WXLR5RZO$9)^.9GO"&43&/\/5:=NNAL.HV7MZB*E>-5V&#+&^
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MK=JNMQX\;J"MI9(034DC?SM5%J,^3X:_C\2AXHWLR*+UB$UK>Z5*QPG,4XI
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M;CIOY-8GD1:ZSE],,QU'(&MOG7O,=. (Y<SRN2 +V; &(J7DX:@JW1YO2/!
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M4!%,_*.T??)>D1QJIW,9'O!IMC_@+_\ EZ\;8K-_N[?WZZ<?3&8MG]33:/\
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MA@#=Y3A?RZZ4A:M8O/,IOM>)OY5SU&-3=2.5WWQUV<^NR4E2O#4)4.$=:B;
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MB/3CJ,OBP.WVCK:S&5+9"/H)N002R/A])NF([1,1QU>.Q ';'ZNS>:V\Y/\
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M_'B+%=0LKNB)*#]._P!_$JLOKKQ&!=1L9'IIDCMV2(G)HKUTA:OH9FP_OY=
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MI+))*-9]10"Q+XQ/%F*WAO%0-MD->+*PV!(AG4=@V.;"1B>\+3L7K]G@0 1
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M5-3IB"1":-G"IMFN6D4LE"=58UJ(#5O;B5C8$(W9TG%T;UGJJY5]]Z!T$)S
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M;' <QLM-=S?D<VU$ Y'OJ \6BX8[$$%48X:(6I*Z'@<SP4Q"&3^](1XW"/\
M,:R/;):BM-_&-:6 \U,X'XPWG[ U#PD.GJ&-M+:=.P*>T:BI3JM)]'0$M?\
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M^R'):"L ITG#GMG!G3X:H. # G[*9"^7RW%IQMW$#YOU#7CLDS88 N^20[>
M(%_UB=KSV]Z#)T$_^4/_V@ , P$  @ #    $
M
M      2[)?3!CB0   ,    *G#1!$_)1$30           ! ) ( !)     $
M    !)!)(( ) !(                         ,
M                     ,
M  ,         (1+*"Y2       (32;       '<X   ,          "
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MO[&D   !0               !BVA@ ( !]U/Q  ^DDDDDDDDDT^
M     '?1K  (!10 'I ..YH!!*!! %[E              %R#L@ ! 10%C
M/Y0LW2&B**5? P              ?P:0     *K  .\CP CF.U0+4W
M        -*^)   )( !)   VDDDDDDDDDE^              !=E^     ')
M                               MW0     ,
M  *8/0X#*0 !:P      ,  !)9((750             ( )! !
M ,    !( (              . H160            ,  !X+Q2; $#22%0
M     ! ( ) !(((        ,   "  !!! !()         "*V"20"!#1*"0
M    ,   )5*#Q+!+(7         #;;:              ,   +2320
M        $"8:              ,   P;02               )9,(;0) !1
M       ,   1( #((8#80         !  ;*9" "(0       ,   2+)1#3!;
M!(
M
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MKJAJGC<X]_?5;!4*\",+9B2(CMFXFTTMR$"SH28A^F7K*F-0',T(HQ.R4 8
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MJKE555RJO[!OX29090&#L$E"8;&HK&@;^#4F%R)?*01JE*F@#_L0&0.!@
M'Z#PD#/$0 (02CD'?05$/*J\*EL\GF70Z2E52P+11%;*:&^+],A[2+58 7]0
MV6)*F@L FM@&AD-1Y%7JZ[D(">D'1L9JHBV*SI._E<20I*@KNZ>N_L_ZOQSE
M9-8)JW:FS_6],$($O%6@*!:(X_J*&#3HH +M@PJO+8HVCA5R001=2*4F"#,-
MF]Z<.]T#:1 F%$I=/C-IPH"%X00UBYG):5B@)DZ4/PJ=8>_\]ZSS/SQ\^?A<
M^#Z]^GCZZ /?*]_'-58S1+"!<864K#E3LEB@82I% %.26)!- !!!GB:8S+Y
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M)K8&+RDSCPQN^<-YT%++ZE-KXN'O#-)%.OQ^O[EP75G-N<(4:'*XKH;$M%'
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MD"!AB@J%)9.A&XA"U0+?!9FS.&ZC0F($+6"I@8+4=M6*07 Y04$+(H9DM=!
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M\8*= #;2_<5*'<"IRH,+\OXKZ\5*:+>C9 ,3A(G752+J.'K%9>7=Y=
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M92 MR6,-'WD.-:,.(H% =P)_(>Q<D !2):-Q$II*T!IX M?B@-@&EBDE*:H
M%,KN\_,,?.C]_;?21FLFK"!D#F !=8@:5DBRY2-=U5,,@,B\@!W+/,XK7=
M    ! #  8 , ;?)D,H!IJ4()0& C+8&=\9DA [,RNL_EZ(YD 0BPF&DWW 8
MEY7*"A557X()$$=QR/VU_6)SF\N>>MI39(%!,-F$KJW/-UA2C%AL4+/WS\8!
M)DLJ)\^*8H@^3Q#&W 4.@5>A(H"#0<% 5PRS&@TCB2!4&  !HZNQ^7@^_P"K
M]<P0"ZD2-%$M,@ <G0*Y>@#@$7/4@W&AAZ]1\B#!)<&CI-$L^TB&9JBE@Q/T
M, J@H+Y8VUQ5.Y<) 9;0L78TCP!ZK1*)5A6E$6-)VD($!ABDA''TP>N3]>7<
MUYGT'\T_6L=7T/?6.KZ'OK'5]#WUCJ^A[ZQU?0]]8ZOH>^L=7T/?6.KZ'OK'
M5]#WUCJ^A[ZQU?0]]8ZOH>^L=7T/?6.KZ'OK'5]#WUCJ^A[ZQU?0]]8ZOH>^
ML=7T/?6.KZ'OK'B_CUW_  FV^=+?Z.G?_OUR%0K6&"2Y >,.P3&LC(6,U%7-
MN+D&AH_@H3V%6&:XVU:GG(L&(H0 ,>'821Z$F$#,6 QV39FH0Y$N6(J,(*%R
M:9V:J[&.VX890PL_C.TZC38P8.8+_H(1)&*T.NU7+DYTAR((4,#" OEO)30;
M)@&UJH!$EH*(,S&;G89@6+1N"XB#")/C.8&5%.)+0L]29@A553BK,S=_D[5X
M_P".:%$D[##F/CP<.N^>^_/X9_7AY^/CUO.N\?\ ?A^.\]Y.<_+WWW_SYH*\
M+K9!!20@4J0+Z&],=%%E<XFDA)BM77D)E?L  ?S]J\?GB>"5I$7$%YI@<?F[
M[FN^_+\_#GU[[VYX^&>F?/\ \_T#M7C_ ([[J*( @91XEB?#S_'GCO;?Y._U
MW]M=O_/O\.^^_7ZKM7C\XE$D9--5 P55EOP/'Q_>/QK/MR\]?M^=_E\_D-B_
M?S[]OF\>>_?4\>_SR^DQKV/[[W??_*]J\?\ '2 KTY)I,=< JGP[[[Z:\OS>
MWO)=3Q?+O/Y^7OO'<^/_ #Y.^^_Q\<\??R^'7OOT_?PSSV?R]J\?GB*,DK+>
M@=*/0^'???EH[S?/[=PUWWW[/???_/AWOWZ;?)W[?'OOO]?(E,/E_5Y[S?I-
M\V%9XJ& 9R#/^$[5X_.D621=(4<T(9FQ4'_#YN2!]-C<9W@(B#\9[>FI>_O_
M %K?Z_M7C\Z2*9N98P$VR-JJZ_O_  K*#\1AX8-;)JQ\E_\ .?+O]?+WW?X;
M[^GT7:O'YU0%@)#?/((5A?-6??'\%[\N]_?5]_3ZA]75)9(1$10PFR8?\)VK
MQ^?QTL[* Y)0 Q8!9_I;& 5P -JL)X/_ -0__\0 *A ! 0$! 0 " @$$ @("
M P   1$ (3$002!10#!087&!D7"AL<'1X?#_V@ ( 0$  3\0_P#&%BJ9*BSC
MG[5OB/N:''3F*X]:N]B?1P3BGP 9^S1#SZ=BU[L1TRN&???=\T+'RQUMZTL9
MW$/5W[5X$ NHO8)!$0"-C;9.I8J[*N^\7*6+8H2_HQD.3J"FE636$ZY\4X:1
MTL77H,/@A@V6_!6KZM0,\@(.>L&^:!KD</@=T91Z%C%.'D3^5K4$1:D!2=B-
M[9/8%6MBPTZ_HALG5]&06FI.FNO])%@KS ]N&$**=9GFQ\4X; ^BZ#:PN](4
MXU@[A:A=UJ8**:WX3DMJE=I9$5IB %VZOA$TJ5IRT9R3#)O:Z/5\*YR>^=.^
M3"A'J!-81@K 6?XVJ[A[;8#"XFCABD<P-."^=J*@571KU$=XI"H-N'=-&\)F
MWO";<<3@>=NH-\4Z8VQTD\*%23%;5"GLMRECOG'G^:?Q\949@M0JK&0Z</F/
M.!^;I/)B8>J18WY7N_%9)_E4*"?PO$PI;N?C=4)S$-U*SOV7BC?E;_*TP!Q
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MI7CL]ZFARD(BR?:KAP%JGN*@N($27J-3&P"!@;$DW7@Z@4MM<$L@X1+1_HN
MW^(4@<K %4!<WOW<P)BO X)$QHSQ(P<K6WKY-L\3SZ8C[$'[QQO8=*2%30G=
M$^G\8?ZZ@[LMNHY@8"07 U"LTZ,):/\ /34]7TA/5H[A"T'9]*Y\)Q8M?E9L
M3@0C"_:JG <"W^6;K*EEA#LDKEPQ&K0'JAAYE-J\AEZX"-\'/72E#TE*81'Q
MX2WW=E1L7HE%N,%C$#C:KF<XZ)?RN"O(.JL$0S@QYB66Y3F<JRI/A,!"<C'
M1X^$=DZIT80H<Y8LX#T^,P\'OH$ ^[$D EN;3HDFD N'BU"]BO"6"0Z3046_
MO$QQ'@9!'T //(90G\6;@4](+>?D,V<F(]KE?T;K]X,-D0)VX/G@.D2(E:;$
MHL*$K^""(E'B/B?IUC] 0AH\#*96#C?  [AF&?\ 09"]=JSF&_0B2H'%U M/
M*.W+Q);0F[%>0 CPF 2#Z;)V^+>(KBPM0%9&P/3A'[8XO32,'D"6$(H0]!3.
M%DT5FK;B21:$^"0@B-#'M^;05]DLB0YGW;*':0'>S8I2GW"A6::>Q&HZ-+4
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M0L(=G*9T6<9@ %8C)0 N$Y1[(&FV1:)'#AE#_==0U=VSGV>$N-+-LKGZ6D4
MQ#=?0C'>5K2ROQCZBRDPW3&5]XE'I-!0IKD&8D Z\ZQ[@C;YQ]I&6#7;6+ 0
MPO&C06Q,AA6+[Y@%IV=54NRX[<62NHN3A*K$:#S-C<B&DS>!Q56-!2(]W\0M
M/=@!TS4N+R-2#Z<.U/,I36#>0 HO^ B7@<H %4#4@C@^H(7&UB+P?)2^V--\
M]Z7/90-C3KQK;HU-B#*,>-M@Q7FTNM[AHRG6EZWI\DT*83^%"RL:#;(-D<:?
M"$9@=I0I7PO7UY_P/_3\L.9VY32&3HF I)@8#=5R0N$ID[/-\[2&^]33FE\]
M'PS%5"O#+P,X#H;PAQ#)^-;"B2P+8KL_J?!U5)&&F(M3!I$A=,876ES0#O7#
M4@Z()\2ZMR"?<RN(G+ \2Z"P SA9^&[NMYM80NMA B*'H=4)R*>+P1,EIX@\
MAZD^/Q8S\Y2?52?5_FK#XGQ=Z-06O@FO\VI8P"OGV:<P84, 0*!'B$=+F-Y,
M 09.#!8+P3?2 ;% 7^3U.8&+FXAA@#4*@*P%S/*?8 G)31-S10?N+&=C@!YO
MAGXL4C-.*R@Q+X&_I/.T._4+0QE,H M.P1E&;[VWCP>MPW+K\'^ <32!XFM?
MN^()I @*(]!Q)!6# ]+0]PP8&%F<LBQ%X<,W'3>N% *:);'1&&@[,?M<:D3,
MFBM-W:"JHYJB,/A2@$/"XSB#  /G_P!GW_:N?[EG/WO*3]\YS 2,V8Z?JQ_^
MLP9S#3SL[F+)1[R!+]IIA$8!J>.\U!_H S'UHS*UA;K:!(@9SY^O0\%DNV,D
MQ%Y-71  %J(2X[P*$ YGO;PH2Z3"!BH.8TG.3"\LXD$4MS<+#O40;(H"@)<T
MB]NL8G^"&9"DRS]J:=4D"C]T$.0P1P_CQ-S DH(!\3U<Z!5]662P_P!E,XTC
M'4TIR!_+NX2M#'EJ^<JD?Z3"[:3*.R(&)K6HT)"% K=U$PAFW.[98'1"N43]
M&J8J&9"A18<ZJCC*NJ,NQ-\0ZI'C;![7EX/ISBV\EN_ROH^W_P !Q/\ $_G.
M!_Z=5$^A",_JBP6I1UZ7/ !0OR_9" [94EHC4> :SH)Q6E>=49N0;"90**(G
M0WLC1-OU_1-Y*("=U$:?VGN,'"$_)G / 4M">5]D1B,R9FVZ90#J%K_*E'/<
MBLZPC)U&?2D<L=SXI30/@JUU%=07+L)XBI=1Y0#3*Q^HE;K."?3\%R#XY8$6
MV#U&/]C6-*^&N^!>Z%,,>014@O.BY,1YK +LEJ!VT0Z)S%59BLB((G8 !^U$
M) X&    ?AT6^;H>3?HYV73V070F4]H3@=5W-4M%@T X'>4DZ&*^=6 :%_1G
M$?>"7 (@Y2@053,*$\D((/5$ ?5!:E%,-"%=['G,U>?J^?@&N!4X$H0ITG3^
M_KE1HFC=R=/#](HY%;X(<XL%\>K@"]6I5?+T((_2FNT"N7$JM][@/6(KUG\V
M1&@[U#W8AH#;79D=N)880&6 &16ZA% XSLHW$SCV$C+B#)+7"Y4-5- =J9%S
MRLK$%BS)1%3G:FI$BX%"W^LH9G'@@,OJVR><_G0[NQB+N^JB @$XB/'C*"P
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M"#T"VO[Z VF@0-1J_%9Q8ZCLGEZ)#GVZ\HGC@M##A3+8"XD SN);H2FC)@$
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LC"JYOC,L@O0^]/.KMI*LZ=4WA31F&LT,G]X+W&4)$G00?T %P3ZR3_RA_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>businessfigure7a1a.jpg
<TEXT>
begin 644 businessfigure7a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M,A/YB\ED@M[JV/ILO*:^ESJVO*FXMG-+9$S0I1\S]GKI",HBG=XAR#5=;GM
MU/&.Q7%38H5NR'NO4[1Z+HNE'S#YQJOE]+,4MA\#;/K]SL-Z/[KI76[-()*<
M/1&[K;'![:FN+:[!C-=F/,?+'W7PF02Z63=?2]74;>A\!W4P9@$6.08 K]>S
MUP\8]I[?>'>B]D_L'Y5OGIO .0)%%UY<W%#ZG/*:^JR\MSRFNKES0S.2\L/<
M_"OJFG+];5."[UW&7U,T)\P?1N\^6O[J_0#X>U;4\UZ&><^'U+/2=E+GL>X-
MA[I,M5V\Z+F+7![L&.0P^ESRV/IL.*<W!KZ9Y$MD3-),>:SX3058/@103P/W
M*.V>^X"4C-B*VH2U7QF@Z??-_%4)[H&Y+=7>>L;J[+O^>,HY)G!V3L5.S3%N
MK<^IKBYYDLQ9QY:>Y^&R"V2:+DK7N5WC^KBN5ZF6P5;)G"LY+5@A:-_A\W>[
M;Q]D\?WC[3Y,\JP\ML@ESJYO*LNKC()L.K>\ICJY<T.SF?++W'PV)\\]$F>;
MZ:#C)3&<62NT-AJ7Y^]X[<4];1_K7XAZN\S0WQ<]CN)M,F3D&Y]GJNP>RUD@
ME[D)/ILNPP\I[J7OJ8ZN?-+9 S0\X\U'0CPS V'P,88 L^[TFZ.JYCF5V(Q>
M2W5W+<_T5YG9;GM=S87[?+EN$&PE)P[:V*F\)0?4YY;'4MRJ;BSCRU]R\/:Q
M&33:9@5#@._X\YTZ(90RAR#(8CS,>WC.R'2.V[-S4(M+Q))L.+8\JVZN,@EC
MBWOJ8^MGU#LYGRP]K\5B_(O79U%BM!*!#9QS,X>5Z/;6UT\KZ9YYHWB.WE<$
M+G-CP8YPWCM=5NV_K9)-EY4GUVG%Y>5.02]Q3'ELY)=(!0[U'S(MUN>MV?,.
M.3C:IO(L*OK;B[O@9MB7(9=4Q]-AY<M%\YU.L=5N9\($Q83,<$T&/,>XEFIN
M:,GEL>2W(IN+./++W3PMF,6H1<6V04VL^=>GUS2[S)C/,(*.AZ](X#0Z/.^5
M/S;TAZ;UKN?T7LC$8.JD\MSZ6OJ<\ID@I[BWOJ8^MGU#LYGRP]R\+BN2ZUG@
M?0H?)G"3S&(C*8VVGW3VG$LXCJSC.WBZ.PKJ+/ +1@XS7W&Z/EYF#74M?4YY
M;'U/>2YU37ELY)=(!0MAK?-OVCQ1+QOVKE2OQP7CM>%GK]3FZA8+%9]+9%5A
M]+I)-MJ#*EK+VFM#TG,S0$/N9F&"S F'>.W1V+";RV/);D4W#+'E9[MX$W#+
MJLNK?)ILSE7::T\\]"C]=LXS&(*/@W5WF_ [&Z>^.A[WN[U_MMFQLGEM>2UZ
M#7T.>4]]<Y!+W%O?4Q];/J'9S/E3[MX#RC)3B.YX\5WV'!;.OY"0LTK#L=3,
MM2_!KZ':AY#MZ'JMMR"0"=M5.X&]YV06YY+7U.>6Q]3WDN=4UY;.272 4+8:
MWS1]H\/X>+>ZV"O9B^PXF[=AQ#Z7MP;(ILN*)%5AU39-%QQ;&EPD$V>NNBZ'
M6FOVB@/F/AF5S'OC:I7^#&*=J(Y??V[I=+BE'RD]Y^>Y!3)!+7EV'U,?4_77
MF7JTU1ON])S&P]_Q=1U&DV_>[:1@UN(^EKRVO):]!KZ'/*>^J<BI[:WL4K4+
MR716_J=$SD\H_>/GS*8X\?VW+S[TG-TW*W;M^#?5*13;:7E^#7T-HVAZ76W,
M]3=-CJMI;/5[%L5VU,D5N>2U]3GEL?4YY3V:EB$Y+H[1T.HEWJH6PUGFG[7X
M8SP7H:/(]K<O6_&I!<GU.;6V058>3.04YRM;.)[-R#)?=Z6N>/>GU'1[737K
MO!Y3*WGG67/5;':W"=7 >>]C+7$4;RKM9+G:7H3^F_R5C9#RE]Z^>I!3'TN>
M6^04YU+8CENMI_(]MN_T?R^2AEZK=^<-VK52U-=+S\!Y!Z9@Y+?6OO\ DWK$
M*]Y9W#^Q37>0Z:H>>=E(;2M3/+NS=X^MZ"_IK\E2%I7E'[U\]YHC5#8(^.^W
M6?UCQ^8:E];)!%AQ;7H3?K/H_)=EK?GNC[!])S.7S+NU.(Z>R=GS,WO=;6?*
M.]<?&)T6[I7F/<-[%-2\YZ]CBU]Y_P!"?EV[=CI:;S.U\\OD;VRO_7GB:.HO
M1_SUZ_FU-J:]%XBQH1/\%T&/A^P3]"UBG*])/>7/@6[. WLJ]+7U7I>8V']V
M_.GS;TM+_(WL<QY+W&U.:7M31(M]1$_J]/+(UW97]<?).$,^:WP=]&99L^QS
M&[U['.[%OT7A*A]*>016KN37Q][E'=Q1R:3<VKR3;%?9K;"^U1Q()J1EJ],Z
MW6YTIXSE/4=3/0U,I.A.ZO4/T*/9/];_ "1V^OS6^!/I#!=QAZ'44'Z"\YP?
M-GLN'ON)^;W1M\];X>==KEZ6#Z+^;TKSZ1Y7?N_/OLC5$DJ]*+MWI;7T&T5^
M$Y3-+6V%&GDW4)W6:B2HT.P'Z@^76?N*->X^YUF_+SU^M]GI]>>@XU%6ZZNK
MTBPN=I7[?JME<M5?M>IMQ]_:UG?[R:5KK7S?)0-Y6J?1;7/[>^<X_P"?.CJ7
MCF\?3/9.A=?-%>L&MVGQ>^CKVR[X?JA\O?%G5G\D?9\D8IW[=.ZGJ)7G]9FI
M)K6WEKSOM71Z.PH^V35MD\O[O8FLGNGA--==,^%ZCI[7H^=N'+\KGKIX2ESQ
M%.=J(L;* M;>!L;COE^I_P M/W4=5_R5]E^49K6W:W[+I*[G3T^WK=9;W%)V
M,XYN<$SC.U*NZ/85"SNGBM-?^<(;I^IL>ITEVY7DV:M;AF>3$%)V(E^R@;>W
M@K6W[F_I/\XW?LM*E1GUU_+KTZ+YS88P7;"-LX3?#YE;"Y2E7,I6.66)7+;%
M6OQAGX9^9*Y;OZSZ'?4/<VJQ?9$OO<L;&0K;.5J;3:'H7(>C?W=\E&,]=?S1
M])@/.-S\Q+G&'*6.6(Y<+X9%V8C[&8VQ)"XQJO!RJV0K2:7B+;L*=LNE@[FV
M199AK6RB;-^.?;5F[8'?\CZ/?>?R)GR: _/'T&J>+]#P)9(P^YQPE'%-2K<*
MMRLR:\Q>Q-E,7:K'ZS'%1CVW:CL.EKUW<(MLQ%C8Q%G81S[:TW6/I])Z5?H)
M\<RMI$*&336*UP&U^8S\ SD,<L8^F/AGCG/W!R(X\SPR;Q,@+->FVQBDSX
M &2<;IWO(6>TCD%8IL2X7:<<9 ^ !R,?3 9X&?H<L8X9EBDSX9 P3:JU^+,O
MADR& #E+%_[+F).PD!5,JOP.UQPD &0/ICZ1#/$D!](_"6&3/AD##-BC+&.4
MOAD  #Z8O'7<YRO59@($.8           <0Y          !&!; Y!4@D@
M                     XAR                        #@$\
M     $&$X                                       $&$X
M                               $<$B
M              $>$@                                'FJ2UR%M#8
M@48)</@-A+!HL)T+,$1@@@[#YQW?,                       =!255"JA
M+X+KDWT8UD"IG $P8M00P4LS$A+!&A30[ &.VI@
M  "GA$@^ $.#@? <!$,X0P/AE# $D%Y                       #K49F
MX!L4QK<S$A90IP8@^AMHQJ(S9 K02@1P<@M@;\,
M
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MKEMFT&4M@C)*CL6UM-!UKQ2RLVU2WO[3;=6L$8N)K.X:(^1UVX(O6\9"KMN
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M.022H)>2H=K*(LX?.&S26MYJW2@:IIG51Z=82>)O<JHQ.%_?DA YA/,+\LY
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M9-TUXIA'9$K"1O02V57TXW>BC-#;+B)0OI/E,?6QXFIM8*GS_KH:S&X*R;)
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M0Z8=(ARU$_B+?W5)TXZ41^9JA'^S6ON:'PA],5Y:PX_V:T]Q7^$?II]^Y/\
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M/J!R*N^GH;/[:7FSVLZ9)<Z+:/X/=:I:OVNH6UT;=;@,MHJI;O;DN(NP,ZW
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M=70]I/ JEA)[8"-\C7[:UONUF5 )K=1$]ZI/&3^;M0H.X_'[I(?N0Y'>X5#
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MO#Z:92.!!!P.8(HT0:--WTU;3%?![8'=WS,V#[M5$?'=[]TG&?3BH^T[2,Q
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M!A0B,D%1$",S87&1D]+3%2 P-$)#4G)S@9*4H;&RL]$U8G2"!Q8D4X/!X25
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MI1OINU[3C?3=KVI&^D[^M>U8WTG?UKVK&\;OZU[6C^-SSJ]KQT\IYU=QC_\
M4\^NXQ_^IY]=R8\3GI*YC'T7/25S6/HN>DK<Q]!STM>\?0<]+7O'DS]+6]GR
M9^FKG,^2/TU(+HH-UL)BMP5>A%OJ"KT7NB[LU].R/&25R0XEVHK5E=-/A+T
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MBW:+I4'!L*!V83F)\;XY#+:-1H3SW;7Y+OO3K070-MH2I<;KI4A[#V'.,2A
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MOD%S*JIHBWM3;S#@+F0<[69-JRY:Y-.-K8T,5NG-Y2)F&Z>Q+X%_SIGY)O\
M E2?X=[\LNSK2(E;]:<G-N[:.#KKA#S3;-XE5K;=#C>U) )P;*FBDF]:5+
MMO;)Q^:Z,=ADEU)4Z30!U5&Q)>:B75:;E&#N) $59&R>V1QE2V19)MBB%EO<
MFV3541;*6:U0;*RL-Q<XP6CR@*-KS39&R-W\%3GHSO$H<IW8<0;,]5)+H0#N
M+(2(O7=*XS,E2X^(1'$;?<?)7&)2FEFL@+R=FHHJNB2(2%HEK74&5L!DUG%U
M' *.Z0VV@"5[@:;]FYJH[E6WLW\[WYQTY\0ON6G;_P!XY^->ST(G62V3[:%@
MY"(ZN5+(BJ**7-0C1,HJ71=:LM)Z_@W#WJ_CK4A4_P#"P]AZ29;^@MFG3O\
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MB+R2Z"'H+YT^WUVMJU$:U :W)]E;A\57RC7)0$[/16BUSJYU;ZWUOK?6^FK
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M+]^UUZ5J3F)2RS) I?H%"T%.\G1V(AV)1;EB191(U0=D\E["BKO5*]^^KO\
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M$G"SD<+,,X,X5 581RL+-[@>[PEE/8E+BS9,2>PX49U(ST%=!=;$@Y!E4-C
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M5;CX(;AJL]!^NC/?W!,J53O\#NQ$\RS2SB3&>7^T]%4_('%X179!7A:>U1,
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M1ZN(_,KB"X(Q/3$&6R FP5#+?LYHN$8BZ5Y#%X:?+G/5DANTA@0  * H  &
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MEC-?&6)^G\G"IQG\?CH\W^"OZ3;HFM/&\P\IL^1+4<6AE![,R(.F2+%-UH%
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M\F]A,>"-M% ,,ZFS'*R(J8KZBGH5JJK1<W.&(%$40J@NBR&K4(JJ32%4*&R
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M#"JV\^:2*A!<^D*HC<!<RN&'U2["54:^ S+Z%X6&E,!RN+>EM7PWP$#CT
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M+S;@K_\ NS%PCI8XIS_D9EOH)<<;C,KE#4;:1H48(=?_ -,__]H # ,!  (
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M%*,((_<9)&H       ))))))              !))))))))))))(
M                   (
M                 )2# !;7Z             7(1+#) 0            *2
M33:232           !(##+2;+(8
M                 /_$ "H1 0 ! P,#! ,! 0$! 0    $1 "$Q05%A<8'P
MD:&QP1#1X?$@0&!P_]H " $# 0$_$*=D\00F64RZ26"D$4@I&#V1!ZM]:FQ:
MA:O48S>V,VJ$%QEO;<1MUWUGQ'O'[4;A JAN9&_PHX$E$F^@V1/6H20K*S&)
M8L\EO5X" I(^C$XEQ>GP"3 AB8&$];'J2)##*4?:>\9H:U[Z*D2@O=B>C#]3
MAH8G;$K=\1)V6A08+3=VMXVUIA! 8%N7CQV)S1:BS!DY63 4FFX$Q*-=;MM*
M')@[J*?4OG3W^<H8'=Z<\^E#=$=6;?>AL#U;+\*50DZ,]=#M1XYU-OSD-FD<
M2(>B"2M.PM3Q<,=(-.<DG>MT*SF.8>:YB<L&67M&K::OA-O]$*._]I,B>0QH
MFB?M1I%0RS8W$G<BAB8#VM^.8\:&1Q!.;T?K-]BAZ8W@2#&V:?NB4,%YBY?&
M?Y2NEX/ZTO&N706WS^>*""10O,3AB'I[E$:(F\JQO98,XA8I$"R"<F]!52!=
MFZQ:W^=FDR20)17S^M+)]QQPJ*M6G.NUW%^M0%@/)UC;\UHA'.@DI+Q9/R&_
MMS6)D31^ORFM89J H=8 ;&@S<+#@TAZL=Z9M##?<X1P9>*6CF*OI9/FM,2]V
M/M1 "6&13T0GG P F@ME.;.#7BK>BI$[6K8)K <TC(D$H0X0</%_2]"**ZS,
M9 !Z4F#61J&A<9];EJ8VGUTX9Q#UO)0,2V^WC[VYM*HA&>>MO[K>I<$9@<6L
MWWF;1MAJ>QKKU\YZXG[LYL3B+:<?-*BP>OUKZA\5*+ ][1Z.E%UP.C_/:\;M
M="Z%2-M=FSYTFF#"0WY/I]ON)38D9AFS'QCOO!<#USYSK'Y N=G6]$(TIU42
MJ"7FTL#  6"C[)A68LWTR.>GVJ!%P8FR@EK)2+-=DDE)LXEOZ8K Z%&+(93K
MH[&>W-9O3[*414O949I)9J'L6H ,AHP:G6[QFU.D$ @.0G7'6B8PB>3*=\42
M    6@+8ZSY:F9 LFHF@6LDQ&O:H<L1$+VSG3K&:8;@2[-XXSO;X358869WC
M#TVI02]3+8B3CN7U.:6(L:L+!+MK5J,C:9UZ$9@\B$WA($[/EC&\UCW^BF;Z
M*7WSC?MWM08C1?K[]2T8HB$:,YCK?I^+78 LL%B=)B*+VS56<TX.8@M.M,("
MXZ:Y:  9 R8D-8]]&E\D,FZ:]>;?NLC[MZ1FV_3:H1I<HD8"3MGR:C#O\?[[
M4\)8-IM$Q'3[K-Z'GF])&B(03.(Q=L>OJB4$0).503B0COTN49)O!TE*&JP#
M:+LEWG7)TABF="4FHG\T^J 001-LZ6DTOX5!$XRO&VM2BI,SH?6V=J<[+IM'
MS:E-1[#$K0!)@26"WO&<_LN'<VF;-M(S6'5]T973^3ZU.-+.KMS/JT)R88G7
M#)M;?;>)_ 2ANAZTU4+I4!.4##9.JJ2 .^UR^&>D7IB8-Y2;1A8QC./O127*
M#,LDR9YS%OP8F)A!JA"^D?O-8/-*$ D%A3;T[5HF\Q/.)G7[JY0, FRW'7,1
ME9O4(K6Y:Y(0>^W>AP;#$\6FM)L >]-34%2EA10SB_J[NN3,HL$[6EZ?=,!L
M[9T3# @6S=- :*&4=+M[;[K-XD:<<?.=%[I$WCMS6H2W@2Y>==-<YOLUU,[9
MO.ASI'%K4EMYW^-?\9B]3&JVWCZT]^EJL)>\CT(N3;@V]4%($BSR6UI@@$HR
MQ]:SA8QZTL/3#W6:&0?/;\1)6 E=B\TU '%QGO'2&B<(!8%Y;$G!^YIC.60K
MQH]STVS6AIJ"&UU9<833T R! 5DTLL LVGTJY@2C:4D.;I=YM0@MI/1BL7?Y
M:RZ/JA,L*L,PVB RV_;>B;656O-EYQVSI&0H.<<4%F4M&YI";3402+C=#C[K
M!TK%\\]?ZP4"6C+C$XB/+4E(9)S<36]F>4S[@ L0R&<]K7MZQBLB(_G\K+U/
MFL>_T<OFABL=S&-L]NY-K5.9YCKE^OZ5YR?WJ/3\>"W4B (EJ$Q-L+06(Q+,
M9Y^:M[ )K!LML#L]'2ERQ0DV=233YFAH*T@2/#L_Y>Y23=*CK%KJV_8TMFRJ
M'EC^_-8'1^:U]O/-Z3,"4"<Q&AW9\@40"NBUI+QC/SZ/)Q*2\%W?:@@OHSFT
M2]L<VL4VL%WB;GZXA*R\;=?EK%Z_14@"C(LN^ <VCB@"6F\%QS<PND]8J(VQ
MMI)\VDV>,_B'9>[IXZG2L.K[K#:[?>."+WUF+6HF2.F)S;[K33'4^K48+1;&
MW%>8W*0QIUQI@&I;N&-31/,T;T2)$<?'A0T@C!*(6,8?7K2(GPLY)+[6UOK2
MLQ> 1'.9-H@QUI);,8=YQ/>SIVK Z'Q7T4L@0(=);L:^EJ 0 L$9&L[Q]FE<
MP 3Z8]_Y1S*"#+CB.8AMV'[M,9#+&K&UM=*T]-9SW\C%&"*</F4J68D3 =Q#
M?6A0PL,H,$2--\6GBH03P1$C)+K,N>NE&<=SC/3KQ?!5T+0;PF=Z9MKY[1M[
M8_ ]O/:3ZF-*P.A\?B.6+WM"GM,U.>5UD(FRFTVDVZ5+.V!+A=G(1Y$4-((#
M&[J]_7UKZ&KXG7BG938Q<M:.1]Z32%TXO!9AR>K$D5F]/LK%W^6O@^J2"DMH
MW[U&6))3&4:.0@$EOB!*"-#Z&8)$15N&T45E8+C@@A:26+4"[!%$#(EDPM(0
M/5F/B7M8Z%&;KJ?#]9[,T0AN(EM>QDB;O[,1,Z3P:X^??%2&:V4=&SR3:^>+
M5K40RC/#-OU-+5[ 6,-]^F.]^ -IAOT#MCX.DHS?AF D1-C0GL;*42$S]>3J
M6NP\WX]K^WX\WNI^(U!(@LMEN'L:.F4Q)"MR5M?33/Q5@")!9U>FCKMUF@M;
M''\MGIFHA(1&9]GK/W%')(8(39=/7?M0I5U56=7,^]8'1^:U]ONARRX?.U("
ME7)Y1=3X=\WI\BN)UN6[E,DR,2,KC&.-O6*EP(()-TWCG'0.[%C0%=V.OSWH
M"YEGSTQFG=9"64VB;LXM_*BS:]\6+Z]#%YJ(K<+DL#9N]>+MJ;$$,FH\=.DG
MQ'@B7=SY,WLA2!%C,MI)F35M0;TGAU..-RYUIEF2'7LX^(YQ.!'%[^Y6!T/B
MK$X?-'7$QD$I@U;SM9N334MY)0) YM?6>=6IR+)TDGV](J,ZXOTV,X^YOM D
M61MO-2L)R"27$LN?YZ(;3<?<@-"#MQ6!T*\G:FR)$+(PY*&JR,+>,^E,[40;
M(]J1Q,K"-%04"M++R %DK> T':= L;XLE %D(%P-6OR4K!7T,J1"H"Y$6LSY
MYW80M*(W2,=H>T4WK%OCR=Y*8&DDP:L6Y@$F>E.--A$*$I=-MW0)<%01:#8X
M@T'4;WX*)8G?+ /:<ZYCB@+B,V80Z+]J_$.SZ-<1_./-JP.A\?F^592)GI<G
M33@;T3&VHVG?B<\:5&"8;S:'TWT_RM?:A 2  JX@)O051%5BQ+;V,>A1#-8Q
M(@W,4 4EV9:/KK3 ",1"1>.:>MRUGC+0L$@+2=NQ09A01;2V+U%*6;V5T"V^
MJ2@EBAV*P;Y*07LK1WBW9R3"S$6$2R!=246U[^UMONF1&JG;-X]J2Y P;P7+
M3K=QI;2KDZF3GFLIT)7X^Z;6(;HN+!C%PSSW5"RBZ1J3$\2EICVH$3)<9TCK
MWQ\U&_;[_M.2,'$QP7TF3G6UYG_$^?QX+=4"SC7.(N/#I9HE=1(V%;IYQ3 &
M1!.\;L_?&M&N+I$1>V9Z])-K5E?$7M-OH\UJXB;@YAOWF@B0M-S2F!"6<)U.
M***(C!9+^?.F*Q=_AK3T^1STM#^LWI]E*X=9]_UUYT/F/GH>:N:5D9GC6V^W
M.$O5GH(\*=LH3(825GCI\4/O'?#AGWJ]@(W#M(Q$?YO1P0D"V4W#Y[O-$A*)
ME_7TV_=2"8@\TS6/U?[U_1K0C1$^F'XM>L+.;]'6WGVE@-JR.I\UYS?^J(6$
MK8UD7$S^Z'%(EMPA\_VLC^\^VOK/X)@2@T3-ND1/SWE)07)2V6;\31!)88%]
M8H* 1MDBLWI]E1?J8LW:45VD5)Z+/!+C)HR9%-,3@&[.1%&5KT$VHZ&I (AY
MG"H'T30!-W*.' "U3LY86\6Z]XZT*.;NC:2LA9J(*@&4'4!%\J-8N&Q!;5KF
MUM]N)YT[Z44-1"74);DG[=)'%Q(+G3FH 1@]@&W;KG%6"EF?@M-)04:*@;R6
M&$(]S5E+P]%1=)A.67II1$$3$6DACDT?P#Y(F&LB/:MQ0,R&W$^L6Q6?:OEB
M^#F'LQ5DKDL#V(\V;-.HNA*,G$.<QOO2Y1&ZNS>&;/Z@P5%2,21-K1Q8MKVH
M&"(O<6Z.3&D5/@!E#;;MYNIZ)M\ I05V @ 4% 0#:04&$) $%2,IM4Y21D43
M$QDB?<I$:(ID1B@ =PQ281$CUEQJM%_%71$=FP"1 X$,?Z_WWJ]9EMY>C:=1
M_3[):A@2-Q'0Q=TP6/VDH,CJL<Z&1'6VM9'7S/\ O>O///[8'VWS@W?>D S!
M%[YP^8WIREVQQ):?NIF$UKVKR>ZI#B0HL,X#7]E1_E84P+W7K][4H1.Y!B;P
M3YO%(W";K,D>79-[4@*4(%(+Q_EK4JX7#.$T6JOIK0 F06@:9UQM^J*()$P
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MB'$SJ;Y;>3HPUY]U];Z?NA [HAP1'3TT>U+"*!F&\>]\V]Z 0Y))<%IM:]"
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M4 ;'R_,SZ?- "HZ1'HSY/72H G/Q>8MIOGO;\>"W5>+<D>;QITOBM?;[IAR
M;3?-M\=YC>8;$@PD9B><5Z'7!S.G-27!D3O% 5(18A&[($@#$B6:!Q&9BONI
M0V6,3B=.TU&AL5?'LJU(B@1IJEL%%% 16UY(J[L^M2RY9)G10[$E6^D"JVR1
MZTR( 67-H=F=?U6+U^BH$9R+CJR3C%-KG"8BTFFE8O7S3[[&JPX/C![O^T@X
M"P8-HN:^1:@$ 1BQO[?V@#:T]8Z^%M,U(BS#/MKQ.,WSM4%]?0QX/>UJ,'0K
M(ZGS3Y(R$YU5HZ>KI6>EHWW,8CXC-FSAFU45.%@="AO(;NU+<<7&^J\KL#\'
MR<8+3FI.HMJS= (JO :+]L"%#41U:"H'R1 % @&6SM'*A @Y+Y(GO:.1 ,66
MO<WC7:S>H@IV&0@8"3S#JQ0QG-F$)*[*CM7]'<F*<RLBI)]6R5AKH-UE!%$>
MYH8,L390O+"&-0P="L5T&2,V!UTCVH47B$PD7XB-_2KBV_T4@1JXZW[+Q4V"
MUVV^D^V=#+BUA!CWM'KEZ=Z ,SI%_P"?JC'?;&->G&K%]"A.^GGGU@\U_!X1
MO'D ("BA$82*6,DC!#$0DL(*OUJ CD= D8(@C;D52IYYI[_S\6\&%%,@%'#%
M#+E7%B=A?HF[1260(O9L"ZPLTL(*3@>YT7 VB* # B<:>ZB5#3+6"+HD!IY@
MF(@@A<FUZ)D*)8*7#OF5%-42>2L:!>)82($*F "4X3B$2AJYJ%T+I@-C5%)*
MC8($H5,0K]#*FHTC<@M)E!>$6%)DM*6JT=R.V_,Q]UY/73X]J9X51*-#8N$@
MC]30: R;ZF+19'1,1HX!B1FULRNAVO<U[4V%B\YM8TMM?7KK1O4]/;,SK1_N
M<^WX\%NI##,#)+,*N+$43%$;B9BTD[^G6:&0<!/M*^FW$4BPB2,"%UM9F/BG
M#DH%B0!D7A'0!9=$*$T)0%!DBI"DBS'>6 @4+VNX6\]*M'.M[?'G>V*1Z8 "
MV1; -# V02*M@@G$2REU$P6FM7?H:39Y!(99-"XR? $LVLJD2A0H&%5G"-KZ
ML7XQ6+U^BA"1 3)%V-;]LSI;0H& 3:V<]>G$Z5B]?HK+H^J0-0S1,3#8',;8
MC8\:BE24@#A]^N]HQ1LN.@8QMQ;:*(T\\QQC2L#H?%"0W![T$I :-=+T;7S-
MLTA&!FIHI)R25X4F&(T@C4#847)04I(!E  P@$8S",DUKV_SUWK9P5M%H>6)
M )9 ?4H;\Q QEB$LR#1J$0X(%.6Q"0N7QSMZ!T,JF'4X0H)L80IG$4?,S4 1
M"E,2L@E,$&C<L2-P&"XD!> UQ8B;YM Z8IB=?<[?J2^*:,1+@A,(7&Z:E[UK
M%?2-%X!&%RS1#$-A767^<V+%J,IMJETTSI,^L5B]7X/Q?V&;Z3YZU9).\1MV
MAMJ:M7CJ"A?OJ:;9::MP+QC&F':?\J2UB(QM_*Q=_E_&#T:S_OF^O7\^^_!N
M\5YTO6._M^AXUZU[75#!8 O'8,#2^O9O'TQ 3-Y$7G%0$)#,%C%K7[9>-H0D
MLH)R?OK%?1^=//ZN4=;H!ZZ@& (6?]3+VH&K4+2ZR"Q;G-#6"1(9 ?D(D41=
M'>,=4Y,6$F5LGA8P8    " " . L!Z'X\\]*\\\T]18B1)K@P\06OF;5$"Q+
M$7T@](LOSL.4.8UV&^MY^K4."Q.+6W8-]][WH1U=+_K32X1V:+@[E>"W4A2%
M;CG/G'O)$<Z8P;1#@MM9TH(C4-_BH%'EI"9(Z<$S%%+;+4!(2!')G 3_ *\\
MBDZL))VLZ^@@@IF>F2E9)A)=N@@%%4YL2#9%0PQ>=FX"[O-XGTUZ44HQ:1S.
MNW]BW+)#<<#.2X#B_,U)F &AJY]IZXF(N3?.KJ$V@F^;:VB;T@81&'MI)#^[
M<4CA.1T?.0J-A0D89Y][Q0DW7B^V;7OZ=;5-,ST]\][OMBD7$>_X\QN4R DJ
MW-UR[>E&J&:!QCE$L<:,#0MFA+AP 7RP754EH    !  ( : $ $ 1:U>>>?%
M7[:^>9[+J:Y6(<R+($A9N:(6<QE"W( 6!3 N:JCF,(0(:$5 9O8!"./"Q&!T
MB[VP.E[Q!"I (LH3!YL8*$P@$5<KYUKST]"=[5]6MQ2QP[Y(N=DY,)@H$6(#
MR3+\XXMI+8<,6USWSYQ :%5<;6VGN4LB--4N]V)9_N\C(<2@[Q;VQ4;A;6<3
M!>][:1;%]*LB&R=)._ZM[TAB6YOAC=_C>D3 =4&)TRS&<ZT$ >??XN'I_P [
MYL3YYJ5YMYY>O.M$3:.&J+Q S#* 0I2;-OT[W[M&"<I]A8=X;0E8'1^:P=_A
MI:P#-D&Y.H]!8H")1,[3+(*,*1%!/>9;XTD1LM(9"ML@J3HFI0J 3 !^1UW0
M7=TMH(-PHK9"P9%869;F(M'>L/2C-./U6;T^RFW-L>]&#IYFO!;JS>%ZE.0D
M#RQA]JA&:PL3O8O,3K!WP"4@I$YC&34]>F9HE/9 [AK 0E4(D:8LY]+QMY;\
M^;XQ\5YYFCC6_KYQO0+8)=B^"7T+]*1.AZEBGBPXS?:''%#H(@L&23@4$!%0
M  <:&Q:-3>SV(D2PF7:<9U\VIR*+I)=F+;1ZRZ9HVG?SOUZT>DA9[KZ]/AI<
M"+METS#$WSASFA@%XF=IV'76>W-8=7W6KM]UB]?HK5V^_P >8W*)(PJ&M5=+
MD"* ),B67M-$5V  %X$JRN-<_K!YNUOCU\U\VJ9[6F/)OSQI6A/3KYF-*4C$
M ;K*!1.@!4IFZWBQW9)9Y+FPW-, L!B0P @ BR6B&$34;^B7G+Q7,:3M\_<:
M=JSK;)KY./2A>P B5Y(803*8L=*6E94'&R4$AD10)I2E#:04VA,G6;7PD:U@
M3H:Z9^M=2G)+QDLE^(LQWII9AC"8C&=KC<QND&@(Y5.D?7IZUB?[YR;STK-?
M//[Q1LO;_?7K;:M?:??SR_X0M11Y;"< 90)>EB7P2 290B%BZ"^?+6WXC^F'
M0M=290JV2A10'@5W4&$LH I)>F;Q%$9F9 E($! 3<%8*'4F8P O<I7-0F[[K
M:2="+D7MS4KE5W<U]&/7S]Z5?),8G1$9]L32J"';?,,_7-!$!& X&X1E["23
M%1YY\U'7U\\OFK]M+=,[_J/Q[\6Y\OM5[1),@;&5O68M30@$(0@EMHQFM?3S
MR']YO3[*=NG[>?H[T8.A7@MU.H/H$[7Z-]-<E&2=R=\U" R%UC+PZ_)W:%MY
M9CSI60DW$(&9(9,$2YF:;W(7V0%Q#3:TW% F8L ! 2*(1&$9O:H\_6W;\%J1
MQP("A&LM R3RC6T6Q820ER4B2HD0JFA*RU"M##>3E"1@X' 8 D@A+?4P1T;J
MEHM%(2#:"+W&[&3FFA(  -LSZT?;\M,A*MG7D_16KM]UP:#[?O\ &'5]UJ[?
M=8O7Z*U=OO\ 'F-RKG,'&19 1$#"AD2="BO'DZ.8D8F2;D/^$IH"F0($ET"A
M>*Z][:CSBY2"@JT:H)/,B $F:7RA(L2JS*RY[ !2OB00H*&Z(39IE*8=:#:,
M^F0%%S!<#"Q. +NJ!UKS7\F!;2%"0PM:4,K8B1I8!((L2S@VEMQ3;"N)>(.D
M6G@^*P>K\'7S;/XRZ/JL?-C_ #XM6?;[*Q[UKYCY3Z_XPPND$B25V0@%D*6A
MB])?L@RT2DRN%=M7I$][16BX 4N $JL +K, +,%05009R)0%F]8I>0*E($P%
MTBL)ALH*21\&YG*!G,(V@L1+6+O\M9='U^#KL6XE\[6K5&(/+_J3<U@E<R1W
MR<_RIARH!:14DL5C"!,%$7$9RX3,"640&S%*%$4^W0P$2A@AKIQF?)C^UOM;
MWT]I]=JB??\ ;\5GG;C67?M'M^ 0YY)!04'4'TQ+%.)\T7ZK-Z?96/F[S]'>
MC!T/-*\[NJ: 4R)YF>_+&W**%!$7\V^JP.A6/1?/>M4 "WDF3R]IFV:3R4&]
MDB.<W2WK4[8:,,:N$NZ8M%>>E, J@!*J #*J@!JL!JT*\2TPFB0+ %"*'E;E
M F4B"6 DD M,P9T3JTJ6JBY',U[Q-1(R L 4)]\'D*$R)?D$&<<?":Y_>M8O
M7Z*,=_DU@='YK5V^ZT]'U^,.K[K5V^ZQ>OT5J[??X\QN59TE[29C^RW>A:R"
MDRL*"1-[Y2CA*,8?3F!0D%P5YYGLZYJ)M\4F(20B^LBBPDQ-@\%)P0J0S:@B
M1!15D2\B51%0%% %:RRR9SWYK-Z?90$=9XL6[YU]:60(PU:ET'4")$9_&GDT
MH74# J%]K[VB]VP46!TU[C$P5DLP #(D-8'0^*R.3KMK]OW6+U^C\9='U6&W
MO-B_U'ZK-Z5B]?HK7V^_^,. F0;7>(F,LP7J1N=[)VHTF421#43S.G,XQGS-
M/KQ\*98Q#&$R#-&#2V#!2 *;%IL0&DZ](MO%6_?XG=MYQ2:DB"DJSQASY%9=
M'U^&A&(9-R?7TCZIC,I.D7GTO>2U)!,93MO^[].<7K]%  0!0E EZM9>HA$F
MQ(%A$PD&1$K&'SVZ?NM;X<;S[[3SBVN+S'>E)%#! P:PI:Y]32;9;(Q,$IPN
M/"OO;K'LS[4:*%F[4B\8MJTI$ +4<1*"$"JBTK8FHBR1%HVX[5YW=67)?;_:
MU=ONL#H?%8N_S1ML'37'WVI@I0C)!AE+8DDG2A5"O::N($#(8;Q2@*P"56
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M&P62%@TCUQ.PC"$N.?P@50!E6 !55L 9:8HB(0B(]$L]JG@3UP$&,"S:K#!
MT!'2&PB)7(F221FE1?-OD@556B)5![5/6(RB%N4/:L3I]9<;4TII>-&-_6K
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M52%]K;2VZH9!64$:0&31O<TK'+,+C!<3I;7<2H"D+ 52"1,E]]+VAJ.)9OQ
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M/ZI"1$[/%Y,.7,TLZ7U=_JID'OXE&&2@K$ P&-N6CP* 2(2"O"D'U-'BH12
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M;\!]$<9I V%9\U\:FR9FLB9($S$QSG1EWO3/1R3J;VT\=J95 QW&G<!'2:!
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MFD/!EGH"\X(3L!P*G0@4B$FV@6#'(14^ &;B$,2#U21N.S9KL%IQQ.OG3-9
MV;WR1;5\P8I!# 0)EF\:ZS;YFK)OF!MK/>,>^28CK"+Q:2,YWMM5HSOB.=G3
M6-<449LCZ@@(FB4@T0"V38+2$E$&)""@TT:-Y[#(B%DT2RAP"F-PFSQ )" (
M5:DM,C'=GM2%Y)9SYS>.U;-;2\FSLX2#%.'HUGZ??F?73,Z>?7O^;6I!*8L.
M>?-L>],A&8<8W(/'M2F$1[@2!N7"0C!))]- R=A-F!4($3$(O-"8U8ALC":Z
M4OK DKA2Q-ICRN:LI*>;)@D,P@ \$)7)4G0L2N2I=**JR)%LAH (+9US1X%U
M ESC45I:LCFN2\6#L;A-+?A=VP1$2HB$K4FB,&,9-Z'*8P@A&<8(E(@6(B-2
M9E?XS&2;]+;S088WG]]=[_16'<^2O]$[QN(]73UU]^=1S?;>^=*S[??L7UBE
MFPWC5Z?1MM3\W\WC#S-8<!\Q]'U6;M\E9='U^/)[*5Q!N"=BVG/K%Z6+W#:/
M/2DPBFY8G<F2\=[ZVJ6] @<H2+6N?V "PD8F^'M\9WQ+].1:!8(1R8*5@C#(
M;8)0(@1DB,E-(2[HOB0.38Q8NM3E@#K6*D$N""+$'%R93+&]R:IH,:?M ! [
M!I9]J26ZS)'35'EN*D,YP\6LV<-LSGM3+:[8MS&7XM669U2)Q+G2<<\Q22.8
ML3?)>(_5TVM6/OUP^E9NWP5D=^FFE9O-*R;7/LV^.?:L'H_%8/1^*T=_JM'?
MZHQW^30D-T>U7)$Q!P<%FM#2U^#ZQ3-P)H(7<6GW>O=12(O<&;#;&J/;0IYL
MR3,LZVXG,WOUN5*(;A(M=S.EM+Q:^C032A=,Z0OT9? (0KI+=W]7/[GC0[7\
MS6:+:1U'&U].^I4728T8QTO]^NM)"#6SKG<XLF*1(FEF^+]6.&W-0O#IAO?+
M%H-<<19$RZ#.$Y[QOHXY420;9^K1U#K3=+#I&>^UY]J;34HE,LQA9=O;)2DA
M0P*!6/?CFG>-C]/&U*;Z_6G?VK!Z/Q6?IX_OKIH[_F"+A%Z)-$2B1.F-9^/(
MJ2.$"!64Z8IKD@*LT&B3E @!8L  8IN)U+GTY/9J\&4$;;#DKPQ)-* R7 8(
M;:%K(0J]0"Z=-NO9>H11V(U^BPVT:78NBR^< ]_,WE(2":@)T9GUJ[+&$!0)
M32S:UF9  W"(W05+Q%*\%LB4(57] Z;NY965930SU45AL92C2D )<J)UF%0U
M.2F\-!!Z/Q3@ZVO$3YCFI06WC.!DT]7/2L6-,/?PTH(HS//GM1OI$SAT8MS)
M%MVG/E]VH1T,>1MT^JS=ODHRC<?P\%LI9 P"Q+HGV['2BAUB\])GS%ZS5#H=
M?&DI!P@'-V/E4LU,4!2,."'%L_"9J9@2F'2F0FFPJ(T\+<,*2+CD&ZJ,QRGE
M>W#T @D)MPSV$X)-T0 ( H\12^7!F7(& !)FF.$0FD1=H!$*I* ))R:A)7@%
M6!4!J)E&6-](]M+4",:3KZ;CSG-JLDX'>0-]6*2 G++SI:G<Y>F=:R.O3X\G
M>M'?ZH^7^Y);SZY:.=<\MK8;S_>F#T=)69VYU:P>C\5H[_5:>_U1ZW?EWKWC
MX:D@2S,>'>_2*(DR^T>S>@"R",FA+IN&WW4=%A('!*20 *K?0BDGS>2" ,T0
M$SH*C.39N7LCKC;U#BI!G6"=M?/U4!&1=ND\TXE9;G#?XC2VEH:<3/#;@=8W
M]N9H'QQZ?>L5""]BVD3>_&QPM$0D$9CI+/,W.E^:$^5W;)1N#RNEF2IS<5_L
M\YSWXJ$SKCM'[I24\7Z\F].1%C):1-^-&K%;Y<==J;,?>>?+T;L1/76/CDYO
MBD;NDZ:3IV\TK!-8?BUJSGI]^:=&M)O)@XWQ3939>/PD4S:H9@J28F0''1I"
MY:G5),L4@HG(H(PA(+!>\:I+YSWI8S_.M9W/GV?BG30XP)B+*5+842#!3>DE
MRA$!/13!:03' .B>PNS(A@1HRM!9,A<$$Q58LV<B9+*P87TA)*@H6P(NZ,^"
M5C0'J@'Y0B+_ #"A(4\E@N!1%*EHP%4 >^9CDH5Q%H%%)8IN"M.# 45R,T"Q
M\2D-J2)( O):A75*:DV(000Y3F"K)D@N7$2B4EU$# *059$ZW+=B%\A,ML92
MSKL21JA0;$8,7+E-W,Y=";/ZOLXKXG/37><N].V8^](]_P!:U<.+I\_':D+P
MO#GCC\>"V4B:Y >P1Z3Z8WK!Z/Q0,-)99VL?<Q:(;8I@C!9ZL9TT>B14YZXU
MO;OM^]*,JMFAV 5R B)G8C_C2470<&REDBK0HVNSG5GK%&#*;Y?WYBB%(-Q)
MJY/1S%Z0G.V\N"2B> *0T81;+$;8<5%!OKCE*#6$ 0JJ4%>SWLS'LYSK3@@G
M35O-M_).-'?ZK(.L_/O?:@#9FM'?ZIBQJ?%GV:S;\6G+;68VXTK5:#:]K='R
M_%)"WKMYXE:79CU_E,L,Z+T\_M2*IB7V:P>C\4VRLP=MCI:\ZOX2X"6$0FI4
MD*RH$H?XQ95!F2=@"$25:>37GKN0<EJ2$4R(K$"B !241$0 EW180-N@$[-!
MMT@-2@!E0#$J;R4W+P&4^,VHJ40VLVAXT8C'\$RTQ0!8$@P&$X I%76=AM85
M"WSB)!10CR!@0+,:W(0&842 W4>%&-+BRB3))89$&\$$HMEFY:8)9K'H_59,
MX5+_ .\5&&.8OM;M>XSBDRQ&76V3B=X?:C8>8HLMN?6/27WDO%-O-[QL:][6
MSL<TX>CY:_I6I<SQF_\ N*8=88XFTUDZOX6F+H<5 @"(B)(TD!UR(1))3SJU
MA)67G+32;),+PD193H6^+&T;,43+L6O,OO6=R)-I\W]-:3$(H:C$,AH764LE
MR&(%!H,C*D(,C#-!W,6P:##:EH6&:<!A().@K2.1 -68^R+/'14$38E0BF86
MI!R0PH20@V9"),#4"<,1@9!,@* @*5C;/CV L4*"BLK/ DZ B01!D%#&1&"H
MC(5AX7E.=_"9&%!U.0(B"D48Z*A%EPPW9;QBKR9QO:=N?\(UJUB/:UOB@&@"
M8F),!!L;(BD@D@D9ZE\.;,)Q2=.ZR:=?>>VR#:+9SKVO_== 0C6_I.NQ.OKF
MA9Z+\YYW_'@ME":;P24U"6+2O+!I47K:'R]IXIK$Y<WG:.]_36*U"5,B:/CK
M/2IWH-X.,XH80B((A)4<IQDJD4MI(0BP41I%L7"4MJ2 +Q!&DM!!.G&MNGA5
MYTC0\VTBLL7(AZZ_JI1)V?<"CA722EQ1!ZTK)U"L8C800FA*>YQ>[*)R"A83
MZ$-6AR2-18@I#,A-CHW;:$UH[_53A===[MS]],;.3FW.%\V[U:G5^JR=O@JY
M>Y;2[_?]FEL_VV/0*$E[$D^>1G2K+6<G-G/^3KK0A+C)Z<=97VHQW^32A-D^
MU.6<N7OJ3K:Y!'8SDWB'@A:Q2;@D*!\2Y/J!@(, E!#(IC"@VP19BVQ0VD%O
M<U-XWXJ?"/O869R*O82PR9/&^$Z4T''A- [<5)A2E2_!$C:([<PC'5\WET'1
M3$/L 5B)60QL1#741L$"2)6$.:14'<!"H9C!F! )589J&@O.)Q*-DC$P90Q,
MKO.!D)@M-]]RU2C(571(J(R#%R)+WK1T"04+AA&;-PS35>8G3IK[YJ4D-D9L
MOQK>V)C+:LG>VF3XT^JQ[UYMEM[Q-^(I%F>MHW[X7<?6F6Q:]W6//2B!9O.&
MZ1MM;''6@VE,]/[Z^M9/5^?Q[!VOGM1),LL3$0^FM# MW$8EF,>OZV C5>K-
M3O8M$MYOYY;,VW+VG_*-)F8[?Z]6E8WE87)BID%A<"R-!:7H2F%$FC"7FXPL
M)HYY=TN<_=*;,"-S>?YYBM/?Z\\*F]#!,%A$#=,,!H 8-/0<+-*H$TNREGAO
M,%02MURP$@C+.)**Z!EKHI6^FQ>$C&2AE8H,JRLJJS,JJNJLJ]?4IG)[S$=-
MZU/7Z^Z"+$Q$9\;[CVHH1$)%VP6>6;-\!TK!]LY[>3Z4X9Q&F?/.H,RL,$[7
M3IX1LP(9AD[6^?QY/95EF+4#&"+;%.0A/^[QMK[2U%9W+]8/I,-%%/7TY_7#
M297:LPUA<P59D7E,7E;,%L6G'3I>*N*PXO><ND6@OS>^]09CGH[]=XVJ4NP$
M7UO/FE7[=?J/N@Q.DQ$QM\;\Q0.P,Y#OG,6X EJC1L/,IRD<()-P*SUX*:TM
MC0XD M.;S];WX-:1B>?/+];H)F-XO.C:[OWOM32(WSS$=,5=EO?O.>GFU*6\
M2*8Y\_:S63U^?W2QSMOKCM-<#$/76W6HH2QM[:?R^6M+SY;$;VVH^WY:\QLT
M!#$X-?W?RD4&Q(># %"8D):(*O&8F)X:UX $@"A34$WE+*.54MTJKK0!+]#$
MQF=]/2\Q6ZQ%RPX8SZ4SR4D87",O*X2%BA+8Y \8#N=/O$:D"T\9/)N4Z MW
M3%EB%1J"5!@U"P?5!%"P !,IR0B304P"QC388Q#5I$DF<8MN;9TUEBAA;KEA
M,=W3VJ$!%G/JRVWTBW7%$2!9M $)T)(/N8H)688//7Y[F!+<>W<#$6[Q?--X
M698MI=T,?-)*9#<XUWWVF^(J,<FVEX],]$-ZU1M?GUM[)!Z.'7//G:L7&";W
MB;1Z_6:MVG!TUC2>=L4LJ\_A0FP?>LIG#B,,9?B*)ZG.9GTBH'.]K\?)>-8O
M1L21&9WQ?R]JDC+\IZ[\XFKV6V5,Z>>9MJ $(MN>U_6D,TC$N()UT!'<DQ3L
M^=?U3$R>=O P.)T=_JLNIJ!(N37T H!3"(A'5E3> (2D4@PA$P@F!B!#)*VL
M1 &,T3+RR23=@!+,SX!:%FVK+'LQS22;8]F:ADEQVOK)AWXH<DQ*[H 1=5Y0
M+%.$TA9" L$(A3H=8L3^,'H^=ZS=ODK]C>T#C7+^/!;*?-TI$9D3$<LQ?W.M
M.;+:,Z6MVZ[P5&9<PD \XMB,9,XB:A6(F,5HL:)! H$ R"&NY$8SM]A6O&<L
MS^JS-YQ:UO[S0$,3EU<ZY_D\U@B\%IQWW[]\7J^NCI+)SK-<Z1-\GZMS1[WA
M:@(A!@L0"K$@R@C8DBZ,*F38I@*+!YMRWUU(NPU9O>+FV^9PB8ZWK)VEG37/
M4[4;3K/:"?>_ZUJ-MW7I_:,1,8?E^HNUDKYIQM:V.M8/1^*P>C\5H[_5:._U
M1CO\FO,;-"<;8K'S>$3%B72@<L?6]7DDI;E0  PO((S:UKBV]8B6U3&MWV))
M_>U1>;R.MR-C&_9URU "WO=W/2]IO5@89M(.D3][XC.QH-V@Q%#A1* T/BZ?
MY 8,UA]DCV#B) (+E(E;-"K3)DPHV+F+YN$S?.M;&5[#!#F4(V[P\5-\SQ%^
MO?>QIFF!,<.B1GK&8UZE/ 26*895L)B&64452(!,-&$D)>:A(WM=BYLO)+AV
M=_2\5AYW]I[36.L?[MSG6(YIA6_OWGWV(H-]OW'WTM8M6?\ LZIVQBL'H_%=
M>8(X)_961IGIIU;?DU&7)@/+E @4;-"="G#2 +R-N$VBIO&%)TZ?Z?Y4$SK]
MQ'QF/JK%'&G9RRI@%R@C<U* XN:X,*,"COFEN@,998F$P!0%%DSA'X4VO+"F
M@" G-2BW>2#;'O>C:((&&FK/P>E0(>J^A];40ME%;]9Y/KK3AL/7K>>-9[TF
M49))3*6JY)E4;PM[1$-V;/\ >M7M>PE\K>(Q[YK_ &^WF&*UL[3+@XVIS,@8
M9UO.\;]+]EO I-YB1M@\TYH (3NA;:N1NW$8;Y9*,YEA<IHZ<PZD-.'HUF[?
M)7TC7ZOKI?C"UY/94+)T .@OEZS0^;<>&M)'7;;_ 'S(AD]7YJPE@(;2)$7)
MADR,VDB\58O(O)8ASB@RV7FFRV2$")(*! "-LU;,&FG-O>*Q:+'G6I!T(DB&
M@-),P+$4,-XX@P0,3+?2UF%J2OOQ6"5$-I G4F)O2'K<:9"&$KE;2D1,F&#M
M #@9R,X)!I"Y@00ZXU]NG^2  W5]JR>K\T25CTK/O\BLW;X*R>K\U@]'XK!Z
M/Q6CO]5H[_5&._R:\QLT5E9)$@$BK*&%6101)0A9T(""C.BZP(0DR,6ANK,Q
MGG$/DU=2+$>N-/XYBC-V9+<]IXT_@=5EUP 4+%)=FH,MQV2(UX]M7%/C.+1)
M@#E!"6R$K- @Z!%@+1G-Y5HG(OV0*IH)D=RA#RYQ6;E73A-"V;#Q9CF;*%P8
MA%+P6IM&+R+8;WMC72B7$HEI]#UNJER*UA9S?,K>$EC$!&<4GDU!L$!&L22
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M$Z_363U?FLGJ]KM&!.F'DMCMQK49+QDF!BUF',-PI#9*$%P*9P=21!46!20
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MY[:]J$+$P:^E:$DSB2<[3,\9H)DH>']2$+RQ UZT 5 <%D2!"1F.S-# %+P
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MW^F:-4^3(FOY.JT[P,9$D[_USSL#W*<KKO&LK DV!S2%ZRG @HC!)T%N5?\
M-8"VI8:4A69!&(-RE8Z$[',;8I-8R53 Q'7AN:19:CG'HUI62ODRS//_ & $
ME!]M[\3S?7(H,,+%%2._]K'0FHN,#1(M^/OSD)- 5 0-K:$18L*W@*:6F "P
M %IQA=_M46983@MC4.;^4(-1!11H!4AA>.2B5J8H1#)1D21PK_-%B<K G7-X
MY_G3 X0CJU'FG%AUC8Z[90C/9. HG:,"@T L3#UB('$FTSPL(>+F_A5%LBJ]
M6QSU>-UG.7^-'^[PG^92T8%42W<[Z<*N#(:M3O?XQA"A-AJ=HOC4X7@45ON3
M2-W/AR+?!M\X4DP0)(=XW'N %*+$EY;(&M_BLV0D((S02GS(XI\@+266PK0!
M40<A(<NE@(H[I]-XKS):CQ/(/,,ULJ2#$)+0EM)(>F+N)W-8?N/M_J\-B'<F
MI:CXN0\9N?S5?WTQAE("!4<\3&#Z3\.&A$%H#I'',7&O).2Y$ ,.23,_ 157
M[PD-+^U<>L& ! ;J8EE=SR\_;C*!'FG4T\\WNMX:$L,U\_\ ,<$FF+UPPG7C
MC[80 5<LL#VW/.]IZ9I(&>8[8YCN([^,90 46%$*1WIXF[U,QY20D@X*G\U_
MV2B>!CMG1[?C$T17^T?B\>H:@2+5#QH)V\T82*)IFUF=C/;Q$)W,C/"9N?/6
M'I\&&LOAZK^*XHLALK1J'M(8F8<652-EXZ*"!X K%2+ !CAJES?H$ 8@0L]Q
M$#&UOA<NC&E()U7-ZWFTKEEJ;[9U?/'/.&LMB+P0$-<S)O4]96#R]RT]U?=_
M7*TBHB>B.YXC\Y*ENQ/ <//GK6\-50"-"CF1)MOWS@")&@S,P;/W*_3."[KN
M)1/%?7]%^"9:MG<[W;#Q&Y,?@@*):8D'4ZCC=O9 E#4\_6[XGGUE?&93=3]S
MOQ. F2N9\_#D$]\X0-&;^(CACWSOPA ;4\QN5[;G([,H5U(36UGG<<;,*'?%
M<0&]D,4]R14YKZ?W]7Z5 ^8A\BU]_P"G*^"ML=W4"^S7%4>B4L[' 4%"+A#B
M>UOVW>[>><<)L^Y$7P.+:S('\/#>65"1P$V_<B\?Z"2'#-"UYA/U4AO1)=+6
MB8+^E;S0_P!^/[^,$)G J0(7T47\9,V_3<3&C7OK!P2" 73)]7H.-:RJCJ9[
M4V^<*V!0!@\3<\QU9UB,#V4 LB(\HW(D.K&STLIF0L&,LE,KMD<W$%W>G4T@
M&%'$K,@32;2CJQ42EQUI9F-1>$61"9A!S*092!C9D2%& F*CXQP*V2!+&3_2
M+*G"&P+(H%*1DX"X[0$253+?/Y!Y!==%RHA"!S:R/S(+ Z-[A@9=0'> 3$2(
M")-I,1N8>3;&*T*4@AB$N2(#Z]U$2U B#9+>N#W[YG'KL2R@JTHA!I09P<#3
M/9BR2-2I)9ER JP#3ZR4RPU*/#KG4A@JKAUSXJ9YJ2 R0 & 1!2,A/>Y"/HX
M$&)"0C3&YU[^D:8%!1Q-^$C\D[,$R*>+M<W?,I]=UAU)])/UW]>-/H_>3TD0
MEY*=>\D"&R(AH"+9\)Q/<2$0#33KB?F?QGP _!*]_C)X%2!)LHN&T[YZ/+I#
M!,K<K%1&@F.=2WE7W3OE[_.\V/[@\O[]]OU"([F33UPOO J+34E2?=6>.XCJ
M,"+N_7'Y7BI]0D=Q4[DCB>OZ<NCZ7OB(KO;'T)SA^GGT?GX=XJNZ#/<NO;O&
M@X$+"[ YN:63JF&E*4)<&[\=FZ_R8CP@"-L1U7XUB7KCY<OEF=='>(T+%+BF
M)&=C522:CN-1!62>@A>?-1U,9$IBZDDUJ&M\B2X*2FC4_4/+J35H9--M/IHA
M#BN//@S;[_WG]>V>^=^&O;!(*)O@O7SS>^L<9 A& %@YY^8\<4QE2W$:D[CK
MWYX)"* %E(2''N1+8?:1+BR>KD.?$\W%91)_?=_NM9OZ'YR%#!"4S%=,S,W_
M $0('ZZOJ>).S\X.R@UTR[KYB8CLSQG-]/\ Z^=\9IOOGN../,<\\9_1_P _
MU[X=;<G6UOSXX*Y9R8 !=JW M>IFB1^L8P14S%3XYNBZ\7%YWYY>^;Y_PZ14
MC,<.X']?&&:B>7N74]D0&^MXIHAD!%+)8C4Q"W6%HC1)=D7X(CDBN,$( &LQ
M6T;%*9$DF\E9QI1,PG>B==O>\;8PG"S?W+\15YT.%/'_ %>N87/P?K+R'0DD
MTSU73@6()!)%CW5S?IF.<L@,K3VP3S+V7K&O8A"S()(PS30]5Z44F$E4?$6E
MWWA@ 9(%XT1";^_Q6;GIB8;CE%/GGQR0:.&#0#':\$(R8SX0!I[7,," J\DD
M93N#" 9EGBAKULRD1$UHI$!%X6B)C.BBJ#%STT.L=%J./SA!5$P)U--,$57N
M-[&]N#>WY]E8S74AU0/W[Y_R]A9A'>KCXF<2@^8)$LR-:ZU7P))J!FR:M\1K
MKS6.DQ +%2T=U/5]8*@1UUTUL]_%1DXG*'<)9#PDF]&)9@#21ILJ/^X+/7Y/
M_9S3Z/WG3X7&J>>)QB(4$->CR?'TJ<1H]CB9Z(N+A0XL'EL?>/Q*L V1 M#+
M-=K(2 8!+T&64(7 2&,1Z!?W6"$GP\Q9[WU-^>RL2#ZJ19+[W1Y-89$2W?,6
M=?'_ +B"LP7+R>S36@MO3C""'@-&JCW)O?$Y>V:)WVP]Q\5S>:H>(UYF>)KC
MN^9Q2 5"4T1%L1+K7#>LT"V(MET3!P5](Q/INZ9F_P"?X-&0[+$!HZVD%Q)5
MQT=Q>*PT([)3>Y5[*XR(C0)9E5/]U]=)]O,/^W<>-. G((>>=S^'%P")"98%
M!$)KW?6-46ULNU@E?KK6;??^\X^WQ/W32O&L9@IJ1W>GQ$XU955%NTK29@_E
MT+1'$OQ)X_HB>!L4@&(C2ZYCCK<-Y+11J7-;?/5$><1*H+5:_O''C*JO)7F\
M9'EN.Y%GG944R.#4=VNBKJ?B9)X&,-U0"8[)) Y>ZU=Q4(*G@\A'NM[CZ8OH
MZ]$'HD2;>>,)(<!-=L?#<W'ZPT%5M-MZB:KWJI,5#D2N8\.;FB^<D%0""X(F
MYX]/K_'&J=9T@$>LH9U[IN2.-P#TK4R81Y\\'$UCK2"J;"0BU:XNE]Y=^Y^?
MSOJ+^" 8#-,(U^*I\?.,:2@!,"#4OQX];1596$L]^_IS0>]/ 'WNY_7&;>GZ
MR7$C*QA^6(6='4S/UC^EP.N$NB9,"(T)<1C@(9%D4J80?$T/HP%G:S9+,4 9
M4#89*&A^4, 6D2DK"DF@&YK07,)H_&()_N6ZXUNI7O ,;602\+AB"4F(;HU/
MJ:B8E";)<_\ %2 93R"=S;W-;W"=4,D)27#9&S_=!+HF,!5$&6'5"VUT(<(2
MP,D$"6M!%]^!XOQER()7[%A+(A4JGBIX['2""1/O]?X_K=LE&-DS,:+_ #UH
MGO <T#7)J*U7V]F7!&H'G5:OZ_C>0CRFM_0_3S&*0M)?1'SS_3C4 V8 >U*\
MA_$8 $IPB8-G9_/&)$-(:7GQ@08H C2H:>"?.5*R0GSAF,B<"?V#U0%-!<(!
M*9U-_DLX2*XD)=.),["36#=0IAK-@$^ERA1LMC".D^Y?U&_S#B"/,C$14=\=
M>9N#$#/=ZB(TRQ"OOXG&H3#1XAEJSOWJ,?* "66))Y;^"9FC M@@5DQV:[!Y
M\25 6A-Q6Y!EW-Q;M,GH0'X5/[F\G".RV^_X\?3+Q%T*C&H)C_FN"<HC8;0C
MW0\RE^%/\F(X&(E,?H_-6UB-L*[*/^?)@"<#)S7W-T39,QFL^^:F-/GZD:XG
MJQ?]S?POVG$/DS @IA9BN@9F+G>2$&2U"/@_O6(<)?"3ZQ'Q@A)$9T\6<3RV
M]/<SF_N_ES0]=>"./?6]\.S[?D\?[]\ IY@(]/26)W#]M9]X_CV_E]X>5\[O
M8G?7^^L\T61YA5/[_66!$!7PG.)JR&_&B(X]\;\X)%34[C23XUE@$!+B&N]&
MO5U@B)1X@%Z_U[\77%]:?]'CYNYR$PB(YF+2=7],T&^"9%2X>=/$WX@QZ!9:
MF"V&Y3\9S]_X0H9Z[/4#R=X0=14,7SU]8KQR+#ACX1'SI_HS?O5_.OB*[O-"
MO[A\?2ZQ2@F 8'<$V["=_&\"-(,1)4DUUWA4(E(T)XFSW$?\R4R$K20ZZ<^6
MVO7V=^,LV\J4") PF4B"S<I!YC9P,=B2F6_N_P %F%KAF'!19STV9R(ODAQ'
MD &%TV6V]4834>/J@>)8WU-;R-P06-R B5LV8$P-MD(1 FH)-+W?ZYOM0<7$
M$"FGL1'7F$X!N8%$2:%2I3!JW1?C(.?"TF8 ^NNXK!:5%>HY.)6MPYP/\F(
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MK2XBV"B% @F$?$W-RB@B(R9:D!P4C"GG.2(..B#$8DTVVC(YD0;,4"/! $D
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MQ!&&#..8UYX'&GH-1:NNCW>O>/($,*;XB9H9V/B,"M'(&I@!LF8%E=$8F.@
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M"QR<,0E0=UB[$"XA-TU5DU)$9(E )T&56F"+<A<9^Z954*?2!3* >H^.1TH
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MYB&J"!3!B?!A*'$A8HD+"WKYS/13(@!%]&_%-O4R$#@QY"X602ZNO,*Z1 0
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M'H_"C%"]+@C <4(R<,EE0_YD *OHJ=M5HD@[WC\V5WA@KL;K4#.$@'<$\<-
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M5$K<W$P=HN* J1<&F  40N(__42)(H-/^$G+L*AQ4N6M"\DCDWV\BW5,.O\
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91> &7+Z??F8D_P#_ $[D?@X)'A*7W^;_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>businessfigure8a1a.jpg
<TEXT>
begin 644 businessfigure8a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M6CJOZ'Q"MM"I,WV4!AL4LO=;:4KB4<G(9M+%*76XC'(+ZM,FDCMJ5N*T%2@
M    !RTKF_)=3 9'>8IEY_TKSF!V67]67WWSU;L&LLD*U^%,MNO$52F.6VYQ
M?>            ,*R,OM1Q7FY6M'6WO^+ZG:S/T-AY>22V8_'=.7V\=6X\C'
MTOC9&)QR8-#+M.>"5OMEKK:FP)8L9LOPZ.2%LOR62S&K+YF^SM+G8'8W.PP
M   !RT3?+]-%S=SU"5UI%'J6.+5,,/9/)R1]%K1MJ67JYC8N=WR2E:X#9'\G
MJ[L]I/77            8+D9G8KC_/BM:.K7H7$UK9=5IPTKK^&;.IH>0 N*
MTX*5N:TMZ5N:TCK:R-U.&C@5H?-%S5;*W];;NM     !RT9KR?4P.1W<=F['
M@HO*N Y#Y.4C:4O:UXJ.$O:K.CGJOCGK4           #"<C*[2\5YR5$--%
MPW4                 F8);6Z6/OD                   %2?AQP
M               !\$C==0 %37N1EXU/E            <U+=J:_4T5
M                 %",NNSBZX5*TIQ5KQUK@F5G>&7J7MN@]OT
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MSVVYE!BC3&PVFX,'6]7-UT?@CZU[QR5N           RC'Q/TC>&_,_%6X
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M>.\G/*?G2^DFM[;+>R.A.9.9&0X]O;'+395[?-CN-@3N1FV$<'U6L?%CU5
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MV*J  !HK.T_FIUOFO.M           EX\CU0X?USXJ  %"-OBS?)P!^>3?\
M$RFWYG#CLMH.T]HM1U$;-B>,7US^:,G+!12I)XFRK1'9.!?X^=2MOQ6WYNMG
M-?N?NE^.;/0?=M_S6WDMO^+K,DU?0XGN.7^;J  9EH^L]1_DK]*:5H!0B2%/
M@  AB:4RY7E               *$;?%F^3@#Q8]:^9M3]OY'>';/R[Z']0//
M_;HV;$\8OKG\T9.7'DL781N5K]@\UW63ZGI,?V6BD\78VDV+2M+:2"1QMA;2
MXU_CYO%?'?XV=8Y&'%9>KUUT_ U5  &9:/K/4?Y*_2FE: 4+:V[8UUH  T_S
M7:^9?S[]?0F!N0          !,9FM]7OJSX"^+;P !0C;XLWR< :*V?.^;6^
MXW((LCTPY[M]E8FUC9L3QB^N?S1DY<>1Q=A'96OV9RGHN7Z7JL2W/+Y;I^IB
M\K61F7K]5]?YF      !F6CZSU'^2OTII6@%"PMNV9=:,6UNYZV\#ZYGVZYC
M?G;>8U.M?"^J>9GSS]B_:^E%:J4*J@%"H      )G,UGKE];?GG\6W@ "A%7
M1Y#-AT5'&==,K7=C\78CBOBZC>E>#2MU@ I6E:5 HI54      "5P]GV*\S]
M]5 4+"V[9EUMM'+Y9_./VANOKO/-@;OE_BEW:WTKQ/K]R'H?EK\W_:N?;GFN
MP?H/D&G..]'V)T/'85I>GR+8Z:'P]EC^!MLWW7,<5LD+A;*WCF@<';9-LM',
M9FNB\7/K6DA/AQ6+G\5LD?CY>1['3\=MV(ZCHO4?ZB^$OBV\  "+,>.,  %T
M9.7              !0L+;MF76PN)L.BOC7TENCK?/M2\QW-S)!WM]F^;.OW
M(^A^6OS=]JSN3A97M=!RWQ\5DD'A;7)=EH^.R^UCG^JTN9(<=UVXG,[5W,L$
M)@[3GOBNYL>P@RKR;'MHI^:^*4RL"8S-?CNNW$-A[+U?^K?@'XMO   %   "
MH              !0L+;MF76CK%YW[%J?F>WLH\CO#[!\Y9#G:OK]R/H?EK\
MW?:LM-CV4.5<R0;5ZG@?JMMW+CVT<]:TO9L:%PMEJ?E?0@     )G,UGKE];
M?GG\6W@                     "A86W;,NM   Z_<CZ'Y:_-WVKSTD %*
M!]5M^:75J      F<S6>N7UM^>?Q;>                      *$51D%7R
M  #&L/8ZPYOM;FE0          .:^+;W7>>45
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M1SNY)WATZCQY!XZ91X5(/MHA?'%N*K6MU?3'?V"OU]!B:JFZZ-J*UVTH&VE
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M\0=]L3F@T\  V IM*P&PI(W\Y0JY03\'F^ZC%(_!T7\E?^,YBB_@^=^<QO\
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M/]"E\W_[=S">]3\P_9]Q5PQ+*@$[AD(/-^/??\H^3ABR46!2I2K J*3;)?>
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MF(D=J.RXMQQ;32<J%N._?%*3P)<_&OQPYHI0]EJD:'3XE,<JT5^))EPHS2)
M0^"%%-Q8;SFR"R">(Q3-&*)2H1A,4Z&I+L5J)-=5%9"Z@AI 1>4 G*K/;,I(
MLG-OM??ABG:(.-2-'HT6B.-H7KI5);2PLH<&[6O,W*PXG<-8>4G<+@;L=HZ+
MJF6!3(*66([\5AI+*$MMQI(M)90E-AD> ]^XY^*C@4NF YA!B?T,4ZY;2H;
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MLV@'G"H?JB7ZL=V;0#SA4/U1+]6.[-H!YPJ'ZHE^K'=FT \X5#]42_5CNS:
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MSJ6$I0%D)RD@\^6V&:/5GU*2S3YCF5$ISDMKU:T0[[465;FWM7E-TM%97:Z
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M_P"9:1^]HPKOE?.?V_=/T'Z"<?H/U3ZL?H5]57JQO\"OJJ]6-_@5]57JQO\
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MIRJM)$N9J-<&&(W\VCLQ6]7&;#3?O3"4(SY0,Z[9EG>H^Y3],:G$1 B".\]
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M()5\MO=[$%3G1-+X<)B2XB'/2\F7&O=E[(TI2%*0=P6A0Y+@Y0&Z]B1A)O\
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M&:A8GQ*:J3#C,.HI#4AQG6SHK%X69H(F2)4=QY:6-9)RK18$$9<4NH:8NUR
MQ4(I;IJXJ5/J5&U86-2X=>ZM$8HCSM<&DJB[6E*4J4 P>^^[5K\"UG_=-2_<
MWL([Q'Y*?V#_ %@GB?R%?]/N'8K_ *[TC_U'^ O". ^;[BI*56S)2H)4E:0H
M!0"TFZ5@&]E).]*AO2=X(/W>M?@6L_[IJ7[F]A'>(_)3^P?ZPX?L^X4JJSZ)
M.:J-->V>8QFU3N5*\N9)2>2JX.XX'99T]'_WK_\ R1^KCNM:>^>AZ)'ZN.ZU
MI[YZ'HD?JX[K6GOGH>B1^KCNM:>^>AZ)'ZN.ZUI[YZ'HD?JX[K6GOGH>B1^K
MCNM:>^>AZ)'ZN.ZUI[YZ'HD?JX[K6GOGH>B1^KCNM:>^>AZ)'ZN.ZUI[YZ'H
MD?JX[K6GOGH>B1^KCNM:>^>AZ)'ZN.ZUI[YZ'HD?JX[K6GOGH>B1^KCNM:>^
M>AZ)'ZN.ZUI[YZ'HD?JX[K6GOGH>B1^KCNM:>^>AZ)'ZN.ZUI[YZ'HD?JX[K
M6GOGH>B1^KCNM:>^>AZ)'ZN.ZUI[YZ'HD?JX>[*FG4AEZ.[60IJ0RZPZG96!
MF:>06W$W";C,A1%Q@"P ' "P_1_^F/_$ %\1  $# 00#" L(#0H%! (#  $"
M P01  42(1,4,08B,D%15)/2%18C4U5A<9*4T=,'$!<P0E*!D2 S-#5B=)6A
MI+&RL^$8)#905G)U@L'40$-SM/ E8Z+"16!FH_'_V@ ( 0(! 3\!L(\A0"DQ
MY"DG,*2PZI)'*%)00?H-M6E<UE>C/^SMJTKFLKT9_P!G;5I7-97HS_L[:M*Y
MK*]&?]G;5I7-97HS_L[:M*YK*]&?]G;5I7-97HS_ +.VK2N:RO1G_9VU:5S6
M5Z,_[.VK2N:RO1G_ &=M6E<UE>C/^SMJTKFLKT9_V=M6E<UE>C/^SMJTKFLK
MT9_V=M6E<UE>C/\ L[:M*YK*]&?]G;5I7-97HS_L[:M*YK*]&?\ 9VU:5S65
MZ,_[.VK2N:RO1G_9VU:5S65Z,_[.VK2N:RO1G_9VU:5S65Z,_P"SMJTKFLKT
M9_V=M6E<UE>C/^SMJTKFLKT9_P!G;5I7-97HS_L[:M*YK*]&?]G;5I7-97HS
M_L[:M*YK*]&?]G;5I7-97HS_ +.VK2N:RO1G_9VU:5S65Z,_[.VK2N:RO1G_
M &=M6E<UE>C/^SL4J22E25)4-J5 I4/*DT(^D62VXY]K;<<IMP(4NGEP@TMJ
M\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=ZMM7D<WD= [U;:O(YO(Z!WJVU>1S>1T
M#O5MJ\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=ZMM7D<WD= [U;:O(YO(Z!WJVU>
M1S>1T#O5MJ\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=ZMM7D<WD= [U;:O(YO(Z!
MWJVU>1S>1T#O5MJ\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=ZMM7D<WD= [U;:O(
MYO(Z!WJVU>1S>1T#O5MJ\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=ZMM7D<WD= [
MU;:O(YO(Z!WJVU>1S>1T#O5MJ\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=ZMM7D<
MWD= [U;:O(YO(Z!WJVU>1S>1T#O5MJ\CF\CH'>K;5Y'-Y'0.]6VKR.;R.@=Z
MMM7D<WD= [U;:O(YO(Z!WJ^^;,//(A7:E#KJ4]CHN]2XM(V*X@0+:XZ5EO6G
M<:1B*=,YB"3L-,6RR)CK@Q(E.J%2*I?614;1PN*RICJ"D*E.I*SA0"^Y51VT
M&^S-+:Q(YP_TSG6MK$CG#_3.=:VL2.</],YUK.3U,TTLQQNNS&^L5IMIOK(F
M.N)Q-RG5I^<E]9'UA5DSEK"BB6XH()"RE]9PD;0=]E2R+S#B@E$\J4=@$E1)
M_P#E8WF$K+:IZ@L&F$R5 UY*8["8Z5% E.E:0"4Z==0#L)&+8:9&QDO@5,AX
M ;27G.M9$]3AHB8ZH\@><ZUG)ZF::68XWBV8Y"Q6GE59N:XZ,34MU:=E4OK(
MKY0JVL2.</\ 3.=:VM/U UEZIV#3.5/_ ,K:Q(YP_P!,YUK:Q(YP_P!,YUK:
MQ(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:
MQ(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:
MQ(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK:Q(YP_P!,YUK&1(H?YP_L/_.<
MZUK_ "3?$TDU)+-2=I_F[6VUTK6B)+*%J0=.QFA12>"KC!%E2W$"JY3B!RJ>
M6!^U9,MU8JB2ZH<H>6?_ +6$IU14!)=)3P@'EU'EWV5A/)-!,57936%U_:LJ
M:I!PJEK2KYI?6#^U;6G:X=9=Q$8@-,NN'YW"V6UA_O[W2N=:PF.*.$2G">33
M+_-OL_HLJ6XC-<EU(_">6/\ [63+<7FB4XJGS7EG_P"UM8?[^]TKG6MK#_?W
MNE<ZUC)>2*JD.@#:2\Y3]JPEN*KAE.&@!-'UY!6RN^RKQ6UA_O[W2N=:VL/]
M_>Z5SK6UA_O[W2N=:VL/]_>Z5SK6UA_O[W2N=:VL/]_>Z5SK6UA_O[W2N=:V
ML/\ ?WNE<ZUM8?[^]TKG6MK#_?WNE<ZUM8?[^]TKG6MK#_?WNE<ZUM8?[^]T
MKG6MK#_?WNE<ZUM8?[^]TKG6MK#_ '][I7.M;6'^_O=*YUK:P_W][I7.M;6'
M^_O=*YUK:P_W][I7.M;6'^_O=*YUK:P_W][I7.M;6'^_O=*YUK:P_P!_>Z5S
MK6UA_O[W2N=:VL/]_>Z5SK6B/OF2P"\Z07!4%Q9!V[03LMZS^OWC9K[DN[_#
M8G[*K*=;8O%U3J@A*XR0E2L@:$U%3R5K2S"G0W$2A:FDORG\Q\I!Q$',';D1
M]%DO/8F4*<*\$]UK$H)Q*0E)P@FFWQBALW)=*HQ,E1<=D*2ZQE1(!6,&&E4@
M42=N=;(END14ETETRUI<%14H!<HE7&!DGDXL]MHLB0MYHJ<J5N.I<:*DT"03
M3"W3$@IH-IWP-IQ;3)A%TI" 7:XZ8>".7*P>2T;Q>8IH3HD-8> J004G!])%
M2,MEH^.*LMK;6TF1'(WY!Q/H22I0H?E<?'LLTA0;@Z; B.M2"'4H.D2M)WB5
M*KD%;"I.TUKG;0.2'I[:$LA*GL*EN!14BJ4\ #>^2N=:TX[/K=9,I#;A&ACQ
M A5!6N+"2<JFHXB39:G$O.LN.+=92&'EXJ$@'$#L W@4 2G^-FPO>!2L3IT)
M:P*Q ;=(3F2BB<EC@$4I:>E2Y,)*"D*)> *TXT\$;1E^O+;:0I]C5F2M* O2
MEQQFC )' 356()\=<U67)<+,<*>4EQ2'58D+2VE834)4IPI-3EP4C?&S:UN/
M0'7'5)4N,OD 4L&F',?+^4..EFI;BA!27B7%..A\5%30*H%\E*>+BL'I*82'
MR^XHO.);))31I&-0)&]HDY 8U5 Y,K%^1H%4?&4D(2HN#&M%,V],$X H'8JE
M",JV@.EUDXBXI27%()<*5'+B"T@)6!Q*^-.P^0VO[[[S/*Q_V[5KK^XY?_78
M_95:70:'%2FF36NRF>VP<;0\\ZW31)9&(IX)<XO*>6EF<;3C:UH4G352XHTH
M5J.))VY<E@E6A!5AT)=4%J":N([H<Z\E>/BL4+7(D);#9JAH5<J: II5/+__
M (;*Q,5;2O[7"60<JXDJX7+]%;$N!24J6I:7&$NK!IL"DXL-!\VN5A6F9KB'
M<@DU./'O<ODD"FR@PUK:9L9S [J-\K-(\9\5@M2-84@I6K1H[HV-ZD8J9C,8
MAMK4^.VE=#;U'*X2WA5B"U#%PA4"E/%Q6<<=:TZ0XI= T0I5*IQG?$4&0'YK
M.%2V'07"I*7&L)Q!1WQS2H@4-*U'Y[/XJ2$8CA;$7D!-3G4@?3XK)X*<\67"
M^=X_^*B?=3'_ %!_K;E\I_7[[#;BH=VE+:U#L=%S":C(*K945:^''4NGSF\7
MZQ;5W,NX+WO![GP?)R?1;5E\W5MQ?:_E<NS;X]MG("G%-KT+B2VYI*I;IB(%
M-\:9BVJKK75E5K6NBSKRUIM\=M66%%0CJ"CM4&]\?*:5LJ,M?"CJ5_>;K^L6
MU9= G5U81F!H\@>4"EC'<53$PLTV5;K3R5MJR\.'5U8?FZ/>_52EA'<%:,+%
M=M$;?+RV,9PUK'4:TK5NM:;*Y9TXK:NY4G0+J10G1YD<A\5DQ5HK@C*37;A:
MI7RT%M7=)!+"ZC8<&8\G)949Q8HJ.I0Y%-U'U$6,59I6,HX>#5O@^3++Z+:J
MO+^;*WN:>Y\$\HRR^BVJK!J(Q!K6NBSKRUIM\=M6<PX=75A^;H][]5*6U5>'
M!JRL'S=%O?JI2PCNI%$L+2.0(H/J%M"]WESS3;0O=Y<\TVT+W>7/--M"]WES
MS3;0O=Y<\TVT+W>7/--M"]WESS3;0O=Y<\TVT+W>7/--M"]WESS3;0O=Y<\T
MVT+W>7/--BR]0]Q<V'Y!M?\ ]^)HXP6:^75VK72A2XDL)25'3L<$5^2JQCNG
M:RL^5LG]8MJSE*:!5.31FGU4L8[IVLK/E0?5;5W*4T*Z<FC-/JI;5W1L96/\
MA]5M7=.UE>RG .SDV;+:N[MT*ZTIP#LY-FRPC. U#"@3QALU^NEC'<.UE9\K
M9/\ I81G!D&% >)LC_2VK. 4#"J<FC-/JI;5W<^XKSV[PY^7+.VK.4IH%4Y-
M&:?52VKN9]Q7GM[F<_+EG;0.C8TOS#ZK:![O3GF*]5M ]WISS%>JV@>[TYYB
MO5;0/=Z<\Q7JMH'N].>8KU6T#W>G/,5ZK:![O3GF*]5M ]WISS%>JV@>[TYY
MBO5;0/=Z<\Q7JMH'N].>8KU6T#W>G/,5ZK:![O3GF*]5M ]WISS%>JV@>[TY
MYBO5;0/=Z<\Q7JMH'N].>8KU6T#W>G/,5ZK:![O3GF*]5M ]WISS%>JV@>[T
MYYBO5;0/=Z<\Q7JMH'N].>8KU6T#W>G/,5ZK:![O3GF*]5HK+HDL$MK #@).
M$Y#/,V]9_7[Z9,E"0E$A]*1L2EUP) Y  J@%M<E\ZD=,YUK:Y+YU(Z9SK6UR
M7SJ1TSG6MKDOG4CIG.M;7)?.I'3.=:VN2^=2.F<ZUM<E\ZD=,YUK:Y+YU(Z9
MSK6UR7SJ1TSG6MKDOG4CIG.M;7)?.I'3.=:VN2^=2.F<ZUM<E\ZD=,YUK:Y+
MYU(Z9SK6UR7SJ1TSG6MKDOG4CIG.M;7)?.I'3.=:VN2^=2.F<ZUM<E\ZD=,Y
MUK:Y+YU(Z9SK6UR7SJ1TSG6MKDOG4CIG.M;7)?.I'3.=:VN2^=2.F<ZUM<E\
MZD=,YUK:Y+YU(Z9SK6UR7SJ1TSG6MKDOG4CIG.M;7)?.I'3.=:VN2^=2.F<Z
MUM<E\ZD=,YUK:Y+YU(Z9SK6UR7SJ1TSG6MKDOG4CIG.M;7)?.I'3.=:RE*62
MI:E+4=JE$J43RDG,V0XXW71N+17;@4I-?+0BVLR._O=*OK6UF1W][I5]:VLR
M._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:
MVLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I
M5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W
M][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6U
MF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*O
MK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O
M=*OK6UF1W][I5]:VLR._O=*OK6UF1W][I5]:VLR._O=*OK?U;MMAMAMAMAMA
MMALQ"ERL1CQW'PGA:,8L-=E>,5MV(O3F$GHS;L1>G,)/1FW8B].82>C-NQ%Z
M<PD]&;=B+TYA)Z,V[$7IS"3T9MV(O3F$GHS;L1>G,)/1FW8B].82>C-NQ%Z<
MPD]&;=B+TYA)Z,V[$7IS"3T9MV(O3F$GHS;L1>G,)/1FW8B].82>C-NQ%Z<P
MD]&;=B+TYA)Z,V[$7IS"3T9MV(O3F$GHS;L1>G,)/1FW8B].82>C-NQ%Z<PD
M]&;=B+TYA)Z,V[$7IS"3T9MV(O3F$GHS8W3>:05*@R0E(*E$MY!(%23X@/ZQ
M3M^@_8\5<Z<O%]>RP!5DD%1Y$@D_FM#FR;O?#\99;6,E)-<*QQH<1QC\XXK7
M3?,>]6JH.CD('=HY.:?PD?/;Y#Q;#_Q,O[DE_BLC]TJPV#R#^L$[?H-HES.R
M6DON/(CMN?:L25+6L#+%A3L1R$[>(6CW1#:2$*:UUX\):M(A _!:0D@Y<:E5
MSY+-1V854,1T,DFJB>ZK-=@QKQ42.(#Z<[!$2JUNPXSCBN5E-%'E5R?12IL%
M84X$(;0WLT26T!NG(4TS^G.R6F6%%N$TAL*HI6B&:UD5.9J0E)R"1D+2H4:4
MI*I3*PZ!32-JT2U)_#&$A9'$JEKOA:A?T((65LO)6MM1R5AHH%"Z9$I(SID<
MC[SKK;#2WG3A;;3B6JA- /$,S:->]W3'@Q'?+CJJT3HUC8"HU)% :#8;..):
M+87B!=7HT42I6^.>>$'"/PCEX[,/-24:1A6D1B6BH!X3:L*QGR&U#R6H;:=K
M6-4Q?SC1:?1T-=$580KDX65E7O=B)&K*F-![$&R,\ <.QM3G "SLH3MLXH--
MK=77 A)4HA)4:#;1*:E1\0S-D[Y(6FN%0"AE3(BHRVCR'/XZ7]R2_P 5D?NE
M6&P>0?U@G;]!M=<UN4RW%.\DQV2E(IO'FF\QA/$XE.U)V@5''8+. I:1A)X:
MZU*J<0^:.6R&L5<2L'C()KR[+4VAME"T(&:E\-7X5:[W/8!LL&$N#>=S7\PG
M$D^(*V@^(_79+2R>0\5-OYK'28=&07*\$[2DCDX_*-ED%L3[K:44ZPE]U214
M%2&"V:A=*TQ+H0DYY$V%O+G^>SB'6FK^5JSRP[>K>$-8D++!;:"W$E QEH9X
MTMYJ%4Y6A(EA$5&"0E#=^8DI4EU.&*IHJ&2U*6&JYT6HYV;9<2W$$QB8;N#]
MYEYN.',>L+>)CK<2W1PME-</%BH3:'#F.R8FN)D5:N]];(=6L!+@>K$$@I(2
MIU":$A5?'6T1F]<$S1JD-R]2D)>0IN0"[(*QA5I75EHNA.+1Z$)!"J;1:Z64
M"\U+CL3&6#=26BN6ERNLZ0:3"7234',T.$FI L4SF(:+K:A.B6B2ZI1,)J3&
MF!;Q6V\7UJ ;"0:E6:@12EG8CJCNA?4A\OIC!$2BW G$J*$NZ!*3A*BK*J>0
M4M*2529K:D3G)2;MNS4]7+M&IA:R+@2H!!*AFI8H:*KG9K&&F@Z:NAIL.G_W
M,(Q__*OQLO[DE_BLC]TJPV#R#X@9FEL Y;8/';!X[8/';!X[8/'9B(]*=T+
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M5A&_WJTI%2I> 44.->RFUYV9H4J2\0H2I 7@;PDH0"6V\TFB>7*JN6T-;BV
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MU9:6EM:ZC>K7P13;G8PY*8J)I:.K.+T:7>(K%<J;>(YV&9H-NRSD1]K3:1&
MQU)0ZA2DA:5+S2,-:GQTK3CLTTIYQ+3>'&NM,2@@9 G-2B ,AQFRV76T-.+0
M4H?"BTH[' A6%13R@*R^+B?=<7\98_>HL=I\I^(V6Q*Y?S6Q*Y?S6Q*Y?S6Q
M*Y?S6Q*Y?S6Q*Y?S6Q*Y?S6Q'EM0<@^JU!R#ZK4'(/JM0<@^JU!R#ZK4'(/J
MM0<@^JU!R#ZK4'(/JM0<@^JU!R#ZK4'(/JM0<@^JU!R#ZK4'(/JM0<@^JU!R
M#ZK4'(/JM0<@^JU!R#ZK4'(/JM0<@^JU!R#ZK4'(/JM0<@^JU!R#[+^'OWQ'
M4_#5@S6RH.@<H37$/JS^BT"]UPV="6M,@54V0K"17/":@U'Y[,:6\KR2M0 )
M4EU>'8AMO8/&3D/'G[^Z3[T2?\G[0]ZZE)1>4%:R$I3*:*E*R  5F2>2R8+,
M:\DRY<B$[%7+=.%#P<H7"XIE3J /M:5X-)R<=DNQPY#[(NP7)VEE8'6@VIAM
MLH.JZQHQ@*=)FV""4CA69+NLK<DS+MUM$,8="(]35W-)>4G0!T(S*J+.#>@5
MM)<B!V\ VM@-.7M=#J DIP+;">ZK &6 *KCRH.,60M3;5Z.,/0G5/RY*(D=;
MD9MMALN''()6 5$C)I -!MV6F/79J[0PL.1,<+1T<CXFL!3IZ-(0'\SBTV-1
M!VC*UYNE<":TJ1"7I9[!AHCEL%,6I""H( HE/X6^3G6SKUWK:?N=+ZZHN]+3
M2E:/5-:8!?QI<Q8L:UE2*X1BR%;27L+#*XC]WH@(9A%#2DMF4)*% OX1A+@<
MQU45+.'!:?+2EV\Y6DCO'68#T2FC<*F$FI3D*\N-)SV8K:6[VKPNYAE;"HSC
MLB>^M004I,EI>C863E1D5 3Q$C*MF96G8N=A2VG&'6I,"2W1!=:<=6I+*\%,
M:0A.#?C>\N=KX4@2]5:PZ*"VB(D@ 8U-_;7#3:5.5S\7Q43[KB_C+'[U%CM/
ME/Q]]S;RN^[W9=UW5V:D,[\P!*$1UQL E1866W$N.CB:.''\DXJ N>[YHEJ;
M<W(/-N-J4AQ"[T"%H6DT4E:51 4J2<B#G;^4 W_9-S\KI_VMOY0#?]DW/RPG
M_:V^'S_^'2ORDJGE^XMGCM_* ;_LFY^5T_[6W\H!O^R;GY83_M;?R@&_[)N?
ME=/^UL?=_0#0[DG0>15[ 'ZC$!M_* ;_ +)N?EA/^UM_* ;_ +)N?EA/^UM_
M* ;_ +)N?EA/^UM_* ;_ +)N?EA/^UL?=_0*5W).C%P:WL!B_N_S3/Z+'W?T
M#;N2='EO8#+ESB;/';^4 W_9-S\L)_VMOY0#?]DW/RPG_:V_E -_V3<_+"?]
MK;X?T4)[4G:#:>RPH.2IU2@KQ<MC[OH3PMR#Z?[UZ8?UPQ;^4 W_ &3<_+"?
M]K;^4 W_ &3<_+"?]K;^4 W_ &3<_+"?]K;^4 W_ &3<_+"?]K;^4 W_ &3<
M_+"?]K;^4 W_ &3<_+"?]K;^4 W_ &3<_+"?]K:Y?=O;OB][KNGM97'-Y3XT
M$/\ 91+FA,EU+>DT>K)QX,6+#B%:4J+'(D<GV/\ #["\HVJ2EI HTYW1KD"2
M=\G_ "J_-:Y8F@CZ98H[(HK^ZW\A/_V/E]_=)]Z)/^3]H>\E"G%!"$J6H[$I
M!43Y +4IQ4LA.-24#:I0 \I-+)AON%Y+;>DT!*5D;*BN0K3$<B0D9TXK)N^8
MI00EA15H]($C#7!Y*Y'\$Y^*P@2%NEEMO2K2VVZ0CB2XD*2,Z9YT('';L?,[
MF= KN@JDU3LPXZJSW@PY[ZENQLG$\E"0M3+Z8ZPDYEQ0*MZ#2J0!F>*PNR<:
M_P W5O20<TC,;=IV>/820!F;=CIF\[@KNE2,T\0KOC7>Y'+%2O%9-VS54"8Z
MJG&0G(*WAHHTK6E<JTS.RVI/E9;2D+4&@\JA PI5RXJ;[BIQG(5M'C7DPM#L
M9+C+BVU%+B5)2H((&*I)WF(*2:*H2""++NV;DHMXBL8SO@5 J<4C"H$UQE0.
M6==MEP9#>'$C?K=T24#-2B4X@13>E)'&#9=WR&V5NN84876V4MDU6XIP5&CP
MU3A'&20.(<=E7=,05!;"DX4I62<(&%1(!!K0[#LY#9R[I+:THPA14HHJ@U2%
M54.%D,\)-1EEGG9V[I+6#>A07L*36E2H#$-J:X5;1Q9_8Q/NN+^,L?O46.T^
M4_$H*0I.(537,>*VEA#((J!^"0=O+_"SY:+AT0HG]?C^Q]T7W-8&Z1B1?%WZ
M*#?;#2W7%TPQ[P0TDJ*9(2-Z_A&\D 5.QS$-A%/>NS=C?P]SZ^INL1S)NZ^[
MBNF(Z8,.K4&3&>2\SFSOL02BJU57^$*VOC<3=4)_=DIN%.;BW2O<WV+><>?+
M9-ZZ!4VKJAADXM(Y@S.BXMEIFYW<;'O?=C#%SWAJVY*X]?/_ *L_IITI4B(D
M8E%)2PRE+RV\(!)%%G? 6OK<==[-XB3=5XW9=<$0+FO5N[+YO(]D7-=;0\N/
M!Q(*IN%0*4E1!)(2;;J=QES7ANDND#&M5_7RB-><Z.]HFKIT%W-/-W,F*D:,
M3)C8T@?<!.9#:21:5N,W+/3V+MN_&B\KVNZ^6KNB-SIC[$6^+N5C@K5(EQXZ
MY#<YM*V76"DI:D"B"<K-;FKB5N]NG<MHI#D1MJ/%ODIE+TK]Y"&J1.T+G_(2
MT[1I"4;W>FNTVN[<YN)O!.YQP7/>K8W07Q>]P)1V7<4(SEVT(O'$6ZN.+"T
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M%C.-O*2IF,ZHJ<801L:6HDJ1L)SM*FRYKJ7Y<AV0\A#;:'758EH;:^UI2K:
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M\_[!L+/:;1+U?1Z:G<]-BT=:_*P[ZE*[..PK05I6@K397CIXJ[+.UT;F&N+
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MK]UO7<Y>"7TQ )QT3XC+83%4Z$%S2G(ET)P5-I%UJN?=%"@J=2^$S;N=;=%
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M5\&_I#W6LWN&W,-.-NMW=A<:<0Z@Z=TT6VH+0:8N)0!MMSY?_P!8_\0 6A
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MLJ Q"D,(Z.TF]0&L,XXIBG16ZK;U"+W5-LE M O.YE::6'"1UU VFK;>GF)
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M_=,LI7B<L'@XS]R=QL\D1IQT)#Z#*>G.,QV\XMJ23=JZ;3T=LD06T(5MZL7
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ME+E#@.PMJ;:=)F1;&2?)#?)HX[9/&@Y4-Y0P5PT%$%"/%4%$3FITGCL[Q/B
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M.M-?6K><#K37UJWG ZTU]:MYP.M-?6K><#K37UJWG ZTU]:KR#=PAF9V]\0
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M@.P;UI3/(N=A#E/6T=I.2;=TO04VJ<?SD=-H9F^:B7XA5?H2H[\&X1K!98?
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MRJJ<W31&2YB,B,B7G(B7,1+\JJJJM,OBB$K#K;J"7DDK9(2(6&W!<-N%-O'
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MF7\R_B&_]?X4[^BM78)2AG8:B<21KD_@!MY@5[##4=U=7-J9E$<J#@E$HFV
M+F!L3%"ULNPB+%<4#'8F7HY5<&!1'U\(\"Y]OP3RA.W36I"O24_^R5 )N"YL
MY9B.*XTONWW]3W+^T=I/<1NUW [I%XO'-91Q2B*D@VT*0QI&JK@PYB".8X'A
MC[G!^TRU@Q;E=8T/4FLV^2$Z&^[-=1R5+O+D\H!M*P"-<2XBV0D0$3B(BK3
MRM>[M%+TQA2)L<8S*#;I$I4GJP:.2&R=;#*@&RJH:"JXX8MNP9LJY&];'YH0
M(DVV1RDFJQ2&1$=D.Z;4:*,ETCCN+B3<3 34L^$IJ1:V7([_  <L3D+CDP7V
M6ILQP&9\T=)]M#?Q4E 5/*RJ*JMJF%.LVQA8\%8MO>9!7QDH6M#9-UT7!5>2
MX\KG(5<P*A"N'^P\"?\ Q19_[L*7YU^]%] U,B%R>;RDPKWC^\_^*]X_O/\
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MR+A]GK<-\[(N'V>MPWSLBX?9ZX&NNV6\---\);0;CKMKG-MM@,L,QN.&P@
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M7)UH@E@>5"C/((+E-MW*2.(*7!FY6+PQ!CQVS)^9%_PD]#EN+R(^,IM_C&8
M-=(6=B*CV<45!(;99^#C4&$]#"7%6W0'^%$A\5Q;,7IK##4>.\+[98M(TN#+
MC.*XN9JLMMG6=Z9%FRD;G19G!QZT-A"3E2Y;=P/*TWQ84)0\K#DM8&1)4S#F
MXK)_HG2?_O3[FJD=B-XML-..*BWXL<N?!57EGY1K\?N1A=22\\P*  $+>FVB
M&1XB>/C&<2QT'0+EXKFPIIV4R1Z0!E48\=?&: C(4ARCG1YQ%+G3#'-\E,@R
MT8"U+%_*0AETT(BR('D]/D^3T<U%(0)+!945#!AA1)U&U;3,QS(R&.;3S+F(
M4VY:BQH\<@<9+$G":;#X.!*A!M\>7C"'H7[P#RBYD,3R&F('E5%RFG2)<Q)\
M5//(TTPCKA'HLIE::S? ;1554!.C;[@OFLE"F'%&4T_IE#B!&REG9QQS[6T1
MH2%$!")"QQJ2V40W7'4:3C#C+".2E%L04WQ%$%HA),XY/YJC2W0+Q7A ,X-,
MZC82''%AD 9=,SB 0X(:<Z<]89'G317<J.,1<BND1D%P)1''C'*0593Q2)1Z
MJ/-JHM"+C$>*I8"#*O HD.4A>>!PE54QY>/QI6D,908<S\890&N4BIR!$R%5
M3(NU%Z/BI,C+R-Y&4-$88'4)DS4"(=HD3(N8@J[",/)1*0--TVL'T?(FV =E
MF3,9IN0>4<HFJM.FHIR44^95QK3BM&VJE'4B5H&LV@LKRD!=I(#X#FZ<J[$3
M!/<LGZTA_P!8:7[W$?*^FNGU:Z?46NGU%KI]1:Z?46NGU:\JL%79_N)O]$_Y
M:G7&'%&;(ALZZ1S,FQ)L"36-5!"-=)K,[D!%(\N5.>DQ<MK DF.<8)R(X<XH
M NZPFZ*8+J&@(H+E3(H+GI9L^&W',7S98>85>+3VP3#79S>3XQ% \N+0KY!%
M@M26>*P(*QY!Q7(HLN33:)LB RD..&SE5--=-$10>7+@8@0*LJ),CQ9,9EC7
M6Y0VW(Z1W57 (TE@U+!3REE7.KJDGDZ>!*=J@VZ&VPD=N7'F.([+D36C'E:<
M8=-L<KS;C1)J9A04,D7."+;;>Y A7 9KZ,O18\=V++8:5<SLEHU-P'18 25<
M<C:BF+F0L!J9_P!+)_HG2?\ [T^YC";?:9TV\1D."ZYJY?&EF!$3(1[0'#$1
MV+[D:0_)BY.(\2?AKGXSJG(3,YE0,-)&<25]#S)S(.-%E#BZF\*JS;N42(VL
MT )$EEERF'%B=Y6/*Q%.BF6Q\%90)TVD<*7IJ!I$12G$B9TFZ8R-( 72UD'9
M6DVQ&1-,A22JR>,(JLD:&O*RZB/(()R<,%4<-N:EXND)U-#,K E(5EU]D9FC
MGPP5%<58ZN")(F9<-FVIQ3.*A$4(_%FW"=1L%<;QDZ!)R\[+FQL2Q_U1*##P
M7HG%8\87&2?$@>8)Y7\>2$HO&Y<B95:3H6FG<(RD\B./!(1TFF"%P6M$L/*$
MTS2R_-Q1,=F%0R9:%MZ6)27!3/@VV*JTWI9EVM2LJR154QP4<.3[NNT-NRMQ
MXR2!=<DJVV1*J.%G!<Q3'$QTP5$031,=E1-(H)2$%S;**0(.*08AX11O%04%
MQ0<F"ZF7'DK4?BF5;CJ#JJ)+G\IW6S"6W0PTN+K@B\^./XBR?K2'_6&E^]9'
MX\R?_P!?OUNW 1+9+*,!'.L\V LB1(!.4KT!U'V\713GBJGC/R99N31 3-@
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M4Y3,3QJ-$WJ*KC:20>5L]HK7@PK98W'?\/KP8*ZE&>\)E:$VLQU<%]&AXO\
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M5.@A';?D2I\.4'&6&Y$/2C 2$+@&N.KG42;(4V8<]2&9#J'QJ>-Q=<RX.<9
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M^L=PR5*,/F\'#MX^!L^L<? 5&8%'*JADCHL0H%#EBD4S:@9%51:=9M_S1/\
M00 &LQ6&4Q#6=:%69=#,E,+!XE!T:0HX"UG+KN"ZVG:BPS1<3=R56MPSK;J+
MNB<L8U>7+05:*H7+N\K)*(Y,;$2FISL[0;YN&CN:LH;/*2Z^JRC"T"&0AC<4
MM8F*LD$3&0N*/:,FVFV;7O>2_P D8,Q,0I\#;<52T95B*$9K)X?9'@W!EJ]
M3PB$ %: -2[7OE;SSJM$@!' GT<]R&*Z)I>-\FBMNT%7!%!^X'B^-EMN"5ZQ
M";:$JJAVM_%7KUZ]>O7KUZ]>O_C>\B09E:^W% #"(F&7@)TDKI*YRNN$Q4)W
M'5908J*8NI2WYS8!P0 P M9&&;*M&]-1Y!H$,2INC,N9(:G6JS,K!"8%L>!%
MU*?U$1H!X*BBQ<V]WYZPEY,]?@%N9I9WG:YS#=S 9;<-5E%BI3%S8M5 QCQT
MSK;$*8L8N%\49D V0'[5\J 7"J=090BA9*MU (" ,Z3X5^TC-%&@3&J4?J0;
MP M'S4"! @0($"! @0($"! @0($"! @0($ CG5:PTK8 JZG#MX>-H5$H[>+1
M:+C_ (F#!@P8,&#!@P8,&#!@P8,&#!@P8,&#!@P8,&#!@P8,B8D_K36BM 6K
MQG$%.VS12^/_ "<F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)
MD!1#1$<PC8G,.1X/_-N;%H <V!3M?,1====_5^R60 _>RI%0.44"+V)[3L3V
MG8GM.Q/:=B>T[$]IV)[3L3VG8GM.Q/:=B>T[$]IV)[3L3VG8GM.Q/:=B>T[$
M]IV)[3L3VG8GM.Q/:=B>T[$]IV)[2C.\V0Q@YX@1$42D43DF$_S_ )[J+RC]
ME>(DOAST>K/YS%,PV$@AQ10.,P&%F#UF7PM;RBY3H*NGG;$R"S4M0&TMVQ#3
MQIOUH_AOU/X;]3^&_4_AOU/X;]3^&_4_AOU/X;]3^&_4_AOU/X;]3^&_4_AO
MU/X;]3^&_4_AOU/X;]3^&_4_AOU/X;]3^&_4_AOU/X;]3^&_4^WY?C_Z#1UX
M4F* :M73B&#A\ ]QL!6\-!CF7!I&W0G)-<%13CE3V$447)MM;^&Q*:PX<U8*
M(5@:P"JD:U[0FT8,W4*B?C LE(4%G=LB8CK$DB./Y$3L,M8#LAM!FG '.9,1
MRZ&O0K)7;AAA)NHJ*&FC%DJ+ :"5 VB7!G$4!B-#RF&?IS@]@SP$:^O*6EN"
M&0*_(->.+N  @X5H5)KE+0CB(^+E!WU\R1&+I0@2:S]*15#\RW:76G6G6G6G
M6EG_  '4=+R22!@8H^&P=/+Z]L>JFY86L!0%%US.,Q2PS64<'*,TS-0X^ %>
MMW4&0"6FB/=&JA4#=ULE0:1@5:P-LE%<N,%B6"8@9S#T7E8,L=Z^-&3$DT(T
MPP5\K-S4)U$A" KV!&&,L%(0 O* ZN"I8(,5AYE<371AO[!'+%!U7-)/;MB9
M#.A$"Y6=+EA'F)HA+$C@H,((7;6C(@U31:68\DPZ>I.#.JER2/HBN\Q;]B;>
MMPEZXH)K!IS\LW:'^/)K2>$7X?XGTY^G/TY^G/TI[LM;9BI,Q*M +*SK.)[O
MFCITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3HT.\Y"/O-T@1*4>&/(Z\"6]D,>EOBE
MC.L\VZ=K36JUH%T<LO17<#*Q%6NT%UVE[\'O $4LN+HV+_U*)V9H #%&6++1
MZ//*T+V@J!A.59JM5*BVCW.?5:[T(6&"D:FF8:OOWNGG6:1K,1@T;P:-F&CQ
M--Y-3*T%RX#746\1T1C!;3-REVN!NV8:=6XZRA]R[UVTN1#DP"5'4?*!<)%@
M4$)7T+IJK),<F *9(2O(8 KA %AZDU 34M *9DK)]?=VXXH<VB=H'3EIO0A[
MB*W>.*U,RF:@-RZ0V,PLX%T*I<S5J(9C^0@6Y:2RREPFI*D(S>(PZE.LX58%
M@F?K3CY%NT[[K\.+9M<U0Z\!RX3.O)%G4!#2CBYPI:@NH2VO"Y9HA4R<I_>@
M&570!E7 9<02 T6 SMRAB) $R@NQR%=RW#DDUQ'K_D(CD+ZHGWF0KB[QMLO,
M+L0J3?+&:5JIH+A&G"[QE[61(X880C.E\(^$:RW>;[R:N\*2OKDJ51I'YZP6
MV(KK? :5&2^]J%N;RITMT=]NL"%,$52D.T+/0:4@#T53:96S@("A01%+3AVT
M8:X49!;^9M'/Z 5B\!"I6!!TV$0#9A3MA]N:0NJBHOU99( I[:!#&&6 &&AB
M@E#>9#30:30OL!G@:R.%[N:0C)#S%^^<WR.O @B6W$2Z!1  _:8N)#!C%;&S
M*6''?,[YG?,Y3\F.32BXN@7$5&9]2N3J;\3!4&:837S!%8DO:PHQO:$/[@P9
M?=ZX0*V5-E+4&K+-MK:0EQ)G91$F-PNNMSHY= :.:[NI^A>=* 0/A08QS8A=
M/*N2PDB#4+H__EFS .B@E@%?T&EN8M' Q0XM 7+0 $S#%MFQI'2(S6C,>!$2
MFZDH5!I@IN$M.LA[0US"FHF#307M$Y"9.A2"MRI B)C%.!6O-L=]US3/D^0;
MM.[ZYUGWV8G=$%C_ (2B[WF ;CR"*93"Z**B'[#3I:^L4-.X ;57";/&F+:M
M@!#,0@/V3A=K4-$,6Y044 $# 14Q(5_3?S.%^8Y42_O$=>"IKZ8 UEV%U"VO
M>'7^JP QX:1IA#C%'@6Q5J(7;+YFHL5Y?X*'[BIA<S4=8&#UI0XFW F8"[YX
M1!T_2D'%JM6NTL.0,IQ$59Y)C,+D"')'?YT .Y%7N@ZKX]0A-5^3*10RP<7E
MI(0%+A5KE15O%3"=DAAT_,B(3%FRKF,LV)\MAJK@6JQUO-VX-RX^(BWR)N*
M;[8ME14<8.J'HT=H6E+YP_?.;Y'7B0U9E&!1.[*EA02==<\7MY57_?4'U_B?
M7^)8&PL?I:"[:R8">^0!H#@!@# 8(Q2 ,ZT?593?,*S9LV;-FS9LV;-FS9LV
M;-FS9LV;,RI>3\%S3N^N%>PPPXNV8G:64\T4T4K?%[DI! 1"TYB9T@$-&WLK
M\#HS+(<F*JUM\;7V\[[_ %QC9S9+F-T80T'A0'G^*8+FV.@;8-#ER13K5A@1
M<F[$ P?"4MOTB#IV#4=F4*64215[<"@PH!\B'[YS?(ZE^,$;EL7FDO$3 '_<
M=+ZX1;MRA6%E'*4VQZ7UQQ;VBP< *5Q!4!%!$,2DSP.#>G0^N,5UC2.(J++*
M<[AC:?7YCFC1HT:-&C1HT:-&C1HT:-&C1HT:-]]BF*VQ0,@A-Y<KE>:\?@=W
MUS:![# .9KA#0'8=J+#35XY.%>N#QZ*(BT'0P-B]'9 19?\ ,,4\0WP\;7V_
M@#!$ K I+UWD7ACR07A([6"H*V%E!27(I<Q:@EF] I]T-U+=TZ;)5V/-99<M
M+;RVZBUMRIMR'@(+AZMUQG/TQ+S^1#]\YOE)+46UK#_CF+[['U\Q"$)34RH.
MS2=C:<'>RZ;N.D!^8$Z=.G3ITZ=.G3ITZ=.G3ITZ=.G3I6BU)0HL8&2$,SC1
M9;Z-? [OK@I:0]8YG,LR*/#-=E102F5:XBX&4E3,K$"L'7U1JL$U3A/N@"GL
MGVH2G(LYN$!,H$0$9K&%SL ZCX6OM_ T(,J%,@ K4U^%*8$D! ,M7LZHEQ,H
MQ/+39XJE./CPP\U+2#B++JC@ /9EE=DYR>'"=CB;<(&YLIZB%2-@6 6DAEP1
MI,Z9U:AV.*).]";6T,:;\<#]\YOE^[?QYW <K2"*N0"(QP+1T'BG+6Y"\Q\R
MC[+S? [WK\-G!QX_X[BJC=FBO5>,M&UL%6<FMG1@X@8 CSZQG+#3.<FYB)EN
MXI)*>I$7G' E"E9 "F N*KPN)_'@CU+8!^,M;18HT!X1VEI&FSK?=M?41M!%
M(1FVMIUQ ;/*&JS'  QJ3(P?0&-MDI"Q0#7@NQV+KD1"X@P(  0^##US]S95
MUHL3RB2++:(LW]S5:;!M^+'CQX\>/'CQX\>/'5TLCQP# =E G?.?E^[?QXE;
M4V5[&02*X$+AO74'FJ+=P#+D=<)!S=J-@X\K!LA'!*I46,6M2Q_%(V@IAS0P
MUB#"@0VS'@K5W"3H*<!NP-T"6$5$BPG&FC- \I)8I99LC9P&J9/>Z%D*.,7T
MCVQ')P" = W!!P .4 !S2!U92CR^]:;UAI;EB;N#$;FJF,E:AE)0>7PWTL Z
MA#6((W3K#T?AH^R\WP#)5E.85G4K2CJ_X\P<.'#APNI8(L)MD!35['#K-&,K
MYD:-&C1HT:-&C1HT:-&C1HT:-&C1HT*"+"4BPCP1HGF^[?QXEI!M%OMCB-:E
MSDR8XRE?M(7!2 S(Q@RG(/2O3(!0!HP>3 52@+V9P;*L$=QZ6W,):<Y4!!\\
M=K;$)X$M*BM>,Q,5J+  )I*<< #1PW%2@924+3/'.L.-B4HF**PU6W2@(ZMV
M)LLC-<#BPG H)H*:9C VUN34(02,JD&#&RP#U4KXF%N 6"<!P4BZG_5^0N()
M#10--]DJ#M-DWUPM2*K2&$;<:JIJOAH^R\WP"7TCC<ZY''@BK 5;\AD2)$K4
ML9(4$]D>.[XPIQ2FSI7;  D UX:77WBYX/K>%==>3\N]**0Y*?Z)3T\JY<N7
M(58<PO4Q=2R. ANA8=.3AX.GAY%RY=@T&\)>K<2^%N>$#(+G2O=8,UFN6?@+
MERY<N7+@$FX ]L*$59'"G+R_=OX\3L.<!J X041PD8.!8V9%H+9\%Y=Q.)X1
M.K8(SI/ 4>7!.;*V05#T 5HT1O#<(-$&@;$;$=.&-P9;*]JFBEX6HRNS\A @
MB;P#<\N)^UD4LE$N!%S!4&C891@$.%@+@U;:NG'PV%3 ;0K1 $TNF#RFV[ Z
MT K4T@;@&6RBAETD$ 90-K6EVE%J"H%IF!D#39A5& 44$7CK=8)J^.8,4L&I
ML1A5  *^1=Q;K+U3A> ['R!@N4-+5UP,E7DG,M-85!AU#C2I5S'JG,0HZ[,H
M&+@ !(EDE;AYC4>H)?#S(^R\WG?#*GC3]--NN/.*F%H3*=+9:B8G>V=(UASB
M;+AIY;3%N6@W&]*W TE-S> LK?(J"W<;<)8W+.Y;5FQ,SR>&'38_?8C2"% F
M@PNPA]V^6MFBB&_ 67D%.@N0=*F<=>;@R?9/3%1T!><]"[TXT7M@<,!AR>'J
MN))2I%BOAEAO.$')3N"8Y 6?F:B2(V+3+$TO3G8DILBR@APQ!V'J8?,P/].8
M@ AJ08QQ@JS6L#73B]'A864O:JC57#=J>&,6]BORNI:I0&+RI(U,G]);=3$0
M>+DP*%<S& )//T^X?SY?NW\>2Y^K0AC@SJQC7 'G"#09@  8 KRX.DQ4&24E
MB+F*1$RS+34'*A5<JW*-JGR0R')<NDPXD4V#8J(&\&M@K%DIY$F7-<5&)01Z
M@DJ;L57R,(0H,:SLBLH4DQ9+UKML^B-#5$( 8 26+>_-JP+;1MG'3]4I!2%A
M);3%.%;"W;*MQ5!UB(T] ([FYW (Q$G?.R9I0E$";HG2A--1NS5/"I; Q;]P
M 55X4+8 Q1(L\!?"15IM;X)2+#H4JH1<0@2=XW(P)"[R*IHJ?TPVUNC4C71L
MP5R\J/LO-YWPZ"@RT*Z4'10A"I8%IK601!'$/C&F=CZ@-51VA/%^7??A.(<J
M1"+)5*Q)MA>D'8J"F#6'Z8XK^@_GPZPPAI'> $6"I@:1$SO%T&:Q&$!(F!<.
MP358-D>>4B4!E6& 7#*8E1U=0@I#"Q:)PR0O*S8IIC,D07+PHN GO0TH')"E
M%/Z2G1$M39M(I6LSR/(4(ET$S)@TY58K<>SZ?JM^1_1+0KY$ (VLRH  1C8B
MP!VOFO+25PMP%MO!DJ2^Z+,SU7'<6SMYX!-#A$%S*H67D4+<:VY9F!LF73P>
MXC,LHVXSF] 155%!JJG F1S3E.$\!X0$6Q[-=-6A;?%HB',1Q74,;+IS08W
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MOHL*/?V&N)-51&(H%!R&?V#X"MD@D&XZHKA;/# 1F;Q%@K/92Q@&'O5D)_\
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MQ#M$R.BXA#7LHL=G6@F3EE7%TTM-F9.<-3>!42Q+X& 0:<46SM.'K[,9LZI
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M\GF<'ZIOS7/N'\^1U"N 7G QBMK?P-VS9LV;-F>8)?SA-HII;A]KLYOS#_\
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M6QEYR=]6VG N7*D-T'TT).#,-Y+)%8:(FBC"#"@JI=^NP>;M %[616=\Y_\
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M)0$TD;<)$%)B;3;;;;;;0(0\3@CMFMMMMMMMMMMMMLB%/AY0=23FWH"P
M "=0/*58L\P           !B$+4+M+H@\R7IMMMMMMF^%Y(>,JHP
M   !2 DDDDDDDDDDDDDDDDDDFVVVVVVVVVVVVVVVVVVVVP
M       &))!%MMMMMMMMMMMLR                       "!/RVVVVVVVV
MVVVVV:                       #[H5$1+3W[@     !J   )  !
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M:;:[2B:R27R3V2221P ,!R &)+NM6'T&+H !(  !(N !%AQW\0E5N,.  -@
M, (@&#ZUO>M2G"' !(  ! ?P(O0S.LI9^,Y7AT-@ &   .            Z
M ! ;<W7A15+@+(265Y&-@ (  ! VVVVVVVVVVVVP  !!Q( ?AP'8**1Y\
M-@!-))(W)))))))))))).  ! (8O?A0=T9; &    -@ &!20*
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M7=>3H:IO<&J   ())))               $(R.#F*A72F+F;->,:   !)))
M               $ G(#O#[\1P      :                       $
M#@ /O_P      :                       /))),-MMMMMMMMMMMT
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MFNS!008( M0*P7<(7> "!HH"$0!0TB4YQ8-+!2.14/$%\<@ / +T:(&M:P
M(% '$61THQV9'*4X,\E!CVN"FJT2"+8P<M\MY/6UY.CCHIVHQV(,6PL=D; Z
M2AK-3BHE80@FHAH;HSTAI/H-<\:QQN%6'NHK]7/TG\Y^D_G/TG\Y^D_G/TG\
MY^D_G/TG\Y^D_G/TG\Y^D_G/TG\Y^D_G*3N'3W^><DV*CT32G@]'J;XP8P=2
M0;$"SI9+K" ":!P]XA^W ^4M=B]T%=^.=X%!! !";$$B0CR0[9!&^W>7FZ:N
MUEN\&*@@*&H(% H&@;#1#%%5%35U?*5U=5IZC@:(2104[3L:&FM&M&(N<2!W
MH*WK7?7 82- X>\0O3CC U0X [H"(FHZFL#@'-(-YH6;NSG.=V"FT=ELG@Z\
M.<"C1&0L;><W=1;OH13@TJY*!S NALZ8  &  " :   '8/Y63)DR9,F3)DR9
M,F3)DR9,F3)DR9,F0#U1(JH #JNC#CZ_V?:U!ZZG*BI[JO\ Q(\>/'CQX\>/
M'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CG%*#$Y@ "] SH(_2WCH3I;.G_)'CQX
M\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX^PBHB)K1(CUB*)U-?\
MT5//K#JY\WV_]SYOM_[GS?;_ -SYOM_[GS?;_P!SYOMACA(">P( *I 8@TF4
MX;Z\?O./WG'[SC]YQ^\X_><?O./WG'[SC]YQ^\X_><?O./WG'[SC]YQ^\X_>
M<?O./WG'[SC]YQ^\X_><+#)T(&N"R= 7I@B";$H]Q_Z'+Z]O<IW/,P1%& 4L
MV"2%C!1<TP"Z<[Q4\9,8F9I"130WB(.T <CD2D7T44;T"T$,RO=\W*]WS<KW
M?-RO=\W*]WS<KW?-RO=\W*]WS<KW?-RO=\W*]WS<KW?-RO=\W*]WS<KW?-RO
M=\W*]WS<KW?-RO=\W*]WS<KW?-RO=\W*]WS<KW?-SF+YCAZ%V?\ 0Y?7M@UM
M3-BB=I4QE4F2A%4@N@M"#R@!UBT,0 !HL)T#=MV2/F%"<20-.0E"WO&$BB&+
M2TQA16KO<;T*6!S9R7""&&JI5Q.1L(BC2@@;3^E0F]0K;1.B@>^)\'%TD"47
M@+FH.[YT9X A4.!ICFE@>H P25F,&G$=2H!9"ET*>'D=Y2Q,TZ=/9[8A*)>*
M._EFRY-LNA5HEW7K)B$.8K; !N .U!3(TDQ(5C$;0:#@%VV+$# %H0"4 C\>
MAZ%V?]#E]>V6)8(9""+%40S"<P 2'4Y0:)50%Z**4"1,[R+&N%MXUBZWXUW
ME!7%0)5:X YN*:^%8R,4(/&^LBE0[*WKLL?I=\XT2TI*+:VH"._*U@V*LL]2
M),ZT0Y^RQ ( /( )V1$3N(CE1OPR<F\.TTD&3LW% #D)0R0@($[PN&+BQ# A
M<)T";%[31%701'>.$JL!0T(P 8/=_40['J2 GLX13MTV+$7DH80,RRP@&&T.
M@M&#?9.D=6'K3!5F-U)0&).FF\II=FGXU#T+L^.H4 $=\)9T*(.(>DYWI0UU
M[^]CS\>.?Z5ST/XGCCQT<^?/GSY\?'/GSY\^?.ZK\F,4"BA5ARZWG'N\OKVQ
M-[+A"'#LP<:S  :(TA)0)IL ZKQD!GHO;=&CO4[KH=%+;OMM)"V+#70/#=00
M.4A33<&U88I?*;C8AV'6E0)A8,*'9!RR3+ #";@H "+=4AHK3&?LL7%JBMW6
M Z;3>N<'A&DV&D=B)T;1--N.9HD:,0;44ZF&<ADRC:V/8,@&;J[C;"7!R#-M
M1V<((1'LJ&D82BAT@S5EK1N!M;7)&-0+FF+-+3#@D4.1(!:Q9BC@&&@@P44
MFV1O4B$;GA1(%TS@BH2#P"AJ# HBTP:[X!2$HB@ :CK!BV](.E#F$%V "S)D
M-LA4@>L&2'ED!6!&K$")S8$M$Q5PA)[: +!+(]%-_!H>A=GPD)UG$7^M_0^6
M$ D'[;@?/DFMZSQ>L]/&")1I['#. $"(FD32.DP5< 57KTFG:E&O8EOY7I7O
M)P\XZ%[#B2',^8JI$@EAIS8?D D PBINS"5ONMW98$K0F"X9CO"1$V@"S6KA
M\-B") 9)(T4JC@00=!!1V!R NY,IOR%31$PH%9#>#;8;@,-:& [%%UCI3- 5
M!.K(^]KC-H![QN%!$*T035N5ZGIQ_L3*W0+,1)OD)5WH$4 $"[!T<29ZI3DM
M%%@U@#;KQM8L!!0P:#K"G0$<6#11F@:;,XSDH";D0=0Z*!UKJ7,%4)0,;NSM
M@5E" 092#.0=>_*Y/S?[]WE]>V?;[B@#II(5H(YO0+?8M66(S!FWW!J';I ;
MJH!T[ZS<! QHJ3<D) 51W'GV6#]L<I@120 B;.U,!<,W P/  / Q%"B45=-0
M:42\F)%DX&=2!#(0-<QL'=;J1($@0-0T-4@ .Q  :,06Z2,/;\NZBZ4B&PPF
M!2D=1.D1H6"(@RA)16II#" $ "(:,((H2"X=(L7(K B<HP4-Z[$=<<= \JP=
MXH$2N&U$J0(SC\+4!:TPR)A5+/! >DAF.D%!"59I%:EB&VNNF>9S,/%25T:'
MP*'H79\%T?1SO(HD30M(H;>B: ;O%@2V0Z<6JB@8+@QMH@JI-^86G0T]<"H2
M^+]NWMW/OAD+HZ?3C1VA#ICL3O@H3.R^R $0Z#0,MI@)D +L;A$Q@& >$SHF
M&J0*Q3E6M4'S:)T!=N<<TC5H$S@ +;"U;0S&O=;J%"";Q=;:&_ 6E!4T%=C<
MF@0-<T\3K?0P828(I& :5 4 5''$F+.PH(H),JE<8L\8@3H!K)"SLZ%EO=NR
M025A!UB&1$)1AQ)FJ&"FCJO8QL$2>-HD32P+$B84&=3<H36+I2S1+*V (QOE
MP(KU7004^:RF ,P$2:$*$!H"P^^_?E<GYO\ ?N\OKV]G.S#>#'/ .6,'"6B[
MD3CZ+2?+63W?M^,GN_;\8!HV1.N*TIX]5FCGKJ\MZUYWO:[<*F"O&"OR2N1R
M>NO]DG7/WC\9^\?C/WC\9^\?C/WC\9^\?C/WC\9^\?C/WC\9^\?C/WC\9^\?
MC/WC\9^\?C/WC\9^\?C/WC\9^\?C/WC\9^\?C/WC\9^\?C/WC\9]^P_HST+L
M^#SSG?/R<#!"%0O!L]'@(=\II/2)ULFF8D4I7L<L/4"\D0<SNZN_AGSXZX'W
M]:\)Q[;_ %^P7J(: &LL9\!Q[-87K1S7U)PHD%8^_ 8Q0T)B*P"V6VF59M$Z
MS["X)T*D10,#@%VZ"'8F/"4M BD72Z.U4$_A2N3\W^_=57[=SJ:RNA_OXR^Q
M]_SE'063C@@*E%FVF7V/O^<#2;1!I:T%X4H/3*1C4%%D8"_:_:R^Q]_SC>>J
M3)&^(HQ*?R4:%"A0H4*%"A0H4*%"A0H4*%"A0H2L!#I5S%E @41'../@TH/6
MG%LNR(E** @>H"<LSFF=E&B#02Z5IYASB69!Y5*1Q6C;P<?K].?UWPO7GVW^
MOV#B-H#,NFD.>RV>Q*!:"0@]!(UN! 52=#@N")AHFA1ISB2%A5-M\1D(RJ7.
M/.B0D1 HTB<#+%0>;*R=HF*&K-#%6!(CLH$NE0*:5=?X,KD_-_OW8!EOF 7Z
M7W^7RR^0$3^#7:&+Z*_S/5'^9Z@_S/4'^9Z@_P SU!_F>H/\SU!_F>H/\SU!
M_F>H/\SU!_F>H/\ ,]0?YGJ#_,]0?YGJ#_,]0?YGJ#_,]0?YGJ#_ #/4'^9Z
M@_S/4'^9Z@_S+$%SEBH8&P(;F4!JE=XI?@I2>CQQZNJ#06!.E8NX.^Z=)THJ
M%4H$$*BOACA1?.24[J%7JPLN""C3Y3UX/7W+_7[!="H\HB08&CP^Q]&7FJA"
MA:MR"X%PVNT;%6IJ:APMS'PFC-&B&I')QJ43RLE(K87@!HQ=@W".#["S S)#
M""HID<D%42$*J5U#,@@U.&IR-=!Q87@"U6V=^#@A3CX\KD_-_OW>'H:^^8M2
M)J)JQ (C$QN0AIL[(3"E$!>G\F+Z;W?">0#Z_P## N #MTSJQ>_7 #CV[$"J
M8!54  VJZ VNL0H+\N:A_3Z]+['D!F"#$HK 0.#V+'$,Y\-X4!4O9&*)\D O
M#OD:-H]EQ^(#7+<O0!1!" ;JP/$$M^5A*A&+57XCIS%$3D&FSHP@# !"#"
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M:-&C1HT:-&C2TGN%2TD!(S3O! .!0^C\#UOK[-20DDA [!('@8   (   =
M0/ ,,K2H$T*) !0$"#G3%@[JCIMI0@2N' ))1*@D#84PNI%F20" '5PV7NN8
MV;-WS^#Z<,]?CSP8]X(XPP(&[^Q[-:U*:1UNK(2##5)CF*#]N1,+'F"!C=T2
M!%4TREMZJ=HT60*AA>XPP*_],@Q%7 D6.TQK0G.8C8=!0E*B4$M,DD4[*:V:
M\>N&($"%51 %[>I5*WVJ(D%! @\B2EZQ+U^'W]8['N\?3V>U&^"1W*.Z@ 4
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M\BTNN0(TEA>9OY_!K>L=WX"11&V[X\,GO[&OOGC>5GC>5GC>5GC>5GI'XP
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MPP=&?OEJ=0I8*DNAPDBPY45*'"!6G&;T'Z2T"T-BHP364R35>B2(U_ &9/\
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M 1&[)5;42MW9>.V+[- 4D'!6HZ#3 P##0 @=@(/Y0
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MFQ5$0D-6%@F,EO\ JX(C"_P7[UCL>[Q]/9[5M+1L8NY5HI*+#<7%T1@[[]X
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M- <!,&&U%5X]OJ70=L L16RHK3; PB%0U3W/*)*!Z71BJ1:2BM,*=6Z 45#
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M "H0 0$  @$" P@# 0$       $1 "$Q05%A<9$0($"!L='P\3"AP5#A_]H
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MVG_)3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR8&]F,<ML
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M30$I<#VL;B?0,(82" 5R.@<>6(D=#QAD2>&O @? M&C/"[CZ5VY_'1)BC8F
M81K- V+F1 I53DW<M$F:Q\36L?2PD0.'/X6;F,1DJ1+R\8#3B,(?P8%I&H,
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MOMUS8$5*%*G<.4\3W\WX+N]SF^7U/;X=-%[6)*I)P(IDH*2@ 08R(/51<
M   " &@ T : X]W-P^1_ON*2AG%!GE>,T)$>2$?/OR^N0(!.)"3B3RU@$@)H
M@$'D.V<AH6I#;;77-WYY#F%[SY?36*$0EL02]X]<*/JMUWN\G"YX.XX&KS.U
MZS(=CB<'$D\IKRP"0"<0">7;%)4G%!GEK6>H7@Y.'CDQ0B$[()MKZH/GO -
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MBTQ>1&*K:5";0$8G7" EE(;2J$5^KD$2I#5[8-P()D-W6"/)1EMVP^!6QR^
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M-T<X5[,$2@#_  Y.4AMQ'ZXZ1)'<_;G_ *I_N%<%FP!D;PT%CTQK@J M+N%
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>businessfigure9a1a.jpg
<TEXT>
begin 644 businessfigure9a1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@*P24-#7U!23T9)3$4  0$   *@;&-M
M<P0P  !M;G1R4D="(%A96B 'Y0 #  P !P W #-A8W-P35-&5
M                        ]M8  0    #3+6QC;7,
M                                              UD97-C   !(
M $!C<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !
MV    !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#
M   "%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D
M;61D   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!-
M %  ( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !
M#&5N55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M        ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#_
M__NA___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@
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M0IG)CY-%L11/F#GI$2H *!9'G47Y.F+E0R8NC'3Y-WFZS.P    6!?@
M  T :V,#,H,--M&Y"Z)4S$    '(9J(Q,WF0AO8V*6Y;F(&9%D;!+L  &&D6
M69'F2%D3!"FO3=1DH    !BBFJ5;XD3&3("W)(AR&-H&?@  U2:?(PD3Y)4Z
ME      .83$3+B^+<W<94      #\/T         Q]31:L\5R%(0F381LD
M   CR0        *12+H        _#]        !IO#D8&9UZ.Q,S\]^,YCY&
MA)UW%CX@      CU)!4       "D4BZ        /P_0        </7+6JLN2
M@,")R.FR; O:[0M9W?*P      , 4P16.,L,*+@WZ7X    !2*1=
MTUL.N8SF85]:N6N+F1V%FWEJ]E'GU?TK>TKBOGU#T]6OFO17CW=*@  <"9#5
MN+%W'G:+R<M;!@HVE<F>_:Q(      CU)!4       "D4BZ       !P/U#E
M.M9F%F,?(D+-V=Q<R0C92*CY"G&R=**F-C7;.6^/>+>??5>/?EE0  .,;>3@
M^7A0%*2.%E;:OX%E(;#V/'Q       CE)%4       "D4BZ       !PITSE
MNJ9V!NM:VV8]6\<XC] V>@]'R?ZH^+H'5MOV'%S>YY>(B<7*LL7*ZLQ\B25
M  A<R+T[M_+][:-U^MYN@       6Y<       'Y0/@^2J  ?M0    '!/4.
M58%<\XG\F_9>6]BXEM#?^97=J[C];'GK+Z#ZM:;V#-U)BQDRV+E9U&R5Q3T
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M-U@%(X9X1])ZTU'=-@;%K'4G8.)<4<"^CK*U>ZCZOQCI/IW'P     !:ET
M      "T4NU0       *12(4Q(PXD"_!;$23Q@Y^&3FT#)@856F+:=ON"Z]L
M^:3^N[BW'G_/'.>LVF/?VYN>AYQ.:T      +!2_5        $>I(*@
M  4BD0YJXE"U),QXJEN9(6!\GX;%,C!A=:>7FX<LY^E=<W]'S?IMI/7/%.%X
MU%U]=^9^]]NY>SUZ/$;G798A3T#VG0^\9S6    +!2^5TR52Z,B(L_2Z($I&
MQ2=   (]2BKK\EBS(TORX*!;'V7IL<  %(I$.8L0I6+0ERL6Y"DH7I-&4EV
M<<2^L:7FM2V;!;EVW%[%YEX6FQEJ,Z^S=RZ*NR>-5IY_Z[N-EA275^PZ?T3F
MQH   $2I>JZ<*)#DB9$4BR/TOR9-@   $*I>*ZP*9]GP71>$:?!'F4$D9<7
M *9'*62NK"^(<MC+2D4RS+HLC,3/2J            ?)I0OS\,8,O)<EC$#)
MB0,C   !&FM3X+4IDV6Y<&*$D0)L(V(?8  ,3,",F,;),^R0*I;DB110-BET
M            #5Y&F0%(C#9A?      C#7I= IE0IE D#[*Y,&2   $4:_+L
ML28(LS4GP
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M/8RKE<QF'!1QM@UEY1A@RI3%Z^^*Y?#>YQJF^.,/FOPR-^AAJ#<E?M"-2O\
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MY'M"I>3K"T>[6O(@%RMJ6A!2L1<#0]WJMXOZWJSA>%NDV,'495KQ9HA8*SW
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M_DE[^R]#J_0D?^]*\_\ $KW]EZ5K30B_4<I6'\*5[^R]1X@Z+'X9E,?A4O\
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M@B>+.X7+[H/TB-ICY[>FWR^<:?TI>U2=U>,.FLJ8+GB]G [+&3.R*PC$R;>
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MQI$9S[4\_;[&'&KT)K]'4*45B:G)=IVJL5ROD359+$+QI8B(*G?$S!Q@@]L
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MZO<.P^P=AQGBCJ%K3IS/5= [PR5Y4EABL035YL"6":"97CDCD &05R" RE6
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M@@$$$9!&"#Z$'U!XN?)?RU:L/-%XRBCQL!6J3J($E)R)D$T<KKC/YH/T?3R
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MK&OG'Z%G1PD[<T6'R<8@O*-,G-)T4)U+TQI:XOI>G[?+Q6IU$Y0/E<#KK0%
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M_I[JO(=0YC$N/)NSO45JU=Z?JJK1A)RV=SBW.9V+EA%NNJ&=D#0IVS36O./
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MJFYE6E$H6$Q4K,L6&(K_ ,"DWN)8#+#F?S>9"EN[PT7!J2!PLXLE2B$;#(M
M+EV[3F0@9\YT^/C'6Z53(4!37)3ZMMN//GM\#Q65M:L@],TR?PRQZ3FV ;I
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M4NK8.'+!EI55?OB8ULL5'I$I ^V]D+<*6V4\[8L<KPJ5+S$,-FBJ<3DVUZD
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M_9^953SB'[ZA.9C[]&TZED<<YZ^)C:ME)1],=O+7>+ZC]@18KM@!B'1/5W6
M1=$/:?:.PU&;AHU"KQRC$1V2DHF$DBKM!VV#/U2>_O<SD.HNHGE&QL7L@JBB
MPH!D*RWCA:N->8UX*3@>YXFN*6N6?I$:N.Q]9-.C1KJJU*E<(6BO70$+4E0#
MY"  ,#$>#S)LR.$S-@T]_D,2Y?\ I%:4Q6&+=*ZJW0*P"!6";X5@NIX4Z/(
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MGJJ/DY2R]E[W495[>*.2]F9'&<58K09B8]":*0]\5TM#I' N27+M$PEHB+9
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M[+9;+-PSL9>P]^[3?;R;<1F:LM76R+ZZ9^<UGI='SWC?(G,;C%<0O2I6N/\
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MT:I><OKA>I0ZS3I!"=ZQAG?-=5B0]<,[=:>2%ZP4%MV;;E&Y;L6K"3FW2=9
MH8_&'"0UEDB$LE-N6#,G$3QM1MDP^C^>=K^HW:/E]6Q9?U^93Y_H8$7QG77R
MT^N?J_0C_FE^[PK^B#_#'CNA2+_G-)$B;PKB(V[B*LL)IQ(C"N;?Y_'336(\
M_'+Q.6N;&.5!D5>1%>4<U-9SB%TQ7D22?<5W[+->)7R*U8,>*]A-*SP.L@OD
M9QEO4->G:M2A:&L.6J3?K<<' @TN2-T0$$60:BF16<=5;8<MEBM*=1@I6*#0
MYDY#?L+?V$/E):+; MG9XJVC6]@6J=B] )E).4E*WF$-7+!V&V:S5;)*"2\2
M4V!(&;*E%5,@L,R2:%P;#D#V_*ZTKW&QAS</YH9>X@@4$C+B"9T\5SFG> +=
MAJ*Y,BNO?QIFQ!G!O$T@2P8.K!C;:X:<_.+5<&!==5N")+%Q)&:K6@MU6O9K
ME[NP2CY.Z2AD0WW#Y(6>D=TTZ2J9!89DJ]"X-ER![?F=83$IV,/O#^;&7N-P
MJ&1E\AKIX84(Q5NY8KRS'5Z-FRWBLS;BL%#*""GM4Z5\MK>H9GBJ7/<#P[BL
MG1HH=2FJEM!IC8Y3:Q&#:2S!>O<6 +,<14*\#9"4213IN@9K9/&.3:7""L"G
MCB*ZW%C4@Q@O<+8)K<I5.*^WE0LS!VK$SOBVD27'(U)J.1EB6J+:2V;)F(9'
MEN'6=-?C,><_@N3:B'5Z+EUD5B]2>:$K>VRQ<^1M]\*U;HF%B)2'FPI\=T?<
M4;L[(9:I&(RX%AQB+4N!U8Y%<0*W</.O8$"S:.WQ$*RN;5Q:Q5@7T]E<"^(;
M)I3#O+6-[=Q:?7K&O@+"J[;5A+!:EMUTMX6!.Z#6D(57Y-\\O)*99#-"@XVA
MMF)C6)\IB?.)B?C$QX(TNR%%4Q!!5K.62%/"=5N5W2;# $)T+MH9%;=$3QQX
M]YD\TX"T*PMCZDB]@Q&POXE[J F-T O0)TC6-(\R]G5>-K $'6&,8^PZ!\_6
MQI%I$EZI!?&O=\ C2-/SUC^G_P#25]W_ .?V_H:_Z_\ %/W1^[]"/^:7[O"O
MZ)?^&/V?NCQR,JG<!EFC4E 0N=>^N(IP4PV1"1"7P<C,^K3;'QU\0^W4.G%E
MP2RN:5,AL/L6$#<C21[E,LIGR,A<M7(C)KVR!%C\@_'OJS;&P\:T)2YM95:R
MFFZR9+* A8L;5C4)EI0Q>U<[2VK T^]5$!%95+<29L)[@16,B&T+=>&6*_D'
M=)0R1&3'9XKT6*EUNR$%36%59DX[G&R4#!R,H>T'B]@68KQ(3)$4SXH,#&D1
MO0QW),*GAM;<:;*:#TDFOGVBF&.B%U]T1JTH\QL][4E(S738OK[8637KWJ^/
M=ON$N-#Y&WJZM:\V"DH%A;-L[*2TTN)0K%5&FVJH"4+*=6Q4U"28:E7%6J@B
M^!.-[-MC88G$ M].QW$.KH005 9R7KH8]@UJK-T3+9'(5"8R86KX[F[ES'@8
M55>$NY[H\-$!WUTA:[C):P0QQ@-6R!$<Q9+;M%108[B&I6?:..]:D5TH!;NR
M4TW/%K-JQ'5!+U+1V[9N5H83-<7UW+M6Z]2Q-<:I6G*79K4;"^;A M_KLI4/
M!S>8B9<<#.Q5FB'%7+? JV+62B R%BV*610I@G$[U%HP"UA@B>L?A9?J*FRB
MS"XO4PTA_(J-B[=7=, 9\>BW)*1Y!!9 >X9$CZ?Z,R7XO3@VN03+\4%'G<X$
M8QQ5C1D*M@UXK'5;AD],=O;R;"^:^Z4#I*I?ZCKA8FS<I,J%TI4=8[09&<=D
ML+6KPIN3OWYF1VBVS1J*U[NK#5RR:>-ZUZCJ7*N5AU%U*KBDJ5A[[S5^+):T
MT%;K-S8"U+Z]YU@0O/4H>".+6]DK09'M\?3LW7\>+R!GPU$F]NR.W@9/8N=L
M20Q,Z:E'Q\9;+].9"JBA\Y*OTW9IXN^="LD$-QJ)%0C<9DKBS)UYW>-K"#)3
M6CD%&QU.CF\'<L*W,KM9T[H;A:E<MC(RIZJV)529SC2BPE=ES%Z6^=>F[*XJ
M]=K9[J'&W2;6M\2<8J[T^U=:$Y%I5$=HPDY K=!@T:^L<*>4!(^5H+R:55X9
M.U=M#2;4WZQHMQ,6HJ[#UB%;XE;"U"&0>P"R&8OG(4\;3LWK$C&YDJJI-YBD
M-8Y7$*YA2H]3#T&/.?&6S'3.4JIJ1%HT],MK8C(%0J+56?B4; 5W3<E?4V;-
MVQ%QU6%G->KJV$;+%+']1XJY85$MKM9TPH3.&5P*P.7("4C"II.YU8\+5=5M
MS5ZVRLITW9C$YC-*S.7QMJ;6/O1514/*=/-767%S2HE%)Q5,I-NA8*LH..(J
M<P[GBQOYFQ_3_P#I*^^?^'[/P5D'2NT9L5X9NLAZ(LDU<#4"0UYYFN^O<[E6
MM:$6$Q+(<1+"\?!975HE7UNF!36:JRT%K,) 29#"@]XI)<%/G$D.DS$ XK"=
M0DMK:[@L0<*&R035D.;RIF%O6(GW1C$1+/1X.F4O*R!( 4KKM)CSL+Y@&L.F
MKM$[F,,/=+@&09P8$,;'V&IT[B3)E:Q +"JUE=KCGC\D]PER!9IM)BCTG9H4
M@4%;T+=K\QM3L*(LD"RVKG5CHJ/X #?+=L0/F0ZU'#RMB\ES*BE+-EEYI*!)
M0* 2C=$;R/<P>,5G)1H);0?!6=24)DM=5[]LPAUBR$&M<@?9C6L18*)B(E4[
M=T$&Y2U8^ZYK[C:E=>R0E\*NJIE;"=AQVGO=\%_#;MJX1YD038I-YDP0AR;2
M$=TJ4[;&Z(UD!:(LT_@VP:3T:LQ'\M?]?^*?OG]_BU;!!V2K(:_MUS$,=Q!)
MRM>OER%$3 1]9:1]?AD\C)5[^:C4K.S%Y59$N:U (@V:;E6UK@ACD[-QQ.WQ
M<9PVX15G&B+H1+1MEE83VH583R$T^2PI11$>DBB==OGX68.<R6V9I+4%6P3B
MMQ%.2KPOCUWC-^L!:^D3(HDO0>BICNNV.LRVZT55P!5KQ&-8FQ8 PA@U;*<F
MEH6--HP)0R!G7;+%,M-$5$\N.E:+1 ]MH[6%Z<;.[1L+7]8I/9"G<;''+W;*
M(WMB$DS<+46'U4\D>Y%UL:KA1!'MD@]1#N'<$9#EI.[6I8L!*7M56*ZI[J]8
M[ J@2L-&L^!7 [I(-FD$:X-Z6A<5" KZL.JR-;3W7E31A?\ "=RL<>Y\QIL-
M,22S+3SKC47=M]Q>"D!+JM 9W/LU66!EPKY$(LU6)=(:D):3MD9U\5*"=S+-
MJ5ZQ&NQ:VT;-V&P91'(/S?A(= :)F,DL8U_+/^:7[O"OZ,/\,?M_?/B2NH*S
M78^I6)(U^ZW':M)KJU3M+<(M8!SY3IIJ,26V)@H52:I)502/LV2DNY8X:<TU
M=MOL+>V+';-J Q3)%Q+.=K)B*5Z5!VECO2JJK6%ERD+KAM8I"-Y#,57/LG\/
M<E+R^,2=,D5F"Q2F%8FF)5[';-L5$)1/%,WVUVH8A0UQ= $4*5.^9#P-FS1%
MMFSL7%8\7#;[5^TDXN)V2J9(5OE)DK=RK6(^[WA >%#4]G%:,QIIXJ.C)XH#
MC #BO'N1A0<9Q/!HF-A>Z](T[-;'US0(O4,4A+B%@\9-T4@HK+$%K!CCV+@(
M""*!"-*BIJ5IY4$VG99CH%1"@0$1KDU F8]NJ"2U(S7)"/0WTA'AE@5H.;HI
MM,R95IE#.W"%K"NXUR3BK^S GBJP0J<C6=M@)CPC1%=MM=JPT0B@X?G_  6N
M:+037$.^A->T8JM:6= )@#ZHDAOP*:LNVN*&425:%MRI%O1@"F62YU6=Y;=W
M*/PD]T:KBDG'%*8,P4%92W(C=-5FJ"6#4:$F4'! $ZKXYCT:1"JZ5(5$S,+2
ML5A$E.I3M"(C4I\YG3SGSG\@\XB_:PF9L,JG>L+2C)T;W:5NS0YV+O[JP9!%
M<4+JY"O*7*[=.^'#$C-8*GRA9U<8Z&+Q@.Q>+L*!+/*?:0^[/)68&2B+')4B
M)VE"8F)W5K[K69SEJGD$Y2K%^RJK15?0</5;/'8I%"I<LA:TL@[(!;8#%H@9
MB$QJQ+1@U- EL O,3 QD3$H^PAF8G[O!/PW4N2PU.%IFK4.E5R;ZKZQP=9(Y
M-[%7&X<"%<GC'$;#V:1? 9VPU=WKS)6:MR89D$^P\8!,8L8X1J$3'+JUH.()
MJ&IN$T(V<HE),EEC%=_;R=BDFA8R>3ME8<591\TIKUPA5*BAC]&$BG74'NU#
M.L*#0EM 6+.-I@8P0$,_&"&?*8^Z?!Z4$3R 2RAD2T=AQ,$(@V3 (*)F)@('
MRF8^$SXYL+U+D\+3 $35J%3IY-]1M1D-J5UY.U(W3PJS!,LQ+C83..(&\H9V
MPY5_KW+VJMZ0/)(]C8@>4U"/$%*60]=.M!C$M0Y-Z7!Z.42DF$=K%]_<RCZ2
M\>_*92X=JQ-4#ATHKIB%TJ%=CQ!IUJ%:NG5:8VZ)7M_,O@@;YMW1M2PXF.)?
MUB&GZL_7/V?=X+R.(&//>LQ\O/X;AC=\/JU^K[8\ EJZZU5L=6:COJ? M=*P
MKNUI3+!]&P*$&2(VS/;B2H8(;O'N,5%Q#\;D+#'8JM5]Q0HMK5[ASN:AG)5<
M:M$I!ME9(/8KD7MFRF:2I3B;%&O+)736$G:2QBG+MVK"!D8E#JSFM:LNY65:
M=VL:OBW2$6\0$ZW>16#:M(T7:,W.FU4E<6ZY0#U5R=*V</-VY:;HQZ/9]:J9
M#F"6H*@/LW3KV,:0% M!I,/F:+0A90Z#\]TEXK F*EA#6UDI[50V($VN%-?R
M#4]HED"G>.L)%Q:[98(G5(J]<J)/74%/9;IJLMB=Z.16V3$6RHF&U7)#6:EN
M/UEX>_90A8Q8U762EO(-=5JJ6R%:I&6H7;4L3)9N"'!I.AQ!OAN*4^!98-FP
M%N5-;=R%.X()3U=D1RLH%WS:6;)V:^+6*Q?+IC#63Y8EB^1F3#VG+X,P"&G8
M*R3G3$#HTR],1(_F! @=N'77W#9^O7XPN(GX_5_P\,LN/A0D3-K'1*H  \R(
MM\1H,1'Q^OZO 1*L97E%?A7':<$I4>_;7 >$)!I#9805AB+'%8-@+XVR4UU)
M[0>X6 "Q57:A88QBV5N>=@\05VSJAQ#Q*8EL$Q9JT\&\0Q@6JD<C"&N!,1*Y
MJMF=Z0,>0.:FYG&1,$2KL/08"8 NVHQVKNW0PZJPB3KIH\(U(V[[(<;*0UXK
M@V/0G2(V*\,6+,:*I3ZX -!XK!U"XAD1_6-U*>V7.\)-&JQ]/A";BL<M@4A5
M64VK$3V3=*H(0OB]0SW' %<(DAAY! 1##B;F3EE&RV8I8MTG'.(:E9JU*Z42
M!?Q@GV*XRH9A_K7$SM./$)TQ>Y7(CCX8$U2#4,*&3(1*/?W$%#72$$RU$P<R
MZ=R )-<UO@;,N766RLB6.&Z1LLA[O>-AW<.))-V-DS9,%KX6\?9J+#&FM;@4
M$%#$N]GL]X Z*$'NFJ3"D%\K)7);RGPI2<G58QTQ "!3,^HEB&[R]W#":J%$
MS:+9:OCDMXZPU+%M66NUBC%@%I.DZ$,R,Z3$Q.D_'\DH^T9_=X6,I=J*QB=!
MCXP$??'[/V^'%DHV4AVF[EWALX6B:V:JGD"0: ,683!#,"43'BT@!4M47QK/
MU(E\1TR8Q-E+^:.&BB=QH;58*T<\;07-C0D&*ZA'F56^.UJ9J?[V*%I!,DYX
MVL;DS2P"@9Y7-AFCI\U("H-FU=:51?:@TX4T7G+5Z\@CCY2;FW2+W$1!397)
M,,))M<\=,O7->G$H V<IVSQYJA+.XUWR=BJ96YV<9*U*P) O<RU377L4ZEGN
M/FCRD%6UR!@8A+A4!A)+>B)T"-P6%1ZQ.2*;=&S(X_MFN<\VL.BD!G1S63JV
M"&.3>4R;H%C(D]C)@EP5)@*6XMO.Z)0E4&UXJU9!H2F$M%BT[%JXWUB$=&J\
M"\#Q4+Y55UES3"@.(=LA(D<+6OWE@B8L13)RXV%O@Y\#9B\A%^M8?R50;"UG
M?LPQ;7V8V^\? Y&5R1GM5W2!G;RI@D6@[9LBU%1$)-SS&3:FJH^.63M4L;28
M&R4;!J$H4G*>$)96"PI*EI]H-9'\76-]POWL9Y[2L';BSYQMV,EDD(^)V&)Z
M3I.TH+2?LG3X3]WZ5K/PCS\">^D52[758'NK3XY*R@?0KS VFP8+2%QM=(1
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MQ9/NN6T]=AAQ9."@E.<\14R/>J'DL-TE9BP%EPK,$B(0-F%-EHDTM2.#'1A
M?&*B"5*6#%BT(0"IY=QD1$QDD"S&T8K5*P@K)>7SGNP/2(@2X'Z'60434KZ1
MQ5Q\_&HQ8$.!J92+R6B9?2#'.?Q+@1%YTUK5N#:([=P )R12^E*W\%A"JY[;
M+09"U7WY(=C0(6++NK+#(Q*#F( == CQR"#8CDY93#2A$F+KCU>[C3R05]XI
M@=(6'%$?P*Y@UUN6>25[S<R6LD4I"N@-T_!:$*6I8Q$>0[BW,(S+\N4,)BXY
M$.%B9@6+;6>NRDPDA,=1:H)T(2$H])1,3X6 19E2VS9%)N@E]T4AOLS[O=+&
M+6*2&2X./Z*H9,L\6,4^S=[!SVO%*VBJ5=Q#^X5OA>K5-99<W:[DXSE?'ME*
MY@1^=ID*MFE#$O@6=O<FY-H)W+,9)W?/@F2/(,;=A 4;I:;ELDGPV#D3B)T=
M3IT2TG;K'N**('S\BW%^MX8+!L-@Z3<;&]W\%19"X&NJ1 9B$<<<+"W.\YYF
M-CRB*U<F<,:S 'Q1$&;&-<WW2E>\>UA,;/PDO.('SU__ &R__\0 *Q ! 0 "
M 0($!@,! 0$!     1$ (3%!41 P8? @0'&!D:&QP?'1X5!P_]H " $!  $_
M(<KNKJ3I/6(<KJ^3X66\=V' VBU:?)(I5:B?U$^"4 PEQ7&D)*CIN Q^29<-
M,, <Z@@U*[P,VGC\M%5.-(4^2-&BB77+95T2\V+YF^NAQX*Q!LDX\@C&YI<Z
M\$IY]&7L?AZYI$GD),,0P,@6%WQCE[++9_\ #-8OM9<_MV=SPGD:4*5;%?&>
M^B@/[9Z6+1ZQGUGX$@9W,5EG;A_J1/\ '"NR)1#?W1G]A'?QDHTF+WC19*]7
MX=2! $Z?/F#:Y='\AWPAJ<:3,K!O,1PTWQ12Z1%H':;+^+3+S>7Q%D<LB,>X
M[Z91P42$\8CCZE$# 8DOA?ECV$3+S1!Y.+NHA,=+$;!^^-B:O/&.9LLN]M\W
M\H^)2N,P1L%D)& #\00Q*N8C+=+QKGH\3MPBOAIIW3E@TG0UK:/$PI] ;-LC
MF<9%I-(SY]2GU,2T8FI,=S>S2_%MTO Q<@ K74UO]Z(I'&%*IC/OHBO C^&\
M)XE3!J$Q.2@D#0A5;*7#0CID<AD/33FW'%JC-O5X/LQS25+V0]0)1!4,#KC=
MPL90=08$<77GY&GM]Y\:?/-PFIMN_+W>LBGKKV2[GE:1A=,9VD-L* ='B_EU
M:3TKYNPLAK&.O$>\ ,*P;*QYKX4 IF#N!OI@?\ [%'0& 3B/@F$>X=*%[V3J
MEMKTMG9;Q!O5*VWM!-5,4X!XC]ZL7:%)1(-]Y =PF!L7@_')9KA5[Q^W37CL
MAU9]/=CC/D#Z;HPY61U.H<XEG13AKG(A:.&Q',GR'"L'V$RJC"<-X!OA?Z6+
MJG;.#=1+-@W![CT<U9H,A1O,9#.NB<YS#ME^+RD*!>,P%=<$2@"#1&,3#V]G
MYFOHF;GD(!  B%$=(CI$Y,9\!D6U36P]KU.78 SP^P],28\,X^P\6655[YL3
M+X)4Z9/:F28:0B>DQP19G&0]!; ?8.\# T8+])J2_P#<9<0<')X3&-_\'AA\
MU8=805^%,->8JL/_ *8&<BO#^#6I?>>Q+P-SF8/7":,MLI+0/ZP7/K.,TR4-
MTBO50:^')!B_2A21R*#$3-[NF93VDI+U7(3J8S4%A/?W2!M>$])C*?,:7U^K
M9DL6LZ=B-KE/\E04X_%)#WYOCD:#N8C"<._?#CCJ<C6$M*C.K#:NN&"#%@5_
M3V#ML\&)Q2Q#UXLSSI87:[?<('*Y>G.%/?3XWY>7?_=]OU_LK]#Y @VAD1>#
MAOUV0 2B?G,\ FK#<>*=Q1*YHM&9Y2.26%K &*YY-),80P%W# X.=XS!@W"P
MPE!7NZ"JMR:@>/*<>$9IS6#%[*)]5.8HM1W7RG"14]J4RX$3QO"$3FG^&,;D
M+T(0\TU7B 2I5?=R['KH(4/#@R?S]\3]BY+DNV*S]VRQ(,E+;2/.JS!;F 2S
M*"C/^<,Z!_$G#C6F AN<7HZ9\>N"D!PXLE9'CK65DA^?I<GP2!<%H@33>'!R
MY\X@/C'@I"-(2[W:O3=B#$H82RC)= TYV:M3C7V_I%)F:'90.!U;A%A84ISR
MI_D!Z@;?L7 )#-![JK<D9+[6J_.;6BEXNLL1$H?IP26WOO&^4FX:9*5F67NP
MS3S!1E^"Q((13IP%D%\DLW^;+;DG\4/KA;B#-E43,*PS*OUZ5RE+ O&H3+[;
MN0X5.5T=?D#;$2HBM#K:85<,7<)% >%7QX=TO<\LS';CYU6^,_\ 4HP"25/<
MX$9A/$E'0*WA'H%JOCZCCWW+;A?2>5QTVV/&K$\("" ZX;F0JO(99WDI?$,#
M!C<=?KR;@1.BI'Q=L>]BSSJ"#AAY"04^GKR[Q!X-OO!'O&8,C[+R?4[>0 >.
MD-DU>R;?6$99&W *1,9VRHANUTL>PEC3KA;OG_X9(>*;,=>CU7(D '+,[%*,
MF8R:CR: Q@5NK3;FJ&TL[7''$Q$*498?&(+7&FED!=LF[JF!/AP,'2. O!B
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M.9$>GOIM$\5U'%+P")E*T84SA?*C*@RB3(TP!C<1[4H&9@/61@A=*H1E G$
M7<^[()A%1FS72%O(?/!F;(YQ/>\V!VSWWL^-O?N$WF$_1X^7X;7[&@?B%@Q+
MLZ>*"F8VV;.)*,(5;%?I&219/>#SB,0%%O\ ?:*,,3E&^CW)MWI*],XW"<H;
M_P!=O.=QW_+Y,G8<0 ;JF  M4S725WBQG:"E#P^2H[Q#-HJ(PVK ,\NV#7VZ
M IWXNPE]%DOEA"64US.=E(!*Z&ZUQZ8 70\*_P#Q@PR6%@@5MF\4T3"/-W07
MYEJ1@QP[WIMV&S]XYR)S*N*1B4$*"H-0G'>(J)MK6=7<!R/K82P7A#W:PUI=
MU')L.CT8=&Y%N@&@NV ##& HA0<^7Z@D-':..3^PO^'F!R<UC1BG(" GGC%H
M[UX3\6=\0K0+VF-1WS*")"XGKI2C)/)F(#5,)F^KO:)(;C99%S4F< (A5K>0
M3>UB#D"G%UL064@S'(!I.J:->7L9&E>.G?.>',T8ZW[Y[;V?'#04F_>E@4YP
M[R<+E.=6B.)60]TW9P6N?MQQDZMSLM.FY<,%<A]SSB#G;L;>E&7+Z!/27US4
MOG1CU2WT#[Y&HI*<+>M&^3,.O5URT>J#:K(MP)&[&L"GXM[%X@["@MXK::_2
MH3.B#_5E[+\* >27C<)+ OP.?A(8= 7,PP6Y=D'/ZZ;B)ZH!PIQ:4K6<I!'G
M0I_BD$ 0S>QEH*,JTS0I,GY(\O*W^3"+$HJ80'C'>QZ]9HEE'5)9OA4R5AV
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M0H45,"(.FO>/B.>>(N_[\U+]M-*D([F\)0%,'C84<RH%K]EW-'GQ@W2O;?F
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M#*:ED5C!(:)"(@:K0\MO_P SO__:  P# 0 "  ,    0          @
M   D        $@        D@@$@    $@  D$ @@  @D  $@  $ $D$$
M          $D$$      $ $D$D@  DD@D@               D@$$     @$
M$@  @   $$@D@     ,$D @    D@       $@$       @         L$$
M               @        @        $7R8      !         @
M  @        $Q%H      !@$                C&.A<Y   !9%       '
M        $@       'XU']ZG   "%K       %                 #G"/R
M&?    G                !-)))     "& 0N\/   $)       %K8^
M &MMMJ     %HVB(\;   <;&G(8   #[A7     %P;M"     #UB":4O   #
M-\IX(  @$?AIT\   'P5F(     ![\P-L7   -&(#TPX  #>/  -8  $]@'8
M'K  @'34'=33   :4Z4'%X  #E,*D-H $'F,^@D1  @!UXH9OC   E2O%#H<
MH !\[P%)    #P@( _   "P-5W 4   1V,?4S_  !#GS3ND,@  @
M         QR^#S7   !K_ANQ3'H  $$D $    >,$                !
M       @@$   @ %_C1       (        #          DD$  @ G 2O.&X
M    L$$$D$   #@D@ $@   @ @@$@@  N&Z O8    8$$$$    ' $@ $$
M H  @D$@            $DDD$      @DDDD   $D$ D@              @
MDD      $$DD@    $$@
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M*9ELQ@("3@\FPZ?HET=KL-X'@CEJ@IS7G$V\3@V$6#N0A\@\ (V.;9$*4UX
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MT2\?I1]+\OVTS9(2,.2<6-# [CIV0Q3;^9$CK!F+]%MP1D 3.&
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MBC4/>_X3>_# 4R )@.0@"!A2,F>HBC7S71P!HUHSS,."^W6IVP!T/@%?JVD
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MG0"JJ3E3"-IXDJ!;4I"B,#>4%5K0*BL-(H!%:HAVI'A#@ZNR.MDRP4]L5^T
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M5<5&T#60V[ RP(40H2)2J@ VU2H_@N@;>($2W50C5%3IMJ:<MP<G(I4 % 7
M<-2A^?/^[Z:]N^-RVGXE8:A5)#6! )W#J6WV6NB-,52 75O\5 10*_@5]8;@
M.)A$@"H81B3\@6!((4%*X#JS:,J@ 558;5>7\044%"5!0O%>EZ=\CV\_+O\
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M *(%.R\70@ Z9P@' !2'(G__ .Q@NJ8-,,@F2 $" =(BB.DTX,S! XM8UJ.
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M@E'1!J]V%Q0Q5  7$8]E<GC!J]^+3@"H]Y1%HMPL[&(M7C-B)*A E,I)L"M
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M5_ SP@0) L/&+I7",P^U%JHMR&7ZYK#U@6! T:968-#HY)R%K@Q"!Z%&E%+
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MILNRB7VU&YI%2!]Q*=8;[:9X,DS>*0"03<![R&#B$<C9^*'+KB^$FS<8\/\
M/PM2=L0>2%8TCLW+V UQWWAI%LT< T37#_9^) [D+OA_ZW^/G-F\?(1#/9^A
M960Y-GIXMP6@-3DO!@_@4<7GX9YQ&P<2 $%L90PV)G1IDP:3]S%B1%;!%5(
M* EO8OFBP^=J1@8)'V<8(4E5I3F(-H+:5"U:]Z7J$^,1%Z\.HK93C\1K/56%
M$=%J55>077R3SB3B#M7APY,9G--GFBT=8%H0.'D-L':V7^"3-]4YMWU0NA:Z
MZ67OU:EG>72^4P]E7 #]/RPDWAURDK#*N3V?(I09 &JR'R/313KS%[]J<YZ(
MZ253SK5#-)91(4F>)'HD8L,T$G'-EWFF=.E:;7V7Q?\ L)1Y%1FJ"G/=8LV&
M/A>]Q=(3&*OJ'F$AW :-]<-_&AO92"QW&WU(5@H"),,BHT!3>U"R[2TJ3=>2
M"#\3D!T?2".C K/*G)6\X:<@7;JU=:KRZ[<V#0\)XYISTR2(":[APT@")!2]
MCY37)M5><;:7A^?R 7R/(S W)8F!<G&2@O@N\J:,@2L(ZBC-5OP0P-[;*A!)
M(T-<W$(V"G;5GX_>7.?U/^N<3Z?^X_=_'D7R]<; L4X\S1&N'C\5$>$I*K.2
M9NX:MZ1.ERE]P$;#_,;MEEP\\D892SC)Z'(I[DR2PC^F"!]^ C!35Q*ON"(D
M# O'TC1Z9,$-T#RX4QL4L0'>7YQ2B:Y3><JT8%2U1!I['PS*B6Y*:)VD,NS+
MX;\@PRZ&!-'@B&J[<3&)DK;MX^ON:.7&F4X/P'+MVW. =O[WT 5%\SH]9&[G
M B][-E?,=H 2!6.R>-<,CJ4?"0>D7J?U.!;7SHP+L=5R1BU83%50:>F(#5Y'
M)D-?%KS3W7X%L-T@XC"4F/T0,2\12'0D"\0(T*8[)GN1^'-[.YYJEZQ?-M'6
MCJS?-6<(V1UB"VQ\HU@]F(&'7 HH3*)B:QVM C 1QP1([LAIM"]/MGQ-S.7I
MI+ /SP=/2RH4:X.0B N PC#[#57P-U=2M0/]="WUF+>%N=R ]D6#1,5 2Z%&
M9U<' B4^'4'I0=I#4T#B9(7:;FB"$\Q.'W$PT%="HGM%'N?>'O0(A#<+^T0P
MR3X3D)C$@)( DJ5B5JS@EL3*E#+<:L#4)IU-KB8ZUN/L :[A5Y #L280&%0X
M50_H&"[)AJ_&FI1U&&@# 5E$0IXE@( 17B.H[>/(-%JA1P,P.9E^+Q@<)(+=
M6H!=Q&.! 3@L)"H]?7A61D H(M)"Y8GD8UA*Y4!VA@PQ1WC#X4P( <1X-W.V
M$-T>)\.Z_P#-JF26L1!2: 0I HV)[6EB"B])$+"$.1C#D9-BF#DXH<8KBQ1@
MTDRAI[7)HR]+A>"<L\@C,$,F?BKKMO@3R3#*M$+I02DK,E0_%)G3%_'4$BQN
MF8A:,ICSI#-'7HWL=CQ-)#;DL&P<IE'G-FB"Y28@J1-&!0]S"&(2'Z>,&9E
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M0<OQU5*_&/ RJ1.PT\)]3\,14G1':&'>NM\<8/@"QP'A\"^,26_H !T5(:?
M(QJ0R.0R 8Y7UR$X6\NJU.*C?UPK@[_KP5#^@X=,]3U)E#^1\"\@O@)C'7-R
M:"8G" [,82*P#D9:/3YD+151%TR"Z&#"N&6""<18&M&F43/(PF5 NA:ID6^
M*.3@C,037DEW@5)B7"W"6.7<XQ'S;0BBI %Q::?*@Y"RKH</A?3P0%=P,G"0
MJ"S2H9Y &%F02FI=W,8$@4V9Q/KK>>P9X7WS_CJCMML>Z@D,HWMX#B1[*JCR
MB-(;7I.]!'Q)[BRG.@J]=''440O=KF:BFUF>Z^TCQ'%1#BP&09:#%\F=-!EX
M4P1?QNQ3.Q2>K&LE)AK3XG K .A#I='Y2>3 47$V)12)&8H>8N#&':A-;8T;
M?#-3I)9R5"52\B@PBF+U"NU&U,%BVE]*BQ+H(44\=C>";BP$JBA7&X-]H/-]
MQ/X_JQ2[7*DR[B:UW\&_P6PC>+_]I\<<]MXFM;7!")V.;V[4U9C( -<VIM[.
M.WM]XJ0M*TVW>W+[_>[F^8[: _@!S[GYPF?3]_.W]]>/&EMNL(L3H'@<K LS
MMFA;(II"SQF;E2E:H5Y"]!2$]F' MN_S%VX?[?U>\N'QO35T, "XLZ#('\;.
MI2!P>9;=9A4.A!!@D9 !752]R=5;<:R6E,8:GNE R)YH>IZ]<6\9S\CHHD#F
M-'D<B_\ R) L3<Z<B2,'<(1\6CV@:*J/N/O]D:[9:.8D B>@)#I$]$.#D<%B
MR1<)W8GQ-#:0>(DG9M_\6 \3TN)H8*\,95Y.]\U_S71(OA*3X9F!!/-D=H&N
MFEF%7*XD^UX*(%[ M_<Y=67T\".@18'3+)@3"!%H"-=,Q..(,"*6*CN@RO-E
M3&!PW4C[\)6L[3_UB64CRB'XIH+#S/Q9TS0,3$@-)<WCB&&K&-P"7L-^EWU#
M@FN>L&2G>&:[?G1+?QOR#[;RMUN^[W;:;O-M\EO_ (0X#O@,"\N4HG)/N?$^
M%#L4F51D_)'6&##;'VV_P4>BZX>J4$ZU ZI0& $EL5(K6;#4&A%#AP'XL 7G
M@F*P([!CGM!Q-K22(H@$4=:P"*3S+W!C4(4X<V>V0E?\"A!C""[CQ<%58E,9
M,75(V LQ#0(#Y$^;A2MJQF2U7/!FP6Y,LS;0)( UW<74IAK'&#'IZD/5H^&1
M09, +4$( #3'6^L\Q<5$3#&28SV.D"]GF+R*ZDLN@)$7G*AI_OFNK%(!Z0NV
MP;/,^96B,95&CIM!C#B"$7^2)_Z!H7]3346235!#' E+H>7N?/S*$9B%N8WJ
M5S26P1(?&M13UWPO)C=QLLDWVB?D3W$UD:)-$@FJ!)[:#@(8]\=GW4Q3E\S"
M"HLT_P E!!$*,=6Y/QQIDI[7,2^/HA4SG/H)^M:7/!,NQ4/3V82X2MC-*SK%
MS&R2.T"S5,^B)K,Y+/:1/Z=!,/QY$\37LQ=W##'+H6-)("[S^'.9%+1F !;8
MQ</@].:\@U5!%@H)12N\&EUUK6]N5 C(BI32%=W K!K!",VTDG -,ISG+6['
M2P8 1;0)A>9VM=W$P:+,A5SP#A.0YYL0<LWY JK*11AY\F2A%0D%S%TM>C(>
MH52D&<, E5KJP]#_ (BC]XK\(^R<Y>VW;=KONRO/RR5=1XVB7D+ >7*$.G$,
M),!*<(4,)CQ\0-ZKN">P:*:&*4O$;H#-EE#CTM@.*::#XN&>.#.>C"GS>?CY
MQ,P].G>M^LM/_$/($?Q$7SM#KMY2MM8Y;YJ4AR\Y(W'22H:[$QP6-G2'N(BQ
M+>O,T]$$]'H/4D.!(HGAW BF *),R_E&N<?+ 4X,D3;$H$;(9#(C?XUSVCNH
M.@C^((5<C*$1%,KY">*8Q[@28( TX6J54M!_ F[C/A@W>M>?T\:IW?EW.3)R
ME#0/1\:P.T2=^=T]@^^7H>Z*<#(]O8;^0^7&3IDT2!.V"'T'L6@ZSL>>FX"0
M,?%?0[(B<P$T3H1$].0&+>'"C"4M?DD'D4&0L[_L?%6+"HO&<691K&2-GN7Y
MA\<,,/!.3VNA<D#RLX_O\%A?6WW\ =.4XG1US1KB#>#%UEW<S1"NA5D^"0>J
M)=>XLV=D'-M9Y.ZIY1OJ,)7.M4TL]ORM:S>&0[]TRJ<QAPG'CG\HR/G \]XL
M'I,'C^ OZ7+;"E 7H06%KUT*:M\N.C# !L?K<C+I(0R;*/&0A+P9@^%II0FP
MS\&_%E]6)2!(U%C-Q,/D]W4'5X3/)#7KH.'5["A>3IIL5/1;-Y2R3Y_S7^#M
M'&@6ZMS!A 4> "J_07'<G!@?6 $Q8C320B)+JU"#)-WHUX"K?@DU@[S@04#C
MR_L8:]ZRMZ0CMU8*,CI)-S3BX$7H*7TU+LW)V!HT5\C*6ZP="HPB[F3 )Z)R
M00T/J*U@46)>1?<Z_'S+^=_WIP C[>(N$IQ;XI5!7#UKD8N6WW5)B=YX>Z%X
MS$Y-L2#6',AT0K*I?,&;- ,A#]9N[J->X!N!#0,:HT@FJ>%>8\!G)C#*RSVO
M3O0?^0\+Q@.+1DTK</[9CC"/94)%M,Q]B^-_B.?W?_8'W^^\_O\ _LS<\-^Y
M_GC_ ,7">1*,9><6D' #PT-"3;B,K>$*1[1LD% 0$Y0N-!DR4ASAC@!>-*"X
MNUSP70$/9H]X_/; 'CI-N*A8[WO@E)2,YJ9ZN"&]@0L\,O$WN..#W9]@%97&
M9(@2W-I<)[@<8 ,&LZ_IH-PCJU!AT"!Y5 TW98EEBVO1;7'P?*]^L"EW,&(<
MO&:\)IZ>DG/1]^'=#1E=NXUZP%,7S8I#C]2!!!@2RYVF:CGKYK#\](AR8%2J
M\V_RV36:9@PNO"/; R_D)/,"7E[&28JND @?VWA%@++*+#5#Q]7&2D$8"$=H
M&MKI*),;SM2&<(, &&LS"MTR* IJX9I0S8+\)^AF;':M W[N)R%<LD/N.OZP
MC_+C247XT_W4PXX@F/DL+@R-]P5E%MT8TS?0R9AK917Y(S/*("Q(P.Q98.<=
M=F/(E 0[J$L(\! I$DG0,_F8%Q132UHNR6:%*R$92)PPN4(7S@[[!5!:@LW0
MKO%59AHIAJ;C+<+*5NRI>WZC01;@"FX@8J3*H'^AAPD1X.,]AXJJQ8U>9,(3
M*#5M2*1<+ESTN5@$L*D59Y578R;UMB6VNVS4$*,AKVXA"X!X#%[(E *@VH;'
MZ>,>FXPN$(4""B <4/E$*4"!K,CN%F!E&+QLM,0@#[X(#4"1GMF=+8 X#<;2
M(>EM\D,I)=NOXB6Y=&50KAJ9;/-OP]\M_P#AJ5NF>0@>(F%Q&'(.L0VXE2R!
M2\PO-0"PZN)0^FA*0;M-ER>!+VY[VD1C%Y")< $#0 "(U"$@4B>J#8B5BR)6
M 5@NL9B=\K@<&UJ547079:8/FR'"J_;>\NWB]5CQ<B>8JVEA(<0( ME98]J8
MU9%=KP-\F&X8R#/<YLH62*O@D>$'T3D4IZALKG$#?9KU...X6G:]_DR5SVYT
M*#/40<3&%@SM]@7GZB2P^67P@2L9(?S/QAH<<#B0OT#IYT3T""\]/B @?Q!*
MW#?1!$#:_(G3=VRXU?B9&8<.[O3PV23@TCPZ,ETAG43YI#(B/KU;QFRQ.%4E
M]QZ0R/"JG3E12$K" @>!ARJ6;)LA" J5VKXV*5"%&/54F9!)B"CE.AEV M1(
M97>%@Y&?I!'1!/\ NJ"S,<00Y,"I.(C (DCO0+DWE<)?P+]S8;A4,=]L%,3E
M)O&@&!PYNDR UBZ]/M,Y&/"KV,XRIV*Y.EE+\,(]2LG>&B=UWTL62 4RK'8K
MEI;1!Z@>K'SQ/#Z8QUAV,*S*Y@7RJ(.  KL='FS'//#0K0 H,. 0R00(:)':
M!0V(,>:UJ<B4--"7&XZ^;#R:'C'J)TC(92960,UL+>'11]NW5(/\*P!AVT3B
M;D0-G <UH9Y6-AD[3C+VB74TXB(L/6PZ&#0KS;_Z6-@A! 5L:H84LCC/:.P6
M%S NSIH,2$'#';EHYA%Y _K3%EK(\N']*S5)!$*=/(%VPSUYP\^L9OA3V,U4
M<[G/#K./:P:P_B4S98A#+7,$!^X!ZI(NJH.$IZ\1Q7: V9^4<0)5@F-"$43S
'&/\ XS/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
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MO*":A\L'?#[DFJV\\,&?-NW&-A=^DS]QXM#3U(6Q:]AHYBON66W4!3ZM_,3
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MR?Z>O=Y*5X%58!58!3Y9@;UD/UGP3;<*K *KP"KP>Q382_;W[/56N@JL JO
M*O#)"NPE^\F";[I58!58!5:!WZ/ 7K*_9Z^WTE5@%5@%5H%/5F OV4\6?-.M
? JO *K *_!X%_@]\8[9H0ZXU*0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image221.jpg
<TEXT>
begin 644 image221.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &H!RH# 2(  A$! Q$!_\0
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M !S]17L7ASQEHWBB'=IUVOG@9:VE^61?P[CW&16;BT:J29TM%%)FD4+1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2B@!:*,48H
M**,48H **** "BBB@ HHHH **** "BBB@ HHQ1B@ HHQ1B@ HHHI %%%%, H
MHHH **** "BC-% !1110 4444 %%%% !111F@ HHHH **** "BBB@ HHQ1B@
M HHQ1B@ HHHH **** "BBB@ HHHH **** "BC%&* "BC%&* "BC%&* "BC%&
M* "BC%&* "BC%&* "BC%&* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHS1F@ HHHH **** "BBB@ HHHI %%&*,4P"BBB@ HHHH **** "BBB@ HH
MQ1B@ HHQ1B@ HHHH **** "BC%&* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BC%&* "BC%&* "BBB@ HHHH **** "BBB@ HHHH **
M,48H **,48H **,48H **,48H **,48H **** "BBB@ HHHH **** "BBB@
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MFDKR#XO^+);;[-H5A</%(0)[EXW(('\*Y'KR?^^?6FE<4G8]?HKY'_MC4_\
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M29@$7L!]!Q34;DN5CZKHKY'_ +8U/_H(W?\ W_;_ !H_MC4_^@C=_P#?]O\
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M$-Y;M;3] 3,VQS]>U<U15IV$STS_ (0O1_\ GW?'_71J=_PA6D_\^[_]_&K
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M4M+N&^M(;JVD62"90\;CH5(JU6)N+1110 4444 %%%% !1110 4444 %%%%
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MAK_R4/1_^NK_ /H#5R==7\-?^2AZ/_UU?_T!J3!;GTY1116!TGSC\6[TW?Q
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M+^8S_P !]Z]^U7_D#7WM;R?^@FLYLU@CY&HHHK0S"NK^&O\ R4/1_P#KJ_\
MZ U<I75_#7_DH>C_ /75_P#T!J3!;GTY1116!TGRMXW'_%<:Y_U^R?\ H1K!
MK?\ ''_(\:W_ -?LG_H1K KH7PG,]PHHHH ^G?AY:K:^ =&1!@-!YGXN2W]:
MZGM7*_#AS+\/]'9NHA*_DS"NJ%<[W.A;"T444#"BBB@ HHHH 3-<C\2+=)_
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MS/P^_P"1!T7_ *]Q_,UTU9&HAKY&U<8UN_\ ^OB3_P!"-?7)KY&U?_D-7_\
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M1_R(^B?]>4?_ *"*Z&N>\$?\B/HG_7E'_P"@BNAK!G0@HHHI#"BBB@ HHHH
M\5^.?_'[HO\ URF_FM>15Z[\<_\ C]T7_KE-_-:\BK:'PG//X@HHHJB3W7X'
M?\BQJ'_7[_[(M>I5Y;\#O^18U#_K]_\ 9%KU*L);G1#8YCXA?\B#K7_7N?YB
MOE^OJ#XA?\B#K7_7N?YBOE^M*9G4"BBBK,SL?A7_ ,E*TG_MM_Z)>OI:OFGX
M5_\ )2M)_P"VW_HEZ^EJRJ;FU/8****@T"BBB@ HHHH **** "BBB@ HS14$
MDJ0Q/+(X6- 69CP !0!YO\8O$G]FZ!'H\#XGOCF4#J(0>?S.!] U>#XK<\7:
M_)XF\3WFI%F\EFV0 C[D8X'^/U)K#K:*L<\G<****H1N^#] ?Q+XGL].VGR6
M??.X[1CEOSZ?4BOJ1$6*,(BA448 '  %>9?!OPY]@T676YTQ<7QVQ$]H5/\
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M5^6*V$6>V7<'_P!DKW2L9[FT-@HS14+R+&A=F 1<DD] !4EGCGQKUO=-8Z#
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MP.D^5_''_(\:W_U^R?\ H1K K?\ &_\ R/&M_P#7[)_Z$:P*Z%\)S/<****
M/IGX:?\ )/-'S_SR?_T-JZT5RWP\V_\ " Z-MQCR.WKN.?UKJ:YWN=$=A:**
M*!A1110 4444 (:Y+XE?\D\UC_KDG_H:UUIKEOB(4'@#6=_3R._KN&/UH6XI
M;'S%11170<P5TOP__P"1^T7_ *^!_(US5=)\/S_Q7^B_]? _D:3*1]1T445@
M=!\N_$#_ )'[6O\ KX/\A7-5TOQ _P"1^UK_ *^#_(5S5;HYV%%%%,1]6^$?
M^1+T+_L'V_\ Z+6MHUB^$?\ D2]"_P"P?;_^BUK:-<YT(****!A1110 4444
M %%%% 'G/QG_ .1'C_Z_8_\ T%J^?J^@?C/_ ,B/'_U^Q_\ H+5\_5K#8QJ;
MA1115F845O>%?"5]XNO)[33YK:.2&+S&,[L!C('\(//-=7_PI'Q+_P _VD_]
M_9/_ (BE>(^5GFU%>D_\*3\2_P#/]I/_ '^D_P#B*7_A2GB7_G^TG_O[)_\
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M)P.O\)]:3T&M3WBTM(;*UBM;= D,*+&BCH% P!5JN-_X6KX+_P"@S_Y*S?\
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MOZ*\_P#^%P^$_P#GM=_]^#7?T6&G<\Z^,_\ R(\?_7['_P"@M7S]7T#\9_\
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M(.M?]>Y_F*^7Z^H/B#_R(.M?]>Y_F*^7ZTIF=0****LS.Q^%8Q\2M)_[;?\
MHEZ^E<U\M^!M8M- \8V&J7SNMM!YGF.@W'F-E''U(KV7_A</A/\ Y[7?_?@U
MG-:FT&DCT"BN _X7#X4_Y[77_?@T?\+A\*?\]KK_ +\&L[,KF1W]%<!_PN'P
MI_SVNO\ OP:/^%P^%/\ GM=?]^#19AS([^BN _X7#X4_Y[77_?@T?\+A\*?\
M]KK_ +\&BS#F1WU&:X'_ (7#X3_Y[7?_ 'X-;7AOQGH_BJ2X32WF8VX4OYD9
M7KG'\J+,=T=+113"P52Q; 'K0,\\^+'B?^Q_#36$#XNM0S'P>5B'WS^/W?Q/
MI7S]72^._$C>)_%5U>1MFVC_ '-L/^F8/7\3D_C7-5M%6,).X44451(49HHI
MB"BBBD 4444 %%%%,84444A$]G=S6%]!=VS[)H&61''9@<BOJ?P]K4'B#0K/
M5(.%GC!9?[C#[P_ Y%?*->J_!GQ+]FU&?P_</^[NLRV^>T@'S#\0,_\  ?>H
MFC2#/<J***R-C%\7?\B7KO\ V#[C_P!%M7RE7U;XN_Y$O7?^P?<?^BVKY2K2
MF95 HHHK0R"BKVCZ7-K>K6NFVKQ+-</L4RDA0??&3^E=W_PI/Q+_ ,_VD_\
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MN0O'X$G\*ZRO)/C?J8BTK3=,4\S3&9A[(,#\]Q_*G%7)D['BE%%%;F 4444
M?2/PKM1:_#[3N,-*9)#^+MC] *[6L7PM:&Q\)Z1;,,/'9Q!O][:-WZYK:K!Z
MLW6@M%%%(H**** "OF;XF7HO?B#JK Y6)EA'MM0*?US7TF[A$+,V% ))[ "O
MDC4[PZCJMY>G[US.\ISZLQ/]:NFM3.IL5:***U,0KWSX<V_V3P189^]+OD/X
MN<?IBO Z^D= @-EX?TVVZ&.VC4_4*,_K3'$UMU&ZH=U&ZBQ1-NHW5#NHW46
MFW57O;M;*PN+IONPQ/(<^@!-.W5S?CV]^Q^"]18-\TB")??<P!_3-%A7/ W9
MGD+OR[<D^YI***0@HHHH$%%%% !1110 5N>"]1_LOQEI-V&VA;E%8_[+_*WZ
M,:PZ4$J=R\$<C%'0?VC[&HJAI%Z-2T:QOATN;=)?^^E!J_7.= 4444#"BBB@
M HHHH **** "BBB@ HHHH XSXJ_\DVU;_MC_ .CDKYKKZ4^*O_)-M6_[8_\
MHY*^:ZTAL8U-PHHHK0S/5_@;_P AG5O^O=/_ $*O<*\/^!G_ "&=6_Z]T_\
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M (,>)?)O;CP[</\ )-F:VS_? ^91]0,_\!/K7M_:L&K&\7<QO%W_ ")>N_\
M8/N/_1;5\I5]6^+O^1+UW_L'W'_HMJ^4JNF14"BBBM#(Z7X?_P#(_:+_ -?
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MZC_W_7_XFCG#V<CY^Q1BOH'_ (4OX6_YZZC_ -_U_P#B:/\ A2_A;_GKJ/\
MW_7_ .)HYP]G(^?L48KZ!_X4OX6_YZZC_P!_U_\ B:/^%+^%O^>NH_\ ?]?_
M (FCG#V;/G[%?8PKSK_A2_A;_GKJ/_?]?_B:]%J).Y<58\Y^-'_(CQ_]?L?_
M *"U?/\ BOJKQ)X<LO%&FKI^H-,(!()/W3;3D ]_QKEO^%+^%O\ GKJ/_?\
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M?A2YQ^S/)/ _PNNM5GCO]<@DMM/0AEMY,K)/]>ZK[]3V]:]XCC6)%1%5448
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M-'_"E_"W_/74?^_Z_P#Q-'.'LY'S]BC%?0/_  I?PM_SUU'_ +_K_P#$T?\
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M;Z@(_P#B*\(KVKXYOC3M&B[--(WY*O\ C7BM:0V,I_$%%%%60%%%% !1110
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M&\J7_GD_Y&CRI?\ GD_Y&CZO3#VM0[G_ (3C3?\ GA=_]\+_ /%4?\)QIO\
MSPN_^^%_^*KAO*E_YY/^1H\J7_GD_P"1H^KTP]K4.Y_X3C3?^>%W_P!\+_\
M%4?\)QIO_/"[_P"^%_\ BJX;RI?^>3_D:/*E_P">3_D:/J],/:U#N?\ A.--
M_P">%W_WPO\ \51_PG&F_P#/"[_[X7_XJN&\J7_GD_Y&CRI?^>3_ )&CZO3#
MVM0[G_A.--_YX7?_ 'PO_P 51_PG&F_\\+O_ +X7_P"*KAO*E_YY/^1H\J7_
M )Y/^1H^KTP]K4.Y_P"$XTW_ )X7?_?"_P#Q5'_"<:;_ ,\+O_OA?_BJX;RI
M?^>3_D:/*E_YY/\ D:/J],/:U#N?^$XTW_GA=_\ ?"__ !5'_"<:;_SPN_\
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M1H\J7_GD_P"1H^KTP]K4.Y_X3C3?^>%W_P!\+_\ %4?\)QIO_/"[_P"^%_\
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M_P"^%_\ BJX;RI?^>3_D:/*E_P">3_D:/J],/:U#N?\ A.--_P">%W_WPO\
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M+_\ %4?\)QIO_/"[_P"^%_\ BJX;RI?^>3_D:/*E_P">3_D:/J],/:U#N?\
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M_"<:;_SPN_\ OA?_ (JN&\J7_GD_Y&CRI?\ GD_Y&CZO3#VM0[G_ (3C3?\
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M<:;_ ,\+O_OA?_BJX;RI?^>3_D:/*E_YY/\ D:/J],/:U#N?^$XTW_GA=_\
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M^@<_U%>Q5YA\$K?R_"EW.1S+>L!] B_US7I]8S^(Z([!1114E!1110 4444
M%%%% !1110 4444 -XZ4N!12T"L)@48%+10%A,"C I:* L)@48%+10%A,"C
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MCZD8%6]U8/C&4)X8NL=7*+_X^*4E8$>64445RFH4444 %%%% !1110 4444
M%%%*JLQPJY+9P*!GTG\+[,V?P^TP%<-*'E/_  )V(_3%=G6?H]D--T6PL?\
MGVMTB_[Y4"K_ &KG>K.A*R%HHHH&%%%% !1110 4444 %%%% !1110 44F:6
M@ HHHH **,TE "T444@"BBBF 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%&: "BBC- !1112 ****8!11FB@ HHI,T +1110 4444 %%%% !1110
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MFZJB\31-;N1ZJ=P_,,?^^:J!G-'D]%%%;&(4444 %%%% !1110 4444 >R_
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M\"N-_LC5/^@==_\ ?AO\*/[(U3_H'7?_ 'X;_"BT0YF=K'\9/%:9WFQ;/]Z
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MXY1@E=-T9V':2YF"_P#CJY_G7C1.*,YZ<FM%!(R<VST>;XV>)7/[NUTR)?\
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M_!WPU'9Z&^NSQ?Z5=EDB)ZK$#CCZD?H*]3K.4C2,#*T_1=+TG":?IUM; ?\
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M/_0UKYFKZ9^)?_).]7_ZY)_Z&M?,U:TS&IN=)\/[1;WQ[I$+<XN!)_WP"_\
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M>E?!$_\ %:7G_8/?_P!&1UM+X3&.Y[[BBBBL3H"BBB@ HHHH **** "C%%%
M'S?\61M^(=\1U*1'\=BUQ%=O\6O^2BWW_7*+_P! 6N(K>/PG/+<^B_A%&$^'
MMHP_CEE8_P#?9']*[SM7"_"3_DGUC_UTE_\ 0VKNNU8RW-H[!1112*"BBB@
MJ.1Q'&SGHH)_*I*KW8_T.?\ ZYM_*@#Y#EE::9Y7Y+L6/U)J2R@%Q?6\!_Y:
M3(A_$@5!2I(\4@D1F5U(((X((]*Z#F/L10%X'2EQ7RQ_PG'BC_H/ZC_W_:C_
M (3CQ1_T']1_[_M6?LV:>TB?5%%?*_\ PG'BC_H/ZC_W_:C_ (3CQ1_T']1_
M[_M1[-C]HCZHHKY7_P"$X\4?]!_4?^_[4?\ "<>*/^@_J/\ W_:CV;#VB/JB
MBOE?_A./%'_0?U'_ +_M1_PG'BC_ *#^H_\ ?]J/9L/:(^J**^5_^$X\4?\
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MXO\ ADZ;KB:U;IBUOSB7'1)@.?\ OH<_4&O?JPO$V@P>)-!N],GX\U<QR?\
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M?^1+T+_L'V__ *+6MHUB^$?^1+T+_L'V_P#Z+6MHU@=""BBB@84444 %%%%
M!BBBB@ HHHH **** "BBB@ HHHH \(^-_P#R,^G_ /7E_P"SM7E]>H?&_P#Y
M&?3_ /KR_P#9VKR^MH_"<\_B/=?@=_R+&H?]?O\ [(M>I5Y;\#O^18U#_K]_
M]D6O4JREN;0V"BBBD4%%%% "4G3O2FOE+Q;_ ,CIKO\ V$+C_P!&-3BKDRE8
M^K*6OG#X2_\ )1+'_KE+_P"@-7T>*&K!&5Q:***104444 !KS+XW_P#(FV?_
M &$$_P#1<E>FFO,OC?\ \B;9_P#803_T7)1'<F>QX+7I7P1_Y'2\_P"P>_\
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M_P!@^W_]%K6T:Q?"/_(EZ%_V#[?_ -%K6T:P.A!1110,**** "BBB@ HHHH
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M1J%]&IU>X7GOY*'^$>_J?PKT2LIR-H1L+1114&@4444 %%%% !1110 4444
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M"_[!]O\ ^BUK:-8'0@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%%
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MD"M*9E4)K3_C]@_ZZK_.OL 5\?V@_P!-@_ZZK_.OL =**@4Q:***S-0HHHH
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MF)L=;N(5]+B%9/U!6O7*6FF2XGA[? W40Q":W;%3ZPL#_.D_X49J7_09M/\
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MA#1122!L****8@HHHQ0,*/>CWKH/"_@_5O%=WY5C#B <2W,@(CC_ ,3["AZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIIDN*9Y+X5^$]]X>\36>JRZG;3+;LS&-$8$Y4C^M>LT4M)L:5@HHHH&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 E<WKW@[0_$B8U*Q1Y.TR?+(/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>prospectussum2a1a.jpg
<TEXT>
begin 644 prospectussum2a1a.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X1..17AI9@  24DJ  @    & !H!!0 !
M    5@   !L!!0 !    7@   "@! P !     P   #$! @ -    9@   #(!
M @ 4    =    &F'!  !    B    )H   #\*0  6P   /PI  !;    1TE-
M4" R+C$P+C(P   R,#(Q.C S.C$Q(#$Y.C4W.C X  $  : #  $    !
M      @   $$  $      0   0$$  $   !J     @$#  ,      0   P$#
M  $    &    !@$#  $    &    %0$#  $    #     0($  $    & 0
M @($  $   " $@        @ "  ( /_8_^  $$I&248  0$   $  0  _]L
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MM-JR>HHRBI7:NNQRF@^*;[5=06">PV1E3ET4D*?<YQ7:+%')&-Z*V1CD56
MZ "K<7^K6G!-+5W%4E&3O%6(UL[9&#+!&".A"BI418U"HH51T IU%49A4D/W
MS]*CJ2'[Y^E $<BJSG(!Y[BF^6G]Q?RJ+4(KF:%TM+D6\N[_ %A0-@?0U5%M
MJ@;)OXBN.GD]Z=A7\B_Y:?W%_*CRT_N+^54DM]1VL'OD)(X*QC@YIAMM4/\
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M
M   -9&5S8P   2    ! 8W!R=    6     V=W1P=    9@    48VAA9
M :P    L<EA96@   =@    48EA96@   >P    49UA96@   @     4<E12
M0P   A0    @9U120P   A0    @8E120P   A0    @8VAR;0   C0    D
M9&UN9    E@    D9&UD9    GP    D;6QU8P         !    #&5N55,
M   D    ' !' $D 30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL
M=6,          0    QE;E53    &@   !P 4 !U &( ; !I &, ( !$ &\
M;0!A &D ;@  6%E:(        /;6  $     TRUS9C,R       !#$(   7>
M___S)0  !Y,  /V0___[H?___:(   /<  # ;EA96B        !OH   ./4
M  .06%E:(        "2?   /A   ML1865H@        8I<  +>'   8V7!A
M<F$       ,    "9F8  /*G   -60  $]    I;8VAR;0       P    "C
MUP  5'P  $S-  "9F@  )F<   ]<;6QU8P         !    #&5N55,    (
M    ' !' $D 30!0;6QU8P         !    #&5N55,    (    ' !S %(
M1P!"_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!_\( $0@#6@@' P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M   &! 4'" $#"0(*_\0 '0$!  $% 0$!              8! @,$!0<("?_:
M  P# 0 "$ ,0   !]\2.@
M
M                           $B.LB0
M
M                                       !+01(
M   '6=2H        $/*RS(
M                    !&,N";6W                  "Z%4
M       2T$2                   !0KK:N         UCJEFMN
M                                                   1#:YV7[:@
M                 "?DA                 ):")
M  H5UM7#J/.%=34IE6K&RO;2D1K6+4;N5I#3 1E FAN IR :NU3+6W
M                                                     (?M\W,%
MEP                  GY(0                "6@B0
M    *%=;5PZ#S"5XI7&%6-*5R^I="XF%ZUB*D[4^5V3E-UE-E% -9ZI1K;@
M                        &/U, 5MVAI?> ?9U&$:VYOI=]GP?9]'T
M                      0O;YV9+*@  815RJI\FOBNS"@@)'%<PJ<@X/LU
M[5A5&;ZTR,=A\GR?1]'P=P   )^2$                 EH(D
M         "A76U<!; :R*[-*?1U':=93%2<G87$ &MM:R+6VP
M              -"+K-CK:^65^/.E+KN5"E(8^JDI;Z.JM+:KZ969)^J
M                     !CS<YF<\=X  &@R[!A;Z5QG6N3%,C*0ZE;;6N2U
MN&5U^4NE&PE:0\O9BY76A7-M*3:M-9EV8:4LE50>OZSL   )^2$
M        EH(D"%9]GR_E,V               &\?"C&R7,XX H5UM7  #78Q
M12L[JF9!BXD^4RX  #62J5ZVX                         !CE37^MLN5
MO!"E+JK2J7!6#UIBI2/J5%:^GMF3Z                          (3M\W
M,UEP  &"U8H<%(6DK"J(NK)E*@Q<KD]28EG(@2XQ8K,U.\Q4KD53DI#<%3D
M  GY(0                "6@B0,-[O1_-/Z?[.               /:N#^:
M^B,;B( H5UM7  #RX7:E4KFJJ4TI93']:[!*>H*T  :U5K)=;;
M                    ' !R                          "*;7.RW;4
M                 3\D(                !+01(&&]WH_FG]/]G  EN'7
M]/HK"/A7$&[T?/:1RT     #/G.Y,JPX+%ERZ[=+L   >U<'\U]$8W$0!0KK
M:N  &."O!1GGPNS"IL"IFD  &LE4KUMP
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M'\F,        "08\D?R8P        )!CR1_)C        ')?L>2P9,8
M   %HS:D^K:        /LO6.^Q9+        !L?I;>2,.8
M  "6@B0,-[O1_-/Z?[.  -ZN#%HUDS[H<..=9E[3Y\5S9Z*MWF_)YEZOQ&!1
M;+L4EU:6MV2M72Q'N=&MMQPS/M2?%KP7/MR[%K1?+L:>]J0ZF]?O@ >U<'\U
M]$8W$0!X">CP#2GO<3Z.3X /L^3@Y.#D'T?)\U?5')R;:\3L:<=[B@
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M         -Q>%VM.N[Q0        -Q>'VM.NYQ0        -Q>'V=.NYQ@
M      -Q^%VM..[Q0        -Q.%V=.^[Q@       !46UVUXO7U"[G'
M      W%X?9TZ[G&        %RLNVAY'4U,[7)        'O1YU/=^(YWP
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M^UO&ZV$]_2W]CG?TM[O%W1X7:T*D7 P;T=$>]'G4]WXCG?
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MA]G3KN<8        7*R[:'D=34SM<D        >]'G4]WXCG?
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MC4DGC3M26'9\0'NAP,&;NS @     !A?6[WC#L2J#Y\8'Z)(_P Z]=J&
M  #7;3E'CCN2",9L8'OAP-3)W9@P      P+K2+QHV9-$LV,#](D?Y?3VH>
M     -2=26^1>]V;7?:)73%^C_@<N)]J*      #7'5DWCAMR&/9;!74?I%X
M/'M79B8      U+T9CY%]#JVG):!^BR/\VY=J&@     #5S4E7C[N]VS9+!(
M+*_I!XG!CG8C      &*N-.?$OK]&%;&$#WH\ZGN_$<[X
M $M!$@                   :W^K_-\#DL#      '-*X_CGI7C5GEF/]G
M/;SF<3+$G\J       Q_'O2/&;++H)L81^@OGQ.IDGG8      YI7%\;]0\;
M=J2PS/A'NUSH[.I+YB      .:5Q='/3?&C:D\2S8A^BC1AUKD4       '9
M;DUTC/K7D-T>I:[[9176_1'HP^$2&$      #ZI=AN-^I>.&Y((YEQUU'Z)]
M2#QZ00<      ?=N3!<8]:\>NAUK#EQC]"6A$OJ1^>      #[MOP+&O5_'S
M?[-ER67^U^B+6@,2[\-      ^K;H-%?6?%CH=N$[&$>]'G4]WXCG?
M           EH(D                   #6_P!7^;X')8&      !S2L2C7
MIOC%L2K&FUK^WG,XF6)/Y4      !S2L&C7IWB[M2B"[&#]!?/B=3)/.P
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M'V,.9='<PAOZ/?2L'V,.V''ZOF?*HU.M?/OM'>\     ):")
M        UO\ 5_F^!R6!@      #FE;-%_4/%S9E/K'@C66)/Y4       /J
ME8;%?5_%;>[_ +H8(94R3SL       <TK&HKZMXL[LA]D,$5G4E\Q
M'U;=CR*>N>+72Z_OU@A-KD4        '=CSX!B7LWD_V[/T'ZD,A$AA
M   [+<F*8E[#XV]7?_0+A@<>D$'       '9;?CV(^P^+75Z7O#KPSZD?G@
M      [;,N$XE[+Y%];9_01B\^B7?AH      '-*XYCOI7C)L2KVT@,XWXCG
M?\ZY-'<CZNQ$<^+$F[J7>R^2X<F(-W3W9X/;UPZG.QCMZLSP9ME.5T]6.ORJ
M6ZF[? [>$M_2A&QKP+8P;4\CJ[(\OI>.$WANR/,Z7I+%9)64N     EH(D
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MP        VX\/^N+II]2/9,<-SX9M@S=9(<>0              2T$2
M              !K?ZO\WP.2P,        ";QZ;0B0PD        "<1Z;P>0
MP@        "<1Z;0>0PD <&N7!E<=U]S)O0XUCP[-SSXKC?BI,=VL?!F.S'>
MB&:NM'@ )O'IQ")#!P!U4KJA&IO(<VI,-K0AVKT,C='DQO!M]U+=7H_,MS93
M ,@;W+  F\>F\(D,(  '72O96@^3Z!16Y*>VZZY,( ^K;IGP9E"I!"P
M   )O'IO")#"        !VV99;Q)9#>]#@       !MQX?\ 7%TT^IYW2:/;
M)\OHZH=CE;%<SHW_ !9+-?CFV#/ MC!.L&> ;&O,\&:>:^QCO:UL:;6MFC0W
M<2[NIE'4VOA3-NAO       "6@B0                   -;_5_F^!R6!@
M       3>/3:$2&$@        3B/3>#R&$         3B/3:#R&$@#'&CUO(
MSYI]@M>OEMV3/(=?1C/0Z63N3'<8]*0[.1'SK&?L$U]D_<O"N0 3>/3B$2&#
M@#67@S#0+YEFF'^O**NS%EWC1?!\HFF?(K!L!R.;[J0+R*+?1$S]5/4?&  )
MO'IO")#"  - H/Z=JEX]):J:[76N^8_KS^:ZT4C66+:V[WZ6+U]^@/%9OM<X
M#ZMNF?!F4*D$+         F\>F\(D,(        ';9EEO$ED-[T.
M&W'A_P!<733ZGGE)8]O/'^YH3(N#%<V*>Z^>38<L+V,.Y7"[&BDAX69='=PU
MO:0B&?%G_F[^NO3YV]T>[NLG6YLAQ9-_HYWP      !+01( &#^##9YO]N6[
MO4Q7R(SD[JR/&7*CN0>EW<<<R/VG#J_2LKW.G;,6O)=KHU=^2W8L&"(_"=M)
MCZCCSF<&Y9=BCLQ=UUV#>!#)?N]7)O4D=%9AQSS.!$=+E; R2=4]F.:[_8
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M%-/F174YFV<Q]0G&_P!D  #6_P!7^;X')8&        !-X]-H1(82
M !.(]-X/(80        !.(]-H/(82!P>;_GWK&O?D'7S3"X7J+-O4MQ8+Y1I
MQ./5]LH;YEA:33#IW\V5_2]/>:=^=9XZ\: $WCTXA$A@X%/;?Y3>4^S0CRNW
M)D<C6M,J]!V=B?G>ILP].V[A?ENOTNG=9U[LS^B<OT$G_F.1MWD@";QZ;PB0
MP@ :*P_TG6GYPZ%)3)=<6MF7AQ.CR9K?DSW?'JZS2KT._P!=2EGW4]B_<?#:
M^_$/JVZ9\&90J00L        ";QZ;PB0P@        =MF66\260WO0X
M   ;<>'_ %Q=-/J                 2T$2              !UTMPYQ(GF
M7MRWZK4  #6_U?YO@<E@8        $WCTVA$AA(        $XCTW@\AA
M     $XCTV@\AA( X,>Z75T_C$\SUVHSB3F]W,?4C\!TNIFCJQZ9;.A)<^F
M )O'IQ")#!P!\F%>5(M=N'*LN=3AP?4Z64NAQ<;Z/6V%[,6DVQIWS+K  ";Q
MZ;PB0P@ 4EM^J\?FNCWE\]N_:MM/!K4][+=*:\COTYIW-3::1PO,W3C]SR80
M/JVZ9\&90J00L        ";QZ;PB0P@        =MF66\260WO0X
M;<>'_7%TT^H                !+01(                   &M_J_S? Y
M+ P        )O'IM")#"0        )Q'IO!Y#"         )Q'IM!Y#"0
M     )O'IQ")#!P        )O'IO")#"  !T4N[%.:T^@   #ZMNF?!F4*D$
M+         F\>F\(D,(        ';9EEO$ED-[T.        &W'A_P!<733Z
M@                $M!$@                   :W^K_-\#DL#
M F\>FT(D,)         G$>F\'D,(         G$>FT'D,)         F\>G$
M(D,'         F\>F\(D,(        'U;=,^#,H5((6        !-X]-X1(8
M0        .VS++>)+(;WH<        -N/#_KBZ:?4                 EH
M(D                   #6_U?YO@<E@8        $WCTVA$AA(        $
MXCTW@\AA         $XCTV@\AA(        $WCTXA$A@X        $WCTWA$
MAA         ^K;IGP9E"I!"P        )O'IO")#"        !VV99;Q)9#>
M]#@       !MQX?]<733Z@                $M!$@
M  :W^K_-\#DL#         F\>FT(D,)         G$>F\'D,(         G$
M>FT'D,)         F\>G$(D,'         F\>F\(D,(        'U;=,^#,H
M5((6        !-X]-X1(80        .VS++>)+(;WH<        -N/#_ *XN
MFGU                 ):")                    UO\ 5_F^!R6!@
M     3>/3:$2&$@        3B/3>#R&$         3B/3:#R&$@        3
M>/3B$2&#@        3>/3>$2&$        #ZMNF?!F4*D$+         F\>F
M\(D,(        ';9EEO$ED-[T.        &W'A_UQ=-/J
M  2T$2                   !K?ZO\ -\#DL#         F\>FT(D,)
M     G$>F\'D,(         G$>FT'D,)         F\>G$(D,'         F
M\>F\(D,(        'U;=,^#,H5((6        !-X]-X1(80        .VS++
M>)+(;WH<        -N/#_KBZ:?4                 EH(D
M       #6_U?YO@<E@8        $WCTVA$AA(        $XCTW@\AA
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MJ[%]VW]MN3XNLX4XK3ZI?]V7X1B/IV+][D@       "?\+TCOLS@
M   "3XLN]$?[ETLO   EH(D#Y.#@     Y. #D'      !R < Y-<O5_G""2
M2!\G .3@ Y!P#D*\* #DFT?F\)D$(X .0< Y"O"@'(.#D'!.(]-X1(80. <A
M7A0<@' .3@')P"<1Z;PB0P@< Y5*#@Y!P<G!R< Y. 9\\;^J*OC2D
M "NK;0TN        ')6UMH:7         8Z]/^>\>R[S+DX.0#@'*I0< Y.
M =MF78;Q'ZV:/8        $KS:W8H            /LK;;N0  "6@B0
M              -;_5_F^!R6!@        3>/3:$2&$@        3B/3>#R&
M$         3B/3:#R&$@        ;%>,?55=QI4        !7+:%<
M !6K:)<        !B[U'YXQQ+_,@       !VV9=D/$/K?[T>P        )?
M?@[:TQ#NZ>*MS4R-J[-32[,FCN    1K+BM-]D[U]@        "6@B0
M              -;_5_F^!R6!@        3>/3:$2&$@        3B/3>#R&
M$         3B/3:#R&$@        ;%>,?55=QI4        !7+:%<
M !6K:)<        !B[U'YXQQ+_,@       !VV9=D/$/K?[T>P        )?
M?@[:T\\I+'MYX_W/-R4QR%9\&S/*Z>3]3:QCMZL^UL\.SX<Q:.Y@CHZ.R/*Z
M66]/;\VI3&\T:&[M[Q>N        !+01(                   &M_J_P W
MP.2P,        ";QZ;0B0PD        "<1Z;P>0P@        "<1Z;0>0PD
M       #8KQCZJKN-*@        *Y;0K@        *U;1+@        ,7>H_
M/&.)?YD        .VS+LAXA];_>CV        !+[\';6GG7)H[D;5V,PZ6YI
MOW.//=;8I;K<7;>KE[2VXWEQXHW-7:3D].TWV[Q1_N8(Z.CCG9UMO>+UP
M     ):")                    UO]7^;X')8&        !-X]-H1(82
M      !.(]-X/(80        !.(]-H/(82        !L5XQ]55W&E0
M  %<MH5P        %:MHEP        &+O4?GC'$O\R        ';9EV0\0^M
M_O1[         E]^#MK36SJ<W/W.W[K9?JOU^5(,>2&Y\,0S89'BR6R^W+>E
MMX7W]+8WE]++.GMX^V=>,Y<69]'=         EH(D
M#6_U?YO@<E@8        $WCTVA$AA(        $XCTW@\AA         $XCT
MV@\AA(        &Q7C'U57<:5         5RVA7         5JVB7
M  8N]1^>,<2_S(        =MF79#Q#ZW^]'L        "7WX.VM
M        ):")                    UO\ 5_F^!R6!@        3>/3:$2
M&$@        3B/3>#R&$         3B/3:#R&$@        ;%>,?55=QI4
M      !7+:%<        !6K:)<        !B[U'YXQQ+_,@       !VV9=D
M/$/K?[T>P        )??@[:T                 EH(D #$?2['F7/?4=@^
M+',T\KB4=]V+.AUMGX_%HCL[E\Q8+9DRP_9W-B.)'-)99.-A^''-A.-'0
M      !K?ZO\WP.2P,        ";QZ;0B0PD        "<1Z;P>0P@
M  "<1Z;0>0PD        #8KQCZJKN-*@        *Y;0K@        *U;1+@
M!\FB5S">2[/&+'9*BLWI2P&I.QGVKP8M\;0 &+O4?GC'$O\ ,@       !VV
M9=D/$/K?[T>P        )??@[:T                 EH(D  >8L_\ 4]B^
M'&=(99.\I<_D]:M'=?VTI1WWY'T>;J1))?F7E\7(6ESL]<:/;0\"+
M   #6_U?YO@<E@8        $WCTVA$AA(        $XCTW@\AA         $
MXCTV@\AA(        &Q7C'U57<:5         5RVA7         5JVB7 # Z
MGY[)I.;+O=*GLQ5%^6CU]27=7NQ[2YLZ[TGKH+YK^E&,QBK !B[U'YXQQ+_,
M@       !VV9=D/$/K?[T>P        )??@[:T                 EH(D
M :FR.7T-]^+]_JY8Y_([+:<F/]WH9+T.9F#F<;3&4S;9S@1;4J22_=2*0?+?
M.Y           UO]7^;X')8&        !-X]-H1(82        !.(]-X/(80
M        !.(]-H/(82        !L5XQ]55W&E0        %<MH5P
M%:MHEP%&?F:D\G[)OZ1?=_J=5F/#\0@$FZ?9L>CS,D2.85>;8@,7A?L+ ?-?
M1&P ,7>H_/&.)?YD        .VS+LAXA];_>CV        !+[\';6@
M          $M!$@                   :W^K_-\#DL#         F\>FT(
MD,)         G$>F\'D,(         G$>FT'D,)         V*\8^JJ[C2H
M       "N6T*X        "M6T2X#J/S<2.28]E<UH<&MD"02N];O1QI&H=-.
MU(K?K:F-XW#LER:9Y9\R\=_0;RN: ,7>H_/&.)?YD        .VS+LAXA];_
M 'H]@        2^_!VUH                !+01( &.=[I8SW^I<<>+,G+X
MN NS(9AK:<>S;%)=?GOCQ_!77[\_T^=56V:^]J1Y1Y_)L^3-.M30M63-F#F<
M77WM2*>:>AC/?ZEJR9I?K:5^PZ^9>7Q0    !K?ZO\WP.2P,        ";QZ
M;0B0PD        "<1Z;P>0P@        "<1Z;0>0PD        #8KQCZJKN-
M*@        *Y;0K@        *U;1+@!H7=3RQ[G>@LV]%@$*\ZG<S]"QK"O.
MY]*9K6\KB2G2Y^^<?C.^F-F]4 8N]1^>,<2_S(        =MF79#Q#ZW^]'L
M        "7WX.VM                 ):")  T'F/H. .S(;CCQWG'@R%I<
MZ';.[ =SH87ZO;SIR>!L-Q(YBWH=:=Z?/QKO]7+O-XNILCE^2-#F;YP_S_&/
M0ZN!>Q(*NVRP9MCHK?&-C:O&/!ZH>>>3]M*     :W^K_-\#DL#
MF\>FT(D,)         G$>F\'D,(         G$>FT'D,)         V*\8^J
MJ[C2H        "N6T*X        "M6T2X "SFH];=@Z5Q'6F9J5B9/"6J]P
M ,7>H_/&.)?YD        .VS+LAXA];_ 'H]@        2^_!VUH
M        !+01( &L??E$=S[599CNV/#K#WY5M7'8E&=C:PEU>YM#'XKJ7)9?
ML)Q([K=W9-G'D<*RYLV.]WI99YO'W C,-Q#T^SY6>A^L;D1>&9IY?#A6UO::
MRB:[2QZ)[WQ" \@    &M_J_S? Y+ P        )O'IM")#"0        )Q'
MIO!Y#"         )Q'IM!Y#"0        -BO&/JJNXTJ         KEM"N
M       K5M$N         Q=ZC\\8XE_F0        [;,NR'B'UO]Z/8
M   $OOP=M:                 2T$2          +7DRZB268[4QV)R;!JC
M!_6[N<.3P@     -;_5_F^!R6!@        3>/3:$2&$@        3B/3>#R
M&$         3B/3:#R&$@        ;%>,?55=QI4        !7+:%<
M  !6UMHJ7         8N]1^>,<2_S(        =MF79#Q#ZW^]'L
M"7WX.VM                 ):")                    UO\ 5_F^!R6!
M@        3>/3:$2&$@        3B/3>#R&$         3B/3:#R&$@
M   ;%>,?55=QI4        !7+:%<        !6UMHJ7         8N]1^>,<
M2_S(        =MF79#Q#ZW^]'L        "7WX.VM                 ):
M")                    UO]7^;X')8&        !-X]-H1(82        !
M.(]-X/(80        !.(]-H/(82        !L5XQ]55W&E0        %<MH5
MP        %;6VBI<        !B[U'YXQQ+_,@       !VV9=D/$/K?[T>P
M       )??@[:T                 EH(D                   #6_P!7
M^;X')8&        !-X]-H1(82        !.(]-X/(80        !.(]-H/(8
M2        !L5XQ]55W&E0        %<MH5P        %:MHEP        &+O
M4?GC'$O\R        ';9EV0\0^M_O1[         E]^#MK0
M   "6@B0                   -;_5_F^!R6!@        3>/3:$2&$@
M     3B/3>#R&$         3B/3:#R&$@        ;%>,?55=QI4
M!7+:%<        !6K:)<        !B[U'YXQQ+_,@       !VV9=D/$/K?[
MT>P        )??@[:T                 EH(D                   #6
M_P!7^;X')8&        !-X]-H1(82        !.(]-X/(80        !.(]-
MH/(82        !L5XQ]55W&E0        %<MH5P        %:MHEP
M &+O4?GC'$O\R        ';9EV0\0^M_O1[         E]^#MK0
M       "6@B0+:4YP=9] ^CY.0?!] [3I/@[CD'2?1]@X/D^CY/HY!\'P=YP
M#I/L[C OJ7SQ$9'!2I0KS2O%;1P?=+N#YK85Y5^J7?-;.#DY5X)IP)G#.]#.
M*TX.5>:5*?-UO-*\TKRN^:V<'*O-*E/FM/JE>*A9.)-<;=Z(@        2[B
M2V(]N)         ;;>0?2\]X4I!4H"H  !0%04*BN64*X<*\J<G"H *%0"A4
M "MK914O '*G 5  *%0  -5/4_ ,;RGST        =EN3</Q?ZCE/-[0
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M  .%>0H"HUJ['&L.2T        <F?.;T9EJ[0        P+V^'17V
M     "\X[]E>7TJVVX  "6@B0                   -;_5_F^!R6!@
M    3>/3:$2&$@        ;!>/?3]VX$U         KEE"O         KZVT
M%+@        *Y;0K@        *U;1+@        *Y90KP       !R5BE$J
M       )??@[:TH+K;3?9=++_HK[;@   +)DQW"RZKI<        !+01(
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MM")#"0        -@O'OI^[<":@        5RRA7@        5];:"EP
M   %<MH5P        %:MHEP        %<LH5X        Y*Q2B5        $
MOOP=M:>=<FCN1]79XJP#T=#).KL=U*XFW-2_X[Y#BRQ;-BR5J[(WUCO>U_Z7
M/PUO:>\L?[@        $M!$@                   :W^K_ #? Y+ P
M    )O'IM")#"0        -@O'OI^[<":@        5RRA7@        5];:
M"EP        %<MH5P        %;6VBI<        !7+*%>        .2L4HE
M0       !+[\';6FC_?XFX'$Z\@QY- )'P)C@S8YVM:GK288<UKNM^U*VV_-
M&CN9<TMORPET7WVCO>V%YO0         EH(D                   #6_U?
MYO@<E@8        $WCTVA$AA(        &P7CWT_=N!-0        *Y90KP
M       *^MM!2X        "N6T*X        "M6T2X        "N64*\
M    <E8I1*@       "7WX.VM                 ):")
M      UO]7^;X')8&        !-X]-H1(82 !U4K3TOK+L?Q2O!V5IQ2L?Q;
M-XR8*JZP #8+Q[Z?NW FH        %<LH5X        %?6V@I<        !7
M+:%<        !6K:)<        !7+*%> !3'65AU')]G!%%).KW@ Y*Q2B5
M ICK*PZCD^S@BBDF5J  2^_!VUH                !+01(
M       &M_J_S? Y+ P        )O'IM")#"0!T4N\E/$/K&!Q#TF_RWSNUX
M\USPY[UT.-'L6S;?.?:I_P"H>"^M/L_RUR #8+Q[Z?NW FH        %<LH5
MX        %?6V@I<        !7+:%< !CH\S]7<SUEP7>ZF'Z5VTNLU\K2DQ
MY<"X\OK1LZ<P5 %:MHEP        %<LH5X L)X-QJ9Q.S++]_DVS#LR'8T^[
M#L1S=YT<@GJFTL_\D]C-S0 ')6*42H LQX.1V7PS7VYET>/:<>:^Y=>NLRQW
M9THQ!_4-E)YY3[.[W- $OOP=M:                 2T$2
M      !K?ZO\WP.2P,        ";QZ;0B0PD#@\XO.O<,;?*GZ"6;+ADW.[/
MS6V$]>/; PCT^P;W,F_(D6L?L_S)ZU?6OYS2O8T0!L%X]]/W;@34
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M5<[M:=>H^"V+<YM%EP;:>:>WX'F?FDAT>I6_37PMZH^P?,H V"\>^G[MP)J
M       !7+*%>        !7UMH*7         5RVA7 #S(Q9=*O%/IO/<+].
MO6KT-2/2_#Y)H=6Q[?/5IMKYI[?AJ50+'WLWS1[XR&(R94"M6T2X
M"N64*\#'2GA#Y%]"_6IT=G_/?8KE@V]-?4_ Z+-K\TKMMYI[?K)Z!X_-N3(<
M]>X?+GKWM:8')6*42H$3/ CR3Z#[-'I[->?^P7?6WM-_4_ [=GU.NM-N/,O<
M=9O0/(9QR)#L+[=\O^M^[SP)??@[:T                 EH(D #6[S?VC&
M,9G.=9UY5J!Y!]%;)>D>+0?B2C+,L\_U>\O]TR!((C3X\WQ;7"D+].]#?H7X
M]PE"/3H7QI-7[&I7Y]37_P _]=S;-O,+1J="4]7A:Y^=>RYRF_EEIU>C?]_D
MU.77LNCU+ELZ5QV=+'T?E\[[L5W)]C^;@ -;_5_F^!R6!@        3>/3:$
M2&$@#R)\1^K[Q\Y_:OW2L8W^1N%YA[OKI.?*L[P[TG ,T\QA?6CUL[<7S7]
M_'/I=Z;X& -@O'OI^[<":@        5RRA7@        5];:"EP        %
M<MH5P T"HT/\"^ML-2J ;'P3UF:<KOQ3H\7&_>B6S$ ]>TJ]9^>YYQ9+1;_)
M]@?9OFS8]<!6UMHJ7         5RRA7@=1^>^-32_>5^]W76W(3UH_M]YC[K
MK;//)=BX+ZMJWZ+XS:MG1MO:C.]_I?B7I[EQ <E8I1*@=)^?V.S"Y>3_ $!<
M<&W"^M'MP/+_ '?6R>^2;&07U;6#T+QVR;?.MW:C6]'I7B?J'GUP)??@[:T
M                EH(D #!\']0Q!$?1<K2J 8LBT]R1)(7B.)>A3?MQB <"
M6W/9T;1I]',DR\WQO&YIMQZW\\ZT^:^V03A2O+4M\_GO>B6NOG7LNR?I/BFN
MWG?L>QGHOC6MGF_M>4I1 ZK+@H<&S$.1([UN\R#\.497E< H,&W2XMC9KTSQ
M  #6_P!7^;X')8&        !-X]-H1(82 (IK[VF43]'U>\?^EI'Z!X[:(/Z
MK53SR2LC<WE\D@V1NS&-TY=YI*MC1[:T &P7CWT_=N!-0        *Y90KP
M       *^MM!2X        "N6T*X 1%3QUYW7PWYS[-:JTH[L=79FQ7)83L'
M!?4[!,O-\H2>#;D]+C>@%52 5M;:*EP        %<LH5X QFIYY8\FH,5GV0
MY+"8IP99(9+"*;@RS+_9C>6\N#T"NMDZO8 <E8I1*@#'"GGECR:?16>Y#DT(
MB<?E\@DT'IN#+,L]F.9=RZ_H+=;*%>P E]^#MK0                "6@B0
M     ,8QB<3CN1>[;?/ Q9%IW/\ OQ*Z;6B         !K?ZO\WP.2P,
M    ";QZ;0B0PD  =%+NZMOS2OW6@    V"\>^G[MP)J        !7+*%>
M      !7UMH*7         5RVA7  <& 5+851>"5$5,Q*U1V  %;6VBI<
M     !7+*%> !P4Q4GP=@   !R5BE$J !P4Y4'P=@   !+[\';6@
M        $M!$@                   :W^K_-\#DL#         F\>FT(D,
M)         V"\>^G[MP)J        !7+*%>        !7UMH*7         5
MRVA7         5JVB7         5RRA7@       #DK%*)4        2^_!V
MUH                !+01(                   &M_J_S? Y+ P
M  )O'IM")#"0        -@O'OI^[<":@        5RRA7@        5];:"E
MP        %<MH5P        %:MHEP        %<LH5X        Y*Q2B5
M     $OOP=M:                 2T$2                   !K?ZO\WP
M.2P,        ";QZ;0B0PD        #8+Q[Z?NW FH        %<LH5X
M    %?6V@I<        !7+:%<        !6K:)<        !7+*%>
M .2L4HE0       !+[\';6@                $M!$@
M   :W^K_ #? Y+ P        )O'IM")#"0        -@O'OI^[<":@
M  5RRA7@        5];:"EP        %<MH5P        %:MHEP        %
M<LH5X        Y*Q2B5        $OOP=M:                 2T$2
M              !K?ZO\WP.2P,        ";QZ;0B0PD        #8+Q[Z?N
MW FH        %<LH5X        %?6V@I<        !7+:%<        !6K:)
M<        !7+*%>        .2L4HE0       !+[\';6@
M $M!$@                   :W^K_-\#DL#         F\>FT(D,)
M   V"\>^G[MP)J        !7+*%>        !7UMH*7         5RVA7
M      5JVB7         5RRA7@       #DK%*)4        2^_!VUH
M           !+01(                   &M_J_S? Y+ P        )O'IM
M")#"0        -@O'OI^[<":@        5RRA7@        5];:"EP
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MQ9LE@            E&+)O/'NY=+;P  ):")                    UO\
M5_F^!R6!@        9P\D^E[O'9T        !=[732\        "N64*\
M     "OK;04N         KEM"N         K:VT5+@        *Y90KP
M   !R5BE$J        +_ )=;[K0            ?17VUY5   EH(D
M            #6_U?YO@<E@8        &??(OIB]QR>         5RVA7
M      5RRA7@        5];:"EP        %<MH5P        %:MHEP
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MV_KMT^=M#R.I,\&;7?I\[7'I\[TFB\D         EH(D
M   #6_U?YO@<E@8        &??(OIB]QR>         5RVA7         5RR
MA7@        5];:"EP        %<MH5P        %:MHEP        %<LH5X
M        Y*Q2B5        $OOP=M:>=<FCN1]79G^OGU4Z_+R!K9Z:ZF,-O5
MR+J[-+=3&^UK;%\OHT=;=V^#V\=;6OH_W^'Z4Q:2@        2T$2
M            !K?ZO\WP.2P,        #/OD7TQ>XY/         *Y;0K@
M      *Y90KP        *^MM!2X        "N6T*X        "M6T2X
M   "N64*\        <E8I1*@       "7WX.VM-4>QRME>5TKS9?ISW./)L.
M2#[&"-Y<<JPY:"ZV;Z^?'^SKYVY^]F71W=)^]Q)9AS;=\7K@        2T$2
M                   !K?ZO\WP.2P,        #/OD7TQ>XY/         *
MY;0K@        *Y90KP        *^MM!2X        "N6T*X        "M6T
M2X        "N64*\        <E8I1*@       "7WX.VM
M  ):")                    UO]7^;X')8&        !GWR+Z8O<<G@
M     %<MH5P &,%(+6F8:5CA2DI*(URK3+9FNEP %<LH5X        %?6V@I
M<        !7+:%<        !6K:)<        !7+*%>        .2L4HE0 .
M <G!R#@I"K.0 2^_!VUH                !+01(
M&M_J_P WP.2P,        #/GD7TQ?(Y/         *Y;0K@!9S\U$@A&+NO&
M?CG]OXI6XY->3TK%;J=W7C&3HW//TQ<&:?0 *Y90KP        *^MM!2X
M     "N6T*X        "MK;14N         KEE"O        ')6*42H QLM\
M,NS%9=I=:3V9<;[.AL1I=7$>UH56ONZS=R(>Q4>G&\5N0 2^_!VUH
M         !+01( %!=CX4H[K+SCS_:M#=CJ:7=M+@ +9?BN5F7D H+L=52[M
MI< !T5MZ:VUMN0#Y4L>77%\Q;'TJ!K?ZO\WP.2P,        #/GD7TQ?(Y/
M        *Y;0K@*8_/IU8WKU/O%^*JC-JQ/B2RY[?,J<NO7[6A>^AQ(7$?3/
MT$0;U[:2W* *Y90KP        *^MM!2X        "N6T*X        "MK;14
MN         KEE"O        ')6*42H$>4\1=G0U(]0^>H3'IKQ5DZ7>:8FA/
MJ^6YOY+!8[.,B2CS[9;QWZA]U]/K?0!+[\';6@                $M!$@
M>?TK\XQ'O\74;OPSU9@OK^#NGP+[BV)[J]''^WS<X<SOX>Z/%R1I]/FE=:NS
M%=I>)+L0]#BW&S+G#F=[ 75CN)-_C;[Q7T3222P+8_CRC7+L1C=6-SOSTEOF
MN;N;WH-LZ&R7'E%XQ9\#]2/:522!U=N3;#A3';'@S'/?+D0UO]7^;X')8&
M      !GWR+Z8O<<G@        %<MH5P%(?FME/G.'.I'KSO\>;R&$1SE2*%
M\"9WSH\.4=>,XRB7ID[D<$V @'M/Z%>/*0!7+*%>        !7UMH*7
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M@V-8EZ5F"<^0XJB/IF2)'!HYPY908-S9&.3GTCYD@W_MS "N64*\
M"OK;04N         KEM"N         K5M$N         KEE"O        ')6
M*42H&.5/S+3/RGXZ? NNYR^%9IWX;"^!,9O((7BN'>HUF3!4Z?4]L(1ZYOM;
MD E]^#MK0                "6@B0 ,5;W'A^QI=]+I9K[F&>EP\O<_M<&(
MNAQ<R\[N8MWN1.=7H8HW^/DW1ZM)=9%L^I--?>SMRY#B?>XW5=2BKCQ/O\>>
M:O1E&';N^/-KQUHSG/F2'!O3C^QO'D^N'8B^:.=WNZE:2MF,][E9DYW;RIH]
M@:W^K_-\#DL#         S[Y%],7N.3P        "N6T*X =9A53S=S:NQ^+
M8P7DP9]QYXK6W,-+\D4KG-7N  *Y90KP        *^MM!2X        "N6T*
MX        "M6T2X        "N64*\        <E8I1*@<&FM;/+[H</"G4CT
MGY_:MFYS;]R)+\=F+9YX\HSGAVM_\6SEI7[ )??@[:T
MEH(D                   #6_U?YO@<E@8        &??(OIB]QR>
M   5RVA7         5RRA7@        5];:"EP        %<MH5P
M%:MHEP        %<LH5X        Y*Q2B5  I2VEP/DKCI.X   E]^#MK0
M              "6@B0                   -;_5_F^!R6!@        9]
M\B^F+W')X        !7+:%<        !7+*%>        !7UMH*7
M 5RVA7         5JVB7         5RRA7@       #DK%*)4        2^_
M!VUH                !+01(                   &M_J_P WP.2P,
M     #/OD7TQ>XY/         *Y;0K@        *Y90KP        *^MM!2X
M        "N6T*X        "M6T2X        "N64*\        <E8I1*@
M    "7WX.VM                 ):")                    UO\ 5_F^
M!R6!@        9]\B^F+W')X        !7+:%<        !7+*%>
M!7UMH*7         5RVA7         5JVB7         5RRA7@       #DK
M%*)4        2^_!VUH                !+01(                   &
MM_J_S? Y+ P        ,^^1?3%[CD\         KEM"N         KEE"O
M       KZVT%+@        *Y;0K@        *U;1+@        *Y90KP
M   !R5BE$J        )??@[:T                 EH(D
M     #6_U?YO@<E@8        &?/(OIB^1R>         5RVA7         5
MRRA7@        5];:"EP        %<MH5P        %;6VBI<        !7+
M*%>        .2L4HE0       !+[\';6@                $M!$@
M             :W^K_-\#DL#         S[Y%],7N.3P        "N6T*X
M      "N64*\        "OK;04N         KEM"N         K5M$N
M    KEE"O        ')6*42H        E]^#MK0                "6@B0
M                   -;?5_F^ R6"         9^\B^E[]')X        !7
M+:%<        !7+*%>        !7UMH*7         5RVA7         5JVB
M7         5RRA7@       #DK%*)4        2^_!VUH
M !+01(                   &A,P@V(-_0         VGC<LVBX?=
M   ^SX         /L^         #[/@         ^SX         /L^
M    #[/@         ^SX        !55I]                 $M!$@
M
M
M "6@B0
M
M            !+01(
M
M                        EH(D
M
M                                   2T$2
M
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M0B*631MQ?#STY.1C7>BQMFBQNQNPLTR3+[>G9[[;[?Z--Z"GT/U(W6YB8O\
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MVIP5)8YQIQ'&G$<:<1QIQ'&G$<:<1QIQ'&G$<:<1QIQ'&G$<:<1QIQ'&G$9
M@B69)E[>K;%7Z:?_  ZKW-83;QIQ'&G$<:<1QIQ'&G$<:<1QIQ'&G$<:<1QI
MQ'&G$<:<1QIQ$QB3;D!N?F%PCKA^_P <O\^^C3>@I]#ZB0^^_GE<3;)HW2.-
MN<8</UC+_,_YY7$V^:-\ACSA&W#],/\ 2OYJ5Z*S&%MTU0/K$X1Y?^H/_G/\
MW@)C#$$U0/3*O8%_Z)_KO\UMUUEV0<>)9:D6(U"!2&3YET]M_-2M:5F\'131
M$ZM2UF6A-[D_X[^:VZME9WC]%,TKDVK&E9^D7]?_ )K;JVUGL 23!&X(%38K
M#3\HZ>'\M*UMK,(DVSEN?V%PCKA^OQR_S[Z--Z"GT/J)#[[^?P$DB[7-6^4Q
M=RBCF,9?YG_/X"51-MFK=(H\XQER##_2OYZ5K2LKA[9.4$BCSC&G(0?_ #G^
M>E:TK,8:W3AO>V1PC[@"?Z[_ #V7W%W9!QXEF"18C4(%+)\RZ>V_GI6MM9O!
MD,W0NK4M9ER;W)_QW\]MU;*S:!M\X0NS0O9%P1?U_P#GMNNLK/<?HYJC7H%3
M8K:?E'3P_FI6M*RZ(MLW;GYA<8XXC\<O\^&=%Z]&@;\6-ZE$C<W?'L^6SJ(-
MQR"51UT;B,F0)2HV[=A3DN!HU64W:ZD'0*&A9CY0_L#&C,R; 2CY*8SGL;$:
MUIX]3)D"JIN5)[$]<IX\M,FSE2^'8:6JU\+"%4HG\\PZ^N![A_(F]!3Z'U$A
M]]H/ /\ 'FN9MDNA[K$7'&7^9Z"E:TK*HFVSELD,=<HTXL/]*T%*] DT8:YP
MV2>+.D5<8/\ YSH*5K;68PQOG3<]LB]@7D_UW0%F7%W9#QVDF*- C4()$Z>V
MT%MU;*SB"(9VWJVM:SNQ_P =H+;JV5F<);9\@?&)PCZ]%_7]!9?<7=/\?HYL
MB*;U38_NGA_/2O0)?$F^:-SZPN$></QR_P ^'Y 776-[9-IG8@98?(95+VAL
M3.>8\P+4#<N=7S$JR,)YJZTQ7$H0QV0^71)PB,!FW^.9C)WB.2*(L!4#L7*5
MF#75S56XTKCYB5160Q14SP55*8F>AA2Y0JQC@_\ HK^]I(\UR-CE&0*Q/(\.
MB$33FT/(_C3>@I]#ZB0^^T3RR-<Q;6*.'12):&E:VUE<3;9VV)V\QICFAI6M
M!((ZU3=M;6,Z-Q70VW5LK,H6W3UN.37(VG0E&W%7R['R"6'NGMM#9?=9=,8,
MWSI.N*J0DT-MUUETMB#9/6TY"8V(-"69<7=+8"@F=[M3HT/@)?$4$R;\(,BV
M/Q 9V3GGHV>E:-@C*91;E_+$47J%BG)D>,95\,DK]C]ARDB9V&07S%Y@,T2*
M[\0Y63*3622V7W0Y&D5<E5$3<G3%],MH;(_.VN=N$(/R(Q&L$&3++(!A0DTB
M#SR/G26-0:=H8FSN,=?C7V-.MCRS?QIO04^A]1(??:-;?<8U:*VZME5]U;D&
MBI6M YWW&(-%9?<7<YUZ4NBL,O+JZ>VT15]Q=[MZ>BMNNLN>ZUNNT1!EY9CQ
MXZ)#2E$@NLMN_>Q92M:4J.H(_52":UV+:TJ676E;++AT4J.K+Z-FE*=00*VV
MUI0@F@H6704MMMH*DDW#8LV:4I;3^--Z"GT/J)#[[1J?B-&M^/T;A\=HW+VF
MC=/;:*GBZ^GHWGQT5GG>/'1(O:!P=FQJL[;Q ('-O="CW9M2J=<F]!3Z'U$A
M]]HU/Q&C6_'Z-P^.[LGR?'(Q>QYAB[T;?/XB6<[Y*BK12/SZ.R*YXF\;8S$\
M]BZI(X9Y:$ZN)3EGEQ'=<O:=R^^TNU^S%%V-0PY3BSY:7/HB:<Z94BC6<PRY
MDD13CD6)MAZG($93MM<^M-%4>DC;)47==/;=[:MZ?UTTK^SU!*:PA:D5=VGB
MZ^GHWGQT5GG>/'1(O:#/UMMZ%J@D.,;GZTW%\W?93%DTGD>0T#$O:,G(5[K*
MYPTQ0ANRBC/=I5.6N*W(\IHKW%PGS:VR20OZ.-M)>1&7LT7F BA;_-6EB84V
M62U](;.&V:)E4W0IY-H$WH*?0^HD/OM&I^(T:WX_1N'QW<D;V@:FZ&HB9,ZS
MU(U$'N,50-,?A4/HZDRUN*8W9HQ\:N$SBW9ZR,L#3P6'_P#PN3>ZY>T[F2Y,
MD:HY!6)"N125$B.?I1'&Z/I8O!DIR!<D5(Y$VXU37%2&/WLCIV;:*-6%C[TL
MJ[KI[;NY9G#BW&W,4Q3ID>5,@K2S<J3H7*LALX49P>7)!269(9J\9EN2%YE)
M) 5L==:/3/\ NGBZ^GHWGQT5GG>/'1(O:#/GLV;XO.)MEZZ76769#E\7F4>E
MZ3)C:8_(*%N>:I-%&:4IXLE*<,O9S2$&0R5(%Z_'D[DULN:<J5HWR%ZD\A=6
M5:A?&[$.-$I)<-C]]8/DC&*<R02G0)O04^AW)N]+V5%'UAZ]J,,L*LNG$:M.
M*4$GE'3B-$&FKTA*6R=QB\R</BYF;ESR>5'#Y*U-:0F<QH\QSD30ST:WMM>;
M'23,S,;9,ERJ3ARE+&TG-3\UO5'63,S,:1(6M6@9<A$+GA(_6W.C:^-KM2R0
M-:E2@DA9=S+D-.K<FU[;7<)) U+E7?D/OM&I^(T:WX_1N'QW[7'[LC**=)XZ
M1A.QMEML.1<8G;&:[M,8FI2 M<R)'9Z<LAFEJF^I<I;%#BUL9,FI5,ZP.:HY
M:W]QR]I^YJ[&,L;:V!1*"V.UIX<S1!"TJLB,:I5?'YVA4%)61(W.YN1UAJFU
M D>REKXT(+KU9\-ED9D2.3-O<=/;=S(>1"8<679(YA))IQ;AL6C-6-MA]4Q\
MCG)BFV/P5O;FUGHX-CN5#XRH8U>0TARAFQ$_I'&+?NGBZ^GHWGQT5GG>/'1(
MO:#,49?9$B12G("1*S0Q^DDIFD3?'3(+RLR,S/;DPR^?/TLAKVWO;N5D"=*)
M! 7EB?']MG&1C*L*/@.,\:R!EDV1H*?) K=\INS2_P"/G8G'L);E;5',]-]+
M2H R< BN@3>@I]#N9-^,B7P.1U1Q#"DAK(9%FIS6$Q.-0]F=HUN;&R,4F;T)
M:.275O@TP_HCD2P4C4-C='5S>%U3)'&5BI-(&5N2R*6D-Z9LG(=RXNXKH;UB
M22QUL2222((DW-9\'9&Y8_L!=O;,A96)2""H*F)8JF)5JH,QMBYV;U_9-YQL
MDNV._(??:-3\1HUOQ^C</COVL*H>EC>VS2E]9G>/.K%-E[@LJ]-U%SS$6IX!
M^/%I-\9B21A)D,I31ZJ="YS5S0-K0TH,1F;,Q[CE[3]S1NHYQJ"FU4IC"7^&
M+XS*U+P<G>&UP4/$&:G.MV.U];F2/HF5'()L4U&,T:5R-0O3LZ5BP3>;N'<=
M/;=S+1>[SB6/#BUEM4M:EZ4LPLXN20>U<;8[RN/A0M>)FL8H8E8CY1*DS*DC
MRR1O!AZ59!9 D/HJ3?JGBZ^GHWGQT5GG>/'1(O::"OA=CM:XO-M*6VZ!-Z"G
MT.Y-6)>^H4\;R2D*3QQX<V*D,FY13=#T21B[%S5*2I@%>S]T%ERI$YQ5Y6QB
M01=S<HQ)H>_.R5MC60D ?(:\T7Q=HDZ<YYACZ2\-4)D2=]K_ .0OA$D3N\>A
MKJTO[O"WU,[Q.(K&]25$94@?F6)NZ*0S6&JGU0UMEZ!BC$4<FQ<BB$I;'W)B
M3_\ G1Q!PUH[\A]]HU/Q&C6_'Z-P^.[F1\=.M7CM7)V4^K_'24R1]LNEB^8L
MR-,[3AQ<'!MG+*K3.DN3N"Y5)'MY+388E9Y4)@R"'I.XY>T_9I=IQ<IQ])(X
M]))DZHESG(F-L10QY(1/SS-VMN*)FZZ]\LG#&8C,E12A:8NDTR4DX1D!AD9C
M:&,-O<=/;=S-K&I7MC3*V)<U=@&=P$G7&1=FCJHY8T/CXUM2>+O:1Z2R+9N;
M6N)-%UYL[ZHY$VR&?/24BU*G_5/%U]/1O/CHK/.\>.B1>T^C3>@I]#774VK:
M0M'>Y4I2VG?D/OM&I^(T:WX_1N'QW=D,9;)*BLP6W6*EV,HRN:V_!4;2*;,9
MQ.RY?A:)+533"X\SIDS.UH[^\Y>T[E:4J);!6>6DMF$&U,KD&*XR^DL^$HTV
MF68TB5@Y)1+?$D584:9*VH$/?=/;=PX@I06]8?B[F+X[-(<I18SE$RNL9<BL
M(NQ)+GPJW%4WCMJ;'<SDR@S ]FW&<>L$;1IT:5)3]T\77T]&\^.BL\[QXZ)%
M[3Z--Z"GT/J)#[[1J?B-&M^/T;A\=HW+VFC=/;=Z\LLP4MMMIT?Q4\77T]&\
M^.BL\[QXZ)%[3Z--Z"GT/J)#[[1J?B-&M^/T;A\=HW+VFC=/;:*GBZ^GHWGQ
MT5GG>/'1(O:?1IO04^A]1(??:-3\1HUOQ^C</CM&Y>TT;I[;14\77T]&\^.B
ML\[QXZ)%[3Z--Z"GT/J)#[[1J?B-&M^/T;A\=HW+VFC=/;:*GBZ^GHWGQT5G
MG>/'1(O:?1IO04^A]1(??:-3\1HUOQ^C</CM&Y>TT;I[;14\77T]&\^.BL\[
MQXZ)%[3Z--Z"GT/J)#[[1J?B-&M^/T;A\=HW+VFC=/;:*GBZ^GHWGQT5GG>/
M'1(O:?1IO04^A]1(??:-3\1HUOQ^C</CM&Y>TT;I[;14\77T]&\^.BL\[QXZ
M)%[3Z--Z"GT/TN<;TEG&#>LL>C;K[GTZA1CX;9?1\-J84\FF5M?#KB;WLVRV
MCV;4VQ^.OLH^&U+-?#2R[G<VTVU].J*R ZA5[T;;?5Y-ZRQX-NOX^=U=[Z=:
M+'HVXTMZ-O%KV;<68^G66\;-ZRQ].OMJ]FT+,>C;*7O1MIUCX==7CYW5WO)M
MM_&3>LL>C;C+9 =4JY].I2UW-J:KNXE9NEHHCMZ;4EM;:I+:6U16TKNEHHDM
MJ-TMV:HK*7416UNHDMK3=+1N=O31%96ZB2VMNZ6]%4EHHCMK=1';6BI/3A-R
M.VEVZ6BB2T51VTI5%92ZB.W;HEMZ*I+15%8-RLVMTMV:I+:6U1VTK1':-SM%
MR2VEM4=M+J([:UHDMK1:FMW+<[>FB.VMU$MM;=SMZ-RL%$5M:T26UMJEMI;N
M5NU1':-SM%4MM*51VTNM1VUNHCMK3<[1N=O31';M42VUHX);>'516TKN=HW2
MWHJEMI;5%;2[<[>G=+15);2E4=M*T165K1';T51VTINEHHCMZ;4EM;:H[:6U
M16TKNEHHDMJ)-DA<@5\T',<T',<T',<T',<T',<T',<T',<T',<T',<T',<T
M',<T',<T',<T',<T',<T',<T',<T',<T',*\MN:@KF@YCF@YCF@YCF@YCF@Y
MCF@YCF@YCF@YCF@YCF@YCF@YCF@YCF@YCF@YCF@YCF@YCF@YCF@YBF47/I5Y
M;<E%O-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S'-!S
M'-!S'-!S'-!S'-!S'-!S#$_&2UKJDMI7<[=JB2VM-SMZ+D=M!N5NUNEO15+;
M2VJ*REVY6].YV].ZV]%4EM*T165NHCMK3=+=FJ2VE-SMVBTEM1+)BXH'3MX[
MCMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[CMX[
MCMX[CMX[@O.CDG+Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y
M].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].0Y].09
M<TKW9U2**J2^^F]!3Z'ZZ*5&S:-FT;-HV;1LVC9M&S:-FT;-HV;1LVC9M&S:
M-FT;%HV;1LVC9M&S:-FT;-HV;1LVC9M&S:-FT;-HV;1LVC9M&Q:-FT;-HV;1
ML6C9M&S:)!_X6]-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'3
M4=-0IK_\1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU"
MWX_IJ.FHZ:CIJ.FHZ:CIJ.FHZ:CIJ.FHZ:CIJ.FHZ:CIJ.FHZ:CIJ'"O_P =
MTU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU"5.GN1[JE&
MZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE!
MB1+L[JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI
M1NJ4;JE!J1+T;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1NJ4;JE&ZI1N
MJ4;JE&ZI1NJ4;JE$@LL+4]-1TU'34=-1TU'34=-1TU'34=-1TU'34=-1TU'3
M4=-1TU'3465KMVDE7$[N0-W(&[D#=R!NY W<@;N0-W(&[D#=R!NY W<@;N0-
MW(&[D#=R!NY W<@6)$NSNB4;HE&Z)1NB4;HE&Z)1NB4;HE&Z)1NB4;HE&Z)1
MNB4;HE&Z)1NB4;HE&Z)1NB4;HE&Z)1NB4;HE&Z)1NB4;HE%$J:VO\";T%/H?
M42'WVC4_$:-;\?HW#X[1HO8Z,WRZ,WPT<D]UHK/.7[?16>02R;,L,3VYBCUU
M(U/X_*3$4Y8U\@_A=G9"R((](FZ3-^C3>@I]#ZB0^^T:GXC1K?C]&X?':-%[
M'1F^71F^&CDGNM%9YR_;Z*SR#/GLV;XN2]57,UKB[H<M'SR91AZFD]X%1ZE6
M38NWO^2DJ"/*G[+38G?)PCC\:*D^6%#3$)<@E[<,I1*4O-F$_P"DZ--Z"GT/
MJ)#[[1J?B-&M^/T;A\=HT7L=&;Y=&;X:.2>ZT5GG+]OHK/(/R LZQO;,5(3D
M$7@3)%KHQ2E<R9T].4R1;21S^&R!/'H["T<TQ,H*RSCYCR?)U,KC21%ERYMQ
M SU:E R5_3<)_P!)T:;T%/H?42'WVC4_$:-;\?HW#X[1HO8Z,WRZ,WPT<D]U
MHK/.7[?16>09$@JB;$HD]4B0-./%+=-Y_"3YE;*\:'O"UZQG+Y:E+QDX61-P
MA&27M(;CIA41<J Y(3-D1B+=$6\2AEOD#)!(L;$&+1IO04^A]1(??:-3\1HU
MOQ^C</CM&B]CHS?+HS?#1R3W6BL\Y?M]%9Y/HTWH*?0^HD/OM&I^(T:WX_1N
M'QVC1>QT9OET9OAHY)[K16><OV^BL\GT:;T%/H=R8H9$O:WA=E-D=F]WE./S
MV3+L4?E\I?4:*7R>2OB3)TCF['%$\>RG%I(KE>0F*'*VG)T;>"DV:(<J7.CZ
MW,[=*<Q-#BQ8S<E[K%=-(??:-3\1HUOQ^C</CM&B]CHS?+HS?#N5KT4GN<F6
M)+(_^29:E6MS]!4BA]_(.(-I$4S[') KEF;8=%C&C/<,=$SY^1SM>NQEFA'-
M3N[)/=:*SSE^WT5GD^C3>@I]#NY&_O\ -Y#&$:R3H%;9,YY6MV2);_KC@G2O
M.6,JLS*QNN4B^(23+K,WQV'F-TL<F:;7.Y<'G47BJ& 8B_IFFD/OM&I^(T:W
MX_1N'QVC1>QT9OET9OAW)?.X_&$J4^CX_P E,3&5,;4S>T1QG+OMD91!*AO8
M2^B1,Q!9+"07:W14ZC=D4B_K">Y)/=:*SSE^WT5GD^C3>@I]#NR?':U^DD]Q
M@;*U5N%G7>'['3@\R5YQTM<YI-\96R8Z/8>6)G.9X^5R:0RF-I)0UI\/2PD]
M^@J1[CUV#Y"<GA<<.B[%II#[[1J?B-&M^/T;A\=HT7L=&;Y=&;X?L^[8)=U2
MN4R5$I;TZBK8DN4NB&BY*D<E;)>:8TNABAZ<%)[9OBA.M<$K78K-W\85RE24
M$]R2>ZT5GG+]OHK/)]&F]!3Z'U$A]]HU/Q&C6_'Z-P^.T:+V.C-\NC-\/W?;
MM6S5L[+Y$=V<TTU$M>Z''.Q!"P]*0IM4QQ#;<W-:=OL>',U "$*IU4D'M22W
M"J58X9([DD]UHK/.7[?16>3Z--Z"GT.Y(94SQ8JF6(554OR=#VYP-<D1**S+
ML(O535Z.0PS'4@5.D+39:A*M4L<42!&W97A;HKD$Q8HQ:\2IG8D.0IFL2,+?
M+4K?$6[*\+=%;]-&"-W,&0(U)E9QQ2<I/E6&*3VB8,;XVE9>A!P;).G72A9D
M^((#X[/8U*#OY)#[[1J?B-&M^/T;A\=HT7L=&;Y=&;X=S*^(K)H9(<?SJ'%6
M2))<280[5/ODZ3JEMSXN.(D%4UB8N12*]-$9T^'-GXSH#$4-@;)"DG<DGNM%
M9YR_;Z*SR?1IO04^AW,[TVFR8Q)E:XC*8DRM^+I:L4\M7#'T1+@#,L4*,+'+
ME2;$-3%"IFD[@YJ(4=C&&JH[F2PDAIRQ=;2&R_\ STUPAJ2(2]LX>X94*WI+
M$8LPL2',*I0GBB>$1>_&N+?\]PK#F-Y;F0NPK*S4QM;[DMX:D43R39_YL_CD
M/OM&I^(T:WX_1N'QVC1>QT9OET9OAW5R!(Y)CL%08Q=V/CW#$N&<?I%ED4CI
M=7/&\(>;V>/,K GH793OR3W6BL\Y?M]%9Y/HTWH*?0[F2H>Y2Y)*H([/4=D<
M(=7;'IV/RW*#\J<@&V+(/0F!-6..F!H<>911WR:"D2&.$XHG:T3?&Y;_ !Y3
MB:?NB9^Q\\.<5D^+W1X8C\2S)>3+<?/3\4A)N3(LC6M=8FU7+#6'$C>:J@V,
M(@XPUF0P!W33F]H<W>=Q'&3XF?\ ^20^^T:GXC1K?C]&X?':-%['1F^71F^&
MCDGNM%9YR_;Z*SR?1IO04^AI5J-,X)N1D.ZQI:43*B_2" LK<^?RR'WVC4_$
M:-;\?HW#X[1HO8Z,WRZ,WPT<D]UHK/.7[?16>3Z--Z"GT/J)#[[1J?B-&M^/
MT;A\=HT7L=&;Y=&;X:.2>ZT5GG+]OHK/)]&F]!3Z'U$A]]HU/Q&C6_'Z-P^.
MT:+V.C-\NC-\-')/=:*SSE^WT5GD^C3>@I]#ZB0^^T:GXC1K?C]&X?':-%['
M1F^71F^&CDGNM%9YR_;Z*SR?1IO04^A]1(??:-3\1HUOQ^C</CM&B]CHS?+H
MS?#1R3W6BL\Y?M]%9Y/HTWH*?0^HD/OM&I^(T:WX_1N'QVC1>QT9OET9OAHY
M)[K16><OV^BL\GT:;T%/H?HU6F(IQ!%TT<45:\4;Z6U<T%M>)(*UM<45XHYH
M*VU<D-HXDAVJ.C?=3B:#HN<T%EM5Z.EU'-!4<5;J6U<4-*\11=-'!%6O%6_9
MJYH+11Q0UNHXH;A1R0UMJYH+:<20[5'-!<.)(:4JXH;15Q0TNHYH*CBK=LU<
M$5*\11=-'%#6O%6ZMM7-!047HZW/%:+#]W.&[G"B<ZM-W.I3=CZ#J#AU!PZ@
M[HW8\;N?T]0:.H-&[G#=CQU!U1U!PW<X;N<-W."HDSA&[GTKU!PZ@T;N<-V/
MZ=W/Z>H-'4'#=SQNQ_3U!W1U!W1U!PW<\;N<.H-I3=SJ5W<X;N=4/4NC3<5V
MZB([=1$=NHB.W41';J(CMU$1VZB([=1$=NHB.W41';J(CMU$1VZB([=1$=NH
MB.W41';J(CMU$1VZB(6Y AEZ'MU$1VZB([=1$=NHB.W41';J(CMU$1VZB([=
M1$=NHB.W41';J(CMU$1VZB([=1$=NHB.W41';J(CMU$1'7QI>V_9N&S4;-1L
MU&S<-FHV:C9J-FHV:C9J-FHV:C9J-FHV:C9J-FHV:@VVNSLU&S4=%1LU&S<-
MFHV:C9J-FHV:C9J-FHV:C9J-FHV:C9J-FHV:@VE>C9N&S4;-1LU&S<-FHV:C
M9J-FHV:C9J-FHV:C9J-FHV:C9N&S4;-1)IS$K'#MU$1VZB([=1$=NHB.W41'
M;J(CMU$1VZB([=1$=NHB.W41';J(CMU$1VZB([=1$=NHB.W41';J(BV=1':9
MWEK>D6B,R1!DIG-" #FA !S0@ YH0 <T( .:$ '-" #FA !S0@ YH0 <T( .
M:$ '-" #FA !S0@ YH0 <T( .:$ '-" #FA !S0@ YH0 <T( .:$ '-" #FA
M  DR+"%RDLTLZWOIO04^A^CT*=3;PQ)M4:T=M:M"&MES2BNNHTHJ76-:.P4:
M45++FI'=3A2.E]K.AMMX2BI;>THK[:MJ2MU&A%059D%;*M:.Z[A:/:HV)+:\
M&0[-S2BN%&M'2^UK1VBC2BI;<T(KJ<*1[5K0BMI5J15MN:D=PJUH[KZ-**T<
M&0[-6Q)==PM'M4:T=MU&9!2RK0BJ*-J2ESM;1";O)HWDT44FTI52;6E51U:[
MR:-Y-&\F]&]'5KO1U*[P;0;R:-Y-&]G=-%)M*;R:-Y-&]&TKO)O0J/,X154=
M6N\FC>31O)O1O1U:[T=T[P;T;R:-Z.&]'=.\F]&\&UIO)HWHX;T<*J3:TWHZ
MM=Y-Z=Y-H%6,HG(1R6@8Y+0,<EH&.2T#'):!CDM QR6@8Y+0,<EH&.2T#'):
M!CDM QR6@8Y+0,<EH&.2T#'):!CDM QR6@8OPI J6<EH&.2T#'):!CDM QR6
M@8Y+0,<EH&.2T#'):!CDM QR6@8Y+0,<EH&.2T#'):!CDM QR6@8Y+0,<EH&
M(_$F6)IMJHVJC:J-JHVJC:J-JHVJC:J-JHVJC:J-JHVJC:J-JHVJC:J-JH-N
MKL[51M5&U4;51M5&U4;51M5&U4;51M5&U4;51M5&U4;51M5&U4;50;=7HVJC
M:J-JHVJC;J-JHVJC:J-JHVJC:J-JHVJC:J-JHVJC:J-JHVJARQ!"5RODM QR
M6@8Y+0,<EH&.2T#'):!CDM QR6@8Y+0,<EH&.2T#'):!CDM QR6@8Y+0,<EH
M&.2T#'):!CDM PR1EJBZ31*,-05<?R/Q^.1^/QR/Q^.1^/QR/Q^.1^/QR/Q^
M.1^/QR/Q^.1^/QR/Q^.1^/QR/Q^.1^/QR/Q^.1^/QR/Q^.1^/QR/Q^.1^/QR
M/Q^.1^/QR/Q^.1^/QR/Q^.1^/PWX>A#6M((+3V=]-Z"GT/J)#[[1J?B-&W>P
MT9GIZ,SR:,WRZ,WPT9VCIXG:.SR ]4F34XRT A6E54M5);C?X37-N(N)/(46
MZ--Z"GT/J)#[[1J?B-&W>PT9GIZ,SR:,WRZ,WPT9VCIXG:.SR#/U-M UXJQ^
M<WWVWX[R8DD"./96:<J1=W<9!)6F-(;,Q16M[K)&AF;R\RQ2Z^]V;BD%<TQ&
M@1+TCBG<]^J@B^*B%*>**5<2R+HTWH*?0^HD/OM&I^(T;=[#1F>GHS/)HS?+
MHS?#1G:.GB=H[/(/R V^'MAV7MPCF/751(F% E6YGS@024;.3HPG=)[(Y?)X
M[=&7B3XKIDM&:SYA>VR^*HYJSDQ["1;JF+$XGS;#T>,H<ZT<=&F]!3Z'U$A]
M]HU/Q&C;O8:,ST]&9Y-&;Y=&;X:,[1T\3M'9Y!F=A>'M*UEWE-XCT=>TV4\P
M,CL]%S"-R)NE$Y<)K.V)ANG<?Q]*))(Y6RJ\4K%,&2SB<)67'S"^M"-[5*D3
M7%"9$F?F>;N;HMT:;T%/H?42'WVC4_$:-N]AHS/3T9GDT9OET9OAHSM'3Q.T
M=GD^C3>@I]#ZB0^^T:GXCNW7V64L4)S/U6ZVT6WV7#P'30*'5N2WE'%'V]UN
M]AHS/3T9GDT9OET9OAHSN\8<24"U"<[]7&66"V^R\5K2@VK>@Y]:"#BS2S;>
MY3Q.[QAQ15"U*<[]7&66"V^R\5K2@VK>@Y]:$YI9I1UO<L\GT:;T%/H?42'W
MVC4_$=PR_JRY#*9+,Y&N+E4"KS"R,Z$ESJ?3"\N732"K'#(\XERDS(4^BUC?
M&GR7E020O,3E/CW6[V&C,]/1F>31F^7NR>3M<4;%/Y,K-Y:_R%ABAL2?D! E
M91OY+-%JM%E2(*V/_HZ'562_\@V1L3-/Y&/A"UC>D3^W]PWPT9W=<UQ;8WN<
MJF>1WSC\TQFK-RQE.XNN0<E3PQFRK,X O<LGY,F2P_,60F)(1$']]3X1G#RA
MD'<IXG=UP541(GN82_(S_<]S/&AYF6,IGE<Q,DSN]JRE-<?KW3*>29FM.S!D
M2/)4T3?Y&1AB;OC5*.Y9Y/HTWH*?0^HD/OM&I^([DSRNNN<,?QYQ0&RML?I"
M^2]"8SQ'&W"B6S(B=<O>DRQDCZ.2H")<T1IM-:6>5T,9Y>S.:9U0=QN]AHS/
M3T9GDT9OE[BM6F0D9VG33)C4Y#2RQR/1XB2/KRSMZ^3'1MD;62-16V2N%8''
M]QC;#8WS*:(DY[+^.*[>(QW#?#1G=Q4H+2)Y[F1WD!\!8EK2B<61\DLAR,0:
MC9H)5KL9I.B6N4NXJQLI<K8K96E;4MZ1O2K.R>2D*Y,XIOW3Q.[AQMI!4[S4
M[O"O'D>6LR1W97R2R+(Y!S?'(%PDIFER-:YRWB;&QERUEMEJ!H27H6XM56*Y
M0;G!,Y)/W9Y/HTWH*?0[DM?53$C*F$U/+C#H\.">Z1,=EY9EAMETA9+###R2
MBK9$QWWJEZ-#3M R[532[2RW]F-,"IP1(120,M35*U(D+*?&@\X]\:$QIC@A
M*3%JDYJ=,X(EA5) RU,4+DB0NZ0,EM79^0M:%AE-CPC8W!2MH<_,R8PI00>5
MV@9=E(N1K[.[(??:-3\1^S*=-D0ZM+*ETI<6&1I9&T+ I3$JR7>".38H+ELC
M0!IBSA+UK(RH8PDELS4W*T+$Y/[5B]U7Q^6=QN]AHS/3T9GDT9OE[GY&/3@C
M;TS!'XTV6VMLD:FYK1M:>6,#HTO"*?-SFEXDRPMO8GB:+%U2$9%3IJPN"B(R
M=UQ3(&9T3O;7^S?#1G=R7%G'1C'=2RSTDQ6,\A2/C6NN7MZ9R3N,+?&!1VRD
M!%C'!E$CO;$2*.()!+W)R=+HVLD+'^/LI<RWW]T\3NX^%WFM$ ZHA83+UK-(
M$C\U+KEZ!,XIG&%/;$HI,9 FM8H2JDQC6@0QM#(YBXKW+LXLD3-@&0N2=U_=
MGD^C3>@I]#N9(^,:G:>E(45\C<F0M*V-UZQ>D11)F@Z1X9+VM.B8GUM;4-LI
MN,41E;#4I$=7O"SL7<I:+2(PL,7,N2[=NCI#T:./NRTY="V)@2(&0I8T&F17
M:>V!&^WIHJ:6>PPK>&?='!::X0DR+(Z1*XDMRA$09TEC)'%=Z)CCD.2O[=#%
M*E*JBL<3OM8!M)7CNR'WVC4_$=S(R)1%IXH?(=*;$..D2%6Z257=,=JE*228
M,S8>A-)/2SA/:O,2(X[$4_,9Y-MQ=$'=6]]QN]AHS/3T9GDT9OE[GY#,]JZ&
ML9)$IB=K=,HK<S/3@2RLSTCD*1VA+(Y!KQXPVJS-E$D>)%)G^YGC+&P$3MZ9
MU+?B5(I18^_9OAHSNY?;2^V5$*(%D54JADRN:(*F9%K=)%BR:WWVV6NLQ94[
MJGN+O)F"&QT<R[X_"4E9U(U1."( [-)_[IXG=PRW;+G"17 \CJET,E]6F I6
M=:FDBQ9.;KK;*/4R94C@1<7<5,D5CFX%UCL(1UG<B4%X+@3PWJ?W9Y/HTWH*
M?0[DX:U[H@1UR.A3LILS/*7E3]4&N'5LCEC;.T*-RAKAP$^/S%P;I6G/3QJU
M!-%S<LAUQL;2(YP55"4:0ER92MUNX35R0O<:4TC30U&TC]&*6LJB/)'&Q&OA
M;A?)'YCM<VE*W39$)"RNJMA-:'"Z'-4?7TB\9;)2C3QJ,KK&\IIFS&(K&#VQ
M/"65R:RXNQN:!_[LA]]HU/Q'<=65N>B)5AAM.24*R*ELKAN0U049LJKQR-D1
MQID R4P59<-/3Q1%@I"4I1L34A3V66%T[C=[#1F>GHS/)HS?+W'QG2OK:]8.
MF+&M;96YL*^52NKV7#Y0EC13_/ECA9%Y$YL!Z_(I"E,3=D)%2*X@E<W6QO\
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M!8\/I$WH*?0_]_IO04^A_P"_TWH*?0_]_IO04^A_[_3>@I]#_P!_IO0__\0
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M@M>VPYW]A/;)\H],53M);YOMJ;1&YYC6J?6@\@2D^F*E(;@>#045A0)23:Y
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M)Q&K=4D)O?W-."_EL<Q[*.W1\Y/I$5;MI?Z,_P 7L E)!&T1,U2:FFVVG2C
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MW!Z8T<T@14FTT^H+"9I LP^H^^VXEJ.U:E&PMM$.M+:44+%B/W^SIAVDA_\
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M+SR58".8B*EH'6*>V7 $S21QL!1]-H3HS7%MET4Z9*1MWGXQ(:)5F>)P2KB
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M3#TS,.LK9ZTS "DD#?-63?CM"T/MTAU+Z%-D+5A2JQ."PML)BF) DVK#BO\
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M>Y%-_0I;[)/^!%#$DBY%QM&T0-$91=014)J;FIU:',:6YDI4V-MDV[T7L(
M  R %@.0#9_8=4/N\Y^OZ1P2I_!"@?2SOVB>"5OX/4SYZ?L^":0?!W17]!>_
MY!]M2JQ.4B8$Q*N$'XR;V2K9MMS"%=4B94S[PA,P1;& =O+>\2^F%8EYQ4V)
MA2\1N6U*. YWL1$UU2:L\UJT-,M$BQ4G$#Y85IA7%)P[K=3G?)9B6ZH5<EV=
M42AXV]\<*BN)[2&JS[VN>FG0>(!1LGR0]4)Q].%Z8=<3R*5<>WTE[DTCR_\
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MO4] C GO4] C GO4] C GO4] C GO4] C GO4] C GO4] C GO4] C GO4]
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M&=I\I_P=I_*3+M9=>;94IH+4V5BUL9(LG;M,;@G-_P#D[GN;>M7LWK??'/9
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M2YU$T)%D)FBE*AJCC:-C<#O3LC3O2JAU;1*ETZ0GD/S; 8UK02H%.%U:E7)
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M=\V#G;,12-.9N8J+<C5:<)$/"S92'L9<) 2"ERV]Y3&D&F<W1ZD)!F29F I
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MC,2>ADDU3TOU.8U+KJ+H!P97 /QK'ZHT;TF;I\UUI>5K& X0R]M(NHCBWN0
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MN3@@X^"#:KR\$''P1/'_ %R\$''Y>!G:?*?\'=4/N\Y^OZ1P3J<_!>3^>_\
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MJX1R8M>?@AF=?>IRII#84]NL* "0;&*=,3<PA1FF=$1J%B/3_@;)OE;7U/\
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M#VP_+ORR]',-J:78'"K78ZC]$4WY?*?7(]/O]D'R/SJ]$4;L6GQ.Q1NR:_\
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M*5NL"0+VN!GKAV4J\^XV)F7#83_F!M(Z1!N8EF=KL-LWO@%K^_V3?*VOJ?\
MV][L=^0)\WH]Q:0M)2;V.61L>>)6D2<FZIYD.8U&Y*UXLSYH4D*2I)U*!2?$
M18PS0Y%@K* [\(E25 N&VZ%CEXHZW*;@T>!W#BQ7TFZZ5M425*DY DL)5<\:
MU8CSVAJD2;4SMM <TURK-=TWSXK>&)VERD_;3H-QQH.%1\9MG$K0Y"3<TK2%
ME7_Y%8QS$0NCR:YK;9#FFQ8M_N;^*T3[8<KK"%"Z5.)"O%<PC8]34.AX(<Q!
M6*Q7=%_)M:W@B;I\M.-AIY.Y3O<.Y(\1ME"-C]-0A;80Y9=KDKNH6[4VR@T>
M3,IM(Z708DJMI#BNF]L[:LXE95J4:#3.+ .V-SS^[*]F)_R6?1[LY),SS>B?
MQ8;WW*L)YXZE2FU#)X5Z$WUJW6?(JV4,TF4887+MA>C<WUUW5KOOK0W19)IE
MUA <P/$%=W+G+D-LHDY!B00I$N%!*B"<2L1R]R=ITK/I"9A!-C?$DX5>+%KM
M$G1Y*14I;"%8E"UW%8R/"FXR/BB8H$A,NJ>=TQ6K6=*?9 V,TL&^%_+/XT^R
M':;*O2Z)9Q!+:!9)ONP/*M>&*!3I=P.(0X5#MUXQS$1,2S,RT674 H(MEK3Y
M)XO-#% ITNZEY"'"I)N M>)/1(]Y)=D9KR3ZWNSDDQ/-:)_$47!W*L)RSUP:
M5**E!)$+T*;6W6ZRU9^>&:9*L2SLHV%AEV^.ZKJS%M<-T21:9<82'=&Z"E5W
M,[',V-HDY%B1;T3 4$7)W2L1SUY^Y.TR4GP ^@Y<:#A5SVB3H\E(JQLH5BY5
MJQ\V4/['Z?,.*=<#Q6LDFSI S\%HZV:7VK_XQ]D35/EYMI#+P7@0 !A58V&6
MOS1+2[<JRAAJ^!&]Q&YY=?N35*E9Q]N8>"](V $X5V&1OF+9PE(2D)&H"P]V
M0[)53Z]/_6/=G9!B?0EN8Q84DD8583GE"J5**E1)D+T(SWVZS_W0BDRC<LJ5
M2%AI5K[K=9>&T(HLDW+N2J0YHG5A:KN9XDBPSM$G),R+9:8Q82;[I6(\_N3M
M,E)_#MA!NGYR#A5JMF;7,25*DY J4PA5U<:SC(\DVRB<IDI/BSZ#XT'"KGM>
M)2C2,DO&RA15_P#D5CMXKCW&:1)L3!FFPYI5**C==Q<F^JWAB:E69QHM/)Q)
M/2'B/%YHEJ%3Y5T/-H65C5I%XTY^ CFY/>4SY7.>;UU>[.R$O/H#<P%E((.Y
M5A.4.4J4=ED2J@O1-[W=;K(6UPBF2K<FY(I"] Y?$,6ZW5KV5YH31)%#"Y8!
MW1KWWPF>N^NT2DHS)-!EG%@&K$<1Y_<G:7*3]M.@W'&@X3SVB3I,G(DEA"KG
MC6<9Y[1.TR4G\.V$&Z?G(.%1\:K7(B2I$E(E2F$$E5LW#C(MVI(R\T$!0*3J
M((/B.42U)E)285,LAS2J!!Q+N,_!$Y),3S8:?Q% -]RK";ZM<2LJU)M!EF^
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MK(%OY0I24 J40 !<DP:_2@O1[9&*]M1U^.$.(<0'$J!01<&_%"Z]2VUEM4R
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M/RV=_K_,5[ZHTF5J2;/)LL:E@9Q+;$95ES&HXDWO;+.)S8_(3B0G!HBD6"D
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M5+Y=,?6'@8^FVG5LK2XVHI6DW!&1CKMJ=K68U6O@S].N)F9=FG5//*Q+4;^
M>+W7JQ-/RB9)8;T2<LD[KBX_-_C;%NQJ/N^C@DGV<J7D,>J>"4_LG-^2KUQP
M2F=E*S]I1_U#@E>[)/?UR\$Y."'\N";#>QJOKE^D<#<^+7Y"O08J7RZ8^L/
MQ_!VQ;L:C[OHX))]G*EY#'JG@E/[)S?DJ]<<$IG92L_:4?\ 4."5[LD]_7+P
M3DX(?RX)L-[&J^N7Z1P-SXM?D*]!BI?+ICZP\#'\';%NQJ/N^C@DGV<J7D,>
MJ>"4_LG-^2KUQP2F=E*S]I1_U#@E>[)/?UR\$Y."'\N";#>QJOKE^D<#<^+7
MY"O08J7RZ8^L/ Q_!VQ;L:C[OHX))]G*EY#'JG@E/[)S?DJ]<<$IG92L_:4?
M]0X)7NR3W]<O!.3@A_+@FPWL:KZY?I' W/BU^0KT&*E\NF/K#P,?P=L6[&H^
M[Z."2?9RI>0QZIX)3^R<WY*O7'!*9V4K/VE'_4."5[LD]_7+P3DX(>";#>QJ
MOKE^D<#<^+7Y"O08J7RZ8^L/ Q_!VQ;L:C[OHX))]G*EY#'JG@E/[)S?DJ]<
M<$IG92L_:4?]0X)7NR3W]<O!.3@AX)L-[&J^N7Z1P-SXM?D*]!BI?+ICZP\#
M'\';&7FD2"&U+2%X0K"=>$#,QMEC<_")W2L"?"KD$;98L3I4V22#X"-<&98!
M4"XFZ0%*'(%;T^>!,L$I =3=0*DCE"=\?- FI<A)#J;*R3X>*-LL;KX1.X5@
M5X%<A\,;98&+X1.X1C5X$=MXHVPQ=*=(FZLTCEROZ(VU+V2=*FRB0#RD:^:-
MM2X"CI4V2I*5'D4K>CSQMAD$C2)ND$GP :S&V&=S\(G=)QI\*3QQMEC<G2IW
M:BA'^Y8UI'A$;:EP%'2HLG?>#B@S+ *@74@IMB\%\QSQMABZ1I$W6@N)_P!R
M$[Y0\ C;+&7PJ=T<(\)/%!F6 "2ZFR24GP$:Q&V6 5#2)NA*5J\"5;T^>)-]
MGJY4/A$[IMG#X;(-^:!-2Y (=396]/+G;TQMAC=?")W"PVK_ &K.I)\,;88&
M+X1.X3B5X$\IC;+!*0'4W4 4^$'5&VI<A)TJ;**DI/*4[X>:-M2]E*TJ<*2
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M D!)L@@ISY,XVJSN]SOUZ16?SH,JR<>Y^,1HU9_-C:K-TJPYHR3GX+>B!)L
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M3J$;'ME$K7DN8$E#C>:AA5;/5NCXHZOTPSFT ZI4SGN4HQ)RY5 VBM;(Z=1
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ME[7YH,ALTJ<C*TQ3>.EC &GPA .CXEJ5BQJ N;@Q6MC<R-C<M3*>RI]]O-T
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M&R38FW5Y9#,LIN7+(&#<:[7MO;<L4S^SN<VW_?E8&&SDH7&//BL;B']@=/F
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M)<TY%A?VF8X282Z,YPA76*\+-.PN4#::F4PHB#T=S@HFI!X62)R(D"B3,PB
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MF:A5)LZ-1Y>X;ZLVCNE!4QH;<Q@06T%;X\4+7=S-87=#*2Q.;_6\MT-L,*=
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M/]CT"J-N#I9<W.%=<TUI$]4YNO.2=1D3FFW*>R,LXMY9Q6\T,T=1"45SP]J
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MHWA-D+C+N(I1Y#$B=;"R*IH.0K==7L_^L3__ &_D0.^\\H/O?/'W#G !JJM
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MR-V9Q-M8L2@HXK+PA)+$G)#U3?&4FFF+8VI-PGGK+RH&'4.M>LD67D]W5/\
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M$Q7:F9_AJO8RSB2W-M(F&5I2'EJ' >'#&ZT4UK/3J?\ \J)Z;;?I.CF)Z9F
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M5<[^P\5#FFQ%]$0F9IM9E@;%BQ R1H $J[1(EUAAJMS3.A8Q69DVMZM'B_\
M& 347+6X.),H(Z+-@B$BIH9H%F6$NF')HC04['9A).JSC ,72XR+&],=KY'@
M<X0K?-%U^PSN<G7)%::PP,NV+<F+;VC$!;2[N)55<()G:&JG1YC0S#2[)7)E
MSDLZUB$7$3D0M4.4J?G)1J6=PXUD97>CZX?BZ5MS%A+42?&3)?<;ENZ7_2->
MR<]0SE@?-LVBWS+I,#A.U^"JCUHF]T\J[*#5)W%IR*50F%Q%C6S.*R9]F)+=
MF^Y*E6Y!6EES261)=-")B&)C%8DL9<L2M?==IWMA)^\JDB*-;&#A-X[+P>S#
ME5K!,%-NVQ++LHP&26R!%7K>P:46::P.:VIMI9EI.Y;(T$8!JLS;.B#^SDV5
ME6RRMPP$U0OIAXJ'-@(/(B$Q--K,RXV+%B;9(T #)=HD2Y<L2[%8G&A9E\5F
MY!I9,',?_CB#BH[;XN+5#;P;;3@.#?-,0$A)?KYI$ON?JCDD5.EC:-I&906G
M<35U"[J$JKM+?*#J5%*7"9-K0JLRPCX8+XME53._+!U6JDR4VX(@2L-(R%AO
M;@(J]?W']'?_ $JQ^>Y[#%7I),C.2Y(;:OM(\W=+ZP54OKAK=6\[)^V[.0&$
MJ@,;&#-E"LO![,4VI5AV5.9I)B<GH)9&0%1=!Y,8(2XN&"=:)*9GW:<KL@ZV
M[+Z*1%M,;1Z0<2(:XDQ:X:FJZ<J;K+:-!O:6273"BWS1"*Z^PB]947/L1_PO
MCI[-*L@X)>1!EVR9^^@7+\;+.+\M[_3$MN=1RG'3I1H664=D0<>01O95=([J
M6>U:)"BU=R3*1IIH<LC$H++B$(:-,;B$N+@]B/\ AF;?DEI>]PE<(2B"]H6Q
M 132X[ZFQY(3<RR[(>U:7X)20D]F6+WW'?7V(9D)-ZEI+L(J-Z2F@99K?,M)
MG'O]'_RL/61,56HJV4W-.$XZK3>B#$2W6P(JV]AOYP/.2-S7\.YYH>XW)5>D
M3 !.R<C*N A=$:)4I["6>9Q(C@YKP2Y86GU*;E0ERVMY2V]#+MD#F</T.G.R
M22,RV;3J/28NNJ+@D)6<4D5%L:YQ.R-%>E1EY]S2/I,RR3"XM'H^AJII@3#R
M)RYQ/U2FNR2352<-V9)^41X5)RV+"*FF'5$],R3M/1RHN..S.DD1-%)T](6!
M,?!3%JA^;=MI9A]R8<LEATCKBN'9.1,1+9(_X6!R1]JD14PK)"K]E6_OV._W
M1O\ HTVK+BXL;1XCE7%++$XQB$#)/BJN8\D.L',TH1= @)6Z:(&B$EKB2.7%
M>LJ1[8S$Y,'.X\8OZ5S2-EKZ&>+$%N3"N4,RC4U33;8;%L2?IXNNJ@"@HIN$
MY<BLF:KK6"J-9F=,\2"B VBMRX84MT-G$0@J_&5-?N-RO_2M'_(]F;&AG* D
M[[_OF628^(K?!N28>"L3]>I[TH,]4C<.:TLLCDNI.(B$HLXT$<A2W6AS=.#T
MHM4=' 1'*H3.'%CL+*G9,^S$QNG%VG^VDS*L2;I+(CH-#+$1-V9QV0KDMUOG
M#U7JBM%./H(FK+>B;L&26!%6WL.RM&FV58=(2T<ZSOL6\(X4%E#-$:'EPBEK
MYPT_7)H#T(8 9E@67EM=\:L(:@KG]_7;V)>@S[DB5/E6FV6D:DQ;=P-  #B<
MQ+=<+8WRAF0DW:2$NP*"V)4QM5LB6S7&EURAUDWZ1@=;-H[4L$7"X*B5ETG6
M6'ZQ2YH&YF9Q*\VX"G*&1HB*2R^- Q62R%K2!I]6FY<99#QJ,C+[S5S*V%U0
M<Z(VO*!9>S*_Q+'YHQN>_P ->_/3V ="V-M<0WS2_:B0I=6<DBE::@I+(Q*"
MR:8&P:3&:$N+@@GTQ_PW/OR94S VWA;E$;>46K8+NXU7+"G)#&Y5AR0]J9<<
M#8E)"3]KD6;V.ZYDO)$MN5FG)):3*( M"$F(/V;Q8<3V*Z[2\GL,ST@^;$PP
M2&!"1)FG7PJET[$%(.35.1DFD94VY! >PHF&^E1S%BZY<L&^^X3KKA*1F9*1
M*JYZUNL/N4,Y4"F+Z3?,LDQK'!E<DME$_NKDRDO;:I:7?).R@N,=&MCT;*E8
M-E+9Y1[_ $?_ "L/61)%5YB6$Z>Z3\L<C+[T,'"# JX@-5V8;D69JGFTV& 2
M?D4=>M:V;I.75;<L.5"J3!/S#JW6ZE@&_(V"D6!.PGL_^L3_ /V_D0.^\\H/
MO?/'W;D_(MBS5Y<5(2%+:44N9B2)9%(L(BA+JAZ2G629F&#4' )-1)KMU^VG
M'*I_BZ_DC[E__P [\Q/ZQ6!G)H6"2Q,C,.HT2=96T+ J=M/ZC</_ !%7_.'B
MFYWYYO\ T_%/Z-/\%F_]>?%-RW=+_I&N*?T=_P#2K'Y[G$V_G \Y(W-?P[GF
MA[A&GIR:=:%+"VY,.FV*:K(!&HHELLDXAN5_Z5H_Y'$Y7^)8_-&-SW^&O?GI
MQ/\ ]8G_ /M_(@=]YY0?>^>/]1O^DMMM5@-6R O:RL1+DEUMG:.D)'_,6?1'
M2$C_ )BSZ(Z0D?\ ,6?1'2$C_F+/HCI"1_S%GT1TA(_YBSZ(Z0D?\Q9]$=(2
M/^8L^B.D)'_,6?1'2$C_ )BSZ(Z0D?\ ,6?1'2$C_F+/HCI"1_S%GT1TA(_Y
MBSZ(Z0D?\Q9]$=(2/^8L^B.D)'_,6?1'2$C_ )BSZ(Z0D?\ ,6?1'2$C_F+/
MHCI"1_S%GT1TA(_YBSZ(Z0D?\Q9]$=(2/^8L^B.D)'_,6?1'2$C_ )BSZ(Z0
MD?\ ,6?1$](5QEIF8?J&^&Q9>%\5;T:#?$.I;\GN9AV4D)N8;Z*F-J7><';3
ME %2/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQ
MZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ
M/@BH>*3'JH^"*AXI,>JC1S<L_+'^Z^T;2_48C[G<4DE*OS*A,5;'H6G'<-WA
MM? )6CX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI
M,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>
MJCX(J'BDQZJ/@BH>*3'JHP3DK,2Q=9]EQJ_:T@C?W.YU):1F7N&V?0V'3X*R
M^O@@N79U1\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%
M0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\
M4F/51\$5#Q28]5'P14/$YCU4:*:8>EW/W'FS:+ZC05]S_1NLC)S$TC=&FD/0
M,N.X56?-<\ E;Z8^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BD
MQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZ
MJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ-'-RS\L?[K[3C2_4X(K[G<NDO(33UN
M$NC8>/@E*-67@@N2\D?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5
M#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q
M28]5'P14/%)CU4?!%0\4F/51?VHJ'B<SZJ%:F&G&7$U@Z!-DG>FB+[@6P12,
MR01%$NI$2V1$1-:JL;@09ITVX;&YEEMX0EWB5L].?!-$!<*]A;+'P14/%)CU
M4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?
M!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%
M0\3F/51HIJ7>EW/W'FC:+ZC05]PU\X'G)&YS>]/FWL,N>+1R[QVN(6OA!=<?
M!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%
M0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\
M4F/51\$5#Q.9]5"M/M.,N#K!T";).])$7W.Y5V3D9J9;3<O2!QLL.N#=&,TN
M $D?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU
M4?!%0\4F/51\$5#Q28]5'P14/%)CU4?!%0\4F/51\$5#Q28]5'P14/%)CU4?
M!%0\4F/51\$5#Q.9]5"M3++K#B:P>;-LOLFB+[B41-:S+")X48H"R].G'4"G
M.H6CEWCLJO(MEP@MH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'
MBDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BDQZJ/@BH>*3'JH^"*AXI,>JCX(J'BD
MQZJ/@BH>*3'JH^"*AXI,>JC1S<L_+'UGV7&E7M:01]S_ .L3_P#V_D0.^\\H
M/O?/'Y),6'%!"556ULU^J.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B
M.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B"WRB,U9L
M267G$1,9JF>$R+@IBL@Y)JAZGU%DFG6B4<5ET;B);A-FJ(ACGK3E]Q0= XH8
MGI^]N7HT=,']WHCI@_N]$=,']WHCI@_N]$=,']WHCI@_N]$=,']WHCI@_N]$
M=,']WHCI@_N]$=,']WHCI@_N]$=,']WHCI@_N]$&Q.H(5,17><]9,>.V$0,B
MX(@(WLMH=D*@R39 2X#5%PN!=<)"5D1;CGE[C<VK3I#_ ,NE!RZVB3L1TP?W
M>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T
M1TP?W>B.F#^[T1TP?W>B.F#^[T0;RH+%:9 E:F41,4Q:YX'#+)-(6$5L.J'I
M"H,DR^R:BMT7"=OC-JJ)B'LI[C<?H'%#%3S5;?Q+D=,']WHCI@_N]$=,']WH
MCI@_N]$=,']WHCI@_N]$=,']WHCI@_N]$=,']WHCI@_N]$=,']WHCI@_N]$=
M,']WHCI@_N]$'ID%NL-BJR\W9,3BVV'"+@BB"EALD.R$^R33K1*F:+8DY%%5
M1+Y>XH&C=(;TV1'*VI)-FW)'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[
MO1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1#M2D&Q
M9K3(J9H-DWW;/,ENJF1?%%(=E9IHFGFB43 T5%NBVY;99:_9I!)DHU*25.VD
MRVJ1($#Q(KDLAGJS*^O5'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'
M3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1!OH@LUMD5
M)N8R19BW")'#+)%6R"*".</2,^R3+[)*)(2*E[<HW1+IGK]F7^?:_,&*5HWB
M&\FQ?5R,AV(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_
M=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(>J5. ):NM!B5!L(SEL
MA%PRNNM2/@#KAV4G&38?:)1(#%17)52Z71."MLEY4]QN;!ET@'VCIZV2VO0#
MV(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1
M'3!_=Z(Z8/[O1'3!_=Z(Z8/[O1'3!_=Z(<GI819KC(D>D2R;[1+D6,B^.2V'
M"(YP[)SC1,OLDH$)(J9IUKHET]FF?XA)_P"H;B4T;Q#B8NNKL=B.F#^[T1TP
M?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^[T1TP?W>B.F#^
M[T1TP?W>B.F#^[T0;4P+;%;9%=ZSEDQ.+9!$'#-<(B(HMK#RP]3Z@R33C9*B
M*J+A,;KA(55$O=,\O<?^L3__ &_D0.^\\H/O?/'Y)+Z?QX@4K-@+52;&\I.V
M327&Y(V1K\5P[8K<D.4^I,D!@JX'+*C;PHML;:KK%>O[.Y_YZH?G<0*6FD!N
MH-BN])S+'>UD%PU^*@I8;0[3Z@R39@2X"5%07!Y%&^O*WL[F_P" E?R4_K[I
MK2" A!BKM"JRTW9$5Q4V6W3UX57-;0[3ZBR33K:K92%41P;JB&%]8E:Z+[.X
MW_#G/]2YQ Q<0&:LR"K+S62*Y;A87"UW6R"-H>I]19)EYDE'A(J(5K9C?DS]
MG<__ (?)_P"C9_KT(5L29HJ0Y4::V#%;8#$H"EM]V2PI^\3BJJD4.RDTT3+[
M)*)@:67)52_:6V7L4K_$9/\ U#<4S^$3SE_K[IK2#<$08K3 *K3^I9FUS5'"
MUDX96%+:X>D)]DF7V2450DM>W*E^3V)?Y]KSQBD_P;/Y+?\ 7H0K94U+!34H
M+<M7&051.V%)JR9"XNT5D1;=F'I&>9-B89)1,#3"O;LO(NM/9W-?X%3OR!_K
MT(5LJ9HL'-R8 Q6V 4D5$MOJW(NLB<(H=DIQHF7V242 TLN2JE^TMO8IO\?)
M_P"H;B3^8]']==,E2"9F!!FK- N]IS)%-439</7J3"-H>IU19-IUHE1,2*B&
MG7&^OD]G_P!8G_\ M_(@=]YY0?>^>/R27T_CQ%9"H"+<Z _L<[LD)_$%PD13
M(,2W44UP[3J@R0**JK+BC87FKK@<"^>$K72_L;G_ )ZH?G<1*4FD!JHMBN])
MS42JF>!Q413/$MA&'J;4F39>:)4123"CB);A#RVS3V-S?\!*_DIQ"Z9+"RLR
M@2]5;']CG=FYVP@+RBBFX")=</7AZFU)@V76RX.-,.D;55T;@_W3%,0]A?8W
M&_X<Y_J7.(736D*V8@Q6& 7>LU:VFM<]&YA3&XXX>$1S[$/TVHLFS,,&HJA)
MAQ6^,B9Y>QN?_P /D_\ 1L\00A54)-2I!U"EM Q7& NK;8V2;04LB" )F=KD
M2DN<.RDTV3+[)*)@>2HJ12O\1D_]0W%,_A$\Y>((J+94@C: &*XP%V7$2V^;
M)DV2"F(W")=9+#]/GV29F&#(2$TLJV54Q6ZRVB7^?:\\8I/\&S^2WQ!"%;*D
M&XR+<M7F04FG42R3.%,2B: F(S*R "JN4/4^I2[DM-,&H&VXEB14[&?7]C<U
M_@5._('B"$*V5-2I!34@V#%>EPN" -DG+)A $ $N3F9&2DN</24XT3,PP9 8
M&EER54O]-HIO\?)_ZAN)/YCT?U]TR5()B80&*JT"K*S>I34;EHW%1%,R,L(C
MG#U-J3)LOLFH\),./#:Y"G6S]C_UB?\ ^W[%)&2GIJ2WQ-,M.'*O&R:BY,-@
MO"!4Y%6)=]S=)NNQNM"96KDQ:ZQ+;EG)^:J-(K71Y8J@\<U--W=%@$TSJZM:
MJ@IKA^7GJ_3Y9Z612?;<<)":1%LJEP5U+#M6I]6E)NFLXM+.-&JLA@5!.ZX4
MV55$7*!E&-U-*=F2/1BR+I8U.]L-L&N^4:2_ PX\7)AM>_U9PY(S.ZBELS;+
MFB<8-TM(#G[JI@UYQ,5*D3IB+K).2\U*N$&(%!<) :66T4A[=5NBG*0T;8JL
M^$\[+/&2L!B0GA0B6VU%,W_5F)=B:9:"0>F7"4IP09 D-"LJF1-V,B6U[WA)
M5S=32AF%(01I72Q8CR%-CE5<H<<JE5<IE--05:A+S!2Q#KPX7@121"SY,[1(
M.R-1*>I34FAL5)]XGR?ETOT=Q\DQ.<MR5(WFFZFE+-:31:'2ECTG[ML&N-]D
MZ*2VC1W3?$T:I="[5EA65W6TA'$/1J&F.^-"PX?>]>+*)^H4R;7"3.)F9ES4
M<L)YB266*?,3LR]-/DTWB=?,G#7;UD5U]BN4>M5>H4F7IK>"0EJ7-N2+SIA,
M$TAFK=T,3#/D6^<;I-S;LZ=3IM&=<.4GGC)Z8-QR<<:<9=F#7$>A0$&UK(NK
M^M#OO/*#[WSQ^22^G\>)'2JF#;<UA7>4]9$-MU4PCI"%-(X I?@XK7AR2J#!
MB&*[#UN ZVMU;)->L+%GUXW/_/5#\[B-TR6"E)L09JC(+O.;1,*EAN>C<PIC
M<)P\*(I%VX>IM19)MUHU%"5,G$3XR:XW-_P$K^2G$;IDO8@I">%MFHMBN\IY
M!050[(EG5!,;J84LB$5D5;P[(5)@VU$ET9JG!<#XI)KUI9=<;C?\.<_U+G$4
M5%LJ00$(,5F7!=ZOHF'36O9LT!$4R(OC&7;AZGU!DFGF34>$EL2(ML2=NT;G
M_P##Y/\ T;/$4(5LJ0=4I;8,5Q@%)QL!PC,HB751 ,(HJ"/+RQ3Y6::)E]FI
MR@&!)945)AN*9_")YR\10A6RIJ5()Q@0EZ]+AT Q3"DS9,(-J((ERUDI&6<)
M(3S),OLS0"J$EKHCMD).W:\4G^#9_);XBA"ME2,Q"6KLLVN]YA$PI,(ES4#$
M$13<,L(B9EEVH?IU18-EYDU#A)D5N5(W-?X%3OR!XBA"JHJ:E2#G9$ 8KTN%
M[ *"DT@I9$P @IB1$554ES6).3G&B9?9J4H) 26U3+<2?S'HXA=(67F!%JIL
MA^R3:)925+DC;F%,3A&:IPB+5KAZGU!DFW6B4454R-$6V)(_]8G_ /M^Q1B$
M%<(9Q@A;369)--J@)V27*)4 _HTJ[H"T*"XE0DD0DZZ76%W9;JI,Z,W3S5FF
M4A["<QH\0O ZKS)*V2"5Q5%1%6*F,T NMR[2/:)Q$-HUWPJ6,"11-.P26B@;
MF&W!H]'F9XW:F4J"LIH7V,:Y2R"5L8IE98=HK$]*L.[V#1S3,@\W.:=H4(52
M:"61ZYN"E^%G?."8TC^^&ZA)2 31XT<67FIDVEN1*CBJK:I9;W2)>5<DV)A^
M?D528G9EIN8F5<-##2(^Z!/"2)RXKW2\5N1>JJ3\B;KSDDTHNZ26:T5@:5QT
MBOA_NV2*'VE_TC4?T<,XE'&W*HJBJBMO:^5OFF<.2XT]BX2+3Z3.C;WYI$9T
MF+?6#3;7]Z$&9=)W>Y2[8&:J3F'',[9DJD:]E8_HXH;#KC#=59IK,PXV9 6A
M==<;,<0*A)=(2BA*2[;CDDC0S^B#?8N**)I=\H&GQ?WL6+LPQ2*WNP:DY>7G
M)MQ^H*W-(KD@2-HQ*I@-7L;*"F(\\5\DC_A_<ON33=2J2?1IZ59EY9T#%BZO
MJ],L"ZO"%3VKQNC:?)U=[FHB+KBN*W?3\"ZJNSJRZT4WYEO_ +D3=4G%Z%*M
M&YAO93PI?"B\BK%3W?TEIZDR\O+JTPS*] >FPESX*Z26)NY&AXL1)?KQ3ADJ
M>ZDX_-/2\Y+&\+D\LV) DPZZ^H8S!Q[$0 JK@SAE]$LCS3;J)UD<!#M]%_ZP
M.^\\H/O?/'Y)+Z?QXF5(K #I+%O2<MPVC6R9JF9)A2V:Q2Z*^2&<N_.DA);-
MMUW$WJ_NVXE=,E2"E9@0:JK(+O2:LER5+X0+5M$NLEBDTU[-V299EG%_O-MX
M5XE=(*G5,1"< 5WI.6X0EKLMK7NMDS6-SU%F%0G9&4<:)4MG=\B35EJ7B2$*
MV5((,(,5M@/V9]$1-,J)A "U)UUNL4J4/;E6&9<^Z98!LOO'B2&"V5(DJ[3Q
M"6K$E-R[\R*(@H^VV\+SQ\@HJ ")9$BF?PB><O$D(5LJ:EAN89 )>N2JMD#B
M(B:= 4405V1R%%6_+%/9+:98%I>VV BOX<20A6RIFD$R\ ,UAD%WM,HB(KBH
MG!$M29ERK%'I[N;DE2Y.7/NFFT%?PXDABME2)2IR8A+5J3F99URR(*3 -O 9
MKR"E@")1.LS;ZE3B1,/"+=2:#]DF;(BJJ;+9:N7/$4/4Z?;5MYJLU"U_C!B!
M!-.P5O8HF@8>>M/2RKHFS<LF^VM>!%M$FBI9= &2Y+[%;>*7>%I93)U6C1M?
MVE=1J.%?KBE;K:7+)//T9_3S$H2(J.,@SHA2Q(N+,U6V%=4:.FT0SW0J ,MR
M9T0P;T^0$JS!2VCL)9W7);0LO6%86N$_+SX,,LL,"SO9TGQ:NT@@>),.=LH2
MDUN3J$M7:9+K+K+M2$T^T[,(A$B(^VUH[744NF45BIUS2*U/&Z[2Z>#.)UN3
M-KH>+ ..Z9I8DO%$9"6F"=1%NT++BN)^R-ZP0<2?5']'"-2[[BMC+:1&VC-6
M_P!@EDX:"*X<\L[0^ B1'[6 F%!52OO;59,[P\SO:8TVFE^A:%S2[4Q_9X<7
MW1N&GI!@BJ5$E)*;WL::,U"7-QP@5#S0E7DM>"EPEJB.Z9N4T3<E[7S:M+.H
MB<#?&BT>&]^%JBC5FL(4\[3ZE-U.?E&T$2&F/M-)+-8&TN\HXK8<*EE=4C>.
MYBG3#NZ Z<VRW+K2'I,5/>Z ^BS),"/!3%FJ\*-UTL_*3#<TCHJ;1,N(JD8O
MEP+CP]?Q;Q3@>:<:-&6[@Z!-DGOGQ21%BHTV76TPXPYH$U8W%&PBJ\D+N=W5
MRD[*3DBZ;.%FG3$VTZT%@$L332@N+#?E@_Z0*;N4)G<U+3*N;Q684C>LX0G,
M)+D.D17U,7<&#@ZN2)*?!DV$<:0=$X) 0*"(*IA)$7[OZP.^\\H/O?/'Y)+Z
M?QXI($:XENZE^TO$T(5LJ9HL,$6:J2*J][Q.Z13#-;DK!77_ ,SB:&"X23-%
M2)55UJJJOV4XFJ@2BJHH_0NN*9_")YR\3$@7"2+KB6[2_IQ-"%;*F:+$J2YJ
MLJRJKV</$Q(%PK=$^A5SB6^:7SN)RULN@M^:GL<(1+ND1?Q]G%@'%^]A2_UZ
MXLN:=F+Z%KP8>CV+JRTJ]=6QO^$85$</[MDM]6J,*@"C^ZHI;ZK6A,0"MM5Q
M1;=KK1:V76C#@##^[A2WU:HPHB(/6ME]47T+5^OHP]$851%'K*ET^J+HRTB]
MAL4_2%1 !$7784S[>6<6%$%.LB63[O8NK32KUU 5_2,. </[N%,/U:HL*(B=
M9$LG]8'?>>4'WOGC\DE]/X\4D.Z>_'BDOW2>;Q2E_,%^9Q24_P!_$3BE,_A$
M\Y>)IVTB5[E?TXI*?PC'F\3#NA_&);YI?QXG+?,M^:GL(Y4IZ6D6RU',NBT*
M_22I'5)1_'F>="OTZ<EYUE%PJY+."Z"+KM<>Q#,E,STLS-S*H+$NXZ(NO$6I
M&P5;DJ]CCX=]YY0?>^>/R27T_CQ20[I[\>*2_=)YO%*7\P7YGNE8?<6<F07"
M<M*D.E!>L2%",JKE/-?_ (PP3S81@J[(8U_^M_\ B$TE08>(K*@M.)=45+IK
MC1R4VVCO(T1IC7M(D:"?J<LT_P K*N6-/HM#LVW5)96VA5532)?)+VU034M)
M3,PRV5E<#1JBVY16^J%.1<PO EW)<R32#G;-$[/NI3_?Q$]RIFJ"(YJJZD2-
M[)I:D:*HGO(FUP*FO%BMRY0JI-#(J.L)LQ0O)O"L!7)!7$Y--K^Z-"4ZV^5[
M+HG!R^N%=I\VT:IM-XT4A[=H66?JTKI16Q@CJ7%>SEUX*I>V,NXVB70 <3&7
M83DC#[7S2R^/#I$T?7M>]]4#.T]T3%43$&)%(%7.Q6Y?=4S^$3SE]W:Z7]UI
M'W!:#]XLDC]G?;=[E;^Y3MI$KW*_IQ24_A&/-XF'=#^,2WS2_CQ.6^9;\U/8
MHH$B$)3LN)"NI1*::147L*D2AGN;I)$3(J1+*-W5>S%-FZ,X3=!KK@LSE,)?
MV5AZ8>0,<NTE@! ;3@\J1N<D)ZC[\J=3>ETIL_HVBWL3J$K9XRX28;+L]>&J
M5*T^>KU3.RN2%*P',, 8JK;CHFJ6 U11'LI 4>HT>I[GIQ[W@*LC;>FRO9M
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MS3/X1/.7W+4LRWIZC-#=EM.1,2ABS3.R\D2M;J3&!MI16^$131H5[62&Y:E
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MOD67>Q4*F:=.NG953]UTER^O^H+Z?QXI(=T]^/%)?ND\WBE+^8+\SW$PTO\
M:,N#]8*D52@.%P%<>UY;2*7_ +H.KTH2>8<)2<!%SSLEL*774,,RLQ(&TIJ@
MDMG,K]L4A*8KO[45K-X<EQ:L_HA2<:1M[_Q1U_4EH4):IFVP7Q5(1R^DH7%:
M8F'-MTQ2^JW92!9T!&X8J0"#96UV^(D;ZG$.7IX?OW'@WZQ8>18=E-.TZRJ%
MCQ&"Y+;^\O6BIA(7WB>#26O@R)SZ-?N93_?Q$]Q5I7E.3=0>Z5(J="F#]Y)U
MKLY.H'_MAUR59.9DW#4D%%5=:J7Q4*VN":F)0V,(JJDJ'R#?XR)#TBTYI'6K
MBXVHY9)=>WDL$Z ;W>7/$'*OUQO?VT)&%78Q!?#W.*ZP,LVV)KK,R%+DJV5=
M=^6'9%B7<<F$2R86SLF),ME+0[5:T:L,J6(,96Y,MK#;-(<E7'&G6FF505Q"
M2W02M;.\5,!Q;TWXXK5[VU#:U_<TS^$3SE]S1IF<3%*FV6"Z7%%69'#$C-4X
M?V3@$[@36.=TR2&C<? ';)B$[)8K9[2]>,8*A 2:TM:"GJ:>]YK:X.5U3LWC
M0STL4Y+"MK9GB^R"PQ*-R;LA)@J8A03 ;7UW(1Y%U1OM)DB+ B%CR3);ZU*"
MT#@.S1I9L0)"LNM-F\&%2;4Y":OM963.WQ4B2G:=,$,M,S30&W>R8770 LNT
MJPS,#J=!"3V4[:1*]ROZ<4E/X1CS>)AW0_C$M\TOX\3EOF6_-3B*Q*U+=%NC
M?K<I(O.O2M.=E6FFVM)J'&WF6'+7UH04R041$[29)Q$.^\\H/O?/'W+3$AHM
M(!$JZ5S1IG:V=E@6):J TR&RV,VW9/\ _5$U3=TLWIWS<;=9<0P=L38E;/"*
M)PE2"IS-0!*8O T>^02[6K,='UN2\.T@]<R"H\ZB)B$S1,6'D75RP]3:?/@-
M*-QQ4869 4(3*ZJ0Z-<ULBKG#<E+N?\ ,053)PE%$=(E0K&6JP+LJB1O:=G@
M,6%'>LOOALF<-[K=<"*.<4RDB$LDU)HRA]'X%@,R7A6SUQ2J3+(QON45K2XW
M<+? %47"5LXIDM+++X).58;,#?011T&L!J/!SSAIANHMMR@%FR$T&'"NUEHK
MY]N JFYV;27FG03?**X#2 2 @JH*HEBQ9JMX=?W155R81$4&I03:=8<$QS<<
M) $A(%V43)8=JNYB;26.:0U>57094%-<P&XE<;)K7.)2J3SS,QA<!V8<5\5<
MQ?&LB"E_8?FZ%."VR^MU=)X&W>%?&F'"6JZVZ\+.S#C<S)FTZ+CIN)IR)QNV
M;8I:U[IVH<J6Y:<26WUC)Y"<!G0$5AT;5Q/$"BEU5<[P_5*XZDQ47274:.#G
MGI,:8>'?DM:)B?ILRTS+34P9O6?$3-HC4\"C@7EM"U29T&@7"JJ+V(U7A8EP
MVZZQ+3-/1K2(O[1I#1NZ96Z]\H:IEA1QN5<9R7@XC0N7K7**@[.Z$69I'$%6
MG4,N&*)JM!S<E,MMR#LTI.V?%#<85;V(,"_5>)-T519A]&V#1-I<#=\TUVO$
MI+?W$<\(*%_4%]/X\4D.Z>_'BDOW2>;Q2E_,%^9[E=TFYSIAQ<3P(J"N5DRL
M)$N20PW7J<8R[BH)/.(]:REAOF BO+"U!M6<>'&EE3'?K6QPU5YX'6Y;3IHC
MP+APBI*F:VRLL:=)D'E4;B#9"9:KYB)7AHVU=8EFG$5!#%=1NE^"J=:,9/Z)
MQL.&+M@S0?BXBSU1I)>D%/M2Y8=+H7RROB^)EG#=)H5)?DS?+1J;;3XVQ96)
M2$D0>S#1/511%\1)X-,UEB3$264+ZX464TDTZG1WE1,1+>^L<ESO[F4_W\1/
M<&T>R:85[43%6W.(KDO,&KI@*V+$1$9)A "76L!(;II!9=MRR:1P7>M_?0$A
MQV5T1.N@J +:HJJIHJ<A7Y8?FJII)<YO2**F-AX0B&T5N6.@NC,NJG!%I=)G
MV<!0W/S1O#*-N(I-"BDFC15R5-<+-#,:A][*R.7[ XKPL\E!*8:O9'=!,%BM
MEK'*)>E4>1?D)<MLT!UMO"A)=2)P"1%LJV@&YVJJ4GB3&.E9*Z=K"G)V8;I\
MD"(B64RM93.UE);>YIG\(GG+[F5J,HTKKDB;>+"BJN!#)PER15AN0JG!-L$:
M,'1LF29[1)&^J;-*C9K?H>CLG8UK$M)R4T3;]["J**&NSK3/\(E9B8+$Z8KC
M6\$Y-DV9(G!;2Q$J\ET1;ZX-]AD&,)H.!+I?*]^$MXF&]];U(P)!<0A0D7L8
MLH]L*E5QFD!<2M..,+>W7LJ+G>%E:13S?E9?@*3;;JZLLL&).2))=[.RTA+/
M-NEI1-OWMP'-3@?W5Y8:EQV6@PI[*=M(E>Y7].*2G\(QYO$P[H?QB6^:7\>)
MRWS+?FI\B!WWGE!][YX\?5+J-^5-:0%2FYV<GG&W-(+4RHFVFNPZKX41;)"(
MF2(ED3K(FK^H+Z?QXI(=T]^/%)?ND\WBE+^8+\SW2R=09$D^(>%%(->S?LK>
M+[[=.40KZ(E'5V4M 4TI1MM&QL+X .E1<-KWC3NOS+XHMT;<T:CVERC$M-8/
M*W":'K6A)E!=E41;Z%@01I>VBQO:6ITNH_&(FTQ'R<*T8Y:189/]X LONY3_
M '\1/<YP@SK>!\-A\!32:K)FO6@'9N8*99;+$+9X23);IE:&VUETE#:'"+LN
M B>N^:KUX5QTGIM>07D D@_^5RYZ1++B:&%F^C6O?>^%O0ZUY/I@91JFRNB%
M-6CUQ^R2K,O?_P ,;>[IG\(GG+[DV7@%QLT42 LT5%R6'W&6$E'W!+#H0$1Q
MKRK#TK*2[TU)8RT2BADEKY:N6R)#L]6'%E<(WEFR4A5"3+42=:T%2F))V:9%
M5%M_"X0X;\BI"34X\@/N*BZ)Y2L%]?)#3].FVW=2G+MF:HJ]I!U0VM:="2E!
M5,8 1B9)RY$EHLW59E&2MC13'Z?BQO9N7":,O?'GQ13)=>M(M+,-LI_<2WN$
M[:1*]ROZ<4E/X1CS>)AW0_C$M\TOX\3EOF6_-3Y$#OO/*#[WSQ^22^G\>*2'
M=/?CQ27[I/-XI2_F"_,XI*?[^(G%*9_")YR^[X8"7=)>+"B(G8_JT[:1*]RO
MZ<4E/X1CS>)AW0_C$M\TOX\3EOF6_-3Y$#OO/*#[WSQ^22^G\>*2'=/?CQ27
M[I/-XI2_F"_,XI*?[^(G%*9_")YR\33MI$KW*_IQ24_A&/-XF'=#^,2WS2_C
MQ.6^9;\U/D0.^\\H/O?/'Y)+Z?QXI(=T]^/%)?ND\WBE+^8+\SBDI_OXB<4I
MG\(GG+Q-.VD2O<K^G%)3^$8\WB8=T/XQ+?-+^/$Y;YEOS4^1 [[SR@^]\\?D
MDOI_'BDAW3WX\4E^Z3S>*4OY@OS.*2G^_B)Q2F?PB><O$T[:1*]ROZ<4E/X1
MCS>)AW0_C$M\TOX\3EOF6_-3Y$#OO/*#[WSQ^22^G\>*2'=/?CQ27[I/-XI2
M_F"_,XI*?[^(G%*9_")YR\33MI$KW*_IQ24_A&/-XF'=#^,2WS2_CQ.6^9;\
MU/D0.^\\H/O?/'Y)+Z?QXI(=T]^/%)?ND\WBE+^8+\SBDI_OXB<4IG\(GG+Q
M-.VD2O<K^G%)3^$8\WB8=T/XQ+?-+^/$Y;YEOS4^1 [[SR@^]\\?DDOI_'BD
MAW3WX\4E^Z3S>*4OY@OS.*2G^_B)Q2F?PB><O$T[:1*]ROZ<4E/X1CS>)AW0
M_C$M\TOX\3EOF6_-3Y$#OO/*#[WSQ]EPQEB>P(JV1;8K0H;R/*4:F<6+XSFM
MKMC$F.\7$WTX\!+B]ZT0W0ERSQ0CGM>Y=74;PXN13PXM7TQ.AO!PMZ/-M"N+
MWU##%C3+*VJ,&\'.DCF[XOC!_8ZM:]>)1%D3'?)")<+WJZ7NN7)&EW@XG[6_
M+8<7(RMD<U:CY(FUWBXN]D84>%[[I5SMEE@C1[Q<]Y<=Q8N4 Q8=7QM429^U
M[B;Z85TDQ>]+BPX%RSZ\8]X.=.;UPXOBVOI=6KL1..)(.%O5K2".+WU<5L*9
M9=>%;WF:IO=E_%BY70Q*';'5$G^P.)OI'U+A>]:'5?+/'R1I/:YR^^6&,./D
M=+"KFK4&N)P-XN+O5P@%<7OMDOB2,&\3Z1&;Q8OC$MM#JUIUXDQWD:;Z=)LE
MQ>]((XL2Y9WU1C]KG/?2;PX^03PXM7+KB;_8'%WLXR"<+WW2I=53+XD:/>)H
MF]7IC%BY6M3>K642W[":;X057A>]XNOER0)[P<15G793#BU"W_:]HNM$Z6\'
M%WHTTX*8O?M(6%13++#KC1[Q<MH])BQ?W,6'5]$2*[P<3?;+KI)B]Y5LL.!<
MLU+7&/>+G3K<IAQ?%/\ MM6H>M$TN\7%WNA*G"]\MUNW&BWB:IO5F8Q8N5U,
MV]6L.6)1-X.)ODGQ7A>]:)+HJ]?'R0A^USF;H-X<?(1X<6KDUQ.!O(UWJ\C0
MKB]]10Q8DZW6C!O$^DEF[XOC(MM#V^S$D&\33?3B 18O>KC?$N4:3VN=OOA]
MC#BY&BPHYJU'KB<7>#B[UWOAX7ONFUVRRP<L:/>9I^S//XL7*T&)&^V>J GC
M3>QN6_9RS(<79[$'T9. WI-6O^[ )IDX2(NK5=( M,B8B,;6U8>7Z8,M,G!(
M!M;7BY?H@TTZ<!%75KLEX;Z,G#;TFK5_=AOHR<-W1ZMG^]!KIDX*VM;7G:#3
M3IP4%;VUXD_2 '3CPVS.]M6#D^F 72IPB1-6J_+!]&3@N*&K7;EASHR=#:%S
M5M*J[/T0":<>%?.VK*\ 6F3A7RMJLMH=73)T-T&]6TA?&^B#Z,G!!2U:[<D
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M68\"WS8;%L1;30@M@%!3ZDM&N-:^QK6-:QK6-?L:UC6L:U]C7&M8UQKC7&N
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MT/XQ+]Q^O$Q[2?(@=]YY0?>^>/R27T_CQ20[I[\>*2_=)YO%*7\P7YG%&/\
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M@=]YY0?>^>/N6WY4&S,U)+.(JIE;K0CK-$%QLMDQ8-47RHFW*W);Q)EP4:3
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MERR2&YBE251%G2 K51=?%R6>X:9MZCUY9IKBAD9JKCK;-S)55;JZ>:KKAJK
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MRLN4.2S3V*13&F#-4R#MVU]B%(U1!1,U7K0Q(ML,3!N."#CB"VN%56RWQ)>
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M!Q1ON$XH/% [A.)I ]KW%7T"*N<OB0==M,D*XT"$Z*9]>^<$#ZH#B==;?C'
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M=>:V362VFY,1-Z1:6;6JP-D& V;F&];U9G7[// 3796IB!IZ M6 TJ(/P4L
M),0!9$$44UH*AE#1I-T8JT/?L%C&W 6F*$)\8C"(>D'-1L#:>TW0RT)I?V$E
MF5<H@J!FC37!^VLD%C+ V^F,Z*Y273GARD^[30T\)@?6EHWQK0'/9SG\38(O
MBKQW+:-;$1.E01<@4B6[L)N7J>UCK"@Q0"#"TY[EQN@4J--\T;"+0*\[D=8B
ML8IK*"Y=?E%"#PJ1E5>$9LRTTQBG<'+.43>A_L3JY7(U[*VSZ(3>6-MPK>D7
MGWQ(!V%WI]VU)&7YOK,V_;^DQC>^V!P+'B+LE,$I.[948RF'-,D*;O>=&MB
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M8:EEPI?B"-.N2ZB_XJ$V&;.A4NJ ,[BEF0;82&:8HR;5+B K4 M%3)D5 4C
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M;4[4BC^5SI;+WK0^*@I@98:_P.?))-0);@%D+5I"C> B'T;@NTV":1(VD&*
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M:-&C1HT:-&C1A%8#9*=$P6%<7AR?3*.6#FY,&I,G]T:-&C1HT:-&C1HT9 7
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MJU<',$6U\<%D>@X1%,,Z:;E-2+%Y#W%H22*-P-69,*7(GF\$ 0.\H1]*2IL
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M7;]_">M?L[L[YN5VC;[.L[EMKMNWA5VX_B\BPC>W\8CQ[6A()T%NC:IO&?\
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MY2GUI*C=;%4!%BHXFD@ELXZE)*5!5]L 4&VV.5-V7@&$H"(9D4HJJ$7EZ)D
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M9225Y1O-J)QQD00K=@MF]#J*%O1HB,\^RDZ.+,%-Z"(JQ]A&9\S0$#0UJXJ
M(Z?BG=-2H;"(G8F0@Z-3G7I;TK(B;-J3Y5;LQ#GSI,3%GF$>&*EXG-"X%?PU
M/Q3M"X1?QU/9@'H@OKBA^96[,2W>=82S+8"9<M(K4:PR1Q>]3A0[F2,^*HK
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MN\&5Z7Z'S@7J*HJ>3I@0;#B*MQG1N!.@9OK3*?%)&3%Y<EJ!L!-FUL%BH:%
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MDN4.)&JB;P.")XQGP76L,;'[0J"LHM3PI+<I#6LB.52FB0["4(/2RB@EP6$
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M7I2 DB=@"%YS]!7I>$[GE]//0DTYQUJ*3K4J9^_&V*=8PK)0%B4WJ94G6XD
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MU*K5F.<\ 4#>\I@]+$(:+5_O))(C)B%B_P!/I'MX3U3A'KGV.$[1N_2([)'
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M"8 0M<XHO[<Y)U&K32:5; <N.PGB6250"I3<Z8 L 1(*<:C;&" -!"RI6C&
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M%P92WJ%HIC O$H;,V*+,H<160P8T+)>!$"!M&]%,.M, Y$ &][T:0*@S%C$
M&1-2@_#.3>='.I@88 JR@2"L$S4VRA6SMMTI#9UIN*I0K S4QI#5[VTQ2&:@
M712IR8+)4%VX00VH:B1-0R21<9WIYX3C9H);HESBM=UV_2X;""S$94>%6^G
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M390FE"M.@6:0'.D6![T,Q&M1H6I 2*B;;R&@ @/RCS3)@!(@RFR&F;T#')E
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M.N$H3"4&NB4GFQX=P:"!=K&DX# V4U+P)D -P8$U?9<4HEV,W1I4C-MD1WD
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MAC21*1@+(S,!+$R:TB&:W-@D>2^CN6WVNBA0[?%U.<V HYTLL&1Z&.53V2E
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M!AR5%$!'R0,[TD7!0]-*2._1W+;[510GPWS.9 MM3ADQ%@J+ 62Q))0>27&
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M[=LX3UWQ]($R@4ALCDHID,6&*=B.+RTKAJX;&  A!B@6@S>=<SAXG%J+L&4
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MM^:[;\UVWYKMOS7;?F@@!@L=/_R544444444444?_]H # ,!  (  P   !
M
M
M
M
M                                    $&       @5)))))))))))))
M))))))))))))))))))))))))))))))))))))))))))))))8
M                                            "         #@
M                                                      !
M              0                                      0"3@\<
M60 ,
M   4                  "
M " "HL)2T0  @                         !<2 $22
M                 42B02!D"      0
M          0 4$ 0"   $                          +[8M',(
M                    4   &^2X6322Q6XB   "
M-MMMMMMMMMMMMMMMT "   5 "4   @                         #,!CB
M)R                          !     4TRVD0V&&V@   0
M        (                @ 0  " ="@  $
M        ""                           8                  "
M                !  "-       /0   $ "   $V@T  !@
M                                             "
M     0                   (  "SYW7B>MFK'@  @ 1K-WHJU+"XY)))))
M))))!)))))))))!)))))))))1)))))))))!))))))))+))))))))))7;;;;;
M;;;:W;;;;;;;;9@                  !   6-)L1"6=-,$  $ #+U;/;;=
MX)U         !@        "         #         !@        ,
M  "         -@        8                   (  "O_ (J1NAS(7H
M( '         $         $                   "         %
M  =                   ?         P                   %   52 6
M$JL     !  X ' H     @$(,S^*ZL @$ZY<(/@=  !59!DMFP 0!^OMQG#6
M HIE[5E-/%#H  41,DX   "^\\6FD?#X6R7HNPZX&
M '  8SDCU2YWLX   ( ' UAXWCHG>$ H3C@1L#P$ +,VZJ(@H  _>T=9S ("
M *U$C6Z$P%$RJ;0E^HP= !_[2,M2   0[]?B-NP?"S@I^H#+ P
M          : #(%QDR*CEHH  !  X?)8C.,(I @%?"S_ &Z/ ( ;Y4'+S0
M YTJLQ2B $ <;:^)2P *)Z!1!F]=@Z .I!<)/2  !>N7%]6I0^$6:6!F>X!@
M                    #0.2#.M$_*>@0  " !PCW@ T(F6! !(L&7HUV! '
M/N)/J0&  $;H) Q9( @/)H/EEV0!0HU@XP]:<'0 48@,,S@   SH,@K=@'PX
M;!D8C8 ,                    !(P             0 .     *   (
M      (                   $         *         Z *
M      ^        !@                    !"DDDDDDDDDDDDDL !VVVVV
MVWZ !6VVVVVVP  VVVVVVW\ !VVVVVVVR !FVVVVVW6 .VVVVVVWT .&VVVV
MVWV  FVVVVVVR +FVVVVVW0 ,
M   %)))))))L #)))))))J /))))))(D '))))))(  #)))))))2!A))))))
M).!1)))))))V -))))))(\!C))))))'P!@
M           !@      %T!@      +$ P      *0!0      $X 0      )
M2.@      !8 0      (, @      %4)P     !XP,
M                    ,       %P,       $X&       * *       &F
M"       !KT       &J"        X$       )E.      !(1@F\9Y7D7)[
M!L                          !@       %I@       #^P       .10
M       />0       )T@        *0       "(@       !+P      !GL.
MR1&@MG<B;/>                          ,        &T        +J
M      *"        +6        .$        /D        !F         F
M      D@."W1YZ?>V;4P                         !@        $0
M     *0        .0        &@        &@        ,0         @
M     .0       !"/ 8Y^'Q^W&,>                          ,
M    &                   "         ,         $        !V
M    *         *        !0L<
M  !@         P                   0 )UB)Z@ !@ +IM:V@  @  &!0*
MP .P        !0        !0        *(1%UI?+=I0
M           ,         &                   " !R-P-<0 ,  1_9Q&
M $  ,/@/= !V         *         *        !0T&7.TW&_(
M !5CUB61"B%P25PIP  !@         P                   0 ,H I#P !
M@!J=NQE.  @ #O3-CP .P        !0        !0        *.C@GR_'!.@
M          #0Z]!A0C'IOF-^@   ,         &                   "
M(3-.&%  , %:YAR=P $  2H*) *!V         *         *        !0
M      (6           +/%YY9T'<*"<ZJ   !@         P
M       0 1*?1(2 !@ CIR_QX  @ $_V'(H .P        !0        !0
M      *                                 #T   ,         &
M               " !<RJJ0  , !<9HT   $ !3>A.L@!V         *
M     *        !0                                     !@
M    P                   0        !@         @  "J    .P
M   !0        !0        *
M  ,         &                   "         ,         $
M !V         *         *        !0
M          !@         P                   0        !@
M @        .P        !0        !0        *
M                   ,         &                   "         ,
M         $        !V         *         *        !0
M                           !@         P                   0
M       !@         @        .P        !0        !0        *
M                                    ,         &
M      "         ,         $        !V         *         *
M     !0                                     !@         P
M               0        !@         @        .P        !0
M    !0        *                    (!! !!! ))))! ) ()( KP?8,
M="M5(ADBB*L\&[ 8G&6Z<-W?M8N1CP CP9;;;;;;;;;9;;;;;;;;:?;;;;;;
M;;;?^1$QQ-JS9B        !FVVVVVVVVVVVV[0     !!))()!! !)))))
M!!._S_R?V/\ ]P_TG]C_ )/+K)_(_+/[_=^9_!?9[[_/]VVVVVVVVVTVVVVV
MVVVV0VVVVVVVVVRY[)_!?Y]_MDDDDDDDDD&VVVVVVVVVVVVQ
M             P         8                   (         8
M   0        $P         H         H        "%9@    O
M                     &         #                   !
M #         "         F         %         %         0:ADESB%0
M                              P         8
M(         8         0        $P         H         H        "
M'Y.3MQ "                              &         #
M        !         #         "         F         %         %
M        01'L;/* 8                              P         8
M                 (         8         0        $P         H
M       H        "                                      &
M     #                   !         #         "         F
M     %         %         0                    R*K^T^*
M    P         8                   (         8         0
M   $P $0%U 0  H         H        "                     E /QE
MRH          &         #                   !         #
M  "         F  1$\SM@ %         %         0
M   &N"U"RC           P         8                   (
M 8         0        $P E <)02  H         H        "
M                             &         #                   !
M         #         "         F $PLH*/X %         %         0
M                    (_X6:% ]E,DM      P         8
M        (         8         0        $P #B0W8/  H         H
M       "                     :$R5IR/G+IVL     &         #
M                !         #         "         F  $AMQ   %
M      %         0                    ,-7#YH\WM^'?      P
M     8                   (         8         0        $P
M     H         H        "                              P!
M   &         #                   !         #         "
M   D         %         %         0
M            P         8                   (         8
M  0        $@         H         H        "
M                    &         #                   !
M#         "         D         %         %         0
M                             P         8                   (
M         8         0        $P         H         H        "
M                                     &         #
M       !         #         "         F         %         %
M       0                                      P         8
M                (         8         0        $P         H
M      H        "                    DDD$@@$@$$@ $ $DD "8<K>.
MZD/)A[4C*X6&><322222222252222222225I%L$D@M@L#IE, E ED$ED - D
M% D@'222222222!         ,DDDDDDDDDDDDB      $@@D@$$ DDDD$  D
M$ DN,$QID)^4PQ3<9;9A/>,A)))))))))!)))))))))=)E,-)E)M))(-(M))
M)!(%,)E)I)@- Q)))))))))(                      U
M           &         #         "         #         !
M "         F         !         F         0EP    !8
M                    P         8         0         8
M(         0        $P         (        $P        "&D:_FN31
M                            &         #         "         #
M        !         "         F         !         F         0Z
M&J;Z\$                               P         8         0
M       8         (         0        $@         (        $P
M      "$PV3B<5R                              &         #
M     "         #         !         "         F         !
M     F         0                                      P
M    8  ,O95P  0         8         (         0        $P
M    (  $  %  $P     %  "
M  &         #  + +V3( "         #         !         "   Z@DM
M( F         !  G:2<6  F  EX-H;  0
M           P         8 (YG7):  0         8         (
M 0  ;X2*6 $P         ( BPS'_ $ !, (&2J@-  @
M  !%<?=H Z*.L8GGMH  !@         P!/:/_K6  @         P
M 0         @ ,\$D#.0)@         0 ?R5D?L )@!!]&<M^ $
M           )BD9L?(J:]3<!1C\  ,         &  @]4/4@ $         &
M         "         $  YX<4[V!(         " ) ]!CA0!,  )#@4D@ @
M                    [V*I6-SY=&AET/WP !@         P  B5#SB  @
M        P         0         @ "3W!UZ )          0 /Q,Z_8 )@
M*T4=.0 $                        &  0          ,         &
M2@    $         &         "         $  )<(0( !(         "  )
M!    !,  (!     @                                     !@
M     P         @         P         0         @        )@
M     0        )@        $
M   ,         &         $         &         "         $
M  !,         "        !,         @
M           !@         P         @         P         0
M  @        )@         0        )@        $
M                    ,         &         $         &
M"         $        !,         "        !,         @
M                            !@         P         @         P
M         0         @        )@         0        )@        $
M                                     ,         &         $
M       &         "         $        !,         "        !,
M       @                                     !@         P
M      @         P         0         @        )@         0
M     )@        $                    ))))!()) !)!( !!()#09*GO
M^M?:.VVVVVVVVVSK1H!!A  )1!9:!+ 8- AY"-(A,K0*!$)!)!)K1I!!A !)
M9!9:#+ 8-(IY"-"A,K0*!$)!=MMMMMMMMMMMMCP
M  !@        !K;;;;;;;;:@         P         0         @
M  )          0        )@        $DDDDDDDDDDDDE"
M           ,         &         *         &         "
M $        !,         "        !,         A/V   !*
M                   !@         P        !0         P
M0         @        )@         0        )@        $'1U8(#H<
M                            ,         &         *         &
M        "         $        !,         "        !,         AT
M=Y1)_P"8                              8         ,         4
M        ,         $         (        "8         $        "8
M       !"83N@_L$                              #         !@
M      "@        !@         @        !         3          @
M      3         (                                      8
M     ,         4  :5*V0  ,         $         (        "8
M     $        "8  "" 20 !
M   #         #@        "@ ""[L[  !@         @        !
M   2          @        3  >I]V"  (                    ;]!$
M2 #4  2@!D\ 8         <         4 2<7<R_  ,         $
M  (        "0         $        "8 .1D,T^ !
M   :-8-RHPTU=_VU&MY(#         !@        "@"5C-%@P !@
M @        !         3          @        3 #N)0AUP (
M           #3A1*V359[?;N_*.O@8         ,         4 !0$B<W@ ,
M         $         (        "8         $        "8 >SP%3" !
M                    J\"25#_ ,.*5[)S84#         !@        "@
M2"0F2  !@         @        !         3          @        3
M)OR8K  (                                      8         ,
M      4         ,         $         (        "8         $
M     "8  22    !                                      #
M    !@        "@        !@         @        !         3
M     @        3         (
M   8         ,         4         ,         $         (
M  "8         $        "8        !
M           #         !@        "@        !@         @
M !         3          @        3         (
M                    8         ,         4         ,
M$         (        "8         $        "8        !
M                            #         #@        "@        !@
M         @        !         2          @        3         (
M                                     8         ,         4
M       ,         $         (        "8         $        "8
M      !                                      !R222222223@
M     "@        !@         @        !         3          @
M     3         (                                      ?;;;;;
M;;;;(DDDDDDDDD@DDDDDDDDDPDDDDDDDDD\DDDDDDDDDPDDDDDDDDD@DDDDD
MDDDDPDDDDDDDDFDDDDDDDDDF
M
M
M
M
M
M
M
M
M
M
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ME-/\2]=[_B7KK62]?XEZ_%,> (D3I]"7?/\ MOHP_P#?3(>6#Z=^/3%=CO\
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M<['7;Z7C*( "*W*<N;3">LW^(CY80D0BKO4^ZQ<B5'%_5]UC5 "=N_?OJ_\
M)5?9_P OAY?+U^-4^_G2SQWZS\XYL22)\O\ SIC<AOS..-^=)&^N&N5G.^/I
MRSWDP2D3#SL_\]<F+-,1^B]]:^AE2""]=K]?C<G)!>$T<HF]OV_[B8"K3H$_
M0]38IWC_ )2JLG3,"*"V>AB.*@3@O;T(^62-<A-.!^ITQ <"@#594W36K/\
M-/K0D2;$2-.C,Y,* 40X),F2O?4:R;]322O4S!_@^S_E\/+Y>OQBFJQ5W>2Z
M^[^F\E\_._SD(+A."0\M=/D]=1(LL\GRO\S?,\D6I^,NU*4IS7\?5V_]Q"#+
M:D3*WW4V^FO^6JT>X]< O.2!*6Y(4B:2<!%I2WOZ#+*+:QMYJ0)4H(UH#=DU
M@IB $I!+ MHG!&XY,F %7'7%KT%R89B$V*QJ\0,!#W!B3)@J$'?%?  T.\#+
M-<W65PV!A9!A1NNO6<-?;KG.TTHA,H8UFIRDH@UXBD;=\99(?I2HAL@6_=JN
MO"A880BUJ\;,G,&DH,=LAX %8%J:$.M0UD6J"#(K Q2VK>5FRGH<731"3I1B
MQ_-)D@O: GE<<Q7"PU8 6PIX^G/P_9_R^$L3S**I  ,JUB=[R]U#JDR\)!JI
M?%:DHZX.)9$BF!+%<%X.-D29"4@Y(T]'$Q(E\JL](+#$$H*'*G:K1SB14@<K
M-"M.!B03"CSF/+!2%$H1 X%4#NXFH DRD1MY+P2 D]BMA-:-+UP2B!-*XD-6
M@:_\E)0(F4)0&N'%S*32;35H6=<"-)G)%)5H6Y..=!RA+!'<T=<^9'E'4UOG
M$[%%(KV!]1J<XEHF4A)$KDO%4,G@A"(+>K#IX2+%BQ8L6+%BQ8L6+%BQ8L6+
M0XXU(37D\)%BQ8L6+%BQ8L6+%BQ8L6+%8OR(@RY -/?PD6+%BQ8L6+%BQ8L6
M+%BQ8L74XJ!33R7X2+%BQ8L6+%BQ8L6+%BQ8L6+ 0N *QU!)$^#BQ8L6+%BQ
M8L6+%BQ8L6+%$8)&C* N%<(&XA=3PD6+%BQ8L6+%BQ8L6+%BQ8L5^%5PWX4(
M&0_GP<2)$B1(D2)$B1(D2)$B1(@J BH!N6@PZ5T$B#"G1->#B1(D2)$B1(D2
M)$B1(D2)$O02:O< 6<_["K1[CUP"6"9MSN_-Y6*K9OFQXS8!EG[]LAM:2MB5
M%\-31]3'^*.A=,VHGE)QZ4+(5 # NCDUO"S0M@&%305%$5!.1!UK'>GED!+P
M2A%2QT<U@8  9[ 1#8.-3.#JXP#(*!.D!*3#WCXIN$Z;"6BD@ADO4F0P< \2
MK=.552:81(!F&=].N$H60@4"&XUO;7&1\)O!+)B+AYXO%;J@(F0+30/? %Q!
M<$PLIH)9HP6ZA" 8 ",J^?Q?9_R^%B!$@"!$A :3KFWF2YEM7;W;RY;02T+%
M=A!!HRX;2AM#4%U73*0JT5'D37RS;Q'!! KL%"V&LV<Q#S#L;L>C6:N$@X3H
M71VR"(O*<"[2Z7E+><4$6&)&)BR288;)UEBWI"V)$0LV15\9H^L ;%TNA7;
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M4!1DI"QH_&I"HD+G4A$^6&684 H;8*0<LXA,186)>DISVB<!"!*)$ZB4G?\
MET9)4 .JL!CBHH$1W"1&+AQ!I).CC.8B4A#JM!OGKAK%D@9B0S:KBZQ*<HO0
MPBI$2&3>=8XI8A:VH<L1DW^0-BZ)B5ZC_)]G_+X?M/S/Y6&*1"6!,V)]<L<J
M&0S)94#4?/$*ADA21(&G> EI*L-(.1'\0E[+W"8&E4TM6?R#._/;&B-R-23Y
M3_@]UZ?Y/FFT"Q$0(^>$PH$LI2;,@CIDJ#C*V"-8CM/SQ,&H"E  PS-S\L?
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M5""@SM1TB>N'(U2!52!E9%YNI.:BB1&!:T_E<Y4EP:&2W0;6L&2339\?V?\
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MG/@>U@8F;(L">63.$WU(T.D#&B T9"62&K.8_&2\_300 GL=;P*8IK$2=\8
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M"<0M(C70Y$^7\NGR<F[U-H1/8EB]L7&@J&86'4JM;D7/*H^85,*R$=<-P/G
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M8R=3J1" /:''7*IA6$MF?K'3(+,B'9;+&;GC/U;"<MSW6T28_CV+HS[S^#X
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M\H*5@L=3K\$LR"F9;:4$'$]_\\*%"A0H4*%"A0H4*$T080J6#8G 0DA"YS5
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MR"""(B)"#O!TG;A!0 IZ<(9-*.%(%B0022)HO/9NKP*<YE1W5 'N(X1?[$3
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MZ,!L8,&"!^IU@G^#/%*$2F1#$,G?# 22C4RP*Z <?/&#B""T)506G2'3)4-
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M]@,8"PP;@?V^>!$D(2/"+"J$$P% 8:BP(YR/\0B.!: GH.FW(B0?L! 2"X2
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M!XB.(8:&X9CZY,:!:$BD@,"N[Z\!_A#"W28&<,@*L"L].] VDJ2"#FNM=\C
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M[]T?_,;)7PL1]^_WB&U>_9NGPB'W[H_^8V2OA8C[]_O$-J]^S=/A$/OW1_\
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M*H([6-&+'T9-H0EM 6\5B&&5J+5%5%"7C>&(@H3%""$B4E '.7@8POD@E]3
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MS,?[=BQV4BI39,ZC+JQT[@(2A,/)&*68MD64@'7@PZ,>[!!@H!;ZR3AJ'"Q
M(20D0WXD']^^$;>?U?">X[?$*2E7 7 M-=.>V,SDD265PIE ,]!R/J$HI F6
MDG]*>:(A@E",B002O:4K3A0*@D.FM'..@4] B!1(1<T,X=K"4SP(J$E@Y6^
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M3) 0V28K >#@5%H["T$U$]*/@]XZO^J"%PQ?17?(G&/%.J]$3RTLG;A#"U,
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MO4&3DQ+!PH07@416(I&6))%!0;S>LJDA4$FD3M6" HV(8P1$-*22FLAZ5#1
M2R)#.]X'XT&*+)2[:P(#2TS0R2I=^/*^!ID%AQ,@D$MWMQE=L C4!4!$$3$+
MFM3->9%)( F*AV&6B$Q0!A%@(EE<0X"E]F.*"%1+*9Q^&6 31 12H211K&W.
M1R@P"I5V!$&F,56EA5$U-)HY)Z8$&_/PDOR%L0[9YP[<:YH0 #L5B)UVE>:*
M_7Q*+[]\(V\_J^$]QV^%!(=8@5K+)WR.%P:^F0QW .-3 B;C3L#(VSA%(),:
M5)XZ.3J I2LM!Q5%T??$((A2 - *DAD3F*GLI%@ D48EI-U#>$ FWCT(B"0;
MF<1624DW>B=G?K2O:4!I!$*24"4PTG-E Z"R.?/Y1\'I>OA-?,_GX2-CW[^6
M#*D+(!-A!+S7X.5\[4*"$"66>DM[_P"ZU !UK8J<-8.8Z3H=@;:9V3Y%U(2&
M2FPGUE,ZGA1IZG:E+K1%$-!>7]H? A)P* -$!$7"0)H.#M2HCDR#H?3XOR/3
MX4;$XPJ&T MY EG)6;>N*B(BDW=?E.6.UC4EQ@J85=R;PR9F&\ R0)5NYF6>
MZ>\S::VA+DC>/("#$;.LB41AW8M\FKV.R,W"B98ZB#C >>5*/+_R#IV]_3X?
M>.K_ +)5D_& 7 RPGOK'&$Z&4IBP81N/@V'GK,R24[,Q&.F6L88Q%A2-P?[$
MKX! /0'Z!C)9F6>LL_7%R%#HI/I/CT7W[X1MY_5\)[CM\:%&Q-(HGD\>> &;
M7JJOE+FT)]^^^!("#ZSYSOTR"(@AP#0'^#TO7PFOF?SX1^1Z>#]XZO\ \**^
M(OOWPC;S^KX3W';PGI>OA-?,_GPC\CT\'[QU?_A17Q%]^^$;>?U?">X[>$]+
MU\)KYG\^$?D>G@_>.K_\**^ _OWPC;S^KX3W';PG/Y>OA-?,_GPC\CT\'[QU
M?_A17Q%]^^$;>?U?">X[>$]+U\)KYG\^$?D>G@_>.K_\**^ _OWPC;S^KX3W
M';PG/Y>OA-?,_GPC\CT\'[QU?_A17Q%]^^$;>?U?">X[>$]+U\)KYG\^$?D>
MG@_>.K_\**^(OOWPC;S^KX3W';PGI>OA-?,_GPC\CT\'[QU?^.6P^:$ 1;]C
M?364VH/N !(7<YOC%0[3?4V70#%+Y?>SH2Z,9T!F.C.C*)4.$%M<GG(@'ZDH
M[& YIY7RYG8?1,M>DOC.@FXS(HM0+WQB<YUP5-C@'.WG,9ZJ:= D,$53S4PI
MD6;$1%\HZTQFP8TXA@7%1O3 Z*3-5,H)^:1BH\)*!6Y$8.B7I*_231V ]BJ!
MFF1U&Y$P&D.Y;R#8ANH4V-EL1@^ (2(FB0VG,)D&S/ ZJCH.!Q7H70M10UO.
M:,398E4%WR'A-:UK6M:UK6M:UK6M//% H4 &=(PO7)=6WB*FGW]LG=,$?.>V
M3>G4_/I[<E!:]]GWWR43+<1S'7%0PJUW??LSS-=)XUZ>?3)5:YGM]L5$BV$1
M?=_/7TQ5VK55DI+:F3\>_IK)>#;?;SUVR:F'>N?./WBI-+$1N_MQDNK2M<\'
MS[#@JE7NFN_E^,ERMI\N'I?GU\LEN!H(DZ_U63V=3Q_?T_\ ,3*J5^15_-@Y
M\GK*)EL(BXZ_GWN4-J*K;Y>_ED]G4_\ GGDM4W/RZ3[^N*BEL-<=?>LEEIK5
M;(._6NO;)=6I_P#./_>#):M>YZ>^OEDH56TUQPQN_<9++36N_E^Y[9+,0Z;X
MFH)^O&"J5>^SY77SR6Z=QY]^*<5)A,%=_?N,EU:-'/3W],EJUS\OK'WCYXJ)
M%,E1]_?TR6[5KOOW4[R6=,0.N>GGKWI)D-MU1\^(:R7S.G'7S[?G%$VIKO\
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MV''[#C]AQ^PX_8<?L./V''[#C]AQ^PX_8<?L./V''[#A-]D@%VKT8\@2TAW
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M B4&#(<M1@E:$=YK@P74DI1E;1U)Z3K-(IE$8@4[86_GE_)#Q*%%JP#RQ0*
M JM !*KP!;A@) BJ*9#CB8R$D20&@B"J(A3Y;_Y(KV+J\(?:_KPGW[X1MY_5
M\)[CMX3?Y/7PFOF?SX1^1Z>#]XZO\,<'@@%16X/KD"T 8U0'I_%8* E-V^3O
MA 8Y8(+1EG?;)?%DZ R0;$ZC>/#>0&E*AXZ.)ZY%"?K(IDHD&/J<8 E2&$0!
M"QQ6!T,SDN%Q3!\SC$8,M_&!5H2HB9XQ+"JZVMI$@K%9]XM1;.HN-2X8%8"*
M(O>_+!R)H1%D *D!FKIG_DBO<NKPA]K^O"??OA&WG]7PGN.WA/2]?":^9_/A
M'Y'IX/WCJ_\ 1%>Q=7O^M>$/M?U\5@@\W!$#/9]F2&T^N#2 =9_K!90GOKBA
MMP1TF)4CZGJCCJ ILY/9\7W[X1MY_5\)[CMX3?Y/7S_+X37S/Y\(_(]/!^\=
M7_HBO8NKW_>_"'VOZ^%0):#'=+'A$+'4B=DA&\-*E@1!3M) @:.S("_KR%$L
M(J+-\-5E-J#',(,@1ABC7.,5D,U$R Y*2]_*7/%R%)JR<#C4])P;#8U9$@!"
M$S-U@%2I+S-$TFN8Z7AP%&02W  J#<_%]^^$;>?U?">X[>$W^3U\OP>$U\S^
M?"/R/3X39?+B^,2ZLV@D+",?6-DQB@]$NF%4A,&WY6YMP0Q<MD78V^MF;_%"
MCPEE$UN(Z7EB^B@B>L1\^OR:0H)BEV(H6GN8G(*"@DF4W!KYZRU[/);$F.!5
MS$O?$. :%#$/,?I'P^\=7_5!G'29Y /R<2"FPZ=2D/GCN9 (TL(V*2;.N A)
M*!#J(HG<?X%-:$ Z "]AG"A:D9CJ(B>3\3<CAY^B)64#O-Z^ - J$,NB OEA
M:[0S'41'Y/Q/0+9SYJ#YN149A.7<6"+B?@4"@!40 "55H M6@S][\?OV8DV9
ME1GK+Z9/;!$$1$D1D3J)2>(*]BZO?]:\(?:_KX6\Z0%$I.H8MH.U1*+><CDE
M,"0MOZ:G=3 &#90$)>=SD>@E\$[.DD\83]B2DXA::2$2ZB<&<ZFU"=H%6S3<
M6X?0?242D@AJTYUE^4&.6'A#SSQAQ&H(*"&==L*8#"P$$;@&[< 1 0B1%NV?
M4"#6_A^_?"-O/ZOA/<=O";_)Z^?Y?":^9_/A'Y'I\ !4 <M8_0PM&9M$6>W4
MTX?4N>(LF6 2IF,/51'8299(4CL8S)!DQ7 ;%Z379AY5-C*  @$@QHWD9 0N
M@5FPHX:J-851*L/2K"@")6@CKB3"CT*#8;;.C4V]23[<)-S,S<S,\SDBF9,L
M(C;K761?A]XZO^JDA*0D<S$?6,5W<=D0P8;(6NFIMMW4@CGO(J:YO)"&JJ58
M(HR08G")R=2P5I91#$<;X28*@L %E-8?BV<AWEJ9(%7C)8431&&!BQ-%FLH)
MPK=31-8%;=,!' "FQ!*$R1A.V!KQFQ4:)!$K,NL.H_=9$T46.PQTV8# LAV%
MJ>F6ZIK*!()(&WRRCS#"* "6-I4#.3^0S="A=2;<!;L&1 % R8),\9>J"'*$
MD'+5=\,#(4E^"0FU" ;7#(<ZAB(",IV7C3U+Z6TE+$WD)1M:[W8=A:PIXA(S
M"B!1868+O#A)PMA GPI"EF&N#Q #+ (I8AB\6F,8M(04E10,N0P.4I81&J9(
M,C9MZ#S6H03NCF<@ODI9<GM2KIA'.N!@DH5:?(G'"!<I-,3"E9"53+4]!RT
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MD_P!)I$5T@O:UDM-%!!+?*F0@6TP9]E41DI*Z")B;*#SL84 RC WE/FXF!V
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MG9#)DR9,F3)DR9,F3)DR9,F3-M $ P9 74%O">Q_?_\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P" @@*N,!5>$*!9@*R3 V9+[1V/_P#_ /\ _P#_ /\
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M(T5 R,STBGCLR$E@AQ'+-JCB9E8B3SEF[JWWE/8\3A@;H$@F^U6";KH9)$N
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M80/! 8!:PP4E.1_]4$4-$V;AC#S"4."Z@LE$SP1>F'I #,(+(R?^<*#_ !A
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MLMRF+H6  (P4(! >; )>^'7L3[4( PH@DF4R<2:)7.M#X)0I*(#A;L3@_8P
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M";>'RD(;EMVEA=MXJ7)E$38SM35#KB*YG!@(R%X)U@01;B1 R9M8\@T]3,%
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MEUZ"&FU 1+$YLF#2(+,L:T=<+DH\P6)&?/LZTL):",&% T*I 63 L4A!R
MKG@8RZ4A1F<M\%D=]#*T41(D5FUMZ?U<@@)$@C<;E0JX848$,:QID;-/; $
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MO[+18 5FXF8&BU?3F$\3WGOSJ6II)00)! :8&!/"55 (VA,03&K0U324Z $
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M34;WX4W8-\ Y"Q E$CGAHO;%69B62A)>&QS,  '=^>C;//TKJ>_\@46ZKO\
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MD<SG43=9C4L$P"1DC'&A6X>$D$G0#*9>%2J(%A#,@=$6EQG%8(<:!$]2%Y*
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ME6WA$C(Q&@=O.D;$AS&R E+WF]BU,PC2$6L>)M,<=Z5Z$&5R:QKDM229PD;
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M(L.]9VBS,9*Q*1EVJ<H2)LL@O"LWM1O%2:L @%R23<&]Z1QE8@$6286443X
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M5"3AO3)C'18+&(WV.7ZN.3W?U68*B*5B(O*@S%]*D8TAHET0 )+2$\*,H2^
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M566]3=ZSMW.:YG/[N.3W?UE,-'>BN(18C"DW-;T]*)MB,%"9Q AL<*D4C6)
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ML_GKKKRO1=S''\)$W&//K7\Q:9,QQY\J;B^)YLQ/AZ7H+Y[^[H])_'777O\
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M "ZK@I,)9!.:D\Z'B:-GFV&.,Q2(PB)D;)W?IY+U^R=:V=DT\?;K'CI^AE0
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M(*8OA++%+Y;)F34Q!LD2)\J#:NAG%8@P07(S,;4^(D"L LR@A&0;+8HX+=.
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M:2#"R@!2P1+L7*>G L(!)L$EE,ZT!,+(IO*PRJ:9>]$)!4!>8WO0\#+X)@&
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MS39="ZVS3$W9O%7Q@7"R;@%)<MBE5\A'JT4$X<[V$&U3#JBZ"6ZP@'/"2_9
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M5+*$,$%CAA) TZ(Y(1'5ATC,:(W0R@@3$FH$3&@0.E"07;;,DTOLC9=#UD0
M!,K]'R(N8*19:4JMV=^?K"@>DHXDJ;PIB0E+K2K(F;9STD:U ,.CA6)LI0Z
M(Z=QR0,510#9,.E5AVAC/1G?*^30EL,7*8F'HZ% "AN ^K=<@0WDKV$E  ;_
M .&=OG"<PN6^928>Z5&(;AJFT7'5$85/F(*T,#$=;*Y--:=+P(FRR3I7'R1
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MN3Z=9)"7%3][%$ZN879C?H-E$!B&B>4=,V/!&U2PM!O(F,,D.)5RM*[6\/\
MV9(M=9N.-P)O6S"4BK9)D+E>%VYY8T$WU"H-FN'_ *D/RO5^]$']8@8)QU"N
M^%%\X&316"[>QBORYHLT!*%Z.V7[\.R[!N0W$UA=SW!NOU:)LP3%-,)H<PIM
M#X"NA:4SO=FI]5CM^\87L7$#WMB7A-7^;CLLP+8TLE<W0U]'Y/J-DD)"GY2K
MS$W'H6$V"N)K?FSIZZG@1,G;K0D.EEDL#%3551)\& !1&N 0))V)<746R*F
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MKP@                     !5HLEQ;F;P))OP@
M!U)JIT"7.BC>=>$                      +D?9M\PTVAX,
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MTJ4!L4?^-2@.EQ=*(06*JW!Y37DCRYI+D.:,^U/K3(B $2N%A/\ W3!M?1A
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M%04QT  .Q^Y +BS2T<+:JE)]^>X8@$>2>H."A0YEXQF@D(XA0Q1WR?UAYQB
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M8C@YU-TQ"EC]RATN"1%XP5,:IX4!=-:"?K[MW_L[(<,9*1G>PB=^V2[A.V"
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M+8G;HC09\CA\CA\CA\CA\CA\CA\CA\CA\CA\CA\CA\CA\CA\C@N;A,P3[:9
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M()U 0 HC1%'"R7((3KH Y,7%]:&5_/@3AD""(C1$B(EU@YI4SL!@R2PK5-X
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M:[8LB)PP:QL&MCW&O'E6&C>&-J;1HV*(UHXT$X)83(T<A.3C<Y;N;@4Z>49
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MC<Q0XZR#K!@L1XWFOX\/!00I!'D8CQ*A(K=$0: \.&3(&D21I+6'%R^'E%3
M)13"Q;XG5W]F[?I*$_97Z W9 VE-@MW)B%=I122ZA>!<0*)Q\E[X1D#8@!6M
MZ"YE6L0Q"A Y2E4LU\9P\P;I]48HT" (KQ1 VY,ZH!M3A?1R$'M30 6:,**4
MA16,%#,H-X/>@BK3 "&(E5PZ$CJ=N65IY3JW>$*/&3].!7$!(QL%F&/HI49"
MPE,7_LQ*WX);.QPIH% 57;UVSI7;GE0A-550+U#)C&3P=41 &@$9+CH?-'9
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M 8FC[&!$T91DB"ICJZ\CR:7!$"8AR@'7F&4(/HV7PC_O'7*GY3@!:)U.O]Y
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MM/!_@6SI@; L:+41K:)I.$TX$$($ "UCP56$+FF:>+1T:Z:__3% K@BH6L+
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M\;T?KB#/[+W_ %ND0Y'W/7/R_IX3EX._8NSPG_9.S]"V<K+UH*2QV9K%=2?
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MF]^%Q7G6)34=@RA.2'.M.[!<+,_(A4(!'27G$J9A+Q 1TFAZ9S'/7#A@/ T
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M;09><90X'1V;NA89@H$%HA,8..* &QEUB".EP-O4^2BF4'<;OG"2Z'(X#=6
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MO*=('4G3[8H(C,@DKR!X'O\ ?!UL"CDR*'$F_MS,&%Q%!XA>QVW?]N#@=MS
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MB>CR+Y=,X&!#@E2NHO'??.-P)MG<\OL.ITP5,Z-B13L#P)B:H> VZ+.)-_;
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M<=RK:>^PI 4)!Q9]6+,2$UE0!9A/#NWG:SG>Q$5[U8Q0KL F(=,(L#(4LIB
M6AU+59LYB*$=G$<+[1Q#FMAI*I7('% ($FP2!HNG6)*31D;AY!#<:#U$R"32
M*#DRK]>DD_&]'PA_K;\#_P!\)^#]?A/9>_ZW2(<C[GKGY?T\)R\'?L79X3_L
MG9_#I)/QO1\)_G](?^^$_!^OWQ_^?M'1I)LA VKL&AZZPS!Z!@$%46CK3,NT
M9Z8).B14=[# SB0D H93;D9#6J70!5(@3E;JYQ9XC$V"!"\='$HA&2:$@N [
MN;Z)L8"L*OYB:F+$LIJS;5=;:_=[+W_6Z1#D?<]<_+^G]^KX3EX._8NS]_\
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MI4DGN/?"B%24E8K3!@L;A,E]8PB"4&KMO> Z=0I/048CJRV[H?@:!.S [XL
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())))))))_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>prospectussum3a1a.jpg
<TEXT>
begin 644 prospectussum3a1a.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X0^H17AI9@  24DJ  @    & !H!!0 !
M    5@   !L!!0 !    7@   "@! P !     P   #$! @ -    9@   #(!
M @ 4    =    &F'!  !    B    )H   #\*0  6P   /PI  !;    1TE-
M4" R+C$P+C(P   R,#(Q.C S.C$Q(#(P.C$Q.C4Q  $  : #  $    !
M      @   $$  $      0   0$$  $    K     @$#  ,      0   P$#
M  $    &    !@$#  $    &    %0$#  $    #     0($  $    & 0
M @($  $   "9#@        @ "  ( /_8_^  $$I&248  0$   $  0  _]L
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MY6=1S^/M^OYUJ*25!88;'(!SBEHH __9 /_B K!)0T-?4%)/1DE,10 ! 0
M J!L8VUS!#   &UN=')21T(@6%E:( ?E  , "P 7 !( #6%C<W!-4T94
M                              #VU@ !     -,M;&-M<P
M                                                    #61E<V,
M  $@    0&-P<G0   %@    -G=T<'0   &8    %&-H860   &L    +')8
M65H   '8    %&)865H   'L    %&=865H   (     %')44D,   (4
M(&=44D,   (4    (&)44D,   (4    (&-H<FT   (T    )&1M;F0   )8
M    )&1M9&0   )\    )&UL=6,          0    QE;E53    )    !P
M1P!) $T 4  @ &( =0!I &P =  M &D ;@ @ ', 4@!' $)M;'5C
M  $    ,96Y54P   !H    < %  =0!B &P :0!C "  1 !O &T 80!I &X
M %A96B        #VU@ !     -,M<V8S,@       0Q"   %WO__\R4   >3
M  #]D/__^Z'___VB   #W   P&Y865H@        ;Z   #CU   #D%A96B
M       DGP  #X0  +;$6%E:(        &*7  "WAP  &-EP87)A       #
M     F9F  #RIP  #5D  !/0   *6V-H<FT       ,     H]<  %1\  !,
MS0  F9H  "9G   /7&UL=6,          0    QE;E53    "    !P 1P!)
M $T 4&UL=6,          0    QE;E53    "    !P <P!2 $< 0O_; $,
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M   !]_
M
M
M
M
M
M           "E8[&>X                      '0?"H
M      .G*GSFNUP                      (G?66TV
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M^)+<^F0        //3[9U, >DF[F(K&=HO*::+?0^C$M/17Y7R_-SZM?]_\
M\L<#P_\ U#Z#=KY70\WOK71V*\Q#;EZ7 WMM]WOE5*QNS<EN?3Q1Z*??;Y-S
M,N^=C\ZON]S%_1NYM\_6WO\ E5#.'BZT+;V\/_USZ+V1_*W!R3Q(0
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MY/@:Y^O[<C7TR%RZ6)^IT=D?,<.(M6=(OJ/T;,WG/+;'>'\R
M
M
M
M                                               (S;77^[7MB3%]
M5]\\U+'>         6AOIK[>KP66?ZDV3X)0        !:>VN ;]>CSC+M:7
M+-:8         8QDUP1TJU3 V5IV+GTW         &/ID/(RO5<@
M =.6(["[(U[1          ,-=JEIC]6XER\^3>/Y9W[KI2@        =><:@
M^_Y&OOT+D["?.>SMYX3J=F,@        "@VVQ]-)>\44SI@         "UYI
M+8VVR57A[0      =&<:0]NA)29N.%:=O6YN;OMIS+W(  '3G'/&>8  !:6^
MMIRZV9/IK3UZ5I;UXO=48>@/G.IEJO8        %JR::2]SGY&CEJL3V'I4S
M_2M9QJ6  !\.C.._#ZR  .!CRQI0L8.Z$&%.M6M7->D+OK;^BWF^M<&NX
M    %)N\6_NW6T+_ $'W(W,VQ/R[E^^/YB\_?=",        85[LG@=^K/08
M<^HV+DY5CTR_-W!]9?AG)YX        #5#V7'\1_VC\^N;ETZ*S+=7E.E[W?
MD+Z/>W/G       Z\X@+..O;7QU_1GDM)/NGB+[J3<HH=W_SY[SUO^#>K^L@
M       #7GTOH/*+]#_<K-]/Z68X_)],_@GP[<KY_P"/        ''.?/7ZK
M]&\\_OWW2ES)E;Q_B_8#\W_!<F<KG      8XETU+[-#-5&S=4*(NQ^<O7K=
M<EC;7ARXEM:8^WUW I3;'\Z7RV]!1UN]!0OZK9]&_*]#;/G3_3'UC3SVZ]6Q
M-Z]N7=-/.G%27%%-#(::^A7#L]L)HS=S+F^W&Z         UJM5\<]:KEWE7
MY=/8/5H>8?3J;+<VUEZ#?!%J/HRWTX\]3%MY4^AH8T[5+.?)L^G_ )KI9=KR
MC7BY%HGU:73+IA3IQZV]33YG$/'#FB#7<3F6>1TQYW2\_P!'96G:
M\[OJ5[QE_8'J<H5K$?M#A6]C9+X)P_T"?F_AWW26+>RQF_:.O#+2GU^^K7HL
M;/\ FF[?D]>W <,L<]'+.=3/1;^7_P!4VMZSG6'U5R<^O=C.W,Z4_I/CGI<[
MW7_$GEMN?"5        !X'_L[Y[C7T7G<@\FYV5<8C]?4M#QGJ/9;\_^IJH&
MN'KH\I<:;T(^67]9_45O%O\ 2'G<3^SA]#?AG4]C/@O>D(L_#4_VM+3CZE3J
M9HO.+Z+0T=^N<MSJO7Z&#=SQ=/87S%JMYFF*/>0_H,_!_P!2R?P[8
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M0*##B=)UY5Y6G C""U1<*/&^W.7,E9DR[Z7TE3U=N/-BOOS%7]1OX3\K<U4
M     .&<>8OV_P YHE]J\A<,,<I9Q300]\DVI/JFK'M457VBTW!)R*DZSJ.(
MSBJDCJCGG%;+#6%)KF/K3QAQD54N-D?.0[:>3KW=#=IMZ];YOL>_GX[^A<P
M     ?#4;VWK]5OIOU+#_I_=QW4LHNA;W1J:3^KIQ&:_7-MP;4^-8+3BT2"L
M7II<[2EQK&1UNL[\NZ3>H.#2A4^@9U[)VPE7HY&XTU1?OVY6K^J/YL^(>B7R
M_P"<    <3SE]'R\>7*?S+EKF7BDGB](=KIK3XAZK7[H::MS5JO?21CSE"K/
MK]>AL:W#P:Y)Y]C?2E)KO-%C2\J(6Y/)L;'<^;1SMU==[R4U;E<G&:.?M/I>
MZ26ASOE#FV,=T9+Q@:V2:[88S0-Y RF6:7X=I'EV$ =F$-+IYR^IY--O7,UN
M,RL.]Q8S>\>U=I/AKIM4>C'ARS1K=-;JCWN.*UKQ>AMNW'W1MC.59VFH[ZJ7
M8K7NKDK[;^<*:>K1:%=^/%=Q?,#=_C9O:E+<V9:/.R/387EW\M5Y     .)]
M(2;;\Y'[,]+:?M;]^Z3=N5NZHK*0QBRHZ]D4>+;45?HBAZ\Z44V>.^W5KO\
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M.OZHON"S"ZS6'TJ&,;=.PY4) FI<Y7Y\V6:5BX(I[)LU<:;Z;E\CHW+KGN9
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M!<CZ\Z((:F+26CEE89I"&:JCWH[&*";7G%I512T4LD=C&7?+_/O</\J?G;Z
M  6'/!YL^BY7&XJJ^^3(MLDU)KA@EJMMI@K\XLK>.SL;7$=VN*^)=\6];K-;
MEB&Q+,6/;VEHDY'ME*C)!S0X^FBM>:.-.@[P<3H.1RU;6\?H;:\VX     !K
M)T*^FW<X_P )G7.48;&1(II>&6MK[2C/=OKCJQI'8S/L-8Y>*:[HIN.,VG-#
M8,\5A]'2VIE]T=L@59+%FAL2:*WIHZ(^',X''=\LOL3G7SZ">=ZF7*TX
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M5]U]!JZ]ZD4MROC7RKTE^/?+]0?HWM\"^\]EG+P?CMW/G/AY&.,
M<",WQPTS0Y1V5)G%%MB,WU^:YZ=76?3F<BIVQ]V2<>U;C:OPK]5:5)4GT
M        'PI\XH-W#7-#G% UHML4.4=E\U=6,\6.+/W#OSCLW=S,GIM7XS7E
M;A7E3AVX?0          "W;6V@/TCHX]]%9W%^;\C+OD8HRQFU;EO2[W6UI=
MK78[P]/*/DE-:=<>.4:!Z&VJ7O[M/<;@?--,F\VA72I+3:5;R.,217ZNX
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MD$0S$#G6WV('.87""9AF(HZ\I,F\)QF>8F\;W#A.939-DWA,ZI<EBH
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MOQK$>BYWFMQ0&SY]   .!BHRP<36LV6!ALN\O4U[,YF R--GS6HO@RZ
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MH.HJ0       <2C-+3<HE@#H/AJV9D,D HRK*0J"G*P    Z3K*HZCB=)6@
M     X%,:3FZQ7 %,<S4XSP7^"C*LI"H*<K    #I.HJSI/AU%8
M
M
M
M
M
M
M
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MO?)AY.9+R&R&PD-Q.@/==RC,2"W9;_8=>M#<F1.=[]N'GWYN*VG;5I<DSL+
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MO#P<_D-F&'/2IB3_ (%)$Y__  X!G#I<3^%\0M$ERMA*,PP7MHWCC4I_R?\
M"PL$&PD@X7@*^2 2 30)/@>/D8<^:1D#\73*O97NF/6%;WL&,B'#_!41*3O*
MC]$U+9^00VDHV('_  M(<(&0/S_K2M2#<FS'4_Z//S0,4]X0EP@\Y[<YICO=
MY_'[CKS+"5:&I2)GIL+2,MIM).$H^P5;KK1>YJ]PIKR/H$%QPY'"6/<O\0;P
M2]Y"_P#(G&C\_2,$R8)@PB,"C HH^V!QPXR9##Q3:S;R 1^#S%J[ >9=2\W^
MP:B21&1DI]A"O)$3<B.Z:W6F@E25D;C9*D3HD4I>CKVV*^(EI3*T>",C1T6K
M76Z4_P"%H\@V0<<.1PN.?EIDR,_\2^M[DZ2@ZCR2FQ])0)DP48PF,"C HH^U
M(&QX#+)JD(C_ $8CB0Q_W9:Z4C\+0(:<H8\?_P"K8:]"3]SM(YHE/1Q] PF-
M[?;@FO 9(.>Y.M^3-H?3#:0A!>2(>09AUSV=7Y"S]P1^ A1^6GS)M$H27O6G
MBFZJ=+F/P7YL*,.VZ"JE92!!6TE/^(M8WW=>ZVIEQ7\+"C^2%> E8<4#]_DA
M7NA0]0]0]0,&' ?R2,BDU732@G_M?6]&?YET%C8U_P"%V]+17+"3])$-NUZX
M20H+2/0%M@T^/DE/N3?D&T%('CY>!Z1Z#'TS'@>!_ _YQ_L270ISRGE^IA97
M5,O-2&OVM%HHU%&FW4RT?3/,@U9>[-AY#$_R)L:'<0=3CK#/R3'L/\0:2,*8
M+Q] B#W@@ZH_4AP_+:_(^F2@4<)C!,8$TD?32")(_P 0KP(%=(M9L6M37U\A
MA0-M255WE*LO)4]%!F223IZ54K0Z2-0,YS8,WC]UNK)JQ=T[KN5J-/<-V&\M
M9R7L':6+@L9\YR?93;4L3F)4YJYWLV=^KXF=8G5O6]DY+7.=?<*>XD1K$1[$
M1YR5'K,['U-=:4UA3/\ _ ]@:",*CD#8))2#!J/U(<,(5Y(F24"C HY!+"1]
M-()"1X2/\0Z7E6(H7;FUDM>2?94/2HCJG5-*K'_N(7[VBTU-E:^]^(NRE/6/
M2]MH(;##31>KR/41GHZXU&ILC'T"!-$/ID#00\> 84W[_2!L@F_ 3[#R#7X#
MCP6\%+!_.(W]1]/DA]0PI7J+):2RRFAIK6->57[RE)0GH?;7692YUO;+9;2V
M/4E)?6!2",;/+.?5<_E9A7\CR"6%+'GYDX"<'U E0_X4' ?R27D8>"I!Q_(;
M_A\O;%W+V<V)'Y+][^!K>MTU \YUW7RUV$Z;;2R])%Y%C"180Y45V$\8] ]!
M!:""T#TA"0E ] 4S[&R/H@F030)D@;8-'@>!X'CP6:84S#]1D?U?:7[IX/KW
MK&#^R9^"T]JNRM_4#5Y!+\&W*409L%)-BX](59QY")F5R\T]3A4PV?4MMQ*B
M,1V'I:EX35)CSVEL.+9/U)94,[22[V7%Y=3'&O<=:4+GI,@RPZ^YD>8.2"EX
M',/1]'SVUJG7HU@RJ!174]>8J:_/MHF)>#;#;P71)6"J5QSSE@F'-VMQ8?JF
M9F6MKGV:V<Y-TF6G6L+'9.=6S+?!,SYL*AA1*J#AZJ%,LZ2OMTUE1!J&I&<I
MY4I4=E;4.DK(#MA3UUH4PHF=I775..>H>H)=,@W+,@S9&D,7))$UZOLFI&)S
M#QZC*2Z5Q+I@E$*^HLK5=GC]'6M2/^[Z1^KZ2D'D,6_?.2N6U[L6SH["G?\
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M,IM2Q/0]GYS1HH[%9P\VV@2Z.$I,NND1%>5"/"D/G6PV8C9^EQ,N@:>-W-R
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M2@F2$R E\$LC_(,B44S*YB8(=#GZX*D Y05+\!<HE%-I,Y+.+64,(SG$0_4
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M"K@5>"@AN$$0PF*$1@B.$M!#9A+1A+8(O'X*F_(4T%,!<?R%Q0N(%0PJ$%0
MJ /T\'7C]-!5H*O,%7A$ %!"8@3%"8P2P$,&$LA*?'XYEY"FO(6R%,!<?R%Q
M0<4+A^0J"%0 =>#KQ^G#].!5H3 !0 F""A!$,(B^ F.$L!+'@):!)(OR#(C!
MLD85'!QPJ*%1 J$#@@X!@X ^Q'V ^P'Z>"@&/L3!0@F&$PP43V3&"6/ )LB_
M)-)&%,^0J.85'"HWD*BA<0C"H0. %03!UX_3A^G#].!5_@)@F$P3"81@H01$
M"8IA,8)CF$M DD7Y)H(PIDC!Q@N*%0P<,@J&#@F%0!^G@Z\?8#[$?8 H *#X
M!0@F&$Q0F,$1@3/@$7C\4TD8^FD&P1@XH.&%0Q]D#@D/L1]@D?8)'V!#[ A]
MB0*$"B H@*,1#Z*1Z$CQ^8:2,&TD''(P<0@<,'#'V(. 0^P(?8)'V!#[$@4
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MNU^&+&W.KY75SXO4JNGL'.[9RVM>/;# ,W5WU:9G(^(UV&8SED/AX@3(5?\
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M2X[#JU)2HFF&6"^2VFW?DXTV\E#:&D_@.QV'P222GGO-+3-:Q*4H3\U1HZW
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M!%]-E93NFOT8EF>W'AM?#GNN+K;/(NFIMG3UE,7-,$?3"SB\/:;6!N<@0;W
M6RMD4552=-*,3A?%UW-LX;LCW>:J&-CGF8WT62O:WN#B!S1B\C!Q>T>T*&GA
M;"(S@#GM):WB!Z1MXBZJXVMJWQMR;C \[*BY",JVM/TM[;@')K3J.];8Y$-V
M92S5 JGR=$QS[%K1Z(ON/9ZA5 ]*>%_BHGES!D,@%+G./&Z>TX(SP%O-,FPY
M63)6N-M#[U4.RMX_DL-F!]QF;6W[_B%"_$VU\Q[N8.'2'^8^]801H/)$X7$#
M<5*^P XBZ^YBL+WU[/\ 50OO=N78I76>?!&5N"UL_GQ4.9ON"+K$]Y4D@>+
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M4SX)FMRPF]^^XWJJM+2XL5NB..VN*_5\-=?#>MF.LTCM*E%3T]^DZF*XN[$
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M23J2;D]Y5-4.I9F3L])AN-R?R[KW0"#Z-& !;%TA/LP)W+#:P860/; '7#B
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MK.(ZHM[E3]N?-X*0# [(:*PX#F;J$YQ&\J-YOJ?-8@6GM'U,7:L7<G'(J]T
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M@C7+GIX7%P<<@.._+[:A=:2WBHOW1[O4AKSG3[$IFY5SPQCG$V"D?C<79VW
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M:8C^:Z23\;_ZBNDD_&_^H_FND?\ C=_45B/XRL3OQ%1R.#VG&[7B>U?2'_\
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MD1 4@:&Q(S! 0E+!T? 5(#-B<I+A)$-04X*R%O$(%S1S@Z+2TR63PN)$16.
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M2*\Z&.@W$TR.S.-!20>J];4:&KFAX&,4G)DXG/+3,/IK,O$4=<&JSR5'1GB
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M*]_T-';1_$GXPUA#\[L$95M8;<=:11Q=>%ISIGG2-@]E<1P.;<Q2<>WC+&8
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MFF@]L2)2EM;AR+JRNAX9FGQAO%)1#@42<J_448G5(G.NG.\537+7,>$8.Z&
M^"<[A[JB$3I7B"D+(M!HW09UMXFOC&* *7>*U&1%<J<*#GSB5= 9'\ ^$.3C
MQ635(-3H/9SB64=_<HU)NJ3WPX1=+_\ ?(^^)]Q)DW0#F0/]PC#7*,E/[RON
MAS]HY_&K_<?HG04\W+;5KF'2$I:82<__ !8V[VV6CI%;7<V9!"VDZ@%!HBJE
M+K2VH.5!XY1TO2)QK#\/QF347!+, NH2JY);-PN2@:KN4*D5ZOG'0UAT[B&&
M33<L\&@IU\)JJG6M'>.Z)_9'I#E\;?4TJ903./[ET3/]WOE6JI7))%#2ND;=
M-E&Q$V,64VJ?3*LADK*=X7=\U=94U*K;M*FE>$8%@.)XIT>R#4DXDJ=P]!2W
M>!4EH42>ME72&^B/:U2E+FI=J58JHES>H=X\DJ$*4QLKL#BDLN::0XW*AF7;
MWB MQPOMDI;%U5JH5+HD5M!.@A:U.+4XLU4LE2CS)CH:E&W=F9XJ(&]4^G6F
MBW!"^C7:.?Q2: 1+,LJF7#OE3#1"4%1H;;A7*F58PG")7H[P.;?F)M"WELK!
M6"$WN*01U47$YDY)J3G'1;(3>(8SB&U2D;QMMYU2%D&MF\)I74=D91M%TD;.
MS^*.?I"4WKLHO=H=#)<I::FA"3IGH=8GS@.UVQ:YJ26DJ4TX 5)M6ES=CM(/
M6!!(-#2.AY9PW'9TJ5G+O!NNE;"H5]MM1&T72#B\OTAL+$PGU26F?DDFHMNE
MRCM74I59X#A'2SA>*S\O)[2O!Q;3@"5"I*$ THI*>!JOK'D(Z(%XJ-F9WU8_
MV=I;Q'B5N%7$<8Q+I VE,Q.R_K+0077&S1M0- K@=YKE&".3,_M#ABWGUK>7
M/2MSKBB5$!]!(*B?&.GMI89P->\O0B4912M<]TUW]T;:AQ?1NS5ZX-8>S<FO
M_P"JCO[Q'0+*K>G<14MP)E_5UBTFG6"'*^=1'2"VAO:S%4(I:'<J>)Y>B1DI
MG$9EN4E$;Q]VMB*TK37..CW <6PO8N8PN=;0R\^N85N[PKJK6X4YUXA48_@\
M_@V(/,3[8;<6ZZM-%!54E:J&H^A; ;S_ (QP'=4WGKAMKI7</1TE[6[3;--X
M6IE[=H<>.\2:G>(182D=84XYYZQB\UB6WO1PZXA94 E+M&G!^U;0OY-=":@*
M)2M.7?2.B"7GV]O,/<E04O8>XZXZ,P0 AQKN^LH1TB;.;>XUM',3DCOERY9;
M[$QNT@AQP]FO"HSC9.6G\-Z-L2P[:1U#LPI#Y5OUI5:VK>6I4I2B*)20"=,N
M$="&#S6(3^..,/I;DT33S3R;@$J&2D_6H1V::QM/T2[7XMM%/NR$JP[*EPV/
M>M- V!2NL475TX1L!L"[L=AV)36)33+;RD7OJ4XA#: V%T[2Z)M!ZRB>_*-J
M\4.*XU./AW>LH=6VPJE.H#G[+JT/$9QT%MSCFT<ZF3<L695L*SI6I=IQ$=(/
M1?MEB^TLS.2\LT^TXE WJIEI!J!F+5*KEI'1IT;JV+?7M7CKS*AAB2\ZV"FB
M&RC=V=I5QO6#=$E)M=*'2BX[*J2G#9$H?<J0!\FXXM)16@()3J(Z6=O-E,-1
M)[-O(3,O2+38HAO>I&[0E/64E*@#XGG'1KB& [?MG#)$I9_1S3BG)0MEL%!!
MS2@TN25."M 1='Z&?P'I65(-)2BV?<4RE(HA+1)%!0TR"3'2EMOC>R\[@GJ+
MJ BR]]NE=X$[J@R4*<14UC::2FND/8=[$&%W.2LL)MM++@M6X*)4A=";T@%7
M5^T.Z.@=,^G:>?9E:H695"70:@@ O4Y<8V^Z0]K-F=KL0D9.88;#0;/7:*U5
M6+CU@XF,4Q[%<?G1,XG-N3#BG$D!2B4()(["23:/;&T<@ZOH4PRC]5(90LBN
M9 W1/'D(Z"FBO87&OE@BXS(2DJIF"[W\8Z-%%OI7P*JODOT[.)?Y*;W<YKW7
M4,=.J6/TNPMBF;SM:4Y>C8W %;3[1X9@H-$SC]BU5I1(0I?Q32)_!MI=D\+.
M'[,RS;CP3NTT<2VEM.0KKUN.0,;38#M8B8F,2Q]EQ3RZK==6N^@&82G6B$C)
M(KD/H:.VC^)/Q$3F+"3Z-VGY5Q"9G<IMNH:=FN50=(V*VJ3C^SD]ATXL(F]V
MMM2FS8JBDJ"5)Y$ZUX&, PUZ6V\PV1)-QQ)5CARN!0ZH&IUY$\XV_P #VRG4
M2:,/4ZZRPM:J-.E%+DT'$UTX1LO@NUC.&SK.,OK#;@^20\[>4BBKLRKC494$
M;)289Z0TH#J%-RCN]<6E0*5)M (!!H:*70ZZ1TE;,8EC6*-36&MLN,)92E14
M^V@A55D]4FIU&<;$[).X%.?I2><3OT(*4)2<D!7;!-3=H*$4I'2+CJ<5Q1++
M3E[<L"%TS&\[E:'JZTT.4;!%P;4X86NW<Y3_ .4JONCI+V9QS:"8P]<DTV\6
MTK"KG4MTOLI2XYZ<(V1Z.,4P?&L*Q7%@TAF7?WCJ*A5B0E8K?4@\.'&.D3%I
M;:+&<-P234"&9OY;K (W50%"[LW  FFM8QC'-G-E]BAA:E)^5;2R$H&\6;T6
MCJ)%2.:M!QCHXVIP*4F9C#D+4'L0*DHN;4E.9K2I%-!IK'21A2);:'#L1:(W
M<S,,)4$C0I>NN)',&D;;8L_A&S4E.2#J$S%64I)%<B!710-=..42F+N;?['/
MIJ!B;$H6RE"@%!Q*J \P5)S]L;-2L](;72LJE)3.,S"VZ=]IKXY1TF;1[18"
MO#&D.H1ZRTXI5R2H_)AJE.N*=J,4VFQK&$!J>G7%LC^Y"E!JO,HN.<=%LDY,
M[.8FM+E@&]%*\=VCOCHUDG7-I\;2EVW=/N)4:ZF]W/7.-J$J:VYF4K5<43C%
M55K]1!CI4?:?P.2*"#U6_N]$O+NS3[<NP@N//*L;0G,J4> $-;,;7R%!*-S3
M840KY%:D];+.@XZ9PM$ZC81U./&YY$H=YO359 :ZU:ZD\>9ARW>+M[-ZK?X:
MFGN^?;G%MI"0!EW_ -()J2>9)\X;FW&T6)X<8;F76U%0/:5<4\-:^R/THX-$
M 'G<?PAV<?>I>LV@@V5RRY\_;#DTM8I2G#6N7H]<7980#E2M?0UBSS2 @(2:
M"F9_I!Q%TKOM''+Q!'*%+*U7+ZV=3#\ZMY"46A(2 ,B> IZ&YQ;8":!5!3,P
M)A8%!EF3YFL-O+;=#R318-:_GNB9G7)GM@#VU^Z/656VD>_T-KW:KJ5A<PI2
MT+I2S2''E.@!7 UAJ94TFT)!UU/.":DGF:_1Y:>7+(* @*KS.GNA1N4I7VB3
MYFL,SSC+>[2!XU@3#B5J6#FHU(.8@8BX-$CS_I#\_,/IL4HA'V0<CX\QW:0F
M;6ALH &8(KI2OH1.K0UNK012F9@FI)TKPAG%764! 0"!34^SE#L^ZX:T A;B
MU]I1\.'E'K2P .0 \O0B84A-M*CO,!Y222G*XU(B]5^\J;JUK7/SAU]3IJ12
MOMA$XM";;0?:8UA"[%!0X0J:4HH-.P:C.')I;B2DB@/?#,R64VA-:]]/N@FI
M)YDGS^B8'CLS@+[K\JD*6Z@(-5%- +N0/VC&(S[V)S;DV_\ M'-<R?>8:V\Q
M).'C#WF6WT;HM7+61U3^[81EXQ@6UN,[.J_^&3"F6KRO=5RJ=>MK!Z7-I5+#
MCF[6H?:/_P!D8[M3C&T2PK$IDN)2:H;3U$)\0F@5KJ1&"=(6/X'*MR<J[5AH
M!*$J52U(H -#I$YTP[23<FJ4M:;N%-Z%5/ENQ\8G\5G\24#.3+CP!)"%*58"
M>(16VO"M*TR]&SNWF(;.2)D9670X@J6J]3JD'KJ*CD$*YP]TDXRXP^TAM#*W
MJ?+)<)4@A234"P5TIKQC%=H\7QE*$3\VMUMOLH'53_J":!1%,B1&SG29BVS&
M#O81A\K+6/WWO+H5=<JT26U#*X_6SAUQ3KCCJNTXM2U>*R5'XQ@^UL_@TBY(
M,I"V7%+70N*30K !RH>0C#MJ9O#9M^;9:053"DJ4FZW-->(3QKK2,4Q5_%)Y
M4\Z AQ1"J)-:$4IG0<HG>D?&,0P%G 9EMI;+* C?%7750 5*;-<OM1LWT@XM
MLSASV&R3;:F7BLDJ5:1>5$_45]H\8>=4^ZX\KM.K4L^*C4Q)S3DE,LS37[1A
MQ+B?%*@?NC:7;3$=IVY=J=0E"9=*0FBRNMH &J12)S;7$YW"#@[J06"TEJZ\
MDVI4%#*WN'&-F-LL0V6#XDVTKWZ5)-RRBEP(KDE5=8Q&?>Q.<>G9C]J^HJ5Q
MU.GHPG$WL(GFI^7 4ZS=:%:=84/ Q_UM[19 );  I0+/_HC'<>F\?F1-38 <
M ID:_</H6$8D_@^)2F)RU"_)N;UL'2MJD9Y'@H\(VJVXQ+:UN5;GVT($JI2D
M%*KJW  UZJ>4;.=(&,;-X9,83+!#LI,**K%J*=V5776]55;BJO","VTG]G\;
M?QR38:]8?04+16U&9!RZAY#A".F7:5+SKBD-+2Y7Y,KR36NAW=>,8ST@;18T
MT[+/3:F95[ML-*I77*\!)IGF.,;/;7XSLSOQADP6D3!N>2#2\T K77@(POIG
MVHPW>_LY@N@BKBZ4K_X:HQW;[:3'TO-3<\XB7>5<IAE1;!&?44I%I6@UH4JR
M/$>C9C:?$=E<0_2&'*HX4VK230+ K3.ATJ>$/]-NU#ZE**6DE7)P_P#MQBW2
M#M/B\N])OX@ZB5?_ &K+2BF\<E*3:5)RT.4;+[68CLI,/S.'TWK[6Z42JT@=
M;B$FO:,8GB4UB\Z]/SKA<??45*437CD*]T;%[:8KL-B:\4PJTO.,&76E9HE2
M"0K[*N('")W;+$Y['_\ B)P)$Y>I8H>*JU%UH/'E&TFU6([3NLNS]*LIM2 :
MY9<:#E&S/25CFS&'NX9+!#\JX"D-N*M"4*S*:6*K4U,;.;=XELSC,[C4BPUO
MYX4<;K8A/:[-$$?6.B1&T..S>TF*S&+3H F)BEP!J $Z"M!\(!H0>1!\H?Z2
ML8F-GT;/+:1ZJAO=A>\-:4 [%E.'.-GMN\7V;D7</DJ%AXJ*@5E/;J3HD\XP
MC&IC",98QIE(7,,3"Y@)*K05.!8/6H2.V<Z1M#M)-[1OA^:0$$**@ LK[6N9
M ]&S^.36SN*2^*R8!F)95S=33.A&M#SY0WTX[2(7>N5EW3^^X?\ VC&TW29B
MNTTNN7FI2792M)25-JJ:$4_RT_'Z&,B#RA_:R??PM.$D ,)%*WGX4 C!\9F<
M%F"_+]:Y)2I!44A7(F@.GA#NT<VO$I;%4(#4U*KO:4E1-#0C[(YQ*=,.T4LW
MNRVR]PJXJOQ;5&,=).T&+)*-XF52H44&3J#WA**>R,-Q:;PR?;GV'"74J*G
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MT K7K1ID?H>SFS[N,S*;@I,JA0O4!VZ9V)_^KN.1K&$8%A^',);:DF$)U-R
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M.@,(862*IRKGI!KNB.Z'$$Q*)M4/&)5X4">,75] 3G7Y\Z>F8-&7#W?>(O\
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M35.,(G-,X<FZZ$0Z\55A2U0VZJ#,*I!FC7.L./E4-DUA#A AMX\(6LD0C-P
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M\J5IS^=Z/L7,IBK4FMU:6WE]07FR[B%"M-!ED8GRTK#4+;0A*K.TE*0JM/M
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M_G5^,7K^TK^8_/RLR_)S#4U+.*:?86'&G$$A25)T((C8WI&D<3POU2;L.(A
M05/46\D@@WM.+JY0C*HIQ3XLXU+J3VP85B;:G,G/(PF8;<DW+3URD4(.?:''
M72,.<"4C>=;+ZV?QK$W-M@T2$CP $-N;SVPZ^EE6@/L$-3#<PFP(2#W) AW!
M7POUO>.6-FXIN5;GEI6AUBU:%9U\X;FFPBA2@GP$#Y>9;0#:%$UIEP)X0[A1
M/9=7_.K\8$@IHYNK/BM1^^+T-H(30KX#C7V]T%4POLM^[^D%$VGZA_/LC>NG
MJ*30'C^1#EW,^^!=7M*\S$HUO'FTJ.I(U[C$VPMI=$5,2Z'5IZS?MI_2%M;A
MX/J)HV:E![)R(S&G&''?6%T0*5/U<OA#3!:1<O0<_P"L;5[626!8?,3"W$)<
M2+645 4XY4=1 XFVXY< >43/3'C*EGU:5:0V%Y*4ZHJ6GO!;HD^!.L85TTNI
M)_2,F$4MM+1WUWVBJ]*+?96)7IGP1:4H>,JD*'6O2UEQSRC:7I;PU]#C,JIQ
MU5JK"P!N;J&T7)4*9ZT&48QM#B.-+_M,P_ZO6Y,J9AUQE*OM6J-I(SH;:IJ:
M?/R<Y,R$PU-R;SDO,,J"VW6EJ0I)&>J2#&Q?2GATS+"1Q=269Y:0@S$Q15QN
M'8?<ZY61P\<XEL6PQ:,UM'Q"3$YZG-JHTXD5^S1/PC]"EAE4[O5K#76MN)&>
M68K2F<.321J!Y"&G4N'( >P1+(W*DOJ%4MYD','AIH=89*IE5S=4#]WJ_")9
M24I"'%Y]YK\8F\)-BYU*B4-"ZVIH:FF? ZQ-NI%:H3_*(=6A:LDI'@!$J-R\
MV^<T(54@Z4H1F-#K#.((41:E(\ !\(9F21S$/SX99<<2RA:T"J04)-3D.([X
M]:]?_:(2S76T!'P B:DF&!O$O*6=:%1(^)AS$W7%^HI831[J;RP7)IUJW6U!
MRYPXRIKM$GQK$E,!*@*#RC#YYUA3;K#*'G6S<AI:0I*S30I*5 BAKH>$3V.(
MFE6STN)5SDRD-BO^BR!+SCJ+Y1"5M<W %&GM"OC$ZJ20X4/N6SA_9MI-$%7(
MIJ <J_5I",/=FEU3<!7@2(F9-&'RJG':9#4CN[XVXVRFES#^&8>\ZPD=5]YI
MQ;:QHH);4@@IX&\*!U3I'Z9QBMWZ5Q*X:*]>FKO/>UC"ND':/#%I*IU^<;2*
M;I^8=->1*R5J/MAWIIQAV3=E#ADJ-ZBW?!]0=3F#5*@R"#E]H1B6VFT&(AUM
M6(3+,NY_<MONBB?LWA0)!T-=1D8US.OS^QVU#F$3"):8F'$22E5'RB@VVI1S
MN34)M)S).D2&/8>_(%%K"UN-BU=B"K.A!!I7VZQZHW/(^3H*_9%/A$Y@3["[
MMZY0<+U4^,-NH0PMH@%:DT"B!6N7'6 #"1""4J"JZ1+*6]1(KGWF$X,Z4[TN
M+I2M"I7XQ,OI;"I2T%2Q8%$"O/(ZQ,LK[QX0A!"L\XEK*I! &>M(3*I7V5D>
M!A.'*U+JOYE?C#TDD-+%^=->.O.%8<I6CBOYC^,'#BC,N*/^H_C#H0VA6=5
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M5(0H&H-R2I5:U^E;![4*E)F5PF9<")=QZU#BE!"$)()*5%1H*JSJ2.6L(M6
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M2+GRU;D#?!RG.:22H*#])D-.D#4-N1E$:@;FPW\6Q)/*VF.%&DD8\E1!J8_
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M!K-MAQ'C95]Y&!6\(L*BMCJJAD_54D,6G2&;NK?AJ+$B[-?QPJ*+*HL!Y#!
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M1EM1,I@J%_;%.JM[SBCGA.J.:KCE1A]QZ9V4_@<2TG2.6C2L.;5DG#F19':
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MPDTNFK2$LM[VWMB@Z+5U75R467MJCE+N9W'; 5VXNH@!["[G8#%^/7?VW_\
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MSR-AO?QM@T-;-+5!XI)09+7AX:%N&M@/*WCBI$U3*JI42QP*#HX2K(RJ%O\
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M+4!?X8V:]L=[$-%0T[U=3.P2*GA&J25VY <E'E=RJ^W -79\VS&U16M;]3<
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M4&+X:R++4R,C@[PK2 JVPAK+%410'2L?F6>:-H1V++'8@1HB$S8P0L2EQGV
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M5/=A,IW:;O\ X9MIHR>F4$<C8\G_ +;!*Q@=6@/.,U:E@>F+[RAMWDU/'12
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M,.2WB-=X <QK9FA4=:V)BXS0E4UZ'IV!58$%F\FOHUK..P/!N*0APRL$I*=
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M0YM+N^:NA"\*-X"(]R@&:SB4EVJ"O-7#*WIYAM *YDO-?KF&5-5N@_B67&6
M\0;ON\(/IBZK33 V1KH?]FLY-"P@V'6KU+,CL#AR0KM94]IC [ODI<;S<I@>
M8(YFYNIGT-R"UKGW;\YL#3X7TKRE]M5O+?JS"> A<I+,W=C9\(8H*8-@9613
M0B:2S,I;TU&552K15"JAVC.^6KS>:Z=H!C:'T@'<B.-$R?"9I2)@V[M!3ZO
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M4^/7Z#&G51O[&?OQ!*J^L<IE*H\_U*)>\'36CDP>B !0 =#!_P R@K%P2.F
M*1R(RSEOBK#@+3LM,FXA%Z:]9^.>TGYGYGO)N\6,)GF?Z,N$N\>THG$[RXI\
M7&,.9?89:#<3%K,+,&F?>7/67440&&)$5+@83A/)*_\ !>IAA649#P\X5 )&
M6(6YV;_ZTP/OH\=&JD"0.98@7$58=UAD<O$@(E7.D7Y3^I0U</28.I3ODBHM
M]X)WWGO"3C/A 942F@2O1!N?=-2Q]&!NJO*<=+^)V7H0> >!!&.(]UUF8G$J
M]RON:?\ B+9Z1OZ+G(N.MYNG>>:C37UJ#2R@U93T(H-;DR!G"4I -H6LR<'6
M)PBUW3*SPJ 4 I5 *=*U7: 4:[!?8?\ &G.KEYRU9\B:2%2OEN6#Z+RKB4I%
M/'_B9TSPK\7,=AU\I:=84*8F(*;BF=#.3<>MOKWC)+]YGV]7Z67+UEC.[[S&
M99UU]96MR]V^L/FC</:4VF%1GL1#>'E'JM5?";H;JW-_\+6;C O'N8F+$#H+
MA:WE>#'-2[WPIXTU?GN>)F$3!(J 5^$L:/2&#'NB'D,' XS@B5TE,V >9$O]
MX+( /0@/)EQ1#\#XRVX/1EQI>C$LECW_ % SRKA_<T%^ITEA1/:R(VYS](;A
M2907C?I[]?*Y5U=#P'O3!H47"F?<'\#T2PIMP@8'JV/>)8- H*.]%D&QR?\
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MK)6V)97B5/R=]X.;47@IXJD.M+L\**%<.$30)CO:3JL+=H<=9C ,I!3C/.&
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M#RC:%YAZ_P"1>CX5*7P5VU%K;TE%6>OMWA*\015?:[(C55<SI',OU4L+2_\
M<03CVB7^G]?Y-+R>NM1(ZGE'_) @!ZIY39^$/.?/#YB >;I\^'E.6L>$/./
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M%+$XN6U6&!#81P) !]0Q3B%S<W&Y=7;9#<[<JBHO;@3MFWDM>5B46SRK,\T
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M!'';/&L]=<T@6W4SLA[Z5E9> ,MH#[9:JKV6)")6<=5!D%N*G#30(M>IV$1
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MWW+Q1R#G_P :63$_B,U%0<_ 8B,^=CQYJZ+X@.D9HK!NZ89:^K!(M2NJ3&X
M   :# 1%-VH0C;%C8:Z0&JT0AT1PD9+F$(0UH?\ +53</'+#'SQL"^0/H**Z
M !W'#+=35UY50P6E>[.TVN!STWR^O_<&8T*P>$8<!L38BZNC-6^L5(%B:TMT
M,&4=4%0 "(M8V_\ C./"GN--/)"A1HA>1B7X;>%H (1PO&):NXKD>5N(4K3]
M6"U:GJ-,L&H  & P!H">YBK""R./ .(81'8SN$/*  6]_P#DK/B"(.$1ZD_R
M3* /H;B*(%T3# _)1QN@8)9I!I"YM,;J\^/_ .UG_]H # ,!  (  P   !
M
M
M
M
M
M
M    /                       +                     "H
M              !@                       @        6$-P($')-X0L
M3H          :F9,H.BK$>R82P        #>E%>!YN0<M@#7"<        3O
MLP$@=Z*+>P>0:         6:[@.F-<L[LXV%%@      !R#SK Q?0=X=.S@
M        "GDM.C005PW7!_@        <E2DCHYJ.&Z:\9<@       !O#WS6
M2<X]GC(I88        !]!J58W'F'O+Q,R$       :B7H@$0T^"E";@
M      :=K(73:PVY)W@        !4X81YN)M"N[TP!,        3\=5-",HC
MNHNS![         ?B=7/U_%7-TB9!@        5L#0)&P,>^?V0
M !?'4 "%%@']:!0         3"MQL4]K:RD D@]        !>AT[!7Y-"WCS
MT9         #;1ZW"[X(SD@OP2,
M
M
M
M                           V>         #\(         !*8
M  !/H         !)          #(          4.@        #4Z@
M  0H          3@      "[MO   5   "-%&H        "'R$  ".@  (F]
MG(        7I?         &V?@        ?/J@      "BHXQ@        =#
MT         ,.$      &+3'ZKFPP0CN8K*         "L2JK*^/@#TZX 1
M      "H%1HQ(5P EAG)P8         3G+\$EX\+FN_N%(        #*C#1@
M*G  ?XZ,.      #R..%/54UDS2HW)          K^]N0473(UI22"8
M   8.EP!)C319* 4YH@        "W\C(A@(5ID%HUC        !TOWE3%QM*
MV8ER[;      +=LIFDW6X&989+0@        '+S-D\T8?7Y2@:=@       !
M,1;\P;+NR1*%S1,        "E L:NJI,6E(/[4P         LV%#NMY@N3JL
M^$,     '-R8200" "02 " _@   0 !16 Z (00020 0 +9.        6NHP
M("2("0*3K$/        !8L"$#]P#9@%20C:         +.[&"LO_ )\Q?Q'C
M0    'H23PD@@@$DDF@PE-D @  EP.9^Q T$@ D PD@2%N       / 3$DP@
M 4$$TA##H       !F-4V^22VQLDJT6M2P      #563>EQ)-&3 HGK,8
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M"J+/9H_2(V0P       "])]L*G!5N.F9.QD,     )L# <O8ZF+4$1WUI9T
M     '89)T8*%^18S?C976OR2    ?V&TH&(TMQ[8CT;PNB@  #NB^FVL4O!
M-G 20 2.      "@>Q/$,7Y+7Q,2 2(6@     )P*!2 ";)12*""#2]<
M  +(;]0+:4H$(.! 6'^T     !_"(/DV2"1]6?3NOJ)<   4 . :]>4FA)9F
M 0<!,      .AUD+L1X?HU^ ""^(P     !"10*00!;+=: 0 2,$@     !R
M;,#S. GNEN",14 (      )<2.P^B+^+)^QH4H'H    '$H"*<(#';FTKG5)
M        ='_8Y(,X'!. I="J       =5SF]-.$?IJ-]X$[J       <SN=T
MD:]9C8+_ !OFG8       3ZY""4>KV*FK:GN)0    " ]:?Y5,2<"%O1
M      'PXHC?A$D'IIC$         "? #OU,W<Q0+Q>@         #F]NYO:
MMB D%<RP          B"T6XC:5ZNX<1P        '.NT1M<G9HQK
M    '@EM0??F6?J(           %+&<L/EY:;$/8           %U+G(46#
ML#$X           !8!LH/T5=X;PX         "0&!()0]+@@@
M CF*.?'G%4#P$           &[%Y3&PGKE)+            'U)C7!C:+#=D
M$           _97/A/?U)R7*$        D $0'R_ZSD D$@         $ DF
M^C6R>HTBV@@         '#NLZ]F6=XST@$          $$0'2RV2]2D0$$
M        &STE'*4,E<6P@D       @$$4"\,0DBB D$@         D $>=,Z
M N\0$ $          *]"LK;1P]N7&TD           B6(-)CK$<B@@D
M    $IG0J]!=%2GUD$$       $$B C::[=$T @@          $DP[(HZ>Z6
MRTD@         "F2RY--EO\ /W A          !)(E+^O3_A8H))
M  !H LY S::.&]!)        ) %) -;5F,               ($ (.;AI(!!
M(             ((A,$@!!()           ! )%()(!!I())
M!(( MA (M!((          !MAE@$9)%)             ()L-MD<H!D!
M          )(,$EIH!               !)DDAIDHI)(              !)
M$ DA)A          !! )!-MV_N               (  )%D[L(  (
M ( )(   !() (  )(         ( !    )()!(!!(!       !  (    ((
M  (((       !)! ! !(!!)!!)!          !(  ( (( ()!!)       !!
M ()!()(!!)( )))(      !!! (!!  ((()!(! !      )) (!  ((! )!)
M !(          )(((!() (!          !((! (  !()) )       )! !!(
M)!(!))!!( !(       (!))( (( )! (( )!       (!  ()())())))!(!
M       )   !!(!  ()                 ! !! !          ( !! !((
M    !(!        !(( !(  !     ! )       !  ! ( ((    !()(
M
M
M
M
M
M
M
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M#2G(:H(B(7)8C,W#TUOZX7:3,1DZZ&4 %9)PF,^7:N:$,))&QB^(R]\;;Z<
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M2>2=_P _PL4PNI!-DB9X">,%ZBA6$60&T[[^NU2DL9A&) ,TNMP/?25P02Z
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M!9 AA,3G4K Y"(6 ( ,)ZYN=(HF:(DL"NY6^8TYY2*V)B;#^-*E#:0$8B$@
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MKJ-H30R3$38?9_TI<\7S$.1N-_UIAU<;( (KWQ@VK1D1"  IJT$*&9VC3$"
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MCIZO'SESJ4)QAV_[G?$YC2^5 LC,V.:S/YYTI@!9O"_'3[MH@0,=W!V],:,
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M]7J'QI6['.<W&,3V\5I".[DQ)O?6C1DJ;*Y_[KCK?X_&G"S$9>349R]_CO\
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M&4GNN>,7.EB+//E.U]-\:30J)D1UF;,&2;-$Z4K':ZMY_P"$L5CO^E$0Z/\
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MP='A$$#Q,"!08("0H/_:  @! @$!/Q#_ /FV"L KP"OMI$81$R-)X_\ G@M
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M;MHL32%$M2URX5W14#9P.)G3?*+18#<A&3.)K1C SR?.0) +JA(#^5C@2!0
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M8BB$ DYEDU ^-(DL0L5*%Q5ZD 4#E6_/SC^G#3P$3/(!AD67%X-/K,3N L*
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M>/3U/WH)$AG@U/L$A$,23$E;7'TU/N4IRIL.98<TSM/]*;&#:\ A]]1<4"(
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M9*;2SJ<)\2H0D1$R^K,5.FH%M10A,QO#VWTI@@;F5A;)2*FFJ#X"4%22@$!
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M=]N]QH-, 6@.Z!E"_P"[:5H2QF#4* +F=IZ:E!!!B"300(W8)8R)J+4,G!.
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M&%6;W+^E0O<5 HW)0#MM/OI*1"=J*^?*T),QM\^_.BLDY:=Y1<]O;^1$@)A
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MNO3C]TICJ8WZOB!GZ1K( !M53ZA_O.IT*PIGO$7.W'%5@Q8*F6P/2(YO[1&
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MJ FO%Q/700!M8=]G'+O/PF93S'IJ7#G;3 NS8S^N_7MI]U/*Y..8GYA,@[1
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M#SM)Z2Z A0]+QNYU-%?HK)TX^"1),'H>W_EOH,YZ*.D""9% 9(J%',?K2$Q
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MECG?)<0MOL3C>_NZ9$AB<+O6BL:0K;@6PZ7Y+K?1SL2FU/*?/WU:>DXR049
MAL82=C3QL04!$[0]&=SPQ-0%3,U[.>\1HQ%;2V@NTEI>A<BF820.*!F0;F#4
M^J@T3#  Q""T7$6"C A,2R4EP%J-:8.FW@%%8$E0B#C32 "(),0J3*@ @6?^
MR<0D-@2-2"DPP3I?N:QX"Y-"D((%+4#:2,%([O6=X]:+4ZH>1HAC)M]-(<3C
M)Q%Y6!L;VTQ'LZN:F^_';5[98D"/0&:YO0@SH\$C98$1)"]=%'1#L4SAAB>8
M,\Z7M,")E5:IO:_MILU5"&$1)9-$3>-%8<<[_1&Y,=KX0%VE-O% 1G;2J62Y
M6H"42*2&)VG5^1QF> ;>29-$EHN$$>I3^7>M79 TQ099(EAQ6*K(TY(/)M<9
MVXO3$(HG,3$)1-2G3C5[F8Q"@#@*!MYTW0;R6,!+7[IC3@D$!@M=6;\SQTMJ
M(+T,H A%4H<34"H^DT@%.5.=JT]8A7?!2_'=[(S929PY 9L*H,&QE%"@HG>$
M$]?35I"6$LG*7CW'=DAV1H&$B@M(%2A$& 40,14COJ,U]* ! PC 956](I0K
MIE12LB0MI6I&TB<3*!RD1,"**J45*JJJK*JVJVK:_P#==G8)Y%;5EH4.HN)T
M>M*U)=J.=M3-\)1:#:^&TAOG2>[.Q S92^.34S>&!DE$(WL9ZS>B7+/18CKI
M,2UPMO'R\:FD)3EG#]>\^=.+="D>*N7;>G?4/0206[8P^-:?U# 5C @TDCZ:
M,,(')(>I4;>UZ,R@I-K$/5KM[:+IT%"0N&87M?>9IK.<AUFFXXZ;:I(E5$0\
ME,3'KUT#$.,%0VJ4E2UC&N09MX7 SVS?.I\T2VL]Y3%7ZN^E=N 937+=3&\8
M#35!=IAMWF(O>Z^E. J@LO%8DW[]=-A+9(DI"0B.9:],ZIF=)0)#T'YT $$X
M5 (GC%?N\ZM1VBHA##27QDWSJE4(!&&)Z"!^/)+"K""3T=ZCF;T)(0X; *2$
M,R1)%KS:;*<0)C!4&!8&M6$0$&.+33"9]349K(0HR(P4A. \:LOX@T0R*$,A
M:)!TC5I)*EJA4*JJ_P#,49%'DIU_O/SI>36*+(QS/O$,:-UFAX)RCM-<5UG6
M8 #4^7%_GC4&2.:./ON9Q>CQ,2\R$'Y-JT>5*%6H-[O'2',1I7*\<.=_3BIG
M1CE*=H!?D3WGIH (DV=RR;Z;62Z#><<8^1]8VE3"D[==XZGSG23266=XCZ73
MZ:KP>D3Z%]NF*T/+V;D[WCV.FE5/T;3GT<U6C'$_?GWVK&B:"ML>[&:;VGKJ
M$$WX(W>*\5<Z ((CM]I^1WTME1! 4C!C9FX.>=(8NQ*TG=AKN%=;=$"DSD5G
M$,<W6]Y=;$YCD\,3MSSN.C&68B1*D56*Y(VV=+%,2H?G-^W']84PIV8^FO\
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MFN/_ /5'_\0 +! ! 0 " @(! P,% 0$! 0$  1$A,0!!46%Q@9&AL<'P$#!
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M@@KKDNJ18C&4'/!\$3-4U.^IT@)! -$*!\(B/CB[:W(ZK8(8SB; $Q4JHO7
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M_)B>!XX)QGU@(I<!$.4@&0S*<,]+'U SC"0:!R=:&GOI NP9_P ,D<*BAJI
MOOC6V\BMNH*J9\<MCE6K2&U!:J'$#9R*TT38L" @3A_:0&%\ ( MY3:.V"I3
MN/96&6@/A:D/@> 2&3CH*:ZB9F\SC#,E0( =<2+'-0PBT%TQ*0%6N&#V#L-W
M#^>4NA: %2(RS49KR4\*ZE.1B!! "(4Z8HZ\:\:H;Y$IZF1K"/ \J&01]_\
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M@"D)6#"6" IT2?"OG$(Q0(2&0R22K2F//OA60G(!9*!5AJ(J\#BR"P5"04
M <'_ )Q-3:!,DGD@49*("@A8+.\FB&],6*%;:HN-$.91@@ =-AD]<!.I1*K*
ML"'E#  XI2#;@%,Y4(AIS$SFL<<;25"B@>%171S818(./"<0L2@H7<*A-%!L
M:XFW%C5H IQG,9T5"KN68:!.+F:?4<*A:! $!/2^R^#E%RG(RKJ/^$->-A$
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MO]#">-=5+FHH& %07]\?U4D_)"]H.2M2"".@T1?#$[X=X@6JH)@5$.EQ!8*
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M$H'6&.T4+\7[H4E87]HS<* O-TH&1>]@L0>3&!4<Z:RT-8< 4[4 "1) /?\
M1$SE@ J" !54 %6<@880% BC1H#(*WI S:()0-/8RG%EYK9$1]HH $51XR32
M^4,6!; P;:,;'0.!4JPE^7@J;ITV8 !G+;<XS>-2T81#J[$4+?IPS.X:JIZ#
M/;"@#A"*/%ME9"&!/E9>7JZ"KK,=:R_&N7!J6Z):$56@DB<SEH6K40KF;M$Q
M/\+40Q>7L84$M;#/( "4C@TEX"BDX  A,,"< : 9MQW3+A$4%8-JE4?V9GB6
MP*.K,-,B@P+Y.SV*!A841+L(<!P-9@=5L4!\_P 0"_>F!.IZ4/3Q*>$.!E4P
M'F\#\"I=H4BT9N#C#S6@NV 3O@B>*>3^F?T!1Q1 ,MD;Q"D00I( !36X#:9&
ML@@!8%3OG4Y!BL'.,C$"(_U%]CF6S1*B&51#C^K)3 IV8$,[$M.4@MVM4]X"
M"EX<PJ=25AB@J CP@7(FK(((+ ,#%[X0]U3IEDU2A10WZ$\_#<%*5E>SP]%F
M2@4%K='=XU" +( ,C4?-$EX1M&)*1*F K"608X1-ROL$3TO@H<A$$1$HF1'2
M/8_W4,G&(& 5!G!+:<@96:V'K71*>,Y?(^6ON>9^_?"JTD3<&'RIIU].*MU.
M!#@!CL,38BG<O)T-E4I&=LO$%H,G3L1M@/,-'#%LBP88Z,NO>F\B*UR,.9#,
M? GC6@C(UDDU8Z4L)C3XXUW$M7P4$E$F 1\+!1.$@"T $G!\R!2,TH:%+5T"
M'!' #432T]^3]>,A?(6NL8FOYXY5!89-JD$PH#&<OLJ0'%FE8D. 3EP@9$!.
M5&!RDWS+57^1W1"8(88/"N3 Y*1$O:7*RF.NGR_IRM$@>&;#DARPSOP?R9G+
M;?J>*HK)Y<V8[VU,\"2*7-8YC3(EAWQM:%)0O58NW+^>2P6)+[+^CP: V'R\
M/J!]>& FYC+&LHI0)$/\*X*+PELHLL"BA@EELK323FX:XSZ[XV"N*R^OK._U
MUG#DWO)>&PP2Y#7$2IY@0XD+A4B-$!'.R"@E@+LZ[V\%39%4:Y'(88&2)].U
MY"+5;3",W//V'ZS'C^>> >RG;$834 6!I;OD@8Q!'1U<$F09:#.S"8C$>T)J
M;>"I5:.5I70MVO#B\AI +#5QJ>^_/C5JD^_ V3.\]^L<R\+E03!B!KJ<&MDX
M$@BY"F@=N6;:JPA4'N(15QV!6T] 82$7!P2DJ514'.7#CW@\\;5?D?4DX&A@
M<>S]_>?KP,E^YX_U_.^9V7RY?./%]O\ WBF;5,7N9P^/>N4=5TJ9T3"=QDWP
M@RO["C\ZIGWXG\7\ECY'/_O.T$(>R%WLTZX9U.PQK*#)0'&:_P"#MYF ^+5%
M4( 5A)N"B?D2>ZG^\<Q(6R;F&;*_%][QS H](:Q/&3^7@/ ,60"<+L'6:9WQ
M)J&PHD"YPX4FLF=T9ONTB#UZ0 1XV$ RH&#0US"MMXTFZ\>>VL*OMXHF$%(/
M7@ Y!'/(0<%4P>/($3 B/J>[P@^C;VA)%BT?/AJ49"[6WC6=8SB%QA-!ZF,[
MY2!10J#&CAH""$K!@)(?'"5@>))U_1GFRR(L*^4N7/1 P ?,Y3EH*&W(L/*@
M@?'64G:*2\L%1M;Q)"N*,3")A!^,=WCJ]FH KJW.36V?HZ"@+VU?+CJ?' H,
M&==:7>/C!^O Q0V>['\?AUCE&TBH-33$]IZSS.,+[1#P>9++CA6>@.O&?&H9
M[^7 J"VDJ(%#6N[Y.(*!-;RB'J5=O2O^'6ZR8AJ&: N <#6,D@!F7 [QJGKW
MP['.)GK#L:*6;N7&,K";VXE\X5?,XU7/$&_2BQV[=\0>"Q1"A"D< ,\G=:%)
M*M_>AYUVWC4QCF(R_+%?5\&.8!YQ -,OVGCZ<*SH- *3/R>/>=DY9#<+ZI6,
M!*L4GE%36+ <.8<RD5Y-&,Y\;^<]3B1$9?/ZL"_7KFJW.M0VWU'QEO)YD;XS
M6(/Y"PWI,*]G;JQY8.C)\D4U*&V\ O*%.(KH]D]K.(R36SO,%A][O7CCJI+M
M\/MGY\E^;GH<S#'6)_LX8CT?T4?M]M]?3W^>*&NLEE72U9R\5C*Q\13UU,<6
M&%KSWK\YG_.&<(,&ZEN 4Z#W)DXR7B#;5 @9H+[/\)4$S6KME28\\-40)?*;
M!:*(;R.N ! S/Z_I)_YR 2S'Y=]XS^V^&DOT,(#.+OS=;O';XD$D E6DG>1X
M6)&"U7C2JA,HWCPQ9]G$0'@@R07AWIHF%+##HQID. I!YOKM+-PJYO=UQHA<
M08CI*D$'@I'JY);'3B:%#D3AN[1 *E/&CN0D\^]" X'T3R\DRV#'FE@3JFW!
MKB#=W^BM0; Z '-$KF$ J$9< XQN3?D-G&HYH=G!Y*-6 ^EJ+$KDS(YCV207
M+%AEYASR(IE,AX &AT:XXRJ!3P6K- QN/$":XY%7.QCYG9DX7 6JK07>"GA-
M^N..-J^@Z[\SZY\<>3%EA2+1QO99^JMG-%9"JU0VW-6\P:,$/$774UOYX-\:
MNBN.[JG>C=X*)B^88-B"01PB82FYH[XR9RN7=_NCZ)JZ5!]1>!,$%@M- #4P
M5#P(2:;7Z/?;X3>>N IC'F:%"9B-Q,['B!3=N4&HS@5%<.*NU?GA8Z0F!S.N
MANUSXX4Q2AXV/'RD/CFY.WAS]9^F?/GC27'<:X+F6'W/H\2P$*E)HZ\8?U.N
M-1JT;MA-.?IGXG"B8"J4S?/\[ZPG!:.WJ>?Y?SQG)Q@OXW]K,^]VM&5%\64D
MQU]^N6LSH%B7S:>O^<SJT=Y/CO/Y_.KF0]G_ *]:^G . ^C_ %77XYM ^#/[
M^>3%M<*/\P_3\\HU\&9WGW_K/,$OSFX^<9^OKXX@*RUL_8ZQ^_%I4")AZ::-
MT&^>#,E9;E'+ZSSGOBLZ!A-)H/.<]YSW(MX4&%RAU [,Q-\1G6,"72YD$<I_
MAF>7FQS'78C-,ZY9P*T#0L,G3Y]\IJ,-E+A[SUGSQ4@*/$SY2WH)'?';,JX.
M';0E5Q/5] +HWYUOCB-P+Z"!?T/C@H<'85F;O/SC7SL\X6F-][?YGZ9X/"81
MR[/?Y[ZQQX$9J-EGWU_)>(JX,*%)TO\ O&9Q7]#A\#K-==&#@@#.()^W\."(
M<-?^XQ+]IYXJR(5N6LY-VS2/VXXW("+4SG-0G:_7C1&IX1'V>,8&9G ZG2<
MT#NGG#[?GAU+XA_WSQC#)\@H;@2\$(N#.7_5_/$&07W^_P"_QQZ,*T1F\]?]
MV\(%*#M*>*$<W@7M@NQ%IXR#=W,Q>(1^KCN=OGY[^>",X77.RF<,QG]$][+$
M4+*W)HKL?X5 ;RK,$Y&L=MO&4K0NX\(Y)ACKO7'<"%P03PCLN2?<CPA/:3$
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M./='8JK>!<.?JZY.0!A&]AN2N[M>8 DP".@@_4/C]>3-"I6'+ITR9JL2B?\
MHR4M:#L4Q]'*:&84[N*)D;96K1050/*@?=XJDT;QV RA !5YK[2DD6"4E44J
M/*"(N&6X*T::B[B.6.BWH&":1R'BP1@G5: HJ(IO(\=H ? &G$-::AK:D7'8
M(:?0.%(S*Q\&?-)&).0D2.D6AUL(HE.*^3T!=(&#!A<>!QJ@#[090L<LX-JT
M?7YD0Y $> 9-^4QD4KQH<"Z6<\$5J9@$)>"BXJ> U-@*P@\;OJI:4T"A9B,'
M#5H*!N&PYBW.QIQ 7BJ1H4T06TR/T)3LF_H_7\YLX]9570.'SE^9<\'@>\)#
MH)$-J$&\7W3K2085@X1U7$. ?B3DF4SKCMP?:_MCZ_\ ."M3PPL_Y^_ 41G&
MC3O\YY98O@\B!UM=XO$Y."ZUW4_YR7$  FNWG]O>>9,1.+U'%-9G7G?(:H+-
MW>YCQ\<#+W-9U?$SU?TXT(')AW[Q=9^9XXQL0IKZ^//XXV#AKCSKQLGO\<BH
MX&X]3[3X<XYK;>9Y^O)2@%E]:Q>"^ F3W\<GA]O)@@09F)X<]X33KF=;O27*
M5 ";/;3<,K H)A#XP_&N8/  QF23Z'\<\/EUBAA"MN &E(XXF*B+1280G  H
M<.!I!T'*+BAA=I=_WV.R 4$^D'+ ,>5T;_D+<O#OX#Q *+@ZQL[W(9%UC(CT
MUR33-N-\= !FQX([D]+^^.&K@7QQ&^3.*YSPN[H ""DE^=GZSMA>VT9P#I=:
MXX*<OC-^+Y]<'@ :H_=_GGA;1^*?J\N8>V'7\D_7O4H%:FUYFQ:"><7BK YQ
MKSK]2:.N+#'G3#QU(KG]F?G?,3OK9GLI_/GBCV WU?Y_LZX:M_,?J^OYUQPQ
M\]M]?\._!QNO1,OC*_IZU>-ZSL+NG6.O]\8K?/Z[Z]9[F=<I_ \ZYJ^OZ//Y
M_/MS)E&"7:-OF\OY#[32$G6Y]N9BK=5SI\3^>.*K+N;%M[BY^V"YX(K,"\*$
M6@($">&*(78*=F%^7?\ ?<EGD4D%U0@D!XX->,^, :4$P<83B@-F=HE<DT9:
M!03,:(HMBY<UN3C5236"UHB1,8Q>\\9SI)GQD\S6''VG(&1^(O=,TF\ZX2I"
M.L.9$64*F7OG<<3><0RXDT#??("ZW=Y1]=)UZXJO,_HTY=[O6I/'\.-F)G%?
MO/WW\[XBO"O<7>+/G'[WE^_N_P!<2E?RWD+P]S\\9V^.W\^FOCMQ:[?+WQXR
M_GP\=GR87.M_[Z?7%I?GZ8<<P7P?G'-GU_5YM^#E!ACSKQQLTOCQ+YQ\N.5J
M)5MPE]#YQ?A*5J%71W_GOQ))=(GU0R^L8SFAR;REN4CD[-%&3SX1JTD.(J&D
M@6!4 Z(;&D$9[P[[_ON2<X *#@ 57 %>9_3=.2#5T$!AYR9RGF'%0"ER<>"%
MAV&%\*%6'!UVFR87DP7/QS&F_ []TQY?CA:WF%D<M)1'(_3C=+0$7*;.!GN[
M[X*3S/?CKFY#OH[X$(CIUG/K)UO\]'ER8Z_G3\8UP93%_P!]]74^^\$0DA3#
MWC'C^5.B03"_:7WK3WZ.$"!\8'^,WX.)?3?1#=OYY%Q8QCSNTZO>NWC8SQT3
MS_&9]N-&'?@_,PY'*3;? ^X]]^.%Z?0,_&?O^?'$&5J::-WK^#P&<(Z#]/?7
MGOFH!O,/IKQYZ\<OP?8_WS21&D-_?F(!C?1(&_-#]^-"!Y1MC[@+_6<%H35F
M&1SG[[UQ4*SNLN/GT9[X6(1B$%6;<>/=?/)&FL#5].H (O[7Y#%$OP<R32%
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MH5H K599-F3QQC")38'2RNSKSCC'5I#CA!A@UYZP40Q"!6#B%2GG!QF9G><
MZ#<Y+1=X6_.^OOGFL-8$5TC8S0Q[,\L.?6,3PB<&!]']K90R8H85/'X\XY17
M-RDEF1EDW6SE\7^?7EDD!Z;\>^(DH;\^'C5@YQC^=<(,Q[@_]Q.N/$)9+RVH
M)]/#%X0I#HDO0"/OKO3P3&\J=]FTZ#'EYFAR!0$0&!BBQ8CGA=-U(W8)K+(O
MB\.E @A2), #?W<61A-SV)"C#4"IF(N&6B!!">MB+QC/ I44/ I),A!:J\E8
MA<G)2(Q,TQ*< CV#4@+@R:#A[QPEE,D5!.H=7@-<EG 1 "P%*N'IX_[E<(J&
M04;66)#C$J*=CD'"!0"W&>*+$*$J1JB55^>,6<6YXJ.449@L;., R!$$$2[F
M 50$'(.$LB@K8E/,,?/*;2JSVS"ESX.^>%F<(.&()YO+CU5V)"K$P4PCF.>&
M9@JP^<G\N]>>+02BCLJ/:?3AZ@[5+@3XS/'SUS,+#>,TV^!=C?7,DY?< 5]%
M DAHCQ04WNA"9\!(BD!3@()(5!,%Y-3F78.5!K$VN5RO?]R7D5D*@4)"Q7<&
MTJS&<US^Q7N, A5)SU?E_P!\$4>?-POTYM4?,AU[_GKB&Q(XQ.^(@A]62^;I
M^O7$P8'OP['6]N7Z\A",B#!'(#Q_)P<N@Q$VPA1QN7'&9H(?HE4I@>!RQ5C1
M9%"652QDUQL,),8$@Y,1.XWA?!UX1DNV3&B9%X6(W:L40<&9R^>/@U2P25*R
MB5QT$J(:MB$(F(ZN_"4=ZT4!J@6W,7ODK;"N #K-*@I(0,],W>H1! <+=WZ7
MC1GE L(, -00NN*C$.F9$QB['S#8D52P'V+'/E/;."] 2G)4$H4"Y<]<U> Z
MPH;38!<B>^#;($\$G2%#<'LXX-5Q3!M&M]GE,)I^#6U$4)X8,V_3B5UT(J3(
M@6P?//G<[;1_::]CPQK+50$T_P!],X[P(!:U)G%[U^U6@STPM#<?K./5E40I
M@BZ(T"ZY@9H)%% #-39"<($<YR,/0T<<9X6M<,6P]NQ*PH<.Z"74@P(,YH$$
MP+,L@&0B1BG;B.\279!)RR3"A0J7T#!%KE7 2_!$N8.QYRRX%">QB87]Z+'D
MS.<D!Y+JWEVE2<$6)F5F?8)Y ZX!]N8T?4Z0,C#EMHI*+6+CAU4\Q:03*%SP
M]8H\$8 "#J I(!18%5JQE**DC4:.L]Y<\!\&6< ZG#]PQ\_7C $P=I+_ !UG
MBDX38N4:?[]&^,T,"2B0H(RS'>7K5J9,"%Q,.2:<_'PB!V,*B3]4_?')0^%3
M6%9R2>OR/(N4A2""VRXF/'#24@D.=Q5/4WGA54H# ) BP0<N=PXEW,6@ BRP
MQ-]YV<0RO 0"Y1O C@^>#D+D$15A1+TY@\#;LA$*1<!$30R#Q%LA805P1:W?
MOOD&S4C880;4:I?7*@9S"JVWHAS.L(J]B)-'>)X;]/.>%@KV)4BN@ HR]QX0
M2, ! \MJ71CQR$H0-DPZ'G_O7$5H90H-&?SG]^+310#E -P8Z9#F.<09N&J!
MG _@X+ A@#$P,D3!\!/)QP4KDY'TG^C/?"0I>T^SCY^_WXR)DOT5Z\_GOAPH
M150HM!6F#L4ZXD?C<W\[NZ!,PL+4TH@4]$Q? 5X&'3FCFGI@@59]RR,D[LV
M0\'/E+T:2(W@<88YT2&#="0OV7!68FM;PL HBV<%G6(O$%D<(%-X/"*5#0@
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MR&,.N]>M>=\9B:>O.<YQ??6>, 4U\X)IZ?KKX*=?MCSXZZ??"XHK$U2:^G?
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M,(U!A@A'KY4L4W!I*^+6(B$"F'Q 79,2BK86Q"^O-!>NJ"$*TLB_TL$RJ"T
MX3@ :AMDJ-S1,9_83XG[4_=OGWB/Z3^G&1ZC]_\ 7/$UJ8SN_G?_ 'BZ4=X)
M^/Y'? LB,[#L]W9Q<,*MOB'?VMSGF(4^R?Q^<<-55,+Z"0PN'OKBI0!%/K A
MRS";QDG!8!X\K,T.WWO[L'$,'8KOW]N)4>J*TP05]";P\0:C"-:9MJ=YVKR+
MDC!%:HJU\4SCPC)RRB?#;GIP+LX^HNNZ:^?I\P](H6B\YZN,8Z(:GU>09(^9
M/9<FD=&[YY2\3A\IUFG6-<J0K4""YTS#?B8',XS[>7\F/Y]..SQMKK7KO\GO
M@&TS?AIA^_QYY/)Y^K?WN?CF5L0]_P I^?KQT 8]OPW^3WQ,C*/\>_H;?/'<
M^T\_%_U^.(@Z#0<_C]/GY@1@ZA V,'8-#BW@$SGQN5P+*$<!YI$[MQCI]J@$
M+^P.+C:P?J%,"4$\=A!RJ)U-TA <>N5806%-,&/!P,'M]^/Q>OOP'@J90]F-
M2?/[<-J8F80_$XFLT$P[G\%YAA*^&NW6/H< V6F,35\'V_\ >*TK!$ X1<S\
M'Z\M &S$T>#WW[X)4 >UG;.9'^37'%$5/--[C]?'$2JRN9_K'>-;\<\%<X'&
M^B_F?KPUU;TH]?+T<H3,/17[[._7CEFOW#-_@_%D)QYC(I,/[;]=>N0A MI/
MT3S])RDM155<ERHIF_OSR8/L'AI_WZI4E&.5KD?.#7_?)(4V*73,^O\ 1QEB
MI+38COK5WW]J,M\OE6:?S^O&8L5)6? \=\S=SG]C^N>&QQ</AP?SY^G,063.
MUF9GXU_*VL+ UOG8]G4TIYX[QYT%KSF?!\9X"2.52N8N7./G)CERR'.T!WC(
M W?%6E*1*$4; HO91M_=<H,5)(*"6I+<_HR(BAV"Y[\D\\8['.,YS[^N>*(<
MY(5Z]/\ WQ+P4(J/3"=:>8V'4H/KKZ3Z\3K<73777WG_ 'C9!@XB>G]OK>"@
MA,!+6:.\_'?& P"#B1D/S]^GA#<//R-_7]N <N%F]GOY^J;XXNVLA\5QN?CK
MBJ%1!Q@Q31?AN?/*( J&8+LR=_/&=#AZ_P!:^+QPF]D*CD]^]_B2SF :'>7H
M[-_)Q@1] CG)G'_KPZ' ,KWO#8:^. !>7IS+W,7Q=><<I\6E@=8R?^E\\*8Q
M&";?#W_R:XBI!M1UE3X_FN3G>^^XZ;^.(H6A@,-"S6<\+,88YUT[. Q6:[W9
M_/.^.*I2W.0=V_GKZ<H@ NS%&B9,^SK[\EW%9?\ ;RZBJ-NA9=6#W_Z)ZM,J
M& P3%H9TIKC2->(\(B^ % PI 0EH /@ #Z?VR@8.-X&%JC&$"%*L5C,V@(LT
MUOW%PG%@7Q4QY>-RN8SS\A^_/P>"23,OWXG8_,^7B'4#M9]KP#(XA.EG\_2W
MA>"S;K)7ZOPW?,12CBM8SDU_,<]!]CF*@-,$.]IP5\3!&+1WZ_FN)5K2*5VS
M.79]^N-!H9O?Q9<?/K@X2L,IL6XD\<)D>\J_2KMF_@//##N5I7IDR_G'U[=#
M(#(J>Q^-]\"SD]OYSGO/C/!:0G88;GK_ -^_)5(;3IQ#!C+/7VIV8=^&_?K_
M 'Q20X*[6F,Y\SOD ,IZSY]^M^M<)A,77R%^_ )@!\?Z.#$LAU_#AC6/C''.
M\_.>)A-"3UZQZXI55B6W4PY^-DXIB-Z%#*44N%1\O5X7#XC4JLDM.($"']P=
M5[G$D@12W0,O(4,:4F;R+;5?XX'9(>.GZ_K>-$DB: Z\&K?OXYEPJ[\/GQ]?
M])),1-,9OC]'F;O75[^)K%N?O$XB><1^F#?\NN8=6+VOCZ8??G/*<DV8$Q[F
M)G4X=.T!<Q@RSJN'H:<$:P>/R?K9M[QQ"H>9JZN$;[^O#) &,$,8<?\ GCB&
M-A%+AW/KZUWB<2P)T]/O]_MKBA X1<CWO+\?ZYK#>X!3,DG9ZYK\\!CN_D^-
M_GC<QZI6TW7Q>)E%353/V?GC]'4T&-9AC[SSQE$PPRE=['^?7F,0!188IDP=
M^/\ ?$X:R4E9/KN[P?0.9!G,@^/W\<,92E$<G=N_]+]DHJOSGHX?N_J_TC[A
M]Z_MRXV8/T[1UPV#'0;V3X_ULSQQJY%P[MQ[^N,=8Y'8BATF8V3(5FI.!4;,
MQN+D&X9HCC@TDCF))8$+G\@,+ I&W)NG@(UB 3((",028G'&W![O(9RN_/\
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MS5F.!N*MKC-)KF/R?VG,##J)YG V .<8AAPH3/59+P4@5A%<:A#<B&^N&70
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M[1>0P#:8,3'+NG@Y$"3XH]J%F YR&4$<$*B0ITBGR\3&N-\X=YW)(- O+RV
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M!46[8#1FN!    ./M^)6$4YQPX.GDFWB=ET8.=E>7BR?@3"2"@*!"JYX
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MN,S:<2)2BJ,9,+]#SQ@*5L8!I4,"S:0%PF^QL0F+3,A-EA8Q)6VB,7 GL/\
MWEBT*.!*8(\I^ J' Q3!,%,KR-!@F6]GA;(3;+(S*1$<8K0E5*&!%JTCQ58$
MWK58O(0UTPXAN!F;;(:D,:K F>(-4?,LXLK@&3L!9$=  J1@%1,IS_B+M<86
M98HEBN!Y5QJ3<<!L)P9F>)P9<0"A@+'7EI.'5)+1 T"[86,:8 "79L&6R.,>
MN);%=O"8=LO1ODP=;!,5#&>OVSUQ7:04@@RM]<V7Q%RF=.MK@HW6[@<7->9
MU=0M$C#1%,ML,079,R9,\73G92'(6=*'0]2\:7-,%/E[^NS\\3F[J_.2=_)]
MZ5J* P;7>3WU,2<G,RS&N'M.EM<3A8 YRR\=SO.SYY90MR5F<+=4^,;YAZ4B
M*$K'1A-C-<&HRX^3[G!U8MI(G-DS-7YY62 Z+/D%5L-.=S/'#FQ38&"80SHQ
MPR$< $J9"=NVG)P4%F"PNQQ3-<N'&9R(2'<=?((WO+J2\F"[2I2D- 99'EXN
M0X^Q-:5MH_XIT31RFP$#V(CPL0.4-9.FYK-^7B5F/T"A7Q2L.FAP$27RZLCC
M@\ \6'MYI4WJ@N>NB?,J$XS7?V[R/M^CD"V-%E< )O1O?07@T'+C5@P8)1X"
M8<9)9MF<YEW"&/"^;/$ :6*TKQ"%($:1Q"RM01]=\/A#D$&%(6&S&OG@6]@)
M$;-)?MY\YX^BZ /92V9Z'E:$1U&I$&CMU^^.C@,CM!T,4?HSP+I2'1O,+.&*
M= * AA";$83&>9%&60>X0X\$G? :,;HE0+/EHZ]VGZ%1*.T0$)IQ^W#2:J)A
MD5D!PHN*\!(M=4&KXC>Y!X-.#-)<& APZX"J6A. ,E((#3$C<TX!8 JI HH2
M3-]<3[B:HDZ;SKJG,O&ED:58HJJ5*J_XA PAKC&H(1MB( ( ,+ZT''@5]JX#
M6O909!H"6!R"?!2/(1%A'1"$#M76>:>9A]=??BODI1(L3#A$?^/?#9KFD46K
M(=;Q7C$8+DF4%*U"+1 6'+-;]X?*F4#(C(!@Q(M-2HHR(<"J"VPV36!W=VE[
MX!!="MXUF?\ ?'*>HRZ6:-;SZ_WQ&5 @@R$!4KITW>LM5& N%WDG=EIB\BH$
M.)&7X8/CISQ JE,@+HJOY\>CG@0JIOE1>UZ];X&0 + 3"P2=7)C&IX )Y(X/
M,_\ /7'D&2]0GN+C>3ZP<":,+=W;$M0,XS/ UZY; 0I(I 1K O+30%H@<*B&
M+ 2QH0I)Y:'2?*Q.GD@R03XZI\S1-.J/J.DWB'\<4@6.->!3B!T!_AYEN(S:
MR\6.?Q24F!VH4/\ H0($O&Z)!(<)M%$=JQ9;QV><I.I@6;"@0C)( ("N2@C:
M@D$85;P@?M;R&K,#1:)0HG"A.^+9,DFM]X O,X+G:'82AU2#<;QR9*XJ8B 1
MVJ@YBV1J 9$ .8DC!P;+17OBHD=@E<-X')9AX,\4) $@AF#CH:&' P/ #@[/
MT"0@A3O3L((I< ,!(01<#%H\*?T8VHA%0"EO2XXCG8P YT[0&7%(B/C:>F15
M@Q4EO  @'2(C\)OA0F:&I\/QP--' %Y) 9YX/?AT=4#H%8>_\H+;"<P23$PV
MU&M[-:J X0RB$]\Q<\RIP2B/8!4AXI,A3SJ!D%;0<2LCC@OJDFA2Y.4A F4[
M#RAD.ZX@NAY<!8%E")V'4(%X0 6[= ZYH0^SC^)P+1*+$9@%7!> R?%9@S6Y
M "<YDP."I]L1IH=D=9X)E6PH[RF *<0/80=X5B%;F2W=)+IT3'%M#D$C LQR
M>/AO9MU"A0$\%)*FY71*ZJSF*>#[)%<G6!:+@C#5!;"C[%BL($X#,(OX V4"
M!@<N13PE/L\LVA*9"'J"@=5X&/@@(LL]G+Y?\D@+RZL*JOTQD<@UD$[D\VIO
M3.8FE+6E&QM%8(H0A#\07/FF#Y6'OY>/)_\ *21%)(-<?9(S:GA,X-QAF)WF
M'>546+DQG*@Z*?\ ]"8Q79;2M&E;7O4;7@O$$=G&=XGK$L\XO])N5+XX(:$/
MC[#298[\X3@;@+492RVA 4S$'+Q?%@0LR 2H@"KWQP[J(10HP:,JPDXHU5-!
M"K"+;Y(IO1LAZ&8_;^3@H04%(Z\EWC5UXXSW_0#@;F Z[.15-JJM^<;JH4 2
M5<*S2\*YSDZ&5(K(.().4(B,5*!([;@ <BB.)Z>#LON9G%;_ "8AD^AEL5_@
MXEB/8"8NA)R0@\<&<5!HY#$<%H$ CP"+$W<#'R@03#$X4F&?8YE^->7 $@=2
M;L" H,8#A*L.;5+'!!XI@30@E2.26_@>=!1OH8F@<0C1#LQC6X<S@9F R'SR
M:F U5;6"Y0$N(S?'W@""23I27#S&D4=!CSJ2Q!G"*23T@>9)@<T8UD@[%UJQ
MD"BF$H:&[/6HWXA.9)D8\91#&*("(CKC&7RJ+.3LE=PTK.-HAU75"W YN-/!
MX$("ZD",$QQH:$CGM#>#(:!>+T4.CE,JR*M27C_:/UBXD%$L5\\    0 @'H
M_P EF3)ML)5U,;K/#P\U] )["FQ&9.73H/9G!DT$ X@02 JBY$"*^ <Z^"9M
MS0/M7!L%466. D2!B& (&J8XA_)*-#1J5PV<R>.)5FD!;(Y86@ 5 L#<^0?]
M<L30"U&).\9,N3#WQ<!<MJ#35S-5TI)Q>E@V (BH'/!(;3=09&*8*!(NTWU<
M8MP(G2"IVXAC.[!%PX\ !<570L+8Y0 X) B<==)WZ^G6)GQXSS(U<MD6G*$@
M0Z(;\!M]<J)-PNYN'XN%HB5:,UA-.<?X8:D"$(1=GB]JE\I#&558*6:XOAA(
M08!["+8PK@U2NE45\T!_BJAH$1B)'(;0>#AUQ,"D!:%A;(6U4<O!L9, 0 P
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MF!*,L5D6S?*5B]A+:#*=JPFD0(A( !'5V -:8;-@@+:J2R V1"UF2W15>9J
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M;^!D<3:'49($=O:8)2Q[,"[&0DL!.P9@;,(!4[+$(0D"J%3!++1:$(<PA,$
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MS=3@2*>&&1*#1<>F10.:5Y,0WZH??!*>H!DU$%,"E;M X]X$3>2$]!12#RL
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MS )'J$!0]G,:>,S0*H9[6Y>R&8!DVK!R5=^W!] S_,\RH)Q:NU1 *9.B$@P
MDVDYWE'V)D(RJX.C1'4J*6:F3-P2+,XIA4@U 82)DQNDSCEHB=$V,W2QE, 8
M6N27[I6R^!NP:PT8G'@GJJLS4DAU@Z3QQ;:P$BHF*]XQ'"NQ9QQ *D5;WCP
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MUR9IA\"W5YA0RR;02$96N1,IG@Q<ZWGK;9<_S?# 4+BS):ZHF40R484Y7G0
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M0>VYQQ42P1):-[F7=[L!J3ER-*%S(14$$\P:(,)Q^#W4MW]7QPK #5B;#.3
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M&@^@-NT>2D)A6 0:DN'_ (ZIC(E40".!XZPM,.CG@2K)@2DOA\OGT[R<)/\
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MV>E(%N^H% JN4C5J1R46Z)J$#6#6P!J5<X%TLA7'^XEQ2A%&',4ZAZ$ X5@
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M+X%1H1((>".I;XF)(E_<F=S%+Y1!H""%GO0$X-!$$?[Z">=L,J6N!!$3@
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C/],@4'%V A323D:S,VP @0,!Q*^(^"2*H"%D#L/_ .UG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>prospectussum4a1a.jpg
<TEXT>
begin 644 prospectussum4a1a.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X0_*17AI9@  24DJ  @    & !H!!0 !
M    5@   !L!!0 !    7@   "@! P !     P   #$! @ -    9@   #(!
M @ 4    =    &F'!  !    B    )H   #\*0  6P   /PI  !;    1TE-
M4" R+C$P+C(P   R,#(Q.C S.C$Q(#(P.C$U.C$W  $  : #  $    !
M      @   $$  $      0   0$$  $   !6     @$#  ,      0   P$#
M  $    &    !@$#  $    &    %0$#  $    #     0($  $    & 0
M @($  $   "\#@        @ "  ( /_8_^  $$I&248  0$   $  0  _]L
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M4^:UM#UG&FHW4M>UCJ+.5SYD$IW21'[W]X'H:O0_ZT5G67[VXFN1]P@(A_O
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M\DUM3JSPLJA23V8<57MXITF#.D87N0!FM8_#N827OK3\"TD:1($C554<!5&
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MJ*** #RV]11Y;>HHHH /+;U%'EMZBBB@ \MO44>6WJ*** #RV]11Y;>HHHH
M/+;U%/B0B0'BBB@#_]G_X@*P24-#7U!23T9)3$4  0$   *@;&-M<P0P  !M
M;G1R4D="(%A96B 'Y0 #  L %P 2  UA8W-P35-&5
M                ]M8  0    #3+6QC;7,
M                                      UD97-C   !(    $!C<')T
M   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !V    !1B
M6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#   "%
M "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D;61D   "
M?    "1M;'5C          $    ,96Y54P   "0    < $< 20!- %  ( !B
M '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !    #&5N55,
M   :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#___NA___]
MH@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@        ))\   ^$
M  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F9@  \J<
M  U9   3T   "EMC:')M       #     */7  !4?   3,T  )F:   F9P
M#UQM;'5C          $    ,96Y54P    @    < $< 20!- %!M;'5C
M      $    ,96Y54P    @    < ', 4@!' $+_VP!#  $! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" *U" T# 1$
M A$! Q$!_\0 '@ !  $$ P$!              @%!@<) 0,$ @K_Q  = 0$
M 04! 0$             !0(#! 8' 0@)_]H # ,!  (0 Q    '?N?
M
M
M .3O!;)20
M
M               =Y>H+9*2
M
M                             #O+U!;)20
M
M                                            =Y>H+9*2
M
M                                                          #O
M+U!;)20           !X>>\>5<^>O/0'OG#SGWQ5X>/0
M                                          &,\K%T7]!T;I]\W1Z)
MNFGS=]/W_P#-]_IM=-0HJ\E7GI\]ZWG7Z]M/OT]
M                     [R]06R4D          >>J*U%:BIYZ]\5>/?'OAX
M>O!ZIJ>>O"JE72KMJZ0
M               !B'-P](V_:3)&*D=A^L[#I-W[2MAFL[#@S/PO-538>18E
M#$R>#9#!M2]:W=:#N]7HK
M   [R]06R4D        #PHK6[JFI50KH5TO:7H    //5/JBM1<>>J[:Y;5T
M@     #7'M&N3LUV=O"S>    Q#FX<6I>+V!ZWL%$N6]66W:MD?%R=D&K[)R
M                                        1EE8S"N?A6K>M8^R<:(L
MW$9,Q,K<YHNYZ*>@Z),J#FH)[#!7UCW\DXN3NVT+=@
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M:MLLS8*:
M                                     [R]06R4D      4^K%\+]E5
M2!YL;(IV!(>3%RNZ[9]F5B>K*QNZ]:^ZJ'H  <4^]=%?GL7_ "XN5Y,7*'MS
M<*HY^!V7* %NXLWE=M>LO0   T:] T:U;UK(^+DWQC7_ !5TU6W7ZO/;4O6L
MG8F5!_8(.JT52TAI?'V5C;F-%W/7SLNO1NDXZ*$S$SUUV>VHZAM0
M                                  ' .'GT]  '!P\Y>\@
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M)QGU72%NXLWE^PKH
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M[7K.$I#"V>:EL^ I*/Q=EXF?(Z1O3'O8]RL>D5VZI17C?+QMFNI[/GR.SP
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MS=OH6[7_ (V0
M    ,"1/0-8FA?5DI,K0YNSO%.KSVWL>2MVQ)V[8E+>L2=NX\G;EB3MW'D[=
ML2=NV)*WK$G;F/)V[8D[>L2=GV);#%S8,V['S;8IMGS5E2=X_G"CVZ*:P
M     !Y_*XD1'5M=.N]_SI/<WVC[U\IWME08      '>7J"V2D@  "U<6[K(
MQGKIM7*#!SE6DHWW9^" /FGW'NG[ABW0M\OK:M5R7O&D5'-PP      /GSVW
M(2:Q/S_?_-8OYEZ5S:X9F' ''GM$A9GZKHK,O$<^E%3'R&3CJJ1J;W+4[,O6
M,YX&?%N6BKFM7I8PTKK@VG6]HNH[3&J6C,"R&!D#&R/5XC_)8$]]<G\1YN)%
MZ7BMC6K[)%F7BJ;53D''R);PLMJCW'59$1DC3ZJ<;96-\O-UNB;K?V-D
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M\^@ *?AY>$.7=1JV?'YDZ7S;MKH ^::J!!3M2D8WWYV$&/D*J%ZT
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MSZ[LVU39\*9^#)Z(E(KS$5**(E(_24?U>KNLW=I&H[2
M                    +=N6]66WZM4J*MI6H[1K%VS69O0$W:-^S!+88*:,
M#-1=F(O:;J&T^ZFJ.,I&POG87P5>9KP,V1,9(0)V*!F)"3%L7K<9Y2,J5-6U
M#4-J]'GH       'SXUR:;]+6Q [O/*>X=7[\1T^>V_8D8NQ/388Q77-T^[?
M'/=[2 !YGGY@-@UFSZK>Q?!D;6JIFWB9LR<;,@?EX-9\]R/1<L^JF<V)G
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M=$
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M8618O_'OQ_DH_;YI6X:1]^T?]!G->A
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M>+R??CI]>GSWR^T_;WM\?'K[\#H]\Y>]GCX]#N\]\WM/I\JZ??.[QT>O3YZ
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M8&;X\7+K<S#AC9*]85T@
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MBJW=?G[CV'7_ *J\6;IZO60
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M4C/3DXRFI8OLG&
M                        $6X+JOY^^0_HK^D7I7YVY'R=?&E68UNT/JK\
M[K#A=K^::J78S9C=5^=/KVG"^I=)S=M_,HYZ'V/"6G].S-MG-L;:SO\ +K@7
MV/MYC)S%^?%6_>QZM;NTNY:QY8RM-?-^UVWF1M3Q\R8?+>\5O%D<";ES./N[
M\ND_SSL61X+;(1];^>+KC9N0^D=2N7Z'^-MS4=,@"R+$SJ)USZ@WD]2^#@
M .\O4%LE) HK6KK(QQ;T!/5J8A^^_9 QGH^[^/%R<L="Y^!X,?*A/Q7Z<FQV
MKYD]^1B #!_.^J05^2OK7.GT)\[87VK2\L86;(J+DP   ,?0.U13XCW&>7UK
M\AYGZ'S0#$^I] Q7JV]RLZKP0#XI]CEQ?L^?>M\EJ>?@@4J+D_JNFIR,<\]8
MV2R<5Z
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M,1 8N4R<9[X
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MOTB(E:_/088V2O6%=(
M                '!:1V%U          ^?/=&G+?O+9S.?/>>,_2
M    *3[34O/>@[SL>@   ##&%M^K2!^C=Y?4O@S[]\    [R]06R4D#'OKE"
MY;Z;-VB0TS<,_ @"-?$^UR([%QWV96,!&/F7<,A[#I^6=LY^ ,#\UZY#'Y?^
MH)K]]^</-518&5C6[<MVM?LWSC9'IIJJ-/OH\JPM(8&4L++R)C97NIJ&!M"Z
M?0\?(V ?6/QYR 1*Y-]!9VWGE=_[!J(&.M,W*D1\AESH?/0.JU<H4)-W%L$
M&/D+ME72
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M\D;)I@&/]0VZW8:9S%TCG 'Q;KMV!GKEV+7@Q[ZY;7*
M                                          +/-1I+LPN;3P
M   "#&K=XAMIW>]Q>X_)'I]MXTW/F,$/JGX%SURGZ Q[M_.1C[;N=WOJ^\SL
M^6OOC ?5_GR\=<W3(.I=%C'V[Y:DSQ/ZBAS]%_%\U/FK[>@I]2_!&P3Y(_1'
MNHO       >?RO3_ *?]92GVSBT_=M^>P    .\O4%LE) Q[ZY0N6^FS=HD-
M,W#/P( C=Q7M,@^O<@]V9B@1HYKVR^)O6,O[?SH >*SDZO/A;[XE)VCB>0)O
M5A8\3LD;8_9I0[/S:ULK#^8/;(/RL?G67U.7\)-@<>(@<3[[(CN'$I2=IX&
M(A\C^AY!;_R*^IW50,<:5NE.P\S+'0>?@=-JY0X2;N+8( ,?(7;*ND
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M0#Y\]A#Q'Z@F/V/YPK.9&@8FY[T&I9V#D?=-, \^/?I$3*U^>@PQLE>L*Z0
M                                                         +<-
M8QGLA,;N@          <$)]8[CK9T/ZDVW[E\F9<F>>?=-SU6,GHNV/GWSKN
M6JO'3'+VE9T3]TW/KRKP94?5L"7ZZ[757;J6')      ##N%MNH74OJW89O'
MS1.K:>"?7H     =Y>H+9*2!:NO/5ZSQY[;6N[#<FPZ]]5> 88YGTJ[-AU^^
M]KU4"Q8/:8Y<X[/,;L7S?SZ &'=&Z5 SY"^OIP?0_P T>>B[!^%WOS=$XO6+
M==(KH^:;L:M=W_;1>UBZ+5X#&FO[A&3CO9=GWW)\&53*P0+?CY>(7(OH>;/:
M_F/LJI P/R?J^3MYT:ZI^! \.#F^/%RJU,1 8N5QD8W-7@  \A#8SX99.
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M!I>)@$ C<<9-
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MNFF5BH!Y./N<I]@W17$B[;_4Z6^0$-69FDV7&HX_2@:K";)G\
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M.LVFF=3709T-I1P
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M,7*_/G,P^^TOK&R>+UC\F-=,#B5)LK.XO([S=:=A\'
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M;D[S]@YIV-49LP/TS'(
M              (C%GE#-?Y _B_Z8^FQ*_I@[?\ ES(P'@MY?13>^_:.SVG[
M]HX\#T5V:59D*A<P^3K\K\E.1[*\;RT7_578Y></?%;RO57C]GM'KKQP
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M                       $?R!Q)@U>$*^)_I]E'2/J66WTI^(^^G/U0
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M,19N)?6/?M2[:P+)8$MX66D!&R$/YN(NBS=GCKT[)Z)E           !;IK
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M,EBR)Z!?DAJ-?R(?/.P<AR3)Z.                       .\O4%LE)
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M*ZN,<9>IS,WCX;VP56      !'W7.R7EG:QE"5T(
M    =Y>H+9*2  !34Q\AD8RKSYIJH$%.5#.P:C(QX ^:?<:Z3NN-=(W?*_0-
M OS;=3^ZJ0- ]-7J^:OMNQYC78K=&XM-[D7T38$WK$J.==HZ*K6.9W5,@PFT
M<O=9/T!\@79&SDY.0_1=-FM8B']"?'/Z#]#WFQ*[=U]$Y[(BN@ ?-/NK'$S-
M3_4> 37[%\P7[-:KC> W/*6QZ)JB^:/OC9%W[XQQ/K._7A*Z[A;4.F2/W_C-
MU24#=4G PJXW]1S,XI]8;?SM                 !@:1P,Y1^=W^>@
M          #@P3(8% NVY'Q<EW^>CS>^1SE(VN6[F>([/Y
M ,>&MHR,:U#Y@_I63.%T,<$0IKYZ_2'G\LO$
M        [R]06R4D   6KBU=9.,]==NN@0<Y4L_ J,C'@ 4.*E,1<[Z)X,7+
MR?O.BWILVL]MRB'A^>Z%V6^-,Z7/WBOT[B7;.?0LZCP?9[\]_8>!=RYK!3L?
MS;L[^??K^M9.%#OH7'<BV,N)'4>"9.P;^TG1MYG+-PF4-[T7SW[.!B0QV'S3
M[0X6;T>2,53OJ;\^8H<S[[./L7R]D6?T[DP_JO0X \0^M;ED82W,"9SWNO*)
M1=&X9<<A#:Q_G?[>E!T7AT>^:=ZWR:3UJ9@
M                              !CXUP$B34$71C=LE):V\"QZX[HRN ;
MQO<3D                               '>7J"V2D@   6+SSU?L/77;K
MH,'.>S+Q*K*1?/H <>+7@9[&.C;Q0HJ6O39M9O79]8HDS#ZZ+UG4!";/?LK
MYENX\9(79LJ3.MW%5;QKC9MMV+\]H:5LB,DMDFK;3(O8M=R9NVE5/.PAT&-S
MR'7;N6K9NW+9O0?DHS5]U?YPD[T;A< ^)?6F8MKYS*GI/!\CS^FU&_AXDUCH
M-/L96<-QYCA34.EP(XI]82KZ5P64W2.$Q5Y']+SFXI]8;4
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M"PY3%FL[[@WF'T%G".G?T2V,O(@
M                      !8)K4,R&IXD-/RDMLW( '4\UTPL5OJC;.6P
M     05WK6Y<:C.8FEL*C7[?Q[X\8-G8[/<!)^^BJB7K=7LUX2FX_(&!D_7G
MN1H[+P#/Q>28W+R#'Y5%O6[0S+%3M5TB];Z:F5HG,Q1+861(W+JENO'DCB7Y
M'Y6;X21       '>7J"V2D@    6+ZGUD6'OG'BG1\A3(Z2JLG%^_.P>?0
M'7;KIV'FTF/S_#BY7GLW?JKSU7[%2S<*J9V#[LO$Y]   ==NNDQ<IYL;(K4Q
M$>G)QPHJQ-<QH"2D'ILE=<O&:U2IZ1UFRMATKU>TT[4NE5'*C^[;N9W;J'3L
MOV,N0=N_N5>UL](
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MJ,&V[D3L?(^L+,V!:UL&T?4-IR9BY0
M      UA'07::L">6ZZ=."6C  !3:F LRC6-C24E:KE^YMBKWJ.NJG[I]J5B
MY<V!DW+@Y.0HK-S+$9N7(W*JE%0                        [R]06R4D
M     4^K-]YZO6%=('18OT_ SO%AY?W<H]>5C>O)Q>^]9^[EOGT  /FGWKMW
M/-CY'EQ<KR8N3]W*??FX/OSL+[KH#PMW%J\N6EVT]
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MO@   ^"-UB_ /$RY 0<SNUT'=LYQ^>!P44Q$\J+W&_M-?\]N8S2]Y
M                        /S%&U*=A)VY6*/DCE*XUF9-$D8_(]E( #S/<
M(6KL;,7(H=B_ENW<E+XR(>@ \55.&\ZQ9%WRI6+F88S+S#&Y7J\]
M             [R]06R4D       #PMW5JX]\7;:NA[X !QY[\6Z_GSWBFI[
MY]>T_57GU71R/0 4U+=:W=>TKUI70     !@+HW%/5:R,X\_[#]>5
M       ")DU$?GOZ=SK;I)1M[U4@    4'SV".)EX/C9#](?+.E91Q,JU33U
M.:A%G;N:Y"W?DF(M?W3.NY\JP9I/6;_R<&>7*?HW9['3H
M               'Y@C<%(Q\[[UFDUTP[GL&145EY-Q+P    Z?&%:*X@6;N
M*+5WSVZ[XIJD9Y[(PR(=I\>^8GS\?#LAC^6JFX[-S.$7EWOBWN0
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MH                             ?F%-J^=CY/E,.96O2?;YZ .#@
M  X."FEH&%S#!B8Q84P\Q0[E&()#&L'.Q[H]27,O$Q\'(D!%9EXG:
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M                          #JKM#GSWJKM]U%T?'M/=1=
M &+LO%_,;UKE^V"4C,EUT =7GL9=<V*3^R:YA"&F+#P<[OJI^/'GIK]%5$I-
MEUO[]#H-24?(2ZU39IUZ].U6BNJT552BNJ4U5&BN]\>]DW%RO.:$N==#MCAG
M<:!GX&R;OW!-BNUZJ  /FGWZJ\ ''BWH^9PKI'3XL<K[YX\;*S=N?,,>P.W8
MPUO><];_ ,DE-U/@N0=AT[GT
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MY0"ZP                       =Y>H+9*2
M  1^Z1Q'Q9&)G;GG9(J]A^;Y \U[;$GL_P R2YXO].PS[G\I3P^=_LVM8,L
M           !JTV[5=;^_:1M2D,#D   MVGW#-N][?:?04Y[G.Y:J/O@@UBY
M77JNS?H!YOT  #I]\\%5/UXJ=-8TG:;N.#_GGZ$RYH^[T[Z+^=MZW9>.#YI]
MQ_I>YX0Y)UJT-8V8#UY.-EKI7-L<T;=@K1^K3H[5\M7=+:\  !:$3L,)>-?3
MGG79R]R^5LF;3HP                         U<E=+<+$+D+?,>&[(J@
M                     !WEZ@MDI(                         !1\V+
MAGW3Y0\E['R%K6[V?-ZO78Z8J&-G69.ZG-;@WUO[;&6            !I1WW
M28];GJ.QO,PP  /#XC+8R)17\?N]"E>>QHLWI/7K'N]0IQLFV=7V3]"G-.A@
M   #1;I6YXDX'WOIKMUCN/$/T-[[HGCQ<F-G!^[8_P!*W3CST #S^78\8W6)
MP=B^8,W] Y:   !YK=Z-G.NU1<YIW78W](_%F1-CTT
M      " 95SD]A6S$AD(FJ<@                      '>7J"V2D@
M                                      'YPNH\WS/L>OR^R,<  #&M
M%=1>7S72 +%HK\!DFNB*6/D1UUZ>_2=RSI7(   !H@UW88X\6[/*?C?8["^D
M_F[] 77.2\E$B);"O*.JXKYWT/HLW@!C6WN'JV7"GWW3Y+[:Z     (J\P[S
MCB$W'8?]$_&WU[X
M      !WEZ@MDI(                                           !^
M;CJ7-LX[# R^R<8  #%-NY<U5-X54@"Q**Z<9,KH@7B9?LU;9?T <WZ
M-#.I[5Y_E/ZJZ+MJD=UX9^@OKW(^0"W(.;PGR7J^,M!WZMRT5E3IG.8&<=^L
M)]]T^2\A;!IT+\BS8U5,W,>]>%-0   I.+GZV/G;[4V-_2/Q9D+8M/
M                                              [R]06R4D
M                                      U!;MI\%MWT[:;GX'(  *!Y
M[ABW<D-=M "/EJ[F.Y;\?GNHZ.D=Y7-]_G7KT\    -(^G;A:WS=]'8FF(>1
MW?>"[J]MU/D ''BWX6:K$I&1_P! Z]&#E?=]@_>?D/GU$*_9O>FK!EVW3S%=
M=%.]>DRC170/:>"8^/>S;;N0KX[],7_LVFRUZY\\@
M                                =Y>H+9*2
M                        87S\+\T_5^9;1Y*-S#<M@ #@P?:NWC53D"N@
M4/SW"%J](>]8UI86;?FM;#^@3FW0?3YZ    /&:AX:8QMK\_M?WC2,W>@  !
M 7@/UQ?\MJTF^D<0&MS+QI4V+L=[UO&E=.8[==AU4T.KRO4^TWWR[*:MA6+D
M<$&.*_4N8MUYK*;JO!
M          .\O4%LE)
M  .#1UTGGT3=CU_:CGX/O]\   P;:NTI[SX^_?,^W;4:K%^!47)_I-Y7TK+>
M%F     #SO+;JINRFL   ?%-6KOY;^\)O]E^7\D;#IHM?WRO^,7UTW1Y[5O/
M?*6Q'S-*]\OG/A^PN3SV@X,KK9^>/M/9O]/?#%VR^O
M                                  =Y>H+9*2
M                          "S,C'_ #H=/YU?<S$;",S#[P  <'G\<'I]
M8BMW-7V!G[FN?;SL=U?9      +=JIK%/OJ>@  "GX^7JL^4_OO9#]"_&%Q9
M\0  *+AR>.=?W'NR,/ON6*=@RN6]JY_Z;EG%>L[U#SDWT=LV^GOA?GT
M                                              !WEZ@MDI(
M                                       !A3/POSS],YWD"4C987\>
M_*Z;RJI]OO@  PU;N:QH_/VD:7M^VG2]M[7H     %H547;37]    M&'V+6
M=\Q_<>S/Z.^(O9>QP!C2NC#MRGHT_HONVG0\5Y6'9=5.PJ"V*R8;:,M;5S_'
ML!M\&.+_ %+M&^I?@W[JI
M             [R]06R4D
M      &)LS$U%[QIL796-QKEXOMO6LA5T=YVO,JW*) 7K-LTU:]\/,VK:1N.
MU[3=K^WH      M"JC&R]FRFCV   &&-+Z7#3BGTSL1[_P#'?( -;67C2WQ<
MK5O5>S)E1MS>55?SW8KB9&(M4Z%ES:N>VC%;#KSX-]?[4_JOX%]%RR
M                                             !WEZ@MDI(
M                                        /-[Y0[EN/4E'X9S\+SU4
MT2]:B[*1L3IF)]/GNUG3MKV/ZOLG;YZ      (QW+NL>5F\0[5O&R/GW*=A]
M-( H=R[A/.DLM8<?:&H[O!+Y]^M]DGT/\6]U=  @MDV*G;NXB@MNR]L&F=/J
MY*?9;V+V$]+Z?FO=.88%T;K$==$[!LD^D_B?GT
M                             !WEZ@MDI(
M                           !P#D       &EN2F/+U7N$6]7TN1NM:;O
M%A== C?)S.E3>.DQ^D96H4TY/C;$O/A7Z;SWWKYJR'L.F22C(:\;.. ,1:GT
M/*>SZ'ZKM@>:W=Q9K.^91V71M=G /L66_7_G>0_1>-
M                                  #O+U!;)20
M                                         #5GD944.F=ENO+SJ7I/
M-][>K:5Y:J]7FU[OJPVS>J17< $J?FCJN7]&E<1_2?$=I.JZ-*>*A !3<?,Q
M%J/1LT[GS'Z]\PWIW2LI[3H$;^>]HQ'K&_[&_I#XN[J[8
M                                     [R]06R4D
M                                            UYW\G5SO'2JW?R?7
MKVJ?H>UK3H#;%MNEC>.D>&JL "LQ&;/[X7^A<??0/&MC\OQ64\5"  4W'S,3
MZOOWL]MY%V/2Z-AR6O#@?V#L9^C_ (OR1LNE
M                             =Y>H+9*2
M                                    :F\O/CYT[LUF8<?[XB"WUZ3S
M>OD2YB?TN;MT?#>=)  9>Y3N,R?D_L<U>[?*<H)3GX   MR/F8 \)^MY#]'X
MS+GK_P Z\@
M  '>7J"V2D@
M         &LK(RM=6\],E=M>\1)YEQG]&\!J];!:=Z_J$W+H,(IS9LOX<?F_
M C,YX$7G/ BZOQKJD4^)_2.09_3[]F]6RML^@W#(PW'B[96 N+/AZ3BR$ N%
M?6F7-QYY-3MOS!VU4
M          #O+U!;)20
M                 #4+(RT?.A]9HEC&]L;#;TM$YE?(!\GBJJ]E-/V <>+/
MA]DQ;JF_8ZU[<<0:?T>B8$J+<C9J\YC6:%A2N6]OYW.SO'RAZ+EH
M                                             #O+U!;)20
M                                                    "//ONGC8
M=L\.R[AGS1>9[GL*.Y       !;T=,8IU/H'OR,3,>Y<U[:Z
M                                          !WEZ@MDI(
M                                                  ,8$<'LMGET
M
M     '>7J"V2D@
M
M                    [R]06R4D
M
M                                  '>7J"V2D@
M
M                                                 [R]06R4D
M
M
M   '>7J"V2D@
M
M                  [R]06R4D
M
M                                '>7J"V2D@
M
M                                               [R]0=1\
M
M
M Y.\'__$ #D0   & @$!!08$!@,! 0$!  (#! 4&!P !$P@0$1(@,Q05%C!
M8!@V-U 7(2(Q,G D-#4X(R4F_]H " $!  $% MC '.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.4K.
M4K.4K.4K.4K.4K.4K.4K.4K.0O?:L]7_ '\5ZO8L]7_?Q7J]BSU?]_%>KV+/
M5_W\5ZO8L]7_ $Y+Y"5%X^.0618[B:JM"N5-=3#XTC<&>WDZS>_N#M<BUL(P
M#U[6EV,PTLK11Y!^&*DQ.];UO7VJ5ZO8L]7_ $Y.8X*4QIE<9O4SF*[(M+RH
M(DAQ+1 OU3O"REL;*8J4?Y&R5K8+]'9-.0K(?;E^R;P1'ISD)Q+[/UJJ6VR@
M3[2(?M4KU>Q9ZO[S:5M2&%R&/KS71E^3.7Y7&XY4%I/T\7XXKT[6B47I+WMV
MA=UKUCYK^?VE:<K>H='ZWL1NL=-;\)@+>P]-*Q6+(%^J=WA$DL",G$GQN1@,
M<K9ZDF'9B%Q>SIXZR &ZYL*DD Y///M8KU>Q9ZOU??K/&'.0&<Q><H,Y 9XP
M_4=07YTAOY5RS[530< 9[=XV^L;72S;5HVD1!B1V#=Q3;6=FIILV22U)VY2)
MPM6V(6XS-])DE6=-'_L9*&OWRPPR4**IEL?1O-I6$'7A#]HO30D?6R04++VM
M:GI6S70VO( C@C1$:IF[9/K-K5-/$"*+WDP(JPITV/+K CHI/%ZMI^5,DNO"
MM'N6*Z6@R^&L?VL5ZO8L]7Z;OUK-G UFU.;/'O/$9O/"/><0\X1YP#S@'G"/
M.(>?_IK.0S6:4"S2@.:&'?T?4%^=(;^5<G@Q.-T$HDI3;$#C&NU;.,$MMA(W
M(53$UPR(103[>:Y6[V>?-E@V_P#^?NFC_P!C+YGSA%FYLIQ\D$5@5HKH&AJ"
M>/LZ0?ZS*]7L6>K]((T(<$HWG>,>:('O-)]9HH&L\.OD^ .;(!O-ILV6,.:,
M&' J,T((OH.HG8@2YMO^<-:!CZ@)PXNMSUX[^^";^6DL%+5V[C>[QK]U,<@W
MXJ#&ZL89VXHXLY+ZCF%H25]GFV=82HH;IIUO3QE[5^X2Q#$[P-AK*ZM$DL%Y
MH-Y?DPOMGOUOY'?K7VD5ZO8L]7Z(9P0X(T0L"4,>!3AUF@ZU]#LL(L$GSN&#
M83]ZP(PB^<>WH%0O<K/@6=I!L0 ##[H:O$$ "PC  P/NAI[P  6$YM;E O=S
M?LL*%" HA"B2;S>M;T-H:C-E(TA&%)DQ&_M(;JUE[(6)%.;WH.MNS4$03R!%
MW%:CN6\.!GOB'4M%9<Q2@MP0'&#, 4$A<B5;-<6]/LIQ;U&[ E@8E'J-G"Z1
MO-RQ27O;_$4RE'&#EZ%/LA:C4X:>2G %Q;Q@*<FXX7V65ZO8L]7Z 1@08,X0
ML"4(6!*"'Z;>M;P9&MYO0R]@/S6];^[Y>GD*ME)HTXXN&R!QA\\O>PE\=3LM
M&KWZ/U69-@#L.,)XO*FNNT4%@W3J7I3,O^17=N7A*O=,+H>-N"6,'4S)GQT>
M0&5U+;:C9$FAM,UXAG:[J'[RI/\ %8(A4L.BTAN-=(FZ2TD_6._ER.IZFC#Y
M-<G,?<JBE$4=-O,?^38=J-L(UJ[;$Y67J)8#Q-D_B3L D\E0#Z48P%A53.+(
ML<+Y@K>8X=24?!BKJ9>/$;>T^78*R+>/WN:W6;GQ+>W?J:787@;'MXC95Z3]
M#B7J9>M;;^I-A'C?=\'<,0RN...@BT+7TQ7J]BSU?GF'YK0C-@)T'Y C  PU
MV0E8.1)@X.2;S<C4YN1+<U(EF:D9^ DH, _HQ86O2'9WZWY]ZUO#",",0-@-
MT/Z6;O*N/QBI+-DDTVVW%-55BV!/FV!-M=2I3,&$RXYJ&PR1;&5\BQ+@ED8F
M;(L-<&G[(N:9+H9&8/!I-8S80W$-%E]2*<[4QB;@D51E)8<+7.%U_J#)?T_Z
M;?SQU&QL7AD<G53H2X[^'5=0Y%,+==+$BR>)R68_HKTO_P#;ZC/S78J<XZF.
MG%:E,CO4PH(\*A&I1T3TO>EU.?F>LOR9\F1A*/NP"1O$0]5K$GH+G0", S(5
M:T:&59EP,6(NH\],)NZ@H>LQ%9\$<-)Y*Q*L"H('KQ@SOUY?$'/&#.4K%#PV
M)<43V()<77-7R/%_4;%4F+NI@0\<>H"<N&$BMF5;;Z(FCR)NZ<6DO2"CH,@Q
M+ (BDT7'& K MZ$&M)R YW:[MIR18)O1#T9'6$W%4!B*K2^D(.OQQZ<6<S2Z
MC9PQX!QN"&B8^H]T2Y'[HA3YB=4G5%_1E>KV+/5^;O>M88;L6%D[%F@Z#YC#
M2RM*'],7A[ZK.S_F*-E,JXW 1L>\!'2-9IA19IC;\VQ(,VP)-X.-@WAD=4:P
MQM7)\+5K4V)Y$8'$SND49K>M^896AX( B]E'=_RK6M<,,PZ77BC::MLDF<-E
M@72X)GEPFET1 N%SY%-(]_&B=)93)II=3 35D_W-V.P+F?/?\IDEI-,;Z<A[
MT-IL63GVG?9<T"OHTJQ>,VQI/JT9U/44'86V:75+RZ]NA:K>;VGDDAV,\^MJ
M8,D N:2_$]GSQ?%&\;_??NFH+872Y1<_ZF17\N_9%EP@,Z8&*M[E8"?X%S=K
MD$^KTJ>L22 W:RI*MI_<356]4#U*7F.QNTC&2EZNE\-E$WCVI1&JRI61L<LD
M[$3)&1MJBUH<YO\ 1<]6C+BJ]UKF/5;;4/<;3JV<RYR;(QH^"CJ"P8BZ-=-3
M"2O=B1%:\0JC8#)(0"[ZTE<V?(2U+&6-_)N&MWEW<HQ<BYJ/:7QO=D_<$>&D
MX>B)'BZ/-2O3A6$35XKIML\1]0K2L^ ):BV%)::#/?\ <1&"FEQ!S5CW$6'^
M*5O8.Q[:-V.:V@9HR36*9BE7*U6"2N>\-($#!<8A,%?2J2CCG3J6'3)6<08<
M+3IR?H#$Y!V/=;Q%^R0]/!.\&DM*MU$5ZB1EC8Y8PR)/]"5ZO8L]7Y@A:!H8
MQ&;*)\QIY1 5DAP1JQ<-,P'F8G9$9. + 7KY1J5.?BB/$#Q2T*TV)W18DVC>
MTZC-;T+7D$'0M&%;!A1W=\FQ!B4W-[O0*FLN'1>.HZ6*)=+*LX@E1!*!4J"W
M",A"*V+V_(G3J(6H_5)92NS+;3DGP'IU_EMB_6KJA_Z-#_D0_P#6?J"/..>:
MY3)TD*MSO;[(ZC!"$W4<'6H&Z_RM>P;6301*YR6VI>QT'H6IQ<_ZF17\N_=4
MOKJ-S$ASA<]JQ9!KB:Y!@#0'!,*PTC#"<,)PTG#"<-(PPG#2,,)PTC#"<-)P
MTG%>R4X5CQRCB]0RR5"9JL@4'(!:->I3&QZ:GDKZ0PHLX$KIF*2+3Q64Z@*B
M%=0"I*-DD+1(4_SRO5[%GJ_+$+0="%LS917A\N]ZUC@^ (P9BM<8AC^]X2E(
M(U\_N[\5-253I8S*4NTCJJ1B1N)"P/D_OAI7APHWN^1=M=.PW8R[WLZ-4W%9
M9L$JADEKJ82RVW^>-%35ZHAT;C"=1JUKS ,<%Z:$H]M\PCD@KB=3*S9#/XWT
M[D'%8QIU&KHZB8ZX/3)3%B&(2#TZC^,MPUTIES-$K=?H*T0Z%R2P9CU,)A^&
MD@"!!'5.H_BK>D4>1K$MI2)]B=)A/:I_<A!X[*BVMZCWVKH019M01H7TAI19
MP)_2+<];8;!E=>+V"2M4A2"!H6&$X:1AI.&D883AA&&DX83AA&&D8:3C[($;
M=J/Q*43]="J9CT8!,92W0B/E?']V/OX5C_95)$]I1^ATG22U@&XH2SL$,(<]
MJ38$01?0C  P,TIZ.2D"MLGE2.M>W,RRLO6];^<5ZO8L]7Y6]]VACV,117A\
MIZ@M.!P>#E6T#0>KVE1$)0_1]W?B]F)5:-(5(#6Q[T9FMZWY3B_#A)GG$$(]
M>P(>_00AT,HLW04*(&\TC1A&846:$I.01AA!)V!1I Z+3)B<TC1Z&, #- 1(
MRQ>Q(_'@D*(>P%EE:-3IS\ 664'V)'L8RBS @1(R]Z1I C&C2&"UK0=?9*AT
M;$FTSBWK=JG%O0X2>2H H=6M(9RE\>WUDT,!A9H3'9J).]]LW)EQV ?$FBC9
M'IQ8Y-!)2KL *U$VHS'=I* 0XMZH.WQDT,(@CTI<VU'M,XMZWZ"21-EE*)^B
M4NJ-T@EF-,N3ZV$>C"<-(PPG#2,,)PTC#2,-)Q0 )893,/$97-+*WW;6T-[.
MESJF7*2VVBF9$W0!4O1(@VG9%7+2%]XO"=&US=Z2R25V0".PUXF5HR1Q!0<Q
MV%4.Z:ORN;49YZE^A<6Q"ZIK$I=4S"J^ZC$QA!Y2DKYA7J]BSU?E'&>+9)7E
M6+2D9:M:>O-;&36LUK0=>49@"]*I&V)L4S8O#9DXF8*2NHLV_.^\#(';6%RA
MT+PF:K=8FF:(S$SLWJO.H3%*0.+4:C$UO(B<"((P]N]=^C >#9)GBU]T6#*0
MQ&-0B)O%P.$M8GVEGNSR@3ZMZ"DWML1=S3K"MJ[)PNC"='0XED:HN=.FW2WC
M3R;)C5%D>+.H.$MS:.C*Y:74B:?JQU';[F2%UDIG$18#9*ADMEU7\&M-<3Y8
M56<.8'6Z'U_0/-+RIC="WII^>I2D+"+!IY6S**UM0#QA9NA:&7H6&$X:1AA.
M&D883B@ 2P368FN:FJ:=(;R0A" /98=;MEB%V7(76G8U()[*I**BXA'):^7/
M#T$.E.4 \(97$'N(LK]N0RQHBNQ )6IK6CY=92N)OQ,E8?H=ZT+5I4\E>":J
MM99'5A!Y2DKY97J]BSU?DGF=VB2_%OR+5A:,I0H/<#VMI F#Y52Y,C X3/NP
MU<YN!B6,.:K$\(!K"HFT%8!F;B]!;T0<VVH18:PMAV'0YK'BF$GAQ0T.C?M%
M(7)!MNEB)7@!@,UY!@"8%V:-I]M+L).((M##VC#XM?S+$ 7BU\EX=DK(WP&U
M39U*+AL.8Q!Q@;PXOL7\MD6XDAQVGI>.$UI9\ZDDN^TNH!*>IA?3>X)1L?4L
MK3\551X:FLVA]5UV_P#3C'!GK.HQ.=\=HJ;D:QGJR'L)<ML[6MVJA_Z6=2GY
M?Z>-_P#^2FGZL=1__AU9K6JIB/ZV=0GY,B"<Y13M7P9UF0I/6:1K6P1O TQ#
MZ#>M"U:M2;5CK:T-J=E*-;S^D>&$X:1AI.&DY:<TX\IRJRD1/]O+;L7#*H4,
M BQU&IVEGEX(H0\1_8/Z^GF/S!LD*Y82@3*DC_*+9T'6@V54S,K;^FI>:H@O
MT&A:%VW%5Q+NFI&SAE"_O\LKU>Q9ZOR!B\(?YF""'PZ[3S@)RUJLUP4-+6%,
M#R"$$&GF6%)\$-Q=SFV&]^DC:C1!^3L(18OCK>NQSBRQ#C>^+VL;4^I','D$
M'0M.[7[,)E=/!OR'E^+1(_#OR6?/)DB=7]WO2((ZIL R;,4\N%]52%UF%R0
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MU%XUZ '@2=LW._\ RA)/A*\DZ6"3,[6G]L7%%Z*+.%X":I!MYELU$%VL^XY
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M['_Y$N* BF8B?&D)TM:I4 83 ?/--+)!;-I&OQ],5D"-(/EE>KV+/5\H_P#
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MWAB\E<8J[Q"3I98R8]NR=D:W"^YXZB<2U^RX]$65>A75H:8^C@K&E:8:P-_
M4SF$N%,V1('%V_?^J+]:.G$OQ57PXM/2-R=4\R"?JHW#6>,IN$.<(<X0YPAS
MA#G"'.$.<(<X0YPAP20H>GBLH4^:=^FEF,&=7U[Q;8;>N2-"1]4C,EVS7Y6S
MSB*7Q5RP BS-=VLV  L>()%'W9M;O#:+W[9K!B*V&0W:"2L#I^TE>KV+/5_=
M9@<]%MSG[Z:$ZU^<E4)8D$ODC3#G-]7JD+.Y'R5W5NS?+="#W:WK?UJQ44A2
MVA-CYE(:PC&S3>S>]:SD+SQ@\WBUFMZWV# $P-@QO;*Y4)-]L[Q_?)VTF/46
M8WIP0MS)$G)W7/DN;XL%/J<N!31.%1*A:TMKHA60Y:QKVU:-DLC6W8[ 'N:<
MS]]ZHOUHZ;$POX2R!\:XRWH61_LM8B:DK<GX<X<X<X<X<X<X<X<X<X<X<X<X
M<X<X<,2 -"N@<3<M/73?6KWB[I-3)=G4/>#"(0^J.-X"\;E9L1=7#06-!U/5
MVKQ%>U4K<W**VD6E%>0MUU\$S!HSXGLIDPBW6DK&R<11YS1A8OV0KU>Q9ZO[
MK:BI:0C<AQLQE\6A0"O/R?!?SN6X)F6=OZLA=-WV#'O:R,1LR/%?67[,-LS$
MP-9CRYMR$IN1]CJT(GE/-8TVMSTF@,=2GB$ DM38<;2G(W-"N1&6-&BS%#B0
M-I8E1R6&5\083&NR9,@'IF2*5#2X0-^+D<9R[FU.SSR9O1C4R-;LPNC7[\(>
M9I9"]M$4\R0U"@D2]6R16IZ<3H!8H) H);#!#3?OG5&$0;EJ&P8[#Z/CQ3=)
MW $DBY8?B>-9\3QK/B>-9\3QK/B>-9\41K/BB-9\41K/BB-9\41K/BB-9\41
MK/BB-9\41K/BB-9\41K/BB-9\41K/BB-9\41K/BF,Y\4QG#'V&FXMU6S@%=
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MC?Y5[\Y5@'G2J6F'+VN*M\'&"4VGV*V]*L"XQ@XG!EF%;\C\KV#4-9=N;@$
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MLQI@*64W#,)DF0PMH.;.GMY5+H_Y%[DB:TZ2TX6M&G?F94&6EE.+''5?L3P
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M$0-,EGS]Q@AS -Y<"RPE ^ZBO5[%GJ_>_44%I^$666>W-\1.5,<F'*0OLV3
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M*80TVELI5?T@;\1$NX766W%<5H"C;AK^*GGU2\NMU%BI/;PYQ2*H_/N+2ZE
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M#4FP[X2M"O16E7U5 ^Z"XVGTEH'BH#WF XVKT7$'P4D^XQ/S?1)=QP9<X22
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M2?#)&'%I,LI/RDG7UF,3*3E93?K6O;NS0I"D4(YN>8CP(%HPOPF_%O[XQ/\
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M?XK,Y)EM7(N3 +SH'@I7Z"@7,+-AY9!NR2X>?#PB?=S*#8X#7V^8PTI]UMI
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MK>$,NXUQZMJ==R--3*TY=1U9=:@FW'B$ZPRTU(2:&FDA#,NU9*4Z )2+Z16
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M)-9[VA[2J,8R-E-SB!H>HOO4HDW\Q"LJ@1VPJSC)[T_;:"+$CL\C1Y0Z.?\
M8=+3#LH^U,L**'F'$NMJ'$+00I)]HC9_B&7VD8)3+/E)JU/:W"KD9RXVE"=^
M>=E$G]\8=ES+84G9<IRN-LU-)OH?1= /WQ.I6F;F$N:K#J\WC?R[4Z-,U>@U
M25EU%*\JW1;3,$H/5Y<8V2.TNF8NF92MLM**R)=OI"4K2EQ#CF8V6"-1&U#9
M1..SRZSAZ72Y*OV466LMA<#T0/6=!%0PQ6Z6WOIV0>9;YJ*56'CII N-1RC!
M&UFLX6R2KZC.2 (&[<-RE/<I68\"8E,6;.,?L!BHMR[,RX.LA:4M*!5_\04I
M]\4[9Y@.@5 5I,TPIMF[C;9>2XE/'Z9"O9&T?:].FI(D\,S(:EI33>I2++*5
M)*=.RUQ%9K]9Q/-"8J3JIM^V5.1O@.P)3?MC9=LWFJ]4T3=4EEM4UCKDK!3G
MM<VL0-+C6,95W9K2I*<H$RU+"::EW$(0U+)SAQ*;"[R$7O=7;& MI%0P[6$R
M;2U.TF8F2E+*M2VV22+$W/  :6BA3'2&&UV_+,M.#M^,0%??!IHWV]*^K?-:
MW9WPB=8+FY!U!RCS*@O)+*(/RDCVQLOP/2)VF*J]21TA2CU1>P1H#J-;Q0\6
M8?-2<P_()0PXP;6RY;FY!UL ?1,35&IL\^U,S,JTZZUZ"U(22-<W,=H$!*4I
MR@ ) L !86[+1CK!M5H%6.(J&%E&?>KW=R4DFZNJ-3>YY1A?:]*OMHD*\VJ7
M?%FRZ0>OXI"1EXVUAFC8.%27BEJ<:SM_'E(=MUKD^CFX];LBM[0L35VJ.2>'
M24RS)4E 0UG*LG,FUQZ/.-F\_B6=:F&L0-'*@Y4J6C+FZH/ C76'%RL@RX\O
M=L-(!4M750/$\(5M!PK4WG:0)H+6Z%L]9LY"I0*!J>J=3&,</3V&ZQ,O;E2I
M)]U2V7$ING*3I>P(' Q+OA]L*'FL)4IUM*-%%5ASUC;*4IV1*0OTS(TC+XA+
M%_T <1"M$^6GHLE2NV)]=W GL%C[?,HLMTNHR[5K@JU]0)^Z*],]"I;B@;$A
M+/J6"GS=G-)Z-(+J#B;.3)RIOQ2&R1]H,;1:VJ9G!2VE?%2VCR0>+J3<']57
MF@%1"4BY)  '$DZ 1LPV<I6ENMUJ62I%TKEFG!KR*5$:'M'.*G4Y.BRA<=R(
M2A-FF1W 6%K@\+17,23M7?42XI$OKE:2>K;UZ_;^*PGB==*>3*OF\HXJQN3U
M+FY(^R'$2-6DU(4&YJ4> S)/6&H[B-1>,?;*ERIF*K1$E<N IUR62!= YY4@
M%6@[3"DJ0I2% I4DE*@=""#8@^!\J5%*DJ'%)!'B#>,%U?X7I"4ND*>E@EEZ
MYN5%04=?5&-Z5\&UATI39N9^.! T!63U?L\RD31E)]AT&W6R>I9"3%<EQ-TQ
MX<<B"XGQ2((L;'B/,DUYV0..70^N)I&5Y7TC?R)XPOT?[#]D6-G,'8IE7'',
MM.GEMR\_<V"6,Q656T!-P.)M"$L3$@\_+6+,[)J6C+P.^9*AV\<T8KE526(J
MM*J3E4S-J04]G52?O\M=E]ZTL6T<04'UQCW!V(:+B:;F)>3FG&W'E3#,Q+MK
M6 5K6KT@FUP(PWMJK^'VFZ?7)54RAH62X_O-]8<LHRCNC&^V25Q+1GJ;+TQI
MM4P"E3A#B5)"@1<=8B\8 V9T6N8*FJW4,R9DF:0VHH39&X(*5))/RHF$!I]Y
ML:A#KB!X)40(:2ZMQ*&0HN*-DI1?,3W6BIX7QI2\/(JLZ[,-T\I!+2B04H5E
MRDI*!8*S"VNL<8V2U#"4C.S:\22K;YW(Z,IU-T(7O!J#G1K:\8FVUTZ0E7*;
MAB42A:P6T.("DY,W5ZME*%SX11=E6+\<;VN3"D-=,5O<\VLMNN%0XV*/HVT[
M(PAL(J$C6Y6<K3K#LK*O!Q3*%A8= N+$94FVM]#%'E=PA-AE0A"4(3]%("1]
M@A2<R2GM%H;IN1[>%5P#<#2%3[XF D#JY@G+KPO:)Z==96E*!;2_VQ-/S2VV
MRD*2#QR\]! ;=>D2'KWMFUX]6YC8I67GE3E%>-V4-%Y()/&Z4VMX1CS"=6P_
M6_X041+BFE%*R&02I*N*S9()U*NV*?MLG)=#<M4J<DN(LA2_CBZ>TD7 OZHE
M*[)O4B6J[RNCL/L(>^-ZA 4+VU,-.RM1E\[:FYAAP6N#F2>T:>,8DV44.LE<
MQ*(Z!,JN264I 6KM45D^&D/;(\1LN=&8G+RZCK\8+93_ ((P+@.3PI+EQ1Z1
M/.ZK=6$W1QT21W'LBLUNGT&6Z5/K#3=P!PN2>&A([(QWM+7B%GX$HC2RW,$H
M6M(5O' JW5L"H$ IO&$=D;"Y60J=3>>;G M+ZF0E&4%*PM%RH!6MA>,;25.7
MABI=,2W9J3=W2E\0L)TRZ\>,4S\K,!/Y,'J>&8_=YN'I94Y6Z;*H&9;TRA"4
M]I(,;?'Q+;/Y2340E3K$J@)YDM)9O8=WZ CTH<.GEE1E8'K,/JS/.'Z7F8,E
M<[[\PK^;2G)XW(,8TFOR$J#HH%2O%*M/,D994Y-L2J/2><"!!+-(HUP,B694
M=WQA:_\ -$]-+G9M^:<-UO.%:CW\/N\W9C@_^$-4$S-)5T*4(6HZV4L== OK
MI=.ND3,Q*TB14Z1E8ET?%HN!>W!(Y1BC$<Y49DO)8?F&LQ2AEM21D2G@3=5M
M1#E;<:<0TY3)I#CFJ$E;5U6TTUAF>F7'$H73)EE*C8N+4V4I[S8W_%4'%,Y1
MUA&8NRZE)S(5K9/=<V$4^H2M7E-\P4K;<19QL]:U_DGE&U+#J:%B)U4NV4R<
MVE#J%?)+[F9QY*>'HDC2VGF;/JH9*K=%6;,3*57':[9*4>^-HM-$S2A-I3UY
M52G%J^@$VMX7/F).525?-(/L-XI+PGJ5+E6I6R YXF\5)DL3LPV>3JR/JYC;
MS*>KTT]OW"*@GKI5W>0<1XQQ3ZO[$-@..3B&@JHTZYFGJ7IF4?RC3A(:2D:G
MJ(1;7U1MKHYIN,9F:RY4U4N3:>PA)0UI^KY76DO(*%<XFL/M3'Y1MIU/(.(S
M>_2-HVRRG8CD%HE95F3J36K+C380%<RE80+J)L -8H>PBOS%20W5"&)-"QO5
M9%@K1?4(()L?$0QA:5E,/? 4J@LRNXW.='5.;*D*7< :J(N3:YBK;!:_\*+$
MB\AR3<=*MZ4.&P4JYUN.TQ@C8Y1,.AJ;GFA/SXLJ[@SM)4/FH<1IJ.V,3X68
MQ-2E4IZ[<LI.4I3=(L+91H#Z-A;2*G^#Q4NG 4ZH,)DRO7>H?6H)N.8MRO&$
M]CN'Z/(I9?DT5&:*?CG7$AQ.;2^[#B+I%^4#9#A838FO@JRPH*W=F\EP;^CD
MMQBF45J7:0WNPRRVG*AM "0D> TA-/ETFX!]9O 2$BPT'EW#6;/D3?MM]\+9
M;<-UH!([1&5-@+"P@BZ2GM!$8<Q!-80K'3F4%;:K(=0/EMYKV%R!?3G$CM@H
M514W+STMD0[9*MZ6RD$]M@><-87PM4TM3S=/DW0NSB5I:;UYW]&-L%4E)"B2
MU)E' PZ%&S31RV;W9 &5/*XC945_P8ET./[Y6=Q7$DC,J]M8J%3DZ6PN8G'D
M--H!)*C;A[8F]K#\UB:4E:;D^#]\&W'%64"FRKD&XXV'$1*S#<RPVZA:5YD)
M)*3I<@7C:$YAB9E425;G4L$J"DI#A2=+CDA48=E]FU%9Z<B>DW%MC,%/DN*2
M1V$M=]HQ/M;JC\\IF@9&Y-DY4J*0HK YI4E2=-.8BK8PQ-7F1*S;RMT?20C,
MD'EJ,YO$G+=';M\H\?-V.T@U/&=/>RYDTUUJ;7I<90HHU]L?A-UK>SM)HS:K
M=#WCCJ1S#S:%(N.ZVGZ UQ,.^0:D0.HS_@^Z";DGS,',Y:>7OGN.)_55&*7M
MY5'4?T75]H!\S 4B)NNLN$7Z(4O_ &E/WQM"GNC454NDY5S*DY?!"A<>SS92
M6<FYEF6:25+=6$I2-;WC!E!:P_0Y642VE#I;2X\K2^O6U/<#&.JXJ9F?@]ES
MXIDE+F7@5"_W'R*_C-=2GDPVY?N-DJ$5::<EF6PRK*ZZO=I/&QM>]H6\IF4W
MJS=8:!)^D4_OCX0FFZ3TMQ?QKA 0<HTN5#AZH+M47(F<4^)?(UGRY4JW@TZQ
M^;?LY1+OU"?E]ZASHR$!7QE@LNE/'JGT;$1)558E)EV9.=4NX&TJM;>J*<PX
M=O#2&D569:Z1TKH^?K-LY$JZAX74=1$C/K>9F Z EV62K,;\; V/KM>)!^HU
M%M:DO[E&;JN9$J/#AE/;VPVE24)"UYU "ZK6N>VW?Y-G,RO?3$M<Y"DKM?GH
M+1MGI3<WAUN=(^,D'''$FVISA"+$\;=GF4U\RL]*O@VW;[2CX!8)]T3B$UBA
M.IM<3LII_BL=(?1NWWF_Z-UQ'ZJRG[O,P<]O)!Q']$X$CPRWC%3.ZJJ^Q3:%
M>M5SYDBJSP':#%03U$GO\J=4P>/]A^S/%;N$<5TZH J+"W0P^V%$)4'CN@I7
M+J9KZQMJH+=?PS+5V2"7GI5*"E:+$=%)6ZZH*%[@$>:_*MO^D->V$TMD&YUC
M<-Y,F498-,8)OPA$JR@6"![XW#7S!K"I"64;E'VF&V&VA9";18=@]GXIQI#H
MLM-XF*>C+=D66-1%(V@XHH$JJ1EWU%JUDA2 O+H;6)!/.)R8J=?FESE0>6XX
MLWNJX''DGA[+11\3XBPPHBGS"DH^:1G3[#<15L0XBQ*X5STTXH?-'Q:?"PL#
M")"92O,"4D<% ZQ3L6XJH04W)SKB4*%K*&]_;S6B:=JE:F53=1?6XXX<Q)/,
M]B. ]4&FN\ ^O*>5S[KQ+23<OKZ2NTQE Y#SMA]!:HM!F\1SX#*WPH;Q8L.B
M]1:5W-N<;2<2N8JQ;4ZDLW2'3*MCEDE5*:2H?6"0?T!J'>/D;U6GQA_1@^ ]
MWFT%&ZI+8&FBU^U(,59PNU"96>:_<+>9LOEOCYV:MQ9#7L<!C:?,YWY*6!_)
M9RH?6"2/-V2TM%1Q0PMU(4F4*'=>_.F*U."GTR9F+VRHW:?%25)'W0\ZIYU;
MJS=3BBI1/,F%: GL!BCC?SL]-'4[P)![04V^Z)^SU6DV>(;*73V<2FT5N92E
ME,H@C>.J2,HX@ CEV6BHI -.D$\+H64CZ*QR]<5U>ZD-PC3?79 [=+V^R%VD
MJ7I8?%#VK3!94W3)-9!R.OM.N>I2AUO5&_:9E0\H@-AL'U6AG.B3GII0($RM
M*4W[,RD#WQ2V0S(RZ +'=C-VDZ\?+LY3_'9A6NC1\.(U\8VMN!&$ID?/S#7@
MJRD:*\/-PE,])H4EK?=,H:/^%(BORW1:M.-6M\:M?ZZE*\S!;ISOM<C=?L $
M8T; ?9=YJLGV)/F2YLZF)W\B?7Y6_1A7'^P\$I(4#8@@@]A&H,;$<5RF,<'.
M86J*TJF:?+F0*%F[LS+K;4XX]E)UR[S)< ",?X5?PI7YJ34BTLXLNRJ@+)W2
MU*R)[+A(X?I&4=GDL#^,P1AF8Q57I2GM(*FLX=F56ZH9:4@N@]Y03:-LV)Y/
M!&"T86IR@B9G97H*$H-G&6,ET/6!TU3:]B(4HJ45*-U*)43VDFY/M_0&^$.>
MEY&-74>,36C!]7FTU.2EM#A\1?VM@Q-JS3+Q[5J]_F;,D?\ LZ8<MQ>6F_ZL
M;1E7KJT_-;:T\4#S=CDX)7$V[41EF4MMF_*Q6K3Q[HQ)+])H\T@"Y S^I(*K
MPH921V0I(4DI/ BVD2LFS)I4AD*LHW.8YB3XQ-4Z7FUAQS>)6G@II>[5[0(%
M'E IM9WRU-DE*G',ZM?G$BY'8.4*D&%S"9HA9<0DI3UNJ ;$Z>J)F19FBTIX
M+^*5G0 JPO:VHYZ1,2C4TUN'<V[ZNB59?1X1T5DL=&*;M!.4 ZD>'?WP*+*
MBZYE24\$+?*F_#(1:W=#\BQ,-!E8(;24D!!RZI-QPA*0A(2. %AY=G%^DS/9
MNU?^'7PC;!_[JN</27?OU;X=A\W9TO/03K?+,K3[$IC&Z,F(IL?0:/M3YF#%
M?Q]Q/_-+/NC&R?BY1?:ZH>Q'F,Z.(\1[XFQ=E?@?*WPA?I?V(;.L7/X-Q-(U
M-MP(EU+2Q.9M4]%<6G?&W)02-%6)'9&,:#1]J6%D5.CNMO3;39>DG4<2Z4)&
MZ<L$J6$I4="0+Q.R;]/FGI2906WF5J0I*A;T21?UVOY20!<Z :DG@!'39/\
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M%0*C=-UWMK&$Z)B#;)M(&,JE*3;.'9:8RL33B#E7+,J=2RPA1S)+[27$%:>
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M+@V[8G:E+R.3?9^N+C*+\[1+3+<TV'6[Y3\X6/\ M3\#T)&!ZF18$S4K?O\
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MW(]YA[^5?^M/[1C$O_$_J*^Z)-*31E7 -F3:X!MI%#2E4\H%((OP(!^=&)@
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MG'LBII2FGN94A.B>  Y=T89_*N_W?_BA'\?JV5?6&=0L3IU"?W1.4MB;92T
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M!@#*@+3I:,'X7K$Q@&:J>*,6*P=@X3\ONYFGRB'JA,S/QVYMN%LS9;WB74*
M44:"_*,3LT"8V /.4C$<WB]F4K4\EJJU&17)S3*T2K0Z. \IQU24 W"\VN:*
MQ@[$F)=F6 $X2J%/H*I9^:7.L3-8E:*XX%*8*7LS[S"WQHIP)ZPY<#&U*K2M
M2F]EN YNLFK52E-2U,Q"^Q,;V4<F5U-;A(<9=7+S'Q#J '03P(!C:PS@9BIT
MFC5+:56L*BF4J1#5*I="F2SU$*;#ZGI5UH.EP#4J!O:]XVUXNP'B2C88EL.U
M:8KE7I;3S,_4YBF+ISCZ?BTLYPK\H4H21<J/V_[:;58VA:;CRR;^1617 \.Z
M)MC>HN/2'"""#8^8R\XPXEUI12M)N"(H->;J#89>(3,)%M?E\KCM)BO8:2_F
MFI,!+G%38X*\.=^,.-K:6IMQ)2M)L4G0CS0;$$<1J(I.,JQ2RE(?5,,IX,NJ
M.0#N B53-XRQ%+LKT<FUA-A>R4IN=./+2*9@3#.')-N9F&FB6$!2WGDI'6 S
M<;C732*35J95&<U-?:=;;.0I;4#EMRTX<8J6&Z15GFIB<DVG7F3=*U)NK2UN
M?=#32&6TM-I"$(%DI' "-JV$':]2Q-R22J;DR72E(ZSB G*$ 6N=5<(P5CZ?
MP@^:?/)6J4"\JVEWNUJ;E*=.?:8IN):!BF26VQ--*W[90MA2D[T!0UNB\4G9
M;*TG$0KB9B\NR^9AIOJ]4];3AH %:1CC:Q,R<VNG4,@;DY5/A1"LPY @D<=(
MP?M1Q"_5Y21GPJ::F74-J4I2U+1F(%[:"PC=-/AMQ;84=%)OQ%Q#CC;*"MQ0
M0A/%1T B9F:77)2:IZ)EA[?MJ:* L'TNZ,1TIZD5><E'FE-A+[F[N+7;*U9"
M.[*/,I]-F*BZ&V4'+?K+MU4^N*93):CRWR0JUW73]NO9&(<0JFE*E9512P-%
M*!]/[B+CS6FRXJW(<8Q#6Y:ATV9J4R;,RR%6'(KRJRC_ !*%O7#OX0E435-X
MU),JD,^7=J+E\E_2 S>EZXP=C.F8QIR)V140KT7FEV"D+38+TN>KF-DF*_CO
M#V&WA+U*;2VZ3;(%)N-0+D$CA>*36)*LRC<[3WDO,.@$*20>.NMN<8JVN8>P
MQ.]">4J9=21O4L95E%^WK",,[0<-XI0GH$ZVA]7_ !1Y:4S'?\6"3II?Q@J"
M1=1L!S,5[:GA7#TST6;F2ZZ#908R+R^/6%HH.**-B261,TN<:>"DW4T%@NM]
MSB1>QMK&-L;2.#J>J9F.L^H'<-?/4!FL=0>'9$I^$-5OA!"7J?**DEO!*E%3
MV\0VI=K@9K:)-]8I%28K%-DZG+&[$XR'FS]%1(^[]'KWY\?JQ6V )*46D>@A
M)OXI3&'VMY.%Q6H2E7MTM$VG+5O%PGWQB-"E,RBP.JA)N?$)BEU.6;D&D.N)
M264!.6_6//A&\WM2SC@ITD>!)M&)?^)_45]T2(O1U <2R?=%'=;8GE%U:4"_
M%1L-+QB-Q+C<NM!S)(58C@>L(ILLF:IFY4HI"M+IX\.^/X,RO].][$_NA^;D
MZ>VW)/MN.( L"4@I.O,Z=L3#%%=:4XA;;:K7"4Y<U_"\4'>">LV3NKJS=XUR
MQ5U9*FM7S7 ?V815Y5,F%EQ.\2C5N_6S6[(HLN7YY;^6[8+A/^.]HGV!*U,J
M>1G96[FZW-&D3;M'98#C$K+.N*&B+<-+]:QN(I2 [+O+Z(S+;Q"@G=@]:Z2-
M;Q)J-,J)#MT)ODOPNFXN?")^MM2Z$]&+;RU<KW [.$34P_-4E;K[:6RI2+ 7
M[3QO&&?YWU_=$W_*I^N/VC%5_D]?@GW1AG\J[_=_^*%I53:IO% A.<JS#Z9)
MB;K3#+ 6RM#KAMU;\/K6BESDQ.MEUYI+:?DVOK[?+5?Y5]GWPIH/2X;42 IM
M(N./HQ_!B5_IWO\ <_=%4IFZI[;;69S<+6Y<VOU@!RBB5%AN6W#S@06^&8V'
M,D"/AQYV<Z/+,H<1FMGZW#MTBM2ZFIQ+ZTYD+#=[\+@76(<<HJ97>HEI93F4
M?%D=:_>+]L43*\5/"18EQ:P6V%7)]9A'\J_]8K]HQB;C+_4/[447\R3X_<(4
M+@CM!'MA]I$K4U"90%M%SY0T*=/")UVCL-)5+RLJ\XOY/9]:QTBF &3>=$JU
M*[Q"]&[ZV2>-_LBE?RD/$?=&(?S,>*ONBAM[V1FD=J=/'(JT4I_X/G5H?ZH(
MW9OP!OQBN3[+S :84'+ZK*3< <M?&*3G^#)O)>]N79D5%',ITA?3<O#J[SAF
MOQO%7?EWIA(E[9$6U' ^$/,F8H;24B]DA>GT<T4&>:ETKEWUAL7*NL0!<Q7I
MQ,TXV&S=MN]E<C?C8]T/RRGJ%**3Q0V"1]$%1)BDFEJ94B<99WJ23F<YCD./
M&&G99^<#,M3952 H=>RK@#CP-K\Q&)  ED#0 "WM,4C\Q;_UR$3]1DV5]'FF
MEJ!M\FZ#]O?$U+T9QE3C;C:%Y;A""F]^RUS&'][TM003NAZ7A<V_3=@DR9?"
M5B;!2T$:]F\$?"/TOMCX1!TO]L;>,+"1K8Q!*-_Q>I9ES:@-$S!4EMM-^]*2
M=?)L7VA4;9]5JE/5EJ;=:FZ?-2K8E&TN*#CTL\RDJ"E)TS."_=%0G!,5*9G6
M"I <?4ZV3HI/9ZXE]I>"<9X8D:!M.EJFW-4=M+5.K5$EVYJH%EMM+#3+IF5I
M;2VVV%%.5/I*/**]4MEM,I3DC@R4JU6G)R:E'W*KB.598G:6F4="RU3C*KR%
M$TFX?WB2=!EBN[0]D6.,+83I.*'\7R$_A^E-R+OP3)2;K"UI=<=)2I]=R.OV
M",9,;.&FI3^ T]B6;>+J^FBO2TJPA+.3J%@RY)4LN:*"M,L8+Q1,8/Q%(5V6
M0EQ4LL)<;5>RY=:D[]/5UZS8(MSBIXYV+3>('L=(IU==Q&ZZ9]5%?D9<4)<_
M>]EN!WI.ZTMFOFM&/=M4K5MH= QSA>5=DUTFG4R6,L\G=(0Y+R?1IIIK*I2M
MP,RDM$FY1:\5C$^P_$U:;Q75$XJI]84ZQ-S5,ITA**I3LPQD5NRMUS?%ITMV
M<-\UEJM&(=J5.Q3C*2GZS19>9PK3T(I\G2U(6KH],;6I2"VUGT> 5ERY\MHH
MN/\ 97L^EJY5,#C$D[B.I2ZF9:6K4I+,TR4W^=+R&W)9>^"&VW5):O>X2F\4
M':/@JMX!7@?:"BKR;4I/R\S3)Z@,-3$SN6U/O.-O=*6&TYGGB.J/1 C$^T_9
MX=F:\ 81IU1E@F8>>3,S,LAE4VMQI#729K(XI._<RW<RBW9&TG%,C@S"V!I/
M$. L,XMJ#TEO>DUA,VMMIA<K+K8$NMEQNZ]V0'01H1I&.*3AR9V7X>VI43#4
MA@NMM5"GLM2%':6U)3J7W7W#.H4^M;RRR6DM)4#EXW$57'FRW:)3Z5-;0&\0
M4S$M.EVI%R<P]*2[Z9V4EF\C)F')M=\Y4I2UA( S<(QM4\*SDU+RF$:7T2ER
M22$3\PUN:G4%+ S&>0E:FOBU AO=VT.O^VT*S"%IL?+*3 6G(KTA]L3DM_.(
M'B/-9><8<2XTHH6DW!!(]T4/$C<V$R\V0A^U@HV 7ZM=;<;G6*S0&*D@NM!+
M<Q;10X+\0.)[R8G)"9D7"W,-J2>1MH1V^OSL'U44;$%/GE^@V[UO!0*?OC%#
M#F(L)/=!60IYM+Z2@FY#:5$BXMQX1@;%KN#:P[*U'/T52]V\";9%7&99O?D+
M:"\26+Z!/LH>9J#!2H ^D=">7 <#I#+S3Z XRL+0K@I.H,$!0((N#R.HC%^S
M"EU\+F)5*96<-SF3HA1[T( ]\53!V+<)OEUE,SND*N)F6*D(-NX+S$1_PB8O
M$FJ06\;*3N\Q:7O?U\][Z1LZP--UNI?"=685T5*BOXT7#JE:\[_*[1#.%J%+
MS*9IFGR[;R/1*&FT@<[V".,+<;:22I24I2+ZD"P$;5,<O3<V*/2)L[I"LKJF
M%*2I2[BR<R2#W<XP?A_&"*I3IL=+1+NJ;<*UK64*;)YC>>\1B_!-/Q#35+?:
M2F>:8!#R $J*TH%\UAF(T/.)^45(S;\JO53*RGV>2GT5V8&_F#T>42>LZL&Q
M[A;7[(D'*3)R95*N-[IL=9?RB;$ZFP)]D5W$;DZ52\L2B7%P3S7ZQ;0]A\U*
M2LV$!QEALH&JB-3&V.9:8PA-(=<"=XXBPOQ.<VT]<4"BS.(*I*TR5_*S+B6P
M>-LQM?B(H-&I6S7"RE/+0EQMDN/N'0J<4E)*1<7T7X\8JU4=QMC-*G'%;J:G
MFFFTDDV0IUM'VQ4YR1V=X*^+1E7+RF1M*="MY*>VW,#G%6J+U6J$U/OJS+?=
M6O7DDK4I(]0-HV X:$W/35<=S;N3NRG*2.NZV%)OR.J(VR[3)VES H-&=#3F
M6\R[Q.4YDE*2"E25!0&NHB9F7YMU3\RZMYU9)4I:BHZF_%1,;-JS/TW$],;E
MYIQIE^::;=;SJ#:@MQ"3=.8#AI&WP2BL/2KSBD%]2UAK47ONKZ<>5X'$1L?F
MA,8'H[87FZ-*M,^'IJL?;^CS5'DYMS>NAS/PZJ[#V6A^49F&.CN [NR4Z&RN
MKPUB3ILM(YMP%];CF5F[H<I$HZ_TA>\WE[Z+L/9:'9=IYO=.)S)M;OTA-!IZ
M%YPEPGL*[CV6@T61+J7LK@4GA9=D^RT3E-EI[=[_ #_%BR<JLNG?$O+-2S09
M;!R#3K&_MAVAR#RRXI*PHFYRKRCV6AZDRC[3;2PO(T+(LNQU-]=-8EI9J5;W
M35\H^<;GR3$JQ,IRNH"N_3,/ Q_!ZG9LUG?#>?Y1+RC$JG*T@#O^4?$Q4]:O
M_P!:/_#!HLB^$.+0H&P]!64>RT2\LU+(R-)RC[3XGG$S*,32<KR >_3-[;0B
M@T]"LP2X3V%=Q[+0E*4)"4@)2- !$U3Y:<_+(U^<G17MAJA2#*@I*%DCYZLP
M]EH?E69AG<+!W>FB3EX1)TZ6D;[C/UN.96:%T:2<?Z0H.;R]]%Z7\+0\PW,-
M%ER^0\;&Q]L2=,EI$J4P%W4+',K-IQB9DI>;%GD7[QH?;"*!3VU9@EPF_P I
M=Q[+0A"6TA" $I' #ROTB3F'^D.!S>=R[#V0!8 #@ ![/(0%"Q%P8=H<@\K,
MI"P?H*RCV6B5ITK*?DD:]JM3[;0_+M3""AU(4#X7'@8% IX5FRN7[,^GLM#3
M2&4!#:<J1_K6!1I(/](LYO+W]/2Y-^%HG*;+3V7?Y^H+#*K+WQ+R[<JV&FKY
M1\XW/DF9*7FQ9Y%_I#17MM#=!I[2\X2X3V*7<>RT9$Y-V!9.4IL--"+0S1Y.
M7>W[8<S]Z[CV6B:E&9QO=O9LOT3E.L2TFQ3VG P%D6*B%*N3E!T$3$Y3)M_+
M,RKS)O93F=*?6;)N8GG*:B6W,B=XI?%7$CGQ($4&74W)DK'Y6QL>S40[0Y!Y
M96I*P2;V0O*/8!"Z+(K;#90H!-[$&RO6JVL*#=-E+(0XZVV/0*KFVO,PEZBS
M;JE/LNRO.Y< 23]5*8J;DH\9=B2&9*#;,.>:W<#$BSNI)AE8]%O*0?$\8>H<
M@\HJ4A8)-^HO*/9:)60EI.^Y1:_-6I]MHG*=+SUM_GZO#*K+###<LV&F[Y1P
MN;GVQ,2;$TG*\@'O^5[8_@]3LV:SOAO/\HEY5F63E:0$]_/UG]-V/SFYPLTF
M]M1S[UQ\(_2^V/A'Z7VQC618Q'0)R1= 4L(+[)Y[YI*RV/6H\(FI=R4F'I9X
M6<96IM8^DDV/X^C;<\94BC25#7*X;K<I3RX95W$5#8K,XV'2+H$S-+*LB0 E
M"18)2 D:1C/:1B7'(DVZNN2EI.0:+4M3:1*BG4UM)67 1)-++.9*B<J@D903
M;C_MU)L8](0H6/D2HI(4#8B)=Y+R+'TN!$34J4DK1P[/-2HI(4DD$<"(HV*5
ML9)>=NMO0!SB4^H>\PZS(5:7U#;R%C0@C,+]MM1%5PM,RI4[*_',\;?*'<$B
MY,*0I!RK2I)[% @^P^8DV4D]B@?88V=5&7J.%Y!*7$K<::R.HN"H7*M"+WX1
MC397)U]:YR0(E9TW)L$Y7#V**C9-R>,3&S#%\D[N\IRYNJ6IG,+7T)R:#E&$
M9.?PYA=:JDLO/,L%XI)S%(:2LE-^.L81VG.X@K[U*>E4MME>1A:5*5?KV%QE
M%M.T^1QEIT6<;0L'DI(5[Q#] PHJ= >EI03:S<)*T)42;GT+COY1+RS$LV&Y
M=M#:!P"  /LB9<4TPZX@9E(0I0':0(Q-BW%E3J$Y)(1-MMA]UI"&VG?1"U)&
MH1S C ^S&I5*=;J=;!9ED*#H"CF<<*2%#.E5E#4?;#U7H=)R2SDQ+,;L94HS
MM I Y:J!$8EVB8>I4@_EFDS$PXTH--LV<!*DVZRFU*RVO?6%)F*I.NJ;25N/
MNJ5P-AF5<7/*P,4C"B&2EZ>LM8L0V""E)^L(Q>XE$M+LL.(2 59VT*3>UAEN
M!K&\6$E.=64\1<V\U*2H@#B8<1T= '\XH:]PC:+MAE\(S1IDA+)GI[*%.9EJ
M0EL*!MUDA0)S)((Y1C#'N(,9@*FTN-R23<-("E-7O<=?*.!'.*#6IK#]3EJG
M*'XV6<2X!VY3>W.,9;4*[C!IN6F#T:50!F9;5<.*R@**C9)U(O:*1.FG5.1G
M?^33<N\KZK;J%J^Q,3$O2]IN#TH2\G^-RMTJ205,/+3S3FX@<E6[XQ9L_KV%
M9MUJ9E7'9<*.[?:2IU*D$G*24)*0<MKB^ATC9!M(D,')GJ=5TK1*S3J7MZA"
MEK0IMK($Y$VXWUN8Q?,IVBXSOAV76M+UF4DH6G-UU6<7F!R7[](I_P"#TZY*
M),[.[J86@*ZH0O*2+V]*,98/J. JNVRI[-E5O9:824YCD4+*(3Z)S<K\HJ^)
MZW76V&JG.N3+<O;=)58!-DY>7'2 E2O12I7@"?='X/N*-TJ<P[,KT<5TAC.;
M90AM* VD'M).G'_8[E-DW7M^MJ[E\V:YXP   !P'^Q'J;)S!S.LA1/J]T-TB
M0:.9# !\2??   L!8>4@*!!%P8<I$@Z<RV 3XD0S39*7.9ID)(]?O_V+LUG-
MSA]M-^SWKCX2^E'PE]*/A+OC:514L3HJLLCXF9-G<O\ 2ZJ4LVX>/#^IR%6T
M,*2%"#IY&W%-JS)AEY+Z;<^8B:E<G71Z/,=G^7G4ZKS=-6"RLE%]6R>H?5%-
MQ-)SH"'B&7>!SD!)/T><5"A2%23GRA"U:AU %SXDQ/X5GI6ZF1OV^01<K]>D
M.-N-**'$E"AQ2K0^6@XLK&'2KX.F5MI7Z2,Q"3I;E&'ML569G6D57*]*K6$N
M*)45(3S*;D"*=4)>IRK4W++"VW4)5H;VN ;>J\;1L:4^ATN:D4O(<GYII;.Y
M205H2X%-J)'$6N#&RF;D6<3[Z>?0R5!&Y*S;,[GX>R\!UO=[W.-WEOGY6M>\
M8NVF4B@-+:EG43<[8A*6U!24*^GJ"-;0SBRHU/$TM4IV=6RCI&977LEIOKV
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MOZ/E?=W+2G"+Y1>T24V)UD/!!0#?0FYT-O,?=W#+CI&;(G-;MB3F1-L!X)*
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M3">?V0JH)'HIO"IYT^CI"WG%\5'U:>:&R8"0F%+ [X*B?]FDV%S%9G3-3*D
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MO,\S&3N]T9.[W1D[O=&3N]T9.[W1D[O=&3N]T9.[W1D[O=&3N]T9/]:0"M/
MG[(#JN8^V XGO@%/;%AVQEC+&6,L9?\ 5H<DI=WTVTD]NO[X,BZWJQ-.H']'
MU<GN)C?3[/Y1I#B!S25%9]7"$U)HZ+0XU]=.4>TPA]EST'$*\% _U "R(#@Y
MZ1U5=\%L&-T>V"A0Y?C+& @F UVP$ 05)$%WL@J)_%[4IO%C%"$OA&GS$[/3
MBEM..2^["I5 RE+EUNM$7U'5).D8@&+,,2(FY_:.OX;;>:WV&.E5#X09SJN=
MX=9;(@64H!P]50 UBK8UK]1V12M4,\]+3[,QT?I,LXMIU:1+YKK6E692KGB3
M&#J+M0Q]AD3LOBIZF4^GKG'&)IYR<+\\XBX>9+S2R5;O+U0L )OSC99B'&-9
MJ-:P),UA[?S$K..HGYM;SC\L[+,Y$9',Q<2@EP+*4\;#G%'PMB"<V@36'I:O
M=&K352<EG*QFF/C'TK(+^9/Q^I%]>M&*:IB6B;3:=0U5^?<::9I:'DM3+Z6'
M5EEL.*R*5KG5<FXN;ZPEQ 0C,M(.5/%0!X#M,!25>BI*O @^[]-6L(2I2C8)
M!/LBJ3RIR84;_%I-D#NXP\NPRCGQ\MB>$95?-/L,95=A]A\ZQ[(X>5I>8=\4
M">W+VX6>HYZ/UN \AX&-HF FI;%:ZY6GU? <^^7'WD%2.C9U$J2M9!]%(^2D
MQBC:#1</TJ7H6 G$!!1=^=;U6HK2DJ&<!M=PH'B.<87V>UC':Q6YF?:Z,7D*
MG%N[PN9+W7UKG7(D\C$XK992'C0IB2<?3+IW;]10XUD2L:*)46L^G'A&(=ET
MC,R2JY@RH(GY= WJY=LN..MCTN)2VD6[NR*;B"LT*J].9=49YD*:^/S.6N1<
M$9K\ASBG;1J9BBDU"F8QEY9,R65=&FD-I;4'%*2.)SKT ,;!YV8=ID]);I?0
MY68<Z,Z1H4K=</NMRCK1=0XZZ^SO_P!OJ3<WAY;;""MP@#UZPAAV=5O'06V0
M>JV=%*[S;0@Z$0EI*!E2  .R,D9(R1DC)&2,D9(R1DC)&2,D9(R1DBQC6+F,
MT7\U33:_30E7UA>%TYA7HYFO[HY/='0YIK\A,C3AOLRXW\^S^4ES,?W("?VC
M J;8_+-K8_O+:?JWAN;EG?0=2KPO]XBX[?\ ;P6J [VP%I,:=T94QNTQNA&Z
MC==\;KOC=1NQ&1/9%D]T7 @N""[V05$_COPD*C5Y.E4-N35,2\F]./B:F)93
M@44!ILV66[%L)/ DB][1B![ +V$I5%(:J%2Q9=I4_47NF$( 62XDYRM!NW;K
M7^3!6E>Q,93?)4BE7<>BC2-AO_U6-_W]9]YC8W_]<%3_ .B57]EJ&*W3\*;9
M*M5:RMUB3;K;[REAE:U9-ZK5*1JH=XXQC>J2E9VNR51D5J<E9A%,4VI22@D;
MIOBDZCC&,]CLYBZJFJM8LGZ4E:/S9@.Y!F"?FO(&ENR-GF 7\#2\PP_7)FLE
M\DA<P%W1=0.F=Q?9;]-K\X66 T@V4Y[A"C87A1S$GRRTT]*+WC.4*^DA*Q[%
M7$4BH3#\G/3,P&5;D61\0VGK*;40?1ULH"'*W/N(4A2F<JA8V8:!MXA, *6J
MP%U*/ #F8;H-0<2E8#(S\$K?0A?ZBCFOW6AV7>9>4PMM6]2K+E )N1\WYWJA
M- J"DA65D7&;*I]M*[6OZ!-X0PM,TVPXDI5O$I(/>8G&TN5:FR:$)LE#2562
M!ULJKYCZN)BNK2JH.!  2E*$V2 !=*;'AX>5I650AM9;6EQ/%)N(D'Q,RK;@
M[ #X@"_DVCTYJH81K27&MZ6Y)YQM(%U9P+:6UOX1LVPTS7\3)I\[+N%CXU)N
MA8"2E+F7,;::@<8KN'\5T&O35%IC501+O/9& QO]TI)RIU6@9!Z7,Z<8_@K.
M8:V:54U>3Z54Y]MW=@)Z0\WF0@@EQ*5+3P(UM&Q>DUI#]0J<P)E%,EF';RSJ
M7"'R4.C*$*^:;<!&&L%RU5JV(L7UJGO,TJ3<>=9DU-.(6Y9E+B2E&5*[70H:
M)(UC!5&D<5[05*33W&:4W,;W<E+B1N2M0&8E(MQ&AB0ILE3&$R\DPVPVD6LA
M*4W\2 +^OR&!_MZ8F$RZ,RKDG1(&I).@]5^<,RZWU"8FO%MKDD<1?M]< 6X?
MIY0@\4I/B 8<D99SBBWU24^ZT?!H3^1=6CQ)5[S&YGV_1F [V H"8Z1/H].5
M2H?.#GW 1\)I3^5:<1]5"U^X0W/,.D!)5<_.04^__;V8]L9U=L;PQO#&]/9&
M\,;PQO#&97;%S^A5:BTJNRBY&KR+%0E%^G+S"2IM7B 1V");9K@232ZB5PO2
MV4/ I=2AI0"P04D'K\TDB$8"P<W3%49&'J<FEK=+ZI$-JW!>*<A<*<]\V73C
MPBE42DT20%+I,A+R%/!<4)1A)2U=[\J;$GT^>L4W!>%:/45U>F4.1DJDXEQ"
MYQELI>4EVV\!45'T["^G**IL]P56YI4[5<-TV>FU^D^^TI3AYZD+$?\ ![@K
MI;4]_!NF]+8#:67]TK>-AH -A)S_ "0 ! %A8<!I^G5F8W\XNWHIT'JT,/JX
M >:3T7#=^"YAQLCO 4I*O?$M3>D-[SI<HU]%UW*KV6BDT]#$VMQQUF8W",_Q
M*LZ;D&VL3,Z\].&:6;N)<S)UX93I[HI#PJ4VNHS*&4+E61D4;Y<Z5?E%$\#K
MJ8=DGW9TS:ZI)%>\OF+_ %@@*T3PY)TA]+$U6I133C;N4;UU39S#,A2>?A$D
MO?UN=F#PE.MZ@LI^^)I9<F'EGFXO]H^8T;H$8:>4IMUD\$=8?XC_ )>1UI#S
M:FG$A2%C*I)X*2>(,4[#%"I+[DS3J;+2K[I*EN-(RJ42222;GF2?7!9;*PX4
MC./E<X>EF7VUM/-I6VX,JTJU"@>1B5DI:3;W4LTEEO7JH%AKQA<NTXTIEQ 6
MTL%*T'@I)T(/B(IN'*+2'77Z=3Y>5=>_*K:005B]['4\]?(E*E&R02>P0U)3
M+KR&0TK>N$!"+=97@.<5'!U0IE/E7:A2Y=AAW*#-2X69F[B@$;S-U1QU[HGY
M82DV_+I)4AM92A9^4GM_'R\N_-.)9EVEO.J-DH0,RB?",.['ZY5DI?GK2#"K
M&SG4>L?HJ3:$;!Z/D^,J\_O+?)2QDO\ JQ5]A]0ET+<I<VB9"=0EY0"SZD)B
MK8=J]%<4W4))YD)-MXI"@A7@2!?_ &4IM"B%*2"4\">7^Q]RUFS9$YAS_JTM
MYEO1QUM![%K2GWD0AYEPV;=;6>-D+2HV\ 3"W6V_RCB&[\,ZDIO^L1'2I7_E
M+'_;-_\ FA"T."[:TK':A04/:+PMQ#8NM:4#M6H)'VD0AYEPV;=:6>Q#B5'V
M G]-G7MQ+/._-03#BLREJ[2H_;#BLRCYB>(OPN+Q5YV77)R4K+.!P-H.\M?1
M6:XX@>2CSS<F\L/#XIY.11O;+QUAMFDRCJII4ZS. 7*)9 6%YCJ,Q6,I /I#
MF(DJLUTF92^A+<M. MG* @- J!S&W&UN4-L4J36N97/,SMB2B7;2M*C<Z7*P
M4FW.*?/RHFIR==+;"BRZEEH)RBZD#* $BW$=T2<_+LR51<+@$U-)4E"/E>FE
M0/OYP3<D]NOF-C*D11JA+R*%[WTE_O\ "!7Y(\[>O_*!79$\5@>O_*!7*>?Y
MY(_UX0*U3O\ E*![?W0*O3CPFD?;^Z/A60/_ !E'V_NAJ<EGU96G4K5QL.[R
M[/L)-8KJ#DN],;A#3:EZ%25G+E.BD\M87@*F85ILW5&&W9^>E4%QC.O>6(4+
M:.)["><.59S&F#GFF2@U2565.RV7KI0RM2M$\!U$]L5]+;\O)S#;*F')9H2L
M\E9!49JY43IPZMM#<]_GA*CP!/@"?.IV'ZQ5E!,A(O/D_-3;]HB*'L7KT\4.
M5%:*>UH5(=0HKMS 4VHZQAK % PTVG<2Z7YFPS/OY7;'M1G0"G6_/@8KV-:'
MAY!$Q,(<? ZLLVJRM.PY2D<H=VU6=.ZICFY!YJ9*B/&*+M4H%2*6YG-3W56
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MJ.8'NZV:WJB@;89=Y2&:U+[DFPW[>=PGO(  ';#,Q2:_*7;4Q.2[J=4DMJ4
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M(J_+O$8RI9DIIMT+*T.))UN;'-ROR[O(AM;J@AM)4HFP [8I&%R<K\]IS#7
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M,9]L851NU1NHW7;&Z[8W7;&ZC=P6U194=8<XQF-[S@+!_IK3YH2DTT^1=*%
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MCF+Y%*;BVNM\CE&TRDGHMB#FG0W\\0^I/Q"X,2;]$TN+QLS--L/O(<4$[T)
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MK[3Q'**3L]-5%0<<"FF+YK5Y1[DJL3]L2%+E*>V$,MIOQ41<D\\]/R0@*%B
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MO+0DI2H@'M@DJS)OX&7"TL*]<3#.] =:%[C.T$$9'* +D"-T\A6!-\^7^>V
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MU+22KG87]T/3*W>P<HN>9\:NS!F)E$JUUL/ ?3S%HHTF)&099 SMC/>L!7Y
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M Y'S8^!1$NI>UC4F5;A2FD,ERU\)WJ4DVRM:T5GX%]HZA5)V=:G*<EN9?+B
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M$2C6YEF&K6P-(2>\)'B5!7D)BGIZBE=MO"6\[_U+$!0((N#D08J>S$G. K9
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MM]?$2E1%R3?A:#LXV7@O?.80A2;8U\?3#&SDHA"TN8W I15FI7'E>\-2S+(
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MGT6H]%6KY.9 0@?[0JU]0\1;33N3K;;@'!:$K_>!A$NPT<3;#+:N:&T(/K2
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MC$&B!:W:#8QM!L12&J>_,RI#"V6U+  2$JL";<X"UMXDI41J#;C8PE"G%!*
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MWR]L3Z*M.383--.;UP]1OS0+\!<@10MG&Y()F)D!<P;$ C)OLL;YCF#XJE!
MN8+;S[@6K)(.0,;!-+<KC*D)OA2KA?*PO%3J#-,DWIQ[R&D%7?:*E/SNUM9
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M>\7,.I:WB2&\1P;NZ<5LN442O257E6G&GD;TI&)NXQ ]WAVBV6D:\T=XD(F
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M901Q"7+>ZT(K=78TF74=A2/M$-;5U-'EJWOUC;W"$[9SHUEVU?VU#_I@;;S
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M^D/6(Q#F/7^"=1A-QH8VCD-^QTA Z[?E?5%R?#LKM*MVB)IU/;'QC+-A+:%
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MZIT2I4UB?G%RRG6T8G"YNL85F<DJS.FD?'3%7VMDN@S&YDY9:,5SNT*PJ4"
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MZWAQJQ'4DW\6J[/TVK(4)AA.\/YY(&\'<8K6P,])8W9&\TR+D(2"IVW;H/\
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MWBT(<P$ E"A<Z"Z2+GNUB39W,H@+F4J4[9Q2NL0J_P!'B$]D-!MO%=Y*@1H
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MS'E$\0"4_6X1)5;?R[=.G6'"MP8 K"OR;9&]NR*0IV2J;U/"]XR$EP?H]3&
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MK2"8FO@\H4RHJ =8OP9PI'NBG["4.0<#F[5,J2;CI 2KW 0A"6TA"$A*4BP
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MO(V/JCTX>HY/9@\$@N8Z:UO4-LSW&-2&KT*W&(OF"6'J#JHPE'RJHV2Q DK
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M /2<;(YQE8DO;9G,*37?NT;75?Z,!E8,IX,I!!]1&XXM5YA14I[JFJ@@/_\
M==<?@==1U?\ %JF&?^B=OR!Z/-:..96!TOILZD]NI;,?KQ\:Y%+/6Y*TERJ7
M<[,D H\2"0H+775W=+"+M%I<Q4 34LAT=/M$9D(,GHL-_P"*9W(50+DDV ^O
M#Y;E :62^AY8U+$G\V,+J#W[UQ'G7*?5%1LPD2F;?)4=MI%.F2(68&_?NQ'2
M9?31T\,2A0$47^D\3]/P<GJ);I3SUM2'(/G^0C-B/U3OQE%33JIFKHS)42Z1
MJ=ED=1O] W8UUE934J]]1/%"/KD9<#+\U3XZJ*=F:***)VA+[O\ TFG8V!TX
M.5\DJ./DYEXZ"I!(9[IO_P LMQN)QEW*&JKJBHGHJI:G?(^DD7^8#I[>[%'R
M@I:5\QEJZ6GV:1K(R[:2./4&:(-I(=]U^)W8RFGS"IJ,EH<]=%H8BFST"6;9
M*':6.-E.J_G'AOP:G^ZRKYUYR*)D,;-[6TM; K*J3XWR96&J*&1:F1DOQ=8(
MY)$%N)Q9;46:0V%30R70J]KML]KI>0"XWA>.[\BDI*ZGCGAE72RNH/U'B/HP
M^?<DV<Q1OM7I4.EX+'5Y.Q:23S2WV8AY.\K3(A!6""KE5@Z-P$<P(4(HWDNY
M]>$F@D62*10R.C!E(87&\$C@?QL?MI]X?"/8'WF_%V'#&H_)+N=_8O:<;[VO
MT4'# FJAOXB,]GK].+ 6 X#Y6IV"CO.+;=92.R,@G!YM"?1M![CC<D2>SJQ_
M?#KZFQ_?TX]3X_OR8^ML;Y=?M$X DAB([QJO^W $T<B-W[M/[<#95,98_-U=
M+Y9250W=Z,:TNT78P[/7A8:@WCX!C\W_ .6 RFX/R+?!8\?TIK\T&^H6%Q2
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M;K:%:0R;NWT\?3BAFF;\)I]5-(O:$@M%&3ZPOXJ/VT^\/A'L#[S?B-.-7?\
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M<G?ID*P3Q@ ]]L4291,(<RS2MYC3/I60H[1EU;0;WX=N#F=9)M*F/+HY))"
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M)"U+(VK65;4+NIO_ %X^*^=2#5,_X1\\;V/?Z._&3T"U4T@A=%UEF77Y9#O
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M2+\:30RK3(Y58I9S8#:2GS%/YUCB/)(^3^=?W1TB_%T<9RNM&6F2 "F$W/\
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M*NY1;OQGTWQA*,@R*"=):=-#1/41.K;SIOYA[&Q6YK4<OUY*PK+/!29725%
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M5AB65_/E6-!(WM.!J/TG G:"$S+PF,2&46[I+:A]>--1!#.O'3-$DHOZG!&
MB*J(HLJH JJ.X*-P'JQM)Z"CFD_/EI8)'W<.DZ$_;C8I%$D-BNR5%6/2>(T
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M,"Y;U 8DH:;+*[-A$Y0U-'- (]QMPD ;%!519?6U[UFTVE+!- LM'L[6VVT
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M4)DVRT3"G;XKD5^=K$VSO-IU6VK;[FV,PR5I7>DDI]I #>VU:55O;YO1P?\
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M%CYIN,1UF7R 3A1MZ=B-I&UC>ZW)[+^K&@,-7=V_ 6D;?V+VG';:_00?_7'
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M+'C\FQW@X:6FZ+<2G8<?.C8'TV/UX"3="3[/KX#%U(([P;_(R^OC@""J*J9
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M U-O/2OJ^G#FD=Y*N1-,*1Z2$N"+OON+&Q&*BIHA+*P)=I&U%5] (PM/4=%
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M:;ZEL-_Y1'[:?>'PCV!]YOQV_%QPQOX8W?+\I$K8O"Y3]6PM]9Q=0K#T/O\
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M$9VC>4+]-]V+9IDF69G1)PJ:.IJJFO=1VM"B*FKT# CS*AS?)I!ND;,J)J2
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M.[$?*KEIRAR2X(ERO)?CB@,%(GG1F734!9B+E2LL>_MP$3/\A55 "JN:Y>
M-P  GQ^^'(_]K4'_ /,8_?#D?^UJ#_\ F,?OAR/_ &M0?_S&/WPY'_M:@_\
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M_?O''MQ3Q933IE%92H%2JI8T621E%@TA;4/3N&)AG-3)F%2^Y)Y5B=H]^ZQ
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ML3<G^651R85 -HD.7TU9M3OWDS\/H[L<H^2+?NFU=.F14]'.M8N3T#O/SII
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MVM305 45D1FY43HB@ *,"\X9ZA(H(@C5#NZW@QP#:@KFA"0[S@#LM*F&!5
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M5G &"1T!@&D&DC8@.E$%]L/7?<+ LRV8./9ADIIJ2,O1E9', (:6$_$8N.Q
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M860@FOG.CTM6\./8RVK[&TH@E9J9Q-!$C-G8H/UP9%M@SU4F%%YV9ZD'[88
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M.1PK0@]B#"/!B'T"8YY>=]0. Q!T%_([P"!^@?H'(U"(I#J!)X<_\5S$' (
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M'Z!\FRZ@^L)R.#V.X7RL"0;IHS_W)%@$WFH]]9YH)Q3&#2:1=J%O)$HX7@*
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M#G+@ &4)]KAP)Q4M0[JYP,J42Y^C[8IB*K\K!(OT,F'1A1+FR2@.!PS0  Z
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M1[C"D(IVFY;J<P)^#2PG2CA.L*6!F<?LST*:PC#VWR,0'&7EE=_7+\'A$ID
M-L@)?4@")'D9; OGS%%2E($><C.R3<%:DD0H8)C#FRQ+.D],43%HX8$ED$)E
M 0$R;)00*BGK(UR>VBC$'E$EF, *<8=#P?W=&NKIR]1L 9O6@(Z7Q:? PN8X
M7?')Y$8MY_Z2BP$TEN$+!M89*UE2;HT-Y$CXG3Z91)O9-2Y$:Q$6MB'HDKVP
M!&\GR,4G"J(&1!8 +6>VF0FV5#1&.T[$+&DQAN(!/P040%E+)D8T!]$X,HT:
M6XYCZ 6)H5CIKC".WYTAM"2,BAD'"(D$-.G.9>L@RZKD&Y!* 8$;P5N0*'8,
M7$DZY4O;K$BI*R+!<9WT.QUX>3/?%U.P7L^3AYQ1MTLR7>U)%-XQE6X>;A 7
M$2ZR:!IC ()EIEB]Y1^KA,FVM.$9<J-(+ELPIS!=I\I1!(03I),6ER%^Q&VO
MOGK3(G04P6EQS<J\#2"NF"$F0B7["<]92G%&AN,.<$FE:MW$Y8*$90#S(_TR
M M_^ECXK2H]U,.ITF:5Y?@SR&L3)/U,>>UL/9;)>C_XV-R44ZZA>=J;8NK(8
M,62)R=1DQQCFKH E*#6',S&,O4*U1*/-L1N'R6 ;>6"V "Z!&V?? !  - 0?
M0_/&+,@=F!?> F<GR0"F\B=GZ6.TA"=V,R^F  L 'L23Y"6U&C3#KE0,QD:J
MK=@2V8I2W1&$@2A)82>HT^?F1J.P#[Y<PU27N98TD6B)'@?7A"7Q0DL P,.3
M>HEY'$<GITW-\8;_ %Z.S$E^+D"D8@DHH"93\ A(DO4)%S2*9PR.;\.H^ 2=
M,&4(GE;72;7Y&XM]E5'LY91"2]P8/J"EX^2L[Q(!,$GF&/FH,> #(+4(C%=F
MMTB%DD@O@W3K&0.=JE,AP8BOA)9-2+!*:5$),8&U-#6,2BH8O(A#+EE<B:"F
M7-Q'HSD"$( S.33(. (:="(%1\.3"J<5=L_W?,%*&1UPQR,1-XK=SDAZV=<
MWA<ZF.@941>"#>5).O\ P-X7+E'I!'ZXCQVR*)*B $@X+XS= &\()\9YUZGU
M$EZ4.]8QH EP2]Z!9*%R_=Q52 4/JDAR=)_L8W D?L,+H>W$LD,;LFA[4-71
M!+U)29NQ& 5(2QX+@+.$T8Z(IV3I'+'PP8S18+$:(RDF,LQ.XT</53!"+:93
MS@ L9$&6U&'B]Y%VEXC09CZ$B,BQY^:E0N<$O&%TYA6O$^6OG5@DVJ X-&4F
M2<XQ+4WHX"*># DA'X""3* 2)Y,ONRF_+<X#C_P.CC)&180^HP>2=8]\[A,<
M.?J<;ZVHAZ'P/ ;YV"'%."$W\DOT-=Y_!7",X E$$&#AX>I>1GSEXV,FQ.3
M(BP.!X#^AF+,*#G?KDHME_7Y"2E0=B0X4ZI8U)HDYPB$4'9^K1\B 1!&D;$\
MF*99!;W0#< @K.7(FE&#<L2\1DKI@#3W&OPONOTOFL4-H>KF]?!5I $DI!2T
M"$R96T4,Q*ABD>C&0G+"90-T74F_D6+:,M&T',$O)KQG1/R+!7U5\LUX_160
M+GG/!;2KU28\3\E=(YFHXE"MS&:RCIAH]F7DV. ]4E"T;Q/4HQ0_0,$,:/)7
M2G 3#=H\9, I+B:2<9@F+(>O[QB6+O\ ;N,AQJ^< +.+P*]R=9HY.OP0@#?;
MXR&J=KZG-GN_O]7%R]:<R)#3P<)H+Q> B2Y)?;\?L925"'L9/X$EM;LER3#B
M"9WH\."JJR$-M0NH AQ.2Q^45=P,L$R3&1B&"ID SB%"#$N"R-  AD0\C8Q(
MWD!M!2:% = ,?,P"X&A;AP:<9W_B>I'KSH,LF!?MJ&A?L9V3A%UMX9!4K>+R
M(PTJ,1Q*"+2#"RQ9Q4&.T(3>$3S0[Q7WUCA297A*%GP>,G/RILLF9%F3=[SQ
M(CA(B.%%1QK%C\E2.U^^7'@&6GJJG:L$3F$#= =2MLO]9,69;W'KCD],.( G
M/R!@0+>F#VPE9(^0$I?N8:X1]/7Y H'D:3% -2+2V(HVBUO(EG*M*)*)0T+S
M@7L!%\42RN/7Y"NR@$1^0(($VY# -LK" 5#U..K&EDCPZ#5Y7D"()Q L;MR#
MG$"J%7<;,/.#*$FPVE]6(,9IUY.]_$DCU')E1C,H<!2T_3 Z3M42V.WA4O\
MK!P#(=/#D^?X!?!X(+!Y<6%TN(%B)$O#(76\!NE4!)<4PXT:,AG10I5UA)5*
M \6<BA-I/RA6D FUE>H8RY"!)L6'PLQUA6!@'@CY)J-TQ974R_,)&W 4)W&&
M$W!F$8"D/885%"E$LXZM4WL:@:Y<3"\W9!78Q4<++M\ T=IHMF$@X@" 'I^5
M(=1)7W5\KC%@!@JA#,Y76&1M!(=(I21$[P(]"@8I=@A7&3<TXBT!PP2=_&+8
MT )?LV3RG)L/T"*C"Z7A]'&C95R48T$80!B'S(2((\8V80Z5,]%[_%+04]Y@
M)*EFL3EAA*V4FTR$M2?&T""8DV9,)P&9)K?JA>5COES!*@JJ^5M0T@<>4Q"Y
M^$2J@6!=#J02X"!+=FA>Z-3\]'U.?J9&P\,1LQ$CS3Q&ZQ?!P6O1&AS_ % <
M7F*F^;)27F,;I%SR92"0%SAW9&8G$YTE8RD)<9&SE=\N1^R88+5K2FJR24EO
MPD;2:!MHH#O).JH!Y"'=0T_V,8LU!3OUY<N"S7RK.R%;@H0H.9</.307R!.A
M*H%X? <AI'Y'!@(EB-(F1DI)#"W'4 2Y 'LZH609+\^<JPNEZ"PN"WG#@DL1
MGX3KZ_<Y"%'(A-XE'1A5%$-IO(<S#IJ!,I'JXV)+NB@(4L[Q=OV @L"WK631
MA:AX6Z(&.07/*#LA$ISB:N,W$24*23SD]07N' \"BF,0<-64"Z@G5N*I@B@*
M4J$0K#KD3'0_W R"=($$X4$"*RVM-(F5.B(UZ8!&1&EF(1"1R3?RABLMO@CT
M8R1:-N"@HFCF#(%D/8E$RW FOD6!>L2$T49%3V>S9\P A($3L:3&G7G(66*<
M(3;+'D$C0 R7RG3">7 EZ 'T_,K3*=+2:6WWC?&#,YF_(0S*$.<J4)3'$GKA
ME+/SN4:?3%X#STF(J*IFMY 8_LE4[:M#L8*(!K8(45(0<85UE*[ )O81G.T
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M0,!W)D6I:X([Z6.96,S15D$&K$EV9>MP\KPA&#U,+%*5R&/=F)88?W<O4.C
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M_6RM.@"B97X*#1" _8X,G$HO(D1><$72@"/;>13K29044+B: #)>H+"&+H,
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M $Q=GZ/^C.2O7_1G">I+]L@OH-S@+\. !!1^ 5('KB< [R=7'.#M3V^2,/(
M%$5B&JQ!E"M63>@6[W@<?A79-ECKC)$&R7 @9[?U<@<% =^&0?J,6,P2YA(6
M$1O)7E IE""G.1FK"=+IO=G-WV[%(0< 94Q3#AV>62CW43A!WR?(Q0"4!M:)
M45%^N$G#42T%!()ATN&,(A)Q- )7ZY NM?:']YQ;3'J7E/M,'FW0"B@'1<.
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M&(S?]>3A3'$(()OG&@IE!:*9V)(K%R#K>QALRS@.,*PH5*=&$JK!M7/3]_\
MF>G[_P#,]/W_ .9Z?O\ \ST_?_F>G[_\ST_?_F>G[_\ ,]/W_P"9Z?O_ ,ST
M_?\ YGI^_P#S/3]_^9Z?O_S/3]_^8'/X"-Y1#@0B$M_P1Z'O&U!G53\W$D/+
M;&[[W6=!W4S1*ZXJ\#>^GEG8\X63GZ&%')$/B(>I/0WZ9Q#4^J9X^#01:?XK
M];!=7B#/ -^<"<]C9A.)MR;SM(A=76$T.LTN'>K<D#A-V3D#'$E(UHY]3G!,
MVWM93Q%;),_1_MTQ9*9*&BD**S8)49/2\]#"TFF.U81)CZ2 K/X[M\/5T-#L
M4&QTF\=,:]"6["DQSJUG$ZNHZYQ\LD 6=#C1'YV:B+JTXEAI<2=XM=0)M)?0
M<;H;@$N,<[/B:*E8G$)\?<XI=&-XY%> #HQ>,&$T2I^!,@UM(X&MAHVMXIV<
MU(( XTP0RU@$?!%Y%Q@;*Y8GP)$4EA+NU"VL#WO,),R DJ7C*3-3#50TX"C5
M8\8?:O%@ P<%?%,A9U"7G69NCL%)"?1[P6"*V99?<Q!$01(1L1V)R.#D<8!4
M@TG:,-( ) RDC-C1E/FP2[1HXFXS<5,"L 3@-29&T-6F0OLT8?PEY0L=566L
MG:+ )#=-0=N\)RKQ%)+> C&L A$+@($.6!8Y>>-)PO)$?&OZ[,0U\-"$Q89.
M<;.44&1<#BY$7-L1E0HY<"' FF(. !    _*WKUZ]9PX<.'#APX<.'#APX<,
M&5EW@Y&UW9>N!+M@H)\/[L.'O5O5+$YO^X>0D8 $;GX'Z&2W=/HL4OMDFNUJ
MSS^HPV#-09]?0Y AE Q15I^Y.#;^^J^V=8',[],A$GVR&M42 O/2$%O.+6TY
MYSJ^<[<14?0,XNT"NZB1Z7<?"F%5J)XHKX201%/[!,69\'Y;8<;M!L$Y#GC
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M@G$#'@U51 PQ0QBZFHGK.H4DN&1$TG0(4=-ATYZT-SWQ5[ZAQA2].(=;62=
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M5;O^F6&ZL (GH,"4X/ ! !X"/\UF+( P0AQ%16)1C \]HJM@&'HBHPKTA%A
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M))))))))))))))))))))) (
M
M                             ! (
M
M                                      ! (
M
M                                               ! (
M
M                                                        ! (
M           'X$:>PP
M                !U]'6@Y0
M     ! (           $^P@PPMFF
M                          0_+BK:@
M              ! (         _"V&     #UF@      (@    <+2
M                                  !D/)&DD
M                       ! (        X'F !Q]K.^  RV      "Q*T?K
M4)(P                                        *HW2).
M                                ! (       "" !#EHYJA;PN GD@
M   "P G+H$+N0
M                                         ! (      .V  @,R&
M L<SV !$P   ()CEM* #L0
M    !(P   X                                       ! (      X
MP.1<@      !\/D Z2    =]WNE2.M0
M          !%FO4%;M%:>U0                                    !
M (     WV!9IP         !=D!#
M                    R:][KV1[7W<N    );"          +_W09>#%6
M        ! (    &"P)5P  "KCZKTP  />0 B       )/?$    @
M                             (L,SLL H\I\D    )+2M(:>0*[M@7IU
M&0AK@X%6         ! (    R$*=P !@7-NB#O>&  'CPP0 -?"F$M<V=D K
M<2                                   !%WU9U >S7<Q^    %2)TX1
M6+Z<YF!>       ..>@       ! (    RAU.  #=N    !O^8 !^>#  +X<
M.2LA"J7&Y>2
M   !MJ=H5<Z=@E5J         !1L@      ! (   /&/T  XD@      !,4P
M #IP\@!P]SHWBX<W6) Z
M  .8         ,(1D+J4[!4&4N#         AY@     ! (   *A_P   EP
M        2/P *D!@#YPCA]'M\66>?)@
M       [)2C(>*;CU       !2B:W".A88C@K:P        *Z@     0"  !
M@#G  6^   9_$;E<  &&  "@#@
M               ;_=-?,<@A6AP       2_W.XF7@"B@*>-@       #/D
M    0"   0"3@!,@ "./$"78&L  X@ :$(L  36  "!
M                        <4-6O$#!VU"X       #O"8UE$ #^[+"[@
M     03P@    0"  ,$ , )X  /YL   #CT  <7@!'A@QS&)&#UUHM@
M                                 :=[DH$4J5D<P        >':0I@
M!S_\NV        4!%@    0"    %@ =  5<@     #@F #J #L!C"_'QP\"
M2NVV
M  #E8_T    !F"*@         /<    0" !^#W@!8 #Z\       !B$ 4X 8
M<$\3'+K\N!5%P@
M            )VU !FC>F[4P  #!E\N&  "(    0"  0 \ ?  9B@  !RE;
M  /< "  "\/D/3CCO[@1Q=
M                     #S/ $NI5Q.B@  ;WB@<\  "T    0"  H(D >
M4D  %/7#OV !=@"8@!T ,
M                               1&@:"H]-/N;@#[V)4CI   T    0"
M !,,@!U  (  #C)(VY@< $, 5@"OAP
M                                        -="ME?8!;^>0>LJ03H*\
M !,    0" - 9  ?@#X  ?U@   =: 'L +  $ (
M                                                 "R@.S00N1;$
M0T )!/I:,  @    0" " +  X =X ""4    !T@!8 7H (!)@
M                                                          "E
M@+!-N))4@?*A L<=[<  8    0" $ ( !4 $  &X=:AMLT. "W@"$ 4@
M
M        >@  '$ @    3V9+KH@ !L    0" ?BH  < #@ ;>F(U*= .P &
M T 1@;
M     ""          *$           $H@    4<    0" 8 L #( 1@ $5E0
MKZ. 80 ! #4 % "@
M               0           4@=C7[9:$S         P@    0" (A0
M( ,  ;, 79$  /  ?@"8 +@/
M                        0           4 ?9NJOQ_7\       '\
M 0" 8BL  L 5  2<#*(-@#>@ 0@ ( 5 "@
M                                "00          1F FR3G+164
M  #T$     0" < \ #<    .*/\ 920 .P +  ! &0"X
M                                           $$           /]L;
MP0\F!@      &-X     $ @  &X ] %7  %@1SLX  H WH 5 "H P   $
M                                                     D
M      4(            'T8      $ @$ '0 6 $"  <N%I4  ?  $ !? %4
M50 D $
M @D            %A*          &)W       $ @#("P \@ K  R/S7UR2?
M $N #P &\M $$DD@
M          $@< %8    ^0  F [+       $+66        $ @ ;&  [( \X
M !+D;*6Z@  0 'X N@&@D DD@
M                   $ , ?(#&@HKKAMZ !.3;X#*N1. Q         $ @
M<"D #\ #C  "7GZX   ,X PP *D'@$D@@
M                            @@#@IK_UK66%L>W   &,KIDZ85
M     $ @   8 !) #_@     H $") '# "%#C$@@
M                                     D$?($%$_O>5G)+Q
M              $ @ 3 @H A( ^?  =G*B%J8@ !, "W$8$$ @         !
M/  <KH     $!;  "V   _@                       $$>H    3
M                       $ @ $ !P #2 %.&$YY>UPT0  T@ X0,0 D
M         2+X/!(P9O+1%QKXP%B]3?9@>FJ5\ 20VKU             @W$$
MB;MPK--FP                       $ @ # 'F $O8 #.)=/Q>O8P %X
MGXS D$@           )Y3^_T;%!<YYGD"X'8B859CC* -(P."M>5
M     @>>'+B9EELST                        $ @  8 ?@  _  ;#2%/
M;5WV [@  9P\MD-8           ?WEYT4_9M0:0K,3@'A.]L9GB3AT1L@T)I
M%            $@9D!+TN$S@+A@                       $ @  $0]8
M'?0 $1(&'L0QA1_@ &1MIA/SP           GW#$:@Z7&H3/G\X "@U3"58[
MD@<&AL4)/T            D Y(H      #H                        $
M @   I$.  ?:  SCQ'K6@0%  %F*#O$25 @                 $
M           9@&L                @@ $H
M        $ @   ;8,P  ,A8#!AJ15E>>D N9*@3I>@/@
M                                        @ G_ (H
M                  ! (   !BPUJ  UQ@!Q;FK;\0  (4N3]@1C'0
M                                                   )!MM"
M     /( , &*!< #           ! (    $F)X@ !^ZH8+_L?0  #J-$AX\-
M)I(                                                        (
M)-ML;         *L"X#."@[63P3J4       ! (     L!V"P   AIX8^
M-F0#!>XUNDH
M        !).224(        "@Z9-".Z:&\1QSZ       ! (     (P!2"P
M        "EF @.Y.()                  E 2P
M                  !&DDE#(       ,#YS"8:1'?8RP88       ! (
M   $4%7C       ![E> *6                     '.$$;+P
M                           !&VVWN1H7>(,
M   ! (      $(P "[&N  !S5QP F&P                     A-. />J
M                                    ! B5&'&+MME)MX
M            ! (       "D@ %],/O</!> PR
M+6    !C$ (* D                               !*WUPVV]?X@ "Y#
M@                    ! (        T>    HNUT  &,      !E0
M         +"     **@& ?T0                               (7I))
M))(KP3LD;*'                   ! (         !^ V     -'"     ,
M'&I4              5H&^  /P" Z4]VDX
M    !=__ /\ _P#_ /\ Y-,1@GU#Z@                $ @          /
M";98'8!0R      /+ZX@             %E 'O5WU %H^,<=FX
M                   $GH $       $$D$DA=D5$              $ @
M          3\% X         ,4C_               +8 (8>?/P!<&8.Y*6
M@      &]                     $                ( /
M     ! (                           2Z3@             (J   <OB
MP)?M\4Q%W@  & !\\)K3P
M              ! (                          (1*$J
M 'P   !!8 (Y7E'@!]P  C2-S!P_K"                          ()
M                       ! (                          .&*#L
M          /X   /.H /@ !3P(<0'1 !WV   +ZP
M      ()                        ! (
M ,8YMZ             !P   UP!^+0    &&QY   M    !GB
M              ((!)                       ! (
M                             0   . !@-H    $:8$@ !G0    !Y0
M                                                  ! (
M                                     &@   B  B)@    /K( +[-!
M%Z   !FP                                                   !
M (                                            *@   2  3%0
M  5H !S.V.#WK/V 0
M        ! (                                            (*  !
M'@"B7     (6P   ( /[,C.A8P
M                 ! (
M    (&@   AC?*     !Z    W $T3;"@8
M                          ! (
M             !TB  !/P3P      >   !M0  !)-!7P
M                                   ! (
M                       )CT@  "SP      P    DP #/J?@I@
M                                            ! (
M                                 ND6SBM&      !_   !60 ,@;!L
MP                                                    ! (
M                                          !M\AU,       *V0 !
M;3P %,S1IMP
M  ! (                                                  )
M    !< !)09-P %@+0
M           ! (
M             (P0I  %_P  #5!Z<@
M                      0"
M                       "P*)@ ",\  &,-D
M                               0"
M                                !.J2,  (L   ")4
M                                        0"
M                                          (T &9(U>S3R#J
M                                                 0"
M                                                   [T !G@#GV
M4DW4                                                      0"
M
ML\        9Y@
M       0"
M         /0
M                0"
M
M                         0"
M
M                                  0"
M
M                                           0"
M
M                                                    0"
M
M
M 0"
M
M          0"
M
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M7\>WGOC,37?^@CY87^J/PO@H@)L0T>XFF(*!'2().T=9ONSF[+WNV   #@
M] U@$ /(!'V<VW9WW_7    X  /0-8YY"9]4<M7\K<'VP=!?)%^H(^YBZMNE
M33LH+\$$B"/(['VQ=5/=1^KBT"NDN#R,&.*V[5Q>*P+KO_B:$4.0#]$.?DIO
M<XH%4 Y5@>[B;$GL@_1K!47)4! <J&0]<2,&HH,()L(-&\FLHN (M2L8?/*8
MH5D"9(+) 'A#OG2'6W.T)^V ( Y4 >JP,7C1R)GLG'(KV>^@..1'LY]$<)$E
M&A"B+?5J;PK=&2]$1!0@Q7Z !\BC6H1W)+N?KB50<(2""I;W-YS\XJ[&?DM/
M<X5#N1 ]T&!$(Y#AZI![XO&W0*+V@G_&@5AM<'7)V_/SDP"=>AV]?7Z]<8KQ
MT/R?&>8[FCV8G4^N"! E?J(B=>G'KTA %QL/1F_U_?$T$KR:3?1/.^\X.,56
MNU_M:H]XR,/ <WZ*';G)NBG)+NFP>W?O,-I"%X$=9RK[XX0A3?C\]_BSCL_/
MR_[Q.F1-<,\YN9U>9OT]//\ E3&/)S9H(.Q[DYQ-#QJ&J0\KTT;S7=Q"-"G,
MX=S3CN0UT"8G1:<.OHF/C5V,A%4(NIIWK6H4_"8H"2 -K4U-4AB)6PPVAXUK
M&TL9%;1=&QO*502*I/7Q4$*ZH^--PY&[]-YO +14K3SD&OKDNZ%0D%+F1T'4
M]VBDK.%)  !T^-XY0!;07 AT>0U)@!: B8%V>YZ9;R#%#6SH&G&0I0.E+ Z.
M=:8-L%HS?%=8CI#"(+%V3AK2=KDC:$#3*6A2DYZ%RB:%!J)$-W2_CAJ6T22+
MJ6]>I@.6SP<! @TW.?=QD%4&\K;[G\;_ $@-M;@CK=M#=W1R981JQ2YH&BJC
MO+R1'->N1['E,I6-!:BB*=3QO//V<@-@/(_1_MG>P(%N -J]C*UD!D,B8$-7
MM<-7%M@.%$#I.F!NFG;AP!7F4P^TPV9R0,YWR==8""FJ>9MZM].OG!"ZY(Z#
M8(-'<Y4Z8<WO+LYT-==O7/!OG>IP7VQ9SBEUM%^F\3V,!0M""BOIR&'I:W<3
MQK&=/OQ@?0M\2A0%>;9L\@J8+<O81$_-Y+ %C<= %7%9RUD#("*Y'J;Q.8QU
M!T1V/_Q 5AS@&BKT3C_?Z??#I+L7M^<?\Q55;\ 0*: ZY-T-)N-O7D>/OD&H
MG#I7;1/=UKQC2K34UZJ/7S<5555>5Y^<FMP$5MG,[.21E0WX:+WTR5Y(;]V_
MFO."%GK'T:3 3HE@_7KPW+]0_4?GUQM\)5^L'Y]U7Q5/NSI[=<14PV(WC0'U
M\^N'*\L V=-7/37[Y2A;*&:YY7YZXDBA1J)&/3O\]@5X6/J=<-$!T&H>_*O/
MUZ3+9C2Q6]*R_P G'-Q<%>!&'C>WO\5*<=3.FG6S\/,Q%R#^?7]?7G^OI%6/
M9!LZZ<6):>3Z6VV\9+[:1')Q?)WP;58""04+K5%XPZ28@ @WF==8<YE;87OY
MUS]L:IRH^J#_ $5.EZ<*/!W3[Y*C71"O8Z'^$QZJ"+3![G')LP>L@ZJT U =
M0FB>JM1<&G;;UV_G&#5:/S(4A[>,ZC( @D3/1<V&3E:UKHZ]YG/Z?J_$T72$
M4*AO;%\L'\8LPE.H!&%&'$X->,F!J$FDEHYT[M?MA#5+8$(4! VST<(&!<JE
M1=G.\_,\L1S_  $T=JD=>@;GGO@3A1Q&)+UUFD=0K:$*>CA7=:F])%[;/R9^
M8[9_$]_]/$#ODIQ7R:U5 .TP"*Z+Z4>HJMMV^,M2D&@V$P.D=>^03H=I ![%
MVG&"A^@=YVQPV3=7.^! H.@4&!&RG&.]5T8WJ;L^F=9DZ =M6^?7#-#@W&RA
M$]3"$=U)/S<8[240XC/#G7./&/J/ZX1VF=U?QD>S]'XQ[/TP3A_3^#*</^';
M#G+T3],%(6%.#>/R^V6A4Z"WB=9<3<LK,>QF&[KIC,NBI5YO3>+C>M3P1>$Z
MRKB6I,"PVMW2175N!!I!B,MN 6T5Y<#:$D8(X\=D&$#A$!_81[*U'WP>Q@=H
M&^?S,KTU>K6@'K<F4^^MS>;3'3$U7+O>^6W&"-I4KJ;WO6LZ@VNS;WO-QP#N
M$*>D=8<,=BX]P=LB+?!FSB0PR.J:IZ1&NF%RHM0'-=ZGWYN*Q^6SNO<=+<$1
M(*W456]H=!F"QP6<=>?4:KMT,&+D?ZV!#/%XX[9M5,9;;1""D6AZZQB)0PRH
MLZ.RGT?_ ( *@<N :_Z?[_3US83?5_/O]#KBW;\!:$^G(<\=>N$A@M9*/IJP
MO^LHPW%.$=G8FS6K'&KE>ET'0]OF8( "47N@/?""M$8=[T(^'ZX>I.T&G5&C
M[=\-6(X=).[L8:B]C#C^*^<I:/39=J*GK]LJ^.FO?G?6OS21QLY=]\]TGOZ[
M;C_GG('F/"[BZYMV'4&_3,=T=B]X<^/O@87U%3O(+D-H!IM_\8P!AT+OU6^_
M.48=J15?3=O?Q@&^4(_0H*?SC(LY$O4!/I\S\JSM-^[770$[=<T.J322]AW[
M\W((HWV#N;6^)Z=L1%$B:1^#L3\_/SIG3&S9_&;'X/SZ^O/R'-A8';3@:U$B
MOGIP@/0,78@;[;\IFKIJTV;!X7AH&NN)]K1(W( @FE>G'+@V<&'">$S59N=\
M2;O!BT10M1>.F5Z9""Z1"2[/]S'-W81PF@A@=W?3G'*D?*E1;T."ZT90.,<[
M<0!$CK9KG?8_8P91I19!![F8@&4 I2TFL;C R6OB17FW".APIB.9P<%_7.>F
MZ;?<)]!]<"\XG$V=YZKYN2H+W2HK>DH[Y^X<XJQT%W!<'=;ZW+Q"Z.PU0 !)
MY3KHU'X: =#7.*,1(7?H!L3KCBDQI2D6H !1KW,W(Q890:@'E&<.\T:RD EB
MI2=3UYPLDB$+0T!"'\W\-GXOM_A(-NB?8=8>^O&6?(1T54'B.8[[W-:65*7!
M5;OC@GIAR!P'H$Z#*Q==S-B^542CS4>]\G.*+"0:!0L:BB$?68?,N C:(N:B
MS?G4R<QHT4!03>RL7>%X&+M $.-#O A&U>X-O3B7#@!.BBJ&Q$/]ES2$ @JM
M+*77DS;I!8;BNG#H[[>RP1X-+0*;HN@.#!/0K":H&FNNV'4IU6L;<:Z.]XIV
MW$T)!Z3#J(K  "$YB<DO1Q9,% F-8HB%@[\.\'X*KO +"!)..VN[W)HB0 "O
M!R\^^&*"-HG9..3%6C+@D ';KKA+!0@ @.33L?Z17IO-Q:D>D/$Q,<RL'5.\
MB%!2N+.:&ZD4-'-3I.^44*"[WTZ^V^_7KRQ#1Z#N^>V^W'[3I@DYXG'3._S9
M 0D.A.JY&]=_7!%%%LSB7-]S?ZXI!:5@?"=1[?680)V4E.K2OZ'IB#R^. \Z
M2K]><$1SR&ZEB[<\>> M@.EU/9V/9UWF+A2\4#ZZXQ5N8XL-&@?0PF%/#.:1
M8M;UKM=WR;]),$A 1^R,-X:>LQ):8Y/&R0[P&1KM1.*MTG+Z\YJ'"S3\=GGD
MG'7(11H);39'MTG/MCP!JF,*JH$JU #?&$K6#B7H'MB'QA=W!4-I2(@H]\;*
MV!REUO$O.-*YM57U:O[!4%.$!Z*C%R=A1('11=.9AT$0H'J *R<PN.NM$=NP
M7>H<O34<JB%\AP1P82\'KB7O#N/)5IO4^?[Z>K?3^3K^=<(*;>WY_OTQ;M^
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M#".P!]$3+&_YW'K N?8_/U#@ @0Z0 3L@;RKN^=IZP, @8:  ][+?-P" 'D
MC[.(5+N%^H#GD->H=[+?-^"RJO=5^J7 (!V 'T R1H^-1>91F P#L ?0 RC2
M\N3>]EP> =@3Z(F(5;N!^H& 0+9@*>6A=]<0\D(=<;1=8 $  X#0>W^%(1_L
MC] S^-3N>;)N\XWWI*\/&'$K@2>BD?KE1WPA>P?MG@3=C3OM)YLQ*@U*"NTW
MN BAL4!.XBCG_7M Q]F=YJ!NEX.6O37P+%K81 BI>2"@4TW 8(HZUN+1LL)Q
MBSJR2WH44>9'7!Z6)'0&@Y=2X.VD #N*!]G!U+.44]5 ]\C0.'4.TW^V"((B
M/"-'T3'HGV<^A9^8O=[^PJ_^!NM[M5%\=C)H$46H9@C(H;H78]'546LT@XBZ
MF=9H<DLCQ[67(Z5)W?RO5G\YOI]ZZ?KOF^YXRDWR\WW#SSN98)$G6KOO7KZ?
MS5&FYU[\]>L3_6<%84ZN_P!RWW^N<4AC2]>%_/.).3?._)KGVU_Q4T@Z%80"
MHJ&.8]./*4=!- A<,X&QE()+931"VF*9TX"M"DC1H65W\!AZUV=&>W/?> X1
M6&U%.?3U]>VW-[A^I,TI0P;!W1UKI_$B>7 G3?9Y?R0*A[5YJ\<<N6A4P7D%
MD,BZ[NIC8E)2!4"I%>+]<(H3F$13C?'COZ7%M^"I )T"AU\G,R+'C:3?&B."
MASU_L@&,8-DBSVZ"=9<,[<>TGN5"\['=Q]@]?U?\T^@]1P*!SM+2$0%"S^V!
M6&UP"LNU?W_.GOEH.#_I^?3X H#:H!Y6&" $QWR-:>T2_KE5U.&GZ7N)$X\_
M*[XHNE#% 9'K'<QN.D\(%1&N!IQ.V*N@LTSK4HL=QR=N7'@6J&JO=?FU]$H#
MV#KAVUM5G<0;.N ,)D3#5[+SWZ=MR@&Q8>IH,Y/1[[R+0ZJO5)^<W#(^F_KI
MRO*WDB>"KK\[TA+)*A]QPN[RHEO[K[87<"B5X$WW_1S8BK0 Y"FOVWQB*1(C
M$>B?,(NHP C9W'/;G 9:!!(06NP5PO; . B7(T"J-["'? CF9$4CKU/D>E$I
M,F5$QUF:LYV[.^.X;JPTEZ^5^O/QW3D]-_GI[Y!DT\_GTGCT_P E/5,*\)*7
M8SO.,('J[AL =<(]-=,(A+LZ1Q<L71TV]L)MZ2*,"M4"$'U8XY@%G0)0>>!#
MOYWC^P9.W8KT5\>3*3Y&021[[4[YMG&10U1Z54*=U^CUT%0JB$WBWCKYUB\I
M C2*%/,68))3W"#TV(2^[\'R!'24&"\[5],>6(56S:EY'WS\CW,<0Z"^F(=@
MTR861'4=)UN]XYJ;AW=[;W]G7"=&"0H^"#J,>="SJJ,!S?8)VW-IKG!OS)P6
MTR"$U'6[<'Q&7J@2 *"A&+SQO4R+T'_G]ARG%S<D1$>H8BBPH2 4M5KZ2<9"
MIY+9!(29U71CCL%$GDUO\_;-N2.[8S\_3.&=VOIO]&^^<$#X[?\ +^GG"^A]
M]Z\<GURX5UR;^G[\^VYBG4'G>SI^FWZ\81 P512#OU3W\8,H#<\'P" HR\$7
M* N)J*(Y *L\8@\#JE4>JK7XDE#<&Z2-OZ.(V!($4P2:W73^V.O-(F@/0ZY%
MJ 6[K?SQ?22D-0R:[!P<_37PA@2LVTOW$O7OFA6C3PC3[WQ],Z_98EL?T#B0
M 0V/9.,)R-6AR\$APCO3K#-;!>L8*7Q_OK_9.2&9B@ ]$01[F+=.\!0'E7!I
MVY< $0MV8)H$NC>'E8^JB'1Z^G]K:O!QZ\?>O/;6:!RZ]NI]'X]^5+PIS[/K
M[83H I#D'J3B/H^'A2E6JJOJWY$CZ&*C2F)NE :R!G201(@*@8H):"^JO7P(
M2,=R4G6B,-<JNUKW?E1?X50G52@;2UX,VN5'S<'7."'.^)@D$>A@$=BZM*W"
M]GPDHZ"7'MKC+>IH/?/ /&_WRNL+ R+Q.NH5YEQR\1-3OF$3VR9IE>_]YN9
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M_7ZW_P /<T,W* 'D03SG1#7!8L4$00'>(=<QKIL-I19W_N%>0^N !#08\P'
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M<-T[HC5T7>=+K\J<> 1#OQDBL!R-0>A>NO3Y@14T%%'Q-BI$V.\#;KF4P%%
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M8CNE(1WT&STW\C&E4?;;W]]9T@!ATVOZ?:<XS+E:_#D[=>M_/SIP=C?M_O\
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M:M:);\8H5*>557U7?]WH>SC]?WZ8P&:>OE[_  <-BB\:$OMWPOL3=[WKQ<5
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M0Y!.3$=7HA%!38P)$UH^CB&+AQ!L$:>B')XQF^:(H=Z;9?VF%"!![@0GIO\
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M*Y^5Q"1*/(M'VR*Q9 04Z%#0J=!T_P .N.!T/:S]-OU,H/%$ZZ_/TP*1_CX
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M>_C(9.K%L%H!N\37Q%M-@07P+K'M* P450!J7CY#10R*#"$%T<\Y'>-B%$T
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M.%*J0PVV#6YD]7.C2M4("4\1ZZ3@B<=!0A!VISK(+(R0-)BQ12=]9.H&0J@
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M)KEUJ#F%*;XF-NA-*"%&E[F[YRS8G.A!)PIIROG#)!3W/=#R"\\KC#8QRL=
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MK^<>NTL77M\0NC-AH[/;\X_WA6X#EZO_ %Z9:G'B]_O^?3%5KM?_ )AX-#L
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ML>C'HQZ,>C'Z.1_4>[E%-M$0O<='CP89I+H"'2J/6R\^,5@&7;G5LG/%Z?4
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M?+:VK\ (CQZR^,=-@/:WC5_3_P"\D"$$H. J:!A"UP^)LHN@@(<D@>[>,
M    @0T:X_MX<S??^A1WO/[H.4;5_I;CVXZ8]&KK3]/Y+?U<Z(3HF="WIZ^F
M+X-Z%4OVGFF\X/,"B7QM3"C> 2^P_C_[P/"/3 NI]7\_3/5?5_B9X_NX#T/J
MN>/[N>'[OY],\K]?]8MU[Z76*<O]D":X$E'8>4YZ&%TV'-"NB"2BF <*2$;
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M.?KK-[/*$:>H&WOZ'ASEJ4T2((=O'73Z:T3)97-H=>7]LIOAHLX3>OR.2(V
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MDDU^>., ( ))-3MZ;=8--UP#DNQU7KA/3V4B B@LW],8ZX1UHZP0=>?I"V:
MU H$[C3%E 5JFE?/?W_;X!.I0%H@G;>X@G! "&Z!M>AY\-$1"VH!KH"!KM_Z
M0 %Z/8-+D1CK'6(K%@LJ[C:1WD[2.AP^OIT>VL1%'D_H5MK>]W]<KW?J_ !T
M$5WK5YUOCBS)T%= %5T]7#XG*'7$W=A1DUI_K*+<7K+]?S[7  3KO^BI6TX[
MZSWN5C43X05XZZ>WC-P6_0*?G''SEI$!;@!X.0>]QH9\W@!1(=J+SI,/"M!2
MHC3):>V5A@-@C&;+=-^,&"VH2\4D(A!P)T=>GR1@H\=$^!R"##PBQ\1F]2XR
M)8[,_1W.TQ5555:KRO\ Z2%G59"SV*S3O^,&4H0V+(P%A4*99V'W]5W]._8Q
M1(/://?IT]_;><DOH^VRE_3OF@">I\^Q#&UZ/\_IY[RV2H ;5XAY7%6UT19U
M Q CK8DI@   (!T#1_6V315H%'7V63SQ_2>$$H[BWQ3E0D!< !^-WS[XZS=[
MX!^S\K97T"KT-7TP8T\&9\6N\:.*!-2$ D'<USC8_>"W@#M-A<2%Y^IQH]&#
M>>,9\@!LFQO<XO'AQ1BZD$-D0TDV'3&W/>BB++<(:1=!\!98M;./+KE9SD1*
M@#2"N-;2_?UQN=(O49_Z4M%H@Z9 I"GTZO=QTW9 9G1L-Z/7Q@2@'-%^BS3]
M&C7UESE%ZE_7TQ9LC#C1J].V^/OV\'Y^;]?&LMR+[I^<%[]<9=%>M?\ GWQK
M3]&C[OZ_?%1"G-T]])?N2X8+G@#EZ_7OWR7<]#P=$15TB-_0   @: _KHI)Z
M/+13KZ8>>@0A8!-BFQ'G^B)HE\4&#AV+KMB<HT1B:2\=<52FJ5>ZM7Z_*..1
M@/>J^N^V*".V#GP@DBZKO6$98I!#?$*(U)VR106E+6KU[;X]=8GA*KZI'Z[[
M&;AP@&^GEK?MUCOX5J$#6\R2CQ*[A\"96_792NS09P7'O\.^!*"1.RO_ $QU
MA.R']3#H\:/6OU8HB6WD'B#\\N/4_MM[=XZ=NKC%Y7C3KZ?CW<(:49W-SG^%
MZ\8<"K%(^)5N+1C^:I[>C@LY4"+OR1UXY]\+<D1%R-ZG42;Y4U@(     !K@
M_KC3T]%RH#R=RQZ;N45 X;EAZJ13FNPRY.FP,HX4 ).";Q^8(NFSY2F"!,5@
MH&&]KQAC<%UOZ!3W,6*#E_@.<UFLE"X';?WG. ;UTVCA)IT>.=RX*T"'FL_?
MY3[4P:.%>>=KZ>.F'H&LTZ7!$:))1UA9^JA<$]$<3BN"M/@MW)5.;Z:AXH"H
M1-NC'J)/TO8=#%,YYG7GX(P1*\8'X O#%DYR]Y:!(5=**S9WP*0IT'#0X$E"
M'O<555J[5_\ 92>&DH),H0&U>V;@'P.CT)TZ/IWQK$C%-@" +BO SMAS>(B:
M]AQHL59._P C5$)E2[&%>'I@9H (9)LI'1Q=&0['TSQ+ :\\3GKE^>BT,D$0
M"/?[Z[5KHE$W;4HM].,-A^:H@-<.^^6[,17S3'[?1?KTQZ0.Z4V1%#F=OEC:
ML:6#&@0G7EQ"@(5>++J3":1IKXS3#Y7>#K<JZU@N25*"6 )0[7IAW3'0R@!5
M8.$P4<B ,:T$.M3=P#NM$GP HH]4\>?_ &5Z8=#0!L;)U2^EQNZQ1)OZ@Q9,
MK3*]$'5*E#MN/3"\C!HB 20@X:'@/@5G0=5(!V-IRXX=B;Y/EW83=>=&"7L
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MP0H52!@>7-<50L%J(#.)H(Z3O_[.>X5(-,ENI#=RE0!%((R=1X7UN*6"$V8
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MO/Z9U..T^KV\<<Y17?S]^73>T^_OQR]#)'3/^6E[%U?!,@0AK!1$;))N.<F
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M[+O%)]<Z;6&:QLI,G2)P:%(3!X;F:Q'?$42804/1$$<_YC]R_JR[3BM2&UI
MY9^ ")."JLB 20+"]R-H%435FQ0URSAK^F&0"Q2%ZH<12A@RR)IZ88AK%3U"
M,1, T8NS6-"-0&%Z 2M-'3!84Z3?8_7$4@1*1$1Z(V8;)G4CU;/=UG2_@)W@
MD(9YA"B)B8QS(32109$ DDB!;G(@#$B$"42&[N.V]B-P*3])O9J%UNN\DZE/
M<3]GO&\VD>^S']917G47^/W3D$U[>L?<\=UFR#O%>W[^.=CQ\_N=MUXY)4>!
MOS'T8?UG8Z^7'EUA_$88*P!MUW1Z:]NA4YF&$J\0!F>V[CK@H91:X&"H(9Z<
M8# H $^;M\U^ /+%#SBNG?KQK'\88#@D%\IQ>)#H+]AQ-KH6H.V=&M^,9.7/
M-@$^3X=?"L R$"CTF/3NY,0F*Q06]G'3].+I'E32@K$*:M/+%&&!6F3B=#._
M":*P5@A30&-$H=@]7IS!I1N3O$AUWJ^G\(>"P@-=G8^&,KA&1AX5T+ 1-=,M
MZ2EH =! E7GSPPX@ 1!+%-)_&4!71CQ&JKO[_O67 M]?#R]]?@H%:!7P"7'3
M7Q)((GS2/OE=-REZ=O%C43\HRU#"D&&!VI*>&"Q,NR2PBT(C:)P A(-)VM(4
MT[:M@QX!H 0 = ^9F+"KP ;O%4E4D$<0P3YY#&.11V[62P<Z8AWV)UZ8^$J:
M "\GW.CA=0^H?C&1J$6,G&@Q@;32Q]/<4SB))]@H\[A/E$^F2P*F,WSE'1\9
M.<#K:5(7A#G^NN"((R-B?,PH 0H.2AF+AT=,1M8"K:P 2"!)!-:&Z.J9'HE
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M7W)2RM$EJ97>.\6'I2 OC;1!BA(H\S?R19%[/U,]PZ,^NS)9%8BE6*J=#L?
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M,C3]!QT$^K'7OA@=O(,B@3N.WUR=<<46$:"P"WMZN(,KK5,K(6"HI]UBG1I
M8D-A9DGKDN,(0(L -O7%*;&IBH1 U,%YVLL"7H37AD]')6I"'1B4M@WC5&UF
M<I@A39!%8-4U'!4-;!%&^=U)(C*HY0#B (I0(B2N2H[XY$ )I#) GZ?[N_D
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M>,>"*A94 \XM)D!%#@DF$":ZY!EH +2=NOA+OM"2Z TZ[CVXB*-(P_("@+5
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MBGKY;.OQ@5U8>,)7@EY+!;$>HG]=.EU\D/0>]4D&I8T.MUD"B1,Q)E]9U-N
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M6;F<D*<0@+DI<#>+Z;#&3"+2MBT$BL70&;E4P>:8K7WHY)J$U,+*V2)\+R6
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MAU+//9F?3K?R!W3\K?QA9.(O&_R>S]6>[=_CI\/UFGQ?O_XB%-"1!$A"U"I
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MC@N80"20+211RWMP=)"!5Y"L327%_)+?D * @OK(Q.APXQ<V&!8D)+)'6:=
M!;6)!T)!P2&KI^6CMEJ$(KF!8B&KQDR>)H:A\7U^07&+[IDD*4*%K* PHP@
M12,^9S?6_DYC8J=$3\.X\-Y! M<NP'OB?*\21.IF@9MGV]OSODH/ _\ %3K&
M0)$:1\3%5F6$>FP"OCN*Q28R&!>BCS<'.#I*4@7"I5[O0,#+:7($\/K_ !F4
M#%")4X*\KK.G*5)Q,$9\OUAEYD&^O"7K'7OA!@!I,BR"=KZ[IP.!@!  0 <
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M*=T*$5&J^V&7 0J[ZC\<8;H0>+H3?<9%4 \C/AX<Y#=ZFS0)!14^%Y(L8S9
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M6**26S'0V3=U 1":1T, " @* T'3Y'+4$QRTOX]<A:F#4A))9<;KQYQ#<.M
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MXAI/@GQ[,5+2DK(@F64DU.L;O(B"UIRW;QB%2P)W!38ZO.'(DQ^F0%)1J*,
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M7 TJY!8>9J&YW$9'NA -5&%'4'+CYN66LJ;T;05VR'O-02\)2<GN6 @)II-
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M@&ZP$$URJ_Q%#>HI"(H@PO+N9$2,HI(CN):/MBQZ15"'C,2BD%X0%S24IU
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M8Z'EB)20]'^"L&PPA,3+M@F22FL,,D%P.V]TH**-+C58""4I4L%A)%;O"!Y
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MPHKSUWU'GE#,E,WQ<GOUS4(]6(\+?L>&1T^Q<&?3J7K'3 .F?G#D [OOK@#
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M"]4GWTP T!X5\5#;FH)?Q[[]<6CJT&_I[[[ER=+GWOW-WA]'$7[Y_P#F@@E
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MF+_!"$2$DB+R=TZ*!Y&"E":_F(B0S_4 [:3Q\L)<)@MZ3,>_K_@4%Z$X5-)
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M<)N%A+#E$QLQDE(O6&&!B>7R;UE"-$ J$$4 @K?1QTHB!4T5@N=,]H+(U@$
M$!0306W_ ) KD0Z"J@&8M0=ZQR9.B&G;( 29.3&\9(0E"(CI$D1X_P#1UYCO
M$Q*'UXKZX+V+;<[KWJ/\!7497W^L<S2A?4^Z\OEG*)*MGKVPO/V,K7&_@*!3
M*'O7GCU!%DPJ"0[0GG_C7"206)#8@0KR8R)02S$[ D *'F,>VP9VV"RR)"^:
MQWDZ;#1D58'!01.OCO!3=>JN48N'6PZ8U7 PV1<6T=)1B/.@T(*(E\B>6.M
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M)""=$KK]\@B((Z01\".JT?=?#WIR5  %50!MMH]/ UBVQF01&R!F!"6G)?\
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M(:@%8WXF0B;;8E9,Y0Q9:WCQ9*47B5 A69\.<GH* P%+ERR&1C6RMA+ '
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M6_US7V0_XMUAR%/+']I]8[Y!7&B+^STP"0.J$]2<9K] *< VO@8WI%A"59$
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M7 F\$EFWT'1Y/<P^'D#0!(17B'].>+)6124@WC"DV0UZX (3;SZ3$:.L;NW
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M'B'JXQ[[N:_+].O7 :)T]#??SK0[>?;"+(') '*JPA?)$ZUB+MM%S=8 =<;
MP\5%W.%R+DBDJ&,/I,K8L&<RD'+KF]9\ "JH9KM8W3J+LD.TFL!$BD:C1>G)
M\E-9K7..A0_S,?Y*@GB5N5E>CC=%5(+3"[@NSE(1X@[?"FTX^Y@/WSUMSO?'
M)?IG_CJX _?]"K.I\HY& $4B1<9?!N@LZ$4D%XJR==I^C'4DE4SDL1\R%+9+
M)%!P2FBEW"2#TBC^HD'-4'N_M^=S//1^0^(8 +ON;AY?3)85$*]+3[DO(??
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M)191$$-"[3Z]52/D]N&/-1=A,6EPP2)$@,Q)(8 H0WB6V2M45!GP@B!88IC
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M;$"3%M>J*7XCPJ0:3*W$UE4B>B&U(PSY*A0G,@2$*(8]S0"PQ J()327  @
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MI3HW2*8IV6<?U@2$$;$(B>$4<?[4*JH@M4TC <<F-)LO8.^GNW(PA&T4B%*
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MBFUS_P )K<G[8(.VA8^18?9R$T-)(222<2:G$Q>ZM(_DL3ZVX02 (H4#!-$
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M5(-*!DVB<UZ:8$(<&CXK!7@VX:R5.U.*$1&C.<-@!H3\$2,");H$V2S0, .
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M) T8QSUHKH$>R04O&\23WX5(H"!3)01R:F'TZ@C0=$$-367ND  -"4M"'CO
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M-W./TD@Y8'>/>)OUG\Y< H)WI_%L^O/R+IM0=F2[X5Z.\)D0"6$7J_7VP
M(!P'R+8!$A?:BC.$;;EM!F^%D$&\W?/RNK*H E"Z !5Z#$@Y/<DP1B6DEH3
ML(V !\17:!L!O(46OA&BDA.0ZXP4 !H G]$G@(0D  LC KKC!BED$B@4]0G
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M@*K? X[QL[RZB(T;A;8/H3CXT4_P!!AT@%HXW@CF3FQH  ;I'#Y*HRBFFRE
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M]ME@0&0%W%RR<90S!/DO02G!&W- A(Y&H#MT5LO*N5!U;V+;W[N[7"X0@9'
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MJ[GMC*6AN@:>[#]OD%TW5^P[^F!5W'\O\?&\>A/W7_.)'7')]=_YW_?"@*L
M57@#:OMB+01TCD7I.\]&(;IM%V!?+^E"6(%3%=K(\+CNU$KFWL!.23!K'E"_
MCKC1;1^GYPH%)@%I4;$IX<.9<2%0"K XWCS JDH]D2.#^Z,@%8"O:]_TQ.-X
M<PY+C:$3,2KMUO>6LN,9;,&^Q$"BW!@KH/T$@Y=3NK_&?GY]_A0AS_H_/]Y>
MG>2>V^_]^F^/E=A&$0FAGVSC#PR&VT?7Y*QX-O1'I-YIZ2Z@\$O*%U\LF1QJ
MW,!(<R#L? 5A](K:1YH5U?H88I @6SZX(4P!/1JS &/3QBV;KG@5"""$#,;1
MVHW$'R3I 3'&NN+9<32(3<JI,631+UGHF\-Y8S5)I-L-'28Y*C%NAV1DN0Q/
MQ)2-*@))@I<405UB!; #0$)AMI]P(QJO"FI.5:>I.#G!*Q?'Q*LB0IZ;14OG
M^,H8B4*F[CV'?=L5PX/8^09-B<;>N#G-6)(U4ER\:^3M6O0EOCUG/TP:3971
M8_Q^_P G<-+KTR_*>?D;WKC]C^^ ^OP!U5P^.,F@,ZI6U(1!,K=DS=C0P(,
M$&\'],7:D-N,8H^6.;%QM.,Z7$*D2J#!K1=B 6;6V:./B@0 H  JJZ -JZ#;
M\..I$N#QH&X1T:3$ P?"!>VA^CAI;IXG*F#U4Q7?UM6JT-#0<S!5"#T+N1(I
MA!0$JPB DU!( ]"GKBTW006,0<=0 NL4R?'K?+-6BJ)QFS^U#-$B# Q.%$#_
M  7(9'IY)F^:*'W4F-C=4XP,_<L\2"T@$.VXJNX28V:054-X&O@']Z,A@LGZ
M(K^JBW'4/0.TTXI(SYV5J\-Q W$%1*!+)?QD%;^AD'/P^G_GQ]ZLON9XCO\
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M?@U2>KWWE?W405P=4'I[]X(@C1!'R.QPVRBIQ1O\,.8OLKK"D"PS4<9$]!#
M\#6L)L2KAK+-=2/ H6,8:)##8]@8JR="P9N(2.@"EJC:=O-2J(HFQ#!-G 2M
ML5-(4\OR.8BR,:#'IUIZYP\*;-@AO87ROO(X;^P*JZA0JHSIZ?%RXU.@!5^@
M8G%@M6R&W>^->,*< @0"N>::O+W\A4*C%XMZX_SSCL$_!#U]??KY&"K*3[B?
MODFED?W_ -7X^/7_ &G^,>?X]CC]O[XJ,6/<@R)$6_&H)Q18E]':UTN+3;7)
M6X"=]@+^G/&&<X (A1!1$1%'"5;#J(2$+13IEJP1[9QHW'=#-X:PB*L$0/&F
ME"E9?T#O5@U %6&3H N!"V$D4G+>.UL*8%BOTK%K;YQ<C6 FI)SM:G:W.HOA
MA\(P&@:-!BZFC1H$TW!#QD';#HF!@'   '@/AK#J:B0IHR@IHI< &R .4$0.
MC07>/M %J"$]%GA"WX/#YDA",S<B%,*ZSS2^13IP#H-EQC^&BY5P0J4UQ_7<
MCJKH;$B.8EI,+LMKP@5A(%H$V)= ,+>G7<T %4/X0CX.       ?II!PB#PC
M@=5$#]&]:XG#GH8OR<7(\<\I>&7W].\,P6K7(;#JW7_OR:SX=5<)RBIV"^F7
M59#!((99#I],&!.$'[E^4Q%,H@]X!?0-O>-]$XL15(A];>SE)-02\]UMWOSB
M$Y$XFHE&P7!O!6W$=FI'#9(!MG'2&J]8H['4FX]KNNR:-UO;16"+\86M5!K'
M7@0EE]09QI<D*XNX,B[//.O'"X$<D#4Z!Z?)%@CQV1*11(.VMYQSXP+2! %Y
M7HW(2\<FR_==_P!OD%<3;6H TB@"5O N(C4J@'!38.9S?.?B.4!T/D('=9>4
M3R[G:>V>(1I+N/913Y&(,>W&6,]-[]\)1U)[B?X^G7/Q_##7W?W5^>K6D%S'
M<+$:%XN.>6G"+!,2[B^)P'5!I#&!YIE($Q$2B(D1]1_NYT2E%0\#$Y F7:NJ
M("T001:,:$BQ#@URRNNB?JAZ[5X@L6UXGHH+:[&OS1=N&PA(*X4D[RZ$K*S0
M(#"($(I769:!:!/U3Y;57)E995#L8M0(_@8X$!J807*^148BIZG#%"AO+,G<
M!P!  R[_ $L@X>OA_C7[S.OM_G\^GQI@T+)/?\N&.U1???R;B12;A,7Q]>_H
MZ^8U9PC7=?'Z_(>M=P3H(ZY#%860JO)PU!T3O%CGJJQ Z4>3IY^66(GM+,[C
M!ZX/3H\=*36KVW7"X,JA P$\)UOWPHZ<^14?47#!<$Z"HP(=L'EP@!=EL0&2
M$7<YW@@.H_5!YA7U]')>!*:"A()-5J:QX. @W)H"4 ;-YR1'2V$LDJJW9S\D
MTS2( D!*4@X?&/'$ 4)ZTG@6<!]Z,"P2C : I-'RR#2<-Z&:M0OK-8_$9JB4
MU);<-GC=^(KH%Y]'P&TQ;WKSGQQT^,(Q,I&\/JIM[^00\)?L,GT9A,8S!2NY
MK6\+4+RQ!<MB@19C^ M=YLCU"T<:[HTJ&G(E';H&.V&FH<.&"H&!2?( YC3
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M!DJK39, 39?, FZU\K=X,!F8& $ "! ^523;%JRB)*D<KPG-<1I,B@J Z1>
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M)C*B.=A4SKHD4+05WC9( A:E8'A<]6-/NY$2#EO &%S0ZW&:[5'TL*I+&;N
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M*C(U#:$J;/"\9)CZD>BESP+48<$L9E9"Z.<17"@"/"B/LN6Y0<-2$J >YEM
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M!KMJ<S4ZY^(!0 JK #M7*0KJ<'5(Z(C:N9DY!^",>;<*CB]7KXJ!708H!H@
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M%H7P 0@@'D-$8:QELN&>83OAXE*L]YJY8;>Z.$)"?X!=2 F>\KO"9T 7! %
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M ]CY\C N05"H%S/K*JO)CA18/A*;23J+ML'=QK1B:Y2ZPF''I1M$,H(RX[*
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M@3IX3C>3W_ BRF21HF[+BG:EJZ@L73<3>.@.6@G9" Z75P?Y$.8XGVD36"I
MJ3TN''+#MNETDAQ@9G"7:S*TUQ<)VX)V(MU;;LDXPY,UBT#^50()!4"J"O/P
M,*?_ (6X3!@D64F.99)T->O(! CT]@<E*FFA7?ZIQ^H8HC%(.UL^%0:YS?\
M\17:^HAF2P5T,]A8XV3=P#(1A:-=VG8Q$ICIWZ,ZOUMYS[/M_#_O$AH$1(A$
MB/HG.%P<="H"T;@-I@E^UBTVX)TC?.(WW>*N8$4!8/-%$(VO1#83.E,=17P
MBOD") &;KC/QV:7TI=# <BA0>L0N0/,QA&CO%>N"KL</OK@2A(FHD4"X4]MC
MDZ"G 6>-#M+;F7D5&A-(8'ZP$#NSFN?9<2\?VH\CJ4$UQ(=Y6 U=VXH<!B(N
M?)3UQ $H(R#SCUSE602%JY-UFBBLN1J CH67*][H(+6#AFF@C<HJ"41&ACN%
MT!,2ABI$@Y_YJ0<=[^^OSG^;DUQKCT]O@@$2B1'>GWQT1=4/<[= 3CO!.RTW
M\=]:GUP:4X=GR*)@>(RR$'1N8CJ ""TH@I*=0C@NJ56DIX%0E0^<.6!+I8D2
MIBA%X?EK@05CV1.,H^CQC\D%R5:#6 HL>+>K";.79,-P2N"OF -%'MX!<*$R
MBWM0A%-8:\QUY01/,<#F,< ](Z3+X5JW!7E%54GG#!@#NAA-TA&KBOV^D]JQ
M1LI=]7"#[6FP5AH@](O>%*4'/"+B00!#1CGSH$^]*: X#'A1%ZKIQ$ =G#,C
M"?:[1FVJ[ V),3'E0<@ZIZBU><!X9A6R2!W3P-O);4&D"TG9WHY;GHFO0(%V
M+)SE!/&Y02,D31L:7",XD+W!0HA8(P=8      < : ] ^0!GCZD3H%8+#C&_
M!"P8I*\26QTP(\-@=0 HRI!4RH8PK#HH;@$#R8OG'@R<.)0*&G!BUXK-J0%:
M:O&G#U9KRNB"V+0AP'6!A:@D/.:%"FCM7>"<H%@1:(J*'*.L(-M<=NOB$-TK
M-8)^7G$*N0"HK7!8-9>43@]$5G>0<+=#2I19Y"CU;G7VZ#SIPX2)X/2$7455
M\8O:=QI! WP/%_3**JF0D&>R,)JY#VP +$6,3$#0JL!J*D)D"$^W"3^+DG4*
M\!>6L?TM.^U*F,@D0R;2KM B*R;2AWCB&,1)$@8+ .F!!-!<@>2EOH;H3253
ME1J-<TIK-L_64!\_-1!=7#=]D="(@(T*0VX13)IJ0A*G)W\#+)$)EJ,+5HH<
M2 )0(,J!/:%29O((3M0Z*Q80.6AQ'HIFK2 B*)B*?L67&V*(*6&%:6:04+\6
MDWB5PF'R;6E&Z& &0./[LNC2'=,7I@ZN$F3JW$!B%IU%<W0EJN3**D]BY,O+
MTDU/C512H;UB$>IVP(*TCM,BLW-44*/$WME6J5,\ U!O8K5Q(>,U79A?K0ZF
M51'=7""XO7D3=S="GBE($L! F*G,R$H5B!>E/!<39&624(!&L/CP]_\ JY13
MPM.)@8D1F$,2>OFQA?@<2TA"#5[! 09K!\N\P\K H77J,>+)9O(LH37:>72-
MU,44VC6 :UAD ^\NHP-Y2-K@BV2*(<A#7Y>,0UR;JIIV'I'!<BP8K@ T)1UT
M9#I]RY0IXT;KW\%.T24:8[Q@"=@X14L"F1W-*V =9HH/>TIF2PBR3#[*B@11
M.F=4N\V)CJ\EQT3BUN\0@44)]$[/T0B],Q!6T*6  *H0<0["4+S#@! !.*KX
MG4!DZYY"HMY/N@74C04P Z,;ESCYWKDB%SRQ!F*G+9(@T[BC7V$8;#\B\&#3
M!U57(:$4%HDH*Y(UE+#(?@Z0<%3)[#J!7!0 76,4$T_F/Z $-,HE[=!U4;E9
MJ'6'!"2H_HU!$:[QZ<-$@<H8M#Q# JHPL%ME_49@* MAI$CCLE 7]2-E'1H2
MEIIL&)<TJEJMJHPLWHEBQU*K9T49GP4?A!A579O]L]/ME?C_ $ROQ_IA)7[-
M+W '0A2ISE&4   TMNPE"%_KF)TD>OJG=]TN*+QE,V@!?I(#_G)!RSU\[FO^
MN?IG%GM[E^(=B"(^'6;6J1:C:J<!KO&Z@@KI#U0-4 VO\_(Z\ P$"(B)PY(+
M=BJ[0[  0-9,2-I.)O04[@@-,,UR8( Q'I88L%>C"Q,$1QXBCZ/R6R.;NK@[
M:IV&L<#I&Q\"A='T8=X$[J70);2 >DL%[P)FNP!XL73G.!Q:;TD+0JZQ^)+'
M5&)HH+I^#/R+H).!=Y9HAO24]\09KTPQ$#0839(2([O.)Q!LJ8!!74!<L \F
M)0T-MC&*6#(]L1[$;R((MT+@.!JZ:"F\EKO>6)%B< 45J+9L'&)_BHKL2(&X
M"PTF%3=/%8JKU8Y*\34(!&AKMB<$PH44.X((G6D%L^5,X!:H?S^?7)PE[*P!
MLEAT#VH2?@SY4@%#6H8N@]HV:H)X)KEQ=C?92LPHTZ6<X(QT5OU*O&@;VR C
M<* .U4 #VL,I+Q!"8["4<)L<")7.82: 0$:'3+5!/K&B""#78AA?@(3W-Y!0
M*59I<&4#JY&H0*A;=><A[FXD<YB0$48QG2 18N(((#@)<E;5-J>"%?;$($"A
M6JPI;H=TQ3[U9I7<3<(!%)T#^@"$H:AOG_A6R K?NW1Z:<AKA(3H4"6BH JJ
M]_\ !G0<\.0! *((BB1Q4>*]%<A55I^V5:R\:U7-HJ\-,#1W\($+#<*U=OQ5
MV56&, HUPN(1YG2D$2K1)UP3=J(K:ED6RK!A+@(P   #@ T'M_P"!H%4:Z80
MD BV3!!GD,!>\*X:<#;@3I+9POD&@/A!YV7Q?[NOO7PY^5_[S\K_ -X(A0C!
M$>1%B>CANT=40Y=+2FU"E7E:F$%<"X1#^T)!QR CP\QUL^V3 9H36D3:3GC6
M&C""KZ"\U5]/WN#2G#L^6Z&A%KFP"=:U7'@TJ42PD!:+H=9:,!P$FHHAQO5<
M%KT'(=&ZH;<]/TP\"B$H^$U\([ST1=&R )=C,X+ :T9 ;6SM#G'[/,W4HH Z
MKL><LHQ>V62#N%8CO).SI$D.B#E-['C&JCDRY/0UT- O&*(5D2\_X3D?&2E.
M4^ 1D2D=UJG\8I*-X;!L1<X&%MS@*PV'U7RTB#!#:9%HI0[UCQRVYHQ;=V-J
M94P(2)2H TD&"6N(6T5!87.H)QMZ2FS,WT5 OH?+SC.Z-8](R);Z..^="33U
M(>@;[<Y%I!4:!4XL5]<8P1H$/U4TKNSN92AF&TA2>H;=*8(@@L>0$'U"/@F,
M!56&,@Y"/1&L6A'[X98'R"\D 3539WE1,OT%,L[CWK"! 7'-8%MDLKO4E"BB
MI*A%((:VN1K9OCU^$%26"8^RQ;+-RX<!+TGBATB&E9TY.6COB(  *![ET1ZH
MM-G0E.5&ZDF%6$HJC@VL.\'K-)T#3(@$K$RLWB=4*)3*SI=7DUCAH0#O!-&E
M;VU8R?QO;@82I0;#O @=H!X$("UBX:J,'B7I:H4)0)HT?WE(31B'P2/">4WA
M@O%'@"5E$WPF5@T=N.I!$VB:Q/T&9+YMK@R[=U**4<@<RSO)\_N9/G]S)\_N
M8@N02%3 WMH77>/(0D26;N9T+.<$ @@$3A$HGHF_[-D' NN^KWZ>GIUUKY#H
M(FG5&,W% 6ZRFY-<TVPUOCS_ )S4/O1P^F^5>._71@ 4(]F_E>&1$!!(B-$1
M1PLY!6;.SD+S6O%P1]Z]R .T*%#;XR!EA@XR1QK4)G6>B/D%AI>#!8O%$741
M:[NW7/.&VE+T\O\ DJH1U@E[_80(C#2)>G'<.DJ[$B%H '3%-F)Q0"8ABC(K
M2 O-_C%Y=5 I3 Z&*H:- : %"[W<(ZK<>L4-(4V:P1%RDB 7B^SB6'8018<!
MD&[P)N37.=78R!0\TF"@MHM$L%<$:'&VAM+,_=I-"FL56 R%;0!@M%*N:2X#
M!M:D6^$4;SDE)@D>:RK>UU/'QXO!>+22.PD4=F$TL:@@3:T7%WUA=C(89R6R
MM&/01!A*Q+2HH$2%R&8P1UR%K@B$)3SA2C.0LC@( +43<J7EJ8?*^Q!0<7V"
M$(Q#3J H5XP5+)JZ8EXB U=7$4!O30$\:*<L Q+[$ U4) 2B ),,"R$<CI2J
M44T7#=)?8.%V&',>V,+D @1_Q;&@&3)*U7 /*)SQEUP T6B[F[V8$%HXP!@
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M0 K:8.$D]*(5.VRIA=''JC/+R+#0C*%ZW-L'"P:6$QZ>P-EKYTM!:()AE,)
M4HU 34)E-3^191$B4)%<*B:#V -#T+6\<)0,B4HB:#:F#OZV&OG%/ 4N,/HS
M4!OM#%01*[C/)['7CDTD_P" D'".N/#_ +_W]]<?! (@CR.5Q-[.A] #EG\Z
MR"$&DV ]9R<X(.:BM+V%5?\ . B"<)P_T/1W8'V<*"H=@[YYQY2WT'VVUSKJ
MY7ES=2>AT/:8ZBO0P^V=1R;N?3\_QC-Y0[@I_![/^[S!&Z^\>WC&A1A$(G$C
MU@( " <!X/Z#LSU4J\!SSEU7@;V\[$?;U]MF:\HU!D[J&OM@R#15%/099^>/
MDJ$))6FA5-P5UO!D)9J/\39! IP+-1L(P+(*[3O'L"+7J7T'DPK6H/ (((53
M83O-1!-.)_R$IY.,%/*'D@X&72;]G&82L6P0IK$G3Y\+&U9EA=)"H:&^,APY
MAS7?GUL.7"J^9)C0"@L.UT99J@(*#SH@)0[Q>P@.$=O2"@'>G# -M*])8'"L
M <1F#@T/8^W]YC:11$KA9,Q.]8_?SE"+X:$#"17M[EGQIL6B!"OP.N(GE!W]
M>_G4S\ _UGX!_K/P#_6?@'^L_ /]84N8T6C44 (+PYJ.>H%1 PI$"QQ8;E^(
MTMF( *%?T*G;3.*F3ZIT.G$P,563IZ2?:'>#.+2WR4!P AG./,*,=G8C(W"2
M;PAXJQ8[L$G@XG  44UO0:3O#>]N(?L!%@X+XK;$AY0)Z.*?$8R-FTB.UG&!
MLET#08[4TI3G S*VE/%$QT$'7PYN.BX[J!R0L@#CY;M29((GT<N,<=M/,LHI
MW>8<3O5 B*>R*T@N\$FOJJ#=B"/AP-:C5%A.Q\8[_(JH, C$V='*S&NOYD6B
M:&X*[W1H)D$]1V>@$NZ4 N/%FH&3((&IK&X G9IRRS!%R:EN,#Z#AZ+1UX4E
MB)U7*PDX@[ALHG&&&IK"*F4TA8J8Y@%-_0S'8$FPOI<,50H<0!OB?KY!Q>-?
M7_?^_E;%O1I'U0J9?T?8Q/NVOI[8>*CR:J=RM7>SS]<F+6 NU]>/_/I@M!I=
M(_I6  MV77.LM'23B\GA\;/YZR.WK0=D]SU^\PE-=,J/EV*>#\V*(#P!_ ?'
MSN?Y_/\ S./:AYYX]_@B9@  B%%"B(B,=98NCU53&*5BUO6'"W H4K!T"0X#
M. GY$E#(A8V!J[Y@=Q$]EJJV.TQRRVW14!%1":G!F^=-K/5340DDZQ$7VY0"
M,P@":0G&'3=U5Q;LUT=0PL5!3P;$D-%T-?\ "$5<RD31DEJP-IEE/**P0[*D
M$4NG%UCIY!0UDDH8WA1*,/#DX1$DO>1WL1,0:P.;I>5C*UDH2=;UAA!68^^X
MOG298Z;Z?V;4Q>TC<T% -JI:.V_5%H;06C8/.+F$"3)Z;WXFM^!W8YHT>AO[
M>?ISGXC_ +S\1_WGXC_O/Q'_ 'GXC_O/Q'_>+&SY0TN-I0=Q,9_BB-4J!_02
M02!?_@XAV\*4E6 " !0(CL1-(FQ-/Z GQB*RJ3G*9FV$>",9#2V'A*@[L6W;
MR4J9T($%XZ>/DF-Y!8!"@Y^) PE86PS4L,"<J;0H5[9.B8LA7,QMD(K@J>UV
MKN6"S,AIC;Y+"R#5:V2T8X\#U2UE."U)D)R8OPW%"JO)+-GHRV&&!-)?-Q;L
MQ6"FS@.!VQ%#A(C \  O M>$EF.ZPPU30S6-M:ER3R$ HY-99$Q $"3FP4 @
MPKE5'G: +L1RG]D]SJ'947D#7&-)FI;"!#;5ML#(@&I&VZWBJ7.3ZT<VR$5L
MEB#@A=-T6KO!I&Q8VY]YJ#R351K#)/?4H6S(DR4 .F!@7F?^,::'$O+5S4T0
M3P\"J\N,G0<4T!JB*IH@@_&DG%M@I#_@9!S\_/S_ $\?+7@\(*_1U^<XB@CP
MJSY@[Z_ZPN1#G7>>:/K^;P4/(0'W?'[Y,J6:I=^@L^OZ "H [682HHNIB>8Z
M_.,X]/6A[#?W\'KC*[5R#/=GYWFN?SHHYB,GA^VDH/,=H<^_Y_CXK/+[?G\Y
MQ^</_GYK*7_7YKZ_O_QH]@D\*VH8@<G+_<" BG&.1K88&L9>1BC*A00X!PO(
M$(@$61B6SC;B'EVE"E9I.*5NL%6B:<%OHF;!2J8Y+[=2, D46[UE'/1!L@33
M%B@8HE-&"J$:"D684D-3 )$0( AX>"O1">42Y8, I/&)-J?":DBR=@O3_9;!
M6W+G/:W*4)2[(DY8<Q6P(9%CD]!9>. 50&'7B>5OGT+X_P Z[]+#TL/2P]+#
MTL/2P&42,0BA2"+=*8/YXW)L"IP$$<,6SJ)BY"\ %3FQ=914\*^NTA)H3&@5
MX#2CE"ZN!+9H$\$_*N^O?,A&>YF7!5WO<EU)@)'D5KC7SLIO#FB8Z]7[A-7[
M%PO*$/&P7;MG%F-$Z3J=4BQ&T2%TY>K$CDA;I$1328/'0B&"AN)LWQO^Q9!P
MK[_S[?Z?8N$[OT_/]8Z\?GGQ^3Y 61' #T5_RU\8*H3Q:OV.?V]?*)U]SH].
M_&\U<1!=FGSKU,*EWSH?S_MX/.2+9TM_L/'O^^LWWM3_ -8)L(^WS\&>[+&H
M\K_,U@SNBQ0C^&]^V*T ?&LOHG6N.O7'@<[:AOJ<>F:XJJ%'OI7CC6)$5-#[
MMCZ^OW[."*30/X^3\]_]?FL^L/V]\'T^\=:V?[_C_C1@+&2F\B,]9J92W!$1
M*:C@4ALR'A0*0MH@18=.K@IXMB5&$H&6I1Y,* "(90& @[43[AJX.(@1 !H#
MKY&\X5DY$D3"[*X9BDTZ@;"#<!WY*9"14JM2ZR$L,/&RY3PT(XW@3A&D1QA"
M7C-3I*<Z@HPH:3^R4HCPZ<HG=I01*- [/B=!,YV3_NW]F:STOYSTOYSTOYST
MOYQ7G]%YH,$;!4N:G7T\F@H6'0Q,5!NDJS%*,2/E$%H@!I%7O:%><];]G^LL
M]\-1%-8T,Q _;MC* B@LJ5F)'[&$P=4,"6RN-:466TC["@IJ80KSVZ106X\@
MYZ'[?]YZ'[?]YZ'[?]X$'T"AY&@X\I,<Y ]LP#@#@R"4Q(X9" V#G"&P.-8&
MTE,Y70Q1$:?H-@Q4U$"NL.Z!+P $/A->3#@#[(_Q_84@XW['W\;]/KKZ?  X
MSQZ_)^[ #_)EMBMVN3Y">#CQN[O[=46_6Z^V7WAX:5^^OSPX>4? K_#^_IFB
MYCPPM^WYKO LI#6\I-L_9]FF'6?4_P#6*[C9T/O[^N+D?-SS7+MX'\?PS: C
MNI/W^_;BP6G9Z]\ZSUZ>!U]S_LXR!LR5%_@^?_.LT(O8?N2X : #P$^;N?ZU
M_P <3"%@2N  55#)/6(K&9Z#27LP:?-3DHP24%9IK+4R+5IS-<JNMZ_HB=15
MVY  ^$3%K)V%6!@'*JU9,A_V2R :#:#HIQ< !T,R'#!N :-+'#Q)K12350P4
M"?(H"J <JP/=<3O*)1%@9P\]'QA* DI]NN2H42!<8R1:$W4'*!I#%]P>?32X
M$B':8!P22:\M'%8$4,J> :3UO0G:CXP$I%$$'A$41\C_ & !XRR";O3KA><$
M2)6V 8/L\:]N,]+[G/2^YP!O%"2K@05  *H9"W7,J/+#Q!(R+%W8AN^'=J I
MPAF32&<R*QCEXN>P>_\ B?YS_P!#_K/_ $/^L_(/\9^0?XQV]D91V>J]3!#:
MHJF\5J[<[NKE!/&6]RE;&#=>5%D:7RM!ALKM(X_I4T/$G(NR %<*2ACV@Z4.
M%6$KFF$W5&MZILW>S/P+_6?@7^L_ O\ 6 TQ3,)$ZAZ89BL\Q>WD$L$3("R"
M/-X[(I;5MX'24.9%(P@*NB]JTN@),3N$<+SK3A14!'H>$;CTZ/\ 84@YWJ_G
M\_GMFN'_ +_US]<]OWU_GYH/)<6Y#],>0O/7GVQ7;^__ +S;)]Q_W@1 CT'_
M 'APCOH_[Q*C0A#/0/L?T/S\^V<4[Z39]_X^O]<D> R>LM<JINF<B-I(%#SI
MO7;"2Y&- IO>EF]_KSCT"'F)NA.-'+9Q2[^\")@6L# ^K6"235X@/D.#^F_?
MB%: MFB6-[S@>Z0MM\?>45HVV!0JV?0J$$";RUH%YDDR! 4D3X H5",F2ZR@
M%IMD30*&ISOQUH8&"JT\G4CD0U(/G^,14Y@G&]7-8B"D4".D"%I#%Z%(.>X@
MU ;-.C*T7T6@O-4:E? @Y#3))&\*4>)BL0;MZ0]\!1*?V"9$LE5T?OE_?Z=Y
M^ _ZQ6!I)2H( @(C;@)!C,0! ^HV)B+7=EE8#0!.L_IV&&&&&&&&&-V$R%R.
MS'WPJC-F:QNVW:4XS6C.H4"1<14.PQ&PO5@)5/ -4>;IJR#B)L44QRFL7%BO
M=$%I>>#Q@LJL,Z9-NC;C?C;R\*P(E'%B%E& X<G%PJ1'T<_\[$"@(CD=)$Y[
MQI=6ZY"<94%IV93->G@\Y?<WS4I:/F),+]I)TIA(80P!3T:,V"LF&8,IXE,U
M.>*/&"((T01.$=C]?[ D'->WOO\ @_QD9>G^?Z_8=O!D\Z_.\UO]I^?X^WP1
M.>>?_?\ O/S\_/O_ %"F3FW*=:*"[ ;PRY<Z&Y7(@Q!LV[^AGV666*;Q"OIF
MT9Y$Y7BN# /"5*),2K938$;DIG051;Y[WC#)(.>(P;H-VN&ZM40*RH#MYP!3
M3E!/=3/UID_RWI80!4)7>L5G]9K#1 &+AVQ"0:LYS#7D7VO6      T $ .@
M-'P_](40@^$=03&"2O@!J^V<\?*&BK&$S20M'FS-N2391I*DH\GP/@-(E% B
M=[.3'#$<=,TFFE.'C%+GEAJI!;!M4&\.@,;@%#T1$],+,5Y'$0NXD2 T6\=J
M4^AOT@3CAJ12RE.^("P*:#!@' 8B>]" TJ\JXRV;::*+4A2:2281V[DJV%
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M%_4[;I10SDP<9204<M1$0WE"N 3U E:AN E0P,#NCV&A 2P0XH&S]/[*@-Q
M!RX43P!/,"=(-:;"<^M<TAE2@"I&$O)5\!$]"LA P  :  /0(8^^CK '"W"9
M3A<!(#R6!59H[2JHO_.CDU:CK2 -U(*8LK(*Y<9MDV:\%Y)\X3K,P* 8 WXW
M<&?   !#Y4"! @3%X/#_ *#SY\^?/GSY\^?/GSY\W8?N7\/$B*'2+B>$8<[)
MKL[GE+W;@GJ3?HJH5O.!0H2Y=K79=294&!3#Q#VM &KB4<#L5H->'CB8TU]#
M(U*I[SKC%!F8L434BR:+E8=4ZMQ%@S1LWZ9M!V4 6E4*BC?G$5-)R383*:36
M:G6*Z:/(*M!RE*='.U9XN6E)XU)YY+C,H:#C42+K1#HN'A*-6C:-JZY,G)O]
M;>8!9!?&_@V3Y.7V_6"Y,"_\Y(.6>/J#_.7T/M/XGP6]![9^ _[^%]OL?ZR]
M_P :_1Z<-%O8(W:]0PZWQ*S%40R;.'13O)W-%%RB3#"KA;J%,E>SJ8;!NI34
MP'JH),!F,!U0#=CZG%U-UX<QPJJ@+7    !P 0#T GZTI@%[Q$7\81MA+715
M$4"E\<8X$R$2K@8,;()O?R* JP!5> -J^V.59Z J>%=6(4J8U$:A0R:*0<D.
M 2VQL0X!DDN)6/7;PD1U1/4 [Y<"V$7'EDT6T2PDHE5*42+Q002.)2=Y<2*!
MA 4=TP$58=G/M!B(TW><KEO@!OT;AMR]_$QBW%$2.Q03#=/X!9@<1>FN]N @
M2V2/2$/0J<OP=O2AK_$$-C<Q.K0<D9HL-:%@5-\)+#*^:32-<2>H2@ 2W(A#
M""@4%9)VZ%H4W@PL,9O3/J;$.#!M65KD*CU((8N%EW$0T%"/#1(8D&@454!
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M1/".G%ZN>0AL',O/E\N"!@%Z'"JGJ[P42!@D9-Q(U_Y+="2KNFQ:%.K8.$2
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M.*:;P[EN&AJ!LPR583%UGTLY_AL%1866%5PXQ!W":,4XUD9'ZD0M-3X* J@
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M%![K .!*-GP?=;[@.@X\E$Y,  #@P7O#()4FB,4/"Y<R9-VYL@$A:S7&  "
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E2)$B1(D2)$B1(D2)$B1(D2)$B1(D2)$AJ_GKA "@$$1!&_'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>prospectusum1a1a.jpg
<TEXT>
begin 644 prospectusum1a1a.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_X1M(17AI9@  24DJ  @    & !H!!0 !
M    5@   !L!!0 !    7@   "@! P !     P   #$! @ -    9@   #(!
M @ 4    =    &F'!  !    B    )H   #\*0  6P   /PI  !;    1TE-
M4" R+C$P+C(P   R,#(Q.C S.C$Q(#$Y.C4Q.C$Q  $  : #  $    !
M      @   $$  $      0   0$$  $   "%     @$#  ,      0   P$#
M  $    &    !@$#  $    &    %0$#  $    #     0($  $    & 0
M @($  $    Y&@        @ "  ( /_8_^  $$I&248  0$   $  0  _]L
M0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N)R B+",<
M'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<(3(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M_\  $0@ A0$  P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$
M!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B
M<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'
M2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JB
MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ
M\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$
M +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&Q
MP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY
M^O_:  P# 0 "$0,1 #\ ]S,C9/S'\Z/,?^\:Y[4K&\O=9G6%S'']F0+*9'78
MVY\E0.">G7VJJFI:DEQ-!&I>2-_EA,9^8&1P26[?* :KE)YCJ_,?^\:/,?\
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M\*/[6N/^>=O_ -^5_P *4JW-M)K^O4J&&Y=X)_=_D']LZC_S]R?G1_;.H_\
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MWT:/[%TG_H')_P!]&M+[4O\ SR_6C[4O_/+]:/8T_P"5?<'UFO\ SO[V9O\
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M4T94                                  #VU@ !     -,M;&-M<P
M
M#61E<V,   $@    0&-P<G0   %@    -G=T<'0   &8    %&-H860   &L
M    +')865H   '8    %&)865H   'L    %&=865H   (     %')44D,
M  (4    (&=44D,   (4    (&)44D,   (4    (&-H<FT   (T    )&1M
M;F0   )8    )&1M9&0   )\    )&UL=6,          0    QE;E53
M)    !P 1P!) $T 4  @ &( =0!I &P =  M &D ;@ @ ', 4@!' $)M;'5C
M          $    ,96Y54P   !H    < %  =0!B &P :0!C "  1 !O &T
M80!I &X  %A96B        #VU@ !     -,M<V8S,@       0Q"   %WO__
M\R4   >3  #]D/__^Z'___VB   #W   P&Y865H@        ;Z   #CU   #
MD%A96B         DGP  #X0  +;$6%E:(        &*7  "WAP  &-EP87)A
M       #     F9F  #RIP  #5D  !/0   *6V-H<FT       ,     H]<
M %1\  !,S0  F9H  "9G   /7&UL=6,          0    QE;E53    "
M !P 1P!) $T 4&UL=6,          0    QE;E53    "    !P <P!2 $<
M0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_" !$(!#((!P,!$0 "$0$#$0'_Q  >  $  00# 0$
M 0(#!08$!P@)"O_$ !P! 0 # 0$! 0$            ! @,$!08'"/_:  P#
M 0 "$ ,0   !^_@
M
M                      !A3'@
M                                                  @I!1VUN>+Y
MZO2]#H8>=3M[C#)CA3>]W72JV=OT-*>+9S[6O0KRLO'MUTO5UIKK8KK6M1;)
M?*]?-?:BUJ\>)S]LXXIXFFU,ZU7Z(OO7?CAQVZZ336::->FK>U-L:<JN68KE
MR.[DMY84\>KNW8YSR7HZ_6N;?#4>-],]FU._=5'S3F^KIY(N/,B:1:+EJTRH
MMO4J4E2J*Q?HCK[7!PPP>AU5<@   "Z;*:X8H
M
M%)2"]U4\L_'? ])^=\_5MLX>1U\<<_/=QYYUVV#K]'V]]5^Q/1SU/Q<-XX<Z
M/2RZPUT[%MMS--YTWL5M@N;*Q=MNJQ=7;5&%$<TQ[1%6/B:+S\^2OOM.G13I
MNOK,WFD492I%67%5KC:[.HZV'3Q_>^3\C_I/Y9UY]'^?W.;(ZXVYYX^&.GVJ
M(^/[6^1_7?4_Y[^Z<7>O3G;^4;C/VF7STW#R?H+==*J:6\[U5O/76E6J*%(K
MSVGG7NST7B;V^7JK]/IK<8   %\W$UPQ0
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M:_\ /?7=T>+]18WUFM0   +YN)KAB@
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MZ/VAX7VU>>+C],   "^;B:X8H
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M6W5A2C."38
M                " 43%'+S6\<IT+5MUV(J35>Z][UM:=(FB*Q7HIM%$3<3
M,3024HN3642FU"I$-:I1%$*I69BHB5Q9$TQ)::95"VM4HBEIM:VX)TY*IZS)
M&1$3O3'/<Y>^XM%]T\QI$<]%?1N36EG6I3-5=Y00$*6/%VY.;GVQET2QKTD
M  "^;B:WG;#IHO2[M2;TL^5C5R:5WZ:/1J]/GGR^Q.<[XUY:.;H:Y))($-<B
MU$WI7+78W*&:,RJETEH3"2)
M                               M@J*P6P5%1!;  )!  !624E( *BH%
M (  *BH %!!)6  2"T  2U*PH9E38 "00"2L    OFXFM96PMXM]N'2_?A@>
MK*,>/8L)[;RZ+]=^I6G;_D^C=MG/1A.6D\W35">CGMZY5YZ48=&H^SXG%C3A
MTWR>>^W1K77:JO-&><TV1K&7*OHTLO>FT5UQ
M                                            I()*@4 J)!0
M"HD@I !42"@   J) !2025   %)  #4J4,RIL   !)4    7S<36Z6PFF?![
M>7\]W?Q]J=//LGL[=>[5WWDI]?/"W^9_%T_6+A[:=J<K?GMY[4<V]G#>YZ'!
M'5RQS]'+\[O\ _1?-]=UU[7PZ^P,NOU7EMQ>K*_EPTYY6N?T*XZZ.CR^3GI9
MSZ(SVN1,VS
M                                               !J5*&94V
M    OFXFM3.&TRX>_%^?KIXON5;F[+\SV\'M'YY_:\_[G)Z8TZ/2WD]/G;3#
MIC?'G9Z>^>;IRW-T^;_1\WR/Z'G]Q<?;[@\KU/!7N_.==M?8'+V[3EVXG+;K
MWU?/\W9^9VKST]S<OK<>.[Q=ZWA]+<V_JSAZO47!TW\]*-I
M
M                        !J5*&94V         OFXFNS7#8[\'V/*_/9]
M1\U]9>+JW[R].A/5K\QN^?NC\]M\4^B?L#EO\&OM?B?LK\5]KTEV\.@R^@7D
M]?R'ZN7ZF1'C#IZ.Q8[=^MP];YZ\"'<O+V=9=7/XK]7Y_P"J/R7O?,7ZWG^G
M_P [CTKZW;T33B]T^9Z/S&[N/ZI</=Z:\#W9VP
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M[G3VYAS;]Y_H>>.SD]6\/=]1?G/?KFH
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M?U=V\G8''V]^_._0S$
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MX'O5[<X
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MKYGW^K/J\,GX7+NWJ]?G3;RNJ.+T/075R=R\7:\3V9[>$
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M@B8D
M          ) $%HB(I(F9@D A6$T$""0   (J*I("$@     "0$(M!3,(BM8
M0BVF9BM!,H0A:A"52*B 2  ) ()($HF(4"T5DEZ(W*9UDQ( *R2DM@L>CQ:Y
MC.T<6_(RZ&FMFW.E)(*022   7
M                                      4E(*0 "\"@@     DK
M      *2V"LD@@%9( +8*BH      %(((!627S<36S$D%105D@@#3*RFYG>J
MFDTM&N24 $@@  H*22\         4E))6              4D K
M     +9)42              0 2            "@M@K!(!6"D      J
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MA7K3@UY&.J+ "P6#@F;!(  BP 35?, (NIJ04*J]")3PKT3UED4@D&$,R5D
M  #MYW-U./J:8NSC<\HD -  +*=:]4U:0K5C4   "#"F<(!?-Q-<,44F$,X5
MTM3$I@)AGHB0 IB  OL $G6 "(84 !)< )+  BB(0")JM7"VC(E\
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M&ZN7O!GY1QGO27!B>AD>KKWZ Z)T[2/ISP]G<'A^A76^'WSR)?
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M"ER3A@Y><\/2M]7@Q?)5G%=/-<Y>G+8[4WIP=<N96+E99WB-2S2H''. 9<$
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ML              @M@N@         #.:>:V>]/MGN]^K3S%?'1]")(+1=
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MP)!               )()!             )(!LQN))() (
M  ),89L OFXFN5RQ6N\\W#X]^0_-/"WPWX]/G>"VZZNCT<YT>DW[<)P>%1ES
MS*DN0X^%KFG!7T4GI]/D:>Q9X^*V\NTY+CMHKZ3BP;<7)ZIY73Z]&GIW\//I
M3<183R*4X..%LY">6CB[:U;[6\,+G+RX[GYZ],[_ $7XSHRSJLQT<6=,JICV
M5;+BQGS]5?=V<CJZN'P>?B?%\3F=<\KH]3B._)L<*\IQ<TU2BM(
M             ()           G*!S_J?JO=_P!=^P=C>]]^Z]*T
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M-\QL&6'KCJ]7I/;TMLIS=.\WD=<>/\W.>5290      )3)!"
M  *IDD1,          3C>.+!ZW'V9]5^A^Z?K?T_,>S]"GM%920
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MW=X<?D]:^=\QHR>\O1];I#T?1[]PY^DO)\KJWYC\_KPY:P
M        !K9(           Z9PUC'PWM?H?NW[[]D[A^E^K9!<*"@J
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M(       J38) *R4           0F@%>MYF0          (M-SLG.^U[OO\
M^G_7>P/I?TEV]$X<0%)070              4EHOE!6             609K
M3/<>;LC;DM6RP?R7WWS)_/\ ]F]4_P!,?S/S\OSCOOXC]?S]..YU>)Q?6YO
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M:B+5JTIHM,S>N)N"0      IAQB2](5PF0          $0HD%KIF"
M   "8Z&WN^G_ *'W?2'T'Z&[O<.!E<4@MEX              I(*#DE
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M722    !:+2)+Z1)(         !&>4LELVDK:W/6VN='H6JS=RYHRT7H0
M     (IE3AY^2]+LGN]M-IIQS&P%)9.4"D             D@L'**2
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MTE;3KA5M;DZ]/O7[/]-[,]7[Z-^^_'$Y^Q?!-0           !263C'.!6
M           4D'&.025@             I.2IL:9:V&LM.E_F/H+GL[YCQ>3
MF_)\O8OZ#ST>MYMJ>;ISLY>WNCCZGZ<.X/#]SH[OX,GW<.Z<G9MOF>ET9]!\
MWVQP^EU5R]?<O7Q>8^[@[L\CVNDO2\OM;IYL/P]W9.'3YZZ.7T]\K]7UM]A\
M=K'1R[;\O]7K7M>#F^??M7D[*>3J4TQ&K.% +YN9K>O)A'7<\KQ? 7R'X]Y0
M^,_/.5CT3P\G,[.CE>][%SDX6GHY:U=?PXKG'AP^6MGMY<G?IO3UV+0G.UG[
M.(R^"YV/V5-O"XN_M;5[O9@'B77H[&]+6\N"[X_!9;9F>BU&V2UC6,_G^!YG
MB7?4]K*Z^E1C:_V;X7@\B.;AF^DVNK4 5E)66P     %  (>D6     J1,H*
M0(D          *<QQ56QMVLMT]P_6??_ $.^A_4+WN_6\[NO,=D5Q*@
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M\_8<>$\[P:^B>Q>CT+L]V/B>I_/^=V#@\-SX*V6L ))!2     !,@ (YR
M  ) (            =*)BF%=:12;WT/=[\^L_5_1'U_ZSRO1ZW-XJFR;@
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M2416FF:4(]*?9_I7OSZG]$>Y]MSNCMGE\V(A,@           "HMG!.>5E(
M           !)08XS!9)             !68XS))2                  8
M@SA +YN)K=M,+>]6/G>3/(^+Z1\3X3E<6]NO53!5;1>RO":RDJ*.;&(FM:A7
MEJ\7?2^644*S",5945%F4Z3QR^5$IIM)2LI6OUBS7&-:3MC.V2L,9 %$*)27
M0             "F%N54+D@           TB+35&U,[\YI[2^K_2=J]CTJ.J
M_/S[7%Z#3C6J            !;. 9$J              +9CC,%DK
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M:%9ODTYU[I,ZJYHSBLS2597NO>*VFV;3*)FF+25              $  $@
M        1*":3%"L:;4M%;2JG-;0D        36U^MG5QV-,*<KLM6DB22"
M             "H  I             (+ALQN)(   *]\;?'U5<O37V<5/I^
M5'E:T4[YCL3-Z,IY>2U]'XU-NBKRO<CAZI][RYY+495KZN6.S"[AVT>;W6]^
M2;Y.7K;5 $F,,R2"^;B:Y.6*K-,7Z@Z\>K._DN7YJ9JF\KRVCG*223":N[D3
M  9Z((HG.)SG*X 6F.FZI &B-ID03%<D<H 3I,:1%Y"I1,
M                             058[=C\?7R>3:J*K51L
M                    *"Z;0;@5$   %9:QVN[8=)?0?/>,/H_F]QPQ]3^-
M]+W!Y?T&G=W)Y)]OPN]L<_G/[/B:Q#V_YWLY*.KR]])\WN?B>GWSX_I^D>?H
M^='='T4\?TMI^?\ <CJ\^->=P=[IH !AC.$ OFXFMTIB8M5TY?+KW_$^-7T?
MS]71QUPBQ,VY54Z)B2I6E6KI3,TRF$#G[:MN:-,&4QE:NU)*"X65J[:.KFHU
MRN9WHSUG/2K+569URIOG3FDB40KK:FTSKG,:N?J3C-^8
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MX>5Y_?<I?']O%<TOS./U^<28LS/-IC;XXSUO/N=%7/VJYM.4
M                              ";U4TWGYKZ+[[?+_2]X^1Z=K#92PJ+
M98.0"0             2<,Y!42             24F8-R*"H   IY=L-]#\_
M\0?T#XCM/ZOY7S)]!Y.7]?S](^9^D[?\'VNL?:\K3/JOF^TOG_K?N-^,_?\
MR$]SP>J?T7XK4>WIYGSO?WWEGY\]'@L?2>-:K;] O\T?N'9/@_95],3KP.#9
MTT $&%,X0"^;B:U.6%Y];^KY>?5_+_%S[KXBCOPGB[.]?)]#Z<>/Z77WG]O&
M[NWL#6F"CGZMGEY3#IO6._D>6I>EH=='9^V_S.]7R-X[?/W'@ZNR_*]+V3EV
M?/>'T%/G%+Z)Y:<CEU^?_N^%TSZ7G;QR].H9;Z-TY?3WRO6\G9Z^<_1\SZDV
MIYM\GU/?Z>,CR,GV-Y^VN6YOCY]1\_B_8X5>I2R^0
M                       %,34+Y^WO#]C[??"_:Y'Y_P!ZUT<HK*"T<@%
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MWOQ=EW?#XU_6_*:U[?C2NRU1(                              !D0
M  :D@   @R %7/M&79'N>9L'S/I?HL_/OO.[?&^CG?A$%!QCF D
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M./9?RWV/Z(_S?Z?NGS.BKT:6^7I%LM'&,F"             "V#AG-*P
M         "DX9G2H@   ISZ*:6NT40HA5KK7,P4%4HZK7//Y+?-BZ][G;TT\
M/%,W6UM7O=M6J_E41J:S6Y"V8 @PQG" 7S<36L;86LWNWG^9OM^1\>O>\2OV
MN"G2DUI$5A6>/TFM&W.SU<W57W^:M6(4@5ND523"  1+.6B+:*Z326G*K9$K
M4E$T"F 3*XE6S/2JU:-,[I;F0             *B!")              2N*
M4@  "68    AH &<<GAZ_KMY'TOTO^*]J,4^ME5Q7$'&. 98%8
M  !0#&F0)+@            (*B#$F;)*0  !T<Z84*%2^I( =&CDJQJWLZ;.
M3%:5RTHLX]%\&E5]S1GD !B#.$ OFXFM9,+17HTSLPM]?+=M>:69S&<J3.EX
MZL)UPBFKGZ)N3 B0FF"+J2B\43( +5:YQ3=76;H5FF32B89W19K(@"4S92Y#
M2EN,N)2O*+@              .(5')              *&MM-!RT@  0Q(
M !,M@!/.XG/;=/6K<\W6K'KCLF.7D%1QS@&7!2             6P8\R9(
M          !!408@S9)2   ,:!8N6) !!RZ.Z[ILY*N.CN*PI16J+L>Q?A=&
M#7I1NQR  Q!G" 7S<37,]<3,1MAK%\^:BW&\KQ"B!*T)JF"59A82 (J2@F0
M ""291 00"28D)@$@B2$D1PT<HJ              (.(<HJ           !+
M(0T+EHF],UEG5E5E>N20 E4    F$@"8$1K68A%ZY78J!Q"T<@'(
M     .,6B#D O@            %DMG$.85E(   J022   5+S%IFL*0O*("
M+)HF$R61  K+1L )+YN)KE;8J4(ZYM3#*Q%J220                   "L
M@J+8             !<*2HM@           3F3*T1HF]6=)0L3"5N$)
M     D J!!))0"H             DDI* 5@             J-H-R*@
M            "V84SX)+YN)K;/$9WEIUGT8ZYW<EZN=%$B8$P$$B2      $
M2F $ $@     @ E,(              $D             *)(O<G2U%^?Q9T
M\W1-.IN=F,XW1(         $  $%(*P             "DK)*0
M   "T73:#=R0                 "#"&< +YN)K5<<-E:YM;Y2>YY?@SZ+P
MJ[<ZDR7$B$ D20@     $RDBLLD DJ0   !60FT
M         "69%#0TRZ_UJ\3N[S\?UN+YOIWIEZ'(PT18
M                           """X;2;B5D                  @PIG"
M 7S<36LLL+2;G=C\4?K/G/F1]K\E>ZN>*6H37$0FF%2)E9+A((!(B8F $)(E
M;.2<8)NS%4(2*4202"  4@N3*( )                            $J$6
MEZ9TN-?9_P O]#]L_FOH.5\][;"SM\]ELBX
M                   H+ALYMY60                 "#"F<(!?-Q-:1A<
MYN=7'\4/K?G/F7]W\I&GD5:]GHCR_:[B^5]'<IUT[DZ.]]^7S[W\'-VQTBM]
MOMOA9=5PW4V5/:W'V_-GU/([6[/.P7%T^E_+]#T#,>"=Z^T.C'YZ]V7TGPWM
M>9[/S<^M^2Q43Q^;IHMGN7G=?T$IIU;G?(TOW#2WBKN\WSSZ'G[;X_L>P<-]
M9TKDFGBKT?.CKXTIC1-@                       @@ %2  6R=&$;4F-G
M-V<G7?[/_ ?1>Y?BOJ6G;.G%%+D@            6B2X              5%
M):+A<*             "HDV$W0H*@                 084SA +YN)K4L+
MFN=/'\4/K/G/F9]Y\I3YW/-?3]R>+[_OGY'UMC='0V>V=Z>2.[@ZFTID<M?
M'J\/T.O'4IR3S&=XL/ WH<'MGJY?*O'W_37S?2V#R>_R&M]);3\T[6^D43IV
M_E_+GZ3YKL3C[/H9Y_H_(7KY_:6]_/M--#SO]#<]/"O)V?0B:_-/TO/]J^+[
M/?V&_67;QY/JX_E3['C\3T?-:Y&AH                       %RX *%
M4HUP=&:NSE[*N_#NWX/Z#] 'Q7U^SO39<X3(            @M@N@
M      %!!07BX4             $ SQN105                  @PIG" 7
MS<36I87-<Z>/XH?6_.?,_P"[^4IY?/LSW^V/&]WWS\IZG7]ML=>WESIY?*'7
MR_3HUK#?ISIS]!R\&'I@RZ/$G5Y77?1C[NVMX2Q[?ICS=OB?CGW3GK1AOON&
M]H^8WO\ S_7_ *WD^J?']CZ9>9Z?QF[N+OFU/4%-.O*:=Q9WU#+HQW9S]3^E
MYW<7B^SWEAT=2:<]5L?E5[/C4>EYC? T-               ) (       N:
M  D  Y83BWS5W<W9>Z.#Z*?$?0?7CY3['G1ZCCP6+2            !;*"^
M             6R"@Y((             !09DW  $ @@K(())!2  5 I*220
M22     084SA +YN)K4L+FN=/'\4/K?G/F;]U\K3;R77TYOB]#+>#MQ.NO)6
MUC;#C;X;KEIBN;JSF.N",<GG(R9J_5S<>66F<3%]I6UOHQVW.=3QON.-L<MK
M7J<]??P;)XOM\?DZ>)W>=PN/3L+.^K9Z9O.^8LZX]?R.-Z7GU>+[.R<_1=A9
MPUUSTO.HZN5 U6D                       *D  L2 #"RV4=&:FU7-V=L
M^9;[_?&^_P!B^+]1>Z>QR<)HM8            5%LLG(              (*
M2@Y)0             25%LR9N!) ((!)0 25@M@ %P$$ I!45     $&%,X0
M"^;B:U,87.;O1R?%#ZSY[YE_;_+7N.+?7UW&M7G8O2Y:<%5L;.N=S':KEZW;
MQ\>T5RN(H*;=-="E(OSWK9SGZMJ,ZIQ1C-5%(GMXJ/+]2(FKU/-NY=D4M335
M2]&.EOJ\^_W^?/C^S3AM3UX+Q5T87"GEZ5M&M1($$    "00$DU      @
M D ")1*43 9)Q "+PL $YZ-*3OFKNYNK[4_)>I[Y^1^@XW)[U[TS'RU=TW
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M>9Z/J;Q/9M\>]R<@!%>E78 3'*9TB4$;;6KVMG(              )*#B'-
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MJK=2ZA.Q(    $$DPHI(E$B2X +YM>>.73OOYOW?T)?&_6[SYWKT[R*@%90
M(6)@DN%N:69BDY              !2#AG.              *B#@G.)*0
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MV]_\O3MIU&>ECSU2>L:NT"W+9(:=I&[Z9^=-L:]N=K1U43       9R %BT
M!AHK#HYN-Y/J?5?Y+ZWZ[_.?25<_: %L(G( '0: ".?.U6*#D@
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M0.#O^@7'U^>8G;(E$^EZQT =GH\.GO@\/ST>[^KG^/\ W\/']#SW7RS&Z)
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MF]O-H_H<KIPN8\J(           <W4C=[7#537G?/>K^@[X[Z?UUX/N60
M   <8MG-              !;.&<\I*P            "DI.$9(H*@
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MZCKMR=E,L\84X9G2GGWY*:S#%U'+O6^<0YAK1SCGD'*.+$Z[6V;,B2084SA
M+YN)K2,.5=O/\3?I/GOFA]3\N[^6)FW9<1"*KZ3@IYJ6%(TBYUXQS=%[GZ%E
MK7*AK7-9OG5?.$3S]5/1SU:9TX[.?>;1);)13$+9NA59.*KG50@MDE%X:4K$
MKD./C>[VVM:Q=\B:NR*.F8SM-+*7FMHMA,T%HI+^UXBE.=*\Z*Q/15(
M4E0    "T3+#7MKPO<_1?\I]9VQY'JT8S;(     !4<<M'+
M *B@X1D22@@            %928XRQ9             !65&+,R204EN*7=(
MU"[6]&ZS.?QSF.@Z+94RN.>R5E921GH((*R(2"@NE!!)!)$@)!B#.%H%\W4U
MFV6)G9K?YW>AYGDKT?"O>CSSI"T3,%:+XP)E6$&<%DWB=$6FT(BIG,9Q%:;:
MQ,H214SU%<I@FK7&+*8@,[*:"F8%=E5PMH%7/-KN7K31Y1V0TO.4K"9FI5$
M")@A!61-+D@    5HXR;B*D@   17:,])IC[6\[O]T^3[\<G68BV      <<
MMG,              !0<(R146P            "Z4&+,N<<K
M!!65F-,R5%L%/.071H751,H(())    04T    3"]  ,,9PH!?-S-:OCB8UB
MO9BKX9S7S[6/55GNK$IBI;GC6)TM5:8B7-5I5=$Z*:U16*PBBN<1"^T4O569
MMFM6*2 0M$6I-(1*T+WF- 2(3"PB23FC']#)3,>=9U3.A2K2L3"DS.*:@":T
M61>\7O-ICFZ42   "$XBJ&/.0F\V    F]9WXU^*Q6:L>^U3=-!0"8  0S*
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M%4@  $=I(   *IXP BYU@  00&,N<3(  !'0;    '(F@ 1V%@!4BE(!">(
M(L=@   !DGF "-CH !@G 4Q$)[\^L_+?;'Z7^-W?J/"L^=V.?SIUM+<
M          "#!F? +YN)K?-7":<USC]WPE^:?O'E[\?_ *2GA]VO?EJ<]N>>
M\PLQTU+TS%:19CGJG6Y'13/0:U1QT(OE!1-8T\NMM2Z)=%RLV^/C "VD:=(
M31:@3%V%JL31&DQHKO%J;7HFAD9UJ<7NX^33JCSO98Z+\1S(@    [BP   *
MG" "YV@   &)R@!;HBW0 )J0 !R(R ">PT   !".$@   %D]P ,T<8   !NG
MI    1RF(   ">PT ".$J   "4]X *(X@   #5/6 #!', #H3T"09CZCX_Z'
M_KW\Q]O_ *+^,U:=;GYZXSEJ               !!A3.$ OFXFMZ;X3OSN^;
M;PG^2?O/F+\;_HF-O8K<E/=GWA[7P747G;[Y?KZPC7LBN?5^=\I'H[[?P^M+
M[W.?UZ:=]?5G<Z.6SXUJ,_>V3J^1QO1V]@;_ #6N]G#L5.[JGE^GY5)C@]&$
M7%[;6;95W\FRM=B_&B_)*;YU:9;!KRUZXZSCG3/MW,."SY_H;=[G/MON?':_
M?;.=/F[&PP>%]_ZN+J_ROI^L_F?LY\[UFF:UT6 "Q( '.    B5=P 0O@
M 7-0 9F0 )  -2X ,2H   "G0  N !!@ $65V "2P *T1B $RL "NJ+@!8D
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MTU\]]5Y/^%_5:_&^P;]3/-G  ;$@     $&( +&H      *&8 -"X
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MK;ZIL %B0      4  +@      @J "Q(        !0  N    05 !)8 $%0
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M7NO*TQT>=;I]"X^9T<]QZ%')Y=VG31:*=:SI2WU<TQ>]R]5,7:Y+X%0 S
M    -  04      !8L "A         !H  9@   $EP 5*@ DN "I4 %BP *$
M      !5F$$ =            *E0 S/O?,?2']A_E7LC]'^(Y=?&HF/.._I?
M/ZO/@"J7LB'M[HS^#,QZ=I'5&;&4G:H?0B[9+OAAJ]GRZMYNCD)[S/9IY(J^
MD/$O I/$=FZ]KJ(]^P\22\>V</98Q>W>5[6YU=6&NSA +YN)KN-</V>A5R>'
MY _._P!VZ%^%_6(KTT=?S%6?U-S.+7J<D^=A<S[4Q%N6F>RWY_J5^EYMFE>1
MP;5[<5&N=OF]:ONXJ.CN<?5/1X5?5]!;XO(5FONO.?133BM1@:79V)N0L4K>
MB*8F;ZEHFT6NA/+I5'FT=WFJ=]6'9Q[6JBUZ\4:YSS[597FU&N3;!39%P J0
M      26"F%)455      !8D %2    %)2DBX   +@ %    "2P (*A;)F91
M58 $%0 6) !4@      *=N9MS4>7W7,=GK^4KB           &1G DE/>'U'
MQGKS]'_ >1]#P49X](;OB#OU_9;DRW_GOA[1\F>RGM[?/YMT=I97^KO/;*TG
MK2V7QOWCZZ;/SPV?>O)ZAX>KBZ3XHWCSELOQ/KKRI^@F:J7G7=\D=WV=TCXR
M[Q[VB?$<1]8\V8M.N9OBJC] &39LIQ.4YP@%\W$URD8K;MF/ENM?G_U3!?+?
M6<S/Y2-O,EJ=ZO,]3I:6E8F)M1&Q6K2DS(IY^6+5FT169SFKS\"U-YB:2I//
M28WIOM&DS*K*@      DX2>4BH              H+9<*P             "
MDH(+P              +9;.0              GD=GI[/];\7BN3+F<':]WR
M8Y_5$P  2@D0  B0F $2$P"B*!5$R<CNYMFUYSFJ[>;YW]^'7%I^K'F[QYW1
M8WS\Z>IS?*7NI32_UNY=>_N;6O*]K3C^1W;&R]CQO1^A#D<CS-J]&*Z'Y^NA
M]R9GX9XW^WO,WFKX7=;[#=$;MST^(G8SNCKOF=F<ZU9QY;=#[2PJRG&\]\X0
M"^;B:Y?CQ5O3CR^?PS^??T)YQ_-/V"FNU71ZZG2K>(['G\C/GEF4A6KKYDZ,
M](B(5JIUSGK%+3>D;5I]7NF.><^9G1EG'G<CL]J>SL:\!Q4TV      $%4J8
M2              "@K              !44%)6              "2T7
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M&UOHYZ>GAK\#FHFO(CLXKV4]M[7R*NV>%IES>+BL\D)]4      0202
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M\OOV_E]=]6'8/9T]6Z^CO>OSV8<O'\OV.A?E?T'A^']A2N
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M6 "8*@   %D2           F:=?0J\K7L']&_%?HQ^V?SAL'TGP]'%T
M       "05G#,X5D             09@ DT "#"F<(!?-Q-:ZL\-OZ=?@\WA
M'\I_IKS)^/?OM=>*B>[G>MX&I_2?)[CS>[B+?/V)Z+]/7LYK->+G^K\UWW'B
M>9^/UL]S>M8Q\V)^FGYC[#E<.%GLXFGT&3]CYKA=WS^#Z>C8:].*IY=7;XF5
MZ^:SR^EB?G?K,EY/U#3TP "0 534   !%BP *)@   !%R00$T
M   18L "B8      "+@D @$@A-  2BP)!5-0   $6+ @$@$ D @$@   A$SY
M_;R/LOS3WK^N?SUWY^@?D-75XS'N             DJ. 9HK(
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M  JFH (L%XE(1<D )H1"*$BM$I@H!7&DE)2"Y.8I*245I!''+Y*10025@H(
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M[Z8WGHK*RLSOS37...\2IUK!=              *3$G7Y2
M5 DH              !=*"D              DN%LJ!              *S.
M&X%8                  ,,9TJ!?-Q-<,44F$,\<'MPZ]UQG/+>L[ZOGK@N
MEM%HYYJ)V :G'%C9USCHV\T:L;=7JQ'5Q:A?GRG%T[SQ=F"]7SM=RUWO';5L
M-MKLUCKYMDYE=&H;-QWC5J4UPS9LAH6F=J:]@\W;P:[4;Y9Z=,!G.$TXM[QM
M/G]]Q:K;,              "@Q)H1              !);(+@
M   ()              !!24%P%0             !L9NI05
M     @PIG" 7S<37#%%)A#/'G3Z#QOCAW^9N5.;UQE?QW7MVZV_L&)\NRT1'
MN \9O.ONOT]7L]EX1\$]^7[J^/ZGD+UO+\B^AQ8'E[OJWP>E\Z?1\GB8[>NN
M3JZ$PZ/K%G;Y4>CYOU0YG3U7Q.Z'Z"#Y<=F?6*-(F?I2?+=/?>6OU9X>CYU:
M9Z%T<GU\PO\ $5-^W+]0N7N].>=[\8ZU7Y@              *#&FD
M         @M@N@              XX.0              4E(+X*
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M!R0              #CG)(             !25G.-K!0
M  8@SA:!?-U-;,24F&,\>;_5X_'G7P:+?S_2=L_ .MO5V/1W5$^5);)#KZ6E
M>KQ>A_.]#NCB[?#';R>@/0\WS)YG9Z8B>],I\!ZQ]-<WS)BOH^GI\N_1TY/!
M]4Z<7RIVW^JE'QFTCTU#HR]>Q-\?8>4_.+2/H#2?G7,^N<;[SG/C2\;++NZE
MNF],[_3S]N\7;]./#]NGEZIUS               @QIARX
M26B@O@             $%!Q3G               '$.:4$@            %
M!65&RE90                  88SA0"^;F:R8@&',Z:CLTC7F[#MQ]#:TU^
MV^BYV[5AV-#SM,>H3IOLPZKY^K<^??;]L?2.W+T!AM=B>U313D33B]GG]%U]
M#UKAV]294[LICTEKIV>=6'H.'G:U;E\^[JNE9<\Z#*\Y[+.XH9LZBTIQ-^?K
M6^?K'#JV3R_3JRTC2@              %1BCC%\              DM%!?
M            !QSBF2              )).$<TI             !05'&-@*
MBT                 "3#&=+9!R#=37#%$&OFPE&>L3@TP:RGJ9T1$E8+>E
M5+54M7:(TS9W%((F*NWEJIK1EO7FBI%P+$QR)1,"W*!$36!<!%\Z-<Q<RT<_
M0%Z@              08DDYH             !06"#E@             %):
M.(<\%8            !!;. 9,D             %!9,<9TK(
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MO.<FCJE:(K+'::7B]0             )(               )!!4"D
M       $E)624             DO%LRQM!4                  5&/,\ 7
MS<37+5Q49SGV]?Y=&$RX[-\(M  C35-I0!&61  EH !"2242FR-A,@OE'3RG
M1*YS,Y<_8(@)8IQ $-#0 -\&F8 GFLH $-22"$PTJ $R[?9>1T3U^)/1SO(]
MFCN\I:%JH D
M            25E)MAN)42                  84SA +YN)K<3B8X:NCV^
MC/<_+.O?HOA:-?4BL"04SW2O$1<F8*(XB! +D:BF0E:(]"B8EFBB:5.822**
M,$QK$Y5."JYOWP6P$DB4B;2L $<V-S+.B$ CIF;!$H)KLF\+S%IF[7@( 2=<
M4^3S\C7SKW/]5V#\O^F<WPO3JRVF:NKE;8L=P
M                                      )*3:C<@2
M   "##&<(!?-Q-:Y>O"QX5?O?0^!?U#^._+GZQ^$1IW1S<,B IC.XB2R27)D
M4E(*6A)$E22U$YS'.8RI4D4DRJO>>CLEO2K#CIRY[N"F40$N@Z1,@TY6G. %
MNSCSM< *^>L9JI04"/-E)LG>Y&E&D"20BC#RZ.'KJZM^5P_>>O/AOV+T!^5_
MT#5YOI1Q]D]/*ZN5S](
M                    %)2;6;L4%0+125%T               @PIG" 7S<
M36K3A<OG*O1^_P#!?Z5_#?E7]?\ YZJ]#ZMCQ2<V$$4<B&.+A;&O"F(*"2JN
MHDN$S-IT0QJ<M+F%;V12255QIQY8=W*C:U.=-JQK:"R S,A>D(V1H %?'O7C
M?C %[;.S:.24%$*9\V%Y=-<=-<[<?3GA%96)BC?R:<_1O>ER.+IV;X7] ]Z?
MCO\ 9&T>#]!5XOL46JZN5CN
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ML>IX3R_*>CHZ^F?'IZ!_/_WCV#^/?V/?^5^AH]3X^>GTJ^4*"
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M_9OE/NW?YLW]VO'SQ00            "Z4E               *2X4EP%L
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ME/L*NCS'SO?Z7_-?Z-]>?E_]"T>%]&Z..K'U:W.((            !<*2@D
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M^>FKMBCKPCQ]W%[+3YF]Y'U/M/\ ._Z0]!_E'[53XG7>[;6^]<X]*KR
M        !;* 7P             "D@H+P             !206SDE!(
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MLM%)RP             "2T<4Y8*P            "D@X1R2X5@
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M:+9>              )+9Q#F J             *2#C'-!
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MOX[_ $;NWPWZO1@X/;R<CC^AO:^>             !46BV7P
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M'Z#'=?D\CQO<N]W,             !!:+9R@             "@MG&,@
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M!,H              6B#@F6!2             72@X*,\FN$2()   02
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M&.,D              "DX!DP4@            %TH."9XK(
M    !!A3.$ OFXFMV[<)Y_CW/;Y?!/[5_*GE;]1_GJYZO33QY3YWK\;+VZ7#
M?ZOGJ+Z7'3Q$\EA;R[*N?JIQZK^K@]&&0V\_AZY7?']/BLN=]+\Q7'+;\K[S
MC\/;?U\RCIRM\_)REN TYJ]#EO5<2D7]9XW?[?-M\%/+Z@ 5F:2 *22"H
M       3$>UYZWHT\U*O*]??OGOT?Z7_ (9_4.R?(?>3CW8[T>#E9S?C4
M          "3B%DYH*P             4&/,F              06S'F4)
M           !44F.,X5D                  @PIG" 7S<36IZ,+P>5<]G;
MPE^M_P X>8/O_P 5>GX$^!Q*5>UC/%I&^S:2Q,%4>9$Q,:%YC2*]T>GI/G9Q
MQ93ZME.&*[J])DKRJ]1>8O$W.272LB_CM/JFGSS;J $U*0 )*"Y*F
M   "(CR.">COFNE7C?5^]OB/UST7^7_U#&.-?*Q>E>5UX\G'I
M   '#+!SP5D@            H+9P3*@             %!8."98DD
M     $%108PS960                 "#"F<(!?-Q-;[^3"^?Q5\_UNB?2?
MG./]#Y"KK^EN>;UHRH]7DJY>Z>698PR*%IO+0NBFC/5R9/7V8>9/'RQV>O.5
MVWF1;JGFV9<+70N:0T1RQ/>UI5/S:OU,5\^:;@!4J %)CD\TO
MC7=U9V]/(N<';NOC?:W^#Z:ON^=JX:8O+?D]^'*PZ0             ).$6#
MG@K)            !04' ,J              4EHQYE@2    !( !     ""
M2DQAFBL@          "H !8    ,(9T@%\W$UPQ108,RY3?-, !( !D
M         )  NK8E;($@            %1<*S$G**P             "^<<X
MQR@              #@'/              +I08@S9:(    $F@ *E
M%1C3*E9           @S !)H    &$,V5@OIW%&N&**36C)%RMD2 $  (N2
M            !  !' 1R#D             $ETDX!47@              6B
MV<D              M$'#,D              26S@&7+9     J5 !)<
M +16<,R902          !<  H    @QAG2X27T[BC6C$$'!)%=46 #,@ &Y(
M       4D$E0 ))  4*"D%:*22T"HD            DDM@J     !0"HD
M   %P%)2              722P2"@$D@ D @ $@ @  $@$%1;+A22 0 "0*&
M02"+HU"0     4%TI)          !.X0!"<0@  D I.85 Y"=T1K1B  -RP
M.>%52:@)        4$ ( %)0D &<LA4"6IH)!45                    %
ML  N      MD%16           "@@DK!;(*BL%L$E0 *2"2H $%(*B0  04@
M   %1( *2!  "2J0I(      )*@ 04@       "  "0     D'(3N:-<5UBT
M52D2=632H <Y5470(F"0     2(D4RH*2@  F$RD$1FC,7$2&T1K,J("HD $
M3 DD$1( $6@ "5A43  4R@  $E5@H  *8 42'(!"$    ( )   *0 "H$$
MJ  +125S%U ID) +8(*9 "8(")  3 (@)1)( 2 "" 2L00B F1($FH0!"*S4
MB$3$ )2@A$)3" 1,DBF(JE,6A)$3,Q"DH$)B F2$51$S$(3$HF8DIRM")F)@
MF*-8J1%JHBI>'1,4B:55E*)3$6Y@CE5OOG)Z765N?YU[9\*[DW+./I2A  Y>
M"Y 5$$]RW8*@  060 5)NKBX4%DH  *RZ5@L4("HO%3&F,:BS(   H0 "Y(
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MF3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,_D^TS^HY/\
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MCO*G5I_3[8Z1T=*;=MA.*#<-U6I5ZI38J]>\MI8%CO6;*8WN>@W%)O6[XW%
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M?E\'C\B$^)-4I?I_>_RY7PW]LS^7Q\,F?\&3)GX^#P+@PAA/C$HX\2V_Z/\
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M)>34A=VY+[;=Q$KRIV5,EMWE[4AY.JR4%P\@MB6GI$^B/&U0H4I6-OV35/\
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M4!NH#=0&Z@-U ;J W4!NH#=0&Z@S$Y@4A<P(B.H!74 CJ W4!NH#=0&Z@-U
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M'?P&_@-_ ;^ W\!OX#?P&_@-_ ;^ W\!OX#?P&_@-_ ;^ W\!OX#?P&_@-_
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M-Y ;R WD!O(#>0&\@-Y+-Y+-Y ;R WD!O(#>0&\@-Y ;R WD!O(#>0&\@-Y
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M:H5$PAW$RF/CD403!$J(0XB(EA6.+MPFJ$^F+_-G!]"GV/'P1$%T(>%,P"+
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M'KC ]<8'KC ]<8'KC ]<8'KC ]<8'KC ]<8'KC ]<8'KC ]<8'KC ]<8'KC
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M,)F$S"9A,PF8#,!F ^@S 9A,PFI#4AJ0U(:D,PF83,!F S 9@,P&8#,!F S
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M7"!6?X"!6"!6$(%9_@XG:=XG*M.\_OB=IWB)VG]TY6<=Y@\>7'\\8@5A7?=
MA BR$5PG*M.\_P!&!"!?= A K"N$"L+]*!6$(%80B=HG':=XB=IWB)VG^A O
MUBTQ6?S!)"2!=GW'_/PT1,$D$7W$?\_22(0_GW$K1$K?T$S9I") X?<9_P#0
MIQ6B,?\ HD2M$XK?NA#]&)"<5HB7ZJ<FTA.3:7ZZ:JPQ [!#]*)6_H1*W[HE
M:)Q6_P"#G)M$XK?UD2M^Z!V']T2+M_QQ%')C$#L,1(A$K?\  Q+[H'8#Q91$
MB[1$OU4#L,0.P_\ $J*)Y 2>X31 0$!-$T31-!E^A 0$T31-$T31-$T30:<1
MB;J$W4)NH3=02G&)HFB:)HFB:)HFB:#(0$!-!I""A'_H:B!D"(((+]C]%18A
M-!$(" 47Z*/9,+(&D(3C"""\OZJ&,P@$848,X":)HFB:#+$8(L800@%D(=8A
M &D3=0(@1?KR*(60-(2D)(++)B$-6X0U;A#5N$-6X0_1-/6""!!9!:0GV2_7
MS1-$T30HL7Z*,OW&41 30QBG!PPL)RAL+[/U\>N?S#9_<X40ILP2=6X0U;A#
M5N$-6X0U?HIRD(_<?W&7^&)$<8F:OH("!#$"(H" @(" /]& @(" @(" @( R
MQ" @(" (L8FB:)HFB:)HFB:)H416C$(":0F:OH#*'_0D8U!20I(()!^S=^B8
M@"($D0"RA^BCM"B"D!*0D@O+^J[;PG$(A:@I0(L1?(31 3098C^0+^X20AB"
MR(=I?=,B)FKZ";#_  #91B%)!D$D$IR!9" @(" /]$D[PE,/N4%(&3]<64A
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M+:QY.P4)6"B*P4)98"B*P-,1:R!V31"Y,$,P/($)@1!O]BDM0<*(-.,-)@$
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M[Z^(Z0*SOKXCI K.^OB.D"L[Z^(Z0*SOKXCI K.^OB.D"L[Z^(Z0*SOKXCI
MK.^OB.D"L[Z^(Z0*SOKXA7*!4#ZV_P Q)^4"S477WC ^&9ZDQ59VC!LL2ZDL
M?8'FDNI"9*3;D^'^<ULFXHE:H?4_[A$D/L$LDIDDQAULTDKO&%E*):L802UX
M[0VRL-299AJ0K4$X.58)5)G$ON)L,4#G!F*!P4#G$10.<&%29<.T.R9<0F3K
MCVB3R98;D:X9 Y)UE'*'F%E:*%8987K"6%P[0MA86PL(DRS,2>0K.&(*P:HV
MCQ'D'-+E@YI<L'-+E@YI<L"\$N33Q#FIRPQS2Y88YJ<L,<U.6&&L%N)5[)@Y
M JP*D:R[ N3+*T*97K%$K6$LKUA$F6=H3(UGV I NP%@E;GNY >!%YH5@APO
M=,'@MPNPP>#G+#",$N+QP,(P,Y8.:%PR&'\%N%V!Z0.1/$89DKA%#&&9*LX
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M/^QC!7)U>#O64Y.33["A_8A(,.HP>Q1')S<UD96?,84PD4N,_5FCO#IP-2;
M\B<'Y+'W@[(C/(J 5)%%BG;@[)3?DK2)TWU:<?<&\$KD[D^F)6.S7\A6B)!M
MS>S*'\$'*W)U*28GD@8DF#CD[2DTA*ZBNSX3'-RJ57K,JU?4Q)Y HO?%3.!=
M8/256<$,'3(Q^\0?DBE$?7@)3@U1Q]8&\&J2K]IN$C8F0BJ(E_6P?*$6HRC
MTFFJ+M!MP9[O[#"I%$Q@Y$7"[,8PBQ/P6LB/M1_<-R*!1GE&-@99-/:&DP"$
MZP2)O;QP?Z;RYKJ?])?^1AE\R3E$OE1DDQA7"4U2L>2(=PS SZT C"<]N=.R
MQ#^$H&>,,X8A[PY^4E/M;Q*.42B][>&L,J6VE<[*5HYY5G;QSZHO>'/YYV\'
MR@/.WA7*UY*U)GGB.&4)Y7O9YWCI:\?O'>%\JGC]\[PGE4_/1UC]M/;\0PQR
MF>H$G./V$]OPD)+RH=IX3SRVAGE2[0>V>2T2OE2[2>T=YB1<J'ID)YXRM$IY
M1/0/K;PKE$].]H[Q)N43V+K'>#Y1O0]HPKE*\E4Z<90UCI<_GGM ^5C^>=X/
ME2\?O'>.DTH/WCO\A@[E&\J5)):SA!7:)5A_+U]XY_ZWM;PQAR/O;P[A@S+V
M@YAM;>-*H'\P?*1XO>.\'RG>+WSO">5;V>=X3RL=SSO"^5CF?O'2MS.._P A
MTK<SCO\ (=*W,X[_ "'2MS.._P ATK=SCO'2QW/.\=*W<_>.E;F<=_D.E;F<
M=_D.E;F<=_D.E;F<=_D.E;F<=_D.E;F<=_D.E;F<=_D.E;F<=_D.E;F<=_D.
ME;F<=_D.E;F<=_D.E;F<=_D$\KG8%U]XZ7.Y^\=+G<_>.ESN?O'2]W/WA7+"
M73C@M4(G#K&.F$OSU[1CIA+\]>T8Z82_/7M&.F$OSU[1CIA+\]>T8Z82_/7M
M&.F$OSU[1CIA+\]>T8Z82_/7M&.F$OSU[1CIA+\]>T8Z82_/7M&.F$OSU[1C
MIAA#/7M&.F$OSU[1CIA+\]>T8Z7R_/7M&.F$OSU[1CIA+\]>T8Z82_/7M&.F
M$OSU[1CIA+\]>T8Z82_/7M&.F$OSU[1CIA+\]>T8Z82_/7M&.F$OSU[1CIA+
M\]>T8Z82_/7M&.F$OSU[1CIA+\]>T8Z82_/7M&.F$OSU[1CIA+\]>T8Z82_/
M7M&.F$OSU[1CIA+\]>T8Z82_/7M&)-RPE%#ZQ9QG'E,+Y7NG[YWCI>[GG>$\
MKW<_>$<KW<\[QR?PQ69%)W5*QJ$CEA*(L86[.('E#78%^T?S_P NGQN! C!&
M"4)#*YDG2G687*B/+C"I07R"WH@UXPZ<5J^85C#C<0IDQ5C,)1ZI'^D/-Q[!
M1'.#+>/("1U#_P!)_05?UBO]1_4,L8@;&(/,&"DQDZ@X>\0=1B#K)XP3.,,M
M&)4W&2.E\(P6U-,@9>K[AA)DU*. D,G-+A8H8Q*&YTA4FTTG]04F,NP(9@$(
M@$]GZAYLU.I/X2+>H-LG-&%$&E)Y1AQ:TK7EAC$JE*R4>,Q)Y8JKEC[3#LH4
MH\MHDR7%Y(F$R%Y2<A[P_@A\S/$K>)/@MXF$$:3]G6%X.>L/>%R)VP]XJ3UB
MMXJ#]A[QS"ZHS5 \9ZPWR?<L,)Y/N=I&#Y/N6!/)Y<]&(_:3]1AK RB8+$?L
M)_\ $@Q@E9/_ /<&L&*HB^0E."U4G;E&#\$JFD)3@-4#Q!>!%1R&)+@-5@/
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M?9'-J<WZCFU.;]1S:G-^HYM3F_4%@Y)=@J:4B82 D\@040\B#<=9?Y/F$>.
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MS& -C%D%!!402 38)L3!(V24LXYIB52=(1)DSA)Y.G4').F 4P2<@>;Q!Y$
MM/W([>[_ *VH*(0""" I<'C+6) YC+N@)*K$0[ O^1SV02SM$I]H4LU4!)Y1
MD#$J@0;EA6BO%:*\4,H7+M85+=8*6%:$RHL6/>#<(SB)Z1/2"6FT&M./&%.9
M?F8,PD-J"78%&.05S6$RLK0F5E;O!2L@[*DFA11[!*7HB=%0DG8%&F 6HA.(
M3B!*(3@P\3:C/5 2J5E:$RPB5E$GE90RA<L*&4(E!.&>H/++&'U!S[D=O_7%
M$(!LC"2#B3-]7S$@2<4B2]GR!9 L%D_D:]D$L[1*<I_,*;-2C,@TVH@V:B[A
M2F7:#E"B[16%&64+E"K0;ZHA+QA+IVBF%,*<4PI@:P1B? $^1"LBE4">5:*R
M9=HK:K04J,\41*'@EWK=XDST Y*8)RBM17E!/@G\8)\4^L'*,67&)5*3QXPB
M4*G=XD\I.&4.2DX91))3C7\@[* Z\#5$$0(H?];(L04.T(" EF<X:H"1,9!)
MVH$%% +,)R%_(UY*H>R=QB6-KQ]1>R?@)2T[$_5N;"O ,R9:DQ-M>7-/P"9*
MO1JV3%67HE[)^ 7)WM&O85X!;#VC<V%> )IV!>K7LGX!3+F8O9/P%$[HU[)^
M 0TO,5LF$M+S%7&%)E$XX-.Y>QM</H)LIT+O]-?@)DIT+W]-?@)LHT+O]-?@
M"*41_9._TU^ HG=$YL*\!0O:)S85X!33W8T[_35X!34HT+O]-?@$HE$Y)&R]
MET:_ 5=W1.;"O *D[NB<V%> 4P]HG-A7@#9?T3O]-?@$M/SB]4[L+\ \U*-"
M[L+\ EJ43OV#W])?@&$/P_9._P!-?@'R?@?JG=A?@$IE-*14#W;^[7X D2C1
M._TU^ ),HT3O]-?@"0_HG?Z:O 37M$[L+\ AMX\5$YL*\!*F'S_<N_TU^ 3)
MI1._8/?TU^ D[+T"]4YL*\ XR[#]FYL*\ AMY)J]4[C^!7@%I?T3NPOP"FGS
M_<N_TU^ )E[0N_TU?E"&78?LG-A7@#9=T3FPKP%"]HG-A7@*%[1.;"O 4+VB
M<V%> H7M$YL*\!0NZ)S85X"B=T;FPKP%$[HW-A7@*)W1N;"O 43NC<V%> HG
M=&YL*\!1.Z-S85X"B=T;FPKP%$[HW-A7@*)W1N;"O 4#VA=_IJ\!0O:)W^FK
MP%"]HG-A7@*%[1.;"O 4+NB<V%> F+S%;)B8O,5LF)B\Q6R8F+S%;)B8O,5L
MF)B\Q6R8F+S%;)B8O,5LF)B\Q6R8F+S%;)B8O,5LF)B\Q6R8F+S%;)B8O,5L
MF)B\Q6R8F+S%;)B8O,5LF)B\Q6R8F+S%;)B8O,5LF)B\Q6R8F+S%;)B8O,5L
MF)B\Q6R8)IP\C:S^25'_ &%"]HG-A7@*%W1.;"O 43NC7L*\!1.:->PKP%&Y
MHU[)^ HW,Q>R?@*-S,7LGX"C<S%[)^ HW,Q>R?@*->8O9/P$Q>8K9,3%YBMD
MQ,7F*V3$Q>8K9,$VN'L*V3\ IIS1KV3\!1.:->RKP"&G-&O9/P"6UYBMDQ)V
M5&1',5LGX"2M0A$@T1$79D#D(!V,3"/93\B_S#$K2$Y-I7B)6E>(E:5XG%:5
MXG)SDWD)Q6E?]T#_ .A.>T7R\0@3B@'E)QXB#SB+$W%X EIL3<0:6CX=P)U%
MB;B!O-YJ;B!OM6)N((DK3B27U>MCR$#D#7PW$#P>U8GCN!X.:U7#F]NP@3C2
M.K-1U<60O )?9S47$*9K-;N+P"W6LU.R7@%/-QR)N2">;L3<7@*9&:FXO 4S
M?:2;DBF;S4[*03K.8C93X"G;S4W)%,WFELI!O-YJ;B%*WFIN+P%,W8BXO 4Z
M,U%Q> IF\U&R7@*=O-1<7@*=&:BXO $\WFHV2\!2M9J=E/@*5K-1LD*5JQ.R
M7@*9JQ-R03S5B;DBF:/W4[*0;K6:C927]A3(L1<7@*9NQ-Q> IF\U-Q> IF\
MU.X4S>8FXO 4S>8FXO 4Z,U.X4S>:FXA3(L3<0)YNQ-Q"F;S4[)> IFK$7%X
M!QUN=[*;B\!2MV)N+\HI6[$W%^44K=B;B_**5NQ-Q?E%*W8FXO 4K5B=DO 4
MK5B=DO 4K5B=DO 4K5B=DO )?:FEB1DL+P!OM9J-W@*9L^Q-Q> -UNQ-Q> I
M6S]U-Q> YO95UH)QX^,0YM9L3QW#FUFQ/'<.;6;$\=PYM9L3QW#FUFQ/'<.;
M6;$\=PYM9L3QW#FUFQ/'<.;6;$\=PYM9L3QW#FUFQ/'<.;F;$\=PYN:L2.;F
MK$\=PJ#7PW"H-?#<.;VO@W#FYFQ&X<W,V('-K-B>.X<VLV)X[AS:S8GCN'-K
M-B>.X%)VI+UH)QXK?[!3S=B+B\ IQ!^ZFXO =0_=*X@2$G[I7!UI)0ZI7"C3
M85Q"C385Q"C385Q"C385Q!;$\\1%<*K\.X57X=PJOP[A5?AW!#,PH&17"C38
M5Q"C385Q"85B;A,*PK@RDJ-.(KO\Q'[7<$_W^Y848,\>4%$&%1M!F<<IAM>3
M&&7-80K$%F06H1$1$1$1/UB?K$\3A/$X[1.UB=K$[6)VL3M8G:Q.UB<%*Q90
M2]82H)4",@LRA^F98^X)Q!3D!*91EQB42R!GC")9$LH3*X=HKF+*%R[7O"I?
M\0+E$IHJ./LXLOF.DRK3O!<I#/M.\=(U6_B\QTA5;O\ ,<YSE&<[+CRA&$/B
MQ?,<X8LN\+E_Q"O?$"ENO>*]KWBOZ]XK^O>.<2MWCG K=XK^O>*_KWBO:]XK
MNO>8KWQ"O?$*]\0KWQ"O?$*_\6\5_P"+>*_\1;_$5_7O'.&O>.<->\5_7O%?
M^+>*]K%>UBO:]XKVO>*]KWBO:]XKVL'+]8YPU\7CG'XN+QSC\7U\0<OCVBO:
M_J*]K^HKVOZBO:_J*]KWBO:]XKVO>*]KWBO:]XYQA[V\<X_%O!80U[Q7]>\Q
M7OB^H/E&:>K')BR^8Z2G;^+S'24[?Q>8Z2G;^+S'24[?Q>8Z2G;^+S'24[?Q
M>8Z2G;^+S'24[?Q>8Z2G;^+S'24[?Q>8Z2G;^+S'217!^8Z2JX/S'255N_S'
M257!EXCI*K@R\1TE/7M#I*>O:'24]>UYCI*=OXO,=)3M_%YCI*=OXO,=)3M_
M%YA.'3E'5CDQY17_ (MYA,NCVAB43H!C&0<1B(4?'!"CXX(4?'!"CXX(,M%
M\@H4V$*%-A"A380H4V$'62G8O 4/$10BA%"$E B+_,1^UW!/]_N6%!1]8)$,
M0<Q$%J!.]: 8<R!"PM64*4)YB>8GF)QB>)PG"<)PG"<8GF)YB>8GF)YB>)YB
M>%KQ E!*@E0)8C']2\K$8EKAXQ*GCQXPT_U0E\Q2&%K.T*4J.4-X-ID$YG8Q
MS3\P6"@6#-8YMUF%.*2XM&:HR#;J@3JH!3B@:U1$50!J4#6H4J@;AGV@G3M!
M.J!+,P2E"*A/,3S$\Q/,*6<!2J%*K@Q2JUWBE,+=5"P$Z8)Q0)2A.4#4H3S$
M\Q/,3S!K,&LR(&XH@IQ0-Y5H:<4:1/5;O,3E:]XGG:=XGG:=XGF)QB>8GF)Y
MA2E3C!*4"<40ICM^HICM^H*0S^MG8^SQ'-_&+Q'-_&+Q'-_&+Q'-_&+Q'-_&
M+Q'-_&+Q'-_&+Q'-_&+Q'-_&+Q'-_&+Q'-_&+Q'-_&(<W\8AS?QB'-_&(<W\
M8AS?K^@YOUCF_7]!S?QB\1S?QB\1S?QB\1S?QB\0Y)SDQ3R[<78#?5:&Y0<<
MHD<HQD)(Z".>0FZA-U";J$W4#7,Q0RBF(4Q"F(4Q CGXX";J$W4)NH3=0/+_
M )B/+QJ"?[_<L*RAPX.&&NPA-#Q0(.G 3NN8DZL@;,X!43(*(0,8QC'6X,8Q
MC&,8QUAC_5+]D$$A.0$"XW_IF8B)0);VB4I.)A)PQ!L(1$4$0<ECV!#BFT$@
MB."<60P<I679N!RQ9=AW!6$%E_L.<EV'<8-$]9J[5'$-,A#(JXJ^H5;$7<%2
M;4%2<&P#9@"9.P)8R!,G!285;$*#4*OJ%7U"KZ@N3]7(*#5N%!J%!J%!J#K&
M+OL!,9 F3Z@F3@I,8.30[!5]6X5?5N%7U"KZMP-C4#D^H*8"F ;0DS$6^\5<
M5;4*OJ%7%7^8J_SX[Q5Q5_F*L*F9XPJ2:@IB 4V9" YQ<3U;,60<Y.\$.<G>
M"'.3O!#G)W@ASD[P0YR=X(<Y.\$.<G>"'.3O!#G)W@ASD[P0YR=X(<Y.\$.<
MG."'.3G!>0YR<X+R'.3G!>0YR<X+R'.3G!>0YR=X(<Y.\$.<G>"'.3O!!N4+
ME1S3]W'D#C9EV C@H21V!D)'*,1"2.SB,3OD)WR$[Y"=\@Z4XQ,U?43-7U$S
M5]1,U?4-]5,!$1$1$'E/_,1^UW!/]_N6%AX_6F).48 BQ"4%E(/F<01'.,28
MC#*<0-$0I HS%&*,Q1BC$P48HS%&*,Q1B8*,3!,$P3!1B8%-X@E(2D)0"0(0
M_35E+[GRQ&)864A*2QF#A.#,(Y0R1!#<>R(JZC]TQ)\%,+9;4HTDHRQD8<P/
M)LY/'<',$,=AI#F!V=05@AK4*%*5J278< RSJ"&3L!MD640;CE3E$&X94P@0
M4ENT@M*-04V0HR/%E% ?:F FH++ @@V>U2;PBCSB%&B&4A!%I""+2$$6D((M
M(+2B;E(3"$PA,+4)B;0\V1IQ8\8)K4$H3$)2BT@1-9Q"8@_9,C%&0HR%&0HR
M"T)[8$%)3J"T),*:C'$#8.P21*$MP69).)B#6<0FMVBB2*%(F(+$<!-;U":W
M:0FMVD)K=I":U-+K$%I;M(.I3;B"TD#2404@DID1FX@C/&.;Y)I47F.;Y)I4
M7F.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I47F.;
MY)I47F.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I$;1^ YODFD1M'X#F^
M2:1&T?@.;Y)I$;1^ YODFE1>?@.;Y)I47F.;Y)I47F.;Y)I47F.;Y)I47F&I
M&PV9FVM*CAD(2ALX' @XVN/LF&"4D\AB2K,A@Q<ZDQV?=$1,1,(FF76,36\X
M36\X36\X36\X+@1]4Q$Q$Q$Q$_\ ,9^UW!/]Q$@L*2JP/D9/'B["_N).M)93
M(@3S,/VB8B4+;,L2B$H(S/$021SL8DQ9 R6('"&4*-%OW0$-?W0$PQ,,3#$P
MQ,,0UD(:R$-9"&LA#6(:R$-8AK(0UD%)B6(3#L"4Z@1 H!<(8OTU%$^[[GSR
M_(2PX1$I5C$R=C#39EV!@LD0R98@A96A*RFD%+"UD%J(3B"OVJS^(PQV L@>
M"BZP(BAW _N,(A/3\P[D,/" 9[ ?[,_D,5NX8K1BMW#%;N$"$"$"$! @LL7Z
M+!PG"<0G$)Q"<0?.,/T7"ZP20003V?<]^T/]$O9"@H@H@9 TZA-U";J$W4)N
MH3=0FZA-U";J$W4)NH3=0FZA-U";J$W4)NH3=0FZA-U";J$W4)NH3=0DIT:S
M/)B#K\0IR(;QAA!F,$(FTO=_G:6),WU?(A,4*,Q,4)AB8=(?S$F2&RQ=P6D.
M)Q@BQ"!B @8(@7Z!B:)HFB:)HFB:)HFA)8_UD! /EB,2[M[Q*8Q,,$5&02HB
MQ!#I$$RDD]H3+-9!,N*:6,*EI'VA4M*T'+"M!RN)Y13=<SUF&7R!2DH90N41
M"GB,Q3XLN\&^78*<&^5H2_UB^8<E!!QTC!.%'*&WB* K)33QBL)%.D5A(K"1
M6"%8UBL:Q6!6-8.4:Q3)M%,5HIBM%,FT%*"+M%:UBLZQ6=8K.L'*"/M%,5HI
MBM%.FT4Z;0IW&">()>+$"E&L%*2#KY3SQBF(4Q6BF(4Q"L%BQ@WR"WB!N W
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M4FM45G H%]1)WG)4BD;44W6J']Q*<+MR14QTSCJQB0N.X03.D\(?%B&%Y:K
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M<'?%M%X#IY@X\[;+P'3O!_Q;9> 3R[P:1XYVT7@"Y?8,L5MEX N7^"[%[9>
M](."LU>V7@"^T/!1>ZO;+\H/[0L$JA%"\7QE^4>D;!9% DN;:? 2GEU@Y_).
M[UEX#I=(R.)*Q?Z@SRYD*/:-1_\ <7@.G^"[%;9> +[0,%E[J]LO >D+!>:O
M;+P!_:#@L_=7MEX#I_@NQ6V7@&_M"P2DNLE9_P#>7Y1Z1,$9CFVG\H/[0\%=
MB5[9> 5R_P %GV+VR\ ?+K!GQ;9?E".7V"TI@:5;9?E'I P5FKVT_E'I P5F
MKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E
M'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5
MFKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_
ME'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P
M5FKVD_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT
M_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I P5FKVT_E'I
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M&.=)5P8=PA*5H-,XTZR/&*S*-.YM"LRC3N;0K,HT[FT*S*-.YM!+\H/]^YM
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M>I)Y;(B5IG';C&!'*!U!Y,9# G*!++28J["[1AKE(EQI13]XPIA9)*G$?O\
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M)^ ;9>IC]4YE/W%6_(2AU]J4&BA=Q$7[M?;W!E;RLK+G]-7@'FGE%^R<V%>
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M.B#*(:;#;>(,E!M) XA06D&0+]5-^8F_,3?F)NH$G'^BCVB_626;55QTA_\
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MK;!,)]C)9J&$4,=DSN_V#6"$.D3A0ZV,-X#;/+-"\ -0]VX2GDZV9'B3=_:
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M@57:S=_Z@OLZP/']SQW!K[/<!IRFSO\ RA7(/ Y'BH8=F7\H5R#P3_\ 5=Y
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M/Z+P57S.1V8@(GF<D(WT9A[G(HWT8@S3R>11/H[!1$U-U7R^(C$AI438WR>
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M37+89XEZ&>)>AGB7H9XEZ"4Q)[4,[3 SM,#.TP,[3 ?24>VKJ*R7%9+BLF'
MK)<(J*O<*J)T@KY"QA:3(AQZTRUP+7 M<"UP+7 M2UP+7 M<"UP+7 M<"UP+
M7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<
M"U+4M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7 M<"UP+7
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MB4M->L6F.ATZ(]'2K-:WWE+RA%6!%;7VM(D1S]JS'0VSG(G5V#HCEVJ-\_\
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MH_ T?@:/P-'X&C\#1^!H_ T?@:/P-'X&C\#1^!H_ T?@:/P-'X&C\#1^!H_
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M?4X\CZG'D?4X\CZG'D?4X\CZG'D?4X\B<''D3@X\B<''D3@X\BM!QY%>!Z7
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M50JH51&"-'(B(JX"MUE52JI54JK^ZI54JJ5%*JC6:Q88L,5O[&>=^^[ST_\
M'^:D/S? RO\ V:F7=L3Q*9YZE%?*$B>L=Y23(VHF]5(4)[KQ:[?)N)O)O/*Q
M/*Q(<1]HJ:_.(+WU=I27.EM4<]TR#$?JUKM0CQEJ[>X>JJX@,51T)9$6$NOU
M$""Y%$8]&D>NBD)SZPCG6+_4>6>6>7U,\LAJ]'%=UXKGWE9Y6>3>XD\2LB"*
M^\F_'F0(CFUID6D.UZRU<Y1C9Z]8^;1[G.OU$WXB*_$17XB5\2%'6$VJMX^D
M3%6:B-$ADI?NK_&3]U=G\=O[J_\ 8DV_NK^ZG[KOW4_=7;_<T_O+OW<D4:VU
MR^U(^C^3DDSR>1"HJ0VM2\B-JJ-38+#UEF699X%D-34F J"H*A(D(@B"(5=2
M_P RS+,LRSP'0]2^K]UB3<U,2S+,L_Z%EU(9#U[!8:;!T,=#V]PK1&R6?[[_
M #T]7\U(3TE(IU$?262:Y$]9E7Z)TND5E;'@I.]%^)2_H#E!7*N=4?@OZB!]
M ,I54_YNC\%_4)] LH?BZ/P7]0__ -/<H/\ _F4;@OZAO_ISE%%UTNC<'?J(
M/T%I</;28"^"_$I'T+IML_ZZ%*=R_$[&4U/^K#X+\1/H;3?O87!?B=CJ;]["
MX+\3L?3/O8?!?B)]":>V(KK6%*>ZOQ(?T4IC4DL2'[*_$B_1"FQ=D2&G_P!5
M^(OT$R@JSMH/LN^(WZ#90;_UH7LK^H?]"LH.3^WA<%_4=@LHJO\ ;P?97]1!
M^@]/A[8T)?\ ZK\1WT1IDO[2'/U+\1WT)ISG?VT))X+\2']!J8W_ .1 X+\3
ML32U26<0."_$B_\ I]3XFRE4?@OZB'_Z<Y11?_=T;@OZA/H#3JM3.J/KU;%_
M4+_Z=4]/_ET;@OZC_A[3D_\ ET?@OZC_ (?4_P#%4?@OZC_A]3_Q5'X+^H3_
M -/Z<W6M*H_!?U'82F_BJ/S_ %"_0.G+_P#*H_/]1V!IWXNC<_U'8"G_ (NC
M\%_4-^@%/3_Y=&Y_J.P-._%4;KQ.P-._%4;@OZCL%3?Q5'Y_J.P=-_%4?G^H
M7Z!T_NI='Y_J'_\ I[E%VRF4;@OZAG_IYE%J_P#O*-P7]0SZ"TUO_P JC\_U
M$3Z!T]VRET;@OZAO_I_E!-M*HRS6Y?U'_#ZG?BJ-KP7]1_P_I_XJC<'?J$^@
M%._%T;@OZA/H)34_^51^'_\ D1OH!E%[IMI=&1/5_P#Y'_#S*7XVC<%_4)_Z
M>Y1_&4;@OZA/H!3_ ,71N"_J$^@E.3_Y5'X?_P"0[Z!T]5GG='Y_J.P5/_%T
M;@OZCL%3_P 71N"_J.P5/_%T;@OZCL%3_P 71N"_J.P&4/QE&X+^H[ 90_%T
M;@OZCL!E#\71N"_J.P&4/Q=&X+^H[ 90_%T;@OZCL!E#\71N"_J.P&4/Q=&X
M+^H[ 90_%T;@OZCL!E#\71N"_J.P&4/Q=&X+^H[ 90_%T;@OZCL!E#\71N"_
MJ.P&4/Q=&X+^H[ 90_%T;@OZCL!E#\91N"_J.P5/_%T;@OZCL%3_ ,71N"_J
M.P64/Q='X+^H[!90_%4?@OZA?H#E"7_NZ/P7]1V RA^+HW!?U'8#*'XNC<%_
M4=@,H?BZ-P7]1V RA^+HW!?U'8#*'XNC<%_4=@,H?BZ-P7]1V RA^+HW!?U'
M8#*'XNC<%_4=@,H?BZ-P7]1V RA^+HW!?U'8#*'XNC<%_4=@,H?BZ-P7]1V
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M] ,H?BZ-P7]1V"I_XNC<%_4=@J?^+HW!?U'8*G_BZ-P7]1V"I_XNC<%_4+]
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M'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O
MM%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'
MKP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M
M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'K
MP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%
MQZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP
M+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%Q
MZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+
M1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ
M\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1<>O M%QZ\"T7'KP+1
M<>O M%QZ\"T7'KP+1<>O 6(LEV[.NXH;WPXL]?G+[U/H[E6S5B*[9+O,C94;
M$8WRNXB/;$818?UB?^7\R1(D2)$B1(D2)$B1(D2)$B1(D2)$OWI3'H*,<-41
M^H>O[$VB/D6A:27 K_MF+$D)%N&1%7:(X5Z#GCG"O&O\I/66K55%+28Y1ZC'
M>6U,172%B"15GW2$>(X5XYP\<,V_OJZ2B+-"G-FU3+\.:/\ $RO"\IQ0F?4M
M]:D.#K(-%F0*!6[AN3DN*7DFD.I$16(M55U:C1%*N7@)DFE7+P^9HBE7+P-$
MTNY>"B9*I4O-=P47)=*W5X#\F4I.Y> [)E*N7@:-I4TU+M3N7XCJ-2JJ:EV7
M*1J/2M>I>!84J>Q>"D"C4I5[^"D&B4ESFHLY*J(HS(M9420W(6N4AF09_9Y#
M/HY62=7D)]'=?FIP- HV7DBY&DGFE)R;51=13*)5GJ%A>466'7$LL.N)98=<
M2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2R
MPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZ
MXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXE
MEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEA
MUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ
M++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++
M#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#K
MB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB6
M6'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'
M7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$
MLL.N)98=<2RPZXEEAUQ++#KB66'7$LL.N)98=<2RPZXEEAUQ++#KB66'7$LL
M.N)98=<2RPZXD6BV6N4N\HE/6!$22GT=RTYU3RKB@4NU8V=R#H=;630FA-":
M$T)H30FA-":$T)H30FA-":$T)H30FA-":$T)H/?5E(M5P+5<"U6\M5("UFJN
M(_O%VC1NH5^LKDRL5RT+4M"N5ASQ[RU6>TAQ!K]1;BQA7BN515DDQM(UD.+,
MF/7N&>>GK'O'Q"T49$%=J+1.OZBNG^RI,JU?WXSZKT24_)3WJ0XBRV%,=-JZ
MC+JZG:KS*_GNU=Y17U8*:N]=9 C:Y53)]'MJNN11\D(J(J1)82^0[)R,V.&4
M.!5UM15O%HL#[M!:- ^[0L("?])%%@T?[EJ"M38E%\;RR8J:Z)/ =1&N_P#C
M2-')]P+DMJK_ &$BDT-E'9-:-7U;"GTUK'JB4'OO^9!C6B_^TE/J\@N;"2LM
M$GATII2R>B9C/7?\RCY5>Y'KF:ZDO^9!R@]VO-%3Q^9 I+EUYMUQ&4I\D_Y;
MF)'5RRS>JB]]V(M5TO)V$2&VI,I[$JN7UF48DJWDCX_E>86_Y?7$M_R^N);_
M )?7$M_R^N);_E]<2W_+ZXEO^7UQ+?\ +ZXEO^7UQ+?\OKB6_P"7UQ+?\OKB
M6_Y?7$M_R^N);_E]<2W_ "^N);_E]<2W_+ZXEO\ E]<2W_+ZXEO^7UQ+?\OK
MB6_Y?7$M_P OKB6_Y?7$M_R^N);_ )?7$M_R^N);_E]<2W_+ZXEO^7UQ+?\
M+ZXEO^7UQ+?\OKB6_P"7UQ+?\OKB6_Y?7$M_R^N);_E]<2W_ "^N);_E]<2W
M_+ZXEO\ E]<2W_+ZXEO^7UQ+?\OKB6_Y?7$M_P OKB6_Y?7$M_R^N);_ )?7
M$M_R^N);_E]<2W_+ZXEO^7UQ+?\ +ZXEO^7UQ+?\OKB6_P"7UQ+?\OKB6_Y?
M7$M_R^N);_E]<2W_ "^N);_E]<2W_+ZXEO\ E]<2W_+ZXEO^7UQ+?\OKB6_Y
M?7$M_P OKB6_Y?7$M_R^N);_ )?7$M_R^N);_E]<2W_+ZXEO^7UQ+?\ +ZXE
MO^7UQ+?\OKB6_P"7UQ+?\OKB6_Y?7$M_R^N);_E]<2W_ "^N);_E]<2W_+ZX
MEO\ E]<2W_+ZXEO^7UQ+?\OKB6_Y?7$M_P OKB6_Y?7$M_R^N);_ )?7$M_R
M^N);_E]<2W_+ZXEO^7UQ+?\ +ZXEO^7UQ+?\OKB6_P"7UQ+?\OKB6_Y?7$M_
MR^N);_E]<2W_ "^N);_E]<2W_+ZXEO\ E]<2W_+ZXEO^7UQ+?\OKB6_Y?7$M
M_P OKB6_Y?7$M_R^N);_ )?7$M_R^N);_E]<2W_+ZXEO^7UQ+?\ +ZXEO^7U
MQ+?\OKB6_P"7UQ+?\OKB6_Y?7$M_R^N);_E]<2W_ "^N);_E]<2W_+ZXEO\
ME]<2W_+ZXEO^7UQ&QM:>1WIUM*91VV*+6VL1>+4(K%2+J7O/HTYZ/9MVH9$5
M5ALG@-3R%]2^[^\N;6++$LL2RQ++$A.LVU=HKY]PJ"((Z0JS4F5B?[)$OV3*
MPNL6%/O,W](:RKWB/DDBJMY56\JE4<R:*D]HVBU?M#6U>\KBK,V>4.?6%:J]
MY46\;Y):32J26_\ 96*^ YT_WT@VGE>'7$2CR0IT-$8[U&7DDCO$ROY[O64*
M$CJ.U?24A,:CD,EO:E4H](9536FPBTIFO6-I+5:FM#.&WF<,O%I#;S.67H04
MH=C#5:LZB7;>)_R2;O!/B5Z$F[R^);4*]O!/B9Q0?1Y?$RC'H2L5/)V?R]93
M\T5Z^;MN3XE'=0VK]G@GQ$BT.I]G@GQ%S-8C?-\Y+B##HFN577ZOB06T-LIU
M>1"=0DW>7Q&QJ"G>WE\2D4FAI!?55)HFK9\1M+9>.I+53:4YZ.:IE%K5K"P4
M6(9NWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ18-N]Q8-N]Q8
M-N]Q8-N]Q8-N]Q8-N]Q8-N]Q8-N]Q8-N]QF[>I&;MZD9NWJ1F[>I&;MZD6#;
MO<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<9NWJ1F[>I&;MZ
MD9NWJ1F[>I%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W
M%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W
M%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W%@V[W&;MZD9NWJ1F[>I&;MZD9NWJ1F
M[;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6
M#;O<6#;O<6#;O<9NWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ
M18-N]Q8-N]Q8-N]Q8-N]Q8-N]QF[>I&;MZD9NWJ1F[>I&;MZD6#;O<6#;O<6
M#;O<6#;O<6#;O<6#;O<6#;O<6#;O<6#;O<9NV[W&;MZD9NWJ1F[>I&;MZD9N
MWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ1F[>I&;MZD9NWJ1F
M[>I&;MZD9NWJ1F[>I&;MZD9NWJ18-37=K[BDTRLVK/8DN&HAP%BQ)R/H]051
M6:KC)4&HQOJ01TFKZO\ O:["2$D)(201-?\ $@.1K5OK?R06,DC*$=*J^HR]
M&U/\3*L2;G%"CU:*U/2<+3:KBA94JJFLA99DGG$?+?I$/+7D-\KN%RSZ0N6O
M2-->D::Q&9<CU&R<NS$?EV/+SUYC\O4A/M+S'?2"D;R\SM!2-]>*E(RM27M\
MY=EZE)I=)<JK-W,;3J2U=J\QF4J3O+S&TVDUD6:ZEGWC<KTA/M+S&99I&J;G
M<QN7*0GVEYB_2"D;Z\5$^D,>:(KEEWSF,R]Z0F7)IYW,C97K(OE%*I\YZS.O
M+,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G1G9G9G9G9G1G9G9G9G9G1G7J,Z
M]1G7J,Z]1G1G9G9G1G1G9G9G1G1G1G7J,Z]1G7J,Z]1G7J,[,[,Z,Z,Z,[,[
M,[,Z,[,[,[,Z,Z,Z,[,[,Z,Z,Z,Z,Z,Z,Z,Z,Z,Z,Z,Z,Z,Z]1G7J,Z]1G7J
M,Z,[,[,[,[,Z,Z,[,[,[,Z,Z,Z,[,[,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z
M]1G7J,Z,Z,[,[,Z,Z]1G7J,Z]1G7J,Z,Z,Z,Z,[,Z,[,[,Z,Z,Z,Z]1G7J,Z
M]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7J,Z]1G7
MJ,Z]1G7J,Z]0M*]1#>Z(^6O:IDG)]HK5JW&1,F(Q&+*XHL.HB>H5W_?)$B1(
ME_$>]6K+ 6(XIJJJ*99@N=7[S*-">Y5U+M(5!B) 235E-2D46*B[%X%'A147
M8HV'&EWD5D6Y2'"C5&[=A91KEZ\18<:Y18<:Y>O$LXV(R,B0VHNU$UCH[1T5
M!T1"LE9-7>GO&JQZ)ZD(E'AJBZB/!8WN(38<]@R"RS59;$$>T1[17H/B(.>N
MQNT8V/B,;&Q%9&EWD6CQ7=RB42+/8IFL6XS6+<9K%N,UBW&;1;C-8MQFL6XS
M6+<9K%N,VB[JF;1=U3-HNZIFT7=4S:+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S
M:+NJ9K%N,UBW&:Q;C-8MQFT7=4S:+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S:+
MNJ9M%W5,VB[JF:Q;N1FL6XS:+<9K%N,UBW&;1=U3-HNZIFT7=4S:+NJ9M%W5
M,VB[JF;1=U3-HNZIFT7=4S:+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S:+NJ9M%
MW5,VB[JF;1=U3-HNZIFT7=4S:+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S:+NJ9
MM%W5,VBW+P,UBW&:Q;C-8MQFL6XS:+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S:
M+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S:+NJ9M%W5,VB[JF:Q;N1FL6XS:+<9K
M%N,UBW&:Q;C-8MQFT6XS6+<9M%N,VB[JF;1=U3-HNZIFT7=4S:+NJ9K%N,UB
MW&;1;C-8MQFL6XS:+NJ9M%W5,VB[JF;1=U3-HNZIFT7=4S:+NJ9M%W5,VB[J
MF;1;E,UBW&:Q;C-HMQFL6XS:+<9K%N,VBW&:Q;C-8MQFT6XS6+<9M%N,UBW&
M:Q;C-HMQFL6XS6+<9K%N,UBW&:Q;C-8MQFT6XS6+<9K%N,G9,<YZ>3WW&0LD
M21DVW=Q1:*D)J:AJHB2)?]\D2)$B7\1[*R^'\Q("J1Z'6384_)E:>HIF19JO
MD\BB_1M'T5'5.]>[U%*^C25O,Y$+Z-Z_,Y#/HWY/F<B-]&DW.1#^C*6;?([K
MCLUZ'+Y"_1KNJ<A?HWZ'([->AR%^B5)555&.DNS4=D*2OV'>S\A?H=2ONW<#
ML72ONW<#L72D^P[@4?Z,4E72JNVRV"?1*DU?,=P*=]$Z2DUJ.X%'^BU)K^8[
M@0OHE25@.\AVMJ]V WZ'4K<=P&_0ZE;CN OT-I/W;N _Z%TG<=P&?0VD,>CG
ML=)%UZOD-^C<OL\AOT=]#D=G?0Y"_1ST.0OT;EKJ<CL[Z'([.^AR.SOH<CL[
MZ'([.^AR.SOH<CL[Z'([.^AR.SOH<CL[Z')#L[Z'N^!V=]#W? [.^A[O@=G?
M0]WP.SOH'9WT$X'9WT$X'9WT/=\#L[Z'N^!V=]#D=G?0Y'9WT.1V=]#D=G?0
MY'9WT/=\#L[Z'N^!V=]#K@=G?0]WP.SOH>[X'9WT.N!V=]#W? [.^AUP.SOH
M>[X'9WT/=\#L[Z'([.^AR.SOH<CL[Z'([.^AR.SOH>[X'9WT/=\#L[Z!V=]#
MW? [.^AUP.SOH>[X'9WT/=\#L[Z'([._E\CL[Z'([.^A[O@=G?0]WP.SOH=<
M#L[Z'N^!V=]#K@=G?0]WP.SOH>[X'9WT.N!V=]#W? [.^A[O@=G?0]WP.SOH
M>[X'9WT/=\#L[Z'N^!V=]#W? [.^A[O@=G?0]WP.SOH>[X'9WT/=\#L[Z'([
M.^AR.SOH<CL[Z'([.^AR.SOH<D^!V=]#W? [.^A[O@=G?0]WP.SOH>[X'9WT
M.1V=]#D=G?03@=G?0]WP.SOH>[X'9WT.N!V=]#W? [.^AUP.SOH>[X'9WT/=
M\#L[Z'([.^AR.SOH<CL[Z'([.^AR.SOH<CL[Z'([.^AR.SOH<CL[Z'([.^A[
MO@=G?0]WP.SOH'9WT/=\#L[Z')/@=G?0Y'9WT.1V=]#D=G?0Y'9WT.1V=]#W
M? [.^A[O@=G?00[.^AR.SOH'9WT/=\#L[Z'N^!V=]#W? [.^A[O@=G?0Y(=G
M?0Y'9WT.1V=]#D=G?0Y'9WT.1V=]#D=G?0Y'9WT.1V=]#D=G?0Y'9WT.1V=]
M#D=G?0Y'9WT.1V=]#D=G?0Y'9WT.1V=]#D=G?0Y'9WT.1V=]#D=G?0Y'9WT.
M1V=]#D9-R1*(GD]_\S)>3T8QNHC-2&FR0D2;I$))L7U?][3:24DI)22CDU?Q
M$60D14[D'1:W<A$@,B;2)DJ!%VJJ>'S*-08,* D)-B*NN6O61<D4>(NMSD\/
MF-R+1F+-'.X)\1*#!;J3W#LG0'+KGP$H,%$E_)#,872&805O-'0<31L&]> V
M'"1J-LF+))3D5(7W3.!5A_=,X$H?W,/@?5RE8P^ RBP8:UD8U=<]@D1LI6$,
MB46!'\Z&U/4A#R116K-$GX?,;!@0X3D2&U?)7N&LA?=,X"6:?]%G 18:_P#1
MA\!4A+_TF<")1X$5JLJ-2MWHFM/4+DB GVEX)\31\%/Z?,S*%?R&Y/@K>:*@
M*DYKP-%0-Y>O$T5 WEZ\314#>7KQ-%0-Y>O$3),!?M+UXBY)@)]IW7B+DV G
M>O7B)DZ!>O7B-R3 =]IW7B.R51VRUNUB9*@+]IW7B)D:CK]IW7B+D2C)]IW7
MB+D>CI]IW7B.R5 3O7KQ-%P+UX&C(%ZFBX.\XT7!WG&BX%Z]>)HN!>O7B:+@
M7KUXFBX%Z]>)HN!>O7B:+@7N-%P=YQHN!>XT7 O7KQ-%P+UZ\31<"]QHN#O.
M-%P+U-%P+UZ\31<"]>O$T7 O7KQ-%P+UZ\31D"]>O$T7 O7KQ-&0+UZ\31<#
M><:+@[SC1<"]31<"]>O$T9 O7KQ-%P=YQHN#O.-%P;U-&0+U-&0+U-%P=YQH
MN#O.-%P+UZ\31<"]>O$T9 O7KQ-%P=YQHN#O.-%P+UZ\31<"]>O$T7 O7KQ-
M%P+UZ\31<"]>O$T7 O7KQ-%P+UZ\31<"]>O$T7 O7KQ-%P+UZ\31<"]>O$T7
M O7KQ-%P+UZ\31<"]>O$T7 O7KQ-%P+UZ\31<"]>O$T7 O<:+@[SC1<'><:+
M@[SC1<'><:,@7KP-%P+U-%P+UX&BX.\XT7!WG&BX%Z]>)HN!>O7B:+@7J:+@
M[SC1<'><:+@7KUXFBX%Z]>)HR!>O7B:+@7KUXFC(%Z]>)HN!>O7B:+@7KUXF
MC(%Z]>)HN!>O7B:+@7KUXFBX%Z]>)HN!>O7B:+@7J:+@[SC1<"]31<"]>O$T
M7 O7KQ-&0+UZ\31<"]>O$T7 O7KQ-%P+UZ\31<"]>O$T9 O4T9 O4T7 O4T7
M!WG&BX&\XT9 O7KQ-%P+UZ\31<"]>O$T7 O7KQ-&0+UZ\31<"]>O$T7 O7KQ
M-&0+UZ\31<"]>O$T9 O7KQ-%P+UZ\31<"]>O$T9 O7KQ-%P+UZ\31D"]>O$T
M7 O7KQ-%P+UZ\31D"]>O$T7 O7KQ-%P+UZ\31<"]>O$T7 O7KQ-%P+UZ\31<
M"]>O$T9 O7KQ-%P+UZ\31<"]>O$A9+@0EK(JS]7S(,2Q22(BD6(L5)*DO4)
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M9#84TDG$6 J)LG>18!8+:-]:%@+!'0A89#AS>W4.A8#H0D+J0V%@+"FFPS?
MS? S? S<AP)+L'PAT+ 2$6:I*23O(T+4@D(LU0>W:1$(7?\ YJY.8CX*)*\6
M + P%@(6"7%FEQ52<BSZU%F5$ZD699H.:C45;B MHK]6J>H6'J7U*=ZRO7WE
M';Y*3VEFFQ>\BP,"P2NWUH+#ZU#H;2+"\!T-!K7([4GJ+.;=<ICV"0T&0R)Y
M*HV\2#J3U(6&!8%@64A\-"(V;JM^T;"&PQ9N<K7-1*HC!6$5I%:-24_\U<GQ
M*M'24MJEL[ KE=M:KWE5HM5%(J(YLD77-!)2363:.:U51T]:;-8E&@U&KKG(
MBM8W81'K)VR<M116,5LW)Y3O.D)1H+FK.>Q>\?0X"5E;.>N6OO*.E5C57SI:
MRUE<.>CMHJ,DKDVIKV]X^D1'L<FI)H,>ODR79B1$<Y4GLF)!AXC8$)%1UQ58
M1:MK4JK*KW7C8#$37M$9#3N(K&N;J37--8UK:K?4GN)-),0A1(<6M5GY*R(B
M-EXBU!T)KGMJJE5//O+*&A)B$5B(^LGVE&,:NTL(<OF4F$B>;XS(^J<ABJLY
M_P":M%>C8:%L)&2\1[:U?[4I3P$BXCHOE;>\M<2U0MD+9#.$J-]1&C35=8Z(
MJJFN4MI"C:T$I;$:JUNZ7(6.BJOK+9!T=:[=>KO+9!'HDT3S5[L2J@C&MUH@
MKY%J6RS=Y<I^;@)%U:UFO>6OUD\"V0MVWC8R5BWQ,X<CW5G^3W(+&1R;9S(;
MTAHY&ZIK,?'U%L@Q]57+.=99ENU-JEL@Z).0QY7([^XI'>0^_P#S58^JDIB1
M<1L27>)%$C8BQ=:EL6REJ6IG'DHF!$C3+7$AQA8DTJHFK;XEJ6I:EL)%FJ(-
M54U+KEWWCGW#H@L01^M%+8M2U+1!(Q;*+$F6RILV%LHL99%LI;*+$GM+67P&
MQ)C8A;8D2(15FHSO_P U576(JB.*Q.8KEFI64K*5U*ZEJ*Z?[$<J%K(KJ5U*
MRE91KU14]9;H+%F*XF*3)E92LHCBTZZ4M.NE*_6LKX^\5ZE92LI64K*,<NLM
M)"Q1T7$59C>__-54U_N(.VK^[L_9+]D_W5V%JHV(HBS$05NJ?\=%D*Y17$U_
M8G^:$5T1'HC5U5><U&*[O&(S[2'U'>B"K W4'NA5M2%:'<5X=Q:,+5I6AKKU
M<2</#B3AX<2</#B3AX<2<.XK,N+1MQ79<3AW%>'<5X=Q7AW%>'<5X=Q]3NDX
M5PCX:%JTMFE=EQ79<5V7%=EP[RTJP]3E+"D[REA2;U+"E;W(L*3O+P&,BPUG
M%FK?YE=EQ79<5F%9EW7 KLN*\.X^JN/JKB<*XK,[B;2;2;2;1T.*]9PU5$+"
MD[REA2=Y2PI.\I84G>4:M1*L3SDVE>'<5X=Q7AW%>'<5V7%=EQ7AW%>'<5X=
MQ.'<3AW$X=Q.'<39<155NS4.I$5%\XH[U=YVLDQ$V"O2NB3[R3<"HTJI<.P-
M?^5R,1VM?4*U&CG*@KGZ]I**MZC8<54[RRBXEE%Q+*+B647$2%$EL4LHEREE
M$N4LHEREE$N4L8EREC$N4L8EREC$N4L8EREE$Q+*+B647$LHN)91,2QB7*6,
M2Y2QB7*6,2Y2QB7%C%NY%C%NY%E%Q+*+B0Z\!UH_8AG[;C/DN,^:9\W BQUC
MHC&IKVZBRBXEE%Q+&*6,6[D6,2Y2QB7*6,2Y2QB7*6,2Y2QB7*6,2Y2QB7*6
M,2Y2QB7*0X^;MJ.37M,_;<9^VXS]MQG[;B(CH[EB-19*6,2Y2QB7*6,2Y2QB
M7*6,2XL8MW(L8EQ8Q+E+&)<HD*)B647$LHN)91<1(,2:;=J$:AOJ[-H^ANK;
M"!17ZM2D2$]&ZYCJR1$P4M,?>6JEI/\ 95[_ /*ZTJZO$M*Q#@U^Z91,CVTO
M)760/HLZ(W^S'?1=S5E4Y'9A=SD=F5W.1V97<Y'9E=P[-OW%.S;]U3LX_=4[
M-OW3LV_=4[-.^[4[-.^[<=FG?=NZ\#LT[<7G\#LT[<7G\#LT[=]YV:=N^\[-
M+NJ=FEW5X'9IVZO!3LV[=4[-.W3LT[=.S:[IV:=NG9M=Q>O [-KN+UX'9I=Q
M>O [-+N+UX#_ **NC-J(Q9J=AXOW:G8>-]WS4[#QMQ3L/&W%(?T/BP%K.8LM
MG>=FEW%Z\#LTNXO7@=FUW%Z\#LVNXO7@=FG;B\_@=FG;B\SLT[<7F=FG;B\S
MLT[<7F-^C+MP[,K]WUP.S*_=]<#LROW?7 [,K]WUP(WT-BQW5FP]4CL/'^[7
MF=AXWW?O.P\;[OWG8>-]W[QGT5?!:C%8NH[-+N\SLT[<7C\CLR[<7C\CLTNZ
MIV:=N'9E=P[-+N\SLT[<4[-.W%$^C3MSK@=FG;G7 [-.W.N!V:=N=<!/HTZ:
M>1W]=Q&R"M7S>X?D!9^80\@K+S"DY$<B+Y)2\D.8CG595=8K506:"*0]8OFK
M_E=&G73_ ,?YJ,VE$V33:9!@,B-AUDUK(R9DZ"K4\E"EY,A)&63>Y#1L/=-&
MP]TT;"N-&P]TT="W31T+=-'PMTT?"W31\+=-&PMTT9"W>1HR%N\C1D+=Y&C(
M6[R-&PMU.1HV#NIR-&0MU.1HV%NFC86ZG(T;"W4-&0MU#1L+=-&PMU.1HV%<
MG(T="W4X(:.A;J<$-&PMU."&C86[R&4*#!<D16IUX$Z-NMY? G1MUO+X$Z-N
MIR^!.C;J<O@1(-'CI5:U)[>[X&C86ZG T;"W>1HR%N\C1D+=Y&C86ZG(T;!W
M4Y&C86ZG(T9"W4Y&C(6ZG(9DV$GV4Y&CH5R<$-'0KDX(:.A7)P0T="N3@@D*
M! \ES4O[O@3HVZWE\"M1MU.7P*U'W4Y? K4?=3E\!]"@QG+$1J:_4:-A;J<C
M1L+=0T=#W4Y&CH6ZAHV%N\C1D+=Y(:-A;J&C86ZAHV%NH:.A[J=>!HZ'<AHZ
M'<AHZ'<AHZ'<A$R:R7FBY*8J^:0\D-EYI3,D-EYO(RODJ4".J)*3%(E%DFPC
M0:I(@KK'^9_E<D.NDQ6(U2BNU:M2J9!I*M2&BK<9*ILF-*12%=$5=>Q"V7'@
M6RXELI;*+'Q+?$M\2WQ+?$2-U,MNIEL6W4RVZF6RWEMB6RELM_7$MEO+92V+
M8MBW+<MRV+91ZK&2S3O_ )&91#,HAF;T,RB#(3X"UU]1;+>6RELI;J6ZEMB6
MV);+>6RWD.-MUEMB6V);8EMB1X+H[J[;I&9/Z0S*(9E$O,RB7C56"EFO<6Z]
M3+92W+=2V4ME+8MEZZZO+;$MRW+<MQ(^M!\AK=>PA0TJE,AI54RO"3-J1_X.
M(T'4I2H:),<DE(>T7S5\/\KH?]FO_DO_ .J$=5K;;C)ZS77K/H[!AN9#FQ%\
MW^1D^%#1B28A2$7.E1/-DT9"99JJHFPRY%BPD=9Q',_\2)E+**19)2XTI[V/
MJ,DTNEOE:1GN35K5=IE'*5+ATR*QD9]6LNJ>SKB-RC2MJTF)ZID+*5*7SHSN
M(E.CK+Z]XVGQYK.([#7M&4F#FT)5E6LVS7$I&4&-74Z1 R@Q9:R)E.C0D2LJ
M:^KQ^4H4IHOJZF:4;/SQN4V+JK:T(N4=2R>4_*\1K?)CN;K38HN6Z363_F8D
MM7VC3<9LITA^O$@Y7B+*<9W$@94G*<29"RI!G)7:S2-':BN=*2"Y6HBIJ5!^
M484M2IX$3*;4V/D.RJO=$7B47*498CD6*Z:N\G7W&3:4Y_G.5WK,I4FI"56.
MDLMJ&5\M4Z'%>C*9%:DUE)QD++-,B1&VM*BO2?VE*?2Y4*&]'K.LGN0BY:L7
MPV*^==U43*C=M<3*K%V/%RFU$UOD1LISE4B*E^LAY41NMT0A95@2FJIL-,45
MR>2YO7B/RG#7S7(.RHB*B6@W*?IFE65JMIK'93E]L?E9?O%XE+RY26TUC8=)
MB-95;-J+J[C(64+1C5BOK_\ D4NEP&P_)1J++N*=E9[(BRC.:DUV*47*[E\Z
M,J^M2)E.$C:SW:[R-E))5FOU#<MNBK$JQ7>0ZKM&95>O_6=Q&93623B+Q(.4
M*/80JU6NYI2,H0FHLE1"/E3=B2\2+EQ6O1ENY%59&EHT_P"W=Q(>4DLV*K_L
MI[C2;-\3*;$UJ_4,RK FB*[:0Z;!56[-J$9=4TN'1(E;4Y2CQ(F^XB3<W6L_
M64F!#5KD<Q%14UHJ&6:%1FPW5(+&ZEUHAEA%8YR-U2F(KU=M4@)J'RJ+_D Q
M$5!^SK']D,8ULMB#V)6V"MP*I)!$2X5$GJ3]DB2$D%_=DI)22DE)*2)$D)(+
ML_=3;_$A_P!FO_DO_P"J$?SN'O,G;3Z.?V</_P"O_P#4H']FA%9.D*N"$I0_
M ^D;5L7CX'UB+ZC)J59&4JRTZ/\ ^8VL,KUI]TAJN$<[$=2WI 8DUU,2\I%.
MB5E(5/B(NU>8ZGO5NO7ZR+E&)B-IT2NKIKSD,I\3'F/ID26U>928\19]_$6+
M$K=^TM7D.D/2\ATV(G>I#RB]-8_*+WPGHKG25,9C<I.:U&HJZDEKF:1B7K[Q
MU/B+WKS%ID2]>9DRD/?3&)KUS*!%<U#*L=;!ZKW(IE9RQ'JY)ZYF1(BLB-OF
M4N.]]#8ESD_D4M5\ERIK8LT(^48C>]>8W*L2>U>8E+?&1LU=J6>I5UCHSWM[
M_ ?2XD)):]5\Q^68C=59>9"RT]$JS[^\AY3B/^T.IL34NOF-IL2]1*2ZNL2:
MS5)#Z;$O7F/IL2]>8L6)$I+7ZUV&1J4]C6Z_>4RGOJ+K784^EQ%>NM=N)1Z=
M$2\92WNASUK/UD>E/[AT9R3EJGK4;2(F/,92HB(DU&4Y[&M6L[81\HQ%[U(M
M,B+KFHZ.YVN6N\2-$QYB90B(UJ:]2(:0B7F>O<YJUG>3BLO$T@Y&S7EM*+E"
M(L2"DUUOA\U0<LX;/_%ON0EY116#F^24G4UWJ4RRJ5'>)EELW.\2IY1"2J@]
MVI4_R :NH5"H0VR76-*L]99ZQT/O%;(KR$UHBE4D2)"MUE7U%4J^HJDB15)$
MOWJOJ*OJ*OJ*I*7\2'_9K_Y+_P#JA'\[A[S)VT^CGF0_#^10/,0>GUDQS_)E
M@93A)&1S52:$;)T>NM541.[44&C4B'_:N:Y.Z22*7DU\:)%<SSG+J60W),>K
MKV^H9DQ6]PF373V:O4)DY;A^3'6+=7V4*1DM9KY)#R6_=Y#LDOEL(V27W<A,
MC/N&9(=<:(=ND7(CW)Y*26=QH%T_-Y&@W7&A7;IHAVZ:)?<.R5$1JZC1;[EX
M"9)?<IH=^[R$R,[5Y)DW)+F4ICJO<O\ (HU%EW&4*):0G)+:BH4_).N2-V;#
M)^2:L1'5=?\ 0AT!8D.K+84W)#NY.12\COFOD\AF1XDYU2BY)?ND#([G([5W
M7%.R.Y$744O)D5%74I R7%5WFKP*'DAZR\E> _([DEY/=<-R0_=-$/W>0_([
MM>H=DA]WO*+D-STK5?M7=TRB9+6&U-12* YS5DA2,C1%5RJG?JU$'(\5J+63
M7-9:NX@Y*B6::M7=J(F2'+W<AV17+]GD)D14^SR%R)$64DE?J-$O;JELP'Y)
MB*NS5ZC0T6NNKR;I+.8W(KMT;D-=T7)#DGY/(7)#[AN2'W<A<BQ(D-6MU+J[
MBBY(>QT&:;',GX*@_4QJ7-3W"><4;8A%B(UI38Z(R+_XF5*6CF.UF4GHKE\1
MK9K,EJ%77+_(!/V(P1LA-0Q=0U!T/ B0Q[5&ZFI^R1(D54*J%4JE1"H5"HA4
M%9J4DI(E^QNU"J@K4*B%5![9-_B0_P"S7_R7_P#5"/YW#WF3CZ.>9"]2% \Q
M",Z3E'Q<1S;0=0I]PM%J=Q#H37,:ZKM0S%MQF+;C,DN,S:G</@LLF_\ BA'H
MS%=L(%#9JU(9@Q6^:1<G,GL0T8S5Y*=>!H^&FU$,P9<9C#N3@9A#GL%H$/N:
M+0&7"T!G<B<#1[+C1S5[N1HIFZ:,;NFCF[IF#$[B'1&,<CI$-C4(S$<BD>@(
M]R^24?)S4EJ0AP60FS7U$2!#B7$7);'_ &30[$7S>0V@,9W(4.C,\O4FPI=!
MANGJ*1D=CE\WD0<BMGYA1,EL;+R4(^3V(K?)[AM!9<9C#N3@/H#+D'T%EQ0:
M##2"JU4\Y184-O<@L)CKAU!8[N0=0&7$.BL1DI&:,N,QAW(9BS=,T9<+D]BZ
MY)P'9/;<9@RY. R@P^]$&T"'</R>R:^2@N3F;)#<G,N(>3F7#<GL1)U=FLBI
MW> G\R"^2%+I-5#*5.JP8RS^PI3LHUFJDRE4BLY=9#68NP7S_'_(%B=XUG>2
MP'W3+22RF05GWC6S0B0<!\'62EJ$_<JX%7 JX"LU",4JX%7 JDM>PJX%FEPD
M/"19)<66 D/7LV%7 JX%7 JX$5),7^)#_LE_\E__ %0C^=P,G;3Z.O94A^6W
M8FUR% BPJB?6P_;;\2DQH==9/8OJ<T=&;/SV\4("M7[3>*"-AR\YOM)\2,D/
M>9[2?$@NAV;4KL]I/B*Z%OL]I/B5H>^WVD^(KV;[?:0KLWF^TA&I34;*LW5Z
M2?$BTI*WG)Q0HM(;J\IO%!D>'+SV>T@^+#GYS-N\GQ%B0Y><S9O(/BLWF<4^
M(L=N\WVD+=N\WBA;-WF\?F9PW>;Q0SAN\WVD+9F\WBA;,WF\4&Q6*OG-]I!8
MD/>;[2"Q&;[?:06,S>;[2?$6.S?;[2%NU?M-]I/B)2&[S?:0MV[[>*"+#5=;
MF\4^)#L]YOM(92C-A0&JUS?.WD^) IB.62N3BA!?#<FMS>*#UAI]IO%/B4B,
MU/M-XH4:E(BO\MNR]!T=KMKF\4/JW;7-XH,2&GVF<4(;X:?:9Q0I<9DVR>W9
MO)\1L=N\WBGQ+=F\WVD'1V=SF\4'QF[S>*%%I#4@KY3?.7[2?$CTM$7SDXH0
MJ7-=;D]H9';+SF[-Y/B/BLWF^TGQ,X:GVF\4$I#=YOM()2&;S?:0MV;S>*&<
M,WF\4$C,JIY3?:3XCHK-YO%/B6K=YO%/B-CMWF^TGQ&TAF^WVD%C,WV\4%BL
MWF\4&Q6;S>*$.-#3[3>*"1F55\MFQ?M)\2,]FORV=_VD%B0Y^>SVD^(D>'+^
MT9[;?B4^DMDOEL7_ .R&6J;4@Q?*VM5-I2:2JIJ68Y[U=L=P4H_4Q5U8CD6M
M/_(#O(8U!XX>Y4B=\M115F0DU#VZB(P>B5E]8U-O+]LD_>D2_9(D5"J52HF'
M(5LD_I^[&_LU_B0%2HL]Y?<A$JKW)P*B_9FGJU$'.?L1HS?5$>G_ /8A.I\O
M_=TI/_YXWZSM#2*"[-WQXZN;K571'N77BJC/I5$^\B<7#?I5$E_:Q?:</^EE
M(^_C>V_XC_I52/OHWMO&_2N/*5O&]M_Q.U<?[^-[;_B)]+(_WT;VW_$[61OO
MHOM/$^EL5/\ JQ?:>+]*HRJLXL7;O/.T\3[R)Q7XG:F*G_5B>TX7Z5TC[^-[
M;_B=JJ1J^OC[=]_Q$^EL>2?7QN[[;SM9'^^B^V\[5Q?OHGM..U<;[V)[3A?I
M7&E_:Q/:<)]+(OWL3VG"?2N+][$]IQVKB_>Q/:<=JHOWL3VG#OI3'[HL7VGG
M:N/]]%]M_P 3M7'^^B^V_P")VJC??1?:=\3M5&^]B^T[XC?I5&G_ &L7VG?$
M[5QOOHGM..U<;[Z)[3CM9&^^B^TX[61_OXOMO'?2R,J>5&BJF+G+[SM8]/\
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M1=YO(TY1=]/]IIRB[Z?[33E%WT_VFG*+OI_M-.47?3_::<HN^G^TTY1=]/\
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MD>3B7&K?)9Y9A&8\KG2N"=#!(D2+U>>DKSTE>>DKSTE>>DKSTE.L>DA#))M
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M ]%83T5*J>BFN>#B&I0VC4Q.@Q+B"FO(;.<_BQ5V 6+SMX%DQM0,V@6(PH;
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M3' 5O&AO(%OV!W*JAABJ-4AX(.R#)CB;X+*0H0:[A$O!57 $<8"GD6=%O@I
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MF&),L%@0$K AE6!U4S$P%DBT5+I+,LV#P54- ;P!3=!82>(>"GD&;&^"DT2
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M9*W_ $RC B/#GF'5$]1L3Z=$M:Z/7$^0*BNWLH$-K>B6^"@F,V$YT"H;9WL
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MK.(D%$H-(+&QF.#. SD#KY5\S:QT1MN^-A<. )E+>9ETP>4*$(!._>19/@/
MF1XUCZ@-OO4&##P.=#!E.5KVC4.-0(\Q;:97W!1(T/Z+9J)0(<C**YLC/BXE
M#\\ J1',X78W#BXT*="Q%IL'$!XJDO:S>,MMK>"?N>0)"(YNO5+B4-A$VNJF
MV9Q+SJ'89&[B X$*]K15MMUK*_Q!5&U.I->0DXBHZVP33J-%:70Q96>#._A(
M1\AY/DP_3;ZP\@] ?B[RD0Q.S@6!U_V2LV[HE8'=$K-NZ)6:?T2LT_HE9MW1
M*P.Z)6;<?Z2LR[H%9I_0*P'HE8'=$K [HE8#T2L!Z)6 ]$K >B4#5=L*M8>B
M4/FCT"L!Z)6 ]$K :OH%3$,C^DH-J.GZ)6 ]$K >B5@/1*P.Z)6 ]$K [HE8
M'=$K-.Z)6:?T"K8;NB5@/1*D6.Z)0E"/0*F6'HE2J.L^Z5@/1*P'HE8#T2L#
MNB5FW'^DK-.Z!6;=T2L!Z)6 ]$K >B5@/1*P'HE8'=$JUCNB5,,/1*P'HE3J
M.Z)6!W1*P'HE9MW1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W
M1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)
M6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P
M.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P.Z)6!W1*P'HE8#T
M2L#NB5FW=$K-NZ)6;=T2LV[HE9MW1*S;NB5FW=$K-NZ)6;=T2LV[HE9MW1*S
M;NB5FW=$K-NZ)6;=T2LV[HE9MW1*S;NB5FW=$K-NZ)6;=T2L#NB4&U#+T2FQ
M7MM4@K?Y''DMN"?D]8EM"=2WVN)_!Q38;1A85:)&S\$(T,R-9O:0@]YF0%,W
M.3GMO]RB0HL,5A,@V"T7*'1'UO-'Q&LN,I6ZS8J'2H55P?-QN*8&S B9&ZR^
MQ>=,D8CWQ+[3;:H\**T3?#(M 1; ?)CZ6Z8'$&IL>0=$$*&_A-C:WY*+N;%-
M7).C$ V?2(_)"&]M:#"B@SE9(S3FS#&,$AJL5(I;R#%A1#4M^Q,C\$:"^(*\
M)T20)U5I#\%2&._TU2(CI;VDQ.#@:H5$HTJS8D(:OH. U<BA0(ULP>T-X52V
MLA@%S+ZH46'9,1X@N]%,K!M:HVVS@3FWR$3\ HF]U,U<BC"%G1(MYIFY.H6Z
M4)_FP<YL\G(6DB\SU+*T2J"6VX9]@'E/)\F'Z;?6'D'H#UG>2R]58Y Y5BA?
M',KX?QS+^&KX84@6*1,,+'#^.99V%\<RL=#5L2'\<RL?#*QP_CF6*'\<RQPE
M?#6.%\<RQ0_CF6*&IDPU?#"M?#*_AK'"6.')7PPK3#G]I6.AJUT-8H?QS+'"
M^.92KPOCF5\-6&&L4,24JS%(OAGXY%BAJPPUBAK%#5F3!6*&KX:OAJ^&LY#"
MSD/XYEG(:OAJ^&KX:OAJ^&KX:OAJ^&KX:OAJ^&KX:OAJ^&OX?QS+^'\<R_A_
M',OX:_A[5_#VK^'M7\/:OX>U?P]J_A[5_#VK^'M7\/:OX>U7PUBA_',L4/XY
MEBA+%"5\-?P]J_A[5_#VK^'M7\/:OX>U?P]J_A[5_#VK^'M7\/:OX>U?P]J_
MA[5_#VK^'M7\/:OX>U?P]J_A[5_#VK^&OX:OAJU\(?'(I,,-_(LT%/)CD6:"
MS(69"S(69"S(69"S(69"S(69"S(69"S(69"S(69"S(69"S(69"S(6:"S0FJK
M;%-7_*/U ?J$>2R\IX;B%NP*+1*4PL ^DZP6N*WD1KVG@5I ;*U9&")BL+1R
MH92T21K6MU-3I"J%5,9IXN="/1I-C0P7AX$S.5B9N536Q"R'%R8BNNE9:I8Z
MK8;FV:FS*.Y<8^;M8]YFZX[XC\E28V5:[YN;>,\2?370C4%(F)\8:O-2)#(U
M>Z0G"CS+8SFMWMF-QY.%>>1;'Q6 UCJN4"A0J2VNYA#CQS1E214?"+CO3K:>
M).@F)-D0PVRND7/=:J52,H",E6ESA4ML1K;:3$%O(U0:;!874-P82UM@K/<T
MSU<*@TAD=H,LS.9WH"I#GO$(5-:C.RC3.D1=]T4UV/YL?@K34<[*#DL"B,-(
M:ZL&?DLF\B3I[Z:BQ7Y'*5'.#CPALQJ3J#"K&C5VMF,,BX^4\GR8?IL]8>0>
M@/6=Y7"'%>+]:TB)TO<K(\3I>Y9^)TEGXG2]RTB)TO<IFD1.DI9:)RUO<L]$
MZ2SL3I+2(G2]REYQ$Z7N6D1.E[EGXG24\O$/]7N4A$?TE;%B=+W*RD1.DL_%
MZ7N4LO$Z7N6?B=+W+2(O2]RW](B])3\XB=+W*L(\20LQ*0CQ.E[E;2(O2]RL
MI$3I>Y9^)TO<JN6B'^KW+.OZ7N6>?/TE,4B)TO<L_$Z2)R\3I>Y9^)TO<IY>
M)TO<L_$Z7N6?B=+W+/Q.E[EGXG2]RS\7I>Y9^+TO<L_%Z7N6?B]+W+/Q>E[E
M;'B]+W+/Q.E[EGXG2]RS\7I>Y9^+TO<L_%Z7N6?B]+W+/Q>E[EGXO2]RS\7I
M>Y9^+TO<L_%Z7N6?B]+W+/Q>E[EGXO2]RS\7I>Y9^)TO<L_$Z7N6?B=+W+/Q
M.E[EGXO2]RS\7I+/Q>DL_%Z2S\7I+/Q>DL_%Z2S\7I+/Q>DL_%Z2S\7I+/Q>
MDM(B=):1$Z2S\3I+/Q.DL_$Z2S\3I+/Q>DL_%Z2S\7I+/Q>DL_%Z2S\7I+/Q
M>DL_%Z2S\7I+/Q>DL_%Z2S\7I+/Q>DL_%Z2S\7I+/Q>DL_%Z2S\7I+/Q>DL_
M%Z2S\7I+2(G26?B=+W+/Q>E[EI$3I*;X\0CC<H.4=.(1:N)6?4!^H#]0A255
M9*()M/"C2:**CC+".!59N<9:T6NK-GQH/B"L>-5&B7D<SA7G59TO>LA$%82E
M:O/83 UU>M,!"C10" VK;R27G5$FPSGO0!KFF4=SG;W%QA5ZHKWW+BN3*55M
M:6.N^RO,FV$-JK+NB/Q3%R; #C+)U>R2_:!B.#MXX6#424^BNBN^<AU-2=NF
MV([?O,2X:Y>";17B<05).E;O4/G'%L\)DG09U:S96+SYI-8N+IR&N2;KL [%
MYNZ8%MW&K''5J&I3ADUYBY9"N_@*R[FC*7SE:CY#\F'Z;?6'D'H#UG>5]_TE
MK6OR"%##B3P3_)?.![?2F/Q4V-B$<(K21@!I+FF6N:K9-VQR.58YO])\$7-#
MY<ZWX?+A,TT-F3P"TH%S7MY01^*WC'R&N1DJQ8>614VML'*K6OLXG*5J%69Y
M%*9!X"@UM9QXIE5\G%V.4HS8@'&'2[4&P6O<.('\E7R<7HO\$(6^!)E*V:^<
M#QRUOS4F5B>*:L:[M55C:W);^"K.AQ)<0<JKP]OI3'XK6A5F>15G![?2F/Q1
M:T/,M8!4W->!Q@^36M:UK6M:UK6M:UK6M:UK6M:UK6M:UK6M:UK6M:UK6M:U
MK7^\MFM:UK6M:U_Y;6M:MFK"5K3(58A@(O3(@(=O=5OU"?J!WU"/)/RUG":W
MH &Q24U-3'DMO6]0&LJ<[.55M95JD/*7.)LNDJTS8@23-7NL54DR"DR<^-'*
M6CE1 L[%4X%54VWJ;E65:Q3\IY/DP_39ZP\@] >L[ROY_(.5% . (F;^90FP
M@*V5@X>5J=E&MKB&Z\">I1VEE8><66#@"\SA4-Y8]QMR32+P.#C5'I#X=2+%
MBP@1( R=5XN-090YF(2W4=4^!>?MARB&!7U<)XDV/%&]:9;Y02 V7S0WLN <
M2@4>! <Z+$FRRJ3^"-,I4$L)@AUH#3K1A41DW9=C;@Z\R*RT5K1$<RM<!>T%
M/+KM2C1W70W63Y$ZKA:2RSE1W1C@%C6DF?W+3>G4&BP9P ^I.3#9RR4*##9\
MX]MLJM\^(+]H1H?SI&]F1])MEA"-&B0?F'R8"6-X2+Y*!3X+/FW.+W<$K5!I
MU'#?FX+09<<^!1J?'E*&(S;?NAW@J>6LFQL$ZAJ,E3HHAUC"(.H\'$O,'0/F
MJ[FG>-U$<7&F;ILAU26L]4'4$X-(FZP)L2EO;.R]TE184$-R639:V7"-:\]A
M-$2)OK!:;IJE1*71W-,.$7";0VV8' J1#JFJQ\NS^2&Q&XCP)M&B.OD+2@YO
MTM]M^H#]0.^H1]3'D^3#]-OK#R#T!^+O*_\ J\@Y45TOP1@1#,-MM^Z?<HVY
ML-T@&-$A]Z:BN>V<-M)YI24WT:$8S9Z[9V*C4*BL<R 'P389BPMX^)4"4,O-
M<SZ(4.&=XXT:[G*A>:Q)1(F3=O;U"BTASG;YMXX %Y[2X(,&!*("X6<:;N-N
M?"E"#3"WALO,K)\:;2'0G.8Y[7\Y*RT7>56NL/W6A%D/L5(>ZPD#\%'<?]5_
MXJD45KOG#"BV<H41CJ,YSBZ590J5':0R=:T<:A-HXK51"L'W6B:@0!1W-E%$
MW<Z@P7G?ECA^*?0BZ^H!KN!4>BDVQ'//!G)^*W0B2Q0(GK+=85*V'_Q46I1'
M6TAV^XJP4"BQ-Z]V2F#]YK4*6^-"$1M9TI&?X*)1Z/$(A0XE5LKI*BAYF[(P
M[4(<1ABP2XB6JU1ZD(0PZ"9[0J0V$V;#$M(Y!_)%MP4-T &J':N90B^\,:.S
M_/#R'Z@=]0CZF/R8?IM]8>0>@/6=Y7S^\K$)B[R94\?X*)&D+GC\4ZEFZ)DP
M1J$JRI5(;OJT6L)W:DZ,?I.)ESJ&^'O7L+3,"V0DF0J6QC\E=6MM7FE%&3AM
M!:*AE8H$XT0L:!]/DXE"H[W&0+9V\03*&&LKQ&.8^)]/4G1@:\0VS(M7F\:%
M#DV6^E;O0OV=1&!D.>)LP=]84V9)X24RBP@)%DGG7K3G3M,T7C?LUAQLDC&B
M4:!E;[M>U>;P8383!8'0YH46E_. V[^VQ96CT: 8NJPBW:F.C3;!#S8#,2*E
M.31X)K WYO>7<1"CP8?TX);)4QT>1$0ML=S*/&91H&7KV&J9[9JJ&U(8D &D
MRWMB,+*OJ.$JL[%E'/+;9GC4&#=DV,;6%YDLE28;'M,]\X6S*?0J#"95B LK
MB8-JB.B$ET21K&\?(N5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN
M5RN5RN5RN5RN\MRN5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN5RN^4V&R=9QD1P
M(1XHK.(:[?!66#@_ST^!31/U [^1S\F'Z;?6'D'H#UG>5X<?M*8*GK5_:JH/
M:N-3^DB=95H6] N1KJ;0.=&Y?.'M3M\9:K5:MXJ\IGC55H&Q&L>2U7]J-MG*
MK)JL+3S%;^QUPD%.9VHM $^166=BFZ1=M7$ZQ665KY*4SOK;U8!/D5PD@)6K
M?*H; +>!3(GRVJHT <TO)>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU
M>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU>KU?Y9
M35_:I!0Z3%;O26E-AL &]_SY1^H7?40^I3\F'Z;?6'D'H#UG>5Q;;>I5#L*P
M'85A.PJ889^B56_\3XJM_P")\5=W2L/=*D!+^DJUL_Z2M[9_25:.Z5:T["G
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MP^*P'8?%8#L/BL!Z)5K".8K =A6 ["L!V%8#L*P'8?%8#L/BL!V'Q6 [#XK
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M<%J6I:EJ6I:EJ6I:EJ6I:EJ6I:EJ6I:EJ6I:EJ6I7!7!:EJ6I:EJ6I:E<%:
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M]5$\$3YM22X?]F(1ZJGYO2;C_"B>RG/\VI-Q_@Q/937NHT?J8D_55E&I(_\
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MS;!K*D;CTAC<DTM%HLWSW"[F4.G;FN;#+:[]XV5T^)0MRJ5$F1)F^=]D2_-
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MFTIPI&6HS[A:,)U\JW0>+C%G5&JP)\)Y9EB<)-MQXE2:=2RR' ;"B.87S K
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M]KJP(XC.]-A1@VD0Q8,HXN_)9.BP84&%&::V3<YI]5'=)QF]SG.M)^DJQHL
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M(/YIK 9_.O\ R5($5P&5@N;;9K!5*I='+'Q+#O;YJD9;> /LK<CE2 7"^/\
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MR65.8Q&RR<YKS1CVUZKFR'& LK>#;_LW;>FPQ<\@;4V,1:X#]P[B63BQ&5^
MFU5F9O4=7R3%BN#6P]\9HPJ.]A>TRL.M57?NZT0JHTB?[@\GR8?IM]8>0>@/
M6=Y7_P!7EWUJ+8,1T,_=65B[^V>^Y9K(0GEC986J0BO#3>)V%9-L:)5LFV=B
M,%KB*Q=,>E>G/AQ',!U!9+*O NO3865?5;$AAPX9%0H,)]1T[9>B%4R\0PA>
MV=DMB,*&]S ;P#>G0C&B&$9[V=B=#$1P::V]U6HO0UC6A"KNJ"6]U6( HPV/
M+01*067N=.<TP1'NB-8UH )N+92V263RC@W@FFM?%>Z'/"38JC(SVC@!54QX
ME0ZIV(%N]>+:VM58L9\1O ZY583W,Y$ZI'B-G.<C?/F64#W!QE,SO1;#C/:3
M>05YQ7=E)XM=J+!%?6E*<[4:8^+$<ZPS/$A5C1&D:P4R*^(YTFRF3R)L5KW2
M 9KX$Y[8\3BM]R,8O=E;Z\[5E(A+G?:-Z#VF4I)K(KB]O ;;U#R.]=*PC4LJ
M(CLI=6G;).B5W"(\52^>^(4:.7NF]TYS3HX>X3<XSFBP4B);KK*M&B/B"_?%
M9*7%_LW6DF17,FP$'84R$W>ZK%50ME<K%-N^XEOMZ[@7 %6;OI:DYSMXJ**)
M38T.#6=6AM=)I^=A\2HD9YM,*%/C.3;,K>VJ1DL(DA(+=&-#<61(5%>Z8OO:
MJ=1Z32HKX;*<UH:XS$JD-"R8JE2$BM\ @Z?,N)&>]EP*Y6W*=989MX5O=:C^
M;#YYC9;V^<BHPIV6=1*\8"N^8SCI?1X$ 7:@K&S;PJ[M7V5*M,J)9=K0(<9V
M*8-E6[Y,/TV^L/(/0'K.\K_ZOEREV*Y3(LDI_16]%O(G,UDS36.<:H(,IJ0O
M\EW9Y>530XE-2EY;E-RFU2/DFKNQ3DKA-7(66S7$MZ-]R*ZU3(MY%O@K!Y+?
M)ON;R7(&5J!E:KK>16"S_9QD("8)'XIKBW?2\$Y_!:G.*<]QJM;/7*Y1&1(S
M716@[UM5YV"93HFYE%BQ63F/\+%=9S0RLJ=SH@JV:'&_^)2I5 BMASO\SC:^
M6$F46._)1GR$GLR=I]*2#V.!A/N+2#9S*B/.;%8N)_Y8:HU$HH,6,(,*QL&O
M_#;/""CYI08KFZO\'&_^)5G;GQ/_ .DC?_$A^U*-$8PG_P#;1/SAIN2BM#R+
MG56'85NN09CS.)*7*U;ITNF&H&4UKKA]B'PHPMQX+XE4RGYNXW<;6%3A[GQ3
M_P#\D;_XD#&W/B #_P#@XW_Q)L+=2&^ Z8 G <SUFM3MUMR7MB ,K2!!. NP
MMGP)^YFZ),&)7J"LRI;7<T6N#>!-I$-S7-E.P@_@A.]5 =]B3F/D&L$YGQ3J
M#1G"+2IN8P-&4WP]&:I.ZE)A_9?)S':V.-Q'$HNYPH\)L41HK9B" ;(A;?55
M>,0QC&UZQDW5PF2?0Z)%RT=LVR:!$M'HS1; H,1[7&P^:1C9RB$I^81/_P"D
MC?\ Q*M&H,67_P#*1O\ XE#H=(E"I$4M:YKF9,UOZI% @S8\5A;-'D^3#]-O
MK#R#T!ZSO*XPA]K4KNZ?%8>X?%7=P^*N[A\5A[A\5:WNGQ6];W#XK#;Z!\5(
MM[A\5=9Z!\58VWT#XH&KR[P^*P]P^*G+N'Q5W</BK6]P^*P'H'Q5C>X?%8;?
M0/BL/</BL/</BKNX?%8>X?%6CN'Q5C>X?%8;?0/BI2[A\5A[A\5A[A\5:WN'
MQ6'N'Q6'N'Q6'N%7=P^*M;W#XK#W#XK?"8_XSXJ8;W#XJ[N'Q5UGH'Q5W</B
MKNX?%2EW#XJUO</BMZV7]!\5:WN'Q6'N'Q6'N'Q5H[A\5:+/0/BL/<*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]T^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*P]P^*
MP]P^*P]P^*P]P^*P]P^*N[A\5A[A\5A[A\5A[A\5A[A\5A/0/BL)Z!\5A/0/
MBL)Z!\5A[A\5A[A\5A[A\5A/0/BL)Z!\5A/0/BL)Z!\5A[A\5A[A\5A[A\5A
M/0/BL)Z!\5A[A\5A[A\5A[A\5A/0/BL)Z!\5A[A\5A[A\5A[A\5A[A\5A[A\
M5E:3*L'W$2*:QMP0 1UB>I4B/<]S759'6YADJ1'ID5QW/);*=<"R(\&VM*Z6
MI,A&AY9X$G&LUWXL*JMW. !MNA__ !HL- #=[+Z M EJAH[N;B/R,"$_*5)N
M)DRW46C7P(4:EN)C0(;&F=\S+Q56""(A<0T\L1JA;I[J;YA;](N%PF!;-"&:
M "]HO-3_ .-5/V<.63/_ (U';#H9A1P#5-<"T-/ P:TPPHY%!-(8T-%>Y\3A
M+N \"C4V=KJ#$+YZ\"IE!HE>&R)3*KC;+"S@DH5(IT'+TF)4>37^T+;' JKY
M@V?]'_QHL?N<#.R8J?\ QJ+NCN4S(1H+"62=RFYH:HW_ .,;M1,K <Z/# E*
MRV&W$7<*A?\ Y'N$"Q@?#CNJ3-@^<.&K]I#<^F1)4ID)C37,IN);<+TX2JR^
MD;CR(RL?([XW*EE[QYP^%$:R1 WTK$=V-T:YHK([8K<H' %KK.$C6J31:*T,
M#84CS,?Q*D3.]RU)L_\ 7>FT&B1*D>(TLX[6"7 4-W=W*17;$+(U5T1S;Y3O
M+@F,\VANJ@"M68;OZ%91H,O_ $__ (TZ4""QTC:3#]A-A;E1@6^?'>PW3E(#
M4)*AOC3K>;PY[$XCC'R8?IM]8>0>@/6=Y3E7#G6-FU8F;5B9M6)FU8F;5B9M
M6)FU8F;5B9M6)FU8F;5>S:KV;5>U8F+$Q7M5[=JO;M5[=JO:L3-JQ,VK$S:K
MV;5>W:L3-JQ,VK$S:KV;5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)N
MU8F[5B;M6)NU8F[5B;M6)NU8F;5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5
MB;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)
MNU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[
M5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6
M)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F
M[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M
M6)NU8F[5B9M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8
MF[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;M6)NU8F[5B;
MM6)NU2:6JLT)P++E@6%85A6%85A6%85A6%85A6%85A6%85A6%85A6%85A6%8
M5A6%85A7 @@HD]3D<F2)NA=H"K.E6G&M_K45K76HESK=2K-=;-4IU(D'9&-?
MZ+5%HL.)-L6/#%4<C50,I8V(*UO_ #0U0F06R;5AFL/^-LT U]JL=OI)M7@W
MRHSV!K(^7@<OT%3&O))&YL2IRUH2IC:8T?\ 4!*MZ$-0F0Q\W4%URF'K$HT&
MD2<U[3?R%-\U,FF,_#_SM3:-'AAYBT:I,VWPFA")1,HR@>=6E@JLJ,#N3@5'
MB08C71LDRN 9FL9J-28[VPA!8\S/"QI/Y)NY- ,1]#@1X9>6[YA:7.8[U51J
M+#A-$=L,-B. D9A4WT#ZKE2?^:D_^\]4$0&ESW1V R]!4.C;GT:F"&88%9A;
M*7218(5/?/5-OM+1-T-K?;3F-HNZ%WW?:4'=W=N'$$1\81G95MHG*=JAP6X8
M<.KL"<>,_)A^FWUAY!Z ]9WE<&Q'"]3RS]JF(S]JSS]JSK]JSK]JSK]JSS]J
MSS]JSS]JSS]JSS]JSS]JSS]JSS]JSS]JSS]JSS]JSK]JSSUG7[5GG[5GG[5G
MG[5G7[5G7[5GG[5GG[5GG[5G7[5GG[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5GG[5GG[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G7[5G
M7[4VM%=*8U\:%9\S53[5>KU>5>5:5>KU>KU>5>5>5>KU>KU85>5>5>KU82KR
MKRKU>KU>5>5>KSY9\"'W[52(;!.I#+A+[C"?R43<2G.="8V)+?3&.([DX$RE
MT>DL)B"M>WVDQQCLM'VF^*KOI#*H$\3>7A43<:B1IEU9GS=N(<1/ J,Z,79-
M]+;BX@%0=W:(UTH,!A-7C<'?^*9N-NB]K(D(N;O[]YO-9' A'A4EDG?>;XJ?
MG#9>DWQ42D1(T+>M)Q-X#]Y0MS-SIN:RD0<$Y;U]7CX%^RXC=_$HIAR-]M3P
M3J7':YD!U,=$)ME(!H_)4?(1864R3 ;0#AMO<K:0SI-\47&D,L^\WQ5*:([#
M2'PSDI&W6-143=>.UY@B-&()M$J]87CB4*!"N8QM;DJ@?DHT2%#!I38;R'!N
M^K'CYU$W*W2>X4<4@@90V56!HXE!W(W%B;^DY"MDCJ?5#KI\*A[K4J'6IL>M
M-SV[[4\6_P!2;6Q1%3/0/JN5)_YJ3_[[U W7@P<IYN<J?Z&#Q3-S-UJ-1F1X
M#60_G!;.S[1",1C*+OK1A]I%M6C3MU-]I$M%'[OM(-HHA"5U4CQ5MY1;Q3^3
M#]-OK#R#T!ZSO*>=#RV*5\^>]5?M6*KP(%3,Y*;)H*8K7VIKAQ>6Q6^0A2O7
M I6>27$JEZ:.&]2LDCK-O&M0':K3L4O]C^--8Y[I3 M*:]I%WU"%-33H;I6@
M@CF4;=*@ 0:2X?P7B%ANP$'6C1:%$CQ&-WK:\:.^[G*DZL?ZXZR=*='#'V&K
M$I L-B;NANR^)%=8XB+&+[N*([C3*=N9!E"AQRYM7@_I4*@;IL%80&,WP&IK
MOM*)NCN!$?#<3A9&<QM\SO6.7F\#*O8++74AWBJSLH.(.I"$&G1H[8<0V_/Q
MQ9SD)NZ.Z ;%C8B7O$1T\7TB3K0AP[&-U:D_YLBD%KM^V33,S^E84YVX,:,8
M4S(.CQC9R!Q7\6S[U(63.5$[,5("8?\ \@BQLF'6#+Q953*<ZS@$R%18;#$D
M)G>N,R)&T35=][K+%DI PW6&8U(T_<MM2DU7.G"-0S)^Y:ANCNZ'.B08CF,$
M5Q=O&NWIE$/$$RCPV@-8!8T672U<BWVI1Z/!M+V$6^B5&W1B,.3<^,=<M]$<
M?S1HE):'%T.K)PLM X5$I^XD1T$EQ>!!C&&.*QC@LA1W1'0VV3,2.Z[C7TML
M=?2Z4=0?VB/F<H)ULK*5GVK%1W1ZH?DVUJMEJJC['Y?)A^FWUAY!Z ]9WE/.
MA\AU)BR!DX@'D)"= ?>#9VIE*EOG,K)V\=(&2?&B:J_8%$9":3+@M3G%C@.1
M&D$;XU2;=9FOFH;I5I7<"#WL=;Q+>M,UOF.V+YMCMB^<!'D)-PK=BR0U21<Y
MPE9K62RT.MP5DPPC-KGL$Q/Z1"\[=*M5)V *+0/OAD^!,KN;OP/QDA2XT1E5
MWWN&U%[(T('@K\',BV&\.$]1FI2_V0;$;PS1@Q7< '8@\:Q]0#R55857)%MD
ME7,.'/C8WP6"#9_VV^"J&##GZ#=7,JC  WB"+'PPXC7((@[WL4MZ;=8FLQ#)
M_P"-G@M]!AR_XV^"G5AME]UO@JDQ+B1E]&_C4LF25:V'+[S K8,/JV>"FV##
MZMG@I5&MX"&@*TS*G$YD"%\XT/.W\5O&"'9<&@?@C63IW+YL6"SA0BY,3LU!
M5A85+>\XFI.APNK;X+-PN@WP6;A=6WP0<UD,$<#&^"F3<C9JO^3#]-OK#R#T
M!^+O*>=#F\ETE"ARF"?S"HT&CP7%CFP02+M]5!5&I0FV<1I<.9-CQF"I#@3M
M4=T"$P.:[5;J)5)A7%IC[WDK*/3Z1#:X!KG53Q%16U(5'E9.:,9@$5M:$!+@
M,UY]&9#F7N%4J)284-K6PF%]EO$HKL@(E0W)])\T$.K9V%1:3$JM+,KO?13J
M/ HE@=*N#[TTC6+>)1XYLJY3U7*+'.&9;+D)4=T,2JPQ=RA1(OG#RT1C\WL4
M-\2QX?"=,\4C)"&7R+Z[ .8*+3'V![PYKE!,ZF3#6SX=\H,Z1DA.&V?,$\G=
M)KB 3*7N3FM<'2=>AP?[(PW-^UAX4RLVI(#\%*?^?'EO\G%P*P2*G*U6&2%M
MNL\*M$U98K%OM\/)8)*PR\EMJM5EBO7'PHU]]P<2J@R"X^%3)G9)3DL-G G!
MHE6,^157&=LUQ*:XE<KD>-6(B?R8?IM]8>0>@/6=Y3SH<R$E8F1XTJK>%0Z-
MDH;JKH;9R.H@)E(AM8' %W!J"B4)T6J\0*EX5)=%BSK.F)D?9=QJETD.LKTG
M\7*/0X3I/+'BSC*BQ*92'3<)_1/YHMA/G*)! M%UJ;#+I.RK_P  HS8\6>7A
M.8)D<(/"J3$@N^<,CJ%LN54AL5XQ&6^' Y4F<61G2-84:OOK;T<G=-1)&3G?
MFTISN%[_ ,5'AUI%\,"_C"B4E\7>F)6Q-5'H<!X<XO@ \Y:#<J!%$23C&M%E
MU5JH\6&X"(Z&39>J.2_?.9#/:H4*BQI/K0[G :@GOI%)?==E 4^LZ9FIB[_9
M%IE8QR8V[>C\%/\ SX^ICR?)A^FWUAY!Z _%WE/.@I*2,&#8XZ_>LI2+7SG-
M>;T=P#92M3Y11OM0>9?BFT=\2PMMM.I.HC'8W.)M/T[[5\T_?.LO)";#CQ#D
MW?9<Z[:FT4/G#+V&\FXZU"@,>'1'2L:0ZUS1P*42+*#]$5R/S42CPG&9LM)E
M8GL=$%5S^$K(B)8Z<]\?I<Z+WVO=SJSZ5MJ$ .WMG8JAM[5_A75>68188H ]
M(A5Z8\O+75AOB189C6LDUQ$. T/;,D?%R91ZY#80E:2%#H[G3#6@7G4FP:/$
MDT2O)3LI&95EJ<?%.=')+N=$?['W)C&@F9%R,1S;72-JEP*7^?'U,>3Y,/TV
M^L/(/0'K.\KOZO)>KU>KPKU>KU>KU>KU,NVJ0*O5X5X5ZO5ZO5ZO5ZO5ZO5Z
MO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5ZO5Z
MO5ZO5ZO5ZO5ZO4YJ]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7
MJ]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7
MJ]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]7J]"&+:TNU-CQ&<!M0:SG^HA]
M2GD^3#]-OK#R#T!ZSO*2P$WZEA=L6%VSW+"_8L+]BN?T5A?T?<L+^BL+]BPO
MZ/N6%^Q87[/<K0_H^Y6!^Q87]%87[%A?L6%_1]RPOV>Y87[%A?T5A?L6%^Q8
M7]%87;%A?L]RPOV+"_H^Y87[/<L+]BPOZ*POZ/N6%_16%_16%_16%_16%_16
M%_16%_16%_16%_16%_1]RN?T?<KG]'W*Y_1]RN?T?<KG]'W*Y_1]RN?T?<KG
M]'W*Y_1]RPOZ*POZ*POZ*POZ*POZ*POZ/N5S^C[E<_H^Y7/Z/N5S^C[E<_H^
MY7/Z/N5S^C[E<_H^Y7/Z/N6%_16%_16%_16%_16%_15S^C[E<_H^Y7/Z/N5S
M^C[E<_H^Y7/Z/N5S^C[E*3^C[E<_H^Y3D_H^Y7/Z/N5S^C[E<_H^Y7/Z/N5S
M^C[E<_H^Y7/Z/N5S^C[E<_H^Y7/Z/N5S^C[E<_H^Y7/Z/N5S^C[E<_H^Y7/Z
M/N5S^C[E<_H^Y7/Z/N6%_1]RPOZ*POZ*POZ*POZ*POZ/N5S^C[E<_H^Y7/Z/
MN5S^C[E<_H^Y3D_H^Y7/Z/N5S^C[E<_H^Y7/Z/N5S^C[E<_H^Y7/Z/N5S^C[
MEA?T5A?T5A?T5A?T5A?T5A?T5A?T5A?T5A?T5A?T5<_H^Y7/Z/N5S^C[E<_H
M^Y7/Z/N6%_16%_16%_16%_16%_15S^C[E<_H^Y87]'W*Y_1]RN?T?<KG]'W*
MY_1]RN?T?<KG]'W+"_H^Y87]%87]%87]%87]%87]%87]%87]%87]%87]%87]
M%87]%87]%87]%87]%87]%87]%87]%87]%87]%87]%87]%87]%87]%87]%,=%
M:Z0+;QP%-95$PU.Y?J(?4IY/DP_3;ZP\@] >L[RVB?*L(V+"%A"PA80L(6$+
M"%A&Q8 L(6$+"%A&Q81L6$+"%A"PA80L 6$+ %@"P-V+ %@"PA80L(6 +"%A
M"PA80L(6 + %@"P-6!JPC8L#5@;L6$;$!5&Q2# 5.J%A&Q81L6 + %@"P!8
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MDSG;JY$VGQ7Y4P73G5(P %4K<V X^<4>BR%MLRYFI4RC[KPXSZ)YP95I-;4
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M';"FPPUUI&H^";$<VV4[?]A9\11*B06NE6$1OXJ%#<]TXSI]H3XK;LB]\_\
MT7%/ASKB'%H[N$9R*/R46&75/\.\6*FTECC)T6M;9]%.,1TY;WAN4%D-QJO?
M";*?WBH9=K%JB45A-M6[BFJ50HPSOG$IC7$K2_%1Z3&F6MDYM8"6(J!N@R>2
M9'+]4I*'NEN9$B->UIG5-6UQ!X^!9$TBDU953\[JN^RJ::3$?YQ&@2,Y$SK
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M; LT-@6:&P+-]@6;&P+-#8%FAL"S0V!9H; LT-@6;&P+-C8%FAL"S0V!9H;
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M%1&PXS(?S5&!.K"R:H38CV1'Y75R*@PZ##<)0W81QNY%1<LUXG4-K>,<:H(
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MK7Y=:UK6M:UK6M:U_NM:UK6M:UK7^XUK7_D+BKBKBKBKOJ&;?D0_3;ZP\@]
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M*YU>DO%AGDC)+$;P,C63X.PD5@9JLFGJ2TP%F.>%PL^JQ^,9Q\BSF@,>$6>
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M+.R,:6+,IBYQ)QB*DQGB489_^BQCEL3;:U>0VM(7<C'"/AAT&SC4&XW>J_\
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MTE1A2:L8LXR?,/4[R=1= 1L%@QFWO%L>]3W]&R-Q@(M;S!6)4B>PIO&2<+^
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M4*/&#?\ /D:I95"PIZT'\E3%&.+O00I6.45@U1D4KWB0K9K82A*O&2N>.?\
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M%2&%/])O,JD=-S9(:*+1GI=-R5"N&,JD6*UUBJ2-+4]PDDG_ ,O<#&W0\O\
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MQYNM9]QO[".G NJ0NL4Y<4I61!G:4H$QRR0/2[=8\NHBF;G,80UX=#$5U/\
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M]Y!,^HY,I+I'\\B#@#C(D2;O"PU?0;-5I<X#+4>;N*&;QJ)0=&79F1FO_+W
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M5M!)%J8UDI^Q,;6"WY*)I-XR35%=0Y908IM8W)).D'-,F5K',=7N@S-(W&?
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M_9*3B:P=)0CHD328W$-D0LPF2:3["D\7""GO86>YW8S%<K%'R-8*ECH/T@O
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M]2GP<^'CP$^"'P(>%?[1/OOOO^*#Q0^*^O//Q ^('Q ^('Q ^*GP4^"GP4^
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ME%!XT"1TV7%;7%CC/L9-T:PDBUL?AD9N3KU_R.N..0<<C_M    "R@;])_\
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M%_:(B'62WS8TB=$TR=-U;<DB'3J*,@:GZG1&E7J-CZS YN53!(XG-&F)7J]
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M\=3,X=S'<>Y;XZDZL.;^H X\0DH1ID-WV.,LBR%P/O\ ZP
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MJ71Z)QQ2Z#@1.L)7%A.MC>QPHX4<*) CAVH6<W5%?X_^\@
M               -LV136ID47K@O<BK4D86@A3)L-8S8,:9(J3BVO@42O_\
MSZ1\CX#)=?\ XON!C;H>7^EE-XB^/2)/<&^J$0CZ?A,S1*5)"A-I'44H.[RB
MZ(+Q!AAML#)= SR%RA1IL<<\9)":J.=26$F+&FW@3-Y)4N[N86IMX'1BT1>H
M+*33474*+I+"F1+,F;"Y_0R*!G21,BVS"()'4<&YC,9U:E$,.AL@UX>N5#@J
M*Z-,A^BWOF)[!DCF^@\QS=$)A)2>L#U41J+2C>I!27+$2<PA.Y<\@5*O&!Z
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M2?\ J    22-+ATN.I-QEDH6*8L42%DX%P]!+)*#&BQ_W@    0%3:_[@
M +TN*+_M@   #>,T+N8.@C#UK. 949)8; 5O &X<8^A.?6?]@W&1L-GJ*O\
MZ>X&-NAY?Z64WB)30D UA0\'W9[1&+0R@9.CK#%H"&I7&*NXDOPIM56XK%Q/
MCUS2W=AC;,;N&BT*#H;6='KT%BE2<"J,K AM3<"ES*F$->I54":226!)E&HR
M=X^Y+0?I%2(7Q$35BH4-MO%+-E (Q$B0L'DV)ZY))+<CQW9 L=55G*(Z08#"
M<HN/U'2K4HSN&IFY#M9O5XCG4@F^1Z0DUDT9,CRR]SJ$%D/1G"=%1.BB0V>9
M*Y8J(4%!% P(6\SK0R74>04<H)Z#F;"5;)DVD\D:-& YNNQ574I#_P -H3,Y
M:N2>.0@EH/+7@\&U,71:;FC7WB@_+9),]M2H[#B(1@2U)Q%9H8$1(+!+"-$.
M"K2442:)U9BY08U>%JKS2U')4&C2YV\-"%@0B/\ X%7_  T(A$(A$(A?ZA#L
M0*497FHWA):2H<K0GOS%%RS1COBT]R"/1!!!!!!!!!!!!!!!!!!!!!!!!! D
M*+400000000000000000000000000000)""XBH$J00000000000000000000
M0000000-#1A;CPZ#)=?54S#T9RDU)&:.PGB$:2HG#77T7J_]Q)!'JO\ T]P,
M;=#R_P!+*;Q,0XM=U*Z@W=@)2<9!$@J.HF&>53+U3-+&XB9U$D&:HPE:)LY#
M.:H%A/ :N&F<%NIK0E&,I[&*S48A$ERZ&]*<M(HZ&H%#A.12*=<NXQB5,*R4
M_=258:E+ H$8*IC /YU PO6L@9B4JGC;A(1A&IM=T<6)KT NJ.B<S9X2%J43
M39)P^@46B&(=W1'IB3Q5\1]8=1U&/6 Q)@[(YZ&*E&: )O9JH]QG_@F=Q528
MC+*,3'04+)=A3JY+^&0WZE+))]F("5(A(5.-$$W2E[ 834IT$_D=%V9_!C&P
MK48:_P#"+H):L4[AD_[D].G3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3ITC_ />U
MP8)$B1)GITZ=.G3HT8KW_P#8D1/3ITZ$1(D2)(@)!!MMA3TC&T!+6JXQ@LB3
MLT54V6J:Z$K:$([+4T-@+^4_[H8AC?\ <A1,1(:_[&AHPQX=!DNOIAC0ET%C
M8>5])^LAQ"UJ14ZA!E6X]K4F&@*=78I6:14UNS,,?5*>%1XEL]"'H_\ $/0H
MU@FS(%\C*<M<A?XP]8;P4^F/K[@8VZ'E_I98>(GT"9!G,DQ<O$H6)]6"[%:/
MT$%IZB@S)PZ>FHM/46!6G_.( @( K J0HB@B JO*"J"@F+0%I_H0%4$06G^(
M888GL>$DA*W_ +Z/E&&&&&&&&&&&6&%(>&&&&&&&&&&&&49K)'QB28T]9SSI
M_P#EN\IAAAAQ5"F.=6$6W\#<GH_N+R[_ /0??OW[TPX<.'IAE5(5VI1'E%#G
MJ#"]"FX6Z2_A[07!<D2)$B1(D2)$B1(D2)$B1(D2)$B1(D2)$B0GL%13$D2)
M$B1(D2)$B1(D2)$B1(D2)$B1(D2)$B0UZ1G5$AB1(D2)$B1(D2)$B1(D2)$B
M1(D2)$B1(D(*)'&I\ W"G<KC0- ]#V$A.9.DB9JY!?@J^S'0AH53L[L R<V;
M9555>X=<=0*@L:LR7CV(SB*RFZG!*KT-(JO<1&*@W2$L:CQJ0A;LB"451W2N
M.R8TY9M%;3G)</B*8:<5H*']@V#RJS>)0;?LB8%TI#3,81JB,)*6XBFY.2:0
MT.5CD/>6)16Q2&(:SBA:3EH0^;&"4<YE%L)Q2T$L*V1-G6<;#+1!#39ZCK5K
M!4W@B:I9F(PA1R_@I"V#J5H&$&EHCZ$:+=6M%[$P";=%8AG31*:&/#(I-"OI
M[!_QF-NAY?Z64WB++@7#DH>>C0,2DN-4T':,8DCI]"EKZ%;4+7_P;WK6M:0!
M $=/ITY4])(DCH]:E>5#RH>5#RH;7U+WM?0K'UMZVOHTY?U( @" ( 6Q%KVB
ME2(\J'E3_6][WO'24=!1T%'04=!6OH4CI".D8Z?_ %KWO>][WO>]VKG@@5)0
M"7IJ%B-B,%2([8QT_P"N][WK BFPC%,IO)CIBS1!H">0Y$D3A".61RR.61RR
M#!@P8,&.6+48YT-6*'+C5)1\(]H>^)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR
M9,F)79Z>(3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,9G%;>(NHF3)DR9,F3
M)DR9,F3)DR9,F3)DR9,F3)B].L*? .J1,%Y,98D>ET\(0J$FI6E)>D58C:G(
M3="5X+;,"3)7$@$POU3S0\90:R+V(HM2GJ6A6&A0!N<CM)_@R&G:P;0G](Q9
M1YI#VM&X(N"TG1-+%)S8R1%OO.I*"=@K9UFR:W4)5^%,S.8'-11)LW@IKH(:
MC"'.)4QK&?U(SK$-.1A#U8GF=1F+]Y)GOZ22G(@JJQ8.HL]QVR$X@B<N;\8\
M^PU1BN.@M#"G(ID/=Q5%".:2Z8WX)]=)TF@N0E&@I8)GPBFC*E=8IHV0MSM;
MRUKQ$Q$3;I#1A306ZTZH>,^GN!C;H>7^EE-XC1707;BG>@MJD$Z$*"J-GA",
M SQ3"*[=S7"> Q1)K%":',R2Q+V(XFI8C9L*L&5N8(FL"RWEKV)6I![M,11T
MJR"D+! MRU X-)NB2>QT.(1D+9?-;(DXS2]A@T(8J,AUPIH:Q$G0C&"E1]2Q
M.[4P3 A%CF3/ .,Q/(FEB')-"C28(M*.(21P(D9M0.M@5LV7AK&=&(IR)W(V
M%WJPS["!F(,I8AC%14F1FC!+00G)MRAXL!81R=4+26:*I2/DTRQ9"J)1,B3]
MA,42J$]60IL"JB"+#PR(T@HD2C)4E(JNOS,L)&TUB"[D1K2RI6)"Q3:9%;C:
M.BO.=& M% ZA!D6 <Z </D3NR9&(SW3IJ13FJ9LA@X\S:KH4"EM<LJ9GH(6X
M-2*L4H&TE2H(95<34,A5R&/!+(Y/"'A#PG_HS,S,S,S/\X2L[H-970L.Q8=C
MQW_@S,S-WA#QA'@F3@2=-F( N%TI<8CEYR*4T<=6;=R'J(>HGJ)ZB>HEJYU)
M:N=26KG4EJYU)ZB>H<LPW:B1@'<T$'23'>;S>;S>;S>;S>;S>;S>;S>;S>;S
M>;S>;S>;S>;S>;S>5$A'L$R-YO-YO-YO-YO-YO-YO-YO-YO-YO-YO-YO-YO-
MYO-YO-XZA"QZDF[]"#74WF\WF\WF\WF\WF\WF\WF\WF\WF\WF\WF\WF\WF\W
MD507$GR?T^ R1%<1LG&XR(F*G1 H)?E2GINW$ATVBN.8;E*0,F=#U)8C4=,?
M[%/-E-J7/46!9LR.:*3G,DKJS6]4G1.@L]K$"KP%+.3V:XSH#R&N,(YAFFQ7
M(#9/2W#+&<QNC$6.9RL37LZ'=:-[R$&<A>:=%Y$H?&8T$R99J.EZ(JE3@RN@
MK,$0I)28AOA*,%,:BR4, B3:CN:F$!5JII\1CU!K;9(H+YC<LC4F<FZBM1#A
M1D:-VIM.BV01,(LT([YYI-$UFD/[TM&"-Y6]"9HP-"B0QD9+!I;D@UE8+ZY\
M\F-SM,#DC4:<36(P)I!F3=*DYB(U>GN!C;H>7^EE/,69C"QMPVY"*2QE)=2L
MDBR]=674,<)X.5BTSJ$,S-#SO1.!O8:.RE+"X:H9USHC$$)O-DJ6UN([%%6J
MU&B/%.FPA.FAVJC),H\M8VLE)8X$8\,U+A3FH"R#)&IS6<B'LEEXI;&?L/M+
MGDIM)L#^B)96;-FDJU1BZ6=Q74EH8/4F\5PN!.1X<L2Z."5,*J31O1AU*WT:
MI>!+%\%/ J"FLZH87&[.S+P@-L9G(3F!W$4O9EQ*BO-"Z5G6X>+"N0B>-)AA
M?4*^&A27+>&0A.%44:+2"(D,18G(I5Y#$I307GH5)8;0/8TE$IOZD,(FVB9M
M5C"![LDTS=C&U!JFS.>HD*LL8J5+#(211[&".X+_ #F;52TS)F/>LF-EE!F3
MZ)+%+?6,ZE)9U'@447#&,5-FT:*F@C*,1&GHGD!L2IR;90T5-M9B#,GCE)-H
MG2I&H9B&["R4I:9XI=HHUM19;>%*BG4R>]P+.L&8\(VK84Y)BI8\Q#&U"K_.
MQ>-4GGH-UHF*!UI7[AK<UFK=D#^]6HT^,R5KS2IK0P$L+;LIF3,=$$]L'FUS
M$TEDI*:4L0/*!O6IZ&G_ ')#9I3)J3RV&,6X0DZB'!IX0Z>Q"(1"(1!!!!'H
M@@@@@)[!3!!!!!!!!!!!!!!!!!!!!!!!!!!!! U5"?P($$$$$$$$$$$$$$$$
M$$$$$$$$$$$$$>A',7N"7J00000000000000000000000000143T_P !*48P
MQXNT]RJ',JT3@2C')Y;R?(=5XIN/!F!F6W2HS&R=4KV-N:]S36K^1]=P&IU#
MI?,,)]D996GJRM8^Q&H^>*2,\90WV2,!@EI&@HK"VQ1E"DI7(6]!U,H@)Q&M
M)JM,0:CYC5#=1YIAK('!+2QN< PX*L$/&PHC21*3KI4E4AJ:\]:PM!S6.H51
MA#T&H!YE)ZEB</X3*0\-&=U-YB<=,I;D4I@@5P$*CLAX492_C,)0L'0NOY1@
M">(R>RT*+0:336Z9D+.%2B*JK"5R&@8C"="LQ5S6=4$:6)*OI[@8VZ'E_I93
MS["S,8?]G\(1N&TL1.U. QHOO(OK@!<?F5)=08Z-$B70P>E/05%:ICXE;,+/
M664;!-R3$&JC@2T%<DQ-)2VN&)(%1)N<C &HAW%4%FUI*K)Z"Z%:*YR5&],U
M&<*\)FN:5>>I/R7%7&:Z0AFF"DB#)5?*P^8@D&Z<A=C5DKHI*'A<,3OI(TY^
M*O4DXTZR;R57!.G#)Q+26;0V'2-$J&FTM,QBD(3BP,PLX(<&1:L;D*"BR5$U
M8+KF;32D1$*'@*O@+ :AR7%$JF= V:1JUS%EHS8-4-3$42@I%4[56B$:92*,
M77W(T&R>#JLCD[!<=>BJI@:%.+JQ&M1-FT)O-\ROH&I="<#"KPFU1T$AZ">.
M[99#B&<F:AM0E YGM<*8!*4O%/,C696+<IK3749=-*A4ZM9Y'15(@4LUQ(8&
M-14A4P20]W I'4)-5CH82Q ;*A[&4U1Z6*97FXXGE;#07D]"(A!D&E)M$J=!
M^*?E3#--0>8JI62I#KCDC$%J&:BJ58MF.K:MSRS0,/XM4\%,(0RD!FC1.5AM
MFJ^KHJ)-TEYCLD8R$2P@( AJF9)LBE0O<JRV,L^*/%ZC!$-"37:1%6'30&)$
M<)U1+N6#9@LKJ@N=2D?]S:6KGY)?D=69(V:5&;SN.Z6#;EB^PH>%2G_K%1W9
M_P!ZTY3%Z1)<*_\ <Q:Q>Y]"$0O^R"+//J? 8Q)+Q$3GA\2\#_",L"B,?I(H
MG66\NTF>!A@MFFY-!:T2V*W5?!5_F*#J%46#TM9&#XU"H5?1C34I6-4IKV&M
MPK85PB!:<_0"@HF+R5,Z'B+563)YR3AC^)0WU"X>A2)S2*0JZ.;!S%VS!!^E
MGFAZ"$2R+(J:&&= K")NK9B:2JH;93I(M$NNB)NFD@X]$\G6&TVR2EG1F59K
M0CPA5%9?\"JK@*O*G4,T12&(8;>2C4=8X!S;!D6F(AX3F>,CFT]:2<I^YLU6
M31I0(%V;HKPJ)=0D30PTE:IYCPK]7-7L@I-]%#AMY%+&FJ2,TP?I[!_PQMT/
M+_2RGGV%Z3Q=WR2RI#QA"(K<K,Y*+&S'8.LH'H4P810'1'"%F'OTDEH<IL1T
M2JFU1S,ZC)JY,Y)0V/U)&*/D)ETB(DH6.0J^/-C&NXN#,SF\#NA*NCD03,I[
M&8O))CFLR)=(UQ.%DO83&:CJX96&&(;?28)YX=>0E:<A<0G#$("R=3H;$=[<
MT5#$@C2BH)(A*L)C1EE*IE#C"4\Q,:!K(4'L3FNT \8>=!X%!#)C&O4J$I=D
M$MJ+O5U4H=M'DA1WN< RPBXN[]\QM44-IZCWDE6;A2C/ J2?[Q4*/2)/9EEM
M5"C(.H8ALQ(XU[JK5%-&;4:A=0+<J3E/4"S4SS5;853 +;+$XLNQ16MCDG)4
M+J(Q:7W&=> RX^\%+VF8Q^!D!2CS)$&%LT0W*E0\PFFE(%J#,W1-)IK \@X>
M:VFU69#*_&>%W%5$Y3C9HJT>1(F1*J<66%&+*NR$*4K^C4-(WA*P\V(0"Q6I
M$ON8JC21$8*4H*=I0.#<\GD+G&5 Z62N.'R-*JJ"154;5*7N1&I76$#C1+,>
M-2GRPQ:D'N%!;B+,0G"U2PE$:*##TKS!(:Q_[L4HU&*Z"$XBPZ"R8TDY)9^!
M:0ADQ_Z@ 1#0OL)O^X    !=T(^L)3J_HHE_V0   &*GSB]P2H-9?]@    C
MVD5F/NSX#&!**^($4*%:U\L2!IP$IM8,O?#4& \PEJ"I,>*K"R*NN!GW-$HH
M+V8U#JBR9CL@W5&\&I1K6&.O-86A"$E@K(2:!SP*?]5AP5QN>R$KF]1(VG4'
M+R_IG9\PL2(:$6\#',UN-HJ):%[L87B(-X0F+V8B].H3A@4U),R+K3,.ZU'E
M>L:49)Z#$<*%D$BJ1AT$ >WA0Q,=.322\'X$"RXB<YY!5JQ%.KJ.ZP$6O6Q+
MJ&78&2ILGR)F4.VA'R5<XB)JZM2BQ$\HD208A57]/<#&W0\O]++&8O1.-N_@
MW00)B)\8$+; ]#APQ0SF5!:P.,:(2L1==UAI8B-H]E[4$!V4&3^X9Y%FN4T]
M+%?ADRK&6P>[!M-,!*<S#"<T+"A5\\/'G*=!:#2FV31-SM',-,DM3BE&>H[X
M!2R5:R"D25+B:RGU(\S;6N!#0.9[F[A2_<.&:KX6(BP%9I4KS(#91FFLZ30S
MU$0.>TQI;15J1DGU07+V0WE4Z(DZ].,S0C\""$JG@/955LSEE/8)E,M4J*52
MRTX6*8PIT,$D<+1QAM!5\@T4)INDG@5WEIDK@J(L,H3HQ6HW1,AR6#^!P&]N
M0K:$3"G^Q)380K!.],H/.;7&I5M0*F1Z"M1F<)0;(<PQ\<&RD5,(]!+9"JJ1
M4)-F'<((YE:R<_31H2, ISU:32<!=".%2M2G,/-"]V+5R8Y*G4HH*Q+ %@M2
M%;)Y^#:V.G@>F-TT1--$*J)MU;2'>CTIJD74A$L6A5"C)/\ TB3@= 58A8B5
MUJG)<)RG(7$.BK"45,R>(Z?(R35:#9G/Y>:VD@;<*F%4YH@/''-&U$\%F:HH
M(F%7463T&Z@21 *5U76H:<YL6-G,0DES5Z_]ST6DZV%_1\ZAHANEH(8+J(_A
M!B09*)1*)1*)1*)1*)1*)1$M'M"F1*)1*)1*)1*)1*)1*)1*)1*)1*)1*)1*
M)1*)1*)1*)1*$N\)W!*=0HD2B42B42B42B42B42B42B42B42B42B42B42B42
MB42B!*Q>X)"$HE$HE$HE$HE$HE$HE$HE$HE$HE$HE$HE$HE$HE$HCVD5GS'P
M#<$])'@ ZXQZ8C;;GN2JS%H1$Y!0UQA"TO2'RK'=*G<>5BZU6HSOP7NM.@N9
M?9)DC5IBSS:/\2A Q@HA$ENQDR*+#>2I&>F,"K':*#B")1G08-"E2GN'7BQ)
M/V/,&H+@LV*_9<*N+32H5. V@MJ<T>PVG"C;5XXU&"P\E(PWFF*4=7U(4T(T
M1*16KSL@Y)14)B:[$XNVEC"&PZ4-K"A#PCHL(RQ%%"X")P*A"()28B6.XFE-
M,TO\22W5I)YI8>GN!C;H>7^EGF!2W&)F'H)3 K"DH:7D\16&<Q65>Y 1--1E
M6F5DL.PE,B<MNAJ-!+5*#;PUZ"+B<B?](:$;.4IT5L*3DE2F9$FE>X"L/6<T
M9+V$T-.X^#WAYX%#<2[XB(#C$3\@@A$<:BK_ *#^C>HE);C<B6S13W0V"I4F
MA=1*14H7P?5G16<U>[Q9)9N4IR.L01K ;H;5I+;RS&&&F"4*?D/P1I&!3&L%
M)%"5'& IRS*)7V4IK:^R18,XF9FSR0T(C=GWQ*J->>?<<ILM83E^\C; VG%*
MKN-SF<4G0T?@;"!(J$TR.LU<F2-IIV',P\FIV,3"C4A.:G=&29H)YF8,^IR.
MFMO-FVAA0Q2DEW8D6-0FWKJ\T(@LJU@A"Q6:BMB6%*FY3K6_42*:KJ=;N1+5
M<"!,DM24)# FEU8"!&U7*:Q[_ICX=TKW,4*J:?%!):CJZ"_*&JT<(@ C'6OX
M)T99I;GW%IKQK]B?U$_N/+'ECRQY8\L>6/+'ECRQY8\L>6&UEWD),^^AM6MT
M>6/+'ECRQY8\L>6/+'ECSA;%MW*4E$GCB2LF9(GH\8K$XX"J$='B&DS>((((
M((((((((%D86WIP0000000000000000000000000000+WCW7P?V""6A @@@@
M@@@@@@@@@@@@@@@@@@@@@@K8Y/L24P:@8D$$$$$$$$$$$$$$$$$$$$$$$$$$
M"_@A,6*22JQ.(R&:'B%IB--I*<+L0U(1)J6"PB >+X,QP+*4#HJ&MJ5>A92G
M5[H)R;4O)$G94$AS21[6&VHK50(VJ+9M(4K3J4< TRJ19ATX&NK^G8A"(::1
ML_A-&%'(S=.%-/ Y2M744K!S7,44:4-LTZL;)(@D"(F9^QD&ZMF#A0J-TJ)R
M1G/N)HM+2<RZOOB*5J#/,+HF\NG9_!-%$DV$V$NIJ,;=#R)L)L&R/^(LW8R,
MDK2TNDY$6$I)8K=I?5Q3A7P/G_\ !MJTOT;8\TN7?!R[X]9S]-?K#+<F^/39
M>GT-Z5ZNW4>>?!_@U ^(?!Q#X$G)'S'X_P (AR:L_K'S\N^#EWQZEEY!G^?O
MO;Y(#-"6AU12>)Z(W#?@CQ?Z4UK+F?QZ:Q8MYZ''_@X_\''_ (./_'K.?)@O
MEH<Q^#G?P<A^#D/P<A^#D/P<A^#D/P<A^#D/P<A^#D/P<A^#D/P**#>:OMZ"
M_D/P<A^#D/P<A^#D/P<A^#D/P<A^#D/P-.')L<C^"ML<8(4,Z@S<G-&K%150
M222II\#-$C_W1A;?]ZO>/=?!RK^C(/\ ZT:LFWSX!?\ 6Q?P9^G\/F,UT(T*
M%!^D30WF\269"(6I"U(6I0H4*%"A0H4*%"A0H4*%"A0H4*%"@XZ@QMT/(H4(
M>MEF&0]5KW"^J'R6&\#:>3/ 3ZM.<>(OB',R^_23SD<.,4#M>YM>CM\ZG2)B
M?'Z;7N;'.II+H+K+K]+AQB?(?-R>DF\O<V^=3;YU-#H+K+K])=9//>XS;YU-
MCG4VO<VO<M??[+'W^QX+HY^DOG#C.5?L=E"9'DS:I7K4C13+61:$])RXS:-@
MGHYU)BGC[.'&<.,X<9PXR>CG4VN_Z5Z?_>/_ /\ OD52G05-$5;T?^7_ /\
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MD R2_P"UGAX#&FL= L$]AR?HX_UZ+Q?HYOT<7Z.+]'%^CB_1Q?KU .+]'/\
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MDH-""PEU<FH/@-FT\GX*:<FR,)IB,:)3-*FZ5U)H:5,O3K(51443>:3VL/\
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M>3&)MZX#W#9FYW'6\$I6=5SE"R&>RY=35LM29A&E6^Z).M[2',V6$\=07T"
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M&IJA5ET$0),FBM0(.8C6*,YQ*":IS1PYZ023R;$JN&K##I,I0QJ6UAFA+4_
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M&RY6S9Q@C^A-9BYQ8EZ/SMKYER#GHA42+5$(J$LO0C&W0\O]+*;Q-3GW/>?
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M-CXV&ZI/%E'P5!;_ ,&L\8&)^[Z,"V0A50JM#1,O!P]RDG2>#=S+W!4D\EC
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MG<V"- VFTV_ZJK:;1:A40]/_ ,#W_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
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M)EP_(-,A;9B::FFG!IJC7I__V@ , P$  @ #    $
M
M
M
M               !TKFF:A10N1.^Q^P/ZM7+T!:YZ+6IN#]M++20F    (
M
M                      ! "S:06?*69;-(XJ3%$>K5&69!A#OH,8^0*7@+
M+0
M                               ( PDOQWG3<9:70PAB#%91:"$L/88;
M7/[/KVVTK6
M                                       ! +6-B2)PA(L4K^-O032.
ML+8/M6EB'#ENOUM9N10
M                                                ( B>B2'D/SV0
M"I.<^5)[=Q3^[2$DTGQ!*ML+=\&     -6>\"% 2RB D22&R&@
M                                                         )*0
M3MT$(\,38GJ0CZ;J%PGGG]%O^_"+)\8")3HP    !WY%-,#DRPR!;2 F@R0
M
M      !    (   (  !    !  (     (!  "82          #.I7'0A"3:*
M\8;M+)X
M               !(!( ))))))(!)( )))(  !    !));+9)))(      /2
MV4XVX1I51QCR@_F0
M                                                     "02
M      (&-"]VS#-2NN)3%Z"R
M
M  ""0          ;)TLFO.FP:DPCTYE3P
M                                       !(\J[F2B-P]!04N6N
M ))KHN'I0.XL'X/6RI'$AD@.C$$-'6(>04>FU>UH.
M                                               ! ,6M^/%[# -P
M5-I<P    ! *FG]+P=QR=U5STC?UD BADIR&P=<2LKW0T@L@G@
M                                                        ( PR
MSSYQ(7[M@2:TX      !9W<4\!Z@/VO]+8%!&LZ@"\X#4E[S]IU1\/"PJ2
M
M    ! (K-JS-F_3_ *VYP\@     0"O.^)&QUYUW$S[<5>+AYD!Q1&SO/NQZ
MZ\++M 8^2222222222222222222222222222222222222222222222222222
M222222222222222 5[X7J5]8D/8]+A?222222  848=Q_0$P113HVL<DMRBH
M1E#]Z_AK FQK"P<MR2222222222222222222222222222222222222222222
M22222222222222222222222 !7N< \BA  0@-QN2222220!IAC#J4KX-_MI,
MDL*U*<<0  " 65C@     "
M                                  0  " 0     0          0""
M0          00"  "" "3K460"2  "0         00              "
M             0              00             2" 0"     "
M  0  20 "                ""  (A!@    ""         "0
M    "0              "2              ""             0"0"
M         "2                  00    "?\IGW_\ DDFVT_\ _MMI))_V
MP))))))))))))))( &W?_P#Q_P"W_P#OOIML!)+AGI-!A5)?I))(())-_P#,
MDG__ -^TLD@ @DDDDD__ .!+UY+)) ))))M?023_ /\ &^TDDDD D  $@*0#
M221)*22223;;22"20;(0                ?Q#;;#9+))::;" $@!  " )9
M90)    @@ #2(  #;;3+#  DD@ !22;;:2( (+$D$    8!#  ;;#*#
MD   D"3;+;; !3;;;9;;:20  (;3                #T20 !;2  #((*0"
MD (1))2)81"*   $$  #*);;( "8#0 $DD  3;:  :;328(D@@    17;;:
M"**8    $@  $@)+<=[%-S_>2VS*.>M\$PU%8                F+VD!";
MRHM0UE"DD #//<UHH).-($  @@  TNS=3@@97>  D  $G&<,L(5.\K*$DD
M  E8MKY8)L&B     D   @ L]1#0;I<?YOZ82_SQ6"17;
M #8K$'\"V=-0CK6 &D 8"<?V>'$1X@@ $$  WY>K]1+VM&X $DD $I>UT*(!
M:_+ DD$   'M2/3\A;'BX    $@  $ :,((W8!H+5'"PP QLZ@9-CX
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ME_L$     )   '#T]P2_=I(]KT^ _?67YLVLG?<S,(UN_P#_ /\ _P#_ /\
M_P!J7[5_ZUO[;:%L$+)?\E!S]@,?3]+P@@2   0-.23-/>P?@ 0" -%DFWL6
MD@H$$ 0     (R622D^+2,@       (Z>]3 DF%P;+XX>_\ ]DD*^2E$4H#1
ME63FMMMMMMMMB5MMMMMMMMMMMMMM EMMMMMMMMMM#5.D$DDDDDDDDDDDDDDD
M$@DDDDDDDDDDDDDD D                   D  85YFRFVQ3754,=Y__1))
M#?O.43]16VR^_P#_ /\ _P#_ /\ Z;__ /\ _P#_ /\ _P#_ /\ _P#_ /\
MO_\ _P#_ /\ _P#_ /\ ]Q/T@ DDDDDDDDDDDDDD@$DDDDDDDDDDDDDD@D D
MDDDDDDDDDDDDDDDDDD@ "/DU=1Q;"5=:_P F*#/#WZ,&9@]AE7MYTW^R2222
M225 222222222222229 2222222222>08) )))))))))))))))!(!)))))))
M)))))(()!( )))))))))))))))))  $+C/N)P,.#\*98NK*OW*>.*"431N1S
MK36*      !-              !]@          A:'))))))))))))))))))
M)))))))))))))))! ) !)))))))))))))))!(  V=^"?2*"GAH]_$8<VF048
MJO;6NV]"=)0R+;;;;;;8I;;;;;;;;;;;;;;3D22222222226/&I!))))))))
M))))))) ))))))))))))))(!&N^+%WY!J=V[=?M/+XLO9   I+3P8^N6_L("
M-R@+P<D\@=,5JZDP^/33MMMMMMMMMMMMMMMMMMMMMMMM/_\ _P#_ /\ _P#_
M /\ _P"428 $               @               $6,SZD21"01#0!)1#
M9C $@ $3UP$_0<,?2E,10_PZ8&FH?X&^ I(N*QK
M   DDDDDDDDDDDDY9#D $DDDDDDDDDDDDDD$DDDDDDDDDDDDDDDDI@E]G(8J
M,#?6+!)>@DJ:D  =<\"B1SSBR8@4]8'CPEF86LC_ "35JGWM7O\ _P#_ /\
M_P#XA_W_ /\ _P#_ /\ _P#_ /\ _?P"VVVVVVVVVVF?G2"2222222222222
M22"2"22222222222202%Q:J%'!"PF-GQR,^_6&RR  $6ZGOWK[= [WA>KD=1
MW36Y5X(DOWZ[:1E(      !) (           8#_ "2222222222L\@D@$DD
MDDDDDDDDDDDD@DDDDDDDDDDDDDD@ :NG'&U>:14( HKP(I1%XD  H1/")K+D
MB5^ 4[<?"_UQMHV8X==-_&-FE-I))))),_)I))))))))))X5G='O_P#_ /\
M_P#_ /\ ]Q"P$                $              DD1^ &8)N/N\4=3J
M'DA N,D$ /ZZ+'O'>>:ST64 *T"W8^YVV >VVVVVR_\ @     -D!
M   !?U:V4          !))! !))))))))))))) !!))))))))))))) "02=1
M%U<=E7248G-4YS3Y((%X(V%A&ETE[$P%_$HL"ANHBDD@DDDDDDFDEMMMMMMS
M9-MMMMMMMMMMGUO!J)))))))))))    )              !(
M  ))(2=Y43X]<>F^Z5E343:1)! )[&K1W/@O-*JV7W]VA=$HBFVV6VVVVVVT
MDMMMMMMMLEMMMMMMMMMML63&\B0            )               !!
M          ! +(0V@"070D"2*28P@6^@I  )-N&34_WC;O#-D_\ I*_Q]_%D
MDDDDDDDDE)) DDDDDDDDDDDDDDDDDDEI@ZE;R222222222222 2222222222
M2222200222222222222200$0 L( (HH-ID-!%((L BR  3&/88/[#KN <#?,
M@";Z66L;_P#Y/_\ _P#_ /Y))222222$"222222222227W*.D'DDDDDDDDDD
MDDD$ DDDDDDDDDDDDDD$@DDDDDDDDDDDDD@@E-&F^N_7OOX(G\E\\OD(D  3
M"A(^I7B1$JYL.$I_S,MC?3;;?;;;;;;;;;;;;;;?;;;;;;;;;;;;;W03*STD
MDDDDDDDDDDDD @DDDDDDDDDDDDDD@DDDDDDDDDDDDDD  $
M    D@ !D3K,K)M!9YJ_M],$")ELV\DD1LDDDDDDDDDDDDDD18 DDDDDDDDD
MDD_%E0;         $@  D@               @@             $@$DDDD@
M$D DDD@@ DDD@   !G$K3)))F^;4\DD22JD0W,#;:2;;;;;;;;;;;;;;?6;[
M;;;;;;;;;;>3/;N\DDDDDDDDD @  $              $@@
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M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;31? ))(             ))
M        ( (   "S;5ZLJZ!@S 6  )  +0V(^%?;/6PS/>RFDK9-:")X6B22
M222222222222222222222222222222222222222227(M)!))))))))))))))
M)!))))))))))))))  !    WZ+)$BTP7>XTP !( !7*G%K9X=(,:+ZO)Y,I+
M0;2!*"DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDB    &DDDD@ &,:9 !)))))
M)))))))))!)!)))))))))))))!!(   *N:CXL9_J]-:R  )  /Y!5=NU0WPQ
MQN3:EY**917:^$FVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVFVVVTVVF,
MD!!              ! (             ( (   !( OJNJJW@=22P !( !MO
M!47%(231#AWVY3"_FS22#A>)MMMMMMMMMMMMMMD-MMMMMMMMMMMMMMM-MMMM
MMMMMMMA-II !)))))))))))))))!))))))))))))))(!(   !$:TE9O4NB)@
MF !)  -Q(4Q+>\)O[KK_ /[^7:SVWMU$E^222222222222222*2222222222
M2222+Y)))22222I)1S^  "0             2 0            "0 0   -!
M @!!%)IK,D  "2  2N8=NKG5-V$L=)(F89@-@;8FZ86VVVVVVVVVVVVVV@6V
MVVVVVVVVVVVVT$@  "6VVVT #HE$"               "0
M0 "   !A)  ($H-MD()  20  0JH%B?S[+;[   #2/G^J1(5?:G_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ :?\ _P#_ /\ _P#_ /\ _P#_ &MM<O%ML22221ML
MAM#( )!))))))))))))(!!)))))))))))))!)()))(%HI)(7">YNB?)) !
M@'U3MMMMMMMMMMMMMMMMMMMMOOMMMMMMMMMMMMMMJ7MMMMMMMMMMMMH-& 2Y
M)))))))))(! )               !!(              )
M    !(( +[?(K>_RVVVVVWSV_P#MMMMMM_N/_P#_ /\ _P#_ /\ _P#_ /\
M_P#[_P#_ /\ _P#_ /\ _P#_ /\ _P &=_@5))))))))))(!() )))))))))
M)))))()))))))))))))) )!))))))))))))))))))(  !WH4VVWLVVVVVVUM
MLNFVVVV\O_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ YY.B-,                                            0"
M0                  "0 "3/QPA>DTVU6'\U^%Y$TT(TL6V222222222222
M22222222222222220#[,C?R2222222222222222222222222222222222222
M2222220""                   2  =29,=O<O'\1^4#8FIXS,F$D90DDDD
MDDDDDDDDDDDDDDDDDDDDMMMDDIXJ\X222222222222200222222222222220
M2022222222222222""                  "0 " -KR-$Q?*:!I]%*X@44-
MYLP4                           !))) J- @            20
M        0"              200                  2  0"V1YOX8[7U^
MA"#5L!K8B4#)@@               0       ))(  %[)KE,
M "              "0               "0  22  0   0 0     "0 ""M6
MTT07$BC8M=JQ'?$1<RI/LR222222222222222222222223  3;:/=HWWR222
M222222222 22222222222222222"222222222222020 "0200"   2 "
M  2  4.Q==<C08&"NGO<C$I/$7AVP?.DE)(   -EMMMMMMOVVUMML7P "VVE
MN=A<D             2               02             2!A$')XU_MM
M^VD@6LF#MIN0 !^P@]WMRED+M;9 B%82-&H$;^.@W6VS;:0IS_\ _P#_ /B9
MN __ ,#1Q)+_ /\ TEN]D             "                "
M      0*3 'H_P#SJ6%IO7_Y?+;Y4@ 'Y#3"_+J:Z>_T"*G_ /25P3W?_P!G
M6$ !DDV5Q$DDDDFUI;0DE]Q4DF22-*U2               2
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M\<&VVVVVVVVVVVV$[(     !(                !              )(
M           )))!+->P"1(!P!Y !(!!(!(  74X^IB9#G6JGC*V##X"3;;NR
MQC#MHL2:'.MMMMMMEEMMMMC;51))))))!))))))))))))))))( )))))))))
M))))((!))))))))))))((   I:N+4\E)!)MLMLD)!)((.J>  W0$TOS,^8B_
MZTKVV[5)^BI=I /_ -6I_;;;;;$';;;;+'&       2               2
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M)1*0  RNR>18KY[+Z$!O?=6FODPZ#P/W2(%L !         (
M       ( (    (         (         (                ;(I@ ;I!!
M H ("!"0(*(2  $;^K_7/]N;QYOTR;LPPBGKC8]-I4=-           !
M   ( !                   ( !  ( !         #2!            ( "
M42X010'T3 S+02;+*2):0 "P/D4$F(NG^JLE/-TL31/BM@3!&!'I  !
M !            (                  !  (    (         228
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M+M            D$B^_LO)/D"PVO/&&<& 2B<@ &P1\Z3KUG;9!VS>,0I_\
M_P#_ (;;;;=__;;;;;W_ .VVVVVVVVVVVVVV[_\ EMMMMMMO_P#_ /\ YMM_
M_P!;;;;8_P#_ /\ _P#_ /\ _P#_ /QEDR222222222222"00
M       "0 #DTT O8$8<0FIN3LWZ$DF2322""3R2:1*2)60F0)2"21)2))))
M))>23R2821(2$R0F2I20F3I0"1)2$R0F2$R222%(BB2222222222222""
M          !))   2  )[;C#)76Q0ECHXRLIW;9;;2VVTVS;:6VFFU;;6VFV
MVVVVTVVVVVU;;6VVFVFFW;;;+*VV;;.VFVV[+99;+;;;;;;(-K
M   22"             !)(  "0 !DS*4D#XA"OU722[>@MM]MMR24&1-MR&2
MP29MJ00R76222"22222=MLR2""0P2)M]OO2"1MO2"V21/M]]OMMMMMMMMI8
M           "200            !  (  2  ,R\PV%+E5HB6^'[6 9MN>86,
MU_VO;84MFMO9MV]NWOV]^UMMMMMO[;"VUM6M^UM[-K=MT-[=OXVM[9M;-K9O
M;;;)M69R22222222222202              )))  0"  " % ,   $@A@@$%
M! ))%O#)H>                0              "               00
M              0             " 0"2222222222222222222   20'2^F
MG_@BV \C_P#M @X(2M&D@              @@              $
M                        @$DDDDDDDDDDDDDDD@                 $
MD@  $G-"C[:N[.&%2YH64?06S9(9               $@DDDDDDDDDDDDDD@
MDDDDDDDDDDDDDDD@@DDDDDDDDDDDDDDD$ DDDDDDDDDDDDDDD$
M        $@   D>O8$9.^6!LUSOO]_T@1E9 P               D
M        @@              $@              $@               @@
M                 D  @DA)S\+CU[TFM#:L?8X V@4]T
M  DDDDDDDDDDDDDDD@DDDDDDDDDDDDDD@$DDDDDDDDDDDDDD@ @DDDDDDDDD
MDDDDD$D                  DD$ DDM)9TPZ\)B"/F()[4-@&C=7<DDDDDD
MDDDDDDDDD $DDDDDDDDDDDDDDDDDDDDDDDDDDDDDD$DDDDDDDDDDDDDDD@DD
MDDDDDDDDDDDDD@$$DDDDDDDDDDDDDDDDD@DD@$ EL?2W;A?J$YZUF$,U1R6W
M<3                $DDDDDDDDDDDDDD@@DDDDDDDDDDDDDDD@ DDDDDDDD
MDDDDD@$ DDDDDDDDDDDDDD @DDDDDDDDDDDDDDDDDD @@  D311,2!"J4&7S
MZ6)_MI(CU*0               $DDDDDDDDDDDDDDD$$DDDDDDDDDDDDDDD$
MDDDDDDDDDDDDDD$ $DDDDDDDDDDDD@D$$DDDDDDDDDDDDDDDDD@@@   """X
MDCCGT@'N_D D@$ DFD\DDDDDDDDDDDDDDD@$              $$
M       $               $@               @DDDDDDDDDDDDDDDDDD$
M@  -LH0!@DHEZ3:?),DA'VUK> GS;;;;:25B_G__ $>8MK))))))))))))))
M)!))))))))))))))! !))))))))))))))!!))))))))))))( !!)))))))))
M))))))))(    A'VV["!K;?_ /VS78 7M@#9DDV23;;+_P#Z_I22OD=DNDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
M  DDDDDDDDDDDDDDDDDD$@ &37_]<G L#_\ 6$ B22DR632;9%__  ]N]T\_
MXI)+K9)-@
M          0                    20 #R!LE9Z)I9*Q_:8)MV42_S]DDL
M  5_G ;+MTDE>NZ!L
M                   " 0"2                2  6_?@)/O\ <$">4M+W
MXD-%61*6DG_^-;H$RL3+?G/1\28
M                            $ @@$D                D  6UX#7R;
M4&%0":!, CY(R'' C)IWDN<OL\U8NS5;+QC DDDDDDDDDDDDD@@DDDDDDDDD
MDDDDD@  DDDDDDDDDDDDDDDDDDDDDDDDDDDDD$A'N';1&8[)FDA:4'MMD@$@
M #Y:$Y-^@2&9RLOBP7L3B^=.!B&T"V,3V5A)LG](!]N<DDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDD$DDDDDDDDDDDDDDD@DDDDDDDDDDDDD@DW@*0+":_*)S/A
MWVM-P$ D  ?/G"F@A0#0^*:$=\'?2B$QM;[:U8+TQ-MW\]U!,87^D$DDDDDD
MDDDDDDD$DDDDDDDDDDDDDD@ DDDDDDDDDDDDDDDD$DDDDDDDDDDDDD C6(#S
MF9@;S?G+[2/Y9$ $@ #XYN=#]9&[H.[[@W;L*1D4F<S$]%_ HNC\!0KY2>#_
M                (               )(              ) (
M    )#^;6$"H(K0<DHTJ73-! )  '&!5+K=L$JT=P_D@BKPE4YCK]E7*>4AB
MBQ23J9=3PF@             !(              !(              !!(
M              0<H=SK_P 6BZ8>N[T6:" 2  ''9F,MQI\9WI_"G/VIL,OW
MWU\#LN^$>Q*-"B(7VPR]@222222222222220222222222222220  2222222
M2222220"22222222222222"1B"M#81&6Y>?_ )%!RVL  D  3RAC8FLOQ8DC
MJ1#;;266_P#_ /\ _P O_P#_ /\ _P#_ /\ _P#^QYOEB222222222222222
M"22222222222222 222222222222222 2"2222222222222 &-RRZ8C2R8&-
M,"5500" 2  =KRL/&DO3LU]# FR 1U]2?_\ DSW_ /\ _P#_ /\ _P#_ /\
M@L>E  0                             2               0"
M        ! ;>)*R&@%5DH@A2)EP "0 ">%OZ:].4RO;[1Q00.V&L!)))))))
M)))))))) E(%2@              "                0
M"2              "9 RF&Q2V4V^VP_,&TL" 2  +!M%#7KMDK;G4HEA^^Y%
MR)               %P[,7222222222222222"222222222222220"222222
M2222222220022222222222220#(4":TK@ F$P2*0"#E@0"0 !7%=<[:DZAR,
M%;VPU^A6TDEDDDDDDDDDDDDDDHL+M6P              2
M 0               000             "6($   (             2  ?U&
M(QQIPC\2_P RY92E,BH  _\ _P#_ /\ _P#_ /\ _P#_ /\ Z'%:2T
M        )               ((                (             !)
M                 )   RTOMUBNS0RG$*7VWR]2K;8DEGTDDDDDDDDDDO 7
MGXY)))))))))))))( )!)))))))))))))!))))))))))))))(!))))))))))
M)))))((                  !( ![7#&!HCUUP>N'M-1?FM=_\ C;;<;;;;
M;;;;;;:0T!C-@             "  0             0              "0
M              020                  "0  ]#P^LK?\ 8;ISC=9%(VR-
M;;221@           J=O'O               DD@            $$
M        $      "22      @ DDDDDDDDDDDDVVTDDDD$@  $ DDDDD]MMM
MMMMMMMMMMMLMM,$DDDDDDDDDDDDD$D$DDDDDDDDDDDDDD@$DDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDD$$$DDDDDDFDDDDDD$$           0      $$@( $A
M;;)).DDDDDDDDDDDDDDLD@D             $@D              $
M          @               D@    "        $ @          "22
M  DD! D$EMMMMMMMMMMMMMMMM))))M,DDDDDDDDDDDDDDDD$DDDDDD@DDDDD
MDD$DDDDDDDDDDDDDDD DDDDD$DD@D$DD@D  D@DDDTB4DDDDDD$ @
M   260     D @$DDVV_39)))))))))!)-DDA( D @
M   $@     $@            D@ D  @ $@  DD   $DDDD  $FV20 DDDDDD
M@  DDDDDDDDD2VP$DD $DD"4TVVVV:T%MMMMM*0D  &D D/^"2;;^0";;VVT
M@VVDDDB @ '2$ NVVVVRVVVV_P#_ +;_ /6VR1VI-L"MM"5MM2V3)-  -H)^
M) 26W@/S *N2H&*S'^Y\'Q)[*9VR&#TU#?P8$@  P$B@DDD@  @$   @ 0
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MXS38#A@/!+<>Y*&$?K#U5YPU9%8!)=A<D4=B#3Q=D $"A<U4EV( <R*C PA
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M!B SF:F2SZ0WF$4L3+M)CHQAAAB3 8F2*3&,UURW0))SB Q,,<QDQ:M+)AD
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MCDIDQD^9A#8WRHGB HEAJPPEKYPA&P8$AJ:8,FE@X'<*[9-2[,;'[#PV=+6
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M2LG,4"@',"K-2?!Q+>$9X)&/:Z# P*A&)R6+QN/?F*XHXU(&I;S&=S5DRD]
M<\L13H=\I\R<8]X*CZ<_OI/?'P3Y9^R$TLS^2:V8F]ZH1Q-F!+N3?HJ@:02,
M\WQ(D%M QP$JXL#FSY3-7J8JB!RP D0:Z'N-:(H#MF\"'W'0A&@7(H1#0*4X
M>BID/>".DXLCD' ONY< 3@>X,,D#"I=LL#>,,H0.P&7UY33%BQQP\?\ .9P<
M.+9$Q6?FB!HBX;$X'3/M3\=$A[-J:S4P1.T::K3>[.EY1T D;[4>-/)LG/!$
M1(11@%X'RI(7-8T!U@;.XR09:@!,AZO)MF4Q8V.0)4L^FNA0^8<^*G-FWF'1
MVRC)!(8@S,#4]9#S2208!BQ+8 ==!8( DV/#Y(I@H((%YN+EBPJVB%#.>0Q.
M#(T\!A64(!,!IA)(&?2ZIG%B2 ,@0X:KR$ @#?%MA,3C$H&A,V88.?B*5'L
MB @4E?W@618!P(,I=O']E'^*8DD($LSC?>48<UEZ2Q:N\%4JP%RRN +:268:
MH9FBEWD*-1Q)48QXMB<R_8,T*HD\'%?+B)..6I+P )"2 (-,:X6?.0<(0A1,
ML :B>LF@'&2 ,G%WJ+ 5,8K#C!<N? CWV&=#B H)S.!':HV!8#1."'BCMW)
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MEFR+PFA0!N..($5;'Z9%L&))@7GYS3# A0O((. D889E",;(7]J$ZT^):<+
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M,2XRP3 U V"=KMN%T3Z7YCA6&P7YCA?F.%8;!,,AL$PR'^'.9W/_  .<SO\
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M*3I\&*:%_MQB1NG&8W"<9C<)QF-PG&8W'_&XS&X3C,;A.,QN$XS&X3C,;_\
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MS,*TCX7R-ASF0.A]3ON#$8IF /KN2,#8YD#1JNNSCN6^_P C8=>RJ6T\/.*
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MS5TUT3Z/$8U%*.U6@?PN<L3X-<7\.XSQJM5:3O4YR'J589K%<2V-&R>GDIN
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M$@#HV%^?298U@XJQ;UF,H?(HL9&1]D]O*<MBKG%_>6P>0J!H7/MMMDX&F:C
M94L:4.*;^Z?E ^D=;89D8YO"(W!#N7\\*-XJ?:"L0%V99Y0'.#D($=;J@L2\
M<5^"G89+*E,/VGB08 2(:E.UT,R@2#)S#5IT@:(,000=FBVLFUD=("687)R
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MPPX?Z^?*Z/X#XMDFY4?,&IM63F93#A@V43% XIIXDO<P8G:36*^6AX>"D"
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MJC*3,:H(#%L#(145@X'[6+&-16TL3>^:(*GQ%68RNS4&*.D$:"26I.--S[9
MP!'.) ]OEB"GHLP[N+@LU3"/ZHA $PNPK#[W-$>9,+%E1@V5P<W1%$ ;, U2
M '#FSRQM\.!+<+N<!O@80HP+LY.9N=7JY0D,(1-@7\.S(-@()<",&L0[Q/P%
M$,#I9BXS@:+$G)$NP$^5 *P7ODHQ@G" 7]#LF)!29P[2^7+ZO,L$[B0_#S'T
MPG)_1!>(,9&ID5S:$SL,CQ&$^[37,]P "&9Q )P(8FO](18<:T;NF/AT>E5@
MQ:LN^'FV:9#(8$6$OQO+E 'RP:F/F<,9HB <,#$'J^+5GH30D.35@<X+T.9"
MP; ?$8O>]S=T3PB4BQJ XES6I5"6G%_Y]J]N^V*OJ7U+ZE]2^I?4OJ7U+ZE]
M2^I?4OJ7U&,WFGM+>Y', \^JGX5]2^I?4OJ7U+ZE]2^I?4OJ7U+ZE]2^I?4O
MJ7U+ZE]2^I?4OJ7U+ZE]2^I?4OJ7U W4M?Z'Q_C%P/"=R5T3[71/M=$^UT3[
M71/M=$^UT3[71/M=$^UT3[71/M=$^UT3[71/M=$^UT3[71/M=$^UT3[71/M=
M$^T$LH$DL1= B=LM7B6[E01$$"#NDR3IYK+X,B2\X5+%PST#/J+)ZI#@5-5L
MF,W!;!!@Q@]3B?'F1/\ T4I$@ %B]488"<VP3,"]_E/Z:_15#$M5M"?@(%&3
M)8-,-/L(K?!W+I1L X2!Y4P'?*9&!GDC)VKX3J\&M+)B 7#U3JY!;*?O_!"8
M6K= KS#N++%HB-$&OW85Q3H%A+%,!\]=D\$^6#[4>/X@\60?-5FJ$,O&2 -9
M &>)32  D " '>0\Q]H.P(U?Z!1.8-[^P%1 ,.B$S: =L2+($49M3ED#-#Z'
M*(,?CE,<ZD@7POI"K\#N)P\(RPK-V/W!#H +_&J!/(6[W$0@>L3.GC/[R0&,
M&<M/>YH&<AJB0G?M?00ZP2VO':TE,@#1W-/C_<;C4WK^A_$V$EJ1C?,R'_4X
M8H/#5W"?X!R"9G.+EK:2C!(.6@L6UTN?00B<(%ABWU\O)E%HP@9O%?G+ *O#
MQK?&AAR/@0,SY&NKE=AHZ,H-1AZ=-&TBA*P" 23B)J8L[X6HA0Y)E:*0!'V%
M@0C, MWED:"&@^!J^.V -BA"7,*.0_UJHD!A(:@T>+Z&KHQZ$/ #C^-AK$0B
MQ$ &:2V.56S0IP8$,\/MNWQ@W, 7&6?@.]YK@BW,F1B[@VOCRSYG"3B/+"+_
M &PA 0  N ]6J6,EO4H@P%,A/ELKO7R(($@=0PBYR= A(Q,^$ZM^FA#)S$$S
ME7V-BX*$DP17)_ZY\M892X F ["!CAO)1$%S!!J&+->&UR?%/Q/+5#8Y\U=$
ME(58' UKF(+32LR0H)(#QC-=6<#$BY@$ED1+1B9'TBP (X&,2&<4_242P23E
MZBF]:3Z3D781F,YG)^$94G*81*7=DQ&,9T>:>D#G+@6('W<9(IF)(AIRB9X(
MK!3-<B0)BV'6H]4/7))R;G#N: #$F?;_ ,PH]T_(0[49C[Q@,4W.;'&=Q&;&
MI3J<L2\N1<_QS."!7)/\3C[@O55U5).&KN>C$5$9$&0H"&3B\?UJH I[CFF8
MQ66V\/E@1NX;VFJ%E7.*8R!C27S..6#3A:;X6JR/L!1I/@OD4"!66DMCC$UK
MIBZF[MX%8-<)]HP+KS7(WJ+851\A ?'"N+N+8#5G'')#DFPM2E;>9"8N0+X!
MLM :'&F;=/.IF-<R+UC!.DI#^:S..4L#M+8$MC5P?. PDQDJ$@0%:6"KLL9G
M'/XR=6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;
ME6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;
ME6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;E6?;
ME6?;E6?;E6?;E X#$^X^<%>/M7C[5X^U>/M7C[5X^U>/M7C[5X^U>/M7C[5X
M^U>/M7C[5X^U>/M7C[5X^U>/M7C[5X^U>/M7C[1D2PS7,=T0 &483A29EGI/
MP@@9R[*OB:7ZTQ"CYLJ01/.#&B:9$Y'Z[^\6!@P69"6!F/YR&_Z*T6(N\7LG
M!:'!#^2R'6< G''9D\R>OB*$2*Z6,]B(; ?6IXNZ& +LAGK_ $@9O&3"PI!H
M/$_;EH',9#9L=(Z6L$3%1FSU^,,,D:7#UVF: 59Z0A #M@!UOD;^,Q,6+9RY
M)^?4:LP3#O80WW\IV\B1J6I[1Q-2 >5+H=KR7_"QR."9)[X+S%&H3%J9"<^)
M/@G[=! EF"<F=Z3X="Q@SCC2V6+MA-876KU_4&"O[RALD O,_O=T1(X,00SG
M'((0S8( "[ZB41(9VSKPJC9OL&0>)+@.]"&\_P 5/ -P_P S(RGP@,+$]P#4
MK7T4(!H'SW#"IDH*0XH2S//YH:7*&3.!Y\X2<B?E$*3G'BA4VEIO7+K;U?<@
M:C/^]K4I$<P"]I^<*+2B-&+9=^O]Q?$L%@8T[H:'=F%>[PA#9#B7CU7"[8H.
M44<]G#M:<PA81#L8$FF-6-W$A'PYC08-<F#4GQBP&# P+N0U! ;9I1,<!B&I
M,"6C6K/2KH,8@-.D^/C,IP$D[RW?/S+(W&!S$@YM7 5H+H<,-=S\8OB=$&3,
MQT\OD8H-V;,594#'^"B#+P:EAN=:X!%@,!@Q-&;,QC5$$AS$MD<6>E2&T1G-
M9ZX";/%;G&4QP!5SR6J!?&Z! 2 @U8S>],HR40$S4?+S-,X,N91*;K,\Y9VR
MB$2!HV#V"?X6S@II'Q?6]\Q)9\$6:W&.<0T2U=.!%. P-1A]Y"C!FE1PD',E
MCW;R!)"(#Z,,3CACC#ZA;"(T^,!%K4@S@  @T8X2Y]MAF@#029PVK[.J*.%,
MZ@!LV9A\NCIB2"[91%3 -6PG5%BQ)9H?2N!:YHL.@PQA]6< T'L$)E(G(N#[
MQ[*Q %\(<-,9Z8HMXG%WL_F))?)!B7*WW?OP0F."7S(FOE[*<  349 OA7:G
MLXX.69VW$Y&W!C,L;WX:I;/#5&1B<FH_M&RC)&8$,1JQ!;(XN\/"'#&)-S>7
M@&Y$[(4(-3X9B7!:NIPT !BL:X+^K^PB$NQMH\84.0P+-0D&#09=TPJOQ OQ
M@OQ@F^18,]8\HJ% 3 FN8C[]"Y  U.$[?U&8W(#>],,-$\G I^ZT<>"B 2&>
MV^GJP03  N<N:"7\@, A0)8$&*M; &XS\MQXK >ZIW (-<;T,Q\5Q",)< "9
MEB?YJ[Y5*"YP*06!%!BQ=8F+3B8%X7>!PN\#A=X'"[P.%W@<+O X7>!PN\#A
M=X'"[P.%W@<+O X7>!PN\#A=X'"[P.%W@<+O X7>!PN\#A=X'"[P.%W@<+O
MX7>!PN\#A=X'"[P.%W@<+O X7>!PN\#A=X'"[P.%W@<+O X7>!PN\#A=X'"[
MP.%W@<+O X7>!PN\#A=X'"[P.%W@<(D D8#,86!'QHK2+2+2+2+2+2+2+2+2
M+2+2+2+2+2+2+2+2+2+2+2+2+2+2(R0P9^Q\2BK.9H*DR/&,J 20S":M+!J
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M%/Q"GXA3\0I^(4_$*?B%/Q"GXA3\0I^(4_$*?B%/Q"GXA1JC_"9JOS^2.?\
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M\X%Y'Q<^2+H"!H!@7&+.V$&'<(X DK:B((P@6I%D1"NTL^DTV&U51[,D9V&
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M&+)$?GN^J(F 6;LD$VQR$X)U@B0-*:>,&P07CAZ!X[&. "?8D@SI+VU%4S7
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M+N &+ ^:XP<047F@#3H:7TRS5P8Y]+8.F,BSAN,NU50#&LNB$L<N)/\ ,_\
M<9+*@7K7?'X9!C %\(L'I>-W<(IX LQ]1H+YZ415],AYK9I;$4C()\S7;7VA
M@7@EBT_!\ZV8G#N1B7K@'J_#(]D)9HL&P^=@F=* DMF(ALM@TET_!0J &#M;
M9B4'#@<&%6AF&7Q<5P!D5 && CG1J%&!9AFUJ*EGH^2+,6&JPSK3HE&S69XO
M$,_R,38Z!!+(08L])&&<4=$ZT.*#+.6\YID4F&C,^$&#4%*9>63RFFP#$AA
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MATU3)A( QA&,Y^D08!@&$/YW'21B8R6($0+_ #^&4 UFNK8^\D9*(8D"0/\
MKH(4[^HD:X/[4J6>#\?"+1X-%^,$U"  DN <OX7X X1(EV =$N78>$0+X.WI
M^4=@!8,\HA+L B29/I$2\ESC_A 0TF,HY^4"07"?D/?*)58(B:D[CA-S._\
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MQ+-XMH],"^2Q@KV&.3M24? =FW=F;!'8',QU\M[506 P=P]<L./#(6$,"_\
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MM$]2]\JXZU5QUJKCK57'6JN.M4# 03@OCRBS!>7?Y8!%$.QH?E.:6(,_90I
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M!.P)V!.P)V!.P)T HA)AW1PK;<\*VW/"MMSPK;<\*VW/"MMSPK;<\*VW/")
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M*O\ L<J_['*O^QRK_L<J_P"QRK_L<J_['*O^QRK_ +'*O^QRK_L<J_['*O\
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M"$$NS^OXA#H%<%PBC)D$68$@5-ZGP3$LB !<B*N3.ONJ$6 W,H,&[Z@IJ*!
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MDU/=)!0R&9:V+UI ^:8DF-(S!(K3IC!\$^X>9_I=^YT3?5;-G1A%@@N 342
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M^<^ FN[S6J93%)G%\ZV^W<D! !%AFQXLRQFW+^B"9[5X?S>[X%A;;,*>C1Y
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M_P 7YAY7YAY7YAY7YAY482 0U4R:1_J****9HB(.3BY%/G' 8/D;DWI.SX&
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MV<2'"L'>]X& Z=$:NX!VWE!83",%*84+^W1!B&L:URO /JCH*"Q;#!K[89*
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M-P45T;JZ-U=&ZNC=71NKHW5T;JZ-U=&Z.,#<GI3?S?U-_-_4W\W]3?S?U&4
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MD%R^ J8<U$R**8Y&9&X8:3\.H-$%P&+&PCVS/1!$@V3@#XM?#E/S/B/(<X*
M D_Q#P;  $#3-_X'>H0I(@" [ D'S0BT4><=(,RP: 7:C37>JHO P"#BAJ/3
MFLIP2#"B9 $CZ-(J9E.A$(3,LN];P"Y52K" %V).7_OA$*""<J%S%'EO?E/
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M*<#C6<(V4KR&D/A\K)P#"/GOD::'! D-& F8D&/E\(U4*8( BGJ*,)I"<0!
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MWE1%C$DV.7?K1!.*6\T[XSJ 26'>]E$H"K2"@> #Z1\TN6PA A  3;^HAD'
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M0)IP&J+P.AR  H!+.^C!$CT3@CKGV@#'&3"'D&0) XEG;N"!$T,CM$ Q@4#
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MLQN.$[,;CA.S&XX3LQN.$[,;CA:A:F8$QW24Z)%Z7M2Y_J*0+O!BNF0K5L$
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MR@1DZB))+.?9Q(S JB$BV"6;Y<408(QL.0\N8(SSPH"#$-R[D P"2'<O=\T
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M&,8QC&,8QC&,8Q@.0,9;R2 4C(W+E2YKGHA*P,33C'\IBY,(U@U'F:-/(FJ
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M7NM2,,RJQ,S#0*".ZU($H6$BOAAJA0$8B0<WL^5(V=O8X<AR:'5[A"% ^=C
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M,/CJFDG4V ^E^JZS]37_ #! 4*<T>&^';K]4GZI/U2?JD$(/Z$?EW^(#%F?
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M" ARY'<@_P 9IISFPOCXSQ#)L&>8P;O\1)8$G"^&VXC%Y!%G%WR'N)^JRR?
M-B.&_A<90Z( RP8/W+)LE,EF/_50Q-BSMC31!-(,;_U^LCY"F--\]480P@&M
M=^Z30(!M,!IA/A"! O6W&]TW,^N$27U8[?<%6_0X5OT.$0<L <NX/OHT0$7^
M-O\ !$VT;A&5' +B1]SVJM^APK?H<*P/(UR(MLK&PI6( B >3\(A @&,&CK\
MV, 0VMAA#<0I$][W-@:@'P@!(#";!:O7]6KU_4S/%\NX[IN8VLV=&PHB$D2;
MX]'WFG9/2=D])V3TG9/2S0VC)N9]<)N9]<*W\<*WZ'" 9HT;%[61'"[9A_L?
MSR@TO#./Z?A-LX8N[N(\UC4?:(X%VPI]=JZ(DBP87_\ 508@EJM^8]91',2S
M$85B.U$HEY39G$M> @!#UG!^FNP76[VG^I!A=J>>]; F%9P[\K2/;,O(\]]Y
MH 07&E>.=,_]'DQ("&#@3412\C%NE@@"9N<_5?I&*PR;B-I^60" FO68N^G_
M !4CO][I_J#MKZQ9.3#/,?0)P[6%*VC#Y1'(C?[1!!8JL:=^O_4#@%RQ+NU"
MA%24)@$4SS^9Y.B1I!&@!( 'G[9L$(9$$0.B)&DO5& >38"7]'XQ-D)! '"2
MQ:&<'SX1+4CW7[SE4)>>4*0 >1PB9^+ 4T/CY==_XN?'67?^+O\ Q&$AB0F1
M%8$53]2>4.2[_8*:H(\GA ;!E9@X"[@5OT5Y[8A=/^H@$) 851@(DXV0(+E=
MP?SPC=R6!,^ @^<W ^PKC;^(D]CC,X^.^%T%PN@N/\!T%PB"#R_J$:8"",20
M][;B]$RU5P-PV$>*JC\PZ$*0U+,<)E#P%R013P+_ "K7?^*UW_BM=_XK7?\
MB%)TSE^$W0&Z-X=>4Y5W=425'MRA&9F+U(?>,,3])F38\IF38\IF38\IF38\
MH@:+KTP5JK56JM4&!:S_ (8]P_UXXXX)U>,A84[ZA=3H(L*>]HB,'Z_Q&JZ,
M@9\((""( LPJ5;;A6VX5MN%"P$FXA[Y,@?.M",','=C'C8(0),)<2\UK'E'Q
MI0_<XG#/(5A9I!.)%79-7D&D-[S5_P">%>[NBR 86K[A/-3!9GV?[]H#$C7\
M[H/_ "XRPHSG4EOH(A Y^&BEW&";##.Q=JU^3KF@K 4,\4UN3CR888T8'Q1W
M[0(M:C,WM.S^D[/Z3L_I.S^D[6 Q8#FD%64!Q!XA])8W$L;B$(LSD" [XX)F
M78(S+L$9EV",R[!&9MCPFYMCPFYMCPFYMCP@9.B$A,D:AN5T?"$ #T_A=#P@
M'^QPA (D8B0P'M](U"8HQ1BC% "]&7T A .";-M:L*X?.:$!GC+<>=O*' ?
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MGI#T1P)"2,&9).#ON,L4(9BT!(<L[F3*Q@>/-9/I&"#2.]^9=# HYNS#T^R
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M#M"&',V0R?SB25"-/P)U*+)+)&(Y:E%7)!<6&OS]/)=''7"W^D)T1G&^9P1
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M>H"#,V,85LB3B@8R &!:,2+IMG*'T#WM^A$ 2P(>L,Q!^NT50T!U=H].QPD
M._\ W\!DYH@1I$=;'/S"!10,VO3YTE307<P\M%:4I%#+/ 1F#/<QZRP3PPU
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MD/QL@"@],"G@B2I]2?/^'T>@0/A"=@2@4!*VCH!4'H%,OKV99Y=>-$E3ZF0
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M!]3#.FQ(,2=SFE:\0B)@"040P=B1G1$BSBYHZH)S\_+H=2Q F3C%0SBV93<
M&!EZL6T?3HG83P[DI]M9Y"I:>:^'W+L,R0SRT\GTQ\9-2/>L U:G/&C50#1K
MGXF;:4=ZHNK1Q>#K.>H=$#34FXVYS1L [K7..]G>DLA3"<($-N#!V@)^QN")
MUF#..3VS*EY#"I1A_4;H %TE#\1.+Z&2)+@#$9 AC-<CX8HQ.S00*,+:U@S9
M%$+@,]J/]C%IA$$&T;Y/5K=@@^6.8#Q7'01!CTFM6Q& 3K&3N]7R QMUSW-0
MV?%2[YP5DX;HN!=:BGE\H,,\V1X>4P68#/O?0#E6[D5ZRY']F4, 3%G=EX?'
M+9)YD^D&AZ<! 8'!D = /)JBR%&Q>A$FI I[\#HRZ,NC+HR(FH'PF9=@F9=@
MF9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@
MF9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@F9=@FB6Q-/X@2'V:Y$P^
M.>=D63  -$/Z#Q06U";Q\<.AG?) P )F"TL[<VT =$41!8-!!J  )EA3Y1RB
M8C*0&K&'C" $[C ':8#')[$:(3(P?$?>'R42#I >MI#^(\HQ(/!'B,O0O/G_
M ,M"0 B=>COC">\@'VXM2ND1" "'<'5W>L:O\/"J.$*Q)\0YP!R.)*Q S326
M . >V&)0!$,)!=V#$":XM&2#,N#,%@_=LX1,:&OD&>M:-6<DPW "'<#"<7 Z
MU$7 X&S^U\C"L)HWBP> U2TL+MJ@V$.L_P!\Y>W\T:.3W1?$+A&W71S=!."[
MV;#9'4;B#!)J TGOP@0)"9D&\]EZNB@&?C4_GE5LM7<LC8@Q. C*:I]'T@Q/
MBD/@YRM*($R3(=27ZS[H3?<9$%@.YLALZX.++(VK'\/H0 B"4"2-<#!M9.9R
M  J"](PQ<Z7Q8;Q1V+6XD%Y?-5G.;$XAO1[@A26,8NYQPQQV<PAC-QC*9H7?
MN/\ @3&D!Q+B?O'T;$(IW5/ F2!FE>E?'RAD!T@N7/\ &=F](<3FXG@1J]Q\
MA 8Q ,L@/)9P[Z.R%3SRD30UC-M)1@0$$N<?L5=;*ZV5ULKK9 $DD^(^#UU9
M]?Q6?7\5GU_%9]?Q.T :X&^$799 %H?/YZ6$P?13OY"L^OXK/K^*SZ_BL^OX
MK/K^*SZ_BL^OXK/K^*SZ_BL^OXK/K^*SZ_BL^OXK/K^*SZ_BL^OXK/K^*SZ_
MBL^OXK/K^*SZ_BB5<BQLI8#IN"^!QRRFNK(!G+EJ$4-(+,17X6!2]1-3\X_P
M5-1Q 4?')\J!QDAF#&L%376*[2C0180Q8,I,6Z4TQF  !PQ! R>,_L;0-CBW
M1%=0B24PT[VJF!S@)T^/O#'_ ,M.XL3E8(_XR:H4Z5 4B&5'JUU"%3J^,5C3
MT@P(N3@C))HV9W/A%('4JC9EIKBCII@.0YD(#94^* @<,]L5)S"G\W_M%MP
M#; VE!DQ?5I-]9JBIH7,$T:AIK94/L#YA 1#L6^V%T?Z71_I ,P8&Q;N$%7S
MCGQ]$*X,LZ.H9C%$F0:C\U/H@ D9(.H@%SC9  &1@!-45Z<4Q(BK]>=\*A!0
MV$)^+0VD,+DT EE@'\\'YQ0,R%14:7.(0/)9:&'J8N,]W18#('DI5QV0@&8/
MYN#ZR4UP,2S+_P!;0&J.TA'DP!%G;LLJ!LG?W)3N6^_90"07>[(&#^X1 @*<
M J>UM1'JB"<4EL"8\3C9$98J6LP^FK'!8?0AA7AYAX%W<NAASADPT+X1NR$N
M.U))?^U\'_66664@J/KD?]<V;-F^<V,A:ESFL;NY?Q>Z/<V@;5_^;-FS9LV;
M-FS9LV;-FS9LV;-FS&BJ UP;($B:IL*9Q#85F'S08"/[*XMZ0J#"7?1QG2\,
M"G(:)&)+SKC&Q#(;I/@-+DDD[Y%LT.@0V+"NK/D'B9:JH<S2U\L@=C&*PI\1
MYPP;Y;%"'9@?(+>Q"]K_ ,N&$!B#PJ(XD8,#A-$W8)!X=L,)>[HZ&JQJ]X-)
M:N5A-0"8T09T'3J@T(1,Q5]6P=F0(YL;-#4BK2[@43\4*L$XV4^<T&)$,59Q
M=+780@P)#W9V-*9</UT&%S0,.M&:B)@<U HW;T1$A\P'$^8]#)I4/A_$[K]F
MC, NXFC[J$0-BWAT_3(B$F\N'I TB7%WYOHH9#HX)_7J4\0;@AG9-7Y)U!,^
M9/-_N2B2$@&55[S4O65' P8NP8G,'-!N(@S.3#2)QM85Q9 R$(P-07V@M@$8
M#)/0"!E>0(3ZS#RX%Q[OLU$$TFCNBN11H3D*11%#@.K&OWPFX 0N34,V?E7Y
M7[Q1!1C&(^")9QYN3^FH#   @6^B&4H\@0'S&W#.F>%:@$&F-&8?(5:$\TM(
M$T\&IKB\('"3$G"!7XZ-YDI%@AC$.$U^)<!I*.^$D %0N6MQ\K]4OZI?U2_J
ME)JFU/\ UEEEE@SMD5#N]?\ Z$T4444444444444444444440Z'8>;%8K;L7
MG\(Y<F8#H>*LQU01'*VN#%F?QL&35>")-V.!VLBF#@NX((/#753E:! $XP&@
M>_%$1+M3$:D/7RWM8(83YP>)^'="Y5ISR5+1@1)CJ/\ S,Y"#7N)'9Q72.5T
MCE=(Y72.5TCE=(Y72.5TCE=(Y3K[A.ON$Z^X3K[A.ON$Z^X3K[A.ON$Z^X3K
M[A.ON$Z^X3K[A.ON$Z^X3K[A.ON$Z^X3K[A.ON$Z^X3K[A.ON$Z^X3K[A.ON
M$Z^X3K[A.ON$#&#ZN3LGI.R>D[)Z3LGI-##.;?7_ *=1I^C_ +G%P0)9/R;%
M/R;%/R;%/R;%/R;%/R;%/R;%/R;%/R;%7/CE=(Y72.5TCE=(Y72.5TCE=(Y7
M2.5TCE=(Y72.5TCE=(Y72.5TCE=(Y72.5TCE=(Y72.5TCE=(Y72.5TCE=(Y7
M2.5TCE=(Y1,5/K^K5Z_JU>OZM7K^K5Z_J!S.\/\ ^G4:?H_[D!,BIQ3C,;A.
M,QN$XS&X3C,;A.,QN$XS&X3C,;A.,QN$XS&X3C,;A.,QN$XS&X3C,;A.,QN$
MXS&X3C,;A.,QN$XS&X3C,;A.,QN$XS&X3C,;A.,QN$XS&X3C,;A.,QN$S,;I
MQF-PF9C=.,QN$XS&X3C,;A.,QN%<&Z<9C<)QF-PG&8W"<9C<(;)!KC&_A-ML
MX6EL3;;.$VVSA$"<:5?M?_3J-33O]_WA$+.R[?I=OTNWZ7;]*&+<GX3,WM#(
M7E_OM+)V3TG9/2=D])V3TG9/2=D])V3TG9/2=D])V3TG9/2=D])V3TG9/2=D
M])V3TG9/2=D])V3TG9)S;[P])V3TC^'\E,S>TS-[3,WM,S>UJ>2?O3KKM^EV
M_2[?I=OTA@YTXE]<>OLRWI&6])IW,M&Y,B8@T%-:[]?_ --^1_@^Q,2'\2/K
M_7;9]8J"G\[K5=@KL%=@KL%;0*/EKNNP5V#RGL6[?)37Z?!30XN?@GN2;=M]
MLFV>!].FY?7";E]<)N7UPFY?7";E]<)N7UPFY?7";E]<)N7UPFY?7";E]<)F
M '0#A=F_B[-_%V;^+LW\79OXNS?Q=F_B[-_%V;^+LW\79OXNS?Q=F_B[-_$)
M@)%28#98*WN_JM[OZK+G8E66X0>!/)P(+MC7#5=[<KO;E=[<KO;E60U_CJQV
M*L=BK'8JQV*("Q]%W!=P_J[@NX(&#L\@JQV*L=BK'8JRV*[A_5W!=P7<$_\
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M\1 @,$!@<%" _]H " $" 0$_$/\ ]6Q2F)-42"7HQ2 !EC 0NV"-)+03LZ%
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MA&"OR[YO2F**0 *R" WQ#UK1@@@ 6ZS-);Q:J&'6\%H81K>,8A%ACV#NP=$
M2P AI%UPTF3D=JZV+8D&HQ$\..<-5"F XI@QMC2VZ$.XFRE0&&+ LVXJ@)A
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MD!6Z^:,$N9M.+XOYM9%,@00-J =GL]W3]@S#DU( <AVB\24^(P"E3@0\ALJ
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MF+Z#XHHX 48D",Z6I3LB&!,6J/<M\%,A<<!Z.[7FF()PQ**HNH&4,7[V-;A
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MP2W "B.*F&!I6L5FYG%/1JD^/32,IP0PH$@8UG*= ?$%@O1I@9N.L6ZXD!@
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M.^R:Y:QQ%LKWS-7,GHD !4-8=6B\]"%&2]PUJUU';(% 9@7$B"#]Z,U0CBP
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M@729H@V& =Y##RJ'0 N%@:O]&"]%"!/1'4:7H< X022(<B2 M>C79ABS6:@
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M:1X3G$[G^& H /\ 1HP8##OCUFA>L5E%?RK4JTS^H7=[N(H[DNGW(YT4B'=
MN <?_?!.&!L*/$OU:R";M5P 9[#:!\."1!NX/?Y3&EC[3)8"F/US)3 Y8OXY
M;_WP(3@%Z.7RR;IBBPJ*OOZY=319S/,OM$!+-+TF]O?A=E_[N#!P1"(JDF.!
MV*8X'8IC@=BBQ$!B 6:*6(S?.71@ @@1!>L3TPM-JL)FA&G.J($F:]#2#GY4
MDC%,FIVY+,@'B!86*8X'8IC@=BF.!V*8X'8_VR2R2R2R2!C @G )C@=BF.!V
M*8X'8IC@=BF.!V*8X'8IC@=BF.!V*8X'8IC@=O[,<#L4QP.Q3' [%.W(E4"-
M?_AL30$H'D$LTC%8UCR@!+ N18)C@=BF.!V*8X'8IC@=B@2 #LLTB"&.R8X'
M8IC@=BF.!V*8X'8IC@=BF.!V*8X'8IC@=BF.!V*8X'8IC@=BF.!V*(,3&K%9
M) Y8 G&(W"<8C?\ LXH\X($H"= 2B*I;'G1$*@&J(:AU("R2!J!NG!H73$T!
M/1?@%5I*!:$>B_.1K"'1$@5(0+TE"F)T*_*1!%01J"$X=GG#_< F@)T!/A$$
M5!&H99) L $ 30$Z E$$5!&H;^K$T!/1,<#L4QP.Q3' [%,<#L4".Q1D4QP.
MQ3' [%,<#L4#2"/3XK_Q6.!V*8X'8IC@=BF.!V*8BH(Z?U) J6>B9B-TXQ&X
M_AB:!TQ%0W^X('!@9=H;%$&H$-C"(Z@@107T3P<$;4/]F.!V*8X'8IC@=BF.
M!V*8X'8_PQ- 2F.!V*8X'8IC@=C_ ,8H$,$FK?*#<OHR!8@8NR(B[G7RB1>P
M-OM.,1NG&(W"<8C<)QB-PG&(W"9'-A1F[D%9_<>UG]Q[6?W'M%HL;9>TXQ&X
M3C$;A.,1N$XQ&X1:#B8$BMKXIV+NCL7='8NZ.Q=T,!I#G>8[E.P=D[!V3L'9
M.P=EH=D[!V3L'9.P=D[!V1?4-PG&(W"<8C<)QB-PG&(W",0QQH=$#%9[?" B
M00-6^4 -9.3>T(0 R+?*>$[P?_A$L"</:$*=[:S<<>@@.XSR30@PQ)T'#^()
M@5-L*5V1-T?(*<8C<)QB-PG&(W"<8C<("*!N$[!V3L'9<F^D/V'L0H$@OI;0
M'%:TUIK36@&9/2?2S LP;IF(W68$ =>&'@>D T!$=Z,09_@%I")P_3^H$B1@
MW03];HF ].P70_"A<$WD#I'=Y1G,N7WV^ZFB)@36..@3!>H* 6R+C.9PHA@U
M;PWA,L$4,.)CY0G&8YGI(V#%F:\_$0\3U1&X.U+]3?I)09?5^:6H T502(@&
M )P+^:(;+V/5V\H3.6#C$5/X-T%I+]IU8)IX?0]![Z[@N;.=7/\ NPZ9/+1N
M$6%G]E^OZJNGR5=T^40 "@MDT=_U#D/EXWZK.['TL[L?2SNQ]+.['TC D;]4
MXQ&X3C$;A.,1N$XQ&X00 <,U(<QO;JA$EJB&/7D?*)$P2!JI; "0^5L^B$0X
M+:_:D;/_ &):2G&(W"<8C<)QB-PG&(W" R1N$XQ&X3C$;A.,1N$XQ&X3Q(G/
M-.,1N$XQ&X6=V/I9W8^E NSXCT@+#HB.((G#"?X8=[LC!,%X^3_N,!-0W)N>
MZ(-F=Z=@?EE(2?DHP#.;:L&[H9 P@/I3[POG55SCZ6=V/I9W8^EG=CZ0>#'L
M?29B-TXQ&X3C$;A.,1N$2&,BF/I,<#L4P)J>R$$:A.#0@KLO^,0S@P[7ZH$2
MTSK[3\!W]I^ [^T^$<ZH(H%<_:?@._M/P'?VGX#O[3\!W]HO&;XGV%G]S[6?
MW/M9_<^UG]S[3\N=4_ =_:?@._M/P'?VC3,S*#/59?OZ67[^EE^_I9?OZ1 @
M$D0)3\!W]I^ [^T_ =_:?@._M/P'?VGX#O[3\!W]I^ [^T_ =_:*2Q G^IH8
M XO^A$,D#G5/P'?VG"8&_M.S[H=Y-H\YG_X1$A"(\%W+3]V,*!ITPIX]80YB
MP>$)<6C[* @01/V/ZD8UT_ =_:?@._M/P'?VGX#O[5%X\?.:SNQ]+.['TL[L
M?2SNQ](G(BCQ_4!.>=PHF [4+^RB0DC^:3K\#^H,Y#%$PR2^P107.4S5,(,F
MW.;P^[B[L9QH(->MF65W" @ 'DHU,)!Z_:%(=W]T1R)S)888U10S,SD'MS%&
M87(QJ_:#RA18E@YF_4Z)<^_S^;! R%JDRYHB8ZL$<&)-8EOT\J9=%PV?&TFR
M,ZH6!SQT?CNI:G^Y::Q>G3,<JC$/FWGS?%&)@6RS0D.XP^44 />N-QIKBBDL
MEKG?#')/P'?VGX#O[3\!W]I^ [^T;O.)_J4C*-;=1S1$)%&.'\$8UT3$3&#]
M;BZ!8#C_ +0-E\I^ [^T_ =_:?@._M/P'?VCD! J/ZF1#E!\I^ [^T_ =_:?
M@._M/P'?VA<!@ 6?&\IJE<3/V-T3L=^<\D$0?^" :>@:IKHW>GA.!<WJ7N:+
M*[CW[1*->@L.[(B &^OA'M5>4_ =_:?@._M/P'?VGX#O[5 T'C^@J&Q"RNX1
M*J_\ D4*=($"X-&^/^,9I1#] W/A / 1[9/@^6Z+$.:&X&?Z=K L^^,VYW10
MB!FX#G?"B?@V&OB=$^(3EM:]F3L&1B5H=D3DQ7 6[7KODLOC3MXE']8]Y++T
MXZ#X<7'/+079.#0,"83L'9/P4>@Y"?@V&#\]([(#!Z#DA]M%6D\QP[H$:3L3
MSE$6*GQRG)8$N8F)P4ZB":X!^L:876$'TL]EE=Q[65UQY197/V-5E<=N>UE+
M*KSM=97C=97<>T4:/$7Y *R-Q1L:Y[564=CQN^2R/-,=,-;+(>O5D8[@AAAR
MFV9HH8G(^LZZF @!-6.D7KJ$9W:;]F[=(='*J(L!B>AMS(O_ /"!Q9>73Q#T
MY5^DC%GP PJ7Z3 ;A1"'IBX(/C$W&R?EC5B6KI77A*/4#:87,>CKE^?2R_/I
M9?GTLOSZM^)N(-8S^N1?)Y/KDK*?XXZB>,^4YBJ$?5_$PZ+"#J)%C,9QZ5"N
M<9:8Z_*U=JZ?:U-J=L(UG):FK<O.@(E  P1-QEL_PUU(S:/?RM;8KDQP]]IR
M624[!+L["CF0^'= H !C[$<P1ZI%XK)[0$#%LG3!85%:(W?F>S?U(TU@'-OS
M^')J2>J=:9.7RY@K)9H)IAL,NR(.6!,QF,L*BITQ1*P!Q@1V&? FO2\M\Z+*
M[A,&:L#KSTB N 7S?SO9$&_,MG61=N99E40<;C[RFPW?.-ZB_I&8P%GI2N2(
M(,X",*_P#L<''PW:B#0@&R%W^G_WF0->]-V+)P.T'K?;F*>6-'%@?Q$@);L?
MGFJ8LV%H@1%!GTLGF6!:)$][/&J=@[)V#LGX,X$:WRU3\&PY8[%40---L RR
M^Q]++\^EE^?2R^Q](2 ,001S]\(D@Q@Q0N]D!BXQK\/.;QG1$<EP:;6@]OM[
MMF3ESWFNR_V!P0$]C"+,/S<I^#84QT0,V;#X3\.<"!B<O11F, YEFWVLOSZ\
MK+\^EE^?2R_/I,I<-/?*3#%V#;Z3\%6IKED<\D_!>V'3ETX6=D<@9HL!&,^=
M,TSB.7JSH_4=^O*YH1=WI^H@QWE$+]O]R$A9\'MEY$71F*=>T7LC$.0^L97C
MH0Z8U5@- ; W?K9E[0\"PMUZ=$<0#)EAW?4;BE$\6:L&X4[!C;E)T3L'9 G$
M!MTI*#886SMT\>EE^?2R_.]/O)9?8^E*!#BC_(9<G[<G- QYSE44M2//+H\E
MV> '_.OX@X@1)9K^?^,^<; O+ST@7P4\!WB'.Y;JP5*+9^])UJQ)*: T#J]1
M+T/*IA"")#4 !Z/):W&&0D$.987BXKGFLK8>?&"H0<+B=[S7\O$';66#3S!
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M=H:X;HCD)$4QLT!_G9"F0"8["I+ 8^U2P'T&]9U*;]73'E<T<** BO1^=$3
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M@_CIN(I (+.'4G;LUT32U:#AQI+9H8< -K_=@)$T: J,;-%&+/(KAN]"$<F
M 3@0((#FS=,$, !B!OVCO#0I7R00UCSV /ZPIBJ9(GY<SG5T6SGIEO?Q)0((
MZ6)'!2(%4;$8!<0UCX'XIH@@5OS"Q::H'(#41AMYTR*<9A7@MA$'&*H!F,0
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M^>KBV8!3 (+&&$/+=R*S%YL8""#RXJ;9;TZ(!0.)>>.?<LA'94]0V.&)ZWA
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M?7-?ZWN!M_2%M1!ZL4"2>7E\><E&8'9I!I$5ANQT37%0)+B@MAEU$P@$8DU
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MLJIN/'5$3?8@?*!22](FG32YFLI@)(-;VZC;M9! L6)DWN':X+5H#=%*'//
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MF9;!&9;!&9;!&9;! ]8:!ODL[RL[RL[RL[RBCN_,P5H<Z(DO[W ")'\L'W]
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M"K.[OG7*708 $._KF<[Y50X!*1C,C)V$C (Z&#L9H2^#/GV1H 088';4 ?\
M16T(O&@?X**,0^:)S0P>\/YB=4Q%!]Z71GUM@GQ@D#<6.!C7VR;<@.;G/:(
M(Y(!AQ$US3B/&*M+%ZVA%0'!FD*] G"I)6)$#HFXMT )9BB$PXZ!Y!'.J$&2
M0!8ID.U_U"AX+ T586N04V\ EKL,9C9&80)U$=7+HGH !+50^F"#A#B"1MRS
MHMP/-^RIO?#@3@2" .8.@00<,/FB!X);?QX=&L$D"TJ-1&6 (>GA$!(#XIR9
MMB>,@I)/H7^4 B#+&W-F=T(VJ%G*)C;#0*R_K#5D6O2G[&:#4"^'.Z"Z"&T1
MZ2 ,WR]H Y(JW]QOT\(=X/SM[S*-F[.-S]]D)W(R<#3#!KYL&0RTPDEX:#4L
M7%]2G&?!-' ]L61.TP9=;96Z((@B='IUYFF5B&8 S=LC'2>BQ(?/YO7U24;D
ML>D<WU6A;[BG8ODJ$#F@]>] TR\#]6AL([(O& 2YFU:T[7R>,D/CA6WWK2:D
M"6RUIICDLMS>FLTBJR!M]HF $;:/K3#."B:PYT]HC02^)J]+=C1#)# 1DSB,
MH;0LZ,)X.$@UFMY R?LG"!-BU^FH>[TR -G; <.@S:&04P  W>D--?5,$W/#
M8BU)N(S;P@ L :]"VVF10KNQHJY@$8ZY20[ET>)!_#/[8,QU*?D@*4RN\84O
M3-7H9.KT^WV5#"\L\13/"-P[J"@UOCI6*2-D+PE&R!U'S](V0-N5TZW0(X /
M#AF/+G?$#0<3!8Z7';$&Z9 $NX=GK>N%]$0<$"&P(<16[/3VADF(.GF#WV8(
M!! D)Z-@$,N!!#D8-TQH:0R("[DD5H_X&R0@#1&O6<$)Q<.Q=]V=B^$R39&;
M+9RY H0U&IT-8N1$7_'K8Z**S"^**RW+.J%)9XG"/.N2:&I+,X<DWN]_0".#
M0[MGH[.YAZ4HQ0- "?B..FY<'G?8X%L32C(8P :2S4+1+M6WXF &$TC/:7H=
M" R*@0! I?I75XSD)L#$4&HI2&@R+9H,&:6Z=C(I@1T0@@9EWUWPW+RC" 9Y
MY.,5S38B4$(? 8+@YX[PU>L)F+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+N
MF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9
MB[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+
MNF8NZ9B[IF+NF8NZ"QV&3/YXZ;EL]IN6SVFY;/:;EL]IN6SVFY;/:;EL]IN6
MSVFY;/:;EL]IN6SVFY;/:;EL]IN6SVFY;/:;EL]IN6SVFY;/:;EL]IN6SVFY
M;/:;EL]IN6SVB )CH %2TY(02>F=;S-23 '9[X%2)QDSW:N NGBUPW,VZ4D@
MJV- P+5M5Z=Y!HZG$486S>UXG4_]$K9^VW3Y59T06)8MVYQD&P7 '4&A]0A
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M@M>W,W0RQ<F6=9-?3B'"&V-8$:HIH'WFN-=BC@&)T;I2N=(1$"9@8'GW$+:
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M0& #TB][5JSBR(5))(%B11P\C =1@1,(AW."[4N&?KT0#8=LA8^CB>[(%!I
M. # QK;AAW<""[&6%32SL>Y]I <@B07N'<];.R"2!PNP9HQP-/A")&# Q6(&
M=W/"@1 6,5B-,FZ0"A@LT; 1G4Q)?5B@E>Y\<.CM_BR+(8>QR43YG SMY8E/
MY(L9PL7IA6NHH&*ZCJ*4KG,(1<=5K9B< 2*"8ED&1N0$7#'A(LS!'!=S>OBE
M1=B:G#'K+]L$4- Q#&*QWR)"G$4.]7,BS]\S%R'B?#X6>XT0QA.7T1NGU'D6
M[=RY^L'OUZ?+HO4!C//3(QL(%X[\9$-N3LGC_P --1@&<DZ@4\*DQ4%!]<M#
M)EY1:K2!Z3Y/!%B&N&I/XF+@\(!IM#9;%U*)<6-B*4>.9(<Q-K0;Q$;P[C&H
M<2ZZ+=9^4#>X;G'0<"68H.:5=,3T&8:)UPJ,J6#R*=78?'WJG&90[L[]G>#A
MG9 (>;X,_!\RJI*3@XG&"=4XA41;IW_"KKVTZ+E 0SG3TJK0TBAR)J-/",/:
M"X=AE29JTO?)'+D%27%8QJ6M?"B$@=3"UJZ2>K!$,%Y+%B/H:=3B%=:7#LT[
M6'*E2(.06(!;&?FM,BGR9"KN.7ONG!%#O J;2VMP,<S![I!%* "XM%W.\HP
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MHU>:7K*(APP5 &9C7)F# 50C0<'\@].BN; "I<13Y^:F00O'-0AF@EA=Y+(
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M1NCCX8=7C% <P$SV'X\UCH@(@T-?6$89(!^ US8AO4P84?7J?WN0N=]9^[(
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M,PC W:_+J5KD$ N'!F:V=QLC"( B<3F104Z48H#DAKW?X??5Y14&+P 9+OB
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M/F" Q <UK@/&-4XT+M;P?6:">8\=6.[G&4 %W<9^YR9ZXIJ(M"<0S?F ;!%
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M:@^20M'8^T9L.H%Y,(9Q@6^Q.(3Q0>H^RC):0+ZMC'&0V48,\$V?"+' YH
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M&V$ ==:B /M^AZQ=\$X]:'1KGRP]H)9NV&6?XNR_\+#@2]+,_P JB)V ;/\
M40EB-OE  F3LB&0,";"O7)!QD@"YC[028(.5.X/QT0-5LP09Z_)66YT3]0Z_
MA66V3+;)EMDRVR"_ AB[AK,GZ=R_7EE+<PE_?=,7[O?=$H=(&N#,:E$SEI%Z
M$UGKJLIM736S]46H#1G]#NLIL/:* @#GIZIW. ,#^JJJF@'=-^W,%G;"L[85
MG;"L[8482.78 V<K*4PO]7[%93991:>RK0R<#;,[)D,'0>:'MDK #V;H8,
M^8C-P0-V3!9WZM\K*/T8:LCDX LV7*KAPKAPKAPKAPKH<Z\S6CSR*8ZU7#GY
M,Y<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<.%<
M.%<.%<.%<.%<.%<.%<.%<.%<.%<.%:/,<ZE:/.7,*Y*SCKYCZ_@_#;E<<EPX
M5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX5PX
M5PX4\!FC#Y7,_:+:ON?:ZMS[GHF9]U"L'-CF[\QNQ;%IBNCY6BLUE&$2:->S
MFQ+Y-7# G@GOY0<2S9E"PLO_  MCJO99F""NH^4!AD>>D3&&R^X\99E @#=C
M_<7NCT & 6<"^!1*1!U<OY/D(R0(9/N2X[ODH%QBT;9]UD>$&"1-X-= [++[
M'TLOL?2R^Q]+0[^D:8!I)9B6:U0LK>?2RMY]+*WGT@ B*\_2:MV?X0C1W0UZ
M -F]4'%F'4!J\?: X-34%]IX*H% G ,%J]@ZSMZ9V],[>F=O0B#D\4<@.Z&9
MMA)SK/'0-!W4Q9PHZGEI8902XS6,#W(W9L@B(-,3D9R0.9&D..P?2=43!!=Z
M<!^$1,X(PXR!MI'EXVD1U(+P-';66#:83BB3=R3AI^R):D=GA%XY,ZZ8HDJ=
MQ11@)Q4R.YRI#]"FP#9$3+ #040&S@-BWI^6LB!(['U\7JB"S=#WCU=?/8^K
M=<T,9^KUS-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7
M#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7#-:7
M#-:7#-<P#\@]F6EPS6ET!^_"Y$'X;PN0!^7\+2ZE\,M+AFM+AFM+AFM+AFM+
MAFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+AFM+
MAFM+AFB4Y.P!9AXU3_UZ+,/'19A01@H,03Y"<'J9=C&P$6T1)CT?UF=T!2V[
M^DX4/1 0 $1D?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?
M)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2?)L?2.P@AFWHBP<!L@C1\
M=J)A&6LX#\^D0 %S-*_#H3M6>>]=J(]M$VVG_IY!Q+G2@'*>F=BG>-ZAV#L'
MK$59 S %<'=AZG!$4!9ZEFTR?+8)P1$^1O+/T1QSAR[ L'A$-0W5V*#U+&FA
MG#=_:?,&CA]M:\[  @%P1%C@$X&PN%.K& S(<!820UST=%0!$M[0 >@N@@0E
MA%'5_P E%P<9V=W6DS#5-D4HI*5%B783LPE""01;6U45K;,L_#8=4!$ LZ9X
MWB<$P@,S0SQ.D(B WJQ3F)QY+(X-D0D<?GMY.@&3 WS2*(X+G%SIK\%"ILQ>
MPLTXR_UA_F !B]?2>>YID!\HS8TZW>WSYBAG>OSI+[B'**(,<(Y7&I?5!E@>
MX[<[,B!(()T>0G@0:3.TCZK[0<_PFTT;*2$XH P!#&C'X@993=:VR:VR:VR:
MVR$(,!ICH&3L.Q])V'8^D[#L?2)@$MC(^D_!N4^ZE%"0^B<#-#01AS+NB@VC
M ^UE=BRNQ978LKL1H' 3Q\=4!H>-/I/G@+,&[,0N;)S9'1/-*8] W(0)Q\23
MT=' N\:GVA,P7=4)4AD0<Y<.RK]D2/-^C@=O:S7.JS7.JS7.JS7.J$J+Q()\
M<C1%J#;Y _5D7. ZM 7 V0;%D2$X"*!HT5Y>N:<8ELBVH<_6Z?@W)^#<GX-R
M?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^
M#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-
MR?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)
M^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX
M-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W)^#<GX-R?@W
M)^#<GX-R)@;@:"='B8*LU([&,(+""C)AFK$?'OX.Y$!CB'\)P8DYB1V1;Z.\
MQ/P/C_IYN$1YVQ^&+)P0)!AIF^'.J?@5(9V>ML- XT=5 V80U;N#=O#HX 8
M!!$[MFJ9'DO1X/OR" 0""&:0PQ@5WC,H0NR4EH#&M#7KK@3!US7,Q&'4.U44
MQJ/9F#U'R]]  A( &:8)Z8>3@@DQ#5JH3V+,*V"+@!V8C(YB)>G8AEP9+L+L
M#3"D>T]X( $F$ FPO^HJJ!(9SI3J8R-("" '(@0V!@"SL3EFC3)WJ+7U$&';
M(,CK  #$)"\#/7*:HN  <DAF;V?E0*#I"Y(-69A QNJVO.<$1C^S1<&G&^52
M^UX/@+:"3?\ S,O4T]_P"<"2T85?]M-2C@ "HCM28RQ)S0!/6UIU:/>2L@AA
M)#?<=5F-D < 1#4/P+H2NDQ^6\A"YM-\E-AD$N['NRY 4]0<G'=(6./0'V?I
M?88M[34, !R"LL>A^5^4?2RVQ1:,:6![4IT1Q)4$AVQ):E>U4 H:IBKUK3IU
M>YD-[MVIUO;"":VAFNXV?9$I:(?*")]='NLZF>3.IGDNJZ00V/,)1AH&S  .
MSZ5RJR:"!+94%."*% P[RT>#K\NI !LW:WSJB:6X".%4X7K2O*T$)XCHUVIS
M%$0T:SY')1P.+18SRN/P$M& Q!_8PGPLEL5DMBODH,=D"/:LQ?M\IA@<L(KN
MC !#H/%1&9Q34&YJ//P>D9HPEQ8AP&#ZY$=Y>J:#2"<#&?.E6!4@T;#IG3-S
M59?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G
M19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G
M19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G
M19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G
M19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G
M19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G19?G12H6OVR0C;2Q
MLQ$.*MLUY=D0S 8.;%KV^!8/H7L.F3\U3X AL;8Y5GK*:UFJQQKS-CG_ -/,
MTMP6IC'I!(&8/#LTM&%Q6K1GD%M$5<,"*DSYJJ:%K-GSJ:*I""!<;6L=9@PC
M&&0-+L_J\M)9#$PXR 2U-N^"&#"T%!.Y:]-NX@K  &T<R*'2PW@.L1,?-,T;
M6ES 5,DN+:0Y+O@3F!(=RPQ!8&"Q:R$&B0]1#%JM6D/B@1,+AYIXWU-S(JT]
M0@AF;J^F3.*LT@.)M+//!G9P#$NTFT2>92I9I)U-VNV+39-+0&Y0,!F_A"",
M??"XWK(Z43A79@2V-W?,4LUKFN[UGF*IG'YSS7#HNT/^AZ<!3='+;M]IT=KW
M0D&+%X=P!I)L3X*-$<!:D.VV'7(,@TC+6K]T"9@QI\=A+]$^R& I )OTI+:%
MV"-0<B+7S#W=K:%"O #H_P UQI@R?0YQRV>F%8%L%0+\9.._PB/\'G-1G[A]
M\G1N7'V9I,>)"$D%3<!^ZF:K.&^3OE64UA6KB[W$-'VKSC<6'.K#)%LR+BHP
MYAK@<,L26R=S0_5PB@Q:-)H V<;HQ>.E>3T04!J @AJ]V^;LG#0T:!]L*#I=
M:6?01?IB.H<32!&4X!WRZ9/).7<=AX/?()Z'$8M?-SV=D?@.([OBXQ,"]%>A
M)#:'&U?J4:)<.\=:F&_$S.P891U@Z!R68BQ08R&G"MKWD-PAEA!.=F=SUKD<
MQQU5:W70]!B$0J(MT+#SO3  < =JZ1]LJ\0<L1G.)>)/C(Q'0VK=G?;%'% Y
MFZS\K>K\"S?'I:*FH22):8I1E7"&AFDUG:SMNZ9 B>"0;XTDXID3%*,W@M*(
M=A+MJ"#TC;)!B&&&KTTL"LOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++
M[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TL
MOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2
MR^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]
M++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#
MTLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL
M/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^P]++[#TLOL/2R^
MP]++[#TFZ4R'P W6+&J# SP1%C(SKC753@CQM*L]<GH9Y%+U%6O'3:44T5>7
MJPB*/K1T#,JSX?LQG_T^W22.AB7'&B&D#R$ND/3IF;:4"$8I L:$:589%.6H
M/!0%D/5]#NI_!@GI8["XQ4YB $!L!.5STLB# /V[96J'82C0)$L8APXSZ15M
MT>2 T6G&NI:*IBEAP$2[&DGH>%PE8A,&_)V 0%$,1>')- PH'IJG,7=PS/%+
ML;DHQ)H0-6SQ#UP;J@L3&"Q)QV\S$)R!@@R W9CWQR3W8F =YP^<4T08FI8G
M-P,M;(Z1LPIE,WX 40$X $ #@"I>\#!4>OE1,9/*H:D@=]_E>'X7:'_0SE#D
MEND<QE Y>'VCX1 T8BHHYG:>,G@/,4<>(AB)>$(A. >U0 <+>;D2P9N0-^C?
M29</(O7T?-VL@(&YJQR;,@G#L14S(ZRXQ0!(JI<9MA:E>[M?. !5R:7+@[TA
M.O!S%7+4@R6;-^JJUM61W^T[I9C&,4U?/J@&@GJ'F-K%X>B !SN :&]XQV6=
M;X?L.U7JL[9SA0?M0L[[8D'N1UU6=41O5[FVT(A,I<,Q[G6'K0M#)@1C.Q;S
M)WC1UQ>E"T =KTR=D0,&I.%'QZ/I9&,@2'782Y%"XTE[P7]H?HSJ6=ZN$_,&
ML[!]ZXC*0R+CO8T >M@U&;?=1,X@=<1$U'94NSBS=G+MUPB91I=J8Y;4EZZ,
MC )4&+4J?)6(,C''6XJ.E2Z"02Q<FO:^-J/" ]%#&CG"[4&=D9BZE289H>7Z
MDQ9."]S1)8_/B8HC7%KOYM3DLC&+QWEHA\2B/1((,+AP+=GHT.Y3X8ECD;NU
M\LGI"?$F6[]=9<NU)3F</1_,5R,EA;-$GNTN=&T%2VL15#&D"2%PS@M?1Z94
M1YSA$',1F]L>R*))@9ZOD[,-F">"\#-J9TQD^4\[YL1E0E\!]IH%BP?#E8MM
M?DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN
M3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-
M]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWT
MN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y
M-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DWTN3?2Y-]+DW
MTN3?2Y-]+DWTN3?2Y-](Y@+MDVEL6S5,[N]FI]MR$^2 8EQ:N%3,ZH8K%6CN
MT169T<0Y: ,A^!?A1RD;=0R'SB\-7_IP UDFE;88],+N0,EP# @"&(&\:,3%
MD7(!JEA:^ M9LV0( $ABC8T#A0S=JB[P <N) F]9WSW9/!P>JL8G= -R <D!
MS%9 SZ?1G0$/D[4F)QO*:^4%D6+5Y=&##) NU>P.QM<(Y27+)O&I-Q/P441)
M7MD %AXK#(.$B) =48DLP6:'HR <T@7B'$B+LXUZ2GG#FQDE]VFXM@2J(#QK
M4 Q G&,D5%B)@ #0X$WES3%%4L 79S8N1W:K]"R"87R,B2_@_:.6*7<1Z>+T
M00&39U5E6C<JGJ/(5&CTNT/^@@@7!\(HW0,1!&,<E : () !BN'(1(1A)G[(
M/=T43.0!V ?6W7=&.1<@:#5_1[NF1+!LS%#NT -\((EFO<AHSC+IHB"P-).=
M9/ZUK(PG6@;$STFX18,"S/>'QG'.<'34X)F[[5%-=609K+P\]C\.VZ =@;Y[
M&YJ_8(1V&0M\/X#-@AL!+7UW_;K*[E9"R.<VLR9,5S-T3#FD0FP,- ZO]-BT
MG \00@\,^9T1:"Y)<C]Y"+(@("30M%!;)1>N)KO6-=1BL;'J]@:O6L;#(%3I
M37$ZIM;USDM1W,])H'D)!!!9F:0^3O#S-0[UE%AWTH'!WIZ"$ @6JY9^331$
M) %H./MLG/5 ,#:X[=*W@V9.&I(P,3UKF=0GU,B^\7Z9N<$$N[ 5KG\]'RE0
M"#'/16;+#)OJ'F3=!46E^@ &43HG8A:NWVM7;[3L1P>^TY(:4@0BS0;Z<B3'
MG!AJU?GEV0;M([-5Q0MQT"+"":N9$")!^'/1$5"\/]39FWH@20P.GPW/I-B'
M&B;$.-$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<:)L0XT38AQHFQ#C1-B'&B
M;$.-$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<:)L0XT38AQHFQ#C1-B'&B;$
M.-$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<:)L0XT38AQHFQ#C1-B'&B;$.-
M$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V
M(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<
M:+FOQ'^(  <538AQF$V(<:)L0XT38AQHFQ#C1-B'&B;$.-$V(<:)L0XT38AQ
MD'_J &*& 2F*S-=,'05*Y#Q9I>7\>P7+@$ ^+C'#Y9#08$C9ZW>+R,:(8%(F
MW?\ *H"0"QF>\?\ 3S&B02,OIVT'4!C$"  =<8QL45E@!0!Y!CVBB?Q*0@@N
M9D5^LBA#@)O V!?#%%$E,F2<;CFR Q02')#D%VSH@%AE^: X_5D,*7*I#E\+
MFWTFI)!!<P0(+9'1T!8"(0S08+FP IU0H26F,FK/J9F4. ("' R(!H+5?&B(
MFR8"YR8L1\FI&;*:7 21IT7PV4 #7+6'9W85DUP12)"07K3"K]L73Y@U.\T^
MFP:9";$)+W(M.)E#HX$'1QW'8X(B")@)P>>YRRHC2*1#DS62_"$"$/;IA.7C
MPG(.!SK7%"6$BY8Y0W;_ $=L1);H,LL0B<,<-F1"4W-)H[X507" [.)#M?$Y
M4"HNH$9_@XR,L*,T$&.QJ]T "[L7^NIQ-'38(+.P(+@M;CWZ/<KQ<<.3[HN7
M2;"HS+3%:]F+Q-4BVK\-[D*T[>V1'RA!K@]/,3E.=&3SA]"Q:I^)I;/  @8G
MPMEE6$2F'!8. UQ<NV%7G51F5,!7I0=7E ]T9#1RVM.Y+!1UYTJ<[7MLL_G%
M2$;@AB,#3YC$1=!&*FEF<;>CN$))(MDVK6G.VLUA!; C:WP\-9-B(<F?&7!A
MJ*\^:.&\KE9<K+.[:5PK= &C&'&S?1!,0#A3@BN(R009C1G9V;H3/R,53!8Q
M0WK)/U=$$'H,_O-G=ZL= #1<"&<#%V^<8<H$L2X:A@GK[R1Q((KN T6$:>*G
M)A Y9OJ>^B8@,SLT-J;13*+B@A"&&F &^&'1G8:6P]2A8+8%N$MLK#'"G#;O
MJLQ>PY?HXH@L#(F@:0VY$8U1<.08O#BN6>ISNU<K/,L >S_B"!,"_ICS52B"
M0[]J_5+VA""SQ9G^/A/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI
M/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^
MD^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;
MZ3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]
MOI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/G
MV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^
M?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3Y]OI/GV^D^?;Z3
MY]OI"Q D5!F^,3H@U@P/MJ\FB  (9J=-;T+!FQHG! M)9C4]6MY+IRER.DF3
M0US-BT(LJ7I67:[S\'_I[@+D!FRS%'MIJ%YXY-O-!+CLB$": <&@QP.LR^#N
M*H 1>8S X(8U1L"ZL!+, TUB^RBNKLR7C#(/IU1)P$@"#.#7PB0  QDL<WF?
MJ=$28 B7 7F*O;&^J"($""'(7#'KEKF$]$;R8U<DD6[44R,D5G!KQI3/4\P(
M.+4='[(X)1.0P!\:7!4H#< =U""VDYED6I! ,Y(<F1@6;3= 0:($L0'[;:;,
MY(08SAB6KC:N.-$ZP!Q$EXT,[(Y$F BK@FX:,NZ(A5SA]\C%T3@DJQ]!#0X/
M\)R16XQ^_.M1+(.V8_TH'L[0YGZ0@5M74!!+:!U;WW1@=H/\\V+H!H   8FF
M/R]",V0()UBW*%499L(&< _'ET_,TLP+6R(Z]<2B((/C%ZZ\S");.K9Z8^<4
M&9  -:HLYWM1&L[4>@R:\Q>O6 &2[/89<KI260V&D&MJX5H$>2S2^!  Q!IC
MZ1.)9))MCSID54@3%;#G=$]AOC7EK,5?8;M=\<5EK86R,=:U60-'C9V0M0#4
M//3*I9+4:=:*4PRG#?N3-J%%B(D0ZGF<ZQEM_M9;?[66W^UEM_M4(*:[UWLA
M+7P#[X8Y 9( &%#+_1JQ?C)N! ?QT/F$>2P!G#4STRP?(/8(!EA=AY#G=@Z;
MH&'<6Z=\:FDN#G3*\_#B$"68]KM>NNU;J4 "E!:T M+[7Q;@(!K'S;%NZ[2)
M$>ZFP9$XHWQJ_99(J#6\T'/3U>X9>.^4H$(%1:N,"3X]IK@&80W;E,24-$ 1
MA2N5GP0@" 0>H;>.9H +#IVYEV1@D'8[1+8F+/9_+<>X;=FX,4W&[&:;CPZ;
M@W'I-P;CTFX-QZ3<&X])N#<>DW!N/2;@W'I-P;CTFX-QZ3<&X])N#<>DW!N/
M2;@W'I-P;CTFX-QZ3<&X])N#<>DW!N/2;@W'I-P;CTFX-QZ3<&X])N#<>DW!
MN/2;@W'I-P;CTFX-QZ3<&X])N#<>DW >H])N.%Q>;_$)N2]1ZZZ)N#<>DW!N
M/2;@W'I-P;CTFX-QZ3<&X])N#<>DW!N/2;@W'I-P;CTFX-QZ3<&X])N#<>DW
M!N/2;@W'I-P;CTFX-QZ3<&X])N#<>DW!N/2;@W'I-P;CTFX-QZ3<&X])N#<>
MDW!N/2;@W'I-P;CTFX-QZ3<&_P!)N/<? /ONFS",QO1-P;CTFX-QZ3<&X])N
M#<>DW!N/2;@W'I-P;CTFX-QZ3<&X])N#<>DW!N/2;@W'I-P;CTFX-QZ3<&X]
M)N#<>DW!N/2;@W'I-P;CTFX-QZ3<&X](QP(!Q!N,NG5D.)#4I'NW290&84+,
M6!\VU.#J5TDX-1[TDNS]$9TEP]:Q['3T,%S^0<Y5-/\ I[@*#3QV8]UE]OM'
MRU@QE/-4P4:W\<JB;!K!J?CKF,@:"]%03? ">VJ;%O/M9FMSO5TWZGWEX0=#
MFRID'Y!;-05W9/27RU[LC3":R<"*-M1HNB[4MK/=LC>@T3*Y-A>1W<&':@A-
MC009$NY:KBP@?,(% DPU"3NQ$YH'J2&&#J7PJ?H$N9:'I&_**H))YO2#E6F.
M)09#*I?9HO*U[OM&IXIRO\.,AV.2#2[OT_T/K /+X3@G".L'TB$'9AE?&N"F
M)4I;&S!SZU9A\M1)E]MAT#CN [FXZ=E4D2V?TIV1/]R\NB R/4_#P7YCT@V&
M2XD4:@TYD T2](95P!RQA8QI-B":.0!=GSC1#DAK$@5O]+*LL7[@1P[KY%QV
M=9+?U62W]4T9$L<A\NLIO[+B/J@C!O5>(IEURZY=<NIXS(Q#P_@Z(*0.[N3C
M0H."/4_$.C";A4&'4,UNJ.#R#(>UNB<P!P\O<V&!K"JE-)@I!KM,*Z@^!Y0!
M4=A^0@,Q32Q3K7,H !?-'!^OPK/\+/\ "_!#N'6:YT1;^4M@P^>R 57AW=$5
MQX6!15QS!#^!(11=X&HW/2J%.$Y+2'$8>:0"S7@IM#!J;Q1KK(UQ& FI:]'A
M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQ
MA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[57;#O*-@>H#WP*
MA%[P-\7&M,%QA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&
M'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M<8>UQA[7&'M99
M5XEZ!^V:(_4/A91,HF43*)E$RB97C-<?L7&'M<8>UQA[7&'M<8>UQA[7&'M<
M8>UH^CV5E$RB91,H@C#BFI&A<3PU9GFR.U*26,M)C45I1GET11+DO<5RIG.R
M:)%NE9ZVT14YQEVD#8U'C_IX&ZT 5B?G5$(H.DGFJJP5>$35\!!%A#9 N@P'
M\ ]UF]@LWL%F]@@$@X$&@L4R! #&>[ 1>VKRC!+5U/QQRYQ!OIJQRH_9-!(&
ME,GXRL\P#%PTBO#1,6Z@_E#R1N&?I'&0#^"-W0I+L(NWK- 1!H* CXY+70$F
M0V;I@Y&OM.=&?-4 .9E,B7H1#??^E/1Y*QS] ?"8+B#W#7IGQD4!@2]' #=L
MX?J:JFI=VK#P,' N(H]DYD$)<,TFANXH841G>YG*3.B",F'GAG&1))[U!LHB
MZ7&Z/E/J>1ZVQOPW5:^K"2<)J^C?*W^3Y,=D0&)D@181F^LRA"P(=1?OG1ZV
M08!D"Y'L>%D]Q[6*.X'O^"<(?"X ]IE4&J7;L#MX6;10.LX=O&?4IJYW>UG$
MSB9Q,XA(B3$S*(':]+@#<&FT* L(!VE6[M9J>B!#)'1S]T0:HJ'--R.=4,1!
M-0*XOF>4E%AB#J/,>33!'!W.KX6);J_1%@MN -L40/-]?@D^$8N27!A\-F9[
M!<?TN/Z6>>W#+/*409K?N4!!QF!C9C;?*)?<]H/"5<?;-X0ROI]D8$IN^>LV
MB'HZP3[#HS_.3*C*,2\T%X&4N<Y_YW>][WO>][WO>][WO>][WO>][VR]M9M;
MHO356'T)&)Z1W':CH2"U(D?!@[>_^=WO>][WO>][WO>][WO>][WO>]S[2\LX
M&3VQ+V5+"@.<"U_C*$\7:ZD&F+CD67[A/W"?N$_<)^X3]PG[A,?I?C_'O>][
MWO69#V?Z7[A/W"?N$_<)+#1BUN3S9% #567&G-7,IM)+D"PG"!)TK 3IVER^
M;O6/,X9B-8O8DT!C>N75/9 'P!'CK_T\Y@(B+ZXCQU0(D!Q.9]N70>:GH?L^
M$.7G-R>E(V^$!-!W^EK36FM-:%H)P!Y0(^!,.9+-5M"_Q"C@SYQ9L*-QJ#FW
MK5&>! &F8G;3/!AZ8@*1)TY@K@+-5P/M,!W?I]/V0%"PZ5[DT2Y!PH/7A.9<
M6(^%(BB.-"WA7=/E P&@*:>]2(W_ -'@B*CUN1SD@1GCRN.:'PC<VW0 P //
M!G1T;1($]<Z7;C%,  !7)+%Q!O32"B6I=3]HGJ6W)A5A6KGU=USOM F#&$(
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MQ3' [%,<#L4QP.Q3' [%,<#L4QP.Q3' [%,<#L4QP.Q3' [%,<#L4QP.Q3'
M[%,<#L4QP.Q3&C%\&3' [%,14$=$QP.Q3' [%,<#L4QP.Q3' [%,<#L4QP.Q
M3' [%,<#L4QP.Q3' [%,<#L4QP.Q3' [%,<#L4QP.Q3' [%,<#L4QP.Q3' [
M%,<#L4QP.Q3' [%,<#L4QP.Q3' [%,<#L4QP.Q3' ['^&.'. [)C@>?AV3'
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MU*Z HD@;ZVSYGUUE!@Y!#O::DL#D[R-4:%UJN=:O#RQ^D$YAR%XQ@XVS35#
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MD%S$QE=^]>I@-QEP=VMD,S/5W@@R!84SE_&Z:2[-FP^R@!9W1A3HW2IK3"(
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M0AA !H:NPP6&ID_AT0": "Y;6V?6X4)@;PS.:DW\@T@0BX@&'$1KTRFT"J)
M%&9Z6L<W[YIV79.R[)V79.R[+HV'I.R[)V79.R[)V79=&P])V79.R[+F5T]D
M.E]#_L5?7Y"OU?/\'2:=JTSALK(R0=G<S'X>.GQ,&NHT+=<LT]F9 ?"A&NKT
M%YH9A,&H]J<9G31<MTGD;YT[-")KE8$_$R'192')<=7PM7L8"#<PAQ6IC<S4
M1&XP2 &#UO7VV?9&<&YPN<##4S1,);2FWQ;H0"(#L!1^[3'9/A&WTGPC;Z0"
M78[U8N8Q[3X1+33H)Z0B::5B9\@;KU??(R7 Z9GGU;CHC+/EAX1 D$@$B0]C
MB/\ &CH?I."56>A;*409CS5->*.?A$')LY\IC1C RG^XEWLS>5 FBE- AOV<
M.]8 .**(:7V<XR,(6+"FGWX9-&%)MW?RJ W:&H#A?'=$#(L;8L;8\:H<EHS(
M?F#79P4,:3?$OE;0T19R-(<@X4S&D/(NADF-W8C3*IN7SJ4 %C]9Q<_LZH[+
M*IXW8FU$*38/8/WGR\T1$8!(!U4!IHV4V3ALZ*''79#DXE#*EQQK0F2F,'.L
M.T>7DLA@+ @26-TQN&ET @70\P7M?'',.$,D!P^-NN-?E%%LE_$'%MW>%.)#
M$"OI^9HHH(@L",*\H@DB<!5LBVO;LAD(/%6UZ/,R2>S)0>],##R^A80L&)Q?
MFJ?I&74MR,UE$EY]+#O7!9W411LFK6D9BEH%VH]2&T^47F!&8<5.H)P;PCX2
M34 PUPTAX9LW6"%,(K:NX1U6M-NM]^Z:,2&%"V>^U$-#@BK-+3J=J3JC!"!(
ML&M(G&;A" )>?N+,2S-; "J(N'&EG#MMWP@ <F#T?*QD8VI=,B@OA[GI";R]
M]:<F\:^;IMB,8W<S%*IN-^X;.H]8+.]W(O,N:3)"%EAR 0%9<N:3:N+LGD@.
M!I85^\\)P$:/2U*V9IC=#!R12WNTCM1'AG 9J@,;OA7/&$VD($*P1.;GF#3(
MSV0X=VXT2$Y0B[R-@01;*%F.(Q&G4$PW<K,W#GK-"!!YRH(X\NZS,;UIE?XF
MRSN_:F?E9W<^DW$[]M>R PV QW]R^Q,(-F)[P]J9AWLHD$'TFUG[E"( )!RC
M<X5TZ(.H >B-@/$3D7#V3*4RE,I3*4RE,I3*4RE,I3*4RE,I3*49&/FRJ64I
ME*92F4H^IRIP%E*92F4IE*,[B_8OI<XQW=!)L?J<;X=B&8XP)8B>KC:K]JH#
M(<8YD]&:,<I0B8UB;?#7.],D*""(@@@$4ZS%R\GK^8/2_,'I-P]O2;A[>D,O
M+Z<";@>WM-P/;VFX'M[3<#V]IN?;VFX'M[3<#V]IN![>TW ]O:(%FC_O=_\
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MWCP=V0I"&W-#77EW_L')9Y(\/Y](&+"W1"80;3T$OJ$8EHAP.F;W'MDXPD,
M.Q<]T*P1N,S09PPO)F91@-0WHE][^T0#,BCR_ND^V />R:/,9C66NAH &S-*
M?$8AL$"#@YF)[,11V#[64@PLSOAY'RX38:"0" 2_4 \W11T]W:_+A/!I$AH-
M=MJ/I8K84I-508.-Q4:H*BJT_44>Z?2)##EWZULU*NGXEEHLHTB?VX0*<PC3
M<A !OB(PLZ%0< %)8,0$ RSH@L2332,^GBR-8EP:[W%#U%H#7.((<Q>3XX A
M2%P >#4LYPW=I91(@1!/G8(H1 MKR>S)X(>!#BWRP'PU61;@7UZE"$(A63:K
MY1JH17:&RQA0&KBH:!KTR4EWTEN-'=>5;EX^U.@P8&34BS'JJ@-&).E.1F 4
ME\ #BTOS(N4&D8%R V[]:"]RB7$/>&[S$;LF*0(Z!Y@29#"GF1. %B&J]=2T
MTWP1!+ F;.8QJ,.V-2B6.69Z R SO^OJFW9;!I(??Q*!#03<##-Y\[OD.Q83
MKH9I8(8);!@ULASM%59X'#M<T631A=6WZA1*U#!JC38>5.@U&89N]<-Q(J%(
M#M#&.[X,]*TD(4'(S>PSGL1@V*%.\]&:!A7F"%#.:QJ "X)PM]D@GJ>*/]=4
M15)$58U*O/(O--61E 2.SR[8-HL]ATP6>6>_AN*@%A\S[\HTB'.UC P)XYDP
MB0P)'3]V-6 L -"X+B(G3D% P.3L"(%@]SRZ)1)%8SPPI+RN"]K@O:X+VN"]
MK@O:X+VN"]K@O:X+VN"]K@O:X+VN"]HH'X?RVZ_)]E^3[+\GV7Y/LG7PCV!7
M!>UP7M<%[7!>T=>D@UC"!)<V;$CH(EPN2&.S/'H'*2CA<'U\/G#LZ."P6?<:
M36<,X1!*0C$4M5OM Q-RU RA&'4XK\LI^6?E/RRGY90<003#N#3)^ZSFZ9S=
M,YNF<W3+.S^05EG8)EG8)EG8)EG8(0 2[FK\Y@/^Q"<'E_D7HB=VFB.J8X<-
M-TQ@);6D]QF< @&&MBST<]4>()G(";MD@($F(ZN^"-$;%R_CA_1$ 0 =R(SI
M=ZP@1 -<@S\O"&)"068G3)H_73Y44:F5:9@&91@L'I36*9-6.J,((.E,;Y:H
M%G(%F?.3U.<[(T )#F.(DANPIWA$%CKOZI-;)]PQLY9\9.' G8N-I,TX"L!#
M$29["V+'7! 0SBXK-_D=ED5D?WI^661YT1$@L\D,V/V<=WE:-GVH? /17 /M
M KD^06C9CR1]MP#[7 /M-AP%@XYPIV$CPF<ZZH "! :\#YG)%4@W7ZW0V8 V
M 8N)!ZO:W=%/@'#S+?2=>"<K=+=4(FP@-D/WO_<F,-)=V")RB;]90DX;@'8#
MY4S#;Y-VKX1K+X89>*TQ3H"@/()$]6#4D4*>=KTFG82.[Z(30@.,PSL]< ];
MPC$S96]F9VU:J/)-Z#-OCO>E&B$,68/KT%^6.'=QI3;;XV("(P;V?F&HA((,
MOA4!NEQ5$$!=JBG!7O9D3(!AM4L>5&2+W?/UA1&YM7K1_P!C!66@-ME/C=PB
M%L--IT:]NJ*2D&LU(=4GP-T^>E.F_P":LB ?&M1'DXCX68#G>G1SG&2IFIX=
MT1D1'4"*YO[9$%C $D9!WS>^*),<QY%>_P 51B3%],^9%W0 P#U03(I+BD2U
M,EE=Q[65W'M97<>UE=Q[1PF:1@?E=0?-GH/-[.)DU@.OE^F")2J/N_*HY) $
M3VF[EMX1Y(3&%3\)AFZLG.)W*<BA.Z<XG<ISB9K* %\FOGG=97<+*[A97<+*
M[A%(#A&#_3[BJ*T*,MTX(T9!$6J">K<W+LCDH:3@=-?CR [W@<@7'Q9/AI@5
M^?GQ1VA#/%,\>4Q#H[,P(;"UL.P1B"P:;UQFY>WAV3Z0V$5UOU[079!#5JLK
MN/:RNX7)Z<R=<GYI]2B1G4_ ]T-;,!8CJ^%*\GLHP NP\\"9!@)8-;/5KG@0
M ).4%FP!-.JN"IH[)F+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[
MIF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ9B[IF+NF8NZ*,)DM)P\]U( 0S,&I1A
M3#'"!@ P88M21JW*9.!=J=1\R#M@@* U>EC;E@Q4Q.SE['##0'%_^[&&GES\
M=^Z%((ZN/I"H[C$GQVAXJ@@, #U\H-BS[\T0)2*FT'.J<8_'6;9A,Q%3G33<
M9+,IK+\U$IRN.K?/ZF8\P]X="V=SQO2[+,KR4S$;HP! 81W]_75&I?'^@J-0
MM'=,P*T=_I!HD/U_5H[IEASNM'=$8A];:5^$S Y\OV3IAFI?/3'_ $<@$8G@
M1/(/FC++2XB&=GMD F"35+H7/KJ@ 1+!JXDX?'F63Q4P/2A(YWD%#7 Z=O1O
MBG0 5=Q($^7&@ET<2Y7B2,ZVF_0L48F2!R!\C+E$]DW/>7AORF,&)JO4/R=I
MP3$"&)8F;M$84[)BLFT]3]5S0H%#=[7JWDU"(+L?'4.-]@CQC2#F/6,WP>P5
M=7U:@G(75$0:0P+ZXM$X&N)) &@*6(9VM-3DB1H+DT:I+9VAE7U7@^(+4KW7
M0+6Q<F[TWS0[4!L#9M^M9T0P+UPU7#:83A0W10T$%W,-YOAHY@HS,$4,UKUA
MKHB$B"#4"F.(R](I'X3%S=MW$Q*!DE&1HDUQFFQ=.]FC?OI*D]._7XR*<7H;
M$5R&98A.."ECB(+B[V>$4@$@03TF_#8LBQ+4O[Z]A9'$I-]8,9D[39@7EHQ<
MXQ;AHC%Y=YI-B>C3!)A$(6$;@XV-?4+E#OT9XZ/:2$1%F">,&ZG,X34,;@:A
MG[7I9PL(-2HI&@;X9JT(^4:##2\$=,5A%#W!W<EVSHGBZ+N,#6U"_0$H-7=0
M:SXIDGQ&%Q+1W<./:C!4-&<'XS_6.QPT-6?>+63B0#H:#?4G+"CE3*N;WBGS
M]$#,,),/1\[VNBP.[!@ 3T=K2WTZ+%4EZ:4>N?7$E.B1V161A)\J?(B\?60Z
MXNGQ)-M*MT?.*)D8A6(%3$'ALU$Y1S6A'L1(>-G4E"U*BNKVFRU-Q2F.-_F4
M)+UD$=;TI@V3H8 R897JT7SU#!7#,*/N&\)B !%'Q:T6*$1\P[OXY*#1!&Y?
M1 B 9W'RG9[A.SW"=GN$[/<)V>X3L]PG9[A.SW"=GN$[/<)V>X3L]PG9[A.S
MW"=GN$[/<)V>X3L]PG9[A.SW"=GN$[/<)V>X0&'1(H93(0 &O&V;=J/< @9V
MT',,!5" =A.;06I:M?#J(>')@S->S/O)J4XX.P.&%:-SO_W9DEF+M=XU/C)J
MH$36!631\9PPZ40":L\N'I6??9"@.V_S]OT0#$;%$Y7=S=OKOC*[=^<G^7^>
M_P#8U.I_H"Q!P+K]FX>RY,L[L5G=BNET].L[L5R;FGU*SNQ72Z>G0""!XZ\\
M7_U%0V*:,FGQ%:X]YA!6%J=LB=+%BSU@$&0 -1  IO@,:,$!I$O%#;'-%N.X
M-YC#E < .$C8,56Q%G"-Z5).Q 2$ ),7$]H=6VJ0#\M;O00AB7$I#-\D?'A
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M+- 1?4I@:&@,6QPJQSC8IQT@02,9>3><O*9KG$D/7\QCHB+B[/A788S6S_\
M=GFQMV/9  DUK/:2].B$W6*4WYY/)*YO/SO]K-._TG#(WN8S I:O5.]W;-V3
MO=^0G:[6^DYQ.Z<S)FLUU3G$ISB4YHY;!TYDOJ7MG_9QB-PG&(W"<8C<)QB-
MPG&(W"<8C<)QB-PG&(W"<8C<)QB-_P#1\+.Q\ =3H@ +A/"!8AH>K4UTZ)D*
M16HI5[9T;.Z90=QL'I+<P8(PBSR&#S@A<%U/M!%Y@U+=J/@PUN@ OG,_#(7S
MZ'V4"L #YRZRB=\>3VB801YJ!SQU9$&+0GPLX[^B)"8&;CP3Y'E.4$]1Y!?C
M40*'8(>S\%RZ;IM^9"<01%V-<C+>41!Y&\@N;S;K5,FC8/D%$6"M"/CZ6ON?
M:F#I!K)VJW*(2&'M\-NFH6JA5B"GM>@[LA $AC#$>:IV'9Z3L.STB(L,3)KT
M@]$S#N4,EB ZWC&$$D"<6.R9P=*<L(79V<(A$ [!Z0 -,QU=^OE9#C59#C5$
M3R\E-_*$2_BVTX5;%<[>ESMZ61W3([H9'@&XQRMCKDFH,@4=\R*'<T1S"]0J
MGO3.\(,SCR ][ZYA&8-)!AKB^]D:T ,H$0)GLS:(&IW>R JNZ,1# [O9T[]0
M^BJHP8E"<S#U'S-)61W3([ID=TR.Z,P[/:F<B=3^NZ(.!@6(+=\O/1F+<>TR
MKG%V&]4T2&!B8AY#P$W!M5N#:K<&U6X-JMP;5;@VJW!M5N#:K<&U6X-JMP;5
M(82\$R.P)>U;L@-BICC@'FAI%;*0%FK/+U>:BO1-P;5;@VJW!M5N#:K<&U6X
M-JMP;5;@VJW!M40 38O'H3;2B<<QH74:AQ<0\.Z>A F09-7 R9;%D^51$GME
MK3&"CF7-7O-Z4C#%$N3,W_[LR09^N90=4D:E%B2V(/=O6H3HJ6Q!-<Q9-4+G
MXZCNB21)J2_^U!T/^5#_ $*@,B26.# /V*))@-XYCYF[3=C#[3&E/E#D.#$O
M'332MV1: +YRVPVNZ+(@!F:[G%<+(O4Z&,;1U?1 @-&%/##X7X(]H0N1O86A
MC Z$^4+4YG+?#'HQ0$""2QS/B$(Z.J.K]T5?L1[1<G)Q;!GU^!KBV!V/<QW'
MI1UZ"/EE^@$0FJ^!?UX1G;N^&^4Z&>JCB]>F79&RS4J2X8OX$#R@ ,((+DAF
MN]403Y[?/55)]OD>4"DN0JY!9^XK5 F=Q]ICG0E(@2(F7\\LLON67W)OLL;6
MN-K:K]Q!1(B&-3]F49LV@=IVA%LUQ2Y#!#CH@A)=K+)E(SW(\'D77"RX67&R
MX61K OG//62!:<VJ!N+R@4L#N_@3W G<Y.?+H,=!OC]MLST">GB3A%J22V0H
M]VH(D,O8_-*$X9RF1\"[G\M%CB@(F8.07E@[S8_"9 #W,*O?'1#AR#&+LUKE
M$*07EHU)"+E^,2S90/M 'Y* 7\1-5G-_I9S?Z6<W^EG-_I$D@M-&<]P0.R J
M_ML3[V0%5^1/ZAQ)!\P_GG5"\#J$00/<IQG19'/19'/19'/19'/19'/19'/1
M9'/19'/19'/19.X+)W!9>[F6D]#A[GSI?>L24V:,R+^!\K(YZ+(YZ+(YZ+(Y
MZ+(YZ+(YZ+(YZ+(YZ+(YZ(5[0Q/YEEJACF?Y&NT]74,RU'27^$2HOZQR.T.7
MP>5>[Z\XR@B2:Y<+9:2L[L?2SNQ]+.['TL[L?2(:]A]+D'HN0>BY!Z+D'HLD
MLDLDLDLDL_#OIW=9IVYRBS^W.16%R#T7(/1<@]%R#T7(/1<@]%R ^EDEDEDE
MDEDEDEDEDEDEDER#T7(/1<@]%R#T3WT(\A9)9)9)9)9)9)9)9HIP:]LUDEG_
M %\[.N8'PS]FS6?T8_G=<@/I<@]%R#T7(/1<@]%R#T7(/19+NLDLDLDLDLDL
MDLDLDLDFOH3X"Y!Z+D'HN0>BY!Z+)+)+)+)+)+-"S_$=_#K-"S_'M9)<@/I<
M@]%R#T7(/1<@/I9)9)9)9)9)9)9)9)9)9+NN0>BY!Z+D'HN0>B>L[CR%DEDE
MDEDDS9W/@+D'HN0>BS^Q]-S%9IV4@$'Q#<^PASBXK?TA9(L%2>=JS1$G"#R4
M38W87V19F!A<9FAU0O\ 5"#@N'<(,U 7A-@.Q3F#\P[?[4%N<[T67N^UE[OM
M9>[[67N^UE[OM9>[[67N^UE[OM9>[[0($&9GGW3_ $ CB!@P)QOJFJB&R?8N
M @ [&:TH^@!:+UHB:Y-,3#8OVG(RA[D@]4 6,!C&F;)MRXPX%ECG1-4'0._C
M5< ^D[+#J_R%EC?Z66-_I98W^EEC?Z66.=$S0 =3Z1Y$GLRRNY97<N3GTN3G
MTN3GTN3GTF!!HS5]@!,SW'M#&;F3K4W^UGN-4[# B;EWRKREUR"N05R"N048
M08]:'=,P=D9@[(S!V1F#LE0 'S!S.'A98W^EEC?Z66-_I98W^D&S >ORX:E@
M@Q #;^4N&!S+8ZNK8#$-[CY0 6?;Y)1#"#0V.LN<16K (#$;D8;Y&^*!#,,^
M&5,L;.Q6>:X_;]$P$M(M(^3S-!!BSU%[X%J_B#JYZ!X+<&J:6,X(:S;<U1H+
MAB<--;M5XZH!K:5+'.\>4Q!+!\/>Z=B>WM.Q/;VG8GM[3L3V]H434&7I9?8>
MEE]AZ67V'I9?CTF8'H0$W [$W [$W [$W [$W [$W [$W [$W [$S [A9?8>
MEE]AZ3EJTIZX)HFN/3D_B:<$9?H/@Y)N!V)N!V)N!V)N!V)N!V)N!V)N!V)N
M!V)N!V)J6W(.RR^P]++[#TLOL/2R^P]( !HDS&W?#PN' N' N' N' BC03>A
M_-I3,1L/29B-AZ3,1L/29B-AZ4*'9N?J=B>WM.Q/;VG8GM[3L3V]IAE^<^<2
MLSFT:*I.D-OZOT3,1L/29B-AZ3,1L/29B-AZ3,1L/29B-AZ3,1L/2U'M[3L3
MV]IV)[>T[$]O:=B>WM.Q/;VG8GM[3L3V]IV)[>UJ/;VF8C8>DS$;#TF8C8>D
MS$;#TFBA'0#TG8GM[3L3V]IV)[>T[$]O:=B>WM.Q/;VG8GM[3<11J6[;4R5*
M1-! #>7[-U1$U(Y&;Q\8)F(V'I,Q&P])F(V'I,Q&P])F(V'I,Q&P])F(V'I,
MQ&P])F(V'I0H=F^D[$]O:=B>WM.Q/;VG8GM[3L3V]IV)[>T[$]O:=B>WM.Q/
M;VFFXZ@>DS$;#TF8C8>DS$;#TF8C8>ED<:-[3L3V]IV)[>T[$]O:S$M>@\%]
MDVY!E_-=WWJB)N,:>W310SB*]VXV:=B>WM:CQJF8C8>DS$;#TF8C8>DS$;#T
MF8@]!Z3L3V]IV)[>T[$]O:=B>WM.Q/;VG8GM[3L3V]IV)[>T[$]O:E4]2T>?
M"9B-AZ3,1L/29B-AZ3,1L/2:*'8#Z3L3V]IV)[>T[$]O:=B>WM--3N ?:9B-
MAZ68-AZ68-AX;WV68,X':,&ZN@ 2Q8$D5U]XH66ZN1DSEG#YA%%]W@7,SC-\
MFLB$D4B].HRF9JR-C<\D6ZZC.@1@N& W_P#DFA))$"[,!@UC=,)=MZ(.H\IY
M. &-X.5(^4)A8/A:G6FZ.%D,;@.2 [3W1QZJ3@B@[67%/A'[KD=)3\TXCD+G
M]"Q]XN]U^TO[2_M+^U_'C&WCTLIPS64X9K([^RRG#-93AFLIPS64X9HD!#)&
M/LOSOM?G?:_.^U^=]H D;19%,BF13(H84!TFQB79\5D>62R/+)9'EDLCRR0I
M.!0D?L&7[2_M+^TO[2@@U>A/&" ")@+($+@/9X/9"J-8-Z0(D[XM'98@L _8
M[91M=@W&^.\>5HN+LL(OV:Z_9'I$%1ZGW0*9 "N3!]D$P.LS,@12G7HJ=AZ/
MP-@B;Y"(F<Y5H]UJRNTV0-DR_$K\2OQ*_$HPC#&%V8\PHLCRR61Y9+(\LEDU
M#A-W^/Q93?Z64W^EE-_I93?Z64W^EE-_I93?Z64W^D,!N!W(61Y9+(\LDQ\W
MJ![K"PR"08X9Q)*/<*E\!M [T64W^EE-_I93?Z64W^EE-_I93?Z64W^EE-_I
M93?Z0P&P>0LCRR61Y9+(\LED>62#KI$F.0YJOVE_:7]I?VE<ACQ1P;RN"?"X
M)\+@GPN"?"^L$> OQ*_$K\2OQ*@B#H2:$O:#\-(!067T?+0H*W<O,8Y9NN"?
M"X)\+@GPN"?"X)\+@GPN"?"S;,B#V7XE?B5^)7XE?B5^)7XE?B5^97!/A<$^
M%P3X7!/A$UC07POQ*_$K\2OQ*_$K\2OQ*ED@UJB;3$&R+SB>9,#DW'5TNB!"
M7KH0WU=?G?2_.^EP3X7!/A<$^%P3X7!/A<$^%P3X3_H^E^)7XE?B5^)7XE?B
M5^)7XE?B4!0]@[GCQ]G@GPN"?"X)\+@GPLTU%?B5^)7XE99TGM=.5-9R -;L
M_9M$*#0,MJ&BM24:;PM <J=U^)7XE<$^%P3X7!/A<$^%R3X7XE?B5^)7XE?B
M5^)7XE?B5^)3?HGR%P3X7!/A<$^%P3X1/\ /',U^)7XE?B5^)0'X&D=QS=<$
M^%P3X6K2[8D,XJV-AC24YL/=C#E[T?)0@D&(-2UAE.I.2<HN8KWDL]#6-W%0
M#O2AAGH9[=I389W-&EN=?)<0:-0\1:I[_*)>?_DD?CF <1TZ-1-AF:,;4?7S
M"*')#9X$[\@V)D" !-X:0T_DX0@:3 !+8L+]SI9!P&PN/A<#[_AB*N*/=059
MZWW1MBM0:R]W@$8:+Y*0V<EAY&J JG^'F2!I#7#)^\"2S$!K,2#YKT4.EOPG
M+6N!5299SH-W)8Y3C#K6-=QS:/N*NR<N:L'"M#2F+75.>L!2Y@;5.(JA2>-Q
M#!C6!.G92P743Z=D6BY",0?%-QJ@+69G.#XMY+;H[!+D7Z';O1:QJU%]=K ,
MH/F-_"E]*P\&RH/7$NXM@^(67-D?N9&@ZKZ@]<Z"/1E/M*\DC&X?I2[I@ODD
M&K>FV)H@02"$5@QC TR/6Y&:W'M9K<>UFMQ[6:W'M/P\OF/<Z+/[#VL_L/:S
M^P]K/[#V@:@C(8\_5P@N$$<.AJLQ:\L]\A7$9TEG#8F9Y8UGX 1E5LR_62<_
M>('(,'$,/E4Y)FSO)^% >:N !K$GV2YHGJ.XQ9'0"</8(.9UM:8J')VDX789
MDZ9J^Z@M&#@O>N)$.)F=@0:I(,^H^=-06[*16,\\S=DYP ) ++6K4-I>Z-QH
MJ&&=]&C=4#V'V>KY:;H@71>C)W#G/NANG<NZ71(0X1>S4^M%P'V7 ?9<!]EP
M'V0" '1PJL]PS6>X9K/<,UGN&:_6?"?K$_6)^L3]8GZQ/UB?K$_6)^L]\LL]
MPS6>X9K-QE^$);]MK22:^!SZMZ+]8GZQ/UB?K$_6)^L3]8GZQ/UB/QO>QYLL
M]PS6>X9K/<,UGN&:GN >6[E;-_1AAABI&B)9XGTOU/M?J?:_4^U^I]HE5QB0
M\ZG+C!<!]EP'V7 ?9<!]D&VO5!PTBWQ*_='I;^_II^47ZGVOU/M?J?:_4^U^
MI]K]3[7ZWVN ^RX#[+@/LN ^RX#[+@/LN ^RX#[+@/LFY/==%BZ_4^U^I]K]
M3[7ZGVB<,\.14YYEM_M<!]EP'V7 ?9<!]EP'V7 ?9<!]E4E-6 #9,_NAAG/=
MW23S1?NCTOW1Z7.>U^I]K]3[7ZGVOU/M?J?:_4^T2JPP%2'OB>>> ^RX#[+@
M/LN ^RX#[+@/LN ^RX#[+@/L@."9; ^6+ _2_4^U^I]K]3[7ZGVGI=U+NLK@
M/LN ^RX#[+@/LF*"Z$N/V=K%P'V7 ?9-SPW7ZGVOU/M?J?:_4^T68,:PKJN
M^RX#[+@/LN ^RX#[+@/LN ^RX#[+@/LA?&P!#P7/"OU/M?J?:_4^U^I]HT1C
M4CY*X#[+@/LN ^RX#[(%7Q8A]@:9K]3[1^R/M5+F9C3CL&VAJF]\W86",[03
M/+.10QKX0TV%P*EL#'YFU$,,O %7>C]F/6E4%W9ZZZ^>$A-G-ZBPH^5=*?\
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M)L1[>DV(]O2;$>WI-B/;TGQ@V4=A7'HLSL?2S.Q]+,['TLSL?2&([,??"OT
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MZL0OSF"8JSH?ELMT\>@G&'8'0$H;B2-+#/$$;X% Q@7<X.:H@91=3Z(]#-J
MMDT/B9I00B0L&R 3-0Y?-YRJ=5%R\ QU[S,44&4X@$7$0.)A"M&<YLT(*,'@
M3!W.@$B0ADPQ)AH-)D06N;Z@,*@<,10S@1QV*;)!F< ,\/I..1R;BD#6 _1Q
MC.,.B=)H'(!'K&U[/+$F+>M!AJ]4016(&@EJSG;'JC0(@XD#2YI#(^0,!Y$O
M?$8W[5!; =6%\VS8E[:II(  M3I(I2&'T2Z;5@&RKSJN,)QA.,)QA 0 B!T_
MV      !( GX'JPDM5<83C"<83C" Q83-' ^'_W       R::,$O%M5D<&2R
M.#)9'!DLC@R5?",0(:V_R  @ '*.9?X@   <(^$S]4XPG&$XP@*0'GD/Z@ <
MBW]0  !)A>D; ]XS7&$XPG&$XPA!A/0?U  GZN !\?<="N;Z+F^BYOHN;Z)_
MLX@#R/Z@ $F+- )^-B<V7&$XPG&$XP@)Q#0?U  X<>O\@   !E[?99?+59?+
M59?+5<?V7-]%S?1<WT7-]%A[V?"XPG&$XPG&$XPG&$XPG&$XPC/U'PN;Z+F^
MBYOHN;Z)_P!P^6RQO"XPG&$XPG&$=VIQ \T^:9_P(^P(=0GP]E?#V4RH 1 @
M.[FYL]_:%NDD)2*LT4>&D7U1]( 8%KDMC(V:KP&(V02!(<S+BF<U^$+][RA_
M67:5,DE$ABXK\?U8L[1SW_! %IZ?J(8G9:NRU=EJ[)N![>_X )!($"O_   1
MI/4>T#6;4A:.Z!J ;A#W  :@_P""'G?"\[P5WR=^\D)TH3;H*:L.N!H9[AY_
M.!#)8F:JV#!XU^&=/B#3<C'=RB$3' R'#.6KX-^SHCR)98R7 []VJRJ0)RT.
M&[/,)X%Z=H^:1&Z,7-(I!OV:0V U1"%9,F,22PC5^%&:(N :'C20G<P#7C'T
M3:LH4S 27';6^P"B:C@Y@7D]4X0+@@DMW;WA0"4 ("XPT(  [\NBED,Q2TP)
MO->\DL4XL"&;#.7Q]53X+8#7&[TWC-#!XDP.4^=("A@%0U>:V,8()-1#GS>D
M;->4\;$U"?'W@CNY>](X+UO=-%+:!% '%6J.:$!<OK;LS 2YEJ1"?./7M$+H
MF&%^M<8;/,&\O%Z@VI3K<UA&& 8$VEH/EIR@ %$4F-XG<".9)Q-N;5QQM3&D
M(H)K <0#9\*#$C4$7<+OSFEYQ.+^$0N.8HV3B ^@+2@D 6@E[Y8^WS3!@&R
M&=WOT8[(0<#!SZ4\9FM56!D#C^+4DL4V9(T@#:%(^S5!"QP8X?$848MN4$D
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M_=[UT1#(<$Y)>8]=WLCB60 X=V?.203:9,J>"1!!O4;.:=M40@&'![DVXZ?
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MB^$X?NR   (-RXT)O3J0%C$:N&]Y8]T.#6M&VL$\H%M:SEA[:'?P**,'GGE
MYS+/VYXS"(DC,#2C#H63X !+2SEBQLXI#C:I 9@Z7OE0'Z[S8:U',$!!Q5G:
M]'A 2A)AO+3#&B<';Z=DZ:@A6MW\><E6 $//.>" (%P5(#B'/D?" )(,&()Q
MG)O!/5$UA4@]P6G#3NF9(O <&!AI+,_)59!+5;5KHD-X,"[S+^LYM#IJ $DN
M 0&:PJ=YJB!@"61=BY->2@/L_+-?+>5,.RE\[CKAW"%B(()9@[Z[Z?W*!C@
M#N?>?1"*#8S7/8X!!C,"YQTHSUZ9$OT(#R2V;^OF@8 6)#,./ U 8ED80]QQ
M&'7J;W(K!J4^%(X$-F/GM&Z([='^HZJ2@]:SY&#[RI7,.%W<Z+]\^T<+Z^W7
M/^ES"G9KS52COE]^=TR H@/)C<>'0#3>/I$ )I X_ ?9 XOI@R,Y1T/52^ZK
MX7Y!.ZN;\[%.>>5.>U8KBFF0+H^3S=%*-Y\TV[)H.0DS0QF^6/2B).7_ *O&
M2:Y#"7=H+G%$0&F/:[3MJX91!/ T=RF"YQ?I6KIC00OY,6#HTF"7 <FE<'!/
MU=?O+]Y?O+]Y?O+]Y?O+]Y?O+]Y?O+]Y?O+]Y,VNN8^6ZLF,*\Q?2/M57FBN
M;]?TV7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>
M7[R_>7[R_>7[R_>7[R\-4:\'5.AL(UR;O;(,B4-2;$T89U7[R_>7[R_>7[R_
M>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[RZ
M,UQS1:UBZJQD8_6X7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_>7[R_
M>7[R_>7[R_>7[R_>7[R_>7[R_>7[R=]W1O@[*SK37@(X4[C:N[5?JVC8ROWE
M^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE^\OWE
M^\OWE^\JJE-<)0S8,;F+<H7M,@K 0:')<L)DYTVHGQ"[F!<DW-:>4&F0QDL&
MW&3RI09S9T;$"EF>:+2FE'V W;Y*?@-R?@-R?@-R?@-RT]_L+2FGO]I^ W)^
M W)^ W)^ W)UP.A)^0M*:4=@-R$_ ;D^XV+_ "%I32C\!N3\!N1#%;"T^2.:
MK@ 3@ ]E=%H.E#\ZNC0'9]D=(069I$@QC.S/@8M!G>Q[*H]?/S=. )#16S.,
M8RZU3<\2.D-6UJYF:N! "8+BCL);*GPCNLQ8EHC*V5ZM@IQFGJ=L2[,_E,A#
M %\@V%"]/QD#A8+OK'2#@SN@^T0*8X3\W02#8WYB_3%3R:##=^K8SW12)'7'
M"?#_ "C EG/Y@<M]2Y8AFIJ1A.SQLFLG.(P> ^38AO%+ET(N2'<$OAEFV%GZ
MIBT, [@Z&9>\1["!C$,X:,:F\XL39XP1PST#EK,]L6KUK@<@0!43\#3+!@)8
M-9%'TY?Y1-$( S T>]*]X8H AY, U[EJYWR31)9A<X=?8SNY* U&K1R[=,2$
M""15ZZ=AB^&29! 12'([OC%=49PT#$U-?A_C% :&=OAXUVP3"Y._):&RB<4Z
M2!#/ U^J7U0)S5^ZTEV %[UE?-8\&=63%;8\X<H18\0-=_'?HP"WFF0>U)](
M(0# ,=&I^ _W8-G.D6OI>Z$0N;^#W19P>1+=':<FFJ$F\'%<"2PP$0*3"'H*
MK!=^HC80CRD_(<1S:R DE>"17 1EE@G26*;6=L='PLBR[@!F[PRSFY 5;1A
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M$&(P-'K,8C%#DB9&XK(FUH<(F!!@$/8UM;#JF63.3!-G(/ON,P$'DP^KMS=
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M3NA\3C7/Q:1\ _(-=C>E[SH P@#6,&$8X=,8. 2:UD7X.FJ"(J49WS)M:I1
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M:@DOWE\&0Z@"B=P<BI#TFG5H0X P19YR[@FITFK,Z" $W <EH)NQ':MZ*>Q
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M3(<FR#& ( 8NS%L.$(TA)(H<[D"!+51I(F,6GJXOZ&I&%E*M5S-3?ZP55$Q
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MG![Z?*&0:\ACI=JQT><P82:A[^:NP%J=$9 9D_;_ , =B \U"=(E\UPQCCP
M@!+"WQWIT.)C+,P!P(@!0D3D#9L1Y"$,RE<SLV/0DHA$EP)# PTTB[O]B4V
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M-T[+<;UTW"8Y;CVG9;B]+WL@1,TU'3'$)H:FL-1WIX43)%\!O.;V= ;M0X8
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M)BF'2Z [BW&0=(L<+QS!. $0<#9,B)O]>NZK_),'9^<PU0H+(.)G7WUOHB4
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MG##>_P"60<D79M32K8![(LSB7@5'O3I/9,DWPP>ZU^&1@DHSR\C'KFBID(Q
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MDDDDDDD#XO!N/CDJD2XBN!;I39&9S@\CIKS!!D2*R8H6440;4=VZMK-"[ (
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M?_RYB!<$C* "W?TCE<,9&MNU:T9!2!RP$Y$-7;M9#.".7( <6[V[F4/B$,L
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M_6I?Y7=/G^M8T^3_ )""3@&E1DF H .B^+^!!!< SAHJG+?\.OIZ_KYWPF&
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M!00# 0$! 0$! 0$! 1$ (3%!46&AT7&1X?"!P?&Q$"! ,%!P8(#_V@ ( 0$
M 3\0_P#^ ;RJ<QDPYA(%4:9)/_\ '2RRRRRRRRRRRRRRRRRRRRRRRRRRRRRR
MRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR
MRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR
MRRRRRR__ )EEEEEEEEEEECBF/^_^Y) 04%H R( #A<'*(0Q &F55B@:'6!,N
M++-%:TUY@63Z/6,\1/<5UU8+,2O\]:(SI4/=)U>E=/+U]D"X K2/0F#T(_L-
M(H)%FJ,L !7H_F!9QA6) 6% !M0-GI "$ !T'_->0/>%2$H@-PKC\>F/P=N$
M6!*8TR!=U=P#F( E*4)*/@5?1FF1)(&0K\?A6UF/HBST-L>HF.RR=W56]X-1
M@B6PP@@GN-U>D!<IJ@"+N@BVGV(". #1AO\ 0UK (&(",+-H@-%5.585%NT
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MNY--X J@8R+HC5CT10 ,+FR@S+MF>@Q@'+;;1A4:,.B-X>5J=&D[Z_$8.,*
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M).LCX,B)6$&\X!@I0'40E43#%1444 &9"J-%29N+$4LHZJ]68@D J=*V-#"
M8C(%H')1-<0>L*"2@E?J %28VP*B0IU)9)LW6Y"ND-82  =$+^4Z7%P*P6D=
M72I1-L3A_P#S4I5M'7Z/^V&)VA095FU^807@$'4*I#+O6XH$!4S#%<8?!AXW
MU4GJ@CH[@4:M [RIC7J U:> NE[JL)S50-"'FM@Z'"?$R<RZZV1T LK0'K:T
M"#O0" ,GC_ <!#_9)(9<72F+YRCH@DWF@H/CX9I2-6 C"$@%4 ';Y.;#Q#HU
M!DZPM3&T:X0:$@S2OPTST<#!  :F!D.SHV>\0-(@:P, <A0'YN(804#; DV'
MB&7\0DA+S B(+%01@_BQNC,6!-\C.W00;Z%)D!0TJ9J"VAR($)@,&^B*DL+0
MQ6^KJ5R!-[M&N4.40 4230 TPJ'&*?0B V$BK4&M=-(<!JZ)#62QC4X5-91@
MLFJH8O'.F,:JA@,&=3OHX$)15%<@BL&>?]$!DL* $!&1N#]W0AOZKD(F6'=#
M>8JG"9+@D;05)>P"MI$I[B0[ 14@1:^.5;(*8L>(IHI0]S1& ^'H@H+6IE4Q
M#^8/>K2 @6*+"@3AO\XD:  T(I:7O""8>=4()%JJ%1US@WGP"%0BK/D72C0;
M% LU H32[A\TM"L(98 &'TH[/I!YS@@&@661#.CME2!"6% "@>E?Z'HF[!Y^
MY9\<X8PE/B 8956!=4[Y:P*,2'#B&;9O6) R %,"U/Z-L7> 5ZOV60/WY6C@
MXAQHB &&>.D!:C/8H9:,Q3B73SMZ"B]*X"V:BM$.2#794YM8&'@@0#7)IG\.
MQ&4%'";&"#B3B,OY!CRE70-*S'WA!;B:"@$&0A&O]2 K&\])@;L)%P=B?XX]
M;"%:P *CD%WR,.CDT0%,F]*$+MG!P 7-=$"B*HJ/;,=3"M) $,6!-1H?JM"@
M22@E%$A#\*AAJ@H&;F" 11/HQ%<,!"SF!F)Z?(A N@0"80!4!V*F&4.D 8DP
M& 5RKB1&P<&BQ1DD!4K!&V]( 35,#A(("U)56$/GKZ0C426(: UJ,93.["*7
M"0TCN#@&2;98@I? 4D9/2!%@'@   5(D5HPEX-!&ITO\L#"L(A+#%L\<OOY_
M^A06LECMP@ 3:E.JUU@ )!). 9AFS"FZL95&=OV B%#:="SYVA (2]+L-%B3
M"!HVD]80:% #BZ<!TWK_ *19J;QF)_G\ADF^&-?]%0#G_P#QM#(=A$,AV$SC
M9%W6&FD(B  $&@FQ4CB-@3+WK6?C&?C&%A2<+\ST3S"2-X:(ROI_(88""&CO
M$X! 6JHR3F>YC77>D^YP9>Y+M=*FT$ "@(3@,A!<2K@ <^OU2%@1"!8DG\'U
M=8"" #-I9-*Y.D-:.8WG*-;$)8*R@$@B(!8BE^PA* ($$#J(L3 "" (;@ @/
M@0T.  )+J TT=3*67NG@:7.DOAP!4=(4-+(. "@=$(L^G6W2UB!3I ;%,C'"
ML D  (0"X'HA $(@ ";H6KI!3@L(O$>@0?!) F@.\(  @H30 LJP% I%&S8'
MJH @(KFM56$SL&.!I,O'HOF! 0@+#R<O')%Y!]<($$((W&<2B@GLJ\F!@&IF
M*!"EX E@0<^D)@ %B;B *@A)< PE0 8 1M+KJ97V38%O._6RN860"!J,!57M
M"35TY0GO, P@(89-YJW4'Z(O+4<VK]JH3-Q#1>Y@ !RP+0TU6&4"BD (#8+A
M6E>D(G(T$$KD&]I8!A8R]UE BH&X-NT$$KA!)V8+%(29HJ$/!UJ3 - 0%MEN
M8L*@' \\QI6.FR E_)8E)8A&1B&;J&F\-"H%B;S.^""%T;BKI*8%,%!@.=%"
M$!$+24&(%0=XGRPK!%1\P^J2%(9)9DBI))S9<!4! $(@>O"$:@C(QZRH10")
M(S-W[3_Z%  ).*J\$QS\#W<^! $*D0P$Y9=X7%56GD/S&$/95MC2@RL#TC9*
ML#8)C'0X*BQC6(#JQG_,!>]XF B30@??SA6)FRQB9MX"Z_Y>>GV/_D ($JYG
M4>K/+VVE6+?_ /BEQZG^_P"$"<E*.:<:,:,:<5M,L/??F:<$@(5Q_P J"IL+
M],9IQIP2"6+&V'_-KY_I_P M'7Z/_.+X^_\ 481IP>@7HO\ FT]?H?\ -[X_
M@_RU\_P_\@U+/OI-.-.#<JS*_P"4802X0>@7HO\ M@5-A4])IQIP2#6PV]Z_
MY:^?X?\ Z%!)")E5DO =5_,>_P F?.!0 % "24%5+OG!SIHB D$!R SFB,;&
M*]A0T;0#469S_E0;F0-*B*@KNB&"':$SX -RMG0JJ+XI&MTA/ )(54$,_B$+
M!?( N<2JA?# RN>(%!0 900C%7"BTB!8T:4"VA)&"-, 4X\0HPA$%$Z:=%C"
M() $@*HOBJ]NH"H?(]KZX!4@PA3I'H3AK  $BQF!W!,#)F"K0.Y]Z2I%H )[
M.%5K0(C/ 0_,!B<&P3@1A#R]5-B!0+1A*\3F;4@EA@8HP1#2=H))*JA0#U0A
M$H8FH $YQ)4' $;P$+0# %P-=8: @$2LP!(:)P(BK.E(#^J567FB S.0AFH@
M5J%79^Z0$U =!!!QS RA D"" =0'W\PD* EIBSZ^Y1NO D.M6*6-.G5?_P )
M)DDTJ3GQ'S&_$"S>,%Z)I]WF:?=YFB>\ZO> -@_!FGW>85%!L*Q\QOQ'S&_$
M?,;\1\QOQ&-R%BIU>\ZO>44LUCYC?B/F-^(^8WXCYC?B ( ?X#"U<?,;\1\Q
MOQ'S&_$?,;\0C-57W_K<^\ZO>*/Z9,?,;\1\QOQ'S&_$?,;\0$%J_P#DI)((
MK'S&_$*"R13_ )0.):7FGW>9I]WF$V4EA>/F-^(^8WXCYC?B/F-^(W/O.KWB
MC^G'S&_$?3WXCYC?B/F-^(^8WXCYC?B,;D+%3J]YU>\HI9K'S&_$*"R13_Z%
M._\ Z$N'7Z$8%8NW5BNU(,@58T& @!P8$DPK\-FDQ,%6NC5HX0D+&J0QD-'A
MT-99ZX)$J%#I4DX5"@* H0@DV#*R3PH97*+-Q)U!T30UZPWW7A.\B!!9*6.*
M"=S*L""4""L%^P@HB"Z!8@"Q.=[T(6$(<<00"@.Y%;NGD, P@EY#6^-TKUQH
M17H =P:UWK\WO+(^@+@$41":&3PO>&&'$!+0, V(#+.1W"   R( ($@&22>U
M.L$9063%*'I:F/RD=,,RB#) PI1]?D.'N4P!8NDH!0W"TH#2%5N$&H1 8W!^
MY0 "E2%"HD5RCV;X<)PTFA$=19PLG4I-"YT-;.UH<%%3BJNDOHP$Q:&A (E2
M28*XXD($DV5#!(9()0]1H:FG96-7AF&"3B5AJ\!7I"FMPB<^F)\6ESTBD10H
M'I6W2$B@(%R!9 -4;LI/8U,0P0E@:,_(]NH1BJ6A9=;VK4?$*QB  U;N;^UH
M?_Z\4[+^1]RWX#X3^A!=B;@T&3.@)"$$N&0   +Q1]?#<+P20066B<=R<8B,
MD*)! 9;+ H=[PW()+=!" *NOS7((X4QT'4; %@WK E(.0T[Y A6[=XD@[@*C
M.-&9](;$>0@&0 9%9ONX)W#NQ+N"2&#M<,PPOUV4#80K%#")EHJ'"- JS8!Z
M* #+Y6!"V2*#.ZA$ 0?!"Q<&#L?W*#(@2A!FI8)4.8,:A1'%8QRB388#'(AY
M@KH/$Q7!J&W1D1$' R3J 1=UN%"@B' @ 6D28N@#A?'$)H0( "1%E_#T@_ G
M' ,&A4G6XZRGY4!,J"3@QZ9PS0W!A4X Q(!#T%@+%L>O2'VC59Y!!1P&JK[%
M<E"@&($)8!<7A=4&-9!6I8#7=FE7+-B2X0#D 2+$%[G2F[Y@FU"&QMD3$,=!
MRB"AI%E3:L*E#*PD.F"P2L#O4?ZP(=ZBF%KP,  P2+G##!GOC_\ U\H +![/
MW  H $$P"(&","$OV'M(54%:@(%!9# X^ .0F55EDN$3BW .SB UY#3=>HSJ
M=;&@^TA!9D#(ONQ?ZO08$, 01H5]!QGP6;^:XYS@X8Q@*YK5%0_Q&'7!+ BH
M%:A4U5*E04=E:GB@E""=B0"02F LOI(.]$+(O=$1 6R1!(%.03(5CA2$2"32
M@"!8K;0]VFA0PL!4@TR&D'1))P J#\)HT0L! @N@6, ).FI,D8V9H3(EPP 3
M1+04H<,H*H)/A:@8D6=:Y1PT, )@*U""&E"! ""!CVM.K&D(5R,E!BIL$$MF
MO2+YE8W17J35JN:IC!'R!!P%-!O *C%*(*4)RKBD 3$I8I&U$XO,@"))('$9
MW^(!_"%$ Z+PP G:]W&#I#S  WP&HZUZP["<8A2'*@Q X=2,$; (&@&$,2"0
M)U$.ZZ: 1"J$C5?$&%UJV&.8X"BS<-\^KE/$X!T:FHP0$J&<C DUSK:_5G_^
M#F0*4KS&<SW,9S/<PI$# .I)'%HW5C#.+"I :@DDUA-VF(-"8JJ,4/KUU(U=
M'&Z5^JWTK>4\1:KITG/S"ZE2]@'Q&)0Z9<^ M N(:H==_P T),'@+" &D2U?
M@3<XRAZEL@ 52S@Q[0",(J"$B 0JW2Z5A_V=+@JC+Z_QP'%8). .!IBK(SC+
M30KB2@&#((0K@N\!#8Q7A-**%]61K2\%@3E 8B*[]K0(!.@ C (%/(.VH$(A
M&'@KH(-*UPZ0U! 09 BM1-/D(J83:@&F'8#!*H>!P"!Q4QA0TUM"95#4#K8T
MI7-1-K(*R5R!T'VLJ4T%$-BSK"![0 0#T 5.(K3)0B EB,&@TJ7@J5ZFT*^B
M5)!**"584/=1O8$@:8%@4H/5A'8J*C#HU4HTW^#"7$$=1;W)_P#T-CT,9S/<
MQG,]S K[1(T -WHZZGNH6DI!R@DW&M.V$*(:%YK@)U$UZO.V>WV=W2AK,+W[
M,$T:B\>"GKVLA]+@&"2.\>57TZ0%EE@(5D*M9"K1/.$PLR54<S7!G=4=S0@T
M4!=HD0QN\%>EX X(1<P46EB*8O.L&1?B'<G6CMEK0J%C,T"4K@ O O0X"$3&
MBG8 I J5.'>T#5)@=5*)( !>AZ90T"A$*!<V%/LZU@))-!&%:Y@"A9%9"52J
MY!!:I (?*<"6"0 !(, ;,%B[RJU22@LEF@.9(P<.$6H8:H19(<+ZA& &Q&T
M()-1_*$ MYTKJ$)%(T $D ,G-ZYQ[E0 N W8N#7?4)J>L!3%D0%C:^JBF9D$
M!BRZ/XHX*[\$4[R"!FKEXNY@@E U!H"O?DXU4 ,P'!5' 4^1>IC)-&E))O44
M00%< 'H93S.4 @D6:$=06]G#J=D!(A(M@#!ZY5E.MD H76I=JC/6KAQ@&HD>
MZ!#I9Z'%%PP""9,!B*#U5",%8QRL!%X.JM3 Y9?.8H7B,Z_"PN<,+^K_ )*"
M=B-NQJ_)]BL*X1]D$2 00&X6-#E>"4JX)%XD!+0,H=,E";Q5#7GHM8N@G,2
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M1''X@=MK+ZE-U<E  458 Z4O+)PP"F/7LK:="2 R" 8 %8#\LU&4/?).:1S
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M6]$$"K3<8,?,&#F, "! $A5QA8:%*C]2&(!   )\5@W*=AB!183#*GW"^P*
M!MH[,ZWA2OPW @!6@''*\1[ J)_ 5HX%&04 INEV>?8PG 1,"@LLZVP<-P%Q
M"1!-[\2%,T(ITR0MG)7 JF=L"OE"E5386A9HW_)2   %5'Y*PQRA\BP#53$D
M^ KNN5&0R$IUA7XI!;W"&2&N"16@&E<H?7D@(80"YW>=Z41 ^68*&B1!87'R
M@8**! @;$HBLU\16$422"$: UH"*!NAM_2142C78N]?\!U[$M_IWJM7I "A6
M;2->8R..$&3[M[P2"X:KK4&#H(O$ @6J0*4LKX&!@"0 !(@A6B'^*(/KWT04
M*@D$ $<P%>J'O$<^K[.+.X=>Z"TE80_Y;HCA83!_<J"DJ=X#I>P,'VC)%T@<
M@M0BO1NM=(3K;%=4[H]6/+L-'$D(  O3 5,&RT-(0H,"PP);;:K&'T-8 &*;
M#9.L4Q<.(FA0%6M#UCFY+PH-TRS9#[PK'5LA H 48(L&H6U-$&!EBH46!G>%
M-82(2@6QU#&=1@91^U$* $P14F@J=B+\T !1JR&B1=X4<1O*?# Q %@S^8.[
MC5%(*B.ODF!91$&!.KH&1GIDH5/Z&A6>B/LJ"@4?R$$12F[IA"K? K= D NA
M7]BDJ6(U"@ ;/7(4AS0,C( )"P **BB5, 5<@#*EA57%W8HX -)1@%JD  M9
M-EJ-/BX&(U 014J:Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,
M?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\
MQ\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?
MS'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M
M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'R
MW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?
M+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q
M\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S
M'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_
M,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S'RW\Q\M_,?+?S&-^
M[_2D!(&" "22!!I?WI#S8<B8!&+)HKXQ*!D% P0;I*^^=Y9N, (Y/4CIO*!"
M\\?+&T-ZWB[ ]<!A>@C>YGA]>8$3@>CEB(]ZP#\1(!4 ]<"0H<R8HO%B$/7"
MQ+DP8GK!J $* R'X,$(ENAO4'7- 4., ,I< &PQ@DZDT.IES:@(2Z $&Q)I7
M&,@ &"'FA(! ;RZPHD;[(E,  5@]!02F'.85I0&P8MP.$2C$D:Q;3477%36,
MJ*!;SA0"R!A<\EE%&A!(3K7!PF 6LAPHR$@58%9:Q^*"1+/2I$ <:&@KB00@
MV,& <R%0[;F YXNSMD$JJ.-# S<K)( !0J (PC*&5@W8$-1HSG!>VP"=D3M
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MN5= "%!8)P8474JH@)9 *$:" D'7J08!8L0TAXB4-C&HA&$3@(L*H+</Y:\
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MCQ-+<<S2W',055\@1_@@(E7-7\1>QA>QA>QA>QCT.'R[P^7> H5K,'B/Q#Q
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M:>#3P:>#3P:?NC3]T:?NC3]T8"O)&/P#'YAC\PQ^88_,,:>#3P:>#3P:>#\
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M DU#,+TZYJ$,,'FZDB:D+%N]7@*ZJA"29L*!=L.NBV!#H3%[&HHF15[0I=&
M<!@55U 2O",$ *+5B]4'7X6<1(!MK&I4% 3N:FD)@=&]\TH1(]<< "C0E+D0
M' K6"$$,B!@E@HX]E>+*-"G\^X00Z" F2^)Z<0D@BA 0H,42K%C'[ARM$HD)
MU9&=+]1&H,8B3Y 6:+6\<G!P(((8H5A :TB@! 4H3C0[=(#J&0"0;9U A9P4
MEU98(@?,I Q8"= +HV3!XC0B 45\AK*J@H0)-$)&=L=@#I 2N0CTKG2$P%-
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M E%JN_\ 1!*,94*]\U*A9N"+] BH05U0JHI!V-85)$ L,AKA ,0 $P@ **P
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M@<1CZ1RA@!Y2KJXR@="'V.& &$1;'U!B %1< )+9BODB I@LEDZU5;68N0'
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M<'$X#Q)0*L5!3@$*1<8L+21PXY,D @*2K1LQ=0,KHS ZG%)5&!S,$HJ2L
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M15(H_P"P@0,!&X$ 2) 97:\+2Z$T(CAJ!&-(,.K4H@#$25A6K<*S,AA^34T
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MH0A5*6 :T$*$"4 ("0SW0OC"(5(A"A@\"<]: ZHA8*D(C^_\[G_)O7\$V?\
M3_EJ]0";$5OV@":SOFQ L/Y ](Y_Y.'[0F:"G2L >(\-0+$ 7K>T*T'!.P0W
M 5<Y*&@9"(!I%%0"3\G,!/IA6Q&46%C7")MWKH!DF!)H,Z06+()BV $'0$4R
M@@3! !DE$V"37O$/8 158H2F2+W9$J7@W4$L@TT5N]8%(?A#AQ484L9P.U!V
M'5$A@L*+BWW+)4 #6BOP;&<)7  4"0H:5![(\7P(1*J9R"+88P.\@TEMJ!0B
MC"T%0P &&0*X$DB,W8,S<A'RU\&-U1#P(1'Q_P WCI]F;#^)MD6]/]"6?]#(
M0"V)I01<5]Y:I25@Y) 0=+,EH0\DR$TFD<5A59:)AU#\!0:FA(W$8F@"BJ %
M-4 "%C!QF"H!X88-"L*1[LDD&NPI5%9""KV7%!U3%2I-B8(:+FHA+43 L$EU
M;@E,N5R="$,;L&ZN8$&KA4P0 (=C+0GJT$69)!&X2'A FQ=*@$#@ " 4(*B/
M.Q#@N5JHIF 06@R4DT(1F!&(SY<GPQ-D84JH$K" &A)_>Q!@"=K,EPK(1RQB
M#%6!!.=0Q[6D  N0'@ 6@S<:J&P51BJS:^8""'8:CIAM_P 6'H?Y+'0_R;P3
M[OZ)?T_R(?1K_P#!1A:8'5C ?';N,K-18%FT%D,$_P"6/V&%5 2+("Q478$(
M0/ZHSAL&ZM6'$[(4  @F:G990](QKLH(8-$#*)O)H3#R-) R" ET(5ADI)%V
M#3.%8GGMP 1@.= % "[,'/\ =T1!%"QIA7X@SB>$(42$B";X5A5Z8U $-4L#
M1?(K V]$&(H0O17PKC*R^N,PF  SA2HP<$;)TL$! +,&U0%$4^L0QJ1E?I<$
MX4TP<(Z#8D-''T5$<P0:X5'>E(+^A^Y_<_\ S9[K.6=/T/\ LI5I+D4,OQ6I
M %?J5-M?:PB+(V;,?V + R(TA(--%'EUT^G%9/@ "44 52- ,:RPO*1&JE@.
M.<*;PDYR"<63,)A!(P 9"B%&<(*#P!D"6"R*%&L+G,4LB "43P"L)6A"@ %@
M(B'00F<PI(@)(-1 <!0: !J   T@$#I0(LINRC4,(+@8#@!:@0;P']4*FK4&
MKC6&C(.PDZ,GF<8Q%!!0P@%BH,( !*@8&2  00N: +,%P> I8Q9M"7A;#25
M@0!# TA'N!GB+4R$/"VPLW4D<,Y2*QX00H1"362 PBL"DA:9%QU,#>FP#(0H
MBA;IT<$3: (#(* #/#JQ&,L\D$!&,T($+*#B*&@"0R0L!AVM $Q5@!D;Q0G(
M9&$2@'^QLA 21K36D)!\$[A'4#=2MPI$YG$O[FV%HNMBB  "  AT.61B/ =
M"0$&H$ D';N;@)2+8FLGO \%!P$D@-,36 4.0R 0016I6%!T*J9)).*Y.,:!
M4 "$18 #0V  '9#4<Y+H ZX+#O>5Y"(!YF$@?Q"L: H "@!0"@I8#3*54!<E
M0D2Z[E0B7-2;]Q/5T3^K^#_W>WS+GS_3#) N/OBEL#JL@,*Q%J90<JPC4@:9
MKH6;ZWA(0 HH EO>\+QZ8A#(@"-;7AUE!X3$:.,9@JTH8O'\$6Q2?%L+0-IB
M"+ -[D.M.)41QE%?+;#$O6PAX=2Q*\R'40Z.@-(@C>NAM> X<2"#5!%JRL&(
MN.@ ;0<$QO+*E63IB3_8L)/!(S,"8""K&02$-1<+YYPG"$*^! @+PT+&.:$H
M":X$A\*+ 8X1Q"2J#OK"EC! RB50G 8RB!68 VQ>/X^X0%IC.22)* :DDPEJ
M36 6G0DNV1AHZQ3(]B4-5H$OA96A1G"!8$*A$ C,B"<,>D #1"0"YF]0)+E,
MQBE-+$$@8&G5P $4!   9!#:&A0 6Q=MM]YZ.AESIC:_Y_R@RQ)@Y&&%UY "
MP<6!490*,*81!!@. 6,3.:4448+I!YP?\IC   +(8 O?6%V!2@'(@$!08=H%
MM<C-5=FHM8F$P@! 0 (0# &F;@"%0P"2P%K)!0UD2IB39=8UNW#3CQ<U"I(
M$FVD _YZ!3< -$*TAI3#FA"+!!!IF%G27XE8,24KU95BN@RO(=Q0#<-VH*P1
M$NVH #"BH*2J69D@G[@HY@H/4"RB3-X( 5$(P!I0H 82H3J  =: ("'50F__
M #N?\F]?P39_T_W0_LTMSS    B+'*#0"(9" 6Z%O..IRT"R2:@3<DWQ,.T
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M58O^=R"0"I!'**D6'9Z6:"HJN&,*&F&":XC$KFHRK'9Q3B#P(&4,>)2 N@H
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M-4""P"+U_I9:  B2:BB($%)O@A#:%!%01<&[#J<K@G2    TC4/+"_R+=(:
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M#-T!(4?"OC!8M671*%QP/V8>DD6(2AA8^0QV@^YME<]$!;L!7I!DE!4!( 2
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MH:B:B&7#M:5S YDH 8C."'\A&[Z(D,S+(Q)H[G),F+TMA:#KL*,FI@^W#+J
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M%,(@D@L:'.'&<O !="32Q.(JY2,HP*@++!1#L+RNYD,I#8"T35;N-%\$54
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M?Y8_RQ_EC_+'^6/\L?Y8_P L?Y8_RQ_EAKU9>?>\?Y8;OISZQ_EC_+'^6/\
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MKDC^Y4"55KMKK!7^6AH1L!)%6@IG?RLJP6L(0,*UKDIABHG@ O+8A(.HS5H
MP3V\).;Y=8#6)\=>O\0T5B8_U _YO7KUX>JV%X=^G>8F*25[0D)>8+]8_P#N
MO7KUZ]>O7KUZ]>O7KUZ]>O7KUZ]>O7KUZ]4&.GJ[Y9S;H4!Z&M%8>4![3Y'>
M?!;?^;]Z]>O7KUZ]>O7KUZ]>O7KUZ]>1?7/&\8"3E6A\@:\\H.6DJ%8RJ Z[
M0-I9L8%+[$X=3 %7$%0&V6E/B-=9C*A*FID?;$P2@# $*A)?WJ>IE] !(="
MWB[]!CE_YT<CV,1R/8_] (93+ 8D+"6'$L 34@@U^2)9A 2=0&4QUI\YP:L
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MLE0V1?<PF'T5[LGVLL,*:7ZE@S#(? 6]3.E=&??F>XYGN.9[CF>XYGN.8I=
MX6U ?JSGP"@TV!E\UXE>58**J2<,_57'W',]QS/<<SW',]QS/<<SW',]QS/<
M<SW',]QS/<<SW',]QS/<<SW',]QS/<<SW',]QS/<<SW',]QS/<<SW',]QS/<
M<SW',]QS 'HI9=LP+VJ_F%PD0[#H7ZX*R * !IZ3TBHH.E^XI[VBII4+6["O
MB\2,%\.F%:3W',]QS/<<SW',]QS/<<SW',]QS/<<SW',]QS/<<SW',]QS/<<
MSW',]QS/<<SW',]QS/<<S)["_C],*E\E6^M8 I$*G^:>XRL3IZ!K]=G%7^$'
M@P@4  H R&F%SE9T-D=Y<+O@>OY2 ;4H4 81L,=;?4T3Z%[K6:)[":)-\!%E
M/8193V$64]A%E/8193V$64]A%E/8193V$64]A%E/8193V$64]A%E/8193V$6
M4]A%E/8193V$64]A"H)1IH)H=PXFAW#B"Q4)S_1[VGI3F>E.9Z4YGI3F5XL,
M5R2ND5$4D=[>]C"":(JFIY..7SZ4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z
M4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z4YGI3
MF>E.9Z4YGI3F,:'-=ZG^]<8(DM?1_"JM0Z@- _@PFB>WF 9!1H1AYGI3F>E.
M9Z4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.9Z4YG
MI3F>E.9Z4YGI3F>E.9Z4YGI3F>E.8!T#[0D[0,56JU?U6I!7 FP*Z>TPM!S#
M(KJ#>Q'%JD%U3U8<[ G,00BUW_5;6VN&,U>W,U>W,U>W,U>W,U>W,U>W,U>W
M,U>W,U>W,?<CVYFIMRFIMRFJVYFKVYA-<CU YFIMRFIMRFKVYFKVYFKVYFKV
MYFKVYFKVYFKVY@&!#=+D?<?Y(-K.&E_9J;<IJ;<IKMN9J]N9J]N9J]N9J]N9
MJ]N9J]N9<$"$/-LB84"9V&<_<<(L+L'NA&*QA;+NR^N/_12KJ(%#XDTCCBK6
MU!6D')10X:8$V^<8*0A1 --?A[C'U^3DQINPYFH[CF>@P12A4PCUJ/6H]:CU
MJ- /O^I4:.^':^6U)<IO=ACX2V@S486F&3[S%TG6D)"TS5%P^L%/2H]*@ +0
M]O6F4."(UH3\&/6H]:CUJ/6H]:CUJ/6H]:CUJ/6H KM33U[U'H45:"KBJ]3@
MVSAQ"=ST*34/&'!$=J_0:89S,$]4=J#^_P":,)70 ?R-+(Q/?<PAS@Y$/Y_)
MJN\:KO&J[QJN\%TBA38NFNW6\)6<46 C/)]Z5I#ROH&U4+:]\)JN\:KO&J[Q
MJN\:KO&J[QJN\:KO&J[QJN\:KO&J[QJN\:KO&J[QJN\:KO&J[QJN\:KO&J[Q
MJN\:KO&J[QJN\:KO&J[QJN\:KO!$V6Y1QSL<:>9;1..%>ORNU\PL1LE3/KA]
MPR^=)=$\/YA>##[KHB;*OU$]7P0/?1A-5WC5=XU7>-5WC5=XU7>-5WC5=XU7
M>-5WC5=XU7>-5WC5=XU7>-5WC5=XU7>-5WC5=XU7>/V(_0;3\80+K ,*'NC4
M2S@- =7<)J_.KYK$R !H  *YBJ657_ Z,0"V9;9_G>5$+G#L:G/<44_-',_-
M3\]S/S4_-3\U/S4_-3\U/S4_-3\U/S4_-3\U/S4_-3\U/S4_-3\U"@5VP/N?
MC\I^/RA.0%:$#[^)I/76:3UUFD]=9I/76.&!J&:Z[_*@*.%0=LSJ*'LC A6'
M2X9^7V]6D]=9I/76:3UUFD]=9I/76:3UUFD]=9I/76:3UUFD]=9I/76:3UUF
MD]=9I/76:3UUFD]=9I/76:3UUFD]=9I/76:3UUFD]=9I/76:3UUFD]=9I/76
M:3UUFD]=9I.XYE!+I<+#YCD5C8W>>-;^F48'!#0RX]M/WA/WAS-)W\S2>NLT
MGKK-)ZZS2>NLTGKK-)ZZS2>NLTGKK-)ZZS2>NLTGKK-)ZZS2>NLTGKK-)ZZS
M2>NLTGKK-)ZZS2>NLTGKK-)ZZS2>NLTGKK-)ZZS2>NL;<%C7S $<5>FU?L1W
M5VKF+W?W8150@0D15JPQ'7M#*@4J=PU*7@0J-G%NM Z370UT-=#70UT-=#70
MUT-= DU+^H] SZ!DC)J,-= ELMW'H&?2,ZZ&NAKH:Z&NAKH:Z%B'>M'Q'J,
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M1%4G%TK'58Z-44&. 8"U;0IZ@B!8;&H38*F9CG);@DUGK?N3@T51?;P%4:A
MZ:P;9^ UY(-HPYWLTJF"UA)4(+NZ?#E1WX!)2^*5I4@RZK],N0;8%"%%1$Z]
MY*C%D 6! 1I&WB%":!=8%BUO&,'Q$)],-*"F%@N,J+"8VH6I/6\'+Q8 $8!)
M6=%:!'A<$<@$A4U-J0<=K<L(0CB74EZ1O!PP30!DD( BZ45(75V  38#FS5A
MBF\7!$## !*(7P@M@9DBC3DFJ$?4(2!OT1$17E@KV@'#.W,A2K5<6Q2$CX'
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MBX  $  ,C[$) 9E ,2#=@E^M), D!N8 LD%D5^H,=BDD$-V -3R(=!@)1(;
M  W2NF46U$3  2!#.KKGWA  &* "XPIG$=.XY@!)3#ZB$@,!Y,>^Z0X@D -J
M#$=.XYB.G<<Q'3N.8CIW',1T[CF(Z=QS$=.XYB.G<<Q'3N.8CIW',1T[CF(Z
M=QS$=.XYB.G<<Q'3N.8CIW',1T[CF(Z=QS$=.XYB.G<<Q'3N.8CIW',1T[CF
M(Z=QS$=.XYB.G<<Q'3N.8CIW',1T[CF&ER.XYF /<(0BB0VKB\1T[CF(Z=QS
M$=.XYB.G<<Q'3N.8CIW',1T[CF(Z=QS$=.XYB.G<<Q'3N.8CIW',1T[CF(Z=
MQS$=.XYB.G<<Q'3N.8CIW',1T[CF(Z=QS$=.XYB.G<<Q'3N.8CIW',1T[CF(
MZ=QS$=.XYB.G<<Q'3N.8EEW',%T0;52!7Y_(6(D,ZB(Z=QS$=.XYB.G<<Q'3
MN.8CIW',1T[CF(Z=QS$=.XYB.G<<Q'3N.8CIW',1T[CF(Z=QS$=.XYB.G<<Q
M'3N.8CIW',1T[CF(Z=QS$=.XYB.G<<PX#YOX "S#'$#UH$@"ZQ1J\+P1P!-8
M%8-)0:U'6%,=Q<*82;AN$,W!BD@-  ,JB;"#><$)!4)8)8P [-FV(B&0["(9
M#L(:0$2/S6RP]HH8TTH&M6!DCWQ)@A($%,,":Y?>@C9-HV3:)D.PB&0["(9#
ML(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD
M.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(<!VAK((HI@
M#/U?V#$2 D?[TPVTM# 9 )16R?3*'(! %K85^/>LH!@;>B(9#L(AD.PB&0["
M(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L
M(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.P@ 5("%T,,9KAQ
M%53"NNE8TP% [W[^Y4($"+!@TR/@P@8%8,^@@A&ZM.NTUMCQ-;8\36V/$UMC
MQ-;8\36V/$UMCQ& A8FQ^<UUPI>%BB::$(8T9>F&BA2=L@AG($JV?\NQ6(Z
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M^0.9'!,GK+&-:_YUE+M4Q6]@USEG"]"A< B<;T5']@SKX^HQ5'JC"]O\L54
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MU*R?@'X/2J@8"- J?QX;OD650LV^6.)A!,G*BO4-B/@8P T1L; ! &H7RQN
M>(4/4'VNT1AH8"RID1FHN@6(JZ8SJV]TG5M.K;\G5MYG5MYG5MYG5MYG5MYG
M5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG
M5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG
M5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG
M5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG
M5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG
M5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYG5MYE UP.$PQ\GW^3#'R??Y!3ZOZ3
M]R_I_D0^C7_\9GNLY9T_0_Z*/L'4?4  +,49D01AY@G%\]#7H6I6R@!GHL[F
MG2D*F' I%M<S_F,]0AR!E$"A597-84Q($YKEXWC8YLC(%%<6'VX:YBM4?F/R
M\'0F2Q^+%Y^F KHQ21U3R]4,#) "+14Q!J*/Q"4E$R34PJS".X.J?V5$[R1]
MG".X.OE 2L7H9_D1<4U4[R1]G 0H&3D )[.$=S'41]P'*!"+@,1\ Q^3A'<Q
MU$?<& !1#&!ASK"T!&A8#'%T_D"D4@X$50,K*D94L;6U%"#3^'V/<(@H/SDS
MUK';7R1YA"I^0F/@G'^RNG>2O^P%L3H_\A60=FCZ,P%L;I)(4(S=$[9QY(#$
M7"L=0YVUZ:;SOK4\Q09(#.S^Q&PM@U3V#/S"4F,05;]QK *P$Z6=" ?B,:/6
M*-=;Q^*>8_%/,?BGF/Q3S'XIYC\4\Q^*>8_%/,?BGF/Q3S'XIYC\4\Q^*>8_
M%/,?BGF/Q3S'XIYC\4\Q^*>8_%/,?BGF/Q3S'XIYC\4\Q^*>8_%/,?BGF/Q3
MS'XIYC\4\Q^*>8_%/,?BGF/Q3S'XIYC\4\Q^*>8_%/,?BGF/Q3S'XIYC\4\Q
M^*>8_%/,?BGF/Q3S'XIYC\4\Q^*>8_%/,?BGF/Q3S'XIYC\4\Q^*>8_%/,?B
MGF/Q3S'XIYC\4\S6_1@?%?3-#L+W[Q%\,(%_V#1D2W+J#&"66N<8G5; @AB9
MLC^1XM- @,0;/-^D' 2H0*J"<@%\J1BI0"0<255'TW $0R';W.(9#M$,AVB&
M0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(
M9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(
MAD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.P
MB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0[
M"(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#
ML(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD
M.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(AD.PB&0["(9#L(0$4!8X
M0 - )Y"88MB?<?Y! )5*_P"F7]/\B'T:_P#XS/=9RSI^A_T4?7/<(9!)!1!$
M$?$,JP+-9$0! (:B*, HJSU@!@$@JDV2!4M_Q&$;#(14H 1=5!.M&(#+-AU2
M3,W! U@$+2PW1<'JH&E(ID=0M)( B[)2@BA>B.R5#2/)IHPI>(P$A RL6)#1
M%8!4II$-BP$!7. O)$91 .(UR!L(/:B@C7R,G80<&;!5+FI1N5 $$B'%Q&Q@
MJ1(:C;N7"HURV0$.Z"LA4M\"3&,C\%VH X3P DC 0$M5;8E7K](/Q&Q4&L$6
M$'LN6! (&@8%"#34T@R:A&\($*&Z@/5PRB!  "0EDE2BCF()&  XQ$  #DM>
MD8JB &9A>31VK3I!*KP JC@4N)!.@L"P,40J1B1I98YP(%@* &(* $@"VS%?
M!(<D@D,95!%PHU*YJBY^!A:U:0N\VQ DA4&2"KKTK"S\'&BU@C5M*+B@B:D0
M4$10Y+0*F@5,C/)H ++X1"0\6R#'(C1)$DA)E)Q."S!9!CJ50:(XQ$.P'IR%
M4%7^P@Z I@&)T((@GU$+3" <AR$BYBP1H/A?*\ 8 %0*V#4ARV=," ($:'1,
M.S<,,X5"QHH AJ"(JU"'QZ3?@6J+,!$E"ZP%$.(A(?49AE'ED)%AJ+%]0F1,
MWF&8P S42HZ,YPB4$0'("JCX/MY_$7MYC=B__P!T@ @!&1J.QF2 6J &@-KX
M2P0H,L.UHH46IH;@AEJ*1: TB,#-6 >T #((:G06A1L:HCYI+E+7&7UO-#I>
MNWJ,?3WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(
M^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WX
MCYC?B/F-^(5%VQ5_?;0H!K\C#WTPHF73,T]TCYC?B/F-^(^8WXCYC?B/F-^(
M^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WX
MCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(@:RVF1\>
M(036CH\-/>N,.N=U2T%1=\3TZ>UCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B
M/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^(^8WXCYC?B/F-^
M(^8WXCYC?B/F-^(^8WXCYC?B/F-^(#8:6-^(AD.P_P L>[I9Z60BZL?L?_C,
M]UG+.GZ'_11]>^/X)_1]?Y38]:&$0*A#PH:#07Z]Z0%@'-27I8WK;^VAGB16
M9TZDE6K>\<8I6C H9 V3090.Y4@@&Y&X1GI>"2429$@K) !%,2QA@X.9^X."
M!V ;*Y.#R81*K 6?0U=4(9X<IB2D*(%'KT$J%1V0L@_U%M:4I@J(W!<,,.\V
M H\(;_ 9?=0.9JJB_P!8FB@&@QDEQ0Q$R @H2J%"F'=W)<+^L!20 6%4 M8L
MSA(;B<@PJ (("Q@)PB8.R)J62*U'3-PE0//< -" ;LZ 0"L5Z1BQT "U;GJ9
MQ%01+ %(L"FT*RB8$A!%!U%')V$$DRU  # L0-.M3U$8F,C6"#<@0(8NF<)
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MH$$Y"IVA!%P1U!']@((!!!!*!!!!.0.<( "2 -B00#T,,@"1B-%?)MOC* R
M9JG>T!U4(XL+NYA\CP6;M"0&%9F:U;5@E6O4:A"HS&L((#((&9MW@K45&8K_
M "&EZ.SHX; :$V!HW9.\19"+%2%4 V)%Z_X &0,P"1W$L&;9X=X*&*C,5'<4
M_P"&>ZSEG3]#_DH5!^K_ "!W+CZAV ,H1;#KW6G2%J"8L1E"%@P+_$H[. 4
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MO@*R/@LL0'G>&NTT((VP)\+?+SQ^!/CU4IXW3[[07E?;[Z"M'#26%AQ^=ND
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MG,]*<PF%,\=W $9MX58O[CH8@)4^S]*7]/\ (@)9O^P&R% 5<%\><A#8ZY2
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M5R:$,AF1J73X:BYB&CT"@)+KA\0U!&5"<!1-\^L'OHABQ1H56)5=%_G6=%>
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MXD!=) 0-2!4I&W"  A(XH567S!PAGA)0030D4"L 5!"8]45>JF;H56MH70#
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ME@O&OIA\R$R[AJ((+%+X0[@%*C8 ;&!8#7Q"(*<Q8',P()!HH>A@>!\@I@
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M#VD2 $XU,?,+Y#BO_  &#<Q#J#E#HC4" 06(N+P^N8*@)$$U(C2STP*N!A%
M54J\@XG(G0 (F#(L!@:&67D :DIA7,?7RH$U:ZPH!N!\5^0$29HF@B"XW4'Q
MA <TZL%(#%0:DJCC_AF/()5N&0*MTP$,8(6<I0FRB,_@"4R2.%I*6 /+$'-*
M %FA32,;0Q2*%"2RAGG_ "D$78#)H01=U^\"(BY.\BX+Q$790K0C(AJ<26&P
M*5Z0K,6< 0@S6A?U *L.NP!89]>T3OUP1)!J"PB7E!8JKLC<\3#H:8"/9CP0
M$&@ =-+X4AR*" D*XS3ZH.D 0DIO0DDW;2#@4GHHO81F2G*I!,Q))ZJ?&NL/
MU(0VK$46@  KG 5-#"B.CKKPO'T+ +4VY)2(QRJH1LYV-<,;_P"L]UG+.GZ'
M_)0OG#N_4/\ 8^H=_BOR5W>T-F</[4":,<KYH%G&F$=G"22K*CQQQ@@9)#0U
M;M]9TJH(DLDJK9H)(15A_(&!0$8Y:%@)65+0N5O,6$"O"KZV(P;'T9#&BLJU
MR<%1A(/ 7"."GU0@1I =0Q%;OI#!3C@*X+@CK+PUK)V E4R7H#:FK1$>E3@
M!L# BJ6RCT0LX5F"A,DF@BR#51\X3%U @*NK>L"9I4#+5LX2%'6XA=U#89 @
MC%1J+?,%'TM@,%446V.;A?7A0,@.I=RPE_A'  &@J;=_B$!X (-ZMB10T%$8
M%O+K;$">M:%Q+%L6D(4&%& 6D$_Z0MT-)(UED45;0Q(=$(DG/H069@'I!:,*
M80JD*B)1-+JTX9^BR*$1%%#VE,.=4C6.,0[AE#1S%#O%I!ZHUI&9!O  !#8"
M+(#N4H5(1(X06!SU'B&1V-L,2U)0P66K"Y@M/<T?! P0QG'N(@1%D*Y!DJ#
M8F\,P^=A "(2K%Q71J6R4 )2N&!KBC L#B4 $H &!:@3O%DI.D&L)"K;KE!.
M3*P* N+#Q&O(KXF$)K((AAX4%U05!((H0$$!V %E!.7 !0J@) %2E86H@(0P
M%$BZBO3"!X8HH>G@%+ !6P=86P!N"! ""Q6&F3\GR5@]T$@)N<G2D.GN,T)J
M&EDW$51 0E5- (HDA0) HQ$$M?.Z!$R,&:WTA -#Z0V FQ!72T9P(H1@:N+9
M-+"T!:IR-H :(#_I<%T9GJBP4 #3*&I"G,L0:P(%"1\*&% T.YB#)E:BL$/]
M;(C)6W -BR1BH-D5P1 "+% B*8%YCOG*(FT&3)("JSA*&CJ 0 H%QXK#DH$(
M5<#M"7FX/Q@#"T&%9UJ =UHKQ)R(H*8-&,<7!PL@GEW(*P<2:NNH/A@&0 <@
M/5>T8-BY3'^KZ,%0#G_Z\$@%6Z$5F&?02O>;;BD0!518G3"(5B@ H"@1$6*H
M<*804E@Q9IE2\%4VLPS]D6FML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQ
MXFML>)K;'B:VQXB$"Q/; +[@!4-%:XU^?5!9@?\ 7-;8\36V/$UMCQ-;8\36
MV/$UMCQ-;8\36V/$UMCQ-;8\36V/$UMCQ-;8\36V/$UMCQ-;8\36V/$UMCQ-
M;8\36V/$UMCQ-;8\36V/$UMCQ-;8\36V/$UMCQ-;8\36V/$ 2YAUH.$/V%9B
M]/@K;>'M8 <[GZM>!!(N]J#GUJ(*%2<YK;'B:VQXFML>)K;'B:VQXFML>)K;
M'B:VQXFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQXFM
ML>)K;'B:VQXFML>)K;'B:VQXFML>(4-16 L"@+IT]^(,W333H (1!"U,+P#!
M2J*A-U]PFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQX
MFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'B:VQXFML>)K;'
MB%!KAD8M/P/T<_;1%H8 ]J[VRP@HEG_4OZ?Y$ZJFZAA4JI.%4+%?/3XA (XP
M$RUL2:O-%QGU(-_L^&PJH<T$8-4TDTHA4V^01WO,BD"F!9UI"XELN24L842.
M %<8_; "K-[:@4[E,FWAI$/ *E"CH8,P;2)0@4(A(G&/$1 239)%#9F\)8-
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M:&?EO[^96T02[5":15/O2T-R&1=#7X,$P(03JZL@2?;Q>* $"!=U0#^94 +
M%5(5T#M7 Y0" D&H&&20KDCW^CD$FP0 JB*_*.FP*DBC(BWN$"Y&#$-A45(S
MEH*.9O2AI44]$/X!5*) ^  %#YTDRJTU3WO$BID  "+ *P-' $ 2 6B@^G\A
M,33VE7ZT@" 6(DW5:>J5A 4"02[FCA>53R #2;L@PI0$E5@K2"19!9'9?G>$
MH@B)) "*Z$+;/$RK (*XV] B(H2J23W@  '1FS-?L\0EHE@=#Q/=9RSI^A"P
MH_(37[/$K I6IAT/^#@!D!C0P:.?9^;0 V^D2ECL^X-C R&!$-85M&DDCVEX
M+M12Q/UTGL7U%5=IS"#&1I C3U:06)8J0;G81OJ]H@R![&H_V)$35FA/WH!-
M*Z?SMM\&$]XN0ZF\]F^O<8NZ<5Q34O3TQ WK6,^X/N$"!:%"47I@#]9S2AF?
MI'\&J$*H1"*E8&I8OX@PC_-]0DX#^"&DS;'9J(+ T*O*!EC5K^-?Y_IX\" (
MP%VZK_E!MN]8'(>[CWG^![_X<2%YI2KT<]I^XS ]<CLAIE_D2(<,(P&#VGOO
MU 'JQVVMIZ;]1U%NCLOXA<:>EC:>R?4J/@2 =+.@/]Z5AVU3F@$ -1<O6T&,
M2!-MX6P=S;,8:W[9""L-7-TLI]CI!3&W4J78!T6%*_X.Z@U5ON# >U*_NVF7
MVOZ,% 6S7Z%O^7[]^_+?X#'\CK]O?8?2G]0&@AN+K_B#9_\ ]%:-&C1HT:-&
MC1H#J6/J*6OUAP9E6W=,A2%%Y7>@?@_&7_RT:-&C1HT:-")LFED_'K^Q9 ?A
MCOK0.GP,(!@2<$L,/(8&C<ZJ IYVGE &ALN,?DK0AX  !N2&GQ>8@"MB-*\4
M^?\ [W#J/[/9ZRY[C_[MS_DW7^I[&J8/GZEW1]2X]3_?_6,$!$8,^^]5!ZQ!
MU?\ .WU.EQI\#WD*6XO/3['_ *[#T/\ );ZON"0K9^N(5475T'U!6SO3O]/X
MBT]_,6GOYB,JWC_,PG^Q\G8Q\G8P  (Q2YPI;#BL.:OGESU$3U$3U$1:>_F+
M3W\Q:>_F+3W\Q:>_F+3W\Q:>_F+3W\Q:>_F+3W\Q:>_F+3W\Q:>_F+3W\Q:>
M_F+3W\Q:>_F+3W\Q:>_F+3W\Q:>_F+3W\Q:>_F+3W\P 2NH\.N3GNLY9T_0A
M#EIXU\Q:>_F!3IT:_9_@$I!F:'OW\1U 2<IZ!J&(2[99&$E !C0Z'H@@0%KD
M(.UBPL*A8""22BP&F%H?8?5:X4[VPC3Z*B/;WJIUKJ.*[361A*"-RPSJWYCC
M#W)^T89?N)7D9%ON)XSS 6(=S_2?KYCFY/B'P$,/F]G_ #K*YH[G\V$KV$:D
M[^G' T/5Q]1G:UK]%K"3O01#OFY^D.(6WAE6NA('TX*+>QX/],)LT]SP_DH@
MQC+?QT1]S_)^R81$:VH[,.>P1[!#:@0R% ?%?>Y_2'$_6\363];Q%4"0N56<
MX]P]#>,]XNFZ_NC^#E'\'* 00IZP_1A0 )BWP+)SFLF>9&(SA.Y _)^H:0&S
M+ Z6NRZX5-CT@6;+A@@.C"ZN*0I0PBV#MC0.N"R<!G_3X]2TK*:PE<U_+U.5
M7 8%I.CPRHS.K;SE7W@_9A8(!.8-MZ_/U/2!@"P?! ^S ="'%Y[/Y>-EWALN
M\-EWALN\?M<@=N]X^MFB[<H2H5,02'W)WCFXG*HIG?WK ^'N/H&#0^2/NL;)
MW$;)W$;)W$;)W$;)W$;)W$;)W$;)W$;+W$;)W$;)W$%41+CIUZ0IQIW![W(2
M_8,J20!-3_<?D*-D[B-D[B-D[B-D[B-D[B-D[B-D[B-D[B-D[B%-@-#W8M>^
M:68K?8>F>-[6%:I$X6^<;JMW7UQ%E22!$4-$W2@K3014H"BCN?Y88'&UX2L@
M1$/WY^%$<CV,1R/8S5351^+Y('],]AY3V'E/8>4]AY35>^X3535353508!"0
M:CI[W@D)V(F+U@A)5A36O2>P\I[#RGL/*>P\I[#RGL/*>PCF:J:J:J:J:J:J
M:J:J:J:J>P\I[#RGL/*>P\I[B#_"9JIJIJIJIJIJIJH0 18 T(E3S-F2(^\'
M!!(*;7 ))]88D1^1SI!ZK!F,EFX3$ZCB.9[#RGL/*>P\I[#RGL/*>P\IJO=I
MJIJIJIJIJIJIJIJIJI[B!_2)[#RGL/*>P\I[#RFJFJFJFJFJC0"!9$T#'R<L
M^\S@1" O3Y=,=5 @"2DGX'MX!(  NE.D$)99;SV$<SV'E/8>4]AY3V$'^&:J
M:J:J:J:J:J:J:J:J-Q3V'E/8>4]AY3V'E%XMC_)JIJIJIJH_%L/[/8>4L Q-
M!48_, @S"),7[RA6TJC +/.&(32[QH%5 YYRB#J5.6A]R AP%W.)T.91 VZQ
MOUXVC_01!>ARKQ7F:VQXBBH-?D;J/KW<1]>[B-B'SO.C?Q'R$?(;\SHW\3HW
M\3HW\3HW\3HW\3HW\3HW\3HW\3HW\3HW\3HWG1OXG1OXG1OXG1OXG1OXG1OX
MG1OXG1OXG1OXG1O.C?Q.C?Q.C?Q.C?Q%JH!E]#Z88OZ(>Z^H!>0MVX@"36:F
MH-/Y.OW\2^&!>=O^"J 17*'I#JI!Y@++2UZ.L0L0*B&*)XURQ@Y5!!4TT!^M
M1/4#Q-!W32=4@._U/QO,T0[OX2)H.Z:#NF@[IH.Z?B>9^-YGXW^%^)YGXWF?
MC>9^-YGXWF?C30=T_!R(GY@YGXWF$7%U.>DTW<<33=QQ--W'$TW<<33;>)^-
MYGXWF?C>9^-YBL'P+=:LZ+YF@[IH.Z:#NF@[II.[^7^;3\;S#E.J;[6^?B:#
MNF@[H1-*&Q0_M]?CJ6$$%3<9G#^4S@<)A0EJNY1>6V/5] E?._80X(#Y'ZAH
M!&?5*'^S2#J%]]G4_,](')?M8,A\I_6.S.F2#9N^C_#UCJ@'4#Z\=!/QO,_&
M\S\;S/QO,_$\S\;S/QO,_&\S\;S/;W8SU^4]?E/7Y3U^4]?E/7Y3U^4]?E/7
MY3\;S/QO,^$!H]=4,G"UE\E-,RZ8!P<J"0L!<6Q#UWGK\IZ_*>ORGK\IZ_*>
MORGK\IZ_*>OR@(4@Z@#[GXWF?C>9^-YGXWF*-0M@/WU3U QZ@8]0,>H&#@;?
MR>ORGK\IZ_*>OR@-8*78Q[X8CYL1/QO,_&\S\;S/QO,H8R-.MJ*K3YB<K95#
MQOF]QC0KR0R[L:7R=9Z_*>ORGK\IZ_*>ORGK\H&#ZOLSS01^:F?C>9^-YGXW
MF?C>9^-YGXWF?C>9^-YA'7:\SU^4]?E/7Y3U^4T ZA?<_&\S\;S/QO,_&\S\
M;S/QO,_&\PPL!+N,;6]Y7,.0:L*AT8%/2CX"@KXDO%BM,SA[@8#Q]#]P_/ZU
MGK\IZ_*>ORGK\IZ_*>OR@-O BHWGXWF?C>9^-YGXWF?C>9^-YGXWF?C>9^-Y
MA!9L]6E;3U^4]?E/7Y3U^4\X/)\S\;S/QO,_&\PC!-K3S'"%;(J&UP^X9A*W
MI_'^*86(4JF&//2?C>8O$T K_9U/K6>ORGK\IZ_*>ORGXWF?C>9^-YGXWF?C
M>9^-YGXWF?C>9^-YA$+#T#GK\IZ_*>ORGK\H"X!U\I^-YGXWF?C>9^-YA'@/
M1ON>OR@;1?A;N$2<3/Q^:5%$(0,:L^ON^R#DJX)8N_G8EXA17,"<1ZGDD,Y4
M(E6-3!N8X6O\U%[@]'58D@=.^2-\H6$![$(V5Q5!U.5YTC2A:Y^_,]Y<3WEQ
M/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$]
MY<3WEQ/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$]Y<3WEQ/>7$&0(&Z2
M<",M<ND)8*8^0SV781S6J-QA#4GJ?^BE402!*!%2TOFD 3&;7%6YS%%@*PYO
M#,"(Q%<],_@L*'X#:C^?X09 =_V=Q%T3))&D[?\ J    S5Z MRYU6;_ (1_
MO^ ?<3*UC4%/_(   ) 0@U+CYJZ6FC[/^)>X21WL>?\ F]>O7M+Z .T:3MG2
M=LZ3MG2=LFG1V'[*^8^</^    F.3HO\GC>*&7TL9[Q/TA-1/;,YI/7669#X
M3TH2X358KG^R/]E*J%4A>-&0/Z<E *W<('6A?]FD'S^R8:[#JM>K5H"M+21"
MWR:$X8!5%C"145F)^_X( "QFE@!/4%_$<RK&"E'KD]7-7V5UO-3V\S4]O,U/
M;S-3V\S1#Y-V'VFA[8T/;&A[8T?9&C[.)H>SB:'LXFA[.)H>SB:'LXFA[.)H
M>SB:'LXFC[.)H>V-#VP_8?AO6D8+!7%)[(+0&%!L  [U.^(FA[.)H>SB:'LX
MFA[.)H>SB:'LXFA[.)H>SB:'LXF@'Q/'O2NA[8T/;&A[8T/; '@/;_"?GXRK
MI^_F:?OYFG[^9I^_F9@9!Y31=DT79-%V31=DRGU 58&N4U/;S-3V\S4]O,U/
M;S 0(*Z6>H=<_:&E(4T_9UCB@ G0:$4P/B:+LFB[)HNR:+LFB[)HNR:,Z)72
M=%H 0[F:GMYFI[>9J>WF:GMYFI[>9J>WF:GMYFI[>9K>WF:+LFB[)HNR:+LF
M2!Z!WPFI[>9J>WF:GMYFI[>9J>WF:GMYFI[>8063S 4N<7=?.8"$>W/T[0HR
M?H[LS-!+02T?9-%V31=DT79-%V31=DT79,AM0'/GX4U/;S-3V\S4]O,U/;S-
M3V\S4]O,U/;S-3V\S4]O,S0(X)EU.\T79-%V31=DT79-6.@<XW,U/;S-3V\S
M4]O,*S7\BOFLK"@QH-'F6>G, J%UI;UJ?F"\$>7,'MM-3V\S6]O,T8^$T79-
M%V31=DT9T2LU/;S-3V\S4]O,U/;S-3V\S4]O,U/;S-3V\S4]O,SEU(4WQI-%
MV31=DT79-%V3(8*X"E13#W#$:GMYFI[>9J>WF:GMYF:EZD-*7][31=D;1/D/
MN&I-,9/6/Y6%MO(4?P=2@2.9) :KIT6@D$TL RO0=L?X;H-!B!7!"GG/*?A#
MCW&$F ? ^P8XHZJK6TT';A-!VX30=N$T';A-!VX30=N$T';A-!VX30=N$T';
MA-!VX30=N$T';A-!VX30=N$T';A-!VX30=N$T';A-!VX30=N$T';A-!VX30=
MN$T';A-!VX30=N$T';A-!VX30=N$T';A-!VX30=N$.2)M@*@B,!!(E\A-":N
MUO@GI4E&!G-GY==GVA")&5.W_!0TN\4C0$HC&M,3=TSIRH0BQ1@H:)Z&4T5"
M (%54P;0TI*,!-1TQ>!:?S,D0CWKU^#P=I^/ ,<6)P^(["VG081]?,N?&)?1
MHB:PQ9KL""2;@8:PBIT0CZ[P\28,T!J*=?\ ,H<#H>.XXU(E$$('6N#^<!!8
M#*L*=;U^F$= E#4$]QI,;(DK,HI??3UU@+C_ #[$$L&G5GO^<CI&JA^+_-L#
M$"4+&-_WTC%H?M#Q>>,:M9 FBV[Z=)@GU/%_N,(P@79RR6_P07A"^ P6$53Y
MZ=A:6=5GU:_O@W71FYBJ[R*_$_*1^4C\I'Y2""O[/X$_73^NG]=/ZZ57NM:U
MTKYGM"?:$G'@ H"ZX6#1N\$&7\%>E'QAN :PM&/XX+OA&?>3]SU+K)6KG.WO
MX@.4.\8%(1:,5?7I5<7U# 9"=#I3Q?504RPJ03@%;_PX0A6$P3B[/1$E47:>
MNO2$-!"X$DXD(Z9FF0UHB>Q?0^K#^C X017(A!4 E9M.L9JE4^L\# 1FFH8#
M5UK0PO+;U',_=',_=',_=',_=', API_53^JG]5/Z*3VC+*?:$^T)]H3[0GV
MA/M"?:$^T)]KW[6?JI_523%F!9)A.15AK)\>O[/:$^T)]H3[0GVA/M"?:$^T
M)]H2 59\K?WO/U4_JI_53^JDVG??KWK^/'X\?CQ^/"K@[3[0GVA/M"?:$TZ]
MT#[5\3]T<S]T<S]T<S]T<PEI0I[[KD+3]B0- C[[PGM"?:$^T)]H3[0GVA+O
M!/[HYG[HYG[HYG[HYG[HYG[HYG[HYG[HYG[HYC^4?-BZ>N>T)]H3[0GVA(?6
MP<LCZWG[HYG[HYG[HYG[HYG[HYG[HYG[HYEV/\/K_% "R >K[T]^9^Q/[$J\
M$^T)]H3[0GVA/M"?:$TZW3B!EJ]^)^Z.9^Z.9^Z.9^Z.9^Z.9^Z.9^Z.9^Z.
M9^Z.8</8Z=7893VA/M"?:$^T)\:1R_L_=',_=',_=',_=',)@BG\>C*KKP_=
M',_=',R^Z.9[0GVA/M"?:$@Q_FB9_=',_=',_=',_=',_=',_=',_=',_=',
M_=',RZ-;@Z9*5Q=5/:$^T)]H3[0G.[@!_K^3]T<S]T<S]T<S]T<PKI=T([IV
M4]H22A$@-Q20Q!9".B_L3-.M=4EZAW540H"3B*Y0EX8$%]E@QA6MIA 9I<*N
M2K_H1D ES131313131313131313131313131313131313131313131313131
M313131313131311'2K.R^X>Q617P9IO $*DOT A)))-S_P E$I=E"UYH<<4Q
M &!,$#.[[ZZ4EQ9T5KIJE89;0&% T#>N&9-,6'T@D2)))Q/Q<Y1AAC\'RN\I
M& (JHD8@6^H+@!<5!#6]%A6O2L" Y1FZ#!JN] HP!@<#4AJL<*=ZU&15H!Z>
MKBXB#>AMBU3.N&PN+Q!'G3TQQB#Y_KIUA@  ( OX'M\8Z2N@).1QZ>H]08"Y
M+!?^,/6WSC[!B9>Y@#6E:Y?QE00)$..I3K\]/[$[L$RVA]&KZRI(.#Q7Q_GF
M#8 319LU0JF)PT@,<6*8%2CYTS(X0&X LEI-]Z#6$D+H%:X_*60[.&W(%E""
M,,Z6$ '-1 &.!K?ZB\80O&$+QA"\804$J^ /X3/8,]@SV#/8,91FE8A^,0_&
M%(/1'#W9URAB9"O4,JLV/S*<!,<@#O0:;,S*J]UA,W4U.,-,@O<&]ZYCTUB]
M!*U1)Z@>C&N*D04C0JI;P^QB,8,AY(AGK8G[I;0$BH7).HK$5P#I 8MHEBET
M5\,^I$)1 D"R;$FNFOQJ!E0 5(@$C$4H [4)>*( #644#I2_]I8HF$2V'$T7
M_G>TH;_VU1KZ5*>V)Q1^:.4Q#^_24R;13)M%,FT4R;13)M%,FT4R;13)M%#@
M/:#2@%U*V<?[>8_V\Q_MYC_;S'^WF/\ ;S'^WF/]O,Z][MCG*9-HIDVBF3:*
M9-HIR46M">EL3'^WF/\ ;S'^WF/]O,?[>8_V\Q_MYC_;S'^WF!5>D;K<=/GO
M3)M%,FT4R;13)M!(%>;'(FG,3+V,3+V,3+V,3+V,;\P_L?[>8_V\Q_MYC_;S
M 1B'OR)3)M%,FT4R;13)M#_;S'^WF/\ ;S'^WF/]O,?[>8_V\Q_MYC_;S/9^
M93$ 8IDVBF3:*9-HIDVBF3:*9-HIDVBF3:"E8?="_D?[>8_V\Q_MYC_;S'GW
MO/'64R;13)M%,FT4R;13)M%,FT4R;13)M%,FT4N/DINSG'^WF/\ ;S'^WF/]
MO,?[>8_V\Q_MYC_;S'^WF4Q'N_L?<IDVBF3:*9-HIDVBF3:*9-HIDVBF3:*9
M-H/[%?<?[>8_V\Q_MYC_ &\RF(CW4#WE,FT4R;13)M%,FT4R;13)M%,FT4R;
M13)L-V_D]GYC_;S'^WF/]O,?[>93)M%,FT4R;13)M%,FT4R;13)M%,FT4R;1
M16/W5Z(_V\Q_MYC_ &\Q_MY@Z5GWU66/Q64R;13)M%,FT4R;05A\E/LQ_MY@
M3#5C7#'&/RCS'Y1YB;A(E4B7T;R<'EJ *S%$/%BAO>XA 29T1#+_ +1(9Y?Y
M[[XECW'_ /#9[K.6=/T/^2FJLW/9MWXGT8[Z+Z<,"H,"X-CW%;Y^*0 @4!IG
M]IB(!YK*% 7@T8Z=("%94*0 KC:$NM&G@>1I$B PF"X@H4AD<%<8U@HM52;*
M:OH2M@!:4,W@28Q%E7$#Q'JQ2M$XDW&C,#2"1(&00$/ ;TTQC3SL)*(34)'/
M^0>[-XP"X@F'2B2;!C)B&"&";D@LX(1*05&!6SH.1I$D$6E9!%0$.Q9SL'"-
M%&1M @@JHO"E97Q4H* ;U:&#0M9#,3$C0TOGC!PR2!M8 Z! U"*+:O&E:32E
MV@CN,8TQ=Z#Y)&=NT>5@  @AJ-&AT,40K[*3% EG05:5XX&/4@,BF*V53&N
M)9@B34%M#*!?W",:_9:?(L<7]C &VF":0R[Z1W844T[BH>M^Q+Z$BI@#H7-*
M5ES5Y:U (9*Y *HA-D@ #V@<$X<!0.1 8'0C^040OY6AK0'4>-(AK5S0QV W
MA5@X*@!*%H/#G^JO<T51B#,P+9G9>E6TKDPQ(&YAH'S6D"*H-Y2%Z[0\APJ
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M<!B0D#.-SA\PFO. #!Z,C\-_V"^3#* J0$4(65X5*N1!TKE0$$*9-S!BHVP
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M5]U?:)D 8@ 2B9B1C\? A+)(L:CY_P"[3U^A_A,:A0+2QNQEG H"$ &MW/\
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M4!(>0!!%&"26 V8"N9%$TD  .)+>=860D*FFHL"+%4J*FT63*+L4&8<TC6T
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M"SEB "@58V&C*EE#.8A !-DZ+VT]UG+.GZ'_ "4-"5ROURA8B[CZ4!(!1$"
M&23E%\JF-BXROR""AB+%-DE=WR:!F50AIAB!CJOF'2)=  8DS+*K#=6B[X@&
M  , DS#$/XD[7CV+/1K0H5)C&BS@3N*@S@\5<%=W@CEEL3HR MOD H) @ %A
M2^;IIC4P)*5"6(LORT5:PPA4:*M\J_K0N&A.L0CZ;L\I4"^XDH;"H[_-H=B
MJ@A=KIGL[0HP 5!!N=E3^:LC! %2OR*D_/$*)Y &QV;,_.D(DY@ZN0%".GSD
M6XF;'"%Z9Z_-1&K @ S7U(][0$", LJ2S]V@!'"*M%_,O^0J+1B&>R=$?B!5
M.%N3 EZ!>@'8.\!!IL'@JZ@6N/A,%,@ZN6RIN#U5:0>!&%1 ;/%1DW\$.61
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M10(0(#0@.@+U@Z.$4()U2!]&F5+!,#/?2SL,'TI,WMGT91Q/@UPPICQ*OQ_
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MJ"G@QXMTTP$<BG\  L+4*5[0/'(J(8K$BW?O$(I6(J\*JCZ06X1D!)),ADT
M-8!^0V Q)#4)=*ABM(8LEMKH +1!8 _D%(* #J0D3"PW!1J*1&*AW$32$N!"
M@ 1@2"B,G>%R%520B +#<=(?8=LZ",LT+I\P)$_SQS_*[7A5>EWM^WO"C/;
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M% 40*JD  *[5^8\, LLP2JS)PO7>P!;UTUK4-QF;C!P$SB90) ZMB\#WB@X
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MJ@0$9 *R,$!6,+3F 5-6KXP#79$U"%-N"!.I 7^(!Q:$6%7*V$%.R-2!9+H
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M\7/Q< K=O_SYYYX:(XE@EZLL3Z1&EJJ*C?2GN$')(C:G70?W_?//:OJ>U?4
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MC<T_G: X *S&5-/[BH0B1D5_T4J[+_,>LR,WCX^O_H@+ #_TW'J?[_EYZ?\
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MNPLXQ>JM@,) *$*B.MLQ"#)U:Z4,[(-C SA"X ZS/*$"91T&(P4AQBHS&O2
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M*N_3??[!V8*AY/ *! 5"J0<*F"1'HY%:"  ZJNMH5.74S S!0(6HTS F6XL
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M]@3V!/8$]@3V!/8$]@0P.ER'F/H'^LN5N^.O/6NDH("^5_'YBY[ GL">P)[
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MB K5C4LHSEE'4X86  E@TZJNM(?I3X $21E(BK-74E&D6T_AB6$4Q:"UA*I
M4DH-$H*N&5<H_/BE#)D!@"<[M.!C">FTW%D(:BF<#$PI@*$H:DD%'I C*D"Z
MB"0$@L(+[3BE-\$=$*8P$BO!5)#*6T701:9A 0!-G ,0]8]>G F"H^,)0W4
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MFO\ 76:_UUFO]=9K_76:_P!=9K_76:_UUFO]=9K_ %UFO]=9K_76:_UUFO\
M76:_UUFO]=9K_76:_P!=9K_76.U15B*UWKGAUJ8!;"C8MH>?AP;0CFU.HS72
MG5<W9"YX:_UUFO\ 76:_UUFO]=9K_76:_P!=9K_76:_UUFO]=9K_ %UFO]=9
MK_76:_UUFO\ 76:_UUFO]=9K_76:_P!=9K_76:_UUFO]=9K_ %UFO]=9K_76
M:_UUFO\ 76/QGUK"(*U<T<HZ46!BV*Q JM<])4/0QT"QUJS3 Y) MT8'S4YY
M<B79%T#>IWFO]=9K_76:_P!=9K_76:_UUFO]=9K_ %UFO]=9K_76:_UUFO\
M76:_UUFO]=9K_76:_P!=9K_76:_UUFO]=9K_ %UFO]=9K_76:_UUFO\ 76:_
MUUFO]=9K_76%@AS0T?F$]R@="*[L^_%=F7>MM+ZV^RH[!+(WF3]\J%C'H?3O
M>_B%H7<W^.\9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,
M]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<
MSW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,
M 14H,XMFX&AA@9DTOLJ[QC3$]Z&&I)S)_P"BE6Y%1)LAUPE0B%T-M<-84'25
M:H-/EU^RJ*H320R*]H#DE:!<:5?RI[/.#OZW*@[]#_)EO=_-;+3(P#L!Z:1D
MO;44]A\PTZ1\7\O3.:&6AD T#C XX#W7Y'[A.4$>\U_9I.SF:3LYFE[(T,B&
MP1\Z^A/246&*F#[-[6F05P0_%#<X5.LM$[.3]4=6I:=@/L\Y32=G,*RPMDKV
M,T,M#()!?>0-9^8BR BM^),TG9S-)V<P#"#C ^Q/8?,KC%5>R^WS/8?,]A\Q
MU4[!]C^":3LYC5!>L#-)ZZPY)$'J^&::Y_,-2CJ Y^IF"/=JAS0RT,M#+0RT
M,M#+0RT,M#+0RT,M#+0RT,M#+0RT,M#+0RT,M#+0RT,M#+0RT,M#+0RT,M#+
M0RT,AD0A%=]G'5Y019@7?IQ[Y_<2HF!4KD!CE[6?B.9^(YGXCF?B.9^(YGXC
MF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9
M^(YGXCF?B.9^(YGXCF?B.9^(Y@>%Q(S=P#Y[1.#E-;/C^XP8D EK +%XUK[G
M^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGX
MCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF'!K )J1=[GXWA(
MC^2:>T/]AU=8:<]?Y'[/W'[OW/Q',_$<S\1S/Q',_$<S\1S/Q',_$<S\1S/Q
M',_$<S\1S/Q',_$<S\1S/Q',_$<S\1S/Q',_$<S\1S/Q',_$<S\1S/Q',_$<
MS\1S"<HB_6!<+B+1I5_=,B>AA7-8>D4I4WI3+.' 6L>_+7MC#FK5 08/?.?B
M.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(Y
MGXCF?B.9^(YGXCF?B.9^(YGXCF?B.9^(YGYCF 4H(+'6._7B#J&N;KX;TH<L
MW%CLU&J^?429B&BWW;IFT91%#M3^7^5-0>NLU!ZZS4'KK-0>NLU!ZZS4'KK-
M0>NLU!ZZS4'KK-0>NLU!ZZS4'KK-0>NLU!ZZS4'KK-0>NLU!ZZS4'KK-0>NL
MU!ZZS4'KK-0>NLU!ZZS4'KK-0>NLU!ZZS4'KK-0>NLU!ZZS4'KK-0>NLU!ZZ
MS4'KK-0>NLU!ZZS4'KK*:/CRQKC!N;-2^MUIC $ '<_]E*H$@@!DV#3T@*'H
MD4QU.9'$I*T!ULDFS?;I#4B($ 'N ]K_ +Q1C>S9\?Y0%AOT\&?D^8O@NOKG
MY/F?D^8#@&YI#\R!OC+,0_)A^3 @)_H/T_@G[";(GU?V/Q, ]-@.M71>(2!'
MMGF 18W.9>T5O2_GS/:Y1-G9TQIA@O\ VD]<QZY@%M<7C\GS 4YUV]JW:^'#
M2HK6],0_>L[WG]/NZ8&&F"!D2H<#Y23]B"X5:%TK@>C"U9^2.9^2.8%!D.-(
M_.\PX OA_<_$1^(_U9X;/R(L]:GX\SV#S/8/,]@\SV#S/8\SV#S/8/,]@\SV
M#S ._8)_@=I^$9_",_A&?PC)#]X'HWG[?F"\WJ?IC?K,Y6*3_P &>N3N" >H
M'_#CCGKG[)'<&;[8TK_;Y] (38?R.1KT>0$M23FQ32A>/F7_ .@R>?.5XZB'
MBQ3?+?6?ACB>YPA/<W;B!A&!T>?N$/!97#N-:S]F?LS]F?LS]F?LS]F?LS]F
M?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F)6!:NBE),)
M$TBQF1[S]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F
M?LS]F?LS]F?LS]F?LS]F$Q!M6K'1<A.4<*.]9^]YG[WF$A)NZS]F?LS]F?LS
M]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LS]F?LP (-<:
MPD)!P</$8($@;H(0 MW(3TA^C/V9^S/V9^S/V9^S/V9^S/V9^S/V9^S/V9^S
M/V9^S/V9^S/V9^S/V9^S/V9^S/V8@S\_;7E/*K1_.!R:I_8&8F($\&B%,JP6
M#"+6M6?B'E#)3376$[D"02;>,1-/[\33^_$T_OQ-/[\33^_$T_OQ-/[\33^_
M$T_OQ-/[\33^_$T_OQ-/[\33^_$T_OQ-/[\33^_$T_OQ-/[\33^_$T_OQ-/[
M\33^_$T_OQ-/[\33^_$T_OQ-/[\33^_$T_OQ-/[\33^_$T_OQ-/[\33^_$T_
MOQ"> H+5&MA[W"1:2G7T=(TEI?' _P#92JR(5P&J],L,#9Q+8H8^.H(U)6-[
M4)ZY#&$ =BRG6?I"?I"?I"?I"(*)2ES.CW/$% A^>9^D)^D(@HM*7,Z/<\3H
M]SQ.CW/$63W,T_8<S3]AS-/V',T_8<Q-4"Z#^$F='N>)T>YXG1[GB='N>)T.
MYG1[GB='N>(ZKM?V?I"*JK7\G0[F4W$?)CJNU_9^AXG[4_2$_2$08!\GB='N
M>(L8[GB+\_,7Y^8OS\Q?GYARCN.9T>YXG1[GB='N>)T>YXG0[F='N>)T>YXG
M1[GB='N>( >$?/)'N,T7<1HNXC1=Q&B[B",9-_J>IXG1[GB='N>)T>YXGHX_
MU',?ZCF/]1S/5^9D6VN/]M_)T>YXF0'OUOA4>BSR,\;^_%1JB0$$46#4E+(8
M@T[G 1LSMS&S.W,?,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[
M<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLS
MMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S
M.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;
M,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<Q
MLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS
M&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W
M,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[
M<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLS
MMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S.W,;,[<QLSMS&S
M.W,;,[<P$Q4W&6<L"37^+!^Z0P-":XT>WSEU@D0:)F@.9_NAPOF::R%W4&>/
MN3IE5'?'YR=*:6TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8T
MS&F8TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8TS&F8,&0=0O#WOI/=9RSI
M^A_R4(!L8B*J2P*9''Q#(X (A@!?%TIVM*AOBVA1Q[=Q5P>$@3 !4)8O58(T
MQ@!36B%O_>H<]?\ J>N_4R#8T/\ P&9@.H_Z!'B0@FA1&UB$-\R6W-3T ,](
M=JG$V]WTM>#6!=1'],HA*>K_  QM0(&P("!J&/\ %!#?XO\  0#!6K:YI 2/
MX^SI/7_N&0'L.A/Y 5*MA(47?./FHG\E=^5TWI!)K5LQ'V(36'\D I !";(>
M[(_V+%%4?INFGUP'M)O"W0YZP?W6 ]UTZ6E2(35)ECWNV/S*!.<  'H6+"ZH
M3C,(A9I9J OAX+4"J<G Y.J 0&MT:DW;5J_'&%AVN/\ Y3#*A*Q">[93U_[G
MJ_W/1?O_  0 NMU_O1VU>'_,R9,F,LR59?=KW6 P:NOV!#:)>A?X?<9[5]SV
MK[C33)N=_P"OK_'-95<I$\."+9I^B8$VM$'LWK !WF-ODB$>)FA]?$!L'J,
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M2;1O1BCE@),(=3 J61&<$V8DD0C<19UJUT<"FU'?I 0EBH!7[E;BEARJ"(:
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M"*%KUH$B:5=<X-#&H;&S8.6GW  $Y 5 O:70#YI#,'&; -2L*@8;02.VT$H
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M-BZCH,ZV A( 1HL&3BQ_G6\&%W8#X#6UEKT@K.YI'$?[3A . H(ZY@_SZ2!
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MQ!IT^@$LIBF^OJYSBJU,*5>N::@75?EJ"(3XJ8)-+L5O08R%R@!"&?E_( !
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M!5,,72Q1T- "HNKIG!I#E!([JL0++-"T$BUA]:!J$!4!A0N,K\P/& &)B+$
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M=6WG_P!E< :$KY=_FVE,)G<#_0]Y37?M0K*&0W.OO\42L.EW?V]?_6: G*5
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M<1<SMQ%S.W$+4"5S4B+].O?JH16P!RZ=8*VF-V'S>5&@A ;"GN\! R( R#2
MK7*%IH@R@*B<@6M;GXA"$ )*-6&:!K*GF$(_04X-A8*LA5 %-!*"-(030H)$
M =>L%@N90R0"J-6^YU+2A4% @T17 T"/P8*%TD@ T- 5<CII!"A!4+#J62%_
MM(:0!, T&BH:UVS$Q^@4TJW 'GYA,Q-TF%Z?=?N % *C 0J2:49-,,!=PP(+
MEF;U:I9V.D  8A,H*E<*(F#1@QU!(T'K,N$JZ)Y).&7Q"$'T5[1U7OQ!D8#=
M57JCB:^L]TW1(W&?PH("!$(O/P+ZLP*@+FI18KYZB- J&"%""KA$$VHNHB1B
MMUPEJ@168@!2$F#@0Q)I[:%)#":%7BG\_6,=)Z4B]WIYN0 6Y@^MW$)ZYX/P
M^XY7)99:* '!'0L(K6XI@1\PWEM6OHB?K<0[@BJBL+/VG7_18=!_K/=9RSI^
MA_R4U="A0+%M6%A3VAUEN9!=:P< H!4L$5<;4QRJX-M+%VT77"6QOM4 3>M;
MG,BC,/D!ZUQKU$(<'$B3E-+TO<#Y5%W=B @F$Z,5XFEQ:%&AH!"S2& &C#X-
M(NF8H0G (! L#<&$=$PM)PH"6F:9 F%[TY R0@ 6J\W5AH\#$>Q JZL!DU8N
M(&BO.;0G=3/:MR=NL7"01Q2!##<#0P4QHD-E&+ZWA4X2 @6C:!8S%>CBRI:+
M?&PH*U.6+1,&X&3PH Z!X5=955'I"UR!08.CI6,XB@J@5"66 3CHS6-PF@$!
M 6")E$W8QQ:1<42@24>"S-7"'Q("8*L(E)M*70@V 0SHB"\#[F#"[%DJ B23
M> L?FY-=0@ C@NL*A&SO$XM6B47-0 +VJCE$XB$65Z2K0&]2($M6 )"<W1%#
M!-]8ND"PT" $&K5-<:4*"3U.A(QO1\A2(6(B4"<V(RCBM.H^ 4&H@14&):^%
M<($A"=,D< PL 4Z_RZJ(X@)IA1&3')PAO>J!!5"0"]%<8Z&4HPT $DN%C4H@
MQFUD$(]*"X2.1L/_ ,<IP.CC;'DEB&#0"BS=P4H],#<BI-J6(Q>9$ K =B!!
MOU ]=H+?(,/B_P U[_\ N%QU']GL]9<]S_\ <'-B@!Z"O\Z5^82UB/PCX_L!
M4_1/ _\ <;QPPUUS]P@HQHW:"M;^ $M_'\$M'7G_ -H L8#<%]Y>ZG^R_H_D
M0^C7_P"B&7_2&0_\C/=9RSI^A_R4;3J[<^K.O'Q_7%3:%='*E9+?/3,?6)AW
M*LG8%V?A7A@F;R&8".U=36 1=4!A59UH+"P2$"SQ(0&2"C%,CUZPZHO086%0
MV!IJ(EA497'%+3WZY"CFXDI+5FCB<7R(I7"J45#8O1AA#9&J57!-!8 STADP
MG38A*-!U ZMP:T238? H0+U2KN/&(V"2"$P EG:AAV A !7PV-! "5E#7,&
M0Q"]X:1TA=Y68*K=BZP(QN(,%8KL$N @VG4(89800&P#$?)P,%*&W\"%B^M
M@8<L-!?D$C0",3W )#[F3 $="H10(+6-)7T(C0 *-38.96E1M5" 222F\EC"
ML?!(R (5.ZE.T-5+@%2]"5.-*X90]6,%GMH#U#KE%4)P2TB0T:O<+N22/K1\
MD1D >@1]X W J0B;($.E+0 J8!2@$(;@@4^Y7>U F25.U;#,*\+85  !8 0B
M'+!PLH%:< BH))*D#<75BH95Z4D $@ %,IN<X6L/$P2:L$K/"ZO6 DYQ8($%
M#G\QI<0)B,)X&0.- (ZD57_+(L5&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,
M9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<
MQG,]S&<SW,9S/<QG,]S&<SW,9S/<QG,]S&<SW,9S/<_Y[WE,*^]>N'B U!-(
M1<X%K"8T5XJ";*XNHKG ]60# +#VXVCL8&1]/Y^V1W?!E?2?W_W7#J/[/9ZR
MY[C_ .X)UP^"JY0K,6I2Z/U!((K$/EG_ -Q%:BNH@+ H#[[?&*]]O&\M_'\$
MM'7Z/_L]/F;#^#+_ %/]E_3_ "(?1K_^,SW6<LZ?H?\ 11J3NTM;T^F$ QCX
M=*U]TQ,,$!39,5_VKK0:DP"JC6W>@BEM.A-7*%(Q84PQ1C.E<"%"E 1(BA":
M6I1M7-N KG'Q$@P00+4S1K45@F+@%54/(OO R2 A!  DB#F<,>T+P@! ) A5
M!J7[E!(TU] L@%8FI_D'$BH&*!,0'1:Q@*:!6@K(@E&]81($F#0&HG6T5=$8
M&U22A+#Q[P8*4(A%"03& 5A1UJR"Y$208 0!*'<PN8%$BR6.8:IA%R+R"<WB
M35XKXPC!2KD J 4:H2ODPP0) JD!9 U$:< H*P,%+DBC%^D>@D8:690)6?98
MT) 45M(PC%L>I%,+1*)!@46&6>(!RZ.A9:P),%!  ,!5=?UAA$65$: 4&_J$
M*E+#;+#MTQ+-8)29 :%6@" L5@AD$8R<S 0B&)IC@I0* *+8!$6PJ5 ,Q2G+
MP!).:D!'=T4-!$$'9* $"]@@3J+'>EL8+*BDA4@V+S.M3:"UYU@@)!8!)J_4
M(#DP$@P"Q* 9_&8X$0TJPU6.(JJ.UE .(D-#H@  )@G2FABSGWXBSGWXBSGW
MXBSGWXB.Q)^/$] ,>@&/0#'H!@H&)I[G9=X11;,!$*\(1+Q8>^X3T QZ 8]
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M?^8HHHHHHHHHHHHHHHHHHHHK]+]2$&EB^EEA-=KQ8(90X5>"-MJUQ2L8/(Z
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MITMS_##J:[ _^!@P8,&#!@7Z0[0_Y,&#!@6Z0[ _^1@P8,&#!@P8%ISCW/\
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6V9$F16GOB"9T)KX $!(!!!(((_S_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
